Citrus Sinensis ID: 042435
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
ID ![]() | Alignment graph ![]() | Length ![]() |
Definition ![]() |
RBH(Q2H) ![]() |
RBH(H2Q) ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 412 | 2.2.26 [Sep-21-2011] | |||||||
| Q8VZG8 | 1045 | Probable LRR receptor-lik | yes | no | 0.851 | 0.335 | 0.418 | 5e-77 | |
| Q9LP24 | 1120 | Probable leucine-rich rep | no | no | 0.849 | 0.312 | 0.391 | 2e-66 | |
| Q9SHI2 | 1101 | Leucine-rich repeat recep | no | no | 0.851 | 0.318 | 0.333 | 2e-47 | |
| Q9LVP0 | 1102 | Probable leucine-rich rep | no | no | 0.866 | 0.323 | 0.330 | 1e-45 | |
| Q9FIZ3 | 1252 | LRR receptor-like serine/ | no | no | 0.907 | 0.298 | 0.298 | 3e-44 | |
| C0LGQ5 | 1249 | LRR receptor-like serine/ | no | no | 0.881 | 0.290 | 0.296 | 8e-43 | |
| Q9M0G7 | 1013 | Leucine-rich repeat recep | no | no | 0.927 | 0.377 | 0.319 | 1e-42 | |
| O49318 | 1124 | Probable leucine-rich rep | no | no | 0.601 | 0.220 | 0.365 | 1e-42 | |
| C0LGF4 | 591 | LRR receptor-like serine/ | no | no | 0.864 | 0.602 | 0.323 | 4e-41 | |
| P47735 | 999 | Receptor-like protein kin | no | no | 0.859 | 0.354 | 0.332 | 2e-40 |
| >sp|Q8VZG8|Y4885_ARATH Probable LRR receptor-like serine/threonine-protein kinase At4g08850 OS=Arabidopsis thaliana GN=At4g08850 PE=1 SV=3 | Back alignment and function desciption |
|---|
Score = 288 bits (737), Expect = 5e-77, Method: Compositional matrix adjust.
Identities = 165/394 (41%), Positives = 233/394 (59%), Gaps = 43/394 (10%)
Query: 31 DMSFNNLDGEIP--TYLRDNPPKSFVGNKGLCGHV---QGFLSCFQRHRLAPSFILSVKI 85
D+S NNL G IP R+ PP +F GNK LCG V QG C ++ I
Sbjct: 652 DVSHNNLQGPIPDNAAFRNAPPDAFEGNKDLCGSVNTTQGLKPCSITSSKKSHKDRNLII 711
Query: 86 FLPLTPILAFTIF-----GFILLLKGKSENLKLVTRAAKNGDVFSVWNYDGKILYENLID 140
++ L PI+ I G + + +++ ++ T + G+ S++++DGK+ Y+ +I
Sbjct: 712 YI-LVPIIGAIIILSVCAGIFICFRKRTKQIEEHTDSESGGETLSIFSFDGKVRYQEIIK 770
Query: 141 ATEYFHIRYCIGTGGYDSVYKAELPDGKVVALKKLHHSETEDSAFVVYSPQ--------- 191
AT F +Y IGTGG+ VYKA+LP+ ++A+KKL+ ET DS+ S +
Sbjct: 771 ATGEFDPKYLIGTGGHGKVYKAKLPNA-IMAVKKLN--ETTDSSISNPSTKQEFLNEIRA 827
Query: 192 ---------------C-----MFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVA 231
C F +YEYMERGSL VL +DDEA +L+W +R+N+VK VA
Sbjct: 828 LTEIRHRNVVKLFGFCSHRRNTFLVYEYMERGSLRKVLENDDEAKKLDWGKRINVVKGVA 887
Query: 232 HALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTYGYI 291
HALSY+HHD +P+IVHRDISS NILL + EA ++DFGT +LL DSSN + AGTYGY+
Sbjct: 888 HALSYMHHDRSPAIVHRDISSGNILLGEDYEAKISDFGTAKLLKPDSSNWSAVAGTYGYV 947
Query: 292 ALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPP 351
A EL Y M VTEKC +YSFGV+ LEV+ G HPG+L+ +LSSS + + + P
Sbjct: 948 APELAYAMKVTEKCDVYSFGVLTLEVIKGEHPGDLVSTLSSSPPDATLSLKSISDHRLPE 1007
Query: 352 INQKIIQDIILVSTIALACLRSKPKSRPTMQRIS 385
+I ++++ + +AL CL S P++RPTM IS
Sbjct: 1008 PTPEIKEEVLEILKVALLCLHSDPQARPTMLSIS 1041
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9LP24|Y1571_ARATH Probable leucine-rich repeat receptor-like protein kinase At1g35710 OS=Arabidopsis thaliana GN=At1g35710 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 253 bits (645), Expect = 2e-66, Method: Compositional matrix adjust.
Identities = 153/391 (39%), Positives = 224/391 (57%), Gaps = 41/391 (10%)
Query: 31 DMSFNNLDGEIPTY--LRDNPPKSFVGNKGLCGHV--QGFLSCFQRHRLAPSFILSVKIF 86
D+S N L+G +P R + N GLC ++ Q C + + + L V I
Sbjct: 731 DISNNKLEGPLPDTPTFRKATADALEENIGLCSNIPKQRLKPCRELKKPKKNGNLVVWIL 790
Query: 87 LPLTPILAF-----TIFGFILLLKGKSENLKLVTRAAKNGDVFSVWNYDGKILYENLIDA 141
+P+ +L F + + K K +N + + G+ S+++ DGK Y+++I++
Sbjct: 791 VPILGVLVILSICANTFTYCIR-KRKLQNGR--NTDPETGENMSIFSVDGKFKYQDIIES 847
Query: 142 TEYFHIRYCIGTGGYDSVYKAELPDGKVVALKKLHHSETEDSAFVVYSPQCM-------- 193
T F + IGTGGY VY+A L D ++A+K+LH + E+ + V + +
Sbjct: 848 TNEFDPTHLIGTGGYSKVYRANLQD-TIIAVKRLHDTIDEEISKPVVKQEFLNEVKALTE 906
Query: 194 -------------------FFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHAL 234
F IYEYME+GSL +L +D+EA L WT+R+N+VK VAHAL
Sbjct: 907 IRHRNVVKLFGFCSHRRHTFLIYEYMEKGSLNKLLANDEEAKRLTWTKRINVVKGVAHAL 966
Query: 235 SYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTYGYIALE 294
SY+HHD IVHRDISS NILL+++ A ++DFGT +LL DSSN + AGTYGY+A E
Sbjct: 967 SYMHHDRITPIVHRDISSGNILLDNDYTAKISDFGTAKLLKTDSSNWSAVAGTYGYVAPE 1026
Query: 295 LVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQ 354
YTM VTEKC +YSFGV+ LE+++G HPG+L+ SLSSS G + L I +R+ P Q
Sbjct: 1027 FAYTMKVTEKCDVYSFGVLILELIIGKHPGDLVSSLSSSPGEALSLRSISDERVLEPRGQ 1086
Query: 355 KIIQDIILVSTIALACLRSKPKSRPTMQRIS 385
+ ++ + +AL CL++ P+SRPTM IS
Sbjct: 1087 N-REKLLKMVEMALLCLQANPESRPTMLSIS 1116
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SHI2|Y1723_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase At1g17230 OS=Arabidopsis thaliana GN=At1g17230 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 189 bits (481), Expect = 2e-47, Method: Compositional matrix adjust.
Identities = 136/408 (33%), Positives = 196/408 (48%), Gaps = 57/408 (13%)
Query: 26 SFLKSDMSFNNLDGEIP--TYLRDNPPKSFVGNKGLCG----HVQ-----------GFLS 68
S L ++S NNL G +P + +F GN GLC H Q ++
Sbjct: 669 SLLICNISNNNLVGTVPDTAVFQRMDSSNFAGNHGLCNSQRSHCQPLVPHSDSKLNWLIN 728
Query: 69 CFQRHRLAPSFILSVKIFLPLTPILAFTIFGFILLLKGKSENLKLVTRAAKNGDVFSVWN 128
QR + IL++ + + + T G +K + + K DV +
Sbjct: 729 GSQRQK-----ILTITCIV-IGSVFLITFLGLCWTIKRREPAFVALEDQTK-PDVMDSYY 781
Query: 129 YDGK-ILYENLIDATEYFHIRYCIGTGGYDSVYKAELPDGKVVALKKLH---HSETEDSA 184
+ K Y+ L+DAT F +G G +VYKAE+ G+V+A+KKL+ + D++
Sbjct: 782 FPKKGFTYQGLVDATRNFSEDVVLGRGACGTVYKAEMSGGEVIAVKKLNSRGEGASSDNS 841
Query: 185 F--------------------VVYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRM 224
F Y +YEYM +GSL L+ ++ L+W R
Sbjct: 842 FRAEISTLGKIRHRNIVKLYGFCYHQNSNLLLYEYMSKGSLGEQLQRGEKNCLLDWNARY 901
Query: 225 NIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVD-SSNRTL 283
I A L YLHHDC P IVHRDI SNNILL+ +A V DFG +L+D+ S + +
Sbjct: 902 RIALGAAEGLCYLHHDCRPQIVHRDIKSNNILLDERFQAHVGDFGLAKLIDLSYSKSMSA 961
Query: 284 QAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHP-------GELLLSLSSSSGP 336
AG+YGYIA E YTM VTEKC IYSFGVV LE++ G P G+L+ + S
Sbjct: 962 VAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKPPVQPLEQGGDLVNWVRRSIRN 1021
Query: 337 KIMLIDILYQRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRI 384
I I++ RL +++ + ++ LV IAL C + P SRPTM+ +
Sbjct: 1022 MIPTIEMFDARLDTN-DKRTVHEMSLVLKIALFCTSNSPASRPTMREV 1068
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LVP0|Y5639_ARATH Probable leucine-rich repeat receptor-like protein kinase At5g63930 OS=Arabidopsis thaliana GN=At5g63930 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 184 bits (466), Expect = 1e-45, Method: Compositional matrix adjust.
Identities = 138/418 (33%), Positives = 207/418 (49%), Gaps = 61/418 (14%)
Query: 20 EEPSS----PSFLKSDMSFNNLDGEIPTYLRDNPPKSFVGNKGLCGHVQGFLSCFQRHRL 75
E PSS S L + S+N+L G IP LR+ SF+GN+GLCG C Q
Sbjct: 665 EIPSSFANLSSLLGYNFSYNSLTGPIP-LLRNISMSSFIGNEGLCGPP--LNQCIQTQPF 721
Query: 76 APSFILSVKIFLPLTPILAFT---IFGFILLLKG-----KSENLKLVTRAAKNG------ 121
APS + + I+A T I G L+L ++ V +A++G
Sbjct: 722 APSQSTGKPGGMRSSKIIAITAAVIGGVSLMLIALIVYLMRRPVRTVASSAQDGQPSEMS 781
Query: 122 -DVFSVWNYDGKILYENLIDATEYFHIRYCIGTGGYDSVYKAELPDGKVVALKKL---HH 177
D++ + +++L+ AT+ F + +G G +VYKA LP G +A+KKL H
Sbjct: 782 LDIY--FPPKEGFTFQDLVAATDNFDESFVVGRGACGTVYKAVLPAGYTLAVKKLASNHE 839
Query: 178 SETEDSAFVVYSPQCM-----------------------FFIYEYMERGSLFCVLRDDDE 214
++ + + + +YEYM +GSL +L D
Sbjct: 840 GGNNNNVDNSFRAEILTLGNIRHRNIVKLHGFCNHQGSNLLLYEYMPKGSLGEILHD--P 897
Query: 215 AIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLL 274
+ L+W++R I A L+YLHHDC P I HRDI SNNILL+ EA V DFG +++
Sbjct: 898 SCNLDWSKRFKIALGAAQGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVI 957
Query: 275 DV-DSSNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHP-------GEL 326
D+ S + + AG+YGYIA E YTM VTEK IYS+GVV LE+L G P G++
Sbjct: 958 DMPHSKSMSAIAGSYGYIAPEYAYTMKVTEKSDIYSYGVVLLELLTGKAPVQPIDQGGDV 1017
Query: 327 LLSLSSSSGPKIMLIDILYQRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRI 384
+ + S + +L RL+ +++I+ ++ V IAL C P +RP+M+++
Sbjct: 1018 VNWVRSYIRRDALSSGVLDARLTLE-DERIVSHMLTVLKIALLCTSVSPVARPSMRQV 1074
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FIZ3|GSO2_ARATH LRR receptor-like serine/threonine-protein kinase GSO2 OS=Arabidopsis thaliana GN=GSO2 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 179 bits (454), Expect = 3e-44, Method: Compositional matrix adjust.
Identities = 132/442 (29%), Positives = 208/442 (47%), Gaps = 68/442 (15%)
Query: 9 SISAACSGVVEEEPSSPSFLKS----DMSFNNLDGEIPTYLRDNPPKSFVGNKGLCG--- 61
S+ + + +V E P +KS ++S+NNL+G++ +FVGN GLCG
Sbjct: 797 SLDLSHNQLVGEVPGQIGDMKSLGYLNLSYNNLEGKLKKQFSRWQADAFVGNAGLCGSPL 856
Query: 62 -HVQGFLSCFQRHRLAPSFILSVKIFLPLTPILAFTIFGFILLLKGKSENLKLVTRAAK- 119
H S QR L+P ++ + L I A + IL K + K V
Sbjct: 857 SHCNRAGSKNQRS-LSPKTVVIISAISSLAAI-ALMVLVIILFFKQNHDLFKKVRGGNSA 914
Query: 120 --------NGDVFSVWNYDGKILYENLIDATEYFHIRYCIGTGGYDSVYKAELPDGKVVA 171
+FS I ++++++AT Y + + IG+GG VYKAEL +G+ +A
Sbjct: 915 FSSNSSSSQAPLFSNGGAKSDIKWDDIMEATHYLNEEFMIGSGGSGKVYKAELKNGETIA 974
Query: 172 LKKL-----------HHSETEDSAFVVY-------------SPQCMFFIYEYMERGSLFC 207
+KK+ + E + + + + IYEYM GS++
Sbjct: 975 VKKILWKDDLMSNKSFNREVKTLGTIRHRHLVKLMGYCSSKADGLNLLIYEYMANGSVWD 1034
Query: 208 VLRDDDEAIE---LNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAF 264
L ++ + L W R+ I +A + YLH+DC P IVHRDI S+N+LL+SN+EA
Sbjct: 1035 WLHANENTKKKEVLGWETRLKIALGLAQGVEYLHYDCVPPIVHRDIKSSNVLLDSNIEAH 1094
Query: 265 VADFGTVRLL----DVDSSNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMG 320
+ DFG ++L D ++ + T+ AG+YGYIA E Y++ TEK +YS G+V +E++ G
Sbjct: 1095 LGDFGLAKILTGNYDTNTESNTMFAGSYGYIAPEYAYSLKATEKSDVYSMGIVLMEIVTG 1154
Query: 321 THPGELL--------------LSLSSSSGPKIMLIDILYQRLSPPINQKIIQDIILVSTI 366
P E + L S + LID + L P + Q V I
Sbjct: 1155 KMPTEAMFDEETDMVRWVETVLDTPPGSEAREKLIDSELKSLLPCEEEAAYQ----VLEI 1210
Query: 367 ALACLRSKPKSRPTMQRISQEL 388
AL C +S P+ RP+ ++ S+ L
Sbjct: 1211 ALQCTKSYPQERPSSRQASEYL 1232
|
Together with GSO1, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Involved in the nuclear division phase of megagametogenesis. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGQ5|GSO1_ARATH LRR receptor-like serine/threonine-protein kinase GSO1 OS=Arabidopsis thaliana GN=GSO1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 174 bits (442), Expect = 8e-43, Method: Compositional matrix adjust.
Identities = 129/435 (29%), Positives = 200/435 (45%), Gaps = 72/435 (16%)
Query: 20 EEPSSPSFLKS----DMSFNNLDGEIPTYLRDNPPKSFVGNKGLCGHVQGFLSCFQRHRL 75
E P S +KS ++SFNNL G++ P SF+GN GLCG C +
Sbjct: 807 EVPGSVGDMKSLGYLNVSFNNLGGKLKKQFSRWPADSFLGNTGLCGSP--LSRCNRVRSN 864
Query: 76 APSFILSVKIFLPLTPILAFTIFGFILLL-----KGKSENLKLVTRA------------A 118
LS + + ++ I A T G ++L+ K + + K V A
Sbjct: 865 NKQQGLSARSVVIISAISALTAIGLMILVIALFFKQRHDFFKKVGHGSTAYTSSSSSSQA 924
Query: 119 KNGDVFSVWNYDGKILYENLIDATEYFHIRYCIGTGGYDSVYKAELPDGKVVALKKL--- 175
+ +F I +E++++AT + IG+GG VYKAEL +G+ VA+KK+
Sbjct: 925 THKPLFRNGASKSDIRWEDIMEATHNLSEEFMIGSGGSGKVYKAELENGETVAVKKILWK 984
Query: 176 --------------------HHSETEDSAFVVYSPQCM-FFIYEYMERGSLFCVLRDDDE 214
H + + + + IYEYM+ GS++ L +D
Sbjct: 985 DDLMSNKSFSREVKTLGRIRHRHLVKLMGYCSSKSEGLNLLIYEYMKNGSIWDWLHEDKP 1044
Query: 215 AIE-----LNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFG 269
+E L+W R+ I +A + YLHHDC P IVHRDI S+N+LL+SN+EA + DFG
Sbjct: 1045 VLEKKKKLLDWEARLRIAVGLAQGVEYLHHDCVPPIVHRDIKSSNVLLDSNMEAHLGDFG 1104
Query: 270 TVRLL----DVDSSNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGE 325
++L D ++ + T A +YGYIA E Y++ TEK +YS G+V +E++ G P +
Sbjct: 1105 LAKVLTENCDTNTDSNTWFACSYGYIAPEYAYSLKATEKSDVYSMGIVLMEIVTGKMPTD 1164
Query: 326 LLLS------------LSSSSGPKIMLIDILYQRLSPPINQKIIQDIILVSTIALACLRS 373
+ L + + LID + L P Q V IAL C ++
Sbjct: 1165 SVFGAEMDMVRWVETHLEVAGSARDKLIDPKLKPLLPFEEDAACQ----VLEIALQCTKT 1220
Query: 374 KPKSRPTMQRISQEL 388
P+ RP+ ++ L
Sbjct: 1221 SPQERPSSRQACDSL 1235
|
Together with GSO2, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9M0G7|PXL2_ARATH Leucine-rich repeat receptor-like protein kinase PXL2 OS=Arabidopsis thaliana GN=PXL2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 174 bits (441), Expect = 1e-42, Method: Compositional matrix adjust.
Identities = 142/445 (31%), Positives = 211/445 (47%), Gaps = 63/445 (14%)
Query: 5 LAFLSISA-ACSGVVEEE-PSSPSFLKSDMSFNNLDGEIPT--YLRDNPPKSFVGNKGLC 60
LA L +S + +GV+ E +SP+ ++S+N L G +P +L+ P GN GLC
Sbjct: 550 LAVLDLSNNSLTGVLPESIGTSPALELLNVSYNKLTGPVPINGFLKTINPDDLRGNSGLC 609
Query: 61 GHVQGFLSCFQRHRLAPSFILSVKI----FLPLTPILAFTIFGFI--LLLKGKSENLKLV 114
G V S FQR + S + +I + + +LA I + L K N
Sbjct: 610 GGVLPPCSKFQRATSSHSSLHGKRIVAGWLIGIASVLALGILTIVTRTLYKKWYSNGFCG 669
Query: 115 TRAAKNGDVFSVWNYDGKILYENLIDATEYFHI---RYCIGTGGYDSVYKAELP-DGKVV 170
A G+ W + + A++ IG G VYKAE+ V+
Sbjct: 670 DETASKGE----WPWRLMAFHRLGFTASDILACIKESNMIGMGATGIVYKAEMSRSSTVL 725
Query: 171 ALKKLHHS--ETEDSA---FV--------------------VYSPQCMFFIYEYMERGSL 205
A+KKL S + ED FV +Y+ + M +YE+M G+L
Sbjct: 726 AVKKLWRSAADIEDGTTGDFVGEVNLLGKLRHRNIVRLLGFLYNDKNMMIVYEFMLNGNL 785
Query: 206 FCVLRDDDEAIEL--NWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEA 263
+ + A L +W R NI VAH L+YLHHDC P ++HRDI SNNILL++NL+A
Sbjct: 786 GDAIHGKNAAGRLLVDWVSRYNIALGVAHGLAYLHHDCHPPVIHRDIKSNNILLDANLDA 845
Query: 264 FVADFGTVRLLDVDSSNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHP 323
+ADFG R++ ++ AG+YGYIA E YT+ V EK IYS+GVV LE+L G P
Sbjct: 846 RIADFGLARMMARKKETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSYGVVLLELLTGRRP 905
Query: 324 GELLLSLSSSSGPKIMLIDILYQRLSPPI-----------NQKIIQ-DIILVSTIALACL 371
L G + +++ + +++ I N + +Q +++LV IAL C
Sbjct: 906 ------LEPEFGESVDIVEWVRRKIRDNISLEEALDPNVGNCRYVQEEMLLVLQIALLCT 959
Query: 372 RSKPKSRPTMQRISQELEGKTPMKK 396
PK RP+M+ + L P +K
Sbjct: 960 TKLPKDRPSMRDVISMLGEAKPRRK 984
|
Involved in the regulation of procambium maintenance and polarity during vascular-tissue development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O49318|Y2317_ARATH Probable leucine-rich repeat receptor-like protein kinase At2g33170 OS=Arabidopsis thaliana GN=At2g33170 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 174 bits (440), Expect = 1e-42, Method: Compositional matrix adjust.
Identities = 105/287 (36%), Positives = 150/287 (52%), Gaps = 39/287 (13%)
Query: 136 ENLIDATEYFHIRYCIGTGGYDSVYKAELPDGKVVALKKL-------------------- 175
+++++AT+ FH Y +G G +VYKA +P GK +A+KKL
Sbjct: 810 KDILEATKGFHDSYIVGRGACGTVYKAVMPSGKTIAVKKLESNREGNNNNSNNTDNSFRA 869
Query: 176 ---------HHSETEDSAFVVY-SPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMN 225
H + +F + +YEYM RGSL +L ++ ++W R
Sbjct: 870 EILTLGKIRHRNIVRLYSFCYHQGSNSNLLLYEYMSRGSLGELLHGG-KSHSMDWPTRFA 928
Query: 226 IVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVD-SSNRTLQ 284
I A L+YLHHDC P I+HRDI SNNIL++ N EA V DFG +++D+ S + +
Sbjct: 929 IALGAAEGLAYLHHDCKPRIIHRDIKSNNILIDENFEAHVGDFGLAKVIDMPLSKSVSAV 988
Query: 285 AGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHP-------GELLLSLSSSSGPK 337
AG+YGYIA E YTM VTEKC IYSFGVV LE+L G P G+L +
Sbjct: 989 AGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELLTGKAPVQPLEQGGDLATWTRNHIRDH 1048
Query: 338 IMLIDILYQRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRI 384
+ +IL L+ + I+ +I V+ IA+ C +S P RPTM+ +
Sbjct: 1049 SLTSEILDPYLTKVEDDVILNHMITVTKIAVLCTKSSPSDRPTMREV 1095
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGF4|FEI1_ARATH LRR receptor-like serine/threonine-protein kinase FEI 1 OS=Arabidopsis thaliana GN=FEI1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 169 bits (428), Expect = 4e-41, Method: Compositional matrix adjust.
Identities = 130/402 (32%), Positives = 201/402 (50%), Gaps = 46/402 (11%)
Query: 31 DMSFNNLDGEIPT--YLRDNPPKSFVGNKGLCG-HVQGFL------------SCFQRHRL 75
++S N L G+IP+ L SF+GN LCG HV S + +
Sbjct: 176 NVSNNFLVGQIPSDGVLSGFSKNSFIGNLNLCGKHVDVVCQDDSGNPSSHSQSGQNQKKN 235
Query: 76 APSFILSVKIFLPLTPILAFTIFGFILLLKGKSENLKLVTRAAKNGDVFSVWNYDGKILY 135
+ ++S + ++A F L K K +++ + A G S+ + G + Y
Sbjct: 236 SGKLLISASATVGALLLVALMCFWGCFLYK-KLGKVEIKSLAKDVGGGASIVMFHGDLPY 294
Query: 136 --ENLIDATEYFHIRYCIGTGGYDSVYKAELPDGKVVALKK-LHHSETEDSAF------- 185
+++I E + + IG GG+ +VYK + DGKV ALK+ L +E D F
Sbjct: 295 SSKDIIKKLEMLNEEHIIGCGGFGTVYKLAMDDGKVFALKRILKLNEGFDRFFERELEIL 354
Query: 186 -------------VVYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAH 232
SP +Y+Y+ GSL L + E +L+W R+NI+ A
Sbjct: 355 GSIKHRYLVNLRGYCNSPTSKLLLYDYLPGGSLDEALHERGE--QLDWDSRVNIIIGAAK 412
Query: 233 ALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSN-RTLQAGTYGYI 291
LSYLHHDC+P I+HRDI S+NILL+ NLEA V+DFG +LL+ + S+ T+ AGT+GY+
Sbjct: 413 GLSYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYL 472
Query: 292 ALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLL---SLSSSSGPKIMLIDILYQRL 348
A E + + TEK +YSFGV+ LEVL G P + L+ K ++ + + +
Sbjct: 473 APEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNVVGWLKFLISEKRPRDI 532
Query: 349 SPPINQKI-IQDIILVSTIALACLRSKPKSRPTMQRISQELE 389
P + + ++ + + +IA C+ P+ RPTM R+ Q LE
Sbjct: 533 VDPNCEGMQMESLDALLSIATQCVSPSPEERPTMHRVVQLLE 574
|
Involved in the signaling pathway that regulates cell wall function, including cellulose biosynthesis, likely via an 1-aminocyclopropane-1-carboxylic acid (ACC)-mediated signal (a precursor of ethylene). Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P47735|RLK5_ARATH Receptor-like protein kinase 5 OS=Arabidopsis thaliana GN=RLK5 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 167 bits (422), Expect = 2e-40, Method: Compositional matrix adjust.
Identities = 135/406 (33%), Positives = 189/406 (46%), Gaps = 52/406 (12%)
Query: 31 DMSFNNLDGEIPT-YLRDNPPKSFVGNKGLCGHVQGFLSCFQRHRLAPSFILSVKIFLPL 89
++S+N+L G+IP Y F+GN GLC + G R + + + IFL
Sbjct: 576 NLSYNHLSGKIPPLYANKIYAHDFIGNPGLCVDLDGLCRKITRSKNIGYVWILLTIFLLA 635
Query: 90 TPILAFTIFGFILLLKGKSENLKLVTRAAKNGDVFSVWNYDGKILYENLIDATEYFHIRY 149
+ I FI + K LK T AA S W K+ + + + +
Sbjct: 636 GLVFVVGIVMFIAKCR-KLRALKSSTLAA------SKWRSFHKLHFSEH-EIADCLDEKN 687
Query: 150 CIGTGGYDSVYKAELPDGKVVALKKLHHS--------------------ETEDSAFVVY- 188
IG G VYK EL G+VVA+KKL+ S E E + +
Sbjct: 688 VIGFGSSGKVYKVELRGGEVVAVKKLNKSVKGGDDEYSSDSLNRDVFAAEVETLGTIRHK 747
Query: 189 ----------SPQCMFFIYEYMERGSLFCVLRDDDEA-IELNWTRRMNIVKSVAHALSYL 237
S C +YEYM GSL VL D + + L W R+ I A LSYL
Sbjct: 748 SIVRLWCCCSSGDCKLLVYEYMPNGSLADVLHGDRKGGVVLGWPERLRIALDAAEGLSYL 807
Query: 238 HHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQ-----AGTYGYIA 292
HHDC P IVHRD+ S+NILL+S+ A VADFG ++ + S ++T + AG+ GYIA
Sbjct: 808 HHDCVPPIVHRDVKSSNILLDSDYGAKVADFGIAKVGQM-SGSKTPEAMSGIAGSCGYIA 866
Query: 293 LELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDI--LYQRLSP 350
E VYT+ V EK IYSFGVV LE++ G P + L + +D L + P
Sbjct: 867 PEYVYTLRVNEKSDIYSFGVVLLELVTGKQPTDSELGDKDMAKWVCTALDKCGLEPVIDP 926
Query: 351 PINQKIIQDIILVSTIALACLRSKPKSRPTMQRIS---QELEGKTP 393
++ K ++I V I L C P +RP+M+++ QE+ G P
Sbjct: 927 KLDLKFKEEISKVIHIGLLCTSPLPLNRPSMRKVVIMLQEVSGAVP 972
|
Receptor with a dual specificity kinase activity acting on both serine/threonine- and tyrosine-containing substrates that controls floral organ abscission. May interact with the 'INFLORESCENCE DEFICIENT IN ABSCISSION' (IDA) ligands family. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST 
Original result of BLAST against Nonredundant Database
GI ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 412 | ||||||
| 296085303 | 789 | unnamed protein product [Vitis vinifera] | 0.912 | 0.476 | 0.509 | 1e-109 | |
| 359484066 | 843 | PREDICTED: probable LRR receptor-like se | 0.912 | 0.446 | 0.509 | 1e-109 | |
| 359484063 | 1003 | PREDICTED: probable LRR receptor-like se | 0.932 | 0.382 | 0.496 | 1e-109 | |
| 296085307 | 874 | unnamed protein product [Vitis vinifera] | 0.907 | 0.427 | 0.507 | 1e-108 | |
| 359484068 | 868 | PREDICTED: probable leucine-rich repeat | 0.907 | 0.430 | 0.507 | 1e-108 | |
| 359488983 | 758 | PREDICTED: probable LRR receptor-like se | 0.910 | 0.494 | 0.477 | 1e-107 | |
| 359488981 | 757 | PREDICTED: probable LRR receptor-like se | 0.910 | 0.495 | 0.473 | 1e-107 | |
| 225452698 | 727 | PREDICTED: probable LRR receptor-like se | 0.878 | 0.497 | 0.501 | 1e-105 | |
| 225465647 | 820 | PREDICTED: probable LRR receptor-like se | 0.856 | 0.430 | 0.495 | 1e-105 | |
| 225452751 | 878 | PREDICTED: probable leucine-rich repeat | 0.941 | 0.441 | 0.467 | 1e-104 |
| >gi|296085303|emb|CBI29035.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 401 bits (1031), Expect = e-109, Method: Compositional matrix adjust.
Identities = 207/406 (50%), Positives = 269/406 (66%), Gaps = 30/406 (7%)
Query: 31 DMSFNNLDGEIPTYLRDN-PPKSFVGNKGLCGHVQGFLSCFQRHRLAPSFILSVKIFLPL 89
D+S N+L+G IP L+ SF NKGLCG ++G C + ++ ++S L
Sbjct: 389 DLSHNDLEGHIPFELQSKFSQGSFDNNKGLCGDIKGLPHCKEEYKTTRIIVIS----LST 444
Query: 90 TPILAFTIFGFILLLKGKSENLKLVTRAAKNGDVFSVWNYDGKILYENLIDATEYFHIRY 149
T L F + GF LLL K+ ++ KNGD+FSVWNYDGKI YE++I ATE F I+Y
Sbjct: 445 TLFLFFVVLGF-LLLSRKTRKIQTKEIPTKNGDIFSVWNYDGKIAYEDIIKATEDFDIKY 503
Query: 150 CIGTGGYDSVYKAELPDGKVVALKKLHHSETEDSAFV----------------------- 186
CIGTGGY SVYKA+LP G VVALKKLH E +++ ++
Sbjct: 504 CIGTGGYGSVYKAQLPTGNVVALKKLHGWERDEAIYLKSFQNEVQILSKIRHRNIVKLQG 563
Query: 187 -VYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSI 245
+CMF IY YM RGSL+CVL ++ EA+EL+W +R+N+VKS+ HA+ Y+HHDCTP I
Sbjct: 564 YCLHKRCMFLIYNYMGRGSLYCVLSNEVEALELDWIKRVNVVKSIVHAVCYMHHDCTPPI 623
Query: 246 VHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTYGYIALELVYTMVVTEKC 305
+HRDISSNNILL+S L+AF++DFGT RLL DSSN+TL AGTYGYIA EL YTMVVTEKC
Sbjct: 624 IHRDISSNNILLDSKLDAFLSDFGTARLLHPDSSNQTLLAGTYGYIAPELAYTMVVTEKC 683
Query: 306 VIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKIIQDIILVST 365
+YSFGVVALE +MG HPGEL LSSSS IML +IL RL P +Q++ +D++LV
Sbjct: 684 DVYSFGVVALETMMGKHPGELFTLLSSSSTQNIMLTNILDSRLPSPQDQQVARDVVLVVW 743
Query: 366 IALACLRSKPKSRPTMQRISQELEGKTPMKKGLKEISIPEMRNQEM 411
+AL C+ S P+SRPTMQ I +L ++P IS+ ++ E+
Sbjct: 744 LALKCIHSNPRSRPTMQHILSKLLTQSPFLGPFNWISLCQLTALEI 789
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359484066|ref|XP_002271307.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g08850-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 401 bits (1030), Expect = e-109, Method: Compositional matrix adjust.
Identities = 207/406 (50%), Positives = 270/406 (66%), Gaps = 30/406 (7%)
Query: 31 DMSFNNLDGEIPTYLRDNPPK-SFVGNKGLCGHVQGFLSCFQRHRLAPSFILSVKIFLPL 89
D+S N+L+G IP L+ + SF NKGLCG ++G C + ++ ++S L
Sbjct: 443 DLSHNDLEGHIPFELQSKFSQGSFDNNKGLCGDIKGLPHCKEEYKTTRIIVIS----LST 498
Query: 90 TPILAFTIFGFILLLKGKSENLKLVTRAAKNGDVFSVWNYDGKILYENLIDATEYFHIRY 149
T L F + GF LLL K+ ++ KNGD+FSVWNYDGKI YE++I ATE F I+Y
Sbjct: 499 TLFLFFVVLGF-LLLSRKTRKIQTKEIPTKNGDIFSVWNYDGKIAYEDIIKATEDFDIKY 557
Query: 150 CIGTGGYDSVYKAELPDGKVVALKKLHHSETEDSAFV----------------------- 186
CIGTGGY SVYKA+LP G VVALKKLH E +++ ++
Sbjct: 558 CIGTGGYGSVYKAQLPTGNVVALKKLHGWERDEAIYLKSFQNEVQILSKIRHRNIVKLQG 617
Query: 187 -VYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSI 245
+CMF IY YM RGSL+CVL ++ EA+EL+W +R+N+VKS+ HA+ Y+HHDCTP I
Sbjct: 618 YCLHKRCMFLIYNYMGRGSLYCVLSNEVEALELDWIKRVNVVKSIVHAVCYMHHDCTPPI 677
Query: 246 VHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTYGYIALELVYTMVVTEKC 305
+HRDISSNNILL+S L+AF++DFGT RLL DSSN+TL AGTYGYIA EL YTMVVTEKC
Sbjct: 678 IHRDISSNNILLDSKLDAFLSDFGTARLLHPDSSNQTLLAGTYGYIAPELAYTMVVTEKC 737
Query: 306 VIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKIIQDIILVST 365
+YSFGVVALE +MG HPGEL LSSSS IML +IL RL P +Q++ +D++LV
Sbjct: 738 DVYSFGVVALETMMGKHPGELFTLLSSSSTQNIMLTNILDSRLPSPQDQQVARDVVLVVW 797
Query: 366 IALACLRSKPKSRPTMQRISQELEGKTPMKKGLKEISIPEMRNQEM 411
+AL C+ S P+SRPTMQ I +L ++P IS+ ++ E+
Sbjct: 798 LALKCIHSNPRSRPTMQHILSKLLTQSPFLGPFNWISLCQLTALEI 843
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359484063|ref|XP_002270651.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g08850-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 400 bits (1028), Expect = e-109, Method: Compositional matrix adjust.
Identities = 209/421 (49%), Positives = 280/421 (66%), Gaps = 37/421 (8%)
Query: 22 PSSPSF--LKSDMSFNNLDGEIPTYLR-DNPPKSFVGNKGLCGHVQGFLSCFQRHR--LA 76
P+ P + L D+S+N+L+G IP L+ ++ P+ F NKGLCG ++G+ C + H+ L
Sbjct: 589 PTLPKYGWLSIDLSYNDLEGHIPIELQLEHSPEVFSYNKGLCGEIKGWPHCKRGHKTMLI 648
Query: 77 PSFILSVKIFLPLTPILAFTIFGFILLLKGKSENLKL--VTRAAKNGDVFSVWNYDGKIL 134
+ +S +FL F +FGF+LL + +N + + KNGD+FS+WNYDGKI
Sbjct: 649 TTIAISTILFL------LFAVFGFLLLSRKMRQNQTKTPLKKNEKNGDIFSIWNYDGKIA 702
Query: 135 YENLIDATEYFHIRYCIGTGGYDSVYKAELPDGKVVALKKLHHSETEDSAFV-------- 186
YE++I+ATE F I+YCIGTGGY +VYKA+LP G VVALKKLH E +++ +
Sbjct: 703 YEDIIEATEDFDIKYCIGTGGYGTVYKAQLPTGNVVALKKLHGWERDEATYFKSFQNEVQ 762
Query: 187 ----------------VYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSV 230
+CMF IY+YMERGSLF VL ++ EA+EL+W +R+N+VKS+
Sbjct: 763 VLSKIQHRNIIKLHGYCLHKRCMFLIYKYMERGSLFGVLSNEVEALELDWIKRVNVVKSI 822
Query: 231 AHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTYGY 290
HAL Y+HHD T I+HRDISS+NILL+S L+AF++DFGT RLL DSSN+T+ AGTYGY
Sbjct: 823 VHALCYMHHDYTLPIIHRDISSSNILLDSKLDAFLSDFGTARLLHHDSSNQTVLAGTYGY 882
Query: 291 IALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSP 350
IA EL YTMVVTEKC +YSFGVVALE +MG HP EL LSSSS IML DIL RL
Sbjct: 883 IAPELAYTMVVTEKCDVYSFGVVALETMMGKHPRELFTLLSSSSAQSIMLTDILDSRLPS 942
Query: 351 PINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELEGKTPMKKGLKEISIPEMRNQE 410
P +Q++ +D++LV +AL C+ S P+SRPTMQ IS L + P + IS+ + QE
Sbjct: 943 PQDQQVARDVVLVVWLALKCIHSNPRSRPTMQLISSRLLTQLPFLETFHGISLWLLNTQE 1002
Query: 411 M 411
+
Sbjct: 1003 I 1003
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|296085307|emb|CBI29039.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 398 bits (1023), Expect = e-108, Method: Compositional matrix adjust.
Identities = 206/406 (50%), Positives = 269/406 (66%), Gaps = 32/406 (7%)
Query: 31 DMSFNNLDGEIPTYLR-DNPPKSFVGNKGLCGHVQGFLSCFQRHRLAPSFILSVKIFLPL 89
D S N+ +G IP L+ PP+ F NKGLCG +G C + H+ LS +FL
Sbjct: 476 DFSHNDFEGHIPHELQFVYPPRVFGHNKGLCGEREGLPHCKRGHKTILIISLSTILFL-- 533
Query: 90 TPILAFTIFGFILLLKGKSENLKLVTRAAKNGDVFSVWNYDGKILYENLIDATEYFHIRY 149
+F G ILLL K+ + + KNGD+FSVWNYDGKI YE++I+ATE F I+Y
Sbjct: 534 ----SFVALG-ILLLSRKTRRNQTKATSTKNGDIFSVWNYDGKIAYEDIIEATEDFDIKY 588
Query: 150 CIGTGGYDSVYKAELPDGKVVALKKLHHSETEDSAFV----------------------- 186
CIGTGGY SVYKA+LP G VVALKKLH E +++ ++
Sbjct: 589 CIGTGGYGSVYKAQLPTGNVVALKKLHGWERDEATYLKSFQNEVQVLSKIQHRNIIKLHG 648
Query: 187 -VYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSI 245
+CMF IY+YMERGSL+CVL ++ EA+EL+W +R+N++KS+ HAL Y+HHD TP I
Sbjct: 649 YCLHKRCMFLIYKYMERGSLYCVLSNEVEALELDWIKRVNVIKSIVHALCYMHHDSTPPI 708
Query: 246 VHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTYGYIALELVYTMVVTEKC 305
+HRD+SSNNILL+ L+AF++DFGT RLL DSSN+TL AGTYGYIA EL YTM VTEKC
Sbjct: 709 IHRDVSSNNILLDFKLDAFLSDFGTARLLHPDSSNQTLLAGTYGYIAPELAYTMAVTEKC 768
Query: 306 VIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKIIQDIILVST 365
+YSFGVVALE +MG HP EL LSSSS IML DIL RL P ++++ +D++LV
Sbjct: 769 DVYSFGVVALETMMGRHPRELFTLLSSSSAQNIMLTDILDSRLPSPQDRQVARDVVLVVW 828
Query: 366 IALACLRSKPKSRPTMQRISQELEGKTPMKKGLKEISIPEMRNQEM 411
+AL C+ S P+SRPTMQ IS +L ++P + IS+ ++ QE+
Sbjct: 829 LALKCIHSNPRSRPTMQHISSKLLIQSPFLEPFHGISLWQLNIQEI 874
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359484068|ref|XP_002271708.2| PREDICTED: probable leucine-rich repeat receptor-like protein kinase At1g35710-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 398 bits (1023), Expect = e-108, Method: Compositional matrix adjust.
Identities = 206/406 (50%), Positives = 269/406 (66%), Gaps = 32/406 (7%)
Query: 31 DMSFNNLDGEIPTYLR-DNPPKSFVGNKGLCGHVQGFLSCFQRHRLAPSFILSVKIFLPL 89
D S N+ +G IP L+ PP+ F NKGLCG +G C + H+ LS +FL
Sbjct: 470 DFSHNDFEGHIPHELQFVYPPRVFGHNKGLCGEREGLPHCKRGHKTILIISLSTILFL-- 527
Query: 90 TPILAFTIFGFILLLKGKSENLKLVTRAAKNGDVFSVWNYDGKILYENLIDATEYFHIRY 149
+F G ILLL K+ + + KNGD+FSVWNYDGKI YE++I+ATE F I+Y
Sbjct: 528 ----SFVALG-ILLLSRKTRRNQTKATSTKNGDIFSVWNYDGKIAYEDIIEATEDFDIKY 582
Query: 150 CIGTGGYDSVYKAELPDGKVVALKKLHHSETEDSAFV----------------------- 186
CIGTGGY SVYKA+LP G VVALKKLH E +++ ++
Sbjct: 583 CIGTGGYGSVYKAQLPTGNVVALKKLHGWERDEATYLKSFQNEVQVLSKIQHRNIIKLHG 642
Query: 187 -VYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSI 245
+CMF IY+YMERGSL+CVL ++ EA+EL+W +R+N++KS+ HAL Y+HHD TP I
Sbjct: 643 YCLHKRCMFLIYKYMERGSLYCVLSNEVEALELDWIKRVNVIKSIVHALCYMHHDSTPPI 702
Query: 246 VHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTYGYIALELVYTMVVTEKC 305
+HRD+SSNNILL+ L+AF++DFGT RLL DSSN+TL AGTYGYIA EL YTM VTEKC
Sbjct: 703 IHRDVSSNNILLDFKLDAFLSDFGTARLLHPDSSNQTLLAGTYGYIAPELAYTMAVTEKC 762
Query: 306 VIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKIIQDIILVST 365
+YSFGVVALE +MG HP EL LSSSS IML DIL RL P ++++ +D++LV
Sbjct: 763 DVYSFGVVALETMMGRHPRELFTLLSSSSAQNIMLTDILDSRLPSPQDRQVARDVVLVVW 822
Query: 366 IALACLRSKPKSRPTMQRISQELEGKTPMKKGLKEISIPEMRNQEM 411
+AL C+ S P+SRPTMQ IS +L ++P + IS+ ++ QE+
Sbjct: 823 LALKCIHSNPRSRPTMQHISSKLLIQSPFLEPFHGISLWQLNIQEI 868
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359488983|ref|XP_002277433.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g08850-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 394 bits (1013), Expect = e-107, Method: Compositional matrix adjust.
Identities = 202/423 (47%), Positives = 271/423 (64%), Gaps = 48/423 (11%)
Query: 31 DMSFNNLDGEIPTYLRDN--------------------PPKSFVGNKGLCGHVQGFLSCF 70
++S NNL G IP + N P ++F NKGLCG ++G C
Sbjct: 338 NLSHNNLSGTIPYSISSNYNKWTLIDLSNNRLEGQTRAPVEAFGHNKGLCGEIKGRPRCK 397
Query: 71 QRHRLAPSFILSVKIFLPLTPILAFTIFGFILLLKGKSENLKLVTRAAKNGDVFSVWNYD 130
+RH++ L + + L T +L+ I GF+ + +N L T KNGD+FS+W+YD
Sbjct: 398 KRHQIT----LIIVVSLSTTLLLSIAILGFLFHKRRIRKNQLLETTKVKNGDLFSIWDYD 453
Query: 131 GKILYENLIDATEYFHIRYCIGTGGYDSVYKAELPDGKVVALKKLHHSETEDSAFV---- 186
G I Y+++I ATE F I+YCIGTGGY SVY+A+LP GKVVALKKLH E D ++
Sbjct: 454 GVIAYQDIIQATEDFDIKYCIGTGGYGSVYRAQLPSGKVVALKKLHGWERGDPTYLKSFE 513
Query: 187 --------------------VYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNI 226
+CMF +Y+YME+GSL+C+LRD+ EA+EL+W +R+N+
Sbjct: 514 NEVQMLTRIRHRNIVKLHGFCLHKRCMFLVYKYMEKGSLYCMLRDEVEAVELDWIKRVNV 573
Query: 227 VKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAG 286
VKS+A+ALSY+HHDC I+HRDISSNNILL+S LEAFV+DFGT RLLD DSSNRTL G
Sbjct: 574 VKSIANALSYMHHDCDLPIIHRDISSNNILLDSKLEAFVSDFGTARLLDNDSSNRTLLVG 633
Query: 287 TYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQ 346
TYGYIA EL YTMVVTEKC IYSFG+VALE +MG HPGE + SLSSSS L D+L
Sbjct: 634 TYGYIAPELAYTMVVTEKCDIYSFGMVALETMMGMHPGEFVTSLSSSSTQNTTLKDVLDS 693
Query: 347 RLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELEGKTPMKKGLKEISIPEM 406
RLS P + ++ +I L+ ++AL CL S P+ RP+MQ +S +L + + IS+ ++
Sbjct: 694 RLSSPKSTQVANNIALIVSLALKCLHSNPQFRPSMQEVSSKLVSTRSFPQPISTISLLQL 753
Query: 407 RNQ 409
+++
Sbjct: 754 KDE 756
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359488981|ref|XP_002275364.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g08850-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 394 bits (1011), Expect = e-107, Method: Compositional matrix adjust.
Identities = 200/422 (47%), Positives = 272/422 (64%), Gaps = 47/422 (11%)
Query: 31 DMSFNNLDGEIPTYLRDN-------------------PPKSFVGNKGLCGHVQGFLSCFQ 71
++S NNL G IP + N P ++F NKGLCG ++G+ C +
Sbjct: 338 NLSHNNLSGTIPYSISSNYRWTLIDLSNNRLEGQARAPVEAFGHNKGLCGEIKGWARCKK 397
Query: 72 RHRLAPSFILSVKIFLPLTPILAFTIFGFILLLKGKSENLKLVTRAAKNGDVFSVWNYDG 131
RH++ L + + L T +L+ I GF+ + +N L T KNGD+FS+W++DG
Sbjct: 398 RHQIT----LIIVVSLSTTLLLSVAILGFLFHKRRIRKNQLLETTKVKNGDLFSIWDFDG 453
Query: 132 KILYENLIDATEYFHIRYCIGTGGYDSVYKAELPDGKVVALKKLHHSETEDSAFV----- 186
I Y+++I ATE F I+YCIGTGGY SVY+A+LP GKVVALKKLH E ED ++
Sbjct: 454 VIAYQDIIQATEDFDIKYCIGTGGYGSVYRAQLPSGKVVALKKLHGWEREDPTYLKSFEN 513
Query: 187 -------------------VYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIV 227
+CMF +Y+YME+GSL+C+LRD+ EA+EL+W +R+N+V
Sbjct: 514 EVQMLTRIRHRNIVKLHGFCLHKRCMFLVYKYMEKGSLYCMLRDEVEAVELDWIKRVNVV 573
Query: 228 KSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGT 287
KS+A+ALSY+HHDC I+HRDISSNNILL+S LEAFV+DFGT RLLD DSSNRTL AGT
Sbjct: 574 KSIANALSYMHHDCDLPIIHRDISSNNILLDSKLEAFVSDFGTARLLDNDSSNRTLLAGT 633
Query: 288 YGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQR 347
YGYIA EL YTMVVTEKC +YSFG+VALE +MG HPGE + SLSSSS L D+L R
Sbjct: 634 YGYIAPELAYTMVVTEKCDVYSFGMVALETMMGMHPGEFITSLSSSSTQNTTLKDVLDSR 693
Query: 348 LSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELEGKTPMKKGLKEISIPEMR 407
LS P + ++ +I L+ ++AL CL P+ P+MQ +S +L + + IS+ +++
Sbjct: 694 LSSPKSTRVANNIALIVSLALKCLHFNPQFCPSMQEVSSKLVSTRSFPQPISAISLLQLK 753
Query: 408 NQ 409
++
Sbjct: 754 DE 755
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225452698|ref|XP_002276923.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g08850-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 389 bits (998), Expect = e-105, Method: Compositional matrix adjust.
Identities = 197/393 (50%), Positives = 267/393 (67%), Gaps = 31/393 (7%)
Query: 31 DMSFNNLDGEIPTYLR-DNPPKSFVGNKGLCGHVQGFLSCFQRHRLAPSFILSVKIFLPL 89
D+S+N+L+G IP L+ ++PP F NK LCG ++ + C + ++ + IL + + L
Sbjct: 321 DLSYNDLEGHIPFELQFESPPGVFEHNKHLCGEIRHWPHCKKGQKI--TLILVISLLATL 378
Query: 90 TPILAFTIFGFILLLKGKSENLKLVTRAA--KNGDVFSVWNYDGKILYENLIDATEYFHI 147
+AF F+LL + + + AA + GD+FSVW+YDG I Y+++I +TE F I
Sbjct: 379 C--IAFAFLKFLLLPRKMRKMRHMSASAAETRRGDLFSVWDYDGTIAYQDIIQSTENFDI 436
Query: 148 RYCIGTGGYDSVYKAELPDGKVVALKKLHHSETEDSAFV--------------------- 186
+YC+G GGY SVY+A+LP GKVVALKKLH E E+ ++
Sbjct: 437 KYCVGVGGYGSVYRAQLPCGKVVALKKLHGWEREEPTYLKSFENEAQILSKIRHRNIVKL 496
Query: 187 ---VYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTP 243
+ MF +Y++MERGSLFC+L + EA+EL+WT+R+N+VKS+AHALSY+HHDC+P
Sbjct: 497 HGFCLHRRSMFLVYQFMERGSLFCMLSHEVEALELDWTKRLNVVKSIAHALSYMHHDCSP 556
Query: 244 SIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTYGYIALELVYTMVVTE 303
I+HRDISSNN+LLNS LEAFV+DFGT RLLD DSS +TL GTYGYIA EL YTM VT+
Sbjct: 557 PIIHRDISSNNVLLNSQLEAFVSDFGTARLLDPDSSIQTLLVGTYGYIAPELAYTMTVTK 616
Query: 304 KCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKIIQDIILV 363
KC +YSFGVVALE +MG HP E++ SLSSSSG I+L D+L RL+ P N ++ +DI+ V
Sbjct: 617 KCDVYSFGVVALETMMGKHPREVITSLSSSSGQDILLRDVLDPRLALPENPQVAKDIVFV 676
Query: 364 STIALACLRSKPKSRPTMQRISQELEGKTPMKK 396
+AL C+ S P+SRPTMQ+IS +L G P K
Sbjct: 677 VLLALKCIHSNPQSRPTMQQISYKLLGDIPFPK 709
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225465647|ref|XP_002270862.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g08850-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 387 bits (994), Expect = e-105, Method: Compositional matrix adjust.
Identities = 201/406 (49%), Positives = 262/406 (64%), Gaps = 53/406 (13%)
Query: 31 DMSFNNLDGEIPTYLRDN-PPKSFVGNKGLCGHVQGFLSCFQRHRLAPSFILSVKIFLPL 89
D+S+N+L+G IP L+ SF NKGLCG ++G C + ++ + I++ KI
Sbjct: 443 DLSYNDLEGHIPFELQSKFSQGSFDNNKGLCGDIKGLPHCKEEYK--TTRIITRKIQTKE 500
Query: 90 TPILAFTIFGFILLLKGKSENLKLVTRAAKNGDVFSVWNYDGKILYENLIDATEYFHIRY 149
P KNGD+FSVWNYDGKI YE++I ATE F I+Y
Sbjct: 501 IP--------------------------TKNGDIFSVWNYDGKIAYEDIIKATEDFDIKY 534
Query: 150 CIGTGGYDSVYKAELPDGKVVALKKLHHSETEDSAFV----------------------- 186
CIGTGGY SVYKA+LP G VVALKKLH ET+++ ++
Sbjct: 535 CIGTGGYGSVYKAQLPTGNVVALKKLHGWETDEATYLKSFQNEVQILSKIRHRNIVKLQG 594
Query: 187 -VYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSI 245
+CMF IY YM RGSL+CVL ++ EA+EL+W +R+N+VKS+ HA+ Y+HHDCTP I
Sbjct: 595 YCLHKRCMFLIYNYMGRGSLYCVLSNEVEALELDWIKRVNVVKSIVHAVCYMHHDCTPPI 654
Query: 246 VHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTYGYIALELVYTMVVTEKC 305
+HRDISSNNILL+S L+AF++DFGT RLL DSSN+TL +GTYGYIA EL YTMVVTEKC
Sbjct: 655 IHRDISSNNILLDSKLDAFLSDFGTSRLLHPDSSNQTLLSGTYGYIAPELAYTMVVTEKC 714
Query: 306 VIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKIIQDIILVST 365
+YSFGVVALE +MG HPGEL LSSSS IML D+L RL P +Q++ +D++LV
Sbjct: 715 DVYSFGVVALETMMGKHPGELFTLLSSSSTQNIMLTDMLDSRLPSPQDQQVARDVVLVVW 774
Query: 366 IALACLRSKPKSRPTMQRISQELEGKTPMKKGLKEISIPEMRNQEM 411
+AL C+ S P+SRPTMQ IS +L ++P IS+ ++ E+
Sbjct: 775 LALKCIHSNPRSRPTMQHISSKLLTQSPFLGPFHGISLWQLNALEI 820
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225452751|ref|XP_002277606.1| PREDICTED: probable leucine-rich repeat receptor-like protein kinase At1g35710-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 384 bits (985), Expect = e-104, Method: Compositional matrix adjust.
Identities = 197/421 (46%), Positives = 273/421 (64%), Gaps = 33/421 (7%)
Query: 15 SGVVEEEPSSPSFLKSDMSFNNLDGEIPTYLRDNPPKSFVGNKGLCGHVQGFLSCFQRHR 74
SG + S+ + D+S N L+G+ P ++F NKGLC ++G C +RH+
Sbjct: 467 SGTIPLSISNNMWTLFDLSHNQLEGQ-----STAPLEAFDHNKGLCDGIKGLSHCKKRHQ 521
Query: 75 LAPSFILSVKIFLPLTPILAFTIFGFILLLKGKSENLKLVTRAAKNGDVFSVWNYDGKIL 134
+ +S+ L +L+ + GF+ + +N T KNGD+FS+W+YDG I
Sbjct: 522 IILIIAISLSATL----LLSVAVLGFLFRKQKIRKNQLPKTTKVKNGDLFSIWDYDGVIA 577
Query: 135 YENLIDATEYFHIRYCIGTGGYDSVYKAELPDGKVVALKKLHHSETEDSAFV-------- 186
Y+++I ATE F I+YCIGTGGY SVY+A+LP GKVVALKKLH E +D ++
Sbjct: 578 YQDIIQATEDFDIKYCIGTGGYGSVYRAQLPSGKVVALKKLHGWERDDPTYLKSFENEVQ 637
Query: 187 ----------------VYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSV 230
+CMF +Y+YME+GSL+C+LRD+ E ++L+W +R+N+VK +
Sbjct: 638 MLSRIQHRNIVKLHGFCLHNKCMFLVYKYMEKGSLYCMLRDEVEVVQLDWIKRVNVVKGI 697
Query: 231 AHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTYGY 290
A+ALSY+HHD T I+HRDISSNNILL+S LEAFVADFGT RLLD DSSN+TL AGTYGY
Sbjct: 698 ANALSYMHHDSTLPIIHRDISSNNILLDSKLEAFVADFGTARLLDPDSSNQTLLAGTYGY 757
Query: 291 IALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSP 350
IA EL YTMVVTEKC +YSFG+VALE +MG HPG+L+ SLS+SS I L D+L RLS
Sbjct: 758 IAPELAYTMVVTEKCDVYSFGMVALETIMGKHPGDLVTSLSASSTQNITLKDVLDSRLSS 817
Query: 351 PINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELEGKTPMKKGLKEISIPEMRNQE 410
P ++ D+ LV ++AL CL P+ RP+MQ++S L + + IS+ +++N+E
Sbjct: 818 PKGPQVANDVALVVSLALKCLHCNPRFRPSMQQVSWRLSASKSFPQPVGAISLLQLKNEE 877
Query: 411 M 411
+
Sbjct: 878 I 878
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST 
Original result of BLAST against Gene Ontology (AMIGO)
ID ![]() |
Alignment graph ![]() |
Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 412 | ||||||
| TAIR|locus:2138268 | 1045 | AT4G08850 [Arabidopsis thalian | 0.463 | 0.182 | 0.497 | 4.2e-67 | |
| TAIR|locus:2011339 | 1120 | AT1G35710 [Arabidopsis thalian | 0.546 | 0.200 | 0.436 | 3.4e-59 | |
| TAIR|locus:2005540 | 999 | HAE "HAESA" [Arabidopsis thali | 0.495 | 0.204 | 0.370 | 5.8e-39 | |
| TAIR|locus:2160791 | 1102 | AT5G63930 [Arabidopsis thalian | 0.451 | 0.168 | 0.375 | 6.1e-39 | |
| TAIR|locus:2139885 | 1013 | AT4G28650 [Arabidopsis thalian | 0.558 | 0.227 | 0.352 | 3.1e-37 | |
| TAIR|locus:2168907 | 966 | XIP1 "XYLEM INTERMIXED WITH PH | 0.541 | 0.230 | 0.330 | 1.3e-36 | |
| TAIR|locus:2169965 | 1003 | BAM1 "BARELY ANY MERISTEM 1" [ | 0.507 | 0.208 | 0.360 | 1.1e-35 | |
| TAIR|locus:2025545 | 1029 | AT1G08590 [Arabidopsis thalian | 0.584 | 0.234 | 0.310 | 6.8e-34 | |
| TAIR|locus:2170668 | 604 | AT5G62710 [Arabidopsis thalian | 0.483 | 0.329 | 0.342 | 7.3e-34 | |
| TAIR|locus:2154344 | 1135 | AT5G48940 [Arabidopsis thalian | 0.531 | 0.192 | 0.325 | 7.5e-34 |
| TAIR|locus:2138268 AT4G08850 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 470 (170.5 bits), Expect = 4.2e-67, Sum P(3) = 4.2e-67
Identities = 96/193 (49%), Positives = 125/193 (64%)
Query: 194 FFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDXXXX 253
F +YEYMERGSL VL +DDEA +L+W +R+N+VK VAHALSY+HHD +P+IVHRD
Sbjct: 850 FLVYEYMERGSLRKVLENDDEAKKLDWGKRINVVKGVAHALSYMHHDRSPAIVHRDISSG 909
Query: 254 XXXXXXXXEAFVADFGTVRLLDVDSSNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVV 313
EA ++DFGT +LL DSSN + AGTYGY+A EL Y M VTEKC +YSFGV+
Sbjct: 910 NILLGEDYEAKISDFGTAKLLKPDSSNWSAVAGTYGYVAPELAYAMKVTEKCDVYSFGVL 969
Query: 314 ALEVLMGTHPGEXXXXXXXXX-GPKIMLIDILYQRLSPPINQKIIQDIILVSTIALACLR 372
LEV+ G HPG+ + L I RL P +I ++++ + +AL CL
Sbjct: 970 TLEVIKGEHPGDLVSTLSSSPPDATLSLKSISDHRLPEP-TPEIKEEVLEILKVALLCLH 1028
Query: 373 SKPKSRPTMQRIS 385
S P++RPTM IS
Sbjct: 1029 SDPQARPTMLSIS 1041
|
|
| TAIR|locus:2011339 AT1G35710 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 456 (165.6 bits), Expect = 3.4e-59, Sum P(3) = 3.4e-59
Identities = 99/227 (43%), Positives = 134/227 (59%)
Query: 159 VYKAELPDGKVVALKKLHHSETEDSAFVVYSPQCMFFIYEYMERGSLFCVLRDDDEAIEL 218
V K E + +V AL ++ H + F IYEYME+GSL +L +D+EA L
Sbjct: 892 VVKQEFLN-EVKALTEIRHRNVVKLFGFCSHRRHTFLIYEYMEKGSLNKLLANDEEAKRL 950
Query: 219 NWTRRMNIVKSVAHALSYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTVRLLDVDS 278
WT+R+N+VK VAHALSY+HHD IVHRD A ++DFGT +LL DS
Sbjct: 951 TWTKRINVVKGVAHALSYMHHDRITPIVHRDISSGNILLDNDYTAKISDFGTAKLLKTDS 1010
Query: 279 SNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGEXXXXXXXXXGPKI 338
SN + AGTYGY+A E YTM VTEKC +YSFGV+ LE+++G HPG+ G +
Sbjct: 1011 SNWSAVAGTYGYVAPEFAYTMKVTEKCDVYSFGVLILELIIGKHPGDLVSSLSSSPGEAL 1070
Query: 339 MLIDILYQRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRIS 385
L I +R+ P Q + ++ + +AL CL++ P+SRPTM IS
Sbjct: 1071 SLRSISDERVLEPRGQNR-EKLLKMVEMALLCLQANPESRPTMLSIS 1116
|
|
| TAIR|locus:2005540 HAE "HAESA" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 309 (113.8 bits), Expect = 5.8e-39, Sum P(3) = 5.8e-39
Identities = 80/216 (37%), Positives = 107/216 (49%)
Query: 189 SPQCMFFIYEYMERGSLFCVLRDDDEA-IELNWTRRMNIVKSVAHALSYLHHDCTPSIVH 247
S C +YEYM GSL VL D + + L W R+ I A LSYLHHDC P IVH
Sbjct: 758 SGDCKLLVYEYMPNGSLADVLHGDRKGGVVLGWPERLRIALDAAEGLSYLHHDCVPPIVH 817
Query: 248 RDXXXXXXXXXXXXEAFVADFGTVRLLDVDSSNRTLQA-----GTYGYIALELVYTMVVT 302
RD A VADFG ++ + S ++T +A G+ GYIA E VYT+ V
Sbjct: 818 RDVKSSNILLDSDYGAKVADFGIAKVGQM-SGSKTPEAMSGIAGSCGYIAPEYVYTLRVN 876
Query: 303 EKCVIYSFGVVALEVLMGTHPGEXXXXXXXXXGPKIMLIDI--LYQRLSPPINQKIIQDI 360
EK IYSFGVV LE++ G P + +D L + P ++ K ++I
Sbjct: 877 EKSDIYSFGVVLLELVTGKQPTDSELGDKDMAKWVCTALDKCGLEPVIDPKLDLKFKEEI 936
Query: 361 ILVSTIALACLRSKPKSRPTMQRIS---QELEGKTP 393
V I L C P +RP+M+++ QE+ G P
Sbjct: 937 SKVIHIGLLCTSPLPLNRPSMRKVVIMLQEVSGAVP 972
|
|
| TAIR|locus:2160791 AT5G63930 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 312 (114.9 bits), Expect = 6.1e-39, Sum P(2) = 6.1e-39
Identities = 74/197 (37%), Positives = 106/197 (53%)
Query: 196 IYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDXXXXXX 255
+YEYM +GSL +L D + L+W++R I A L+YLHHDC P I HRD
Sbjct: 881 LYEYMPKGSLGEILHDP--SCNLDWSKRFKIALGAAQGLAYLHHDCKPRIFHRDIKSNNI 938
Query: 256 XXXXXXEAFVADFGTVRLLDVD-SSNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVA 314
EA V DFG +++D+ S + + AG+YGYIA E YTM VTEK IYS+GVV
Sbjct: 939 LLDDKFEAHVGDFGLAKVIDMPHSKSMSAIAGSYGYIAPEYAYTMKVTEKSDIYSYGVVL 998
Query: 315 LEVLMGTHP-------GEXXXXXXXXXGPKIMLIDILYQRLSPPINQKIIQDIILVSTIA 367
LE+L G P G+ + +L RL+ +++I+ ++ V IA
Sbjct: 999 LELLTGKAPVQPIDQGGDVVNWVRSYIRRDALSSGVLDARLTLE-DERIVSHMLTVLKIA 1057
Query: 368 LACLRSKPKSRPTMQRI 384
L C P +RP+M+++
Sbjct: 1058 LLCTSVSPVARPSMRQV 1074
|
|
| TAIR|locus:2139885 AT4G28650 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 333 (122.3 bits), Expect = 3.1e-37, Sum P(3) = 3.1e-37
Identities = 84/238 (35%), Positives = 120/238 (50%)
Query: 167 GKVVALKKLHHSETEDSAFVVYSPQCMFFIYEYMERGSLFCVLRDDDEAIEL--NWTRRM 224
G+V L KL H +Y+ + M +YE+M G+L + + A L +W R
Sbjct: 747 GEVNLLGKLRHRNIVRLLGFLYNDKNMMIVYEFMLNGNLGDAIHGKNAAGRLLVDWVSRY 806
Query: 225 NIVKSVAHALSYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTVRLLDVDSSNRTLQ 284
NI VAH L+YLHHDC P ++HRD +A +ADFG R++ ++
Sbjct: 807 NIALGVAHGLAYLHHDCHPPVIHRDIKSNNILLDANLDARIADFGLARMMARKKETVSMV 866
Query: 285 AGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHP--GEXXXXXXXXXGPKIMLID 342
AG+YGYIA E YT+ V EK IYS+GVV LE+L G P E + + D
Sbjct: 867 AGSYGYIAPEYGYTLKVDEKIDIYSYGVVLLELLTGRRPLEPEFGESVDIVEWVRRKIRD 926
Query: 343 --ILYQRLSPPI-NQKIIQD-IILVSTIALACLRSKPKSRPTMQRISQELEGKTPMKK 396
L + L P + N + +Q+ ++LV IAL C PK RP+M+ + L P +K
Sbjct: 927 NISLEEALDPNVGNCRYVQEEMLLVLQIALLCTTKLPKDRPSMRDVISMLGEAKPRRK 984
|
|
| TAIR|locus:2168907 XIP1 "XYLEM INTERMIXED WITH PHLOEM 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 300 (110.7 bits), Expect = 1.3e-36, Sum P(3) = 1.3e-36
Identities = 77/233 (33%), Positives = 105/233 (45%)
Query: 168 KVVALKKLHHSETEDSAFVVYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIV 227
+V L + H S C +YEYM G+L+ L + L W R I
Sbjct: 709 EVETLGSIRHKNIVKLFSYFSSLDCSLLVYEYMPNGNLWDALHKG--FVHLEWRTRHQIA 766
Query: 228 KSVAHALSYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTVRLLDV--DSSNRTLQA 285
VA L+YLHHD +P I+HRD + VADFG ++L S T+ A
Sbjct: 767 VGVAQGLAYLHHDLSPPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGKDSTTTVMA 826
Query: 286 GTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHP-----GEXXXXXXXXXGPKIML 340
GTYGY+A E Y+ T KC +YSFGVV +E++ G P GE KI
Sbjct: 827 GTYGYLAPEYAYSSKATIKCDVYSFGVVLMELITGKKPVDSCFGENKNIVNWVS-TKIDT 885
Query: 341 IDILYQRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELEGKTP 393
+ L + L +++ D+I +A+ C P RPTM + Q L TP
Sbjct: 886 KEGLIETLDKRLSESSKADMINALRVAIRCTSRTPTIRPTMNEVVQLLIDATP 938
|
|
| TAIR|locus:2169965 BAM1 "BARELY ANY MERISTEM 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 298 (110.0 bits), Expect = 1.1e-35, Sum P(3) = 1.1e-35
Identities = 79/219 (36%), Positives = 105/219 (47%)
Query: 196 IYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDXXXXXX 255
+YEYM GSL VL L+W R I A L YLHHDC+P IVHRD
Sbjct: 768 VYEYMPNGSLGEVLHGKKGG-HLHWDTRYKIALEAAKGLCYLHHDCSPLIVHRDVKSNNI 826
Query: 256 XXXXXXEAFVADFGTVRLLDVDSSNRTLQA--GTYGYIALELVYTMVVTEKCVIYSFGVV 313
EA VADFG + L ++ + A G+YGYIA E YT+ V EK +YSFGVV
Sbjct: 827 LLDSNFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVV 886
Query: 314 ALEVLMGTHP-GEXXXXXXXXXGPKIMLI---DILYQRLSPPINQKIIQDIILVSTIALA 369
LE++ G P GE + M D + + L P ++ I ++ V +A+
Sbjct: 887 LLELVTGRKPVGEFGDGVDIVQWVRKMTDSNKDSVLKVLDPRLSSIPIHEVTHVFYVAML 946
Query: 370 CLRSKPKSRPTMQRISQ---ELEGKTPMKKGLKEISIPE 405
C+ + RPTM+ + Q E+ P K S PE
Sbjct: 947 CVEEQAVERPTMREVVQILTEIPKLPPSKDQPMTESAPE 985
|
|
| TAIR|locus:2025545 AT1G08590 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 302 (111.4 bits), Expect = 6.8e-34, Sum P(3) = 6.8e-34
Identities = 78/251 (31%), Positives = 122/251 (48%)
Query: 168 KVVALKKLHHSETEDSAFVVYSPQCMFFIYEYMERGSLFCVLRDDDEAIEL-NWTRRMNI 226
+V L L H V++ + + +YEYM G+L L DE L +W R N+
Sbjct: 772 EVNLLGGLRHRNIVKILGYVHNEREVMMVYEYMPNGNLGTALHSKDEKFLLRDWLSRYNV 831
Query: 227 VKSVAHALSYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTVRLLDVDSSNRTLQAG 286
V L+YLH+DC P I+HRD EA +ADFG +++ + ++ AG
Sbjct: 832 AVGVVQGLNYLHNDCYPPIIHRDIKSNNILLDSNLEARIADFGLAKMMLHKNETVSMVAG 891
Query: 287 TYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHP----GEXXXXXXXXXGPKIMLID 342
+YGYIA E YT+ + EK IYS GVV LE++ G P E K+ +
Sbjct: 892 SYGYIAPEYGYTLKIDEKSDIYSLGVVLLELVTGKMPIDPSFEDSIDVVEWIRRKVKKNE 951
Query: 343 ILYQRLSPPIN---QKIIQDIILVSTIALACLRSKPKSRPTMQRISQELEGKTPMKKGLK 399
L + + I + +I++++L IAL C PK RP+++ + L P +K +
Sbjct: 952 SLEEVIDASIAGDCKHVIEEMLLALRIALLCTAKLPKDRPSIRDVITMLAEAKPRRKSVC 1011
Query: 400 EIS--IPEMRN 408
+++ +P RN
Sbjct: 1012 QVAGDLPIFRN 1022
|
|
| TAIR|locus:2170668 AT5G62710 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 283 (104.7 bits), Expect = 7.3e-34, Sum P(3) = 7.3e-34
Identities = 71/207 (34%), Positives = 105/207 (50%)
Query: 190 PQCMFFIYEYMERGSLFCVL--RDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVH 247
P IY+Y+ GSL +L R ++ + LNW R+ I A L+YLHHDC+P IVH
Sbjct: 378 PSSRLLIYDYLTLGSLDDLLHERAQEDGL-LNWNARLKIALGSARGLAYLHHDCSPKIVH 436
Query: 248 RDXXXXXXXXXXXXEAFVADFGTVRLL-DVDSSNRTLQAGTYGYIALELVYTMVVTEKCV 306
RD E V+DFG +LL D D+ T+ AGT+GY+A E + TEK
Sbjct: 437 RDIKSSNILLNDKLEPRVSDFGLAKLLVDEDAHVTTVVAGTFGYLAPEYLQNGRATEKSD 496
Query: 307 IYSFGVVALEVLMGTHPGEXXXXXXXXXGPKIMLIDILYQRLSPPINQKII----QDIIL 362
+YSFGV+ LE++ G P + M + RL I+++ + +
Sbjct: 497 VYSFGVLLLELVTGKRPTDPIFVKRGLNVVGWMNTVLKENRLEDVIDKRCTDVDEESVEA 556
Query: 363 VSTIALACLRSKPKSRPTMQRISQELE 389
+ IA C + P++RP M +++Q LE
Sbjct: 557 LLEIAERCTDANPENRPAMNQVAQLLE 583
|
|
| TAIR|locus:2154344 AT5G48940 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 303 (111.7 bits), Expect = 7.5e-34, Sum P(2) = 7.5e-34
Identities = 74/227 (32%), Positives = 110/227 (48%)
Query: 168 KVVALKKLHHSETEDSAFVVYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIV 227
+V L + H ++ +Y+YM GSL +L + L W R I+
Sbjct: 839 EVKTLGSIRHKNIVRFLGCCWNKNTRLLMYDYMSNGSLGSLLHERSGVCSLGWEVRYKII 898
Query: 228 KSVAHALSYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTVRLLDVDS---SNRTLQ 284
A L+YLHHDC P IVHRD E ++ DFG +L+D S+ T+
Sbjct: 899 LGAAQGLAYLHHDCVPPIVHRDIKANNILIGPDFEPYIGDFGLAKLVDDGDFARSSNTI- 957
Query: 285 AGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGEXXXXXXXXXGP---KIMLI 341
AG+YGYIA E Y+M +TEK +YS+GVV LEVL G P + KI I
Sbjct: 958 AGSYGYIAPEYGYSMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGLHIVDWVKKIRDI 1017
Query: 342 DILYQRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQEL 388
++ Q L ++ ++++ +AL C+ P+ RPTM+ ++ L
Sbjct: 1018 QVIDQGLQARPESEV-EEMMQTLGVALLCINPIPEDRPTMKDVAAML 1063
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries 
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server 
Original result from Ezypred Server
Fail to connect to Ezypred Server
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING 
Original result from the STRING server
| Your Input: | |||||||||||
| GSVIVG00031862001 | SubName- Full=Chromosome undetermined scaffold_60, whole genome shotgun sequence; (722 aa) | ||||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against CDD database part I
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 412 | |||
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 5e-28 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-27 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 9e-27 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 1e-23 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 7e-22 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-20 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 3e-20 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 5e-20 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-19 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-18 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-18 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 4e-18 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-17 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-17 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 3e-16 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-15 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-14 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-14 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-14 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 3e-14 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 3e-14 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 4e-14 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 8e-14 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 3e-13 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 5e-13 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 5e-13 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 1e-12 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-12 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-12 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-12 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-12 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 4e-12 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 5e-12 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 9e-12 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 9e-12 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 3e-11 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 3e-11 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 4e-11 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 4e-11 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 5e-11 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 5e-11 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 6e-11 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 6e-11 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 9e-11 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 1e-10 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 1e-10 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-10 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 3e-10 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 3e-10 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 3e-10 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 3e-10 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 5e-10 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 6e-10 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 7e-10 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 7e-10 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 7e-10 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 7e-10 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 8e-10 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 8e-10 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-09 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 1e-09 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-09 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-09 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 1e-09 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-09 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-09 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-09 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-09 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 3e-09 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 4e-09 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 5e-09 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 5e-09 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 5e-09 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 5e-09 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 7e-09 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 7e-09 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-08 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 3e-08 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 3e-08 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 3e-08 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 4e-08 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 4e-08 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 8e-08 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 1e-07 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 1e-07 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 1e-07 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-07 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-07 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-07 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-07 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 3e-07 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 3e-07 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 3e-07 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 4e-07 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 4e-07 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 4e-07 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 4e-07 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 5e-07 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 6e-07 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 7e-07 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 7e-07 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 8e-07 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 8e-07 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 8e-07 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 9e-07 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 9e-07 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-06 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 1e-06 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 1e-06 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-06 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 1e-06 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-06 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 1e-06 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 1e-06 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 1e-06 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 1e-06 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-06 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-06 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 2e-06 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 2e-06 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 2e-06 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 2e-06 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-06 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-06 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-06 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-06 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-06 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 3e-06 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 3e-06 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 3e-06 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 4e-06 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 4e-06 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 4e-06 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 4e-06 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 4e-06 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 5e-06 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 5e-06 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 5e-06 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 6e-06 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 6e-06 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 7e-06 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 7e-06 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 7e-06 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 7e-06 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 8e-06 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-05 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 1e-05 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-05 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 1e-05 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 2e-05 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-05 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-05 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 2e-05 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 3e-05 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 3e-05 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 3e-05 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 3e-05 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 3e-05 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 3e-05 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 3e-05 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 3e-05 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 3e-05 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 4e-05 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 4e-05 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 4e-05 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 4e-05 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 4e-05 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 4e-05 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 4e-05 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 5e-05 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 5e-05 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 5e-05 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 6e-05 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 7e-05 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 7e-05 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 8e-05 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 8e-05 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 9e-05 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 9e-05 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 1e-04 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 1e-04 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 1e-04 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 1e-04 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 1e-04 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-04 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-04 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 2e-04 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-04 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 2e-04 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-04 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-04 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 3e-04 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 3e-04 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 3e-04 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 3e-04 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 3e-04 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 4e-04 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 4e-04 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 4e-04 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 4e-04 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 4e-04 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 4e-04 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 5e-04 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 5e-04 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 6e-04 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 6e-04 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 7e-04 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 7e-04 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 7e-04 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 7e-04 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 7e-04 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 8e-04 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 8e-04 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 9e-04 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 9e-04 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 0.001 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 0.001 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 0.001 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 0.001 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 0.001 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 0.001 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 0.001 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 0.001 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 0.001 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 0.001 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 0.002 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 0.002 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 0.002 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 0.002 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 0.002 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 0.002 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 0.002 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 0.002 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 0.002 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 0.002 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 0.003 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 0.003 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 0.003 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 0.003 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 0.004 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 0.004 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 0.004 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 5e-28
Identities = 56/191 (29%), Positives = 88/191 (46%), Gaps = 30/191 (15%)
Query: 151 IGTGGYDSVYKAE-LPDGKVVALKKLHHSETEDSA----------------------FVV 187
+G GG+ +VY A GK VA+K + ++ V
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 188 YSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVH 247
++ + EY E GSL +L++++ +L+ + I+ + L YLH + I+H
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENE--GKLSEDEILRILLQILEGLEYLHSN---GIIH 115
Query: 248 RDISSNNILLNS-NLEAFVADFGTVRLLDVDSSNRTLQAGTYGYIALE-LVYTMVVTEKC 305
RD+ NILL+S N + +ADFG +LL D S GT Y+A E L+ +EK
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKS 175
Query: 306 VIYSFGVVALE 316
I+S GV+ E
Sbjct: 176 DIWSLGVILYE 186
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 2e-27
Identities = 64/267 (23%), Positives = 101/267 (37%), Gaps = 42/267 (15%)
Query: 145 FHIRYCIGTGGYDSVYKA-ELPDGKVVALKKLHHSETE----------------DSAFVV 187
+ I +G G + VY A + GK+VA+K + + + +V
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 188 ------YSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDC 241
++ + EY E G LF +L+ + + R ++ + AL YLH
Sbjct: 61 RLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRG-RLSEDEARF--YLRQILSALEYLHSKG 117
Query: 242 TPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTYGYIALELVYTMVV 301
IVHRD+ NILL+ + +ADFG R LD T GT Y+A E++
Sbjct: 118 ---IVHRDLKPENILLDEDGHVKLADFGLARQLD-PGEKLTTFVGTPEYMAPEVLLGKGY 173
Query: 302 TEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKIIQD-- 359
+ I+S GV+ E+L G P + I + P + I
Sbjct: 174 GKAVDIWSLGVILYELLTGKPP------FPGDDQLLELFKKIGKPKPPFPPPEWDISPEA 227
Query: 360 IILVSTIALACLRSKPKSRPTMQRISQ 386
L+ L P+ R T + Q
Sbjct: 228 KDLIR----KLLVKDPEKRLTAEEALQ 250
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 9e-27
Identities = 68/270 (25%), Positives = 104/270 (38%), Gaps = 42/270 (15%)
Query: 145 FHIRYCIGTGGYDSVYKA-ELPDGKVVALKKLHHSETEDSAF------------------ 185
+ + +G+G + +VYKA GK+VA+K L +
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60
Query: 186 -----VVYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHD 240
++ + EY E G LF L L+ I + L YLH +
Sbjct: 61 VRLIDAFEDKDHLYLVMEYCEGGDLFDYLS---RGGPLSEDEAKKIALQILRGLEYLHSN 117
Query: 241 CTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTYGYIALE-LVYTM 299
I+HRD+ NILL+ N +ADFG + L SS+ T GT Y+A E L+
Sbjct: 118 ---GIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGN 174
Query: 300 VVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKIIQD 359
K ++S GV+ E+L G P S + + ++ + L PP+ +
Sbjct: 175 GYGPKVDVWSLGVILYELLTGKPP--------FSGENILDQLQLIRRILGPPLEFDEPKW 226
Query: 360 IILVST---IALACLRSKPKSRPTMQRISQ 386
+ CL P RPT + I Q
Sbjct: 227 SSGSEEAKDLIKKCLNKDPSKRPTAEEILQ 256
|
Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 98.4 bits (246), Expect = 1e-23
Identities = 54/209 (25%), Positives = 86/209 (41%), Gaps = 42/209 (20%)
Query: 144 YFHIRYCIGTGGYDSVYKAE-LPDGKVVALKKLHHSETEDSAFVV--------------- 187
F I IG GG+ VYKA GK VA+K + E ++
Sbjct: 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIV 60
Query: 188 ------YSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMN------IVKSVAHALS 235
++ + E+ GSL + ++ + + + + K + L
Sbjct: 61 KYYGSYLKKDELWIVMEFCSGGSL-------KDLLK-STNQTLTESQIAYVCKELLKGLE 112
Query: 236 YLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGT-VRLLDVDSSNRTLQAGTYGYIALE 294
YLH + I+HRDI + NILL S+ E + DFG +L D + N GT ++A E
Sbjct: 113 YLH---SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTM--VGTPYWMAPE 167
Query: 295 LVYTMVVTEKCVIYSFGVVALEVLMGTHP 323
++ K I+S G+ A+E+ G P
Sbjct: 168 VINGKPYDYKADIWSLGITAIELAEGKPP 196
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 93.8 bits (234), Expect = 7e-22
Identities = 68/268 (25%), Positives = 101/268 (37%), Gaps = 49/268 (18%)
Query: 143 EYFHIRYCIGTGGYDSVYKAEL-PDGKVVALKKLHHSETED----------------SAF 185
+G G VYK P GK+ ALKK+H E+ S +
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPY 60
Query: 186 VV------YSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRM--NIVKSVAHALSYL 237
VV Y + + EYM+ GSL D + I + + L YL
Sbjct: 61 VVKCYGAFYKEGEISIVLEYMDGGSL-----ADLLKKVGKIPEPVLAYIARQILKGLDYL 115
Query: 238 HHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTYGYIALELVY 297
H I+HRDI +N+L+NS E +ADFG ++L+ GT Y++ E +
Sbjct: 116 HTK--RHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQ 173
Query: 298 TMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIM-LIDILYQRLSPPINQKI 356
+ I+S G+ LE +G P P L+ + P + +
Sbjct: 174 GESYSYAADIWSLGLTLLECALGKFP------FLPPGQPSFFELMQAICDGPPPSLPAEE 227
Query: 357 I----QDIILVSTIALACLRSKPKSRPT 380
+D I ACL+ PK RP+
Sbjct: 228 FSPEFRDFI------SACLQKDPKKRPS 249
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 89.5 bits (223), Expect = 2e-20
Identities = 64/273 (23%), Positives = 105/273 (38%), Gaps = 57/273 (20%)
Query: 151 IGTGGYDSVYKAEL--PDGKV---VALKKL--HHSETEDSAF------------------ 185
+G G + VYK +L GK VA+K L SE + F
Sbjct: 7 LGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVKL 66
Query: 186 --VVYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTP 243
V + ++ + EYME G L LR + + + + ++ +A + YL
Sbjct: 67 LGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKL--SLSDLLSFALQIARGMEYLESKN-- 122
Query: 244 SIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQA-GTYGYIALELVYTMVVT 302
+HRD+++ N L+ NL ++DFG R L D R ++A E + T
Sbjct: 123 -FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKEGKFT 181
Query: 303 EKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQ-----RLSPPIN--QK 355
K ++SFGV+ E + +L P + ++L RL P N +
Sbjct: 182 SKSDVWSFGVLLWE----------IFTLGEQPYPGMSNEEVLEYLKNGYRLPQPPNCPPE 231
Query: 356 IIQDIILVSTIALACLRSKPKSRPTMQRISQEL 388
+ + L C P+ RPT + + L
Sbjct: 232 LYD-------LMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 89.1 bits (222), Expect = 3e-20
Identities = 63/273 (23%), Positives = 104/273 (38%), Gaps = 56/273 (20%)
Query: 151 IGTGGYDSVYKAEL----PDGKV-VALKKL--HHSETEDSAF------------------ 185
+G G + VYK L +V VA+K L SE + F
Sbjct: 7 LGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVKL 66
Query: 186 --VVYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTP 243
V + + + EYM G L LR + EL+ + ++ +A + YL
Sbjct: 67 LGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPK-ELSLSDLLSFALQIARGMEYLESKN-- 123
Query: 244 SIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQA-GTYGYIALELVYTMVVT 302
+HRD+++ N L+ NL ++DFG R L D + ++A E + T
Sbjct: 124 -FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKEGKFT 182
Query: 303 EKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQ-----RLSPPIN--QK 355
K ++SFGV+ E+ +L P + ++L RL P N +
Sbjct: 183 SKSDVWSFGVLLWEI----------FTLGEEPYPGMSNAEVLEYLKKGYRLPKPPNCPPE 232
Query: 356 IIQDIILVSTIALACLRSKPKSRPTMQRISQEL 388
+ + + L C P+ RPT + + L
Sbjct: 233 LYK-------LMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 90.6 bits (223), Expect = 5e-20
Identities = 67/273 (24%), Positives = 113/273 (41%), Gaps = 41/273 (15%)
Query: 145 FHIRYCIGTGGYDSVYKAELPDGKVVALKKLHHSETEDSAF------------------- 185
+ I +G G + VY A D K+VALK L S
Sbjct: 2 YRILRKLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPN 59
Query: 186 ------VVYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHH 239
++ + EY++ GSL +L+ L+ + + I+ + AL YLH
Sbjct: 60 IVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH- 118
Query: 240 DCTPSIVHRDISSNNILLNSNLEAFV-ADFGTVRLLDVDSSNRTLQA------GTYGYIA 292
+ I+HRDI NILL+ + DFG +LL S ++ A GT GY+A
Sbjct: 119 --SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMA 176
Query: 293 LELVYTMV---VTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLS 349
E++ + + I+S G+ E+L G P E + S++S +++++ L+
Sbjct: 177 PEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLA 236
Query: 350 PPINQKIIQDII-LVSTIALACLRSKPKSRPTM 381
P++ + I S + L PK+R +
Sbjct: 237 SPLSPSNPELISKAASDLLKKLLAKDPKNRLSS 269
|
Length = 384 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 87.6 bits (218), Expect = 1e-19
Identities = 65/275 (23%), Positives = 104/275 (37%), Gaps = 60/275 (21%)
Query: 151 IGTGGYDSVYKAEL-----PDGKVVALKKL--HHSETEDSAF------------------ 185
+G G + VYK L VA+K L SE E F
Sbjct: 7 LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66
Query: 186 --VVYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLH-HDCT 242
V + ++ + EYM G L LR E + L + + +A + YL +
Sbjct: 67 LGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKD--LLQMALQIAKGMEYLESKNF- 123
Query: 243 PSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTYG---YIALELVYTM 299
VHRD+++ N L+ NL ++DFG R + D R G ++A E +
Sbjct: 124 ---VHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRG-GGKLPIKWMAPESLKDG 179
Query: 300 VVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQ-----RLSPPIN- 353
T K ++SFGV+ E + +L P + ++L RL P N
Sbjct: 180 KFTSKSDVWSFGVLLWE----------IFTLGEQPYPGMSNEEVLELLEDGYRLPRPENC 229
Query: 354 QKIIQDIILVSTIALACLRSKPKSRPTMQRISQEL 388
+ +++ L C P+ RPT + ++L
Sbjct: 230 PDELYELM------LQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 84.9 bits (211), Expect = 1e-18
Identities = 71/266 (26%), Positives = 108/266 (40%), Gaps = 57/266 (21%)
Query: 150 CIGTGGYDSVYKAELPD-GKVVALKK--LHHSETEDSA---------------FVV-Y-- 188
+G G + SVY A D G+++A+K L E+ +V Y
Sbjct: 7 LLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYG 66
Query: 189 ----SPQCMFFIY-EYMERGSLFCVLRDD---DEAIELNWTRRMNIVKSVAHALSYLH-H 239
+ I+ EY+ GSL +L+ E + +TR+ + L+YLH +
Sbjct: 67 SERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQ------ILEGLAYLHSN 120
Query: 240 DCTPSIVHRDISSNNILLNSNLEAFVADFGT-VRLLDVDSSNRTLQ-AGTYGYIALELVY 297
IVHRDI NIL++S+ +ADFG RL D+++ T GT ++A E++
Sbjct: 121 G----IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIR 176
Query: 298 TMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKI- 356
I+S G +E+ G P S P L I P I + +
Sbjct: 177 GEEYGRAADIWSLGCTVIEMATGKPP------WSELGNPMAALYKIGSSGEPPEIPEHLS 230
Query: 357 --IQDIILVSTIALACLRSKPKSRPT 380
+D + CLR PK RPT
Sbjct: 231 EEAKDFL------RKCLRRDPKKRPT 250
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 84.1 bits (209), Expect = 2e-18
Identities = 63/279 (22%), Positives = 109/279 (39%), Gaps = 59/279 (21%)
Query: 151 IGTGGYDSVYKAELPDGK----VVALKKLHHSETED--SAF------------------- 185
+G G + VYK +L VA+K L +E+ F
Sbjct: 3 LGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLL 62
Query: 186 -VVYSPQCMFFIYEYMERGSLFCVLR------DDDEAIELNWTRRMNIVKSVAHALSYLH 238
V + ++ + EYME G L LR E L+ ++ +A + YL
Sbjct: 63 GVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA 122
Query: 239 HDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGT--YGYIALELV 296
VHRD+++ N L+ +L ++DFG R + D R G ++A E +
Sbjct: 123 S---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESL 179
Query: 297 YTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQ-----RLSPP 351
+ T K ++SFGV+ E+ +L ++ P + ++L RL P
Sbjct: 180 KDGIFTSKSDVWSFGVLLWEI----------FTLGATPYPGLSNEEVLEYLRKGYRLPKP 229
Query: 352 IN-QKIIQDIILVSTIALACLRSKPKSRPTMQRISQELE 389
+ +++ L+C + P+ RPT + + LE
Sbjct: 230 EYCPDELYELM------LSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 83.8 bits (208), Expect = 4e-18
Identities = 58/200 (29%), Positives = 91/200 (45%), Gaps = 38/200 (19%)
Query: 151 IGTGGYDSVYKA-ELPDGKVVALKKLH-HSETEDSAF-------------VV--YS---- 189
IG G VYKA + GK VA+KK+ + ++ +V Y
Sbjct: 27 IGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLV 86
Query: 190 PQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMN------IVKSVAHALSYLHHDCTP 243
++ + EYM+ GSL + I N+ R MN + + V L YLH +
Sbjct: 87 GDELWVVMEYMDGGSL-------TDIITQNFVR-MNEPQIAYVCREVLQGLEYLH---SQ 135
Query: 244 SIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTYGYIALELVYTMVVTE 303
+++HRDI S+NILL+ + +ADFG L + S R GT ++A E++
Sbjct: 136 NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKRKDYGP 195
Query: 304 KCVIYSFGVVALEVLMGTHP 323
K I+S G++ +E+ G P
Sbjct: 196 KVDIWSLGIMCIEMAEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.9 bits (203), Expect = 1e-17
Identities = 71/263 (26%), Positives = 106/263 (40%), Gaps = 58/263 (22%)
Query: 150 CIGTGGYDSVYKA-ELPDGKVVALKK--LHHSETE--------------DSAFVV----- 187
CIG G + VYKA + +VVA+K L +E E S ++
Sbjct: 8 CIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGS 67
Query: 188 YSPQC-MFFIYEYMERGSLFCVLR---DDDEAIELNWTRRMNIVKSVAHALSYLHHDCTP 243
+ ++ I EY GS +L+ D+ I I++ V L YLH +
Sbjct: 68 FLKGSKLWIIMEYCGGGSCLDLLKPGKLDETYIAF-------ILREVLLGLEYLHEEGK- 119
Query: 244 SIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTYGYIALELVYTMVVTE 303
+HRDI + NILL+ + +ADFG L S R GT ++A E++ E
Sbjct: 120 --IHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQSGYDE 177
Query: 304 KCVIYSFGVVALEVLMGT------HPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKII 357
K I+S G+ A+E+ G HP +L + ++ P + S P
Sbjct: 178 KADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEGNKF-----SKPFKD--- 229
Query: 358 QDIILVSTIALACLRSKPKSRPT 380
VS CL PK RP+
Sbjct: 230 ----FVS----LCLNKDPKERPS 244
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 4e-17
Identities = 100/395 (25%), Positives = 166/395 (42%), Gaps = 48/395 (12%)
Query: 26 SFLKSDMSFNNLDGEIPT---YLRDNPPKSFVGNKGLCG--HVQGFLSCFQRHRLAPSFI 80
S ++ ++S N+L G +P+ +L N + GN LCG G C +R R PS+
Sbjct: 572 SLVQVNISHNHLHGSLPSTGAFLAINA-SAVAGNIDLCGGDTTSGLPPC-KRVRKTPSWW 629
Query: 81 LSVKIFLPLTPILAFTIFGFILLLKGKSENLKLVTRA----------AKNGDVFSVWNYD 130
+ L +LA FGF+ + + LK V +K ++ +
Sbjct: 630 FYITCTLGAFLVLALVAFGFVFIRGRNNLELKRVENEDGTWELQFFDSKVSKSITINDIL 689
Query: 131 GKILYENLI-DATEYFHIRYCIGTGGYDSVYKA-----ELPDGKVVALKKLHHSETEDSA 184
+ EN+I + + G V K +P ++ + KL H
Sbjct: 690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIADMGKLQHPNIVKLI 749
Query: 185 FVVYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPS 244
+ S + + I+EY+E +L VLR+ L+W RR I +A AL +LH C+P+
Sbjct: 750 GLCRSEKGAYLIHEYIEGKNLSEVLRN------LSWERRRKIAIGIAKALRFLHCRCSPA 803
Query: 245 IVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTYGYIALELVYTMVVTEK 304
+V ++S I+++ E + LL D+ A Y+A E T +TEK
Sbjct: 804 VVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFISSA----YVAPETRETKDITEK 858
Query: 305 CVIYSFGVVALEVLMGTHPGELLLSLSSS---------SGPKI-MLIDILYQRLSPPINQ 354
IY FG++ +E+L G P + + S S + M ID + +NQ
Sbjct: 859 SDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRG-DVSVNQ 917
Query: 355 KIIQDIILVSTIALACLRSKPKSRPTMQRISQELE 389
+I+ V +AL C + P +RP + + LE
Sbjct: 918 N---EIVEVMNLALHCTATDPTARPCANDVLKTLE 949
|
Length = 968 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 77.8 bits (192), Expect = 3e-16
Identities = 77/283 (27%), Positives = 121/283 (42%), Gaps = 52/283 (18%)
Query: 139 IDATEYFHIRYCIGTGGYDSVYKA--ELPDGKV--VALKKLH--HSETEDSAF------- 185
ID + Y I IG G + V + +LP K VA+K L S+ + F
Sbjct: 1 IDPS-YVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIM 59
Query: 186 -------------VVYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAH 232
VV + + I EYME GSL LR++D + + + +++ +A
Sbjct: 60 GQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDG--KFTVGQLVGMLRGIAS 117
Query: 233 ALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTYG--Y 290
+ YL VHRD+++ NIL+NSNL V+DFG R L+ + T + G +
Sbjct: 118 GMKYLSEMNY---VHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRW 174
Query: 291 IALELVYTMVVTEKCVIYSFGVVALEVL-MGTHPGELLLSLSSSSGPKIM-LIDILYQRL 348
A E + T ++SFG+V EV+ G P S ++ ++ Y RL
Sbjct: 175 TAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYW------DMSNQDVIKAVEDGY-RL 227
Query: 349 SPPIN--QKIIQDIILVSTIALACLRSKPKSRPTMQRISQELE 389
PP++ + Q + L C + RPT +I L+
Sbjct: 228 PPPMDCPSALYQ-------LMLDCWQKDRNERPTFSQIVSTLD 263
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.1 bits (188), Expect = 1e-15
Identities = 55/212 (25%), Positives = 80/212 (37%), Gaps = 48/212 (22%)
Query: 145 FHIRYCIGTGGYDSVYKAE-LPDGKVVA-----------------------LKKLHHS-- 178
+ + IG G + VYK L G VA LK L H
Sbjct: 2 YQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNI 61
Query: 179 -------ETEDSAFVVYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVA 231
ET DS ++ I EY E GSL +++ + V V
Sbjct: 62 VKYIGSIETSDS---------LYIILEYAENGSLRQIIKKFGP---FPESLVAVYVYQVL 109
Query: 232 HALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTYGYI 291
L+YLH ++HRDI + NIL + +ADFG L+ S + GT ++
Sbjct: 110 QGLAYLH---EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWM 166
Query: 292 ALELVYTMVVTEKCVIYSFGVVALEVLMGTHP 323
A E++ + I+S G +E+L G P
Sbjct: 167 APEVIEMSGASTASDIWSLGCTVIELLTGNPP 198
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 73.0 bits (180), Expect = 2e-14
Identities = 62/288 (21%), Positives = 109/288 (37%), Gaps = 72/288 (25%)
Query: 151 IGTGGYDSVYKA-ELPDGKVVALK-----------KLHHSETE--------DSAFVV--- 187
IG G + +V A E K A+K K+ + + E ++
Sbjct: 9 IGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLY 68
Query: 188 ---YSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPS 244
+ ++F+ EY G L +R +++ TR + AL YLH +
Sbjct: 69 YTFQDEENLYFVLEYAPNGELLQYIRKY-GSLDEKCTR--FYAAEILLALEYLH---SKG 122
Query: 245 IVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQA------------------- 285
I+HRD+ NILL+ ++ + DFGT ++LD +SS + +
Sbjct: 123 IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASF 182
Query: 286 -GTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHP----GELLLSLSSSSGPKIML 340
GT Y++ EL+ + +++ G + ++L G P E L KI+
Sbjct: 183 VGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQ------KILK 236
Query: 341 IDILYQRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQEL 388
++ + PP +D+I L P+ R + EL
Sbjct: 237 LEYSF----PPNFPPDAKDLI------EKLLVLDPQDRLGVNEGYDEL 274
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 72.7 bits (179), Expect = 2e-14
Identities = 63/273 (23%), Positives = 110/273 (40%), Gaps = 56/273 (20%)
Query: 145 FHIRYCIGTGGYDSVYKA-ELPDGKVVALKKLHH---SETEDSA---------------- 184
+ + IG G + +V K DGK++ K++ + +E E
Sbjct: 2 YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNI 61
Query: 185 ------FVVYSPQCMFFIYEYMERGSLFCVL---RDDDEAIELN--WTRRMNIVKSVAHA 233
+ S Q ++ + EY E G L ++ + + + IE W I+ + A
Sbjct: 62 VRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIW----RILTQLLLA 117
Query: 234 LSYLHH--DCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTYGYI 291
L H+ D +++HRD+ NI L++N + DFG ++L DSS GT Y+
Sbjct: 118 LYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTPYYM 177
Query: 292 ALELVYTMVVTEKCVIYSFGVVALEVLMGTHP----GELLLSLSSSSGPKIMLIDILYQR 347
+ E + M EK I+S G + E+ + P +L L+ G + R
Sbjct: 178 SPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGK----FRRIPYR 233
Query: 348 LSPPINQKIIQDIILVSTIALACLRSKPKSRPT 380
S +N+ +I+ + L P RP+
Sbjct: 234 YSSELNE-VIK----------SMLNVDPDKRPS 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 72.3 bits (178), Expect = 2e-14
Identities = 65/262 (24%), Positives = 108/262 (41%), Gaps = 48/262 (18%)
Query: 151 IGTGGYDSVYKAE-LPDGKVVALKKLHHSETE----------------DSAFVV------ 187
+G G V K P GK++A+K + E +S ++V
Sbjct: 9 LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAF 68
Query: 188 YSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVH 247
Y+ + EYM+ GSL +L++ I ++ + +V L+YLH I+H
Sbjct: 69 YNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAV--AVLKGLTYLHEKH--KIIH 124
Query: 248 RDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTYGYIALELVYTMVVTEKCVI 307
RD+ +NIL+NS + + DFG L V+S +T GT Y+A E + + K I
Sbjct: 125 RDVKPSNILVNSRGQIKLCDFGVSGQL-VNSLAKTF-VGTSSYMAPERIQGNDYSVKSDI 182
Query: 308 YSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQ-------RLSPPINQKIIQDI 360
+S G+ +E+ G P + P + ++L RL QD
Sbjct: 183 WSLGLSLIELATGRFP------YPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDFQDF 236
Query: 361 ILVSTIALACLRSKPKSRPTMQ 382
+ + CL P+ RP+ +
Sbjct: 237 VNL------CLIKDPRERPSYK 252
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.3 bits (178), Expect = 3e-14
Identities = 72/291 (24%), Positives = 109/291 (37%), Gaps = 62/291 (21%)
Query: 138 LIDATEYFHIRYCIGTGGYDSVYKA-ELPDGKVVALKKLHHSETEDS------------- 183
L D T F + IG G Y VYKA G++VA+K + E E+
Sbjct: 1 LPDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYS 60
Query: 184 ----------AFVVYSPQCM----FFIYEYMERGS---LFCVLRDDDEAIELNWTRRMNI 226
AF+ +P + + E GS L LR + ++ W I
Sbjct: 61 NHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAY--I 118
Query: 227 VKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAG 286
++ L+YLH + ++HRDI NILL N E + DFG LD R G
Sbjct: 119 LRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFIG 175
Query: 287 TYGYIALELV-----YTMVVTEKCVIYSFGVVALEV------LMGTHPGELLLSLSSSSG 335
T ++A E++ + ++S G+ A+E+ L HP L + +
Sbjct: 176 TPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPP 235
Query: 336 PKIMLIDILYQRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQ 386
P + SP K D I CL + RP M+ + +
Sbjct: 236 PTLK---------SPENWSKKFNDFISE------CLIKNYEQRPFMEELLE 271
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 3e-14
Identities = 60/262 (22%), Positives = 108/262 (41%), Gaps = 45/262 (17%)
Query: 145 FHIRYCIGTGGYDSVYKA-ELPDGKVVALKKLHHSETE-----------------DSAFV 186
F I IG G + V+K D +V A+K++ S+ DS+++
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61
Query: 187 VYSPQC------MFFIYEYMERGSLFCVLRDDDEAIELNWTRRM---NIVKSVAHALSYL 237
+ + + + EY E G L + +++ R + + + L L
Sbjct: 62 IRYYESFLDKGKLNIVMEYAENGDL-------HKLLKMQRGRPLPEDQVWRFFIQILLGL 114
Query: 238 HHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTYGYIALELVY 297
H + I+HRDI S N+ L++ + D G +LL +++ GT Y++ EL
Sbjct: 115 AHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCE 174
Query: 298 TMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKII 357
EK +++ GVV E G HP + +++ G I+ I + + PP++Q
Sbjct: 175 DKPYNEKSDVWALGVVLYECCTGKHPFD-----ANNQGALILKI---IRGVFPPVSQMYS 226
Query: 358 QDIILVSTIALACLRSKPKSRP 379
Q + + CL + RP
Sbjct: 227 QQLAQLID---QCLTKDYRQRP 245
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 4e-14
Identities = 66/247 (26%), Positives = 111/247 (44%), Gaps = 22/247 (8%)
Query: 146 HIRYCIGTGGYDSVYKAELPDGKVVALKKLHHSETEDSAFVVYSPQCMFFIYEYMERGSL 205
+R I D + K + +V ALK+L H V + ++ I E ME+GSL
Sbjct: 30 RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELMEKGSL 89
Query: 206 FCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFV 265
LR + + L +++ VA ++YL + +HRD+++ NIL+ +L V
Sbjct: 90 LAFLRSPEGQV-LPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKV 145
Query: 266 ADFGTVRLLDVD---SSNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLM-GT 321
ADFG RL+ D SS++ + Y + A E + K ++SFG++ E+ G
Sbjct: 146 ADFGLARLIKEDVYLSSDKKI---PYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQ 202
Query: 322 HPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTM 381
P ++ I Y+ P K Q+I I L C ++P+ RP+
Sbjct: 203 VPYP-----GMNNHEVYDQITAGYRMPCPA---KCPQEI---YKIMLECWAAEPEDRPSF 251
Query: 382 QRISQEL 388
+ + +EL
Sbjct: 252 KALREEL 258
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 70.6 bits (174), Expect = 8e-14
Identities = 73/270 (27%), Positives = 110/270 (40%), Gaps = 57/270 (21%)
Query: 151 IGTGGYDSVYKAE-LPDGKVVALKK--LHHSETEDSAFVVYSPQCM-----FFI---YE- 198
IG G + VY DGK+ LK+ L + ++ + + + I YE
Sbjct: 8 IGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYES 67
Query: 199 YMERGSLFCVL-----RDDDEAIE--------------LNWTRRMNIVKSVAHALSYLHH 239
+ E+G L V+ D + I+ L+W ++ AL YLH
Sbjct: 68 FEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQL------CLALKYLHS 121
Query: 240 DCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTYGYIALELVYTM 299
I+HRDI NI L SN + DFG ++L GT Y++ EL
Sbjct: 122 R---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELCQNK 178
Query: 300 VVTEKCVIYSFGVVALEVLMGTHP--GELLLSLSSSSGPKIMLIDILYQRLSPPINQKII 357
K I+S G V E+ HP GE LL L+ KI+ + PPI +
Sbjct: 179 PYNYKSDIWSLGCVLYELCTLKHPFEGENLLELAL----KIL------KGQYPPIPSQYS 228
Query: 358 QDII-LVSTIALACLRSKPKSRPTMQRISQ 386
++ LVS + L+ P+ RP++ +I Q
Sbjct: 229 SELRNLVS----SLLQKDPEERPSIAQILQ 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 69.3 bits (170), Expect = 3e-13
Identities = 70/277 (25%), Positives = 115/277 (41%), Gaps = 75/277 (27%)
Query: 151 IGTGGYDSVYKAE-LPDGKVVALKKLH----HSETED--------------------SAF 185
IG G VY A LP+ + VA+K++ + ++ ++F
Sbjct: 9 IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSF 68
Query: 186 VVYSPQCMFFIYEYMERGSLFCVLRDD------DEAIELNWTRRMNIVKSVAHALSYLHH 239
VV ++ + Y+ GSL +++ DEAI ++K V L YLH
Sbjct: 69 VV--GDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAI------IATVLKEVLKGLEYLHS 120
Query: 240 DCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLL--DVDSSNRTLQ--AGTYGYIALEL 295
+ +HRDI + NILL + +ADFG L D + + + GT ++A E+
Sbjct: 121 N---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEV 177
Query: 296 V-----YTMVVTEKCVIYSFGVVALEVLMGTHPGE-------LLLSLSSSSGPKIMLIDI 343
+ Y K I+SFG+ A+E+ G P L+L+L + P +
Sbjct: 178 MEQVHGY----DFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQND--PPSLETGA 231
Query: 344 LYQRLSPPINQKIIQDIILVSTIALACLRSKPKSRPT 380
Y++ S K + +I + CL+ P RPT
Sbjct: 232 DYKKYS-----KSFRKMISL------CLQKDPSKRPT 257
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 68.6 bits (167), Expect = 5e-13
Identities = 71/274 (25%), Positives = 111/274 (40%), Gaps = 53/274 (19%)
Query: 140 DATEYFHIRYCIGTGGYDSVYKA-ELPDGKVVALKKLHHSETED-----SAFVVYSPQC- 192
D E F IG G + V+K + KVVA+K + E ED + QC
Sbjct: 1 DPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCD 60
Query: 193 ----------------MFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSY 236
++ I EY+ GS +L E L+ T+ I++ + L Y
Sbjct: 61 SPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL----EPGPLDETQIATILREILKGLDY 116
Query: 237 LHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTYGYIALELV 296
LH + +HRDI + N+LL+ + E +ADFG L R GT ++A E++
Sbjct: 117 LHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI 173
Query: 297 YTMVVTEKCVIYSFGVVALEVLMGT------HPGELLLSLSSSSGPKIMLIDILYQRLSP 350
K I+S G+ A+E+ G HP ++L + ++ P L S
Sbjct: 174 KQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPT------LEGNYSK 227
Query: 351 PINQKIIQDIILVSTIALACLRSKPKSRPTMQRI 384
P+ + ACL +P RPT + +
Sbjct: 228 PLKE-----------FVEACLNKEPSFRPTAKEL 250
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 5e-13
Identities = 66/267 (24%), Positives = 111/267 (41%), Gaps = 68/267 (25%)
Query: 151 IGTGGYDSVYKA-ELPDGKVVALKKLHHSETED--------------------SAFVVYS 189
IG G Y +VY+ +P G+VVALK ++ +D Y
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68
Query: 190 PQCM-----FFIYEYMERGSLFCVLRD---DDEAIELNWTRRMNIVKSVAHALSYLHHDC 241
+ + I EY E GS+ +++ ++ I + I++ V AL Y+H
Sbjct: 69 GSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISV-------IIREVLVALKYIHKV- 120
Query: 242 TPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTYGYIALELVYTMVV 301
++HRDI + NIL+ + + DFG LL+ +SS R+ GT ++A E V+
Sbjct: 121 --GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPE-----VI 173
Query: 302 TE------KCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPIN-- 353
TE K I+S G+ E+ G P S + ++ + P +
Sbjct: 174 TEGKYYDTKADIWSLGITIYEMATGNPP--------YSDVDAFRAMMLIPKSKPPRLEDN 225
Query: 354 --QKIIQDIILVSTIALACLRSKPKSR 378
K++++ + ACL +PK R
Sbjct: 226 GYSKLLREFV------AACLDEEPKER 246
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 1e-12
Identities = 60/211 (28%), Positives = 96/211 (45%), Gaps = 37/211 (17%)
Query: 139 IDATEYFHIRYCIGTGGYDSVYKAEL-PDGK---VVALKKLH--HSETEDSAF------- 185
ID + I IG G + V + L GK VA+K L ++E + F
Sbjct: 1 IDVS-CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIM 59
Query: 186 -------------VVYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAH 232
VV + + I E+ME G+L LR +D + + + +++ +A
Sbjct: 60 GQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDG--QFTVIQLVGMLRGIAA 117
Query: 233 ALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTYGYI- 291
+ YL + VHRD+++ NIL+NSNL V+DFG R L+ D+S+ T + G I
Sbjct: 118 GMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIP 174
Query: 292 ----ALELVYTMVVTEKCVIYSFGVVALEVL 318
A E + T ++S+G+V EV+
Sbjct: 175 IRWTAPEAIAYRKFTSASDVWSYGIVMWEVM 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.0 bits (164), Expect = 2e-12
Identities = 46/195 (23%), Positives = 78/195 (40%), Gaps = 31/195 (15%)
Query: 151 IGTGGYDSVYKA-ELPDGKVVALKKL---HHSETEDSAF--------------------V 186
IG G Y VYKA + G++VA+KK+ SE V
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66
Query: 187 VYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIV 246
++ ++E+M+ L+ +++D L + + + + L++ H I+
Sbjct: 67 FRHKGDLYLVFEFMDT-DLYKLIKD--RQRGLPESLIKSYLYQLLQGLAFCHSH---GIL 120
Query: 247 HRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTYGYIALELVYTM-VVTEKC 305
HRD+ N+L+N+ +ADFG R T T Y A EL+ +
Sbjct: 121 HRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYSTPV 180
Query: 306 VIYSFGVVALEVLMG 320
I+S G + E+L
Sbjct: 181 DIWSVGCIFAELLSR 195
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 66.5 bits (163), Expect = 2e-12
Identities = 59/203 (29%), Positives = 87/203 (42%), Gaps = 29/203 (14%)
Query: 143 EYFHIRYCIGTGGYDSVYKA-ELPDGKVVALKKLHHSET-------------EDSAFVV- 187
E F I +G G Y SVYKA G+VVA+K + E DS ++V
Sbjct: 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCDSPYIVK 62
Query: 188 -----YSPQCMFFIYEYMERGSLFCVLRDDDEAIE--LNWTRRMNIVKSVAHALSYLHHD 240
+ ++ + EY GS+ D + L I+ L YLH +
Sbjct: 63 YYGSYFKNTDLWIVMEYCGAGSV----SDIMKITNKTLTEEEIAAILYQTLKGLEYLHSN 118
Query: 241 CTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTYGYIALELVYTMV 300
+HRDI + NILLN +A +ADFG L + R GT ++A E++ +
Sbjct: 119 ---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEIG 175
Query: 301 VTEKCVIYSFGVVALEVLMGTHP 323
K I+S G+ A+E+ G P
Sbjct: 176 YNNKADIWSLGITAIEMAEGKPP 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.4 bits (163), Expect = 2e-12
Identities = 54/206 (26%), Positives = 83/206 (40%), Gaps = 47/206 (22%)
Query: 151 IGTGGYDSVYKA-ELPDGKVVALKKLH-----------HSETE-------DSAFVV---Y 188
+G G + V + GK+ A+K L H+ TE + F+V Y
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60
Query: 189 SPQC---MFFIYEYMERGSLFCVLRDD---DEAIELNWTRRMNIVKSVAHALSYLH-HDC 241
+ Q ++ + EY G LF L + E R + AL YLH
Sbjct: 61 AFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEE----RARF--YAAEIVLALEYLHSLG- 113
Query: 242 TPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTYGYIALELV----Y 297
I++RD+ NILL+++ + DFG + L + S GT Y+A E++ Y
Sbjct: 114 ---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGY 170
Query: 298 TMVVTEKCVIYSFGVVALEVLMGTHP 323
V +S GV+ E+L G P
Sbjct: 171 GKAVD----WWSLGVLLYEMLTGKPP 192
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 2e-12
Identities = 60/203 (29%), Positives = 94/203 (46%), Gaps = 35/203 (17%)
Query: 151 IGTGGYDSVYKA--ELPDGK--VVALKKLH--HSETEDSAF------------------- 185
IG G + V++ ++P K VA+K L ++E + F
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLE 72
Query: 186 -VVYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPS 244
VV + I EYME G+L LRD D E + + + +++ +A + YL +
Sbjct: 73 GVVTKFKPAMIITEYMENGALDKYLRDHDG--EFSSYQLVGMLRGIAAGMKYLSD---MN 127
Query: 245 IVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAG---TYGYIALELVYTMVV 301
VHRD+++ NIL+NSNLE V+DFG R+L+ D +G + A E +
Sbjct: 128 YVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKF 187
Query: 302 TEKCVIYSFGVVALEVL-MGTHP 323
T ++SFG+V EV+ G P
Sbjct: 188 TSASDVWSFGIVMWEVMSFGERP 210
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.8 bits (161), Expect = 4e-12
Identities = 70/276 (25%), Positives = 112/276 (40%), Gaps = 63/276 (22%)
Query: 143 EYFHIRYCIGTGGYDSVYKA-ELPDGKVVALKKLHHSETEDSAFVVYS----PQC----- 192
E + + IG+G Y VYKA ++ G++VA+K + +D + +C
Sbjct: 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNI 62
Query: 193 ------------MFFIYEYMERGSL---FCVLRDDDEAIELNWTRRMNIVKSVAHALSYL 237
++ + EY GSL + V R +++ + + + L+YL
Sbjct: 63 VAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAY-----VCRETLKGLAYL 117
Query: 238 HHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTYGYIALELV- 296
H +HRDI NILL + + +ADFG L + R GT ++A E+
Sbjct: 118 HET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAA 174
Query: 297 ------YTMVVTEKCVIYSFGVVALEV------LMGTHPGELLLSLSSSSGPKIMLIDIL 344
Y KC I++ G+ A+E+ + HP L +S S+ P L D
Sbjct: 175 VERKGGY----DGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKD-- 228
Query: 345 YQRLSPPINQKIIQDIILVSTIALACLRSKPKSRPT 380
++ SP + D I CL PK RPT
Sbjct: 229 KEKWSP-----VFHDFIKK------CLTKDPKKRPT 253
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.6 bits (161), Expect = 5e-12
Identities = 37/147 (25%), Positives = 62/147 (42%), Gaps = 30/147 (20%)
Query: 150 CIGTGGYDSVYKA-ELPDGKVVALKKLHHSETEDSAF----------------------- 185
+G G Y VYKA + G++VALKK+ E+
Sbjct: 6 KLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLD 65
Query: 186 VVYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSI 245
V+++ + ++ ++EY + L L + N + I+ + L+Y H I
Sbjct: 66 VIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKS--IMYQLLRGLAYCHSHR---I 119
Query: 246 VHRDISSNNILLNSNLEAFVADFGTVR 272
+HRD+ NIL+N + +ADFG R
Sbjct: 120 LHRDLKPQNILINRDGVLKLADFGLAR 146
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.9 bits (159), Expect = 9e-12
Identities = 45/161 (27%), Positives = 68/161 (42%), Gaps = 40/161 (24%)
Query: 151 IGTGGYDSVYKAE-LPDGKVVALKKLHHSETEDSAF------------------------ 185
IG G Y VYKA G++VALKK+ E E F
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKIR-MENEKEGFPITAIREIKLLQKLRHPNIVRLKE 65
Query: 186 VVYSPQC--MFFIYEYME---RGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHD 240
+V S ++ ++EYM+ G L D ++ ++ +K + L YLH +
Sbjct: 66 IVTSKGKGSIYMVFEYMDHDLTGLL------DSPEVKFTESQIKCYMKQLLEGLQYLHSN 119
Query: 241 CTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNR 281
I+HRDI +NIL+N++ +ADFG R +S
Sbjct: 120 ---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSAD 157
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 9e-12
Identities = 53/202 (26%), Positives = 90/202 (44%), Gaps = 45/202 (22%)
Query: 151 IGTGGYDSVYKAE-LPDGK----VVALKKLHHS-------ETEDSAFVVYSPQC------ 192
+G+G + +VYK +P+G+ VA+K L E D A+V+ S
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 193 --------MFFIYEYMERGSLFCVLRDDDEAIE----LNWTRRMNIVKSVAHALSYL--H 238
+ I + M G L +R+ + I LNW + +A +SYL
Sbjct: 75 LGICLSSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQ------IAKGMSYLEEK 128
Query: 239 HDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTY--GYIALELV 296
+VHRD+++ N+L+ + + DFG +LLDVD + G ++ALE +
Sbjct: 129 R-----LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESI 183
Query: 297 YTMVVTEKCVIYSFGVVALEVL 318
+ T K ++S+GV E++
Sbjct: 184 LHRIYTHKSDVWSYGVTVWELM 205
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 63.0 bits (154), Expect = 3e-11
Identities = 56/214 (26%), Positives = 85/214 (39%), Gaps = 55/214 (25%)
Query: 151 IGTGGYDSVYKAE-LPDGKVVALKKL-----------HHSETE-------DSAFVV---Y 188
I G Y V+ A+ G + A+K + TE S +VV Y
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60
Query: 189 SPQC---MFFIYEYMERGSLFCVLR-----DDDEAIELNWTRRMNIVKSVAHALSYLHHD 240
S Q ++ + EY+ G L +L D+D A + + AL YLH +
Sbjct: 61 SFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVA--------RIYIAEIVLALEYLHSN 112
Query: 241 CTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQA-----------GTYG 289
I+HRD+ +NIL++SN + DFG L V R + GT
Sbjct: 113 ---GIIHRDLKPDNILIDSNGHLKLTDFG---LSKVGLVRRQINLNDDEKEDKRIVGTPD 166
Query: 290 YIALELVYTMVVTEKCVIYSFGVVALEVLMGTHP 323
YIA E++ ++ +S G + E L+G P
Sbjct: 167 YIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPP 200
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 3e-11
Identities = 68/261 (26%), Positives = 107/261 (40%), Gaps = 49/261 (18%)
Query: 151 IGTGGYDSVYKA-ELPDGKVVALKKLHHSETED-----SAFVVYSPQC------------ 192
IG G + VYK + +VVA+K + E ED + QC
Sbjct: 12 IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSY 71
Query: 193 -----MFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVH 247
++ I EY+ GS +L+ L T I++ + L YLH + +H
Sbjct: 72 LKGTKLWIIMEYLGGGSALDLLKPG----PLEETYIATILREILKGLDYLHSE---RKIH 124
Query: 248 RDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTYGYIALELVYTMVVTEKCVI 307
RDI + N+LL+ + +ADFG L R GT ++A E++ K I
Sbjct: 125 RDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKADI 184
Query: 308 YSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQ----KIIQDIILV 363
+S G+ A+E+ G P +S P M + L + SPP + K ++ +
Sbjct: 185 WSLGITAIELAKGEPP-------NSDLHP--MRVLFLIPKNSPPTLEGQYSKPFKEFV-- 233
Query: 364 STIALACLRSKPKSRPTMQRI 384
ACL P+ RPT + +
Sbjct: 234 ----EACLNKDPRFRPTAKEL 250
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 4e-11
Identities = 45/163 (27%), Positives = 75/163 (46%), Gaps = 12/163 (7%)
Query: 167 GKVVALKKLHHSETEDSAFVVYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNI 226
++ LK+L H + EY+ GS+ +L ++ A E R N
Sbjct: 55 REIALLKELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALL-NNYGAFEETLVR--NF 111
Query: 227 VKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQA- 285
V+ + L+YLH I+HRDI NIL+++ ++DFG + L+ +S +
Sbjct: 112 VRQILKGLNYLH---NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGA 168
Query: 286 -----GTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHP 323
G+ ++A E+V T K I+S G + +E+L G HP
Sbjct: 169 RPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 4e-11
Identities = 69/271 (25%), Positives = 117/271 (43%), Gaps = 53/271 (19%)
Query: 151 IGTGGYDSVYKA-ELPDGK----VVALKKLHHS-------ETEDSAFV---VYSPQ---- 191
+G+G + +VYK +PDG+ VA+K L + E D A+V V SP
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74
Query: 192 ---CMF----FIYEYMERGSLFCVLRDDDEAIE----LNWTRRMNIVKSVAHALSYLHHD 240
C+ + + M G L +R++ + I LNW + +A +SYL
Sbjct: 75 LGICLTSTVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQ------IAKGMSYLEE- 127
Query: 241 CTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTY--GYIALELVYT 298
+VHRD+++ N+L+ S + DFG RLLD+D + G ++ALE +
Sbjct: 128 --VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILH 185
Query: 299 MVVTEKCVIYSFGVVALEVL-MGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKII 357
T + ++S+GV E++ G P + + + P ++ +RL P I
Sbjct: 186 RRFTHQSDVWSYGVTVWELMTFGAKPYD---GIPAREIPDLLEKG---ERLPQPPICTID 239
Query: 358 QDIILVSTIALACLRSKPKSRPTMQRISQEL 388
+I+V C + RP + + E
Sbjct: 240 VYMIMVK-----CWMIDSECRPRFRELVDEF 265
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 5e-11
Identities = 59/265 (22%), Positives = 115/265 (43%), Gaps = 46/265 (17%)
Query: 151 IGTGGYDSVYKAELPDGKVVALKKLHHSETEDSAFV-------------------VYSPQ 191
+G G + V+ VA+K L AF+ V + +
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVTQE 73
Query: 192 CMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDIS 251
++ I EYME GSL L+ E I+L + +++ +A ++++ + +HRD+
Sbjct: 74 PIYIITEYMENGSLVDFLKTP-EGIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLR 129
Query: 252 SNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGT---YGYIALELVYTMVVTEKCVIY 308
+ NIL++ L +ADFG RL ++ + T + G + A E + T K ++
Sbjct: 130 AANILVSETLCCKIADFGLARL--IEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVW 187
Query: 309 SFGVVALEVLMG---THPGELLLSLSSSSGPKIML-IDILYQRLSPPINQKIIQDIILVS 364
SFG++ E++ +PG + P+++ ++ Y+ P + + +++
Sbjct: 188 SFGILLTEIVTYGRIPYPG--------MTNPEVIQNLERGYRMPRPDNCPEELYELM--- 236
Query: 365 TIALACLRSKPKSRPTMQRISQELE 389
C + KP+ RPT + + LE
Sbjct: 237 ---RLCWKEKPEERPTFEYLRSVLE 258
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 5e-11
Identities = 59/272 (21%), Positives = 109/272 (40%), Gaps = 54/272 (19%)
Query: 146 HIRYCIGTGGYDSVYKAELPDGKVVALKKLHHSETEDSAF-------------------- 185
+ IG G + V + G+ VA+K L T AF
Sbjct: 9 KLGATIGKGEFGDVMLGDY-RGQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLG 67
Query: 186 VVYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSI 245
VV ++ + EYM +GSL LR A+ + +++ V + YL +
Sbjct: 68 VVLQGNPLYIVTEYMAKGSLVDYLRSRGRAV-ITLAQQLGFALDVCEGMEYLE---EKNF 123
Query: 246 VHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTY--GYIALELVYTMVVTE 303
VHRD+++ N+L++ +L A V+DFG + +++ +G + A E + +
Sbjct: 124 VHRDLAARNVLVSEDLVAKVSDFGLAK-----EASQGQDSGKLPVKWTAPEALREKKFST 178
Query: 304 KCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDIL------YQRLSPPINQKII 357
K ++SFG++ E+ S P+I L D++ Y+ +P +
Sbjct: 179 KSDVWSFGILLWEI----------YSFGRVPYPRIPLKDVVPHVEKGYRMEAPEGCPPEV 228
Query: 358 QDIILVSTIALACLRSKPKSRPTMQRISQELE 389
++ C P RPT +++ ++L
Sbjct: 229 YKVM------KDCWELDPAKRPTFKQLREQLA 254
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 6e-11
Identities = 59/227 (25%), Positives = 102/227 (44%), Gaps = 32/227 (14%)
Query: 172 LKKLHHSETEDSAFVVYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVA 231
+KKL H E + V S + ++ + EYM +GSL L+ + L + +++ +A
Sbjct: 55 MKKLRH-EKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKY-LRLPQLVDMAAQIA 112
Query: 232 HALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTY--G 289
++Y+ + VHRD+ + NIL+ NL VADFG RL++ D+ Q +
Sbjct: 113 SGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIK 168
Query: 290 YIALELVYTMVVTEKCVIYSFGVVALEVLMG---THPG----ELLLSLSSSSGPKIMLID 342
+ A E T K ++SFG++ E+ +PG E+L +
Sbjct: 169 WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG--------- 219
Query: 343 ILYQRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELE 389
Y+ PP + + D++ C R +P+ RPT + + LE
Sbjct: 220 --YRMPCPPECPESLHDLM------CQCWRKEPEERPTFEYLQAFLE 258
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 62.3 bits (152), Expect = 6e-11
Identities = 44/172 (25%), Positives = 73/172 (42%), Gaps = 31/172 (18%)
Query: 151 IGTGGYDSVYKA-ELPDGKVVALKKLHHSETED-----------------SAFVVY---- 188
IG G + V+KA + G+ VALKK+ E +VV
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67
Query: 189 --SPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIV 246
+ EYM L VLRD++ + + ++ + ++Y+H + I+
Sbjct: 68 FPHGSGFVLVMEYMPS-DLSEVLRDEERPLPEAQVKS--YMRMLLKGVAYMHAN---GIM 121
Query: 247 HRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNR-TLQAGTYGYIALELVY 297
HRD+ N+L++++ +ADFG RL + + Q T Y A EL+Y
Sbjct: 122 HRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLY 173
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 9e-11
Identities = 60/211 (28%), Positives = 96/211 (45%), Gaps = 26/211 (12%)
Query: 186 VVYSPQCMFFIYEYMERGSLFCVLRDDD---EAIELNWTRRMNIVKSVAHALSYLHHDCT 242
VV + + + EYME GSL LR D I+L + +++ +A + YL
Sbjct: 73 VVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQL-----VGMLRGIASGMKYL---SD 124
Query: 243 PSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVD-SSNRTLQAGTYG--YIALELVYTM 299
VHRD+++ NIL+NSNL V+DFG R+L+ D + T + G + A E +
Sbjct: 125 MGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYR 184
Query: 300 VVTEKCVIYSFGVVALEVL-MGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKIIQ 358
T ++S+G+V EV+ G P S+ I I+ Y RL P++
Sbjct: 185 KFTSASDVWSYGIVMWEVMSYGERP-----YWEMSNQDVIKAIEEGY-RLPAPMDCPAA- 237
Query: 359 DIILVSTIALACLRSKPKSRPTMQRISQELE 389
+ + L C + RP ++I L+
Sbjct: 238 ----LHQLMLDCWQKDRNERPKFEQIVSILD 264
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 61.2 bits (149), Expect = 1e-10
Identities = 51/208 (24%), Positives = 82/208 (39%), Gaps = 40/208 (19%)
Query: 145 FHIRYCIGTGGYDSVYKAELPD-GKVVALK---KLHHSETEDSA---------------F 185
F + IG G + V + D K+ A+K K E F
Sbjct: 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPF 61
Query: 186 VV---YSPQ---CMFFIYEYMERGSL-FCVLRD---DDEAIELNWTRRMNIVKSVAHALS 235
+V YS Q M+ + + + G L + + + +E ++ + + AL
Sbjct: 62 LVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKF-------WICEIVLALE 114
Query: 236 YLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTYGYIALEL 295
YLH + I+HRDI +NILL+ + DF + + T +GT GY+A E+
Sbjct: 115 YLH---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVT-PDTLTTSTSGTPGYMAPEV 170
Query: 296 VYTMVVTEKCVIYSFGVVALEVLMGTHP 323
+ + +S GV A E L G P
Sbjct: 171 LCRQGYSVAVDWWSLGVTAYECLRGKRP 198
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 1e-10
Identities = 45/165 (27%), Positives = 83/165 (50%), Gaps = 11/165 (6%)
Query: 161 KAELPDGKVVALKKLHHSETED--SAFVVYSPQCMFFIYEYMERGSLFCVLRDDDEAIEL 218
+ EL +VV ++ HH D ++++V ++ + E++E G+L D +
Sbjct: 62 RRELLFNEVVIMRDYHHENVVDMYNSYLVGDE--LWVVMEFLEGGAL----TDIVTHTRM 115
Query: 219 NWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDS 278
N + + SV ALSYLH ++HRDI S++ILL S+ ++DFG + +
Sbjct: 116 NEEQIATVCLSVLRALSYLH---NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV 172
Query: 279 SNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHP 323
R GT ++A E++ + + I+S G++ +E++ G P
Sbjct: 173 PKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPP 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 2e-10
Identities = 69/283 (24%), Positives = 123/283 (43%), Gaps = 52/283 (18%)
Query: 138 LIDATEYFHIRYCIGTGGYDSVYKA-ELPDGK----VVALKKLHHS-------ETEDSAF 185
++ TE+ I+ +G+G + +VYK +P+G+ VA+K+L + E D A+
Sbjct: 3 ILKETEFKKIK-VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 61
Query: 186 VVYSPQ----------CMF----FIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVA 231
V+ S C+ I + M G L +R+ + I + +N +A
Sbjct: 62 VMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYL--LNWCVQIA 119
Query: 232 HALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTY--G 289
++YL +VHRD+++ N+L+ + + DFG +LL D + G
Sbjct: 120 KGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIK 176
Query: 290 YIALELVYTMVVTEKCVIYSFGVVALEVL-MGTHPGELLLSLSSSSGPKIMLIDILY--Q 346
++ALE + + T + ++S+GV E++ G+ P + + P + IL +
Sbjct: 177 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI--------PASEISSILEKGE 228
Query: 347 RL-SPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQEL 388
RL PPI I V I + C SRP + + E
Sbjct: 229 RLPQPPICT------IDVYMIMVKCWMIDADSRPKFRELIIEF 265
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 60.0 bits (146), Expect = 3e-10
Identities = 58/228 (25%), Positives = 100/228 (43%), Gaps = 33/228 (14%)
Query: 172 LKKLHHSETEDSAFVVYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVA 231
+KKL H + V + ++ + EYM +GSL L+ E +L + +++ +A
Sbjct: 55 MKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSG-EGKKLRLPQLVDMAAQIA 113
Query: 232 HALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTYGYI 291
++YL + +HRD+++ NIL+ NL +ADFG RL++ D T + G I
Sbjct: 114 EGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIEDDEY--TAREGAKFPI 168
Query: 292 ---ALELVYTMVVTEKCVIYSFGVVALEVLM-------GTHPGELLLSLSSSSGPKIMLI 341
A E T K ++SFG++ E++ G E+L +
Sbjct: 169 KWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERG-------- 220
Query: 342 DILYQRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELE 389
Y+ PP + + D++ L C P+ RPT + + LE
Sbjct: 221 ---YRMPRPPNCPEELYDLM------LQCWDKDPEERPTFEYLQSFLE 259
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 3e-10
Identities = 55/224 (24%), Positives = 98/224 (43%), Gaps = 25/224 (11%)
Query: 172 LKKLHHSETEDSAFVVYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVA 231
+KKL H + V + ++ + E M+ GSL L+ L + +++ VA
Sbjct: 55 MKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGR-ALKLPQLIDMAAQVA 113
Query: 232 HALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSN-RTLQAGTYGY 290
++YL + +HRD+++ N+L+ N VADFG R++ D R +
Sbjct: 114 SGMAYLE---AQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKW 170
Query: 291 IALELVYTMVVTEKCVIYSFGVVALEVLMGTH-----PGELLLSLSSSSGPKIMLIDILY 345
A E + K ++SFG++ E++ T+ PG ++ + +D Y
Sbjct: 171 TAPEAALYNRFSIKSDVWSFGILLTEIV--TYGRMPYPG-------MTNAEVLQQVDQGY 221
Query: 346 QRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELE 389
+ PP K + DI+ L C + P RPT + + +LE
Sbjct: 222 RMPCPPGCPKELYDIM------LDCWKEDPDDRPTFETLQWKLE 259
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 3e-10
Identities = 59/226 (26%), Positives = 101/226 (44%), Gaps = 30/226 (13%)
Query: 172 LKKLHHSETEDSAFVVYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVA 231
+KKL H + + V S + ++ + EYM +GSL L+D + L +++ VA
Sbjct: 55 MKKLRHDKLV-QLYAVVSEEPIYIVTEYMSKGSLLDFLKDGE-GRALKLPNLVDMAAQVA 112
Query: 232 HALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTY--G 289
++Y+ + +HRD+ S NIL+ L +ADFG RL++ D+ Q +
Sbjct: 113 AGMAYIER---MNYIHRDLRSANILVGDGLVCKIADFGLARLIE-DNEYTARQGAKFPIK 168
Query: 290 YIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQ--- 346
+ A E T K ++SFG++ E L++ P + ++L Q
Sbjct: 169 WTAPEAALYGRFTIKSDVWSFGILLTE----------LVTKGRVPYPGMNNREVLEQVER 218
Query: 347 --RLSPPINQKIIQDI-ILVSTIALACLRSKPKSRPTMQRISQELE 389
R+ P QD I + + L C + P+ RPT + + LE
Sbjct: 219 GYRMPCP------QDCPISLHELMLQCWKKDPEERPTFEYLQSFLE 258
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 3e-10
Identities = 68/279 (24%), Positives = 105/279 (37%), Gaps = 65/279 (23%)
Query: 145 FHIRYCIGTGGYDSVYKAE-LPDGKVVALKK-----LHHSETEDS--------------- 183
F + +G G Y SVYK + L D + ALK+ + E ED+
Sbjct: 2 FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNI 61
Query: 184 -----AFVVYSPQCMFFIYEYMERGSLFCVLRDDDEAI-----ELNWTRRMNIVKSVAHA 233
AF+ + C+ + EY G L + + + W I +
Sbjct: 62 ISYKEAFLDGNKLCI--VMEYAPFGDLSKAISKRKKKRKLIPEQEIW----RIFIQLLRG 115
Query: 234 LSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTYGYIAL 293
L LH I+HRD+ S NILL +N + D G ++L + + Q GT Y+A
Sbjct: 116 LQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKT--QIGTPHYMAP 170
Query: 294 ELVYTMVVTEKCVIYSFGVVALEVLMGTHP------GELLLSLSSSSGPKIMLIDILYQR 347
E+ + K I+S G + E+ P +L + P I
Sbjct: 171 EVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPI--------- 221
Query: 348 LSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQ 386
PPI + +Q+ I + L+ KPK RP +I
Sbjct: 222 --PPIYSQDLQNFI------RSMLQVKPKLRPNCDKILA 252
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 5e-10
Identities = 50/198 (25%), Positives = 88/198 (44%), Gaps = 35/198 (17%)
Query: 151 IGTGGYDSVYKA-ELPDGKVVALKKLHHSETEDSAFVVYSPQCM---------------- 193
IG G +VY A ++ G+ VA+K+++ + ++ M
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYL 86
Query: 194 -----FFIYEYMERGSLFCVLRD---DDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSI 245
+ + EY+ GSL V+ + D+ I + + AL +LH + +
Sbjct: 87 VGDELWVVMEYLAGGSLTDVVTETCMDEGQIAA-------VCRECLQALEFLHSN---QV 136
Query: 246 VHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTYGYIALELVYTMVVTEKC 305
+HRDI S+NILL + + DFG + + S R+ GT ++A E+V K
Sbjct: 137 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKV 196
Query: 306 VIYSFGVVALEVLMGTHP 323
I+S G++A+E++ G P
Sbjct: 197 DIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 58.9 bits (143), Expect = 6e-10
Identities = 55/207 (26%), Positives = 89/207 (42%), Gaps = 19/207 (9%)
Query: 186 VVYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSI 245
VV + M + E GSL LR D + + +A+ + YL +
Sbjct: 64 VVLTHPLMM-VTELAPLGSLLDRLRKDALGH-FLISTLCDYAVQIANGMRYLE---SKRF 118
Query: 246 VHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGT---YGYIALELVYTMVVT 302
+HRD+++ NILL S+ + + DFG +R L + + ++ + + A E + T +
Sbjct: 119 IHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFS 178
Query: 303 EKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIM-LIDILYQRLSPPINQKIIQDII 361
++ FGV E M T+ E L SG +I+ ID +RL P + QDI
Sbjct: 179 HASDVWMFGVTLWE--MFTYGEEPWAGL---SGSQILKKIDKEGERLERP--EACPQDIY 231
Query: 362 LVSTIALACLRSKPKSRPTMQRISQEL 388
+ L C P RPT + + L
Sbjct: 232 ---NVMLQCWAHNPADRPTFAALREFL 255
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 7e-10
Identities = 47/199 (23%), Positives = 83/199 (41%), Gaps = 42/199 (21%)
Query: 198 EYMERGSLFCVLRDD---DEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNN 254
E+M GS+ +L EA+ +N+T + + LSYLH + I+HRD+ N
Sbjct: 83 EWMAGGSVSHLLSKYGAFKEAVIINYTEQ------LLRGLSYLHEN---QIIHRDVKGAN 133
Query: 255 ILLNSNLEAF-VADFGTVRLLDVDSSNR-TLQA---GTYGYIALELVYTMVVTEKCVIYS 309
+L++S + +ADFG L + Q GT ++A E++ C ++S
Sbjct: 134 LLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWS 193
Query: 310 FGVVALEVLMGTHPG---------ELLLSLSSSSGPKIMLIDILYQRLSPPINQKIIQDI 360
G V +E+ P L+ ++S++ P I + +
Sbjct: 194 VGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTA-------------PSIPEHLSPG- 239
Query: 361 ILVSTIALACLRSKPKSRP 379
+ + L CL +P+ RP
Sbjct: 240 --LRDVTLRCLELQPEDRP 256
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 7e-10
Identities = 68/269 (25%), Positives = 107/269 (39%), Gaps = 43/269 (15%)
Query: 140 DATEYFHIRYCIGTGGYDSVYKA-ELPDGKVVALKKLHHSETED-----SAFVVYSPQC- 192
D E F IG G + V+K + +VVA+K + E ED + QC
Sbjct: 1 DPEELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCD 60
Query: 193 ----------------MFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSY 236
++ I EY+ GS +LR A + + ++K + L Y
Sbjct: 61 SPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLR----AGPFDEFQIATMLKEILKGLDY 116
Query: 237 LHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTYGYIALELV 296
LH + +HRDI + N+LL+ + +ADFG L R GT ++A E++
Sbjct: 117 LHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI 173
Query: 297 YTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKI 356
K I+S G+ A+E+ G P +S P M + L + +PP +
Sbjct: 174 QQSAYDSKADIWSLGITAIELAKGEPP-------NSDMHP--MRVLFLIPKNNPP---TL 221
Query: 357 IQDIIL-VSTIALACLRSKPKSRPTMQRI 384
+ ACL P RPT + +
Sbjct: 222 TGEFSKPFKEFIDACLNKDPSFRPTAKEL 250
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 7e-10
Identities = 50/197 (25%), Positives = 88/197 (44%), Gaps = 33/197 (16%)
Query: 151 IGTGGYDSVYKA-ELPDGKVVALKKLHHSETEDSAFVVYSPQCM---------------- 193
IG G +VY A ++ G+ VA+K+++ + ++ M
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 86
Query: 194 -----FFIYEYMERGSLFCVLRDD--DEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIV 246
+ + EY+ GSL V+ + DE + + + AL +LH + ++
Sbjct: 87 VGDELWVVMEYLAGGSLTDVVTETCMDEG------QIAAVCRECLQALDFLHSN---QVI 137
Query: 247 HRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTYGYIALELVYTMVVTEKCV 306
HRDI S+NILL + + DFG + + S R+ GT ++A E+V K
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVD 197
Query: 307 IYSFGVVALEVLMGTHP 323
I+S G++A+E++ G P
Sbjct: 198 IWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 7e-10
Identities = 44/167 (26%), Positives = 81/167 (48%), Gaps = 19/167 (11%)
Query: 163 ELPDGKVVALKKLHHS---ETEDSAFVVYSPQCMFFIYEYMERGSLFCVL---RDDDEAI 216
EL +VV ++ H E S V ++ + E++E G+L ++ R ++E I
Sbjct: 61 ELLFNEVVIMRDYQHPNIVEMYSSYLV---GDELWVVMEFLEGGALTDIVTHTRMNEEQI 117
Query: 217 ELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDV 276
+ +V ALS+LH ++HRDI S++ILL S+ ++DFG +
Sbjct: 118 A-------TVCLAVLKALSFLH---AQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSK 167
Query: 277 DSSNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHP 323
+ R GT ++A E++ + + I+S G++ +E++ G P
Sbjct: 168 EVPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 8e-10
Identities = 57/262 (21%), Positives = 116/262 (44%), Gaps = 40/262 (15%)
Query: 151 IGTGGYDSVYKAELPDGKVVALKKLHHSETEDSAFV-------------------VYSPQ 191
+G G + V+ A VA+K + AF+ V + +
Sbjct: 14 LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTKE 73
Query: 192 CMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDIS 251
++ I E+M +GSL L+ D E + + ++ +A ++++ + +HRD+
Sbjct: 74 PIYIITEFMAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLR 129
Query: 252 SNNILLNSNLEAFVADFGTVRLL-DVDSSNRTLQAGTYGYIALELVYTMVVTEKCVIYSF 310
+ NIL++++L +ADFG R++ D + + R + A E + T K ++SF
Sbjct: 130 AANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSF 189
Query: 311 GVVALEVLM---GTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKIIQDIILVSTIA 367
G++ +E++ +PG S P++ I L + P + +++ I
Sbjct: 190 GILLMEIVTYGRIPYPG--------MSNPEV--IRALERGYRMPRPENCPEELY---NIM 236
Query: 368 LACLRSKPKSRPTMQRISQELE 389
+ C +++P+ RPT + I L+
Sbjct: 237 MRCWKNRPEERPTFEYIQSVLD 258
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 8e-10
Identities = 67/277 (24%), Positives = 118/277 (42%), Gaps = 43/277 (15%)
Query: 123 VFSVWNYDGKIL-YENLIDATEYFHIRYCIGTGGYDSVYK-AELPDGKVVALKKLH---- 176
++ ++ Y+ +L E+L D T+ + I IG G Y VYK DG + A+K L
Sbjct: 1 LYGLFPYNSSMLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD 60
Query: 177 -----HSETEDSAFVVYSPQC-----MFFIYEYMERGSLFCVLR-----DDDEAIE--LN 219
+E + P MF+ + + G L+ VL E ++ L
Sbjct: 61 VDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLI 120
Query: 220 WTRRMN------IVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRL 273
+R++ I+ L +LH++ I+HRD+ NNILL + + DFG
Sbjct: 121 CGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQ 177
Query: 274 LDVDSSNRTLQAGTYGYIALELV-----YTMVVTEKCVIYSFGVVALEV------LMGTH 322
L R GT ++A E++ Y +C ++S G+ A+E+ L H
Sbjct: 178 LTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMH 237
Query: 323 PGELLLSLSSSSGPKIMLIDILYQRLSPPINQKIIQD 359
P + L + + P ++ + + + I+Q +I+D
Sbjct: 238 PVKTLFKIPRNPPPTLLHPEKWCRSFNHFISQCLIKD 274
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 59.0 bits (142), Expect = 1e-09
Identities = 40/133 (30%), Positives = 68/133 (51%), Gaps = 11/133 (8%)
Query: 193 MFFIYEYMERGSLFCVLRDD--DEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDI 250
+F + EY+ GSL V+ + DEA + + + AL +LH + ++HRDI
Sbjct: 91 LFVVMEYLAGGSLTDVVTETCMDEA------QIAAVCRECLQALEFLHAN---QVIHRDI 141
Query: 251 SSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTYGYIALELVYTMVVTEKCVIYSF 310
S+N+LL + + DFG + + S R+ GT ++A E+V K I+S
Sbjct: 142 KSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSL 201
Query: 311 GVVALEVLMGTHP 323
G++A+E++ G P
Sbjct: 202 GIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 58.5 bits (142), Expect = 1e-09
Identities = 58/211 (27%), Positives = 82/211 (38%), Gaps = 51/211 (24%)
Query: 151 IGTGGYDSVYKA-ELPDGKVVALKKLH--------HSETEDSAFV--------------- 186
IG G + VY A L G+++A+K++ E D V
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGV 67
Query: 187 -VYSPQCMFFIYEYMERGSLFCVL---RDDDEAIELNWTRRMNIVKSVAHALSYLHHDCT 242
V+ + F+ EY G+L +L R DE + R + L+YLH +
Sbjct: 68 EVHREKVYIFM-EYCSGGTLEELLEHGRILDEHV----IRVY--TLQLLEGLAYLH---S 117
Query: 243 PSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQ-------AGTYGYIALEL 295
IVHRDI NI L+ N + DFG L +N T AGT Y+A E+
Sbjct: 118 HGIVHRDIKPANIFLDHNGVIKLGDFGCAVKL---KNNTTTMGEEVQSLAGTPAYMAPEV 174
Query: 296 VYTMVVTEK---CVIYSFGVVALEVLMGTHP 323
+ I+S G V LE+ G P
Sbjct: 175 ITGGKGKGHGRAADIWSLGCVVLEMATGKRP 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 58.0 bits (141), Expect = 1e-09
Identities = 53/202 (26%), Positives = 85/202 (42%), Gaps = 40/202 (19%)
Query: 151 IGTGGYDSVYKAEL-PDGKVVALKKL--HH-----------SETE-----DSAFVV---- 187
+G GG+ V ++ + ALK + H SE E + F+V
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 188 --YSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSI 245
+ ++ + EY G L+ +LRD + +T R + V A YLH+ I
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILRD--RGLFDEYTARF-YIACVVLAFEYLHNR---GI 114
Query: 246 VHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTYGYIALELV----YTMVV 301
++RD+ N+LL+SN + DFG + L T GT Y+A E++ Y V
Sbjct: 115 IYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTF-CGTPEYVAPEIILNKGYDFSV 173
Query: 302 TEKCVIYSFGVVALEVLMGTHP 323
+S G++ E+L G P
Sbjct: 174 D----YWSLGILLYELLTGRPP 191
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 1e-09
Identities = 35/131 (26%), Positives = 67/131 (51%), Gaps = 7/131 (5%)
Query: 193 MFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISS 252
++ + E+++ G+L ++ LN + + +SV AL YLH + ++HRDI S
Sbjct: 93 LWVLMEFLQGGALTDIVSQ----TRLNEEQIATVCESVLQALCYLH---SQGVIHRDIKS 145
Query: 253 NNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGV 312
++ILL + ++DFG + D R GT ++A E++ + I+S G+
Sbjct: 146 DSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGI 205
Query: 313 VALEVLMGTHP 323
+ +E++ G P
Sbjct: 206 MVIEMVDGEPP 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 1e-09
Identities = 54/207 (26%), Positives = 86/207 (41%), Gaps = 38/207 (18%)
Query: 192 CMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYL---HHDCTPSIVHR 248
CM E+M+ GSL + + + + I +V L+YL H I+HR
Sbjct: 81 CM----EFMDCGSLDRIYK---KGGPIPVEILGKIAVAVVEGLTYLYNVHR-----IMHR 128
Query: 249 DISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTYGYIALELVYTMVVTEKCVIY 308
DI +NIL+NS + + DFG L ++S T GT Y++ E + T K ++
Sbjct: 129 DIKPSNILVNSRGQIKLCDFGVSGEL-INSIADTF-VGTSTYMSPERIQGGKYTVKSDVW 186
Query: 309 SFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQ-------RLS----PPINQKII 357
S G+ +E+ +G P + ++D+L Q RL P + +
Sbjct: 187 SLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFPEDLRDFV 246
Query: 358 QDIILVSTIALACLRSKPKSRPTMQRI 384
ACL P RPT Q++
Sbjct: 247 D----------ACLLKDPTERPTPQQL 263
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 2e-09
Identities = 52/202 (25%), Positives = 90/202 (44%), Gaps = 25/202 (12%)
Query: 194 FFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSN 253
+ I E+M G+L LR+ + E+N + + ++ A+ YL + +HRD+++
Sbjct: 78 YIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAAR 133
Query: 254 NILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGT---YGYIALELVYTMVVTEKCVIYSF 310
N L+ N VADFG RL+ D+ T AG + A E + + K +++F
Sbjct: 134 NCLVGENHLVKVADFGLSRLMTGDTY--TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAF 191
Query: 311 GVVALEVL---MGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKIIQDIILVSTIA 367
GV+ E+ M +PG + LS L++ Y+ P + +++
Sbjct: 192 GVLLWEIATYGMSPYPG---IDLSQVYE----LLEKGYRMERPEGCPPKVYELM------ 238
Query: 368 LACLRSKPKSRPTMQRISQELE 389
AC + P RP+ I Q E
Sbjct: 239 RACWQWNPSDRPSFAEIHQAFE 260
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 2e-09
Identities = 67/279 (24%), Positives = 115/279 (41%), Gaps = 76/279 (27%)
Query: 151 IGTGGYDSVYKA-ELPDGKVVALKKLH--HSE--------------TEDSAFVVYSPQC- 192
IG+G +VYK P G++ ALK ++ H + + VV +C
Sbjct: 82 IGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVV---KCH 138
Query: 193 -MF-------FIYEYMERGSLFCVLRDDDEAIELNWTRRM-NIVKSVAHALSYLHHDCTP 243
MF + E+M+ GSL E + + + ++ + + ++YLH
Sbjct: 139 DMFDHNGEIQVLLEFMDGGSL--------EGTHIADEQFLADVARQILSGIAYLHRR--- 187
Query: 244 SIVHRDISSNNILLNSNLEAFVADFGTVRLLD--VDSSNRTLQAGTYGYIALELVYTMV- 300
IVHRDI +N+L+NS +ADFG R+L +D N ++ GT Y++ E + T +
Sbjct: 188 HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSV--GTIAYMSPERINTDLN 245
Query: 301 --VTEKCV--IYSFGVVALEVLMGTHP---------GELLLSLSSSSGPKIMLIDILYQR 347
+ I+S GV LE +G P L+ ++ S P+
Sbjct: 246 HGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPE---------- 295
Query: 348 LSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQ 386
+P + + I CL+ +P R + ++ Q
Sbjct: 296 -APATASREFRHFISC------CLQREPAKRWSAMQLLQ 327
|
Length = 353 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 57.8 bits (139), Expect = 2e-09
Identities = 49/197 (24%), Positives = 88/197 (44%), Gaps = 33/197 (16%)
Query: 151 IGTGGYDSVYKA-ELPDGKVVALKKLHHSETEDSAFVVYSPQCM---------------- 193
IG G +VY A ++ G+ VA+++++ + ++ M
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 194 -----FFIYEYMERGSLFCVLRDD--DEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIV 246
+ + EY+ GSL V+ + DE + + + AL +LH + ++
Sbjct: 88 VGDELWVVMEYLAGGSLTDVVTETCMDEG------QIAAVCRECLQALEFLHSN---QVI 138
Query: 247 HRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTYGYIALELVYTMVVTEKCV 306
HRDI S+NILL + + DFG + + S R+ GT ++A E+V K
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVD 198
Query: 307 IYSFGVVALEVLMGTHP 323
I+S G++A+E++ G P
Sbjct: 199 IWSLGIMAIEMIEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 2e-09
Identities = 43/166 (25%), Positives = 79/166 (47%), Gaps = 17/166 (10%)
Query: 222 RRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNR 281
R NI + AL YLH + IVHRD++ NNI+L + + + DFG + S
Sbjct: 114 RIWNIFVQMVLALRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQ-PESKL 170
Query: 282 TLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHP--GELLLSLSSSSGPKIM 339
T GT Y E+V EK +++FG + ++ P +LSL++
Sbjct: 171 TSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATK------ 224
Query: 340 LIDILYQRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRIS 385
+++ +Y+ P+ + + + V+ + +CL ++RP + ++S
Sbjct: 225 IVEAVYE----PLPEGMYSE--DVTDVITSCLTPDAEARPDIIQVS 264
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 3e-09
Identities = 52/223 (23%), Positives = 103/223 (46%), Gaps = 24/223 (10%)
Query: 172 LKKLHHSETEDSAFVVYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVA 231
+KKL H + + V S + ++ + E+M +GSL L++ D L + +++ +A
Sbjct: 55 MKKLRHDKLV-PLYAVVSEEPIYIVTEFMGKGSLLDFLKEGD-GKYLKLPQLVDMAAQIA 112
Query: 232 HALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTY--G 289
++Y+ + +HRD+ + NIL+ NL +ADFG RL++ D+ Q +
Sbjct: 113 DGMAYIER---MNYIHRDLRAANILVGDNLVCKIADFGLARLIE-DNEYTARQGAKFPIK 168
Query: 290 YIALELVYTMVVTEKCVIYSFGVVALEVLMG---THPGELLLSLSSSSGPKIMLIDILYQ 346
+ A E T K ++SFG++ E++ +PG + + + ++ Y+
Sbjct: 169 WTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREV-------LEQVERGYR 221
Query: 347 RLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELE 389
P + + +++ + C + P RPT + I LE
Sbjct: 222 MPCPQGCPESLHELMKL------CWKKDPDERPTFEYIQSFLE 258
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 4e-09
Identities = 56/226 (24%), Positives = 105/226 (46%), Gaps = 32/226 (14%)
Query: 171 ALKKLHHSETEDSAFVVYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSV 230
+ KLHH V+ ++ + E M +G+L LR A+ ++ + + V
Sbjct: 52 VMTKLHHKNLVRLLGVILH-NGLYIVMELMSKGNLVNFLRTRGRAL-VSVIQLLQFSLDV 109
Query: 231 AHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRL--LDVDSSNRTLQAGTY 288
A + YL + +VHRD+++ NIL++ + A V+DFG R+ + VD+S ++
Sbjct: 110 AEGMEYLE---SKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVK---- 162
Query: 289 GYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQ-- 346
+ A E + + K ++S+GV+ EV S + PK+ L ++
Sbjct: 163 -WTAPEALKHKKFSSKSDVWSYGVLLWEV----------FSYGRAPYPKMSLKEVKECVE 211
Query: 347 ---RLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELE 389
R+ PP + D V + +C ++PK RP+ ++ ++LE
Sbjct: 212 KGYRMEPP--EGCPAD---VYVLMTSCWETEPKKRPSFHKLREKLE 252
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 5e-09
Identities = 57/241 (23%), Positives = 96/241 (39%), Gaps = 45/241 (18%)
Query: 138 LIDATEYFHIRYCIGTGGYDSVYKAE-LPDGKVVALKKL--------------------- 175
L D F + +G G Y VYK + G++ A+K +
Sbjct: 1 LRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYS 60
Query: 176 HHSE--TEDSAFVVYSPQCM----FFIYEYMERGSLFCVLRDDD-EAIELNWTRRMNIVK 228
HH T AF+ +P M + + E+ GS+ ++++ ++ W I +
Sbjct: 61 HHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWI--AYICR 118
Query: 229 SVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTY 288
+ LS+LH ++HRDI N+LL N E + DFG LD R GT
Sbjct: 119 EILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTP 175
Query: 289 GYIALELVYT-----MVVTEKCVIYSFGVVALEVLMGT------HPGELLLSLSSSSGPK 337
++A E++ K ++S G+ A+E+ G HP L + + P+
Sbjct: 176 YWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPR 235
Query: 338 I 338
+
Sbjct: 236 L 236
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 5e-09
Identities = 59/220 (26%), Positives = 84/220 (38%), Gaps = 46/220 (20%)
Query: 198 EYMERGSLFCVLRDDDEAIELNWTRRMN---------IVKSVAHALSYLHHDCTPSIVHR 248
EY E GSL ++I +R I +SV LSYLH + I+HR
Sbjct: 81 EYCEGGSL--------DSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLH---SRKIIHR 129
Query: 249 DISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTYGYIALELVYTMVVTEKCVIY 308
DI +NILL + + DFG L V+S T GT Y+A E + + ++
Sbjct: 130 DIKPSNILLTRKGQVKLCDFGVSGEL-VNSLAGTF-TGTSFYMAPERIQGKPYSITSDVW 187
Query: 309 SFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDIL--YQRLSPPINQ----------KI 356
S G+ LEV P P + I++L + P + +
Sbjct: 188 SLGLTLLEVAQNRFP------FPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGIKWSEE 241
Query: 357 IQDIILVSTIALACLRSKPKSRPTMQRISQELEGKTPMKK 396
+D I CL P RPT + + K MKK
Sbjct: 242 FKDFIKQ------CLEKDPTRRPTPWDMLEHPWIKAQMKK 275
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 56.8 bits (138), Expect = 5e-09
Identities = 52/199 (26%), Positives = 77/199 (38%), Gaps = 59/199 (29%)
Query: 151 IGTGGYDSVYKAE-LPDGKVVALKKL---HHSETED----SAF----------------- 185
+G G Y VYKA G++VA+KK+ E +D +A
Sbjct: 8 LGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGL 67
Query: 186 --VVYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAH----------A 233
V + ++E+ME L V++D +IV + A
Sbjct: 68 LDVFGHKSNINLVFEFME-TDLEKVIKD------------KSIVLTPADIKSYMLMTLRG 114
Query: 234 LSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTYGYIAL 293
L YLH + I+HRD+ NN+L+ S+ +ADFG R + T Q T Y A
Sbjct: 115 LEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVTRWYRAP 171
Query: 294 ELVYTMVVTEKCVIYSFGV 312
EL++ Y GV
Sbjct: 172 ELLF------GARHYGVGV 184
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 5e-09
Identities = 52/201 (25%), Positives = 98/201 (48%), Gaps = 32/201 (15%)
Query: 198 EYMERGSLFCVLRDD---DEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNN 254
EY+ GS+ LR +E + +T + V L+YLH + I+HRD+ ++N
Sbjct: 88 EYVPGGSIGSCLRTYGRFEEQLVRFFTEQ------VLEGLAYLH---SKGILHRDLKADN 138
Query: 255 ILLNSNLEAFVADFGTVRLLD---VDSSNRTLQAGTYGYIALELV--YTMVVTEKCVIYS 309
+L++++ ++DFG + D + N ++Q G+ ++A E++ Y+ + K I+S
Sbjct: 139 LLVDADGICKISDFGISKKSDDIYDNDQNMSMQ-GSVFWMAPEVIHSYSQGYSAKVDIWS 197
Query: 310 FGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKIIQDIILVSTIAL- 368
G V LE+ G P ++++ + + +R +PPI + +S +AL
Sbjct: 198 LGCVVLEMFAGRRPWSDEEAIAA-------MFKLGNKRSAPPIPPDVSM---NLSPVALD 247
Query: 369 ---ACLRSKPKSRPTMQRISQ 386
AC P +RPT + + Q
Sbjct: 248 FLNACFTINPDNRPTARELLQ 268
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 7e-09
Identities = 63/250 (25%), Positives = 101/250 (40%), Gaps = 49/250 (19%)
Query: 151 IGTGGYDSVYKA-ELPDGKVVALKK-----------------------LHHSETEDSAFV 186
IG G Y VY+A + G++VALKK L H + V
Sbjct: 15 IGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEV 74
Query: 187 VYSPQ--CMFFIYEYMER--GSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCT 242
V +F + EY E+ SL D+ + ++ ++ + L YLH +
Sbjct: 75 VVGKHLDSIFLVMEYCEQDLASLL-----DNMPTPFSESQVKCLMLQLLRGLQYLHENF- 128
Query: 243 PSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTYGYIALELVYTMVVT 302
I+HRD+ +N+LL +ADFG R + + T + T Y A EL+
Sbjct: 129 --IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLGCTTY 186
Query: 303 EKCV-IYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKI---IQ 358
+ +++ G + E+L + LL S +I +D++ Q L P N+ I
Sbjct: 187 TTAIDMWAVGCILAELLA----HKPLLPGKS----EIEQLDLIIQLLGTP-NESIWPGFS 237
Query: 359 DIILVSTIAL 368
D+ LV L
Sbjct: 238 DLPLVGKFTL 247
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 7e-09
Identities = 57/241 (23%), Positives = 99/241 (41%), Gaps = 45/241 (18%)
Query: 138 LIDATEYFHIRYCIGTGGYDSVYKAE-LPDGKVVALKKLHHSETEDS------------- 183
L D F + +G G Y VYK + G++ A+K + +E E+
Sbjct: 11 LRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYS 70
Query: 184 ----------AFVVYSP----QCMFFIYEYMERGSLFCVLRDDD-EAIELNWTRRMNIVK 228
AF+ SP ++ + E+ GS+ ++++ A++ +W I +
Sbjct: 71 HHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWI--AYICR 128
Query: 229 SVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTY 288
+ L++LH ++HRDI N+LL N E + DFG LD R GT
Sbjct: 129 EILRGLAHLH---AHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTP 185
Query: 289 GYIALELVYT-----MVVTEKCVIYSFGVVALEVLMGT------HPGELLLSLSSSSGPK 337
++A E++ + I+S G+ A+E+ G HP L + + PK
Sbjct: 186 YWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPK 245
Query: 338 I 338
+
Sbjct: 246 L 246
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 2e-08
Identities = 66/288 (22%), Positives = 116/288 (40%), Gaps = 67/288 (23%)
Query: 151 IGTGGYDSVYKAEL-----PDGKV-VALKKLHHSETE-DSAFVVYSPQCM---------- 193
+G G + V KAE P+ VA+K L TE D + +V + M
Sbjct: 20 LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNII 79
Query: 194 ------------FFIYEYMERGSLFCVLR-----------DDDEAIELNWTRR--MNIVK 228
+ + EY G+L LR DD E T++ ++
Sbjct: 80 NLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAY 139
Query: 229 SVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVR-LLDVDSSNRTLQAG- 286
VA + +L + +HRD+++ N+L+ + +ADFG R + +D +T
Sbjct: 140 QVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRL 196
Query: 287 TYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKI---MLIDI 343
++A E ++ V T + ++SFGV+ E+ +L S P I L +
Sbjct: 197 PVKWMAPEALFDRVYTHQSDVWSFGVLLWEI----------FTLGGSPYPGIPVEELFKL 246
Query: 344 LYQ--RLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELE 389
L + R+ P N Q+ + + C P RPT +++ ++L+
Sbjct: 247 LKEGYRMEKPQNCT--QE---LYHLMRDCWHEVPSQRPTFKQLVEDLD 289
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 54.6 bits (132), Expect = 3e-08
Identities = 46/185 (24%), Positives = 78/185 (42%), Gaps = 44/185 (23%)
Query: 151 IGTGGYDSVYKA-ELPDGKVVALKK-LHHSETED------------------------SA 184
+G G + VYKA ++ G+VVALKK L H+E +
Sbjct: 16 LGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDM 75
Query: 185 FVVYSPQ------CMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLH 238
V + ++ + YM+ L +L ++ +++L ++ + + ++YLH
Sbjct: 76 AVERPDKSKRKRGSVYMVTPYMDH-DLSGLL--ENPSVKLTESQIKCYMLQLLEGINYLH 132
Query: 239 HDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTYGYIALELVYT 298
+ I+HRDI + NIL+++ +ADFG R D N G YT
Sbjct: 133 EN---HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPN-----PKGGGGGGTRKYT 184
Query: 299 -MVVT 302
+VVT
Sbjct: 185 NLVVT 189
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 3e-08
Identities = 53/205 (25%), Positives = 87/205 (42%), Gaps = 39/205 (19%)
Query: 151 IGTGGYDSVYKA-ELPDGKVVALKKLHHSETEDSAF-----------------------V 186
+G G Y SVYK P G +A+K++ E ++S F
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIR-LELDESKFNQIIMELDILHKAVSPYIVDFYGA 67
Query: 187 VYSPQCMFFIYEYMERGSLFCVL--RDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPS 244
+ ++ EYM+ GSL + E I + RR I +V L +L + +
Sbjct: 68 FFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRR--ITYAVVKGLKFLKEE--HN 123
Query: 245 IVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTYGYIALELVYTMVVTEK 304
I+HRD+ N+L+N N + + DFG L V S +T G Y+A E + + +
Sbjct: 124 IIHRDVKPTNVLVNGNGQVKLCDFGVSGNL-VASLAKT-NIGCQSYMAPERIKSGGPNQN 181
Query: 305 CV------IYSFGVVALEVLMGTHP 323
++S G+ LE+ +G +P
Sbjct: 182 PTYTVQSDVWSLGLSILEMALGRYP 206
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 3e-08
Identities = 35/106 (33%), Positives = 54/106 (50%), Gaps = 15/106 (14%)
Query: 226 IVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQA 285
I S+ AL YLH S++HRD+ +N+L+N N + + DFG L VDS +T+ A
Sbjct: 108 IAVSIVKALEYLHS--KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYL-VDSVAKTIDA 164
Query: 286 GTYGYIALELV--------YTMVVTEKCVIYSFGVVALEVLMGTHP 323
G Y+A E + Y + K ++S G+ +E+ G P
Sbjct: 165 GCKPYMAPERINPELNQKGYDV----KSDVWSLGITMIELATGRFP 206
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 4e-08
Identities = 40/163 (24%), Positives = 75/163 (46%), Gaps = 7/163 (4%)
Query: 161 KAELPDGKVVALKKLHHSETEDSAFVVYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNW 220
+ EL +VV ++ H + ++ + E++E G+L D +N
Sbjct: 60 RRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL----TDIVTHTRMNE 115
Query: 221 TRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSN 280
+ + +V ALS LH ++HRDI S++ILL + ++DFG + +
Sbjct: 116 EQIAAVCLAVLKALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR 172
Query: 281 RTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHP 323
R GT ++A EL+ + + I+S G++ +E++ G P
Sbjct: 173 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 4e-08
Identities = 38/148 (25%), Positives = 75/148 (50%), Gaps = 5/148 (3%)
Query: 172 LKKLHHSETEDSAFVVYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVA 231
+K L H + VV + ++ I EYM +GSL L+ D E ++ + ++ +A
Sbjct: 55 MKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSD-EGGKVLLPKLIDFSAQIA 113
Query: 232 HALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLL-DVDSSNRTLQAGTYGY 290
++Y+ + +HRD+ + N+L++ +L +ADFG R++ D + + R +
Sbjct: 114 EGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKW 170
Query: 291 IALELVYTMVVTEKCVIYSFGVVALEVL 318
A E + T K ++SFG++ E++
Sbjct: 171 TAPEAINFGSFTIKSDVWSFGILLYEIV 198
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 8e-08
Identities = 47/217 (21%), Positives = 91/217 (41%), Gaps = 26/217 (11%)
Query: 174 KLHHSETEDSAFVVYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHA 233
KL H + V + ++ + EYM G L LR+ + + ++ + + K V
Sbjct: 55 KLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQP--SQLLEMCKDVCEG 112
Query: 234 LSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVR-LLDVDSSNRTLQAGTYGYIA 292
++YL + +HRD+++ N L++ V+DFG R +LD + ++ +
Sbjct: 113 MAYLE---SKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSP 169
Query: 293 LELVYTMVVTEKCVIYSFGVVALEVL-MGTHPGELL----LSLSSSSGPKIMLIDILYQR 347
E++ + K +++FGV+ EV +G P E S G ++ + ++
Sbjct: 170 PEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRPHLASEK 229
Query: 348 LSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRI 384
V I +C K + RPT Q++
Sbjct: 230 ---------------VYAIMYSCWHEKAEERPTFQQL 251
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 52.8 bits (126), Expect = 1e-07
Identities = 71/304 (23%), Positives = 127/304 (41%), Gaps = 65/304 (21%)
Query: 151 IGTGGYDSVYKA-ELPDGKVV----ALKKLHHS-------ETEDSAFVVYS---PQ---- 191
+G+G + +VYK +P+G+ V A+K L+ + E D A ++ S P
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74
Query: 192 ---CMF----FIYEYMERGSLFCVLRDDDEAIE----LNWTRRMNIVKSVAHALSYLHHD 240
C+ + + M G L + + + I LNW + +A + YL
Sbjct: 75 LGVCLSPTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQ------IAKGMMYLEER 128
Query: 241 CTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTY--GYIALELVYT 298
+VHRD+++ N+L+ S + DFG RLL+ D G ++ALE ++
Sbjct: 129 ---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHY 185
Query: 299 MVVTEKCVIYSFGVVALEVL-MGTHPGELLLSLSSSSGPKIMLIDILY--QRL-SPPINQ 354
T + ++S+GV E++ G P + + P + D+L +RL PPI
Sbjct: 186 RKFTHQSDVWSYGVTIWELMTFGGKPYDGI--------PTREIPDLLEKGERLPQPPICT 237
Query: 355 KIIQDIILVSTIALACLRSKPKSRPTMQRISQELE--GKTPMK----KGLKEISIPEMRN 408
I V + + C SRP + ++ E + P + +G + +P +
Sbjct: 238 ------IDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDPQRYLVIQGDDRMKLPSPND 291
Query: 409 QEMF 412
+ F
Sbjct: 292 SKFF 295
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 1e-07
Identities = 69/275 (25%), Positives = 110/275 (40%), Gaps = 50/275 (18%)
Query: 143 EYFHIRYCIGTGGYDSVYKAE-LPDGKVVALKKLHHSETEDSAFV---------VYSPQC 192
E F + IG+G Y VYKA + G++ A+K + ED A V
Sbjct: 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNI 68
Query: 193 MFFIYEYMERGSL-----FC---VLRDDDEAI-ELNWTRRMNIVKSVAHALSYLHHDCTP 243
+ + Y+ R L FC L+D L+ ++ + + L YLH +
Sbjct: 69 VAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLH---SK 125
Query: 244 SIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTYGYIALELVYTMVVTE 303
+HRDI NILL N +ADFG + + R GT ++A E+ V
Sbjct: 126 GKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVA---AVER 182
Query: 304 K------CVIYSFGVVALEV------LMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPP 351
K C I++ G+ A+E+ + HP L ++ S+ +Q P
Sbjct: 183 KGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSN----------FQ--PPK 230
Query: 352 INQKIIQDIILVSTIALACLRSKPKSRPTMQRISQ 386
+ K+ + +A L PK RPT +++ Q
Sbjct: 231 LKDKMKWSNSFHHFVKMA-LTKNPKKRPTAEKLLQ 264
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 1e-07
Identities = 38/138 (27%), Positives = 63/138 (45%), Gaps = 12/138 (8%)
Query: 193 MFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISS 252
++ + EY G L +L ++ + + + + + A+ +H VHRDI
Sbjct: 76 LYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFY--LAELVLAIHSVH---QMGYVHRDIKP 130
Query: 253 NNILLNSNLEAFVADFGTVRLLDVDSS-NRTLQAGTYGYIALELVYTMVVTEK------C 305
N+L++ +ADFG+ L + N L GT YIA E++ TM K C
Sbjct: 131 ENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVEC 190
Query: 306 VIYSFGVVALEVLMGTHP 323
+S GV+A E++ G P
Sbjct: 191 DWWSLGVIAYEMIYGRSP 208
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 1e-07
Identities = 57/205 (27%), Positives = 82/205 (40%), Gaps = 27/205 (13%)
Query: 145 FHIRYCIGTGGYDSVYKAELPDG------KVVALKKLHHSETEDSAFVVY------SPQC 192
+ I IG G + +Y A+ K + L K+ E E S V P
Sbjct: 2 YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNI 61
Query: 193 MFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHA----LSY-------LHHDC 241
+ F + E G LF V+ D + +R+N + V + LS+ L H
Sbjct: 62 VTFFASFQENGRLFIVMEYCDGG---DLMKRINRQRGVLFSEDQILSWFVQISLGLKHIH 118
Query: 242 TPSIVHRDISSNNILLNSN-LEAFVADFGTVRLLDVDSSNRTLQAGTYGYIALELVYTMV 300
I+HRDI S NI L+ N + A + DFG R L+ GT Y++ E+
Sbjct: 119 DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQNRP 178
Query: 301 VTEKCVIYSFGVVALEVLMGTHPGE 325
K I+S G V E+ HP E
Sbjct: 179 YNNKTDIWSLGCVLYELCTLKHPFE 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 2e-07
Identities = 36/136 (26%), Positives = 58/136 (42%), Gaps = 14/136 (10%)
Query: 193 MFFIYEYMERGSLFCVLRDDD-----EAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVH 247
++ + EY + G L ++ E L W +M + + ++H ++H
Sbjct: 73 LYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCL------GVQHIHEK---RVLH 123
Query: 248 RDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTYGYIALELVYTMVVTEKCVI 307
RDI S NI L N + + DFG+ RLL + GT Y+ E+ M K I
Sbjct: 124 RDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWENMPYNNKSDI 183
Query: 308 YSFGVVALEVLMGTHP 323
+S G + E+ HP
Sbjct: 184 WSLGCILYELCTLKHP 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 2e-07
Identities = 49/202 (24%), Positives = 78/202 (38%), Gaps = 42/202 (20%)
Query: 151 IGTGGYDSVYKAE------------LPDGKVVALKKLHHSETE--------DSAFVV--- 187
I G + SVY A+ L ++A ++ + + E +S +V
Sbjct: 4 ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLY 63
Query: 188 YSPQC---MFFIYEYMERG---SLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDC 241
YS Q ++ + EY+ G SL L E +W + + V + LH
Sbjct: 64 YSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPE----DWAK--QYIAEVVLGVEDLHQR- 116
Query: 242 TPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTYGYIALELVYTMVV 301
I+HRDI N+L++ + DFG R N+ GT Y+A E + +
Sbjct: 117 --GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE---NKKF-VGTPDYLAPETILGVGD 170
Query: 302 TEKCVIYSFGVVALEVLMGTHP 323
+ +S G V E L G P
Sbjct: 171 DKMSDWWSLGCVIFEFLFGYPP 192
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 2e-07
Identities = 46/203 (22%), Positives = 91/203 (44%), Gaps = 29/203 (14%)
Query: 193 MFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISS 252
++ + EYM +GSL LR ++ L + V A+ YL + + VHRD+++
Sbjct: 75 LYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAA 130
Query: 253 NNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGV 312
N+L++ + A V+DFG + + S+ T + + A E + + K ++SFG+
Sbjct: 131 RNVLVSEDNVAKVSDFGLTK--EASSTQDTGKLPV-KWTAPEALREKKFSTKSDVWSFGI 187
Query: 313 VALEVLMGTHPGELLLSLSSSSGPKIMLIDIL------YQRLSPPINQKIIQDIILVSTI 366
+ E+ S P+I L D++ Y+ +P ++ D++
Sbjct: 188 LLWEI----------YSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPVVYDVM----- 232
Query: 367 ALACLRSKPKSRPTMQRISQELE 389
C +RP+ ++ ++LE
Sbjct: 233 -KQCWHLDAATRPSFLQLREQLE 254
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 3e-07
Identities = 42/132 (31%), Positives = 65/132 (49%), Gaps = 11/132 (8%)
Query: 192 CMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDIS 251
CM E+M+ GSL VL+ E + I +V L+YL I+HRD+
Sbjct: 77 CM----EHMDGGSLDQVLKKAGRIPENILGK---ISIAVLRGLTYLREK--HKIMHRDVK 127
Query: 252 SNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTYGYIALELVYTMVVTEKCVIYSFG 311
+NIL+NS E + DFG L +DS + GT Y++ E + T + I+S G
Sbjct: 128 PSNILVNSRGEIKLCDFGVSGQL-IDSMANSF-VGTRSYMSPERLQGTHYTVQSDIWSLG 185
Query: 312 VVALEVLMGTHP 323
+ +E+ +G +P
Sbjct: 186 LSLVEMAIGRYP 197
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 3e-07
Identities = 48/217 (22%), Positives = 95/217 (43%), Gaps = 18/217 (8%)
Query: 174 KLHHSETEDSAFVVYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHA 233
KL H + V + ++ + E+ME G L LR + + +++ + V
Sbjct: 55 KLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDML--LSMCQDVCEG 112
Query: 234 LSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVR-LLDVDSSNRTLQAGTYGYIA 292
+ YL + S +HRD+++ N L++S V+DFG R +LD + ++ + +
Sbjct: 113 MEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSP 169
Query: 293 LELVYTMVVTEKCVIYSFGVVALEVLM-GTHPGELLLSLSSSSGPKIMLIDILYQRLSPP 351
E+ + K ++SFGV+ EV G P E S+ + +I ++ P
Sbjct: 170 PEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFE-----KKSNYEVVEMISRGFRLYRPK 224
Query: 352 INQKIIQDIILVSTIALACLRSKPKSRPTMQRISQEL 388
+ + +++ +C KP+ RPT + + +
Sbjct: 225 LASMTVYEVM------YSCWHEKPEGRPTFAELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 3e-07
Identities = 55/260 (21%), Positives = 103/260 (39%), Gaps = 38/260 (14%)
Query: 151 IGTGGYDSVYKAELPDGKVVALK--------------------KLHHSETEDSAFVVYSP 190
IG+G + V+ + + VA+K KL H + V
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTER 71
Query: 191 QCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDI 250
+ ++E+ME G L LR M + V ++YL ++HRD+
Sbjct: 72 SPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCL--DVCEGMAYLESSN---VIHRDL 126
Query: 251 SSNNILLNSNLEAFVADFGTVRL-LDVDSSNRTLQAGTYGYIALELVYTMVVTEKCVIYS 309
++ N L+ N V+DFG R LD ++ T + + E+ + K ++S
Sbjct: 127 AARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWS 186
Query: 310 FGVVALEVLM-GTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKIIQDIILVSTIAL 368
FGV+ EV G P E + S+ + I+ ++ P + + + +++
Sbjct: 187 FGVLMWEVFSEGKTPYE-----NRSNSEVVETINAGFRLYKPRLASQSVYELM------Q 235
Query: 369 ACLRSKPKSRPTMQRISQEL 388
C + +P+ RP+ + +L
Sbjct: 236 HCWKERPEDRPSFSLLLHQL 255
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 4e-07
Identities = 54/205 (26%), Positives = 89/205 (43%), Gaps = 30/205 (14%)
Query: 196 IYEYMERGSLFCVL---RDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISS 252
I +M+ G L L R D L + + +A + YL + S +HRD+++
Sbjct: 84 ILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYL---SSKSFIHRDLAA 140
Query: 253 NNILLNSNLEAFVADFGTVRLL---DVDSSNRTLQAGTYGYIALELVYTMVVTEKCVIYS 309
N +LN N+ VADFG + + D R + +IA+E + V T K ++S
Sbjct: 141 RNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPV-KWIAIESLADRVYTTKSDVWS 199
Query: 310 FGVVALEVL---MGTHPGELLLSLSSSSGPKIMLIDILYQ--RLSPPINQKIIQDIILVS 364
FGV E+ +PG + +S + D L Q RL P + + +
Sbjct: 200 FGVTMWEIATRGQTPYPG-----VENSE-----IYDYLRQGNRLKQPPDC-----LDGLY 244
Query: 365 TIALACLRSKPKSRPTMQRISQELE 389
++ +C PK RP+ + + ELE
Sbjct: 245 SLMSSCWLLNPKDRPSFETLRCELE 269
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 4e-07
Identities = 49/201 (24%), Positives = 92/201 (45%), Gaps = 32/201 (15%)
Query: 199 YMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLN 258
Y+++ +L +D+ A++ ++ VA +S+L + + +HRD+++ NILL
Sbjct: 194 YIDQDVTSEILEEDELALDTE--DLLSFSYQVAKGMSFL---ASKNCIHRDLAARNILLT 248
Query: 259 SNLEAFVADFGTVRLLDVDSSNRTLQAGT---YGYIALELVYTMVVTEKCVIYSFGVVAL 315
+ DFG R + D SN ++ ++A E ++ V T + ++S+G++
Sbjct: 249 HGRITKICDFGLARDIRND-SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLW 307
Query: 316 EVLMGTHPGELLLSLSSSSGPKI-------MLIDILYQRLSPPINQKIIQDIILVSTIAL 368
E + SL SS P + +I Y+ LSP + DI+
Sbjct: 308 E----------IFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPECAPSEMYDIM------K 351
Query: 369 ACLRSKPKSRPTMQRISQELE 389
+C + P RPT ++I Q +E
Sbjct: 352 SCWDADPLKRPTFKQIVQLIE 372
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 4e-07
Identities = 42/161 (26%), Positives = 70/161 (43%), Gaps = 17/161 (10%)
Query: 195 FIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNN 254
+ + GSL +R ++ L+ R +N +A + YL +VHR++++ N
Sbjct: 85 LVTQLSPLGSLLDHVRQHRDS--LDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARN 139
Query: 255 ILLNSNLEAFVADFGTVRLLDVDSSNRTLQ--AGTYGYIALELVYTMVVTEKCVIYSFGV 312
ILL S+ +ADFG LL D ++ALE + T + ++S+GV
Sbjct: 140 ILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGV 199
Query: 313 VALEVLM-------GTHPGE---LLLSLSSSSGPKIMLIDI 343
E++ G P E LL + P+I ID+
Sbjct: 200 TVWEMMSYGAEPYAGMRPHEVPDLLEKGERLAQPQICTIDV 240
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 4e-07
Identities = 78/305 (25%), Positives = 122/305 (40%), Gaps = 56/305 (18%)
Query: 145 FHIRYCIGTGGYDSVY---KAELPD-GKVVALKKL------------HHSETE------- 181
F + +GTG Y V+ K D GK+ A+K L H+ TE
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHV 61
Query: 182 -DSAFVV---YSPQC---MFFIYEYMERGSLFCVL--RDDDEAIELNWTRRMNIVKSVAH 232
S F+V Y+ Q + I +Y+ G +F L RD+ E+ + +
Sbjct: 62 RQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRF-----YSGEIIL 116
Query: 233 ALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQ-AGTYGYI 291
AL +LH IV+RDI NILL+S + DFG + + RT GT Y+
Sbjct: 117 ALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYM 173
Query: 292 ALELVYTMVVTEKCV-IYSFGVVALEVLMGTHPGELLLSLSSSS--GPKIMLIDILYQRL 348
A E++ K V +S G++ E+L G P L ++ S +I+ D +
Sbjct: 174 APEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSF 233
Query: 349 SPPINQKIIQDIILVSTIALACLRSKPKSR-PTMQRISQELEGKTPMKKGLKEISIPEMR 407
P Q ++ + LR PK R + + E++ P KGL ++ +
Sbjct: 234 IGPEAQDLLHKL----------LRKDPKKRLGAGPQGASEIKEH-PFFKGLDWEALALRK 282
Query: 408 NQEMF 412
F
Sbjct: 283 VNPPF 287
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 5e-07
Identities = 66/269 (24%), Positives = 111/269 (41%), Gaps = 58/269 (21%)
Query: 151 IGTGGYDSVYKA-ELPDGKVVALKKLHHSETEDSAFVVYSPQCMFFIYE----------- 198
+G+G Y VYKA L G++ A+K + +D + + Q +F + E
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLI---QQEIFMVKECKHCNIVAYFG 73
Query: 199 -YMERGSLF-CV-------LRDDDEAI-ELNWTRRMNIVKSVAHALSYLHHDCTPSIVHR 248
Y+ R L+ C+ L+D L+ + + + L+YLH + +HR
Sbjct: 74 SYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLH---SKGKMHR 130
Query: 249 DISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTYGYIALELVYTMVVTEK---- 304
DI NILL N + +ADFG + + R GT ++A E+ EK
Sbjct: 131 DIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEV----AAVEKNGGY 186
Query: 305 ---CVIYSFGVVALEV------LMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQK 355
C I++ G+ A+E+ + HP L +S S+ +Q P + K
Sbjct: 187 NQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSN----------FQ--PPKLKDK 234
Query: 356 IIQDIILVSTIALACLRSKPKSRPTMQRI 384
+ + ++ L PK RPT +R+
Sbjct: 235 TKWSSTFHNFVKIS-LTKNPKKRPTAERL 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 6e-07
Identities = 40/139 (28%), Positives = 66/139 (47%), Gaps = 12/139 (8%)
Query: 190 PQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRD 249
+ ++ + EYM G L ++ + D I W R V AL +H + +HRD
Sbjct: 115 DKYLYMVMEYMPGGDLVNLMSNYD--IPEKWARFY--TAEVVLALDAIH---SMGFIHRD 167
Query: 250 ISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQA-GTYGYIALELVYTMVVT----EK 304
+ +N+LL+ + +ADFGT +D + R A GT YI+ E++ + +
Sbjct: 168 VKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRE 227
Query: 305 CVIYSFGVVALEVLMGTHP 323
C +S GV E+L+G P
Sbjct: 228 CDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 7e-07
Identities = 42/154 (27%), Positives = 68/154 (44%), Gaps = 6/154 (3%)
Query: 170 VALKKLHHSETEDSAFVVYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKS 229
V LK + H F + ++F+ +Y+ G LF L+ + +E R
Sbjct: 48 VLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLE---PRARFYAAE 104
Query: 230 VAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTYG 289
+A AL YLH + +IV+RD+ NILL+S + DFG + + + GT
Sbjct: 105 IASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPE 161
Query: 290 YIALELVYTMVVTEKCVIYSFGVVALEVLMGTHP 323
Y+A E+++ + G V E+L G P
Sbjct: 162 YLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 7e-07
Identities = 63/269 (23%), Positives = 102/269 (37%), Gaps = 50/269 (18%)
Query: 151 IGTGGYDSVYKA--ELPDGKV--VALKKLH--HSETEDSAF------------------- 185
+G G + SV K + GK VA+K L H F
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 186 -VVYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPS 244
V M + E G L L+ E + + VA ++YL +
Sbjct: 63 GVCKGEPLML-VMELAPLGPLLKYLKKRREIPVSDLK---ELAHQVAMGMAYLE---SKH 115
Query: 245 IVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSN-RTLQAGTY--GYIALELVYTMVV 301
VHRD+++ N+LL + +A ++DFG R L S R AG + + A E +
Sbjct: 116 FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKF 175
Query: 302 TEKCVIYSFGVVALEVL-MGTHP-GELLLSLSSSSGPKIMLIDILYQRLSPPINQKIIQD 359
+ K ++S+GV E G P GE+ G +++ + +RL P
Sbjct: 176 SSKSDVWSYGVTLWEAFSYGAKPYGEM-------KGAEVIAMLESGERLPRPEECP---- 224
Query: 360 IILVSTIALACLRSKPKSRPTMQRISQEL 388
+ +I L+C + +P+ RPT +
Sbjct: 225 -QEIYSIMLSCWKYRPEDRPTFSELESTF 252
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 8e-07
Identities = 61/271 (22%), Positives = 103/271 (38%), Gaps = 36/271 (13%)
Query: 133 ILYENLIDATEYFHIRYCIGTGGYDSVYKA-ELPDGKVVALKKL-------HHSETEDSA 184
I++++ D ++ + I IG G Y V+K +G A+K L E E +
Sbjct: 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNI 67
Query: 185 FVVYS--PQC-----MFFIYEYMERGSLFCVLR-------DDDEAIELNWTRRMN--IVK 228
S P M++ + L+ VL D L RM I+
Sbjct: 68 LKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIA 127
Query: 229 SVAH-ALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGT 287
+ H AL L H +HRD+ NNILL + + DFG L R GT
Sbjct: 128 YILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGT 187
Query: 288 YGYIALELV-----YTMVVTEKCVIYSFGVVALEV------LMGTHPGELLLSLSSSSGP 336
++A E++ +C ++S G+ A+E+ L HP L + + P
Sbjct: 188 PFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPP 247
Query: 337 KIMLIDILYQRLSPPINQKIIQDIILVSTIA 367
+ ++ + I + + +D T++
Sbjct: 248 TLHQPELWSNEFNDFIRKCLTKDYEKRPTVS 278
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 8e-07
Identities = 58/268 (21%), Positives = 101/268 (37%), Gaps = 49/268 (18%)
Query: 151 IGTGGYDSVYKAELPDGKVVA----------------------LKKLHHSETEDSAFVVY 188
IG G + VYK L VA LK+ H V
Sbjct: 3 IGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCV 62
Query: 189 SPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHR 248
Q ++ + E + GSL LR + + + + + A + YL +HR
Sbjct: 63 QKQPIYIVMELVPGGSLLTFLRKKKNRLTVK--KLLQMSLDAAAGMEYLESKNC---IHR 117
Query: 249 DISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGT----YGYIALELVYTMVVTEK 304
D+++ N L+ N ++DFG R + + T+ G + A E + T +
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSR--EEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSE 175
Query: 305 CVIYSFGVVALEVLM---GTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKIIQDII 361
++S+G++ E +PG +S+ + I+ Y R+ P Q ++I
Sbjct: 176 SDVWSYGILLWETFSLGDTPYPG-----MSNQQTRE--RIESGY-RMPAP--QLCPEEI- 224
Query: 362 LVSTIALACLRSKPKSRPTMQRISQELE 389
+ L C P++RP+ I EL+
Sbjct: 225 --YRLMLQCWAYDPENRPSFSEIYNELQ 250
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 8e-07
Identities = 34/131 (25%), Positives = 63/131 (48%), Gaps = 6/131 (4%)
Query: 193 MFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISS 252
+FF+ E++ G L ++D + R + L +LH + I++RD+
Sbjct: 71 LFFVMEFLNGGDLMFHIQDKGR---FDLYRATFYAAEIVCGLQFLH---SKGIIYRDLKL 124
Query: 253 NNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGV 312
+N++L+ + +ADFG + + + GT YIA E++ + T +SFGV
Sbjct: 125 DNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGV 184
Query: 313 VALEVLMGTHP 323
+ E+L+G P
Sbjct: 185 LLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 9e-07
Identities = 54/209 (25%), Positives = 87/209 (41%), Gaps = 49/209 (23%)
Query: 151 IGTGGYDSVYKAELPD-GKVVALKKLHHSE---------------------TEDSAFVV- 187
IG G + VY+ D ++ A+K L E ++S F+V
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 188 -----YSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLH-HDC 241
+ ++ + +YM G LF L+ + E R + + AL +LH +D
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSE---DRAKFYIAELVLALEHLHKYD- 116
Query: 242 TPSIVHRDISSNNILLNSNLEAFVADFGTVR--LLDVDSSNRTLQAGTYGYIALELV--- 296
IV+RD+ NILL++ + DFG + L D ++N GT Y+A E++
Sbjct: 117 ---IVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTF--CGTTEYLAPEVLLDE 171
Query: 297 --YTMVVTEKCVIYSFGVVALEVLMGTHP 323
YT V +S GV+ E+ G P
Sbjct: 172 KGYTKHVD----FWSLGVLVFEMCCGWSP 196
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 9e-07
Identities = 56/222 (25%), Positives = 95/222 (42%), Gaps = 33/222 (14%)
Query: 172 LKKLHH--------SETEDSAFVVYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRR 223
LK L H + ED A ++ + EY G+L ++ ++ T
Sbjct: 53 LKLLSHPNIIEYYENFLEDKALMI--------VMEYAPGGTLAEYIQKRCNSLLDEDT-- 102
Query: 224 MNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAF-VADFGTVRLLDVDSSNRT 282
I+ L LHH T I+HRD+ + NILL+ + + DFG ++L S T
Sbjct: 103 --ILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYT 160
Query: 283 LQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLID 342
+ GT YI+ EL +K I++ G V E+ L + +++ P ++L
Sbjct: 161 V-VGTPCYISPELCEGKPYNQKSDIWALGCVLYELA------SLKRAFEAANLPALVL-K 212
Query: 343 ILYQRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRI 384
I+ + PI+ + D + + L+ L P RP + +I
Sbjct: 213 IMSGTFA-PISDRYSPD---LRQLILSMLNLDPSKRPQLSQI 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 1e-06
Identities = 58/223 (26%), Positives = 91/223 (40%), Gaps = 26/223 (11%)
Query: 172 LKKLHHSETEDSAFVVYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVA 231
+ KL H V + +F + EYM G L LR+ + W M V
Sbjct: 53 MMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDM--CSDVC 110
Query: 232 HALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVR-LLDVDSSNRTLQAGT--- 287
A+ YL + +HRD+++ N L+ + V+DFG R +LD T GT
Sbjct: 111 EAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLD---DQYTSSQGTKFP 164
Query: 288 YGYIALELVYTMVVTEKCVIYSFGVVALEVL-MGTHPGELLLSLSSSSGPKIMLIDILYQ 346
+ E+ + K ++SFGV+ EV G P E +S + LY+
Sbjct: 165 VKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERF--SNSEVVESVSAGYRLYR 222
Query: 347 -RLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQEL 388
+L+P V TI +C KP+ RP +++ +L
Sbjct: 223 PKLAPT----------EVYTIMYSCWHEKPEDRPAFKKLLSQL 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 1e-06
Identities = 53/189 (28%), Positives = 78/189 (41%), Gaps = 23/189 (12%)
Query: 202 RGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNL 261
+ L+C L + + I +SV A+ YLH + I+HRDI + NI +N
Sbjct: 166 KTDLYCYLAAKRN---IAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPG 219
Query: 262 EAFVADFGTVRL-LDVDSSNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMG 320
+ + DFG +D++++ AGT A EL+ I+S G+V E M
Sbjct: 220 DVCLGDFGAACFPVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFE--MA 277
Query: 321 THPGELL----LSLSSSSGPKIMLIDILYQRLSP---PINQKIIQDIILVSTIALACLRS 373
T L L S +I LI I P PI+ + D I + +S
Sbjct: 278 TCHDSLFEKDGLDGDCDSDRQIKLI-IRRSGTHPNEFPIDAQANLDEIYIGL----AKKS 332
Query: 374 --KPKSRPT 380
KP SRP
Sbjct: 333 SRKPGSRPL 341
|
Length = 391 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 1e-06
Identities = 64/285 (22%), Positives = 106/285 (37%), Gaps = 64/285 (22%)
Query: 151 IGTGGYDSVYKAELPDGK------VVALKKLHHSETED------------SAF------- 185
+G G + V+ E + +VA+K L + + D + F
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 186 ---VVYSPQCMFFIYEYMERGSLFCVLR-----------DDDEAIELNWTRRMNIVKSVA 231
V ++EYME G L LR D EL ++ + I +A
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132
Query: 232 HALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGT---- 287
+ YL + VHRD+++ N L+ +L + DFG R DV +++ G
Sbjct: 133 SGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSR--DVYTTDYYRVGGHTMLP 187
Query: 288 YGYIALELVYTMVVTEKCVIYSFGVVALEVL-MGTHPGELLLSLSSSSGPKIMLIDILYQ 346
++ E + T + ++SFGVV E+ G P LS+ + + L Q
Sbjct: 188 IRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP---WYGLSNEEVIECITQGRLLQ 244
Query: 347 --RLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELE 389
R P V I L C + P+ R ++ I + L+
Sbjct: 245 RPRTCPS----------EVYDIMLGCWKRDPQQRINIKDIHERLQ 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 49.5 bits (119), Expect = 1e-06
Identities = 54/208 (25%), Positives = 79/208 (37%), Gaps = 42/208 (20%)
Query: 145 FHIRYCIGTGGYDSVYKAE------------LPDGKVVALKKLHHSETE-------DSAF 185
F +GTG + V L K+V LK++ H E F
Sbjct: 3 FEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPF 62
Query: 186 VVY------SPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHH 239
+V ++ + EY+ G LF LR R V AL YLH
Sbjct: 63 LVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSG-RFPEPVARFY--AAQVVLALEYLHS 119
Query: 240 DCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTYGYIALELV--- 296
IV+RD+ N+LL+S+ + DFG + V TL GT Y+A E++
Sbjct: 120 L---DIVYRDLKPENLLLDSDGYIKITDFGFAKR--VKGRTYTL-CGTPEYLAPEIILSK 173
Query: 297 -YTMVVTEKCVIYSFGVVALEVLMGTHP 323
Y V ++ G++ E+L G P
Sbjct: 174 GYGKAVD----WWALGILIYEMLAGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 1e-06
Identities = 36/131 (27%), Positives = 62/131 (47%), Gaps = 6/131 (4%)
Query: 193 MFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISS 252
+FF+ EY+ G L ++ + + R + L +LH + IV+RD+
Sbjct: 71 LFFVMEYLNGGDLMFHIQ---SCHKFDLPRATFYAAEIICGLQFLH---SKGIVYRDLKL 124
Query: 253 NNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGV 312
+NILL+++ +ADFG + + + GT YIA E++ +SFGV
Sbjct: 125 DNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGV 184
Query: 313 VALEVLMGTHP 323
+ E+L+G P
Sbjct: 185 LLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 1e-06
Identities = 68/246 (27%), Positives = 101/246 (41%), Gaps = 57/246 (23%)
Query: 190 PQCMFFIYEYMERGSLFCVLRDDD--EAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVH 247
P +F ++EY+ +L VL D A E T R+ + V AL+ H+ IVH
Sbjct: 51 PGLLFAVFEYVPGRTLREVLAADGALPAGE---TGRL--MLQVLDALACAHNQ---GIVH 102
Query: 248 RDISSNNILLN-SNLE--AFVADFGTVRLL----DVDSSNRTLQA---GTYGYIALELVY 297
RD+ NI+++ + + A V DFG LL D D + T GT Y A E +
Sbjct: 103 RDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLR 162
Query: 298 TMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKII 357
VT +Y++G++ LE L G+ ++ +S + +ILYQ+LSP
Sbjct: 163 GEPVTPNSDLYAWGLIFLECLT----GQRVVQGAS-------VAEILYQQLSP------- 204
Query: 358 QDIILVSTIAL----ACLRSKPKSRPTMQRISQE-------------LEGKTPM--KKGL 398
D+ L IA LR P + S L G M G
Sbjct: 205 VDVSLPPWIAGHPLGQVLRKALNKDPRQRAASAPALAERFRALELCALVGILRMGEGAGR 264
Query: 399 KEISIP 404
+ I+ P
Sbjct: 265 EAIAAP 270
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 1e-06
Identities = 55/218 (25%), Positives = 95/218 (43%), Gaps = 42/218 (19%)
Query: 193 MFFIYEYMERGSLFCVLR--DDDEAI-----------ELNWTRRMNIVKSVAHALSYLHH 239
+ ++EYM+ G L LR D I EL ++ ++I +A + YL
Sbjct: 82 LIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYL-- 139
Query: 240 DCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTYGYIALE----- 294
+ VHRD+++ N L+ +NL + DFG R DV S++ + G + + +
Sbjct: 140 -ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR--DVYSTD-YYRVGGHTMLPIRWMPPE 195
Query: 295 -LVYTMVVTEKCVIYSFGVVALEVLM-GTHPGELLLSLSSSSGPKIMLIDILYQRL--SP 350
++Y TE V +SFGV+ E+ G P L ++ I R+ P
Sbjct: 196 SIMYRKFTTESDV-WSFGVILWEIFTYGKQPWFQL-------SNTEVIECITQGRVLERP 247
Query: 351 PINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQEL 388
+ K + DI+ L C + +P+ R ++ I + L
Sbjct: 248 RVCPKEVYDIM------LGCWQREPQQRLNIKEIYKIL 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 1e-06
Identities = 66/256 (25%), Positives = 109/256 (42%), Gaps = 44/256 (17%)
Query: 151 IGTGGYDSVYKA-ELPDGKVVALK-----------KLHHSETE-----DSAFVV--YSPQ 191
+G G +VYKA L +++A+K K SE E DS +++ Y
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGA- 67
Query: 192 CMFFI-------YEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPS 244
FF+ E+M+ GSL + + + I +V L+YL +
Sbjct: 68 --FFVENRISICTEFMDGGSLDVYRKIPEHVLG-------RIAVAVVKGLTYL---WSLK 115
Query: 245 IVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTYGYIALELVYTMVVTEK 304
I+HRD+ +N+L+N+ + + DFG L V+S +T GT Y+A E +
Sbjct: 116 ILHRDVKPSNMLVNTRGQVKLCDFGVSTQL-VNSIAKTY-VGTNAYMAPERISGEQYGIH 173
Query: 305 CVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKIIQDIILVS 364
++S G+ +E+ +G P + S P +L I+ + PP+ V
Sbjct: 174 SDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDE--DPPVLPVGQFSEKFVH 231
Query: 365 TIALACLRSKPKSRPT 380
I C+R +PK RP
Sbjct: 232 FIT-QCMRKQPKERPA 246
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 1e-06
Identities = 55/216 (25%), Positives = 89/216 (41%), Gaps = 44/216 (20%)
Query: 143 EYFHIRYCIGTGGYDSVYKAELPD-GKVVALKKLHHSE----TEDSAFVV---------- 187
+ F I IG G + V ++ + G+V A+K L+ E E + F
Sbjct: 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDR 60
Query: 188 -------YSPQ---CMFFIYEYMERGSLFCVLRDDDEAIELNWTR----RMNIVKSVAHA 233
Y+ Q ++ + +Y G L +L ++ + + R M + H
Sbjct: 61 RWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQ 120
Query: 234 LSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQA-GTYGYIA 292
L Y VHRDI +N+LL+ N +ADFG+ L D + ++ A GT YI+
Sbjct: 121 LGY---------VHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYIS 171
Query: 293 LELVYTM-----VVTEKCVIYSFGVVALEVLMGTHP 323
E++ M +C +S GV E+L G P
Sbjct: 172 PEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.6 bits (119), Expect = 1e-06
Identities = 40/168 (23%), Positives = 69/168 (41%), Gaps = 43/168 (25%)
Query: 145 FHIRYCIGTGGYDSVYKA---ELPDGKVVALKK------------------------LHH 177
+ I CIG G Y VYKA DGK A+KK L H
Sbjct: 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKH 61
Query: 178 SE--TEDSAFVVYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKS----VA 231
+ F+ ++ + ++ +++Y E L+ +++ +A ++ M VKS +
Sbjct: 62 ENVVSLVEVFLEHADKSVYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSM--VKSLLWQIL 118
Query: 232 HALSYLHHDCTPSIVHRDISSNNILLNSNLEAF----VADFGTVRLLD 275
+ + YLH + ++HRD+ NIL+ + D G RL +
Sbjct: 119 NGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFN 163
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 2e-06
Identities = 50/199 (25%), Positives = 89/199 (44%), Gaps = 20/199 (10%)
Query: 210 RDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFG 269
++ A L + + VA + YL +HRD+++ N+L+ NL + +ADFG
Sbjct: 108 KEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFG 164
Query: 270 TVRLLDVDSSNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVL-MGTHPGELLL 328
R +V +T+ ++A+E + V T K ++SFGV+ E++ +G P
Sbjct: 165 LSRGEEV-YVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTP---YC 220
Query: 329 SLSSSSGPKIMLIDILYQ--RLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQ 386
++ + L + L Q R+ P N D V + C R +P RP +IS
Sbjct: 221 GMTCAE-----LYEKLPQGYRMEKPRN---CDD--EVYELMRQCWRDRPYERPPFAQISV 270
Query: 387 ELEGKTPMKKGLKEISIPE 405
+L +K +++ E
Sbjct: 271 QLSRMLEARKAYVNMALFE 289
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 48.9 bits (117), Expect = 2e-06
Identities = 61/284 (21%), Positives = 115/284 (40%), Gaps = 59/284 (20%)
Query: 151 IGTGGYDSVYKA--ELPDGK---VVALKKLHHSETE----------------DSAFVV-- 187
+G G + V + VA+K L+HS E D +V
Sbjct: 12 LGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKY 71
Query: 188 ----YSP--QCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDC 241
P + + I EY+ GSL L+ + ++N R + + + YL
Sbjct: 72 KGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRD--QINLKRLLLFSSQICKGMDYLG--- 126
Query: 242 TPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDS----SNRTLQAGTYGYIALELVY 297
+ +HRD+++ NIL+ S ++DFG ++L D ++ + Y A E +
Sbjct: 127 SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY-APECLR 185
Query: 298 TMVVTEKCVIYSFGVVALEVLMGTH-------PGELLLSLSSSSGPKIM--LIDILY--Q 346
T + ++SFGV E + T+ P E L + + G I+ L+++L +
Sbjct: 186 TSKFSSASDVWSFGVTLYE--LFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEGE 243
Query: 347 RLSPPIN-QKIIQDIILVSTIALACLRSKPKSRPTMQRISQELE 389
RL P + + D++ + C ++P+ RP+ + ++
Sbjct: 244 RLPRPPSCPDEVYDLMKL------CWEAEPQDRPSFADLILIVD 281
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 48.7 bits (117), Expect = 2e-06
Identities = 36/150 (24%), Positives = 65/150 (43%), Gaps = 31/150 (20%)
Query: 185 FVVYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLH-HDCTP 243
+ V + + I +Y++ G LF +L+ + + + I++ + AL+ LH H
Sbjct: 76 YSVTTLKGHVLIMDYIKDGDLFDLLKKEG-KLSEAEVK--KIIRQLVEALNDLHKH---- 128
Query: 244 SIVHRDISSNNILLNSNLE-AFVADFGTVRLLDVDSSNRTLQAGTYGYIALE----LVYT 298
+I+H DI N+L + + ++ D+G +++ S GT Y + E Y
Sbjct: 129 NIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPS----CYDGTLDYFSPEKIKGHNYD 184
Query: 299 MVVTEKCVIYSF-----GVVALEVLMGTHP 323
SF GV+ E+L G HP
Sbjct: 185 ---------VSFDWWAVGVLTYELLTGKHP 205
|
Length = 267 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 2e-06
Identities = 43/163 (26%), Positives = 70/163 (42%), Gaps = 40/163 (24%)
Query: 151 IGTGGYDSVYKAELPD-GKVVALKK-----------------------LHH--------- 177
IG G Y VYKA D G++VALKK L+H
Sbjct: 15 IGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEI 74
Query: 178 -SETEDSAFVVYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSY 236
++ +D+ + ++EYM+ L +L + + + + +K + L+Y
Sbjct: 75 VTDKQDALDFKKDKGAFYLVFEYMDH-DLMGLL--ESGLVHFSEDHIKSFMKQLLEGLNY 131
Query: 237 LHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSS 279
H + +HRDI +NILLN+ + +ADFG RL + + S
Sbjct: 132 CHKK---NFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEES 171
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 2e-06
Identities = 65/266 (24%), Positives = 105/266 (39%), Gaps = 39/266 (14%)
Query: 148 RYCIGTGGYDSVYKA------------ELPDGKVVALKKLH-----HSETEDSAFVVYSP 190
R +G G Y VY A E+P+ ++ LH HS + V Y
Sbjct: 13 RVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLG 72
Query: 191 QCMF--FIYEYMER---GSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSI 245
F +ME+ GSL +LR ++ N + K + L YLH + I
Sbjct: 73 SDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDN---QI 129
Query: 246 VHRDISSNNILLNSNLEAF-VADFGTV-RLLDVDSSNRTLQAGTYGYIALELVYTMV--V 301
VHRDI +N+L+N+ ++DFGT RL ++ T GT Y+A E++
Sbjct: 130 VHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETF-TGTLQYMAPEVIDKGPRGY 188
Query: 302 TEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKIIQDII 361
I+S G +E+ G P + L P+ + + ++ P I + + +
Sbjct: 189 GAPADIWSLGCTIVEMATGKPP---FIELGE---PQAAMFKVGMFKIHPEIPESLSAE-- 240
Query: 362 LVSTIALACLRSKPKSRPTMQRISQE 387
L C P R + + Q+
Sbjct: 241 -AKNFILRCFEPDPDKRASAHDLLQD 265
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 2e-06
Identities = 42/154 (27%), Positives = 71/154 (46%), Gaps = 16/154 (10%)
Query: 230 VAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLL--DVDSSNRTLQAGT 287
VA + +L + +HRD+++ NILL+ N + DFG R + D D +
Sbjct: 183 VARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP 239
Query: 288 YGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQR 347
++A E ++ V T + ++SFGV+ E+ SL +S P + + + QR
Sbjct: 240 LKWMAPESIFDKVYTTQSDVWSFGVLLWEI----------FSLGASPYPGVQINEEFCQR 289
Query: 348 LSPPINQKIIQDII-LVSTIALACLRSKPKSRPT 380
L + ++ + I LAC + PK RPT
Sbjct: 290 LKDGTRMRAPENATPEIYRIMLACWQGDPKERPT 323
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 2e-06
Identities = 65/253 (25%), Positives = 103/253 (40%), Gaps = 41/253 (16%)
Query: 145 FHIRYCIGTGGYDSVY---KAELPD-GKVVALKKL------------HHSETE------- 181
F + +GTG Y V+ K D GK+ A+K L H+ TE
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 61
Query: 182 -DSAFVV---YSPQC---MFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHAL 234
S F+V Y+ Q + I +Y+ G LF L + E + AL
Sbjct: 62 RQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQI---YSGEIVLAL 118
Query: 235 SYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQ-AGTYGYIAL 293
+LH I++RDI NILL+SN + DFG + D R GT Y+A
Sbjct: 119 EHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAP 175
Query: 294 ELVYTMVVTEKCVI--YSFGVVALEVLMGTHPGELLLSLSSSS--GPKIMLIDILYQRLS 349
++V + +S GV+ E+L G P + +S + +I+ + Y +
Sbjct: 176 DIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEM 235
Query: 350 PPINQKIIQDIIL 362
+ + IIQ +++
Sbjct: 236 SALAKDIIQRLLM 248
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 2e-06
Identities = 53/216 (24%), Positives = 86/216 (39%), Gaps = 44/216 (20%)
Query: 143 EYFHIRYCIGTGGYDSVYKAELPDG-KVVALKKLHHSETEDSA----------------- 184
E F I IG G + V +L + KV A+K L+ E A
Sbjct: 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDN 60
Query: 185 -------FVVYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTR----RMNIVKSVAHA 233
+ ++ + +Y G L +L ++ + + R M I H
Sbjct: 61 QWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQ 120
Query: 234 LSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGT-VRLLDVDSSNRTLQAGTYGYIA 292
L Y VHRDI +NIL++ N +ADFG+ ++L++ + ++ GT YI+
Sbjct: 121 LHY---------VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYIS 171
Query: 293 LELVYTMV-----VTEKCVIYSFGVVALEVLMGTHP 323
E++ M +C +S GV E+L G P
Sbjct: 172 PEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 2e-06
Identities = 68/289 (23%), Positives = 118/289 (40%), Gaps = 57/289 (19%)
Query: 146 HIRYC--IGTGGYDSVYKAE---LPD--GKVVALKKLHHSETED---------------S 183
H+++ +G G + SV L D G+VVA+KKL HS E
Sbjct: 5 HLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQH 64
Query: 184 AFVV------YSP--QCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKS-VAHAL 234
+V YS + + + EY+ GSL L+ E ++ R++ + S + +
Sbjct: 65 DNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLD---HRKLLLYASQICKGM 121
Query: 235 SYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTL----QAGTYGY 290
YL + VHRD+++ NIL+ S + DFG ++L D + ++ + Y
Sbjct: 122 EYLG---SKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWY 178
Query: 291 IALELVYTMVVTEKCVIYSFGVVALEVL----MGTHPGELLLSL--SSSSGPKIM--LID 342
A E + + ++SFGVV E+ P + + + G I+ LI+
Sbjct: 179 -APESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIE 237
Query: 343 ILY--QRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELE 389
+L RL P + I C + P RP+ ++ ++E
Sbjct: 238 LLKNNGRLPAPPGCP-----AEIYAIMKECWNNDPSQRPSFSELALQVE 281
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 2e-06
Identities = 55/237 (23%), Positives = 102/237 (43%), Gaps = 54/237 (22%)
Query: 143 EYFHIRYCIGTGGYDSVYKAELPDGKVVALKKLHHSETEDS------------------- 183
E++ I +G G + VYKA+ + V+A K+ +++E+
Sbjct: 5 EFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNI 64
Query: 184 -----AFVVYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLH 238
AF Y ++ + E+ G++ V+ + + + R + K AL+YLH
Sbjct: 65 VKLLDAF--YYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRV--VCKQTLEALNYLH 120
Query: 239 HDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSN-RTLQ-----AGTYGYIA 292
+ I+HRD+ + NIL + + +ADFG V + N RT+Q GT ++A
Sbjct: 121 EN---KIIHRDLKAGNILFTLDGDIKLADFG------VSAKNTRTIQRRDSFIGTPYWMA 171
Query: 293 LELVYTMVVTE-----KCVIYSFGVVALEVLM------GTHPGELLLSLSSSSGPKI 338
E+V + K ++S G+ +E+ +P +LL ++ S P +
Sbjct: 172 PEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTL 228
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 2e-06
Identities = 49/173 (28%), Positives = 72/173 (41%), Gaps = 46/173 (26%)
Query: 234 LSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSS-NRTLQAGTYGYIA 292
L YLH + I+HRDI N+L+NSN + DFG R+ + D S + T + T Y A
Sbjct: 116 LKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRA 172
Query: 293 LELV-----YTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQR 347
E++ YT V I+S G + E+L IL+Q
Sbjct: 173 PEILMGSRHYTSAVD----IWSVGCIFAELLGRR---------------------ILFQA 207
Query: 348 LSPPINQKIIQDIILVSTIA---LAC-------LRS--KPKSRPTMQRISQEL 388
SP +I D++ ++ AC LR KP S P + +S +
Sbjct: 208 QSPIQQLDLITDLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQA 260
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 3e-06
Identities = 46/183 (25%), Positives = 81/183 (44%), Gaps = 22/183 (12%)
Query: 210 RDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFG 269
+ A L+ + ++ VA + YL +HRD+++ NIL+ N A +ADFG
Sbjct: 101 IANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFG 157
Query: 270 TVRLLDVDSSNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVL-MGTHPGELLL 328
R +V +T+ ++A+E + V T ++S+GV+ E++ +G P
Sbjct: 158 LSRGQEV-YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP----- 211
Query: 329 SLSSSSGPKIMLIDILYQRLSPPINQKIIQDIIL---VSTIALACLRSKPKSRPTMQRIS 385
G M LY++L P ++ + + V + C R KP RP+ +I
Sbjct: 212 ----YCG---MTCAELYEKL--PQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQIL 262
Query: 386 QEL 388
L
Sbjct: 263 VSL 265
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 3e-06
Identities = 51/225 (22%), Positives = 94/225 (41%), Gaps = 46/225 (20%)
Query: 193 MFFIYEYMERGSLFCVLR---------------------DDDEAIELNWTRRMNIVKSVA 231
+ I EY + GSL LR D+ + L ++ ++
Sbjct: 78 LLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQIS 137
Query: 232 HALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSS--NRTLQAGTYG 289
+ YL +VHRD+++ N+L+ + ++DFG R + + S R+
Sbjct: 138 RGMQYLAE---MKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVK 194
Query: 290 YIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIM---LIDILYQ 346
++A+E ++ + T + ++SFGV+ E +++L + P I L ++L
Sbjct: 195 WMAIESLFDHIYTTQSDVWSFGVLLWE----------IVTLGGNPYPGIAPERLFNLLKT 244
Query: 347 --RLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELE 389
R+ P N + + L C + +P RPT IS+ELE
Sbjct: 245 GYRMERPENCSE-----EMYNLMLTCWKQEPDKRPTFADISKELE 284
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 48.3 bits (116), Expect = 3e-06
Identities = 19/48 (39%), Positives = 29/48 (60%), Gaps = 3/48 (6%)
Query: 233 ALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSN 280
L YLH + +++HRD+ +NIL+NSN + + DFG R +D D
Sbjct: 115 GLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDE 159
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 4e-06
Identities = 53/212 (25%), Positives = 86/212 (40%), Gaps = 41/212 (19%)
Query: 193 MFFIYEYMERGSLFCVLRD-------------DDEAIELNWTRRMNIVKSVAHALSYLHH 239
++ EY G+L LR + A L+ + ++ VA + YL
Sbjct: 83 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ 142
Query: 240 DCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTYGYIALELVYTM 299
+HRD+++ NIL+ N A +ADFG R +V +T+ ++A+E +
Sbjct: 143 K---QFIHRDLAARNILVGENYVAKIADFGLSRGQEV-YVKKTMGRLPVRWMAIESLNYS 198
Query: 300 VVTEKCVIYSFGVVALEVL-MGTHP------GELLLSLSSSSGPKIMLIDILYQRLSPPI 352
V T ++S+GV+ E++ +G P EL L RL P+
Sbjct: 199 VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP------------QGYRLEKPL 246
Query: 353 NQKIIQDIILVSTIALACLRSKPKSRPTMQRI 384
N D V + C R KP RP+ +I
Sbjct: 247 N---CDD--EVYDLMRQCWREKPYERPSFAQI 273
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 4e-06
Identities = 50/200 (25%), Positives = 86/200 (43%), Gaps = 20/200 (10%)
Query: 196 IYEYMERGSLFCVL---RDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISS 252
I +M+ G L L R +E L + + +A + YL + + +HRD+++
Sbjct: 85 ILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLS---SKNFIHRDLAA 141
Query: 253 NNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTY--GYIALELVYTMVVTEKCVIYSF 310
N +LN N+ VADFG + + R A ++ALE + V T +++F
Sbjct: 142 RNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAF 201
Query: 311 GVVALEVL-MGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKIIQDIILVSTIALA 369
GV E++ G P + +I I RL P + ++D+ +
Sbjct: 202 GVTMWEIMTRGQTP------YAGVENSEIYNYLIKGNRLKQPPD--CLEDVY---ELMCQ 250
Query: 370 CLRSKPKSRPTMQRISQELE 389
C +PK RP+ Q + +LE
Sbjct: 251 CWSPEPKCRPSFQHLRDQLE 270
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 4e-06
Identities = 35/131 (26%), Positives = 60/131 (45%), Gaps = 6/131 (4%)
Query: 193 MFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISS 252
+FF+ EY+ G L ++ + + R + L +LH I++RD+
Sbjct: 71 LFFVMEYLNGGDLMFHIQS---SGRFDEARARFYAAEIICGLQFLH---KKGIIYRDLKL 124
Query: 253 NNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGV 312
+N+LL+ + +ADFG + + GT YIA E++ E +SFGV
Sbjct: 125 DNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKYNESVDWWSFGV 184
Query: 313 VALEVLMGTHP 323
+ E+L+G P
Sbjct: 185 LLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 4e-06
Identities = 44/157 (28%), Positives = 74/157 (47%), Gaps = 27/157 (17%)
Query: 237 LHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDV---DSSNRTLQAGTYGYIAL 293
+HH + ++HRDI S NILL SN + DFG ++ D RT GT Y+A
Sbjct: 156 VHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTF-CGTPYYVAP 214
Query: 294 ELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLS---- 349
E+ ++K ++S GV+ E+L P + G + +++++ L+
Sbjct: 215 EIWRRKPYSKKADMFSLGVLLYELLTLKRPFD---------GENME--EVMHKTLAGRYD 263
Query: 350 --PPINQKIIQDIILVSTIALACLRSKPKSRPTMQRI 384
PP +Q+I V+ + L S PK RP+ ++
Sbjct: 264 PLPPSISPEMQEI--VTAL----LSSDPKRRPSSSKL 294
|
Length = 496 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 4e-06
Identities = 39/147 (26%), Positives = 64/147 (43%), Gaps = 28/147 (19%)
Query: 190 PQCMFFIYEYMERGSL--FCVLR-----------DDDEAIELNWTRRMNIVKSVAHALSY 236
P CM ++EY+ G L F V D+ L+ + ++I +A + Y
Sbjct: 82 PTCM--LFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEY 139
Query: 237 L--HHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGT----YGY 290
L HH VHRD+++ N L+ L ++DFG R D+ S++ +
Sbjct: 140 LSSHH-----FVHRDLAARNCLVGEGLTVKISDFGLSR--DIYSADYYRVQSKSLLPVRW 192
Query: 291 IALELVYTMVVTEKCVIYSFGVVALEV 317
+ E + T + I+SFGVV E+
Sbjct: 193 MPPEAILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.5 bits (114), Expect = 5e-06
Identities = 34/147 (23%), Positives = 62/147 (42%), Gaps = 29/147 (19%)
Query: 150 CIGTGGYDSVYKA-ELPDGKVVALKKL-----------------------HHSETEDSAF 185
+G G + SVY A G++VA+KK+ H
Sbjct: 6 QLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKE 65
Query: 186 VVYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSI 245
V ++F++EYME G+L+ +++D + + +I+ + L+++H
Sbjct: 66 VFRENDELYFVFEYME-GNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIHKH---GF 120
Query: 246 VHRDISSNNILLNSNLEAFVADFGTVR 272
HRD+ N+L++ +ADFG R
Sbjct: 121 FHRDLKPENLLVSGPEVVKIADFGLAR 147
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 5e-06
Identities = 42/154 (27%), Positives = 67/154 (43%), Gaps = 6/154 (3%)
Query: 170 VALKKLHHSETEDSAFVVYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKS 229
V LK + H + + + ++F+ +++ G LF L+ + E R
Sbjct: 48 VLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPE---PRARFYAAE 104
Query: 230 VAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTYG 289
+A AL YLH + +IV+RD+ NILL+S + DFG + S T GT
Sbjct: 105 IASALGYLH---SINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPE 161
Query: 290 YIALELVYTMVVTEKCVIYSFGVVALEVLMGTHP 323
Y+A E++ + G V E+L G P
Sbjct: 162 YLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 5e-06
Identities = 39/172 (22%), Positives = 67/172 (38%), Gaps = 29/172 (16%)
Query: 226 IVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQA 285
+ + + AL++LH ++HRD+ + NILL + + +ADFG R
Sbjct: 108 VCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFI 164
Query: 286 GTYGYIALELVYTMVVTE-----KCVIYSFGVVALEVLMG------THPGELLLSLSSSS 334
GT ++A E+V + K I+S G+ +E+ +P +LL + S
Sbjct: 165 GTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSE 224
Query: 335 GPKIMLIDILYQRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQ 386
P + P D + +CL P RPT + +
Sbjct: 225 PPTL---------DQPSKWSSSFNDFL------KSCLVKDPDDRPTAAELLK 261
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 6e-06
Identities = 48/183 (26%), Positives = 80/183 (43%), Gaps = 15/183 (8%)
Query: 170 VALKKLHHSETEDSAFVVYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKS 229
V LK L H + + + ++F+ +Y+ G LF L+ + +E R
Sbjct: 48 VLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLE---PRARFYAAE 104
Query: 230 VAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRL-LDVDSSNRTLQAGTY 288
VA A+ YLH + +I++RD+ NILL+S + DFG + ++ + + T GT
Sbjct: 105 VASAIGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTF-CGTP 160
Query: 289 GYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRL 348
Y+A E++ + G V E+L G P S M +IL++ L
Sbjct: 161 EYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPP-------FYSRDVSQMYDNILHKPL 213
Query: 349 SPP 351
P
Sbjct: 214 QLP 216
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 6e-06
Identities = 50/207 (24%), Positives = 86/207 (41%), Gaps = 41/207 (19%)
Query: 151 IGTGGYDSVYKAELPDGKVVALKKLH-HSETEDSA---------------------FVVY 188
+G G Y +VY G+++A+K++ + +A V Y
Sbjct: 8 LGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQY 67
Query: 189 SPQCM------FFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCT 242
C+ F+ E++ GS+ +L E + + K + ++YLH++C
Sbjct: 68 LGTCLDDNTISIFM-EFVPGGSISSILNRFGPLPEPVFCK---YTKQILDGVAYLHNNC- 122
Query: 243 PSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRT----LQA--GTYGYIALELV 296
+VHRDI NN++L N + DFG R L + T L++ GT ++A E++
Sbjct: 123 --VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVI 180
Query: 297 YTMVVTEKCVIYSFGVVALEVLMGTHP 323
K I+S G E+ G P
Sbjct: 181 NESGYGRKSDIWSIGCTVFEMATGKPP 207
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 7e-06
Identities = 50/207 (24%), Positives = 87/207 (42%), Gaps = 31/207 (14%)
Query: 193 MFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISS 252
+ I EY G L LR E+ L ++ VA +++L + + +HRD+++
Sbjct: 114 ILVITEYCCYGDLLNFLRRKRESF-LTLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAA 169
Query: 253 NNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTY---GYIALELVYTMVVTEKCVIYS 309
N+LL + DFG R + D SN ++ ++A E ++ V T + ++S
Sbjct: 170 RNVLLTHGKIVKICDFGLARDIMND-SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWS 228
Query: 310 FGVVALEVLMGTHPGELLLSLSSSSGPKIM-------LIDILYQRLSPPINQKIIQDIIL 362
+G++ E + SL S+ P + LI Y+ P I DI+
Sbjct: 229 YGILLWE----------IFSLGSNPYPGMPVDSKFYKLIKEGYRMAQPEHAPAEIYDIM- 277
Query: 363 VSTIALACLRSKPKSRPTMQRISQELE 389
C + P RPT ++I Q +
Sbjct: 278 -----KTCWDADPLKRPTFKQIVQLIG 299
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 7e-06
Identities = 38/136 (27%), Positives = 65/136 (47%), Gaps = 12/136 (8%)
Query: 193 MFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISS 252
++ + EYM G L ++ + D + W R V AL +H + +HRD+
Sbjct: 118 LYMVMEYMPGGDLVNLMSNYD--VPEKWARFYT--AEVVLALDAIH---SMGFIHRDVKP 170
Query: 253 NNILLNSNLEAFVADFGTVRLLDVDSSNRTLQA-GTYGYIALELVYTM----VVTEKCVI 307
+N+LL+ + +ADFGT ++ + R A GT YI+ E++ + +C
Sbjct: 171 DNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDW 230
Query: 308 YSFGVVALEVLMGTHP 323
+S GV E+L+G P
Sbjct: 231 WSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 47.2 bits (113), Expect = 7e-06
Identities = 49/186 (26%), Positives = 69/186 (37%), Gaps = 54/186 (29%)
Query: 143 EYFHIRYCIGTGGYDSVYKA-ELPDGKVVALKK-----------------------LHHS 178
+ I +G G Y V+KA + +VVALKK L
Sbjct: 7 RKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDH 66
Query: 179 ETEDSAFVVYSPQCMFFIY---EYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAH--- 232
V + IY EYME +L+ R NI++ V
Sbjct: 67 PNIVKLLNVIKAENDKDIYLVFEYME--------------TDLHAVIRANILEDVHKRYI 112
Query: 233 ------ALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAG 286
AL Y+H + +++HRD+ +NILLNS+ +ADFG R L N
Sbjct: 113 MYQLLKALKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVL 169
Query: 287 TYGYIA 292
T Y+A
Sbjct: 170 TD-YVA 174
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 46.6 bits (111), Expect = 7e-06
Identities = 65/273 (23%), Positives = 102/273 (37%), Gaps = 75/273 (27%)
Query: 151 IGTGGYDSVYKA-ELPDGKVVA--------------------------LKKLHH------ 177
+G+G + SVY+ L DG A L KL H
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 178 --SETEDSAFVVYSPQCMFFIYEYMERGSLFCVLRDDD---EAIELNWTRRMNIVKSVAH 232
+E E+ ++ E + GSL +L+ E + +TR+ I+
Sbjct: 68 LGTEREEDNLYIF--------LELVPGGSLAKLLKKYGSFPEPVIRLYTRQ--ILL---- 113
Query: 233 ALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTYGYIA 292
L YLH + VHRDI NIL+++N +ADFG + + S ++ + Y ++A
Sbjct: 114 GLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFKGSPY-WMA 169
Query: 293 LELV-----YTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQR 347
E++ Y + I+S G LE+ G P S + I +
Sbjct: 170 PEVIAQQGGYGLAAD----IWSLGCTVLEMATGKPP-------WSQLEGVAAVFKIGRSK 218
Query: 348 LSPPINQKIIQDIILVSTIALACLRSKPKSRPT 380
PPI + + L CL+ P RPT
Sbjct: 219 ELPPIPDHLSDE---AKDFILKCLQRDPSLRPT 248
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 8e-06
Identities = 40/148 (27%), Positives = 69/148 (46%), Gaps = 24/148 (16%)
Query: 193 MFFIYEYMERGSLFCVLR----------DDDEAIELNWTRRMNIVKSVAHALSYLHHDCT 242
+ ++EYM+ G L LR + + EL ++ ++I + +A + YL +
Sbjct: 82 LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYL---AS 138
Query: 243 PSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTYGYIALE------LV 296
VHRD+++ N L+ NL + DFG R DV S++ + G + + + ++
Sbjct: 139 QHFVHRDLATRNCLVGENLLVKIGDFGMSR--DVYSTD-YYRVGGHTMLPIRWMPPESIM 195
Query: 297 YTMVVTEKCVIYSFGVVALEVLM-GTHP 323
Y TE V +S GVV E+ G P
Sbjct: 196 YRKFTTESDV-WSLGVVLWEIFTYGKQP 222
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 46.2 bits (110), Expect = 1e-05
Identities = 47/172 (27%), Positives = 73/172 (42%), Gaps = 38/172 (22%)
Query: 151 IGTGGYDSVYKAE-LPDGKVVALKKLHHSETE--------DSAFVVYSPQCMFFIYEYME 201
IG+G VYK G V+A+K++ + + D V+ S C + + Y
Sbjct: 23 IGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYG- 81
Query: 202 RGSLFCVLRDDDEAI--ELNWT------RRMN----------IVKSVAHALSYLHHDCTP 243
+ D D I EL T +R+ + ++ AL YL
Sbjct: 82 -----YFITDSDVFICMELMSTCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKE--KH 134
Query: 244 SIVHRDISSNNILLNSNLEAFVADFGTV-RLLDVDSSNRTLQAGTYGYIALE 294
++HRD+ +NILL+++ + DFG RL VDS +T AG Y+A E
Sbjct: 135 GVIHRDVKPSNILLDASGNVKLCDFGISGRL--VDSKAKTRSAGCAAYMAPE 184
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 1e-05
Identities = 38/136 (27%), Positives = 65/136 (47%), Gaps = 12/136 (8%)
Query: 193 MFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISS 252
++ + EYM G L ++ + D + W + V AL +H + ++HRD+
Sbjct: 118 LYMVMEYMPGGDLVNLMSNYD--VPEKWAKFYT--AEVVLALDAIH---SMGLIHRDVKP 170
Query: 253 NNILLNSNLEAFVADFGTVRLLDVDSSNRTLQA-GTYGYIALELVYTM----VVTEKCVI 307
+N+LL+ + +ADFGT +D R A GT YI+ E++ + +C
Sbjct: 171 DNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDW 230
Query: 308 YSFGVVALEVLMGTHP 323
+S GV E+L+G P
Sbjct: 231 WSVGVFLFEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 1e-05
Identities = 56/246 (22%), Positives = 109/246 (44%), Gaps = 53/246 (21%)
Query: 135 YENL---IDATEYFHIRYCIGTGGYDSVYKAELPDGKVVALKKLHHSETE---------- 181
YE++ +D E + I +G G + VYKA+ + +A K+ +++E
Sbjct: 1 YEHVRRDLDPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEI 60
Query: 182 ------DSAFVV------YSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKS 229
+ ++V Y ++ + E+ G++ ++ + D + + I +
Sbjct: 61 EILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQ--VICRQ 118
Query: 230 VAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSN-RTLQA--- 285
+ AL YLH + I+HRD+ + N+LL + + +ADFG V + N +TLQ
Sbjct: 119 MLEALQYLH---SMKIIHRDLKAGNVLLTLDGDIKLADFG------VSAKNVKTLQRRDS 169
Query: 286 --GTYGYIALELVYTMVVTE-----KCVIYSFGVVALEVLM------GTHPGELLLSLSS 332
GT ++A E+V + + K I+S G+ +E+ +P +LL ++
Sbjct: 170 FIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAK 229
Query: 333 SSGPKI 338
S P +
Sbjct: 230 SEPPTL 235
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 1e-05
Identities = 49/201 (24%), Positives = 86/201 (42%), Gaps = 46/201 (22%)
Query: 151 IGTGGYDSVYKAE-LPDGKVVALKKLH-HSETE---DSAF-------------------V 186
IG G Y VYKA G+VVALKK+ +ETE +A V
Sbjct: 8 IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 67
Query: 187 VYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKS----VAHALSYLHHDCT 242
+++ ++ ++E++ + D + + ++KS + L++ H +
Sbjct: 68 IHTENKLYLVFEFLHQD--LKKFMDASPLSGI----PLPLIKSYLFQLLQGLAFCH---S 118
Query: 243 PSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTYGYIALELV-----Y 297
++HRD+ N+L+N+ +ADFG R V T + T Y A E++ Y
Sbjct: 119 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYY 178
Query: 298 TMVVTEKCVIYSFGVVALEVL 318
+ V I+S G + E++
Sbjct: 179 STAVD----IWSLGCIFAEMV 195
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 2e-05
Identities = 30/98 (30%), Positives = 50/98 (51%), Gaps = 12/98 (12%)
Query: 232 HALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGT-VRLLDVDSSNRTLQAGTYGY 290
H++ LH+ VHRDI +N+LL+ N +ADFG+ +++ + ++ GT Y
Sbjct: 116 HSIHQLHY------VHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDY 169
Query: 291 IALELVYTM-----VVTEKCVIYSFGVVALEVLMGTHP 323
I+ E++ M +C +S GV E+L G P
Sbjct: 170 ISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 2e-05
Identities = 47/219 (21%), Positives = 96/219 (43%), Gaps = 42/219 (19%)
Query: 193 MFFIYEYMERGSL---------------FCVLRDDDEAIELNWTRRMNIVKSVAHALSYL 237
++ I EY +G+L + + R DE ++ + ++ VA + YL
Sbjct: 96 LYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDE--QMTFKDLVSCTYQVARGMEYL 153
Query: 238 HHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVR-LLDVDSSNRTLQAG-TYGYIALEL 295
+ +HRD+++ N+L+ N +ADFG R + ++D +T ++A E
Sbjct: 154 ---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEA 210
Query: 296 VYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILY-----QRLSP 350
++ V T + ++SFGV+ E+ +L S P I + ++ R+
Sbjct: 211 LFDRVYTHQSDVWSFGVLMWEI----------FTLGGSPYPGIPVEELFKLLKEGHRMDK 260
Query: 351 PINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELE 389
P N ++ ++ C + P RPT +++ ++L+
Sbjct: 261 PAN--CTNELYMMMR---DCWHAIPSHRPTFKQLVEDLD 294
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 2e-05
Identities = 51/196 (26%), Positives = 86/196 (43%), Gaps = 30/196 (15%)
Query: 151 IGTGGYDSVYKAELPDGKVVALKKLHHSETE-----------------DSAFVV------ 187
+G G V K + ++ +KL H E + +S ++V
Sbjct: 13 LGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 72
Query: 188 YSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVH 247
YS + E+M+ GSL VL+ EA + + +V L+YL I+H
Sbjct: 73 YSDGEISICMEHMDGGSLDQVLK---EAKRIPEEILGKVSIAVLRGLAYLRE--KHQIMH 127
Query: 248 RDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTYGYIALELVYTMVVTEKCVI 307
RD+ +NIL+NS E + DFG L +DS + GT Y++ E + + + I
Sbjct: 128 RDVKPSNILVNSRGEIKLCDFGVSGQL-IDSMANSF-VGTRSYMSPERLQGTHYSVQSDI 185
Query: 308 YSFGVVALEVLMGTHP 323
+S G+ +E+ +G +P
Sbjct: 186 WSMGLSLVELAIGRYP 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 2e-05
Identities = 43/172 (25%), Positives = 74/172 (43%), Gaps = 34/172 (19%)
Query: 230 VAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSS-----NRTLQ 284
VA + +L + + +HRD+++ N+LL A + DFG R + DS+ N L
Sbjct: 221 VAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLP 277
Query: 285 AGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIM----- 339
++A E ++ V T + ++S+G++ E+ SL S P I+
Sbjct: 278 V---KWMAPESIFDCVYTVQSDVWSYGILLWEI----------FSLGKSPYPGILVNSKF 324
Query: 340 --LIDILYQRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELE 389
++ YQ P I +I C +P RPT +ISQ ++
Sbjct: 325 YKMVKRGYQMSRPDFAPPEIY------SIMKMCWNLEPTERPTFSQISQLIQ 370
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.4 bits (108), Expect = 3e-05
Identities = 39/156 (25%), Positives = 63/156 (40%), Gaps = 49/156 (31%)
Query: 151 IGTGGYDSVYKA-ELPDGKVVALKKLHHSETEDSAF------------------------ 185
IG G Y VYKA + G++VALKK+ ETED
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIR-LETEDEGVPSTAIREISLLKELNHPNIVRLLD 65
Query: 186 VVYSPQCMFFIYEYMERGSLFCVLRDD-----DEAIELNWTRRMNIVKS----VAHALSY 236
VV+S ++ ++E+ L D D + + +KS + ++Y
Sbjct: 66 VVHSENKLYLVFEF---------LDLDLKKYMDSSPLTGLDPPL--IKSYLYQLLQGIAY 114
Query: 237 LHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVR 272
H + ++HRD+ N+L++ +ADFG R
Sbjct: 115 CH---SHRVLHRDLKPQNLLIDREGALKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 3e-05
Identities = 38/140 (27%), Positives = 63/140 (45%), Gaps = 12/140 (8%)
Query: 189 SPQCMFFIYEYMERGSLFCVL---RDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSI 245
+ +FF+ EY+ G L + R DE R V AL +LH +
Sbjct: 67 TKDRLFFVMEYVNGGDLMFQIQRSRKFDEP------RSRFYAAEVTLALMFLHRH---GV 117
Query: 246 VHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTYGYIALELVYTMVVTEKC 305
++RD+ +NILL++ +ADFG + ++ T GT YIA E++ +
Sbjct: 118 IYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGPSV 177
Query: 306 VIYSFGVVALEVLMGTHPGE 325
++ GV+ E++ G P E
Sbjct: 178 DWWALGVLMYEMMAGQPPFE 197
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 3e-05
Identities = 36/139 (25%), Positives = 62/139 (44%), Gaps = 6/139 (4%)
Query: 185 FVVYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPS 244
F SP+ ++ + ++ G LF L+ + + +R + AL LH +
Sbjct: 60 FSFQSPEKLYLVLAFINGGELFHHLQREGR---FDLSRARFYTAELLCALENLH---KFN 113
Query: 245 IVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTYGYIALELVYTMVVTEK 304
+++RD+ NILL+ + DFG +L D GT Y+A EL+ T+
Sbjct: 114 VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTKA 173
Query: 305 CVIYSFGVVALEVLMGTHP 323
++ GV+ E+L G P
Sbjct: 174 VDWWTLGVLLYEMLTGLPP 192
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 3e-05
Identities = 45/195 (23%), Positives = 84/195 (43%), Gaps = 28/195 (14%)
Query: 209 LRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADF 268
L DD + L ++ VA + +L + + VHRD+++ N+LL + DF
Sbjct: 225 LLSDDGSEGLTTLDLLSFTYQVARGMEFL---ASKNCVHRDLAARNVLLAQGKIVKICDF 281
Query: 269 GTVRLLDVDSSNRTLQAGTY---GYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGE 325
G R + D SN + T+ ++A E ++ + T ++S+G++ E+
Sbjct: 282 GLARDIMHD-SNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEI-------- 332
Query: 326 LLLSLSSSSGPKIMLIDILYQ------RLSPPINQKIIQDIILVSTIALACLRSKPKSRP 379
SL + P +++ Y R++ P Q+ V I + C S+P+ RP
Sbjct: 333 --FSLGGTPYPGMIVDSTFYNKIKSGYRMAKP--DHATQE---VYDIMVKCWNSEPEKRP 385
Query: 380 TMQRISQELEGKTPM 394
+ +S +E P
Sbjct: 386 SFLHLSDIVESLLPS 400
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 3e-05
Identities = 48/222 (21%), Positives = 77/222 (34%), Gaps = 49/222 (22%)
Query: 189 SPQCMFFIYEYMERGSLFCVLRDDDEAIE------LNWTRRMNIVKSVAHALSYLHHDCT 242
P M I EY + G L LR E L+ +++ + +A + +L
Sbjct: 81 EPHYM--ILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLS---N 135
Query: 243 PSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTYG---YIALELVYTM 299
VHRD+++ N L++S E V+ + DV +S ++A E V
Sbjct: 136 ARFVHRDLAARNCLVSSQREVKVSLLSLSK--DVYNSEYYKLRNALIPLRWLAPEAVQED 193
Query: 300 VVTEKCVIYSFGVVALEVLMGT---HPG----ELLLSLSSSSGPKIMLIDILYQRLSPPI 352
+ K ++SFGV+ EV G E+L L + L P
Sbjct: 194 DFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGK-----------LELPVPE 242
Query: 353 N-----QKIIQDIILVSTIALACLRSKPKSRPTMQRISQELE 389
K++ C PK RP+ + L
Sbjct: 243 GCPSRLYKLMT----------RCWAVNPKDRPSFSELVSALG 274
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 3e-05
Identities = 51/211 (24%), Positives = 85/211 (40%), Gaps = 51/211 (24%)
Query: 192 CMFFIYEYMERGSLFC-------VLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPS 244
++ + +Y E G L+ VL +D+ L+W ++ + AL ++H
Sbjct: 73 NLYIVMDYCEGGDLYKKINAQRGVLFPEDQI--LDWFVQICL------ALKHVHDR---K 121
Query: 245 IVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQ-----AGTYGYIALELVYTM 299
I+HRDI S NI L + + DFG R+L N T++ GT Y++ E+
Sbjct: 122 ILHRDIKSQNIFLTKDGTIKLGDFGIARVL-----NSTVELARTCIGTPYYLSPEICENR 176
Query: 300 VVTEKCVIYSFGVVALEVLMGTHPGE------LLLSLSSSSGPKIMLIDILYQRLSPPIN 353
K I++ G V E+ H E L+L + S P + S +
Sbjct: 177 PYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSS------HYSYDLR 230
Query: 354 QKIIQDIILVSTIALACLRSKPKSRPTMQRI 384
LVS + + P+ RP++ I
Sbjct: 231 N-------LVSQL----FKRNPRDRPSVNSI 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 3e-05
Identities = 53/216 (24%), Positives = 83/216 (38%), Gaps = 47/216 (21%)
Query: 145 FHIRYCIGTGGYDSVYKAEL----PDGKVVALKKL------------HHSETE------- 181
F + +GTG Y V+ GK+ A+K L H+ TE
Sbjct: 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAV 61
Query: 182 -DSAFVV---YSPQC---MFFIYEYMERGSLFCVL----RDDDEAIELNWTRRMNIVKSV 230
F+V Y+ Q + I +Y+ G LF L + + + + +
Sbjct: 62 RRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRV-------YIAEI 114
Query: 231 AHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQ-AGTYG 289
AL +LH I++RDI NILL+S + DFG + + R GT
Sbjct: 115 VLALDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIE 171
Query: 290 YIALELVYTMVVTEKCVI--YSFGVVALEVLMGTHP 323
Y+A E++ + +S GV+ E+L G P
Sbjct: 172 YMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 45.1 bits (106), Expect = 3e-05
Identities = 44/194 (22%), Positives = 83/194 (42%), Gaps = 30/194 (15%)
Query: 151 IGTGGYDSVYKAELP-DGKVVALKKLHHSETEDSAF----------------------VV 187
+G G Y +VYK + +GK+VALK + E E + F ++
Sbjct: 13 LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDII 72
Query: 188 YSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVH 247
++ + + ++EY+ + C D L+ + + LSY+H I+H
Sbjct: 73 HTKETLTLVFEYVH--TDLCQYMDKHPG-GLHPENVKLFLFQLLRGLSYIHQR---YILH 126
Query: 248 RDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTYGYIALELVYTMVVTEKCV- 306
RD+ N+L++ E +ADFG R V S + + T Y +++ C+
Sbjct: 127 RDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLD 186
Query: 307 IYSFGVVALEVLMG 320
++ G + +E++ G
Sbjct: 187 MWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 3e-05
Identities = 40/160 (25%), Positives = 66/160 (41%), Gaps = 24/160 (15%)
Query: 226 IVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQA 285
I L+YLH +HRDI + NILL +ADFG+ L V +N +
Sbjct: 120 ICHGALQGLAYLHSHER---IHRDIKAGNILLTEPGTVKLADFGSASL--VSPANSFV-- 172
Query: 286 GTYGYIALELVYTM---VVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLID 342
GT ++A E++ M K ++S G+ +E+ P L ++++ S
Sbjct: 173 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP---LFNMNAMSA------- 222
Query: 343 ILYQ--RLSPPINQKIIQDIILVSTIALACLRSKPKSRPT 380
LY + P + + CL+ P+ RP+
Sbjct: 223 -LYHIAQNDSPTLSSNDWSDYFRNFVDS-CLQKIPQDRPS 260
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 44.6 bits (106), Expect = 4e-05
Identities = 52/228 (22%), Positives = 90/228 (39%), Gaps = 52/228 (22%)
Query: 186 VVYSPQCMFFIYEYMERGSLFCVLR----DDDEA---IELNWTRRMNIVKSVAHALSYLH 238
VV + Q + E M +G L LR + + + + + +A ++YL
Sbjct: 77 VVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLA 136
Query: 239 HDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGT----YGYIALE 294
VHRD+++ N ++ +L + DFG R D+ ++ + G ++A E
Sbjct: 137 ---AKKFVHRDLAARNCMVAEDLTVKIGDFGMTR--DIYETDYYRKGGKGLLPVRWMAPE 191
Query: 295 LVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQ 354
+ V T K ++SFGVV E M T L + YQ LS N+
Sbjct: 192 SLKDGVFTTKSDVWSFGVVLWE--MAT------------------LAEQPYQGLS---NE 228
Query: 355 KIIQDII-------------LVSTIALACLRSKPKSRPTMQRISQELE 389
++++ +I + + C + PK RPT I L+
Sbjct: 229 EVLKFVIDGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 4e-05
Identities = 29/93 (31%), Positives = 43/93 (46%), Gaps = 4/93 (4%)
Query: 226 IVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQA 285
I K + L YLH I+HRD+ + NI +N + + D G + V + L A
Sbjct: 162 IEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGL-A 217
Query: 286 GTYGYIALELVYTMVVTEKCVIYSFGVVALEVL 318
GT A E++ K I+S G+V E+L
Sbjct: 218 GTVETNAPEVLARDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 4e-05
Identities = 43/157 (27%), Positives = 67/157 (42%), Gaps = 41/157 (26%)
Query: 190 PQCMFFIYEYMERGSLFCVLR----DDDEA------------IELNWTRRMNIVKSVAHA 233
P CM I EYME G L L DD E ++++ +++ +A
Sbjct: 93 PLCM--ITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASG 150
Query: 234 LSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTY----- 288
+ YL + + VHRD+++ N L+ NL +ADFG +R L AG Y
Sbjct: 151 MKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGM---------SRNLYAGDYYRIQG 198
Query: 289 ------GYIALELVYTMVVTEKCVIYSFGVVALEVLM 319
++A E + T +++FGV E+LM
Sbjct: 199 RAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILM 235
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 4e-05
Identities = 39/140 (27%), Positives = 64/140 (45%), Gaps = 12/140 (8%)
Query: 189 SPQCMFFIYEYMERGSLFCVL---RDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSI 245
+P +FF+ E++ G L + R DEA R + AL +LH I
Sbjct: 67 TPDRLFFVMEFVNGGDLMFHIQKSRRFDEA------RARFYAAEITSALMFLH---DKGI 117
Query: 246 VHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTYGYIALELVYTMVVTEKC 305
++RD+ +N+LL+ +ADFG + + + GT YIA E++ M+
Sbjct: 118 IYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLYGPSV 177
Query: 306 VIYSFGVVALEVLMGTHPGE 325
++ GV+ E+L G P E
Sbjct: 178 DWWAMGVLLYEMLCGHAPFE 197
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 44.6 bits (106), Expect = 4e-05
Identities = 52/238 (21%), Positives = 81/238 (34%), Gaps = 75/238 (31%)
Query: 190 PQCMFFIYEYMERGSL-----FCVLRDDDEAIELNWTRR---MNIVKSVAHALSYLHHDC 241
P CM I EYME G L V A + + +A + YL
Sbjct: 93 PLCM--IMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLE--- 147
Query: 242 TPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTYGYI---------- 291
+ + VHRD+++ N L+ N +ADFG +R L + Y +
Sbjct: 148 SLNFVHRDLATRNCLVGKNYTIKIADFGM---------SRNLYSSDYYRVQGRAPLPIRW 198
Query: 292 -ALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSP 350
A E V T K +++FGV E+L P Y+ L+
Sbjct: 199 MAWESVLLGKFTTKSDVWAFGVTLWEILT-----------LCREQP--------YEHLT- 238
Query: 351 PINQKIIQDIIL--------------------VSTIALACLRSKPKSRPTMQRISQEL 388
+Q++I++ + + L C R + RPT + I L
Sbjct: 239 --DQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFL 294
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 4e-05
Identities = 42/181 (23%), Positives = 73/181 (40%), Gaps = 53/181 (29%)
Query: 230 VAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTY- 288
+A + YL + +HRD+++ N +L ++ VADFG ++ + +G Y
Sbjct: 122 IALGMEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGL---------SKKIYSGDYY 169
Query: 289 ----------GYIALELVYTMVVTEKCVIYSFGVVALEVL---MGTHPG-------ELLL 328
+IA+E + V T K +++FGV E+ +PG + L
Sbjct: 170 RQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLR 229
Query: 329 SLSSSSGPKIMLIDILYQRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQEL 388
+ P+ L D LY + +C R+ PK RPT ++ + L
Sbjct: 230 HGNRLKQPEDCL-DELYDLMY-------------------SCWRADPKDRPTFTKLREVL 269
Query: 389 E 389
E
Sbjct: 270 E 270
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 4e-05
Identities = 31/95 (32%), Positives = 49/95 (51%), Gaps = 5/95 (5%)
Query: 230 VAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQ-AGTY 288
+A AL +LH + I++RD+ NILL+ + DFG + +D + GT
Sbjct: 107 LALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSK-ESIDHEKKAYSFCGTV 162
Query: 289 GYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHP 323
Y+A E+V T+ +SFGV+ E+L G+ P
Sbjct: 163 EYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLP 197
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 5e-05
Identities = 48/204 (23%), Positives = 83/204 (40%), Gaps = 36/204 (17%)
Query: 150 CIGTGGYDSVYKA-ELPDGKVVALKKLH------HSETEDSAF---------------VV 187
+G G + VY ++ G+ +A+K++ ++ E +A V
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQ 68
Query: 188 Y-----SPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCT 242
Y + + EYM GS+ L+ A+ TR+ + + + YLH +
Sbjct: 69 YYGCLRDDETLSIFMEYMPGGSVKDQLKAYG-ALTETVTRKYT--RQILEGVEYLH---S 122
Query: 243 PSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQA---GTYGYIALELVYTM 299
IVHRDI NIL +S + DFG + L S+ T GT +++ E++
Sbjct: 123 NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGE 182
Query: 300 VVTEKCVIYSFGVVALEVLMGTHP 323
K ++S G +E+L P
Sbjct: 183 GYGRKADVWSVGCTVVEMLTEKPP 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.2 bits (105), Expect = 5e-05
Identities = 67/287 (23%), Positives = 104/287 (36%), Gaps = 74/287 (25%)
Query: 151 IGTGGYDSVYKA-ELPDGKVVALKKLHHSETEDSAFV-------------VYSPQCMFFI 196
+G G Y V K G++VA+KK E+ED V + +
Sbjct: 9 VGEGAYGVVLKCRNKATGEIVAIKKF--KESEDDEDVKKTALREVKVLRQLRHENIVNLK 66
Query: 197 YEYMERGSLFCVLRDDDEAIELNWTRRMN---------IVKS----VAHALSYLH-HDCT 242
+ +G L+ V E +E + V+S + A++Y H H+
Sbjct: 67 EAFRRKGRLYLVF----EYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHN-- 120
Query: 243 PSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNR-TLQAGTYGYIALELVYTMVV 301
I+HRDI NIL++ + + DFG R L ++ T T Y A EL+
Sbjct: 121 --IIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTN 178
Query: 302 TEKCV-IYSFGVVALEVLMGT--HPG----------------------ELLLSLSSSSG- 335
K V +++ G + E+L G PG EL S +G
Sbjct: 179 YGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGV 238
Query: 336 --PKIMLIDILYQRLSPPINQKIIQDIILVSTIALACLRSKPKSRPT 380
P+ + L +R ++ + ACLR PK R T
Sbjct: 239 AFPEPSQPESLERRYPGKVSSPALD-------FLKACLRMDPKERLT 278
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 5e-05
Identities = 46/199 (23%), Positives = 84/199 (42%), Gaps = 36/199 (18%)
Query: 151 IGTGGYDSVYKAELPDGK------------VVALKKLHHSETEDSA-------FVV---- 187
+GTG + V+ + V+ LK+ H E F++
Sbjct: 9 VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFW 68
Query: 188 --YSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSI 245
+ + ++ + EY+ G LF LR+ + + + + + AL YLH + I
Sbjct: 69 TEHDQRFLYMLMEYVPGGELFSYLRN---SGRFSNSTGLFYASEIVCALEYLH---SKEI 122
Query: 246 VHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQ-AGTYGYIALELVYTMVVTEK 304
V+RD+ NILL+ + DFG + L +RT GT Y+A E++ + +
Sbjct: 123 VYRDLKPENILLDKEGHIKLTDFGFAKKL----RDRTWTLCGTPEYLAPEVIQSKGHNKA 178
Query: 305 CVIYSFGVVALEVLMGTHP 323
++ G++ E+L+G P
Sbjct: 179 VDWWALGILIYEMLVGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 6e-05
Identities = 37/146 (25%), Positives = 67/146 (45%), Gaps = 13/146 (8%)
Query: 246 VHRDISSNNILLNSNLEAFVADFGTVRLL--DVDSSNRTLQAGTYGYIALELVYTMVVTE 303
+HRD+++ NILL+ N + DFG R + D D + ++A E ++ V T
Sbjct: 195 IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFDKVYTT 254
Query: 304 KCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKIIQDIIL- 362
+ ++SFGV+ E+ SL +S P + + + +RL + +
Sbjct: 255 QSDVWSFGVLLWEI----------FSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPE 304
Query: 363 VSTIALACLRSKPKSRPTMQRISQEL 388
+ +I L C + P+ RPT + + L
Sbjct: 305 IYSIMLDCWHNNPEDRPTFSELVEIL 330
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 7e-05
Identities = 39/167 (23%), Positives = 77/167 (46%), Gaps = 25/167 (14%)
Query: 230 VAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVR-LLDVDSSNRTLQAG-T 287
VA + YL + +HRD+++ N+L+ + +ADFG R + ++D +T
Sbjct: 143 VARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLP 199
Query: 288 YGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILY-- 345
++A E ++ V T + ++SFGV+ E+ +L S P I + ++
Sbjct: 200 VKWMAPEALFDRVYTHQSDVWSFGVLLWEI----------FTLGGSPYPGIPVEELFKLL 249
Query: 346 ---QRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELE 389
R+ P N ++ + I C + P RPT +++ ++L+
Sbjct: 250 KEGHRMDKPAN--CTHELYM---IMRECWHAVPSQRPTFKQLVEDLD 291
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 7e-05
Identities = 59/204 (28%), Positives = 87/204 (42%), Gaps = 42/204 (20%)
Query: 151 IGTGGYDSVYKAELP-DGKVVALKKLH-----------HSETEDSA--------FVV--- 187
IG G + V A+ DGK A+K L H E + F+V
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 188 YSPQC---MFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPS 244
YS Q ++F+ +Y+ G LF L+ + E R +A AL YLH + +
Sbjct: 63 YSFQTADKLYFVLDYVNGGELFFHLQRERSFPE---PRARFYAAEIASALGYLH---SLN 116
Query: 245 IVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQ-AGTYGYIALELV----YTM 299
I++RD+ NILL+S + DFG + ++ S T GT Y+A E++ Y
Sbjct: 117 IIYRDLKPENILLDSQGHVVLTDFGLCK-EGIEHSKTTSTFCGTPEYLAPEVLRKQPYDR 175
Query: 300 VVTEKCVIYSFGVVALEVLMGTHP 323
V C+ G V E+L G P
Sbjct: 176 TVDWWCL----GAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 8e-05
Identities = 50/207 (24%), Positives = 81/207 (39%), Gaps = 47/207 (22%)
Query: 145 FHIRYCIGTGGYDSVYKAE-LPDGKVVALKKLHHSETEDS-------------------- 183
F I IG G + VYKA L DG+VVALKK+ E D+
Sbjct: 4 FKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPN 63
Query: 184 -----AFVVYSPQCMFFIYEYMERGSLFCVL---RDDDEAIELN--WTRRMNIVKSVAHA 233
A + + + + + E + G L ++ + I W + + A
Sbjct: 64 VIKYLASFIENNE-LNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQL----CSA 118
Query: 234 LSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQA----GTYG 289
L ++H + I+HRDI N+ + + + D G R S++T A GT
Sbjct: 119 LEHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFF----SSKTTAAHSLVGTPY 171
Query: 290 YIALELVYTMVVTEKCVIYSFGVVALE 316
Y++ E ++ K I+S G + E
Sbjct: 172 YMSPERIHENGYNFKSDIWSLGCLLYE 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.8 bits (104), Expect = 8e-05
Identities = 38/167 (22%), Positives = 68/167 (40%), Gaps = 49/167 (29%)
Query: 151 IGTGGYDSVYKA-ELPDGKVVA-----------------------LKKLHHSETE----- 181
IG G Y +VYKA +L G+ VA LK+L E
Sbjct: 7 IGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRL 66
Query: 182 -DSAFVVYSPQCM--FFIYEYMERGSLFCVLRD------DDEAIELNWTRRMNIVKSVAH 232
D + + + ++E++++ L L E I+ ++++ +
Sbjct: 67 LDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIK-------DLMRQLLR 118
Query: 233 ALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSS 279
+ +LH + IVHRD+ NIL+ S+ + +ADFG R+ + +
Sbjct: 119 GVDFLH---SHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMA 162
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 9e-05
Identities = 45/177 (25%), Positives = 65/177 (36%), Gaps = 56/177 (31%)
Query: 147 IRYC--IGTGGYDSVYKAELP------DGKVVALKKLHHSETED------------SAF- 185
I Y IG G + V++A P +VA+K L + D + F
Sbjct: 7 IEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFD 66
Query: 186 -----------VVYSPQCMFFIYEYMERGSLFCVLRD-------------------DDEA 215
V P C+ F EYM G L LR
Sbjct: 67 HPNIVKLLGVCAVGKPMCLLF--EYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNP 124
Query: 216 IELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVR 272
+ L+ T ++ I K VA ++YL VHRD+++ N L+ N+ +ADFG R
Sbjct: 125 LPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSR 178
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 9e-05
Identities = 41/161 (25%), Positives = 68/161 (42%), Gaps = 26/161 (16%)
Query: 230 VAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTYG 289
+ A+SY+H I+HRDI + NI L + DFG ++L + S GT
Sbjct: 110 IVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPY 166
Query: 290 YIALELVYTMVVTEKCVIYSFGVVALEVLM------GTHPGELLLSLSSSSGPKIMLIDI 343
Y++ EL + K I++ G V E+L T+P L++ KI+
Sbjct: 167 YMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVV--------KIV---- 214
Query: 344 LYQRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRI 384
Q P+ ++I + + L+ P+ RPT +
Sbjct: 215 --QGNYTPVVSVYSSELISLVH---SLLQQDPEKRPTADEV 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 1e-04
Identities = 38/157 (24%), Positives = 66/157 (42%), Gaps = 35/157 (22%)
Query: 246 VHRDISSNNILLNSNLEAFVADFGTVRLL--DVDSSNRTLQAGTYGYIALELVYTMVVTE 303
+HRD+++ NILL+ N + DFG R + D D + ++A E ++ V T
Sbjct: 201 IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTI 260
Query: 304 KCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRL------------SPP 351
+ ++SFGV+ E+ SL +S P + + + +RL +P
Sbjct: 261 QSDVWSFGVLLWEI----------FSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPE 310
Query: 352 INQKIIQDIILVSTIALACLRSKPKSRPTMQRISQEL 388
+ Q + L C +P RPT + + L
Sbjct: 311 MYQTM-----------LDCWHGEPSQRPTFSELVEHL 336
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 1e-04
Identities = 33/131 (25%), Positives = 62/131 (47%), Gaps = 6/131 (4%)
Query: 193 MFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISS 252
++F+ EY+ G L ++ + E + + ++ L +LH I++RD+
Sbjct: 76 LYFVMEYVNGGDLMYHIQQVGKFKE---PQAVFYAAEISVGLFFLHRR---GIIYRDLKL 129
Query: 253 NNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGV 312
+N++L+S +ADFG + VD GT YIA E++ + +++GV
Sbjct: 130 DNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGV 189
Query: 313 VALEVLMGTHP 323
+ E+L G P
Sbjct: 190 LLYEMLAGQPP 200
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 1e-04
Identities = 38/152 (25%), Positives = 66/152 (43%), Gaps = 11/152 (7%)
Query: 172 LKKLHHSETEDSAFVVYSPQCMFFIYEYMERGSLFCVLRDDDEAIE--LNWTRRMNIVKS 229
LK+L H + V + ++ ++E+++ L DD E L+ +R +
Sbjct: 54 LKQLRHENLVNLIEVFRRKKRLYLVFEFVDHTVL-----DDLEKYPNGLDESRVRKYLFQ 108
Query: 230 VAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTYG 289
+ + + H +I+HRDI NIL++ + + DFG R L T T
Sbjct: 109 ILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRW 165
Query: 290 YIALELVYTMVVTEKCV-IYSFGVVALEVLMG 320
Y A EL+ + V I++ G + E+L G
Sbjct: 166 YRAPELLVGDTKYGRAVDIWAVGCLVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 1e-04
Identities = 28/96 (29%), Positives = 50/96 (52%), Gaps = 7/96 (7%)
Query: 230 VAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVR--LLDVDSSNRTLQAGT 287
+A L +LH + I++RD+ +N++L++ +ADFG + + + RT GT
Sbjct: 110 IAIGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG-GKTTRTF-CGT 164
Query: 288 YGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHP 323
YIA E++ + ++FGV+ E+L G P
Sbjct: 165 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPP 200
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 1e-04
Identities = 44/189 (23%), Positives = 80/189 (42%), Gaps = 34/189 (17%)
Query: 166 DGKVVALKKLHHSETEDSAFVVYSPQCMFFI---YEYMERGSLFCVLRDDDEAIELNW-- 220
+ +++AL +L+H ++ S + I Y++ L+ + D+ +W
Sbjct: 211 ENEILALGRLNHENILKIEEILRSEANTYMITQKYDF----DLYSFMYDEA----FDWKD 262
Query: 221 ------TRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLL 274
TR I+K + A+ Y+H ++HRDI NI LN + + + DFGT
Sbjct: 263 RPLLKQTRA--IMKQLLCAVEYIH---DKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPF 317
Query: 275 DVDSSNRTLQ-AGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLM---------GTHPG 324
+ + GT + E++ E I+S G++ L++L G PG
Sbjct: 318 EKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPG 377
Query: 325 ELLLSLSSS 333
+ LL + S
Sbjct: 378 KQLLKIIDS 386
|
Length = 501 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 2e-04
Identities = 40/132 (30%), Positives = 65/132 (49%), Gaps = 11/132 (8%)
Query: 192 CMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDIS 251
CM E+M+ GSL VL+ E + + +V L+YL I+HRD+
Sbjct: 81 CM----EHMDGGSLDQVLKKAGRIPEQILGK---VSIAVIKGLTYLRE--KHKIMHRDVK 131
Query: 252 SNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTYGYIALELVYTMVVTEKCVIYSFG 311
+NIL+NS E + DFG L +DS + GT Y++ E + + + I+S G
Sbjct: 132 PSNILVNSRGEIKLCDFGVSGQL-IDSMANSF-VGTRSYMSPERLQGTHYSVQSDIWSMG 189
Query: 312 VVALEVLMGTHP 323
+ +E+ +G +P
Sbjct: 190 LSLVEMAIGRYP 201
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 43.2 bits (101), Expect = 2e-04
Identities = 42/169 (24%), Positives = 75/169 (44%), Gaps = 26/169 (15%)
Query: 226 IVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQA 285
I L+YLH + +++HRDI + NILL + +ADFG+ + +S
Sbjct: 130 ITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPANSF----V 182
Query: 286 GTYGYIALELVYTMVVTE---KCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLID 342
GT ++A E++ M + K ++S G+ +E+ P L ++++ S
Sbjct: 183 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP---LFNMNAMSA------- 232
Query: 343 ILY---QRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQEL 388
LY Q SP + D +CL+ P+ RPT + + + +
Sbjct: 233 -LYHIAQNESPTLQSNEWSDYF--RNFVDSCLQKIPQDRPTSEELLKHM 278
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 2e-04
Identities = 48/171 (28%), Positives = 76/171 (44%), Gaps = 31/171 (18%)
Query: 230 VAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDV-DSSNRTLQAGTY 288
VA + YL + VHRD+++ N +L+ + VADFG R D+ D ++ T
Sbjct: 107 VAKGMEYL---ASKKFVHRDLAARNCMLDESFTVKVADFGLAR--DIYDKEYYSVHNHTG 161
Query: 289 G-----YIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDI 343
++ALE + T T K ++SFGV+ E L++ + P + DI
Sbjct: 162 AKLPVKWMALESLQTQKFTTKSDVWSFGVLLWE----------LMTRGAPPYPDVDSFDI 211
Query: 344 ---LYQ--RLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELE 389
L Q RL P + D + + L+C KP+ RPT + +E
Sbjct: 212 TVYLLQGRRLLQP---EYCPDPLY--EVMLSCWHPKPEMRPTFSELVSRIE 257
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 2e-04
Identities = 35/133 (26%), Positives = 61/133 (45%), Gaps = 6/133 (4%)
Query: 193 MFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISS 252
++F+ EY+ G L ++ E + +A L +LH + I++RD+
Sbjct: 76 LYFVMEYVNGGDLMYQIQQVGRFKE---PHAVFYAAEIAIGLFFLH---SKGIIYRDLKL 129
Query: 253 NNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGV 312
+N++L+S +ADFG + D GT YIA E++ + ++FGV
Sbjct: 130 DNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGV 189
Query: 313 VALEVLMGTHPGE 325
+ E+L G P E
Sbjct: 190 LLYEMLAGQAPFE 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 2e-04
Identities = 38/150 (25%), Positives = 64/150 (42%), Gaps = 38/150 (25%)
Query: 151 IGTGGYDSVYKA-ELPDGKVVALKK-----------------------LHHSETEDSAFV 186
IG G Y +V+KA ++VALK+ L H V
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67
Query: 187 VYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKS----VAHALSYLHHDCT 242
++S + + ++EY ++ L+ ++ N IVKS + L++ H
Sbjct: 68 LHSDKKLTLVFEYCDQD-----LKKYFDS--CNGDIDPEIVKSFMFQLLKGLAFCHSH-- 118
Query: 243 PSIVHRDISSNNILLNSNLEAFVADFGTVR 272
+++HRD+ N+L+N N E +ADFG R
Sbjct: 119 -NVLHRDLKPQNLLINKNGELKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 2e-04
Identities = 38/154 (24%), Positives = 68/154 (44%), Gaps = 9/154 (5%)
Query: 193 MFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISS 252
+FF+ EY+ G L ++ + E ++ AL+YLH I++RD+
Sbjct: 71 LFFVIEYVNGGDLMFHMQRQRKLPE---EHARFYSAEISLALNYLHER---GIIYRDLKL 124
Query: 253 NNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGV 312
+N+LL+S + D+G + + GT YIA E++ ++ GV
Sbjct: 125 DNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGV 184
Query: 313 VALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQ 346
+ E++ G P ++ + SS P D L+Q
Sbjct: 185 LMFEMMAGRSPFDI---VGSSDNPDQNTEDYLFQ 215
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 42.3 bits (100), Expect = 2e-04
Identities = 21/71 (29%), Positives = 34/71 (47%), Gaps = 7/71 (9%)
Query: 234 LSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNR----TLQAGTYG 289
L Y+H ++HRD+ +N+L+N + E + DFG R L + T T
Sbjct: 120 LKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRW 176
Query: 290 YIALELVYTMV 300
Y A EL+ ++
Sbjct: 177 YRAPELLLSLP 187
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 3e-04
Identities = 28/95 (29%), Positives = 45/95 (47%), Gaps = 10/95 (10%)
Query: 226 IVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQA 285
I L+YLH ++HRDI + NILL + +ADFG+ SS
Sbjct: 126 ITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASK----SSPANSFV 178
Query: 286 GTYGYIALELVYTMVVTE---KCVIYSFGVVALEV 317
GT ++A E++ M + K ++S G+ +E+
Sbjct: 179 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 3e-04
Identities = 26/93 (27%), Positives = 44/93 (47%), Gaps = 13/93 (13%)
Query: 190 PQCMFFIYEYMERGSL---FCVLR-----DDDEAIELNWTRRMNIVKSVAHALSYLHHDC 241
P CM I EYME G L + + + ++++ + + +A + YL
Sbjct: 93 PLCM--ITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLS--- 147
Query: 242 TPSIVHRDISSNNILLNSNLEAFVADFGTVRLL 274
+ + VHRD+++ N L+ N +ADFG R L
Sbjct: 148 SLNFVHRDLATRNCLVGKNYTIKIADFGMSRNL 180
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 3e-04
Identities = 40/138 (28%), Positives = 63/138 (45%), Gaps = 16/138 (11%)
Query: 193 MFFIYEYMERGSL-FCVLRDD--DEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRD 249
+FF+ EY+ G L F + R DE R + L +LH I++RD
Sbjct: 71 LFFVMEYVNGGDLMFHIQRSGRFDEP------RARFYAAEIVLGLQFLHER---GIIYRD 121
Query: 250 ISSNNILLNSNLEAFVADFGTVR--LLDVDSSNRTLQAGTYGYIALELVYTMVVTEKCVI 307
+ +N+LL+S +ADFG + +L ++ T GT YIA E++
Sbjct: 122 LKLDNVLLDSEGHIKIADFGMCKEGILGGVTT-STF-CGTPDYIAPEILSYQPYGPAVDW 179
Query: 308 YSFGVVALEVLMGTHPGE 325
++ GV+ E+L G P E
Sbjct: 180 WALGVLLYEMLAGQSPFE 197
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 3e-04
Identities = 52/224 (23%), Positives = 80/224 (35%), Gaps = 52/224 (23%)
Query: 151 IGTGGYDSVYKAE-LPDGKVVALKKLHHSE-----TEDSAFV------------------ 186
+G G Y V KA GK+VA+KK+ E T+D V
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76
Query: 187 VYSPQCMFFIYEYMERGSLFCVL--------RDDDEAIELNWTRRMNIVKSVAHALSYLH 238
+ M + Y+E + V+ + D I L ++ I+ + + L+ LH
Sbjct: 77 IKHENIMGLVDVYVEGDFINLVMDIMASDLKKVVDRKIRLTESQVKCILLQILNGLNVLH 136
Query: 239 HDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTYGYIALELVYT 298
+HRD+S NI +NS +ADFG R + TL E+
Sbjct: 137 ---KWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSK 193
Query: 299 MVV---------------TEKCVIYSFGVVALEVLMGT--HPGE 325
+V ++S G + E+L G PGE
Sbjct: 194 VVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGE 237
|
Length = 335 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 3e-04
Identities = 34/101 (33%), Positives = 48/101 (47%), Gaps = 6/101 (5%)
Query: 226 IVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQA 285
I + AL+YL + I+HRD+ +NILL+ N + DFG L VDS +T A
Sbjct: 112 IAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQL-VDSIAKTRDA 168
Query: 286 GTYGYIALELVYTMVVTEKCV---IYSFGVVALEVLMGTHP 323
G Y+A E + V ++S G+ EV G P
Sbjct: 169 GCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFP 209
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 4e-04
Identities = 53/204 (25%), Positives = 81/204 (39%), Gaps = 41/204 (20%)
Query: 151 IGTGGYDSVYKAELPD-GKVVALK-------KLHHSET--------------EDSAFVV- 187
IG GG+ VY D GK+ A+K K+ ET D F+V
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 188 -----YSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCT 242
++P + FI + M G L L E + A + L H
Sbjct: 62 MSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSE------AEMRFYAAEIILGLEHMHN 115
Query: 243 PSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQA--GTYGYIALELVYTMV 300
+V+RD+ NILL+ + ++D G L D S + A GT+GY+A E++ V
Sbjct: 116 RFVVYRDLKPANILLDEHGHVRISDLG----LACDFSKKKPHASVGTHGYMAPEVLQKGV 171
Query: 301 VTEKCV-IYSFGVVALEVLMGTHP 323
+ +S G + ++L G P
Sbjct: 172 AYDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 4e-04
Identities = 29/88 (32%), Positives = 44/88 (50%), Gaps = 7/88 (7%)
Query: 234 LSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTYGYIAL 293
L Y+H + +VHRD+ +NIL+N N + + DFG R+ D T T Y A
Sbjct: 121 LKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLARIQD---PQMTGYVSTRYYRAP 174
Query: 294 ELVYT-MVVTEKCVIYSFGVVALEVLMG 320
E++ T + I+S G + E+L G
Sbjct: 175 EIMLTWQKYDVEVDIWSAGCIFAEMLEG 202
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 4e-04
Identities = 36/143 (25%), Positives = 63/143 (44%), Gaps = 16/143 (11%)
Query: 186 VVYSPQCMFFIYEYMERGSLFCVLRDDDEAIELN-------WTRRMNIVKSVAHALSYLH 238
VV Q I E M RG L LR +E N + + + +A ++YL+
Sbjct: 77 VVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLN 136
Query: 239 HDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGT----YGYIALE 294
+ VHRD+++ N ++ + + DFG R D+ ++ + G +++ E
Sbjct: 137 AN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR--DIYETDYYRKGGKGLLPVRWMSPE 191
Query: 295 LVYTMVVTEKCVIYSFGVVALEV 317
+ V T ++SFGVV E+
Sbjct: 192 SLKDGVFTTYSDVWSFGVVLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 4e-04
Identities = 50/217 (23%), Positives = 96/217 (44%), Gaps = 38/217 (17%)
Query: 193 MFFIYEYMERGSLFCVLR-----------DDDEAIE--LNWTRRMNIVKSVAHALSYLHH 239
++ I EY +G+L LR D + E L++ ++ VA + YL
Sbjct: 93 LYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLE- 151
Query: 240 DCTPSIVHRDISSNNILLNSNLEAFVADFGTVR-LLDVDSSNRTLQAGT-YGYIALELVY 297
+ +HRD+++ N+L+ + +ADFG R + D+D +T ++A E ++
Sbjct: 152 --SRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALF 209
Query: 298 TMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKI---MLIDILYQ--RLSPPI 352
V T + ++SFG++ E+ +L S P I L +L + R+ P
Sbjct: 210 DRVYTHQSDVWSFGILMWEI----------FTLGGSPYPGIPVEELFKLLREGHRMDKPS 259
Query: 353 NQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELE 389
N ++ + + C + P RPT +++ + L+
Sbjct: 260 N--CTHELYM---LMRECWHAVPTQRPTFKQLVEALD 291
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 4e-04
Identities = 50/202 (24%), Positives = 86/202 (42%), Gaps = 35/202 (17%)
Query: 151 IGTGGYDSVYKAELPDG----KVVALKKLH------------HSETE-------DSAFVV 187
+G GGY V++ G K+ A+K L H++ E F+V
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63
Query: 188 ---YSPQC---MFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDC 241
Y+ Q ++ I EY+ G LF L + E I + T + + ++ AL +LH
Sbjct: 64 DLIYAFQTGGKLYLILEYLSGGELFMHL--EREGIFMEDTACFYLSE-ISLALEHLHQQ- 119
Query: 242 TPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTYGYIALELVYTMVV 301
I++RD+ NILL++ + DFG + + + GT Y+A E++
Sbjct: 120 --GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMRSGH 177
Query: 302 TEKCVIYSFGVVALEVLMGTHP 323
+ +S G + ++L G P
Sbjct: 178 GKAVDWWSLGALMYDMLTGAPP 199
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 4e-04
Identities = 38/152 (25%), Positives = 63/152 (41%), Gaps = 6/152 (3%)
Query: 172 LKKLHHSETEDSAFVVYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVA 231
LK H + + + F+ EY+ G LF L + + TR +
Sbjct: 49 LKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGELFFHL-SRERVFSEDRTRFYG--AEIV 105
Query: 232 HALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTYGYI 291
AL YLH + IV+RD+ N++L+ + + DFG + D++ GT Y+
Sbjct: 106 SALDYLH---SGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYL 162
Query: 292 ALELVYTMVVTEKCVIYSFGVVALEVLMGTHP 323
A E++ + GVV E++ G P
Sbjct: 163 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 5e-04
Identities = 48/186 (25%), Positives = 81/186 (43%), Gaps = 33/186 (17%)
Query: 224 MNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVR--------LLD 275
++I + + Y+H + ++HRD+ +NILL E + D+G LLD
Sbjct: 116 LSIFHKICATIEYVH---SKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLD 172
Query: 276 VD-------SSNRTLQA---GTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGE 325
+D S+ T+ GT Y+A E + + +E IY+ GV+ ++L + P
Sbjct: 173 IDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFP-- 230
Query: 326 LLLSLSSSSGPKIMLIDILYQRLSPPINQKIIQDII-LVSTIALACLRSKPKSR-PTMQR 383
G KI D + PI ++I +S IA+ L P R ++Q
Sbjct: 231 ----YRRKKGRKISYRD----VILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQE 282
Query: 384 ISQELE 389
+ Q+LE
Sbjct: 283 LKQDLE 288
|
Length = 932 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 5e-04
Identities = 39/152 (25%), Positives = 69/152 (45%), Gaps = 41/152 (26%)
Query: 151 IGTGGYDSVYKAE-LPDGKVVALKKLH-HSE--TEDSAF-------------------VV 187
+G G Y +VYK G++VALK++H +E T +A V+
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVI 67
Query: 188 YSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRR---MNIVKSVAHAL----SYLHHD 240
++ + ++EYM++ D + ++ + R N VKS + L ++ H +
Sbjct: 68 HTENKLMLVFEYMDK--------DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN 119
Query: 241 CTPSIVHRDISSNNILLNSNLEAFVADFGTVR 272
++HRD+ N+L+N E +ADFG R
Sbjct: 120 ---RVLHRDLKPQNLLINKRGELKLADFGLAR 148
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 6e-04
Identities = 36/127 (28%), Positives = 60/127 (47%), Gaps = 13/127 (10%)
Query: 195 FIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNN 254
+ E E G L L+ + E N T +V V+ + YL + VHRD+++ N
Sbjct: 72 LVMELAELGPLNKFLQKNKHVTEKNITE---LVHQVSMGMKYLEET---NFVHRDLAARN 125
Query: 255 ILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTYG-----YIALELVYTMVVTEKCVIYS 309
+LL + A ++DFG + L D + +A T+G + A E + + K ++S
Sbjct: 126 VLLVTQHYAKISDFGLSKALGADEN--YYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWS 183
Query: 310 FGVVALE 316
FGV+ E
Sbjct: 184 FGVLMWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 6e-04
Identities = 66/293 (22%), Positives = 113/293 (38%), Gaps = 72/293 (24%)
Query: 147 IRYCIGTGGYDSVYKAE----LPDGK-----VVALKKLHHSETED-------------SA 184
+++ +G G + V+ AE LP+ V ALK+ S +D
Sbjct: 9 LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQH 68
Query: 185 FVVYSPQC-----MFFIYEYMERGSLFCVLR------------DDDEAIELNWTRRMNIV 227
V + C + ++EYM G L LR +D +L + + I
Sbjct: 69 IVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIA 128
Query: 228 KSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAG- 286
+A + YL + VHRD+++ N L+ L + DFG R D+ S++ G
Sbjct: 129 SQIASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSR--DIYSTDYYRVGGR 183
Query: 287 ---TYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDI 343
++ E + T + I+SFGVV E+ T+ + LS++ I+
Sbjct: 184 TMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIF--TYGKQPWYQLSNTEA-----IEC 236
Query: 344 LYQ-------RLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELE 389
+ Q R PP I+Q C + +P+ R ++ I L+
Sbjct: 237 ITQGRELERPRTCPPEVYAIMQ----------GCWQREPQQRMVIKDIHSRLQ 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 7e-04
Identities = 57/263 (21%), Positives = 104/263 (39%), Gaps = 42/263 (15%)
Query: 151 IGTGGYDSVYKAELPDGKVVA----------------------LKKLHHSETEDSAFVVY 188
+G G + V+K L D VA LK+ H V
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62
Query: 189 SPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHR 248
Q ++ + E + G LR + EL + + A ++YL + + +HR
Sbjct: 63 QRQPIYIVMELVPGGDFLSFLRKKKD--ELKTKQLVKFALDAAAGMAYLE---SKNCIHR 117
Query: 249 DISSNNILLNSNLEAFVADFGTVRLLD--VDSSNRTLQAGTYGYIALELVYTMVVTEKCV 306
D+++ N L+ N ++DFG R D + SS+ L+ + A E + + +
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSRQEDDGIYSSS-GLKQIPIKWTAPEALNYGRYSSESD 176
Query: 307 IYSFGVVALEVL-MGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKIIQDIILVST 365
++S+G++ E +G P + + + ++ Y R+S P QK D+
Sbjct: 177 VWSYGILLWETFSLGVCPYPGMTNQQAREQ-----VEKGY-RMSCP--QKCPDDV---YK 225
Query: 366 IALACLRSKPKSRPTMQRISQEL 388
+ C KP++RP + +EL
Sbjct: 226 VMQRCWDYKPENRPKFSELQKEL 248
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 7e-04
Identities = 46/205 (22%), Positives = 74/205 (36%), Gaps = 44/205 (21%)
Query: 151 IGTGGYDSVYKAELPD-GKVVALKKLHHS------------------ETEDSAFVV---- 187
+G GG+ V ++ GK+ A KKL E S F+V
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 188 --YSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSI 245
+ + + M G L + + E R + + L +LH I
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEPG-FPEARAIFYAAQIICGLEHLHQR---RI 116
Query: 246 VHRDISSNNILLNSNLEAFVADFGTVRLLDV-------DSSNRTLQAGTYGYIALELVYT 298
V+RD+ N+LL+ D G VR+ D+ +AGT GY+A E++
Sbjct: 117 VYRDLKPENVLLD--------DHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQG 168
Query: 299 MVVTEKCVIYSFGVVALEVLMGTHP 323
V ++ G E++ G P
Sbjct: 169 EVYDFSVDWFALGCTLYEMIAGRSP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 7e-04
Identities = 31/97 (31%), Positives = 44/97 (45%), Gaps = 16/97 (16%)
Query: 233 ALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTL---QAGTYG 289
AL Y+H T ++ HRD+ NIL N++ + + DFG R+ D+ T
Sbjct: 115 ALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRW 171
Query: 290 YIALELV------YTMVVTEKCVIYSFGVVALEVLMG 320
Y A EL YT + I+S G + EVL G
Sbjct: 172 YRAPELCGSFFSKYTPAID----IWSIGCIFAEVLTG 204
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 7e-04
Identities = 43/217 (19%), Positives = 93/217 (42%), Gaps = 38/217 (17%)
Query: 193 MFFIYEYMERGSL-------------FCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHH 239
++ I EY +G+L +C +L++ ++ VA + YL
Sbjct: 99 LYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYL-- 156
Query: 240 DCTPSIVHRDISSNNILLNSNLEAFVADFGTVR-LLDVDSSNRTLQAG-TYGYIALELVY 297
+ +HRD+++ N+L+ + +ADFG R + +D +T ++A E ++
Sbjct: 157 -ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALF 215
Query: 298 TMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILY-----QRLSPPI 352
+ T + ++SFGV+ E+ +L S P + + ++ R+ P
Sbjct: 216 DRIYTHQSDVWSFGVLLWEI----------FTLGGSPYPGVPVEELFKLLKEGHRMDKPS 265
Query: 353 NQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELE 389
N ++ ++ C + P RPT +++ ++L+
Sbjct: 266 N--CTNELYMMMR---DCWHAVPSQRPTFKQLVEDLD 297
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 7e-04
Identities = 30/96 (31%), Positives = 45/96 (46%), Gaps = 7/96 (7%)
Query: 226 IVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQA 285
+V + L Y+H I+HRD+ N+ +N + E + DFG R D S T
Sbjct: 123 LVYQMLKGLKYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQTD---SEMTGYV 176
Query: 286 GTYGYIALELVYT-MVVTEKCVIYSFGVVALEVLMG 320
T Y A E++ M T+ I+S G + E+L G
Sbjct: 177 VTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTG 212
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 8e-04
Identities = 48/223 (21%), Positives = 91/223 (40%), Gaps = 18/223 (8%)
Query: 168 KVVALKKLHHSETEDSAFVVYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIV 227
+ + L + HS V+ M + EYM G+L LR + +L + M ++
Sbjct: 56 EALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEG--QLVAGQLMGML 113
Query: 228 KSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGT 287
+A + YL VH+ ++++ +L+NS+L ++ F ++ ++ T+ +
Sbjct: 114 PGLASGMKYLSE---MGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKS 170
Query: 288 YG-YIALELVYTMVVTEKCVIYSFGVVALEVL-MGTHPGELLLSLSSSSGPKIMLIDILY 345
+ A E + + ++SFG+V EV+ G P SG ++
Sbjct: 171 PVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERP------YWDMSGQDVIKAVEDG 224
Query: 346 QRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQEL 388
RL P N L+ + L C + + RP +I L
Sbjct: 225 FRLPAPRNCP-----NLLHQLMLDCWQKERGERPRFSQIHSIL 262
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.7 bits (96), Expect = 8e-04
Identities = 16/48 (33%), Positives = 30/48 (62%), Gaps = 3/48 (6%)
Query: 233 ALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSN 280
L Y+H + +++HRD+ +N+LLN+N + + DFG R+ D + +
Sbjct: 118 GLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDH 162
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 9e-04
Identities = 45/204 (22%), Positives = 85/204 (41%), Gaps = 31/204 (15%)
Query: 141 ATEYFHIRYCIGTGGYDSVYKA-ELPDGKVVALKKLHHSETEDSAF-------------- 185
AT Y ++ +G G Y +VYK +G++VALK + E F
Sbjct: 4 ATSYLNLEK-LGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKH 62
Query: 186 --------VVYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYL 237
++++ + + F++EYM +++ L+ + + L+Y+
Sbjct: 63 ANIVLLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGG---LHPYNVRLFMFQLLRGLAYI 119
Query: 238 HHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTYGYIALE-LV 296
H I+HRD+ N+L++ E +ADFG R + S + + T Y + L+
Sbjct: 120 HGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLL 176
Query: 297 YTMVVTEKCVIYSFGVVALEVLMG 320
+ I+ G + +E+L G
Sbjct: 177 GATDYSSALDIWGAGCIFIEMLQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 9e-04
Identities = 49/213 (23%), Positives = 81/213 (38%), Gaps = 52/213 (24%)
Query: 145 FHIRYCIGTGGYDSVYKAELPD-GKVVALKKL-----------HHSETEDSAF------- 185
F I +G GGY V+ A+ D G++VALK++ H TE
Sbjct: 3 FQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEW 62
Query: 186 ---VVYS---PQCMFFIYEYMERG---SLFCVLR--DDDEAIELNWTRRMNIVKSVAHAL 234
++Y+ + ++ EY+ G +L L +D A R + + A+
Sbjct: 63 LVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHA-------RFYMAEMFE-AV 114
Query: 235 SYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQA----GTYGY 290
LH +HRD+ N L++++ + DFG S A G+ Y
Sbjct: 115 DALHE---LGYIHRDLKPENFLIDASGHIKLTDFGL-------SKGIVTYANSVVGSPDY 164
Query: 291 IALELVYTMVVTEKCVIYSFGVVALEVLMGTHP 323
+A E++ +S G + E L G P
Sbjct: 165 MAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPP 197
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 0.001
Identities = 31/96 (32%), Positives = 44/96 (45%), Gaps = 18/96 (18%)
Query: 190 PQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNI-----------VKSVAHALSYLH 238
P CM I EYME G L L + IE +T NI +A + YL
Sbjct: 91 PLCM--ITEYMENGDLNQFLSQRE--IESTFTHANNIPSVSIANLLYMAVQIASGMKYL- 145
Query: 239 HDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLL 274
+ + VHRD+++ N L+ ++ +ADFG R L
Sbjct: 146 --ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNL 179
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.001
Identities = 33/136 (24%), Positives = 56/136 (41%), Gaps = 32/136 (23%)
Query: 168 KVVALKKLHHSETEDSAFVVYSPQCMFFIYEYMER---------GSLFCVLRDDDEAIEL 218
+V LK L H+ ++++ +C+ ++EY++ G+L
Sbjct: 53 EVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLDSDLKQYLDNCGNLMS----------- 101
Query: 219 NWTRRMNIVK----SVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLL 274
M+ VK + LSY H I+HRD+ N+L+N E +ADFG R
Sbjct: 102 -----MHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAK 153
Query: 275 DVDSSNRTLQAGTYGY 290
V + + + T Y
Sbjct: 154 SVPTKTYSNEVVTLWY 169
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.001
Identities = 37/129 (28%), Positives = 58/129 (44%), Gaps = 9/129 (6%)
Query: 198 EYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILL 257
E+M GS+ L+ E N TR+ + + +SYLH + IVHRDI NIL
Sbjct: 86 EHMPGGSIKDQLKSYGALTE-NVTRKYT--RQILEGVSYLH---SNMIVHRDIKGANILR 139
Query: 258 NSNLEAFVADFGTVRLLD---VDSSNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVA 314
+S + DFG + L + + GT +++ E++ K I+S G
Sbjct: 140 DSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTV 199
Query: 315 LEVLMGTHP 323
+E+L P
Sbjct: 200 VEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.001
Identities = 46/193 (23%), Positives = 86/193 (44%), Gaps = 26/193 (13%)
Query: 198 EYMERGSLFCVLRDD---DEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNN 254
EYM GS+ L+ E++ +TR+ + +SYLH + IVHRDI N
Sbjct: 86 EYMPGGSVKDQLKAYGALTESVTRKYTRQ------ILEGMSYLHSNM---IVHRDIKGAN 136
Query: 255 ILLNSNLEAFVADFG-TVRLLDVDSSNRTLQA--GTYGYIALELVYTMVVTEKCVIYSFG 311
IL +S + DFG + RL + S +++ GT +++ E++ K ++S G
Sbjct: 137 ILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLG 196
Query: 312 VVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKIIQDIILVSTIALACL 371
+E+L P ++++ + I Q +P + I + + L C+
Sbjct: 197 CTVVEMLTEKPPWAEYEAMAA-------IFKIATQPTNPQLPSHISEH----ARDFLGCI 245
Query: 372 RSKPKSRPTMQRI 384
+ + RP+ + +
Sbjct: 246 FVEARHRPSAEEL 258
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 40.7 bits (96), Expect = 0.001
Identities = 35/124 (28%), Positives = 52/124 (41%), Gaps = 28/124 (22%)
Query: 233 ALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTYGYIA 292
L Y+H + I+HRD+ +NI +N + E + DFG R D + T T Y A
Sbjct: 130 GLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE---MTGYVATRWYRA 183
Query: 293 LELVYT-MVVTEKCVIYSFGVVALEVL---------------------MGTHPGELLLSL 330
E++ M + I+S G + E+L +GT ELL +
Sbjct: 184 PEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKI 243
Query: 331 SSSS 334
SS S
Sbjct: 244 SSES 247
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.001
Identities = 52/205 (25%), Positives = 84/205 (40%), Gaps = 43/205 (20%)
Query: 151 IGTGGYDSVYKAELPD-GKVVALK-------KLHHSET--------------EDSAFVV- 187
IG GG+ VY D GK+ A+K K+ ET D F+V
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 188 -----YSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKS-VAHALSYLHHDC 241
++P + FI + M G L L E + M + + L ++H+
Sbjct: 62 MTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSE----KEMRFYATEIILGLEHMHNRF 117
Query: 242 TPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQA--GTYGYIALELVYTM 299
+V+RD+ NILL+ + ++D G L D S + A GT+GY+A E++
Sbjct: 118 ---VVYRDLKPANILLDEHGHVRISDLG----LACDFSKKKPHASVGTHGYMAPEVLQKG 170
Query: 300 VVTEKCV-IYSFGVVALEVLMGTHP 323
+ +S G + ++L G P
Sbjct: 171 TAYDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.4 bits (95), Expect = 0.001
Identities = 57/235 (24%), Positives = 84/235 (35%), Gaps = 64/235 (27%)
Query: 145 FHIRYCIGTGGYDSVYKA-ELPDGKVVALKKLH-----------HSETE-------DSAF 185
F + IG G + V+ + G+V A+K L H E DS +
Sbjct: 3 FEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPW 62
Query: 186 VV---YSPQCMFFIY---EYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVA--HALSYL 237
+V YS Q +Y EYM G L +L D E R I + V ++ L
Sbjct: 63 IVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPE-ETAR-FYIAELVLALDSVHKL 120
Query: 238 HHDCTPSIVHRDISSNNILLNSNLEAFVADFGT------------VRLLDVDSSNRTLQ- 284
+HRDI +NIL++++ +ADFG + R
Sbjct: 121 GF------IHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVL 174
Query: 285 ----------------AGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHP 323
GT YIA E++ +C +S GV+ E+L G P
Sbjct: 175 VRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPP 229
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 39.9 bits (94), Expect = 0.001
Identities = 32/148 (21%), Positives = 60/148 (40%), Gaps = 33/148 (22%)
Query: 151 IGTGGYDSVYKA-ELPDGKVVALKKL---HHSETEDSAF--------------------V 186
IG G + V KA GK A+K + S + + V
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEV 66
Query: 187 VY--SPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPS 244
++ + ++E M+ +L+ +++ L R + + + +L ++H +
Sbjct: 67 LFDRKTGRLALVFELMD-MNLYELIKGRKRP--LPEKRVKSYMYQLLKSLDHMHRN---G 120
Query: 245 IVHRDISSNNILLNSNLEAFVADFGTVR 272
I HRDI NIL+ ++ +ADFG+ R
Sbjct: 121 IFHRDIKPENILIKDDILK-LADFGSCR 147
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.001
Identities = 39/175 (22%), Positives = 73/175 (41%), Gaps = 38/175 (21%)
Query: 151 IGTGGYDSVYKA-ELPDGKVVALKK-----------------------LHHSETEDSAFV 186
IG G Y VYKA + + +ALKK + H V
Sbjct: 10 IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDV 69
Query: 187 VYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKS----VAHALSYLHHDCT 242
V+S + ++ ++EY++ + + D + + R+ +K+ + ++Y H +
Sbjct: 70 VHSEKRLYLVFEYLD----LDLKKHMDSSPDFAKNPRL--IKTYLYQILRGIAYCH---S 120
Query: 243 PSIVHRDISSNNILLNSNLEAF-VADFGTVRLLDVDSSNRTLQAGTYGYIALELV 296
++HRD+ N+L++ A +ADFG R + T + T Y A E++
Sbjct: 121 HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEIL 175
|
Length = 294 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 0.001
Identities = 18/46 (39%), Positives = 28/46 (60%), Gaps = 3/46 (6%)
Query: 233 ALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDS 278
AL+YL + VHRDI++ N+L++S + DFG R L+ +S
Sbjct: 119 ALAYLE---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDES 161
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 39.7 bits (93), Expect = 0.002
Identities = 41/176 (23%), Positives = 69/176 (39%), Gaps = 42/176 (23%)
Query: 151 IGTGGYDSVYKAELPD-GKVVALKKLHHSETEDSAF------------------------ 185
IG G Y V+K + G++VA+KK SE +D
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESE-DDPVIKKIALREIRMLKQLKHPNLVNLIE 67
Query: 186 VVYSPQCMFFIYEYMERGSLFCVLRD----DDEAIELNWTRRMNIVKSVAHALSYLH-HD 240
V + + ++EY + L + ++ + I I+ A+++ H H+
Sbjct: 68 VFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLI-------KKIIWQTLQAVNFCHKHN 120
Query: 241 CTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTYGYIALELV 296
C +HRD+ NIL+ + + DFG R+L + T T Y A EL+
Sbjct: 121 C----IHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELL 172
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.002
Identities = 47/207 (22%), Positives = 80/207 (38%), Gaps = 55/207 (26%)
Query: 151 IGTGGYDSVYKA-ELPDGKVVALKKLH--------------------HSETED------- 182
+G+G Y SV A + G+ VA+KKL H + E+
Sbjct: 23 VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDV 82
Query: 183 --SAFVVYSPQCMFFIYEYME------RGSLFCVLRDDDEAIELNWTRRMNIVKSVAHAL 234
SA Q + + YM+ G ++ ++ +V + L
Sbjct: 83 FTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPL-----SEDKVQY-------LVYQMLCGL 130
Query: 235 SYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTYGYIALE 294
Y+H + I+HRD+ N+ +N + E + DFG R D + + + T Y A E
Sbjct: 131 KYIH---SAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVV---TRWYRAPE 184
Query: 295 LVYT-MVVTEKCVIYSFGVVALEVLMG 320
++ M + I+S G + E+L G
Sbjct: 185 VILNWMHYNQTVDIWSVGCIMAEMLTG 211
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.002
Identities = 33/124 (26%), Positives = 57/124 (45%), Gaps = 16/124 (12%)
Query: 226 IVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQA 285
++ + L Y+H + I+HRD+ +N+ +N + E + DFG R D T
Sbjct: 125 LIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTD---DEMTGYV 178
Query: 286 GTYGYIALELVYT-MVVTEKCVIYSFGVVALEVLMGT--HPG-------ELLLSLSSSSG 335
T Y A E++ M + I+S G + E+L G PG +L+L L + G
Sbjct: 179 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG 238
Query: 336 PKIM 339
+++
Sbjct: 239 AELL 242
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 39.5 bits (92), Expect = 0.002
Identities = 19/60 (31%), Positives = 34/60 (56%), Gaps = 5/60 (8%)
Query: 198 EYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILL 257
E++E G L LR + + + W ++ + + +A ALSYL ++VH ++ + NILL
Sbjct: 96 EFVEHGPLDVCLRKEKGRVPVAW--KITVAQQLASALSYLEDK---NLVHGNVCAKNILL 150
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.002
Identities = 42/168 (25%), Positives = 70/168 (41%), Gaps = 18/168 (10%)
Query: 169 VVALKKLHHSETEDSAF----------VVYSPQC---MFFIYEYMERGSLFCVLRDDDEA 215
+VA ++ H+ TE+ + YS Q + F+ EY G LF L +
Sbjct: 33 IVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVF 92
Query: 216 IELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLD 275
E R + AL YLH + ++V+RD+ N++L+ + + DFG +
Sbjct: 93 SE---DRARFYGAEIVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGI 147
Query: 276 VDSSNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHP 323
D + GT Y+A E++ + GVV E++ G P
Sbjct: 148 KDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 39.1 bits (91), Expect = 0.002
Identities = 42/152 (27%), Positives = 61/152 (40%), Gaps = 11/152 (7%)
Query: 171 ALKKLHHSETEDSAFVVYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSV 230
A+ K H S E AF + I EY E L C L + + + +
Sbjct: 63 AIVKFHASFLERDAFCI--------ITEYCEGRDLDCKLEELKHTGKT--LSENQVCEWF 112
Query: 231 AHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTYGY 290
L +H+ I+HRD+ + NI L +NL + DFG RLL T GT Y
Sbjct: 113 IQLLLGVHYMHQRRILHRDLKAKNIFLKNNLLK-IGDFGVSRLLMGSCDLATTFTGTPYY 171
Query: 291 IALELVYTMVVTEKCVIYSFGVVALEVLMGTH 322
++ E + K I+S G + E+ H
Sbjct: 172 MSPEALKHQGYDSKSDIWSLGCILYEMCCLAH 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 39.5 bits (93), Expect = 0.002
Identities = 37/151 (24%), Positives = 61/151 (40%), Gaps = 38/151 (25%)
Query: 151 IGTGGYDSVYKA-ELPDGKVVALKKLHHSETEDSAF------------------------ 185
I G Y VY+A + G++VALKKL E E F
Sbjct: 13 IEEGTYGVVYRARDKKTGEIVALKKLKM-EKEKEGFPITSLREINILLKLQHPNIVTVKE 71
Query: 186 -VVYSPQCMFFI-YEYMERGSLFCVLRD--DDEAIELNWTRRMNIVKSVAHALSYLHHDC 241
VV S ++ EY+E L+ + + ++ + +++LH +
Sbjct: 72 VVVGSNLDKIYMVMEYVEHD-----LKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDN- 125
Query: 242 TPSIVHRDISSNNILLNSNLEAFVADFGTVR 272
I+HRD+ ++N+LLN+ + DFG R
Sbjct: 126 --WILHRDLKTSNLLLNNRGILKICDFGLAR 154
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.002
Identities = 46/196 (23%), Positives = 78/196 (39%), Gaps = 23/196 (11%)
Query: 145 FHIRYCIGTGGYDSVYKAE-LPDGKVVALKKLHHSETEDSAF------------VVYSPQ 191
F I IG G + VY+A L D K VALKK+ E D+ + P
Sbjct: 4 FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPN 63
Query: 192 CMFFIYEYMERGSLFCVLR-----DDDEAIE-LNWTRRM----NIVKSVAHALSYLHHDC 241
+ ++ ++E L VL D + I+ +R+ + K S + H
Sbjct: 64 VIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH 123
Query: 242 TPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTYGYIALELVYTMVV 301
+ ++HRDI N+ + + + D G R ++ GT Y++ E ++
Sbjct: 124 SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGY 183
Query: 302 TEKCVIYSFGVVALEV 317
K I+S G + E+
Sbjct: 184 NFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 39.2 bits (92), Expect = 0.002
Identities = 35/152 (23%), Positives = 54/152 (35%), Gaps = 47/152 (30%)
Query: 151 IGTGGYDSVYKAELPD-GKVVALK-----------KLHHSETE-------DSAFVVY--- 188
+G G V+ L GK+ ALK K+ TE D F+
Sbjct: 9 LGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYA 68
Query: 189 ---SPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKS---------VAHALSY 236
+ + + +Y G LF +L+ + + V AL Y
Sbjct: 69 SFQTETYLCLVMDYCPGGELFRLLQ----------RQPGKCLSEEVARFYAAEVLLALEY 118
Query: 237 LHHDCTPSIVHRDISSNNILLNSNLEAFVADF 268
LH IV+RD+ NILL+ + ++DF
Sbjct: 119 LH---LLGIVYRDLKPENILLHESGHIMLSDF 147
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.002
Identities = 30/96 (31%), Positives = 46/96 (47%), Gaps = 18/96 (18%)
Query: 183 SAFVV---YSPQCMFFIY---EYMERG---SLFCVLRDDDEAIELNWTRRMNIVKSVAHA 233
S F+V YS Q +Y EY+ G SL + DE + + + + VA A
Sbjct: 63 SPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKY------ISEVALA 116
Query: 234 LSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFG 269
L YLH I+HRD+ +N+L+++ + DFG
Sbjct: 117 LDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFG 149
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 39.1 bits (91), Expect = 0.003
Identities = 54/216 (25%), Positives = 82/216 (37%), Gaps = 42/216 (19%)
Query: 194 FFIYEYMERGSLFCVLRDDDEAIE----LNWTRRMNIVKSVAHALSYLHHDCTPSIVHRD 249
+ I E ME G L LRD L ++I VA YL +HRD
Sbjct: 75 YIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQ---MHFIHRD 131
Query: 250 ISSNNILLNSNLEAF-----VADFGTVRLLDVDSSNRTLQAGT----YGYIALELVYTMV 300
+++ N L++ + DFG R D+ S+ + G ++A E +
Sbjct: 132 LAARNCLVSEKGYDADRVVKIGDFGLAR--DIYKSDYYRKEGEGLLPVRWMAPESLLDGK 189
Query: 301 VTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQ-----RLSPPIN-- 353
T + ++SFGV+ E+L +L P + ++L RL P N
Sbjct: 190 FTTQSDVWSFGVLMWEIL----------TLGQQPYPALNNQEVLQHVTAGGRLQKPENCP 239
Query: 354 QKIIQDIILVSTIALACLRSKPKSRPTMQRISQELE 389
KI Q + C P RPT RI + L+
Sbjct: 240 DKIYQ-------LMTNCWAQDPSERPTFDRIQEILQ 268
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.003
Identities = 38/140 (27%), Positives = 58/140 (41%), Gaps = 8/140 (5%)
Query: 184 AFVVYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTP 243
AF + C F+ EY G LF L + E R + AL YLH +
Sbjct: 63 AFQTHDRLC--FVMEYANGGELFFHLSRERVFTE---ERARFYGAEIVSALEYLH---SR 114
Query: 244 SIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTYGYIALELVYTMVVTE 303
+V+RDI N++L+ + + DFG + D + GT Y+A E++
Sbjct: 115 DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGR 174
Query: 304 KCVIYSFGVVALEVLMGTHP 323
+ GVV E++ G P
Sbjct: 175 AVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 39.0 bits (91), Expect = 0.003
Identities = 41/147 (27%), Positives = 67/147 (45%), Gaps = 23/147 (15%)
Query: 192 CMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDIS 251
CM + EY+E G +L++ A+ ++ RM ++V AL YLH IVHRD+
Sbjct: 77 CM--VMEYVEGGDCATLLKNIG-ALPVD-MARMYFAETVL-ALEYLH---NYGIVHRDLK 128
Query: 252 SNNILLNSNLEAFVADFG---------TVRLLD--VDSSNRTLQ----AGTYGYIALELV 296
+N+L+ S + DFG T L + ++ R GT YIA E++
Sbjct: 129 PDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVI 188
Query: 297 YTMVVTEKCVIYSFGVVALEVLMGTHP 323
+ ++ G++ E L+G P
Sbjct: 189 LRQGYGKPVDWWAMGIILYEFLVGCVP 215
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 38.8 bits (90), Expect = 0.003
Identities = 38/155 (24%), Positives = 66/155 (42%), Gaps = 14/155 (9%)
Query: 230 VAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTYG 289
+A AL YLH I+HRD+ + N+ L V D G R+L+ + GT
Sbjct: 111 IAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPY 167
Query: 290 YIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLS 349
Y++ EL K +++ G E+ H ++ ++ I+ +L
Sbjct: 168 YMSPELFSNKPYNYKSDVWALGCCVYEMATLKHA-------FNAKDMNSLVYRIIEGKL- 219
Query: 350 PPINQKIIQDIILVSTIALACLRSKPKSRPTMQRI 384
PP+ + + L IA L +P+ RP+++ I
Sbjct: 220 PPMPKDYSPE--LGELIA-TMLSKRPEKRPSVKSI 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 38.8 bits (90), Expect = 0.004
Identities = 18/49 (36%), Positives = 29/49 (59%), Gaps = 3/49 (6%)
Query: 225 NIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRL 273
++++ L +LH +C IVHRD+ NIL+ S + +ADFG R+
Sbjct: 112 DLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARI 157
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 38.7 bits (90), Expect = 0.004
Identities = 30/95 (31%), Positives = 45/95 (47%), Gaps = 5/95 (5%)
Query: 226 IVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLD--VDSSNRTL 283
I + + AL+YLH I+HRD+ + NI L+ A + DFG LD D+
Sbjct: 190 IQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYG 246
Query: 284 QAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVL 318
+GT + EL+ K I+S G+V E+
Sbjct: 247 WSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMS 281
|
Length = 392 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 38.5 bits (89), Expect = 0.004
Identities = 38/129 (29%), Positives = 61/129 (47%), Gaps = 9/129 (6%)
Query: 198 EYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILL 257
EYM GS+ L+ E N TRR + + +SYLH + IVHRDI NIL
Sbjct: 86 EYMPGGSIKDQLKAYGALTE-NVTRRYT--RQILQGVSYLHSNM---IVHRDIKGANILR 139
Query: 258 NSNLEAFVADFG-TVRLLDVDSSNRTLQA--GTYGYIALELVYTMVVTEKCVIYSFGVVA 314
+S + DFG + R+ + S +++ GT +++ E++ K ++S
Sbjct: 140 DSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTV 199
Query: 315 LEVLMGTHP 323
+E+L P
Sbjct: 200 VEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
Conserved Domains Detected by HHsearch 
Original result of HHsearch against CDD database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 412 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.98 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.98 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.98 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.98 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.98 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.97 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.97 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.97 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.97 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.96 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.96 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.96 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.96 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.95 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.95 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.95 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.95 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.94 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.94 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.94 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.94 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.94 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.93 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.93 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.93 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.92 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.91 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.9 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.88 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.86 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.85 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.85 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.85 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.84 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.83 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.83 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.81 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.8 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.79 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.79 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.79 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.77 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.76 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.75 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.74 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.72 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.69 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.69 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.63 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.61 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.61 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.59 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.59 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.46 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.43 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.41 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.39 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.27 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.21 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.2 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.1 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.07 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.06 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.99 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.93 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 98.9 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 98.87 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.85 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.81 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.78 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.66 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.63 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.54 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.45 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.37 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.26 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.24 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.23 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.19 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.16 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.02 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 97.79 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.65 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.5 | |
| PF12799 | 44 | LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_ | 97.45 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 97.43 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 97.43 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 97.27 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.1 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.96 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 96.89 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 96.83 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 96.82 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 96.8 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 96.78 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 96.63 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 96.51 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 96.41 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 96.38 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 96.36 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 96.33 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 96.32 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 96.02 | |
| PF00560 | 22 | LRR_1: Leucine Rich Repeat; InterPro: IPR001611 Le | 95.91 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 95.74 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 95.7 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 95.67 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 95.51 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 94.31 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 93.08 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 93.05 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 92.94 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 92.82 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 92.8 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 92.2 | |
| PF13504 | 17 | LRR_7: Leucine rich repeat; PDB: 3OJA_B 3G06_A 1OO | 91.69 | |
| PF03109 | 119 | ABC1: ABC1 family; InterPro: IPR004147 This entry | 91.11 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 90.61 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 90.56 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 90.47 | |
| PF08693 | 40 | SKG6: Transmembrane alpha-helix domain; InterPro: | 90.08 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 89.79 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-52 Score=404.57 Aligned_cols=262 Identities=35% Similarity=0.552 Sum_probs=216.9
Q ss_pred CccccHHHHHHhhcCcccceeeeecCceEEEEEEeCCCcEEEEEec---------------------cCCccccceEEEe
Q 042435 130 DGKILYENLIDATEYFHIRYCIGTGGYDSVYKAELPDGKVVALKKL---------------------HHSETEDSAFVVY 188 (412)
Q Consensus 130 ~~~~~~~~l~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~l---------------------~~~~~~~~~~~~~ 188 (412)
.+.|++++|..||++|...++||+|+||.||+|.+.+|+.||||++ +|+|+....++|.
T Consensus 62 ~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC~ 141 (361)
T KOG1187|consen 62 LRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYCL 141 (361)
T ss_pred cceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEEe
Confidence 4578999999999999999999999999999999999999999964 5677777788899
Q ss_pred cCc-eEEEEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEee
Q 042435 189 SPQ-CMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVAD 267 (412)
Q Consensus 189 ~~~-~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~D 267 (412)
+.+ ..+||||||++|+|.++|+..... .++|.+|++||.++|+||+|||+.+.++|+||||||+|||+|+++++||+|
T Consensus 142 e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsD 220 (361)
T KOG1187|consen 142 EGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSD 220 (361)
T ss_pred cCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccC
Confidence 888 599999999999999999987654 689999999999999999999999999999999999999999999999999
Q ss_pred cCCccccCCCCCCcccc-cccccccccccccCcccCcccccHHHHHHHHHHHhCCCCccccc--------ccccCCCCcc
Q 042435 268 FGTVRLLDVDSSNRTLQ-AGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLL--------SLSSSSGPKI 338 (412)
Q Consensus 268 fGla~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~--------~~~~~~~~~~ 338 (412)
||+|+............ .||.+|+|||+...+..+.|+|||||||+|+|++||+.|.+... .+........
T Consensus 221 FGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~ 300 (361)
T KOG1187|consen 221 FGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEG 300 (361)
T ss_pred ccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCc
Confidence 99997654312222222 89999999999999999999999999999999999998876321 0000111112
Q ss_pred hhhHHhhhccCCccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhcCCC
Q 042435 339 MLIDILYQRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELEGKTP 393 (412)
Q Consensus 339 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 393 (412)
.+.+++|+.+...... ..++...+..++.+|++.+|++||+|.||+++|+.+..
T Consensus 301 ~~~eiiD~~l~~~~~~-~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~ 354 (361)
T KOG1187|consen 301 KLREIVDPRLKEGEYP-DEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILS 354 (361)
T ss_pred chhheeCCCccCCCCC-hHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhcc
Confidence 4556666666521111 11566679999999999999999999999999966554
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-51 Score=446.37 Aligned_cols=374 Identities=25% Similarity=0.404 Sum_probs=260.6
Q ss_pred eechhhccCCC-ceeeCCC-CCCCCCCCEEeCccccccccCCC-CCcCC-CCcccccCcCCCCCCC--CCCcccccCCCC
Q 042435 3 VLLAFLSISAA-CSGVVEE-EPSSPSFLKSDMSFNNLDGEIPT-YLRDN-PPKSFVGNKGLCGHVQ--GFLSCFQRHRLA 76 (412)
Q Consensus 3 ~~~~~l~~~~~-~~G~ip~-~~~~~~l~~~~ls~N~l~G~iP~-~~~~~-~~~~~~gn~~lcg~~~--~~~~c~~~~~~~ 76 (412)
..|++|||+.| ++|.+|. +.++++|..+|+|+|+|+|++|. +.+.. ++++|.||+++||... +..+|....+ .
T Consensus 547 ~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~~~~c~~~~~-~ 625 (968)
T PLN00113 547 PVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKRVRK-T 625 (968)
T ss_pred ccCCEEECCCCcccccCChhHhcCcccCEEeccCCcceeeCCCcchhcccChhhhcCCccccCCccccCCCCCccccc-c
Confidence 45788888888 8888877 77888899999999999999997 55666 7889999999998643 3356753322 2
Q ss_pred ccceeeehhhHHHHHHHHHHHHHHHHHhhcccchhhhHhhhccCCCc-eeee--ccCccccHHHHHHhhcCcccceeeee
Q 042435 77 PSFILSVKIFLPLTPILAFTIFGFILLLKGKSENLKLVTRAAKNGDV-FSVW--NYDGKILYENLIDATEYFHIRYCIGT 153 (412)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~--~~~~~~~~~~l~~~~~~f~~~~~lG~ 153 (412)
...++.+++++++++++++++++++++++++..+.+.. ....+.. .... .....++++++. ..|...++||+
T Consensus 626 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~ig~ 700 (968)
T PLN00113 626 PSWWFYITCTLGAFLVLALVAFGFVFIRGRNNLELKRV--ENEDGTWELQFFDSKVSKSITINDIL---SSLKEENVISR 700 (968)
T ss_pred ceeeeehhHHHHHHHHHHHHHHHHHHHHhhhccccccc--ccccccccccccccccchhhhHHHHH---hhCCcccEEcc
Confidence 22222222222222222222222222222221111111 1111110 0000 011234444443 45777889999
Q ss_pred cCceEEEEEEe-CCCcEEEEEec-----------------cCCccccceEEEecCceEEEEEEeccCCceeeeeccCccc
Q 042435 154 GGYDSVYKAEL-PDGKVVALKKL-----------------HHSETEDSAFVVYSPQCMFFIYEYMERGSLFCVLRDDDEA 215 (412)
Q Consensus 154 G~~g~Vy~~~~-~~~~~vAvK~l-----------------~~~~~~~~~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~ 215 (412)
|+||.||+|.. .+++.||||++ +|+++.+..+++.+.+..++||||+++|+|.++++
T Consensus 701 G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~----- 775 (968)
T PLN00113 701 GKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLR----- 775 (968)
T ss_pred CCCeeEEEEEECCCCcEEEEEEccCCccccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHh-----
Confidence 99999999987 57899999964 58888888888999999999999999999999985
Q ss_pred ccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCCCCccccccccccccccc
Q 042435 216 IELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTYGYIALEL 295 (412)
Q Consensus 216 ~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~gt~~y~aPE~ 295 (412)
.++|.++.+++.|+++||+|||+.+.++|+|||+||+||+++.++.+++. ||.+...... ....+|+.|+|||+
T Consensus 776 -~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~----~~~~~t~~y~aPE~ 849 (968)
T PLN00113 776 -NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD----TKCFISSAYVAPET 849 (968)
T ss_pred -cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC----CCccccccccCccc
Confidence 38999999999999999999998877899999999999999999888876 6665433211 12367899999999
Q ss_pred ccCcccCcccccHHHHHHHHHHHhCCCCccccccccc-------CCCCcchhhHHhhhccCCccchhhHHHHHHHHHHHH
Q 042435 296 VYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSS-------SSGPKIMLIDILYQRLSPPINQKIIQDIILVSTIAL 368 (412)
Q Consensus 296 ~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 368 (412)
+.+..++.++|||||||++|||+||+.||+....... ..........+.++.+.... ....++...+.+++.
T Consensus 850 ~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~ 928 (968)
T PLN00113 850 RETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDV-SVNQNEIVEVMNLAL 928 (968)
T ss_pred ccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCC-CccHHHHHHHHHHHH
Confidence 9999999999999999999999999999863211000 00001111222233332221 122344556889999
Q ss_pred hcCcCCCCCCCCHHHHHHHHhcCCCC
Q 042435 369 ACLRSKPKSRPTMQRISQELEGKTPM 394 (412)
Q Consensus 369 ~Cl~~dP~~RPs~~evl~~L~~~~~~ 394 (412)
+||+.||++||||+|+++.|+++...
T Consensus 929 ~Cl~~~P~~RPt~~evl~~L~~~~~~ 954 (968)
T PLN00113 929 HCTATDPTARPCANDVLKTLESASRS 954 (968)
T ss_pred hhCcCCchhCcCHHHHHHHHHHhhcc
Confidence 99999999999999999999988654
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-47 Score=364.37 Aligned_cols=233 Identities=32% Similarity=0.485 Sum_probs=195.3
Q ss_pred cceeeeecCceEEEEEEeCCCcEEEEEe-----------------------ccCCccccceEEEecCc-eEEEEEEeccC
Q 042435 147 IRYCIGTGGYDSVYKAELPDGKVVALKK-----------------------LHHSETEDSAFVVYSPQ-CMFFIYEYMER 202 (412)
Q Consensus 147 ~~~~lG~G~~g~Vy~~~~~~~~~vAvK~-----------------------l~~~~~~~~~~~~~~~~-~~~lv~ey~~~ 202 (412)
..+.||+|+||+||+|.+.....||||+ ++|+|++...++|..+. ..++|||||++
T Consensus 45 ~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~ 124 (362)
T KOG0192|consen 45 IEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPG 124 (362)
T ss_pred hhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCC
Confidence 3455999999999999996555599994 57899999999999888 79999999999
Q ss_pred CceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCC-cEEeCCCCCCEEecCCC-cEEEeecCCccccCCCCCC
Q 042435 203 GSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPS-IVHRDISSNNILLNSNL-EAFVADFGTVRLLDVDSSN 280 (412)
Q Consensus 203 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~-ivHrDlkp~NILl~~~~-~~kl~DfGla~~~~~~~~~ 280 (412)
|+|.++++.. ....++|..+++++.|||+||.|||++ + ||||||||+|||++.++ ++||+|||+++........
T Consensus 125 GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~~~ 200 (362)
T KOG0192|consen 125 GSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISKTS 200 (362)
T ss_pred CcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccceeecccccc
Confidence 9999999874 223699999999999999999999998 6 99999999999999997 9999999999876554344
Q ss_pred ccccccccccccccccc--CcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccchhhHH
Q 042435 281 RTLQAGTYGYIALELVY--TMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKIIQ 358 (412)
Q Consensus 281 ~~~~~gt~~y~aPE~~~--~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 358 (412)
.+...||+.|||||++. ...|+.|+|||||||++|||+||+.||... ........+.....+++.+..
T Consensus 201 ~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~-------~~~~~~~~v~~~~~Rp~~p~~--- 270 (362)
T KOG0192|consen 201 MTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDL-------APVQVASAVVVGGLRPPIPKE--- 270 (362)
T ss_pred ccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCC-------CHHHHHHHHHhcCCCCCCCcc---
Confidence 45578999999999999 568999999999999999999999999843 222334444555555554443
Q ss_pred HHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhcCCC
Q 042435 359 DIILVSTIALACLRSKPKSRPTMQRISQELEGKTP 393 (412)
Q Consensus 359 ~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 393 (412)
....+..++.+||+.||+.||++.+++..|+.+..
T Consensus 271 ~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~ 305 (362)
T KOG0192|consen 271 CPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMS 305 (362)
T ss_pred CCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHH
Confidence 33347888999999999999999999999987644
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-46 Score=341.50 Aligned_cols=236 Identities=27% Similarity=0.346 Sum_probs=189.1
Q ss_pred cccHHHHHHhhcCcccceeeeecCceEEEEEEeC-CCcEEEEEec----------------------cCCccccceEEEe
Q 042435 132 KILYENLIDATEYFHIRYCIGTGGYDSVYKAELP-DGKVVALKKL----------------------HHSETEDSAFVVY 188 (412)
Q Consensus 132 ~~~~~~l~~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l----------------------~~~~~~~~~~~~~ 188 (412)
.++..||. ..+.||+|..|+|||+.++ +++.+|+|.+ +++.++..++.++
T Consensus 75 ~i~~~dle-------~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~ 147 (364)
T KOG0581|consen 75 GISLSDLE-------RLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFY 147 (364)
T ss_pred ccCHHHhh-------hhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEE
Confidence 35555554 3468999999999999774 6899999976 3566777777888
Q ss_pred cCc-eEEEEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHh-CCCCCcEEeCCCCCCEEecCCCcEEEe
Q 042435 189 SPQ-CMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHH-DCTPSIVHRDISSNNILLNSNLEAFVA 266 (412)
Q Consensus 189 ~~~-~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~-~~~~~ivHrDlkp~NILl~~~~~~kl~ 266 (412)
.+. ...++||||.+|||++++...+ .+++...-+|+.+|++||.|||+ + +|+||||||+|||++..+++|||
T Consensus 148 ~~~~~isI~mEYMDgGSLd~~~k~~g---~i~E~~L~~ia~~VL~GL~YLh~~~---~IIHRDIKPsNlLvNskGeVKic 221 (364)
T KOG0581|consen 148 SNGEEISICMEYMDGGSLDDILKRVG---RIPEPVLGKIARAVLRGLSYLHEER---KIIHRDIKPSNLLVNSKGEVKIC 221 (364)
T ss_pred eCCceEEeehhhcCCCCHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHhhcc---CeeeccCCHHHeeeccCCCEEec
Confidence 888 5999999999999999987653 48899999999999999999996 5 99999999999999999999999
Q ss_pred ecCCccccCCCCCCcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhh
Q 042435 267 DFGTVRLLDVDSSNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQ 346 (412)
Q Consensus 267 DfGla~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 346 (412)
|||.++.+... ...+..||..|||||.+.+..|+.++||||||+.++|+.+|+.||... .........+...+-.
T Consensus 222 DFGVS~~lvnS--~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~---~~~~~~~~~Ll~~Iv~ 296 (364)
T KOG0581|consen 222 DFGVSGILVNS--IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPP---NPPYLDIFELLCAIVD 296 (364)
T ss_pred cccccHHhhhh--hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCc---CCCCCCHHHHHHHHhc
Confidence 99999977554 345678999999999999999999999999999999999999998732 0000111112222222
Q ss_pred ccCCccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 347 RLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
..++..+.. ....++..++..|+++||.+|||+.|+++|
T Consensus 297 ~ppP~lP~~--~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 297 EPPPRLPEG--EFSPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred CCCCCCCcc--cCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 222322232 234458899999999999999999999876
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-44 Score=346.62 Aligned_cols=234 Identities=24% Similarity=0.381 Sum_probs=195.1
Q ss_pred cccceeeeecCceEEEEEEeCCCcEEEEEe--------------------ccCCccccceEEEecCceEEEEEEeccCCc
Q 042435 145 FHIRYCIGTGGYDSVYKAELPDGKVVALKK--------------------LHHSETEDSAFVVYSPQCMFFIYEYMERGS 204 (412)
Q Consensus 145 f~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~--------------------l~~~~~~~~~~~~~~~~~~~lv~ey~~~gs 204 (412)
+...+.||+|-||+||.|.++....||+|. ++|+++++..++|...+.++||||||++|+
T Consensus 208 l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~Gs 287 (468)
T KOG0197|consen 208 LKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGS 287 (468)
T ss_pred HHHHHHhcCCccceEEEEEEcCCCcccceEEeccccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCc
Confidence 344578999999999999998777898884 578999999999999899999999999999
Q ss_pred eeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCCCC-ccc
Q 042435 205 LFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSN-RTL 283 (412)
Q Consensus 205 L~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~-~~~ 283 (412)
|.++|+... ...+...+.+.++.|||+|++||+++ ++|||||..+|||++++..+||+|||+|+....+... ...
T Consensus 288 Ll~yLr~~~-~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~~ 363 (468)
T KOG0197|consen 288 LLDYLRTRE-GGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTASEG 363 (468)
T ss_pred HHHHhhhcC-CCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccccccccCCCceeecCC
Confidence 999999733 23588999999999999999999999 9999999999999999999999999999954433322 223
Q ss_pred ccccccccccccccCcccCcccccHHHHHHHHHHHh-CCCCcccccccccCCCCcchhhHHhhhccCCccchhhHHHHHH
Q 042435 284 QAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLM-GTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKIIQDIIL 362 (412)
Q Consensus 284 ~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 362 (412)
..-++.|.|||.+..+.++.|||||||||+||||+| |+.||..+ ......+.+....+.+.+..++. .
T Consensus 364 ~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~m--------sn~ev~~~le~GyRlp~P~~CP~---~ 432 (468)
T KOG0197|consen 364 GKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGM--------SNEEVLELLERGYRLPRPEGCPD---E 432 (468)
T ss_pred CCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCC--------CHHHHHHHHhccCcCCCCCCCCH---H
Confidence 344678999999999999999999999999999999 88887632 12234455555555444444444 4
Q ss_pred HHHHHHhcCcCCCCCCCCHHHHHHHHhcCCC
Q 042435 363 VSTIALACLRSKPKSRPTMQRISQELEGKTP 393 (412)
Q Consensus 363 ~~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 393 (412)
+.+++..||+.+|++|||++.+...|++...
T Consensus 433 vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~ 463 (468)
T KOG0197|consen 433 VYELMKSCWHEDPEDRPTFETLREVLEDFFT 463 (468)
T ss_pred HHHHHHHHhhCCcccCCCHHHHHHHHHHhhh
Confidence 8899999999999999999999999988754
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=344.96 Aligned_cols=227 Identities=26% Similarity=0.409 Sum_probs=195.2
Q ss_pred cCcccceeeeecCceEEEEEEe-CCCcEEEEEe------------------------ccCCccccceEEEecCceEEEEE
Q 042435 143 EYFHIRYCIGTGGYDSVYKAEL-PDGKVVALKK------------------------LHHSETEDSAFVVYSPQCMFFIY 197 (412)
Q Consensus 143 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~------------------------l~~~~~~~~~~~~~~~~~~~lv~ 197 (412)
..|...+.||+|||+.||.++. ..|+.||+|. ++|+|++.....+.+.+.+|+|.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5699999999999999999987 8899999995 47899999999999999999999
Q ss_pred EeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCC
Q 042435 198 EYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVD 277 (412)
Q Consensus 198 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~ 277 (412)
|+|++|+|..+++... .+++..+..++.||+.||.|||++ +|+|||||..|+++++++++||+|||+|..+..+
T Consensus 98 ELC~~~sL~el~Krrk---~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~ 171 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRRK---PLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD 171 (592)
T ss_pred EecCCccHHHHHHhcC---CCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeeecCc
Confidence 9999999999888443 699999999999999999999999 9999999999999999999999999999998877
Q ss_pred CCCcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccchhhH
Q 042435 278 SSNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKII 357 (412)
Q Consensus 278 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 357 (412)
.....+.+|||.|+|||++.....+..+||||+||++|.|++|++||+.. .-......+.......| .
T Consensus 172 ~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk-------~vkety~~Ik~~~Y~~P--~--- 239 (592)
T KOG0575|consen 172 GERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETK-------TVKETYNKIKLNEYSMP--S--- 239 (592)
T ss_pred ccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccc-------hHHHHHHHHHhcCcccc--c---
Confidence 77777889999999999999999999999999999999999999999821 11112222222222221 1
Q ss_pred HHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 358 QDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 358 ~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
.-.....+|+.++|+.||.+|||+++|+.+
T Consensus 240 ~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 240 HLSAEAKDLIRKLLRPNPSERPSLDEVLDH 269 (592)
T ss_pred ccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 122237789999999999999999999976
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=326.06 Aligned_cols=222 Identities=24% Similarity=0.369 Sum_probs=183.5
Q ss_pred hhcCcccceeeeecCceEEEEEEe-CCCcEEEEEec------------------------cCCccccceEEEecCceEEE
Q 042435 141 ATEYFHIRYCIGTGGYDSVYKAEL-PDGKVVALKKL------------------------HHSETEDSAFVVYSPQCMFF 195 (412)
Q Consensus 141 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l------------------------~~~~~~~~~~~~~~~~~~~l 195 (412)
..++|++.++||+|+||+||.++. ++++.+|+|.| +|+.++.....+++++.+|+
T Consensus 23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLyl 102 (357)
T KOG0598|consen 23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYL 102 (357)
T ss_pred ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEE
Confidence 356799999999999999999966 46899999965 56677777777899999999
Q ss_pred EEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccC
Q 042435 196 IYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLD 275 (412)
Q Consensus 196 v~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~ 275 (412)
|+||+.||.|..+|+..+ .++.....-++.+|+.||.|||++ +||||||||+|||+|.+|.++|+|||+++...
T Consensus 103 Vld~~~GGeLf~hL~~eg---~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~ 176 (357)
T KOG0598|consen 103 VLDYLNGGELFYHLQREG---RFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLCKEDL 176 (357)
T ss_pred EEeccCCccHHHHHHhcC---CcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccchhcc
Confidence 999999999999998665 588888888999999999999999 99999999999999999999999999999655
Q ss_pred CCCCCcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccchh
Q 042435 276 VDSSNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQK 355 (412)
Q Consensus 276 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 355 (412)
.........+||+.|||||++.+..|+..+|.||+|+++|||++|.+||... ........+.......+ +..
T Consensus 177 ~~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~-------~~~~~~~~I~~~k~~~~-p~~ 248 (357)
T KOG0598|consen 177 KDGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAE-------DVKKMYDKILKGKLPLP-PGY 248 (357)
T ss_pred cCCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCc-------cHHHHHHHHhcCcCCCC-Ccc
Confidence 5555556689999999999999999999999999999999999999999732 11222233333332221 111
Q ss_pred hHHHHHHHHHHHHhcCcCCCCCCC
Q 042435 356 IIQDIILVSTIALACLRSKPKSRP 379 (412)
Q Consensus 356 ~~~~~~~~~~l~~~Cl~~dP~~RP 379 (412)
.. ....+++.+.+..||++|-
T Consensus 249 ls---~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 249 LS---EEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred CC---HHHHHHHHHHhccCHHHhc
Confidence 22 2377899999999999995
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=328.20 Aligned_cols=178 Identities=27% Similarity=0.441 Sum_probs=161.5
Q ss_pred hhcCcccceeeeecCceEEEEEEeC-CCcEEEEEe-----------------------ccCCccccceEEEecCceEEEE
Q 042435 141 ATEYFHIRYCIGTGGYDSVYKAELP-DGKVVALKK-----------------------LHHSETEDSAFVVYSPQCMFFI 196 (412)
Q Consensus 141 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~-----------------------l~~~~~~~~~~~~~~~~~~~lv 196 (412)
...+|...+.||+|+||+||+|+++ ++..||||. ++|++++.....+..++.+|||
T Consensus 8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lV 87 (429)
T KOG0595|consen 8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLV 87 (429)
T ss_pred ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEE
Confidence 3467888899999999999999874 689999995 3788999999999999999999
Q ss_pred EEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCC------CcEEEeecCC
Q 042435 197 YEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSN------LEAFVADFGT 270 (412)
Q Consensus 197 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~------~~~kl~DfGl 270 (412)
||||.+|||.++++..+ .++..+...++.|+|.||++||++ +||||||||.|||++.. -.+||+|||+
T Consensus 88 MEyC~gGDLs~yi~~~~---~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGf 161 (429)
T KOG0595|consen 88 MEYCNGGDLSDYIRRRG---RLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADFGF 161 (429)
T ss_pred EEeCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecccch
Confidence 99999999999999875 589999999999999999999999 99999999999999764 5689999999
Q ss_pred ccccCCCCCCcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcc
Q 042435 271 VRLLDVDSSNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGE 325 (412)
Q Consensus 271 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~ 325 (412)
|+.+.... .....+|++.|||||++....|+.|+|+||.|+++||+++|+.||+
T Consensus 162 AR~L~~~~-~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~ 215 (429)
T KOG0595|consen 162 ARFLQPGS-MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFD 215 (429)
T ss_pred hhhCCchh-HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCcc
Confidence 99887433 3356799999999999999999999999999999999999999998
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=327.64 Aligned_cols=232 Identities=26% Similarity=0.308 Sum_probs=186.9
Q ss_pred hhcCcccceeeeecCceEEEEEEe-CCCcEEEEEe----------------------------ccCCccccceEEEecCc
Q 042435 141 ATEYFHIRYCIGTGGYDSVYKAEL-PDGKVVALKK----------------------------LHHSETEDSAFVVYSPQ 191 (412)
Q Consensus 141 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~----------------------------l~~~~~~~~~~~~~~~~ 191 (412)
..+.|.+.+.||+|+||.|-+|.. ++|+.||||. ++||++++....+..++
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 445678889999999999999954 6899999994 46788888888888999
Q ss_pred eEEEEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCC---CcEEEeec
Q 042435 192 CMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSN---LEAFVADF 268 (412)
Q Consensus 192 ~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~---~~~kl~Df 268 (412)
..|+||||++||+|.+.+-... .+....-..++.|++.|+.|||++ ||+||||||+|||+..+ ..+||+||
T Consensus 250 s~YmVlE~v~GGeLfd~vv~nk---~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llKItDF 323 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVANK---YLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLKITDF 323 (475)
T ss_pred ceEEEEEEecCccHHHHHHhcc---ccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEEeccc
Confidence 9999999999999999886654 366666788999999999999999 99999999999999755 78999999
Q ss_pred CCccccCCCCCCcccccccccccccccccCcc---cCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchh-hHHh
Q 042435 269 GTVRLLDVDSSNRTLQAGTYGYIALELVYTMV---VTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIML-IDIL 344 (412)
Q Consensus 269 Gla~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~-~~~~ 344 (412)
|+|+... ...-..+.+||+.|.|||++.+.. +..+.|+||+||+||-+++|..||... .....+ .++.
T Consensus 324 GlAK~~g-~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~-------~~~~sl~eQI~ 395 (475)
T KOG0615|consen 324 GLAKVSG-EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEE-------YTDPSLKEQIL 395 (475)
T ss_pred chhhccc-cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccc-------cCCccHHHHHh
Confidence 9999876 333445679999999999997654 234789999999999999999999832 222212 2333
Q ss_pred hhccCCccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 345 YQRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
..+... .+..+.+-..+..+++.++|..||++|||+.|++++
T Consensus 396 ~G~y~f-~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h 437 (475)
T KOG0615|consen 396 KGRYAF-GPLQWDRISEEALDLINWMLVVDPENRPSADEALNH 437 (475)
T ss_pred cCcccc-cChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence 333322 223344445568999999999999999999999876
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-43 Score=334.14 Aligned_cols=237 Identities=29% Similarity=0.448 Sum_probs=196.9
Q ss_pred cccHHHHHHhhcCcccceeeeecCceEEEEEEeCCCcEEEEEe--------------ccCCccccceEEEecCceEEEEE
Q 042435 132 KILYENLIDATEYFHIRYCIGTGGYDSVYKAELPDGKVVALKK--------------LHHSETEDSAFVVYSPQCMFFIY 197 (412)
Q Consensus 132 ~~~~~~l~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~--------------l~~~~~~~~~~~~~~~~~~~lv~ 197 (412)
.+.|++|.+. +-||+|+.|.||+|++ .++.||||+ ++|+|+..+.++|....++||||
T Consensus 120 eiPFe~IsEL-------eWlGSGaQGAVF~Grl-~netVAVKKV~elkETdIKHLRkLkH~NII~FkGVCtqsPcyCIiM 191 (904)
T KOG4721|consen 120 EIPFEEISEL-------EWLGSGAQGAVFLGRL-HNETVAVKKVRELKETDIKHLRKLKHPNIITFKGVCTQSPCYCIIM 191 (904)
T ss_pred cCCHHHhhhh-------hhhccCcccceeeeec-cCceehhHHHhhhhhhhHHHHHhccCcceeeEeeeecCCceeEEee
Confidence 5667776543 5699999999999999 568899995 57999999999999999999999
Q ss_pred EeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCC
Q 042435 198 EYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVD 277 (412)
Q Consensus 198 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~ 277 (412)
|||+.|.|+.+|+..+ .++-.....+..+||.|+.|||.+ .|||||||+-||||..+..+||+|||-++.....
T Consensus 192 EfCa~GqL~~VLka~~---~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~ 265 (904)
T KOG4721|consen 192 EFCAQGQLYEVLKAGR---PITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKELSDK 265 (904)
T ss_pred eccccccHHHHHhccC---ccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHhhhhh
Confidence 9999999999998776 578888899999999999999999 9999999999999999999999999999876544
Q ss_pred CCCcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccchhhH
Q 042435 278 SSNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKII 357 (412)
Q Consensus 278 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 357 (412)
...-.++||..|||||++...++++|.|||||||+||||+||..||.+..+.+ .+-.+-...+..+.+...+
T Consensus 266 -STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssA-------IIwGVGsNsL~LpvPstcP 337 (904)
T KOG4721|consen 266 -STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSA-------IIWGVGSNSLHLPVPSTCP 337 (904)
T ss_pred -hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhe-------eEEeccCCcccccCcccCc
Confidence 44456789999999999999999999999999999999999999998543211 1111111222223333333
Q ss_pred HHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhcCCC
Q 042435 358 QDIILVSTIALACLRSKPKSRPTMQRISQELEGKTP 393 (412)
Q Consensus 358 ~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 393 (412)
+ .+.-|+.+||+..|..||++.+++.+|+=..+
T Consensus 338 ~---GfklL~Kqcw~sKpRNRPSFrqil~HldIa~p 370 (904)
T KOG4721|consen 338 D---GFKLLLKQCWNSKPRNRPSFRQILLHLDIASP 370 (904)
T ss_pred h---HHHHHHHHHHhcCCCCCccHHHHHHHHhhcCH
Confidence 3 36678899999999999999999999986654
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=314.61 Aligned_cols=237 Identities=24% Similarity=0.301 Sum_probs=188.7
Q ss_pred cCcccceeeeecCceEEEEEE-eCCCcEEEEEec-----------------------cCCccccceE-EEe-cCceEEEE
Q 042435 143 EYFHIRYCIGTGGYDSVYKAE-LPDGKVVALKKL-----------------------HHSETEDSAF-VVY-SPQCMFFI 196 (412)
Q Consensus 143 ~~f~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~l-----------------------~~~~~~~~~~-~~~-~~~~~~lv 196 (412)
.+|++.++||+|+||+|||+. ..+|..+|.|.+ +|+|++.... .+. +.+.++||
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 357788999999999999994 578999999954 6778777655 233 34458999
Q ss_pred EEeccCCceeeeeccCc-ccccCCHHHHHHHHHHHHHHHHHHHhCCCCC--cEEeCCCCCCEEecCCCcEEEeecCCccc
Q 042435 197 YEYMERGSLFCVLRDDD-EAIELNWTRRMNIVKSVAHALSYLHHDCTPS--IVHRDISSNNILLNSNLEAFVADFGTVRL 273 (412)
Q Consensus 197 ~ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~--ivHrDlkp~NILl~~~~~~kl~DfGla~~ 273 (412)
||||..|+|.+.++... ....++...+++++.|+++||..+|+. -+. |+||||||.||+++.++.+||+|||+++.
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~-~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~ 177 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSK-IPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRF 177 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhcc-ccccceeeccCcchheEEcCCCceeeccchhHhH
Confidence 99999999999887543 234689999999999999999999984 224 99999999999999999999999999999
Q ss_pred cCCCCCCcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccc
Q 042435 274 LDVDSSNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPIN 353 (412)
Q Consensus 274 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 353 (412)
+..........+|||.||+||.+.+..|+.||||||+||++|||+.-+.||... .-..+..-+.+.-.++.+
T Consensus 178 l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~--------n~~~L~~KI~qgd~~~~p 249 (375)
T KOG0591|consen 178 LSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD--------NLLSLCKKIEQGDYPPLP 249 (375)
T ss_pred hcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc--------cHHHHHHHHHcCCCCCCc
Confidence 887766667789999999999999999999999999999999999999999732 111122222222222222
Q ss_pred hhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhc
Q 042435 354 QKIIQDIILVSTIALACLRSKPKSRPTMQRISQELEG 390 (412)
Q Consensus 354 ~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~ 390 (412)
. .-....+.+|+..|+..||+.||+...++..+..
T Consensus 250 ~--~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 250 D--EHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred H--HHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 1 2234458889999999999999996666555554
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=324.90 Aligned_cols=232 Identities=23% Similarity=0.375 Sum_probs=191.3
Q ss_pred HHhhcCcccceeeeecCceEEEEEEe-CCCcEEEEEec-------------------------cCCccccceEEEecCce
Q 042435 139 IDATEYFHIRYCIGTGGYDSVYKAEL-PDGKVVALKKL-------------------------HHSETEDSAFVVYSPQC 192 (412)
Q Consensus 139 ~~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l-------------------------~~~~~~~~~~~~~~~~~ 192 (412)
....++|..++.||+|+|++||+|+. ..++.+|||++ .|+.+.+....+.+...
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s 148 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES 148 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence 45567899999999999999999965 57999999976 35556666666889999
Q ss_pred EEEEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCcc
Q 042435 193 MFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVR 272 (412)
Q Consensus 193 ~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~ 272 (412)
+|+|+||+++|+|.++++..+ .++......++.+|+.||+|||++ |||||||||+|||+|+|+++||+|||.|+
T Consensus 149 LYFvLe~A~nGdll~~i~K~G---sfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFGsAK 222 (604)
T KOG0592|consen 149 LYFVLEYAPNGDLLDLIKKYG---SFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFGSAK 222 (604)
T ss_pred eEEEEEecCCCcHHHHHHHhC---cchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeeccccc
Confidence 999999999999999998765 588888889999999999999999 99999999999999999999999999999
Q ss_pred ccCCCCCC-------------cccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcch
Q 042435 273 LLDVDSSN-------------RTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIM 339 (412)
Q Consensus 273 ~~~~~~~~-------------~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~ 339 (412)
.+...... ....+||..|.+||++.....+..+|+|+|||+||+|+.|++||... .+-..
T Consensus 223 ~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~-------Neyli 295 (604)
T KOG0592|consen 223 ILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAA-------NEYLI 295 (604)
T ss_pred cCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccc-------cHHHH
Confidence 87542211 14578999999999999999999999999999999999999999832 22233
Q ss_pred hhHHhhhccCCccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHH
Q 042435 340 LIDILYQRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQEL 388 (412)
Q Consensus 340 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L 388 (412)
+..++.-....+ +...+ .+.+|+.+.|..||++|+|..+|-+|.
T Consensus 296 FqkI~~l~y~fp--~~fp~---~a~dLv~KLLv~dp~~Rlt~~qIk~Hp 339 (604)
T KOG0592|consen 296 FQKIQALDYEFP--EGFPE---DARDLIKKLLVRDPSDRLTSQQIKAHP 339 (604)
T ss_pred HHHHHHhcccCC--CCCCH---HHHHHHHHHHccCccccccHHHHhhCc
Confidence 444443333222 22222 377899999999999999999987763
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-41 Score=324.56 Aligned_cols=239 Identities=23% Similarity=0.318 Sum_probs=181.6
Q ss_pred hcCcccceeeeecCceEEEEEEe------CCCcEEEEEec-----------------------cCCccccceEEEec-Cc
Q 042435 142 TEYFHIRYCIGTGGYDSVYKAEL------PDGKVVALKKL-----------------------HHSETEDSAFVVYS-PQ 191 (412)
Q Consensus 142 ~~~f~~~~~lG~G~~g~Vy~~~~------~~~~~vAvK~l-----------------------~~~~~~~~~~~~~~-~~ 191 (412)
.++|++.+.||+|+||.||+|.+ .+++.||||.+ +|+++......+.. .+
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG 85 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence 46789999999999999999964 23578999976 35555555555554 34
Q ss_pred eEEEEEEeccCCceeeeeccCcc---------------------------------------------------------
Q 042435 192 CMFFIYEYMERGSLFCVLRDDDE--------------------------------------------------------- 214 (412)
Q Consensus 192 ~~~lv~ey~~~gsL~~~l~~~~~--------------------------------------------------------- 214 (412)
..++||||+++|+|.+++.....
T Consensus 86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (338)
T cd05102 86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD 165 (338)
T ss_pred ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence 58999999999999988764311
Q ss_pred --cccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCCC--Ccccccccccc
Q 042435 215 --AIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSS--NRTLQAGTYGY 290 (412)
Q Consensus 215 --~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~--~~~~~~gt~~y 290 (412)
...+++.....++.|+++||+|||+. +|+||||||+|||++.++.+||+|||+++....... ......++..|
T Consensus 166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y 242 (338)
T cd05102 166 LWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW 242 (338)
T ss_pred cccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence 12478889999999999999999998 999999999999999999999999999986533221 11233466789
Q ss_pred cccccccCcccCcccccHHHHHHHHHHHh-CCCCcccccccccCCCCcchhhHHhhhccCCccchhhHHHHHHHHHHHHh
Q 042435 291 IALELVYTMVVTEKCVIYSFGVVALEVLM-GTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKIIQDIILVSTIALA 369 (412)
Q Consensus 291 ~aPE~~~~~~~s~ksDv~S~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 369 (412)
+|||++.+..++.++|||||||++|||++ |..||.... ........+........+.. ....+.+++.+
T Consensus 243 ~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~-------~~~~~~~~~~~~~~~~~~~~---~~~~l~~li~~ 312 (338)
T cd05102 243 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQ-------INEEFCQRLKDGTRMRAPEN---ATPEIYRIMLA 312 (338)
T ss_pred cCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCC-------ccHHHHHHHhcCCCCCCCCC---CCHHHHHHHHH
Confidence 99999998899999999999999999997 999986321 11112222221111111111 12347899999
Q ss_pred cCcCCCCCCCCHHHHHHHHhcCCC
Q 042435 370 CLRSKPKSRPTMQRISQELEGKTP 393 (412)
Q Consensus 370 Cl~~dP~~RPs~~evl~~L~~~~~ 393 (412)
||+.||++|||+.|+++.|+++..
T Consensus 313 cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 313 CWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred HccCChhhCcCHHHHHHHHHHHHh
Confidence 999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=339.30 Aligned_cols=240 Identities=24% Similarity=0.345 Sum_probs=196.3
Q ss_pred cCcccceeeeecCceEEEEEEeC------CCcEEEEEe----------------------ccCCccccceEEEecCceEE
Q 042435 143 EYFHIRYCIGTGGYDSVYKAELP------DGKVVALKK----------------------LHHSETEDSAFVVYSPQCMF 194 (412)
Q Consensus 143 ~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vAvK~----------------------l~~~~~~~~~~~~~~~~~~~ 194 (412)
.+....+.||+|+||+||+|+.. +.+.||||. ++|+|+++..++|..++..+
T Consensus 486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~ 565 (774)
T KOG1026|consen 486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLC 565 (774)
T ss_pred hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeE
Confidence 34455678999999999999763 457899995 46899999999999999999
Q ss_pred EEEEeccCCceeeeeccCcc-----------cccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcE
Q 042435 195 FIYEYMERGSLFCVLRDDDE-----------AIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEA 263 (412)
Q Consensus 195 lv~ey~~~gsL~~~l~~~~~-----------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~ 263 (412)
+|+|||..|||.++|+...+ ..+|+-.+.+.||.|||.|++||-++ .+|||||..+|+|+.++..+
T Consensus 566 MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVge~l~V 642 (774)
T KOG1026|consen 566 MVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVGENLVV 642 (774)
T ss_pred EEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceeccceEE
Confidence 99999999999999975421 12388999999999999999999998 89999999999999999999
Q ss_pred EEeecCCccccCCCCCCc--ccccccccccccccccCcccCcccccHHHHHHHHHHHh-CCCCcccccccccCCCCcchh
Q 042435 264 FVADFGTVRLLDVDSSNR--TLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLM-GTHPGELLLSLSSSSGPKIML 340 (412)
Q Consensus 264 kl~DfGla~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~ 340 (412)
||+|||+++..-..+..+ ....-.++|||||.+..++||++||||||||+|||+++ |+.||.. ...++.+
T Consensus 643 KIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~g-------lSn~EVI 715 (774)
T KOG1026|consen 643 KISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYG-------LSNQEVI 715 (774)
T ss_pred EecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccc-------cchHHHH
Confidence 999999999765443332 12234679999999999999999999999999999998 9999873 2333344
Q ss_pred hHHhhhccCCccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhcCCCCCC
Q 042435 341 IDILYQRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELEGKTPMKK 396 (412)
Q Consensus 341 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~~~ 396 (412)
..+-...+. +.++ .++..+.+|+..||+.+|++||+++||-..|++.....+
T Consensus 716 e~i~~g~lL-~~Pe---~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s~ 767 (774)
T KOG1026|consen 716 ECIRAGQLL-SCPE---NCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQASP 767 (774)
T ss_pred HHHHcCCcc-cCCC---CCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcCc
Confidence 444444442 2223 334459999999999999999999999999998876544
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-41 Score=323.08 Aligned_cols=230 Identities=24% Similarity=0.327 Sum_probs=189.8
Q ss_pred hcCcccceeeeecCceEEEEEE-eCCCcEEEEEecc---------------------CCccccceEEEecCceEEEEEEe
Q 042435 142 TEYFHIRYCIGTGGYDSVYKAE-LPDGKVVALKKLH---------------------HSETEDSAFVVYSPQCMFFIYEY 199 (412)
Q Consensus 142 ~~~f~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~l~---------------------~~~~~~~~~~~~~~~~~~lv~ey 199 (412)
...|..-.+||+|+.|.||.|. ..+++.||||++. |+|++.....+...+.+|+||||
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEy 351 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEY 351 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEee
Confidence 3457777899999999999995 4678999999873 55555554445566899999999
Q ss_pred ccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCCC
Q 042435 200 MERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSS 279 (412)
Q Consensus 200 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 279 (412)
|++|+|.+++.... ++..++..|++++++||+|||.+ +|+|||||.+|||++.++.+||+|||++..+.....
T Consensus 352 m~ggsLTDvVt~~~----~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~ 424 (550)
T KOG0578|consen 352 MEGGSLTDVVTKTR----MTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS 424 (550)
T ss_pred cCCCchhhhhhccc----ccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeeccccccC
Confidence 99999999987654 89999999999999999999999 999999999999999999999999999998887777
Q ss_pred CcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccchhhHHH
Q 042435 280 NRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKIIQD 359 (412)
Q Consensus 280 ~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 359 (412)
.+...+||+.|||||+.....|++|.||||||++++||+-|.+||-.. .+-..+ ..+...-.+. .......
T Consensus 425 KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE-------~PlrAl-yLIa~ng~P~-lk~~~kl 495 (550)
T KOG0578|consen 425 KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNE-------NPLRAL-YLIATNGTPK-LKNPEKL 495 (550)
T ss_pred ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCC-------ChHHHH-HHHhhcCCCC-cCCcccc
Confidence 788889999999999999999999999999999999999999998622 111111 1222222222 1222333
Q ss_pred HHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 360 IILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 360 ~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
...+.+++.+||..|+.+||++.|++++
T Consensus 496 S~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 496 SPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred CHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 4458999999999999999999999986
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=326.39 Aligned_cols=246 Identities=22% Similarity=0.353 Sum_probs=188.7
Q ss_pred HHHHHHhhcCcccceeeeecCceEEEEEEeCCCcEEEEEec-----------------------cCCccccceEEEecCc
Q 042435 135 YENLIDATEYFHIRYCIGTGGYDSVYKAELPDGKVVALKKL-----------------------HHSETEDSAFVVYSPQ 191 (412)
Q Consensus 135 ~~~l~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~l-----------------------~~~~~~~~~~~~~~~~ 191 (412)
.++.....+.+.+...||+|.||+||+|+|. -.||||.+ +|.|+.-+-+.|..+.
T Consensus 384 ~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~ 461 (678)
T KOG0193|consen 384 LEEWEIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPP 461 (678)
T ss_pred ccccccCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCc
Confidence 3445555566677889999999999999995 35899976 3455554445555555
Q ss_pred eEEEEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCc
Q 042435 192 CMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTV 271 (412)
Q Consensus 192 ~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla 271 (412)
. .||+.+|++.+|+.+++..+. .++..+...||.|||+|+.|||.+ +|||||||+.||++.+++++||+|||++
T Consensus 462 ~-AIiTqwCeGsSLY~hlHv~et--kfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgDFGLa 535 (678)
T KOG0193|consen 462 L-AIITQWCEGSSLYTHLHVQET--KFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGDFGLA 535 (678)
T ss_pred e-eeeehhccCchhhhhccchhh--hhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEecccce
Confidence 5 999999999999999998764 588999999999999999999999 9999999999999999999999999998
Q ss_pred cccCC--CCCCccccccccccccccccc---CcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhh
Q 042435 272 RLLDV--DSSNRTLQAGTYGYIALELVY---TMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQ 346 (412)
Q Consensus 272 ~~~~~--~~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 346 (412)
..... .........|+..|||||++. ..+|++.+||||||+++|||+||..||... ..+..+-.+-..
T Consensus 536 tvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~-------~~dqIifmVGrG 608 (678)
T KOG0193|consen 536 TVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQ-------NRDQIIFMVGRG 608 (678)
T ss_pred eeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCC-------ChhheEEEeccc
Confidence 64322 222334557889999999986 457999999999999999999999998721 111111111111
Q ss_pred ccCCccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhcCCCCC
Q 042435 347 RLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELEGKTPMK 395 (412)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~~ 395 (412)
.+.+............+.+|+..||..++++||.+.+|+..|+++.+..
T Consensus 609 ~l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~~ 657 (678)
T KOG0193|consen 609 YLMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPSL 657 (678)
T ss_pred ccCccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhcc
Confidence 1222222222333445899999999999999999999999998887743
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=314.99 Aligned_cols=237 Identities=25% Similarity=0.337 Sum_probs=182.7
Q ss_pred hcCcccceeeeecCceEEEEEEeC-CCcEEEEEecc---------------------CCccccceEEEecCc--eEEEEE
Q 042435 142 TEYFHIRYCIGTGGYDSVYKAELP-DGKVVALKKLH---------------------HSETEDSAFVVYSPQ--CMFFIY 197 (412)
Q Consensus 142 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~---------------------~~~~~~~~~~~~~~~--~~~lv~ 197 (412)
..++...+.||+|+||.||++... +|+..|||... |+++++..+.....+ ..++.|
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m 95 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM 95 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence 345777899999999999999775 49999999653 444444444322233 689999
Q ss_pred EeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecC-CCcEEEeecCCccccCC
Q 042435 198 EYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNS-NLEAFVADFGTVRLLDV 276 (412)
Q Consensus 198 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~-~~~~kl~DfGla~~~~~ 276 (412)
||+++|+|.+++..... .++...+..+..||++||+|||++ +|+||||||+|||++. ++.+||+|||+++....
T Consensus 96 Ey~~~GsL~~~~~~~g~--~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~ 170 (313)
T KOG0198|consen 96 EYAPGGSLSDLIKRYGG--KLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAKKLES 170 (313)
T ss_pred eccCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCcccccccc
Confidence 99999999999987653 489999999999999999999998 9999999999999999 79999999999987663
Q ss_pred CC---CCcccccccccccccccccCc-ccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCcc
Q 042435 277 DS---SNRTLQAGTYGYIALELVYTM-VVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPI 352 (412)
Q Consensus 277 ~~---~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 352 (412)
.. .......||+.|||||++..+ ....++|||||||++.||+||+.||... ......+..+......|..
T Consensus 171 ~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~------~~~~~~~~~ig~~~~~P~i 244 (313)
T KOG0198|consen 171 KGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF------FEEAEALLLIGREDSLPEI 244 (313)
T ss_pred ccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh------cchHHHHHHHhccCCCCCC
Confidence 11 223456899999999999853 3445999999999999999999998742 1111112222222323333
Q ss_pred chhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhcCC
Q 042435 353 NQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELEGKT 392 (412)
Q Consensus 353 ~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 392 (412)
+....+ ...+++.+|+..||++|||+++++++.--..
T Consensus 245 p~~ls~---~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~ 281 (313)
T KOG0198|consen 245 PDSLSD---EAKDFLRKCFKRDPEKRPTAEELLEHPFLKQ 281 (313)
T ss_pred CcccCH---HHHHHHHHHhhcCcccCcCHHHHhhChhhhc
Confidence 333333 3778999999999999999999999875544
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=303.26 Aligned_cols=239 Identities=22% Similarity=0.298 Sum_probs=182.7
Q ss_pred cCcccceeeeecCceEEEEEEeC-CCcEEEEEec-----------------------cCCccccceEEEecCceEEEEEE
Q 042435 143 EYFHIRYCIGTGGYDSVYKAELP-DGKVVALKKL-----------------------HHSETEDSAFVVYSPQCMFFIYE 198 (412)
Q Consensus 143 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l-----------------------~~~~~~~~~~~~~~~~~~~lv~e 198 (412)
+.|+...++|+|+||.|||++.+ +|+.||||++ +|+|.+....++.....++||+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 45777789999999999999885 5999999975 67788777788888999999999
Q ss_pred eccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCC
Q 042435 199 YMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDS 278 (412)
Q Consensus 199 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~ 278 (412)
||+..-|. -|..... .++.....+++.|+++|+.|+|++ +++||||||+|||++.++.+||||||+|+.+....
T Consensus 82 ~~dhTvL~-eLe~~p~--G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pg 155 (396)
T KOG0593|consen 82 YCDHTVLH-ELERYPN--GVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLSAPG 155 (396)
T ss_pred ecchHHHH-HHHhccC--CCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhcCCc
Confidence 99874444 3433322 378889999999999999999999 99999999999999999999999999999988666
Q ss_pred CCcccccccccccccccccC-cccCcccccHHHHHHHHHHHhCCCCccccccccc------CCCCc-chhhHHhhhc---
Q 042435 279 SNRTLQAGTYGYIALELVYT-MVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSS------SSGPK-IMLIDILYQR--- 347 (412)
Q Consensus 279 ~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~------~~~~~-~~~~~~~~~~--- 347 (412)
...+..+.|.+|+|||.+.+ ..|+...||||.||++.||++|..-|.....+.. ...+- ....+++...
T Consensus 156 d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F 235 (396)
T KOG0593|consen 156 DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFF 235 (396)
T ss_pred chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCce
Confidence 66777889999999999987 6799999999999999999999987652211100 00000 0001111110
Q ss_pred --c--CC-----ccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 348 --L--SP-----PINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 348 --~--~~-----~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
+ +. +.....+.....+++++..|++.||.+|++.+|++.+
T Consensus 236 ~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H 284 (396)
T KOG0593|consen 236 HGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHH 284 (396)
T ss_pred eeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence 0 00 0111111222348899999999999999999998754
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=308.86 Aligned_cols=235 Identities=25% Similarity=0.354 Sum_probs=188.1
Q ss_pred hcCcccceeeeecCceEEEEEEe-CCCcEEEEEec----------------------cCCccccceEEEecCceEEEEEE
Q 042435 142 TEYFHIRYCIGTGGYDSVYKAEL-PDGKVVALKKL----------------------HHSETEDSAFVVYSPQCMFFIYE 198 (412)
Q Consensus 142 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l----------------------~~~~~~~~~~~~~~~~~~~lv~e 198 (412)
.++|++.++||.|..++||+|+. +.++.||||++ +|+|+......+..+..+|+||.
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp 104 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP 104 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence 35799999999999999999965 67899999975 68999998888999999999999
Q ss_pred eccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCC
Q 042435 199 YMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDS 278 (412)
Q Consensus 199 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~ 278 (412)
||.+||+.++++..-.. .++...+..|++++++||.|||.+ |.||||||+.|||++++|.+||+|||.+-.+....
T Consensus 105 fMa~GS~ldIik~~~~~-Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G 180 (516)
T KOG0582|consen 105 FMAGGSLLDIIKTYYPD-GLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSG 180 (516)
T ss_pred hhcCCcHHHHHHHHccc-cccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeeeeecccC
Confidence 99999999998765332 388999999999999999999999 99999999999999999999999999876554332
Q ss_pred CC---c-ccccccccccccccccC--cccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCc-
Q 042435 279 SN---R-TLQAGTYGYIALELVYT--MVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPP- 351 (412)
Q Consensus 279 ~~---~-~~~~gt~~y~aPE~~~~--~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 351 (412)
.. . ....||+.|||||++.. ..|+.|+||||||++..||.+|..||... .+...+..-+....+.+
T Consensus 181 ~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~-------pPmkvLl~tLqn~pp~~~ 253 (516)
T KOG0582|consen 181 DRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKY-------PPMKVLLLTLQNDPPTLL 253 (516)
T ss_pred ceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccC-------ChHHHHHHHhcCCCCCcc
Confidence 21 1 45589999999999643 46999999999999999999999999832 12222222222222100
Q ss_pred ----cchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 352 ----INQKIIQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 352 ----~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
...........+.+++..|+..||++|||+++++++
T Consensus 254 t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh 293 (516)
T KOG0582|consen 254 TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH 293 (516)
T ss_pred cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence 011111223358899999999999999999999875
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=336.69 Aligned_cols=237 Identities=28% Similarity=0.405 Sum_probs=197.7
Q ss_pred cccceeeeecCceEEEEEEeC----CCcEEEEEec----------------------cCCccccceEEEecCceEEEEEE
Q 042435 145 FHIRYCIGTGGYDSVYKAELP----DGKVVALKKL----------------------HHSETEDSAFVVYSPQCMFFIYE 198 (412)
Q Consensus 145 f~~~~~lG~G~~g~Vy~~~~~----~~~~vAvK~l----------------------~~~~~~~~~~~~~~~~~~~lv~e 198 (412)
..+.++||.|.||+||+|+++ ....||||.| .|+|+.+..+++.....++||+|
T Consensus 631 i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTE 710 (996)
T KOG0196|consen 631 VKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITE 710 (996)
T ss_pred eEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhh
Confidence 456789999999999999884 3568999954 69999999999999999999999
Q ss_pred eccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCC
Q 042435 199 YMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDS 278 (412)
Q Consensus 199 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~ 278 (412)
||+||+|+.+|+.+.. .+++.+...++++||.|+.||-+. ++|||||..+|||++.+..+|++|||+++.+..+.
T Consensus 711 yMENGsLDsFLR~~DG--qftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~ 785 (996)
T KOG0196|consen 711 YMENGSLDSFLRQNDG--QFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 785 (996)
T ss_pred hhhCCcHHHHHhhcCC--ceEeehHHHHHHHHHHHhHHHhhc---CchhhhhhhhheeeccceEEEeccccceeecccCC
Confidence 9999999999998874 489999999999999999999999 99999999999999999999999999999886654
Q ss_pred CCc-ccccc--cccccccccccCcccCcccccHHHHHHHHHHHh-CCCCcccccccccCCCCcchhhHHhhhccCCccch
Q 042435 279 SNR-TLQAG--TYGYIALELVYTMVVTEKCVIYSFGVVALEVLM-GTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQ 354 (412)
Q Consensus 279 ~~~-~~~~g--t~~y~aPE~~~~~~~s~ksDv~S~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 354 (412)
... +...| .++|.|||.+...++|.+||||||||++||.++ |..||.++ ..+. ....+.+..+-|.+.
T Consensus 786 ~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdm-------SNQd-VIkaIe~gyRLPpPm 857 (996)
T KOG0196|consen 786 EAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDM-------SNQD-VIKAIEQGYRLPPPM 857 (996)
T ss_pred CccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCccccc-------chHH-HHHHHHhccCCCCCC
Confidence 322 33333 468999999999999999999999999999887 99998743 2222 233333333332222
Q ss_pred hhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhcCCCCCCC
Q 042435 355 KIIQDIILVSTIALACLRSKPKSRPTMQRISQELEGKTPMKKG 397 (412)
Q Consensus 355 ~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~~~~ 397 (412)
++...+.+|++.||++|-.+||++.||+.+|+++...+..
T Consensus 858 ---DCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~S 897 (996)
T KOG0196|consen 858 ---DCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPNS 897 (996)
T ss_pred ---CCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCchh
Confidence 3444589999999999999999999999999998765543
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-40 Score=322.55 Aligned_cols=222 Identities=23% Similarity=0.335 Sum_probs=184.8
Q ss_pred hhcCcccceeeeecCceEEEEEEeC-CCcEEEEEeccCCcccc-------------------------ceEEEecCceEE
Q 042435 141 ATEYFHIRYCIGTGGYDSVYKAELP-DGKVVALKKLHHSETED-------------------------SAFVVYSPQCMF 194 (412)
Q Consensus 141 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~~~~~-------------------------~~~~~~~~~~~~ 194 (412)
..++|...++||+|+||+|+++..+ +++.+|||.++...+.. ....+++++++|
T Consensus 366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~ 445 (694)
T KOG0694|consen 366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLF 445 (694)
T ss_pred cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEE
Confidence 4578999999999999999999875 58899999886554443 333367889999
Q ss_pred EEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCcccc
Q 042435 195 FIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLL 274 (412)
Q Consensus 195 lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~ 274 (412)
.||||+.||++..+.+.. .++.....-++..|+.||.|||++ +||+||||.+|||+|.+|.+||+|||+++..
T Consensus 446 fvmey~~Ggdm~~~~~~~----~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~ 518 (694)
T KOG0694|consen 446 FVMEYVAGGDLMHHIHTD----VFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGLCKEG 518 (694)
T ss_pred EEEEecCCCcEEEEEecc----cccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEeccccccccc
Confidence 999999999977776654 389999999999999999999999 9999999999999999999999999999976
Q ss_pred CCCCCCcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccch
Q 042435 275 DVDSSNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQ 354 (412)
Q Consensus 275 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 354 (412)
.......++.+||+.|||||++.+..|+...|.|||||+||||+.|..||. ...+++....++......|.
T Consensus 519 m~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~-------gddEee~FdsI~~d~~~yP~-- 589 (694)
T KOG0694|consen 519 MGQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFP-------GDDEEEVFDSIVNDEVRYPR-- 589 (694)
T ss_pred CCCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCC-------CCCHHHHHHHHhcCCCCCCC--
Confidence 545556678899999999999999999999999999999999999999997 23444445555544443332
Q ss_pred hhHHHHHHHHHHHHhcCcCCCCCCCCH
Q 042435 355 KIIQDIILVSTIALACLRSKPKSRPTM 381 (412)
Q Consensus 355 ~~~~~~~~~~~l~~~Cl~~dP~~RPs~ 381 (412)
.... +..+++.+.+.++|++|-.+
T Consensus 590 ~ls~---ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 590 FLSK---EAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred cccH---HHHHHHHHHhccCcccccCC
Confidence 2222 37789999999999999865
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=313.18 Aligned_cols=241 Identities=21% Similarity=0.309 Sum_probs=187.5
Q ss_pred hhcCcccceeeeecCceEEEEEEe-CCCcEEEEEec----------------------c-CCccccceEEEecCc-eEEE
Q 042435 141 ATEYFHIRYCIGTGGYDSVYKAEL-PDGKVVALKKL----------------------H-HSETEDSAFVVYSPQ-CMFF 195 (412)
Q Consensus 141 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l----------------------~-~~~~~~~~~~~~~~~-~~~l 195 (412)
..++|.+.++||.|+||.||+|+. .+|+.||||+| . |+++.....++.+.+ .+++
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f 87 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF 87 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence 456788899999999999999965 56999999965 3 888888888888887 9999
Q ss_pred EEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccC
Q 042435 196 IYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLD 275 (412)
Q Consensus 196 v~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~ 275 (412)
|||||+. +|++++++++ ..++..++..|+.||.+||+|+|.+ |+.|||+||+|||+..+..+||+|||+|+...
T Consensus 88 VfE~Md~-NLYqLmK~R~--r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLARev~ 161 (538)
T KOG0661|consen 88 VFEFMDC-NLYQLMKDRN--RLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLAREVR 161 (538)
T ss_pred eHHhhhh-hHHHHHhhcC--CcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEecccccccccc
Confidence 9999965 9999998874 4699999999999999999999999 99999999999999999999999999999775
Q ss_pred CCCCCccccccccccccccccc-CcccCcccccHHHHHHHHHHHhCCCCccccccc-------------ccCCCCc-chh
Q 042435 276 VDSSNRTLQAGTYGYIALELVY-TMVVTEKCVIYSFGVVALEVLMGTHPGELLLSL-------------SSSSGPK-IML 340 (412)
Q Consensus 276 ~~~~~~~~~~gt~~y~aPE~~~-~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~-------------~~~~~~~-~~~ 340 (412)
... ..+..+.|.+|+|||++. .+.|+.+.||||+|||++|+.+-+.-|.....+ ......+ ..+
T Consensus 162 Skp-PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~L 240 (538)
T KOG0661|consen 162 SKP-PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNL 240 (538)
T ss_pred cCC-CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHH
Confidence 433 345568899999999875 567999999999999999999988766422110 0011111 111
Q ss_pred hHHhhhccCCc----cchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHH
Q 042435 341 IDILYQRLSPP----INQKIIQDIILVSTIALACLRSKPKSRPTMQRISQEL 388 (412)
Q Consensus 341 ~~~~~~~~~~~----~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L 388 (412)
...+.-.++.- ...-.........+++.+|+++||.+|||+.|.+++-
T Consensus 241 a~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~p 292 (538)
T KOG0661|consen 241 ASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHP 292 (538)
T ss_pred HHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCc
Confidence 11221111110 0111112334588999999999999999999999874
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=310.08 Aligned_cols=238 Identities=26% Similarity=0.336 Sum_probs=184.0
Q ss_pred hcCcccceeeeecCceEEEEEEe-CCCcEEEEEec-----------------------cCCccccceEEEecC--ceEEE
Q 042435 142 TEYFHIRYCIGTGGYDSVYKAEL-PDGKVVALKKL-----------------------HHSETEDSAFVVYSP--QCMFF 195 (412)
Q Consensus 142 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l-----------------------~~~~~~~~~~~~~~~--~~~~l 195 (412)
.+.|+..++||+|+||.||||+. .+|+.||+|++ +|+|+.....+..+. ..+||
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl 195 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL 195 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence 34577778999999999999954 78999999964 688888888877765 78999
Q ss_pred EEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccC
Q 042435 196 IYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLD 275 (412)
Q Consensus 196 v~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~ 275 (412)
|+|||++ ||..++.... ..++..++..++.|++.||+|+|++ +|+|||||.+|||||.++.+||+|||+|+++.
T Consensus 196 VFeYMdh-DL~GLl~~p~--vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~ 269 (560)
T KOG0600|consen 196 VFEYMDH-DLSGLLSSPG--VKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLARFYT 269 (560)
T ss_pred EEecccc-hhhhhhcCCC--cccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccceeecc
Confidence 9999987 8988887643 4699999999999999999999999 99999999999999999999999999999887
Q ss_pred CCCCC-cccccccccccccccccCc-ccCcccccHHHHHHHHHHHhCCCCccccccc---------ccC----CCCcchh
Q 042435 276 VDSSN-RTLQAGTYGYIALELVYTM-VVTEKCVIYSFGVVALEVLMGTHPGELLLSL---------SSS----SGPKIML 340 (412)
Q Consensus 276 ~~~~~-~~~~~gt~~y~aPE~~~~~-~~s~ksDv~S~Gvil~elltg~~P~~~~~~~---------~~~----~~~~~~~ 340 (412)
..... .+..+-|.+|+|||.+.+. .|+.+.|+||.||||.||++|+..|..-..+ ..+ .++...+
T Consensus 270 ~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kL 349 (560)
T KOG0600|consen 270 PSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKL 349 (560)
T ss_pred CCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccC
Confidence 66543 5667789999999999875 6999999999999999999999988632111 000 0000000
Q ss_pred h--HHhhhccCCccchhhH----HHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 341 I--DILYQRLSPPINQKII----QDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 341 ~--~~~~~~~~~~~~~~~~----~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
- ..+.+ ..+...... ......++|+..+|..||.+|.|+.++++.
T Consensus 350 P~~~~~kp--~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s 400 (560)
T KOG0600|consen 350 PHATIFKP--QQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQS 400 (560)
T ss_pred CcccccCC--CCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence 0 00000 000001111 112347789999999999999999998864
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=317.22 Aligned_cols=240 Identities=22% Similarity=0.301 Sum_probs=185.1
Q ss_pred HHhhcCcccceeeeecCceEEEEEEe------CCCcEEEEEec-----------------------cCCccccceEEEec
Q 042435 139 IDATEYFHIRYCIGTGGYDSVYKAEL------PDGKVVALKKL-----------------------HHSETEDSAFVVYS 189 (412)
Q Consensus 139 ~~~~~~f~~~~~lG~G~~g~Vy~~~~------~~~~~vAvK~l-----------------------~~~~~~~~~~~~~~ 189 (412)
....++|++.+.||+|+||.||+|.+ .++..||||.+ +|+++......+..
T Consensus 31 ~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~ 110 (375)
T cd05104 31 EFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTV 110 (375)
T ss_pred ccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeecc
Confidence 33456799999999999999999964 24668999975 35666666677888
Q ss_pred CceEEEEEEeccCCceeeeeccCcc-------------------------------------------------------
Q 042435 190 PQCMFFIYEYMERGSLFCVLRDDDE------------------------------------------------------- 214 (412)
Q Consensus 190 ~~~~~lv~ey~~~gsL~~~l~~~~~------------------------------------------------------- 214 (412)
.+..++||||+++|+|.++++....
T Consensus 111 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (375)
T cd05104 111 GGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVR 190 (375)
T ss_pred CCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccc
Confidence 8899999999999999888754210
Q ss_pred -----------------cccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCC
Q 042435 215 -----------------AIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVD 277 (412)
Q Consensus 215 -----------------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~ 277 (412)
...++|..+.+++.|+++||+|||+. +++||||||+|||++.+..+||+|||+++.....
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~ 267 (375)
T cd05104 191 SGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRND 267 (375)
T ss_pred cceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccCc
Confidence 12478999999999999999999998 9999999999999999999999999999865433
Q ss_pred CCC--cccccccccccccccccCcccCcccccHHHHHHHHHHHh-CCCCcccccccccCCCCcchhhHHhhhccCCccch
Q 042435 278 SSN--RTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLM-GTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQ 354 (412)
Q Consensus 278 ~~~--~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 354 (412)
... .....++..|+|||++.+..++.++|||||||++|||++ |..||... .........+........+.
T Consensus 268 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~-------~~~~~~~~~~~~~~~~~~~~ 340 (375)
T cd05104 268 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGM-------PVDSKFYKMIKEGYRMLSPE 340 (375)
T ss_pred ccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCC-------CchHHHHHHHHhCccCCCCC
Confidence 221 122345678999999999999999999999999999998 88888632 11112223333222221111
Q ss_pred hhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhcC
Q 042435 355 KIIQDIILVSTIALACLRSKPKSRPTMQRISQELEGK 391 (412)
Q Consensus 355 ~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 391 (412)
.. ...+.+++.+||+.||++|||+.||++.|++.
T Consensus 341 ~~---~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 341 CA---PSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred CC---CHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 11 22478999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=313.24 Aligned_cols=230 Identities=22% Similarity=0.312 Sum_probs=185.9
Q ss_pred HhhcCcccceeeeecCceEEEEEEe-CCCcEEEEEecc---------------------------CCccccceEEEecCc
Q 042435 140 DATEYFHIRYCIGTGGYDSVYKAEL-PDGKVVALKKLH---------------------------HSETEDSAFVVYSPQ 191 (412)
Q Consensus 140 ~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l~---------------------------~~~~~~~~~~~~~~~ 191 (412)
...+.|.+.+.||+|+||+|+.|.. .+++.||+|.++ |+++.+...+.....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 4456899999999999999999965 568999999532 556666666777888
Q ss_pred eEEEEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCC-CcEEEeecCC
Q 042435 192 CMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSN-LEAFVADFGT 270 (412)
Q Consensus 192 ~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~-~~~kl~DfGl 270 (412)
..++||||+.+|+|.+++.... .+......+++.|++.|++|+|++ +|+||||||+|||+|.+ +++||+|||+
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~~g---~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~DFG~ 167 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVNKG---RLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSDFGL 167 (370)
T ss_pred eEEEEEEecCCccHHHHHHHcC---CCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEecccc
Confidence 8999999999999999998743 588899999999999999999999 99999999999999999 9999999999
Q ss_pred ccccCCCCCCcccccccccccccccccCcc-cC-cccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhcc
Q 042435 271 VRLLDVDSSNRTLQAGTYGYIALELVYTMV-VT-EKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRL 348 (412)
Q Consensus 271 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s-~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 348 (412)
+.............+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||+.. ........+.....
T Consensus 168 s~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~-------~~~~l~~ki~~~~~ 240 (370)
T KOG0583|consen 168 SAISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDS-------NVPNLYRKIRKGEF 240 (370)
T ss_pred ccccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCc-------cHHHHHHHHhcCCc
Confidence 997743344456679999999999999877 76 6899999999999999999999841 11111122222222
Q ss_pred CCccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHH
Q 042435 349 SPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQ 386 (412)
Q Consensus 349 ~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~ 386 (412)
.-+ .... ...+..++.+|+..||.+|+|+.|+++
T Consensus 241 ~~p--~~~~--S~~~~~Li~~mL~~~P~~R~t~~~i~~ 274 (370)
T KOG0583|consen 241 KIP--SYLL--SPEARSLIEKMLVPDPSTRITLLEILE 274 (370)
T ss_pred cCC--CCcC--CHHHHHHHHHHcCCCcccCCCHHHHhh
Confidence 221 1110 334788999999999999999999993
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=305.65 Aligned_cols=231 Identities=20% Similarity=0.255 Sum_probs=175.9
Q ss_pred CcccceeeeecCceEEEEEEe-CCCcEEEEEecc------------------------CCccccceEEEecCceEEEEEE
Q 042435 144 YFHIRYCIGTGGYDSVYKAEL-PDGKVVALKKLH------------------------HSETEDSAFVVYSPQCMFFIYE 198 (412)
Q Consensus 144 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l~------------------------~~~~~~~~~~~~~~~~~~lv~e 198 (412)
.|+..+.||+|+||.||+|.. .+|+.||+|.+. |+++......+...+..++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 377889999999999999976 579999999753 3333333344667788999999
Q ss_pred eccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCC
Q 042435 199 YMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDS 278 (412)
Q Consensus 199 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~ 278 (412)
|+++|+|.+++..... ..+++..+..++.|++.||+|||+. +|+||||||+|||+++++.++|+|||+++......
T Consensus 81 ~~~~g~L~~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05631 81 IMNGGDLKFHIYNMGN-PGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE 156 (285)
T ss_pred ecCCCcHHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC
Confidence 9999999877754322 2488999999999999999999998 99999999999999999999999999998653322
Q ss_pred CCcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccchhhHH
Q 042435 279 SNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKIIQ 358 (412)
Q Consensus 279 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 358 (412)
......||..|+|||++.+..++.++|||||||++|||++|+.||.... ... ..+.+..............
T Consensus 157 -~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~-------~~~-~~~~~~~~~~~~~~~~~~~ 227 (285)
T cd05631 157 -TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRK-------ERV-KREEVDRRVKEDQEEYSEK 227 (285)
T ss_pred -eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCC-------cch-hHHHHHHHhhcccccCCcc
Confidence 2233468999999999999999999999999999999999999987321 100 1111111111100000111
Q ss_pred HHHHHHHHHHhcCcCCCCCCCC-----HHHHHHH
Q 042435 359 DIILVSTIALACLRSKPKSRPT-----MQRISQE 387 (412)
Q Consensus 359 ~~~~~~~l~~~Cl~~dP~~RPs-----~~evl~~ 387 (412)
....+.+++.+||+.||++||+ +++++++
T Consensus 228 ~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 228 FSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred CCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence 1234788999999999999997 8888875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-40 Score=313.33 Aligned_cols=229 Identities=25% Similarity=0.363 Sum_probs=180.9
Q ss_pred hhcCcccceeeeecCceEEEEEEe-CCCcEEEEEeccCCc------------------------cccceEEEecCceEEE
Q 042435 141 ATEYFHIRYCIGTGGYDSVYKAEL-PDGKVVALKKLHHSE------------------------TEDSAFVVYSPQCMFF 195 (412)
Q Consensus 141 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l~~~~------------------------~~~~~~~~~~~~~~~l 195 (412)
..++|++...||+|+||.||.|+- .+|+.+|+|+|+.+. ++.....+++.+.+||
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence 567899999999999999999966 469999999986543 2333344788999999
Q ss_pred EEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccC
Q 042435 196 IYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLD 275 (412)
Q Consensus 196 v~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~ 275 (412)
||||+|||++..+|...+ .|+......++.+++.|++-||+. |++||||||+|+|||..|++||+|||+++-+.
T Consensus 219 iMEylPGGD~mTLL~~~~---~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~ 292 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLLMRKD---TLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLD 292 (550)
T ss_pred EEEecCCccHHHHHHhcC---cCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccccccchhh
Confidence 999999999999998765 588888888999999999999999 99999999999999999999999999985331
Q ss_pred C-----------------------CCC----Cc--------------------ccccccccccccccccCcccCcccccH
Q 042435 276 V-----------------------DSS----NR--------------------TLQAGTYGYIALELVYTMVVTEKCVIY 308 (412)
Q Consensus 276 ~-----------------------~~~----~~--------------------~~~~gt~~y~aPE~~~~~~~s~ksDv~ 308 (412)
. +.. .. ...+|||.|||||++.+..|+..+|.|
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwW 372 (550)
T KOG0605|consen 293 KKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWW 372 (550)
T ss_pred hhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHH
Confidence 1 000 00 123699999999999999999999999
Q ss_pred HHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhc--cCCccchhhHHHHHHHHHHHHhcCcCCCCCCCC---HHH
Q 042435 309 SFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQR--LSPPINQKIIQDIILVSTIALACLRSKPKSRPT---MQR 383 (412)
Q Consensus 309 S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs---~~e 383 (412)
|+|||+|||+.|.+||. +..+......++.-+ +..|...... ....+|+.+|+. ||++|-. ++|
T Consensus 373 SLG~ImyEmLvGyPPF~-------s~tp~~T~rkI~nwr~~l~fP~~~~~s---~eA~DLI~rll~-d~~~RLG~~G~~E 441 (550)
T KOG0605|consen 373 SLGCIMYEMLVGYPPFC-------SETPQETYRKIVNWRETLKFPEEVDLS---DEAKDLITRLLC-DPENRLGSKGAEE 441 (550)
T ss_pred HHHHHHHHHHhCCCCCC-------CCCHHHHHHHHHHHhhhccCCCcCccc---HHHHHHHHHHhc-CHHHhcCcccHHH
Confidence 99999999999999998 233334444444332 3332222222 348899999999 9999964 666
Q ss_pred HHH
Q 042435 384 ISQ 386 (412)
Q Consensus 384 vl~ 386 (412)
|-+
T Consensus 442 IK~ 444 (550)
T KOG0605|consen 442 IKK 444 (550)
T ss_pred Hhc
Confidence 544
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=316.40 Aligned_cols=240 Identities=22% Similarity=0.319 Sum_probs=184.0
Q ss_pred HHhhcCcccceeeeecCceEEEEEEe------CCCcEEEEEec-----------------------cCCccccceEEEec
Q 042435 139 IDATEYFHIRYCIGTGGYDSVYKAEL------PDGKVVALKKL-----------------------HHSETEDSAFVVYS 189 (412)
Q Consensus 139 ~~~~~~f~~~~~lG~G~~g~Vy~~~~------~~~~~vAvK~l-----------------------~~~~~~~~~~~~~~ 189 (412)
.-..++|++.+.||+|+||.||+|.. .+++.||+|++ +|+++......+..
T Consensus 34 ~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~ 113 (374)
T cd05106 34 EFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTH 113 (374)
T ss_pred cccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecC
Confidence 34456799999999999999999864 23468999965 35556666666778
Q ss_pred CceEEEEEEeccCCceeeeeccCcc-------------------------------------------------------
Q 042435 190 PQCMFFIYEYMERGSLFCVLRDDDE------------------------------------------------------- 214 (412)
Q Consensus 190 ~~~~~lv~ey~~~gsL~~~l~~~~~------------------------------------------------------- 214 (412)
.+..++||||+++|+|.++++....
T Consensus 114 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (374)
T cd05106 114 GGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQ 193 (374)
T ss_pred CCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccc
Confidence 8899999999999999888753210
Q ss_pred ------------cccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCCCC--
Q 042435 215 ------------AIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSN-- 280 (412)
Q Consensus 215 ------------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~-- 280 (412)
...+++.+..+++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+++........
T Consensus 194 ~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~ 270 (374)
T cd05106 194 SSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVV 270 (374)
T ss_pred cccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceee
Confidence 12478899999999999999999998 9999999999999999999999999999765432211
Q ss_pred cccccccccccccccccCcccCcccccHHHHHHHHHHHh-CCCCcccccccccCCCCcchhhHHhhhccCCccchhhHHH
Q 042435 281 RTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLM-GTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKIIQD 359 (412)
Q Consensus 281 ~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 359 (412)
.....++..|+|||++.+..++.++|||||||++|||++ |+.||.... .................+...
T Consensus 271 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~-------~~~~~~~~~~~~~~~~~~~~~--- 340 (374)
T cd05106 271 KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGIL-------VNSKFYKMVKRGYQMSRPDFA--- 340 (374)
T ss_pred ccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCcccc-------ccHHHHHHHHcccCccCCCCC---
Confidence 122335678999999988899999999999999999997 999987321 111122222222222111111
Q ss_pred HHHHHHHHHhcCcCCCCCCCCHHHHHHHHhcC
Q 042435 360 IILVSTIALACLRSKPKSRPTMQRISQELEGK 391 (412)
Q Consensus 360 ~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 391 (412)
...+.+++.+||+.||++|||+.++++.|+++
T Consensus 341 ~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~ 372 (374)
T cd05106 341 PPEIYSIMKMCWNLEPTERPTFSQISQLIQRQ 372 (374)
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 23478899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=312.04 Aligned_cols=228 Identities=26% Similarity=0.370 Sum_probs=183.0
Q ss_pred cCcccceeeeecCceEEEEEEe-CCCcEEEEEeccCC----------------------ccccceEEEecCceEEEEEEe
Q 042435 143 EYFHIRYCIGTGGYDSVYKAEL-PDGKVVALKKLHHS----------------------ETEDSAFVVYSPQCMFFIYEY 199 (412)
Q Consensus 143 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l~~~----------------------~~~~~~~~~~~~~~~~lv~ey 199 (412)
..|...++||+|+||.||||.. ..++.||+|.++.. ++...+..+..+..++++|||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 4466678999999999999965 57999999987543 233333345567778999999
Q ss_pred ccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCCC
Q 042435 200 MERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSS 279 (412)
Q Consensus 200 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 279 (412)
|.+|++.+.++... .++.....-+++++..||.|||++ +.+|||||+.|||+..++.+|++|||++-.+.....
T Consensus 93 ~~gGsv~~lL~~~~---~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~ 166 (467)
T KOG0201|consen 93 CGGGSVLDLLKSGN---ILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK 166 (467)
T ss_pred hcCcchhhhhccCC---CCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeeechhh
Confidence 99999999998664 346667777899999999999999 999999999999999999999999999988877666
Q ss_pred CcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccchhhHHH
Q 042435 280 NRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKIIQD 359 (412)
Q Consensus 280 ~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 359 (412)
......||+.|||||++.+..|+.|+||||||++.+||.+|.+|+.... +... .-.+.+..+|.. .. ..
T Consensus 167 rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~h-------Pmrv-lflIpk~~PP~L-~~--~~ 235 (467)
T KOG0201|consen 167 RRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLH-------PMRV-LFLIPKSAPPRL-DG--DF 235 (467)
T ss_pred ccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccC-------cceE-EEeccCCCCCcc-cc--cc
Confidence 6677899999999999998899999999999999999999999987432 1111 111112222211 11 33
Q ss_pred HHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 360 IILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 360 ~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
...+.+++..|++.||+.||++.+++++
T Consensus 236 S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 236 SPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred CHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 4458899999999999999999999876
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=309.44 Aligned_cols=221 Identities=22% Similarity=0.286 Sum_probs=176.6
Q ss_pred eeeeecCceEEEEEEe-CCCcEEEEEec------------------------cCCccccceEEEecCceEEEEEEeccCC
Q 042435 149 YCIGTGGYDSVYKAEL-PDGKVVALKKL------------------------HHSETEDSAFVVYSPQCMFFIYEYMERG 203 (412)
Q Consensus 149 ~~lG~G~~g~Vy~~~~-~~~~~vAvK~l------------------------~~~~~~~~~~~~~~~~~~~lv~ey~~~g 203 (412)
+.||+|+||.||++.. .+|+.||+|.+ +|+++......+...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 3699999999999976 57899999964 4566666667788889999999999999
Q ss_pred ceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCCCCccc
Q 042435 204 SLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTL 283 (412)
Q Consensus 204 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 283 (412)
+|.+++.... .+++.....++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++...........
T Consensus 81 ~L~~~l~~~~---~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~ 154 (323)
T cd05571 81 ELFFHLSRER---VFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKT 154 (323)
T ss_pred cHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccc
Confidence 9988886543 589999999999999999999998 9999999999999999999999999999754333333344
Q ss_pred ccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccchhhHHHHHHH
Q 042435 284 QAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKIIQDIILV 363 (412)
Q Consensus 284 ~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 363 (412)
..||+.|+|||++.+..++.++|||||||++|||++|+.||... ........+....... +.. ....+
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~-------~~~~~~~~~~~~~~~~--p~~---~~~~~ 222 (323)
T cd05571 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ-------DHEKLFELILMEEIRF--PRT---LSPEA 222 (323)
T ss_pred eecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCC-------CHHHHHHHHHcCCCCC--CCC---CCHHH
Confidence 57999999999999999999999999999999999999998621 1111111111111111 111 12237
Q ss_pred HHHHHhcCcCCCCCCC-----CHHHHHHH
Q 042435 364 STIALACLRSKPKSRP-----TMQRISQE 387 (412)
Q Consensus 364 ~~l~~~Cl~~dP~~RP-----s~~evl~~ 387 (412)
.+++.+||+.||++|| ++.+++++
T Consensus 223 ~~li~~~L~~dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 223 KSLLAGLLKKDPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred HHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence 8899999999999999 79998764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-39 Score=301.85 Aligned_cols=225 Identities=20% Similarity=0.251 Sum_probs=176.1
Q ss_pred eeeeecCceEEEEEEeCCCcEEEEEecc------------------------CCccccceEEEec----CceEEEEEEec
Q 042435 149 YCIGTGGYDSVYKAELPDGKVVALKKLH------------------------HSETEDSAFVVYS----PQCMFFIYEYM 200 (412)
Q Consensus 149 ~~lG~G~~g~Vy~~~~~~~~~vAvK~l~------------------------~~~~~~~~~~~~~----~~~~~lv~ey~ 200 (412)
..||+|++|.||+|.+ +|+.||||+++ |+++....+.+.+ ....++||||+
T Consensus 26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~ 104 (283)
T PHA02988 26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104 (283)
T ss_pred eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence 6799999999999998 78999999764 4444444444444 35689999999
Q ss_pred cCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCCCC
Q 042435 201 ERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSN 280 (412)
Q Consensus 201 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 280 (412)
++|+|.+++.... .++|.....++.+++.||+|||+.. +++||||||+||++++++.+||+|||+++......
T Consensus 105 ~~g~L~~~l~~~~---~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~-- 177 (283)
T PHA02988 105 TRGYLREVLDKEK---DLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP-- 177 (283)
T ss_pred CCCcHHHHHhhCC---CCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCCCcEEEcccchHhhhcccc--
Confidence 9999999997654 5899999999999999999999732 67899999999999999999999999998653321
Q ss_pred cccccccccccccccccC--cccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccchhhHH
Q 042435 281 RTLQAGTYGYIALELVYT--MVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKIIQ 358 (412)
Q Consensus 281 ~~~~~gt~~y~aPE~~~~--~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 358 (412)
....|+..|+|||++.+ ..++.++|||||||++|||++|+.||... ........+.......+.+..
T Consensus 178 -~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~-------~~~~~~~~i~~~~~~~~~~~~--- 246 (283)
T PHA02988 178 -FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENL-------TTKEIYDLIINKNNSLKLPLD--- 246 (283)
T ss_pred -ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCC-------CHHHHHHHHHhcCCCCCCCCc---
Confidence 23467899999999876 67899999999999999999999999732 111111222222222222211
Q ss_pred HHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhcCC
Q 042435 359 DIILVSTIALACLRSKPKSRPTMQRISQELEGKT 392 (412)
Q Consensus 359 ~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 392 (412)
....+.+++.+||+.||++|||+.|+++.|+...
T Consensus 247 ~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 247 CPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred CcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 2234889999999999999999999999998754
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=337.94 Aligned_cols=239 Identities=25% Similarity=0.393 Sum_probs=194.2
Q ss_pred cCcccceeeeecCceEEEEEEeCC--Cc----EEEEEe----------------------ccCCccccceEEEecCceEE
Q 042435 143 EYFHIRYCIGTGGYDSVYKAELPD--GK----VVALKK----------------------LHHSETEDSAFVVYSPQCMF 194 (412)
Q Consensus 143 ~~f~~~~~lG~G~~g~Vy~~~~~~--~~----~vAvK~----------------------l~~~~~~~~~~~~~~~~~~~ 194 (412)
++.+..+.||+|.||.||+|.+.+ |. .||||. ++|+|+....++|.+....+
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~ 771 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPL 771 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcE
Confidence 445667899999999999997743 33 489995 47999999999999999999
Q ss_pred EEEEeccCCceeeeeccCcc----cccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCC
Q 042435 195 FIYEYMERGSLFCVLRDDDE----AIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGT 270 (412)
Q Consensus 195 lv~ey~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGl 270 (412)
+++|||++|||..+|++.+. ...++....+.++.|||+|+.||+++ +.|||||..+|+|+++...+||+|||+
T Consensus 772 i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIaDFGl 848 (1025)
T KOG1095|consen 772 ILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIADFGL 848 (1025)
T ss_pred EEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEcccch
Confidence 99999999999999998632 34588999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCCcccc--cccccccccccccCcccCcccccHHHHHHHHHHHh-CCCCcccccccccCCCCcchhhHHhhh-
Q 042435 271 VRLLDVDSSNRTLQ--AGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLM-GTHPGELLLSLSSSSGPKIMLIDILYQ- 346 (412)
Q Consensus 271 a~~~~~~~~~~~~~--~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~- 346 (412)
|+.+.......... .-...|||||.+..+.++.|+|||||||++||++| |..||... .....+..+...
T Consensus 849 ArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~-------~n~~v~~~~~~gg 921 (1025)
T KOG1095|consen 849 ARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSR-------SNFEVLLDVLEGG 921 (1025)
T ss_pred hHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCc-------chHHHHHHHHhCC
Confidence 99554433332222 23468999999999999999999999999999999 88998732 222333334333
Q ss_pred ccCCccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhcCCCCCC
Q 042435 347 RLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELEGKTPMKK 396 (412)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~~~ 396 (412)
++.+ +..+++ .+.+++..||+.+|++||++.++++.++.+.....
T Consensus 922 RL~~--P~~CP~---~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~ 966 (1025)
T KOG1095|consen 922 RLDP--PSYCPE---KLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAAL 966 (1025)
T ss_pred ccCC--CCCCCh---HHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhc
Confidence 3333 233333 48899999999999999999999999988765443
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=298.13 Aligned_cols=233 Identities=21% Similarity=0.309 Sum_probs=182.5
Q ss_pred cCcccceeeeecCceEEEEEEeC----CCcEEEEEec----------------------cCCccccceEEEecCceEEEE
Q 042435 143 EYFHIRYCIGTGGYDSVYKAELP----DGKVVALKKL----------------------HHSETEDSAFVVYSPQCMFFI 196 (412)
Q Consensus 143 ~~f~~~~~lG~G~~g~Vy~~~~~----~~~~vAvK~l----------------------~~~~~~~~~~~~~~~~~~~lv 196 (412)
++|++.+.||+|+||.||+|.+. .+..||+|.+ +|+++......+..++..++|
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 84 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV 84 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence 56888999999999999999753 4678999964 466777777777888899999
Q ss_pred EEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCC
Q 042435 197 YEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDV 276 (412)
Q Consensus 197 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~ 276 (412)
|||+++|+|.+++.... ..++|.+++.++.|++.||+|||+. +++||||||+||+++.++.++++|||.+.....
T Consensus 85 ~e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~ 159 (266)
T cd05064 85 TEYMSNGALDSFLRKHE--GQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKS 159 (266)
T ss_pred EEeCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCcccccccc
Confidence 99999999999887543 2589999999999999999999998 999999999999999999999999998765322
Q ss_pred CCCC-cccccccccccccccccCcccCcccccHHHHHHHHHHHh-CCCCcccccccccCCCCcchhhHHhhhccCCccch
Q 042435 277 DSSN-RTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLM-GTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQ 354 (412)
Q Consensus 277 ~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 354 (412)
.... .....++..|+|||.+.+..++.++|||||||++||+++ |+.||.... . ....+.+......+.+.
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~-------~-~~~~~~~~~~~~~~~~~ 231 (266)
T cd05064 160 EAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMS-------G-QDVIKAVEDGFRLPAPR 231 (266)
T ss_pred cchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCC-------H-HHHHHHHHCCCCCCCCC
Confidence 2111 112235678999999999999999999999999999775 999986321 1 11122222222222222
Q ss_pred hhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhcC
Q 042435 355 KIIQDIILVSTIALACLRSKPKSRPTMQRISQELEGK 391 (412)
Q Consensus 355 ~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 391 (412)
. ....+.+++.+||+.+|++||+++|+.+.|+++
T Consensus 232 ~---~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 232 N---CPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred C---CCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 2 223478899999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-40 Score=314.11 Aligned_cols=227 Identities=27% Similarity=0.358 Sum_probs=192.1
Q ss_pred cCcccceeeeecCceEEEEEEeC-CCcEEEEEe-----------------------ccCCccccceEEEecCceEEEEEE
Q 042435 143 EYFHIRYCIGTGGYDSVYKAELP-DGKVVALKK-----------------------LHHSETEDSAFVVYSPQCMFFIYE 198 (412)
Q Consensus 143 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~-----------------------l~~~~~~~~~~~~~~~~~~~lv~e 198 (412)
++|.+.+.||+|+||.||||+.+ +.+.||+|. ++|+|+......+.+..++|+|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 57888999999999999999664 689999994 478888888888999999999999
Q ss_pred eccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCC
Q 042435 199 YMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDS 278 (412)
Q Consensus 199 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~ 278 (412)
|+.+ +|+.+|.... .++..++..++.+++.||.|||++ +|+|||+||.|||++..+.+|+||||+|+.+..+.
T Consensus 82 ~a~g-~L~~il~~d~---~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t 154 (808)
T KOG0597|consen 82 YAVG-DLFTILEQDG---KLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT 154 (808)
T ss_pred hhhh-hHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhcccCc
Confidence 9976 9999998765 599999999999999999999999 99999999999999999999999999999988777
Q ss_pred CCcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccchhhHH
Q 042435 279 SNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKIIQ 358 (412)
Q Consensus 279 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 358 (412)
...+...||+.|||||...+..|+..+|.||+||++||+++|++||.... -......+......++. .
T Consensus 155 ~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~s-------i~~Lv~~I~~d~v~~p~-----~ 222 (808)
T KOG0597|consen 155 SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARS-------ITQLVKSILKDPVKPPS-----T 222 (808)
T ss_pred eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHH-------HHHHHHHHhcCCCCCcc-----c
Confidence 77788899999999999999999999999999999999999999987210 00111122222222221 2
Q ss_pred HHHHHHHHHHhcCcCCCCCCCCHHHHHHHH
Q 042435 359 DIILVSTIALACLRSKPKSRPTMQRISQEL 388 (412)
Q Consensus 359 ~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L 388 (412)
....+..++...+.+||.+|.|..+++.+-
T Consensus 223 ~S~~f~nfl~gLL~kdP~~RltW~~Ll~Hp 252 (808)
T KOG0597|consen 223 ASSSFVNFLQGLLIKDPAQRLTWTDLLGHP 252 (808)
T ss_pred ccHHHHHHHHHHhhcChhhcccHHHHhcCh
Confidence 223478889999999999999999988763
|
|
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=307.04 Aligned_cols=226 Identities=22% Similarity=0.320 Sum_probs=176.2
Q ss_pred CcccceeeeecCceEEEEEEeC-CCcEEEEEeccC-------------------------CccccceEEEecCceEEEEE
Q 042435 144 YFHIRYCIGTGGYDSVYKAELP-DGKVVALKKLHH-------------------------SETEDSAFVVYSPQCMFFIY 197 (412)
Q Consensus 144 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~-------------------------~~~~~~~~~~~~~~~~~lv~ 197 (412)
+|++.+.||+|+||.||+|... +++.||+|.++. +++......+...+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 5788999999999999999765 578999997642 22223334466778899999
Q ss_pred EeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCC
Q 042435 198 EYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVD 277 (412)
Q Consensus 198 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~ 277 (412)
||+++|+|.+++.... .+++.++..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 81 E~~~~g~L~~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~ 154 (323)
T cd05616 81 EYVNGGDLMYQIQQVG---RFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD 154 (323)
T ss_pred cCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCceecCCC
Confidence 9999999988886543 488999999999999999999998 9999999999999999999999999999754333
Q ss_pred CCCcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccchhhH
Q 042435 278 SSNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKII 357 (412)
Q Consensus 278 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 357 (412)
........||+.|+|||++.+..++.++|||||||++|||+||+.||... ........+.......+ ...
T Consensus 155 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~-------~~~~~~~~i~~~~~~~p--~~~- 224 (323)
T cd05616 155 GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE-------DEDELFQSIMEHNVAYP--KSM- 224 (323)
T ss_pred CCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCC-------CHHHHHHHHHhCCCCCC--CcC-
Confidence 33334557899999999999999999999999999999999999998732 11111222222222111 111
Q ss_pred HHHHHHHHHHHhcCcCCCCCCCCH-----HHHHHH
Q 042435 358 QDIILVSTIALACLRSKPKSRPTM-----QRISQE 387 (412)
Q Consensus 358 ~~~~~~~~l~~~Cl~~dP~~RPs~-----~evl~~ 387 (412)
...+.+++.+|++.||++|++. .++.++
T Consensus 225 --s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h 257 (323)
T cd05616 225 --SKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 257 (323)
T ss_pred --CHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcC
Confidence 2237789999999999999974 566543
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-39 Score=281.61 Aligned_cols=239 Identities=24% Similarity=0.303 Sum_probs=185.1
Q ss_pred cCcccceeeeecCceEEEEEEe-CCCcEEEEEec-----------------------cCCccccceEEEecCceEEEEEE
Q 042435 143 EYFHIRYCIGTGGYDSVYKAEL-PDGKVVALKKL-----------------------HHSETEDSAFVVYSPQCMFFIYE 198 (412)
Q Consensus 143 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l-----------------------~~~~~~~~~~~~~~~~~~~lv~e 198 (412)
++|...+++|+|.||.||+|+. .+|+.||||++ +|+++.....++...+.+-||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 3577788999999999999954 68999999976 45666666667788889999999
Q ss_pred eccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCC
Q 042435 199 YMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDS 278 (412)
Q Consensus 199 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~ 278 (412)
||+. +|+..+++.. ..++..++..++.++.+|++|||++ .|+||||||.|+|+++++.+||+|||+|+.+....
T Consensus 82 fm~t-dLe~vIkd~~--i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~ 155 (318)
T KOG0659|consen 82 FMPT-DLEVVIKDKN--IILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN 155 (318)
T ss_pred eccc-cHHHHhcccc--cccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhccCCCC
Confidence 9975 9999998765 4688999999999999999999999 99999999999999999999999999999987766
Q ss_pred CCcccccccccccccccccCc-ccCcccccHHHHHHHHHHHhCCCCccccccc-------------ccCCCCc-chhhHH
Q 042435 279 SNRTLQAGTYGYIALELVYTM-VVTEKCVIYSFGVVALEVLMGTHPGELLLSL-------------SSSSGPK-IMLIDI 343 (412)
Q Consensus 279 ~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~S~Gvil~elltg~~P~~~~~~~-------------~~~~~~~-~~~~~~ 343 (412)
......+-|.+|+|||.+.+. .|+...||||.|||+.||+-|.+-|.....+ ....+++ ..+.+.
T Consensus 156 ~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY 235 (318)
T KOG0659|consen 156 RIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDY 235 (318)
T ss_pred cccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccH
Confidence 666666889999999998765 5999999999999999999887655421111 0011111 111121
Q ss_pred hhhc-cCC-ccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 344 LYQR-LSP-PINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 344 ~~~~-~~~-~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
..-. .+. +...-.......+.+++..++..||.+|+|+.|++++
T Consensus 236 ~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 236 VKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred HHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 1111 111 1111122223347899999999999999999999876
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-39 Score=303.15 Aligned_cols=224 Identities=22% Similarity=0.297 Sum_probs=179.4
Q ss_pred cCcccceeeeecCceEEEEEEeC-CCcEEEEEec------------------------cCCccccceEEEecCceEEEEE
Q 042435 143 EYFHIRYCIGTGGYDSVYKAELP-DGKVVALKKL------------------------HHSETEDSAFVVYSPQCMFFIY 197 (412)
Q Consensus 143 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l------------------------~~~~~~~~~~~~~~~~~~~lv~ 197 (412)
++|++.+.||+|+||.||+|... +++.||+|.+ +|+++......+.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 46889999999999999999775 6899999975 3455555555566778899999
Q ss_pred EeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCC
Q 042435 198 EYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVD 277 (412)
Q Consensus 198 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~ 277 (412)
||+++|+|.+++.... .+++.....++.|++.||+|||++ +++||||||+|||++.++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~ 154 (291)
T cd05612 81 EYVPGGELFSYLRNSG---RFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR 154 (291)
T ss_pred eCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchhccCC
Confidence 9999999999887654 588999999999999999999998 9999999999999999999999999999865432
Q ss_pred CCCcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccchhhH
Q 042435 278 SSNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKII 357 (412)
Q Consensus 278 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 357 (412)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||... ........+.......+ ...
T Consensus 155 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~-------~~~~~~~~i~~~~~~~~--~~~- 221 (291)
T cd05612 155 ---TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDD-------NPFGIYEKILAGKLEFP--RHL- 221 (291)
T ss_pred ---cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-------CHHHHHHHHHhCCcCCC--ccC-
Confidence 22346899999999999888999999999999999999999998632 11111222222222111 111
Q ss_pred HHHHHHHHHHHhcCcCCCCCCCC-----HHHHHHH
Q 042435 358 QDIILVSTIALACLRSKPKSRPT-----MQRISQE 387 (412)
Q Consensus 358 ~~~~~~~~l~~~Cl~~dP~~RPs-----~~evl~~ 387 (412)
...+.+++.+||+.||.+||+ ++|++++
T Consensus 222 --~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 222 --DLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred --CHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 223788999999999999995 8888876
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=308.12 Aligned_cols=229 Identities=19% Similarity=0.278 Sum_probs=182.0
Q ss_pred cCcccceeeeecCceEEEEEEeC-CCcEEEEEec------------------------cCCccccceEEEecCceEEEEE
Q 042435 143 EYFHIRYCIGTGGYDSVYKAELP-DGKVVALKKL------------------------HHSETEDSAFVVYSPQCMFFIY 197 (412)
Q Consensus 143 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l------------------------~~~~~~~~~~~~~~~~~~~lv~ 197 (412)
++|++.+.||+|+||.||+|... +++.||+|.+ +|+++......+...+..++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 46899999999999999999875 5899999965 3566666677788889999999
Q ss_pred EeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCC
Q 042435 198 EYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVD 277 (412)
Q Consensus 198 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~ 277 (412)
||+++|+|.+++.... .+++.....++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 81 e~~~g~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~- 153 (333)
T cd05600 81 EYVPGGDFRTLLNNLG---VLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT- 153 (333)
T ss_pred eCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCccccc-
Confidence 9999999999987543 588999999999999999999998 999999999999999999999999999976543
Q ss_pred CCCcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhh--hccCCccch-
Q 042435 278 SSNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILY--QRLSPPINQ- 354 (412)
Q Consensus 278 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~- 354 (412)
......||+.|+|||++.+..++.++|||||||++|||++|+.||.... .......+.. .....+...
T Consensus 154 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~-------~~~~~~~i~~~~~~~~~~~~~~ 224 (333)
T cd05600 154 --YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGST-------PNETWENLKYWKETLQRPVYDD 224 (333)
T ss_pred --ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCC-------HHHHHHHHHhccccccCCCCCc
Confidence 2234578999999999998899999999999999999999999986321 1111111111 011111100
Q ss_pred hhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 355 KIIQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 355 ~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
........+.+++.+||..+|++||++.|++++
T Consensus 225 ~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 225 PRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred cccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 001112347889999999999999999999976
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=305.78 Aligned_cols=226 Identities=21% Similarity=0.308 Sum_probs=175.0
Q ss_pred CcccceeeeecCceEEEEEEeC-CCcEEEEEeccCC-------------------------ccccceEEEecCceEEEEE
Q 042435 144 YFHIRYCIGTGGYDSVYKAELP-DGKVVALKKLHHS-------------------------ETEDSAFVVYSPQCMFFIY 197 (412)
Q Consensus 144 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~-------------------------~~~~~~~~~~~~~~~~lv~ 197 (412)
+|++.+.||+|+||.||+|... +++.||+|.++.. .+......+...+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 5788999999999999999775 5789999976421 1222333456678899999
Q ss_pred EeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCC
Q 042435 198 EYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVD 277 (412)
Q Consensus 198 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~ 277 (412)
||+++|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 81 E~~~~g~L~~~~~~~~---~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05587 81 EYVNGGDLMYHIQQVG---KFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG 154 (324)
T ss_pred cCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCcceecCCC
Confidence 9999999998886543 488999999999999999999998 9999999999999999999999999998754333
Q ss_pred CCCcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccchhhH
Q 042435 278 SSNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKII 357 (412)
Q Consensus 278 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 357 (412)
........||+.|+|||++.+..++.++|||||||++|||+||+.||... ........+....... +...
T Consensus 155 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~-------~~~~~~~~i~~~~~~~--~~~~- 224 (324)
T cd05587 155 GKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGE-------DEDELFQSIMEHNVSY--PKSL- 224 (324)
T ss_pred CCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCC-------CHHHHHHHHHcCCCCC--CCCC-
Confidence 33334457999999999999999999999999999999999999998632 1111122222221111 1111
Q ss_pred HHHHHHHHHHHhcCcCCCCCCCCH-----HHHHHH
Q 042435 358 QDIILVSTIALACLRSKPKSRPTM-----QRISQE 387 (412)
Q Consensus 358 ~~~~~~~~l~~~Cl~~dP~~RPs~-----~evl~~ 387 (412)
...+.+++.+||+.||++||+. .++.++
T Consensus 225 --~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 257 (324)
T cd05587 225 --SKEAVSICKGLLTKHPAKRLGCGPTGERDIREH 257 (324)
T ss_pred --CHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 2237789999999999999976 566544
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=304.08 Aligned_cols=238 Identities=21% Similarity=0.275 Sum_probs=176.7
Q ss_pred cCcccceeeeecCceEEEEEEeCC-----------------CcEEEEEec----------------------cCCccccc
Q 042435 143 EYFHIRYCIGTGGYDSVYKAELPD-----------------GKVVALKKL----------------------HHSETEDS 183 (412)
Q Consensus 143 ~~f~~~~~lG~G~~g~Vy~~~~~~-----------------~~~vAvK~l----------------------~~~~~~~~ 183 (412)
++|.+.++||+|+||.||+|.+.+ +..||+|.+ +|+++...
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 468888999999999999997532 347999965 35566666
Q ss_pred eEEEecCceEEEEEEeccCCceeeeeccCc----------------ccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEE
Q 042435 184 AFVVYSPQCMFFIYEYMERGSLFCVLRDDD----------------EAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVH 247 (412)
Q Consensus 184 ~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~----------------~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH 247 (412)
...+...+..++||||+++|+|.+++.... ....++|..+.+++.|++.||+|||+. +|+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~ivH 161 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFVH 161 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---Cccc
Confidence 666777888999999999999998875421 112478899999999999999999998 9999
Q ss_pred eCCCCCCEEecCCCcEEEeecCCccccCCCCCC--cccccccccccccccccCcccCcccccHHHHHHHHHHHh--CCCC
Q 042435 248 RDISSNNILLNSNLEAFVADFGTVRLLDVDSSN--RTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLM--GTHP 323 (412)
Q Consensus 248 rDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~ellt--g~~P 323 (412)
|||||+|||++.++.+||+|||+++........ .....++..|+|||++.+..++.++||||||+++|||++ +..|
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p 241 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP 241 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence 999999999999999999999999865432211 123345788999999988889999999999999999987 5567
Q ss_pred cccccccccCCCCcchhh---HHhhhccCCccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhc
Q 042435 324 GELLLSLSSSSGPKIMLI---DILYQRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELEG 390 (412)
Q Consensus 324 ~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~ 390 (412)
|.... ...... .....................+.+++.+||+.||++|||+.||.+.|++
T Consensus 242 ~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 242 YGELT-------DEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred CCcCC-------HHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 65321 111111 1111100000000000112347899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=294.48 Aligned_cols=234 Identities=23% Similarity=0.362 Sum_probs=183.7
Q ss_pred cCcccceeeeecCceEEEEEEeCCCcEEEEEecc--------------------CCccccceEEEecCceEEEEEEeccC
Q 042435 143 EYFHIRYCIGTGGYDSVYKAELPDGKVVALKKLH--------------------HSETEDSAFVVYSPQCMFFIYEYMER 202 (412)
Q Consensus 143 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~l~--------------------~~~~~~~~~~~~~~~~~~lv~ey~~~ 202 (412)
++|++.++||+|+||.||+|...+++.||+|.+. |+++......+...+..+++|||+++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 85 (261)
T cd05072 6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAK 85 (261)
T ss_pred HHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCchhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCCC
Confidence 5688899999999999999998888899999653 45555555566777889999999999
Q ss_pred CceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCCCC-c
Q 042435 203 GSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSN-R 281 (412)
Q Consensus 203 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~-~ 281 (412)
|+|.++++.... ..+++.+++.++.|++.||+|||+. +++||||||+||+++.++.++|+|||+++........ .
T Consensus 86 ~~L~~~l~~~~~-~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~ 161 (261)
T cd05072 86 GSLLDFLKSDEG-GKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAR 161 (261)
T ss_pred CcHHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceecCCCceecc
Confidence 999998865432 2588999999999999999999998 9999999999999999999999999999865432211 1
Q ss_pred ccccccccccccccccCcccCcccccHHHHHHHHHHHh-CCCCcccccccccCCCCcchhhHHhhhccCCccchhhHHHH
Q 042435 282 TLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLM-GTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKIIQDI 360 (412)
Q Consensus 282 ~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 360 (412)
....++..|+|||+.....++.++||||||+++|||+| |+.||... .. ......+......+.... ..
T Consensus 162 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~-------~~-~~~~~~~~~~~~~~~~~~---~~ 230 (261)
T cd05072 162 EGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGM-------SN-SDVMSALQRGYRMPRMEN---CP 230 (261)
T ss_pred CCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCC-------CH-HHHHHHHHcCCCCCCCCC---CC
Confidence 22345678999999988889999999999999999998 99998621 11 111122222211111111 22
Q ss_pred HHHHHHHHhcCcCCCCCCCCHHHHHHHHhcC
Q 042435 361 ILVSTIALACLRSKPKSRPTMQRISQELEGK 391 (412)
Q Consensus 361 ~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 391 (412)
..+.+++.+||+.+|++||+++++.+.|++.
T Consensus 231 ~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 231 DELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred HHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 3478899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=292.59 Aligned_cols=231 Identities=22% Similarity=0.330 Sum_probs=181.4
Q ss_pred cCcccceeeeecCceEEEEEEeCCCcEEEEEec--------------------cCCccccceEEEecCceEEEEEEeccC
Q 042435 143 EYFHIRYCIGTGGYDSVYKAELPDGKVVALKKL--------------------HHSETEDSAFVVYSPQCMFFIYEYMER 202 (412)
Q Consensus 143 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~l--------------------~~~~~~~~~~~~~~~~~~~lv~ey~~~ 202 (412)
++|++.+.||+|+||.||++.+.++..+|+|.+ +|+++......+...+..++||||+++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~ 83 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMEN 83 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCC
Confidence 458888999999999999999988889999964 455666666667788889999999999
Q ss_pred CceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCCCC-c
Q 042435 203 GSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSN-R 281 (412)
Q Consensus 203 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~-~ 281 (412)
|+|.++++.... .++|..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||.++........ .
T Consensus 84 ~~L~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~ 158 (256)
T cd05114 84 GCLLNYLRQRQG--KLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSS 158 (256)
T ss_pred CcHHHHHHhCcc--CCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccCCCceecc
Confidence 999998875432 489999999999999999999998 9999999999999999999999999998765322211 1
Q ss_pred ccccccccccccccccCcccCcccccHHHHHHHHHHHh-CCCCcccccccccCCCCcchhhHHhhhccCCccchhhHHHH
Q 042435 282 TLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLM-GTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKIIQDI 360 (412)
Q Consensus 282 ~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 360 (412)
....++..|+|||++.+..++.++||||||+++|||++ |+.||.... . ......+........+.. ..
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~-------~-~~~~~~i~~~~~~~~~~~---~~ 227 (256)
T cd05114 159 SGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKS-------N-YEVVEMISRGFRLYRPKL---AS 227 (256)
T ss_pred CCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCC-------H-HHHHHHHHCCCCCCCCCC---CC
Confidence 22235668999999988889999999999999999999 899986321 1 111111211111111111 12
Q ss_pred HHHHHHHHhcCcCCCCCCCCHHHHHHHHh
Q 042435 361 ILVSTIALACLRSKPKSRPTMQRISQELE 389 (412)
Q Consensus 361 ~~~~~l~~~Cl~~dP~~RPs~~evl~~L~ 389 (412)
..+.+++.+||+.+|++||+++|+++.|.
T Consensus 228 ~~~~~li~~c~~~~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 228 MTVYEVMYSCWHEKPEGRPTFAELLRAIT 256 (256)
T ss_pred HHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 34789999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=305.93 Aligned_cols=224 Identities=22% Similarity=0.287 Sum_probs=181.3
Q ss_pred cCcccceeeeecCceEEEEEEeC-CCcEEEEEec------------------------cCCccccceEEEecCceEEEEE
Q 042435 143 EYFHIRYCIGTGGYDSVYKAELP-DGKVVALKKL------------------------HHSETEDSAFVVYSPQCMFFIY 197 (412)
Q Consensus 143 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l------------------------~~~~~~~~~~~~~~~~~~~lv~ 197 (412)
++|++.+.||+|+||.||+|... +++.||+|.+ +|+++......+..++..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 57899999999999999999875 6899999954 4677777777788889999999
Q ss_pred EeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCC
Q 042435 198 EYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVD 277 (412)
Q Consensus 198 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~ 277 (412)
||+++|+|.+++.... .+++.....++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 98 e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 171 (329)
T PTZ00263 98 EFVVGGELFTHLRKAG---RFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR 171 (329)
T ss_pred cCCCCChHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceEcCCC
Confidence 9999999999887643 478888899999999999999998 9999999999999999999999999999865432
Q ss_pred CCCcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccchhhH
Q 042435 278 SSNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKII 357 (412)
Q Consensus 278 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 357 (412)
. ....||+.|+|||++.+..++.++|||||||++|||++|+.||.... .......+.......+ ...
T Consensus 172 ~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~-------~~~~~~~i~~~~~~~p--~~~- 238 (329)
T PTZ00263 172 T---FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDT-------PFRIYEKILAGRLKFP--NWF- 238 (329)
T ss_pred c---ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCC-------HHHHHHHHhcCCcCCC--CCC-
Confidence 2 23478999999999999889999999999999999999999986321 1111122222222111 111
Q ss_pred HHHHHHHHHHHhcCcCCCCCCCC-----HHHHHHH
Q 042435 358 QDIILVSTIALACLRSKPKSRPT-----MQRISQE 387 (412)
Q Consensus 358 ~~~~~~~~l~~~Cl~~dP~~RPs-----~~evl~~ 387 (412)
...+.+++.+||+.||++||+ ++|++++
T Consensus 239 --~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 239 --DGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred --CHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 123778999999999999996 6888766
|
|
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=303.12 Aligned_cols=224 Identities=23% Similarity=0.315 Sum_probs=177.9
Q ss_pred cccceeeeecCceEEEEEEeC-CCcEEEEEec---------------------------cCCccccceEEEecCceEEEE
Q 042435 145 FHIRYCIGTGGYDSVYKAELP-DGKVVALKKL---------------------------HHSETEDSAFVVYSPQCMFFI 196 (412)
Q Consensus 145 f~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l---------------------------~~~~~~~~~~~~~~~~~~~lv 196 (412)
|++.+.||+|+||.||+|... +++.||||.+ +|+++......+...+..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 667899999999999999764 6899999965 255666666667788899999
Q ss_pred EEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCC
Q 042435 197 YEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDV 276 (412)
Q Consensus 197 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~ 276 (412)
|||+++|+|..+++.. .+++.....++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++....
T Consensus 81 ~E~~~~~~L~~~~~~~----~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05589 81 MEYAAGGDLMMHIHTD----VFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG 153 (324)
T ss_pred EcCCCCCcHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCccCCC
Confidence 9999999998877643 489999999999999999999998 999999999999999999999999999875433
Q ss_pred CCCCcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccchhh
Q 042435 277 DSSNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKI 356 (412)
Q Consensus 277 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 356 (412)
.........|++.|+|||.+.+..++.++|||||||++|||++|+.||... ........+.......+ ...
T Consensus 154 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~-------~~~~~~~~i~~~~~~~p--~~~ 224 (324)
T cd05589 154 FGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGD-------DEEEVFDSIVNDEVRYP--RFL 224 (324)
T ss_pred CCCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCC-------CHHHHHHHHHhCCCCCC--CCC
Confidence 333334567999999999999989999999999999999999999998632 11111122222211111 111
Q ss_pred HHHHHHHHHHHHhcCcCCCCCCC-----CHHHHHHH
Q 042435 357 IQDIILVSTIALACLRSKPKSRP-----TMQRISQE 387 (412)
Q Consensus 357 ~~~~~~~~~l~~~Cl~~dP~~RP-----s~~evl~~ 387 (412)
...+.+++.+||+.||++|| ++.+++++
T Consensus 225 ---~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~ 257 (324)
T cd05589 225 ---SREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ 257 (324)
T ss_pred ---CHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence 22377899999999999999 57777664
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=314.53 Aligned_cols=240 Identities=25% Similarity=0.352 Sum_probs=191.9
Q ss_pred hcCcccceeeeecCceEEEEEEeCC--C---cEEEEEe------------------------ccCCccccceEEEecCce
Q 042435 142 TEYFHIRYCIGTGGYDSVYKAELPD--G---KVVALKK------------------------LHHSETEDSAFVVYSPQC 192 (412)
Q Consensus 142 ~~~f~~~~~lG~G~~g~Vy~~~~~~--~---~~vAvK~------------------------l~~~~~~~~~~~~~~~~~ 192 (412)
-++-...++||+|+||+||+|.+.. + ..||||. ++|+|++...+++...+.
T Consensus 156 H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~P 235 (474)
T KOG0194|consen 156 HSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEP 235 (474)
T ss_pred ccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCc
Confidence 3444556899999999999997743 2 2389994 478999999999999999
Q ss_pred EEEEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCcc
Q 042435 193 MFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVR 272 (412)
Q Consensus 193 ~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~ 272 (412)
+++|||+|+||+|.++|+...+ .++..+++.++.+.|.||+|||++ +++||||..+|+|++.+..+||+|||+++
T Consensus 236 l~ivmEl~~gGsL~~~L~k~~~--~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vKISDFGLs~ 310 (474)
T KOG0194|consen 236 LMLVMELCNGGSLDDYLKKNKK--SLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVKISDFGLSR 310 (474)
T ss_pred cEEEEEecCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEEeCcccccc
Confidence 9999999999999999987754 489999999999999999999999 99999999999999999999999999987
Q ss_pred ccCCCCCCcccccccccccccccccCcccCcccccHHHHHHHHHHHh-CCCCcccccccccCCCCcchhhHHhhhccCCc
Q 042435 273 LLDVDSSNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLM-GTHPGELLLSLSSSSGPKIMLIDILYQRLSPP 351 (412)
Q Consensus 273 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 351 (412)
.-...........-...|+|||.+....|+.++|||||||++||+++ |..||..... ......+.....+.+
T Consensus 311 ~~~~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~-------~~v~~kI~~~~~r~~ 383 (474)
T KOG0194|consen 311 AGSQYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKN-------YEVKAKIVKNGYRMP 383 (474)
T ss_pred CCcceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCH-------HHHHHHHHhcCccCC
Confidence 54311111112235679999999999999999999999999999999 8889874321 122223323333333
Q ss_pred cchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhcCCCCCC
Q 042435 352 INQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELEGKTPMKK 396 (412)
Q Consensus 352 ~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~~~ 396 (412)
.+...+. .+..++.+||..||++||+|.++.+.|+.+.....
T Consensus 384 ~~~~~p~---~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~ 425 (474)
T KOG0194|consen 384 IPSKTPK---ELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKE 425 (474)
T ss_pred CCCCCHH---HHHHHHHHhccCChhhccCHHHHHHHHHHHHhccc
Confidence 3333333 36778889999999999999999999998876544
|
|
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=302.99 Aligned_cols=220 Identities=25% Similarity=0.361 Sum_probs=172.7
Q ss_pred eeeeecCceEEEEEEeC-CCcEEEEEec-------------------------cCCccccceEEEecCceEEEEEEeccC
Q 042435 149 YCIGTGGYDSVYKAELP-DGKVVALKKL-------------------------HHSETEDSAFVVYSPQCMFFIYEYMER 202 (412)
Q Consensus 149 ~~lG~G~~g~Vy~~~~~-~~~~vAvK~l-------------------------~~~~~~~~~~~~~~~~~~~lv~ey~~~ 202 (412)
++||+|+||.||+|... +++.||+|.+ +|+++......+..++..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999774 5889999965 355555556667778899999999999
Q ss_pred CceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCCCCcc
Q 042435 203 GSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRT 282 (412)
Q Consensus 203 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 282 (412)
|+|.+++.... .++......++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++..........
T Consensus 81 g~L~~~~~~~~---~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~ 154 (316)
T cd05592 81 GDLMFHIQSSG---RFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAS 154 (316)
T ss_pred CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCccc
Confidence 99998886543 488899999999999999999998 999999999999999999999999999986543333334
Q ss_pred cccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccchhhHHHHHH
Q 042435 283 LQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKIIQDIIL 362 (412)
Q Consensus 283 ~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 362 (412)
...||+.|+|||++.+..++.++|||||||++|||++|+.||... ........+.... +..+... ...
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~-------~~~~~~~~i~~~~--~~~~~~~---~~~ 222 (316)
T cd05592 155 TFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGE-------DEDELFDSILNDR--PHFPRWI---SKE 222 (316)
T ss_pred cccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCC-------CHHHHHHHHHcCC--CCCCCCC---CHH
Confidence 557999999999999889999999999999999999999998732 1111111111111 1111111 223
Q ss_pred HHHHHHhcCcCCCCCCCCHH-HHHH
Q 042435 363 VSTIALACLRSKPKSRPTMQ-RISQ 386 (412)
Q Consensus 363 ~~~l~~~Cl~~dP~~RPs~~-evl~ 386 (412)
+.+++.+||+.||++||++. ++++
T Consensus 223 ~~~ll~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05592 223 AKDCLSKLFERDPTKRLGVDGDIRQ 247 (316)
T ss_pred HHHHHHHHccCCHHHcCCChHHHHc
Confidence 67899999999999999875 5544
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=296.59 Aligned_cols=235 Identities=24% Similarity=0.352 Sum_probs=182.6
Q ss_pred cCcccceeeeecCceEEEEEEeCC------CcEEEEEecc----------------------CCccccceEEEecCceEE
Q 042435 143 EYFHIRYCIGTGGYDSVYKAELPD------GKVVALKKLH----------------------HSETEDSAFVVYSPQCMF 194 (412)
Q Consensus 143 ~~f~~~~~lG~G~~g~Vy~~~~~~------~~~vAvK~l~----------------------~~~~~~~~~~~~~~~~~~ 194 (412)
++|++.+.||+|+||.||+|.... ...||+|.++ |+++......+...+..+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 468888999999999999997633 2579999763 445555555666778899
Q ss_pred EEEEeccCCceeeeeccCcc-------------cccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCC
Q 042435 195 FIYEYMERGSLFCVLRDDDE-------------AIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNL 261 (412)
Q Consensus 195 lv~ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~ 261 (412)
++|||+++|+|.+++..... ...+++.....++.|++.||+|||+. +++||||||+||++++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEcCCC
Confidence 99999999999988865321 13488899999999999999999998 999999999999999999
Q ss_pred cEEEeecCCccccCCCCC--CcccccccccccccccccCcccCcccccHHHHHHHHHHHh-CCCCcccccccccCCCCcc
Q 042435 262 EAFVADFGTVRLLDVDSS--NRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLM-GTHPGELLLSLSSSSGPKI 338 (412)
Q Consensus 262 ~~kl~DfGla~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~ellt-g~~P~~~~~~~~~~~~~~~ 338 (412)
.++|+|||+++....... ......+++.|+|||.+.+..++.++|||||||++|||++ |..||... .. .
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~-------~~-~ 233 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGF-------SN-Q 233 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCC-------CH-H
Confidence 999999999976533221 1223456788999999988899999999999999999998 99998632 11 1
Q ss_pred hhhHHhhhccCCccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhcC
Q 042435 339 MLIDILYQRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELEGK 391 (412)
Q Consensus 339 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 391 (412)
.....+......+.+. .....+.+++.+||+.||++||++.||+++|+++
T Consensus 234 ~~~~~i~~~~~~~~~~---~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~ 283 (283)
T cd05048 234 EVIEMIRSRQLLPCPE---DCPARVYALMIECWNEIPARRPRFKDIHTRLRSW 283 (283)
T ss_pred HHHHHHHcCCcCCCcc---cCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence 2222232222222211 2234488999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=284.02 Aligned_cols=215 Identities=23% Similarity=0.284 Sum_probs=177.4
Q ss_pred cCcccceeeeecCceEEEEEEeC-CCcEEEEEecc------------------------CCccccceEEEecCceEEEEE
Q 042435 143 EYFHIRYCIGTGGYDSVYKAELP-DGKVVALKKLH------------------------HSETEDSAFVVYSPQCMFFIY 197 (412)
Q Consensus 143 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~------------------------~~~~~~~~~~~~~~~~~~lv~ 197 (412)
++|+..+.||.|+||.|..++.+ +|..+|+|.++ |+.+......+.+....++||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 56788899999999999999875 58899999774 344444445577889999999
Q ss_pred EeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCC
Q 042435 198 EYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVD 277 (412)
Q Consensus 198 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~ 277 (412)
||.++|.|..+++..+ .++.....-+|.||+.||+|||+. .|++|||||+|||+|.+|.+||+|||+|+.....
T Consensus 124 eyv~GGElFS~Lrk~~---rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r 197 (355)
T KOG0616|consen 124 EYVPGGELFSYLRKSG---RFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR 197 (355)
T ss_pred eccCCccHHHHHHhcC---CCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEeccceEEecCc
Confidence 9999999999998765 589999999999999999999999 9999999999999999999999999999976433
Q ss_pred CCCcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccchhhH
Q 042435 278 SSNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKII 357 (412)
Q Consensus 278 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 357 (412)
..+.+||+.|+|||+++...+..++|.|||||++|||+.|.+||... .+......++...+..|. ...
T Consensus 198 ---T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~-------~~~~iY~KI~~~~v~fP~--~fs 265 (355)
T KOG0616|consen 198 ---TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDD-------NPIQIYEKILEGKVKFPS--YFS 265 (355)
T ss_pred ---EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCC-------ChHHHHHHHHhCcccCCc--ccC
Confidence 45679999999999999999999999999999999999999999732 222233444444444432 111
Q ss_pred HHHHHHHHHHHhcCcCCCCCC
Q 042435 358 QDIILVSTIALACLRSKPKSR 378 (412)
Q Consensus 358 ~~~~~~~~l~~~Cl~~dP~~R 378 (412)
..+.+|+...++.|-.+|
T Consensus 266 ---~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 266 ---SDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred ---HHHHHHHHHHHhhhhHhh
Confidence 236788888888888888
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=304.14 Aligned_cols=221 Identities=24% Similarity=0.352 Sum_probs=174.3
Q ss_pred eeeeecCceEEEEEEeC-CCcEEEEEec-------------------------cCCccccceEEEecCceEEEEEEeccC
Q 042435 149 YCIGTGGYDSVYKAELP-DGKVVALKKL-------------------------HHSETEDSAFVVYSPQCMFFIYEYMER 202 (412)
Q Consensus 149 ~~lG~G~~g~Vy~~~~~-~~~~vAvK~l-------------------------~~~~~~~~~~~~~~~~~~~lv~ey~~~ 202 (412)
+.||+|+||.||+|... +++.||+|.+ +|+++......+...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999774 5889999965 255555556667788899999999999
Q ss_pred CceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCCCCcc
Q 042435 203 GSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRT 282 (412)
Q Consensus 203 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 282 (412)
|+|.+++.... .+++..+..++.|++.||+|||++ +++||||||+|||++.++.+||+|||+++..........
T Consensus 81 g~L~~~i~~~~---~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~ 154 (320)
T cd05590 81 GDLMFHIQKSR---RFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTS 154 (320)
T ss_pred chHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCccc
Confidence 99998886543 588999999999999999999998 999999999999999999999999999876433333334
Q ss_pred cccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccchhhHHHHHH
Q 042435 283 LQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKIIQDIIL 362 (412)
Q Consensus 283 ~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 362 (412)
...||+.|+|||++.+..++.++|||||||++|||++|+.||... ........+.......+ .. ....
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~-------~~~~~~~~i~~~~~~~~--~~---~~~~ 222 (320)
T cd05590 155 TFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAE-------NEDDLFEAILNDEVVYP--TW---LSQD 222 (320)
T ss_pred ccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCC-------CHHHHHHHHhcCCCCCC--CC---CCHH
Confidence 457999999999999889999999999999999999999998732 11111112222111111 11 1223
Q ss_pred HHHHHHhcCcCCCCCCCCH------HHHHHH
Q 042435 363 VSTIALACLRSKPKSRPTM------QRISQE 387 (412)
Q Consensus 363 ~~~l~~~Cl~~dP~~RPs~------~evl~~ 387 (412)
+.+++.+|++.||++||++ ++++++
T Consensus 223 ~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h 253 (320)
T cd05590 223 AVDILKAFMTKNPTMRLGSLTLGGEEAILRH 253 (320)
T ss_pred HHHHHHHHcccCHHHCCCCCCCCCHHHHHcC
Confidence 7789999999999999998 666554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=304.25 Aligned_cols=221 Identities=22% Similarity=0.313 Sum_probs=175.8
Q ss_pred eeeeecCceEEEEEEe-CCCcEEEEEec------------------------cCCccccceEEEecCceEEEEEEeccCC
Q 042435 149 YCIGTGGYDSVYKAEL-PDGKVVALKKL------------------------HHSETEDSAFVVYSPQCMFFIYEYMERG 203 (412)
Q Consensus 149 ~~lG~G~~g~Vy~~~~-~~~~~vAvK~l------------------------~~~~~~~~~~~~~~~~~~~lv~ey~~~g 203 (412)
+.||+|+||.||++.. .+|+.||+|.+ +|+++......+...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 3699999999999976 46899999965 4666666666778888999999999999
Q ss_pred ceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCCCCccc
Q 042435 204 SLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTL 283 (412)
Q Consensus 204 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 283 (412)
+|..++.... .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++...........
T Consensus 81 ~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~ 154 (323)
T cd05595 81 ELFFHLSRER---VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT 154 (323)
T ss_pred cHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCcccc
Confidence 9988876543 589999999999999999999998 9999999999999999999999999998754333333344
Q ss_pred ccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccchhhHHHHHHH
Q 042435 284 QAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKIIQDIILV 363 (412)
Q Consensus 284 ~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 363 (412)
..||+.|+|||++.+..++.++|||||||++|||++|+.||... ........+.......+ ... ...+
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~-------~~~~~~~~~~~~~~~~p--~~~---~~~~ 222 (323)
T cd05595 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ-------DHERLFELILMEEIRFP--RTL---SPEA 222 (323)
T ss_pred ccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCC-------CHHHHHHHHhcCCCCCC--CCC---CHHH
Confidence 57999999999999889999999999999999999999998622 11111122222221111 111 2237
Q ss_pred HHHHHhcCcCCCCCCC-----CHHHHHHH
Q 042435 364 STIALACLRSKPKSRP-----TMQRISQE 387 (412)
Q Consensus 364 ~~l~~~Cl~~dP~~RP-----s~~evl~~ 387 (412)
.+++.+||+.||++|| ++.+++++
T Consensus 223 ~~li~~~L~~dP~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 223 KSLLAGLLKKDPKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred HHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence 7899999999999998 88888764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=298.59 Aligned_cols=232 Identities=23% Similarity=0.268 Sum_probs=174.1
Q ss_pred cCcccceeeeecCceEEEEEEeC--CCcEEEEEecc--------------------------CCccccceEEEe-----c
Q 042435 143 EYFHIRYCIGTGGYDSVYKAELP--DGKVVALKKLH--------------------------HSETEDSAFVVY-----S 189 (412)
Q Consensus 143 ~~f~~~~~lG~G~~g~Vy~~~~~--~~~~vAvK~l~--------------------------~~~~~~~~~~~~-----~ 189 (412)
++|++.+.||+|+||.||+|... +++.||+|.++ |+++.....++. .
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 36888999999999999999762 46889999653 455555444443 2
Q ss_pred CceEEEEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecC
Q 042435 190 PQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFG 269 (412)
Q Consensus 190 ~~~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG 269 (412)
....++||||++ ++|.+++..... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~Dfg 155 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPE-PGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFG 155 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEcccc
Confidence 456899999996 688888865432 2489999999999999999999998 99999999999999999999999999
Q ss_pred CccccCCCCCCcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhh---
Q 042435 270 TVRLLDVDSSNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQ--- 346 (412)
Q Consensus 270 la~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~--- 346 (412)
+++..... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||...... ..+..+.+.
T Consensus 156 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~-------~~~~~i~~~~~~ 227 (290)
T cd07862 156 LARIYSFQ-MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV-------DQLGKILDVIGL 227 (290)
T ss_pred ceEeccCC-cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHH-------HHHHHHHHHhCC
Confidence 99865433 2233456899999999998888999999999999999999999998732110 001111100
Q ss_pred -------------------ccCCccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 347 -------------------RLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 347 -------------------~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
....+...........+.+++.+|++.||++|||+.|++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h 287 (290)
T cd07862 228 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 287 (290)
T ss_pred CChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence 00000000001112346789999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=294.02 Aligned_cols=237 Identities=25% Similarity=0.390 Sum_probs=187.9
Q ss_pred HhhcCcccceeeeecCceEEEEEEeCCCcEEEEEec---------------------cCCccccceEEEecCceEEEEEE
Q 042435 140 DATEYFHIRYCIGTGGYDSVYKAELPDGKVVALKKL---------------------HHSETEDSAFVVYSPQCMFFIYE 198 (412)
Q Consensus 140 ~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~l---------------------~~~~~~~~~~~~~~~~~~~lv~e 198 (412)
++.++|++.+.||+|+||.||+|...+++.+|+|.+ +|+++......+...+..++|||
T Consensus 3 ~~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 82 (261)
T cd05148 3 RPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITE 82 (261)
T ss_pred CcHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEe
Confidence 345678899999999999999999888999999965 35555555566778888999999
Q ss_pred eccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCC
Q 042435 199 YMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDS 278 (412)
Q Consensus 199 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~ 278 (412)
|+++|+|.+++..... ..+++.++..++.|++.||+|||+. +++||||||+||++++++.+||+|||++.......
T Consensus 83 ~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~ 158 (261)
T cd05148 83 LMEKGSLLAFLRSPEG-QVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDV 158 (261)
T ss_pred ecccCCHHHHHhcCCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhcCCcc
Confidence 9999999999976432 3589999999999999999999998 99999999999999999999999999998664332
Q ss_pred CCcccccccccccccccccCcccCcccccHHHHHHHHHHHh-CCCCcccccccccCCCCcchhhHHhhhccCCccchhhH
Q 042435 279 SNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLM-GTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKII 357 (412)
Q Consensus 279 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 357 (412)
.......++..|+|||......++.++||||||+++|+|++ |+.||... .... ..+........+.+.
T Consensus 159 ~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~-------~~~~-~~~~~~~~~~~~~~~--- 227 (261)
T cd05148 159 YLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGM-------NNHE-VYDQITAGYRMPCPA--- 227 (261)
T ss_pred ccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcC-------CHHH-HHHHHHhCCcCCCCC---
Confidence 22233346678999999988889999999999999999998 89998632 1111 122222222222111
Q ss_pred HHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhcC
Q 042435 358 QDIILVSTIALACLRSKPKSRPTMQRISQELEGK 391 (412)
Q Consensus 358 ~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 391 (412)
.....+.+++.+||+.||++|||+.++++.|+.+
T Consensus 228 ~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 228 KCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred CCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 2223478999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=303.36 Aligned_cols=219 Identities=24% Similarity=0.331 Sum_probs=173.6
Q ss_pred eeecCceEEEEEEeC-CCcEEEEEec------------------------cCCccccceEEEecCceEEEEEEeccCCce
Q 042435 151 IGTGGYDSVYKAELP-DGKVVALKKL------------------------HHSETEDSAFVVYSPQCMFFIYEYMERGSL 205 (412)
Q Consensus 151 lG~G~~g~Vy~~~~~-~~~~vAvK~l------------------------~~~~~~~~~~~~~~~~~~~lv~ey~~~gsL 205 (412)
||+|+||.||+|... +++.||+|.+ +|+++......+...+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 699999999999774 5889999965 456666666677888899999999999999
Q ss_pred eeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCCCCccccc
Q 042435 206 FCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQA 285 (412)
Q Consensus 206 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 285 (412)
.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.............
T Consensus 81 ~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 154 (312)
T cd05585 81 FHHLQREG---RFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFC 154 (312)
T ss_pred HHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCcccccc
Confidence 99886543 489999999999999999999998 999999999999999999999999999986443333334457
Q ss_pred ccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccchhhHHHHHHHHH
Q 042435 286 GTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKIIQDIILVST 365 (412)
Q Consensus 286 gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 365 (412)
||+.|+|||++.+..++.++|||||||++|||++|+.||... ........+.......+ .. ....+.+
T Consensus 155 gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~-------~~~~~~~~~~~~~~~~~--~~---~~~~~~~ 222 (312)
T cd05585 155 GTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDE-------NVNEMYRKILQEPLRFP--DG---FDRDAKD 222 (312)
T ss_pred CCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCC-------CHHHHHHHHHcCCCCCC--Cc---CCHHHHH
Confidence 999999999999999999999999999999999999998632 11111122222211111 11 1223778
Q ss_pred HHHhcCcCCCCCCCC---HHHHHHH
Q 042435 366 IALACLRSKPKSRPT---MQRISQE 387 (412)
Q Consensus 366 l~~~Cl~~dP~~RPs---~~evl~~ 387 (412)
++.+||+.||++||+ +.|++++
T Consensus 223 li~~~L~~dp~~R~~~~~~~e~l~h 247 (312)
T cd05585 223 LLIGLLSRDPTRRLGYNGAQEIKNH 247 (312)
T ss_pred HHHHHcCCCHHHcCCCCCHHHHHcC
Confidence 999999999999975 5666654
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=305.83 Aligned_cols=230 Identities=23% Similarity=0.310 Sum_probs=175.8
Q ss_pred CcccceeeeecCceEEEEEEe----CCCcEEEEEecc--------------------------CCccccceEEEecCceE
Q 042435 144 YFHIRYCIGTGGYDSVYKAEL----PDGKVVALKKLH--------------------------HSETEDSAFVVYSPQCM 193 (412)
Q Consensus 144 ~f~~~~~lG~G~~g~Vy~~~~----~~~~~vAvK~l~--------------------------~~~~~~~~~~~~~~~~~ 193 (412)
+|++.+.||+|+||.||+++. .+++.||+|.++ |+++......+...+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 588899999999999999965 368899999653 34444555556778889
Q ss_pred EEEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccc
Q 042435 194 FFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRL 273 (412)
Q Consensus 194 ~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~ 273 (412)
++||||+++|+|.+++.... .+++.....++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG~~~~ 154 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRD---NFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSKE 154 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence 99999999999998886543 488999999999999999999998 999999999999999999999999999986
Q ss_pred cCCCCC-CcccccccccccccccccCc-ccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCc
Q 042435 274 LDVDSS-NRTLQAGTYGYIALELVYTM-VVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPP 351 (412)
Q Consensus 274 ~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 351 (412)
...... ......||+.|+|||++.+. .++.++|||||||++|||+||+.||..... ......+...+.. ..++
T Consensus 155 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~----~~~~~~~~~~~~~-~~~~ 229 (332)
T cd05614 155 FLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGE----RNTQSEVSRRILK-CDPP 229 (332)
T ss_pred ccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCC----CCCHHHHHHHHhc-CCCC
Confidence 533322 22345799999999998765 478899999999999999999999863210 0000111111111 1111
Q ss_pred cchhhHHHHHHHHHHHHhcCcCCCCCCC-----CHHHHHHH
Q 042435 352 INQKIIQDIILVSTIALACLRSKPKSRP-----TMQRISQE 387 (412)
Q Consensus 352 ~~~~~~~~~~~~~~l~~~Cl~~dP~~RP-----s~~evl~~ 387 (412)
.+.. ....+.+++.+||+.||++|| ++++++++
T Consensus 230 ~~~~---~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 230 FPSF---IGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred CCCC---CCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 1111 122377899999999999999 77788765
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=303.84 Aligned_cols=228 Identities=22% Similarity=0.317 Sum_probs=174.7
Q ss_pred eeeeecCceEEEEEEeC-CCcEEEEEec-------------------------cCCccccceEEEecCceEEEEEEeccC
Q 042435 149 YCIGTGGYDSVYKAELP-DGKVVALKKL-------------------------HHSETEDSAFVVYSPQCMFFIYEYMER 202 (412)
Q Consensus 149 ~~lG~G~~g~Vy~~~~~-~~~~vAvK~l-------------------------~~~~~~~~~~~~~~~~~~~lv~ey~~~ 202 (412)
+.||+|+||.||+|... +++.||+|.+ +|+++......+...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 36999999999999764 6889999964 356666666667788899999999999
Q ss_pred CceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCCCCcc
Q 042435 203 GSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRT 282 (412)
Q Consensus 203 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 282 (412)
|+|..++.... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++..........
T Consensus 81 ~~L~~~~~~~~---~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~ 154 (329)
T cd05618 81 GDLMFHMQRQR---KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTS 154 (329)
T ss_pred CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCccc
Confidence 99988776543 589999999999999999999998 999999999999999999999999999875433333334
Q ss_pred cccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCC-cchhhH-HhhhccCCccchhhHHHH
Q 042435 283 LQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGP-KIMLID-ILYQRLSPPINQKIIQDI 360 (412)
Q Consensus 283 ~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~-~~~~~~-~~~~~~~~~~~~~~~~~~ 360 (412)
...||+.|+|||++.+..++.++|||||||++|||++|+.||............ .....+ +....... +.. ..
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~--p~~---~~ 229 (329)
T cd05618 155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRI--PRS---LS 229 (329)
T ss_pred cccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCC--CCC---CC
Confidence 457899999999999999999999999999999999999999632111100000 001111 11111111 111 12
Q ss_pred HHHHHHHHhcCcCCCCCCCC------HHHHHHH
Q 042435 361 ILVSTIALACLRSKPKSRPT------MQRISQE 387 (412)
Q Consensus 361 ~~~~~l~~~Cl~~dP~~RPs------~~evl~~ 387 (412)
..+.+++.+||+.||++||+ +.+++++
T Consensus 230 ~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05618 230 VKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 262 (329)
T ss_pred HHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence 34778999999999999998 5677654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=303.99 Aligned_cols=221 Identities=22% Similarity=0.292 Sum_probs=175.5
Q ss_pred eeeeecCceEEEEEEe-CCCcEEEEEec------------------------cCCccccceEEEecCceEEEEEEeccCC
Q 042435 149 YCIGTGGYDSVYKAEL-PDGKVVALKKL------------------------HHSETEDSAFVVYSPQCMFFIYEYMERG 203 (412)
Q Consensus 149 ~~lG~G~~g~Vy~~~~-~~~~~vAvK~l------------------------~~~~~~~~~~~~~~~~~~~lv~ey~~~g 203 (412)
+.||+|+||.||++.. .+++.||+|.+ +|+++......+...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 3699999999999976 46899999965 3566666666778888999999999999
Q ss_pred ceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCCCCccc
Q 042435 204 SLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTL 283 (412)
Q Consensus 204 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 283 (412)
+|.+++.... .+++.++..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++...........
T Consensus 81 ~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~ 154 (328)
T cd05593 81 ELFFHLSRER---VFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKT 154 (328)
T ss_pred CHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCCccccccc
Confidence 9988876543 589999999999999999999998 9999999999999999999999999998764333333344
Q ss_pred ccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccchhhHHHHHHH
Q 042435 284 QAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKIIQDIILV 363 (412)
Q Consensus 284 ~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 363 (412)
..||+.|+|||++.+..++.++|||||||++|||++|+.||.... .......+....... +... ...+
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~-------~~~~~~~~~~~~~~~--p~~~---~~~~ 222 (328)
T cd05593 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD-------HEKLFELILMEDIKF--PRTL---SADA 222 (328)
T ss_pred ccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCC-------HHHHHHHhccCCccC--CCCC---CHHH
Confidence 579999999999998899999999999999999999999986321 111111111111111 1111 2237
Q ss_pred HHHHHhcCcCCCCCCC-----CHHHHHHH
Q 042435 364 STIALACLRSKPKSRP-----TMQRISQE 387 (412)
Q Consensus 364 ~~l~~~Cl~~dP~~RP-----s~~evl~~ 387 (412)
.+++.+||+.||++|| ++.|++++
T Consensus 223 ~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 223 KSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred HHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 7899999999999997 89999876
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=303.84 Aligned_cols=221 Identities=25% Similarity=0.348 Sum_probs=175.2
Q ss_pred eeeeecCceEEEEEEeC-CCcEEEEEec-------------------------cCCccccceEEEecCceEEEEEEeccC
Q 042435 149 YCIGTGGYDSVYKAELP-DGKVVALKKL-------------------------HHSETEDSAFVVYSPQCMFFIYEYMER 202 (412)
Q Consensus 149 ~~lG~G~~g~Vy~~~~~-~~~~vAvK~l-------------------------~~~~~~~~~~~~~~~~~~~lv~ey~~~ 202 (412)
++||+|+||.||+|... +++.||+|.+ +|+++......+...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 36899999999999774 5889999965 345555556667788899999999999
Q ss_pred CceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCCCCcc
Q 042435 203 GSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRT 282 (412)
Q Consensus 203 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 282 (412)
|+|..++.... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++..........
T Consensus 81 ~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~ 154 (321)
T cd05591 81 GDLMFQIQRSR---KFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTT 154 (321)
T ss_pred CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceecccCCcccc
Confidence 99988886543 588999999999999999999998 999999999999999999999999999875433333334
Q ss_pred cccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccchhhHHHHHH
Q 042435 283 LQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKIIQDIIL 362 (412)
Q Consensus 283 ~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 362 (412)
...||+.|+|||++.+..++.++|||||||++|||++|+.||... ........+.......+ ... ...
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~-------~~~~~~~~i~~~~~~~p--~~~---~~~ 222 (321)
T cd05591 155 TFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEAD-------NEDDLFESILHDDVLYP--VWL---SKE 222 (321)
T ss_pred ccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCC-------CHHHHHHHHHcCCCCCC--CCC---CHH
Confidence 457899999999999889999999999999999999999998732 11111222222221111 111 123
Q ss_pred HHHHHHhcCcCCCCCCC-------CHHHHHHH
Q 042435 363 VSTIALACLRSKPKSRP-------TMQRISQE 387 (412)
Q Consensus 363 ~~~l~~~Cl~~dP~~RP-------s~~evl~~ 387 (412)
+.+++.+||+.||++|| ++.+++++
T Consensus 223 ~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 223 AVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred HHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 77899999999999999 88888765
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=306.39 Aligned_cols=226 Identities=25% Similarity=0.325 Sum_probs=172.1
Q ss_pred CcccceeeeecCceEEEEEEeC-CCcEEEEEec----------------------cCCccccceEEEecCceEEEEEEec
Q 042435 144 YFHIRYCIGTGGYDSVYKAELP-DGKVVALKKL----------------------HHSETEDSAFVVYSPQCMFFIYEYM 200 (412)
Q Consensus 144 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l----------------------~~~~~~~~~~~~~~~~~~~lv~ey~ 200 (412)
+|+..+.||+|+||.||+|... +++.||||.+ +|+++......+...+..++||||+
T Consensus 75 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 154 (353)
T PLN00034 75 ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFM 154 (353)
T ss_pred HHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecC
Confidence 4556688999999999999764 6899999965 4566666667778888999999999
Q ss_pred cCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCCCC
Q 042435 201 ERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSN 280 (412)
Q Consensus 201 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 280 (412)
++|+|.+.. ..++.....++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+++........
T Consensus 155 ~~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~ 224 (353)
T PLN00034 155 DGGSLEGTH-------IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDP 224 (353)
T ss_pred CCCcccccc-------cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceeccccccc
Confidence 999987532 245677788999999999999998 9999999999999999999999999999876543333
Q ss_pred cccccccccccccccccC-----cccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccchh
Q 042435 281 RTLQAGTYGYIALELVYT-----MVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQK 355 (412)
Q Consensus 281 ~~~~~gt~~y~aPE~~~~-----~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 355 (412)
.....||..|+|||++.. ...+.++|||||||++|||++|+.||.... .....................
T Consensus 225 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~-----~~~~~~~~~~~~~~~~~~~~~- 298 (353)
T PLN00034 225 CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGR-----QGDWASLMCAICMSQPPEAPA- 298 (353)
T ss_pred ccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCC-----CccHHHHHHHHhccCCCCCCC-
Confidence 344579999999998743 234568999999999999999999987210 000000111111111111111
Q ss_pred hHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 356 IIQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 356 ~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
.....+.+++.+||+.||++|||+.|++++
T Consensus 299 --~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 299 --TASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred --ccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 122347899999999999999999999987
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=299.60 Aligned_cols=249 Identities=22% Similarity=0.375 Sum_probs=184.6
Q ss_pred cCcccceeeeecCceEEEEEEeCCCcEEEEEec--------------------cCCccccceEEEec----CceEEEEEE
Q 042435 143 EYFHIRYCIGTGGYDSVYKAELPDGKVVALKKL--------------------HHSETEDSAFVVYS----PQCMFFIYE 198 (412)
Q Consensus 143 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~l--------------------~~~~~~~~~~~~~~----~~~~~lv~e 198 (412)
...+..++||+|.||.||||.+ +++.||||++ +|+++.++...-.. .-..+||+|
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL-~~~~VAVKifp~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~ 288 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQL-DNRLVAVKIFPEQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTE 288 (534)
T ss_pred CchhhHHHhhcCccceeehhhc-cCceeEEEecCHHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEee
Confidence 3445567899999999999999 4599999976 45555544433222 347899999
Q ss_pred eccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhC------CCCCcEEeCCCCCCEEecCCCcEEEeecCCcc
Q 042435 199 YMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHD------CTPSIVHRDISSNNILLNSNLEAFVADFGTVR 272 (412)
Q Consensus 199 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~------~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~ 272 (412)
|.++|+|.++|..+ .++|....+|+..+++||+|||+. +.|+|+|||||++|||+.+|+++.|+|||+|.
T Consensus 289 fh~kGsL~dyL~~n----tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl 364 (534)
T KOG3653|consen 289 FHPKGSLCDYLKAN----TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLAL 364 (534)
T ss_pred eccCCcHHHHHHhc----cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeE
Confidence 99999999999876 499999999999999999999985 36789999999999999999999999999998
Q ss_pred ccCCCCCC--cccccccccccccccccCcc-cC-----cccccHHHHHHHHHHHhCCCCcc--------cccc--cccCC
Q 042435 273 LLDVDSSN--RTLQAGTYGYIALELVYTMV-VT-----EKCVIYSFGVVALEVLMGTHPGE--------LLLS--LSSSS 334 (412)
Q Consensus 273 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~-~s-----~ksDv~S~Gvil~elltg~~P~~--------~~~~--~~~~~ 334 (412)
.+...... ....+||.+|||||++.+.. +. .+.||||+|.+||||+++-.-.+ .... +....
T Consensus 365 ~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hP 444 (534)
T KOG3653|consen 365 RLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHP 444 (534)
T ss_pred EecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCC
Confidence 87654332 23478999999999997532 22 36999999999999998643221 1100 00011
Q ss_pred CCcchhhHHhhhccCCccchhhH--HHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhcCCCCCC
Q 042435 335 GPKIMLIDILYQRLSPPINQKII--QDIILVSTIALACLRSKPKSRPTMQRISQELEGKTPMKK 396 (412)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~~~ 396 (412)
.-+....-++.++.+|..+..+. ..+..+.+.+..||+.||+.|.|+.=|.+++.++....+
T Consensus 445 t~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~ 508 (534)
T KOG3653|consen 445 TLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWE 508 (534)
T ss_pred CHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCC
Confidence 11111222344455554443332 234458899999999999999999998888877665443
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=308.86 Aligned_cols=228 Identities=23% Similarity=0.315 Sum_probs=180.8
Q ss_pred cCcccceeeeecCceEEEEEEeC-CCcEEEEEecc------------------------CCccccceEEEecCceEEEEE
Q 042435 143 EYFHIRYCIGTGGYDSVYKAELP-DGKVVALKKLH------------------------HSETEDSAFVVYSPQCMFFIY 197 (412)
Q Consensus 143 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~------------------------~~~~~~~~~~~~~~~~~~lv~ 197 (412)
++|++.+.||+|+||.||+|... +++.||+|.++ |+++......+..++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 46899999999999999999875 68999999763 444444455567788999999
Q ss_pred EeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCC
Q 042435 198 EYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVD 277 (412)
Q Consensus 198 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~ 277 (412)
||+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 154 (350)
T cd05573 81 EYMPGGDLMNLLIRKD---VFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKA 154 (350)
T ss_pred cCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCCccCccc
Confidence 9999999999987653 588999999999999999999998 9999999999999999999999999999865433
Q ss_pred C-----------------------------CCcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCccccc
Q 042435 278 S-----------------------------SNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLL 328 (412)
Q Consensus 278 ~-----------------------------~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~ 328 (412)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~ 234 (350)
T cd05573 155 KDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT 234 (350)
T ss_pred CcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCC
Confidence 2 12234568999999999999999999999999999999999999987321
Q ss_pred ccccCCCCcchhhHHhh--hccCCccchhhHHHHHHHHHHHHhcCcCCCCCCCC-HHHHHHH
Q 042435 329 SLSSSSGPKIMLIDILY--QRLSPPINQKIIQDIILVSTIALACLRSKPKSRPT-MQRISQE 387 (412)
Q Consensus 329 ~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs-~~evl~~ 387 (412)
.......+.. .....+.... ....+.+++.+|+. ||.+||+ ++|++++
T Consensus 235 -------~~~~~~~i~~~~~~~~~p~~~~---~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 235 -------LQETYNKIINWKESLRFPPDPP---VSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred -------HHHHHHHHhccCCcccCCCCCC---CCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 1111122222 1111111111 12347788999997 9999999 9999986
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-38 Score=302.79 Aligned_cols=228 Identities=21% Similarity=0.321 Sum_probs=175.8
Q ss_pred eeeeecCceEEEEEEeC-CCcEEEEEec-------------------------cCCccccceEEEecCceEEEEEEeccC
Q 042435 149 YCIGTGGYDSVYKAELP-DGKVVALKKL-------------------------HHSETEDSAFVVYSPQCMFFIYEYMER 202 (412)
Q Consensus 149 ~~lG~G~~g~Vy~~~~~-~~~~vAvK~l-------------------------~~~~~~~~~~~~~~~~~~~lv~ey~~~ 202 (412)
++||+|+||.||+|... +++.||+|.+ +|+++......+...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 36999999999999774 6889999965 356666666777888899999999999
Q ss_pred CceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCCCCcc
Q 042435 203 GSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRT 282 (412)
Q Consensus 203 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 282 (412)
|+|.+++.... .+++..+..++.|++.||+|||++ +++||||||+||+++.++.+||+|||+++..........
T Consensus 81 g~L~~~~~~~~---~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~ 154 (329)
T cd05588 81 GDLMFHMQRQR---KLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTS 154 (329)
T ss_pred CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCccccccccCCCccc
Confidence 99988876543 589999999999999999999998 999999999999999999999999999875332223334
Q ss_pred cccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCC--CCcchhhHHhhhccCCccchhhHHHH
Q 042435 283 LQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSS--GPKIMLIDILYQRLSPPINQKIIQDI 360 (412)
Q Consensus 283 ~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 360 (412)
...||+.|+|||++.+..++.++|||||||++|||+||+.||+......... ........+.......+ .. ..
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p--~~---~~ 229 (329)
T cd05588 155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIP--RS---LS 229 (329)
T ss_pred cccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCC--CC---CC
Confidence 4579999999999999999999999999999999999999997321111000 00011111122221111 11 12
Q ss_pred HHHHHHHHhcCcCCCCCCCC------HHHHHHH
Q 042435 361 ILVSTIALACLRSKPKSRPT------MQRISQE 387 (412)
Q Consensus 361 ~~~~~l~~~Cl~~dP~~RPs------~~evl~~ 387 (412)
..+.+++.+|++.||++||+ ++|++++
T Consensus 230 ~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05588 230 VKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH 262 (329)
T ss_pred HHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence 24788999999999999997 6777654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=304.16 Aligned_cols=238 Identities=23% Similarity=0.305 Sum_probs=180.0
Q ss_pred cCcccceeeeecCceEEEEEEeC------CCcEEEEEecc-----------------------CCccccceEEEe-cCce
Q 042435 143 EYFHIRYCIGTGGYDSVYKAELP------DGKVVALKKLH-----------------------HSETEDSAFVVY-SPQC 192 (412)
Q Consensus 143 ~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vAvK~l~-----------------------~~~~~~~~~~~~-~~~~ 192 (412)
++|++.+.||+|+||.||+|... +++.||+|+++ |+++......+. ....
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~ 86 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGP 86 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCC
Confidence 46889999999999999999642 35789999764 333333333343 3456
Q ss_pred EEEEEEeccCCceeeeeccCcc----------------------------------------------------------
Q 042435 193 MFFIYEYMERGSLFCVLRDDDE---------------------------------------------------------- 214 (412)
Q Consensus 193 ~~lv~ey~~~gsL~~~l~~~~~---------------------------------------------------------- 214 (412)
.++++||+++|+|.+++.....
T Consensus 87 ~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (337)
T cd05054 87 LMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELY 166 (337)
T ss_pred EEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHh
Confidence 8899999999999888753211
Q ss_pred cccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCCCC--cccccccccccc
Q 042435 215 AIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSN--RTLQAGTYGYIA 292 (412)
Q Consensus 215 ~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~--~~~~~gt~~y~a 292 (412)
...++|..+..++.|++.||+|||+. +|+||||||+||++++++.++|+|||+++.+...... .....++..|+|
T Consensus 167 ~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~a 243 (337)
T cd05054 167 KEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA 243 (337)
T ss_pred hcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccC
Confidence 12589999999999999999999998 9999999999999999999999999999875433221 223356678999
Q ss_pred cccccCcccCcccccHHHHHHHHHHHh-CCCCcccccccccCCCCcchhhHHhhhccCCccchhhHHHHHHHHHHHHhcC
Q 042435 293 LELVYTMVVTEKCVIYSFGVVALEVLM-GTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKIIQDIILVSTIALACL 371 (412)
Q Consensus 293 PE~~~~~~~s~ksDv~S~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl 371 (412)
||++.+..++.++|||||||++|||++ |..||... .........+........+. .....+.+++.+||
T Consensus 244 PE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~-------~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~~cl 313 (337)
T cd05054 244 PESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGV-------QIDEEFCRRLKEGTRMRAPE---YATPEIYSIMLDCW 313 (337)
T ss_pred cHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCC-------CccHHHHHHHhccCCCCCCc---cCCHHHHHHHHHHc
Confidence 999999999999999999999999998 99998631 11111222222222211111 11234789999999
Q ss_pred cCCCCCCCCHHHHHHHHhcCCC
Q 042435 372 RSKPKSRPTMQRISQELEGKTP 393 (412)
Q Consensus 372 ~~dP~~RPs~~evl~~L~~~~~ 393 (412)
+.+|++||++.|++++|+.+.+
T Consensus 314 ~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 314 HNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred cCChhhCcCHHHHHHHHHHHHh
Confidence 9999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=300.79 Aligned_cols=220 Identities=23% Similarity=0.322 Sum_probs=172.3
Q ss_pred eeeeecCceEEEEEEeC-CCcEEEEEecc-------------------------CCccccceEEEecCceEEEEEEeccC
Q 042435 149 YCIGTGGYDSVYKAELP-DGKVVALKKLH-------------------------HSETEDSAFVVYSPQCMFFIYEYMER 202 (412)
Q Consensus 149 ~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~-------------------------~~~~~~~~~~~~~~~~~~lv~ey~~~ 202 (412)
+.||+|+||.||+|... +|+.||+|.++ |+++......+...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 36999999999999875 68899999653 44555555567778899999999999
Q ss_pred CceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCCCCcc
Q 042435 203 GSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRT 282 (412)
Q Consensus 203 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 282 (412)
|+|..++.... .+++.+...++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++..........
T Consensus 81 g~L~~~i~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 154 (316)
T cd05620 81 GDLMFHIQDKG---RFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAS 154 (316)
T ss_pred CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCcee
Confidence 99988886543 488999999999999999999998 999999999999999999999999999875433333334
Q ss_pred cccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccchhhHHHHHH
Q 042435 283 LQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKIIQDIIL 362 (412)
Q Consensus 283 ~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 362 (412)
...||+.|+|||++.+..++.++|||||||++|||++|+.||.... . ....+.+.... +..+.. ....
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~-------~-~~~~~~~~~~~-~~~~~~---~~~~ 222 (316)
T cd05620 155 TFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDD-------E-DELFESIRVDT-PHYPRW---ITKE 222 (316)
T ss_pred ccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC-------H-HHHHHHHHhCC-CCCCCC---CCHH
Confidence 5679999999999999999999999999999999999999986321 1 11111111111 111111 1223
Q ss_pred HHHHHHhcCcCCCCCCCCHH-HHHH
Q 042435 363 VSTIALACLRSKPKSRPTMQ-RISQ 386 (412)
Q Consensus 363 ~~~l~~~Cl~~dP~~RPs~~-evl~ 386 (412)
+.+++.+||+.||++||++. ++.+
T Consensus 223 ~~~li~~~l~~dP~~R~~~~~~~~~ 247 (316)
T cd05620 223 SKDILEKLFERDPTRRLGVVGNIRG 247 (316)
T ss_pred HHHHHHHHccCCHHHcCCChHHHHc
Confidence 77899999999999999984 5653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-38 Score=295.03 Aligned_cols=239 Identities=20% Similarity=0.217 Sum_probs=175.6
Q ss_pred cCcccceeeeecCceEEEEEEeC-CCcEEEEEecc-----------------------CCccccceEEEecCceEEEEEE
Q 042435 143 EYFHIRYCIGTGGYDSVYKAELP-DGKVVALKKLH-----------------------HSETEDSAFVVYSPQCMFFIYE 198 (412)
Q Consensus 143 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~-----------------------~~~~~~~~~~~~~~~~~~lv~e 198 (412)
++|++.+.||+|+||.||+|+.. +++.||+|+++ |+++......+...+..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 46899999999999999999875 68899999753 3444444445677888999999
Q ss_pred eccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCC
Q 042435 199 YMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDS 278 (412)
Q Consensus 199 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~ 278 (412)
|++++.+..+.... ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++......
T Consensus 81 ~~~~~~l~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 154 (287)
T cd07848 81 YVEKNMLELLEEMP---NGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS 154 (287)
T ss_pred cCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCcccccccc
Confidence 99987766443322 2488999999999999999999998 99999999999999999999999999998764332
Q ss_pred C-CcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccc------cC--CCCcchhhHHhh-h--
Q 042435 279 S-NRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLS------SS--SGPKIMLIDILY-Q-- 346 (412)
Q Consensus 279 ~-~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~------~~--~~~~~~~~~~~~-~-- 346 (412)
. ......|++.|+|||++.+..++.++|||||||++|||++|+.||....... .. ..+......... .
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd07848 155 NANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRF 234 (287)
T ss_pred cccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchh
Confidence 2 2234568999999999998889999999999999999999999986321100 00 000000000000 0
Q ss_pred -ccCCccc---hh-----hHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 347 -RLSPPIN---QK-----IIQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 347 -~~~~~~~---~~-----~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
....+.. .. .......+.+++.+||+.||++|||++|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h 284 (287)
T cd07848 235 HGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH 284 (287)
T ss_pred cccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 0000000 00 00112348899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=289.77 Aligned_cols=234 Identities=23% Similarity=0.344 Sum_probs=183.8
Q ss_pred hcCcccceeeeecCceEEEEEEeCCCcEEEEEecc--------------------CCccccceEEEecCceEEEEEEecc
Q 042435 142 TEYFHIRYCIGTGGYDSVYKAELPDGKVVALKKLH--------------------HSETEDSAFVVYSPQCMFFIYEYME 201 (412)
Q Consensus 142 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~l~--------------------~~~~~~~~~~~~~~~~~~lv~ey~~ 201 (412)
.++|++.+.||+|++|.||+|...+++.||+|.++ |+++......+...+..+++|||++
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 84 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMK 84 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeeccc
Confidence 45688899999999999999998788899999753 4555555566777888999999999
Q ss_pred CCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCCCC-
Q 042435 202 RGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSN- 280 (412)
Q Consensus 202 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~- 280 (412)
+++|.+++.... ...++|..+..++.|++.||.|||+. +++||||||+||++++++.++|+|||+++........
T Consensus 85 ~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~ 160 (261)
T cd05068 85 YGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEA 160 (261)
T ss_pred CCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEccCCcccc
Confidence 999999987643 23589999999999999999999998 9999999999999999999999999999876532211
Q ss_pred cccccccccccccccccCcccCcccccHHHHHHHHHHHh-CCCCcccccccccCCCCcchhhHHhhhccCCccchhhHHH
Q 042435 281 RTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLM-GTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKIIQD 359 (412)
Q Consensus 281 ~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 359 (412)
......+..|+|||+..+..++.++||||||+++|||+| |+.||... .. ......+......+... ..
T Consensus 161 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~-------~~-~~~~~~~~~~~~~~~~~---~~ 229 (261)
T cd05068 161 REGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGM-------TN-AEVLQQVDQGYRMPCPP---GC 229 (261)
T ss_pred cCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCC-------CH-HHHHHHHHcCCCCCCCC---cC
Confidence 111223457999999998899999999999999999999 99998632 11 11122222221111111 12
Q ss_pred HHHHHHHHHhcCcCCCCCCCCHHHHHHHHhc
Q 042435 360 IILVSTIALACLRSKPKSRPTMQRISQELEG 390 (412)
Q Consensus 360 ~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~ 390 (412)
...+.+++.+||+.+|++||++.++.+.|++
T Consensus 230 ~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 230 PKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred CHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 2348889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=300.69 Aligned_cols=220 Identities=24% Similarity=0.344 Sum_probs=173.7
Q ss_pred eeeeecCceEEEEEEeC-CCcEEEEEec-------------------------cCCccccceEEEecCceEEEEEEeccC
Q 042435 149 YCIGTGGYDSVYKAELP-DGKVVALKKL-------------------------HHSETEDSAFVVYSPQCMFFIYEYMER 202 (412)
Q Consensus 149 ~~lG~G~~g~Vy~~~~~-~~~~vAvK~l-------------------------~~~~~~~~~~~~~~~~~~~lv~ey~~~ 202 (412)
+.||+|+||.||+|... +++.||+|.+ +|+++......+.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 36999999999999874 5789999954 456666666677888899999999999
Q ss_pred CceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCCCCcc
Q 042435 203 GSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRT 282 (412)
Q Consensus 203 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 282 (412)
|+|.+++.... .+++.+...++.|++.||+|||++ +++||||||+|||++.++.+||+|||+++..........
T Consensus 81 g~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 154 (316)
T cd05619 81 GDLMFHIQSCH---KFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTC 154 (316)
T ss_pred CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCcee
Confidence 99998886543 588999999999999999999998 999999999999999999999999999875433333334
Q ss_pred cccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccchhhHHHHHH
Q 042435 283 LQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKIIQDIIL 362 (412)
Q Consensus 283 ~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 362 (412)
...||+.|+|||++.+..++.++|||||||++|||++|+.||.... . ....+.+.... +..+.. ....
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~-------~-~~~~~~i~~~~-~~~~~~---~~~~ 222 (316)
T cd05619 155 TFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHD-------E-EELFQSIRMDN-PCYPRW---LTRE 222 (316)
T ss_pred eecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCC-------H-HHHHHHHHhCC-CCCCcc---CCHH
Confidence 4578999999999998899999999999999999999999986321 1 11111111111 111111 1223
Q ss_pred HHHHHHhcCcCCCCCCCCHH-HHHH
Q 042435 363 VSTIALACLRSKPKSRPTMQ-RISQ 386 (412)
Q Consensus 363 ~~~l~~~Cl~~dP~~RPs~~-evl~ 386 (412)
+.+++.+||+.||++||++. ++.+
T Consensus 223 ~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 223 AKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred HHHHHHHHhccCHhhcCCChHHHHc
Confidence 77899999999999999997 6644
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=290.74 Aligned_cols=234 Identities=28% Similarity=0.377 Sum_probs=182.8
Q ss_pred hcCcccceeeeecCceEEEEEEeCC----CcEEEEEecc----------------------CCccccceEEEecCceEEE
Q 042435 142 TEYFHIRYCIGTGGYDSVYKAELPD----GKVVALKKLH----------------------HSETEDSAFVVYSPQCMFF 195 (412)
Q Consensus 142 ~~~f~~~~~lG~G~~g~Vy~~~~~~----~~~vAvK~l~----------------------~~~~~~~~~~~~~~~~~~l 195 (412)
.++|++.+.||+|+||.||+|.+.. ...||+|.++ |+++......+...+..++
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 82 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI 82 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence 3578999999999999999998742 4589999653 4555555555677888999
Q ss_pred EEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccC
Q 042435 196 IYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLD 275 (412)
Q Consensus 196 v~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~ 275 (412)
+|||+++++|.+++..... .+++.++..++.|++.||+|||+. +|+||||||+||++++++.++|+|||+++...
T Consensus 83 v~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~ 157 (266)
T cd05033 83 ITEYMENGSLDKFLRENDG--KFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRRLE 157 (266)
T ss_pred EEEcCCCCCHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchhhccc
Confidence 9999999999999876432 589999999999999999999998 99999999999999999999999999998764
Q ss_pred CCCCCc--ccccccccccccccccCcccCcccccHHHHHHHHHHHh-CCCCcccccccccCCCCcchhhHHhhhccCCcc
Q 042435 276 VDSSNR--TLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLM-GTHPGELLLSLSSSSGPKIMLIDILYQRLSPPI 352 (412)
Q Consensus 276 ~~~~~~--~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 352 (412)
...... ....++..|+|||.+.+..++.++||||||+++|||++ |..||.... .....+.+......+.
T Consensus 158 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~--------~~~~~~~~~~~~~~~~ 229 (266)
T cd05033 158 DSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMS--------NQDVIKAVEDGYRLPP 229 (266)
T ss_pred ccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCC--------HHHHHHHHHcCCCCCC
Confidence 222111 12234678999999998899999999999999999998 999985221 1111222222111111
Q ss_pred chhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhcC
Q 042435 353 NQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELEGK 391 (412)
Q Consensus 353 ~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 391 (412)
+. .....+.+++.+||+.+|++||++.|++++|+++
T Consensus 230 ~~---~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 230 PM---DCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred CC---CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 11 1223478999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-38 Score=297.90 Aligned_cols=240 Identities=20% Similarity=0.276 Sum_probs=176.3
Q ss_pred hcCcccceeeeecCceEEEEEEeC-CCcEEEEEecc----------------------CCccccceEEEecCceEEEEEE
Q 042435 142 TEYFHIRYCIGTGGYDSVYKAELP-DGKVVALKKLH----------------------HSETEDSAFVVYSPQCMFFIYE 198 (412)
Q Consensus 142 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~----------------------~~~~~~~~~~~~~~~~~~lv~e 198 (412)
.++|++.+.||+|+||.||+|... +++.||+|.++ |+++......+...+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 468999999999999999999875 68999999753 4555555666778889999999
Q ss_pred eccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCC
Q 042435 199 YMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDS 278 (412)
Q Consensus 199 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~ 278 (412)
|++ ++|.+++.... ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++......
T Consensus 84 ~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 157 (303)
T cd07869 84 YVH-TDLCQYMDKHP--GGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKSVPS 157 (303)
T ss_pred CCC-cCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceeccCCC
Confidence 995 57877765433 2478889999999999999999998 99999999999999999999999999987554333
Q ss_pred CCcccccccccccccccccC-cccCcccccHHHHHHHHHHHhCCCCccccccccc---------CCCCcchhhHH-----
Q 042435 279 SNRTLQAGTYGYIALELVYT-MVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSS---------SSGPKIMLIDI----- 343 (412)
Q Consensus 279 ~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~---------~~~~~~~~~~~----- 343 (412)
.......+|+.|+|||++.+ ..++.++|||||||++|||++|+.||........ ...........
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (303)
T cd07869 158 HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPH 237 (303)
T ss_pred ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccc
Confidence 33344568999999998865 4578899999999999999999999974211100 00000000000
Q ss_pred hh-hccCCccchhhH------HHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 344 LY-QRLSPPINQKII------QDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 344 ~~-~~~~~~~~~~~~------~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
.. .......+.... .....+.+++.+|++.||++|||+.|++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h 288 (303)
T cd07869 238 FKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSH 288 (303)
T ss_pred cccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcC
Confidence 00 000000000000 011246789999999999999999999864
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-38 Score=300.88 Aligned_cols=220 Identities=21% Similarity=0.328 Sum_probs=172.6
Q ss_pred CcccceeeeecCceEEEEEEe-CCCcEEEEEeccC-------------------------CccccceEEEecCceEEEEE
Q 042435 144 YFHIRYCIGTGGYDSVYKAEL-PDGKVVALKKLHH-------------------------SETEDSAFVVYSPQCMFFIY 197 (412)
Q Consensus 144 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l~~-------------------------~~~~~~~~~~~~~~~~~lv~ 197 (412)
+|+..+.||+|+||.||+|.. .+|+.||+|.++. +.+......+...+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 477889999999999999976 4689999997642 22333344466778899999
Q ss_pred EeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCC
Q 042435 198 EYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVD 277 (412)
Q Consensus 198 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~ 277 (412)
||+++|+|.+++.... .+++.++..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 81 Ey~~~g~L~~~i~~~~---~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~ 154 (323)
T cd05615 81 EYVNGGDLMYHIQQVG---KFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD 154 (323)
T ss_pred cCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccccccCCC
Confidence 9999999998886543 589999999999999999999998 9999999999999999999999999998754333
Q ss_pred CCCcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccchhhH
Q 042435 278 SSNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKII 357 (412)
Q Consensus 278 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 357 (412)
........||+.|+|||++.+..++.++|||||||++|||++|+.||... ........+.......+ ...
T Consensus 155 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~-------~~~~~~~~i~~~~~~~p--~~~- 224 (323)
T cd05615 155 GVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGE-------DEDELFQSIMEHNVSYP--KSL- 224 (323)
T ss_pred CccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCC-------CHHHHHHHHHhCCCCCC--ccC-
Confidence 33334456899999999999888999999999999999999999998732 11111222222222211 111
Q ss_pred HHHHHHHHHHHhcCcCCCCCCCCH
Q 042435 358 QDIILVSTIALACLRSKPKSRPTM 381 (412)
Q Consensus 358 ~~~~~~~~l~~~Cl~~dP~~RPs~ 381 (412)
...+.+++.+||+.||++|++.
T Consensus 225 --~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 225 --SKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred --CHHHHHHHHHHcccCHhhCCCC
Confidence 2237789999999999999974
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=290.14 Aligned_cols=234 Identities=24% Similarity=0.321 Sum_probs=182.6
Q ss_pred cCcccceeeeecCceEEEEEEeC-CCcEEEEEecc--------------------CCccccceEEEecCceEEEEEEecc
Q 042435 143 EYFHIRYCIGTGGYDSVYKAELP-DGKVVALKKLH--------------------HSETEDSAFVVYSPQCMFFIYEYME 201 (412)
Q Consensus 143 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~--------------------~~~~~~~~~~~~~~~~~~lv~ey~~ 201 (412)
.+|++.+.||+|+||.||+|... +++.||+|.++ |+++......+...+..+++|||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMT 85 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCC
Confidence 35778899999999999999764 58899999653 4555555666777888999999999
Q ss_pred CCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCCCCc
Q 042435 202 RGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNR 281 (412)
Q Consensus 202 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 281 (412)
+++|.+++..... ..+++..++.++.|++.||+|||+. +++||||||+||++++++.+||+|||+++.........
T Consensus 86 ~~~L~~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~ 161 (263)
T cd05052 86 YGNLLDYLRECNR-QEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTA 161 (263)
T ss_pred CCcHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCccccccccceeec
Confidence 9999998865432 2489999999999999999999998 99999999999999999999999999998654332111
Q ss_pred -ccccccccccccccccCcccCcccccHHHHHHHHHHHh-CCCCcccccccccCCCCcchhhHHhhhccCCccchhhHHH
Q 042435 282 -TLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLM-GTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKIIQD 359 (412)
Q Consensus 282 -~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 359 (412)
....++..|+|||...+..++.++|||||||++|||++ |..||... ......+.+........+.. .
T Consensus 162 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~--------~~~~~~~~~~~~~~~~~~~~---~ 230 (263)
T cd05052 162 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI--------DLSQVYELLEKGYRMERPEG---C 230 (263)
T ss_pred cCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCC--------CHHHHHHHHHCCCCCCCCCC---C
Confidence 12234568999999988899999999999999999998 88897621 11111222222222222111 1
Q ss_pred HHHHHHHHHhcCcCCCCCCCCHHHHHHHHhcC
Q 042435 360 IILVSTIALACLRSKPKSRPTMQRISQELEGK 391 (412)
Q Consensus 360 ~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 391 (412)
...+.+++.+||+.||++|||+.|+++.|+.+
T Consensus 231 ~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 231 PPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 23488899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-38 Score=295.94 Aligned_cols=239 Identities=18% Similarity=0.227 Sum_probs=175.5
Q ss_pred cCcccceeeeecCceEEEEEEeC-CCcEEEEEecc----------------------CCccccceEEEecCceEEEEEEe
Q 042435 143 EYFHIRYCIGTGGYDSVYKAELP-DGKVVALKKLH----------------------HSETEDSAFVVYSPQCMFFIYEY 199 (412)
Q Consensus 143 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~----------------------~~~~~~~~~~~~~~~~~~lv~ey 199 (412)
++|++.+.||+|+||.||+|... +++.||+|.++ |+++......+...+..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 56889999999999999999764 68999999653 45555555566777889999999
Q ss_pred ccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCCC
Q 042435 200 MERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSS 279 (412)
Q Consensus 200 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 279 (412)
+++ +|.+++.... ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.......
T Consensus 85 ~~~-~l~~~l~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~ 158 (288)
T cd07871 85 LDS-DLKQYLDNCG--NLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK 158 (288)
T ss_pred CCc-CHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc
Confidence 974 8888776443 2478899999999999999999998 999999999999999999999999999976543333
Q ss_pred CcccccccccccccccccC-cccCcccccHHHHHHHHHHHhCCCCcccccccc------c--CCCCcc---------hhh
Q 042435 280 NRTLQAGTYGYIALELVYT-MVVTEKCVIYSFGVVALEVLMGTHPGELLLSLS------S--SSGPKI---------MLI 341 (412)
Q Consensus 280 ~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~------~--~~~~~~---------~~~ 341 (412)
......+++.|+|||.+.+ ..++.++||||+||++|||+||+.||....... . ...... ...
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (288)
T cd07871 159 TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFR 238 (288)
T ss_pred cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhh
Confidence 3344568999999998865 568899999999999999999999986321000 0 000000 000
Q ss_pred HHhhhccCCcc-chhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 342 DILYQRLSPPI-NQKIIQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 342 ~~~~~~~~~~~-~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
....+...... ............+++.+|++.||++|||++|++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h 285 (288)
T cd07871 239 SYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH 285 (288)
T ss_pred ccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 00000000000 00000112247789999999999999999999864
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=294.87 Aligned_cols=227 Identities=31% Similarity=0.446 Sum_probs=173.3
Q ss_pred cceeeeecCceEEEEEEeC-----CCcEEEEEec----------------------cCCccccceEEEecCceEEEEEEe
Q 042435 147 IRYCIGTGGYDSVYKAELP-----DGKVVALKKL----------------------HHSETEDSAFVVYSPQCMFFIYEY 199 (412)
Q Consensus 147 ~~~~lG~G~~g~Vy~~~~~-----~~~~vAvK~l----------------------~~~~~~~~~~~~~~~~~~~lv~ey 199 (412)
+.+.||.|.||.||+|.+. .+..|+||.+ +|+++....+.+...+..++|+||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 4678999999999999886 3678999965 577777778888888889999999
Q ss_pred ccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCCC
Q 042435 200 MERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSS 279 (412)
Q Consensus 200 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 279 (412)
+++|+|.++|..... ..+++.++..|+.|+++||+|||++ +++|+||+++||++++++.+||+|||+++.......
T Consensus 83 ~~~g~L~~~L~~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~ 158 (259)
T PF07714_consen 83 CPGGSLDDYLKSKNK-EPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK 158 (259)
T ss_dssp -TTEBHHHHHHHTCT-TTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred ccccccccccccccc-ccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccc
Confidence 999999999987621 2589999999999999999999998 999999999999999999999999999987632211
Q ss_pred C--cccccccccccccccccCcccCcccccHHHHHHHHHHHh-CCCCcccccccccCCCCcchhhHHhhhccCCccchhh
Q 042435 280 N--RTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLM-GTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKI 356 (412)
Q Consensus 280 ~--~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 356 (412)
. .........|+|||.+.+..++.++||||||+++||+++ |+.||... ....+.+.+......+.+...
T Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~--------~~~~~~~~~~~~~~~~~~~~~ 230 (259)
T PF07714_consen 159 YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDY--------DNEEIIEKLKQGQRLPIPDNC 230 (259)
T ss_dssp EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTS--------CHHHHHHHHHTTEETTSBTTS
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccc--------ccccccccccccccceeccch
Confidence 1 123456788999999998889999999999999999999 67887622 111122222222222222222
Q ss_pred HHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHH
Q 042435 357 IQDIILVSTIALACLRSKPKSRPTMQRISQEL 388 (412)
Q Consensus 357 ~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L 388 (412)
...+.+++.+||+.||++|||+.++++.|
T Consensus 231 ---~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 231 ---PKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp ---BHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ---hHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 22378899999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=303.88 Aligned_cols=225 Identities=21% Similarity=0.286 Sum_probs=181.6
Q ss_pred hcCcccceeeeecCceEEEEEEeCC--CcEEEEEec------------------------cCCccccceEEEecCceEEE
Q 042435 142 TEYFHIRYCIGTGGYDSVYKAELPD--GKVVALKKL------------------------HHSETEDSAFVVYSPQCMFF 195 (412)
Q Consensus 142 ~~~f~~~~~lG~G~~g~Vy~~~~~~--~~~vAvK~l------------------------~~~~~~~~~~~~~~~~~~~l 195 (412)
.++|++.+.||+|+||.||+|...+ +..||+|.+ +|+++......+...+..++
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 108 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL 108 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence 3568899999999999999997643 368999964 47777777788888899999
Q ss_pred EEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccC
Q 042435 196 IYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLD 275 (412)
Q Consensus 196 v~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~ 275 (412)
||||+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 109 v~Ey~~~g~L~~~i~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~ 182 (340)
T PTZ00426 109 VLEFVIGGEFFTFLRRNK---RFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKVVD 182 (340)
T ss_pred EEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCCeecC
Confidence 999999999999887553 488999999999999999999998 99999999999999999999999999998654
Q ss_pred CCCCCcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccchh
Q 042435 276 VDSSNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQK 355 (412)
Q Consensus 276 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 355 (412)
.. .....||+.|+|||++.+..++.++|||||||++|||++|+.||... ........+.......+ ..
T Consensus 183 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~-------~~~~~~~~i~~~~~~~p--~~ 250 (340)
T PTZ00426 183 TR---TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYAN-------EPLLIYQKILEGIIYFP--KF 250 (340)
T ss_pred CC---cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCC-------CHHHHHHHHhcCCCCCC--CC
Confidence 32 23457899999999999888999999999999999999999998732 11111122222222111 11
Q ss_pred hHHHHHHHHHHHHhcCcCCCCCCC-----CHHHHHHH
Q 042435 356 IIQDIILVSTIALACLRSKPKSRP-----TMQRISQE 387 (412)
Q Consensus 356 ~~~~~~~~~~l~~~Cl~~dP~~RP-----s~~evl~~ 387 (412)
.. ..+.+++.+|++.||++|+ +++|++++
T Consensus 251 ~~---~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 251 LD---NNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred CC---HHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 11 2367899999999999995 89998876
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-38 Score=299.45 Aligned_cols=235 Identities=23% Similarity=0.374 Sum_probs=181.9
Q ss_pred cCcccceeeeecCceEEEEEEeC-CCc----EEEEEec----------------------cCCccccceEEEecCceEEE
Q 042435 143 EYFHIRYCIGTGGYDSVYKAELP-DGK----VVALKKL----------------------HHSETEDSAFVVYSPQCMFF 195 (412)
Q Consensus 143 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~----~vAvK~l----------------------~~~~~~~~~~~~~~~~~~~l 195 (412)
.+|++.+.||+|+||.||+|.+. +++ .||+|.+ +|+++....+.+.. +..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~-~~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT-STVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcC-CCcee
Confidence 46899999999999999999763 343 4899975 35566655555554 45789
Q ss_pred EEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccC
Q 042435 196 IYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLD 275 (412)
Q Consensus 196 v~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~ 275 (412)
++||+++|+|.+++..... .+++...+.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 86 v~e~~~~g~l~~~l~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~ 160 (316)
T cd05108 86 ITQLMPFGCLLDYVREHKD--NIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 160 (316)
T ss_pred eeecCCCCCHHHHHHhccc--cCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEcccccccccc
Confidence 9999999999998876432 488999999999999999999998 99999999999999999999999999998765
Q ss_pred CCCCCc--ccccccccccccccccCcccCcccccHHHHHHHHHHHh-CCCCcccccccccCCCCcchhhHHhhhccCCcc
Q 042435 276 VDSSNR--TLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLM-GTHPGELLLSLSSSSGPKIMLIDILYQRLSPPI 352 (412)
Q Consensus 276 ~~~~~~--~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 352 (412)
...... ....++..|+|||++.+..++.++|||||||++|||++ |+.||+.. ....+..+.......+.
T Consensus 161 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~--------~~~~~~~~~~~~~~~~~ 232 (316)
T cd05108 161 ADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI--------PASEISSILEKGERLPQ 232 (316)
T ss_pred CCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCC--------CHHHHHHHHhCCCCCCC
Confidence 433221 12234678999999999999999999999999999998 99998632 11112223322222221
Q ss_pred chhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhcCCCC
Q 042435 353 NQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELEGKTPM 394 (412)
Q Consensus 353 ~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~ 394 (412)
+.. ....+.+++.+||+.||++||++.+++..|..+...
T Consensus 233 ~~~---~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~ 271 (316)
T cd05108 233 PPI---CTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 271 (316)
T ss_pred CCC---CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcC
Confidence 111 123478899999999999999999999999877643
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=288.75 Aligned_cols=240 Identities=22% Similarity=0.202 Sum_probs=183.6
Q ss_pred hcCcccceeeeecCceEEEEEEe-CCCcEEEEEec-----------------------cCCccccceEEEe--cCceEEE
Q 042435 142 TEYFHIRYCIGTGGYDSVYKAEL-PDGKVVALKKL-----------------------HHSETEDSAFVVY--SPQCMFF 195 (412)
Q Consensus 142 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l-----------------------~~~~~~~~~~~~~--~~~~~~l 195 (412)
.++|+..+.|++|+||.||+|+. ++++.||+|++ +|+|++....++. +-+.+|+
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~ 154 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYI 154 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence 45688889999999999999976 57999999976 5788877766643 4567999
Q ss_pred EEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccC
Q 042435 196 IYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLD 275 (412)
Q Consensus 196 v~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~ 275 (412)
|||||+. ||..++.... .++...++..++.|+++|++|||.+ .|+||||||+|+|++..|.+||+|||+|+.+.
T Consensus 155 VMe~~Eh-DLksl~d~m~--q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLAR~yg 228 (419)
T KOG0663|consen 155 VMEYVEH-DLKSLMETMK--QPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLAREYG 228 (419)
T ss_pred eHHHHHh-hHHHHHHhcc--CCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchhhhhc
Confidence 9999976 9999887665 2588889999999999999999999 99999999999999999999999999999988
Q ss_pred CCCCCcccccccccccccccccCc-ccCcccccHHHHHHHHHHHhCCCCccccccc-------------ccCCCCcchhh
Q 042435 276 VDSSNRTLQAGTYGYIALELVYTM-VVTEKCVIYSFGVVALEVLMGTHPGELLLSL-------------SSSSGPKIMLI 341 (412)
Q Consensus 276 ~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~S~Gvil~elltg~~P~~~~~~~-------------~~~~~~~~~~~ 341 (412)
......+..+-|.+|+|||.+.+. .|++..|+||+|||+.|++++++-|.....+ ....++.....
T Consensus 229 sp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~l 308 (419)
T KOG0663|consen 229 SPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSEL 308 (419)
T ss_pred CCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCcccc
Confidence 777777778889999999998875 5999999999999999999999876521100 00001110000
Q ss_pred HHhh-hccCCccc----hhhHH--HHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 342 DILY-QRLSPPIN----QKIIQ--DIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 342 ~~~~-~~~~~~~~----~~~~~--~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
..+. -....... ..... ....-.+++...+..||++|.|++|.+++
T Consensus 309 p~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h 361 (419)
T KOG0663|consen 309 PAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH 361 (419)
T ss_pred chhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence 0000 00000000 00000 11346788999999999999999999876
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=300.51 Aligned_cols=238 Identities=22% Similarity=0.256 Sum_probs=182.5
Q ss_pred hcCcccceeeeecCceEEEEEEeC-CCcEEEEEec----------------------cCCccccceEEEecCceEEEEEE
Q 042435 142 TEYFHIRYCIGTGGYDSVYKAELP-DGKVVALKKL----------------------HHSETEDSAFVVYSPQCMFFIYE 198 (412)
Q Consensus 142 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l----------------------~~~~~~~~~~~~~~~~~~~lv~e 198 (412)
.++|++.+.||+|+||.||++... ++..+|+|.+ +|+++......+...+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 367999999999999999999775 6888999954 46677777777888889999999
Q ss_pred eccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCC
Q 042435 199 YMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDS 278 (412)
Q Consensus 199 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~ 278 (412)
|+++|+|.+++.... .+++..+..++.|++.||+|||+.+ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 84 ~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~- 157 (331)
T cd06649 84 HMDGGSLDQVLKEAK---RIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 157 (331)
T ss_pred cCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccccc-
Confidence 999999999887543 4889999999999999999999752 6999999999999999999999999998765332
Q ss_pred CCcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCccccccc------cc----CC--------------
Q 042435 279 SNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSL------SS----SS-------------- 334 (412)
Q Consensus 279 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~------~~----~~-------------- 334 (412)
......||..|+|||++.+..++.++|||||||++|||+||+.||...... .. ..
T Consensus 158 -~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (331)
T cd06649 158 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPP 236 (331)
T ss_pred -ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcccccc
Confidence 223346899999999999889999999999999999999999998632100 00 00
Q ss_pred -----------CCcch---hhHHhhhccCCccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHH
Q 042435 335 -----------GPKIM---LIDILYQRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQEL 388 (412)
Q Consensus 335 -----------~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L 388 (412)
.+... ..+.+.....+..+. ......+.+++.+||+.||++|||++|++++-
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~ 302 (331)
T cd06649 237 GRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPN--GVFTPDFQEFVNKCLIKNPAERADLKMLMNHT 302 (331)
T ss_pred cccccccccccccchhHHHHHHHHHhCCCcCCCC--ccccHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence 00000 000011111111000 01223488999999999999999999999874
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=288.78 Aligned_cols=239 Identities=21% Similarity=0.250 Sum_probs=186.1
Q ss_pred cCcccceeeeecCceEEEEEEeC-CCcEEEEEecc------------------------CCccccceEEEecCceEEEEE
Q 042435 143 EYFHIRYCIGTGGYDSVYKAELP-DGKVVALKKLH------------------------HSETEDSAFVVYSPQCMFFIY 197 (412)
Q Consensus 143 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~------------------------~~~~~~~~~~~~~~~~~~lv~ 197 (412)
++|++.+.||+|+||.||+|... +|+.||+|.++ |+++......+...+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 67999999999999999999876 79999999653 333333444466678899999
Q ss_pred EeccCCceeeeeccCc-ccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCC
Q 042435 198 EYMERGSLFCVLRDDD-EAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDV 276 (412)
Q Consensus 198 ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~ 276 (412)
||+++|+|.+++.... ....+++.++..++.+++.||+|||+. +++||||||+||+++.++.++|+|||+++....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 9999999998886432 223589999999999999999999998 999999999999999999999999999886544
Q ss_pred CCCCcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccchhh
Q 042435 277 DSSNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKI 356 (412)
Q Consensus 277 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 356 (412)
.........++..|+|||.+.+..++.++|||||||++|||++|+.||.... .......+.......++.+.
T Consensus 159 ~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~------~~~~~~~~~~~~~~~~~~~~-- 230 (267)
T cd08224 159 KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK------MNLYSLCKKIEKCDYPPLPA-- 230 (267)
T ss_pred CCcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCC------ccHHHHHhhhhcCCCCCCCh--
Confidence 3333344568889999999988889999999999999999999999985221 00001111111111121111
Q ss_pred HHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhcCC
Q 042435 357 IQDIILVSTIALACLRSKPKSRPTMQRISQELEGKT 392 (412)
Q Consensus 357 ~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 392 (412)
......+.+++.+||..+|++|||+.+|++.|+++.
T Consensus 231 ~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 231 DHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred hhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 122234789999999999999999999999998875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=319.24 Aligned_cols=237 Identities=22% Similarity=0.253 Sum_probs=178.9
Q ss_pred HHHHhhcCcccceeeeecCceEEEEEEe-CCCcEEEEEeccCCcc-----------------------ccceEEEec---
Q 042435 137 NLIDATEYFHIRYCIGTGGYDSVYKAEL-PDGKVVALKKLHHSET-----------------------EDSAFVVYS--- 189 (412)
Q Consensus 137 ~l~~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l~~~~~-----------------------~~~~~~~~~--- 189 (412)
+.....++|.+.+.||+|+||+||+|.. .+|+.||||.++.... ......+..
T Consensus 26 ~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~ 105 (496)
T PTZ00283 26 TAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDP 105 (496)
T ss_pred cccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccc
Confidence 3445567999999999999999999965 5799999998754321 111111111
Q ss_pred -----CceEEEEEEeccCCceeeeeccCc-ccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcE
Q 042435 190 -----PQCMFFIYEYMERGSLFCVLRDDD-EAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEA 263 (412)
Q Consensus 190 -----~~~~~lv~ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~ 263 (412)
....++||||+++|+|.+++.... ....+++.....++.|++.||+|||+. +|+||||||+|||++.++.+
T Consensus 106 ~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~v 182 (496)
T PTZ00283 106 RNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLV 182 (496)
T ss_pred cCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCE
Confidence 113689999999999999886532 223588999999999999999999998 99999999999999999999
Q ss_pred EEeecCCccccCCCC--CCcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhh
Q 042435 264 FVADFGTVRLLDVDS--SNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLI 341 (412)
Q Consensus 264 kl~DfGla~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~ 341 (412)
||+|||+++...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.... ......
T Consensus 183 kL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~-------~~~~~~ 255 (496)
T PTZ00283 183 KLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN-------MEEVMH 255 (496)
T ss_pred EEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC-------HHHHHH
Confidence 999999998654322 12234579999999999999999999999999999999999999986321 111111
Q ss_pred HHhhhccCCccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 342 DILYQRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 342 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
........ +.+.. ....+.+++.+||+.||++||++.+++++
T Consensus 256 ~~~~~~~~-~~~~~---~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 256 KTLAGRYD-PLPPS---ISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred HHhcCCCC-CCCCC---CCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 11111111 11111 12347889999999999999999999875
|
|
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=303.59 Aligned_cols=221 Identities=23% Similarity=0.314 Sum_probs=174.8
Q ss_pred eeeeecCceEEEEEEe-CCCcEEEEEec------------------------cCCccccceEEEecCceEEEEEEeccCC
Q 042435 149 YCIGTGGYDSVYKAEL-PDGKVVALKKL------------------------HHSETEDSAFVVYSPQCMFFIYEYMERG 203 (412)
Q Consensus 149 ~~lG~G~~g~Vy~~~~-~~~~~vAvK~l------------------------~~~~~~~~~~~~~~~~~~~lv~ey~~~g 203 (412)
+.||+|+||.||++.. .+|+.||+|.+ +|+++......+...+..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 3699999999999976 57899999965 3566666666778888999999999999
Q ss_pred ceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHh-CCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCCCCcc
Q 042435 204 SLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHH-DCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRT 282 (412)
Q Consensus 204 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~-~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 282 (412)
+|..++.... .+++..+..++.|++.||+|||+ . +|+||||||+|||++.++.+||+|||+++..........
T Consensus 81 ~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~ 154 (325)
T cd05594 81 ELFFHLSRER---VFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMK 154 (325)
T ss_pred cHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcccc
Confidence 9988876543 58999999999999999999997 6 899999999999999999999999999875433333334
Q ss_pred cccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccchhhHHHHHH
Q 042435 283 LQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKIIQDIIL 362 (412)
Q Consensus 283 ~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 362 (412)
...||+.|+|||++.+..++.++|||||||++|||+||+.||... ........+.......+ ... ...
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~-------~~~~~~~~i~~~~~~~p--~~~---~~~ 222 (325)
T cd05594 155 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ-------DHEKLFELILMEEIRFP--RTL---SPE 222 (325)
T ss_pred cccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCC-------CHHHHHHHHhcCCCCCC--CCC---CHH
Confidence 457999999999999889999999999999999999999998621 11111111111111111 111 223
Q ss_pred HHHHHHhcCcCCCCCCC-----CHHHHHHH
Q 042435 363 VSTIALACLRSKPKSRP-----TMQRISQE 387 (412)
Q Consensus 363 ~~~l~~~Cl~~dP~~RP-----s~~evl~~ 387 (412)
+.+++.+||+.||++|+ ++.+++++
T Consensus 223 ~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 223 AKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred HHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 77899999999999996 89999866
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=307.41 Aligned_cols=241 Identities=20% Similarity=0.295 Sum_probs=186.0
Q ss_pred HhhcCcccceeeeecCceEEEEEEeC------CCcEEEEEecc-----------------------CCccccceEEEecC
Q 042435 140 DATEYFHIRYCIGTGGYDSVYKAELP------DGKVVALKKLH-----------------------HSETEDSAFVVYSP 190 (412)
Q Consensus 140 ~~~~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vAvK~l~-----------------------~~~~~~~~~~~~~~ 190 (412)
...++|.+.++||+|+||.||+|... .+..||||+++ |+++......+...
T Consensus 34 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~ 113 (400)
T cd05105 34 FPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKS 113 (400)
T ss_pred ccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccC
Confidence 34568889999999999999999752 23579999652 67777777778888
Q ss_pred ceEEEEEEeccCCceeeeeccCcc--------------------------------------------------------
Q 042435 191 QCMFFIYEYMERGSLFCVLRDDDE-------------------------------------------------------- 214 (412)
Q Consensus 191 ~~~~lv~ey~~~gsL~~~l~~~~~-------------------------------------------------------- 214 (412)
+..++|||||++|+|.++++....
T Consensus 114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (400)
T cd05105 114 GPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLE 193 (400)
T ss_pred CceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhh
Confidence 999999999999999887754210
Q ss_pred -------------------------------------cccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEe
Q 042435 215 -------------------------------------AIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILL 257 (412)
Q Consensus 215 -------------------------------------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl 257 (412)
...+++..+..++.|+++||+|||+. +++||||||+||++
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Nill 270 (400)
T cd05105 194 IKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNVLL 270 (400)
T ss_pred hhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhEEE
Confidence 12478889999999999999999998 99999999999999
Q ss_pred cCCCcEEEeecCCccccCCCCC--CcccccccccccccccccCcccCcccccHHHHHHHHHHHh-CCCCcccccccccCC
Q 042435 258 NSNLEAFVADFGTVRLLDVDSS--NRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLM-GTHPGELLLSLSSSS 334 (412)
Q Consensus 258 ~~~~~~kl~DfGla~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~ellt-g~~P~~~~~~~~~~~ 334 (412)
+.++.+||+|||+++....... ......++..|+|||.+.+..++.++|||||||++|||++ |..||....
T Consensus 271 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~------ 344 (400)
T cd05105 271 AQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMI------ 344 (400)
T ss_pred eCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccc------
Confidence 9999999999999986543221 1223356788999999998889999999999999999997 999986321
Q ss_pred CCcchhhHHhhhccCCccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhcCCC
Q 042435 335 GPKIMLIDILYQRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELEGKTP 393 (412)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 393 (412)
........+......+.+. .....+.+++.+||+.||++|||+.++.+.|++..+
T Consensus 345 -~~~~~~~~~~~~~~~~~~~---~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 345 -VDSTFYNKIKSGYRMAKPD---HATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred -hhHHHHHHHhcCCCCCCCc---cCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 1111112222221111111 122347899999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-38 Score=292.91 Aligned_cols=234 Identities=25% Similarity=0.329 Sum_probs=179.9
Q ss_pred hcCcccceeeeecCceEEEEEEe-CCCcEEEEEecc---------------------CCccccceEEEecCceEEEEEEe
Q 042435 142 TEYFHIRYCIGTGGYDSVYKAEL-PDGKVVALKKLH---------------------HSETEDSAFVVYSPQCMFFIYEY 199 (412)
Q Consensus 142 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l~---------------------~~~~~~~~~~~~~~~~~~lv~ey 199 (412)
.++|++.+.||+|+||.||+|.. .+++.||+|.++ |+++......+...+..++||||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~ 87 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY 87 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence 35789999999999999999976 578899999653 45555555567778889999999
Q ss_pred ccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCCC
Q 042435 200 MERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSS 279 (412)
Q Consensus 200 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 279 (412)
+++++|.++++... .+++.++..++.|++.||+|||+. +|+||||||+||+++.++.++|+|||+++.......
T Consensus 88 ~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd06646 88 CGGGSLQDIYHVTG---PLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKITATIA 161 (267)
T ss_pred CCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceeeccccc
Confidence 99999999886543 588999999999999999999998 999999999999999999999999999986643333
Q ss_pred Cccccccccccccccccc---CcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccchhh
Q 042435 280 NRTLQAGTYGYIALELVY---TMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKI 356 (412)
Q Consensus 280 ~~~~~~gt~~y~aPE~~~---~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 356 (412)
......|+..|+|||.+. ...++.++|||||||++|||++|+.||...... ............++.....
T Consensus 162 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~-------~~~~~~~~~~~~~~~~~~~ 234 (267)
T cd06646 162 KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPM-------RALFLMSKSNFQPPKLKDK 234 (267)
T ss_pred ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchh-------hhheeeecCCCCCCCCccc
Confidence 333456889999999874 345788999999999999999999998532111 0000111111111111111
Q ss_pred HHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHH
Q 042435 357 IQDIILVSTIALACLRSKPKSRPTMQRISQEL 388 (412)
Q Consensus 357 ~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L 388 (412)
......+.+++.+||+.+|++|||+++++++|
T Consensus 235 ~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 235 TKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred cccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 11223478999999999999999999998764
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=292.98 Aligned_cols=236 Identities=21% Similarity=0.283 Sum_probs=180.9
Q ss_pred hhcCcccceeeeecCceEEEEEEeC------CCcEEEEEecc----------------------CCccccceEEEecCce
Q 042435 141 ATEYFHIRYCIGTGGYDSVYKAELP------DGKVVALKKLH----------------------HSETEDSAFVVYSPQC 192 (412)
Q Consensus 141 ~~~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vAvK~l~----------------------~~~~~~~~~~~~~~~~ 192 (412)
.+++|++.+.||+|+||.||+|... +++.||+|.++ |+++......+.....
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4678999999999999999999753 35679999653 4555555556777788
Q ss_pred EEEEEEeccCCceeeeeccCcc-------cccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEE
Q 042435 193 MFFIYEYMERGSLFCVLRDDDE-------AIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFV 265 (412)
Q Consensus 193 ~~lv~ey~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl 265 (412)
.++||||+++|+|.+++..... ...++|.++..++.|++.||+|||+. +++||||||+||++++++.++|
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCCEEE
Confidence 9999999999999998865321 12468899999999999999999998 9999999999999999999999
Q ss_pred eecCCccccCCCCCCc--ccccccccccccccccCcccCcccccHHHHHHHHHHHh-CCCCcccccccccCCCCcchhhH
Q 042435 266 ADFGTVRLLDVDSSNR--TLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLM-GTHPGELLLSLSSSSGPKIMLID 342 (412)
Q Consensus 266 ~DfGla~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~ 342 (412)
+|||+++......... ....+++.|+|||++.+..++.++|||||||++|||++ |..||... .. ....+
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~-------~~-~~~~~ 232 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGM-------SN-EQVLR 232 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCC-------CH-HHHHH
Confidence 9999987654322111 12345778999999998889999999999999999999 68887621 11 11122
Q ss_pred HhhhccCCccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhc
Q 042435 343 ILYQRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELEG 390 (412)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~ 390 (412)
..........+.. ....+.+++.+||+.||++|||+.|++++|++
T Consensus 233 ~~~~~~~~~~~~~---~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 233 FVMEGGLLDKPDN---CPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred HHHcCCcCCCCCC---CCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 2111111111111 12347889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=305.82 Aligned_cols=231 Identities=20% Similarity=0.331 Sum_probs=193.7
Q ss_pred hcCcccceeeeecCceEEEEEEeC-CCcEEEEEec-----------------------cCCccccceEEEecCce-EEEE
Q 042435 142 TEYFHIRYCIGTGGYDSVYKAELP-DGKVVALKKL-----------------------HHSETEDSAFVVYSPQC-MFFI 196 (412)
Q Consensus 142 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l-----------------------~~~~~~~~~~~~~~~~~-~~lv 196 (412)
.++|...+.+|+|+||.++..+.+ +++.+++|++ +|++++.....+..++. .+||
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv 82 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV 82 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence 357888999999999999999764 5788999954 67888887777777777 9999
Q ss_pred EEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCC
Q 042435 197 YEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDV 276 (412)
Q Consensus 197 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~ 276 (412)
|+||+||+|.+.+...+ +..++...+.+++.|++.|+.|||++ .|+|||||+.||+++.+..+||+|||+|+.+..
T Consensus 83 m~Y~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~ 158 (426)
T KOG0589|consen 83 MEYCEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNP 158 (426)
T ss_pred EeecCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhcCC
Confidence 99999999999998765 34688999999999999999999988 999999999999999999999999999999887
Q ss_pred CCCCcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccchhh
Q 042435 277 DSSNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKI 356 (412)
Q Consensus 277 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 356 (412)
.........||+.||+||.+.+.+|..|+|||||||++|||++-+.+|+.. ........+.... ..+.+.
T Consensus 159 ~~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~-------~m~~Li~ki~~~~-~~Plp~-- 228 (426)
T KOG0589|consen 159 EDSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKAS-------NMSELILKINRGL-YSPLPS-- 228 (426)
T ss_pred chhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCcc-------chHHHHHHHhhcc-CCCCCc--
Confidence 765667789999999999999999999999999999999999999998732 1122223333322 222222
Q ss_pred HHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 357 IQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 357 ~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
.....+..++..|++.+|..||++.+++.+
T Consensus 229 -~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 229 -MYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred -cccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 233348889999999999999999999876
|
|
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=289.10 Aligned_cols=231 Identities=23% Similarity=0.315 Sum_probs=180.5
Q ss_pred cCcccceeeeecCceEEEEEEeCCCcEEEEEec--------------------cCCccccceEEEecCceEEEEEEeccC
Q 042435 143 EYFHIRYCIGTGGYDSVYKAELPDGKVVALKKL--------------------HHSETEDSAFVVYSPQCMFFIYEYMER 202 (412)
Q Consensus 143 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~l--------------------~~~~~~~~~~~~~~~~~~~lv~ey~~~ 202 (412)
++|++.+.||+|+||.||+|++.++..+|+|.+ +|+++......+...+..+++|||+++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSN 83 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCC
Confidence 457888999999999999999877778999965 355555555667777788999999999
Q ss_pred CceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCCCC-c
Q 042435 203 GSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSN-R 281 (412)
Q Consensus 203 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~-~ 281 (412)
|+|.+++..... .+++.+++.++.|++.||+|||+. +++|+||||+||++++++.+||+|||.++........ .
T Consensus 84 ~~l~~~i~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~ 158 (256)
T cd05113 84 GCLLNYLREHGK--RFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSS 158 (256)
T ss_pred CcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCCCceeec
Confidence 999998875432 589999999999999999999998 9999999999999999999999999998765432211 1
Q ss_pred ccccccccccccccccCcccCcccccHHHHHHHHHHHh-CCCCcccccccccCCCCcchhhHHhhhccCCccchhhHHHH
Q 042435 282 TLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLM-GTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKIIQDI 360 (412)
Q Consensus 282 ~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 360 (412)
....++..|+|||...+..++.++||||||+++|||++ |+.||.... . ....+.+........... ..
T Consensus 159 ~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~-------~-~~~~~~~~~~~~~~~~~~---~~ 227 (256)
T cd05113 159 VGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFN-------N-SETVEKVSQGLRLYRPHL---AS 227 (256)
T ss_pred CCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCC-------H-HHHHHHHhcCCCCCCCCC---CC
Confidence 12235678999999988889999999999999999999 999986321 1 111122212111111111 12
Q ss_pred HHHHHHHHhcCcCCCCCCCCHHHHHHHHh
Q 042435 361 ILVSTIALACLRSKPKSRPTMQRISQELE 389 (412)
Q Consensus 361 ~~~~~l~~~Cl~~dP~~RPs~~evl~~L~ 389 (412)
..+.+++.+||+.||.+||++.++++.|+
T Consensus 228 ~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 228 EKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred HHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 34889999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-38 Score=301.21 Aligned_cols=216 Identities=25% Similarity=0.341 Sum_probs=171.7
Q ss_pred eeeeecCceEEEEEEeC-CCcEEEEEec-------------------------cCCccccceEEEecCceEEEEEEeccC
Q 042435 149 YCIGTGGYDSVYKAELP-DGKVVALKKL-------------------------HHSETEDSAFVVYSPQCMFFIYEYMER 202 (412)
Q Consensus 149 ~~lG~G~~g~Vy~~~~~-~~~~vAvK~l-------------------------~~~~~~~~~~~~~~~~~~~lv~ey~~~ 202 (412)
+.||+|+||+||+|... +|+.||+|.+ +|+++......+...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 36999999999999774 6899999964 355666666667788899999999999
Q ss_pred CceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCCCCcc
Q 042435 203 GSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRT 282 (412)
Q Consensus 203 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 282 (412)
|+|..++.... .+++.....++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++..........
T Consensus 81 g~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 154 (323)
T cd05575 81 GELFFHLQRER---SFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTS 154 (323)
T ss_pred CCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCccc
Confidence 99988886543 588899999999999999999998 999999999999999999999999999875433333334
Q ss_pred cccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccchhhHHHHHH
Q 042435 283 LQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKIIQDIIL 362 (412)
Q Consensus 283 ~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 362 (412)
...||+.|+|||++.+..++.++|||||||++|||++|+.||... ........+.......+ ... ...
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~-------~~~~~~~~i~~~~~~~~--~~~---~~~ 222 (323)
T cd05575 155 TFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSR-------DTAEMYDNILNKPLRLK--PNI---SVS 222 (323)
T ss_pred cccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCC-------CHHHHHHHHHcCCCCCC--CCC---CHH
Confidence 457999999999999989999999999999999999999998632 11111122222211111 111 234
Q ss_pred HHHHHHhcCcCCCCCCCCHH
Q 042435 363 VSTIALACLRSKPKSRPTMQ 382 (412)
Q Consensus 363 ~~~l~~~Cl~~dP~~RPs~~ 382 (412)
+.+++.+|++.||++||++.
T Consensus 223 ~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 223 ARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred HHHHHHHHhhcCHHhCCCCC
Confidence 78899999999999999874
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=299.57 Aligned_cols=221 Identities=23% Similarity=0.338 Sum_probs=175.1
Q ss_pred eeeeecCceEEEEEEe----CCCcEEEEEec-------------------------cCCccccceEEEecCceEEEEEEe
Q 042435 149 YCIGTGGYDSVYKAEL----PDGKVVALKKL-------------------------HHSETEDSAFVVYSPQCMFFIYEY 199 (412)
Q Consensus 149 ~~lG~G~~g~Vy~~~~----~~~~~vAvK~l-------------------------~~~~~~~~~~~~~~~~~~~lv~ey 199 (412)
+.||+|+||.||++.. .+++.||+|.+ +|+++......+..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 5799999999999975 35789999964 456666666677788899999999
Q ss_pred ccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCCC
Q 042435 200 MERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSS 279 (412)
Q Consensus 200 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 279 (412)
+++|+|.+++.... .+.+.....++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 155 (323)
T cd05584 82 LSGGELFMHLEREG---IFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT 155 (323)
T ss_pred CCCchHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC
Confidence 99999998886543 477888889999999999999998 999999999999999999999999999875433333
Q ss_pred CcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccchhhHHH
Q 042435 280 NRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKIIQD 359 (412)
Q Consensus 280 ~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 359 (412)
......||+.|+|||++.+..++.++|||||||++|||++|+.||.... .......+....... +...
T Consensus 156 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~-------~~~~~~~~~~~~~~~--~~~~--- 223 (323)
T cd05584 156 VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAEN-------RKKTIDKILKGKLNL--PPYL--- 223 (323)
T ss_pred cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCC-------HHHHHHHHHcCCCCC--CCCC---
Confidence 3334579999999999998889999999999999999999999987321 111122222222211 1111
Q ss_pred HHHHHHHHHhcCcCCCCCCC-----CHHHHHHH
Q 042435 360 IILVSTIALACLRSKPKSRP-----TMQRISQE 387 (412)
Q Consensus 360 ~~~~~~l~~~Cl~~dP~~RP-----s~~evl~~ 387 (412)
...+.+++.+||+.||++|| ++.+++++
T Consensus 224 ~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 224 TPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred CHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence 22378899999999999999 78888775
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=304.82 Aligned_cols=238 Identities=20% Similarity=0.213 Sum_probs=181.3
Q ss_pred cCcccceeeeecCceEEEEEEe-CCCcEEEEEe---------------ccCCccccceEEEecCceEEEEEEeccCCcee
Q 042435 143 EYFHIRYCIGTGGYDSVYKAEL-PDGKVVALKK---------------LHHSETEDSAFVVYSPQCMFFIYEYMERGSLF 206 (412)
Q Consensus 143 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~---------------l~~~~~~~~~~~~~~~~~~~lv~ey~~~gsL~ 206 (412)
++|++.+.||+|+||.||++.. .+++.||+|. ++|+++......+......++|+||+. ++|.
T Consensus 92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~-~~L~ 170 (391)
T PHA03212 92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQRGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYK-TDLY 170 (391)
T ss_pred CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhhhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecCC-CCHH
Confidence 5799999999999999999966 5689999994 578899888888888899999999995 6888
Q ss_pred eeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCC-CCccccc
Q 042435 207 CVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDS-SNRTLQA 285 (412)
Q Consensus 207 ~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~-~~~~~~~ 285 (412)
.++.... .+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++...... .......
T Consensus 171 ~~l~~~~---~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~~~~~~ 244 (391)
T PHA03212 171 CYLAAKR---NIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWA 244 (391)
T ss_pred HHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCccccccccccccccccc
Confidence 7776543 588999999999999999999998 99999999999999999999999999997543221 2223457
Q ss_pred ccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcch----------------------hhHH
Q 042435 286 GTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIM----------------------LIDI 343 (412)
Q Consensus 286 gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~----------------------~~~~ 343 (412)
||+.|+|||++.+..++.++|||||||++|||+||+.|+............... ....
T Consensus 245 gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~~~ 324 (391)
T PHA03212 245 GTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLDEI 324 (391)
T ss_pred CccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHHHHHH
Confidence 999999999999889999999999999999999999886422111000000000 0000
Q ss_pred h----hhcc-CC---ccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 344 L----YQRL-SP---PINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 344 ~----~~~~-~~---~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
. .... .+ +...........+.+++.+||+.||++|||++|++++
T Consensus 325 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~h 376 (391)
T PHA03212 325 YIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDF 376 (391)
T ss_pred HHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 0 0000 00 0001111223357889999999999999999999864
|
|
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=291.93 Aligned_cols=236 Identities=23% Similarity=0.305 Sum_probs=180.8
Q ss_pred cCcccceeeeecCceEEEEEEeC-CCc----EEEEEec----------------------cCCccccceEEEecCceEEE
Q 042435 143 EYFHIRYCIGTGGYDSVYKAELP-DGK----VVALKKL----------------------HHSETEDSAFVVYSPQCMFF 195 (412)
Q Consensus 143 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~----~vAvK~l----------------------~~~~~~~~~~~~~~~~~~~l 195 (412)
++|++.+.||+|+||.||+|.+. +++ .+++|.+ .|+++......+ .....++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~-~~~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGIC-PGASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEE-CCCccEE
Confidence 46778899999999999999873 344 4777765 344444444444 3456789
Q ss_pred EEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccC
Q 042435 196 IYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLD 275 (412)
Q Consensus 196 v~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~ 275 (412)
++||+++|+|.+++..... .++|..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||+++...
T Consensus 86 i~e~~~~gsL~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~ 160 (279)
T cd05111 86 VTQLSPLGSLLDHVRQHRD--SLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLLY 160 (279)
T ss_pred EEEeCCCCcHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCccceecc
Confidence 9999999999999875432 489999999999999999999998 99999999999999999999999999998654
Q ss_pred CCCC--CcccccccccccccccccCcccCcccccHHHHHHHHHHHh-CCCCcccccccccCCCCcchhhHHhhhccCCcc
Q 042435 276 VDSS--NRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLM-GTHPGELLLSLSSSSGPKIMLIDILYQRLSPPI 352 (412)
Q Consensus 276 ~~~~--~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 352 (412)
.... ......++..|+|||.+.+..++.++||||||+++||+++ |+.||.... .....+.+......+.
T Consensus 161 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~--------~~~~~~~~~~~~~~~~ 232 (279)
T cd05111 161 PDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMR--------PHEVPDLLEKGERLAQ 232 (279)
T ss_pred CCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCC--------HHHHHHHHHCCCcCCC
Confidence 3322 1223456788999999988899999999999999999998 999986321 1112233332222221
Q ss_pred chhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhcCCCCC
Q 042435 353 NQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELEGKTPMK 395 (412)
Q Consensus 353 ~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~~ 395 (412)
+.. ....+.+++.+||..||++|||+.|+++.|+.+....
T Consensus 233 ~~~---~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~~ 272 (279)
T cd05111 233 PQI---CTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARDP 272 (279)
T ss_pred CCC---CCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhCC
Confidence 111 1223678899999999999999999999998876544
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=299.09 Aligned_cols=221 Identities=24% Similarity=0.318 Sum_probs=175.5
Q ss_pred eeeeecCceEEEEEEeC-CCcEEEEEec-------------------------cCCccccceEEEecCceEEEEEEeccC
Q 042435 149 YCIGTGGYDSVYKAELP-DGKVVALKKL-------------------------HHSETEDSAFVVYSPQCMFFIYEYMER 202 (412)
Q Consensus 149 ~~lG~G~~g~Vy~~~~~-~~~~vAvK~l-------------------------~~~~~~~~~~~~~~~~~~~lv~ey~~~ 202 (412)
+.||+|+||.||+|... +++.||+|.+ +|+++......+...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999775 5889999965 356666666677788899999999999
Q ss_pred CceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCCCCcc
Q 042435 203 GSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRT 282 (412)
Q Consensus 203 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 282 (412)
|+|..++.... .+++.++..++.|++.||+|||+. +++||||||+||++++++.+||+|||+++..........
T Consensus 81 ~~L~~~~~~~~---~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 154 (318)
T cd05570 81 GDLMFHIQRSG---RFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTS 154 (318)
T ss_pred CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCccc
Confidence 99988876543 589999999999999999999998 999999999999999999999999999875333333333
Q ss_pred cccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccchhhHHHHHH
Q 042435 283 LQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKIIQDIIL 362 (412)
Q Consensus 283 ~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 362 (412)
...||+.|+|||++.+..++.++|||||||++|||++|+.||.... .......+.......+ .. ....
T Consensus 155 ~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~-------~~~~~~~i~~~~~~~~--~~---~~~~ 222 (318)
T cd05570 155 TFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDD-------EDELFQSILEDEVRYP--RW---LSKE 222 (318)
T ss_pred ceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCC-------HHHHHHHHHcCCCCCC--Cc---CCHH
Confidence 4568999999999999999999999999999999999999986321 1111111221111111 11 1224
Q ss_pred HHHHHHhcCcCCCCCCCCH-----HHHHHH
Q 042435 363 VSTIALACLRSKPKSRPTM-----QRISQE 387 (412)
Q Consensus 363 ~~~l~~~Cl~~dP~~RPs~-----~evl~~ 387 (412)
+.+++.+||+.||++||++ .+++++
T Consensus 223 ~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 223 AKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred HHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 7889999999999999999 888765
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=288.67 Aligned_cols=239 Identities=20% Similarity=0.229 Sum_probs=186.2
Q ss_pred cCcccceeeeecCceEEEEEEe-CCCcEEEEEec------------------------cCCccccceEEEecCceEEEEE
Q 042435 143 EYFHIRYCIGTGGYDSVYKAEL-PDGKVVALKKL------------------------HHSETEDSAFVVYSPQCMFFIY 197 (412)
Q Consensus 143 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l------------------------~~~~~~~~~~~~~~~~~~~lv~ 197 (412)
++|++.+.||+|+||.||+|.. .+++.||||.+ +|+++......+...+..++++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 5789999999999999999976 47899999954 3455555555566778899999
Q ss_pred EeccCCceeeeeccCcc-cccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCC
Q 042435 198 EYMERGSLFCVLRDDDE-AIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDV 276 (412)
Q Consensus 198 ey~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~ 276 (412)
||+++|+|.+++..... ...++......++.|++.||+|||++ +++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 99999999888754321 22478889999999999999999998 999999999999999999999999999887654
Q ss_pred CCCCcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccchhh
Q 042435 277 DSSNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKI 356 (412)
Q Consensus 277 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 356 (412)
.........|++.|+|||.+.+..++.++|+||||+++|||++|+.||.... .......+.+.....++...
T Consensus 159 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~------~~~~~~~~~~~~~~~~~~~~-- 230 (267)
T cd08228 159 KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK------MNLFSLCQKIEQCDYPPLPT-- 230 (267)
T ss_pred hhHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccc------ccHHHHHHHHhcCCCCCCCh--
Confidence 3332334568889999999988889999999999999999999999985211 11111222222222222111
Q ss_pred HHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhcCC
Q 042435 357 IQDIILVSTIALACLRSKPKSRPTMQRISQELEGKT 392 (412)
Q Consensus 357 ~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 392 (412)
......+.+++.+||+.+|++||++.+|++.|+.++
T Consensus 231 ~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 231 EHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred hhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 122345889999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=291.36 Aligned_cols=235 Identities=22% Similarity=0.332 Sum_probs=181.1
Q ss_pred cCcccceeeeecCceEEEEEEe-----CCCcEEEEEecc----------------------CCccccceEEEecCceEEE
Q 042435 143 EYFHIRYCIGTGGYDSVYKAEL-----PDGKVVALKKLH----------------------HSETEDSAFVVYSPQCMFF 195 (412)
Q Consensus 143 ~~f~~~~~lG~G~~g~Vy~~~~-----~~~~~vAvK~l~----------------------~~~~~~~~~~~~~~~~~~l 195 (412)
++|++.+.||+|+||.||+|.+ .++..||+|.+. |+++......+...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 4578889999999999999974 356789999763 4555555556677788999
Q ss_pred EEEeccCCceeeeeccCc--------------ccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCC
Q 042435 196 IYEYMERGSLFCVLRDDD--------------EAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNL 261 (412)
Q Consensus 196 v~ey~~~gsL~~~l~~~~--------------~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~ 261 (412)
||||+++|+|.+++.... ....+++.+.+.++.|++.||+|||++ +++||||||+||++++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEcCCC
Confidence 999999999998875321 122478999999999999999999998 999999999999999999
Q ss_pred cEEEeecCCccccCCCCC--CcccccccccccccccccCcccCcccccHHHHHHHHHHHh-CCCCcccccccccCCCCcc
Q 042435 262 EAFVADFGTVRLLDVDSS--NRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLM-GTHPGELLLSLSSSSGPKI 338 (412)
Q Consensus 262 ~~kl~DfGla~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~ellt-g~~P~~~~~~~~~~~~~~~ 338 (412)
.+||+|||+++....... ......++..|+|||++.+..++.++||||||+++|||++ |..||... . ..
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~-------~-~~ 233 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGF-------S-NQ 233 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCC-------C-HH
Confidence 999999999986533221 1223345678999999988889999999999999999998 88887521 1 11
Q ss_pred hhhHHhhhccCCccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhcC
Q 042435 339 MLIDILYQRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELEGK 391 (412)
Q Consensus 339 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 391 (412)
...+.+......+.+.. ....+.+++.+||+.||++||++.++.++|.++
T Consensus 234 ~~~~~~~~~~~~~~~~~---~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~~ 283 (283)
T cd05090 234 EVIEMVRKRQLLPCSED---CPPRMYSLMTECWQEGPSRRPRFKDIHTRLRSW 283 (283)
T ss_pred HHHHHHHcCCcCCCCCC---CCHHHHHHHHHHcccCcccCcCHHHHHHHhhcC
Confidence 22233322222221111 123478899999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=293.33 Aligned_cols=226 Identities=21% Similarity=0.253 Sum_probs=172.1
Q ss_pred eeecCceEEEEEEe-CCCcEEEEEecc------------------------CCccccceEEEecCceEEEEEEeccCCce
Q 042435 151 IGTGGYDSVYKAEL-PDGKVVALKKLH------------------------HSETEDSAFVVYSPQCMFFIYEYMERGSL 205 (412)
Q Consensus 151 lG~G~~g~Vy~~~~-~~~~~vAvK~l~------------------------~~~~~~~~~~~~~~~~~~lv~ey~~~gsL 205 (412)
||+|+||+||++.. .+++.||+|.+. |+++......+......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 69999999999976 468999999763 34444444456677889999999999999
Q ss_pred eeeeccCc-ccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCCCCcccc
Q 042435 206 FCVLRDDD-EAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQ 284 (412)
Q Consensus 206 ~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 284 (412)
.+++.... ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++|+|||+++............
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~ 157 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGY 157 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcccccc
Confidence 87764322 223589999999999999999999998 99999999999999999999999999997665443333445
Q ss_pred cccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccchhhHHHHHHHH
Q 042435 285 AGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKIIQDIILVS 364 (412)
Q Consensus 285 ~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 364 (412)
.||+.|+|||++.+..++.++|||||||++|||++|+.||.... ...............+. .........+.
T Consensus 158 ~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~-------~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 229 (280)
T cd05608 158 AGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARG-------EKVENKELKQRILNDSV-TYPDKFSPASK 229 (280)
T ss_pred CCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC-------cchhHHHHHHhhcccCC-CCcccCCHHHH
Confidence 78999999999999999999999999999999999999986321 00011111111111110 00111223478
Q ss_pred HHHHhcCcCCCCCCC-----CHHHHHHH
Q 042435 365 TIALACLRSKPKSRP-----TMQRISQE 387 (412)
Q Consensus 365 ~l~~~Cl~~dP~~RP-----s~~evl~~ 387 (412)
+++.+||+.||++|| ++++++++
T Consensus 230 ~li~~~l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 230 SFCEALLAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred HHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence 899999999999999 77788765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=299.46 Aligned_cols=228 Identities=20% Similarity=0.299 Sum_probs=172.3
Q ss_pred eeeeecCceEEEEEEe-CCCcEEEEEecc-------------------------CCccccceEEEecCceEEEEEEeccC
Q 042435 149 YCIGTGGYDSVYKAEL-PDGKVVALKKLH-------------------------HSETEDSAFVVYSPQCMFFIYEYMER 202 (412)
Q Consensus 149 ~~lG~G~~g~Vy~~~~-~~~~~vAvK~l~-------------------------~~~~~~~~~~~~~~~~~~lv~ey~~~ 202 (412)
+.||+|+||.||+|.. .+++.||+|.++ |+++......+...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 3699999999999976 467899999764 33444444556677889999999999
Q ss_pred CceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCCCCcc
Q 042435 203 GSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRT 282 (412)
Q Consensus 203 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 282 (412)
|+|..++.... .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++..........
T Consensus 81 ~~L~~~~~~~~---~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~ 154 (327)
T cd05617 81 GDLMFHMQRQR---KLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTS 154 (327)
T ss_pred CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCcee
Confidence 99988776443 589999999999999999999998 999999999999999999999999999875333233334
Q ss_pred cccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccchhhHHHHHH
Q 042435 283 LQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKIIQDIIL 362 (412)
Q Consensus 283 ~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 362 (412)
...||+.|+|||++.+..++.++|||||||++|||++|+.||+.................+...... .+.. ....
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--~p~~---~~~~ 229 (327)
T cd05617 155 TFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIR--IPRF---LSVK 229 (327)
T ss_pred cccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCC--CCCC---CCHH
Confidence 4579999999999999999999999999999999999999996321111001101111111111111 1111 1223
Q ss_pred HHHHHHhcCcCCCCCCCC------HHHHHHH
Q 042435 363 VSTIALACLRSKPKSRPT------MQRISQE 387 (412)
Q Consensus 363 ~~~l~~~Cl~~dP~~RPs------~~evl~~ 387 (412)
+.+++.+||+.||++||+ +.++.++
T Consensus 230 ~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 260 (327)
T cd05617 230 ASHVLKGFLNKDPKERLGCQPQTGFSDIKSH 260 (327)
T ss_pred HHHHHHHHhccCHHHcCCCCCCCCHHHHHcC
Confidence 678999999999999998 4576554
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=291.70 Aligned_cols=235 Identities=23% Similarity=0.339 Sum_probs=178.8
Q ss_pred HHhhcCcccceeeeecCceEEEEEEeC-CCcEEEEEec---------------------cCCccccceEEEec------C
Q 042435 139 IDATEYFHIRYCIGTGGYDSVYKAELP-DGKVVALKKL---------------------HHSETEDSAFVVYS------P 190 (412)
Q Consensus 139 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l---------------------~~~~~~~~~~~~~~------~ 190 (412)
..+++.|++.+.||+|+||.||+|... +++.||+|.+ +|+++......+.. .
T Consensus 2 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 2 RDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred CChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 356788999999999999999999764 6889999975 34555544444432 2
Q ss_pred ceEEEEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCC
Q 042435 191 QCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGT 270 (412)
Q Consensus 191 ~~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGl 270 (412)
...+++|||+++|+|.+++..... ..+++..+..++.|++.||+|||++ +++||||||+||++++++.++|+|||+
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~Dfg~ 157 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNTKG-NTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGV 157 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEccCCC
Confidence 468999999999999998875432 2588999999999999999999998 999999999999999999999999999
Q ss_pred ccccCCCCCCccccccccccccccccc-----CcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhh
Q 042435 271 VRLLDVDSSNRTLQAGTYGYIALELVY-----TMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILY 345 (412)
Q Consensus 271 a~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~ 345 (412)
++.............|+..|+|||++. ...++.++|||||||++|||++|+.||..... .........
T Consensus 158 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~-------~~~~~~~~~ 230 (272)
T cd06637 158 SAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP-------MRALFLIPR 230 (272)
T ss_pred ceecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCH-------HHHHHHHhc
Confidence 986544333344567899999999986 34578899999999999999999999863211 000111111
Q ss_pred hccCCccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 346 QRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
......... .....+.+++.+||..||.+|||+.|++++
T Consensus 231 ~~~~~~~~~---~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 269 (272)
T cd06637 231 NPAPRLKSK---KWSKKFQSFIESCLVKNHSQRPTTEQLMKH 269 (272)
T ss_pred CCCCCCCCC---CcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence 110000001 112247899999999999999999999864
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=302.77 Aligned_cols=177 Identities=25% Similarity=0.361 Sum_probs=152.2
Q ss_pred cCcccceeeeecCceEEEEEEeC-CCcEEEEEecc------------------------CCccccceEEEecCceEEEEE
Q 042435 143 EYFHIRYCIGTGGYDSVYKAELP-DGKVVALKKLH------------------------HSETEDSAFVVYSPQCMFFIY 197 (412)
Q Consensus 143 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~------------------------~~~~~~~~~~~~~~~~~~lv~ 197 (412)
++|++.+.||+|+||+||+|... +++.||+|.++ |+++......+.+....++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 47899999999999999999764 68999999763 445555556677888999999
Q ss_pred EeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCC
Q 042435 198 EYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVD 277 (412)
Q Consensus 198 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~ 277 (412)
||+++|+|.+++.... .+++.....++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 81 E~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~ 154 (363)
T cd05628 81 EFLPGGDMMTLLMKKD---TLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKA 154 (363)
T ss_pred cCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCccccccc
Confidence 9999999999987543 589999999999999999999998 9999999999999999999999999998754321
Q ss_pred CC-----------------------------------CcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCC
Q 042435 278 SS-----------------------------------NRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTH 322 (412)
Q Consensus 278 ~~-----------------------------------~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~ 322 (412)
.. ......||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~ 234 (363)
T cd05628 155 HRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (363)
T ss_pred ccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCC
Confidence 10 0123479999999999999999999999999999999999999
Q ss_pred Ccc
Q 042435 323 PGE 325 (412)
Q Consensus 323 P~~ 325 (412)
||.
T Consensus 235 Pf~ 237 (363)
T cd05628 235 PFC 237 (363)
T ss_pred CCC
Confidence 996
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=305.22 Aligned_cols=230 Identities=20% Similarity=0.286 Sum_probs=178.3
Q ss_pred cCcccceeeeecCceEEEEEEeC-CCcEEEEEec------------------------cCCccccceEEEecCceEEEEE
Q 042435 143 EYFHIRYCIGTGGYDSVYKAELP-DGKVVALKKL------------------------HHSETEDSAFVVYSPQCMFFIY 197 (412)
Q Consensus 143 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l------------------------~~~~~~~~~~~~~~~~~~~lv~ 197 (412)
++|++.+.||+|+||.||+|+.. +++.||||.+ +|+++......+.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 47899999999999999999774 6899999965 3566666677788899999999
Q ss_pred EeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCC
Q 042435 198 EYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVD 277 (412)
Q Consensus 198 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~ 277 (412)
||+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.++|+|||+++.+...
T Consensus 81 E~~~~g~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 154 (364)
T cd05599 81 EYLPGGDMMTLLMKKD---TFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKS 154 (364)
T ss_pred CCCCCcHHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceecccc
Confidence 9999999999887543 489999999999999999999998 9999999999999999999999999998754321
Q ss_pred CC--------------------------------------CcccccccccccccccccCcccCcccccHHHHHHHHHHHh
Q 042435 278 SS--------------------------------------NRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLM 319 (412)
Q Consensus 278 ~~--------------------------------------~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~ellt 319 (412)
.. ......||+.|+|||++.+..++.++|||||||++|||++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~ 234 (364)
T cd05599 155 HRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLV 234 (364)
T ss_pred ccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhc
Confidence 10 0012358999999999998899999999999999999999
Q ss_pred CCCCcccccccccCCCCcchhhHHhhhccCCccchhhHHHHHHHHHHHHhcCcCCCCCCCC---HHHHHHH
Q 042435 320 GTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKIIQDIILVSTIALACLRSKPKSRPT---MQRISQE 387 (412)
Q Consensus 320 g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs---~~evl~~ 387 (412)
|..||.... .......+.........+.. ......+.+++.+|+. +|.+|++ +.|++++
T Consensus 235 G~~Pf~~~~-------~~~~~~~i~~~~~~~~~~~~-~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h 296 (364)
T cd05599 235 GYPPFCSDN-------PQETYRKIINWKETLQFPDE-VPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH 296 (364)
T ss_pred CCCCCCCCC-------HHHHHHHHHcCCCccCCCCC-CCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence 999987321 11111111111111000010 0112236788888886 9999997 8888775
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-38 Score=305.92 Aligned_cols=233 Identities=22% Similarity=0.285 Sum_probs=180.7
Q ss_pred HhhcCcccceeeeecCceEEEEEEeC-CCcEEEEEec------------------------cCCccccceEEEecCceEE
Q 042435 140 DATEYFHIRYCIGTGGYDSVYKAELP-DGKVVALKKL------------------------HHSETEDSAFVVYSPQCMF 194 (412)
Q Consensus 140 ~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l------------------------~~~~~~~~~~~~~~~~~~~ 194 (412)
...++|++.+.||+|+||.||++... +++.||+|.+ +|+++......+.+++..+
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~ 119 (370)
T cd05596 40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLY 119 (370)
T ss_pred CCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence 34578999999999999999999774 6889999965 3555666666677888999
Q ss_pred EEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCcccc
Q 042435 195 FIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLL 274 (412)
Q Consensus 195 lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~ 274 (412)
+||||+++|+|.+++... .++......++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 120 lv~Ey~~gg~L~~~l~~~----~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~ 192 (370)
T cd05596 120 MVMEYMPGGDLVNLMSNY----DIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKM 192 (370)
T ss_pred EEEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEeccceeec
Confidence 999999999999988654 377788888999999999999998 9999999999999999999999999999865
Q ss_pred CCCCC-CcccccccccccccccccCc----ccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccC
Q 042435 275 DVDSS-NRTLQAGTYGYIALELVYTM----VVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLS 349 (412)
Q Consensus 275 ~~~~~-~~~~~~gt~~y~aPE~~~~~----~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 349 (412)
..... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||.... .......+......
T Consensus 193 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~-------~~~~~~~i~~~~~~ 265 (370)
T cd05596 193 DANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS-------LVGTYSKIMDHKNS 265 (370)
T ss_pred cCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCC-------HHHHHHHHHcCCCc
Confidence 43322 22345799999999998653 47889999999999999999999987321 11112222221111
Q ss_pred CccchhhHHHHHHHHHHHHhcCcCCCCC--CCCHHHHHHH
Q 042435 350 PPINQKIIQDIILVSTIALACLRSKPKS--RPTMQRISQE 387 (412)
Q Consensus 350 ~~~~~~~~~~~~~~~~l~~~Cl~~dP~~--RPs~~evl~~ 387 (412)
...+. .......+.+++.+|++.+|++ |||++|++++
T Consensus 266 ~~~~~-~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 266 LTFPD-DIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred CCCCC-cCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 11111 1112234788999999999987 9999999876
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=290.28 Aligned_cols=238 Identities=24% Similarity=0.383 Sum_probs=182.0
Q ss_pred hcCcccceeeeecCceEEEEEEe-CCCc----EEEEEecc----------------------CCccccceEEEecCceEE
Q 042435 142 TEYFHIRYCIGTGGYDSVYKAEL-PDGK----VVALKKLH----------------------HSETEDSAFVVYSPQCMF 194 (412)
Q Consensus 142 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~----~vAvK~l~----------------------~~~~~~~~~~~~~~~~~~ 194 (412)
.++|+..+.||+|+||.||+|.+ .+++ .||+|.++ |+++......+. ....+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-~~~~~ 84 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICL-TSTVQ 84 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEc-CCCcE
Confidence 35688889999999999999975 3444 48999753 344444444444 34578
Q ss_pred EEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCcccc
Q 042435 195 FIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLL 274 (412)
Q Consensus 195 lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~ 274 (412)
+++||+++|+|.++++.... .+++..++.++.|++.||+|||+. +++||||||+||++++++.+||+|||+++..
T Consensus 85 l~~~~~~~g~l~~~l~~~~~--~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~ 159 (279)
T cd05109 85 LVTQLMPYGCLLDYVRENKD--RIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (279)
T ss_pred EEEEcCCCCCHHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCceeec
Confidence 99999999999999876432 489999999999999999999998 9999999999999999999999999999876
Q ss_pred CCCCCCc--ccccccccccccccccCcccCcccccHHHHHHHHHHHh-CCCCcccccccccCCCCcchhhHHhhhccCCc
Q 042435 275 DVDSSNR--TLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLM-GTHPGELLLSLSSSSGPKIMLIDILYQRLSPP 351 (412)
Q Consensus 275 ~~~~~~~--~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 351 (412)
....... ....++..|+|||...+..++.++|||||||++|||++ |..||+.. ........+......+
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~--------~~~~~~~~~~~~~~~~ 231 (279)
T cd05109 160 DIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGI--------PAREIPDLLEKGERLP 231 (279)
T ss_pred ccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCC--------CHHHHHHHHHCCCcCC
Confidence 4332211 12234678999999988889999999999999999998 89998632 1111222332222222
Q ss_pred cchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhcCCCCCC
Q 042435 352 INQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELEGKTPMKK 396 (412)
Q Consensus 352 ~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~~~ 396 (412)
... .....+.+++.+||+.||++||++.|+++.|+.+.....
T Consensus 232 ~~~---~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~~ 273 (279)
T cd05109 232 QPP---ICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDPS 273 (279)
T ss_pred CCc---cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCCc
Confidence 111 122347889999999999999999999999988876543
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=290.91 Aligned_cols=234 Identities=24% Similarity=0.333 Sum_probs=181.4
Q ss_pred cCcccceeeeecCceEEEEEEeCC------CcEEEEEecc----------------------CCccccceEEEecCceEE
Q 042435 143 EYFHIRYCIGTGGYDSVYKAELPD------GKVVALKKLH----------------------HSETEDSAFVVYSPQCMF 194 (412)
Q Consensus 143 ~~f~~~~~lG~G~~g~Vy~~~~~~------~~~vAvK~l~----------------------~~~~~~~~~~~~~~~~~~ 194 (412)
++|.+.+.||+|+||.||+|...+ ++.||+|.++ |+++......+......+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 468888999999999999997633 4789999753 445555556677788899
Q ss_pred EEEEeccCCceeeeeccCc-----------ccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcE
Q 042435 195 FIYEYMERGSLFCVLRDDD-----------EAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEA 263 (412)
Q Consensus 195 lv~ey~~~gsL~~~l~~~~-----------~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~ 263 (412)
+||||+++|+|.++++... ....+++.+...++.|++.|++|||++ +++||||||+||+++.++.+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCCCeE
Confidence 9999999999999886542 123478999999999999999999998 99999999999999999999
Q ss_pred EEeecCCccccCCCCC--CcccccccccccccccccCcccCcccccHHHHHHHHHHHh-CCCCcccccccccCCCCcchh
Q 042435 264 FVADFGTVRLLDVDSS--NRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLM-GTHPGELLLSLSSSSGPKIML 340 (412)
Q Consensus 264 kl~DfGla~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~ 340 (412)
+|+|||+++....... ......+++.|+|||++.+..++.++||||||+++|||++ |+.||... .. ...
T Consensus 162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~-------~~-~~~ 233 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGL-------SN-EEV 233 (280)
T ss_pred EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCC-------CH-HHH
Confidence 9999999875433221 1123345788999999999999999999999999999998 99998622 11 112
Q ss_pred hHHhhhccCCccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhc
Q 042435 341 IDILYQRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELEG 390 (412)
Q Consensus 341 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~ 390 (412)
.+.+........+. .....+.+++.+||+.||++||++.|+++.|++
T Consensus 234 ~~~~~~~~~~~~~~---~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 234 IECITQGRLLQRPR---TCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred HHHHHcCCcCCCCC---CCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 22222211111111 122348899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=284.81 Aligned_cols=229 Identities=25% Similarity=0.327 Sum_probs=183.4
Q ss_pred CcccceeeeecCceEEEEEEeC-CCcEEEEEec-----------------------cCCccccceEEEecCceEEEEEEe
Q 042435 144 YFHIRYCIGTGGYDSVYKAELP-DGKVVALKKL-----------------------HHSETEDSAFVVYSPQCMFFIYEY 199 (412)
Q Consensus 144 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l-----------------------~~~~~~~~~~~~~~~~~~~lv~ey 199 (412)
+|++.+.||+|++|.||+|... +++.|++|.+ +|+++......+...+..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4778899999999999999774 6899999964 456666666667788899999999
Q ss_pred ccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCCC
Q 042435 200 MERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSS 279 (412)
Q Consensus 200 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 279 (412)
+++++|.++++.... ..+++.++..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||+++.......
T Consensus 81 ~~~~~L~~~l~~~~~-~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~ 156 (256)
T cd08529 81 AENGDLHKLLKMQRG-RPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN 156 (256)
T ss_pred CCCCcHHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceeccCccc
Confidence 999999999876422 3589999999999999999999988 999999999999999999999999999987654433
Q ss_pred CcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccchhhHHH
Q 042435 280 NRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKIIQD 359 (412)
Q Consensus 280 ~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 359 (412)
......|++.|+|||+..+..++.++|+||||+++|||++|+.||.... . ............++... ..
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-------~-~~~~~~~~~~~~~~~~~---~~ 225 (256)
T cd08529 157 FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANN-------Q-GALILKIIRGVFPPVSQ---MY 225 (256)
T ss_pred hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC-------H-HHHHHHHHcCCCCCCcc---cc
Confidence 3344568899999999998889999999999999999999999987321 1 11111111111121111 22
Q ss_pred HHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 360 IILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 360 ~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
...+.+++.+||+.+|++||++.+++++
T Consensus 226 ~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 226 SQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred CHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 2348899999999999999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=293.13 Aligned_cols=239 Identities=23% Similarity=0.324 Sum_probs=184.2
Q ss_pred HhhcCcccceeeeecCceEEEEEEeC------CCcEEEEEec-----------------------cCCccccceEEEecC
Q 042435 140 DATEYFHIRYCIGTGGYDSVYKAELP------DGKVVALKKL-----------------------HHSETEDSAFVVYSP 190 (412)
Q Consensus 140 ~~~~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vAvK~l-----------------------~~~~~~~~~~~~~~~ 190 (412)
...++|++.+.||+|+||.||++... ....+|+|.+ +|+++......+...
T Consensus 9 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 88 (293)
T cd05053 9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQE 88 (293)
T ss_pred cCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCC
Confidence 34467888999999999999999763 2368999965 345555555667778
Q ss_pred ceEEEEEEeccCCceeeeeccC-------------cccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEe
Q 042435 191 QCMFFIYEYMERGSLFCVLRDD-------------DEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILL 257 (412)
Q Consensus 191 ~~~~lv~ey~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl 257 (412)
+..+++|||+++|+|.++++.. .....+++..++.++.|++.||+|||+. +|+||||||+||++
T Consensus 89 ~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~Nil~ 165 (293)
T cd05053 89 GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNVLV 165 (293)
T ss_pred CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CccccccceeeEEE
Confidence 8899999999999999988642 1123589999999999999999999988 99999999999999
Q ss_pred cCCCcEEEeecCCccccCCCCCC--cccccccccccccccccCcccCcccccHHHHHHHHHHHh-CCCCcccccccccCC
Q 042435 258 NSNLEAFVADFGTVRLLDVDSSN--RTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLM-GTHPGELLLSLSSSS 334 (412)
Q Consensus 258 ~~~~~~kl~DfGla~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~ellt-g~~P~~~~~~~~~~~ 334 (412)
++++.+||+|||+++........ .....++..|+|||...+..++.++|||||||++||+++ |..||...
T Consensus 166 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~------- 238 (293)
T cd05053 166 TEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI------- 238 (293)
T ss_pred cCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCC-------
Confidence 99999999999999865433211 122235678999999988889999999999999999998 88887621
Q ss_pred CCcchhhHHhhhccCCccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhcCC
Q 042435 335 GPKIMLIDILYQRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELEGKT 392 (412)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 392 (412)
......+..........+. .....+.+++.+||+.||++|||+.|+++.|+++.
T Consensus 239 -~~~~~~~~~~~~~~~~~~~---~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 239 -PVEELFKLLKEGYRMEKPQ---NCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred -CHHHHHHHHHcCCcCCCCC---CCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 1111222222222211111 12234889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-38 Score=304.77 Aligned_cols=227 Identities=22% Similarity=0.280 Sum_probs=187.7
Q ss_pred cCcccceeeeecCceEEEEEEe-CCCcEEEEEec------------------------cCCccccceEEEecCceEEEEE
Q 042435 143 EYFHIRYCIGTGGYDSVYKAEL-PDGKVVALKKL------------------------HHSETEDSAFVVYSPQCMFFIY 197 (412)
Q Consensus 143 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l------------------------~~~~~~~~~~~~~~~~~~~lv~ 197 (412)
+-|++++-||.|+.|.|-.|++ .+|+.+|||.+ .|+|+.....++.+..++|+|.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 4578889999999999999966 67999999954 5788888888899999999999
Q ss_pred EeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCC
Q 042435 198 EYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVD 277 (412)
Q Consensus 198 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~ 277 (412)
||+++|.|++++-..+ .+......+++.||+.|+.|+|.. +|+||||||+|+|+|.++++||+|||+|..-. .
T Consensus 92 Eyv~gGELFdylv~kG---~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsLe~-~ 164 (786)
T KOG0588|consen 92 EYVPGGELFDYLVRKG---PLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASLEV-P 164 (786)
T ss_pred EecCCchhHHHHHhhC---CCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeeccc-C
Confidence 9999999999998765 588899999999999999999998 99999999999999999999999999998643 3
Q ss_pred CCCcccccccccccccccccCcccC-cccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccchhh
Q 042435 278 SSNRTLQAGTYGYIALELVYTMVVT-EKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKI 356 (412)
Q Consensus 278 ~~~~~~~~gt~~y~aPE~~~~~~~s-~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 356 (412)
.....+.+|++.|.|||++.+.+|. .++||||.|||||.|+||+.||++. .-..+..-+.... ..++...
T Consensus 165 gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDd--------Nir~LLlKV~~G~-f~MPs~I 235 (786)
T KOG0588|consen 165 GKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDD--------NIRVLLLKVQRGV-FEMPSNI 235 (786)
T ss_pred CccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCc--------cHHHHHHHHHcCc-ccCCCcC
Confidence 3444566999999999999999886 6899999999999999999999832 1111111111111 1122222
Q ss_pred HHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHH
Q 042435 357 IQDIILVSTIALACLRSKPKSRPTMQRISQEL 388 (412)
Q Consensus 357 ~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L 388 (412)
. .++.+|+.+|+..||+.|.|++||++|-
T Consensus 236 s---~eaQdLLr~ml~VDp~~RiT~~eI~kHP 264 (786)
T KOG0588|consen 236 S---SEAQDLLRRMLDVDPSTRITTEEILKHP 264 (786)
T ss_pred C---HHHHHHHHHHhccCccccccHHHHhhCc
Confidence 2 2377899999999999999999999885
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=304.22 Aligned_cols=228 Identities=20% Similarity=0.282 Sum_probs=174.0
Q ss_pred CcccceeeeecCceEEEEEEe-CCCcEEEEEec------------------------cCCccccceEEEecCceEEEEEE
Q 042435 144 YFHIRYCIGTGGYDSVYKAEL-PDGKVVALKKL------------------------HHSETEDSAFVVYSPQCMFFIYE 198 (412)
Q Consensus 144 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l------------------------~~~~~~~~~~~~~~~~~~~lv~e 198 (412)
.|+..+.||+|+||+||+|.. .+++.||+|.+ +|+++......+.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 588899999999999999966 56889999975 34555666666788889999999
Q ss_pred eccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCC
Q 042435 199 YMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDS 278 (412)
Q Consensus 199 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~ 278 (412)
|+++|+|.+++.... .+++.....++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~ 155 (381)
T cd05626 82 YIPGGDMMSLLIRME---VFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTH 155 (381)
T ss_pred cCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCccccccc
Confidence 999999999887543 478888899999999999999998 99999999999999999999999999976431100
Q ss_pred C-----------------------------------------------CcccccccccccccccccCcccCcccccHHHH
Q 042435 279 S-----------------------------------------------NRTLQAGTYGYIALELVYTMVVTEKCVIYSFG 311 (412)
Q Consensus 279 ~-----------------------------------------------~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G 311 (412)
. ......||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (381)
T cd05626 156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVG 235 (381)
T ss_pred ccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehh
Confidence 0 00124699999999999988899999999999
Q ss_pred HHHHHHHhCCCCcccccccccCCCCcchhhHHhhh--ccCCccchhhHHHHHHHHHHHHh--cCcCCCCCCCCHHHHHHH
Q 042435 312 VVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQ--RLSPPINQKIIQDIILVSTIALA--CLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 312 vil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~l~~~--Cl~~dP~~RPs~~evl~~ 387 (412)
|++|||+||+.||... ........+... ....+..... ...+.+++.+ |+..+|..||+++|++++
T Consensus 236 ~il~elltG~~Pf~~~-------~~~~~~~~i~~~~~~~~~~~~~~~---s~~~~dli~~ll~~~~~~~~R~~~~~~l~h 305 (381)
T cd05626 236 VILFEMLVGQPPFLAP-------TPTETQLKVINWENTLHIPPQVKL---SPEAVDLITKLCCSAEERLGRNGADDIKAH 305 (381)
T ss_pred hHHHHHHhCCCCCcCC-------CHHHHHHHHHccccccCCCCCCCC---CHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 9999999999999732 111111122211 1111111111 1225566665 667777789999999886
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=291.49 Aligned_cols=237 Identities=24% Similarity=0.337 Sum_probs=183.4
Q ss_pred cCcccceeeeecCceEEEEEEe------CCCcEEEEEec---------------------cCCccccceEEEecCceEEE
Q 042435 143 EYFHIRYCIGTGGYDSVYKAEL------PDGKVVALKKL---------------------HHSETEDSAFVVYSPQCMFF 195 (412)
Q Consensus 143 ~~f~~~~~lG~G~~g~Vy~~~~------~~~~~vAvK~l---------------------~~~~~~~~~~~~~~~~~~~l 195 (412)
++|.+.+.||+|+||.||++.. .++..+|+|.+ +|+++......+...+..++
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 84 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 4688889999999999999974 23566899865 45666666667788889999
Q ss_pred EEEeccCCceeeeeccCc----------ccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEE
Q 042435 196 IYEYMERGSLFCVLRDDD----------EAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFV 265 (412)
Q Consensus 196 v~ey~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl 265 (412)
||||+++++|.+++.... ....+++.+++.++.|++.||+|||++ +++||||||+||++++++.++|
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~~~kl 161 (288)
T cd05093 85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKI 161 (288)
T ss_pred EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcEEe
Confidence 999999999998886432 112489999999999999999999998 9999999999999999999999
Q ss_pred eecCCccccCCCCCC--cccccccccccccccccCcccCcccccHHHHHHHHHHHh-CCCCcccccccccCCCCcchhhH
Q 042435 266 ADFGTVRLLDVDSSN--RTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLM-GTHPGELLLSLSSSSGPKIMLID 342 (412)
Q Consensus 266 ~DfGla~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~ 342 (412)
+|||+++........ .....++..|+|||++.+..++.++|||||||++|||+| |..||.... .......
T Consensus 162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~-------~~~~~~~ 234 (288)
T cd05093 162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLS-------NNEVIEC 234 (288)
T ss_pred ccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC-------HHHHHHH
Confidence 999999865332211 122345778999999998889999999999999999998 899876221 1111111
Q ss_pred HhhhccCCccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhcCCC
Q 042435 343 ILYQRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELEGKTP 393 (412)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 393 (412)
+..... ...... ....+.+++.+||+.||.+|||+.|+.+.|+++..
T Consensus 235 i~~~~~-~~~~~~---~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~ 281 (288)
T cd05093 235 ITQGRV-LQRPRT---CPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAK 281 (288)
T ss_pred HHcCCc-CCCCCC---CCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence 111111 111111 12248899999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=285.95 Aligned_cols=232 Identities=25% Similarity=0.389 Sum_probs=180.9
Q ss_pred cCcccceeeeecCceEEEEEEeCCCcEEEEEecc--------------------CCccccceEEEecCceEEEEEEeccC
Q 042435 143 EYFHIRYCIGTGGYDSVYKAELPDGKVVALKKLH--------------------HSETEDSAFVVYSPQCMFFIYEYMER 202 (412)
Q Consensus 143 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~l~--------------------~~~~~~~~~~~~~~~~~~lv~ey~~~ 202 (412)
++|++.++||+|+||.||+|..++++.||+|.+. |+++...... ...+..+++|||+++
T Consensus 6 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~-~~~~~~~~v~e~~~~ 84 (260)
T cd05067 6 ETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAV-VTQEPIYIITEYMEN 84 (260)
T ss_pred HHceeeeeeccCccceEEeeecCCCceEEEEEecCCCCcHHHHHHHHHHHHhcCCcCeeeEEEE-EccCCcEEEEEcCCC
Confidence 5688899999999999999999889999999764 3333333333 345678999999999
Q ss_pred CceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCC-CCc
Q 042435 203 GSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDS-SNR 281 (412)
Q Consensus 203 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~-~~~ 281 (412)
|+|.+++..... ..+++.++..++.|++.||+|||+. +++||||||+||++++++.++|+|||++....... ...
T Consensus 85 ~~L~~~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~ 160 (260)
T cd05067 85 GSLVDFLKTPEG-IKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAR 160 (260)
T ss_pred CCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceeecCCCCcccc
Confidence 999998865432 3589999999999999999999988 99999999999999999999999999997654222 122
Q ss_pred ccccccccccccccccCcccCcccccHHHHHHHHHHHh-CCCCcccccccccCCCCcchhhHHhhhccCCccchhhHHHH
Q 042435 282 TLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLM-GTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKIIQDI 360 (412)
Q Consensus 282 ~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 360 (412)
....++..|+|||++....++.++||||||+++||+++ |+.||.... .......+......+.+.. ..
T Consensus 161 ~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~--------~~~~~~~~~~~~~~~~~~~---~~ 229 (260)
T cd05067 161 EGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMT--------NPEVIQNLERGYRMPRPDN---CP 229 (260)
T ss_pred cCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCC--------hHHHHHHHHcCCCCCCCCC---CC
Confidence 23345678999999988889999999999999999999 999986321 1112222222222221111 12
Q ss_pred HHHHHHHHhcCcCCCCCCCCHHHHHHHHhc
Q 042435 361 ILVSTIALACLRSKPKSRPTMQRISQELEG 390 (412)
Q Consensus 361 ~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~ 390 (412)
..+.+++.+||+.+|++|||++++.+.|+.
T Consensus 230 ~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 230 EELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred HHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 348899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=286.56 Aligned_cols=230 Identities=23% Similarity=0.324 Sum_probs=178.2
Q ss_pred CcccceeeeecCceEEEEEEeCCCcEEEEEecc--------------------CCccccceEEEecCceEEEEEEeccCC
Q 042435 144 YFHIRYCIGTGGYDSVYKAELPDGKVVALKKLH--------------------HSETEDSAFVVYSPQCMFFIYEYMERG 203 (412)
Q Consensus 144 ~f~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~l~--------------------~~~~~~~~~~~~~~~~~~lv~ey~~~g 203 (412)
+|++.+.||+|+||.||+|.++++..+|+|.++ |+++......+...+..++||||++++
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 84 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANG 84 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCccEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCCC
Confidence 477889999999999999988878889999754 344444444566777899999999999
Q ss_pred ceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCCCC-cc
Q 042435 204 SLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSN-RT 282 (412)
Q Consensus 204 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~-~~ 282 (412)
+|.+++..... .++|..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||+++........ ..
T Consensus 85 ~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~~ 159 (256)
T cd05059 85 CLLNYLRERKG--KLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQ 159 (256)
T ss_pred CHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceecccccccccC
Confidence 99998875432 589999999999999999999998 9999999999999999999999999998765332111 11
Q ss_pred cccccccccccccccCcccCcccccHHHHHHHHHHHh-CCCCcccccccccCCCCcchhhHHhhhccCCccchhhHHHHH
Q 042435 283 LQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLM-GTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKIIQDII 361 (412)
Q Consensus 283 ~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 361 (412)
...++..|+|||.+.+..++.++||||||+++||+++ |+.||+... . ......+......+.+.. ...
T Consensus 160 ~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~-------~-~~~~~~~~~~~~~~~~~~---~~~ 228 (256)
T cd05059 160 GTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFS-------N-SEVVESVSAGYRLYRPKL---APT 228 (256)
T ss_pred CCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCC-------H-HHHHHHHHcCCcCCCCCC---CCH
Confidence 1234457999999998899999999999999999999 888986321 1 111122222211111111 223
Q ss_pred HHHHHHHhcCcCCCCCCCCHHHHHHHHh
Q 042435 362 LVSTIALACLRSKPKSRPTMQRISQELE 389 (412)
Q Consensus 362 ~~~~l~~~Cl~~dP~~RPs~~evl~~L~ 389 (412)
.+.+++.+||+.+|++|||+.|+++.|.
T Consensus 229 ~~~~li~~cl~~~p~~Rpt~~~~l~~l~ 256 (256)
T cd05059 229 EVYTIMYSCWHEKPEDRPAFKKLLSQLT 256 (256)
T ss_pred HHHHHHHHHhcCChhhCcCHHHHHHHhC
Confidence 4889999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=291.44 Aligned_cols=237 Identities=24% Similarity=0.326 Sum_probs=184.4
Q ss_pred cCcccceeeeecCceEEEEEEeC------CCcEEEEEec---------------------cCCccccceEEEecCceEEE
Q 042435 143 EYFHIRYCIGTGGYDSVYKAELP------DGKVVALKKL---------------------HHSETEDSAFVVYSPQCMFF 195 (412)
Q Consensus 143 ~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vAvK~l---------------------~~~~~~~~~~~~~~~~~~~l 195 (412)
.+|.+.+.||+|+||.||+|... ++..+++|.+ +|+++......+...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 35778899999999999999642 3567888865 46666666677788888999
Q ss_pred EEEeccCCceeeeeccCcc-------------cccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCc
Q 042435 196 IYEYMERGSLFCVLRDDDE-------------AIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLE 262 (412)
Q Consensus 196 v~ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~ 262 (412)
||||+++++|.+++..... ...++|..++.++.|++.||+|||++ +++||||||+||+++.++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCc
Confidence 9999999999998865321 12489999999999999999999998 9999999999999999999
Q ss_pred EEEeecCCccccCCCCC--CcccccccccccccccccCcccCcccccHHHHHHHHHHHh-CCCCcccccccccCCCCcch
Q 042435 263 AFVADFGTVRLLDVDSS--NRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLM-GTHPGELLLSLSSSSGPKIM 339 (412)
Q Consensus 263 ~kl~DfGla~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~ 339 (412)
++|+|||+++....... ......++..|+|||++.+..++.++||||||+++|||+| |+.||.... . ..
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~-------~-~~ 233 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLS-------N-TE 233 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC-------H-HH
Confidence 99999999976543221 1123456788999999998899999999999999999999 999986321 1 11
Q ss_pred hhHHhhhccCCccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhcCCC
Q 042435 340 LIDILYQRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELEGKTP 393 (412)
Q Consensus 340 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 393 (412)
..+............ .....+.+++.+||+.||++|||+.+|++.|+++..
T Consensus 234 ~~~~~~~~~~~~~~~---~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~ 284 (291)
T cd05094 234 VIECITQGRVLERPR---VCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK 284 (291)
T ss_pred HHHHHhCCCCCCCCc---cCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence 112222211111111 122348899999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=298.56 Aligned_cols=219 Identities=24% Similarity=0.289 Sum_probs=172.0
Q ss_pred eeeeecCceEEEEEEeC-CCcEEEEEec-------------------------cCCccccceEEEecCceEEEEEEeccC
Q 042435 149 YCIGTGGYDSVYKAELP-DGKVVALKKL-------------------------HHSETEDSAFVVYSPQCMFFIYEYMER 202 (412)
Q Consensus 149 ~~lG~G~~g~Vy~~~~~-~~~~vAvK~l-------------------------~~~~~~~~~~~~~~~~~~~lv~ey~~~ 202 (412)
+.||+|+||.||+|... +++.||+|.+ +|+++......+...+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 36999999999999775 5788999964 355666666667788899999999999
Q ss_pred CceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCCCCcc
Q 042435 203 GSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRT 282 (412)
Q Consensus 203 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 282 (412)
|+|.+++.... .+.......++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++..........
T Consensus 81 ~~L~~~~~~~~---~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~ 154 (325)
T cd05602 81 GELFYHLQRER---CFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTS 154 (325)
T ss_pred CcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCcc
Confidence 99998886543 477788888999999999999998 999999999999999999999999999975433333334
Q ss_pred cccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccchhhHHHHHH
Q 042435 283 LQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKIIQDIIL 362 (412)
Q Consensus 283 ~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 362 (412)
...||+.|+|||++.+..++.++|||||||++|||++|+.||... ........+.......+ .. ....
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~-------~~~~~~~~i~~~~~~~~--~~---~~~~ 222 (325)
T cd05602 155 TFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSR-------NTAEMYDNILNKPLQLK--PN---ITNS 222 (325)
T ss_pred cccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCC-------CHHHHHHHHHhCCcCCC--CC---CCHH
Confidence 557999999999999999999999999999999999999998632 11111122222211111 11 1223
Q ss_pred HHHHHHhcCcCCCCCCCCHHHHH
Q 042435 363 VSTIALACLRSKPKSRPTMQRIS 385 (412)
Q Consensus 363 ~~~l~~~Cl~~dP~~RPs~~evl 385 (412)
+.+++.+|++.||.+||++.+.+
T Consensus 223 ~~~li~~~l~~~p~~R~~~~~~~ 245 (325)
T cd05602 223 ARHLLEGLLQKDRTKRLGAKDDF 245 (325)
T ss_pred HHHHHHHHcccCHHHCCCCCCCH
Confidence 77899999999999999877443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=311.74 Aligned_cols=230 Identities=21% Similarity=0.226 Sum_probs=182.3
Q ss_pred CcccceeeeecCceEEEEEEeC-C-CcEEEEEe---------------------ccCCccccceEEEecCceEEEEEEec
Q 042435 144 YFHIRYCIGTGGYDSVYKAELP-D-GKVVALKK---------------------LHHSETEDSAFVVYSPQCMFFIYEYM 200 (412)
Q Consensus 144 ~f~~~~~lG~G~~g~Vy~~~~~-~-~~~vAvK~---------------------l~~~~~~~~~~~~~~~~~~~lv~ey~ 200 (412)
.|.+.+.||+|+||.||+|... + ++.||+|. ++|+++......+...+..++||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 3889999999999999999653 3 67888884 36788888888888899999999999
Q ss_pred cCCceeeeeccCc-ccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCCC
Q 042435 201 ERGSLFCVLRDDD-EAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSS 279 (412)
Q Consensus 201 ~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 279 (412)
++|+|.+++.... ....+++.....++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 224 (478)
T PTZ00267 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS 224 (478)
T ss_pred CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence 9999998876432 223588899999999999999999998 999999999999999999999999999987643321
Q ss_pred --CcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccchhhH
Q 042435 280 --NRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKII 357 (412)
Q Consensus 280 --~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 357 (412)
......||+.|+|||++.+..++.++|||||||++|||++|+.||... ...............+ .+..
T Consensus 225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~-------~~~~~~~~~~~~~~~~-~~~~-- 294 (478)
T PTZ00267 225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGP-------SQREIMQQVLYGKYDP-FPCP-- 294 (478)
T ss_pred cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCC-------CHHHHHHHHHhCCCCC-CCcc--
Confidence 123456999999999999989999999999999999999999998632 1111122222222111 1111
Q ss_pred HHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 358 QDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 358 ~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
....+.+++.+||+.||++||++++++.+
T Consensus 295 -~s~~~~~li~~~L~~dP~~Rps~~~~l~~ 323 (478)
T PTZ00267 295 -VSSGMKALLDPLLSKNPALRPTTQQLLHT 323 (478)
T ss_pred -CCHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence 12347889999999999999999998753
|
|
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-38 Score=301.84 Aligned_cols=229 Identities=21% Similarity=0.307 Sum_probs=178.2
Q ss_pred cCcccceeeeecCceEEEEEEe-CCCcEEEEEecc------------------------CCccccceEEEecCceEEEEE
Q 042435 143 EYFHIRYCIGTGGYDSVYKAEL-PDGKVVALKKLH------------------------HSETEDSAFVVYSPQCMFFIY 197 (412)
Q Consensus 143 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l~------------------------~~~~~~~~~~~~~~~~~~lv~ 197 (412)
++|++.+.||+|+||.||++.. .+|+.||+|.++ |+++......+...+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 4789999999999999999976 468999999753 455555556677788899999
Q ss_pred EeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCC
Q 042435 198 EYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVD 277 (412)
Q Consensus 198 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~ 277 (412)
||+++|+|.+++..... .+++.....++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~l~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 155 (330)
T cd05601 81 EYQPGGDLLSLLNRYED--QFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARLTAN 155 (330)
T ss_pred CCCCCCCHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence 99999999999876522 588999999999999999999998 9999999999999999999999999999866443
Q ss_pred CCC-ccccccccccccccccc------CcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhc--c
Q 042435 278 SSN-RTLQAGTYGYIALELVY------TMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQR--L 348 (412)
Q Consensus 278 ~~~-~~~~~gt~~y~aPE~~~------~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~--~ 348 (412)
... .....||+.|+|||++. ...++.++|||||||++|||++|+.||.... .......+.... .
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~-------~~~~~~~i~~~~~~~ 228 (330)
T cd05601 156 KMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGT-------SAKTYNNIMNFQRFL 228 (330)
T ss_pred CceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCC-------HHHHHHHHHcCCCcc
Confidence 222 23346899999999986 4567889999999999999999999986321 111112221111 1
Q ss_pred CCccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 349 SPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 349 ~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
..+... .....+.+++.+|+. +|++|||+.+++++
T Consensus 229 ~~~~~~---~~~~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 229 KFPEDP---KVSSDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred CCCCCC---CCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 111111 112237788899997 99999999999865
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=300.84 Aligned_cols=237 Identities=26% Similarity=0.349 Sum_probs=171.7
Q ss_pred CcccceeeeecCceEEEEEEe-CCCcEEEEEecc-----------------------CCccccceEEEecC-----ceEE
Q 042435 144 YFHIRYCIGTGGYDSVYKAEL-PDGKVVALKKLH-----------------------HSETEDSAFVVYSP-----QCMF 194 (412)
Q Consensus 144 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l~-----------------------~~~~~~~~~~~~~~-----~~~~ 194 (412)
+|++.+.||+|+||.||+|.. .+++.||||+++ |+++.....++... ...+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 478889999999999999976 468999999753 44444444333221 3579
Q ss_pred EEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCcccc
Q 042435 195 FIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLL 274 (412)
Q Consensus 195 lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~ 274 (412)
+||||+. ++|.+++.... .+++..+..++.|+++||+|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 81 lv~e~~~-~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~ 153 (338)
T cd07859 81 VVFELME-SDLHQVIKAND---DLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARVA 153 (338)
T ss_pred EEEecCC-CCHHHHHHhcc---cCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCcccccc
Confidence 9999995 68888876543 589999999999999999999998 9999999999999999999999999999864
Q ss_pred CCCCC---CcccccccccccccccccC--cccCcccccHHHHHHHHHHHhCCCCccccccccc--------CCCCcchhh
Q 042435 275 DVDSS---NRTLQAGTYGYIALELVYT--MVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSS--------SSGPKIMLI 341 (412)
Q Consensus 275 ~~~~~---~~~~~~gt~~y~aPE~~~~--~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~--------~~~~~~~~~ 341 (412)
..... ......||+.|+|||++.+ ..++.++|||||||++|||+||+.||........ .........
T Consensus 154 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (338)
T cd07859 154 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETIS 233 (338)
T ss_pred ccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence 32221 1234568999999999865 6789999999999999999999999863211000 000000000
Q ss_pred --------HH---hhhccCCccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 342 --------DI---LYQRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 342 --------~~---~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
.. +......+...........+.+++.+||+.||++|||++|++++
T Consensus 234 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 234 RVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred HhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 00 00000110000001112346789999999999999999999976
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=291.39 Aligned_cols=231 Identities=19% Similarity=0.241 Sum_probs=176.6
Q ss_pred CcccceeeeecCceEEEEEEe-CCCcEEEEEecc------------------------CCccccceEEEecCceEEEEEE
Q 042435 144 YFHIRYCIGTGGYDSVYKAEL-PDGKVVALKKLH------------------------HSETEDSAFVVYSPQCMFFIYE 198 (412)
Q Consensus 144 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l~------------------------~~~~~~~~~~~~~~~~~~lv~e 198 (412)
+|++.++||+|+||+||++.. .+++.||+|.+. |+++......+..++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 478889999999999999976 468999999763 3334444445667788999999
Q ss_pred eccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCC
Q 042435 199 YMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDS 278 (412)
Q Consensus 199 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~ 278 (412)
|+++|+|.+++..... ..+++..+..++.|++.||+|||+. +++||||||+||++++++.++|+|||+++......
T Consensus 81 ~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05605 81 LMNGGDLKFHIYNMGN-PGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE 156 (285)
T ss_pred ccCCCcHHHHHHhcCc-CCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceecCCCC
Confidence 9999999887754322 2589999999999999999999998 99999999999999999999999999998654322
Q ss_pred CCcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccchhhHH
Q 042435 279 SNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKIIQ 358 (412)
Q Consensus 279 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 358 (412)
. .....|+..|+|||++.+..++.++|||||||++|||++|+.||..... ......+...+... ....+. .
T Consensus 157 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~----~~~~~~~~~~~~~~-~~~~~~---~ 227 (285)
T cd05605 157 T-IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKE----KVKREEVERRVKED-QEEYSE---K 227 (285)
T ss_pred c-cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCch----hhHHHHHHHHhhhc-ccccCc---c
Confidence 2 2234689999999999888899999999999999999999999873210 00000111111111 111111 1
Q ss_pred HHHHHHHHHHhcCcCCCCCCC-----CHHHHHHH
Q 042435 359 DIILVSTIALACLRSKPKSRP-----TMQRISQE 387 (412)
Q Consensus 359 ~~~~~~~l~~~Cl~~dP~~RP-----s~~evl~~ 387 (412)
....+.+++.+||+.||++|| ++++++++
T Consensus 228 ~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 228 FSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred cCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 223478899999999999999 88888765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=292.30 Aligned_cols=239 Identities=24% Similarity=0.272 Sum_probs=185.1
Q ss_pred HhhcCcccceeeeecCceEEEEEEe-CCCcEEEEEec-----------------------------------cCCccccc
Q 042435 140 DATEYFHIRYCIGTGGYDSVYKAEL-PDGKVVALKKL-----------------------------------HHSETEDS 183 (412)
Q Consensus 140 ~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l-----------------------------------~~~~~~~~ 183 (412)
...++|++...||+|.||.|-+|+. .+++.||||.+ +|+|+++.
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence 3457899999999999999999976 57999999954 46666666
Q ss_pred eEEEec--CceEEEEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCC
Q 042435 184 AFVVYS--PQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNL 261 (412)
Q Consensus 184 ~~~~~~--~~~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~ 261 (412)
..+..+ .+.+|||+|||..|.+...=. ....++..+..+++.++..||+|||.+ +|+||||||+|+|+++++
T Consensus 174 iEvLDDP~s~~~YlVley~s~G~v~w~p~---d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl~~~g 247 (576)
T KOG0585|consen 174 IEVLDDPESDKLYLVLEYCSKGEVKWCPP---DKPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLLSSDG 247 (576)
T ss_pred EEeecCcccCceEEEEEeccCCccccCCC---CcccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEEcCCC
Confidence 666544 467899999999887753322 222389999999999999999999999 999999999999999999
Q ss_pred cEEEeecCCccccCCCC-----CCcccccccccccccccccCcc----cCcccccHHHHHHHHHHHhCCCCccccccccc
Q 042435 262 EAFVADFGTVRLLDVDS-----SNRTLQAGTYGYIALELVYTMV----VTEKCVIYSFGVVALEVLMGTHPGELLLSLSS 332 (412)
Q Consensus 262 ~~kl~DfGla~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~----~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~ 332 (412)
++||+|||.+....... .......||+.|+|||.+.++. .+.+.||||+||+||.|+.|+.||-..
T Consensus 248 ~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~----- 322 (576)
T KOG0585|consen 248 TVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDD----- 322 (576)
T ss_pred cEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccc-----
Confidence 99999999987653221 1123468999999999987632 356899999999999999999998632
Q ss_pred CCCCcchhhHHhhhccCCccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhcCCCC
Q 042435 333 SSGPKIMLIDILYQRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELEGKTPM 394 (412)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~ 394 (412)
........++...+..+... +....+.+|+.++|.+||++|.+..+|..+.--....
T Consensus 323 --~~~~l~~KIvn~pL~fP~~p---e~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~g 379 (576)
T KOG0585|consen 323 --FELELFDKIVNDPLEFPENP---EINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRDG 379 (576)
T ss_pred --hHHHHHHHHhcCcccCCCcc---cccHHHHHHHHHHhhcChhheeehhhheecceeccCC
Confidence 11122334444444443322 2233488999999999999999999999887555443
|
|
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=289.12 Aligned_cols=236 Identities=22% Similarity=0.287 Sum_probs=180.3
Q ss_pred hhcCcccceeeeecCceEEEEEEeC------CCcEEEEEec----------------------cCCccccceEEEecCce
Q 042435 141 ATEYFHIRYCIGTGGYDSVYKAELP------DGKVVALKKL----------------------HHSETEDSAFVVYSPQC 192 (412)
Q Consensus 141 ~~~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vAvK~l----------------------~~~~~~~~~~~~~~~~~ 192 (412)
.+++|.+.+.||+|+||.||+|.+. .+..||+|.+ +|+++......+.+.+.
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 3567899999999999999999774 3578899965 34455555566777788
Q ss_pred EEEEEEeccCCceeeeeccCcc----cccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCC---cEEE
Q 042435 193 MFFIYEYMERGSLFCVLRDDDE----AIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNL---EAFV 265 (412)
Q Consensus 193 ~~lv~ey~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~---~~kl 265 (412)
.++||||+++|+|.+++..... ...++|.+++.++.|++.||+|||+. +++||||||+||+++.++ .+||
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcceEe
Confidence 8999999999999998865431 12589999999999999999999998 999999999999998654 6999
Q ss_pred eecCCccccCCCCCC--cccccccccccccccccCcccCcccccHHHHHHHHHHHh-CCCCcccccccccCCCCcchhhH
Q 042435 266 ADFGTVRLLDVDSSN--RTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLM-GTHPGELLLSLSSSSGPKIMLID 342 (412)
Q Consensus 266 ~DfGla~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~ 342 (412)
+|||+++........ ......+..|+|||++.+..++.++|||||||++|||++ |..||... . .....+
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~-------~-~~~~~~ 232 (277)
T cd05036 161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGR-------T-NQEVME 232 (277)
T ss_pred ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCC-------C-HHHHHH
Confidence 999999866322211 112233568999999998899999999999999999997 99998632 1 111222
Q ss_pred HhhhccCCccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhc
Q 042435 343 ILYQRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELEG 390 (412)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~ 390 (412)
.+........+.. ....+.+++.+||+.+|++|||+.+|+++|+.
T Consensus 233 ~~~~~~~~~~~~~---~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~~ 277 (277)
T cd05036 233 FVTGGGRLDPPKG---CPGPVYRIMTDCWQHTPEDRPNFATILERIQY 277 (277)
T ss_pred HHHcCCcCCCCCC---CCHHHHHHHHHHcCCCcccCcCHHHHHHHhhC
Confidence 2222222111111 12347889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=297.65 Aligned_cols=216 Identities=25% Similarity=0.339 Sum_probs=170.1
Q ss_pred eeeeecCceEEEEEEeC-CCcEEEEEec-------------------------cCCccccceEEEecCceEEEEEEeccC
Q 042435 149 YCIGTGGYDSVYKAELP-DGKVVALKKL-------------------------HHSETEDSAFVVYSPQCMFFIYEYMER 202 (412)
Q Consensus 149 ~~lG~G~~g~Vy~~~~~-~~~~vAvK~l-------------------------~~~~~~~~~~~~~~~~~~~lv~ey~~~ 202 (412)
++||+|+||.||+|+.. +++.||+|.+ +|+++......+...+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999774 6889999964 466666666677888899999999999
Q ss_pred CceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCCCCcc
Q 042435 203 GSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRT 282 (412)
Q Consensus 203 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 282 (412)
|+|..++.... .++......++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++..........
T Consensus 81 ~~L~~~l~~~~---~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 154 (321)
T cd05603 81 GELFFHLQRER---CFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTS 154 (321)
T ss_pred CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCccc
Confidence 99988776433 478888889999999999999998 999999999999999999999999999875433223334
Q ss_pred cccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccchhhHHHHHH
Q 042435 283 LQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKIIQDIIL 362 (412)
Q Consensus 283 ~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 362 (412)
...||+.|+|||++.+..++.++|||||||++|||++|+.||... ........+.......+ .. ....
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~-------~~~~~~~~i~~~~~~~~--~~---~~~~ 222 (321)
T cd05603 155 TFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSR-------DVSQMYDNILHKPLQLP--GG---KTVA 222 (321)
T ss_pred cccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCC-------CHHHHHHHHhcCCCCCC--CC---CCHH
Confidence 457899999999999888999999999999999999999998632 11111122222211111 11 1224
Q ss_pred HHHHHHhcCcCCCCCCCCHH
Q 042435 363 VSTIALACLRSKPKSRPTMQ 382 (412)
Q Consensus 363 ~~~l~~~Cl~~dP~~RPs~~ 382 (412)
+.+++.+|++.||++||++.
T Consensus 223 ~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 223 ACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred HHHHHHHHccCCHhhcCCCC
Confidence 77899999999999999754
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=303.60 Aligned_cols=236 Identities=22% Similarity=0.285 Sum_probs=180.9
Q ss_pred HHHHhhcCcccceeeeecCceEEEEEEeC-CCcEEEEEec------------------------cCCccccceEEEecCc
Q 042435 137 NLIDATEYFHIRYCIGTGGYDSVYKAELP-DGKVVALKKL------------------------HHSETEDSAFVVYSPQ 191 (412)
Q Consensus 137 ~l~~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l------------------------~~~~~~~~~~~~~~~~ 191 (412)
++....++|++.+.||+|+||.||++... +++.+|+|.+ +|+++......+..++
T Consensus 37 ~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~ 116 (370)
T cd05621 37 KLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDK 116 (370)
T ss_pred hcCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC
Confidence 34445678999999999999999999875 5889999965 3566666667778889
Q ss_pred eEEEEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCc
Q 042435 192 CMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTV 271 (412)
Q Consensus 192 ~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla 271 (412)
..++||||+++|+|.+++... .++......++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 117 ~~~lv~Ey~~gg~L~~~l~~~----~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG~a 189 (370)
T cd05621 117 YLYMVMEYMPGGDLVNLMSNY----DVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTC 189 (370)
T ss_pred EEEEEEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEecccc
Confidence 999999999999999988654 378888999999999999999998 9999999999999999999999999999
Q ss_pred cccCCCCC-CcccccccccccccccccCc----ccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhh
Q 042435 272 RLLDVDSS-NRTLQAGTYGYIALELVYTM----VVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQ 346 (412)
Q Consensus 272 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~----~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 346 (412)
+....... ......||+.|+|||++.+. .++.++||||+||++|||++|+.||.... .......+...
T Consensus 190 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~-------~~~~~~~i~~~ 262 (370)
T cd05621 190 MKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADS-------LVGTYSKIMDH 262 (370)
T ss_pred eecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCC-------HHHHHHHHHhC
Confidence 87643322 22345799999999998654 37889999999999999999999997321 11122223222
Q ss_pred ccCCccchhhHHHHHHHHHHHHhcCcCCCC--CCCCHHHHHHH
Q 042435 347 RLSPPINQKIIQDIILVSTIALACLRSKPK--SRPTMQRISQE 387 (412)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~--~RPs~~evl~~ 387 (412)
......+.. ......+.+++.+|+..+|. .||++.|++++
T Consensus 263 ~~~~~~p~~-~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 263 KNSLNFPED-VEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred CcccCCCCc-ccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 111111111 11122367788888875554 38899999987
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=299.00 Aligned_cols=217 Identities=26% Similarity=0.329 Sum_probs=172.0
Q ss_pred eeeeecCceEEEEEEe-CCCcEEEEEec-------------------------cCCccccceEEEecCceEEEEEEeccC
Q 042435 149 YCIGTGGYDSVYKAEL-PDGKVVALKKL-------------------------HHSETEDSAFVVYSPQCMFFIYEYMER 202 (412)
Q Consensus 149 ~~lG~G~~g~Vy~~~~-~~~~~vAvK~l-------------------------~~~~~~~~~~~~~~~~~~~lv~ey~~~ 202 (412)
+.||+|+||+||+|.. .+|+.+|+|.+ +|+++......+...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 3699999999999976 46899999954 356666666677788899999999999
Q ss_pred CceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCCCCcc
Q 042435 203 GSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRT 282 (412)
Q Consensus 203 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 282 (412)
|+|..++.... .+++.....++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++..........
T Consensus 81 ~~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~ 154 (325)
T cd05604 81 GELFFHLQRER---SFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTT 154 (325)
T ss_pred CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCcc
Confidence 99988776543 588999999999999999999998 999999999999999999999999999875433333334
Q ss_pred cccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccchhhHHHHHH
Q 042435 283 LQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKIIQDIIL 362 (412)
Q Consensus 283 ~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 362 (412)
...||+.|+|||++.+..++.++|||||||++|||++|+.||... ........+........ .. ....
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~-------~~~~~~~~~~~~~~~~~--~~---~~~~ 222 (325)
T cd05604 155 TFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCR-------DVAEMYDNILHKPLVLR--PG---ASLT 222 (325)
T ss_pred cccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCC-------CHHHHHHHHHcCCccCC--CC---CCHH
Confidence 557999999999999999999999999999999999999998632 11111122222221111 11 1223
Q ss_pred HHHHHHhcCcCCCCCCCCHHH
Q 042435 363 VSTIALACLRSKPKSRPTMQR 383 (412)
Q Consensus 363 ~~~l~~~Cl~~dP~~RPs~~e 383 (412)
+.+++.+|++.||.+||++.+
T Consensus 223 ~~~ll~~ll~~~p~~R~~~~~ 243 (325)
T cd05604 223 AWSILEELLEKDRQRRLGAKE 243 (325)
T ss_pred HHHHHHHHhccCHHhcCCCCC
Confidence 678999999999999998763
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=296.34 Aligned_cols=177 Identities=25% Similarity=0.292 Sum_probs=153.3
Q ss_pred hcCcccceeeeecCceEEEEEEeC-CCcEEEEEec----------------------cCCccccceEEEecCceEEEEEE
Q 042435 142 TEYFHIRYCIGTGGYDSVYKAELP-DGKVVALKKL----------------------HHSETEDSAFVVYSPQCMFFIYE 198 (412)
Q Consensus 142 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l----------------------~~~~~~~~~~~~~~~~~~~lv~e 198 (412)
.++|++.+.||+|+||.||++... +++.+|+|.+ +|+++......+...+..++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 367999999999999999999775 6888999853 46677777777888999999999
Q ss_pred eccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCC
Q 042435 199 YMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDS 278 (412)
Q Consensus 199 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~ 278 (412)
|+++|+|.+++.... .+++.....++.|++.||+|||+.+ +++||||||+||+++.++.+||+|||++......
T Consensus 84 ~~~~~~L~~~l~~~~---~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~- 157 (333)
T cd06650 84 HMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 157 (333)
T ss_pred cCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh-
Confidence 999999999987543 4788899999999999999999742 7999999999999999999999999998755322
Q ss_pred CCcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcc
Q 042435 279 SNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGE 325 (412)
Q Consensus 279 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~ 325 (412)
......|+..|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 158 -~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~ 203 (333)
T cd06650 158 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIP 203 (333)
T ss_pred -ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCC
Confidence 1223468999999999998889999999999999999999999986
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=270.45 Aligned_cols=228 Identities=27% Similarity=0.338 Sum_probs=190.4
Q ss_pred hcCcccceeeeecCceEEEEEEe-CCCcEEEEEec------------------------cCCccccceEEEecCceEEEE
Q 042435 142 TEYFHIRYCIGTGGYDSVYKAEL-PDGKVVALKKL------------------------HHSETEDSAFVVYSPQCMFFI 196 (412)
Q Consensus 142 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l------------------------~~~~~~~~~~~~~~~~~~~lv 196 (412)
.++|++++.||+|.||.||.|+. +++-.||+|++ +|+|+.+....+.+....||+
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi 100 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI 100 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence 46799999999999999999976 46889999964 678888888889999999999
Q ss_pred EEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCC
Q 042435 197 YEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDV 276 (412)
Q Consensus 197 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~ 276 (412)
+||.++|+|+..|++.... .++......++.|+|.||.|+|.. +++||||||+|+|++.++..|++|||.+-...
T Consensus 101 lEya~~gel~k~L~~~~~~-~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p- 175 (281)
T KOG0580|consen 101 LEYAPRGELYKDLQEGRMK-RFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP- 175 (281)
T ss_pred EEecCCchHHHHHHhcccc-cccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCCceeecC-
Confidence 9999999999999865432 477788888999999999999988 99999999999999999999999999986533
Q ss_pred CCCCcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccchhh
Q 042435 277 DSSNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKI 356 (412)
Q Consensus 277 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 356 (412)
...+...+||..|.+||+..+...+.+.|+|++|++.||++.|..||... .......++..-....+ ...
T Consensus 176 -~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~-------~~~etYkrI~k~~~~~p--~~i 245 (281)
T KOG0580|consen 176 -SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQ-------SHSETYKRIRKVDLKFP--STI 245 (281)
T ss_pred -CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhh-------hhHHHHHHHHHccccCC--ccc
Confidence 44566789999999999999999999999999999999999999999832 22222333333333322 222
Q ss_pred HHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 357 IQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 357 ~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
. ..+.+++.+|+..+|.+|.+..|++++
T Consensus 246 s---~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 246 S---GGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred C---hhHHHHHHHHhccCccccccHHHHhhh
Confidence 2 237889999999999999999999876
|
|
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-37 Score=290.91 Aligned_cols=239 Identities=26% Similarity=0.359 Sum_probs=180.7
Q ss_pred cCcccceeeeecCceEEEEEEeCC-Cc--EEEEEecc-----------------------CCccccceEEEecCceEEEE
Q 042435 143 EYFHIRYCIGTGGYDSVYKAELPD-GK--VVALKKLH-----------------------HSETEDSAFVVYSPQCMFFI 196 (412)
Q Consensus 143 ~~f~~~~~lG~G~~g~Vy~~~~~~-~~--~vAvK~l~-----------------------~~~~~~~~~~~~~~~~~~lv 196 (412)
++|++.+.||+|+||.||+|...+ +. .+++|.++ |+++......+...+..+++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 578889999999999999997743 33 46777553 45555555566677789999
Q ss_pred EEeccCCceeeeeccCc-------------ccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcE
Q 042435 197 YEYMERGSLFCVLRDDD-------------EAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEA 263 (412)
Q Consensus 197 ~ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~ 263 (412)
+||+++|+|.++++... ....+++..+..++.|++.||+|||++ +++||||||+||++++++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCCCeE
Confidence 99999999999886532 112488999999999999999999998 99999999999999999999
Q ss_pred EEeecCCccccCCCCCCcccccccccccccccccCcccCcccccHHHHHHHHHHHh-CCCCcccccccccCCCCcchhhH
Q 042435 264 FVADFGTVRLLDVDSSNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLM-GTHPGELLLSLSSSSGPKIMLID 342 (412)
Q Consensus 264 kl~DfGla~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~ 342 (412)
||+|||++....... .......+..|+|||+..+..++.++|||||||++|||++ |..||.... . ....+
T Consensus 159 kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~-------~-~~~~~ 229 (297)
T cd05089 159 KIADFGLSRGEEVYV-KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMT-------C-AELYE 229 (297)
T ss_pred EECCcCCCcccccee-ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC-------H-HHHHH
Confidence 999999986432111 1111233567999999988889999999999999999998 999986321 1 11112
Q ss_pred HhhhccCCccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhcCCCCCC
Q 042435 343 ILYQRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELEGKTPMKK 396 (412)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~~~ 396 (412)
..........+.. ....+.+++.+||+.+|.+||+++++++.|+.+....+
T Consensus 230 ~~~~~~~~~~~~~---~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~ 280 (297)
T cd05089 230 KLPQGYRMEKPRN---CDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARK 280 (297)
T ss_pred HHhcCCCCCCCCC---CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhc
Confidence 2222222211111 12347899999999999999999999999988776544
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-37 Score=284.11 Aligned_cols=232 Identities=25% Similarity=0.400 Sum_probs=179.4
Q ss_pred cCcccceeeeecCceEEEEEEeCCCcEEEEEeccC--------------------CccccceEEEecCceEEEEEEeccC
Q 042435 143 EYFHIRYCIGTGGYDSVYKAELPDGKVVALKKLHH--------------------SETEDSAFVVYSPQCMFFIYEYMER 202 (412)
Q Consensus 143 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~l~~--------------------~~~~~~~~~~~~~~~~~lv~ey~~~ 202 (412)
++|++.+.||+|+||.||+|...++..+|+|.++. +++......+ .....+++|||+++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~-~~~~~~lv~e~~~~ 84 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVV-SEEPIYIVTEYMSK 84 (260)
T ss_pred HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCCCHHHHHHHHHHHHhcCCCceEEEEeEE-CCCCcEEEEEecCC
Confidence 46888899999999999999988888999997753 2322222223 45568999999999
Q ss_pred CceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCCCC-c
Q 042435 203 GSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSN-R 281 (412)
Q Consensus 203 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~-~ 281 (412)
++|.+++..... ..+++.++..++.|++.||+|||+. +++||||||+||++++++.++|+|||++......... .
T Consensus 85 ~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~ 160 (260)
T cd05070 85 GSLLDFLKDGEG-RALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTAR 160 (260)
T ss_pred CcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeeccCcccccc
Confidence 999998875432 2489999999999999999999998 9999999999999999999999999999765433211 1
Q ss_pred ccccccccccccccccCcccCcccccHHHHHHHHHHHh-CCCCcccccccccCCCCcchhhHHhhhccCCccchhhHHHH
Q 042435 282 TLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLM-GTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKIIQDI 360 (412)
Q Consensus 282 ~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 360 (412)
....++..|+|||...+..++.++||||||+++|||++ |..||... . .....+.+......+.+. ...
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~-------~-~~~~~~~~~~~~~~~~~~---~~~ 229 (260)
T cd05070 161 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGM-------N-NREVLEQVERGYRMPCPQ---DCP 229 (260)
T ss_pred cCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCC-------C-HHHHHHHHHcCCCCCCCC---cCC
Confidence 22235678999999988889999999999999999999 88888632 1 111222222222222211 222
Q ss_pred HHHHHHHHhcCcCCCCCCCCHHHHHHHHhc
Q 042435 361 ILVSTIALACLRSKPKSRPTMQRISQELEG 390 (412)
Q Consensus 361 ~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~ 390 (412)
..+.+++.+||..+|++|||+.++.+.|++
T Consensus 230 ~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 230 ISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred HHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 348899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=289.23 Aligned_cols=233 Identities=23% Similarity=0.305 Sum_probs=178.3
Q ss_pred CcccceeeeecCceEEEEEEeC------CCcEEEEEecc----------------------CCccccceEEEecCceEEE
Q 042435 144 YFHIRYCIGTGGYDSVYKAELP------DGKVVALKKLH----------------------HSETEDSAFVVYSPQCMFF 195 (412)
Q Consensus 144 ~f~~~~~lG~G~~g~Vy~~~~~------~~~~vAvK~l~----------------------~~~~~~~~~~~~~~~~~~l 195 (412)
+|++.+.||+|+||.||+|... +++.||+|+++ |+++......+...+..++
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~ 85 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM 85 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence 4677788999999999999763 35789999764 4555555566777788999
Q ss_pred EEEeccCCceeeeeccCc-------------ccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCc
Q 042435 196 IYEYMERGSLFCVLRDDD-------------EAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLE 262 (412)
Q Consensus 196 v~ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~ 262 (412)
++||+++++|.+++.... ....+++..+..++.|++.||+|||++ +++||||||+||++++++.
T Consensus 86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~ 162 (283)
T cd05091 86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLN 162 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecCCCc
Confidence 999999999988874221 122488899999999999999999998 9999999999999999999
Q ss_pred EEEeecCCccccCCCCCC--cccccccccccccccccCcccCcccccHHHHHHHHHHHh-CCCCcccccccccCCCCcch
Q 042435 263 AFVADFGTVRLLDVDSSN--RTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLM-GTHPGELLLSLSSSSGPKIM 339 (412)
Q Consensus 263 ~kl~DfGla~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~ 339 (412)
+||+|||+++........ .....+++.|+|||.+.+..++.++||||||+++|||++ |..||... ... .
T Consensus 163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~-------~~~-~ 234 (283)
T cd05091 163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGY-------SNQ-D 234 (283)
T ss_pred eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCC-------CHH-H
Confidence 999999998865432211 123345778999999988889999999999999999998 88887621 111 1
Q ss_pred hhHHhhhccCCccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhc
Q 042435 340 LIDILYQRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELEG 390 (412)
Q Consensus 340 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~ 390 (412)
..+.+......+.+.. ....+.+++.+||+.+|++||++.+|++.|+.
T Consensus 235 ~~~~i~~~~~~~~~~~---~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 235 VIEMIRNRQVLPCPDD---CPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HHHHHHcCCcCCCCCC---CCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 2222222211111122 22337899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=285.69 Aligned_cols=239 Identities=20% Similarity=0.237 Sum_probs=185.4
Q ss_pred cCcccceeeeecCceEEEEEEe-CCCcEEEEEec------------------------cCCccccceEEEecCceEEEEE
Q 042435 143 EYFHIRYCIGTGGYDSVYKAEL-PDGKVVALKKL------------------------HHSETEDSAFVVYSPQCMFFIY 197 (412)
Q Consensus 143 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l------------------------~~~~~~~~~~~~~~~~~~~lv~ 197 (412)
++|++.+.||+|+||.||+|.. .+++.+|||.+ +|+++......+..++..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 4688889999999999999976 57899999954 3455555555567778899999
Q ss_pred EeccCCceeeeeccCc-ccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCC
Q 042435 198 EYMERGSLFCVLRDDD-EAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDV 276 (412)
Q Consensus 198 ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~ 276 (412)
||+++++|.+++.... ....+++.++..++.|++.||+|||+. +++|+||||+||+++.++.++++|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 9999999998886422 123589999999999999999999998 999999999999999999999999999886644
Q ss_pred CCCCcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccchhh
Q 042435 277 DSSNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKI 356 (412)
Q Consensus 277 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 356 (412)
.........|+..|+|||.+.+..++.++|+||||+++|||++|..||.... .........+.....++...
T Consensus 159 ~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~------~~~~~~~~~~~~~~~~~~~~-- 230 (267)
T cd08229 159 KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK------MNLYSLCKKIEQCDYPPLPS-- 230 (267)
T ss_pred CCcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCccccc------chHHHHhhhhhcCCCCCCCc--
Confidence 3333334568899999999988889999999999999999999999986221 00001111111111111111
Q ss_pred HHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhcCC
Q 042435 357 IQDIILVSTIALACLRSKPKSRPTMQRISQELEGKT 392 (412)
Q Consensus 357 ~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 392 (412)
......+.+++.+||+.||++|||+.+|++.++++.
T Consensus 231 ~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 231 DHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred ccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 112234889999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-37 Score=282.59 Aligned_cols=226 Identities=22% Similarity=0.325 Sum_probs=176.2
Q ss_pred eeeeecCceEEEEEEe-CCCcEEEEEec----------------------cCCccccceEEEecCceEEEEEEeccCCce
Q 042435 149 YCIGTGGYDSVYKAEL-PDGKVVALKKL----------------------HHSETEDSAFVVYSPQCMFFIYEYMERGSL 205 (412)
Q Consensus 149 ~~lG~G~~g~Vy~~~~-~~~~~vAvK~l----------------------~~~~~~~~~~~~~~~~~~~lv~ey~~~gsL 205 (412)
+.||+|+||.||+|.. .+++.+|+|.. +|+++......+......++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 3689999999999977 47899999953 466666667778888899999999999999
Q ss_pred eeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCCCCc--cc
Q 042435 206 FCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNR--TL 283 (412)
Q Consensus 206 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~--~~ 283 (412)
.+++.... ..+++.+++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++......... ..
T Consensus 81 ~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 155 (252)
T cd05084 81 LTFLRTEG--PRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGM 155 (252)
T ss_pred HHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcccccccccccCCC
Confidence 99886543 2488999999999999999999998 99999999999999999999999999987543221111 11
Q ss_pred ccccccccccccccCcccCcccccHHHHHHHHHHHh-CCCCcccccccccCCCCcchhhHHhhhccCCccchhhHHHHHH
Q 042435 284 QAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLM-GTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKIIQDIIL 362 (412)
Q Consensus 284 ~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 362 (412)
...+..|+|||.+.+..++.++||||||+++|||++ |..||.... .......+......+.+. .....
T Consensus 156 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~--------~~~~~~~~~~~~~~~~~~---~~~~~ 224 (252)
T cd05084 156 KQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLS--------NQQTREAIEQGVRLPCPE---LCPDA 224 (252)
T ss_pred CCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccC--------HHHHHHHHHcCCCCCCcc---cCCHH
Confidence 123457999999988889999999999999999998 888886321 111222222222222111 11234
Q ss_pred HHHHHHhcCcCCCCCCCCHHHHHHHHhc
Q 042435 363 VSTIALACLRSKPKSRPTMQRISQELEG 390 (412)
Q Consensus 363 ~~~l~~~Cl~~dP~~RPs~~evl~~L~~ 390 (412)
+.+++.+||+.+|++|||+.|+.+.|+.
T Consensus 225 ~~~li~~~l~~~p~~Rps~~~~~~~l~~ 252 (252)
T cd05084 225 VYRLMERCWEYDPGQRPSFSTVHQELQS 252 (252)
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHHHhC
Confidence 8889999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=283.81 Aligned_cols=233 Identities=24% Similarity=0.356 Sum_probs=179.5
Q ss_pred cCcccceeeeecCceEEEEEEeCCCcEEEEEeccC--------------------CccccceEEEecCceEEEEEEeccC
Q 042435 143 EYFHIRYCIGTGGYDSVYKAELPDGKVVALKKLHH--------------------SETEDSAFVVYSPQCMFFIYEYMER 202 (412)
Q Consensus 143 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~l~~--------------------~~~~~~~~~~~~~~~~~lv~ey~~~ 202 (412)
++|++.++||+|+||.||+|...++..||+|.++. +++...... ...+..++||||+++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~-~~~~~~~lv~e~~~~ 84 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV-VSEEPIYIVTEYMSK 84 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCccCHHHHHHHHHHHHhCCCCCcceEEEE-ECCCCcEEEEEcCCC
Confidence 56899999999999999999887777899997753 333333332 345567999999999
Q ss_pred CceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCCCCc-
Q 042435 203 GSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNR- 281 (412)
Q Consensus 203 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~- 281 (412)
|+|.+++..... ..+++..+..++.|++.||+|||+. +++||||||+||++++++.++|+|||.++.........
T Consensus 85 ~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~~ 160 (262)
T cd05071 85 GSLLDFLKGEMG-KYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR 160 (262)
T ss_pred CcHHHHHhhccc-cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceeeccccccccc
Confidence 999999875422 2579999999999999999999998 99999999999999999999999999998654332211
Q ss_pred ccccccccccccccccCcccCcccccHHHHHHHHHHHh-CCCCcccccccccCCCCcchhhHHhhhccCCccchhhHHHH
Q 042435 282 TLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLM-GTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKIIQDI 360 (412)
Q Consensus 282 ~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 360 (412)
....++..|+|||+..+..++.++||||||+++|||+| |..||.... .. ...+........+.. ....
T Consensus 161 ~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~-------~~-~~~~~~~~~~~~~~~---~~~~ 229 (262)
T cd05071 161 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV-------NR-EVLDQVERGYRMPCP---PECP 229 (262)
T ss_pred cCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC-------hH-HHHHHHhcCCCCCCc---cccC
Confidence 23346678999999988889999999999999999999 888876321 11 111111111111111 1223
Q ss_pred HHHHHHHHhcCcCCCCCCCCHHHHHHHHhcC
Q 042435 361 ILVSTIALACLRSKPKSRPTMQRISQELEGK 391 (412)
Q Consensus 361 ~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 391 (412)
..+.+++.+||+.||++||++.++++.|++.
T Consensus 230 ~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 230 ESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred HHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 3478999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=289.02 Aligned_cols=227 Identities=22% Similarity=0.276 Sum_probs=171.7
Q ss_pred eeecCceEEEEEEeC-CCcEEEEEecc------------------------CCccccceEEEecCceEEEEEEeccCCce
Q 042435 151 IGTGGYDSVYKAELP-DGKVVALKKLH------------------------HSETEDSAFVVYSPQCMFFIYEYMERGSL 205 (412)
Q Consensus 151 lG~G~~g~Vy~~~~~-~~~~vAvK~l~------------------------~~~~~~~~~~~~~~~~~~lv~ey~~~gsL 205 (412)
||+|+||.||++..+ +|+.+|+|.+. |+++......+..+...++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 699999999999764 68999999653 44444445556778889999999999999
Q ss_pred eeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCCCCccccc
Q 042435 206 FCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQA 285 (412)
Q Consensus 206 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 285 (412)
.+++..... ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||++....... ......
T Consensus 81 ~~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~-~~~~~~ 155 (277)
T cd05607 81 KYHIYNVGE-RGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK-TITQRA 155 (277)
T ss_pred HHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc-eeeccC
Confidence 887754332 2488999999999999999999998 99999999999999999999999999987654322 223346
Q ss_pred ccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccchhhHHHHHHHHH
Q 042435 286 GTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKIIQDIILVST 365 (412)
Q Consensus 286 gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 365 (412)
|+..|+|||++.+..++.++|||||||++|||++|+.||.... ......++...................+.+
T Consensus 156 ~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (277)
T cd05607 156 GTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHK-------EKVAKEELKRRTLEDEVKFEHQNFTEESKD 228 (277)
T ss_pred CCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCc-------chhhHHHHHHHhhccccccccccCCHHHHH
Confidence 8999999999998889999999999999999999999986321 000111111111111100000112234789
Q ss_pred HHHhcCcCCCCCCCCHHHHHHHHh
Q 042435 366 IALACLRSKPKSRPTMQRISQELE 389 (412)
Q Consensus 366 l~~~Cl~~dP~~RPs~~evl~~L~ 389 (412)
++.+||+.||++||++.|+++.+.
T Consensus 229 li~~~L~~~P~~R~~~~~~~~~~~ 252 (277)
T cd05607 229 ICRLFLAKKPEDRLGSREKNDDPR 252 (277)
T ss_pred HHHHHhccCHhhCCCCccchhhhh
Confidence 999999999999999977664443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=299.75 Aligned_cols=220 Identities=23% Similarity=0.320 Sum_probs=169.4
Q ss_pred eeecCceEEEEEEeC-CCcEEEEEecc---------------------------CCccccceEEEecCceEEEEEEeccC
Q 042435 151 IGTGGYDSVYKAELP-DGKVVALKKLH---------------------------HSETEDSAFVVYSPQCMFFIYEYMER 202 (412)
Q Consensus 151 lG~G~~g~Vy~~~~~-~~~~vAvK~l~---------------------------~~~~~~~~~~~~~~~~~~lv~ey~~~ 202 (412)
||+|+||+||+|+.. +++.||+|.+. |+++......+...+..++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 699999999999764 68999999753 44444455566778889999999999
Q ss_pred CceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCCCCcc
Q 042435 203 GSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRT 282 (412)
Q Consensus 203 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 282 (412)
|+|.+++.... .+++..+..++.|+++||+|||++ +|+||||||+|||++.++.+||+|||+++..........
T Consensus 81 g~L~~~l~~~~---~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~ 154 (330)
T cd05586 81 GELFWHLQKEG---RFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTN 154 (330)
T ss_pred ChHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCcc
Confidence 99988886543 588999999999999999999998 999999999999999999999999999876433333334
Q ss_pred cccccccccccccccCc-ccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccchhhHHHHH
Q 042435 283 LQAGTYGYIALELVYTM-VVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKIIQDII 361 (412)
Q Consensus 283 ~~~gt~~y~aPE~~~~~-~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 361 (412)
...||+.|+|||++.+. .++.++|||||||++|||+||+.||... ........+.......+. .. ...
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~-------~~~~~~~~i~~~~~~~~~-~~---~~~ 223 (330)
T cd05586 155 TFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAE-------DTQQMYRNIAFGKVRFPK-NV---LSD 223 (330)
T ss_pred CccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCC-------CHHHHHHHHHcCCCCCCC-cc---CCH
Confidence 45799999999998754 4789999999999999999999998632 111111122211111111 11 122
Q ss_pred HHHHHHHhcCcCCCCCCC----CHHHHHHH
Q 042435 362 LVSTIALACLRSKPKSRP----TMQRISQE 387 (412)
Q Consensus 362 ~~~~l~~~Cl~~dP~~RP----s~~evl~~ 387 (412)
.+.+++.+||+.||++|| ++.|++++
T Consensus 224 ~~~~li~~~L~~~P~~R~~~~~~~~~ll~h 253 (330)
T cd05586 224 EGRQFVKGLLNRNPQHRLGAHRDAVELKEH 253 (330)
T ss_pred HHHHHHHHHcCCCHHHCCCCCCCHHHHhcC
Confidence 367899999999999998 56666653
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=297.83 Aligned_cols=217 Identities=24% Similarity=0.304 Sum_probs=173.3
Q ss_pred eeeeecCceEEEEEEe----CCCcEEEEEec-----------------------cCCccccceEEEecCceEEEEEEecc
Q 042435 149 YCIGTGGYDSVYKAEL----PDGKVVALKKL-----------------------HHSETEDSAFVVYSPQCMFFIYEYME 201 (412)
Q Consensus 149 ~~lG~G~~g~Vy~~~~----~~~~~vAvK~l-----------------------~~~~~~~~~~~~~~~~~~~lv~ey~~ 201 (412)
+.||+|+||.||++.. .+|+.||+|.+ +|+++......+..++..++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999965 36889999964 46777777777888899999999999
Q ss_pred CCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCCCCc
Q 042435 202 RGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNR 281 (412)
Q Consensus 202 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 281 (412)
+|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.........
T Consensus 82 ~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~ 155 (318)
T cd05582 82 GGDLFTRLSKEV---MFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKA 155 (318)
T ss_pred CCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCce
Confidence 999998886543 589999999999999999999998 99999999999999999999999999998654433333
Q ss_pred ccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccchhhHHHHH
Q 042435 282 TLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKIIQDII 361 (412)
Q Consensus 282 ~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 361 (412)
....||+.|+|||.+.+..++.++|||||||++|||++|+.||... ........+....... +... ..
T Consensus 156 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~-------~~~~~~~~i~~~~~~~--p~~~---~~ 223 (318)
T cd05582 156 YSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGK-------DRKETMTMILKAKLGM--PQFL---SP 223 (318)
T ss_pred ecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCC-------CHHHHHHHHHcCCCCC--CCCC---CH
Confidence 4457899999999998888999999999999999999999998732 1111112222221111 1111 22
Q ss_pred HHHHHHHhcCcCCCCCCCCHHH
Q 042435 362 LVSTIALACLRSKPKSRPTMQR 383 (412)
Q Consensus 362 ~~~~l~~~Cl~~dP~~RPs~~e 383 (412)
.+.+++.+||+.||++||++.+
T Consensus 224 ~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 224 EAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred HHHHHHHHHhhcCHhHcCCCCC
Confidence 3778999999999999999544
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-37 Score=301.58 Aligned_cols=239 Identities=19% Similarity=0.275 Sum_probs=184.2
Q ss_pred HhhcCcccceeeeecCceEEEEEEeC------CCcEEEEEecc-----------------------CCccccceEEEecC
Q 042435 140 DATEYFHIRYCIGTGGYDSVYKAELP------DGKVVALKKLH-----------------------HSETEDSAFVVYSP 190 (412)
Q Consensus 140 ~~~~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vAvK~l~-----------------------~~~~~~~~~~~~~~ 190 (412)
-..++|.+.+.||+|+||.||+|.+. .++.||+|+++ |+++......+...
T Consensus 34 ~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~ 113 (401)
T cd05107 34 MPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKG 113 (401)
T ss_pred ecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccC
Confidence 34456888899999999999999863 34689999763 55666666667778
Q ss_pred ceEEEEEEeccCCceeeeeccCcc--------------------------------------------------------
Q 042435 191 QCMFFIYEYMERGSLFCVLRDDDE-------------------------------------------------------- 214 (412)
Q Consensus 191 ~~~~lv~ey~~~gsL~~~l~~~~~-------------------------------------------------------- 214 (412)
...++||||+++|+|.++++....
T Consensus 114 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (401)
T cd05107 114 GPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQ 193 (401)
T ss_pred CCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchh
Confidence 889999999999999988864311
Q ss_pred ---------------------------------------cccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCE
Q 042435 215 ---------------------------------------AIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNI 255 (412)
Q Consensus 215 ---------------------------------------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NI 255 (412)
...++|.....++.|++.||+|||+. +++||||||+||
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp~Ni 270 (401)
T cd05107 194 DMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAARNV 270 (401)
T ss_pred cchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCcceE
Confidence 12367888999999999999999988 999999999999
Q ss_pred EecCCCcEEEeecCCccccCCCCC--CcccccccccccccccccCcccCcccccHHHHHHHHHHHh-CCCCccccccccc
Q 042435 256 LLNSNLEAFVADFGTVRLLDVDSS--NRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLM-GTHPGELLLSLSS 332 (412)
Q Consensus 256 Ll~~~~~~kl~DfGla~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~ellt-g~~P~~~~~~~~~ 332 (412)
|+++++.+||+|||+++....... ......++..|+|||.+.+..++.++|||||||++|||++ |..||...
T Consensus 271 Ll~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~----- 345 (401)
T cd05107 271 LICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPEL----- 345 (401)
T ss_pred EEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCC-----
Confidence 999999999999999986532221 1223356788999999988889999999999999999998 88897632
Q ss_pred CCCCcchhhHHhhhccCCccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhcC
Q 042435 333 SSGPKIMLIDILYQRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELEGK 391 (412)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 391 (412)
.........+......+.+.. ....+.+++.+||..+|.+||+++|+++.|+++
T Consensus 346 --~~~~~~~~~~~~~~~~~~p~~---~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~ 399 (401)
T cd05107 346 --PMNEQFYNAIKRGYRMAKPAH---ASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDL 399 (401)
T ss_pred --CchHHHHHHHHcCCCCCCCCC---CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 111112222222222221111 123488999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=290.56 Aligned_cols=239 Identities=22% Similarity=0.326 Sum_probs=183.4
Q ss_pred hcCcccceeeeecCceEEEEEEe--------CCCcEEEEEec-----------------------cCCccccceEEEecC
Q 042435 142 TEYFHIRYCIGTGGYDSVYKAEL--------PDGKVVALKKL-----------------------HHSETEDSAFVVYSP 190 (412)
Q Consensus 142 ~~~f~~~~~lG~G~~g~Vy~~~~--------~~~~~vAvK~l-----------------------~~~~~~~~~~~~~~~ 190 (412)
.++|++.+.||+|+||.||+|.. .++..||+|.+ +|+++......+...
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 93 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 93 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence 45688889999999999999964 13457999965 355666666667778
Q ss_pred ceEEEEEEeccCCceeeeeccCcc-------------cccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEe
Q 042435 191 QCMFFIYEYMERGSLFCVLRDDDE-------------AIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILL 257 (412)
Q Consensus 191 ~~~~lv~ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl 257 (412)
...++||||+++|+|.+++..... ...++|.++..++.|++.||+|||++ +++||||||+||++
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nili 170 (304)
T cd05101 94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNVLV 170 (304)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---CeeecccccceEEE
Confidence 889999999999999998865321 12478999999999999999999998 99999999999999
Q ss_pred cCCCcEEEeecCCccccCCCCCC--cccccccccccccccccCcccCcccccHHHHHHHHHHHh-CCCCcccccccccCC
Q 042435 258 NSNLEAFVADFGTVRLLDVDSSN--RTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLM-GTHPGELLLSLSSSS 334 (412)
Q Consensus 258 ~~~~~~kl~DfGla~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~ellt-g~~P~~~~~~~~~~~ 334 (412)
++++.+||+|||+++........ .....+++.|+|||++.+..++.++||||||+++||+++ |..||...
T Consensus 171 ~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~------- 243 (304)
T cd05101 171 TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI------- 243 (304)
T ss_pred cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccC-------
Confidence 99999999999999866432221 122345678999999988889999999999999999998 77887521
Q ss_pred CCcchhhHHhhhccCCccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhcCCCC
Q 042435 335 GPKIMLIDILYQRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELEGKTPM 394 (412)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~ 394 (412)
....+.+.+........+. .....+.+++.+||+.+|++|||+.|+++.|+++...
T Consensus 244 -~~~~~~~~~~~~~~~~~~~---~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~ 299 (304)
T cd05101 244 -PVEELFKLLKEGHRMDKPA---NCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL 299 (304)
T ss_pred -CHHHHHHHHHcCCcCCCCC---CCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence 1111122222211111111 1223478899999999999999999999999887643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-37 Score=287.39 Aligned_cols=238 Identities=19% Similarity=0.270 Sum_probs=184.8
Q ss_pred hcCcccceeeeecCceEEEEEEeCC-----CcEEEEEec----------------------cCCccccceEEEec-CceE
Q 042435 142 TEYFHIRYCIGTGGYDSVYKAELPD-----GKVVALKKL----------------------HHSETEDSAFVVYS-PQCM 193 (412)
Q Consensus 142 ~~~f~~~~~lG~G~~g~Vy~~~~~~-----~~~vAvK~l----------------------~~~~~~~~~~~~~~-~~~~ 193 (412)
.++|++.+.||+|+||.||+|...+ +..||+|.+ +|+++......+.. +...
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 84 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP 84 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence 4678889999999999999998765 788999965 45666665555544 5778
Q ss_pred EEEEEeccCCceeeeeccCccc-----ccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeec
Q 042435 194 FFIYEYMERGSLFCVLRDDDEA-----IELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADF 268 (412)
Q Consensus 194 ~lv~ey~~~gsL~~~l~~~~~~-----~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Df 268 (412)
++++||+++|+|.+++...... ..+++.++..++.|++.||+|||+. +++||||||+||++++++.+||+||
T Consensus 85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl~d~ 161 (280)
T cd05043 85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDN 161 (280)
T ss_pred EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEECCC
Confidence 9999999999999988654321 3589999999999999999999998 9999999999999999999999999
Q ss_pred CCccccCCCCCC--cccccccccccccccccCcccCcccccHHHHHHHHHHHh-CCCCcccccccccCCCCcchhhHHhh
Q 042435 269 GTVRLLDVDSSN--RTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLM-GTHPGELLLSLSSSSGPKIMLIDILY 345 (412)
Q Consensus 269 Gla~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~ 345 (412)
|+++.+...... .....++..|+|||++.+..++.++||||||+++||+++ |+.||.... ...+...+.
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~--------~~~~~~~~~ 233 (280)
T cd05043 162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEID--------PFEMAAYLK 233 (280)
T ss_pred CCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCC--------HHHHHHHHH
Confidence 999865433211 122345678999999988889999999999999999999 999986321 111222222
Q ss_pred hccCCccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhcCCC
Q 042435 346 QRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELEGKTP 393 (412)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 393 (412)
.......... ....+.+++.+||+.||++|||+.|+++.|+.+..
T Consensus 234 ~~~~~~~~~~---~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 234 DGYRLAQPIN---CPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred cCCCCCCCCc---CCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 2222111111 12347899999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=284.39 Aligned_cols=233 Identities=23% Similarity=0.364 Sum_probs=175.6
Q ss_pred cccceeeeecCceEEEEEEeCC----CcEEEEEecc-----------------------CCccccceEEEecCc------
Q 042435 145 FHIRYCIGTGGYDSVYKAELPD----GKVVALKKLH-----------------------HSETEDSAFVVYSPQ------ 191 (412)
Q Consensus 145 f~~~~~lG~G~~g~Vy~~~~~~----~~~vAvK~l~-----------------------~~~~~~~~~~~~~~~------ 191 (412)
|++.+.||+|+||.||+|.... +..||+|+++ |+++......+...+
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 5677899999999999997642 4689999764 333333333343333
Q ss_pred eEEEEEEeccCCceeeeeccCc---ccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeec
Q 042435 192 CMFFIYEYMERGSLFCVLRDDD---EAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADF 268 (412)
Q Consensus 192 ~~~lv~ey~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Df 268 (412)
..++++||+++|+|..++.... ....+++.....++.|++.||+|||+. +++||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECCc
Confidence 3799999999999988875432 223589999999999999999999998 9999999999999999999999999
Q ss_pred CCccccCCCCCCc--ccccccccccccccccCcccCcccccHHHHHHHHHHHh-CCCCcccccccccCCCCcchhhHHhh
Q 042435 269 GTVRLLDVDSSNR--TLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLM-GTHPGELLLSLSSSSGPKIMLIDILY 345 (412)
Q Consensus 269 Gla~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~ 345 (412)
|+++......... ....++..|+|||.+.+..++.++||||||+++|||++ |..||.... . ....+.+.
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~-------~-~~~~~~~~ 229 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVE-------N-HEIYDYLR 229 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCC-------H-HHHHHHHH
Confidence 9998654332211 12235678999999988889999999999999999999 888876321 1 11222222
Q ss_pred hccCCccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhcC
Q 042435 346 QRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELEGK 391 (412)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 391 (412)
.......+. .....+.+++.+||+.||++|||+.|+++.|+++
T Consensus 230 ~~~~~~~~~---~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 230 HGNRLKQPE---DCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred cCCCCCCCc---CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 211111111 1233488999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=282.87 Aligned_cols=223 Identities=21% Similarity=0.295 Sum_probs=172.6
Q ss_pred eeeecCceEEEEEEe---CCCcEEEEEecc-----------------------CCccccceEEEecCceEEEEEEeccCC
Q 042435 150 CIGTGGYDSVYKAEL---PDGKVVALKKLH-----------------------HSETEDSAFVVYSPQCMFFIYEYMERG 203 (412)
Q Consensus 150 ~lG~G~~g~Vy~~~~---~~~~~vAvK~l~-----------------------~~~~~~~~~~~~~~~~~~lv~ey~~~g 203 (412)
.||+|+||.||+|.+ .+++.+|+|.++ |+++......+ ..+..++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGIC-EAESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEE-cCCCcEEEEecCCCC
Confidence 589999999999965 357899999764 33443333333 456779999999999
Q ss_pred ceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCCCC---
Q 042435 204 SLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSN--- 280 (412)
Q Consensus 204 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~--- 280 (412)
+|.+++.... .+++..+..++.|++.||+|||++ +++||||||+||+++.++.+||+|||+++........
T Consensus 81 ~L~~~l~~~~---~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 154 (257)
T cd05116 81 PLNKFLQKNK---HVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKA 154 (257)
T ss_pred cHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeee
Confidence 9999886543 588999999999999999999998 9999999999999999999999999999866443221
Q ss_pred cccccccccccccccccCcccCcccccHHHHHHHHHHHh-CCCCcccccccccCCCCcchhhHHhhhccCCccchhhHHH
Q 042435 281 RTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLM-GTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKIIQD 359 (412)
Q Consensus 281 ~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 359 (412)
.....++..|+|||.+....++.++||||||+++|||++ |+.||... ......+.+.....++.+...
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~--------~~~~~~~~i~~~~~~~~~~~~--- 223 (257)
T cd05116 155 KTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGM--------KGNEVTQMIESGERMECPQRC--- 223 (257)
T ss_pred cCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCC--------CHHHHHHHHHCCCCCCCCCCC---
Confidence 122234578999999988889999999999999999998 99998732 111223333332222222222
Q ss_pred HHHHHHHHHhcCcCCCCCCCCHHHHHHHHhc
Q 042435 360 IILVSTIALACLRSKPKSRPTMQRISQELEG 390 (412)
Q Consensus 360 ~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~ 390 (412)
...+.+++.+||+.||++||++.+|.+.|+.
T Consensus 224 ~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 224 PPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred CHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 2347899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=288.53 Aligned_cols=235 Identities=24% Similarity=0.363 Sum_probs=182.0
Q ss_pred CcccceeeeecCceEEEEEEeC------CCcEEEEEec----------------------cCCccccceEEEecCceEEE
Q 042435 144 YFHIRYCIGTGGYDSVYKAELP------DGKVVALKKL----------------------HHSETEDSAFVVYSPQCMFF 195 (412)
Q Consensus 144 ~f~~~~~lG~G~~g~Vy~~~~~------~~~~vAvK~l----------------------~~~~~~~~~~~~~~~~~~~l 195 (412)
+|++.+.||+|+||.||+|... ....+|+|.+ +|+++......+...+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 4778899999999999999752 2357888854 35666666666777888999
Q ss_pred EEEeccCCceeeeeccCc---------------------ccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCC
Q 042435 196 IYEYMERGSLFCVLRDDD---------------------EAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNN 254 (412)
Q Consensus 196 v~ey~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~N 254 (412)
++||+++|+|.+++.... ....+++.+++.++.|++.||+|||+. +++||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---Ceehhhhhhhe
Confidence 999999999998875421 113588999999999999999999988 99999999999
Q ss_pred EEecCCCcEEEeecCCccccCCCCC--CcccccccccccccccccCcccCcccccHHHHHHHHHHHh-CCCCcccccccc
Q 042435 255 ILLNSNLEAFVADFGTVRLLDVDSS--NRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLM-GTHPGELLLSLS 331 (412)
Q Consensus 255 ILl~~~~~~kl~DfGla~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~ellt-g~~P~~~~~~~~ 331 (412)
|++++++.+||+|||+++....... ......++..|+|||...+..++.++||||||+++|||+| |..||...
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~---- 233 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI---- 233 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCC----
Confidence 9999999999999999976533221 1122345678999999988889999999999999999999 99998622
Q ss_pred cCCCCcchhhHHhhhccCCccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhcCC
Q 042435 332 SSSGPKIMLIDILYQRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELEGKT 392 (412)
Q Consensus 332 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 392 (412)
....+.+........+.+... ...+.+++.+||+.+|++||++.|+++.|+++.
T Consensus 234 ----~~~~~~~~~~~~~~~~~~~~~---~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~ 287 (290)
T cd05045 234 ----APERLFNLLKTGYRMERPENC---SEEMYNLMLTCWKQEPDKRPTFADISKELEKMM 287 (290)
T ss_pred ----CHHHHHHHHhCCCCCCCCCCC---CHHHHHHHHHHccCCcccCCCHHHHHHHHHHHH
Confidence 111222333332222222211 234788999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=282.16 Aligned_cols=230 Identities=22% Similarity=0.313 Sum_probs=177.3
Q ss_pred cCcccceeeeecCceEEEEEEeCCCcEEEEEecc-------------------CCccccceEEE-ecCceEEEEEEeccC
Q 042435 143 EYFHIRYCIGTGGYDSVYKAELPDGKVVALKKLH-------------------HSETEDSAFVV-YSPQCMFFIYEYMER 202 (412)
Q Consensus 143 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~l~-------------------~~~~~~~~~~~-~~~~~~~lv~ey~~~ 202 (412)
++|++.+.||+|+||.||++... |..||+|.++ |+++......+ ...+..++++||+++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~ 84 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAK 84 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCchHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCCC
Confidence 46888899999999999999874 7889999664 34444444333 345678999999999
Q ss_pred CceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCCCCcc
Q 042435 203 GSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRT 282 (412)
Q Consensus 203 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 282 (412)
|+|.++++.... ..+++..++.++.|++.||+|||++ +++||||||+||++++++.+|++|||+++...... .
T Consensus 85 ~~L~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~---~ 157 (256)
T cd05082 85 GSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ---D 157 (256)
T ss_pred CcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceeccccC---C
Confidence 999998876432 2488999999999999999999998 99999999999999999999999999987543222 2
Q ss_pred cccccccccccccccCcccCcccccHHHHHHHHHHHh-CCCCcccccccccCCCCcchhhHHhhhccCCccchhhHHHHH
Q 042435 283 LQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLM-GTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKIIQDII 361 (412)
Q Consensus 283 ~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 361 (412)
...++..|+|||+..+..++.++||||||+++|||++ |+.||.... .......+.......... ....
T Consensus 158 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~--------~~~~~~~~~~~~~~~~~~---~~~~ 226 (256)
T cd05082 158 TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP--------LKDVVPRVEKGYKMDAPD---GCPP 226 (256)
T ss_pred CCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCC--------HHHHHHHHhcCCCCCCCC---CCCH
Confidence 2344678999999988889999999999999999998 999976211 111111122221111111 1223
Q ss_pred HHHHHHHhcCcCCCCCCCCHHHHHHHHhcC
Q 042435 362 LVSTIALACLRSKPKSRPTMQRISQELEGK 391 (412)
Q Consensus 362 ~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 391 (412)
.+.+++.+||+.+|++|||+.++++.|+++
T Consensus 227 ~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 227 VVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred HHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 478899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-37 Score=291.48 Aligned_cols=237 Identities=22% Similarity=0.314 Sum_probs=181.7
Q ss_pred cCcccceeeeecCceEEEEEEeC--------CCcEEEEEecc-----------------------CCccccceEEEecCc
Q 042435 143 EYFHIRYCIGTGGYDSVYKAELP--------DGKVVALKKLH-----------------------HSETEDSAFVVYSPQ 191 (412)
Q Consensus 143 ~~f~~~~~lG~G~~g~Vy~~~~~--------~~~~vAvK~l~-----------------------~~~~~~~~~~~~~~~ 191 (412)
++|.+.+.||+|+||.||++... ++..+|+|.++ |+++......+...+
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 97 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 97 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence 56899999999999999999752 23579999764 344444455567778
Q ss_pred eEEEEEEeccCCceeeeeccCcc-------------cccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEec
Q 042435 192 CMFFIYEYMERGSLFCVLRDDDE-------------AIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLN 258 (412)
Q Consensus 192 ~~~lv~ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~ 258 (412)
..++||||+++|+|.+++..... ...++|.+++.++.|++.||+|||+. +++||||||+||+++
T Consensus 98 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill~ 174 (307)
T cd05098 98 PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVT 174 (307)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHheEEc
Confidence 89999999999999999875421 12489999999999999999999998 999999999999999
Q ss_pred CCCcEEEeecCCccccCCCCCCc--ccccccccccccccccCcccCcccccHHHHHHHHHHHh-CCCCcccccccccCCC
Q 042435 259 SNLEAFVADFGTVRLLDVDSSNR--TLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLM-GTHPGELLLSLSSSSG 335 (412)
Q Consensus 259 ~~~~~kl~DfGla~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~ellt-g~~P~~~~~~~~~~~~ 335 (412)
.++.+||+|||+++......... ....++..|+|||++.+..++.++|||||||++|||++ |..||...
T Consensus 175 ~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~-------- 246 (307)
T cd05098 175 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV-------- 246 (307)
T ss_pred CCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcC--------
Confidence 99999999999987653321111 12234568999999988889999999999999999998 88887521
Q ss_pred CcchhhHHhhhccCCccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhcCCC
Q 042435 336 PKIMLIDILYQRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELEGKTP 393 (412)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 393 (412)
+...+.+.+......+.+.. ....+.+++.+||+.+|++|||+.|+++.|+++.+
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~---~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~ 301 (307)
T cd05098 247 PVEELFKLLKEGHRMDKPSN---CTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILA 301 (307)
T ss_pred CHHHHHHHHHcCCCCCCCCc---CCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHH
Confidence 11112222222222111111 22347889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=284.58 Aligned_cols=233 Identities=24% Similarity=0.331 Sum_probs=173.8
Q ss_pred cccceeeeecCceEEEEEEeCC-Cc--EEEEEec-----------------------cCCccccceEEEec------Cce
Q 042435 145 FHIRYCIGTGGYDSVYKAELPD-GK--VVALKKL-----------------------HHSETEDSAFVVYS------PQC 192 (412)
Q Consensus 145 f~~~~~lG~G~~g~Vy~~~~~~-~~--~vAvK~l-----------------------~~~~~~~~~~~~~~------~~~ 192 (412)
|.+.+.||+|+||.||+|.+.+ ++ .+|+|.+ +|+++......+.. ...
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 3567889999999999998754 33 5899864 35555555444432 235
Q ss_pred EEEEEEeccCCceeeeeccCc---ccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecC
Q 042435 193 MFFIYEYMERGSLFCVLRDDD---EAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFG 269 (412)
Q Consensus 193 ~~lv~ey~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG 269 (412)
.++++||+++|+|.+++.... ....+++.....++.|++.||+|||++ +|+||||||+||++++++.+||+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCCC
Confidence 689999999999988764221 123489999999999999999999998 99999999999999999999999999
Q ss_pred CccccCCCCCC--cccccccccccccccccCcccCcccccHHHHHHHHHHHh-CCCCcccccccccCCCCcchhhHHhhh
Q 042435 270 TVRLLDVDSSN--RTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLM-GTHPGELLLSLSSSSGPKIMLIDILYQ 346 (412)
Q Consensus 270 la~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~ 346 (412)
+++........ .....+++.|+|||...+..++.++||||||+++|||++ |+.||.... .....+.+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~--------~~~~~~~~~~ 229 (272)
T cd05075 158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVE--------NSEIYDYLRQ 229 (272)
T ss_pred cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCC--------HHHHHHHHHc
Confidence 99876433221 122345678999999998899999999999999999999 788886311 1111222222
Q ss_pred ccCCccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhcC
Q 042435 347 RLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELEGK 391 (412)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 391 (412)
....+.... ....+.+++.+||+.||++|||+.++++.|+++
T Consensus 230 ~~~~~~~~~---~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 230 GNRLKQPPD---CLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred CCCCCCCCC---CCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 111111111 122378999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=287.52 Aligned_cols=232 Identities=26% Similarity=0.333 Sum_probs=178.6
Q ss_pred cCcccceeeeecCceEEEEEEe-CCCcEEEEEecc---------------------CCccccceEEEecCceEEEEEEec
Q 042435 143 EYFHIRYCIGTGGYDSVYKAEL-PDGKVVALKKLH---------------------HSETEDSAFVVYSPQCMFFIYEYM 200 (412)
Q Consensus 143 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l~---------------------~~~~~~~~~~~~~~~~~~lv~ey~ 200 (412)
++|++.+.||+|+||.||+|.. .+++.||+|.++ |+++......+...+..++|+||+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 4688888999999999999976 468999999653 455555556677788999999999
Q ss_pred cCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCCCC
Q 042435 201 ERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSN 280 (412)
Q Consensus 201 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 280 (412)
++++|.+++.... .+++.+...++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++.........
T Consensus 89 ~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~ 162 (267)
T cd06645 89 GGGSLQDIYHVTG---PLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAK 162 (267)
T ss_pred CCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEccCcccc
Confidence 9999999886543 588999999999999999999998 9999999999999999999999999998765443333
Q ss_pred ccccccccccccccccc---CcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccchhhH
Q 042435 281 RTLQAGTYGYIALELVY---TMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKII 357 (412)
Q Consensus 281 ~~~~~gt~~y~aPE~~~---~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 357 (412)
.....|+..|+|||++. ...++.++|||||||++|||++|+.||.... +.............++......
T Consensus 163 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~-------~~~~~~~~~~~~~~~~~~~~~~ 235 (267)
T cd06645 163 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLH-------PMRALFLMTKSNFQPPKLKDKM 235 (267)
T ss_pred cccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCccccc-------chhhHHhhhccCCCCCcccccC
Confidence 34457899999999874 4568889999999999999999999975321 1111111111111111111111
Q ss_pred HHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 358 QDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 358 ~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
.....+.+++.+||+.+|++||++++++++
T Consensus 236 ~~~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 236 KWSNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred CCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 112247789999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=281.96 Aligned_cols=232 Identities=24% Similarity=0.383 Sum_probs=179.0
Q ss_pred cCcccceeeeecCceEEEEEEeCCCcEEEEEecc--------------------CCccccceEEEecCceEEEEEEeccC
Q 042435 143 EYFHIRYCIGTGGYDSVYKAELPDGKVVALKKLH--------------------HSETEDSAFVVYSPQCMFFIYEYMER 202 (412)
Q Consensus 143 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~l~--------------------~~~~~~~~~~~~~~~~~~lv~ey~~~ 202 (412)
++|.+...||+|+||.||+|...++..+|+|.+. |+++...... ...+..+++|||+++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~-~~~~~~~~v~e~~~~ 84 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAV-VSEEPIYIVTEFMGK 84 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCccHHHHHHHHHHHHhCCCCCeeeEEEE-EcCCCcEEEEEcCCC
Confidence 4588889999999999999998777789999754 3333333332 345668999999999
Q ss_pred CceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCCC-Cc
Q 042435 203 GSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSS-NR 281 (412)
Q Consensus 203 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~-~~ 281 (412)
|+|.++++.... ..++|..+..++.|++.||+|||+. +++|+||||+||++++++.++|+|||+++....... ..
T Consensus 85 ~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~~ 160 (260)
T cd05069 85 GSLLDFLKEGDG-KYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTAR 160 (260)
T ss_pred CCHHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEccCCccccc
Confidence 999999875432 2489999999999999999999998 999999999999999999999999999976543321 11
Q ss_pred ccccccccccccccccCcccCcccccHHHHHHHHHHHh-CCCCcccccccccCCCCcchhhHHhhhccCCccchhhHHHH
Q 042435 282 TLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLM-GTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKIIQDI 360 (412)
Q Consensus 282 ~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 360 (412)
....++..|+|||...+..++.++||||||+++|||+| |+.||.... .. ...+........+.+. ...
T Consensus 161 ~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~-------~~-~~~~~~~~~~~~~~~~---~~~ 229 (260)
T cd05069 161 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMV-------NR-EVLEQVERGYRMPCPQ---GCP 229 (260)
T ss_pred CCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCC-------HH-HHHHHHHcCCCCCCCc---ccC
Confidence 22345678999999988889999999999999999999 899986321 11 1112222222222111 123
Q ss_pred HHHHHHHHhcCcCCCCCCCCHHHHHHHHhc
Q 042435 361 ILVSTIALACLRSKPKSRPTMQRISQELEG 390 (412)
Q Consensus 361 ~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~ 390 (412)
..+.+++.+||+.||++||+++++.+.|++
T Consensus 230 ~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 230 ESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred HHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 348899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=282.58 Aligned_cols=229 Identities=21% Similarity=0.283 Sum_probs=180.3
Q ss_pred cCcccceeeeecCceEEEEEEe-CCCcEEEEEec--------------------------cCCccccceEEEecCceEEE
Q 042435 143 EYFHIRYCIGTGGYDSVYKAEL-PDGKVVALKKL--------------------------HHSETEDSAFVVYSPQCMFF 195 (412)
Q Consensus 143 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l--------------------------~~~~~~~~~~~~~~~~~~~l 195 (412)
++|++.+.||+|++|.||+|.. .+++.+|+|.+ +|+++......+...+..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 5799999999999999999976 46899999964 35555555666778889999
Q ss_pred EEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccC
Q 042435 196 IYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLD 275 (412)
Q Consensus 196 v~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~ 275 (412)
|+||+++++|.+++.... .+++.....++.|++.||+|||+. +++||||+|+||++++++.++|+|||+++...
T Consensus 82 v~e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~ 155 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYG---ALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQ 155 (263)
T ss_pred EEEECCCCcHHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence 999999999998886543 478899999999999999999998 99999999999999999999999999987654
Q ss_pred CCCCCc---ccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCcc
Q 042435 276 VDSSNR---TLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPI 352 (412)
Q Consensus 276 ~~~~~~---~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 352 (412)
...... ....++..|+|||.+.+..++.++||||||+++||+++|+.||.... .................
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-------~~~~~~~~~~~~~~~~~ 228 (263)
T cd06625 156 TICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFE-------AMAAIFKIATQPTNPQL 228 (263)
T ss_pred ccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccc-------hHHHHHHHhccCCCCCC
Confidence 322111 23457889999999998889999999999999999999999986321 11111111111111111
Q ss_pred chhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 353 NQKIIQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 353 ~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
+.. ....+.+++.+||..+|++|||+.|++++
T Consensus 229 ~~~---~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 229 PSH---VSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred Ccc---CCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 111 12247889999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=300.09 Aligned_cols=239 Identities=21% Similarity=0.273 Sum_probs=182.2
Q ss_pred HHHHHHhhcCcccceeeeecCceEEEEEEeC-CCcEEEEEec------------------------cCCccccceEEEec
Q 042435 135 YENLIDATEYFHIRYCIGTGGYDSVYKAELP-DGKVVALKKL------------------------HHSETEDSAFVVYS 189 (412)
Q Consensus 135 ~~~l~~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l------------------------~~~~~~~~~~~~~~ 189 (412)
+.++....++|++.+.||+|+||.||++... +++.+|+|.+ +|+++......+..
T Consensus 35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (371)
T cd05622 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 114 (371)
T ss_pred HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 3455566789999999999999999999775 6889999964 36666667777788
Q ss_pred CceEEEEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecC
Q 042435 190 PQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFG 269 (412)
Q Consensus 190 ~~~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG 269 (412)
.+..++||||+++|+|.+++... .++...+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~DfG 187 (371)
T cd05622 115 DRYLYMVMEYMPGGDLVNLMSNY----DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFG 187 (371)
T ss_pred CCEEEEEEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeCC
Confidence 88999999999999999988654 378888889999999999999998 99999999999999999999999999
Q ss_pred CccccCCCCC-CcccccccccccccccccCc----ccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHh
Q 042435 270 TVRLLDVDSS-NRTLQAGTYGYIALELVYTM----VVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDIL 344 (412)
Q Consensus 270 la~~~~~~~~-~~~~~~gt~~y~aPE~~~~~----~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 344 (412)
+++....... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||.... .......+.
T Consensus 188 ~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~-------~~~~~~~i~ 260 (371)
T cd05622 188 TCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS-------LVGTYSKIM 260 (371)
T ss_pred ceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCC-------HHHHHHHHH
Confidence 9986643322 22345799999999998653 37889999999999999999999987321 111122222
Q ss_pred hhccCCccchhhHHHHHHHHHHHHhcCcCCCCC--CCCHHHHHHHH
Q 042435 345 YQRLSPPINQKIIQDIILVSTIALACLRSKPKS--RPTMQRISQEL 388 (412)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~--RPs~~evl~~L 388 (412)
........+. .......+.+++.+|+..++.+ ||+++|++++.
T Consensus 261 ~~~~~~~~~~-~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 261 NHKNSLTFPD-DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred cCCCcccCCC-cCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 2111111111 0112233778889999844433 78999999874
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=283.56 Aligned_cols=234 Identities=28% Similarity=0.384 Sum_probs=180.4
Q ss_pred hcCcccceeeeecCceEEEEEEeC-CC---cEEEEEecc----------------------CCccccceEEEecCceEEE
Q 042435 142 TEYFHIRYCIGTGGYDSVYKAELP-DG---KVVALKKLH----------------------HSETEDSAFVVYSPQCMFF 195 (412)
Q Consensus 142 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~---~~vAvK~l~----------------------~~~~~~~~~~~~~~~~~~l 195 (412)
+++|+..+.||+|+||.||+|... ++ ..+|+|.++ |+++......+...+..++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 357888899999999999999874 23 379999753 4444445555677788999
Q ss_pred EEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccC
Q 042435 196 IYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLD 275 (412)
Q Consensus 196 v~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~ 275 (412)
||||+++++|.+++.... ..+++.++..++.|++.|++|||+. +++||||||+||++++++.+|++|||++....
T Consensus 84 v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~ 158 (268)
T cd05063 84 ITEYMENGALDKYLRDHD--GEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVLE 158 (268)
T ss_pred EEEcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCccceecc
Confidence 999999999999886543 2589999999999999999999998 99999999999999999999999999987654
Q ss_pred CCCCCc---ccccccccccccccccCcccCcccccHHHHHHHHHHHh-CCCCcccccccccCCCCcchhhHHhhhccCCc
Q 042435 276 VDSSNR---TLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLM-GTHPGELLLSLSSSSGPKIMLIDILYQRLSPP 351 (412)
Q Consensus 276 ~~~~~~---~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 351 (412)
...... .....+..|+|||++.+..++.++|||||||++||+++ |+.||... .. ......+......+
T Consensus 159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~-------~~-~~~~~~i~~~~~~~ 230 (268)
T cd05063 159 DDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDM-------SN-HEVMKAINDGFRLP 230 (268)
T ss_pred cccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcC-------CH-HHHHHHHhcCCCCC
Confidence 322211 11123457999999988889999999999999999998 99998632 11 11222222222221
Q ss_pred cchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhcC
Q 042435 352 INQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELEGK 391 (412)
Q Consensus 352 ~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 391 (412)
... .....+.+++.+||+.+|++||++.+|++.|+++
T Consensus 231 ~~~---~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 231 APM---DCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred CCC---CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 111 1223478999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=295.72 Aligned_cols=239 Identities=21% Similarity=0.278 Sum_probs=178.1
Q ss_pred hcCcccceeeeecCceEEEEEEe------CCCcEEEEEeccC-----------------------CccccceEEEe-cCc
Q 042435 142 TEYFHIRYCIGTGGYDSVYKAEL------PDGKVVALKKLHH-----------------------SETEDSAFVVY-SPQ 191 (412)
Q Consensus 142 ~~~f~~~~~lG~G~~g~Vy~~~~------~~~~~vAvK~l~~-----------------------~~~~~~~~~~~-~~~ 191 (412)
.++|++.+.||+|+||.||+|.. .+++.||||.++. +++......+. .+.
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 35789999999999999999963 3578999997642 33333333333 345
Q ss_pred eEEEEEEeccCCceeeeeccCcc---------------------------------------------------------
Q 042435 192 CMFFIYEYMERGSLFCVLRDDDE--------------------------------------------------------- 214 (412)
Q Consensus 192 ~~~lv~ey~~~gsL~~~l~~~~~--------------------------------------------------------- 214 (412)
..+++|||+++|+|.++++....
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 67899999999999988754210
Q ss_pred -------cccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCCC--Cccccc
Q 042435 215 -------AIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSS--NRTLQA 285 (412)
Q Consensus 215 -------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~--~~~~~~ 285 (412)
...++|.++..++.|+++||+|||++ +|+||||||+||+++.++++||+|||+++....... ......
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 242 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 242 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence 12378889999999999999999998 999999999999999999999999999876532221 112234
Q ss_pred ccccccccccccCcccCcccccHHHHHHHHHHHh-CCCCcccccccccCCCCcchhhHHhhhccCCccchhhHHHHHHHH
Q 042435 286 GTYGYIALELVYTMVVTEKCVIYSFGVVALEVLM-GTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKIIQDIILVS 364 (412)
Q Consensus 286 gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 364 (412)
++..|+|||.+.+..++.++||||||+++|||++ |..||.... ........+......+.+.. ....+.
T Consensus 243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~-------~~~~~~~~~~~~~~~~~~~~---~~~~~~ 312 (343)
T cd05103 243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK-------IDEEFCRRLKEGTRMRAPDY---TTPEMY 312 (343)
T ss_pred CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCcc-------ccHHHHHHHhccCCCCCCCC---CCHHHH
Confidence 5678999999988889999999999999999997 899976321 11112222222221111111 112478
Q ss_pred HHHHhcCcCCCCCCCCHHHHHHHHhcCCC
Q 042435 365 TIALACLRSKPKSRPTMQRISQELEGKTP 393 (412)
Q Consensus 365 ~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 393 (412)
+++.+||+.||++|||+.|++++|+.+..
T Consensus 313 ~~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 313 QTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred HHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 89999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=301.48 Aligned_cols=228 Identities=21% Similarity=0.292 Sum_probs=176.0
Q ss_pred cCcccceeeeecCceEEEEEEe-CCCcEEEEEec------------------------cCCccccceEEEecCceEEEEE
Q 042435 143 EYFHIRYCIGTGGYDSVYKAEL-PDGKVVALKKL------------------------HHSETEDSAFVVYSPQCMFFIY 197 (412)
Q Consensus 143 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l------------------------~~~~~~~~~~~~~~~~~~~lv~ 197 (412)
++|++.+.||+|+||.||++.. .+++.||||.+ +|+++......+.+.+..|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 4788999999999999999976 57899999964 4666777777788889999999
Q ss_pred EeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCC
Q 042435 198 EYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVD 277 (412)
Q Consensus 198 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~ 277 (412)
||+++|+|.+++.... .+++.....++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 81 E~~~gg~L~~~l~~~~---~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~ 154 (377)
T cd05629 81 EFLPGGDLMTMLIKYD---TFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQ 154 (377)
T ss_pred eCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeecccccccccc
Confidence 9999999999887543 478888999999999999999998 9999999999999999999999999998632110
Q ss_pred CC-----------------------------------------------CcccccccccccccccccCcccCcccccHHH
Q 042435 278 SS-----------------------------------------------NRTLQAGTYGYIALELVYTMVVTEKCVIYSF 310 (412)
Q Consensus 278 ~~-----------------------------------------------~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~ 310 (412)
.. ......||+.|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 234 (377)
T cd05629 155 HDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSL 234 (377)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEec
Confidence 00 0012468999999999998899999999999
Q ss_pred HHHHHHHHhCCCCcccccccccCCCCcchhhHHhh--hccCCccchhhHHHHHHHHHHHHhcCcCCCCCC---CCHHHHH
Q 042435 311 GVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILY--QRLSPPINQKIIQDIILVSTIALACLRSKPKSR---PTMQRIS 385 (412)
Q Consensus 311 Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~R---Ps~~evl 385 (412)
||++|||+||+.||.... .......+.. ..+..+... .....+.+++.+|+. +|.+| |++.|++
T Consensus 235 Gvil~elltG~~Pf~~~~-------~~~~~~~i~~~~~~~~~p~~~---~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l 303 (377)
T cd05629 235 GAIMFECLIGWPPFCSEN-------SHETYRKIINWRETLYFPDDI---HLSVEAEDLIRRLIT-NAENRLGRGGAHEIK 303 (377)
T ss_pred chhhhhhhcCCCCCCCCC-------HHHHHHHHHccCCccCCCCCC---CCCHHHHHHHHHHhc-CHhhcCCCCCHHHHh
Confidence 999999999999986321 1111111211 111111100 112237788899997 77765 5999988
Q ss_pred HH
Q 042435 386 QE 387 (412)
Q Consensus 386 ~~ 387 (412)
++
T Consensus 304 ~h 305 (377)
T cd05629 304 SH 305 (377)
T ss_pred cC
Confidence 86
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=285.37 Aligned_cols=235 Identities=22% Similarity=0.291 Sum_probs=181.2
Q ss_pred hcCcccceeeeecCceEEEEEEeC------CCcEEEEEecc----------------------CCccccceEEEecCceE
Q 042435 142 TEYFHIRYCIGTGGYDSVYKAELP------DGKVVALKKLH----------------------HSETEDSAFVVYSPQCM 193 (412)
Q Consensus 142 ~~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vAvK~l~----------------------~~~~~~~~~~~~~~~~~ 193 (412)
.++|++.+.||+|+||.||+|... .+..||+|.+. |+++......+......
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 357888999999999999999764 24689999753 44555555567778889
Q ss_pred EEEEEeccCCceeeeeccCcc-------cccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEe
Q 042435 194 FFIYEYMERGSLFCVLRDDDE-------AIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVA 266 (412)
Q Consensus 194 ~lv~ey~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~ 266 (412)
++||||+++|+|.+++..... ...++|..++.++.|++.||.|||+. +++||||||+||+++.++.+||+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCEEEC
Confidence 999999999999998865321 12478999999999999999999988 99999999999999999999999
Q ss_pred ecCCccccCCCCC--CcccccccccccccccccCcccCcccccHHHHHHHHHHHh-CCCCcccccccccCCCCcchhhHH
Q 042435 267 DFGTVRLLDVDSS--NRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLM-GTHPGELLLSLSSSSGPKIMLIDI 343 (412)
Q Consensus 267 DfGla~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~ 343 (412)
|||+++....... ......++..|+|||.+.+..++.++|||||||++||++| |..||... ... .....
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~-------~~~-~~~~~ 233 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGL-------SNE-EVLKF 233 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccC-------CHH-HHHHH
Confidence 9999876543321 1223356788999999988889999999999999999998 88887521 111 11222
Q ss_pred hhhccCCccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhc
Q 042435 344 LYQRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELEG 390 (412)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~ 390 (412)
.........+... ...+.+++.+||+.+|++|||+.++++.|++
T Consensus 234 ~~~~~~~~~~~~~---~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 234 VIDGGHLDLPENC---PDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred HhcCCCCCCCCCC---CHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 2221111111111 3348899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=285.98 Aligned_cols=238 Identities=21% Similarity=0.294 Sum_probs=176.4
Q ss_pred cccceeeeecCceEEEEEEe-----CCCcEEEEEecc----------------------CCccccceEEEec--CceEEE
Q 042435 145 FHIRYCIGTGGYDSVYKAEL-----PDGKVVALKKLH----------------------HSETEDSAFVVYS--PQCMFF 195 (412)
Q Consensus 145 f~~~~~lG~G~~g~Vy~~~~-----~~~~~vAvK~l~----------------------~~~~~~~~~~~~~--~~~~~l 195 (412)
|+..+.||+|+||+||++.+ .+++.||+|.++ |+++......+.. ....++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 37789999999999988643 357899999764 3333333333333 346899
Q ss_pred EEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccC
Q 042435 196 IYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLD 275 (412)
Q Consensus 196 v~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~ 275 (412)
+|||+++|+|.+++... .+++.++..++.|++.||+|||++ +++||||||+||++++++.++|+|||+++...
T Consensus 86 v~e~~~~~~l~~~~~~~----~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~ 158 (283)
T cd05080 86 IMEYVPLGSLRDYLPKH----KLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 158 (283)
T ss_pred EecCCCCCCHHHHHHHc----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeecccccccC
Confidence 99999999999988654 389999999999999999999998 99999999999999999999999999998664
Q ss_pred CCCCC---cccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCccccccc-------ccCCCCcchhhHHhh
Q 042435 276 VDSSN---RTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSL-------SSSSGPKIMLIDILY 345 (412)
Q Consensus 276 ~~~~~---~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~-------~~~~~~~~~~~~~~~ 345 (412)
..... .....++..|+|||...+..++.++||||||+++|||+||..|+...... ...........+...
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (283)
T cd05080 159 EGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLE 238 (283)
T ss_pred CcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhh
Confidence 32211 12234567799999998888999999999999999999999997632110 000000011111122
Q ss_pred hccCCccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhcCC
Q 042435 346 QRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELEGKT 392 (412)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 392 (412)
.....+.+.. ....+.+++.+||+.||++|||++++++.|+++.
T Consensus 239 ~~~~~~~~~~---~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 239 RGMRLPCPKN---CPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred cCCCCCCCCC---CCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 2221111111 1234889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=287.46 Aligned_cols=237 Identities=22% Similarity=0.281 Sum_probs=180.9
Q ss_pred hhcCcccceeeeecCceEEEEEEeC------CCcEEEEEecc----------------------CCccccceEEEecCce
Q 042435 141 ATEYFHIRYCIGTGGYDSVYKAELP------DGKVVALKKLH----------------------HSETEDSAFVVYSPQC 192 (412)
Q Consensus 141 ~~~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vAvK~l~----------------------~~~~~~~~~~~~~~~~ 192 (412)
.+++|++.+.||+|+||.||+|..+ .+..||+|.++ |+++......+...+.
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4578999999999999999999653 24589999653 4455555556777888
Q ss_pred EEEEEEeccCCceeeeeccCcc-------cccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEE
Q 042435 193 MFFIYEYMERGSLFCVLRDDDE-------AIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFV 265 (412)
Q Consensus 193 ~~lv~ey~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl 265 (412)
.++||||+++|+|.++++.... ....++..+..++.|++.||+|||++ +++||||||+||++++++.++|
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCcEEE
Confidence 9999999999999999864321 13457788899999999999999998 9999999999999999999999
Q ss_pred eecCCccccCCCCCCc--ccccccccccccccccCcccCcccccHHHHHHHHHHHh-CCCCcccccccccCCCCcchhhH
Q 042435 266 ADFGTVRLLDVDSSNR--TLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLM-GTHPGELLLSLSSSSGPKIMLID 342 (412)
Q Consensus 266 ~DfGla~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~ 342 (412)
+|||+++......... ....++..|+|||.+.+..++.++|||||||++|||++ |..||... ... ...+
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~-------~~~-~~~~ 232 (288)
T cd05061 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGL-------SNE-QVLK 232 (288)
T ss_pred CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCC-------CHH-HHHH
Confidence 9999988654322111 22245678999999998889999999999999999998 78887621 111 1111
Q ss_pred HhhhccCCccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhcC
Q 042435 343 ILYQRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELEGK 391 (412)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 391 (412)
.+......+.+. .....+.+++.+||+.||++|||+.|+++.|++.
T Consensus 233 ~~~~~~~~~~~~---~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~ 278 (288)
T cd05061 233 FVMDGGYLDQPD---NCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 278 (288)
T ss_pred HHHcCCCCCCCC---CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence 111111111111 1123488999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=302.48 Aligned_cols=228 Identities=21% Similarity=0.273 Sum_probs=174.0
Q ss_pred cCcccceeeeecCceEEEEEEe-CCCcEEEEEec------------------------cCCccccceEEEecCceEEEEE
Q 042435 143 EYFHIRYCIGTGGYDSVYKAEL-PDGKVVALKKL------------------------HHSETEDSAFVVYSPQCMFFIY 197 (412)
Q Consensus 143 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l------------------------~~~~~~~~~~~~~~~~~~~lv~ 197 (412)
++|++.+.||+|+||.||+|+. .+++.||+|.+ +|+++......+..++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 3689999999999999999976 46899999975 3455666666678889999999
Q ss_pred EeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCC
Q 042435 198 EYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVD 277 (412)
Q Consensus 198 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~ 277 (412)
||+++|+|.+++.... .++......++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++..+...
T Consensus 81 E~~~~g~L~~~i~~~~---~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~ 154 (376)
T cd05598 81 DYIPGGDMMSLLIRLG---IFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 154 (376)
T ss_pred eCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCcccccc
Confidence 9999999999987653 478888888999999999999998 9999999999999999999999999997532100
Q ss_pred C-------------------------------------------CCcccccccccccccccccCcccCcccccHHHHHHH
Q 042435 278 S-------------------------------------------SNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVA 314 (412)
Q Consensus 278 ~-------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil 314 (412)
. .......||+.|+|||++.+..++.++|||||||++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil 234 (376)
T cd05598 155 HDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 234 (376)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeecccee
Confidence 0 001124699999999999999999999999999999
Q ss_pred HHHHhCCCCcccccccccCCCCcchhhHHhhh--ccCCccchhhHHHHHHHHHHHHhcCcCCCCCCC---CHHHHHHH
Q 042435 315 LEVLMGTHPGELLLSLSSSSGPKIMLIDILYQ--RLSPPINQKIIQDIILVSTIALACLRSKPKSRP---TMQRISQE 387 (412)
Q Consensus 315 ~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RP---s~~evl~~ 387 (412)
|||++|+.||.... .......+... ....+.... ....+.+++.+|+ .+|.+|+ ++.|++++
T Consensus 235 yell~G~~Pf~~~~-------~~~~~~~i~~~~~~~~~~~~~~---~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h 301 (376)
T cd05598 235 YEMLVGQPPFLADT-------PAETQLKVINWETTLHIPSQAK---LSREASDLILRLC-CGAEDRLGKNGADEIKAH 301 (376)
T ss_pred eehhhCCCCCCCCC-------HHHHHHHHhccCccccCCCCCC---CCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence 99999999997321 11111111111 111111011 1123566777765 4999999 89999877
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=280.30 Aligned_cols=231 Identities=23% Similarity=0.355 Sum_probs=181.5
Q ss_pred hcCcccceeeeecCceEEEEEEeCCCcEEEEEecc--------------------CCccccceEEEecCceEEEEEEecc
Q 042435 142 TEYFHIRYCIGTGGYDSVYKAELPDGKVVALKKLH--------------------HSETEDSAFVVYSPQCMFFIYEYME 201 (412)
Q Consensus 142 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~l~--------------------~~~~~~~~~~~~~~~~~~lv~ey~~ 201 (412)
.++|++.+.||+|+||.||+|... |+.||+|.++ |+++......+...+..++||||++
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 83 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMA 83 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchhHHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecC
Confidence 356888999999999999999874 7889999763 4444445555667888999999999
Q ss_pred CCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCCCCc
Q 042435 202 RGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNR 281 (412)
Q Consensus 202 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 281 (412)
+++|.+++..... ..+++..+..++.|++.||.|||+. +++||||||+||+++.++.++|+|||.++.......
T Consensus 84 ~~~L~~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~-- 157 (256)
T cd05039 84 KGSLVDYLRSRGR-AVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD-- 157 (256)
T ss_pred CCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEcccccccccccccc--
Confidence 9999998875432 2489999999999999999999998 999999999999999999999999999986532221
Q ss_pred ccccccccccccccccCcccCcccccHHHHHHHHHHHh-CCCCcccccccccCCCCcchhhHHhhhccCCccchhhHHHH
Q 042435 282 TLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLM-GTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKIIQDI 360 (412)
Q Consensus 282 ~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 360 (412)
....+..|+|||++.+..++.++||||||+++||+++ |+.||... ........+........+. ...
T Consensus 158 -~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~--------~~~~~~~~~~~~~~~~~~~---~~~ 225 (256)
T cd05039 158 -SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI--------PLKDVVPHVEKGYRMEAPE---GCP 225 (256)
T ss_pred -cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCC--------CHHHHHHHHhcCCCCCCcc---CCC
Confidence 2334668999999988889999999999999999997 99998622 1111222222221111111 112
Q ss_pred HHHHHHHHhcCcCCCCCCCCHHHHHHHHhcC
Q 042435 361 ILVSTIALACLRSKPKSRPTMQRISQELEGK 391 (412)
Q Consensus 361 ~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 391 (412)
..+.+++.+||..+|++|||++|+++.|+.+
T Consensus 226 ~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 226 PEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred HHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 3478999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=283.17 Aligned_cols=246 Identities=20% Similarity=0.224 Sum_probs=181.7
Q ss_pred cCcccceeeeecCceEEEEEEe-CCCcEEEEEecc-----------------------CCc-cccceEEEecCc------
Q 042435 143 EYFHIRYCIGTGGYDSVYKAEL-PDGKVVALKKLH-----------------------HSE-TEDSAFVVYSPQ------ 191 (412)
Q Consensus 143 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l~-----------------------~~~-~~~~~~~~~~~~------ 191 (412)
..|+..++||+|+||+||+|+. .+|+.||+|+++ |.+ ++....++.+.+
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 4466667899999999999966 578999999763 445 555555666655
Q ss_pred eEEEEEEeccCCceeeeeccCccc-ccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCC
Q 042435 192 CMFFIYEYMERGSLFCVLRDDDEA-IELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGT 270 (412)
Q Consensus 192 ~~~lv~ey~~~gsL~~~l~~~~~~-~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGl 270 (412)
..++|+||+.. +|..++...... ..++-..+..++.|+++||+|||++ +|+||||||.|||+++++.+||+|||+
T Consensus 91 ~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDFGl 166 (323)
T KOG0594|consen 91 KLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADFGL 166 (323)
T ss_pred eEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeeccch
Confidence 78999999965 899888765421 2366688999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCCcccccccccccccccccCc-ccCcccccHHHHHHHHHHHhCCCCccccccc-------------ccCCCC
Q 042435 271 VRLLDVDSSNRTLQAGTYGYIALELVYTM-VVTEKCVIYSFGVVALEVLMGTHPGELLLSL-------------SSSSGP 336 (412)
Q Consensus 271 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~S~Gvil~elltg~~P~~~~~~~-------------~~~~~~ 336 (412)
|+.........+...+|.+|.|||++.+. .|++..||||+|||+.||++++.-|...... ....++
T Consensus 167 Ara~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp 246 (323)
T KOG0594|consen 167 ARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWP 246 (323)
T ss_pred HHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCC
Confidence 99776555556777899999999999876 6999999999999999999988777532110 001111
Q ss_pred cchhhHHhhhccCCcc-chhhH----HHHHHHHHHHHhcCcCCCCCCCCHHHHHHH--HhcCC
Q 042435 337 KIMLIDILYQRLSPPI-NQKII----QDIILVSTIALACLRSKPKSRPTMQRISQE--LEGKT 392 (412)
Q Consensus 337 ~~~~~~~~~~~~~~~~-~~~~~----~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~--L~~~~ 392 (412)
................ +.... .......+++.+|++.+|.+|.|++.++.+ +.+..
T Consensus 247 ~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~ 309 (323)
T KOG0594|consen 247 GVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELP 309 (323)
T ss_pred CccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhcccc
Confidence 1100000000000000 00111 111247889999999999999999999987 55543
|
|
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=279.02 Aligned_cols=224 Identities=22% Similarity=0.325 Sum_probs=175.9
Q ss_pred eeeecCceEEEEEEeCCCcEEEEEec----------------------cCCccccceEEEecCceEEEEEEeccCCceee
Q 042435 150 CIGTGGYDSVYKAELPDGKVVALKKL----------------------HHSETEDSAFVVYSPQCMFFIYEYMERGSLFC 207 (412)
Q Consensus 150 ~lG~G~~g~Vy~~~~~~~~~vAvK~l----------------------~~~~~~~~~~~~~~~~~~~lv~ey~~~gsL~~ 207 (412)
+||+|+||.||+|...++..+|+|.+ +|+++......+...+..++||||+++++|.+
T Consensus 2 ~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 81 (250)
T cd05085 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLS 81 (250)
T ss_pred ccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHHH
Confidence 68999999999999888999999964 35666666667778888999999999999999
Q ss_pred eeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCCCCc-ccccc
Q 042435 208 VLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNR-TLQAG 286 (412)
Q Consensus 208 ~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~-~~~~g 286 (412)
++..... .+++..+..++.|++.||.|+|++ +++||||||+||+++.++.+|++|||++.......... ....+
T Consensus 82 ~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~ 156 (250)
T cd05085 82 FLRKKKD--ELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI 156 (250)
T ss_pred HHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCC
Confidence 8865432 478999999999999999999988 99999999999999999999999999987543322111 12234
Q ss_pred cccccccccccCcccCcccccHHHHHHHHHHHh-CCCCcccccccccCCCCcchhhHHhhhccCCccchhhHHHHHHHHH
Q 042435 287 TYGYIALELVYTMVVTEKCVIYSFGVVALEVLM-GTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKIIQDIILVST 365 (412)
Q Consensus 287 t~~y~aPE~~~~~~~s~ksDv~S~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 365 (412)
+..|+|||++.+..++.++||||||+++||+++ |..||.... . ......+........+.. ....+.+
T Consensus 157 ~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~-------~-~~~~~~~~~~~~~~~~~~---~~~~~~~ 225 (250)
T cd05085 157 PIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMT-------N-QQAREQVEKGYRMSCPQK---CPDDVYK 225 (250)
T ss_pred cccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCC-------H-HHHHHHHHcCCCCCCCCC---CCHHHHH
Confidence 678999999988889999999999999999998 999986321 1 111111212111111111 1234889
Q ss_pred HHHhcCcCCCCCCCCHHHHHHHHh
Q 042435 366 IALACLRSKPKSRPTMQRISQELE 389 (412)
Q Consensus 366 l~~~Cl~~dP~~RPs~~evl~~L~ 389 (412)
++.+||+.+|++||++.|+++.|.
T Consensus 226 li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 226 VMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred HHHHHcccCcccCCCHHHHHHHhc
Confidence 999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-37 Score=300.69 Aligned_cols=227 Identities=21% Similarity=0.291 Sum_probs=172.7
Q ss_pred CcccceeeeecCceEEEEEEe-CCCcEEEEEec------------------------cCCccccceEEEecCceEEEEEE
Q 042435 144 YFHIRYCIGTGGYDSVYKAEL-PDGKVVALKKL------------------------HHSETEDSAFVVYSPQCMFFIYE 198 (412)
Q Consensus 144 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l------------------------~~~~~~~~~~~~~~~~~~~lv~e 198 (412)
.|+..+.||+|+||.||+|.. .+++.||+|.+ +|+++......+.+++..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 588899999999999999976 46889999975 35666666777888899999999
Q ss_pred eccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCC
Q 042435 199 YMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDS 278 (412)
Q Consensus 199 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~ 278 (412)
|+++|+|.+++.... .++......++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~ 155 (382)
T cd05625 82 YIPGGDMMSLLIRMG---IFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (382)
T ss_pred CCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCccccccc
Confidence 999999999886543 478888889999999999999998 99999999999999999999999999975321000
Q ss_pred -----------------------------------------------CCcccccccccccccccccCcccCcccccHHHH
Q 042435 279 -----------------------------------------------SNRTLQAGTYGYIALELVYTMVVTEKCVIYSFG 311 (412)
Q Consensus 279 -----------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G 311 (412)
.......||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (382)
T cd05625 156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG 235 (382)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEech
Confidence 001124689999999999998999999999999
Q ss_pred HHHHHHHhCCCCcccccccccCCCCcchhhHHhh--hccCCccchhhHHHHHHHHHHHHhcCcCCCCCCCC---HHHHHH
Q 042435 312 VVALEVLMGTHPGELLLSLSSSSGPKIMLIDILY--QRLSPPINQKIIQDIILVSTIALACLRSKPKSRPT---MQRISQ 386 (412)
Q Consensus 312 vil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs---~~evl~ 386 (412)
|++|||++|+.||.... +......+.. .....+..... ...+.+++.+++ .+|++|++ +.|+++
T Consensus 236 vil~elltG~~Pf~~~~-------~~~~~~~i~~~~~~~~~p~~~~~---s~~~~~li~~l~-~~p~~R~~~~~~~ei~~ 304 (382)
T cd05625 236 VILYEMLVGQPPFLAQT-------PLETQMKVINWQTSLHIPPQAKL---SPEASDLIIKLC-RGPEDRLGKNGADEIKA 304 (382)
T ss_pred HHHHHHHhCCCCCCCCC-------HHHHHHHHHccCCCcCCCCcccC---CHHHHHHHHHHc-cCHhHcCCCCCHHHHhc
Confidence 99999999999997321 1111122221 11111111111 122556666654 49999987 888876
Q ss_pred H
Q 042435 387 E 387 (412)
Q Consensus 387 ~ 387 (412)
+
T Consensus 305 h 305 (382)
T cd05625 305 H 305 (382)
T ss_pred C
Confidence 5
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=288.80 Aligned_cols=236 Identities=21% Similarity=0.305 Sum_probs=183.5
Q ss_pred hcCcccceeeeecCceEEEEEEe------CCCcEEEEEec-----------------------cCCccccceEEEecCce
Q 042435 142 TEYFHIRYCIGTGGYDSVYKAEL------PDGKVVALKKL-----------------------HHSETEDSAFVVYSPQC 192 (412)
Q Consensus 142 ~~~f~~~~~lG~G~~g~Vy~~~~------~~~~~vAvK~l-----------------------~~~~~~~~~~~~~~~~~ 192 (412)
.++|++.+.||+|+||.||++.. ..+..||+|.+ +|+++......+...+.
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 113 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP 113 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence 35789999999999999999964 23557999954 35666666666777888
Q ss_pred EEEEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCcc
Q 042435 193 MFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVR 272 (412)
Q Consensus 193 ~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~ 272 (412)
.+++|||+++|+|.++++.... ..+++.++..++.|++.||+|||++ +++|+||||+||+++.+..++++|||+++
T Consensus 114 ~~lv~e~~~~~~L~~~i~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~dfg~~~ 189 (302)
T cd05055 114 ILVITEYCCYGDLLNFLRRKRE-SFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFGLAR 189 (302)
T ss_pred eEEEEEcCCCCcHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCCcccc
Confidence 9999999999999999875432 2389999999999999999999998 99999999999999999999999999998
Q ss_pred ccCCCCC--CcccccccccccccccccCcccCcccccHHHHHHHHHHHh-CCCCcccccccccCCCCcchhhHHhhhccC
Q 042435 273 LLDVDSS--NRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLM-GTHPGELLLSLSSSSGPKIMLIDILYQRLS 349 (412)
Q Consensus 273 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 349 (412)
....... ......++..|+|||.+.+..++.++|||||||++|||++ |..||... ...............
T Consensus 190 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~-------~~~~~~~~~~~~~~~ 262 (302)
T cd05055 190 DIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGM-------PVDSKFYKLIKEGYR 262 (302)
T ss_pred cccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCC-------CchHHHHHHHHcCCc
Confidence 6543321 1122345778999999998889999999999999999998 99998632 111112222222222
Q ss_pred CccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhcC
Q 042435 350 PPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELEGK 391 (412)
Q Consensus 350 ~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 391 (412)
...+.. ....+.+++.+||+.+|++|||+.|+++.|++.
T Consensus 263 ~~~~~~---~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 263 MAQPEH---APAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred CCCCCC---CCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 111111 122488999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-37 Score=294.62 Aligned_cols=233 Identities=22% Similarity=0.281 Sum_probs=173.9
Q ss_pred cCcccceeeeecCceEEEEEEeC-CCcEEEEEecc------------------------CCccccceEEEecCceEEEEE
Q 042435 143 EYFHIRYCIGTGGYDSVYKAELP-DGKVVALKKLH------------------------HSETEDSAFVVYSPQCMFFIY 197 (412)
Q Consensus 143 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~------------------------~~~~~~~~~~~~~~~~~~lv~ 197 (412)
++|++.+.||+|+||.||++..+ +++.+|+|.+. |+++......+.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 47889999999999999999875 57889999763 344444455677788999999
Q ss_pred EeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCC
Q 042435 198 EYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVD 277 (412)
Q Consensus 198 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~ 277 (412)
||+++|+|.++++.... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 81 ey~~~g~L~~~l~~~~~--~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~ 155 (332)
T cd05623 81 DYYVGGDLLTLLSKFED--RLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED 155 (332)
T ss_pred eccCCCcHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchheecccC
Confidence 99999999999975322 488899999999999999999998 9999999999999999999999999998765333
Q ss_pred CCC-ccccccccccccccccc-----CcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCc
Q 042435 278 SSN-RTLQAGTYGYIALELVY-----TMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPP 351 (412)
Q Consensus 278 ~~~-~~~~~gt~~y~aPE~~~-----~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 351 (412)
... .....||+.|+|||++. ...++.++|||||||++|||++|+.||.... .......+.......+
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~-------~~~~~~~i~~~~~~~~ 228 (332)
T cd05623 156 GTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAES-------LVETYGKIMNHKERFQ 228 (332)
T ss_pred CcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCC-------HHHHHHHHhCCCcccc
Confidence 222 23357999999999986 3457889999999999999999999987321 1111112221111111
Q ss_pred cchhhHHHHHHHHHHHHhcCcCCC--CCCCCHHHHHHH
Q 042435 352 INQKIIQDIILVSTIALACLRSKP--KSRPTMQRISQE 387 (412)
Q Consensus 352 ~~~~~~~~~~~~~~l~~~Cl~~dP--~~RPs~~evl~~ 387 (412)
.+.........+.+++.+|+..+| ..||++.|++++
T Consensus 229 ~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 229 FPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred CCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 111111122346778888775544 347899999887
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=288.01 Aligned_cols=230 Identities=24% Similarity=0.336 Sum_probs=180.6
Q ss_pred hcCcccceeeeecCceEEEEEEe-CCCcEEEEEec---------------------cCCccccceEEEecCceEEEEEEe
Q 042435 142 TEYFHIRYCIGTGGYDSVYKAEL-PDGKVVALKKL---------------------HHSETEDSAFVVYSPQCMFFIYEY 199 (412)
Q Consensus 142 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l---------------------~~~~~~~~~~~~~~~~~~~lv~ey 199 (412)
..+|++.+.||+|+||.||+|.. .+++.||+|.+ .|+++......+......++||||
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~ 98 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecc
Confidence 35788889999999999999975 46889999965 355555556667778899999999
Q ss_pred ccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCCC
Q 042435 200 MERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSS 279 (412)
Q Consensus 200 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 279 (412)
+++++|.+++... .+++.++..++.|++.||+|||+. +++||||||+||+++.++.++|+|||++........
T Consensus 99 ~~~~~L~~~~~~~----~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~ 171 (296)
T cd06654 99 LAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (296)
T ss_pred cCCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchhcccccc
Confidence 9999999988643 378999999999999999999998 999999999999999999999999999876544333
Q ss_pred CcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccchhhHHH
Q 042435 280 NRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKIIQD 359 (412)
Q Consensus 280 ~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 359 (412)
......+++.|+|||.+.+..++.++|||||||++|||++|+.||.... +........... .+.. ......
T Consensus 172 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~-------~~~~~~~~~~~~-~~~~-~~~~~~ 242 (296)
T cd06654 172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN-------PLRALYLIATNG-TPEL-QNPEKL 242 (296)
T ss_pred ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCC-------HHHhHHHHhcCC-CCCC-CCcccc
Confidence 3334568899999999988889999999999999999999999986321 111111111111 1110 011112
Q ss_pred HHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 360 IILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 360 ~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
...+.+++.+||..||++|||+.|++++
T Consensus 243 ~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 243 SAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred CHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 2347889999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=270.08 Aligned_cols=242 Identities=23% Similarity=0.343 Sum_probs=184.1
Q ss_pred hcCcccceeeeecCceEEEEEE-eCCCcEEEEEeccCCccccce---------------------E-----EEecCceEE
Q 042435 142 TEYFHIRYCIGTGGYDSVYKAE-LPDGKVVALKKLHHSETEDSA---------------------F-----VVYSPQCMF 194 (412)
Q Consensus 142 ~~~f~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~l~~~~~~~~~---------------------~-----~~~~~~~~~ 194 (412)
.++|.+.+.+|+|||+.||.++ ..+++.+|+|++..++..... . ........|
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~y 99 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAY 99 (302)
T ss_pred CceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEE
Confidence 4679999999999999999996 568999999987544422111 0 012345689
Q ss_pred EEEEeccCCceeeeeccCc-ccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccc
Q 042435 195 FIYEYMERGSLFCVLRDDD-EAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRL 273 (412)
Q Consensus 195 lv~ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~ 273 (412)
|+++|...|+|.+.+.... ++..++..+.+.|+.++++||++||+. .+++.||||||.|||+.+++.+++.|||.+..
T Consensus 100 ll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS~~~ 178 (302)
T KOG2345|consen 100 LLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGSATQ 178 (302)
T ss_pred EEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccCccc
Confidence 9999999999999887653 334689999999999999999999998 45699999999999999999999999999876
Q ss_pred cCCCCCC---------ccccccccccccccccc---CcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhh
Q 042435 274 LDVDSSN---------RTLQAGTYGYIALELVY---TMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLI 341 (412)
Q Consensus 274 ~~~~~~~---------~~~~~gt~~y~aPE~~~---~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~ 341 (412)
....... ......|..|+|||.+. +...++++|||||||+||+|+.|..||+....-..+ ...
T Consensus 179 a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgS-----laL 253 (302)
T KOG2345|consen 179 APIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGS-----LAL 253 (302)
T ss_pred cceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCe-----EEE
Confidence 5332111 13346789999999985 456789999999999999999999999854321111 111
Q ss_pred HHhhhccCCccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhcCC
Q 042435 342 DILYQRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELEGKT 392 (412)
Q Consensus 342 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 392 (412)
.+....+..|.... ....+.+++..|++.||.+||++.+++..++...
T Consensus 254 Av~n~q~s~P~~~~---yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 254 AVQNAQISIPNSSR---YSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred eeeccccccCCCCC---ccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 12222222222121 3334889999999999999999999999988753
|
|
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=317.14 Aligned_cols=239 Identities=25% Similarity=0.339 Sum_probs=181.8
Q ss_pred cCcccceeeeecCceEEEEEEeC-CCcEEEEEec------------------------cCCccccceEEEecCceEEEEE
Q 042435 143 EYFHIRYCIGTGGYDSVYKAELP-DGKVVALKKL------------------------HHSETEDSAFVVYSPQCMFFIY 197 (412)
Q Consensus 143 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l------------------------~~~~~~~~~~~~~~~~~~~lv~ 197 (412)
++|++.++||+|+||.||+|... +|+.||+|++ +|+++......+..++..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 57899999999999999999764 6899999975 3566666667778888999999
Q ss_pred EeccCCceeeeeccCc--------ccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecC
Q 042435 198 EYMERGSLFCVLRDDD--------EAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFG 269 (412)
Q Consensus 198 ey~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG 269 (412)
||+++|+|.+++.... ....+++..++.++.|+++||+|||+. +|+||||||+||+++.++.++|+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEecC
Confidence 9999999998886421 112467788899999999999999998 99999999999999999999999999
Q ss_pred CccccCCCC------------------CCcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccc
Q 042435 270 TVRLLDVDS------------------SNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLS 331 (412)
Q Consensus 270 la~~~~~~~------------------~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~ 331 (412)
+++...... .......||+.|+|||++.+..++.++|||||||++|||+||+.||.....
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~-- 236 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKG-- 236 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcch--
Confidence 998652110 011224689999999999999999999999999999999999999863210
Q ss_pred cCCCCcchhhHHhhhccCCccchhhHHHHHHHHHHHHhcCcCCCCCCC-CHHHHHHHHhcCCC
Q 042435 332 SSSGPKIMLIDILYQRLSPPINQKIIQDIILVSTIALACLRSKPKSRP-TMQRISQELEGKTP 393 (412)
Q Consensus 332 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RP-s~~evl~~L~~~~~ 393 (412)
.......... .+............+.+++.+|++.||++|| +++++.+.|+....
T Consensus 237 ----~ki~~~~~i~---~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq 292 (932)
T PRK13184 237 ----RKISYRDVIL---SPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ 292 (932)
T ss_pred ----hhhhhhhhcc---ChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 0000000000 0000000011223477899999999999995 67778888876544
|
|
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=281.19 Aligned_cols=229 Identities=19% Similarity=0.302 Sum_probs=179.9
Q ss_pred CcccceeeeecCceEEEEEEeC-CCcEEEEEec----------------------cCCccccceEEEecCceEEEEEEec
Q 042435 144 YFHIRYCIGTGGYDSVYKAELP-DGKVVALKKL----------------------HHSETEDSAFVVYSPQCMFFIYEYM 200 (412)
Q Consensus 144 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l----------------------~~~~~~~~~~~~~~~~~~~lv~ey~ 200 (412)
+|++.+.||+|+||.||++... +++.+|+|.+ +|+++......+...+..+++|||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 4788899999999999999764 6889999964 3555555566677888999999999
Q ss_pred cCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCCCC
Q 042435 201 ERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSN 280 (412)
Q Consensus 201 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 280 (412)
++|+|.+++..... ..++......++.|++.||.|||++ +++|+||||+||++++++.++++|||.++........
T Consensus 81 ~~~~l~~~~~~~~~-~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 156 (255)
T cd08219 81 DGGDLMQKIKLQRG-KLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAY 156 (255)
T ss_pred CCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceeecccccc
Confidence 99999888764322 2478889999999999999999998 9999999999999999999999999999766443333
Q ss_pred cccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccchhhHHHH
Q 042435 281 RTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKIIQDI 360 (412)
Q Consensus 281 ~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 360 (412)
.....|+..|+|||++.+..++.++|+||||+++|+|++|+.||.... ............. .+.+.. ..
T Consensus 157 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~-------~~~~~~~~~~~~~-~~~~~~---~~ 225 (255)
T cd08219 157 ACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANS-------WKNLILKVCQGSY-KPLPSH---YS 225 (255)
T ss_pred cccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCC-------HHHHHHHHhcCCC-CCCCcc---cC
Confidence 334568899999999988889999999999999999999999987321 1111111111111 111111 12
Q ss_pred HHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 361 ILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 361 ~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
..+.+++.+||+.||++|||+.|++..
T Consensus 226 ~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 226 YELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred HHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 347789999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=285.52 Aligned_cols=234 Identities=24% Similarity=0.334 Sum_probs=179.9
Q ss_pred cCcccceeeeecCceEEEEEEeC------CCcEEEEEec---------------------cCCccccceEEEecCceEEE
Q 042435 143 EYFHIRYCIGTGGYDSVYKAELP------DGKVVALKKL---------------------HHSETEDSAFVVYSPQCMFF 195 (412)
Q Consensus 143 ~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vAvK~l---------------------~~~~~~~~~~~~~~~~~~~l 195 (412)
.+|...++||+|+||.||++... ++..+|+|.+ +|+++......+...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 35677889999999999999642 3568888854 56666666677777888999
Q ss_pred EEEeccCCceeeeeccCcc------------cccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcE
Q 042435 196 IYEYMERGSLFCVLRDDDE------------AIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEA 263 (412)
Q Consensus 196 v~ey~~~gsL~~~l~~~~~------------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~ 263 (412)
+|||+++|+|.+++..... ...+++.+++.++.|++.|++|||+. +++||||||+||++++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcCCCCE
Confidence 9999999999998865421 12488999999999999999999998 99999999999999999999
Q ss_pred EEeecCCccccCCCCC--CcccccccccccccccccCcccCcccccHHHHHHHHHHHh-CCCCcccccccccCCCCcchh
Q 042435 264 FVADFGTVRLLDVDSS--NRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLM-GTHPGELLLSLSSSSGPKIML 340 (412)
Q Consensus 264 kl~DfGla~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~ 340 (412)
||+|||+++....... ......+++.|+|||.+.+..++.++|||||||++|||++ |+.||.... . ...
T Consensus 162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~-------~-~~~ 233 (280)
T cd05092 162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLS-------N-TEA 233 (280)
T ss_pred EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCC-------H-HHH
Confidence 9999999875533221 1122345678999999998899999999999999999998 899986321 1 111
Q ss_pred hHHhhhccCCccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhc
Q 042435 341 IDILYQRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELEG 390 (412)
Q Consensus 341 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~ 390 (412)
.+..........+.. ....+.+++.+||+.||.+||++.||.+.|++
T Consensus 234 ~~~~~~~~~~~~~~~---~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 234 IECITQGRELERPRT---CPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred HHHHHcCccCCCCCC---CCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence 122222111111111 12337899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=297.30 Aligned_cols=241 Identities=22% Similarity=0.281 Sum_probs=188.9
Q ss_pred cCcccceeeeecCceEEEEEEeCCCcEEEEEec----------------------cCCccccceEEEecCceEEEEEEec
Q 042435 143 EYFHIRYCIGTGGYDSVYKAELPDGKVVALKKL----------------------HHSETEDSAFVVYSPQCMFFIYEYM 200 (412)
Q Consensus 143 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~l----------------------~~~~~~~~~~~~~~~~~~~lv~ey~ 200 (412)
+...+.++||+|.||.|..+....+..||||.+ +|+|+.+..++|..++.+++|+|||
T Consensus 538 s~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYm 617 (807)
T KOG1094|consen 538 SRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYM 617 (807)
T ss_pred hheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHH
Confidence 445667899999999999999988899999954 7899999999999999999999999
Q ss_pred cCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCCCC
Q 042435 201 ERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSN 280 (412)
Q Consensus 201 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 280 (412)
++|+|.+++..+... .+.-..-.+|+.|||.|++||.+. ++||||+.++|||+|+++++||+|||+++.+-.....
T Consensus 618 EnGDLnqFl~aheap-t~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy 693 (807)
T KOG1094|consen 618 ENGDLNQFLSAHELP-TAETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYY 693 (807)
T ss_pred hcCcHHHHHHhccCc-ccccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCcccccccccCCce
Confidence 999999999876422 245556678999999999999988 9999999999999999999999999999966554433
Q ss_pred c--ccccccccccccccccCcccCcccccHHHHHHHHHHHh--CCCCcccccccccCCCCcchhhHHhhhccCCccchhh
Q 042435 281 R--TLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLM--GTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKI 356 (412)
Q Consensus 281 ~--~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~ellt--g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 356 (412)
. ....-.++|||||.+.-+++|++||||+||+++||+++ ...||.......-- +......+..-........
T Consensus 694 ~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vv----en~~~~~~~~~~~~~l~~P 769 (807)
T KOG1094|consen 694 RVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVV----ENAGEFFRDQGRQVVLSRP 769 (807)
T ss_pred eeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHH----HhhhhhcCCCCcceeccCC
Confidence 3 33456789999999999999999999999999999865 88898743211000 0001111111110001111
Q ss_pred HHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhcC
Q 042435 357 IQDIILVSTIALACLRSKPKSRPTMQRISQELEGK 391 (412)
Q Consensus 357 ~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 391 (412)
.-+...+.+++.+||..|-++||+++++...|++.
T Consensus 770 ~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 770 PACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred CcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 12233488999999999999999999999998764
|
|
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=285.40 Aligned_cols=241 Identities=23% Similarity=0.335 Sum_probs=178.1
Q ss_pred cCcccceeeeecCceEEEEEEe-----CCCcEEEEEecc---------------------CCccccceEEEe--cCceEE
Q 042435 143 EYFHIRYCIGTGGYDSVYKAEL-----PDGKVVALKKLH---------------------HSETEDSAFVVY--SPQCMF 194 (412)
Q Consensus 143 ~~f~~~~~lG~G~~g~Vy~~~~-----~~~~~vAvK~l~---------------------~~~~~~~~~~~~--~~~~~~ 194 (412)
++|++.+.||+|+||.||++.. .+++.||+|+++ |+++......+. .....+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 4688889999999999999975 358899999753 455544444443 234689
Q ss_pred EEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCcccc
Q 042435 195 FIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLL 274 (412)
Q Consensus 195 lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~ 274 (412)
+|+||+++|+|.+++..... .++|..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||+++..
T Consensus 84 lv~e~~~~~~L~~~l~~~~~--~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~ 158 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKHRE--RLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLTKVL 158 (284)
T ss_pred EEEEecCCCCHHHHHHhcCc--CCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCcccccc
Confidence 99999999999999865432 489999999999999999999998 9999999999999999999999999999866
Q ss_pred CCCCCCc---ccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCccccccc-----ccCCCCcc---hhhHH
Q 042435 275 DVDSSNR---TLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSL-----SSSSGPKI---MLIDI 343 (412)
Q Consensus 275 ~~~~~~~---~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~-----~~~~~~~~---~~~~~ 343 (412)
....... ....++..|+|||++.+..++.++||||||+++|||++|..|+...... ........ .+.+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05081 159 PQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIEL 238 (284)
T ss_pred cCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHH
Confidence 4332211 1122345699999998888999999999999999999988775422110 00000000 11122
Q ss_pred hhhccCCccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhcC
Q 042435 344 LYQRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELEGK 391 (412)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 391 (412)
+......+.... ....+.+++.+||+.+|++|||+.|+++.|+.+
T Consensus 239 ~~~~~~~~~~~~---~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 239 LKNNGRLPAPPG---CPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HhcCCcCCCCCC---CCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 222111111111 123488999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=290.32 Aligned_cols=239 Identities=26% Similarity=0.365 Sum_probs=180.9
Q ss_pred cCcccceeeeecCceEEEEEEeC-CCc--EEEEEec-----------------------cCCccccceEEEecCceEEEE
Q 042435 143 EYFHIRYCIGTGGYDSVYKAELP-DGK--VVALKKL-----------------------HHSETEDSAFVVYSPQCMFFI 196 (412)
Q Consensus 143 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~--~vAvK~l-----------------------~~~~~~~~~~~~~~~~~~~lv 196 (412)
++|++.+.||+|+||.||+|.+. ++. .+|+|++ +|+++......+...+..++|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 56888999999999999999864 444 4577754 355555556667778889999
Q ss_pred EEeccCCceeeeeccCc-------------ccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcE
Q 042435 197 YEYMERGSLFCVLRDDD-------------EAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEA 263 (412)
Q Consensus 197 ~ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~ 263 (412)
|||+++|+|.++++... ....+++.+++.++.|++.||+|||+. +++||||||+|||++.++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA 163 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecCCCcE
Confidence 99999999999886432 112578999999999999999999998 99999999999999999999
Q ss_pred EEeecCCccccCCCCCCcccccccccccccccccCcccCcccccHHHHHHHHHHHh-CCCCcccccccccCCCCcchhhH
Q 042435 264 FVADFGTVRLLDVDSSNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLM-GTHPGELLLSLSSSSGPKIMLID 342 (412)
Q Consensus 264 kl~DfGla~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~ 342 (412)
||+|||+++...... ......++..|+|||+..+..++.++|||||||++|||+| |..||.... . ....+
T Consensus 164 kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~-------~-~~~~~ 234 (303)
T cd05088 164 KIADFGLSRGQEVYV-KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT-------C-AELYE 234 (303)
T ss_pred EeCccccCcccchhh-hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCC-------h-HHHHH
Confidence 999999986432111 1112234667999999988889999999999999999998 999986221 1 11111
Q ss_pred HhhhccCCccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhcCCCCCC
Q 042435 343 ILYQRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELEGKTPMKK 396 (412)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~~~ 396 (412)
..........+.. ....+.+++.+||+.+|++||++.++++.|+.+....+
T Consensus 235 ~~~~~~~~~~~~~---~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~ 285 (303)
T cd05088 235 KLPQGYRLEKPLN---CDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 285 (303)
T ss_pred HHhcCCcCCCCCC---CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhh
Confidence 1211111111111 12247889999999999999999999999988765544
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=284.35 Aligned_cols=229 Identities=28% Similarity=0.421 Sum_probs=180.8
Q ss_pred cccceeeeecCceEEEEEEeC-CCcEEEEEec-----------------------cCCccccceEEEecCceEEEEEEec
Q 042435 145 FHIRYCIGTGGYDSVYKAELP-DGKVVALKKL-----------------------HHSETEDSAFVVYSPQCMFFIYEYM 200 (412)
Q Consensus 145 f~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l-----------------------~~~~~~~~~~~~~~~~~~~lv~ey~ 200 (412)
|++.+.||+|+||+||++... +++.+|+|.+ +|+++.............++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 567899999999999999875 4678999965 4667766777777889999999999
Q ss_pred cCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCCCC
Q 042435 201 ERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSN 280 (412)
Q Consensus 201 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 280 (412)
++++|.+++... ..+++..+..++.|+++||++||+. +++|+||||+||++++++.++|+|||.+.........
T Consensus 81 ~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~ 154 (260)
T PF00069_consen 81 PGGSLQDYLQKN---KPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNEN 154 (260)
T ss_dssp TTEBHHHHHHHH---SSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSE
T ss_pred cccccccccccc---ccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccccc
Confidence 999999998722 2589999999999999999999999 9999999999999999999999999999764333334
Q ss_pred ccccccccccccccccc-CcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccchh---h
Q 042435 281 RTLQAGTYGYIALELVY-TMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQK---I 356 (412)
Q Consensus 281 ~~~~~gt~~y~aPE~~~-~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~ 356 (412)
.....++..|+|||+.. +..++.++||||+|+++|+|++|..||... .................... .
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~ 226 (260)
T PF00069_consen 155 FNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEES--------NSDDQLEIIEKILKRPLPSSSQQS 226 (260)
T ss_dssp BSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTS--------SHHHHHHHHHHHHHTHHHHHTTSH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccc--------cchhhhhhhhhccccccccccccc
Confidence 44567899999999998 888999999999999999999999998732 00111111111111100000 0
Q ss_pred HHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 357 IQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 357 ~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
......+.+++.+||+.||++||++.+++++
T Consensus 227 ~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~ 257 (260)
T PF00069_consen 227 REKSEELRDLIKKMLSKDPEQRPSAEELLKH 257 (260)
T ss_dssp TTSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred chhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0011458899999999999999999999864
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=292.59 Aligned_cols=233 Identities=21% Similarity=0.278 Sum_probs=174.0
Q ss_pred cCcccceeeeecCceEEEEEEeC-CCcEEEEEec------------------------cCCccccceEEEecCceEEEEE
Q 042435 143 EYFHIRYCIGTGGYDSVYKAELP-DGKVVALKKL------------------------HHSETEDSAFVVYSPQCMFFIY 197 (412)
Q Consensus 143 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l------------------------~~~~~~~~~~~~~~~~~~~lv~ 197 (412)
++|++.+.||+|+||.||++... +++.||+|.+ +|+++......+.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 47899999999999999999864 6899999975 3556666666778889999999
Q ss_pred EeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCC
Q 042435 198 EYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVD 277 (412)
Q Consensus 198 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~ 277 (412)
||+++|+|.+++.... ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++......
T Consensus 81 e~~~g~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (331)
T cd05597 81 DYYVGGDLLTLLSKFE--DRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD 155 (331)
T ss_pred ecCCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceeecCCC
Confidence 9999999999986532 2488899999999999999999998 9999999999999999999999999998765433
Q ss_pred CCC-cccccccccccccccccC-----cccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCc
Q 042435 278 SSN-RTLQAGTYGYIALELVYT-----MVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPP 351 (412)
Q Consensus 278 ~~~-~~~~~gt~~y~aPE~~~~-----~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 351 (412)
... .....||+.|+|||++.. ..++.++|||||||++|||++|+.||.... .......+........
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~-------~~~~~~~i~~~~~~~~ 228 (331)
T cd05597 156 GTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAES-------LVETYGKIMNHKEHFQ 228 (331)
T ss_pred CCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCC-------HHHHHHHHHcCCCccc
Confidence 222 223468999999999863 457889999999999999999999986321 0111111111111011
Q ss_pred cchhhHHHHHHHHHHHHhcCcC--CCCCCCCHHHHHHH
Q 042435 352 INQKIIQDIILVSTIALACLRS--KPKSRPTMQRISQE 387 (412)
Q Consensus 352 ~~~~~~~~~~~~~~l~~~Cl~~--dP~~RPs~~evl~~ 387 (412)
.+.........+.+++.+|+.. ++..||++.+++++
T Consensus 229 ~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 229 FPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred CCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 1111111122356677776644 44458899999888
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-37 Score=294.60 Aligned_cols=233 Identities=20% Similarity=0.286 Sum_probs=175.1
Q ss_pred cCcccceeeeecCceEEEEEEeC-CCcEEEEEecc------------------------CCccccceEEEecCceEEEEE
Q 042435 143 EYFHIRYCIGTGGYDSVYKAELP-DGKVVALKKLH------------------------HSETEDSAFVVYSPQCMFFIY 197 (412)
Q Consensus 143 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~------------------------~~~~~~~~~~~~~~~~~~lv~ 197 (412)
++|++.+.||+|+||.||+++.. +++.||+|.+. |+++......+...+..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47899999999999999999774 68899999753 344444555577788999999
Q ss_pred EeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCC
Q 042435 198 EYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVD 277 (412)
Q Consensus 198 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~ 277 (412)
||+++|+|.+++..... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 81 Ey~~gg~L~~~l~~~~~--~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 155 (331)
T cd05624 81 DYYVGGDLLTLLSKFED--RLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD 155 (331)
T ss_pred eCCCCCcHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence 99999999999875322 478889999999999999999998 9999999999999999999999999999765443
Q ss_pred CCC-cccccccccccccccccC-----cccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCc
Q 042435 278 SSN-RTLQAGTYGYIALELVYT-----MVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPP 351 (412)
Q Consensus 278 ~~~-~~~~~gt~~y~aPE~~~~-----~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 351 (412)
... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||.... .......+.......+
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~-------~~~~~~~i~~~~~~~~ 228 (331)
T cd05624 156 GTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAES-------LVETYGKIMNHEERFQ 228 (331)
T ss_pred CceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCC-------HHHHHHHHHcCCCccc
Confidence 222 233569999999999865 467889999999999999999999986321 1111112221111111
Q ss_pred cchhhHHHHHHHHHHHHhcCcCCCCC--CCCHHHHHHH
Q 042435 352 INQKIIQDIILVSTIALACLRSKPKS--RPTMQRISQE 387 (412)
Q Consensus 352 ~~~~~~~~~~~~~~l~~~Cl~~dP~~--RPs~~evl~~ 387 (412)
.+.........+.+++.+|+..++++ |+++++++++
T Consensus 229 ~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 229 FPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred CCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 11111112234778888888765543 4688888766
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=284.87 Aligned_cols=244 Identities=24% Similarity=0.374 Sum_probs=184.9
Q ss_pred cCcccceeeeecCceEEEEEEeCCCcEEEEEec--------------------cCCccccceEEEec----CceEEEEEE
Q 042435 143 EYFHIRYCIGTGGYDSVYKAELPDGKVVALKKL--------------------HHSETEDSAFVVYS----PQCMFFIYE 198 (412)
Q Consensus 143 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~l--------------------~~~~~~~~~~~~~~----~~~~~lv~e 198 (412)
.+..+.+.||+|.||+||+|+| .|+.||||.+ +|+|+..+...-.. -..+|||++
T Consensus 211 rqI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~srdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvTd 289 (513)
T KOG2052|consen 211 RQIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSSRDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVTD 289 (513)
T ss_pred heeEEEEEecCccccceeeccc-cCCceEEEEecccchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEeee
Confidence 4567789999999999999999 6899999975 56666554333221 236899999
Q ss_pred eccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhC-----CCCCcEEeCCCCCCEEecCCCcEEEeecCCccc
Q 042435 199 YMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHD-----CTPSIVHRDISSNNILLNSNLEAFVADFGTVRL 273 (412)
Q Consensus 199 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~-----~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~ 273 (412)
|.++|||+|+|... .++-...++++..+|.||++||.. ..|.|.|||||+.|||+..++.+.|+|+|+|-.
T Consensus 290 YHe~GSL~DyL~r~----tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~ 365 (513)
T KOG2052|consen 290 YHEHGSLYDYLNRN----TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 365 (513)
T ss_pred cccCCcHHHHHhhc----cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEE
Confidence 99999999999875 489999999999999999999974 468899999999999999999999999999976
Q ss_pred cCCCCC----CcccccccccccccccccCcc----c-C-cccccHHHHHHHHHHHhC----------CCCcccccccccC
Q 042435 274 LDVDSS----NRTLQAGTYGYIALELVYTMV----V-T-EKCVIYSFGVVALEVLMG----------THPGELLLSLSSS 333 (412)
Q Consensus 274 ~~~~~~----~~~~~~gt~~y~aPE~~~~~~----~-s-~ksDv~S~Gvil~elltg----------~~P~~~~~~~~~~ 333 (412)
...... .....+||-+|||||++.... + + ..+||||||.++||+..+ +.||.+.. ..
T Consensus 366 h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~V---p~ 442 (513)
T KOG2052|consen 366 HDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVV---PS 442 (513)
T ss_pred ecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCC---CC
Confidence 544321 224568999999999986432 1 1 359999999999999752 35665332 12
Q ss_pred CCCcchhhHHh-hhccCCccchhh--HHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhcCCCC
Q 042435 334 SGPKIMLIDIL-YQRLSPPINQKI--IQDIILVSTIALACLRSKPKSRPTMQRISQELEGKTPM 394 (412)
Q Consensus 334 ~~~~~~~~~~~-~~~~~~~~~~~~--~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~ 394 (412)
....+.+.+++ .++++|.++..+ .+.+..+.+++..||..+|..|-|+--+-+.|.++...
T Consensus 443 DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~~ 506 (513)
T KOG2052|consen 443 DPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSNS 506 (513)
T ss_pred CCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhcC
Confidence 22222333332 334444433322 23455688999999999999999999999999888754
|
|
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=280.17 Aligned_cols=224 Identities=20% Similarity=0.294 Sum_probs=170.9
Q ss_pred eeecCceEEEEEEeC---CCcEEEEEecc----------------------CCccccceEEEecCceEEEEEEeccCCce
Q 042435 151 IGTGGYDSVYKAELP---DGKVVALKKLH----------------------HSETEDSAFVVYSPQCMFFIYEYMERGSL 205 (412)
Q Consensus 151 lG~G~~g~Vy~~~~~---~~~~vAvK~l~----------------------~~~~~~~~~~~~~~~~~~lv~ey~~~gsL 205 (412)
||+|+||.||+|.+. ++..||+|.+. |+++......+ ..+..++||||+++|+|
T Consensus 3 ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~-~~~~~~lv~e~~~~~~L 81 (257)
T cd05115 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVC-EAEALMLVMEMASGGPL 81 (257)
T ss_pred cCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEE-cCCCeEEEEEeCCCCCH
Confidence 899999999999763 35679999764 33443333333 45678999999999999
Q ss_pred eeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCCCC---cc
Q 042435 206 FCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSN---RT 282 (412)
Q Consensus 206 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~---~~ 282 (412)
.+++.... ..+++.++++++.|++.||+|||++ +++||||||+||+++.++.+||+|||+++........ ..
T Consensus 82 ~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 156 (257)
T cd05115 82 NKFLSGKK--DEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARS 156 (257)
T ss_pred HHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCccceeccC
Confidence 99886533 2589999999999999999999998 9999999999999999999999999999865433221 11
Q ss_pred cccccccccccccccCcccCcccccHHHHHHHHHHHh-CCCCcccccccccCCCCcchhhHHhhhccCCccchhhHHHHH
Q 042435 283 LQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLM-GTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKIIQDII 361 (412)
Q Consensus 283 ~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 361 (412)
...++..|+|||.+....++.++||||||+++||+++ |..||.... .......+........+.. ...
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~--------~~~~~~~~~~~~~~~~~~~---~~~ 225 (257)
T cd05115 157 AGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMK--------GPEVMSFIEQGKRLDCPAE---CPP 225 (257)
T ss_pred CCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCC--------HHHHHHHHHCCCCCCCCCC---CCH
Confidence 2233578999999988889999999999999999996 999986321 1112222222222221121 123
Q ss_pred HHHHHHHhcCcCCCCCCCCHHHHHHHHhcC
Q 042435 362 LVSTIALACLRSKPKSRPTMQRISQELEGK 391 (412)
Q Consensus 362 ~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 391 (412)
.+.+++.+||..||++||++.+|.+.|+..
T Consensus 226 ~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 226 EMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 478899999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=279.30 Aligned_cols=234 Identities=27% Similarity=0.355 Sum_probs=183.6
Q ss_pred hcCcccceeeeecCceEEEEEEeC-CCcEEEEEec---------------------cCCccccceEEEecCceEEEEEEe
Q 042435 142 TEYFHIRYCIGTGGYDSVYKAELP-DGKVVALKKL---------------------HHSETEDSAFVVYSPQCMFFIYEY 199 (412)
Q Consensus 142 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l---------------------~~~~~~~~~~~~~~~~~~~lv~ey 199 (412)
.++|++.+.||+|+||.||+|... +++.+|+|.+ +|+++..........+..+++|||
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~ 81 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY 81 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence 367899999999999999999774 5788999953 566777766777788899999999
Q ss_pred ccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCCC
Q 042435 200 MERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSS 279 (412)
Q Consensus 200 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 279 (412)
+++++|.+++.... ..++..++..++.|++.||+|||++ +++|+||||+||++++++.++|+|||++........
T Consensus 82 ~~~~~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~ 156 (262)
T cd06613 82 CGGGSLQDIYQVTR--GPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA 156 (262)
T ss_pred CCCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhhhhhh
Confidence 99999999886542 2588999999999999999999998 999999999999999999999999999876554332
Q ss_pred CcccccccccccccccccCc---ccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccchhh
Q 042435 280 NRTLQAGTYGYIALELVYTM---VVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKI 356 (412)
Q Consensus 280 ~~~~~~gt~~y~aPE~~~~~---~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 356 (412)
......++..|+|||.+.+. .++.++||||||+++|||+||+.||.... ..............++.....
T Consensus 157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~-------~~~~~~~~~~~~~~~~~~~~~ 229 (262)
T cd06613 157 KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLH-------PMRALFLISKSNFPPPKLKDK 229 (262)
T ss_pred ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCC-------HHHHHHHHHhccCCCccccch
Confidence 33445688899999998776 78999999999999999999999986321 111111111111111111112
Q ss_pred HHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 357 IQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 357 ~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
......+.+++.+||..+|.+|||+.+++++
T Consensus 230 ~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 260 (262)
T cd06613 230 EKWSPVFHDFIKKCLTKDPKKRPTATKLLQH 260 (262)
T ss_pred hhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 2233458899999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=305.96 Aligned_cols=243 Identities=17% Similarity=0.191 Sum_probs=172.6
Q ss_pred HHHHHhhcCcccceeeeecCceEEEEEEe-CCCcEEEEEeccCC--------------------c------cccceEEEe
Q 042435 136 ENLIDATEYFHIRYCIGTGGYDSVYKAEL-PDGKVVALKKLHHS--------------------E------TEDSAFVVY 188 (412)
Q Consensus 136 ~~l~~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l~~~--------------------~------~~~~~~~~~ 188 (412)
+++...+++|++.++||+|+||+||+|.. .+++.||||+++.. + +......+.
T Consensus 122 ~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~ 201 (467)
T PTZ00284 122 EDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ 201 (467)
T ss_pred CccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence 34455678999999999999999999976 46889999987431 1 111111222
Q ss_pred -cCceEEEEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCC------
Q 042435 189 -SPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNL------ 261 (412)
Q Consensus 189 -~~~~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~------ 261 (412)
.....++|||++ +++|.+++.... .+++..+..|+.|++.||+|||+++ +|+||||||+|||++.++
T Consensus 202 ~~~~~~~iv~~~~-g~~l~~~l~~~~---~l~~~~~~~i~~qi~~aL~yLH~~~--gIiHrDlKP~NILl~~~~~~~~~~ 275 (467)
T PTZ00284 202 NETGHMCIVMPKY-GPCLLDWIMKHG---PFSHRHLAQIIFQTGVALDYFHTEL--HLMHTDLKPENILMETSDTVVDPV 275 (467)
T ss_pred cCCceEEEEEecc-CCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhcC--CeecCCCCHHHEEEecCCcccccc
Confidence 245789999988 678888776543 5899999999999999999999732 899999999999998655
Q ss_pred ----------cEEEeecCCccccCCCCCCcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccc
Q 042435 262 ----------EAFVADFGTVRLLDVDSSNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLS 331 (412)
Q Consensus 262 ----------~~kl~DfGla~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~ 331 (412)
.+||+|||.+.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||+......
T Consensus 276 ~~~~~~~~~~~vkl~DfG~~~~~~---~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~ 352 (467)
T PTZ00284 276 TNRALPPDPCRVRICDLGGCCDER---HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLE 352 (467)
T ss_pred cccccCCCCceEEECCCCccccCc---cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH
Confidence 49999999876432 22234579999999999999999999999999999999999999996321100
Q ss_pred ------c--CCCCc--------chhhHHhhhc--cCCccch------------hhHHHHHHHHHHHHhcCcCCCCCCCCH
Q 042435 332 ------S--SSGPK--------IMLIDILYQR--LSPPINQ------------KIIQDIILVSTIALACLRSKPKSRPTM 381 (412)
Q Consensus 332 ------~--~~~~~--------~~~~~~~~~~--~~~~~~~------------~~~~~~~~~~~l~~~Cl~~dP~~RPs~ 381 (412)
. ...+. ....+..... +.+.... ........+.+|+.+||+.||++|||+
T Consensus 353 ~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta 432 (467)
T PTZ00284 353 HLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNA 432 (467)
T ss_pred HHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCH
Confidence 0 00000 0000000000 0000000 000012347799999999999999999
Q ss_pred HHHHHH
Q 042435 382 QRISQE 387 (412)
Q Consensus 382 ~evl~~ 387 (412)
+|+++|
T Consensus 433 ~e~L~H 438 (467)
T PTZ00284 433 RQMTTH 438 (467)
T ss_pred HHHhcC
Confidence 999975
|
|
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=285.57 Aligned_cols=241 Identities=24% Similarity=0.337 Sum_probs=182.4
Q ss_pred ccHHHHHHhhcCcccceeeeecCceEEEEEEe-CCCcEEEEEecc---------------------CCccccceEEEe--
Q 042435 133 ILYENLIDATEYFHIRYCIGTGGYDSVYKAEL-PDGKVVALKKLH---------------------HSETEDSAFVVY-- 188 (412)
Q Consensus 133 ~~~~~l~~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l~---------------------~~~~~~~~~~~~-- 188 (412)
.++.++..+.+.|++.+.||+|+||.||+|.. .+++.+|+|.+. |+++......+.
T Consensus 6 ~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 85 (282)
T cd06636 6 IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKK 85 (282)
T ss_pred hhhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence 46677778889999999999999999999977 568899999653 344433333332
Q ss_pred ----cCceEEEEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEE
Q 042435 189 ----SPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAF 264 (412)
Q Consensus 189 ----~~~~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~k 264 (412)
.....+++|||+++|+|.+++..... ..+++..+..++.|++.||+|||+. +++|+||||+||++++++.++
T Consensus 86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~~~~ 161 (282)
T cd06636 86 SPPGHDDQLWLVMEFCGAGSVTDLVKNTKG-NALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVK 161 (282)
T ss_pred cccCCCCEEEEEEEeCCCCcHHHHHHHccC-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEE
Confidence 24578999999999999998865432 2478888999999999999999998 999999999999999999999
Q ss_pred EeecCCccccCCCCCCccccccccccccccccc-----CcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcch
Q 042435 265 VADFGTVRLLDVDSSNRTLQAGTYGYIALELVY-----TMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIM 339 (412)
Q Consensus 265 l~DfGla~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~ 339 (412)
|+|||++..............|+..|+|||.+. ...++.++|||||||++|||++|+.||..... ...
T Consensus 162 l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~-------~~~ 234 (282)
T cd06636 162 LVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHP-------MRA 234 (282)
T ss_pred EeeCcchhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCH-------Hhh
Confidence 999999876543333334456899999999875 34678899999999999999999999863211 011
Q ss_pred hhHHhhhccCCccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 340 LIDILYQRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 340 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
.... ........ ........+.+++.+||+.||.+|||+.|++++
T Consensus 235 ~~~~-~~~~~~~~--~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~ 279 (282)
T cd06636 235 LFLI-PRNPPPKL--KSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKH 279 (282)
T ss_pred hhhH-hhCCCCCC--cccccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence 1111 11111110 001122348899999999999999999999764
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=280.14 Aligned_cols=234 Identities=24% Similarity=0.391 Sum_probs=183.1
Q ss_pred hcCcccceeeeecCceEEEEEEeCCCcEEEEEecc--------------------CCccccceEEEecCceEEEEEEecc
Q 042435 142 TEYFHIRYCIGTGGYDSVYKAELPDGKVVALKKLH--------------------HSETEDSAFVVYSPQCMFFIYEYME 201 (412)
Q Consensus 142 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~l~--------------------~~~~~~~~~~~~~~~~~~lv~ey~~ 201 (412)
.++|.+.+.||+|+||.||+|...+++.||||.++ |+++......+......++||||++
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 84 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMS 84 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEeccC
Confidence 46789999999999999999998888899999764 4444444555666688999999999
Q ss_pred CCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCCCC-
Q 042435 202 RGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSN- 280 (412)
Q Consensus 202 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~- 280 (412)
+++|.+++..... ..+++.++..++.+++.|++|||++ +++|+||||+||++++++.++++|||+++........
T Consensus 85 ~~~L~~~i~~~~~-~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~ 160 (261)
T cd05034 85 KGSLLDFLKSGEG-KKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTA 160 (261)
T ss_pred CCCHHHHHhcccc-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceeccchhhhh
Confidence 9999999876432 2589999999999999999999998 9999999999999999999999999998865432111
Q ss_pred cccccccccccccccccCcccCcccccHHHHHHHHHHHh-CCCCcccccccccCCCCcchhhHHhhhccCCccchhhHHH
Q 042435 281 RTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLM-GTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKIIQD 359 (412)
Q Consensus 281 ~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 359 (412)
.....++..|+|||.+.+..++.++||||||+++||++| |+.||... ... ...+........+.+...
T Consensus 161 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~-------~~~-~~~~~~~~~~~~~~~~~~--- 229 (261)
T cd05034 161 REGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGM-------TNR-EVLEQVERGYRMPRPPNC--- 229 (261)
T ss_pred hhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCC-------CHH-HHHHHHHcCCCCCCCCCC---
Confidence 112234568999999998889999999999999999999 99998622 111 112222222221111111
Q ss_pred HHHHHHHHHhcCcCCCCCCCCHHHHHHHHhc
Q 042435 360 IILVSTIALACLRSKPKSRPTMQRISQELEG 390 (412)
Q Consensus 360 ~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~ 390 (412)
...+.+++.+|++.+|++||+++++.+.|+.
T Consensus 230 ~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 230 PEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred CHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 2347899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=288.42 Aligned_cols=239 Identities=17% Similarity=0.212 Sum_probs=175.8
Q ss_pred cCcccceeeeecCceEEEEEEeC-CCcEEEEEec----------------------cCCccccceEEEecCceEEEEEEe
Q 042435 143 EYFHIRYCIGTGGYDSVYKAELP-DGKVVALKKL----------------------HHSETEDSAFVVYSPQCMFFIYEY 199 (412)
Q Consensus 143 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l----------------------~~~~~~~~~~~~~~~~~~~lv~ey 199 (412)
++|.+.+.||+|+||.||+|... +++.||+|.+ +|+++......+..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 56889999999999999999764 6889999965 355666666667788899999999
Q ss_pred ccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCCC
Q 042435 200 MERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSS 279 (412)
Q Consensus 200 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 279 (412)
+++ +|.+++..... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.......
T Consensus 86 ~~~-~l~~~~~~~~~--~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 159 (309)
T cd07872 86 LDK-DLKQYMDDCGN--IMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK 159 (309)
T ss_pred CCC-CHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceecCCCcc
Confidence 975 78777654432 478899999999999999999998 999999999999999999999999999976543333
Q ss_pred CcccccccccccccccccC-cccCcccccHHHHHHHHHHHhCCCCccccccccc--------CCCCcchhhH------Hh
Q 042435 280 NRTLQAGTYGYIALELVYT-MVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSS--------SSGPKIMLID------IL 344 (412)
Q Consensus 280 ~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~--------~~~~~~~~~~------~~ 344 (412)
......+++.|+|||.+.+ ..++.++|||||||++|||+||+.||........ .......... ..
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (309)
T cd07872 160 TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFK 239 (309)
T ss_pred ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhh
Confidence 3334567899999998865 4688999999999999999999999863211000 0000000000 00
Q ss_pred hhccCCccc----hhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 345 YQRLSPPIN----QKIIQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 345 ~~~~~~~~~----~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
......... .........+.+++.+|++.||.+|||+.|++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 286 (309)
T cd07872 240 NYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKH 286 (309)
T ss_pred hhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcC
Confidence 000000000 0000112347789999999999999999999874
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=281.47 Aligned_cols=239 Identities=23% Similarity=0.300 Sum_probs=180.7
Q ss_pred HHHHhhcCcccceeeeecCceEEEEEEeC-CCcEEEEEec---------------------cCCccccceEEEecCceEE
Q 042435 137 NLIDATEYFHIRYCIGTGGYDSVYKAELP-DGKVVALKKL---------------------HHSETEDSAFVVYSPQCMF 194 (412)
Q Consensus 137 ~l~~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l---------------------~~~~~~~~~~~~~~~~~~~ 194 (412)
|++.+++++.....||+|+||.||+|... ++..||+|.+ +|+++......+..++..+
T Consensus 2 ~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 81 (268)
T cd06624 2 EYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFK 81 (268)
T ss_pred CcccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEE
Confidence 34567778888889999999999999764 6788999954 4666666666677888999
Q ss_pred EEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecC-CCcEEEeecCCccc
Q 042435 195 FIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNS-NLEAFVADFGTVRL 273 (412)
Q Consensus 195 lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~-~~~~kl~DfGla~~ 273 (412)
+|+||+++++|.+++.........++..+..++.|++.||+|||+. +|+||||||+||+++. ++.++|+|||++..
T Consensus 82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~ 158 (268)
T cd06624 82 IFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKR 158 (268)
T ss_pred EEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchhhee
Confidence 9999999999999887543221227888899999999999999998 9999999999999976 67999999999876
Q ss_pred cCCCCCCcccccccccccccccccCcc--cCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCc
Q 042435 274 LDVDSSNRTLQAGTYGYIALELVYTMV--VTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPP 351 (412)
Q Consensus 274 ~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 351 (412)
............|+..|+|||++.... ++.++||||||+++|||++|+.||..... ..............+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~------~~~~~~~~~~~~~~~~ 232 (268)
T cd06624 159 LAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGE------PQAAMFKVGMFKIHPE 232 (268)
T ss_pred cccCCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccC------hhhhHhhhhhhccCCC
Confidence 543333333346889999999986543 78899999999999999999999863211 0000101100011111
Q ss_pred cchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 352 INQKIIQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 352 ~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
.+.. ....+.+++.+||+.+|++|||+.|++++
T Consensus 233 ~~~~---~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 233 IPES---LSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred CCcc---cCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 1111 12237889999999999999999999865
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=281.34 Aligned_cols=233 Identities=27% Similarity=0.389 Sum_probs=181.1
Q ss_pred cCcccceeeeecCceEEEEEEeC----CCcEEEEEec----------------------cCCccccceEEEecCceEEEE
Q 042435 143 EYFHIRYCIGTGGYDSVYKAELP----DGKVVALKKL----------------------HHSETEDSAFVVYSPQCMFFI 196 (412)
Q Consensus 143 ~~f~~~~~lG~G~~g~Vy~~~~~----~~~~vAvK~l----------------------~~~~~~~~~~~~~~~~~~~lv 196 (412)
++|++.+.||+|+||.||+|... .+..+|+|.+ +|+++......+...+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 46888999999999999999763 2347999965 356666666667788899999
Q ss_pred EEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCC
Q 042435 197 YEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDV 276 (412)
Q Consensus 197 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~ 276 (412)
|||+++++|.+++..... .+++.+++.++.|++.||+|||+. +++||||||+||+++.++.++++|||+++....
T Consensus 84 ~e~~~~~~L~~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd05066 84 TEYMENGSLDAFLRKHDG--QFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 158 (267)
T ss_pred EEcCCCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence 999999999999875432 489999999999999999999998 999999999999999999999999999986644
Q ss_pred CCCCc---ccccccccccccccccCcccCcccccHHHHHHHHHHHh-CCCCcccccccccCCCCcchhhHHhhhccCCcc
Q 042435 277 DSSNR---TLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLM-GTHPGELLLSLSSSSGPKIMLIDILYQRLSPPI 352 (412)
Q Consensus 277 ~~~~~---~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 352 (412)
..... ....++..|+|||.+.+..++.++|+||||+++||+++ |..||.... .. .....+......+.
T Consensus 159 ~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~-------~~-~~~~~~~~~~~~~~ 230 (267)
T cd05066 159 DPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMS-------NQ-DVIKAIEEGYRLPA 230 (267)
T ss_pred ccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCC-------HH-HHHHHHhCCCcCCC
Confidence 32211 11223568999999998889999999999999999887 999986321 11 11111221111111
Q ss_pred chhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhcC
Q 042435 353 NQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELEGK 391 (412)
Q Consensus 353 ~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 391 (412)
.. .....+.+++.+||+.+|.+||++.++++.|+++
T Consensus 231 ~~---~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 231 PM---DCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred CC---CCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 11 1223478899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=285.14 Aligned_cols=230 Identities=20% Similarity=0.253 Sum_probs=174.0
Q ss_pred cccceeeeecCceEEEEEEe-CCCcEEEEEecc------------------------CCccccceEEEecCceEEEEEEe
Q 042435 145 FHIRYCIGTGGYDSVYKAEL-PDGKVVALKKLH------------------------HSETEDSAFVVYSPQCMFFIYEY 199 (412)
Q Consensus 145 f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l~------------------------~~~~~~~~~~~~~~~~~~lv~ey 199 (412)
|+..+.||+|+||+||+|.. .+++.+|+|.+. |+++......+..++..+++|||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 66778999999999999976 468999999763 33333334446677889999999
Q ss_pred ccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCCC
Q 042435 200 MERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSS 279 (412)
Q Consensus 200 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 279 (412)
+++++|.+++..... ..+++..+..++.|++.||.|||+. +|+||||||+||++++++.++|+|||++.......
T Consensus 82 ~~~~~L~~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~- 156 (285)
T cd05632 82 MNGGDLKFHIYNMGN-PGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE- 156 (285)
T ss_pred ccCccHHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcceecCCCC-
Confidence 999999887764322 2589999999999999999999998 99999999999999999999999999987653322
Q ss_pred CcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccchhhHHH
Q 042435 280 NRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKIIQD 359 (412)
Q Consensus 280 ~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 359 (412)
......|+..|+|||++.+..++.++|+||||+++|||++|+.||.... .... .+.+...............
T Consensus 157 ~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~-------~~~~-~~~~~~~~~~~~~~~~~~~ 228 (285)
T cd05632 157 SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRK-------EKVK-REEVDRRVLETEEVYSAKF 228 (285)
T ss_pred cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCC-------HHHH-HHHHHHhhhccccccCccC
Confidence 2233468999999999988889999999999999999999999987321 1100 1111111111000000111
Q ss_pred HHHHHHHHHhcCcCCCCCCCC-----HHHHHHH
Q 042435 360 IILVSTIALACLRSKPKSRPT-----MQRISQE 387 (412)
Q Consensus 360 ~~~~~~l~~~Cl~~dP~~RPs-----~~evl~~ 387 (412)
...+.+++.+||+.||++||+ +++++++
T Consensus 229 ~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 229 SEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred CHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 223778999999999999999 6677665
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=285.76 Aligned_cols=244 Identities=23% Similarity=0.336 Sum_probs=183.8
Q ss_pred ccHHHHHHhhcCcccceeeeecCceEEEEEEe-CCCcEEEEEecc---------------------CCccccceEEEe--
Q 042435 133 ILYENLIDATEYFHIRYCIGTGGYDSVYKAEL-PDGKVVALKKLH---------------------HSETEDSAFVVY-- 188 (412)
Q Consensus 133 ~~~~~l~~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l~---------------------~~~~~~~~~~~~-- 188 (412)
+.++.+.+++++|++.+.||+|+||.||++.. .+++.+|+|.++ |+++......+.
T Consensus 8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 87 (286)
T cd06638 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKK 87 (286)
T ss_pred EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeec
Confidence 55678888999999999999999999999976 468899999753 344444433332
Q ss_pred ---cCceEEEEEEeccCCceeeeeccCc-ccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEE
Q 042435 189 ---SPQCMFFIYEYMERGSLFCVLRDDD-EAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAF 264 (412)
Q Consensus 189 ---~~~~~~lv~ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~k 264 (412)
.++..++||||+++++|.+++.... ....+++..+..++.|++.||.|||+. +++||||||+||++++++.++
T Consensus 88 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~k 164 (286)
T cd06638 88 DVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVK 164 (286)
T ss_pred ccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCCCEE
Confidence 3456899999999999998775321 123588899999999999999999998 999999999999999999999
Q ss_pred EeecCCccccCCCCCCcccccccccccccccccC-----cccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcch
Q 042435 265 VADFGTVRLLDVDSSNRTLQAGTYGYIALELVYT-----MVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIM 339 (412)
Q Consensus 265 l~DfGla~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~ 339 (412)
|+|||+++.............|++.|+|||++.. ..++.++|||||||++|||++|+.||...... ..
T Consensus 165 l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~-------~~ 237 (286)
T cd06638 165 LVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPM-------RA 237 (286)
T ss_pred EccCCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchh-------HH
Confidence 9999999866543333344568999999998753 45788999999999999999999998632110 11
Q ss_pred hhHHhhhccCCccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHH
Q 042435 340 LIDILYQRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQEL 388 (412)
Q Consensus 340 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L 388 (412)
..... ....+.. .........+.+++.+||+.||++|||+.|++++.
T Consensus 238 ~~~~~-~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 238 LFKIP-RNPPPTL-HQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred Hhhcc-ccCCCcc-cCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 11110 1110000 00001122478899999999999999999999764
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=282.14 Aligned_cols=234 Identities=22% Similarity=0.322 Sum_probs=181.1
Q ss_pred CcccceeeeecCceEEEEEEeCC--CcEEEEEec--------------------------------cCCccccceEEEec
Q 042435 144 YFHIRYCIGTGGYDSVYKAELPD--GKVVALKKL--------------------------------HHSETEDSAFVVYS 189 (412)
Q Consensus 144 ~f~~~~~lG~G~~g~Vy~~~~~~--~~~vAvK~l--------------------------------~~~~~~~~~~~~~~ 189 (412)
+|++.+.||+|+||.||+|.... ++.+|+|.+ +|+++......+..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47888999999999999998754 788999854 34555555556777
Q ss_pred CceEEEEEEeccCCceeeeeccCc-ccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeec
Q 042435 190 PQCMFFIYEYMERGSLFCVLRDDD-EAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADF 268 (412)
Q Consensus 190 ~~~~~lv~ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Df 268 (412)
.+..+++|||+++++|.+++.... ....+++..++.++.|++.||.|||+.. +++|+||||+||+++.++.++|+||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK--RIVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC--ceeecCCCHHHEEECCCCcEEEecc
Confidence 889999999999999988875421 2235889999999999999999999631 7999999999999999999999999
Q ss_pred CCccccCCCCCCcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhcc
Q 042435 269 GTVRLLDVDSSNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRL 348 (412)
Q Consensus 269 Gla~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 348 (412)
|.+....... ......|+..|+|||.+.+..++.++||||||+++|||++|+.||... ..............
T Consensus 159 g~~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~-------~~~~~~~~~~~~~~ 230 (269)
T cd08528 159 GLAKQKQPES-KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYST-------NMLSLATKIVEAVY 230 (269)
T ss_pred cceeeccccc-ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCccccc-------CHHHHHHHHhhccC
Confidence 9998654433 334456889999999999888999999999999999999999998622 11111111111111
Q ss_pred CCccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhc
Q 042435 349 SPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELEG 390 (412)
Q Consensus 349 ~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~ 390 (412)
. +... ......+.+++.+||+.||++||++.|+.+++++
T Consensus 231 ~-~~~~--~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~~ 269 (269)
T cd08528 231 E-PLPE--GMYSEDVTDVITSCLTPDAEARPDIIQVSAMISD 269 (269)
T ss_pred C-cCCc--ccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhcC
Confidence 1 1111 0112347889999999999999999999998863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=285.90 Aligned_cols=243 Identities=25% Similarity=0.331 Sum_probs=183.6
Q ss_pred ccHHHHHHhhcCcccceeeeecCceEEEEEEe-CCCcEEEEEecc---------------------CCccccceEEEecC
Q 042435 133 ILYENLIDATEYFHIRYCIGTGGYDSVYKAEL-PDGKVVALKKLH---------------------HSETEDSAFVVYSP 190 (412)
Q Consensus 133 ~~~~~l~~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l~---------------------~~~~~~~~~~~~~~ 190 (412)
++..++.+++++|++.+.||+|+||.||++.. .+++.+|+|.+. |+++......+...
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~ 91 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKA 91 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEec
Confidence 45677788899999999999999999999977 568899999763 44444444444332
Q ss_pred -----ceEEEEEEeccCCceeeeeccCc-ccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEE
Q 042435 191 -----QCMFFIYEYMERGSLFCVLRDDD-EAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAF 264 (412)
Q Consensus 191 -----~~~~lv~ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~k 264 (412)
...++|+||+++|+|.++++... ....+++..+..++.|++.||+|||+. +++||||||+||+++.++.+|
T Consensus 92 ~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~~~k 168 (291)
T cd06639 92 DKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVK 168 (291)
T ss_pred cccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEE
Confidence 46899999999999998875421 123589999999999999999999998 999999999999999999999
Q ss_pred EeecCCccccCCCCCCcccccccccccccccccCc-----ccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcch
Q 042435 265 VADFGTVRLLDVDSSNRTLQAGTYGYIALELVYTM-----VVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIM 339 (412)
Q Consensus 265 l~DfGla~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~ 339 (412)
|+|||+++.............|+..|+|||.+... .++.++|||||||++|||++|+.||.... ....
T Consensus 169 l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~-------~~~~ 241 (291)
T cd06639 169 LVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMH-------PVKT 241 (291)
T ss_pred EeecccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCc-------HHHH
Confidence 99999988654433233345688999999987543 36889999999999999999999986321 1111
Q ss_pred hhHHhhhccCCccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 340 LIDILYQRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 340 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
..++... ..+.. .........+.+++.+||+.+|++||++.|++++
T Consensus 242 ~~~~~~~-~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 242 LFKIPRN-PPPTL-LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred HHHHhcC-CCCCC-CcccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 1111111 11110 0111122348899999999999999999999875
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=280.94 Aligned_cols=233 Identities=28% Similarity=0.411 Sum_probs=179.6
Q ss_pred cCcccceeeeecCceEEEEEEeCC-C---cEEEEEecc----------------------CCccccceEEEecCceEEEE
Q 042435 143 EYFHIRYCIGTGGYDSVYKAELPD-G---KVVALKKLH----------------------HSETEDSAFVVYSPQCMFFI 196 (412)
Q Consensus 143 ~~f~~~~~lG~G~~g~Vy~~~~~~-~---~~vAvK~l~----------------------~~~~~~~~~~~~~~~~~~lv 196 (412)
++|++.+.||+|+||.||+|.... + ..||+|.++ |+++......+..++..++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 357888999999999999998743 3 369999753 55556666667778889999
Q ss_pred EEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCC
Q 042435 197 YEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDV 276 (412)
Q Consensus 197 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~ 276 (412)
|||+++|+|.+++..... .+++.+++.++.|++.||+|||+. +++||||||+||+++.++.++++|||+++....
T Consensus 84 ~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 158 (269)
T cd05065 84 TEFMENGALDSFLRQNDG--QFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 158 (269)
T ss_pred EecCCCCcHHHHHhhCCC--CCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCcccccccc
Confidence 999999999998875432 489999999999999999999998 999999999999999999999999999876543
Q ss_pred CCCCc--c-ccc--ccccccccccccCcccCcccccHHHHHHHHHHHh-CCCCcccccccccCCCCcchhhHHhhhccCC
Q 042435 277 DSSNR--T-LQA--GTYGYIALELVYTMVVTEKCVIYSFGVVALEVLM-GTHPGELLLSLSSSSGPKIMLIDILYQRLSP 350 (412)
Q Consensus 277 ~~~~~--~-~~~--gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 350 (412)
..... . ... .+..|+|||.+.+..++.++||||||+++||+++ |..||.... . ......+......
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~-------~-~~~~~~i~~~~~~ 230 (269)
T cd05065 159 DTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS-------N-QDVINAIEQDYRL 230 (269)
T ss_pred CccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCC-------H-HHHHHHHHcCCcC
Confidence 32211 1 111 2457999999998899999999999999999887 999986321 1 1112222221111
Q ss_pred ccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhcC
Q 042435 351 PINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELEGK 391 (412)
Q Consensus 351 ~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 391 (412)
+.+. .....+.+++.+||+.+|++||++.+++..|+++
T Consensus 231 ~~~~---~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 231 PPPM---DCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred CCcc---cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 1111 1223478899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=302.37 Aligned_cols=242 Identities=18% Similarity=0.206 Sum_probs=171.1
Q ss_pred hhcCcccceeeeecCceEEEEEEe-CCCcEEEEEec-----------------cCCccccceEEEec--------CceEE
Q 042435 141 ATEYFHIRYCIGTGGYDSVYKAEL-PDGKVVALKKL-----------------HHSETEDSAFVVYS--------PQCMF 194 (412)
Q Consensus 141 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l-----------------~~~~~~~~~~~~~~--------~~~~~ 194 (412)
..++|++.+.||+|+||.||+|.. .+++.||||++ +|+++......+.. ....+
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~ 143 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLN 143 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCcchHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEE
Confidence 346799999999999999999977 46899999965 46666665443221 12467
Q ss_pred EEEEeccCCceeeeeccC-cccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCC-cEEEeecCCcc
Q 042435 195 FIYEYMERGSLFCVLRDD-DEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNL-EAFVADFGTVR 272 (412)
Q Consensus 195 lv~ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~-~~kl~DfGla~ 272 (412)
+||||+++ +|.+++... .....+++.....++.|++.||+|||+. +|+||||||+|||++.++ .+||+|||+++
T Consensus 144 lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~DFGla~ 219 (440)
T PTZ00036 144 VVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCDFGSAK 219 (440)
T ss_pred EEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeeeccccch
Confidence 99999975 676655432 1223588999999999999999999998 999999999999998654 79999999998
Q ss_pred ccCCCCCCcccccccccccccccccC-cccCcccccHHHHHHHHHHHhCCCCccccccccc-------CCCCcchhhHHh
Q 042435 273 LLDVDSSNRTLQAGTYGYIALELVYT-MVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSS-------SSGPKIMLIDIL 344 (412)
Q Consensus 273 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~-------~~~~~~~~~~~~ 344 (412)
....... .....||+.|+|||++.+ ..++.++|||||||++|||+||..||........ ...+........
T Consensus 220 ~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~ 298 (440)
T PTZ00036 220 NLLAGQR-SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEM 298 (440)
T ss_pred hccCCCC-cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHh
Confidence 6643322 223468999999998865 4689999999999999999999999863211000 000000000000
Q ss_pred hh---c--cCCccchhhH-----HHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 345 YQ---R--LSPPINQKII-----QDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 345 ~~---~--~~~~~~~~~~-----~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
.+ . .+........ .....+.+++.+||..||.+|||+.|++++
T Consensus 299 ~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h 351 (440)
T PTZ00036 299 NPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD 351 (440)
T ss_pred chhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence 00 0 0000000000 012347899999999999999999999865
|
|
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=281.93 Aligned_cols=231 Identities=22% Similarity=0.272 Sum_probs=176.3
Q ss_pred cCcccceeeeecCceEEEEEEe-CCCcEEEEEec----------------------cCCccccceEEEecCceEEEEEEe
Q 042435 143 EYFHIRYCIGTGGYDSVYKAEL-PDGKVVALKKL----------------------HHSETEDSAFVVYSPQCMFFIYEY 199 (412)
Q Consensus 143 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l----------------------~~~~~~~~~~~~~~~~~~~lv~ey 199 (412)
++|++.+.||+|+||.||+|.. .+++.||+|.+ +|+++......+...+..++||||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 3678889999999999999975 57899999964 345555556667778889999999
Q ss_pred ccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCCC
Q 042435 200 MERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSS 279 (412)
Q Consensus 200 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 279 (412)
+++++|..+. .+++.....++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~-- 148 (279)
T cd06619 81 MDGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS-- 148 (279)
T ss_pred CCCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceecccc--
Confidence 9999986442 367888899999999999999998 9999999999999999999999999999765332
Q ss_pred CcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccchhhHHH
Q 042435 280 NRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKIIQD 359 (412)
Q Consensus 280 ~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 359 (412)
......|+..|+|||++.+..++.++||||||+++|||++|+.||............. ...........+.... ...
T Consensus 149 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~--~~~ 225 (279)
T cd06619 149 IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPL-QLLQCIVDEDPPVLPV--GQF 225 (279)
T ss_pred cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchH-HHHHHHhccCCCCCCC--CcC
Confidence 2233578999999999998889999999999999999999999986422111111010 1111111111111101 011
Q ss_pred HHHHHHHHHhcCcCCCCCCCCHHHHHHHH
Q 042435 360 IILVSTIALACLRSKPKSRPTMQRISQEL 388 (412)
Q Consensus 360 ~~~~~~l~~~Cl~~dP~~RPs~~evl~~L 388 (412)
...+.+++.+||+.||++||+++|++++-
T Consensus 226 ~~~~~~li~~~l~~~P~~Rp~~~eil~~~ 254 (279)
T cd06619 226 SEKFVHFITQCMRKQPKERPAPENLMDHP 254 (279)
T ss_pred CHHHHHHHHHHhhCChhhCCCHHHHhcCc
Confidence 22478899999999999999999998763
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=283.91 Aligned_cols=226 Identities=27% Similarity=0.379 Sum_probs=177.8
Q ss_pred CcccceeeeecCceEEEEEEe-CCCcEEEEEec----------------------cCCccccceEEEecCceEEEEEEec
Q 042435 144 YFHIRYCIGTGGYDSVYKAEL-PDGKVVALKKL----------------------HHSETEDSAFVVYSPQCMFFIYEYM 200 (412)
Q Consensus 144 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l----------------------~~~~~~~~~~~~~~~~~~~lv~ey~ 200 (412)
.|+..+.||+|+||.||+|.. .+++.||+|.+ +|+++......+..++..++||||+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence 356667899999999999976 46889999965 3455555555577788899999999
Q ss_pred cCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCCCC
Q 042435 201 ERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSN 280 (412)
Q Consensus 201 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 280 (412)
++++|.+++... .+++..+..++.|++.|+.|||+. +++|+||+|+||++++++.++++|||+++........
T Consensus 85 ~~~~L~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~ 157 (277)
T cd06642 85 GGGSALDLLKPG----PLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK 157 (277)
T ss_pred CCCcHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccccccCcchh
Confidence 999999888643 488999999999999999999988 9999999999999999999999999999866543333
Q ss_pred cccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccchhhHHHH
Q 042435 281 RTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKIIQDI 360 (412)
Q Consensus 281 ~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 360 (412)
.....++..|+|||++.+..++.++||||||+++|||+||+.|+.... +.. ..........+.... ...
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~-------~~~-~~~~~~~~~~~~~~~---~~~ 226 (277)
T cd06642 158 RNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLH-------PMR-VLFLIPKNSPPTLEG---QYS 226 (277)
T ss_pred hhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccc-------hhh-HHhhhhcCCCCCCCc---ccC
Confidence 334467889999999998889999999999999999999999986321 111 111111111111111 122
Q ss_pred HHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 361 ILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 361 ~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
..+.+++.+||+.+|++||++.|++++
T Consensus 227 ~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 227 KPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred HHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 347899999999999999999999985
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-36 Score=277.83 Aligned_cols=232 Identities=23% Similarity=0.399 Sum_probs=179.8
Q ss_pred cCcccceeeeecCceEEEEEEeCCCcEEEEEecc--------------------CCccccceEEEecCceEEEEEEeccC
Q 042435 143 EYFHIRYCIGTGGYDSVYKAELPDGKVVALKKLH--------------------HSETEDSAFVVYSPQCMFFIYEYMER 202 (412)
Q Consensus 143 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~l~--------------------~~~~~~~~~~~~~~~~~~lv~ey~~~ 202 (412)
++|++.+.||+|+||.||++...++..+|+|.++ |+++......+.. ...+++|||+++
T Consensus 6 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~~~ 84 (260)
T cd05073 6 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMAK 84 (260)
T ss_pred cceeEEeEecCccceEEEEEEecCCccEEEEecCCChhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeCCC
Confidence 5688999999999999999998788889999664 3444444444444 678999999999
Q ss_pred CceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCCC-Cc
Q 042435 203 GSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSS-NR 281 (412)
Q Consensus 203 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~-~~ 281 (412)
|+|.+++..... ..+++.+++.++.|++.||+|||+. +++|+||||+||+++.++.+||+|||.+........ ..
T Consensus 85 ~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~ 160 (260)
T cd05073 85 GSLLDFLKSDEG-SKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAR 160 (260)
T ss_pred CcHHHHHHhCCc-cccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceeeccCCCcccc
Confidence 999999876432 3588999999999999999999988 999999999999999999999999999876543221 12
Q ss_pred ccccccccccccccccCcccCcccccHHHHHHHHHHHh-CCCCcccccccccCCCCcchhhHHhhhccCCccchhhHHHH
Q 042435 282 TLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLM-GTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKIIQDI 360 (412)
Q Consensus 282 ~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 360 (412)
....++..|+|||++....++.++|+|||||++||++| |+.||.... .......+......+... ...
T Consensus 161 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~--------~~~~~~~~~~~~~~~~~~---~~~ 229 (260)
T cd05073 161 EGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMS--------NPEVIRALERGYRMPRPE---NCP 229 (260)
T ss_pred cCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCC--------HHHHHHHHhCCCCCCCcc---cCC
Confidence 22345678999999988889999999999999999999 899986321 111122222222111111 122
Q ss_pred HHHHHHHHhcCcCCCCCCCCHHHHHHHHhc
Q 042435 361 ILVSTIALACLRSKPKSRPTMQRISQELEG 390 (412)
Q Consensus 361 ~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~ 390 (412)
..+.+++.+||+.+|++||++.++.+.|+.
T Consensus 230 ~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 230 EELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred HHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 347899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=283.86 Aligned_cols=244 Identities=23% Similarity=0.285 Sum_probs=183.2
Q ss_pred HHHhhcCcccceeeeecCceEEEEEEe-CCCcEEEEEec-----------------------cCCccccceEEEec----
Q 042435 138 LIDATEYFHIRYCIGTGGYDSVYKAEL-PDGKVVALKKL-----------------------HHSETEDSAFVVYS---- 189 (412)
Q Consensus 138 l~~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l-----------------------~~~~~~~~~~~~~~---- 189 (412)
..+....|...+.||+|+||.|+.+.. .+|+.||||++ +|+|+.....+...
T Consensus 17 ~~~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~ 96 (359)
T KOG0660|consen 17 LFEIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRD 96 (359)
T ss_pred EEeccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccc
Confidence 334455666678999999999999965 57999999965 57777776665433
Q ss_pred -CceEEEEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeec
Q 042435 190 -PQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADF 268 (412)
Q Consensus 190 -~~~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Df 268 (412)
-+.+|+|+|+| ..+|.+.++... .++......+++|+++||.|+|+. +|+||||||+|++++.+...||+||
T Consensus 97 ~f~DvYiV~elM-etDL~~iik~~~---~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DF 169 (359)
T KOG0660|consen 97 KFNDVYLVFELM-ETDLHQIIKSQQ---DLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDF 169 (359)
T ss_pred ccceeEEehhHH-hhHHHHHHHcCc---cccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEeccc
Confidence 46789999999 459999998764 488889999999999999999998 9999999999999999999999999
Q ss_pred CCccccCCC--CCCccccccccccccccccc-CcccCcccccHHHHHHHHHHHhCCCCccccccccc--------CCCCc
Q 042435 269 GTVRLLDVD--SSNRTLQAGTYGYIALELVY-TMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSS--------SSGPK 337 (412)
Q Consensus 269 Gla~~~~~~--~~~~~~~~gt~~y~aPE~~~-~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~--------~~~~~ 337 (412)
|+|+..... ....+..+.|.+|.|||.+. ...||.+.||||.|||+.||++|+.-|.....+.+ ...++
T Consensus 170 GLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~ 249 (359)
T KOG0660|consen 170 GLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSE 249 (359)
T ss_pred cceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCH
Confidence 999987543 22335567899999999875 56799999999999999999999987753221100 11111
Q ss_pred chh--------hHHhhhccCC---ccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHH
Q 042435 338 IML--------IDILYQRLSP---PINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQEL 388 (412)
Q Consensus 338 ~~~--------~~~~~~~~~~---~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L 388 (412)
..+ ...+...... +.............+|+.+|+..||.+|+|++|.+++-
T Consensus 250 e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hP 311 (359)
T KOG0660|consen 250 EDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHP 311 (359)
T ss_pred HHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcCh
Confidence 111 1111111111 11111112234588999999999999999999998763
|
|
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=285.42 Aligned_cols=229 Identities=24% Similarity=0.337 Sum_probs=181.1
Q ss_pred cCcccceeeeecCceEEEEEEe-CCCcEEEEEec---------------------cCCccccceEEEecCceEEEEEEec
Q 042435 143 EYFHIRYCIGTGGYDSVYKAEL-PDGKVVALKKL---------------------HHSETEDSAFVVYSPQCMFFIYEYM 200 (412)
Q Consensus 143 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l---------------------~~~~~~~~~~~~~~~~~~~lv~ey~ 200 (412)
.+|+..+.||.|+||.||+|.. .+++.||+|.+ +|+++......+...+..++|+||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 4688999999999999999975 57899999965 4556666666677788999999999
Q ss_pred cCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCCCC
Q 042435 201 ERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSN 280 (412)
Q Consensus 201 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 280 (412)
++++|..++... .+++.++..++.|++.||+|||+. +++||||||+||+++.++.++|+|||++.........
T Consensus 99 ~~~~L~~~~~~~----~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~ 171 (296)
T cd06655 99 AGGSLTDVVTET----CMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK 171 (296)
T ss_pred CCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhccccccc
Confidence 999999888643 489999999999999999999998 9999999999999999999999999998866544333
Q ss_pred cccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccchhhHHHH
Q 042435 281 RTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKIIQDI 360 (412)
Q Consensus 281 ~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 360 (412)
.....++..|+|||.+.+..++.++|||||||++||+++|+.||.... +........... .+.. .......
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~-------~~~~~~~~~~~~-~~~~-~~~~~~~ 242 (296)
T cd06655 172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNEN-------PLRALYLIATNG-TPEL-QNPEKLS 242 (296)
T ss_pred CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-------HHHHHHHHHhcC-Cccc-CCcccCC
Confidence 344568899999999988889999999999999999999999986321 111111111111 1100 0111122
Q ss_pred HHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 361 ILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 361 ~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
..+.+++.+||..||++||++.+++++
T Consensus 243 ~~~~~li~~~l~~dp~~Rpt~~~il~~ 269 (296)
T cd06655 243 PIFRDFLNRCLEMDVEKRGSAKELLQH 269 (296)
T ss_pred HHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 347789999999999999999999865
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=297.25 Aligned_cols=228 Identities=21% Similarity=0.302 Sum_probs=172.9
Q ss_pred cCcccceeeeecCceEEEEEEeC-CCcEEEEEecc------------------------CCccccceEEEecCceEEEEE
Q 042435 143 EYFHIRYCIGTGGYDSVYKAELP-DGKVVALKKLH------------------------HSETEDSAFVVYSPQCMFFIY 197 (412)
Q Consensus 143 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~------------------------~~~~~~~~~~~~~~~~~~lv~ 197 (412)
++|+..+.||+|+||.||++... +++.||+|.++ |+++......+...+..++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46888999999999999999774 68999999763 344444555577788999999
Q ss_pred EeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCC
Q 042435 198 EYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVD 277 (412)
Q Consensus 198 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~ 277 (412)
||+++|+|.+++.... .+++.....++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 81 E~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~ 154 (360)
T cd05627 81 EFLPGGDMMTLLMKKD---TLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKA 154 (360)
T ss_pred eCCCCccHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCcccccc
Confidence 9999999999887543 488999999999999999999998 9999999999999999999999999998754221
Q ss_pred CC-----------------------------------CcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCC
Q 042435 278 SS-----------------------------------NRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTH 322 (412)
Q Consensus 278 ~~-----------------------------------~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~ 322 (412)
.. ......||+.|+|||++.+..++.++|||||||++|||+||+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~ 234 (360)
T cd05627 155 HRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (360)
T ss_pred cccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCC
Confidence 00 0113469999999999999999999999999999999999999
Q ss_pred CcccccccccCCCCcchhhHHhh--hccCCccchhhHHHHHHHHHHHHhcCcCCCCCCCC---HHHHHHH
Q 042435 323 PGELLLSLSSSSGPKIMLIDILY--QRLSPPINQKIIQDIILVSTIALACLRSKPKSRPT---MQRISQE 387 (412)
Q Consensus 323 P~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs---~~evl~~ 387 (412)
||... ........+.. ..+..+.... ....+.+++.+++. ||.+|++ +.|++++
T Consensus 235 Pf~~~-------~~~~~~~~i~~~~~~~~~p~~~~---~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~h 293 (360)
T cd05627 235 PFCSE-------TPQETYRKVMNWKETLVFPPEVP---ISEKAKDLILRFCT-DSENRIGSNGVEEIKSH 293 (360)
T ss_pred CCCCC-------CHHHHHHHHHcCCCceecCCCCC---CCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcC
Confidence 98632 11111122221 1111110001 11235667777664 9999985 6777665
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=284.77 Aligned_cols=230 Identities=20% Similarity=0.267 Sum_probs=174.1
Q ss_pred cccceeeeecCceEEEEEEe-CCCcEEEEEeccC------------------------CccccceEEEecCceEEEEEEe
Q 042435 145 FHIRYCIGTGGYDSVYKAEL-PDGKVVALKKLHH------------------------SETEDSAFVVYSPQCMFFIYEY 199 (412)
Q Consensus 145 f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l~~------------------------~~~~~~~~~~~~~~~~~lv~ey 199 (412)
|+..+.||+|+||.||++.. .+++.||+|.+.. +++......+...+..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 67788999999999999976 4689999997632 2233333345667889999999
Q ss_pred ccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCCC
Q 042435 200 MERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSS 279 (412)
Q Consensus 200 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 279 (412)
+++|+|.+++..... ..+++.++..++.|++.||.|||+. +++||||||+||++++++.++|+|||++.......
T Consensus 82 ~~g~~L~~~l~~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~- 156 (285)
T cd05630 82 MNGGDLKFHIYHMGE-AGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ- 156 (285)
T ss_pred cCCCcHHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc-
Confidence 999999988754322 2488999999999999999999988 99999999999999999999999999987654322
Q ss_pred CcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccchhhHHH
Q 042435 280 NRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKIIQD 359 (412)
Q Consensus 280 ~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 359 (412)
......|+..|+|||++.+..++.++||||||+++|||++|+.||...... ............ ........ .
T Consensus 157 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~----~~~~~~~~~~~~-~~~~~~~~---~ 228 (285)
T cd05630 157 TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKK----IKREEVERLVKE-VQEEYSEK---F 228 (285)
T ss_pred cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCcc----chHHHHHhhhhh-hhhhcCcc---C
Confidence 122346899999999999889999999999999999999999999732100 000011111110 11111111 1
Q ss_pred HHHHHHHHHhcCcCCCCCCCC-----HHHHHHH
Q 042435 360 IILVSTIALACLRSKPKSRPT-----MQRISQE 387 (412)
Q Consensus 360 ~~~~~~l~~~Cl~~dP~~RPs-----~~evl~~ 387 (412)
...+.+++.+||+.||++||| ++|++++
T Consensus 229 ~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h 261 (285)
T cd05630 229 SPDARSLCKMLLCKDPKERLGCQGGGAREVKEH 261 (285)
T ss_pred CHHHHHHHHHHhhcCHHHccCCCCCchHHHHcC
Confidence 223778999999999999999 8888874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=286.74 Aligned_cols=238 Identities=22% Similarity=0.320 Sum_probs=181.8
Q ss_pred hcCcccceeeeecCceEEEEEEeC--------CCcEEEEEecc-----------------------CCccccceEEEecC
Q 042435 142 TEYFHIRYCIGTGGYDSVYKAELP--------DGKVVALKKLH-----------------------HSETEDSAFVVYSP 190 (412)
Q Consensus 142 ~~~f~~~~~lG~G~~g~Vy~~~~~--------~~~~vAvK~l~-----------------------~~~~~~~~~~~~~~ 190 (412)
.++|.+.+.||+|+||.||+|... ....+|+|.++ |+++......+...
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE 90 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence 357888999999999999999642 24578998643 55555555667777
Q ss_pred ceEEEEEEeccCCceeeeeccCcc-------------cccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEe
Q 042435 191 QCMFFIYEYMERGSLFCVLRDDDE-------------AIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILL 257 (412)
Q Consensus 191 ~~~~lv~ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl 257 (412)
...+++|||+++|+|.+++..... ...++|.++..++.|++.||+|||++ +++||||||+||++
T Consensus 91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill 167 (314)
T cd05099 91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARNVLV 167 (314)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeeccccceeEEE
Confidence 889999999999999998865321 12489999999999999999999998 99999999999999
Q ss_pred cCCCcEEEeecCCccccCCCCCC--cccccccccccccccccCcccCcccccHHHHHHHHHHHh-CCCCcccccccccCC
Q 042435 258 NSNLEAFVADFGTVRLLDVDSSN--RTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLM-GTHPGELLLSLSSSS 334 (412)
Q Consensus 258 ~~~~~~kl~DfGla~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~ellt-g~~P~~~~~~~~~~~ 334 (412)
+.++.+||+|||+++........ .....++..|+|||.+.+..++.++||||||+++|||++ |..||...
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~------- 240 (314)
T cd05099 168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGI------- 240 (314)
T ss_pred cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCC-------
Confidence 99999999999999865432211 112234567999999988889999999999999999999 88887622
Q ss_pred CCcchhhHHhhhccCCccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhcCCC
Q 042435 335 GPKIMLIDILYQRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELEGKTP 393 (412)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 393 (412)
......+..........+. .....+.+++.+||+.||++|||+.|+++.|+++..
T Consensus 241 -~~~~~~~~~~~~~~~~~~~---~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~ 295 (314)
T cd05099 241 -PVEELFKLLREGHRMDKPS---NCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLA 295 (314)
T ss_pred -CHHHHHHHHHcCCCCCCCC---CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence 1111122222211111111 112247789999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=278.38 Aligned_cols=232 Identities=26% Similarity=0.356 Sum_probs=182.6
Q ss_pred hcCcccceeeeecCceEEEEEEeCC-CcEEEEEec-------------------cCCccccceEEEecCceEEEEEEecc
Q 042435 142 TEYFHIRYCIGTGGYDSVYKAELPD-GKVVALKKL-------------------HHSETEDSAFVVYSPQCMFFIYEYME 201 (412)
Q Consensus 142 ~~~f~~~~~lG~G~~g~Vy~~~~~~-~~~vAvK~l-------------------~~~~~~~~~~~~~~~~~~~lv~ey~~ 201 (412)
.++|+..+.||+|+||.||+|...+ ++.+|+|.+ +|+++......+......++++||++
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 81 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCG 81 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCC
Confidence 3678999999999999999998864 889999965 45566666666778889999999999
Q ss_pred CCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCCCCc
Q 042435 202 RGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNR 281 (412)
Q Consensus 202 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 281 (412)
+++|.+++.... ..+++.....++.|++.||.|||+. +++|+||+|+||++++++.++|+|||++..........
T Consensus 82 ~~~L~~~l~~~~--~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~~ 156 (256)
T cd06612 82 AGSVSDIMKITN--KTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKR 156 (256)
T ss_pred CCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhcccCcccc
Confidence 999999886533 2589999999999999999999998 99999999999999999999999999998765443333
Q ss_pred ccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccchhhHHHHH
Q 042435 282 TLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKIIQDII 361 (412)
Q Consensus 282 ~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 361 (412)
....++..|+|||++.+..++.++||||||+++|||++|+.||..... ...... ........ .........
T Consensus 157 ~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~-------~~~~~~-~~~~~~~~-~~~~~~~~~ 227 (256)
T cd06612 157 NTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHP-------MRAIFM-IPNKPPPT-LSDPEKWSP 227 (256)
T ss_pred ccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcch-------hhhhhh-hccCCCCC-CCchhhcCH
Confidence 345578899999999888999999999999999999999999873211 010111 11111111 011111223
Q ss_pred HHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 362 LVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 362 ~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
.+.+++.+||+.||++|||+.|++++
T Consensus 228 ~~~~~i~~~l~~~P~~Rps~~~il~~ 253 (256)
T cd06612 228 EFNDFVKKCLVKDPEERPSAIQLLQH 253 (256)
T ss_pred HHHHHHHHHHhcChhhCcCHHHHhcC
Confidence 47889999999999999999999864
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=284.79 Aligned_cols=235 Identities=22% Similarity=0.294 Sum_probs=175.9
Q ss_pred cCcccceeeeecCceEEEEEEeCC---------------CcEEEEEec----------------------cCCccccceE
Q 042435 143 EYFHIRYCIGTGGYDSVYKAELPD---------------GKVVALKKL----------------------HHSETEDSAF 185 (412)
Q Consensus 143 ~~f~~~~~lG~G~~g~Vy~~~~~~---------------~~~vAvK~l----------------------~~~~~~~~~~ 185 (412)
++|++.+.||+|+||.||++...+ ...||+|.+ +|+++.....
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 578899999999999999986532 235899965 3455555556
Q ss_pred EEecCceEEEEEEeccCCceeeeeccCc---------ccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEE
Q 042435 186 VVYSPQCMFFIYEYMERGSLFCVLRDDD---------EAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNIL 256 (412)
Q Consensus 186 ~~~~~~~~~lv~ey~~~gsL~~~l~~~~---------~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NIL 256 (412)
.+...+..++||||+++++|.+++.... ....++|..++.++.|++.||+|||+. +++||||||+||+
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil 161 (295)
T cd05097 85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATRNCL 161 (295)
T ss_pred EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChhhEE
Confidence 6777888999999999999998885432 112478999999999999999999998 9999999999999
Q ss_pred ecCCCcEEEeecCCccccCCCCCC--cccccccccccccccccCcccCcccccHHHHHHHHHHHh--CCCCccccccccc
Q 042435 257 LNSNLEAFVADFGTVRLLDVDSSN--RTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLM--GTHPGELLLSLSS 332 (412)
Q Consensus 257 l~~~~~~kl~DfGla~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~ellt--g~~P~~~~~~~~~ 332 (412)
+++++.+||+|||+++........ .....++..|+|||+..+..++.++|||||||++|||++ |..||....
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~---- 237 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLS---- 237 (295)
T ss_pred EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccC----
Confidence 999999999999999765332211 122345678999999988889999999999999999998 566765221
Q ss_pred CCCCcchhhHH---hhh---ccCCccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhc
Q 042435 333 SSGPKIMLIDI---LYQ---RLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELEG 390 (412)
Q Consensus 333 ~~~~~~~~~~~---~~~---~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~ 390 (412)
........ ... ........ .....+.+++.+||+.||++|||+++|++.|+.
T Consensus 238 ---~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 238 ---DEQVIENTGEFFRNQGRQIYLSQTP---LCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred ---hHHHHHHHHHhhhhccccccCCCCC---CCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 00101110 000 00000001 112348899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=299.10 Aligned_cols=239 Identities=20% Similarity=0.199 Sum_probs=180.1
Q ss_pred cCcccceeeeecCceEEEEEEeC-CCcEEEEEe---------------ccCCccccceEEEecCceEEEEEEeccCCcee
Q 042435 143 EYFHIRYCIGTGGYDSVYKAELP-DGKVVALKK---------------LHHSETEDSAFVVYSPQCMFFIYEYMERGSLF 206 (412)
Q Consensus 143 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~---------------l~~~~~~~~~~~~~~~~~~~lv~ey~~~gsL~ 206 (412)
.+|.+.+.||+|+||.||+|... .++.||||. ++|+++......+...+..++||||+. ++|.
T Consensus 169 ~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~~-~~L~ 247 (461)
T PHA03211 169 LGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWYASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYR-SDLY 247 (461)
T ss_pred CCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEccC-CCHH
Confidence 46999999999999999999775 578999994 578999988888888899999999995 6888
Q ss_pred eeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCCCC--cccc
Q 042435 207 CVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSN--RTLQ 284 (412)
Q Consensus 207 ~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~--~~~~ 284 (412)
+++.... ..++|.+++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++........ ....
T Consensus 248 ~~l~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~ 322 (461)
T PHA03211 248 TYLGARL--RPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGI 322 (461)
T ss_pred HHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceeccccccccccccc
Confidence 8776432 2589999999999999999999998 9999999999999999999999999999865433221 2235
Q ss_pred cccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhcc----------------
Q 042435 285 AGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRL---------------- 348 (412)
Q Consensus 285 ~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~---------------- 348 (412)
.||..|+|||++.+..++.++|||||||++|||++|..|+...............+..++....
T Consensus 323 ~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l~~ 402 (461)
T PHA03211 323 AGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSRLVS 402 (461)
T ss_pred CCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchHHHH
Confidence 6999999999999999999999999999999999987654211000000000001111111000
Q ss_pred ----------CCccc-hhh---HHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 349 ----------SPPIN-QKI---IQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 349 ----------~~~~~-~~~---~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
.+... ..+ ......+.+++.+||+.||++|||+.|++++
T Consensus 403 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 403 QYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred HHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 00000 000 0111247789999999999999999999976
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=306.69 Aligned_cols=238 Identities=22% Similarity=0.278 Sum_probs=185.8
Q ss_pred hcCcccceeeeecCceEEEEEEeCCC-cEEEEEec----------------------cCCccccceEE----Eec---Cc
Q 042435 142 TEYFHIRYCIGTGGYDSVYKAELPDG-KVVALKKL----------------------HHSETEDSAFV----VYS---PQ 191 (412)
Q Consensus 142 ~~~f~~~~~lG~G~~g~Vy~~~~~~~-~~vAvK~l----------------------~~~~~~~~~~~----~~~---~~ 191 (412)
..+.++.++|.+|||+.||.|....+ ..+|+|++ .|+|++..... ... .-
T Consensus 36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~ 115 (738)
T KOG1989|consen 36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVW 115 (738)
T ss_pred CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCcee
Confidence 34567889999999999999988665 99999986 26666655441 111 24
Q ss_pred eEEEEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCc
Q 042435 192 CMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTV 271 (412)
Q Consensus 192 ~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla 271 (412)
+++|.||||++|+|-+++..+... .|+..++++|+.|+++|+++||.. .++|||||||-+||||+.+++.||||||.|
T Consensus 116 EvllLmEyC~gg~Lvd~mn~Rlq~-~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGSa 193 (738)
T KOG1989|consen 116 EVLLLMEYCKGGSLVDFMNTRLQT-RLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGSA 193 (738)
T ss_pred EEEeehhhccCCcHHHHHHHHHhc-cCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCccccc
Confidence 678999999999999999865433 399999999999999999999986 788999999999999999999999999998
Q ss_pred cccCCCCCCc---------cccccccccccccccc---CcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcch
Q 042435 272 RLLDVDSSNR---------TLQAGTYGYIALELVY---TMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIM 339 (412)
Q Consensus 272 ~~~~~~~~~~---------~~~~gt~~y~aPE~~~---~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~ 339 (412)
.......... .....|+.|+|||++. +..+++|+|||+|||+||-|+....||+..-
T Consensus 194 tt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg----------- 262 (738)
T KOG1989|consen 194 TTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESG----------- 262 (738)
T ss_pred ccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCc-----------
Confidence 6432222110 1234689999999874 6779999999999999999999999998321
Q ss_pred hhHHhhhccCCccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhcCCCCC
Q 042435 340 LIDILYQRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELEGKTPMK 395 (412)
Q Consensus 340 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~~ 395 (412)
...++......|..+ .....+.+||..||+.||.+||++-+|+..+.++....
T Consensus 263 ~laIlng~Y~~P~~p---~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~ 315 (738)
T KOG1989|consen 263 KLAILNGNYSFPPFP---NYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKP 315 (738)
T ss_pred ceeEEeccccCCCCc---cHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCC
Confidence 122333333333222 23344889999999999999999999999998876544
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=294.19 Aligned_cols=237 Identities=23% Similarity=0.262 Sum_probs=172.6
Q ss_pred CcccceeeeecCceEEEEEEe-CCCcEEEEEecc-----------------------CCccccceEEEecCc-----eEE
Q 042435 144 YFHIRYCIGTGGYDSVYKAEL-PDGKVVALKKLH-----------------------HSETEDSAFVVYSPQ-----CMF 194 (412)
Q Consensus 144 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l~-----------------------~~~~~~~~~~~~~~~-----~~~ 194 (412)
+|++.+.||+|+||.||++.. .+|+.||+|++. |+++......+...+ ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 478889999999999999976 579999999753 445554444555544 789
Q ss_pred EEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCcccc
Q 042435 195 FIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLL 274 (412)
Q Consensus 195 lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~ 274 (412)
+|+||+. ++|.+++.... .+++..+..++.|++.||+|||+. +++||||||+|||++.++.+||+|||+++..
T Consensus 81 lv~e~~~-~~l~~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~ 153 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSPQ---PLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVE 153 (372)
T ss_pred EEeeccc-cCHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccceeec
Confidence 9999996 57777665433 589999999999999999999998 9999999999999999999999999999865
Q ss_pred CCCCC-CcccccccccccccccccCc-ccCcccccHHHHHHHHHHHhCCCCccccccccc--------CCCCcch-----
Q 042435 275 DVDSS-NRTLQAGTYGYIALELVYTM-VVTEKCVIYSFGVVALEVLMGTHPGELLLSLSS--------SSGPKIM----- 339 (412)
Q Consensus 275 ~~~~~-~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~--------~~~~~~~----- 339 (412)
..... ......++..|+|||.+.+. .++.++|||||||++|||++|+.||........ .......
T Consensus 154 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 233 (372)
T cd07853 154 EPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSAC 233 (372)
T ss_pred ccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhh
Confidence 43322 22334678999999998764 478999999999999999999999963211000 0000000
Q ss_pred --hhHHhhh-ccCCccchh----hHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 340 --LIDILYQ-RLSPPINQK----IIQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 340 --~~~~~~~-~~~~~~~~~----~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
....+.. ...++.... .......+.+++.+||+.||++|||+.|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 234 EGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 0000000 011100000 00112347889999999999999999999976
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=283.28 Aligned_cols=235 Identities=23% Similarity=0.353 Sum_probs=179.9
Q ss_pred hcCcccceeeeecCceEEEEEEeC------CCcEEEEEecc----------------------CCccccceEEEecCceE
Q 042435 142 TEYFHIRYCIGTGGYDSVYKAELP------DGKVVALKKLH----------------------HSETEDSAFVVYSPQCM 193 (412)
Q Consensus 142 ~~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vAvK~l~----------------------~~~~~~~~~~~~~~~~~ 193 (412)
.++|++.+.||+|+||.||+|... ++..||+|.++ |+++......+..++..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 467899999999999999999763 46789999753 45555555667777889
Q ss_pred EEEEEeccCCceeeeeccCc-------------------ccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCC
Q 042435 194 FFIYEYMERGSLFCVLRDDD-------------------EAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNN 254 (412)
Q Consensus 194 ~lv~ey~~~gsL~~~l~~~~-------------------~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~N 254 (412)
++++||+++|+|.+++.... ....+++.+++.++.|++.||+|||+. +++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CeecccccHhh
Confidence 99999999999998886421 112478899999999999999999998 99999999999
Q ss_pred EEecCCCcEEEeecCCccccCCCCC--CcccccccccccccccccCcccCcccccHHHHHHHHHHHh-CCCCcccccccc
Q 042435 255 ILLNSNLEAFVADFGTVRLLDVDSS--NRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLM-GTHPGELLLSLS 331 (412)
Q Consensus 255 ILl~~~~~~kl~DfGla~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~ellt-g~~P~~~~~~~~ 331 (412)
|++++++.++|+|||+++....... .......+..|+|||...+..++.++|||||||++|||++ |..||...
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~---- 236 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGM---- 236 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCC----
Confidence 9999999999999999875433221 1122234677999999988899999999999999999998 88887522
Q ss_pred cCCCCcchhhHHhhhccCCccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhc
Q 042435 332 SSSGPKIMLIDILYQRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELEG 390 (412)
Q Consensus 332 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~ 390 (412)
........+...... +.+. .....+.+++.+||+.||++|||+.|+++.|++
T Consensus 237 ---~~~~~~~~~~~~~~~-~~~~---~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 237 ---AHEEVIYYVRDGNVL-SCPD---NCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred ---CHHHHHHHHhcCCCC-CCCC---CCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 111111111111111 1111 122348899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=277.02 Aligned_cols=231 Identities=21% Similarity=0.325 Sum_probs=178.1
Q ss_pred cCcccceeeeecCceEEEEEEeCCCcEEEEEecc--------------------CCccccceEEEecCceEEEEEEeccC
Q 042435 143 EYFHIRYCIGTGGYDSVYKAELPDGKVVALKKLH--------------------HSETEDSAFVVYSPQCMFFIYEYMER 202 (412)
Q Consensus 143 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~l~--------------------~~~~~~~~~~~~~~~~~~lv~ey~~~ 202 (412)
.+|++.+.||+|+||.||+|.+.++..+|+|.++ |+++......+......++||||+++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~ 83 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEH 83 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCC
Confidence 4678889999999999999988778899999764 33444444556667788999999999
Q ss_pred CceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCCCC-c
Q 042435 203 GSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSN-R 281 (412)
Q Consensus 203 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~-~ 281 (412)
++|.+++..... .+++..+..++.+++.|++|||+. +++||||||+||+++.++.++|+|||+++........ .
T Consensus 84 ~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~ 158 (256)
T cd05112 84 GCLSDYLRAQRG--KFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSS 158 (256)
T ss_pred CcHHHHHHhCcc--CCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeecccCccccc
Confidence 999988865432 478999999999999999999998 9999999999999999999999999998755332111 1
Q ss_pred ccccccccccccccccCcccCcccccHHHHHHHHHHHh-CCCCcccccccccCCCCcchhhHHhhhccCCccchhhHHHH
Q 042435 282 TLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLM-GTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKIIQDI 360 (412)
Q Consensus 282 ~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 360 (412)
....++..|+|||.+.+..++.++||||||+++|||++ |+.||.... .....+.+........+.. ..
T Consensus 159 ~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~--------~~~~~~~~~~~~~~~~~~~---~~ 227 (256)
T cd05112 159 TGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRS--------NSEVVETINAGFRLYKPRL---AS 227 (256)
T ss_pred CCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCC--------HHHHHHHHhCCCCCCCCCC---CC
Confidence 22235678999999988889999999999999999998 999986211 1111111111111111111 12
Q ss_pred HHHHHHHHhcCcCCCCCCCCHHHHHHHHh
Q 042435 361 ILVSTIALACLRSKPKSRPTMQRISQELE 389 (412)
Q Consensus 361 ~~~~~l~~~Cl~~dP~~RPs~~evl~~L~ 389 (412)
..+.+++.+||+.+|++|||+.|+++.|.
T Consensus 228 ~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 228 QSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred HHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 34889999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=286.08 Aligned_cols=230 Identities=24% Similarity=0.323 Sum_probs=181.1
Q ss_pred hcCcccceeeeecCceEEEEEEe-CCCcEEEEEec---------------------cCCccccceEEEecCceEEEEEEe
Q 042435 142 TEYFHIRYCIGTGGYDSVYKAEL-PDGKVVALKKL---------------------HHSETEDSAFVVYSPQCMFFIYEY 199 (412)
Q Consensus 142 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l---------------------~~~~~~~~~~~~~~~~~~~lv~ey 199 (412)
..+|++.+.||+|+||.||+|.. .+++.||+|.+ +|+++......+...+..++||||
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 97 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 97 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence 36788999999999999999976 57999999965 355555566667778899999999
Q ss_pred ccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCCC
Q 042435 200 MERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSS 279 (412)
Q Consensus 200 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 279 (412)
+++++|.+++... .+++.++..++.|++.||.|||+. +++||||||+||+++.++.++|+|||++........
T Consensus 98 ~~~~~L~~~~~~~----~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~ 170 (297)
T cd06656 98 LAGGSLTDVVTET----CMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (297)
T ss_pred cCCCCHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceEccCCcc
Confidence 9999999988653 378999999999999999999998 999999999999999999999999999886554433
Q ss_pred CcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccchhhHHH
Q 042435 280 NRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKIIQD 359 (412)
Q Consensus 280 ~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 359 (412)
......+++.|+|||.+.+..++.++|+|||||++|++++|+.||...... .......... .+. .......
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~-------~~~~~~~~~~-~~~-~~~~~~~ 241 (297)
T cd06656 171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPL-------RALYLIATNG-TPE-LQNPERL 241 (297)
T ss_pred CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcc-------hheeeeccCC-CCC-CCCcccc
Confidence 334456889999999999888999999999999999999999998632110 0000000000 000 0011111
Q ss_pred HHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 360 IILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 360 ~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
...+.+++.+||+.||++||++++++++
T Consensus 242 ~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (297)
T cd06656 242 SAVFRDFLNRCLEMDVDRRGSAKELLQH 269 (297)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 2337789999999999999999999983
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-36 Score=276.47 Aligned_cols=229 Identities=22% Similarity=0.349 Sum_probs=176.2
Q ss_pred CcccceeeeecCceEEEEEEeC-CCcEEEEEecc-----------------------CCccccceEEEe-cCceEEEEEE
Q 042435 144 YFHIRYCIGTGGYDSVYKAELP-DGKVVALKKLH-----------------------HSETEDSAFVVY-SPQCMFFIYE 198 (412)
Q Consensus 144 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~-----------------------~~~~~~~~~~~~-~~~~~~lv~e 198 (412)
+|++.+.||+|++|.||++... +++.||+|++. |+++......+. .....+++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4888999999999999999764 57899999763 333333322233 2345789999
Q ss_pred eccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCC
Q 042435 199 YMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDS 278 (412)
Q Consensus 199 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~ 278 (412)
|+++++|.+++..... ..+++.++..++.+++.|++|||+. +++||||||+||+++.++.++|+|||+++......
T Consensus 81 ~~~~~~l~~~l~~~~~-~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~ 156 (257)
T cd08223 81 FCEGGDLYHKLKEQKG-KLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC 156 (257)
T ss_pred ccCCCcHHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence 9999999998875422 2489999999999999999999998 99999999999999999999999999998764433
Q ss_pred CCcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccchhhHH
Q 042435 279 SNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKIIQ 358 (412)
Q Consensus 279 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 358 (412)
.......+++.|+|||+..+..++.++||||||++++|+++|+.||... .............. ++.+. .
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~-------~~~~~~~~~~~~~~-~~~~~---~ 225 (257)
T cd08223 157 DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAK-------DMNSLVYRIIEGKL-PPMPK---D 225 (257)
T ss_pred CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCC-------CHHHHHHHHHhcCC-CCCcc---c
Confidence 3334456889999999999989999999999999999999999998621 11111111111111 11111 1
Q ss_pred HHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 359 DIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 359 ~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
....+.+++.+||+.||++|||+.+++++
T Consensus 226 ~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 226 YSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred cCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 22348899999999999999999999865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=275.97 Aligned_cols=227 Identities=26% Similarity=0.405 Sum_probs=177.3
Q ss_pred eeeeecCceEEEEEEeCC----CcEEEEEecc----------------------CCccccceEEEecCceEEEEEEeccC
Q 042435 149 YCIGTGGYDSVYKAELPD----GKVVALKKLH----------------------HSETEDSAFVVYSPQCMFFIYEYMER 202 (412)
Q Consensus 149 ~~lG~G~~g~Vy~~~~~~----~~~vAvK~l~----------------------~~~~~~~~~~~~~~~~~~lv~ey~~~ 202 (412)
+.||+|+||.||+|.... +..||+|.++ |+++......+......++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 368999999999998754 7889999764 34444444556677889999999999
Q ss_pred CceeeeeccCcc------cccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCC
Q 042435 203 GSLFCVLRDDDE------AIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDV 276 (412)
Q Consensus 203 gsL~~~l~~~~~------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~ 276 (412)
++|.+++..... ...+++..+..++.|++.||+|||++ +++||||||+||++++++.++|+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEccccccccccc
Confidence 999999877521 13689999999999999999999998 999999999999999999999999999987654
Q ss_pred CC--CCcccccccccccccccccCcccCcccccHHHHHHHHHHHh-CCCCcccccccccCCCCcchhhHHhhhccCCccc
Q 042435 277 DS--SNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLM-GTHPGELLLSLSSSSGPKIMLIDILYQRLSPPIN 353 (412)
Q Consensus 277 ~~--~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 353 (412)
.. .......++..|+|||.+....++.++||||+|+++|||++ |..||... ......+.+........+
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~--------~~~~~~~~~~~~~~~~~~ 229 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGL--------SNEEVLEYLRKGYRLPKP 229 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCC--------CHHHHHHHHHcCCCCCCC
Confidence 32 12233457889999999988889999999999999999999 69998732 111112222211111111
Q ss_pred hhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHh
Q 042435 354 QKIIQDIILVSTIALACLRSKPKSRPTMQRISQELE 389 (412)
Q Consensus 354 ~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~ 389 (412)
.. ....+.+++.+||..||++|||+.|++++|+
T Consensus 230 ~~---~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 230 EY---CPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred cc---CChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 11 1234889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=292.17 Aligned_cols=238 Identities=22% Similarity=0.215 Sum_probs=171.9
Q ss_pred hhcCcccceeeeecCceEEEEEEe-CCCcEEEEEecc-----------------------CCccccceEEEecC------
Q 042435 141 ATEYFHIRYCIGTGGYDSVYKAEL-PDGKVVALKKLH-----------------------HSETEDSAFVVYSP------ 190 (412)
Q Consensus 141 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l~-----------------------~~~~~~~~~~~~~~------ 190 (412)
..++|++.+.||+|+||.||++.. .+|+.||+|.+. |+++.....++...
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 457899999999999999999976 468999999763 34444444433322
Q ss_pred ceEEEEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCC
Q 042435 191 QCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGT 270 (412)
Q Consensus 191 ~~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGl 270 (412)
...++||||+++ +|.+.+.. .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Dfg~ 169 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIHM-----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 169 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHhc-----cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecCCC
Confidence 357999999975 56555432 378888999999999999999998 999999999999999999999999999
Q ss_pred ccccCCCCCCcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccc-------cCCCCcch----
Q 042435 271 VRLLDVDSSNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLS-------SSSGPKIM---- 339 (412)
Q Consensus 271 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~-------~~~~~~~~---- 339 (412)
++...... ......||+.|+|||++.+..++.++|||||||++|||+||+.||....... ....+...
T Consensus 170 a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (359)
T cd07876 170 ARTACTNF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNR 248 (359)
T ss_pred ccccccCc-cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHH
Confidence 97543322 2233468999999999999999999999999999999999999996321100 00000000
Q ss_pred ----hhHHhhhccCCcc---------------chhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHH
Q 042435 340 ----LIDILYQRLSPPI---------------NQKIIQDIILVSTIALACLRSKPKSRPTMQRISQEL 388 (412)
Q Consensus 340 ----~~~~~~~~~~~~~---------------~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L 388 (412)
...........+. ..........+.+++.+||+.||++|||+.|++++-
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp 316 (359)
T cd07876 249 LQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHP 316 (359)
T ss_pred HHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCc
Confidence 0000000000000 000000123478999999999999999999999863
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=283.52 Aligned_cols=240 Identities=18% Similarity=0.202 Sum_probs=175.0
Q ss_pred CcccceeeeecCceEEEEEEeC-CCcEEEEEecc-----------------------CCccccceEEEecCceEEEEEEe
Q 042435 144 YFHIRYCIGTGGYDSVYKAELP-DGKVVALKKLH-----------------------HSETEDSAFVVYSPQCMFFIYEY 199 (412)
Q Consensus 144 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~-----------------------~~~~~~~~~~~~~~~~~~lv~ey 199 (412)
+|++.+.||+|++|.||+|... +++.||+|+++ |+++......+..++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4788899999999999999774 68999999753 44555555567778899999999
Q ss_pred ccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCCC
Q 042435 200 MERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSS 279 (412)
Q Consensus 200 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 279 (412)
++ ++|.+++........+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||+++.......
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR 156 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeecCCCcc
Confidence 97 68887776543334689999999999999999999998 999999999999999999999999999876543333
Q ss_pred CcccccccccccccccccCc-ccCcccccHHHHHHHHHHHhCCCCcccccccc----------cC---CCCcchhhHHhh
Q 042435 280 NRTLQAGTYGYIALELVYTM-VVTEKCVIYSFGVVALEVLMGTHPGELLLSLS----------SS---SGPKIMLIDILY 345 (412)
Q Consensus 280 ~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~----------~~---~~~~~~~~~~~~ 345 (412)
......+++.|+|||.+.+. .++.++||||||+++|||+||+.||....... .. ..+.........
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (285)
T cd07861 157 VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYK 236 (285)
T ss_pred cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHH
Confidence 33344678899999988654 57889999999999999999999986321100 00 000000000000
Q ss_pred hccCC----ccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 346 QRLSP----PINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 346 ~~~~~----~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
..... ............+.+++.+||+.||++|||+.+++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 237 NTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred hhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 00000 0000000012346789999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=284.27 Aligned_cols=236 Identities=24% Similarity=0.301 Sum_probs=178.3
Q ss_pred hcCcccceeeeecCceEEEEEEeCC-----------------CcEEEEEecc----------------------CCcccc
Q 042435 142 TEYFHIRYCIGTGGYDSVYKAELPD-----------------GKVVALKKLH----------------------HSETED 182 (412)
Q Consensus 142 ~~~f~~~~~lG~G~~g~Vy~~~~~~-----------------~~~vAvK~l~----------------------~~~~~~ 182 (412)
.++|++.+.||+|+||.||+|...+ +..||+|.+. |+++..
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 3578899999999999999997642 3468999753 445555
Q ss_pred ceEEEecCceEEEEEEeccCCceeeeeccCcc--------cccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCC
Q 042435 183 SAFVVYSPQCMFFIYEYMERGSLFCVLRDDDE--------AIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNN 254 (412)
Q Consensus 183 ~~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~--------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~N 254 (412)
....+..++..++++||+++++|.+++..... ...+++..++.++.|++.||+|||++ +++||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccccchhc
Confidence 55556777889999999999999998865431 12589999999999999999999998 99999999999
Q ss_pred EEecCCCcEEEeecCCccccCCCCC--CcccccccccccccccccCcccCcccccHHHHHHHHHHHh--CCCCccccccc
Q 042435 255 ILLNSNLEAFVADFGTVRLLDVDSS--NRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLM--GTHPGELLLSL 330 (412)
Q Consensus 255 ILl~~~~~~kl~DfGla~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~ellt--g~~P~~~~~~~ 330 (412)
|+++.++.++|+|||+++....... ......+++.|+|||++.+..++.++|||||||++|||++ |..||....
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~-- 238 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLT-- 238 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcC--
Confidence 9999999999999999876533221 1233456788999999988889999999999999999998 667765221
Q ss_pred ccCCCCcchhhHHhhh------ccCCccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhc
Q 042435 331 SSSSGPKIMLIDILYQ------RLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELEG 390 (412)
Q Consensus 331 ~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~ 390 (412)
....+...... ....+.+. .....+.+++.+||+.||++|||+.|+++.|+.
T Consensus 239 -----~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 239 -----DQQVIENAGHFFRDDGRQIYLPRPP---NCPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred -----hHHHHHHHHhccccccccccCCCcc---CCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence 11111111100 00001011 112348899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=276.50 Aligned_cols=226 Identities=24% Similarity=0.332 Sum_probs=172.7
Q ss_pred eeeeecCceEEEEEEeCC----CcEEEEEecc----------------------CCccccceEEEecCceEEEEEEeccC
Q 042435 149 YCIGTGGYDSVYKAELPD----GKVVALKKLH----------------------HSETEDSAFVVYSPQCMFFIYEYMER 202 (412)
Q Consensus 149 ~~lG~G~~g~Vy~~~~~~----~~~vAvK~l~----------------------~~~~~~~~~~~~~~~~~~lv~ey~~~ 202 (412)
++||+|+||.||+|.+.. +..+|+|.++ |+++......+ ..+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVC-KGEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEE-cCCceEEEEEeCCC
Confidence 369999999999996532 3689999764 33333333333 45668999999999
Q ss_pred CceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCCCCc-
Q 042435 203 GSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNR- 281 (412)
Q Consensus 203 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~- 281 (412)
|+|.+++.... .+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++.........
T Consensus 80 ~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~ 153 (257)
T cd05060 80 GPLLKYLKKRR---EIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR 153 (257)
T ss_pred CcHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecCCcccc
Confidence 99999997654 589999999999999999999988 99999999999999999999999999998664433221
Q ss_pred --ccccccccccccccccCcccCcccccHHHHHHHHHHHh-CCCCcccccccccCCCCcchhhHHhhhccCCccchhhHH
Q 042435 282 --TLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLM-GTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKIIQ 358 (412)
Q Consensus 282 --~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 358 (412)
....++..|+|||...+..++.++||||||+++||+++ |..||.... .......+......+.+..
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~--------~~~~~~~~~~~~~~~~~~~--- 222 (257)
T cd05060 154 ATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMK--------GAEVIAMLESGERLPRPEE--- 222 (257)
T ss_pred cccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCC--------HHHHHHHHHcCCcCCCCCC---
Confidence 11223567999999998889999999999999999998 999986321 1112222222211111111
Q ss_pred HHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhcCC
Q 042435 359 DIILVSTIALACLRSKPKSRPTMQRISQELEGKT 392 (412)
Q Consensus 359 ~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 392 (412)
....+.+++.+||..+|++||++.++++.|++..
T Consensus 223 ~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 223 CPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred CCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 1234789999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=280.87 Aligned_cols=228 Identities=29% Similarity=0.411 Sum_probs=181.9
Q ss_pred cCcccceeeeecCceEEEEEEeC-CCcEEEEEec----------------------cCCccccceEEEecCceEEEEEEe
Q 042435 143 EYFHIRYCIGTGGYDSVYKAELP-DGKVVALKKL----------------------HHSETEDSAFVVYSPQCMFFIYEY 199 (412)
Q Consensus 143 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l----------------------~~~~~~~~~~~~~~~~~~~lv~ey 199 (412)
++|++.+.||.|+||.||+|... +++.||+|.+ +|+++......+..+...++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 36788899999999999999764 6889999965 345555555556777889999999
Q ss_pred ccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCCC
Q 042435 200 MERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSS 279 (412)
Q Consensus 200 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 279 (412)
+++++|.+++... .+++..+..++.|++.||.|||+. +++||||+|+||++++++.++|+|||+++.......
T Consensus 81 ~~~~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~ 153 (274)
T cd06609 81 CGGGSCLDLLKPG----KLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS 153 (274)
T ss_pred eCCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeeccccc
Confidence 9999999988754 589999999999999999999998 999999999999999999999999999987755433
Q ss_pred CcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccchhhHHH
Q 042435 280 NRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKIIQD 359 (412)
Q Consensus 280 ~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 359 (412)
......++..|+|||.+.+..++.++||||||+++|||+||+.||.... +. .....+.....+..... ..
T Consensus 154 ~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~-------~~-~~~~~~~~~~~~~~~~~--~~ 223 (274)
T cd06609 154 KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLH-------PM-RVLFLIPKNNPPSLEGN--KF 223 (274)
T ss_pred ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCc-------hH-HHHHHhhhcCCCCCccc--cc
Confidence 3444568889999999998889999999999999999999999986321 11 11111112222211111 02
Q ss_pred HHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 360 IILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 360 ~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
...+.+++.+||..||++|||+++++++
T Consensus 224 ~~~~~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 224 SKPFKDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred CHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 2347889999999999999999999875
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=279.44 Aligned_cols=229 Identities=26% Similarity=0.358 Sum_probs=171.9
Q ss_pred eeeeecCceEEEEEEeCC-Cc--EEEEEecc-----------------------CCccccceEEEecCceEEEEEEeccC
Q 042435 149 YCIGTGGYDSVYKAELPD-GK--VVALKKLH-----------------------HSETEDSAFVVYSPQCMFFIYEYMER 202 (412)
Q Consensus 149 ~~lG~G~~g~Vy~~~~~~-~~--~vAvK~l~-----------------------~~~~~~~~~~~~~~~~~~lv~ey~~~ 202 (412)
+.||+|+||.||+|...+ +. .+|+|.++ |+++......+...+..+++|||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 368999999999998754 43 46888653 44555555566777789999999999
Q ss_pred CceeeeeccCc-------------ccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecC
Q 042435 203 GSLFCVLRDDD-------------EAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFG 269 (412)
Q Consensus 203 gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG 269 (412)
|+|.+++.... ....+++.++..++.|++.||+|||+. +++||||||+||++++++.+|++|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECCCC
Confidence 99999886532 112478999999999999999999998 99999999999999999999999999
Q ss_pred CccccCCCCCCcccccccccccccccccCcccCcccccHHHHHHHHHHHh-CCCCcccccccccCCCCcchhhHHhhhcc
Q 042435 270 TVRLLDVDSSNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLM-GTHPGELLLSLSSSSGPKIMLIDILYQRL 348 (412)
Q Consensus 270 la~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 348 (412)
+++...... .......+..|+|||+.....++.++||||||+++|||++ |..||.... . ....+.+....
T Consensus 158 l~~~~~~~~-~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~-------~-~~~~~~~~~~~ 228 (270)
T cd05047 158 LSRGQEVYV-KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT-------C-AELYEKLPQGY 228 (270)
T ss_pred Cccccchhh-hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccC-------H-HHHHHHHhCCC
Confidence 986322111 1112234567999999988889999999999999999997 999986321 1 11111121211
Q ss_pred CCccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhcCC
Q 042435 349 SPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELEGKT 392 (412)
Q Consensus 349 ~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 392 (412)
..+.... ....+.+++.+||+.||.+|||+.|+++.|+++.
T Consensus 229 ~~~~~~~---~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 229 RLEKPLN---CDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred CCCCCCc---CCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 1111111 1224789999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-36 Score=280.14 Aligned_cols=227 Identities=25% Similarity=0.357 Sum_probs=180.3
Q ss_pred cCcccceeeeecCceEEEEEEeC-CCcEEEEEec----------------------cCCccccceEEEecCceEEEEEEe
Q 042435 143 EYFHIRYCIGTGGYDSVYKAELP-DGKVVALKKL----------------------HHSETEDSAFVVYSPQCMFFIYEY 199 (412)
Q Consensus 143 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l----------------------~~~~~~~~~~~~~~~~~~~lv~ey 199 (412)
..|+..+.||+|+||.||+|... +++.||+|.+ .|+++......+..++..++||||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 34677788999999999999764 5889999964 355555566667788899999999
Q ss_pred ccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCCC
Q 042435 200 MERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSS 279 (412)
Q Consensus 200 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 279 (412)
+++|+|.+++... .+++.+...++.|++.||+|||+. +++|+||+|+||+++.++.++++|||++........
T Consensus 84 ~~~~~L~~~i~~~----~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06640 84 LGGGSALDLLRAG----PFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred CCCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceeccCCcc
Confidence 9999999988653 488899999999999999999998 999999999999999999999999999976654333
Q ss_pred CcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccchhhHHH
Q 042435 280 NRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKIIQD 359 (412)
Q Consensus 280 ~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 359 (412)
......++..|+|||++.+..++.++|+||||+++|||+||+.||..... . ...........+.. ....
T Consensus 157 ~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~-------~-~~~~~~~~~~~~~~---~~~~ 225 (277)
T cd06640 157 KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHP-------M-RVLFLIPKNNPPTL---TGEF 225 (277)
T ss_pred ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcCh-------H-hHhhhhhcCCCCCC---chhh
Confidence 33344678899999999888899999999999999999999999863211 0 01111111111111 1123
Q ss_pred HHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 360 IILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 360 ~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
...+.+++.+||+.+|++||+++|++++
T Consensus 226 ~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 226 SKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred hHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 3458899999999999999999999877
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-36 Score=277.58 Aligned_cols=228 Identities=25% Similarity=0.326 Sum_probs=169.7
Q ss_pred eeeeecCceEEEEEEeC----CCcEEEEEec----------------------cCCccccceEEEe-cCceEEEEEEecc
Q 042435 149 YCIGTGGYDSVYKAELP----DGKVVALKKL----------------------HHSETEDSAFVVY-SPQCMFFIYEYME 201 (412)
Q Consensus 149 ~~lG~G~~g~Vy~~~~~----~~~~vAvK~l----------------------~~~~~~~~~~~~~-~~~~~~lv~ey~~ 201 (412)
+.||+|+||.||+|.+. +...||+|++ +|+++......+. .+...++++||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 36899999999999753 2457999965 3445544444444 3456899999999
Q ss_pred CCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCC---
Q 042435 202 RGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDS--- 278 (412)
Q Consensus 202 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~--- 278 (412)
+|+|.+++..... .+++..++.++.|++.||+|||+. +++||||||+||++++++.+||+|||+++......
T Consensus 81 ~~~L~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~ 155 (262)
T cd05058 81 HGDLRNFIRSETH--NPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS 155 (262)
T ss_pred CCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCCccee
Confidence 9999999875432 367888899999999999999998 99999999999999999999999999987543221
Q ss_pred -CCcccccccccccccccccCcccCcccccHHHHHHHHHHHhCC-CCcccccccccCCCCcchhhHHhhhccCCccchhh
Q 042435 279 -SNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGT-HPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKI 356 (412)
Q Consensus 279 -~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~-~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 356 (412)
.......++..|+|||...+..++.++||||||+++|||++|. .||... ........+........+...
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~ 227 (262)
T cd05058 156 VHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV--------DSFDITVYLLQGRRLLQPEYC 227 (262)
T ss_pred ecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCC--------CHHHHHHHHhcCCCCCCCCcC
Confidence 1112334577899999998888999999999999999999954 455421 111112222111111111111
Q ss_pred HHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhcCC
Q 042435 357 IQDIILVSTIALACLRSKPKSRPTMQRISQELEGKT 392 (412)
Q Consensus 357 ~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 392 (412)
...+.+++.+||+.+|++||++.|+++.|+++.
T Consensus 228 ---~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 228 ---PDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred ---CHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence 224789999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=284.11 Aligned_cols=238 Identities=22% Similarity=0.301 Sum_probs=175.9
Q ss_pred cCcccceeeeecCceEEEEEEeC-----------------CCcEEEEEecc----------------------CCccccc
Q 042435 143 EYFHIRYCIGTGGYDSVYKAELP-----------------DGKVVALKKLH----------------------HSETEDS 183 (412)
Q Consensus 143 ~~f~~~~~lG~G~~g~Vy~~~~~-----------------~~~~vAvK~l~----------------------~~~~~~~ 183 (412)
++|++.+.||+|+||.||++... ++..||+|.++ |+++...
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 56899999999999999998532 24468998654 4444445
Q ss_pred eEEEecCceEEEEEEeccCCceeeeeccCcc--------cccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCE
Q 042435 184 AFVVYSPQCMFFIYEYMERGSLFCVLRDDDE--------AIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNI 255 (412)
Q Consensus 184 ~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~--------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NI 255 (412)
...+...+..+++|||+++|+|.+++..... ...+++.+...++.|++.||+|||+. +++||||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp~Ni 161 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRNC 161 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCChheE
Confidence 5556777889999999999999988865321 12478889999999999999999998 999999999999
Q ss_pred EecCCCcEEEeecCCccccCCCCCC--cccccccccccccccccCcccCcccccHHHHHHHHHHHh--CCCCcccccccc
Q 042435 256 LLNSNLEAFVADFGTVRLLDVDSSN--RTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLM--GTHPGELLLSLS 331 (412)
Q Consensus 256 Ll~~~~~~kl~DfGla~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~ellt--g~~P~~~~~~~~ 331 (412)
+++.++.++|+|||+++.+...... .....+++.|+|||...+..++.++|||||||++|||++ |..||.......
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~ 241 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ 241 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHH
Confidence 9999999999999999865332211 122334678999999888889999999999999999998 778875321000
Q ss_pred cCCCCcchhhHHhhh---ccCCccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhc
Q 042435 332 SSSGPKIMLIDILYQ---RLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELEG 390 (412)
Q Consensus 332 ~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~ 390 (412)
. .......... ....+.+. .....+.+++.+||+.||++||++.||.+.|++
T Consensus 242 ~----~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 242 V----IENTGEFFRDQGRQVYLPKPA---LCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred H----HHHHHHHHhhccccccCCCCC---CCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 0 0000011100 00011111 112347899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=282.04 Aligned_cols=231 Identities=24% Similarity=0.322 Sum_probs=177.2
Q ss_pred cCcccceeeeecCceEEEEEEeC-CCcEEEEEec---------------------cCCccccceEEEecCceEEEEEEec
Q 042435 143 EYFHIRYCIGTGGYDSVYKAELP-DGKVVALKKL---------------------HHSETEDSAFVVYSPQCMFFIYEYM 200 (412)
Q Consensus 143 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l---------------------~~~~~~~~~~~~~~~~~~~lv~ey~ 200 (412)
+.|++.+.||+|+||.||+|... +++.+|+|.+ +|+++......+......++||||+
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC 91 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence 56888999999999999999774 5889999965 4555555566677788999999999
Q ss_pred cCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCCCC
Q 042435 201 ERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSN 280 (412)
Q Consensus 201 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 280 (412)
++++|..++.... ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||++.........
T Consensus 92 ~~~~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~ 166 (292)
T cd06644 92 PGGAVDAIMLELD--RGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQR 166 (292)
T ss_pred CCCcHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccceeccccccc
Confidence 9999988765433 2489999999999999999999998 9999999999999999999999999998754333333
Q ss_pred ccccccccccccccccc-----CcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccchh
Q 042435 281 RTLQAGTYGYIALELVY-----TMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQK 355 (412)
Q Consensus 281 ~~~~~gt~~y~aPE~~~-----~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 355 (412)
.....++..|+|||++. ...++.++|||||||++|||++|+.||.... ........... ..+.. ..
T Consensus 167 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~-------~~~~~~~~~~~-~~~~~-~~ 237 (292)
T cd06644 167 RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELN-------PMRVLLKIAKS-EPPTL-SQ 237 (292)
T ss_pred cceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCcccc-------HHHHHHHHhcC-CCccC-CC
Confidence 34456888999999985 3456789999999999999999999986321 11111111111 11110 00
Q ss_pred hHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 356 IIQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 356 ~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
.......+.+++.+||+.||++||+++|++++
T Consensus 238 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 238 PSKWSMEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred CcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 11122347889999999999999999999864
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=282.35 Aligned_cols=231 Identities=24% Similarity=0.277 Sum_probs=170.4
Q ss_pred CcccceeeeecCceEEEEEEeC-CCcEEEEEecc--------------------------CCccccceEEEec-----Cc
Q 042435 144 YFHIRYCIGTGGYDSVYKAELP-DGKVVALKKLH--------------------------HSETEDSAFVVYS-----PQ 191 (412)
Q Consensus 144 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~--------------------------~~~~~~~~~~~~~-----~~ 191 (412)
+|++.+.||+|+||.||+|... +++.||+|.++ |+++.....++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4788899999999999999764 68999999764 2333333322222 34
Q ss_pred eEEEEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCc
Q 042435 192 CMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTV 271 (412)
Q Consensus 192 ~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla 271 (412)
..+++|||+++ +|.+++..... ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg~~ 155 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKVPP-PGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGLA 155 (288)
T ss_pred eEEEEEccccc-CHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccCcc
Confidence 57999999974 88887765432 2489999999999999999999998 9999999999999999999999999999
Q ss_pred cccCCCCCCcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhh------
Q 042435 272 RLLDVDSSNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILY------ 345 (412)
Q Consensus 272 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~------ 345 (412)
+...... ......||..|+|||++.+..++.++|||||||++|||++|+.||...... .....+..
T Consensus 156 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~-------~~~~~~~~~~~~~~ 227 (288)
T cd07863 156 RIYSCQM-ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEA-------DQLGKIFDLIGLPP 227 (288)
T ss_pred ccccCcc-cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHH-------HHHHHHHHHhCCCC
Confidence 8654322 223346789999999999888999999999999999999999998532100 00000000
Q ss_pred ------------hccCC----ccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 346 ------------QRLSP----PINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 346 ------------~~~~~----~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
....+ +...........+.+++.+|++.||++|||+.|++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h 285 (288)
T cd07863 228 EDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH 285 (288)
T ss_pred hhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00000 0000001112347899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-37 Score=295.33 Aligned_cols=243 Identities=22% Similarity=0.288 Sum_probs=197.1
Q ss_pred HHHHHhhcCcccceeeeecCceEEEEEEeCC-CcEEEEEe--------------------ccCCccccceEEEecCceEE
Q 042435 136 ENLIDATEYFHIRYCIGTGGYDSVYKAELPD-GKVVALKK--------------------LHHSETEDSAFVVYSPQCMF 194 (412)
Q Consensus 136 ~~l~~~~~~f~~~~~lG~G~~g~Vy~~~~~~-~~~vAvK~--------------------l~~~~~~~~~~~~~~~~~~~ 194 (412)
+++..-..+....++||-|.||.||.|.|+. .-.||||. ++|+|.++..++|.....+|
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFY 339 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFY 339 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeE
Confidence 3443334455667899999999999999964 56788884 47999999999999999999
Q ss_pred EEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCcccc
Q 042435 195 FIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLL 274 (412)
Q Consensus 195 lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~ 274 (412)
||+|||.+|+|.+||++.... .++-...+.++.||+.|++||..+ ++|||||..+|+|+.++..+|++|||+++++
T Consensus 340 IiTEfM~yGNLLdYLRecnr~-ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGLsRlM 415 (1157)
T KOG4278|consen 340 IITEFMCYGNLLDYLRECNRS-EVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGLSRLM 415 (1157)
T ss_pred EEEecccCccHHHHHHHhchh-hcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccchhhhh
Confidence 999999999999999976543 477778889999999999999998 9999999999999999999999999999998
Q ss_pred CCCCCCc-ccccccccccccccccCcccCcccccHHHHHHHHHHHh-CCCCcccccccccCCCCcchhhHHhhhccCCcc
Q 042435 275 DVDSSNR-TLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLM-GTHPGELLLSLSSSSGPKIMLIDILYQRLSPPI 352 (412)
Q Consensus 275 ~~~~~~~-~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 352 (412)
..+.... ....-.+.|.|||.+....++.|+|||+|||+|||+.| |..||..+. .....+.+....+...
T Consensus 416 tgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGid--------lSqVY~LLEkgyRM~~ 487 (1157)
T KOG4278|consen 416 TGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGID--------LSQVYGLLEKGYRMDG 487 (1157)
T ss_pred cCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCcc--------HHHHHHHHhccccccC
Confidence 7654332 22334678999999999999999999999999999998 888875321 1123344444444333
Q ss_pred chhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhcCCC
Q 042435 353 NQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELEGKTP 393 (412)
Q Consensus 353 ~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 393 (412)
++. +...+.+|+..||+++|++||++.|+-+.++.+-.
T Consensus 488 PeG---CPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~ 525 (1157)
T KOG4278|consen 488 PEG---CPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFS 525 (1157)
T ss_pred CCC---CCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhc
Confidence 333 34459999999999999999999999999987643
|
|
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-36 Score=281.15 Aligned_cols=230 Identities=23% Similarity=0.315 Sum_probs=176.6
Q ss_pred cccceeeeecCceEEEEEEeC-CCcEEEEEec---------------------cCCccccceEEEecCceEEEEEEeccC
Q 042435 145 FHIRYCIGTGGYDSVYKAELP-DGKVVALKKL---------------------HHSETEDSAFVVYSPQCMFFIYEYMER 202 (412)
Q Consensus 145 f~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l---------------------~~~~~~~~~~~~~~~~~~~lv~ey~~~ 202 (412)
|++.+.||+|+||.||+|... ++..+|+|.+ +|+++......+...+..++|+||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 677788999999999999775 5778898864 456666666667788899999999999
Q ss_pred CceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCCCCcc
Q 042435 203 GSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRT 282 (412)
Q Consensus 203 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 282 (412)
++|..++.... ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.+|++|||++...........
T Consensus 87 ~~l~~~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~ 161 (282)
T cd06643 87 GAVDAVMLELE--RPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRD 161 (282)
T ss_pred CcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEccccccccccccccccc
Confidence 99988775432 2589999999999999999999998 999999999999999999999999999876543333334
Q ss_pred ccccccccccccccc-----CcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccchhhH
Q 042435 283 LQAGTYGYIALELVY-----TMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKII 357 (412)
Q Consensus 283 ~~~gt~~y~aPE~~~-----~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 357 (412)
...++..|+|||++. +..++.++|||||||++|||++|+.||.... ............ .+.. ....
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~-------~~~~~~~~~~~~-~~~~-~~~~ 232 (282)
T cd06643 162 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELN-------PMRVLLKIAKSE-PPTL-AQPS 232 (282)
T ss_pred cccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccC-------HHHHHHHHhhcC-CCCC-CCcc
Confidence 456889999999974 3457889999999999999999999986321 111111111111 1100 0001
Q ss_pred HHHHHHHHHHHhcCcCCCCCCCCHHHHHHHH
Q 042435 358 QDIILVSTIALACLRSKPKSRPTMQRISQEL 388 (412)
Q Consensus 358 ~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L 388 (412)
.....+.+++.+||+.||.+||++.+++++-
T Consensus 233 ~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 263 (282)
T cd06643 233 RWSSEFKDFLKKCLEKNVDARWTTTQLLQHP 263 (282)
T ss_pred ccCHHHHHHHHHHccCChhhCcCHHHHhcCC
Confidence 1123478999999999999999999998664
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=281.75 Aligned_cols=241 Identities=20% Similarity=0.299 Sum_probs=178.1
Q ss_pred cCcccceeeeecCceEEEEEEe-----CCCcEEEEEecc----------------------CCccccceEEEecC--ceE
Q 042435 143 EYFHIRYCIGTGGYDSVYKAEL-----PDGKVVALKKLH----------------------HSETEDSAFVVYSP--QCM 193 (412)
Q Consensus 143 ~~f~~~~~lG~G~~g~Vy~~~~-----~~~~~vAvK~l~----------------------~~~~~~~~~~~~~~--~~~ 193 (412)
..|++.+.||+|+||.||++.+ .++..||+|.++ |+++......+... ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 3467889999999999999974 357899999764 33444434444443 568
Q ss_pred EEEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccc
Q 042435 194 FFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRL 273 (412)
Q Consensus 194 ~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~ 273 (412)
++||||+++++|.+++.... ..++|..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||+++.
T Consensus 84 ~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRNK--NKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKA 158 (284)
T ss_pred EEEEEccCCCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCccccc
Confidence 99999999999999886543 2489999999999999999999998 999999999999999999999999999986
Q ss_pred cCCCCCC---cccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccc----cCCCCcch---hhHH
Q 042435 274 LDVDSSN---RTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLS----SSSGPKIM---LIDI 343 (412)
Q Consensus 274 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~----~~~~~~~~---~~~~ 343 (412)
....... .....++..|+|||++.+..++.++||||||+++|||+|++.|+....... ........ ....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05079 159 IETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRV 238 (284)
T ss_pred cccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHH
Confidence 6433221 123456778999999988889999999999999999999877643211100 00000100 1111
Q ss_pred hhhccCCccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhcC
Q 042435 344 LYQRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELEGK 391 (412)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 391 (412)
.......+.... ....+.+++.+||+.||++|||+.++++.|+++
T Consensus 239 ~~~~~~~~~~~~---~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 239 LEEGKRLPRPPN---CPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHcCccCCCCCC---CCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 111111111111 223488999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=281.55 Aligned_cols=226 Identities=24% Similarity=0.315 Sum_probs=187.2
Q ss_pred cCcccceeeeecCceEEEEEEe-CCCcEEEEEe------------------------ccCCccccceEEEecCceEEEEE
Q 042435 143 EYFHIRYCIGTGGYDSVYKAEL-PDGKVVALKK------------------------LHHSETEDSAFVVYSPQCMFFIY 197 (412)
Q Consensus 143 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~------------------------l~~~~~~~~~~~~~~~~~~~lv~ 197 (412)
.+|++.+.||+|.||+|-+|.. ..|+.||||. ++|+++...+.++...+.+.|||
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM 132 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM 132 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence 4577788999999999999954 7899999994 36788888888899999999999
Q ss_pred EeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCC
Q 042435 198 EYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVD 277 (412)
Q Consensus 198 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~ 277 (412)
||..+|.|++|+.+.+ .|+......++.||..|+.|+|.+ +++|||||.+|||+|.++++||+|||++-.+...
T Consensus 133 EYaS~GeLYDYiSer~---~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGLSNly~~~ 206 (668)
T KOG0611|consen 133 EYASGGELYDYISERG---SLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGLSNLYADK 206 (668)
T ss_pred EecCCccHHHHHHHhc---cccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccchhhhhccc
Confidence 9999999999998765 589999999999999999999999 9999999999999999999999999999876533
Q ss_pred CCCcccccccccccccccccCcccC-cccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccchhh
Q 042435 278 SSNRTLQAGTYGYIALELVYTMVVT-EKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKI 356 (412)
Q Consensus 278 ~~~~~~~~gt~~y~aPE~~~~~~~s-~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 356 (412)
.-..+++|++-|.+||+..+.+|. +..|-||+||+||.|+.|..||+.. +....+.++-......+..
T Consensus 207 -kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~-------Dhk~lvrQIs~GaYrEP~~--- 275 (668)
T KOG0611|consen 207 -KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGR-------DHKRLVRQISRGAYREPET--- 275 (668)
T ss_pred -cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCc-------hHHHHHHHhhcccccCCCC---
Confidence 334567999999999999998885 6899999999999999999999832 1122222222222222111
Q ss_pred HHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHH
Q 042435 357 IQDIILVSTIALACLRSKPKSRPTMQRISQEL 388 (412)
Q Consensus 357 ~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L 388 (412)
.....-|+.+|+..||++|.|+.||..+-
T Consensus 276 ---PSdA~gLIRwmLmVNP~RRATieDiAsHW 304 (668)
T KOG0611|consen 276 ---PSDASGLIRWMLMVNPERRATIEDIASHW 304 (668)
T ss_pred ---CchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence 11255688999999999999999999886
|
|
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=275.46 Aligned_cols=227 Identities=24% Similarity=0.317 Sum_probs=173.7
Q ss_pred eeeeecCceEEEEEEeCC--C--cEEEEEecc----------------------CCccccceEEEecCceEEEEEEeccC
Q 042435 149 YCIGTGGYDSVYKAELPD--G--KVVALKKLH----------------------HSETEDSAFVVYSPQCMFFIYEYMER 202 (412)
Q Consensus 149 ~~lG~G~~g~Vy~~~~~~--~--~~vAvK~l~----------------------~~~~~~~~~~~~~~~~~~lv~ey~~~ 202 (412)
+.||+|++|.||+|.+.+ + ..||+|.++ |+++......+.. ...++|+||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 368999999999998743 3 368999754 4555555555555 888999999999
Q ss_pred CceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCCCC--
Q 042435 203 GSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSN-- 280 (412)
Q Consensus 203 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~-- 280 (412)
|+|.+++..... ..++|.....++.|++.||+|||+. +++|+||||+||+++.++.+||+|||+++........
T Consensus 80 ~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 155 (257)
T cd05040 80 GSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV 155 (257)
T ss_pred CcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEecccccccccccccccee
Confidence 999999876542 3589999999999999999999998 9999999999999999999999999999876443221
Q ss_pred -cccccccccccccccccCcccCcccccHHHHHHHHHHHh-CCCCcccccccccCCCCcchhhHHhhhccCCccchhhHH
Q 042435 281 -RTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLM-GTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKIIQ 358 (412)
Q Consensus 281 -~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 358 (412)
.....++..|+|||++.+..++.++||||||+++|||++ |+.||.... .......+.......+.+. .
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~-------~~~~~~~~~~~~~~~~~~~---~ 225 (257)
T cd05040 156 MEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLS-------GSQILKKIDKEGERLERPE---A 225 (257)
T ss_pred cccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCC-------HHHHHHHHHhcCCcCCCCc---c
Confidence 123456789999999988889999999999999999999 999986221 1111111111111111111 1
Q ss_pred HHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhc
Q 042435 359 DIILVSTIALACLRSKPKSRPTMQRISQELEG 390 (412)
Q Consensus 359 ~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~ 390 (412)
....+.+++.+||+.+|++||++.|+++.|.+
T Consensus 226 ~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~ 257 (257)
T cd05040 226 CPQDIYNVMLQCWAHNPADRPTFAALREFLPE 257 (257)
T ss_pred CCHHHHHHHHHHCCCCcccCCCHHHHHHHhcC
Confidence 22348889999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=277.52 Aligned_cols=228 Identities=22% Similarity=0.303 Sum_probs=177.7
Q ss_pred CcccceeeeecCceEEEEEEeCCCcEEEEEecc---------------------------CCccccceEEEecCceEEEE
Q 042435 144 YFHIRYCIGTGGYDSVYKAELPDGKVVALKKLH---------------------------HSETEDSAFVVYSPQCMFFI 196 (412)
Q Consensus 144 ~f~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~l~---------------------------~~~~~~~~~~~~~~~~~~lv 196 (412)
+|+..+.||+|+||.||+|...+++.+|+|.++ |+++......+...+..+++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 477889999999999999988889999999653 44444555567778899999
Q ss_pred EEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCC
Q 042435 197 YEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDV 276 (412)
Q Consensus 197 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~ 276 (412)
+||+++++|.+++.... .+++..+..++.|++.||+|||+. +++|+||+|+||++++++.++|+|||+++....
T Consensus 81 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 154 (265)
T cd06631 81 MEFVPGGSISSILNRFG---PLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW 154 (265)
T ss_pred EecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence 99999999999986543 478899999999999999999998 999999999999999999999999999875432
Q ss_pred CC------CCcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhh-ccC
Q 042435 277 DS------SNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQ-RLS 349 (412)
Q Consensus 277 ~~------~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~-~~~ 349 (412)
.. .......|+..|+|||++.+..++.++||||||+++|||++|+.||..... .......... ...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~-------~~~~~~~~~~~~~~ 227 (265)
T cd06631 155 VGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDR-------LAAMFYIGAHRGLM 227 (265)
T ss_pred ccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCCh-------HHHHHHhhhccCCC
Confidence 11 111234688999999999988899999999999999999999999863211 1111111111 111
Q ss_pred CccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 350 PPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 350 ~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
++.+.. ....+.+++.+||+.+|++||++.|++++
T Consensus 228 ~~~~~~---~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 262 (265)
T cd06631 228 PRLPDS---FSAAAIDFVTSCLTRDQHERPSALQLLRH 262 (265)
T ss_pred CCCCCC---CCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 111111 22347889999999999999999999863
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=279.77 Aligned_cols=239 Identities=21% Similarity=0.278 Sum_probs=175.7
Q ss_pred cCcccceeeeecCceEEEEEEeC-CCcEEEEEecc-----------------------CCccccceEEEecCceEEEEEE
Q 042435 143 EYFHIRYCIGTGGYDSVYKAELP-DGKVVALKKLH-----------------------HSETEDSAFVVYSPQCMFFIYE 198 (412)
Q Consensus 143 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~-----------------------~~~~~~~~~~~~~~~~~~lv~e 198 (412)
++|+..+.||+|+||.||+|... +|+.||+|++. |+++......+......++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 46888999999999999999875 58999999653 3344444445667788999999
Q ss_pred eccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCC
Q 042435 199 YMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDS 278 (412)
Q Consensus 199 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~ 278 (412)
|+++++|..++.... .+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~~~~~~---~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07847 81 YCDHTVLNELEKNPR---GVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGPG 154 (286)
T ss_pred ccCccHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceecCCCc
Confidence 999988887765433 489999999999999999999998 99999999999999999999999999998765443
Q ss_pred CCcccccccccccccccccC-cccCcccccHHHHHHHHHHHhCCCCccccccccc------CCCCc-chhhHHhh-----
Q 042435 279 SNRTLQAGTYGYIALELVYT-MVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSS------SSGPK-IMLIDILY----- 345 (412)
Q Consensus 279 ~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~------~~~~~-~~~~~~~~----- 345 (412)
.......++..|+|||.+.+ ..++.++||||||+++|||++|+.||........ ..... .......+
T Consensus 155 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T cd07847 155 DDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFF 234 (286)
T ss_pred ccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccccc
Confidence 33334467889999999865 4578899999999999999999999863211000 00000 00000000
Q ss_pred hc--cCCcc-----chhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 346 QR--LSPPI-----NQKIIQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 346 ~~--~~~~~-----~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
.. ...+. ..........+.+++.+||+.||++||++.|++.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 235 KGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred ccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 00 00000 00001112347899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=276.13 Aligned_cols=229 Identities=21% Similarity=0.330 Sum_probs=179.6
Q ss_pred CcccceeeeecCceEEEEEEe-CCCcEEEEEecc-----------------------CCccccceEEEecCceEEEEEEe
Q 042435 144 YFHIRYCIGTGGYDSVYKAEL-PDGKVVALKKLH-----------------------HSETEDSAFVVYSPQCMFFIYEY 199 (412)
Q Consensus 144 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l~-----------------------~~~~~~~~~~~~~~~~~~lv~ey 199 (412)
+|++.+.||+|+||.||++.. .+|+.||+|++. |+++......+...+..++|+||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 478889999999999999966 468999999653 44555555567778899999999
Q ss_pred ccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCCC
Q 042435 200 MERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSS 279 (412)
Q Consensus 200 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 279 (412)
+++++|.+++..... ..+++.++..++.|++.||+|||+. +++|+||+|+||+++.++.++++|||++........
T Consensus 81 ~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 156 (256)
T cd08218 81 CEGGDLYKKINAQRG-VLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE 156 (256)
T ss_pred CCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh
Confidence 999999988865332 2478999999999999999999998 999999999999999999999999999986544332
Q ss_pred CcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccchhhHHH
Q 042435 280 NRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKIIQD 359 (412)
Q Consensus 280 ~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 359 (412)
......|++.|+|||+..+..++.++|+|||||+++||++|+.||... ........+..... ++.+. ..
T Consensus 157 ~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~-------~~~~~~~~~~~~~~-~~~~~---~~ 225 (256)
T cd08218 157 LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAG-------NMKNLVLKIIRGSY-PPVSS---HY 225 (256)
T ss_pred hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCC-------CHHHHHHHHhcCCC-CCCcc---cC
Confidence 233346888999999998888999999999999999999999998621 11111112221111 11111 22
Q ss_pred HHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 360 IILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 360 ~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
...+.+++.+||+.+|++||++.||+++
T Consensus 226 ~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 226 SYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred CHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 3348899999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=282.25 Aligned_cols=241 Identities=24% Similarity=0.247 Sum_probs=181.4
Q ss_pred cCcccceeeeecCceEEEEEEeC-CCcEEEEEec----------------------cCCccccceEEEecCceEEEEEEe
Q 042435 143 EYFHIRYCIGTGGYDSVYKAELP-DGKVVALKKL----------------------HHSETEDSAFVVYSPQCMFFIYEY 199 (412)
Q Consensus 143 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l----------------------~~~~~~~~~~~~~~~~~~~lv~ey 199 (412)
++|++.+.||+|+||+||++... +++.||+|.+ +|+++......+...+..++||||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 46788899999999999999764 6889999954 355555566667778899999999
Q ss_pred ccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCCC
Q 042435 200 MERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSS 279 (412)
Q Consensus 200 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 279 (412)
+++++|.+++.... .+++.....++.+++.||.|||+.+ +++||||||+||++++++.++|+|||++.......
T Consensus 85 ~~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~- 158 (284)
T cd06620 85 MDCGSLDRIYKKGG---PIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI- 158 (284)
T ss_pred CCCCCHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccchhhhc-
Confidence 99999998886543 5899999999999999999999732 79999999999999999999999999986543221
Q ss_pred CcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccch-hhHH
Q 042435 280 NRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQ-KIIQ 358 (412)
Q Consensus 280 ~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 358 (412)
.....|+..|+|||++.+..++.++|||||||++||++||+.||.................+............ ....
T Consensus 159 -~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd06620 159 -ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSD 237 (284)
T ss_pred -cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCCchh
Confidence 12346899999999998888999999999999999999999998743211000011111112222111110000 0111
Q ss_pred HHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhc
Q 042435 359 DIILVSTIALACLRSKPKSRPTMQRISQELEG 390 (412)
Q Consensus 359 ~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~ 390 (412)
....+.+++.+||+.||++|||+.|++++.--
T Consensus 238 ~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~ 269 (284)
T cd06620 238 FPEDLRDFVDACLLKDPTERPTPQQLCAMPPF 269 (284)
T ss_pred cCHHHHHHHHHHhcCCcccCcCHHHHhcCccc
Confidence 22347889999999999999999999987533
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=275.44 Aligned_cols=228 Identities=23% Similarity=0.366 Sum_probs=176.6
Q ss_pred cCcccceeeeecCceEEEEEEeCCCcEEEEEec-------------------cCCccccceEEEecCceEEEEEEeccCC
Q 042435 143 EYFHIRYCIGTGGYDSVYKAELPDGKVVALKKL-------------------HHSETEDSAFVVYSPQCMFFIYEYMERG 203 (412)
Q Consensus 143 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~l-------------------~~~~~~~~~~~~~~~~~~~lv~ey~~~g 203 (412)
++|++.+.||+|+||.||++.. +++.||+|.+ +|+++......+. .+..+++|||+++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-~~~~~~v~e~~~~~ 83 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVIL-HNGLYIVMELMSKG 83 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcchHHHHHHHHHHHHhCCCCCcCeEEEEEc-CCCcEEEEECCCCC
Confidence 4588899999999999999975 6788999965 3455555444443 45579999999999
Q ss_pred ceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCCCCccc
Q 042435 204 SLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTL 283 (412)
Q Consensus 204 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 283 (412)
+|.+++..... ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++..... ...
T Consensus 84 ~L~~~l~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~---~~~ 156 (254)
T cd05083 84 NLVNFLRTRGR-ALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG---VDN 156 (254)
T ss_pred CHHHHHHhcCc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceecccc---CCC
Confidence 99999875432 2488999999999999999999988 9999999999999999999999999998754322 112
Q ss_pred ccccccccccccccCcccCcccccHHHHHHHHHHHh-CCCCcccccccccCCCCcchhhHHhhhccCCccchhhHHHHHH
Q 042435 284 QAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLM-GTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKIIQDIIL 362 (412)
Q Consensus 284 ~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 362 (412)
...+..|+|||.+.+..++.++|+||||+++|||++ |+.||.... . ....+............ .....
T Consensus 157 ~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~-------~-~~~~~~~~~~~~~~~~~---~~~~~ 225 (254)
T cd05083 157 SKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMS-------L-KEVKECVEKGYRMEPPE---GCPAD 225 (254)
T ss_pred CCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCC-------H-HHHHHHHhCCCCCCCCC---cCCHH
Confidence 234568999999988889999999999999999998 999986321 1 11122222222221111 12234
Q ss_pred HHHHHHhcCcCCCCCCCCHHHHHHHHhc
Q 042435 363 VSTIALACLRSKPKSRPTMQRISQELEG 390 (412)
Q Consensus 363 ~~~l~~~Cl~~dP~~RPs~~evl~~L~~ 390 (412)
+.+++.+||+.+|++||+++++++.|++
T Consensus 226 ~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 226 VYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 7899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=281.05 Aligned_cols=230 Identities=23% Similarity=0.307 Sum_probs=175.6
Q ss_pred cCcccceeeeecCceEEEEEEeC-CCcEEEEEecc----------------------CCccccceEEEecCceEEEEEEe
Q 042435 143 EYFHIRYCIGTGGYDSVYKAELP-DGKVVALKKLH----------------------HSETEDSAFVVYSPQCMFFIYEY 199 (412)
Q Consensus 143 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~----------------------~~~~~~~~~~~~~~~~~~lv~ey 199 (412)
++|++.+.||+|+||.||++... +++.||+|.++ |+++......+...+..++||||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 36888899999999999999875 78999999654 33444444446678889999999
Q ss_pred ccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCCC
Q 042435 200 MERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSS 279 (412)
Q Consensus 200 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 279 (412)
+++++|..++........+++..+..++.|++.||.|||+.+ +++||||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~- 157 (286)
T cd06622 81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL- 157 (286)
T ss_pred cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc-
Confidence 999999888876432235899999999999999999999632 89999999999999999999999999987653221
Q ss_pred CcccccccccccccccccCcc------cCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhh---hccCC
Q 042435 280 NRTLQAGTYGYIALELVYTMV------VTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILY---QRLSP 350 (412)
Q Consensus 280 ~~~~~~gt~~y~aPE~~~~~~------~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~---~~~~~ 350 (412)
.....++..|+|||.+.+.. ++.++|+|||||++|||++|+.||.... ... ....+. ....+
T Consensus 158 -~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~-------~~~-~~~~~~~~~~~~~~ 228 (286)
T cd06622 158 -AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPET-------YAN-IFAQLSAIVDGDPP 228 (286)
T ss_pred -cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcc-------hhh-HHHHHHHHhhcCCC
Confidence 22345788999999985443 5789999999999999999999986321 111 111111 11111
Q ss_pred ccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 351 PINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 351 ~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
..+. .....+.+++.+||+.+|++||++++++++
T Consensus 229 ~~~~---~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 229 TLPS---GYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred CCCc---ccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 1111 123347889999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=286.95 Aligned_cols=237 Identities=22% Similarity=0.317 Sum_probs=181.7
Q ss_pred cCcccceeeeecCceEEEEEEeC--------CCcEEEEEec-----------------------cCCccccceEEEecCc
Q 042435 143 EYFHIRYCIGTGGYDSVYKAELP--------DGKVVALKKL-----------------------HHSETEDSAFVVYSPQ 191 (412)
Q Consensus 143 ~~f~~~~~lG~G~~g~Vy~~~~~--------~~~~vAvK~l-----------------------~~~~~~~~~~~~~~~~ 191 (412)
.+|.+.+.||+|+||.||+|... .+..||+|.+ +|+++......+...+
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 91 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence 35888999999999999999642 1236899954 3556666666677788
Q ss_pred eEEEEEEeccCCceeeeeccCc-------------ccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEec
Q 042435 192 CMFFIYEYMERGSLFCVLRDDD-------------EAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLN 258 (412)
Q Consensus 192 ~~~lv~ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~ 258 (412)
..++++||+++|+|.+++.... ....++|.+++.++.|++.||+|||++ +++||||||+||+++
T Consensus 92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nill~ 168 (334)
T cd05100 92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARNVLVT 168 (334)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEc
Confidence 8999999999999999886432 123488999999999999999999998 999999999999999
Q ss_pred CCCcEEEeecCCccccCCCCCCc--ccccccccccccccccCcccCcccccHHHHHHHHHHHh-CCCCcccccccccCCC
Q 042435 259 SNLEAFVADFGTVRLLDVDSSNR--TLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLM-GTHPGELLLSLSSSSG 335 (412)
Q Consensus 259 ~~~~~kl~DfGla~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~ellt-g~~P~~~~~~~~~~~~ 335 (412)
.++.+||+|||+++......... ....++..|+|||++.+..++.++||||||+++|||++ |..||...
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~-------- 240 (334)
T cd05100 169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI-------- 240 (334)
T ss_pred CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCC--------
Confidence 99999999999998654322111 22234567999999999899999999999999999998 88887522
Q ss_pred CcchhhHHhhhccCCccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhcCCC
Q 042435 336 PKIMLIDILYQRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELEGKTP 393 (412)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 393 (412)
........+......+.+.. ....+.+++.+||+.+|++|||+.|+++.|+++..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~---~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~ 295 (334)
T cd05100 241 PVEELFKLLKEGHRMDKPAN---CTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLT 295 (334)
T ss_pred CHHHHHHHHHcCCCCCCCCC---CCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhh
Confidence 11112222222222111111 12247899999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=282.98 Aligned_cols=237 Identities=23% Similarity=0.263 Sum_probs=180.0
Q ss_pred cCcccceeeeecCceEEEEEEeC-CCcEEEEEec----------------------cCCccccceEEEecCceEEEEEEe
Q 042435 143 EYFHIRYCIGTGGYDSVYKAELP-DGKVVALKKL----------------------HHSETEDSAFVVYSPQCMFFIYEY 199 (412)
Q Consensus 143 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l----------------------~~~~~~~~~~~~~~~~~~~lv~ey 199 (412)
++|++.+.||+|+||.||++... ++..+|+|.+ +|+++......+..++..++||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 46899999999999999999764 6888998854 456777777778889999999999
Q ss_pred ccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCCC
Q 042435 200 MERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSS 279 (412)
Q Consensus 200 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 279 (412)
+++++|.++++... .+++..+..++.|+++||+|||+.+ +++||||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-- 153 (308)
T cd06615 81 MDGGSLDQVLKKAG---RIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 153 (308)
T ss_pred cCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCccccccc--
Confidence 99999999987553 5889999999999999999999732 8999999999999999999999999998754322
Q ss_pred CcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccc-----cCC---CC---------------
Q 042435 280 NRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLS-----SSS---GP--------------- 336 (412)
Q Consensus 280 ~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~-----~~~---~~--------------- 336 (412)
......|+..|+|||.+.+..++.++||||||+++|||++|+.||....... ... ..
T Consensus 154 ~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (308)
T cd06615 154 MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDS 233 (308)
T ss_pred ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCc
Confidence 1233468899999999988889999999999999999999999985221000 000 00
Q ss_pred --cchhhHHhhh---ccCCccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHH
Q 042435 337 --KIMLIDILYQ---RLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQEL 388 (412)
Q Consensus 337 --~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L 388 (412)
.....+..+. ...+..+.. .....+.+++.+||+.||++|||+.|++++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~ 288 (308)
T cd06615 234 PRPMAIFELLDYIVNEPPPKLPSG--AFSDEFQDFVDKCLKKNPKERADLKELTKHP 288 (308)
T ss_pred cchhhHHHHHHHHhcCCCccCcCc--ccCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence 0000000000 000000000 1123478999999999999999999999873
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=273.53 Aligned_cols=230 Identities=20% Similarity=0.271 Sum_probs=182.5
Q ss_pred CcccceeeeecCceEEEEEEe-CCCcEEEEEec-----------------------cCCccccceEEEecCceEEEEEEe
Q 042435 144 YFHIRYCIGTGGYDSVYKAEL-PDGKVVALKKL-----------------------HHSETEDSAFVVYSPQCMFFIYEY 199 (412)
Q Consensus 144 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l-----------------------~~~~~~~~~~~~~~~~~~~lv~ey 199 (412)
+|+..+.||+|+||.||.++. .+++.+++|.+ +|+++......+...+..+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 478889999999999999965 56889999964 355555666667788899999999
Q ss_pred ccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCCC
Q 042435 200 MERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSS 279 (412)
Q Consensus 200 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 279 (412)
+++|+|.+++.... ...+++.++..++.|++.||+|||+. +++|+||+|+||++++++.+||+|||+++.......
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~ 156 (256)
T cd08221 81 ANGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS 156 (256)
T ss_pred cCCCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEcccccc
Confidence 99999999887643 23589999999999999999999998 999999999999999999999999999987654443
Q ss_pred CcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccchhhHHH
Q 042435 280 NRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKIIQD 359 (412)
Q Consensus 280 ~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 359 (412)
......+++.|+|||...+..++.++||||||+++|||++|+.||... ........+......+. . ...
T Consensus 157 ~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~-------~~~~~~~~~~~~~~~~~-~---~~~ 225 (256)
T cd08221 157 MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDAT-------NPLNLVVKIVQGNYTPV-V---SVY 225 (256)
T ss_pred cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCC-------CHHHHHHHHHcCCCCCC-c---ccc
Confidence 334456899999999998888899999999999999999999998631 11111222222222111 1 112
Q ss_pred HHHHHHHHHhcCcCCCCCCCCHHHHHHHH
Q 042435 360 IILVSTIALACLRSKPKSRPTMQRISQEL 388 (412)
Q Consensus 360 ~~~~~~l~~~Cl~~dP~~RPs~~evl~~L 388 (412)
...+.+++.+||+.+|++||+++|+++++
T Consensus 226 ~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 226 SSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred CHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 23478899999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=282.59 Aligned_cols=174 Identities=24% Similarity=0.375 Sum_probs=139.3
Q ss_pred ceeeeecCceEEEEEEeC---CCcEEEEEec-------------------cCCccccceEEEe--cCceEEEEEEeccCC
Q 042435 148 RYCIGTGGYDSVYKAELP---DGKVVALKKL-------------------HHSETEDSAFVVY--SPQCMFFIYEYMERG 203 (412)
Q Consensus 148 ~~~lG~G~~g~Vy~~~~~---~~~~vAvK~l-------------------~~~~~~~~~~~~~--~~~~~~lv~ey~~~g 203 (412)
..+||+|+||.||+|... +++.||+|.+ +|+++......+. .....+++|||+. +
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~-~ 84 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE-H 84 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC-C
Confidence 468999999999999764 4678999965 4666666555543 3456899999996 4
Q ss_pred ceeeeeccCc------ccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEe----cCCCcEEEeecCCccc
Q 042435 204 SLFCVLRDDD------EAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILL----NSNLEAFVADFGTVRL 273 (412)
Q Consensus 204 sL~~~l~~~~------~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl----~~~~~~kl~DfGla~~ 273 (412)
+|.+++.... ....+++..+..++.|++.||+|||++ +|+||||||+|||+ +.++.+||+|||+++.
T Consensus 85 ~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~ 161 (317)
T cd07868 85 DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARL 161 (317)
T ss_pred CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeecCceec
Confidence 7776654321 122488899999999999999999998 99999999999999 4567899999999987
Q ss_pred cCCCCC---CcccccccccccccccccC-cccCcccccHHHHHHHHHHHhCCCCcc
Q 042435 274 LDVDSS---NRTLQAGTYGYIALELVYT-MVVTEKCVIYSFGVVALEVLMGTHPGE 325 (412)
Q Consensus 274 ~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~S~Gvil~elltg~~P~~ 325 (412)
...... ......||+.|+|||++.+ ..++.++||||+||++|||++|+.||.
T Consensus 162 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~ 217 (317)
T cd07868 162 FNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 217 (317)
T ss_pred cCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCcc
Confidence 643321 1234578999999999876 458899999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=276.65 Aligned_cols=234 Identities=23% Similarity=0.314 Sum_probs=178.3
Q ss_pred cCcccceeeeecCceEEEEEEeCC----CcEEEEEec----------------------cCCccccceEEEecCceEEEE
Q 042435 143 EYFHIRYCIGTGGYDSVYKAELPD----GKVVALKKL----------------------HHSETEDSAFVVYSPQCMFFI 196 (412)
Q Consensus 143 ~~f~~~~~lG~G~~g~Vy~~~~~~----~~~vAvK~l----------------------~~~~~~~~~~~~~~~~~~~lv 196 (412)
++|.+.+.||+|+||.||+|...+ ...||+|.. .|+++......+. .+..++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-~~~~~lv 84 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVIT-ENPVWIV 84 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEc-CCCcEEE
Confidence 457888999999999999997643 246898964 3455555554444 4567899
Q ss_pred EEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCC
Q 042435 197 YEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDV 276 (412)
Q Consensus 197 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~ 276 (412)
|||+++|+|.+++..... .+++..++.++.|++.||+|||+. +++||||||+||+++.++.++++|||+++....
T Consensus 85 ~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 159 (270)
T cd05056 85 MELAPLGELRSYLQVNKY--SLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLED 159 (270)
T ss_pred EEcCCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCceeeeccc
Confidence 999999999999875432 489999999999999999999988 999999999999999999999999999986543
Q ss_pred CCCC-cccccccccccccccccCcccCcccccHHHHHHHHHHHh-CCCCcccccccccCCCCcchhhHHhhhccCCccch
Q 042435 277 DSSN-RTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLM-GTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQ 354 (412)
Q Consensus 277 ~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 354 (412)
.... .....++..|+|||.+....++.++||||||+++||+++ |..||.... ... ....+......+.+.
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~-------~~~-~~~~~~~~~~~~~~~ 231 (270)
T cd05056 160 ESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVK-------NND-VIGRIENGERLPMPP 231 (270)
T ss_pred ccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCC-------HHH-HHHHHHcCCcCCCCC
Confidence 3211 122234568999999988889999999999999999986 999986321 111 111111111111111
Q ss_pred hhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhcCCC
Q 042435 355 KIIQDIILVSTIALACLRSKPKSRPTMQRISQELEGKTP 393 (412)
Q Consensus 355 ~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 393 (412)
. ....+.+++.+||..+|++|||+.++++.|+++..
T Consensus 232 ~---~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~ 267 (270)
T cd05056 232 N---CPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ 267 (270)
T ss_pred C---CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 1 12348889999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=273.29 Aligned_cols=226 Identities=23% Similarity=0.317 Sum_probs=174.6
Q ss_pred eeeeecCceEEEEEEeCCCcEEEEEecc----------------------CCccccceEEEecCceEEEEEEeccCCcee
Q 042435 149 YCIGTGGYDSVYKAELPDGKVVALKKLH----------------------HSETEDSAFVVYSPQCMFFIYEYMERGSLF 206 (412)
Q Consensus 149 ~~lG~G~~g~Vy~~~~~~~~~vAvK~l~----------------------~~~~~~~~~~~~~~~~~~lv~ey~~~gsL~ 206 (412)
++||+|+||.||++...+++.||+|.++ |+++......+......++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 3689999999999988779999999754 344444445567778899999999999999
Q ss_pred eeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCCCCc--ccc
Q 042435 207 CVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNR--TLQ 284 (412)
Q Consensus 207 ~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~--~~~ 284 (412)
+++..... .+++..++.++.+++.||+|||++ +++||||||+||+++.++.++|+|||+++......... ...
T Consensus 81 ~~l~~~~~--~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 155 (251)
T cd05041 81 TFLRKKKN--RLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLK 155 (251)
T ss_pred HHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccC
Confidence 98865432 478999999999999999999998 99999999999999999999999999997654221111 112
Q ss_pred cccccccccccccCcccCcccccHHHHHHHHHHHh-CCCCcccccccccCCCCcchhhHHhhhccCCccchhhHHHHHHH
Q 042435 285 AGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLM-GTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKIIQDIILV 363 (412)
Q Consensus 285 ~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 363 (412)
.++..|+|||.+.+..++.++|+||||+++|||+| |..||.... .....+.+......+.+.. ....+
T Consensus 156 ~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~--------~~~~~~~~~~~~~~~~~~~---~~~~~ 224 (251)
T cd05041 156 QIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMS--------NQQTRERIESGYRMPAPQL---CPEEI 224 (251)
T ss_pred cceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCC--------HHHHHHHHhcCCCCCCCcc---CCHHH
Confidence 33567999999988889999999999999999999 888875321 1112222222211111111 12348
Q ss_pred HHHHHhcCcCCCCCCCCHHHHHHHHhc
Q 042435 364 STIALACLRSKPKSRPTMQRISQELEG 390 (412)
Q Consensus 364 ~~l~~~Cl~~dP~~RPs~~evl~~L~~ 390 (412)
.+++.+||..+|++|||+.|+++.|++
T Consensus 225 ~~li~~~l~~~p~~Rp~~~ell~~l~~ 251 (251)
T cd05041 225 YRLMLQCWAYDPENRPSFSEIYNELQI 251 (251)
T ss_pred HHHHHHHhccChhhCcCHHHHHHHhhC
Confidence 899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=291.72 Aligned_cols=177 Identities=23% Similarity=0.276 Sum_probs=151.3
Q ss_pred hhcCcccceeeeecCceEEEEEEeC-CCcEEEEEe---------------ccCCccccceEEEecCceEEEEEEeccCCc
Q 042435 141 ATEYFHIRYCIGTGGYDSVYKAELP-DGKVVALKK---------------LHHSETEDSAFVVYSPQCMFFIYEYMERGS 204 (412)
Q Consensus 141 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~---------------l~~~~~~~~~~~~~~~~~~~lv~ey~~~gs 204 (412)
...+|++.+.||+|+||.||+|... +++.||+|. ++|+++.+....+...+..++|+||+. ++
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~ 142 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGTTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYS-SD 142 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCccccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEccC-Cc
Confidence 3457999999999999999999775 578899994 468888888888888899999999995 68
Q ss_pred eeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCCCCcccc
Q 042435 205 LFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQ 284 (412)
Q Consensus 205 L~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 284 (412)
|.+++.... ..++|..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++..... ......
T Consensus 143 l~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-~~~~~~ 216 (357)
T PHA03209 143 LYTYLTKRS--RPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA-PAFLGL 216 (357)
T ss_pred HHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCccccccccC-cccccc
Confidence 888876533 2589999999999999999999998 9999999999999999999999999999753322 122345
Q ss_pred cccccccccccccCcccCcccccHHHHHHHHHHHhCCCCc
Q 042435 285 AGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPG 324 (412)
Q Consensus 285 ~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~ 324 (412)
.||+.|+|||++.+..++.++|||||||++|||+++..|+
T Consensus 217 ~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 217 AGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred cccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 6899999999999999999999999999999999866554
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=270.37 Aligned_cols=233 Identities=23% Similarity=0.308 Sum_probs=189.2
Q ss_pred HHhhcCcccceeeeecCceEEEEEEe-CCCcEEEEEec------------------------------cCCccccceEEE
Q 042435 139 IDATEYFHIRYCIGTGGYDSVYKAEL-PDGKVVALKKL------------------------------HHSETEDSAFVV 187 (412)
Q Consensus 139 ~~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l------------------------------~~~~~~~~~~~~ 187 (412)
...-+.|+..+.||.|..+.|-++.. .+|..+|+|++ -|+++.....++
T Consensus 13 ~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~y 92 (411)
T KOG0599|consen 13 KGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVY 92 (411)
T ss_pred hhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeec
Confidence 44556788889999999999998855 57888999965 367777777778
Q ss_pred ecCceEEEEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEee
Q 042435 188 YSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVAD 267 (412)
Q Consensus 188 ~~~~~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~D 267 (412)
.++..+++|+|.|+.|.|+++|.+.- .++.....+|+.|+..|++|||.. +||||||||+|||+|++.++||+|
T Consensus 93 es~sF~FlVFdl~prGELFDyLts~V---tlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~isD 166 (411)
T KOG0599|consen 93 ESDAFVFLVFDLMPRGELFDYLTSKV---TLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKISD 166 (411)
T ss_pred cCcchhhhhhhhcccchHHHHhhhhe---eecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEec
Confidence 88889999999999999999997653 688899999999999999999999 999999999999999999999999
Q ss_pred cCCccccCCCCCCcccccccccccccccccC------cccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhh
Q 042435 268 FGTVRLLDVDSSNRTLQAGTYGYIALELVYT------MVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLI 341 (412)
Q Consensus 268 fGla~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~ 341 (412)
||++..+.+.. .....+|||+|.|||.+.. ..|+...|+||.|||+|.++.|..||..- .+..+.
T Consensus 167 FGFa~~l~~Ge-kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHR--------kQmlML 237 (411)
T KOG0599|consen 167 FGFACQLEPGE-KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHR--------KQMLML 237 (411)
T ss_pred cceeeccCCch-hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHH--------HHHHHH
Confidence 99999876553 3455799999999999853 34788999999999999999999998621 111222
Q ss_pred HHh-hhccCCccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 342 DIL-YQRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 342 ~~~-~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
..+ ....... .+.+.+....+.+|+.+|++.||.+|.|++|++++
T Consensus 238 R~ImeGkyqF~-speWadis~~~KdLIsrlLqVdp~~Ritake~LaH 283 (411)
T KOG0599|consen 238 RMIMEGKYQFR-SPEWADISATVKDLISRLLQVDPTKRITAKEALAH 283 (411)
T ss_pred HHHHhcccccC-CcchhhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence 222 2222221 23344445568999999999999999999999876
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=289.27 Aligned_cols=238 Identities=21% Similarity=0.186 Sum_probs=172.2
Q ss_pred HhhcCcccceeeeecCceEEEEEEe-CCCcEEEEEecc-----------------------CCccccceEEEec------
Q 042435 140 DATEYFHIRYCIGTGGYDSVYKAEL-PDGKVVALKKLH-----------------------HSETEDSAFVVYS------ 189 (412)
Q Consensus 140 ~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l~-----------------------~~~~~~~~~~~~~------ 189 (412)
...++|++.+.||+|+||.||++.. ..++.||||++. |+++.....++..
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~ 100 (364)
T cd07875 21 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE 100 (364)
T ss_pred chhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccc
Confidence 3457899999999999999999976 468899999764 3444443333322
Q ss_pred CceEEEEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecC
Q 042435 190 PQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFG 269 (412)
Q Consensus 190 ~~~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG 269 (412)
....++||||+++ +|.+.+.. .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||
T Consensus 101 ~~~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG 171 (364)
T cd07875 101 FQDVYIVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG 171 (364)
T ss_pred cCeEEEEEeCCCC-CHHHHHHh-----cCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeCC
Confidence 2357999999965 66665532 378889999999999999999998 99999999999999999999999999
Q ss_pred CccccCCCCCCcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccc-------cCCCCcchh--
Q 042435 270 TVRLLDVDSSNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLS-------SSSGPKIML-- 340 (412)
Q Consensus 270 la~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~-------~~~~~~~~~-- 340 (412)
+++...... ......||..|+|||++.+..++.++|||||||++|||++|+.||....... ....+....
T Consensus 172 ~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (364)
T cd07875 172 LARTAGTSF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMK 250 (364)
T ss_pred CccccCCCC-cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence 998654322 2233468999999999999999999999999999999999999986321100 000000000
Q ss_pred ------hHHhhhccC--------------Cc-cchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 341 ------IDILYQRLS--------------PP-INQKIIQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 341 ------~~~~~~~~~--------------~~-~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
......... .+ ...........+.+++.+|++.||++|||+.|++++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 251 KLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred hhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 000000000 00 000000012347899999999999999999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=277.94 Aligned_cols=229 Identities=22% Similarity=0.257 Sum_probs=166.9
Q ss_pred eeeecCceEEEEEEeCC---CcEEEEEecc----------------------CCccccceEEEecCceEEEEEEeccCCc
Q 042435 150 CIGTGGYDSVYKAELPD---GKVVALKKLH----------------------HSETEDSAFVVYSPQCMFFIYEYMERGS 204 (412)
Q Consensus 150 ~lG~G~~g~Vy~~~~~~---~~~vAvK~l~----------------------~~~~~~~~~~~~~~~~~~lv~ey~~~gs 204 (412)
.||+|+||.||+|.+.+ +..+|+|+++ |+++......+.+....++||||+++|+
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGD 81 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCc
Confidence 58999999999997643 4578999653 5555555566777788899999999999
Q ss_pred eeeeeccCcc--cccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCCC--C
Q 042435 205 LFCVLRDDDE--AIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSS--N 280 (412)
Q Consensus 205 L~~~l~~~~~--~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~--~ 280 (412)
|.++++.... ....++..+..++.|++.||+|||+. +++||||||+||+++.++++||+|||+++....... .
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~ 158 (269)
T cd05087 82 LKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVT 158 (269)
T ss_pred HHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccCcceeec
Confidence 9999875431 23467888889999999999999998 999999999999999999999999999875433221 1
Q ss_pred cccccccccccccccccCc-------ccCcccccHHHHHHHHHHHh-CCCCcccccccccCCCCcchhhHHh-hhccCCc
Q 042435 281 RTLQAGTYGYIALELVYTM-------VVTEKCVIYSFGVVALEVLM-GTHPGELLLSLSSSSGPKIMLIDIL-YQRLSPP 351 (412)
Q Consensus 281 ~~~~~gt~~y~aPE~~~~~-------~~s~ksDv~S~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 351 (412)
.....++..|+|||++.+. .++.++||||||+++|||++ |+.||.... ......... ......+
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~-------~~~~~~~~~~~~~~~~~ 231 (269)
T cd05087 159 PDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLS-------DEQVLTYTVREQQLKLP 231 (269)
T ss_pred CCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCC-------hHHHHHHHhhcccCCCC
Confidence 1234567889999988532 35789999999999999996 999986321 111111111 1111111
Q ss_pred cchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHh
Q 042435 352 INQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELE 389 (412)
Q Consensus 352 ~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~ 389 (412)
.+.........+.+++.+|| .+|++|||++||+..|+
T Consensus 232 ~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 232 KPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 00100011223677889999 58999999999998875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=277.62 Aligned_cols=235 Identities=26% Similarity=0.403 Sum_probs=181.4
Q ss_pred cCcccceeeeecCceEEEEEEeC-CCc----EEEEEec----------------------cCCccccceEEEecCceEEE
Q 042435 143 EYFHIRYCIGTGGYDSVYKAELP-DGK----VVALKKL----------------------HHSETEDSAFVVYSPQCMFF 195 (412)
Q Consensus 143 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~----~vAvK~l----------------------~~~~~~~~~~~~~~~~~~~l 195 (412)
++|++.+.||+|+||.||+|.++ +|+ .+|+|.+ +|+++......+.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 46788899999999999999764 233 6899865 35555555555655 78899
Q ss_pred EEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccC
Q 042435 196 IYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLD 275 (412)
Q Consensus 196 v~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~ 275 (412)
|+||+++|+|.+++..... .+++.....++.|++.||+|||+. +++||||||+||++++++.+||+|||+++...
T Consensus 86 v~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~ 160 (279)
T cd05057 86 ITQLMPLGCLLDYVRNHKD--NIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLD 160 (279)
T ss_pred EEecCCCCcHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCccccccc
Confidence 9999999999999876432 489999999999999999999998 99999999999999999999999999998765
Q ss_pred CCCCCc--ccccccccccccccccCcccCcccccHHHHHHHHHHHh-CCCCcccccccccCCCCcchhhHHhhhccCCcc
Q 042435 276 VDSSNR--TLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLM-GTHPGELLLSLSSSSGPKIMLIDILYQRLSPPI 352 (412)
Q Consensus 276 ~~~~~~--~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 352 (412)
...... ....++..|+|||.+....++.++|+||||+++||+++ |+.||+.. ....+.+.+......+.
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~--------~~~~~~~~~~~~~~~~~ 232 (279)
T cd05057 161 VDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGI--------PAVEIPDLLEKGERLPQ 232 (279)
T ss_pred CcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCC--------CHHHHHHHHhCCCCCCC
Confidence 332211 11223568999999988889999999999999999999 99998732 11112222222221111
Q ss_pred chhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhcCCCC
Q 042435 353 NQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELEGKTPM 394 (412)
Q Consensus 353 ~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~ 394 (412)
+.. ....+.+++.+||..||++||++.++++.|+.+...
T Consensus 233 ~~~---~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05057 233 PPI---CTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARD 271 (279)
T ss_pred CCC---CCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhC
Confidence 111 123478899999999999999999999999987543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=283.13 Aligned_cols=235 Identities=23% Similarity=0.362 Sum_probs=179.8
Q ss_pred cCcccceeeeecCceEEEEEEeC-CCc----EEEEEec----------------------cCCccccceEEEecCceEEE
Q 042435 143 EYFHIRYCIGTGGYDSVYKAELP-DGK----VVALKKL----------------------HHSETEDSAFVVYSPQCMFF 195 (412)
Q Consensus 143 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~----~vAvK~l----------------------~~~~~~~~~~~~~~~~~~~l 195 (412)
++|+..+.||+|+||.||+|.+. +|+ .||+|.+ +|+++......+.. ...++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~-~~~~~ 85 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLS-PTIQL 85 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcC-CCcee
Confidence 46778889999999999999763 444 5788854 45566665555544 45679
Q ss_pred EEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccC
Q 042435 196 IYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLD 275 (412)
Q Consensus 196 v~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~ 275 (412)
++||+++|+|.+++..... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++...
T Consensus 86 v~e~~~~g~l~~~~~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~ 160 (303)
T cd05110 86 VTQLMPHGCLLDYVHEHKD--NIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLE 160 (303)
T ss_pred eehhcCCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEcccccccccc
Confidence 9999999999998875432 478999999999999999999998 99999999999999999999999999998664
Q ss_pred CCCCC--cccccccccccccccccCcccCcccccHHHHHHHHHHHh-CCCCcccccccccCCCCcchhhHHhhhccCCcc
Q 042435 276 VDSSN--RTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLM-GTHPGELLLSLSSSSGPKIMLIDILYQRLSPPI 352 (412)
Q Consensus 276 ~~~~~--~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 352 (412)
..... .....++..|+|||++.+..++.++||||||+++||+++ |+.||... ......+.+......+.
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~--------~~~~~~~~~~~~~~~~~ 232 (303)
T cd05110 161 GDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGI--------PTREIPDLLEKGERLPQ 232 (303)
T ss_pred CcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCC--------CHHHHHHHHHCCCCCCC
Confidence 33221 122345678999999988889999999999999999997 88998632 11112223322222211
Q ss_pred chhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhcCCCC
Q 042435 353 NQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELEGKTPM 394 (412)
Q Consensus 353 ~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~ 394 (412)
... ....+.+++.+||..+|++||+++++++.|+++...
T Consensus 233 ~~~---~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~ 271 (303)
T cd05110 233 PPI---CTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD 271 (303)
T ss_pred CCC---CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 111 123478899999999999999999999999987543
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=275.54 Aligned_cols=234 Identities=25% Similarity=0.377 Sum_probs=180.0
Q ss_pred cCcccceeeeecCceEEEEEEe-CCCcEEEEEecc----------------------CCccccceEEEecCceEEEEEEe
Q 042435 143 EYFHIRYCIGTGGYDSVYKAEL-PDGKVVALKKLH----------------------HSETEDSAFVVYSPQCMFFIYEY 199 (412)
Q Consensus 143 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l~----------------------~~~~~~~~~~~~~~~~~~lv~ey 199 (412)
++|++.+.||.|+||+||+|.. .++..+|+|++. |+++......+...+..++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 4789999999999999999986 468899999763 33344444456678889999999
Q ss_pred ccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCCC
Q 042435 200 MERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSS 279 (412)
Q Consensus 200 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 279 (412)
+++++|.++++.......+++.....++.|++.||+|||+. +++||||||+||++++++.++|+|||++........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 99999999987643323589999999999999999999998 999999999999999999999999999876654322
Q ss_pred C----cccccccccccccccccCc-ccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccch
Q 042435 280 N----RTLQAGTYGYIALELVYTM-VVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQ 354 (412)
Q Consensus 280 ~----~~~~~gt~~y~aPE~~~~~-~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 354 (412)
. .....|+..|+|||++... .++.++|+|||||++|||++|+.||..... .....+...... +....
T Consensus 158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~-------~~~~~~~~~~~~-~~~~~ 229 (267)
T cd06610 158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPP-------MKVLMLTLQNDP-PSLET 229 (267)
T ss_pred ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccCh-------hhhHHHHhcCCC-CCcCC
Confidence 2 1334688999999998776 789999999999999999999999873211 111122221111 11100
Q ss_pred hh--HHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 355 KI--IQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 355 ~~--~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
.. ......+.+++.+||+.||++||++.|++++
T Consensus 230 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 230 GADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred ccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 00 1122347899999999999999999999874
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=275.67 Aligned_cols=228 Identities=21% Similarity=0.295 Sum_probs=171.5
Q ss_pred cCcccceeeeecCceEEEEEEe-CCCcEEEEEecc--------------------------CCccccceEEEec--CceE
Q 042435 143 EYFHIRYCIGTGGYDSVYKAEL-PDGKVVALKKLH--------------------------HSETEDSAFVVYS--PQCM 193 (412)
Q Consensus 143 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l~--------------------------~~~~~~~~~~~~~--~~~~ 193 (412)
.+|+..+.||+|+||.||+|.. .++..||+|.++ |+++......+.. ....
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 4788999999999999999976 468999999653 3343333333333 3567
Q ss_pred EEEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccc
Q 042435 194 FFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRL 273 (412)
Q Consensus 194 ~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~ 273 (412)
++++||+++++|.+++.... .+++.....++.|++.||+|||+. +++||||||+||+++.++.++|+|||+++.
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg~~~~ 155 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYG---ALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKR 155 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence 89999999999999887543 488999999999999999999988 999999999999999999999999999876
Q ss_pred cCCCC---CCcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCC
Q 042435 274 LDVDS---SNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSP 350 (412)
Q Consensus 274 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 350 (412)
..... .......++..|+|||.+.+..++.++|||||||++||+++|+.||.... ..............+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~-------~~~~~~~~~~~~~~~ 228 (266)
T cd06651 156 LQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYE-------AMAAIFKIATQPTNP 228 (266)
T ss_pred cccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccc-------hHHHHHHHhcCCCCC
Confidence 53211 11223458889999999998889999999999999999999999987321 111111111111111
Q ss_pred ccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 351 PINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 351 ~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
..+.. ....+.+++ +||..+|++||+++|++++
T Consensus 229 ~~~~~---~~~~~~~li-~~~~~~p~~Rp~~~eil~h 261 (266)
T cd06651 229 QLPSH---ISEHARDFL-GCIFVEARHRPSAEELLRH 261 (266)
T ss_pred CCchh---cCHHHHHHH-HHhcCChhhCcCHHHHhcC
Confidence 11111 112245555 7888999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=289.73 Aligned_cols=238 Identities=21% Similarity=0.195 Sum_probs=172.9
Q ss_pred HhhcCcccceeeeecCceEEEEEEe-CCCcEEEEEecc-----------------------CCccccceEEEec------
Q 042435 140 DATEYFHIRYCIGTGGYDSVYKAEL-PDGKVVALKKLH-----------------------HSETEDSAFVVYS------ 189 (412)
Q Consensus 140 ~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l~-----------------------~~~~~~~~~~~~~------ 189 (412)
...++|++.+.||+|+||.||++.. ..++.||||++. |+++.....++..
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 4557899999999999999999976 468899999763 4444444444332
Q ss_pred CceEEEEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecC
Q 042435 190 PQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFG 269 (412)
Q Consensus 190 ~~~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG 269 (412)
....++||||+++ +|.+.+.. .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||
T Consensus 94 ~~~~~lv~e~~~~-~l~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~Dfg 164 (355)
T cd07874 94 FQDVYLVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG 164 (355)
T ss_pred cceeEEEhhhhcc-cHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEeeCc
Confidence 2357999999965 66555532 378889999999999999999998 99999999999999999999999999
Q ss_pred CccccCCCCCCcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCccccccccc-------CCCCc-----
Q 042435 270 TVRLLDVDSSNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSS-------SSGPK----- 337 (412)
Q Consensus 270 la~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~-------~~~~~----- 337 (412)
+++...... ......||..|+|||++.+..++.++|||||||++|||++|+.||........ ...+.
T Consensus 165 ~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (355)
T cd07874 165 LARTAGTSF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK 243 (355)
T ss_pred ccccCCCcc-ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 998654322 22334689999999999988999999999999999999999999863211000 00000
Q ss_pred ---chhhHHhhhccC---------------CccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 338 ---IMLIDILYQRLS---------------PPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 338 ---~~~~~~~~~~~~---------------~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
............ +............+.+++.+|++.||++|||+.|++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 244 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred hhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 000001000000 00000000112347899999999999999999999987
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=281.85 Aligned_cols=239 Identities=18% Similarity=0.238 Sum_probs=176.4
Q ss_pred cCcccceeeeecCceEEEEEEeC-CCcEEEEEec----------------------cCCccccceEEEecCceEEEEEEe
Q 042435 143 EYFHIRYCIGTGGYDSVYKAELP-DGKVVALKKL----------------------HHSETEDSAFVVYSPQCMFFIYEY 199 (412)
Q Consensus 143 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l----------------------~~~~~~~~~~~~~~~~~~~lv~ey 199 (412)
++|.+.+.||+|+||.||+|... +++.||+|.+ +|+++......+...+..++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 56888999999999999999764 6889999964 456666667778888899999999
Q ss_pred ccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCCC
Q 042435 200 MERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSS 279 (412)
Q Consensus 200 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 279 (412)
++ ++|.+++..... .+++.....++.|++.||+|||+. +++||||||+||+++.++.++|+|||+++.......
T Consensus 86 ~~-~~l~~~l~~~~~--~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 159 (301)
T cd07873 86 LD-KDLKQYLDDCGN--SINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK 159 (301)
T ss_pred cc-cCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC
Confidence 97 588887765432 478899999999999999999998 999999999999999999999999999976543333
Q ss_pred CcccccccccccccccccC-cccCcccccHHHHHHHHHHHhCCCCccccccccc--------CCCCcchhhHHhhh----
Q 042435 280 NRTLQAGTYGYIALELVYT-MVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSS--------SSGPKIMLIDILYQ---- 346 (412)
Q Consensus 280 ~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~--------~~~~~~~~~~~~~~---- 346 (412)
......+++.|+|||.+.+ ..++.++|||||||++|||+||+.||........ ..............
T Consensus 160 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (301)
T cd07873 160 TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFK 239 (301)
T ss_pred cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcccccc
Confidence 3334467889999998865 4578899999999999999999999863211000 00000000000000
Q ss_pred ccC-Cccchh-----hHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 347 RLS-PPINQK-----IIQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 347 ~~~-~~~~~~-----~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
... +..... .......+.+++.+|++.||.+|||++|++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h 286 (301)
T cd07873 240 SYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKH 286 (301)
T ss_pred ccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 000 000000 00112247789999999999999999999874
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-36 Score=283.04 Aligned_cols=226 Identities=26% Similarity=0.344 Sum_probs=174.5
Q ss_pred ccceeeeecCceEEEEEEe-CCCcEEEEEecc---------------------CCccccceEEEecCceEEEEEEeccCC
Q 042435 146 HIRYCIGTGGYDSVYKAEL-PDGKVVALKKLH---------------------HSETEDSAFVVYSPQCMFFIYEYMERG 203 (412)
Q Consensus 146 ~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l~---------------------~~~~~~~~~~~~~~~~~~lv~ey~~~g 203 (412)
.....||+|+||.||++.. .+++.||||.+. |+++......+...+..++||||++++
T Consensus 25 ~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~ 104 (292)
T cd06658 25 DSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGG 104 (292)
T ss_pred hhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCC
Confidence 3346799999999999976 468899999763 344444444566778899999999999
Q ss_pred ceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCCCCccc
Q 042435 204 SLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTL 283 (412)
Q Consensus 204 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 283 (412)
+|.+++... .+++..+..++.|++.||+|||++ +++||||||+||++++++.++|+|||++............
T Consensus 105 ~L~~~~~~~----~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~ 177 (292)
T cd06658 105 ALTDIVTHT----RMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKS 177 (292)
T ss_pred cHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhcccccccCce
Confidence 999887543 388999999999999999999998 9999999999999999999999999998765433333334
Q ss_pred ccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccchhhHHHHHHH
Q 042435 284 QAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKIIQDIILV 363 (412)
Q Consensus 284 ~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 363 (412)
..|+..|+|||...+..++.++||||||+++|||++|+.||.... ... ....+........ .........+
T Consensus 178 ~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~-------~~~-~~~~~~~~~~~~~-~~~~~~~~~~ 248 (292)
T cd06658 178 LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEP-------PLQ-AMRRIRDNLPPRV-KDSHKVSSVL 248 (292)
T ss_pred eecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-------HHH-HHHHHHhcCCCcc-ccccccCHHH
Confidence 568899999999988889999999999999999999999986321 111 1111111111111 1111122247
Q ss_pred HHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 364 STIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 364 ~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
.+++.+||..||++|||++|++++
T Consensus 249 ~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 249 RGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred HHHHHHHccCChhHCcCHHHHhhC
Confidence 788999999999999999999976
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=281.04 Aligned_cols=236 Identities=18% Similarity=0.216 Sum_probs=161.9
Q ss_pred cCcccceeeeecCceEEEEEEeCC----CcEEEEEecc--------------------------------CCccccceEE
Q 042435 143 EYFHIRYCIGTGGYDSVYKAELPD----GKVVALKKLH--------------------------------HSETEDSAFV 186 (412)
Q Consensus 143 ~~f~~~~~lG~G~~g~Vy~~~~~~----~~~vAvK~l~--------------------------------~~~~~~~~~~ 186 (412)
++|++.++||+|+||.||+|...+ +..+|+|... |.++......
T Consensus 12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~ 91 (294)
T PHA02882 12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC 91 (294)
T ss_pred CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence 579999999999999999998754 4566666432 1112221111
Q ss_pred EecC----ceEEEEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCc
Q 042435 187 VYSP----QCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLE 262 (412)
Q Consensus 187 ~~~~----~~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~ 262 (412)
+... ...++++|++.. ++.+.+.... ..++..+..++.|++.||+|||+. +|+||||||+|||++.++.
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~~~~~ 164 (294)
T PHA02882 92 GSFKRCRMYYRFILLEKLVE-NTKEIFKRIK---CKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVDGNNR 164 (294)
T ss_pred eeEecCCceEEEEEEehhcc-CHHHHHHhhc---cCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCc
Confidence 1111 123566776643 4444443221 256788889999999999999998 9999999999999999999
Q ss_pred EEEeecCCccccCCCC-------CCcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCC
Q 042435 263 AFVADFGTVRLLDVDS-------SNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSG 335 (412)
Q Consensus 263 ~kl~DfGla~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~ 335 (412)
++|+|||+++...... .......||+.|+|||+..+..++.++|||||||++|||++|+.||.........
T Consensus 165 ~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~-- 242 (294)
T PHA02882 165 GYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNL-- 242 (294)
T ss_pred EEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHH--
Confidence 9999999998653321 1112346999999999999999999999999999999999999999743110000
Q ss_pred CcchhhHHhhhccCCccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHh
Q 042435 336 PKIMLIDILYQRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELE 389 (412)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~ 389 (412)
......+.......+.. ........+.+++..||+.+|++||++.++.+.|+
T Consensus 243 ~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 243 IHAAKCDFIKRLHEGKI--KIKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred HHHhHHHHHHHhhhhhh--ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 00000111111111100 00111234789999999999999999999998763
|
|
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=275.68 Aligned_cols=235 Identities=21% Similarity=0.272 Sum_probs=179.4
Q ss_pred cCcccceeeeecCceEEEEEEeC------CCcEEEEEec----------------------cCCccccceEEEecCceEE
Q 042435 143 EYFHIRYCIGTGGYDSVYKAELP------DGKVVALKKL----------------------HHSETEDSAFVVYSPQCMF 194 (412)
Q Consensus 143 ~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vAvK~l----------------------~~~~~~~~~~~~~~~~~~~ 194 (412)
++|++...||+|+||.||+|..+ +.+.||+|.+ +|+++......+...+..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 56888899999999999999863 3567999965 3455555555677778899
Q ss_pred EEEEeccCCceeeeeccCccc------ccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeec
Q 042435 195 FIYEYMERGSLFCVLRDDDEA------IELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADF 268 (412)
Q Consensus 195 lv~ey~~~gsL~~~l~~~~~~------~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Df 268 (412)
+||||+++|+|.+++...... ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.++++||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEEccc
Confidence 999999999999998754421 1589999999999999999999998 9999999999999999999999999
Q ss_pred CCccccCCCC-CCcccccccccccccccccCcccCcccccHHHHHHHHHHHh-CCCCcccccccccCCCCcchhhHHhhh
Q 042435 269 GTVRLLDVDS-SNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLM-GTHPGELLLSLSSSSGPKIMLIDILYQ 346 (412)
Q Consensus 269 Gla~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~ 346 (412)
|+++...... .......++..|+|||.+.+..++.++||||||+++||+++ |..||.... ...........
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~-------~~~~~~~~~~~ 234 (275)
T cd05046 162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLS-------DEEVLNRLQAG 234 (275)
T ss_pred ccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccc-------hHHHHHHHHcC
Confidence 9987543221 12233356778999999988888999999999999999999 788875221 11111111111
Q ss_pred ccCCccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhc
Q 042435 347 RLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELEG 390 (412)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~ 390 (412)
....+.... ....+.+++.+||+.+|++|||+.|+++.|.+
T Consensus 235 ~~~~~~~~~---~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~~ 275 (275)
T cd05046 235 KLELPVPEG---CPSRLYKLMTRCWAVNPKDRPSFSELVSALGE 275 (275)
T ss_pred CcCCCCCCC---CCHHHHHHHHHHcCCCcccCCCHHHHHHHhcC
Confidence 111111111 12248889999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=279.52 Aligned_cols=232 Identities=23% Similarity=0.352 Sum_probs=181.3
Q ss_pred hcCcccceeeeecCceEEEEEEeC-CCcEEEEEec---------------------cCCccccceEEEecCceEEEEEEe
Q 042435 142 TEYFHIRYCIGTGGYDSVYKAELP-DGKVVALKKL---------------------HHSETEDSAFVVYSPQCMFFIYEY 199 (412)
Q Consensus 142 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l---------------------~~~~~~~~~~~~~~~~~~~lv~ey 199 (412)
.++|++.+.||+|+||.||+|... +++.+|+|.+ +|+++......+..+...++||||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 467899999999999999999874 6899999964 466666667777888899999999
Q ss_pred ccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCCC
Q 042435 200 MERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSS 279 (412)
Q Consensus 200 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 279 (412)
+++++|.+++..... .+++.....++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++........
T Consensus 84 ~~~~~L~~~~~~~~~--~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~ 158 (280)
T cd06611 84 CDGGALDSIMLELER--GLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ 158 (280)
T ss_pred cCCCcHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhhccccc
Confidence 999999998865432 489999999999999999999998 999999999999999999999999999876544333
Q ss_pred Cccccccccccccccccc-----CcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccch
Q 042435 280 NRTLQAGTYGYIALELVY-----TMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQ 354 (412)
Q Consensus 280 ~~~~~~gt~~y~aPE~~~-----~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 354 (412)
......+++.|+|||.+. ...++.++||||||+++|||++|+.||.... .......+.. ...+.. .
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~-------~~~~~~~~~~-~~~~~~-~ 229 (280)
T cd06611 159 KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELN-------PMRVLLKILK-SEPPTL-D 229 (280)
T ss_pred ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCC-------HHHHHHHHhc-CCCCCc-C
Confidence 334456899999999874 3457789999999999999999999986321 1111111111 111110 0
Q ss_pred hhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 355 KIIQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 355 ~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
........+.+++.+||+.+|++||++.+++++
T Consensus 230 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 230 QPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred CcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 001112247789999999999999999999876
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=277.64 Aligned_cols=239 Identities=22% Similarity=0.266 Sum_probs=175.3
Q ss_pred CcccceeeeecCceEEEEEEeC-CCcEEEEEe-----------------ccCCccccceEEEecC-----ceEEEEEEec
Q 042435 144 YFHIRYCIGTGGYDSVYKAELP-DGKVVALKK-----------------LHHSETEDSAFVVYSP-----QCMFFIYEYM 200 (412)
Q Consensus 144 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~-----------------l~~~~~~~~~~~~~~~-----~~~~lv~ey~ 200 (412)
.|...+++|.|+||.||+|... +++.||||+ ++|+|+++....+... -+..+|||||
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleym 104 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYM 104 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhc
Confidence 4666789999999999999874 479999995 4799998877664432 2456899999
Q ss_pred cCCceeeeeccCc-ccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCC-CcEEEeecCCccccCCCC
Q 042435 201 ERGSLFCVLRDDD-EAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSN-LEAFVADFGTVRLLDVDS 278 (412)
Q Consensus 201 ~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~-~~~kl~DfGla~~~~~~~ 278 (412)
|. +|.++++... ....++...+.-+..|+.+||+|||+. +|+||||||.|+|+|.+ +.+||||||.|+.+..+.
T Consensus 105 P~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~e 180 (364)
T KOG0658|consen 105 PE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGE 180 (364)
T ss_pred hH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCcceeeccCC
Confidence 87 8998887421 112466667778999999999999998 99999999999999965 999999999999887665
Q ss_pred CCcccccccccccccccccCc-ccCcccccHHHHHHHHHHHhCCCCccccccccc--------CCCCcchhh-------H
Q 042435 279 SNRTLQAGTYGYIALELVYTM-VVTEKCVIYSFGVVALEVLMGTHPGELLLSLSS--------SSGPKIMLI-------D 342 (412)
Q Consensus 279 ~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~--------~~~~~~~~~-------~ 342 (412)
.+ .....|..|+|||.+.+. .|+.+.||||.||++.||+-|+.-|........ .......+. +
T Consensus 181 pn-iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~~ 259 (364)
T KOG0658|consen 181 PN-ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNYTE 259 (364)
T ss_pred Cc-eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCccccc
Confidence 55 344678999999998865 699999999999999999999988763211100 000000000 0
Q ss_pred HhhhccCCccc-h-hhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 343 ILYQRLSPPIN-Q-KIIQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 343 ~~~~~~~~~~~-~-~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
...+.+.+... . ..........+++.+++..+|.+|.++.|++.+
T Consensus 260 ~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h 306 (364)
T KOG0658|consen 260 FKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH 306 (364)
T ss_pred ccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence 01111111100 0 011122347899999999999999999998765
|
|
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=276.70 Aligned_cols=218 Identities=23% Similarity=0.281 Sum_probs=166.9
Q ss_pred eeeecCceEEEEEEeCC-------------------------CcEEEEEec---------------------cCCccccc
Q 042435 150 CIGTGGYDSVYKAELPD-------------------------GKVVALKKL---------------------HHSETEDS 183 (412)
Q Consensus 150 ~lG~G~~g~Vy~~~~~~-------------------------~~~vAvK~l---------------------~~~~~~~~ 183 (412)
.||+|+||.||+|.+.. ...||+|.+ +|+++...
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 58999999999996421 235888854 57778888
Q ss_pred eEEEecCceEEEEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCC--
Q 042435 184 AFVVYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNL-- 261 (412)
Q Consensus 184 ~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~-- 261 (412)
...+......++||||+++|+|..++..... .+++..++.++.|+++||+|||+. +|+||||||+||+++.++
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~~~~~ 156 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEKG--RVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLARLGLA 156 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEeccCcc
Confidence 8888888899999999999999988865332 488999999999999999999988 999999999999997543
Q ss_pred -----cEEEeecCCccccCCCCCCcccccccccccccccccC-cccCcccccHHHHHHHHHHH-hCCCCcccccccccCC
Q 042435 262 -----EAFVADFGTVRLLDVDSSNRTLQAGTYGYIALELVYT-MVVTEKCVIYSFGVVALEVL-MGTHPGELLLSLSSSS 334 (412)
Q Consensus 262 -----~~kl~DfGla~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~S~Gvil~ell-tg~~P~~~~~~~~~~~ 334 (412)
.+|++|||++...... ....++..|+|||.+.+ ..++.++||||||+++||++ +|+.||....
T Consensus 157 ~~~~~~~kl~d~g~~~~~~~~----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~------ 226 (274)
T cd05076 157 EGTSPFIKLSDPGVSFTALSR----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERT------ 226 (274)
T ss_pred cCccceeeecCCccccccccc----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccC------
Confidence 3799999987643221 22356788999998865 56889999999999999985 6899886321
Q ss_pred CCcchhhHHhhhccCCccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHh
Q 042435 335 GPKIMLIDILYQRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELE 389 (412)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~ 389 (412)
. .............+. .. ...+.+++.+||+.+|++|||+.++++.|.
T Consensus 227 -~-~~~~~~~~~~~~~~~--~~---~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 227 -P-SEKERFYEKKHRLPE--PS---CKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred -h-HHHHHHHHhccCCCC--CC---ChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 1 111122222221111 11 123788999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=277.28 Aligned_cols=232 Identities=23% Similarity=0.324 Sum_probs=174.8
Q ss_pred cCcccceeeeecCceEEEEEEeC-CCcEEEEEecc-----------------------CCccccceEEEecCceEEEEEE
Q 042435 143 EYFHIRYCIGTGGYDSVYKAELP-DGKVVALKKLH-----------------------HSETEDSAFVVYSPQCMFFIYE 198 (412)
Q Consensus 143 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~-----------------------~~~~~~~~~~~~~~~~~~lv~e 198 (412)
++|++.+.||+|+||.||+|... +|+.||+|+++ |+++......+..++..+++||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 47889999999999999999774 69999999753 3444445555677888999999
Q ss_pred eccCCceeeeeccCc-ccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCC
Q 042435 199 YMERGSLFCVLRDDD-EAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVD 277 (412)
Q Consensus 199 y~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~ 277 (412)
|++ |+|.+++.... ....+++..+..++.|++.||+|||+++ +++||||||+||+++.++.+||+|||+++.....
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 996 68877765421 2235899999999999999999999753 7999999999999999999999999998865322
Q ss_pred CCCcccccccccccccccccC----cccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccc
Q 042435 278 SSNRTLQAGTYGYIALELVYT----MVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPIN 353 (412)
Q Consensus 278 ~~~~~~~~gt~~y~aPE~~~~----~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 353 (412)
. ......++..|+|||.+.+ ..++.++|+||||+++|||++|+.||.... ............ ..+..+
T Consensus 158 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~------~~~~~~~~~~~~-~~~~~~ 229 (283)
T cd06617 158 V-AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWK------TPFQQLKQVVEE-PSPQLP 229 (283)
T ss_pred c-ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccc------cCHHHHHHHHhc-CCCCCC
Confidence 1 1233467889999998864 446889999999999999999999986321 011111222211 111111
Q ss_pred hhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 354 QKIIQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 354 ~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
.. .....+.+++.+||..+|++||++.+++++
T Consensus 230 ~~--~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 261 (283)
T cd06617 230 AE--KFSPEFQDFVNKCLKKNYKERPNYPELLQH 261 (283)
T ss_pred cc--ccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11 112347889999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=290.90 Aligned_cols=239 Identities=22% Similarity=0.224 Sum_probs=178.9
Q ss_pred hcCcccceeeeecCceEEEEEEeC---CCcEEEEEec----------------cCCccccceEEEecCceEEEEEEeccC
Q 042435 142 TEYFHIRYCIGTGGYDSVYKAELP---DGKVVALKKL----------------HHSETEDSAFVVYSPQCMFFIYEYMER 202 (412)
Q Consensus 142 ~~~f~~~~~lG~G~~g~Vy~~~~~---~~~~vAvK~l----------------~~~~~~~~~~~~~~~~~~~lv~ey~~~ 202 (412)
..+|++.+.||+|+||.||++... .++.||+|.+ +|+++......+......+++|||+.
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e~~~- 169 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGKTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKYK- 169 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEehhcC-
Confidence 357999999999999999999653 3678999954 57777777777777889999999995
Q ss_pred CceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCCCC--
Q 042435 203 GSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSN-- 280 (412)
Q Consensus 203 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~-- 280 (412)
++|.+++.... .+++..++.++.|++.||+|||++ +|+||||||+|||++.++.++|+|||+++........
T Consensus 170 ~~l~~~l~~~~---~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~~~ 243 (392)
T PHA03207 170 CDLFTYVDRSG---PLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQ 243 (392)
T ss_pred CCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCccccccCccccccc
Confidence 68888774332 589999999999999999999998 9999999999999999999999999999765443221
Q ss_pred cccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccc---------------cCCCCc---chhhH
Q 042435 281 RTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLS---------------SSSGPK---IMLID 342 (412)
Q Consensus 281 ~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~---------------~~~~~~---~~~~~ 342 (412)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||....... ....+. .....
T Consensus 244 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~ 323 (392)
T PHA03207 244 CYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLCK 323 (392)
T ss_pred ccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhHHH
Confidence 234579999999999999999999999999999999999999985321100 000000 00000
Q ss_pred Hhh---hccCCcc--chhh--HHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 343 ILY---QRLSPPI--NQKI--IQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 343 ~~~---~~~~~~~--~~~~--~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
... ....++. +... ......+.+++.+|+..||++|||+.|++++
T Consensus 324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 324 HFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred HHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 000 0001100 0000 0112346788999999999999999999987
|
|
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=275.29 Aligned_cols=226 Identities=27% Similarity=0.395 Sum_probs=178.7
Q ss_pred CcccceeeeecCceEEEEEEe-CCCcEEEEEec----------------------cCCccccceEEEecCceEEEEEEec
Q 042435 144 YFHIRYCIGTGGYDSVYKAEL-PDGKVVALKKL----------------------HHSETEDSAFVVYSPQCMFFIYEYM 200 (412)
Q Consensus 144 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l----------------------~~~~~~~~~~~~~~~~~~~lv~ey~ 200 (412)
-|+..+.||+|+||.||+|.. .+++.||+|.+ +|+++......+..++..++||||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 367778999999999999976 46899999964 3455555555677788899999999
Q ss_pred cCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCCCC
Q 042435 201 ERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSN 280 (412)
Q Consensus 201 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 280 (412)
++++|.+++... .+++.....++.|++.|+.|||+. +++|+||||+||+++.++.++++|||+++........
T Consensus 85 ~~~~l~~~i~~~----~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~ 157 (277)
T cd06641 85 GGGSALDLLEPG----PLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK 157 (277)
T ss_pred CCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceecccchhh
Confidence 999999888643 489999999999999999999998 9999999999999999999999999998766443333
Q ss_pred cccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccchhhHHHH
Q 042435 281 RTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKIIQDI 360 (412)
Q Consensus 281 ~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 360 (412)
.....++..|+|||.+.+..++.++|+|||||++|||++|..||.... . ......+.....+.... ...
T Consensus 158 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~-------~-~~~~~~~~~~~~~~~~~---~~~ 226 (277)
T cd06641 158 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELH-------P-MKVLFLIPKNNPPTLEG---NYS 226 (277)
T ss_pred hccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccc-------h-HHHHHHHhcCCCCCCCc---ccC
Confidence 334467889999999988888999999999999999999999986321 1 11111111111111111 112
Q ss_pred HHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 361 ILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 361 ~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
..+.+++.+||+.+|++||++.+++++
T Consensus 227 ~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 227 KPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 347789999999999999999999996
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=275.53 Aligned_cols=228 Identities=24% Similarity=0.330 Sum_probs=173.7
Q ss_pred eeeeecCceEEEEEEeCC-------CcEEEEEec----------------------cCCccccceEEEecCceEEEEEEe
Q 042435 149 YCIGTGGYDSVYKAELPD-------GKVVALKKL----------------------HHSETEDSAFVVYSPQCMFFIYEY 199 (412)
Q Consensus 149 ~~lG~G~~g~Vy~~~~~~-------~~~vAvK~l----------------------~~~~~~~~~~~~~~~~~~~lv~ey 199 (412)
+.||+|+||.||+|...+ ++.+|+|.+ +|+++......+...+..++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 368999999999997642 257888854 456666666667778889999999
Q ss_pred ccCCceeeeeccCc----ccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCC-----cEEEeecCC
Q 042435 200 MERGSLFCVLRDDD----EAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNL-----EAFVADFGT 270 (412)
Q Consensus 200 ~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~-----~~kl~DfGl 270 (412)
+++|+|.+++.... ....++|.+++.++.|++.||+|||+. +++|+||||+||+++.+. .++++|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 99999999986532 122478999999999999999999988 999999999999999877 899999999
Q ss_pred ccccCCCCC--CcccccccccccccccccCcccCcccccHHHHHHHHHHHh-CCCCcccccccccCCCCcchhhHHhhhc
Q 042435 271 VRLLDVDSS--NRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLM-GTHPGELLLSLSSSSGPKIMLIDILYQR 347 (412)
Q Consensus 271 a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~ 347 (412)
++....... ......++..|+|||++.+..++.++||||||+++|||+| |+.||.... .......+...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~--------~~~~~~~~~~~ 229 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALN--------NQEVLQHVTAG 229 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccC--------HHHHHHHHhcC
Confidence 876533221 1122345678999999999999999999999999999998 999986221 11111222111
Q ss_pred cCCccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhc
Q 042435 348 LSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELEG 390 (412)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~ 390 (412)
........ ....+.+++.+||..+|++||++.++.+.|++
T Consensus 230 ~~~~~~~~---~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 230 GRLQKPEN---CPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred CccCCccc---chHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 11111111 12347899999999999999999999999864
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=276.36 Aligned_cols=229 Identities=22% Similarity=0.270 Sum_probs=166.6
Q ss_pred eeeecCceEEEEEEeCC---CcEEEEEec----------------------cCCccccceEEEecCceEEEEEEeccCCc
Q 042435 150 CIGTGGYDSVYKAELPD---GKVVALKKL----------------------HHSETEDSAFVVYSPQCMFFIYEYMERGS 204 (412)
Q Consensus 150 ~lG~G~~g~Vy~~~~~~---~~~vAvK~l----------------------~~~~~~~~~~~~~~~~~~~lv~ey~~~gs 204 (412)
.||+|+||.||+|...+ ...+|+|.+ +|+++......+......++||||+++|+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 58999999999996543 457888854 46666666667778888999999999999
Q ss_pred eeeeeccCcc--cccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCCC--C
Q 042435 205 LFCVLRDDDE--AIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSS--N 280 (412)
Q Consensus 205 L~~~l~~~~~--~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~--~ 280 (412)
|.+++..... ....++.....++.|++.||+|||+. +|+||||||+||++++++++||+|||+++....... .
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT 158 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence 9999876432 12356788899999999999999998 999999999999999999999999999875432211 1
Q ss_pred ccccccccccccccccc-------CcccCcccccHHHHHHHHHHHh-CCCCcccccccccCCCCcchhhHHhhhc-cCCc
Q 042435 281 RTLQAGTYGYIALELVY-------TMVVTEKCVIYSFGVVALEVLM-GTHPGELLLSLSSSSGPKIMLIDILYQR-LSPP 351 (412)
Q Consensus 281 ~~~~~gt~~y~aPE~~~-------~~~~s~ksDv~S~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 351 (412)
.....++..|+|||+.. ...++.++|||||||++|||++ |..||.... +........... ...+
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~-------~~~~~~~~~~~~~~~~~ 231 (269)
T cd05042 159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLS-------DEQVLKQVVREQDIKLP 231 (269)
T ss_pred cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCC-------HHHHHHHHhhccCccCC
Confidence 12234567899999864 2356789999999999999999 778876321 111111111111 1111
Q ss_pred cchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHh
Q 042435 352 INQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELE 389 (412)
Q Consensus 352 ~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~ 389 (412)
.+.........+.+++..|| .||++|||++||++.|.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 232 KPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred CCcccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 11111112233567888898 49999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=271.93 Aligned_cols=227 Identities=24% Similarity=0.306 Sum_probs=176.9
Q ss_pred CcccceeeeecCceEEEEEEeC-CCcEEEEEecc--------------------------CCccccceEEEecCceEEEE
Q 042435 144 YFHIRYCIGTGGYDSVYKAELP-DGKVVALKKLH--------------------------HSETEDSAFVVYSPQCMFFI 196 (412)
Q Consensus 144 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~--------------------------~~~~~~~~~~~~~~~~~~lv 196 (412)
+|+..+.||+|+||.||+|... +++.||+|.+. |+++......+......+++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 3677789999999999999875 78999999653 44455555567777889999
Q ss_pred EEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCC
Q 042435 197 YEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDV 276 (412)
Q Consensus 197 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~ 276 (412)
+||+++++|.+++.... .+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.+||+|||++.....
T Consensus 81 ~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~ 154 (258)
T cd06632 81 LELVPGGSLAKLLKKYG---SFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVE 154 (258)
T ss_pred EEecCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence 99999999999887543 488999999999999999999998 999999999999999999999999999876543
Q ss_pred CCCCcccccccccccccccccCcc-cCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccchh
Q 042435 277 DSSNRTLQAGTYGYIALELVYTMV-VTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQK 355 (412)
Q Consensus 277 ~~~~~~~~~gt~~y~aPE~~~~~~-~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 355 (412)
.. ......|+..|+|||.+.... ++.++|+||||+++|+|++|+.||.... ..............+..+..
T Consensus 155 ~~-~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~-------~~~~~~~~~~~~~~~~~~~~ 226 (258)
T cd06632 155 FS-FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLE-------GVAAVFKIGRSKELPPIPDH 226 (258)
T ss_pred cc-cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCc-------HHHHHHHHHhcccCCCcCCC
Confidence 32 223456889999999987766 8999999999999999999999986321 11111111110111111111
Q ss_pred hHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 356 IIQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 356 ~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
....+.+++.+||+.+|++||++.+++.+
T Consensus 227 ---~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 255 (258)
T cd06632 227 ---LSDEAKDFILKCLQRDPSLRPTAAELLEH 255 (258)
T ss_pred ---cCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence 12337789999999999999999999864
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=272.52 Aligned_cols=233 Identities=24% Similarity=0.316 Sum_probs=179.1
Q ss_pred CcccceeeeecCceEEEEEEe-CCCcEEEEEecc-----------------------CCccccceEEEe--cCceEEEEE
Q 042435 144 YFHIRYCIGTGGYDSVYKAEL-PDGKVVALKKLH-----------------------HSETEDSAFVVY--SPQCMFFIY 197 (412)
Q Consensus 144 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l~-----------------------~~~~~~~~~~~~--~~~~~~lv~ 197 (412)
+|++.+.||+|+||.||++.. .+++.+|+|.++ |+++......+. .....+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 478889999999999999965 568899999753 444444333332 345689999
Q ss_pred EeccCCceeeeeccCc-ccccCCHHHHHHHHHHHHHHHHHHHhCC--CCCcEEeCCCCCCEEecCCCcEEEeecCCcccc
Q 042435 198 EYMERGSLFCVLRDDD-EAIELNWTRRMNIVKSVAHALSYLHHDC--TPSIVHRDISSNNILLNSNLEAFVADFGTVRLL 274 (412)
Q Consensus 198 ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~~LH~~~--~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~ 274 (412)
||+++++|.+++.... ....+++...+.++.|++.||+|||..+ ..+++|+||||+||++++++.+|++|||++...
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 9999999999886532 2236899999999999999999999332 239999999999999999999999999999876
Q ss_pred CCCCCCcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccch
Q 042435 275 DVDSSNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQ 354 (412)
Q Consensus 275 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 354 (412)
...........++..|+|||.+.+..++.++|+||||+++|+|++|+.||.... .....+.+.....+..+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~--------~~~~~~~~~~~~~~~~~~ 232 (265)
T cd08217 161 GHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN--------QLQLASKIKEGKFRRIPY 232 (265)
T ss_pred cCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC--------HHHHHHHHhcCCCCCCcc
Confidence 554432334568999999999988889999999999999999999999987321 111222222222222111
Q ss_pred hhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 355 KIIQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 355 ~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
.....+.+++.+|++.+|++||++.+|+++
T Consensus 233 ---~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 233 ---RYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred ---ccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 222348899999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=276.19 Aligned_cols=241 Identities=21% Similarity=0.283 Sum_probs=179.6
Q ss_pred cCcccceeeeecCceEEEEEEeC-----CCcEEEEEeccCC----------------------ccccceEEEec--CceE
Q 042435 143 EYFHIRYCIGTGGYDSVYKAELP-----DGKVVALKKLHHS----------------------ETEDSAFVVYS--PQCM 193 (412)
Q Consensus 143 ~~f~~~~~lG~G~~g~Vy~~~~~-----~~~~vAvK~l~~~----------------------~~~~~~~~~~~--~~~~ 193 (412)
+.|+..+.||+|+||.||+|.+. +++.+|+|.++.. ++......+.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 35677789999999999999763 3689999977533 33333333444 5578
Q ss_pred EEEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccc
Q 042435 194 FFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRL 273 (412)
Q Consensus 194 ~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~ 273 (412)
+++|||+++++|.+++..... .+++..+..++.|++.||+|||+. +++|+||||+||+++.++.++|+|||.+..
T Consensus 84 ~lv~e~~~~~~l~~~l~~~~~--~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRHRD--QINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAKV 158 (284)
T ss_pred EEEEecCCCCCHHHHHHhCcc--ccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccccccc
Confidence 999999999999999876542 489999999999999999999998 999999999999999999999999999987
Q ss_pred cCCCCCCc---ccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCccccccccc----CC---CCcchhhHH
Q 042435 274 LDVDSSNR---TLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSS----SS---GPKIMLIDI 343 (412)
Q Consensus 274 ~~~~~~~~---~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~----~~---~~~~~~~~~ 343 (412)
........ ....++..|+|||...+..++.++||||||+++|||+||+.|+........ .. .....+.+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05038 159 LPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLEL 238 (284)
T ss_pred cccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHH
Confidence 65322111 122345679999999888899999999999999999999999763211100 00 001111222
Q ss_pred hhhccCCccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhcC
Q 042435 344 LYQRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELEGK 391 (412)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 391 (412)
+......+.+. .....+.+++.+||+.+|++|||+.||+++|+++
T Consensus 239 ~~~~~~~~~~~---~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 239 LKEGERLPRPP---SCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHcCCcCCCCc---cCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 22222221111 1223488999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=273.80 Aligned_cols=235 Identities=20% Similarity=0.298 Sum_probs=180.9
Q ss_pred HHHHHHhhcCcccceee--eecCceEEEEEEe-CCCcEEEEEecc-----------------CCccccceEEEecCceEE
Q 042435 135 YENLIDATEYFHIRYCI--GTGGYDSVYKAEL-PDGKVVALKKLH-----------------HSETEDSAFVVYSPQCMF 194 (412)
Q Consensus 135 ~~~l~~~~~~f~~~~~l--G~G~~g~Vy~~~~-~~~~~vAvK~l~-----------------~~~~~~~~~~~~~~~~~~ 194 (412)
..+.....++|++.+.+ |+|+||.||++.. .+++.+|+|... |+++......+...+..+
T Consensus 6 ~~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~e~~~~~~~~~h~~iv~~~~~~~~~~~~~ 85 (267)
T PHA03390 6 LSELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAIEPMVHQLMKDNPNFIKLYYSVTTLKGHV 85 (267)
T ss_pred HHHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchhhHHHHHHhhcCCCEEEEEEEEecCCeeE
Confidence 34556666778887776 9999999999976 468889999653 444444555567788899
Q ss_pred EEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCC-cEEEeecCCccc
Q 042435 195 FIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNL-EAFVADFGTVRL 273 (412)
Q Consensus 195 lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~-~~kl~DfGla~~ 273 (412)
+||||+++|+|.+++.... .++|.++..++.|+++||+|||+. +++||||||+||+++.++ .++|+|||+++.
T Consensus 86 iv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~ 159 (267)
T PHA03390 86 LIMDYIKDGDLFDLLKKEG---KLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCKI 159 (267)
T ss_pred EEEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEecCcccee
Confidence 9999999999999987653 589999999999999999999998 999999999999999888 999999999876
Q ss_pred cCCCCCCcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccc
Q 042435 274 LDVDSSNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPIN 353 (412)
Q Consensus 274 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 353 (412)
.... ....++..|+|||++.+..++.++||||||+++|||++|+.||..... ............ ....
T Consensus 160 ~~~~----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~------~~~~~~~~~~~~-~~~~- 227 (267)
T PHA03390 160 IGTP----SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDED------EELDLESLLKRQ-QKKL- 227 (267)
T ss_pred cCCC----ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCc------chhhHHHHHHhh-cccC-
Confidence 5432 223588999999999988899999999999999999999999872210 111111111111 1110
Q ss_pred hhhHHHHHHHHHHHHhcCcCCCCCCCC-HHHHHHH
Q 042435 354 QKIIQDIILVSTIALACLRSKPKSRPT-MQRISQE 387 (412)
Q Consensus 354 ~~~~~~~~~~~~l~~~Cl~~dP~~RPs-~~evl~~ 387 (412)
.........+.+++.+||+.||.+||+ ++|++++
T Consensus 228 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h 262 (267)
T PHA03390 228 PFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKH 262 (267)
T ss_pred CcccccCHHHHHHHHHHhccChhhCCchHHHHhcC
Confidence 111122334889999999999999996 6988753
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=296.99 Aligned_cols=236 Identities=24% Similarity=0.381 Sum_probs=189.5
Q ss_pred cccceeeeecCceEEEEEEe-CCC----cEEEEEec----------------------cCCccccceEEEecCceEEEEE
Q 042435 145 FHIRYCIGTGGYDSVYKAEL-PDG----KVVALKKL----------------------HHSETEDSAFVVYSPQCMFFIY 197 (412)
Q Consensus 145 f~~~~~lG~G~~g~Vy~~~~-~~~----~~vAvK~l----------------------~~~~~~~~~~~~~~~~~~~lv~ 197 (412)
....++||+|+||+||||.| +.| -+||+|.+ +|+++.+..++|.... +.||+
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt 776 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT 776 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence 34457899999999999977 344 46888854 5777777777777665 88999
Q ss_pred EeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCC
Q 042435 198 EYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVD 277 (412)
Q Consensus 198 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~ 277 (412)
+|||.|+|.++++.++. .+.-...+.|..|||+||.|||.+ .++||||..+|||+.+-..+||.|||+++.+..+
T Consensus 777 q~mP~G~LlDyvr~hr~--~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d 851 (1177)
T KOG1025|consen 777 QLMPLGCLLDYVREHRD--NIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPD 851 (1177)
T ss_pred HhcccchHHHHHHHhhc--cccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhccCcc
Confidence 99999999999998764 477788999999999999999999 9999999999999999999999999999988776
Q ss_pred CCCccccc--ccccccccccccCcccCcccccHHHHHHHHHHHh-CCCCcccccccccCCCCcchhhHHhhhccCCccch
Q 042435 278 SSNRTLQA--GTYGYIALELVYTMVVTEKCVIYSFGVVALEVLM-GTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQ 354 (412)
Q Consensus 278 ~~~~~~~~--gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 354 (412)
........ -.+.|||-|.+....|+.++|||||||++||++| |..|++.. +...+.+.+....+-+-++
T Consensus 852 ~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi--------~~~eI~dlle~geRLsqPp 923 (1177)
T KOG1025|consen 852 EKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGI--------PAEEIPDLLEKGERLSQPP 923 (1177)
T ss_pred cccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCC--------CHHHhhHHHhccccCCCCC
Confidence 55443333 3578999999999999999999999999999999 99998743 1222334443332222112
Q ss_pred hhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhcCCCCCCC
Q 042435 355 KIIQDIILVSTIALACLRSKPKSRPTMQRISQELEGKTPMKKG 397 (412)
Q Consensus 355 ~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~~~~ 397 (412)
-....+..++.+||..|+..||+++++...+.++......
T Consensus 924 ---iCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ardpqr 963 (1177)
T KOG1025|consen 924 ---ICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARDPQR 963 (1177)
T ss_pred ---CccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcCcce
Confidence 2334488899999999999999999999999887766554
|
|
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=273.09 Aligned_cols=227 Identities=25% Similarity=0.347 Sum_probs=177.0
Q ss_pred CcccceeeeecCceEEEEEEe-CCCcEEEEEecc------------------------------CCccccceEEEecCce
Q 042435 144 YFHIRYCIGTGGYDSVYKAEL-PDGKVVALKKLH------------------------------HSETEDSAFVVYSPQC 192 (412)
Q Consensus 144 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l~------------------------------~~~~~~~~~~~~~~~~ 192 (412)
.|.+...||+|+||.||+|.. .+++.+|+|.+. |+++......+...+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 367788999999999999976 468899999553 4455555556677888
Q ss_pred EEEEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCcc
Q 042435 193 MFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVR 272 (412)
Q Consensus 193 ~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~ 272 (412)
.++++||+++++|.+++.... .+++..+..++.|++.||+|||+. +++||||+|+||++++++.++|+|||.++
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg~~~ 154 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYG---AFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISK 154 (267)
T ss_pred cEEEEEecCCCCHHHHHHhcc---CccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccCCCc
Confidence 999999999999999987643 488899999999999999999998 99999999999999999999999999988
Q ss_pred ccCCCCC------CcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhh
Q 042435 273 LLDVDSS------NRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQ 346 (412)
Q Consensus 273 ~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 346 (412)
....... ......|+..|+|||.+.+..++.++|+||||+++|||++|+.||.... ..........
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-------~~~~~~~~~~- 226 (267)
T cd06628 155 KLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCT-------QLQAIFKIGE- 226 (267)
T ss_pred ccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCcc-------HHHHHHHHhc-
Confidence 6643211 1123457889999999988889999999999999999999999987321 1111111111
Q ss_pred ccCCccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 347 RLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
...+..+.. ....+.+++.+||+.||.+||++.|++++
T Consensus 227 ~~~~~~~~~---~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 264 (267)
T cd06628 227 NASPEIPSN---ISSEAIDFLEKTFEIDHNKRPTAAELLKH 264 (267)
T ss_pred cCCCcCCcc---cCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence 111111111 22347889999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=271.60 Aligned_cols=218 Identities=22% Similarity=0.311 Sum_probs=166.7
Q ss_pred eeeeecCceEEEEEEeCCCc-----------EEEEEec--------------------cCCccccceEEEecCceEEEEE
Q 042435 149 YCIGTGGYDSVYKAELPDGK-----------VVALKKL--------------------HHSETEDSAFVVYSPQCMFFIY 197 (412)
Q Consensus 149 ~~lG~G~~g~Vy~~~~~~~~-----------~vAvK~l--------------------~~~~~~~~~~~~~~~~~~~lv~ 197 (412)
+.||+|+||.||+|...+.. .+++|.+ +|+++......+.. ...++||
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~ 79 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVE 79 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEE
Confidence 36899999999999875432 5777754 45556555555666 6789999
Q ss_pred EeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCC-------cEEEeecCC
Q 042435 198 EYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNL-------EAFVADFGT 270 (412)
Q Consensus 198 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~-------~~kl~DfGl 270 (412)
||+++|+|.+++..... .+++..++.++.|++.||+|||++ +++||||||+||+++.++ .+||+|||+
T Consensus 80 e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~ 154 (259)
T cd05037 80 EYVKFGPLDVFLHREKN--NVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI 154 (259)
T ss_pred EcCCCCcHHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEeCCCCc
Confidence 99999999998876432 488999999999999999999998 999999999999999887 799999999
Q ss_pred ccccCCCCCCcccccccccccccccccCc--ccCcccccHHHHHHHHHHHh-CCCCcccccccccCCCCcchhhHHhhhc
Q 042435 271 VRLLDVDSSNRTLQAGTYGYIALELVYTM--VVTEKCVIYSFGVVALEVLM-GTHPGELLLSLSSSSGPKIMLIDILYQR 347 (412)
Q Consensus 271 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~ksDv~S~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~ 347 (412)
+..... .....++..|+|||++.+. .++.++||||||+++||+++ |..||.... ... ........
T Consensus 155 a~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~-------~~~-~~~~~~~~ 222 (259)
T cd05037 155 PITVLS----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLS-------SSE-KERFYQDQ 222 (259)
T ss_pred cccccc----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCC-------chh-HHHHHhcC
Confidence 986543 2223567789999998776 78999999999999999999 577765321 111 11111111
Q ss_pred cCCccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHh
Q 042435 348 LSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELE 389 (412)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~ 389 (412)
...+.+. ...+.+++.+||..+|.+|||+.|+++.|+
T Consensus 223 ~~~~~~~-----~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 223 HRLPMPD-----CAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred CCCCCCC-----chHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 1111111 134889999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=272.69 Aligned_cols=228 Identities=21% Similarity=0.265 Sum_probs=171.6
Q ss_pred cCcccceeeeecCceEEEEEEe-CCCcEEEEEecc--------------------------CCccccceEEEec--CceE
Q 042435 143 EYFHIRYCIGTGGYDSVYKAEL-PDGKVVALKKLH--------------------------HSETEDSAFVVYS--PQCM 193 (412)
Q Consensus 143 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l~--------------------------~~~~~~~~~~~~~--~~~~ 193 (412)
++|++.+.||+|+||.||+|.. .+++.||+|.++ |+++......+.+ ....
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 5789999999999999999976 458999999764 2222222332333 3467
Q ss_pred EEEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccc
Q 042435 194 FFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRL 273 (412)
Q Consensus 194 ~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~ 273 (412)
+++|||+++++|.+++.... .+++...+.++.|++.||+|||+. +++|+||||+||+++.++.++|+|||+++.
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~ 155 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYG---ALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKR 155 (265)
T ss_pred EEEEEecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCccccc
Confidence 89999999999999886543 478888999999999999999998 999999999999999999999999999876
Q ss_pred cCCCC---CCcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCC
Q 042435 274 LDVDS---SNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSP 350 (412)
Q Consensus 274 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 350 (412)
..... .......|+..|+|||.+.+..++.++||||||+++|||++|+.||.... ..............+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~-------~~~~~~~~~~~~~~~ 228 (265)
T cd06652 156 LQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFE-------AMAAIFKIATQPTNP 228 (265)
T ss_pred cccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccc-------hHHHHHHHhcCCCCC
Confidence 53211 11223458889999999988889999999999999999999999986321 111111111111111
Q ss_pred ccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 351 PINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 351 ~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
..+ ......+.+++.+|+. +|++||+++|++++
T Consensus 229 ~~~---~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 229 VLP---PHVSDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred CCc---hhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 111 1222347788888985 99999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=275.40 Aligned_cols=219 Identities=20% Similarity=0.307 Sum_probs=167.8
Q ss_pred eeeeecCceEEEEEEeCC--------CcEEEEEe---------------------ccCCccccceEEEecCceEEEEEEe
Q 042435 149 YCIGTGGYDSVYKAELPD--------GKVVALKK---------------------LHHSETEDSAFVVYSPQCMFFIYEY 199 (412)
Q Consensus 149 ~~lG~G~~g~Vy~~~~~~--------~~~vAvK~---------------------l~~~~~~~~~~~~~~~~~~~lv~ey 199 (412)
+.||+|+||.||+|.... ...+|+|. ++|+++......+..++..++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 368999999999997632 23477774 3577777777778888889999999
Q ss_pred ccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCc--------EEEeecCCc
Q 042435 200 MERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLE--------AFVADFGTV 271 (412)
Q Consensus 200 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~--------~kl~DfGla 271 (412)
+++|+|.++++.... .+++..++.++.|++.||+|||+. +|+||||||+||+++.++. ++++|||++
T Consensus 81 ~~~g~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~ 155 (258)
T cd05078 81 VKFGSLDTYLKKNKN--LINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS 155 (258)
T ss_pred CCCCcHHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEecccccc
Confidence 999999999876542 489999999999999999999998 9999999999999987665 589999988
Q ss_pred cccCCCCCCcccccccccccccccccC-cccCcccccHHHHHHHHHHHhCC-CCcccccccccCCCCcchhhHHhhhccC
Q 042435 272 RLLDVDSSNRTLQAGTYGYIALELVYT-MVVTEKCVIYSFGVVALEVLMGT-HPGELLLSLSSSSGPKIMLIDILYQRLS 349 (412)
Q Consensus 272 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~S~Gvil~elltg~-~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 349 (412)
..... .....++..|+|||++.+ ..++.++||||||+++|||++|. .|+... ..............
T Consensus 156 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~--------~~~~~~~~~~~~~~ 223 (258)
T cd05078 156 ITVLP----KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSAL--------DSQKKLQFYEDRHQ 223 (258)
T ss_pred cccCC----chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhc--------cHHHHHHHHHcccc
Confidence 65432 223467889999999876 45789999999999999999985 554421 11111112222111
Q ss_pred CccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHh
Q 042435 350 PPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELE 389 (412)
Q Consensus 350 ~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~ 389 (412)
.+ ... ...+.+++.+||+.||++|||++++++.|+
T Consensus 224 ~~--~~~---~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 224 LP--APK---WTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred CC--CCC---cHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 11 111 124789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=272.59 Aligned_cols=218 Identities=21% Similarity=0.202 Sum_probs=166.7
Q ss_pred eeeeecCceEEEEEEeCC-------------CcEEEEEec---------------------cCCccccceEEEecCceEE
Q 042435 149 YCIGTGGYDSVYKAELPD-------------GKVVALKKL---------------------HHSETEDSAFVVYSPQCMF 194 (412)
Q Consensus 149 ~~lG~G~~g~Vy~~~~~~-------------~~~vAvK~l---------------------~~~~~~~~~~~~~~~~~~~ 194 (412)
+.||+|+||.||+|.+.+ ...||+|.+ +|+++......+......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 358999999999997532 235888853 5777777777788888899
Q ss_pred EEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCc-------EEEee
Q 042435 195 FIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLE-------AFVAD 267 (412)
Q Consensus 195 lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~-------~kl~D 267 (412)
+||||+++|+|..++.... ..+++..+..++.|+++||+|||+. +|+||||||+|||++.++. ++++|
T Consensus 81 lv~e~~~~~~l~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d 155 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKS--DVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLSD 155 (262)
T ss_pred EEEecccCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeEeCC
Confidence 9999999999988876433 2489999999999999999999998 9999999999999986654 89999
Q ss_pred cCCccccCCCCCCccccccccccccccccc-CcccCcccccHHHHHHHHHHH-hCCCCcccccccccCCCCcchhhHHhh
Q 042435 268 FGTVRLLDVDSSNRTLQAGTYGYIALELVY-TMVVTEKCVIYSFGVVALEVL-MGTHPGELLLSLSSSSGPKIMLIDILY 345 (412)
Q Consensus 268 fGla~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~ksDv~S~Gvil~ell-tg~~P~~~~~~~~~~~~~~~~~~~~~~ 345 (412)
||++...... ....++..|+|||.+. +..++.++|||||||++|||+ +|..|+.... .........
T Consensus 156 ~g~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~--------~~~~~~~~~ 223 (262)
T cd05077 156 PGIPITVLSR----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKT--------LAEKERFYE 223 (262)
T ss_pred CCCCccccCc----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcc--------hhHHHHHHh
Confidence 9998754322 2235788999999886 466889999999999999997 5888865211 000111111
Q ss_pred hccCCccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHH
Q 042435 346 QRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQEL 388 (412)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L 388 (412)
...... .. ....+.+++.+||+.||.+||++.++++.|
T Consensus 224 ~~~~~~--~~---~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 224 GQCMLV--TP---SCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred cCccCC--CC---ChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 111111 11 112378899999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=273.24 Aligned_cols=230 Identities=23% Similarity=0.276 Sum_probs=189.9
Q ss_pred cCcccceeeeecCceEEEEEEeCC-CcEEEEEec------------------------cCCccccceEEEecCceEEEEE
Q 042435 143 EYFHIRYCIGTGGYDSVYKAELPD-GKVVALKKL------------------------HHSETEDSAFVVYSPQCMFFIY 197 (412)
Q Consensus 143 ~~f~~~~~lG~G~~g~Vy~~~~~~-~~~vAvK~l------------------------~~~~~~~~~~~~~~~~~~~lv~ 197 (412)
+.|++.+.||.|.-|+||++++++ +..+|+|++ +|+.....+..+.+++..|++|
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m 156 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM 156 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence 346677899999999999999865 589999965 5667777777788999999999
Q ss_pred EeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCC-
Q 042435 198 EYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDV- 276 (412)
Q Consensus 198 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~- 276 (412)
|||+||+|..+++.+... .++.....-++.+|+-||+|||-. |||.|||||+|||+.++|++.|+||-++.....
T Consensus 157 eyCpGGdL~~LrqkQp~~-~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDLS~~~~~~ 232 (459)
T KOG0610|consen 157 EYCPGGDLHSLRQKQPGK-RFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDLSLRCPVS 232 (459)
T ss_pred ecCCCccHHHHHhhCCCC-ccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeeccccccCCCC
Confidence 999999999988776544 588899999999999999999998 999999999999999999999999998643210
Q ss_pred --------------------------------CCCC-----------------------cccccccccccccccccCccc
Q 042435 277 --------------------------------DSSN-----------------------RTLQAGTYGYIALELVYTMVV 301 (412)
Q Consensus 277 --------------------------------~~~~-----------------------~~~~~gt~~y~aPE~~~~~~~ 301 (412)
.... ....+||-.|+|||++.+...
T Consensus 233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH 312 (459)
T KOG0610|consen 233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH 312 (459)
T ss_pred CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence 0000 012468999999999999999
Q ss_pred CcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccchhhHHHHHHHHHHHHhcCcCCCCCCCC-
Q 042435 302 TEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKIIQDIILVSTIALACLRSKPKSRPT- 380 (412)
Q Consensus 302 s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs- 380 (412)
+.+.|.|+|||++|||+.|..||. .......+..++.+.+..+... .....+.+|+.+.|.+||++|..
T Consensus 313 gsAVDWWtfGIflYEmLyG~TPFK-------G~~~~~Tl~NIv~~~l~Fp~~~---~vs~~akDLIr~LLvKdP~kRlg~ 382 (459)
T KOG0610|consen 313 GSAVDWWTFGIFLYEMLYGTTPFK-------GSNNKETLRNIVGQPLKFPEEP---EVSSAAKDLIRKLLVKDPSKRLGS 382 (459)
T ss_pred CchhhHHHHHHHHHHHHhCCCCcC-------CCCchhhHHHHhcCCCcCCCCC---cchhHHHHHHHHHhccChhhhhcc
Confidence 999999999999999999999998 3455566778887777665433 33445889999999999999987
Q ss_pred ---HHHHHH
Q 042435 381 ---MQRISQ 386 (412)
Q Consensus 381 ---~~evl~ 386 (412)
+.||-+
T Consensus 383 ~rGA~eIK~ 391 (459)
T KOG0610|consen 383 KRGAAEIKR 391 (459)
T ss_pred ccchHHhhc
Confidence 666643
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=279.96 Aligned_cols=231 Identities=24% Similarity=0.283 Sum_probs=178.7
Q ss_pred cCcccceeeeecCceEEEEEEeC-CCcEEEEEecc------------------------CCccccceEEEecCceEEEEE
Q 042435 143 EYFHIRYCIGTGGYDSVYKAELP-DGKVVALKKLH------------------------HSETEDSAFVVYSPQCMFFIY 197 (412)
Q Consensus 143 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~------------------------~~~~~~~~~~~~~~~~~~lv~ 197 (412)
++|+..+.||+|+||.||+|... +++.||+|.+. |+++......+......++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 46888999999999999999775 58999999764 344444455567778899999
Q ss_pred EeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCC
Q 042435 198 EYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVD 277 (412)
Q Consensus 198 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~ 277 (412)
||+++++|.+++..... ..+++..+..++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++......
T Consensus 81 e~~~~~~L~~~~~~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 156 (316)
T cd05574 81 DYCPGGELFRLLQRQPG-KCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVE 156 (316)
T ss_pred EecCCCCHHHHHHhCCC-CccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhccccc
Confidence 99999999998865422 2589999999999999999999998 9999999999999999999999999998754322
Q ss_pred CC-----------------------------CcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCccccc
Q 042435 278 SS-----------------------------NRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLL 328 (412)
Q Consensus 278 ~~-----------------------------~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~ 328 (412)
.. ......|+..|+|||++.+..++.++||||||+++|+|++|+.||...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~- 235 (316)
T cd05574 157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGS- 235 (316)
T ss_pred ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCC-
Confidence 11 011235788999999999888999999999999999999999998632
Q ss_pred ccccCCCCcchhhHHhhhccCCccchhhHHHHHHHHHHHHhcCcCCCCCCCC----HHHHHHH
Q 042435 329 SLSSSSGPKIMLIDILYQRLSPPINQKIIQDIILVSTIALACLRSKPKSRPT----MQRISQE 387 (412)
Q Consensus 329 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs----~~evl~~ 387 (412)
........+.......+... .....+.+++.+||+.||++||| ++|++++
T Consensus 236 ------~~~~~~~~~~~~~~~~~~~~---~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~ 289 (316)
T cd05574 236 ------NRDETFSNILKKEVTFPGSP---PVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH 289 (316)
T ss_pred ------chHHHHHHHhcCCccCCCcc---ccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcC
Confidence 11122223332222221111 12334889999999999999999 7777664
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=292.15 Aligned_cols=173 Identities=21% Similarity=0.316 Sum_probs=146.5
Q ss_pred CcccceeeeecCceEEEEEE-eCCCcEEEEEeccCC--------------------------ccccceEEEecCceEEEE
Q 042435 144 YFHIRYCIGTGGYDSVYKAE-LPDGKVVALKKLHHS--------------------------ETEDSAFVVYSPQCMFFI 196 (412)
Q Consensus 144 ~f~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~l~~~--------------------------~~~~~~~~~~~~~~~~lv 196 (412)
+|++.+.||+|+||.|.||. ..+++.||||.++.. ++++....+...++.|||
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciV 266 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIV 266 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceeee
Confidence 78999999999999999995 567999999987531 222333446678899999
Q ss_pred EEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecC--CCcEEEeecCCcccc
Q 042435 197 YEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNS--NLEAFVADFGTVRLL 274 (412)
Q Consensus 197 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~--~~~~kl~DfGla~~~ 274 (412)
+|.+. -+|+++++.+... .++......++.||+.||.+||+. +|||+||||+||||.+ ...+||+|||.|...
T Consensus 267 fELL~-~NLYellK~n~f~-Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~ 341 (586)
T KOG0667|consen 267 FELLS-TNLYELLKNNKFR-GLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVIDFGSSCFE 341 (586)
T ss_pred ehhhh-hhHHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEEeccccccc
Confidence 99995 4999999887543 489999999999999999999998 9999999999999963 457999999999865
Q ss_pred CCCCCCcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCc
Q 042435 275 DVDSSNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPG 324 (412)
Q Consensus 275 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~ 324 (412)
..... ....+..|+|||++.+.+|+.+.||||||||+.||++|.+-|
T Consensus 342 ~q~vy---tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLf 388 (586)
T KOG0667|consen 342 SQRVY---TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLF 388 (586)
T ss_pred CCcce---eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCcccc
Confidence 43322 456788999999999999999999999999999999997655
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=284.58 Aligned_cols=231 Identities=22% Similarity=0.289 Sum_probs=191.7
Q ss_pred hhcCcccceeeeecCceEEEEEEeCC-CcEEEEEec------------------------c-CCccccceEEEecCceEE
Q 042435 141 ATEYFHIRYCIGTGGYDSVYKAELPD-GKVVALKKL------------------------H-HSETEDSAFVVYSPQCMF 194 (412)
Q Consensus 141 ~~~~f~~~~~lG~G~~g~Vy~~~~~~-~~~vAvK~l------------------------~-~~~~~~~~~~~~~~~~~~ 194 (412)
..+.|++.+.||+|.||.||+++.+. |+.+|+|.+ . |+++......+.+....+
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~ 112 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY 112 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence 44568888999999999999998764 999999965 3 777777888899999999
Q ss_pred EEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCC----CcEEEeecCC
Q 042435 195 FIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSN----LEAFVADFGT 270 (412)
Q Consensus 195 lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~----~~~kl~DfGl 270 (412)
+|||++.+|.|.+.+... .++......++.|++.++.|||+. +|+||||||+|+|+... +.+|++|||+
T Consensus 113 lvmEL~~GGeLfd~i~~~----~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGl 185 (382)
T KOG0032|consen 113 LVMELCEGGELFDRIVKK----HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLIDFGL 185 (382)
T ss_pred EEEEecCCchHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEeeCCC
Confidence 999999999999988765 288899999999999999999998 99999999999999533 5799999999
Q ss_pred ccccCCCCCCcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCC
Q 042435 271 VRLLDVDSSNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSP 350 (412)
Q Consensus 271 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 350 (412)
+..... .......+||+.|+|||++....|+..+||||+||++|.|++|..||... ........+.......
T Consensus 186 a~~~~~-~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~-------~~~~~~~~i~~~~~~f 257 (382)
T KOG0032|consen 186 AKFIKP-GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGE-------TEFEIFLAILRGDFDF 257 (382)
T ss_pred ceEccC-CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCC-------ChhHHHHHHHcCCCCC
Confidence 998776 44556789999999999999999999999999999999999999999732 2222333444433322
Q ss_pred ccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 351 PINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 351 ~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
.. ..+......+.+++..|+..||.+|+|+.++++|
T Consensus 258 ~~-~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 258 TS-EPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred CC-CCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 21 1222234458899999999999999999999997
|
|
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=271.62 Aligned_cols=232 Identities=26% Similarity=0.370 Sum_probs=182.9
Q ss_pred cCcccceeeeecCceEEEEEEeC-CCcEEEEEecc----------------------CCccccceEEEecCceEEEEEEe
Q 042435 143 EYFHIRYCIGTGGYDSVYKAELP-DGKVVALKKLH----------------------HSETEDSAFVVYSPQCMFFIYEY 199 (412)
Q Consensus 143 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~----------------------~~~~~~~~~~~~~~~~~~lv~ey 199 (412)
++|++.+.||+|++|.||+|... +++.||+|++. |+++......+...+..++|+||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 46888999999999999999875 59999999753 44444455557778899999999
Q ss_pred ccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHh-CCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCC
Q 042435 200 MERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHH-DCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDS 278 (412)
Q Consensus 200 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~-~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~ 278 (412)
+++++|.+++.... .+++..+..++.|+++|++|||+ . +++||||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~~---~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~ 154 (264)
T cd06623 81 MDGGSLADLLKKVG---KIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTL 154 (264)
T ss_pred cCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccceecccCC
Confidence 99999999987543 58999999999999999999998 8 99999999999999999999999999998765444
Q ss_pred CCcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccchhhHH
Q 042435 279 SNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKIIQ 358 (412)
Q Consensus 279 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 358 (412)
.......++..|+|||...+..++.++|+||||+++|||+||+.||..... .........+.....+..... .
T Consensus 155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~-----~~~~~~~~~~~~~~~~~~~~~--~ 227 (264)
T cd06623 155 DQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQ-----PSFFELMQAICDGPPPSLPAE--E 227 (264)
T ss_pred CcccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccc-----cCHHHHHHHHhcCCCCCCCcc--c
Confidence 333345688999999999888899999999999999999999999863311 011111111111111111111 0
Q ss_pred HHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 359 DIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 359 ~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
....+.+++.+||+.+|++||++.|++++
T Consensus 228 ~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 228 FSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred CCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 23348889999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=275.85 Aligned_cols=221 Identities=20% Similarity=0.275 Sum_probs=167.5
Q ss_pred eeeecCceEEEEEEe-CCCcEEEEEeccC---------------------------CccccceEEEecCceEEEEEEecc
Q 042435 150 CIGTGGYDSVYKAEL-PDGKVVALKKLHH---------------------------SETEDSAFVVYSPQCMFFIYEYME 201 (412)
Q Consensus 150 ~lG~G~~g~Vy~~~~-~~~~~vAvK~l~~---------------------------~~~~~~~~~~~~~~~~~lv~ey~~ 201 (412)
.||+|+||.||++.. .+++.+|+|.++. +++......+...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 489999999999976 4689999996632 222222333556778899999999
Q ss_pred CCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCCCCc
Q 042435 202 RGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNR 281 (412)
Q Consensus 202 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 281 (412)
+|+|.+++.... .+++.....++.|++.||+|||+. +++||||||+||++++++.++++|||++....... .
T Consensus 81 ~~~L~~~i~~~~---~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~--~ 152 (279)
T cd05633 81 GGDLHYHLSQHG---VFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--P 152 (279)
T ss_pred CCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceeccccC--c
Confidence 999998886543 589999999999999999999998 99999999999999999999999999987543222 2
Q ss_pred cccccccccccccccc-CcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccchhhHHHH
Q 042435 282 TLQAGTYGYIALELVY-TMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKIIQDI 360 (412)
Q Consensus 282 ~~~~gt~~y~aPE~~~-~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 360 (412)
....|+..|+|||... +..++.++|||||||++|||++|..||..... ......... ........+.. ..
T Consensus 153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~-----~~~~~~~~~-~~~~~~~~~~~---~~ 223 (279)
T cd05633 153 HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKT-----KDKHEIDRM-TLTVNVELPDS---FS 223 (279)
T ss_pred cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCC-----cCHHHHHHH-hhcCCcCCccc---cC
Confidence 2346899999999886 45688999999999999999999999863211 000111111 11111111111 12
Q ss_pred HHHHHHHHhcCcCCCCCCC-----CHHHHHHH
Q 042435 361 ILVSTIALACLRSKPKSRP-----TMQRISQE 387 (412)
Q Consensus 361 ~~~~~l~~~Cl~~dP~~RP-----s~~evl~~ 387 (412)
..+.+++.+||+.||++|| +++|++++
T Consensus 224 ~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 224 PELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred HHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 3477899999999999999 69999886
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=276.94 Aligned_cols=239 Identities=22% Similarity=0.301 Sum_probs=174.9
Q ss_pred cCcccceeeeecCceEEEEEEeC-CCcEEEEEecc-----------------------CCccccceEEEecCceEEEEEE
Q 042435 143 EYFHIRYCIGTGGYDSVYKAELP-DGKVVALKKLH-----------------------HSETEDSAFVVYSPQCMFFIYE 198 (412)
Q Consensus 143 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~-----------------------~~~~~~~~~~~~~~~~~~lv~e 198 (412)
++|++.+.||+|+||.||+|... +++.||+|++. |+++......+..++..++|+|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 46888999999999999999875 58999999753 3333344444667788999999
Q ss_pred eccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCC
Q 042435 199 YMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDS 278 (412)
Q Consensus 199 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~ 278 (412)
|+++++|..+..... .++|.++..++.|++.||+|||+. +++|+||+|+||++++++.++|+|||+++......
T Consensus 81 ~~~~~~l~~~~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07846 81 FVDHTVLDDLEKYPN---GLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG 154 (286)
T ss_pred cCCccHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc
Confidence 999988887665432 489999999999999999999998 99999999999999999999999999988765443
Q ss_pred CCcccccccccccccccccC-cccCcccccHHHHHHHHHHHhCCCCcccccccc---------cCCCCcc-h---hhHHh
Q 042435 279 SNRTLQAGTYGYIALELVYT-MVVTEKCVIYSFGVVALEVLMGTHPGELLLSLS---------SSSGPKI-M---LIDIL 344 (412)
Q Consensus 279 ~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~---------~~~~~~~-~---~~~~~ 344 (412)
.......++..|+|||++.+ ..++.++||||||+++|||++|+.||....... ....... . .....
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T cd07846 155 EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLF 234 (286)
T ss_pred cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHh
Confidence 33334567889999999865 447889999999999999999999885321100 0000000 0 00000
Q ss_pred hhccCCccc------hhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 345 YQRLSPPIN------QKIIQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 345 ~~~~~~~~~------~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
.....+... .........+.+++.+||+.+|++||++.+++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 235 AGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred hccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 000000000 0000112348899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=283.91 Aligned_cols=239 Identities=22% Similarity=0.230 Sum_probs=172.0
Q ss_pred HHHhhcCcccceeeeecCceEEEEEEe-CCCcEEEEEecc-----------------------CCccccceEEEe-----
Q 042435 138 LIDATEYFHIRYCIGTGGYDSVYKAEL-PDGKVVALKKLH-----------------------HSETEDSAFVVY----- 188 (412)
Q Consensus 138 l~~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l~-----------------------~~~~~~~~~~~~----- 188 (412)
..+..++|++.+.||+|+||.||+|.. .+++.||||++. |+++.....++.
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07878 10 VWEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSI 89 (343)
T ss_pred HhhhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccc
Confidence 334567899999999999999999976 568899999764 333333222221
Q ss_pred -cCceEEEEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEee
Q 042435 189 -SPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVAD 267 (412)
Q Consensus 189 -~~~~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~D 267 (412)
.....++++|++ +++|.+++... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|
T Consensus 90 ~~~~~~~~~~~~~-~~~l~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~D 161 (343)
T cd07878 90 ENFNEVYLVTNLM-GADLNNIVKCQ----KLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILD 161 (343)
T ss_pred cccCcEEEEeecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEcC
Confidence 124578999998 77888777543 489999999999999999999998 999999999999999999999999
Q ss_pred cCCccccCCCCCCcccccccccccccccccC-cccCcccccHHHHHHHHHHHhCCCCccccccccc--------CCCCcc
Q 042435 268 FGTVRLLDVDSSNRTLQAGTYGYIALELVYT-MVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSS--------SSGPKI 338 (412)
Q Consensus 268 fGla~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~--------~~~~~~ 338 (412)
||+++..... .....||..|+|||++.+ ..++.++|||||||++|||++|+.||........ ......
T Consensus 162 fg~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 238 (343)
T cd07878 162 FGLARQADDE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPE 238 (343)
T ss_pred CccceecCCC---cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 9999865432 233468999999999876 5688999999999999999999999863211000 000000
Q ss_pred hhhHH-------hhhccCCccchhh----HHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 339 MLIDI-------LYQRLSPPINQKI----IQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 339 ~~~~~-------~~~~~~~~~~~~~----~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
....+ ....+........ ......+.+++.+|++.||++|||+.|++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 239 VLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred HHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000 0000000000000 0011236789999999999999999999976
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=280.27 Aligned_cols=224 Identities=24% Similarity=0.326 Sum_probs=174.1
Q ss_pred ceeeeecCceEEEEEEe-CCCcEEEEEecc---------------------CCccccceEEEecCceEEEEEEeccCCce
Q 042435 148 RYCIGTGGYDSVYKAEL-PDGKVVALKKLH---------------------HSETEDSAFVVYSPQCMFFIYEYMERGSL 205 (412)
Q Consensus 148 ~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l~---------------------~~~~~~~~~~~~~~~~~~lv~ey~~~gsL 205 (412)
...||+|+||.||+|.. .+++.||+|.++ |+++......+..++..++++||+++++|
T Consensus 26 ~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L 105 (297)
T cd06659 26 YIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGAL 105 (297)
T ss_pred hhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCH
Confidence 45799999999999976 468999999753 44444445556778889999999999999
Q ss_pred eeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCCCCccccc
Q 042435 206 FCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQA 285 (412)
Q Consensus 206 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 285 (412)
.+++... .+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||++..............
T Consensus 106 ~~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~~ 178 (297)
T cd06659 106 TDIVSQT----RLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV 178 (297)
T ss_pred HHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhccccccccccee
Confidence 8877543 489999999999999999999998 999999999999999999999999999876544333334456
Q ss_pred ccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccchhhHHHHHHHHH
Q 042435 286 GTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKIIQDIILVST 365 (412)
Q Consensus 286 gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 365 (412)
|+..|+|||++.+..++.++||||||+++|||++|+.||.... ... ....+....... ..........+.+
T Consensus 179 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~-------~~~-~~~~~~~~~~~~-~~~~~~~~~~l~~ 249 (297)
T cd06659 179 GTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDS-------PVQ-AMKRLRDSPPPK-LKNAHKISPVLRD 249 (297)
T ss_pred cCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-------HHH-HHHHHhccCCCC-ccccCCCCHHHHH
Confidence 8999999999998889999999999999999999999986221 111 111111111110 0011111223778
Q ss_pred HHHhcCcCCCCCCCCHHHHHHH
Q 042435 366 IALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 366 l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
++.+||+.+|++||++++++++
T Consensus 250 ~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 250 FLERMLTREPQERATAQELLDH 271 (297)
T ss_pred HHHHHhcCCcccCcCHHHHhhC
Confidence 9999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=269.79 Aligned_cols=232 Identities=21% Similarity=0.269 Sum_probs=184.2
Q ss_pred hhcCcccceeeeecCceEEEEEEe-CCCcEEEEEe-----------------------ccCCccccceEEEecCceEEEE
Q 042435 141 ATEYFHIRYCIGTGGYDSVYKAEL-PDGKVVALKK-----------------------LHHSETEDSAFVVYSPQCMFFI 196 (412)
Q Consensus 141 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~-----------------------l~~~~~~~~~~~~~~~~~~~lv 196 (412)
.+++|++.++||+|.|+.||++.. .+|+.+|+|. ++|+++.+......+....|+|
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv 88 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 88 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence 356788889999999999999954 5788888873 4788888888888888999999
Q ss_pred EEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecC---CCcEEEeecCCccc
Q 042435 197 YEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNS---NLEAFVADFGTVRL 273 (412)
Q Consensus 197 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~---~~~~kl~DfGla~~ 273 (412)
+|+|.||+|..-+-.. ...+....-..+.||+.+|.|+|.+ +|||||+||+|+++.+ ..-+|++|||+|..
T Consensus 89 Fe~m~G~dl~~eIV~R---~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~ 162 (355)
T KOG0033|consen 89 FDLVTGGELFEDIVAR---EFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFGLAIE 162 (355)
T ss_pred EecccchHHHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccceEEE
Confidence 9999999996544332 2467777788999999999999999 9999999999999953 34589999999998
Q ss_pred cCCCCCCcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccc
Q 042435 274 LDVDSSNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPIN 353 (412)
Q Consensus 274 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 353 (412)
+. +........|||+|||||++...+|+..+|||+.||+||-|+.|..||... .......++.......+.
T Consensus 163 l~-~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~-------~~~rlye~I~~g~yd~~~- 233 (355)
T KOG0033|consen 163 VN-DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDE-------DQHRLYEQIKAGAYDYPS- 233 (355)
T ss_pred eC-CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCc-------cHHHHHHHHhccccCCCC-
Confidence 87 555566778999999999999999999999999999999999999998731 111222233322222211
Q ss_pred hhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 354 QKIIQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 354 ~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
+.+........+|+.+|+..||++|.|+.|.+++
T Consensus 234 ~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~H 267 (355)
T KOG0033|consen 234 PEWDTVTPEAKSLIRRMLTVNPKKRITADEALKH 267 (355)
T ss_pred cccCcCCHHHHHHHHHHhccChhhhccHHHHhCC
Confidence 1222223347899999999999999999998875
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=278.08 Aligned_cols=230 Identities=27% Similarity=0.371 Sum_probs=189.0
Q ss_pred CcccceeeeecCceEEEEEEe-CCCcEEEEEecc-------------------CCccccceEEEecCceEEEEEEeccCC
Q 042435 144 YFHIRYCIGTGGYDSVYKAEL-PDGKVVALKKLH-------------------HSETEDSAFVVYSPQCMFFIYEYMERG 203 (412)
Q Consensus 144 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l~-------------------~~~~~~~~~~~~~~~~~~lv~ey~~~g 203 (412)
-|++..+||+|+||.||||.+ ..|+.+|||++. .+.++..++.++....+|+|||||..|
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAG 113 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAG 113 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCCC
Confidence 367778999999999999965 569999999763 233444555567788899999999999
Q ss_pred ceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCCCCccc
Q 042435 204 SLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTL 283 (412)
Q Consensus 204 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 283 (412)
+..++++.+++ +|+...+..++...++||+|||.. .-+|||||..|||++.++.+|++|||.|..+...-..+..
T Consensus 114 SiSDI~R~R~K--~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAKRNT 188 (502)
T KOG0574|consen 114 SISDIMRARRK--PLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAKRNT 188 (502)
T ss_pred cHHHHHHHhcC--CccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhhhHHhhCc
Confidence 99999987654 589999999999999999999998 8899999999999999999999999999887665556677
Q ss_pred ccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccchhhHHHHHHH
Q 042435 284 QAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKIIQDIILV 363 (412)
Q Consensus 284 ~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 363 (412)
..||+.|||||++..-.|+.++||||+|++..||..|++||.+...... + .+.+.-+++...........+
T Consensus 189 VIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRA-------I--FMIPT~PPPTF~KPE~WS~~F 259 (502)
T KOG0574|consen 189 VIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRA-------I--FMIPTKPPPTFKKPEEWSSEF 259 (502)
T ss_pred cccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccce-------e--EeccCCCCCCCCChHhhhhHH
Confidence 8999999999999999999999999999999999999999875422111 0 111222233333344455568
Q ss_pred HHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 364 STIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 364 ~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
-+++.+|+-++|++|-|+.+++++
T Consensus 260 ~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 260 NDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred HHHHHHHhcCCHHHHHHHHHHhhh
Confidence 999999999999999999998876
|
|
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=278.23 Aligned_cols=174 Identities=25% Similarity=0.380 Sum_probs=138.1
Q ss_pred ceeeeecCceEEEEEEeC---CCcEEEEEec-------------------cCCccccceEEE--ecCceEEEEEEeccCC
Q 042435 148 RYCIGTGGYDSVYKAELP---DGKVVALKKL-------------------HHSETEDSAFVV--YSPQCMFFIYEYMERG 203 (412)
Q Consensus 148 ~~~lG~G~~g~Vy~~~~~---~~~~vAvK~l-------------------~~~~~~~~~~~~--~~~~~~~lv~ey~~~g 203 (412)
..+||+|+||.||+|... ++..||+|.+ +|+++......+ ......++|+||+++
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~- 84 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH- 84 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCCcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC-
Confidence 368999999999999864 4578999965 355555554444 345678999999965
Q ss_pred ceeeeeccCc------ccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEe----cCCCcEEEeecCCccc
Q 042435 204 SLFCVLRDDD------EAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILL----NSNLEAFVADFGTVRL 273 (412)
Q Consensus 204 sL~~~l~~~~------~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl----~~~~~~kl~DfGla~~ 273 (412)
+|.+++.... ....+++..+..++.|++.||+|||+. +|+||||||+||++ +.++.+||+|||+++.
T Consensus 85 ~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~ 161 (317)
T cd07867 85 DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARL 161 (317)
T ss_pred cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeeccceec
Confidence 7766654221 123488999999999999999999998 99999999999999 5667899999999987
Q ss_pred cCCCCC---CcccccccccccccccccC-cccCcccccHHHHHHHHHHHhCCCCcc
Q 042435 274 LDVDSS---NRTLQAGTYGYIALELVYT-MVVTEKCVIYSFGVVALEVLMGTHPGE 325 (412)
Q Consensus 274 ~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~S~Gvil~elltg~~P~~ 325 (412)
...... ......||+.|+|||++.+ ..++.++|||||||++|||+||+.||.
T Consensus 162 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~ 217 (317)
T cd07867 162 FNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 217 (317)
T ss_pred cCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcc
Confidence 643322 1233468999999999876 457899999999999999999999986
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=276.56 Aligned_cols=238 Identities=18% Similarity=0.213 Sum_probs=170.1
Q ss_pred CcccceeeeecCceEEEEEEeC-CCcEEEEEeccC-----------------------CccccceEEEecCceEEEEEEe
Q 042435 144 YFHIRYCIGTGGYDSVYKAELP-DGKVVALKKLHH-----------------------SETEDSAFVVYSPQCMFFIYEY 199 (412)
Q Consensus 144 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~-----------------------~~~~~~~~~~~~~~~~~lv~ey 199 (412)
+|++.+.||+|+||.||+|... +|+.||+|+++. +++......+.+.+..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 4778899999999999999774 689999997643 2222222335567788999999
Q ss_pred ccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCCC
Q 042435 200 MERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSS 279 (412)
Q Consensus 200 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 279 (412)
++ ++|.+++.... ..+++.....++.|+++||.|||+. +++||||||+||+++.++.++|+|||+++.......
T Consensus 81 ~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 154 (284)
T cd07839 81 CD-QDLKKYFDSCN--GDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR 154 (284)
T ss_pred CC-CCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccCCCCC
Confidence 97 57877765432 2489999999999999999999998 999999999999999999999999999986544333
Q ss_pred CcccccccccccccccccCc-ccCcccccHHHHHHHHHHHhCCCCccccccccc---------CCCCcch---hhHHhhh
Q 042435 280 NRTLQAGTYGYIALELVYTM-VVTEKCVIYSFGVVALEVLMGTHPGELLLSLSS---------SSGPKIM---LIDILYQ 346 (412)
Q Consensus 280 ~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~---------~~~~~~~---~~~~~~~ 346 (412)
......++..|+|||++.+. .++.++|||||||++|||+||..|+........ ....... ..+..+.
T Consensus 155 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd07839 155 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDY 234 (284)
T ss_pred CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccc
Confidence 33344678899999988764 478999999999999999999998642111000 0000000 0000000
Q ss_pred ccCCccc------hhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 347 RLSPPIN------QKIIQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 347 ~~~~~~~------~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
...+... .........+.+++.+||+.||.+|||++|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h 281 (284)
T cd07839 235 KPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH 281 (284)
T ss_pred cccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence 0000000 0000112347789999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=278.86 Aligned_cols=228 Identities=20% Similarity=0.266 Sum_probs=179.2
Q ss_pred hcCcccceeeeecCceEEEEEEe-CCCcEEEEEeccC------------------------CccccceEEEecCceEEEE
Q 042435 142 TEYFHIRYCIGTGGYDSVYKAEL-PDGKVVALKKLHH------------------------SETEDSAFVVYSPQCMFFI 196 (412)
Q Consensus 142 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l~~------------------------~~~~~~~~~~~~~~~~~lv 196 (412)
.+.|..-++||+||||.||-++. .+|+.+|.|++.. +.++.....+.+++.+++|
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClV 263 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLV 263 (591)
T ss_pred ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEE
Confidence 35688889999999999999976 4699999986632 2233334447789999999
Q ss_pred EEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCC
Q 042435 197 YEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDV 276 (412)
Q Consensus 197 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~ 276 (412)
+..|.||+|.-+|.+.+. ..++.....-++.+|+.||++||.. +||.|||||+|||+|++|+++|+|.|+|..+..
T Consensus 264 LtlMNGGDLkfHiyn~g~-~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~ 339 (591)
T KOG0986|consen 264 LTLMNGGDLKFHIYNHGN-PGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLGLAVEIPE 339 (591)
T ss_pred EEeecCCceeEEeeccCC-CCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccceEEecCC
Confidence 999999999999987764 3589999999999999999999999 999999999999999999999999999987765
Q ss_pred CCCCcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccchhh
Q 042435 277 DSSNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKI 356 (412)
Q Consensus 277 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 356 (412)
...... .+||.+|||||++.+..|+...|.||+||++|||+.|+.||.... +..-.+-++.+.........
T Consensus 340 g~~~~~-rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~K--------eKvk~eEvdrr~~~~~~ey~ 410 (591)
T KOG0986|consen 340 GKPIRG-RVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRK--------EKVKREEVDRRTLEDPEEYS 410 (591)
T ss_pred CCcccc-ccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhh--------hhhhHHHHHHHHhcchhhcc
Confidence 544333 489999999999999999999999999999999999999997321 11112223332222111111
Q ss_pred HHHHHHHHHHHHhcCcCCCCCCCCHH
Q 042435 357 IQDIILVSTIALACLRSKPKSRPTMQ 382 (412)
Q Consensus 357 ~~~~~~~~~l~~~Cl~~dP~~RPs~~ 382 (412)
........++....+++||++|-...
T Consensus 411 ~kFS~eakslc~~LL~Kdp~~RLGcr 436 (591)
T KOG0986|consen 411 DKFSEEAKSLCEGLLTKDPEKRLGCR 436 (591)
T ss_pred cccCHHHHHHHHHHHccCHHHhccCC
Confidence 22233477888899999999997543
|
|
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=273.89 Aligned_cols=227 Identities=26% Similarity=0.413 Sum_probs=177.0
Q ss_pred CcccceeeeecCceEEEEEEe-CCCcEEEEEecc-------------------------CCccccceEEEecCceEEEEE
Q 042435 144 YFHIRYCIGTGGYDSVYKAEL-PDGKVVALKKLH-------------------------HSETEDSAFVVYSPQCMFFIY 197 (412)
Q Consensus 144 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l~-------------------------~~~~~~~~~~~~~~~~~~lv~ 197 (412)
.|+..+.||+|+||.||+|.. .+++.||+|.++ |+++......+..+...++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 477788999999999999986 578999999753 344444445566778899999
Q ss_pred EeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCC
Q 042435 198 EYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVD 277 (412)
Q Consensus 198 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~ 277 (412)
||+++++|.++++.. .+++.....++.|++.||.|||+. +++|+||+|+||++++++.++|+|||++......
T Consensus 82 e~~~~~~L~~~~~~~----~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06917 82 EYAEGGSVRTLMKAG----PIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQN 154 (277)
T ss_pred ecCCCCcHHHHHHcc----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence 999999999888653 489999999999999999999998 9999999999999999999999999999876554
Q ss_pred CCCcccccccccccccccccC-cccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccchhh
Q 042435 278 SSNRTLQAGTYGYIALELVYT-MVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKI 356 (412)
Q Consensus 278 ~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 356 (412)
........|+..|+|||.+.+ ..++.++|+||||+++|+|++|+.||...... . ..........+.....
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~-------~-~~~~~~~~~~~~~~~~- 225 (277)
T cd06917 155 SSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAF-------R-AMMLIPKSKPPRLEDN- 225 (277)
T ss_pred ccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChh-------h-hhhccccCCCCCCCcc-
Confidence 433444578899999998865 45788999999999999999999998632111 0 0011111111111111
Q ss_pred HHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 357 IQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 357 ~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
.....+.+++.+||+.||++||++.|++++
T Consensus 226 -~~~~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 226 -GYSKLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred -cCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 122347889999999999999999999874
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=274.44 Aligned_cols=236 Identities=25% Similarity=0.371 Sum_probs=179.2
Q ss_pred HhhcCcccceeeeecCceEEEEEEeC-CCcEEEEEec---------------------cCCccccceEEEec------Cc
Q 042435 140 DATEYFHIRYCIGTGGYDSVYKAELP-DGKVVALKKL---------------------HHSETEDSAFVVYS------PQ 191 (412)
Q Consensus 140 ~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l---------------------~~~~~~~~~~~~~~------~~ 191 (412)
.++++|++.+.||+|+||.||+|... +++.+++|.+ .|+++......+.. ..
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD 82 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence 46789999999999999999999874 5789999965 34555555554443 34
Q ss_pred eEEEEEEeccCCceeeeeccCc-ccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCC
Q 042435 192 CMFFIYEYMERGSLFCVLRDDD-EAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGT 270 (412)
Q Consensus 192 ~~~lv~ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGl 270 (412)
..++||||+++++|.+++.... ....+++..+..++.|++.||+|||+. +++|+||+|+||++++++.++|+|||+
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d~~~ 159 (275)
T cd06608 83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGV 159 (275)
T ss_pred EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECCCcc
Confidence 5899999999999998876432 123589999999999999999999998 999999999999999999999999999
Q ss_pred ccccCCCCCCcccccccccccccccccC-----cccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhh
Q 042435 271 VRLLDVDSSNRTLQAGTYGYIALELVYT-----MVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILY 345 (412)
Q Consensus 271 a~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~ 345 (412)
+..............|+..|+|||++.. ..++.++||||||+++|||++|+.||.... .......+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-------~~~~~~~~~~ 232 (275)
T cd06608 160 SAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMH-------PMRALFKIPR 232 (275)
T ss_pred ceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccc-------hHHHHHHhhc
Confidence 8765443333344568899999998753 346789999999999999999999986321 1111112111
Q ss_pred hccCCccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 346 QRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
. ..+.. .........+.+++.+||..||++|||+.|++++
T Consensus 233 ~-~~~~~-~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~ 272 (275)
T cd06608 233 N-PPPTL-KSPENWSKKFNDFISECLIKNYEQRPFMEELLEH 272 (275)
T ss_pred c-CCCCC-CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 1 11111 1111123347899999999999999999999864
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=277.26 Aligned_cols=229 Identities=25% Similarity=0.342 Sum_probs=179.6
Q ss_pred cCcccceeeeecCceEEEEEEe-CCCcEEEEEec---------------------cCCccccceEEEecCceEEEEEEec
Q 042435 143 EYFHIRYCIGTGGYDSVYKAEL-PDGKVVALKKL---------------------HHSETEDSAFVVYSPQCMFFIYEYM 200 (412)
Q Consensus 143 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l---------------------~~~~~~~~~~~~~~~~~~~lv~ey~ 200 (412)
++|++.+.||+|+||.||++.. .+++.||+|.+ +|+++......+...+..++|+||+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 98 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL 98 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence 6788999999999999999975 46889999965 3455555555567778899999999
Q ss_pred cCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCCCC
Q 042435 201 ERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSN 280 (412)
Q Consensus 201 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 280 (412)
++++|.+++... .+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||++.........
T Consensus 99 ~~~~L~~~~~~~----~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~ 171 (293)
T cd06647 99 AGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 171 (293)
T ss_pred CCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceecccccccc
Confidence 999999988654 378999999999999999999998 9999999999999999999999999998765544333
Q ss_pred cccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccchhhHHHH
Q 042435 281 RTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKIIQDI 360 (412)
Q Consensus 281 ~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 360 (412)
.....+++.|+|||.+....++.++||||||+++||+++|+.||...... .......... .+.. .......
T Consensus 172 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~-------~~~~~~~~~~-~~~~-~~~~~~~ 242 (293)
T cd06647 172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPL-------RALYLIATNG-TPEL-QNPEKLS 242 (293)
T ss_pred cccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChh-------hheeehhcCC-CCCC-CCccccC
Confidence 34456888999999998888999999999999999999999998732110 0000000000 0100 0111112
Q ss_pred HHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 361 ILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 361 ~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
..+.+++.+||+.+|++||++.+++.+
T Consensus 243 ~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 243 AIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 347789999999999999999999977
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=292.47 Aligned_cols=226 Identities=27% Similarity=0.367 Sum_probs=182.2
Q ss_pred eeeecCceEEEEEEeCC-CcEEEEEec---------------------cCCccccceEEEecCceEEEEEEeccCCceee
Q 042435 150 CIGTGGYDSVYKAELPD-GKVVALKKL---------------------HHSETEDSAFVVYSPQCMFFIYEYMERGSLFC 207 (412)
Q Consensus 150 ~lG~G~~g~Vy~~~~~~-~~~vAvK~l---------------------~~~~~~~~~~~~~~~~~~~lv~ey~~~gsL~~ 207 (412)
+||+|.||+||.|+..+ ...+|||.+ +|.|+++..+.+..++.+-+.||-.|||+|.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 79999999999997754 557899954 67788888888888899999999999999999
Q ss_pred eeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEec-CCCcEEEeecCCccccCCCCCCcccccc
Q 042435 208 VLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLN-SNLEAFVADFGTVRLLDVDSSNRTLQAG 286 (412)
Q Consensus 208 ~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~-~~~~~kl~DfGla~~~~~~~~~~~~~~g 286 (412)
+|+..-+...=+..+.-.+..||++||.|||++ .|||||||-+|+|++ -.|.+||+|||-++.+..-.....+..|
T Consensus 662 LLrskWGPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TETFTG 738 (1226)
T KOG4279|consen 662 LLRSKWGPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTETFTG 738 (1226)
T ss_pred HHHhccCCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhccCCcccccccc
Confidence 998765433336777888899999999999999 999999999999996 5789999999999987665555667789
Q ss_pred cccccccccccCc--ccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccchhhHHHHHHHH
Q 042435 287 TYGYIALELVYTM--VVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKIIQDIILVS 364 (412)
Q Consensus 287 t~~y~aPE~~~~~--~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 364 (412)
|..|||||++..+ .|+.++|||||||++.||.||++||....+. ...+-.+---...|+++... .....
T Consensus 739 TLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgsp------qAAMFkVGmyKvHP~iPeel---saeak 809 (1226)
T KOG4279|consen 739 TLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSP------QAAMFKVGMYKVHPPIPEEL---SAEAK 809 (1226)
T ss_pred chhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCCh------hHhhhhhcceecCCCCcHHH---HHHHH
Confidence 9999999999765 4888999999999999999999999744221 11111221122233443333 34478
Q ss_pred HHHHhcCcCCCCCCCCHHHHHHH
Q 042435 365 TIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 365 ~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
.++.+|+.+||.+||++.+++..
T Consensus 810 ~FilrcFepd~~~R~sA~~LL~D 832 (1226)
T KOG4279|consen 810 NFILRCFEPDPCDRPSAKDLLQD 832 (1226)
T ss_pred HHHHHHcCCCcccCccHHHhccC
Confidence 89999999999999999999864
|
|
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=307.96 Aligned_cols=236 Identities=19% Similarity=0.264 Sum_probs=176.7
Q ss_pred HHhhcCcccceeeeecCceEEEEEEeC-CCcEEEEEec-----------------------cCCccccceEEEe--cCce
Q 042435 139 IDATEYFHIRYCIGTGGYDSVYKAELP-DGKVVALKKL-----------------------HHSETEDSAFVVY--SPQC 192 (412)
Q Consensus 139 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l-----------------------~~~~~~~~~~~~~--~~~~ 192 (412)
....++|++.+.||+|+||.||+|... +++.||+|.+ +|+++......+. ..+.
T Consensus 9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ 88 (1021)
T PTZ00266 9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQK 88 (1021)
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCE
Confidence 345578999999999999999999764 5778899864 4566666555443 3467
Q ss_pred EEEEEEeccCCceeeeeccCcc-cccCCHHHHHHHHHHHHHHHHHHHhCCC----CCcEEeCCCCCCEEecC--------
Q 042435 193 MFFIYEYMERGSLFCVLRDDDE-AIELNWTRRMNIVKSVAHALSYLHHDCT----PSIVHRDISSNNILLNS-------- 259 (412)
Q Consensus 193 ~~lv~ey~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~gL~~LH~~~~----~~ivHrDlkp~NILl~~-------- 259 (412)
+|+||||+++|+|.++|..... ...+++..++.|+.||+.||+|||+... .+|+||||||+|||++.
T Consensus 89 lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i 168 (1021)
T PTZ00266 89 LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI 168 (1021)
T ss_pred EEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence 8999999999999998865321 2358999999999999999999998521 35999999999999964
Q ss_pred ---------CCcEEEeecCCccccCCCCCCcccccccccccccccccC--cccCcccccHHHHHHHHHHHhCCCCccccc
Q 042435 260 ---------NLEAFVADFGTVRLLDVDSSNRTLQAGTYGYIALELVYT--MVVTEKCVIYSFGVVALEVLMGTHPGELLL 328 (412)
Q Consensus 260 ---------~~~~kl~DfGla~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~ksDv~S~Gvil~elltg~~P~~~~~ 328 (412)
...+||+|||+++....... .....||+.|+|||++.+ ..++.++|||||||++|||+||+.||....
T Consensus 169 ~~~~~n~ng~~iVKLsDFGlAr~l~~~s~-~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~ 247 (1021)
T PTZ00266 169 TAQANNLNGRPIAKIGDFGLSKNIGIESM-AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKAN 247 (1021)
T ss_pred cccccccCCCCceEEccCCcccccccccc-ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCC
Confidence 34589999999986543322 233468999999999854 458899999999999999999999986321
Q ss_pred ccccCCCCcchhhHHhhhccCCccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHH
Q 042435 329 SLSSSSGPKIMLIDILYQRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQ 386 (412)
Q Consensus 329 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~ 386 (412)
....+...+......+.. .....+.+|+..||+.+|.+||++.|++.
T Consensus 248 -------~~~qli~~lk~~p~lpi~----~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 248 -------NFSQLISELKRGPDLPIK----GKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred -------cHHHHHHHHhcCCCCCcC----CCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 111112222221111111 11234788999999999999999999984
|
|
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-35 Score=277.54 Aligned_cols=233 Identities=21% Similarity=0.244 Sum_probs=177.5
Q ss_pred cCcccceeeeecCceEEEEEEeC-CCcEEEEEecc------------------------CCccccceEEEecCceEEEEE
Q 042435 143 EYFHIRYCIGTGGYDSVYKAELP-DGKVVALKKLH------------------------HSETEDSAFVVYSPQCMFFIY 197 (412)
Q Consensus 143 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~------------------------~~~~~~~~~~~~~~~~~~lv~ 197 (412)
++|++.+.||+|+||.||++... +++.||+|.+. |+++......+..++..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 46889999999999999999774 57899999653 444555555567778899999
Q ss_pred EeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCC
Q 042435 198 EYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVD 277 (412)
Q Consensus 198 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~ 277 (412)
||+++++|.+++.... .+++..+..++.|++.||+|||+. +++||||||+||+++.++.++++|||+++.....
T Consensus 81 e~~~g~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~ 154 (305)
T cd05609 81 EYVEGGDCATLLKNIG---ALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMS 154 (305)
T ss_pred ecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCccccCcC
Confidence 9999999999986643 588999999999999999999998 9999999999999999999999999998742111
Q ss_pred CC---------------CcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhH
Q 042435 278 SS---------------NRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLID 342 (412)
Q Consensus 278 ~~---------------~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~ 342 (412)
.. ......++..|+|||.+.+..++.++|+||||+++||+++|+.||... ........
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~-------~~~~~~~~ 227 (305)
T cd05609 155 LTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGD-------TPEELFGQ 227 (305)
T ss_pred ccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-------CHHHHHHH
Confidence 00 011235788999999998888999999999999999999999998621 11111122
Q ss_pred HhhhccCCccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhc
Q 042435 343 ILYQRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELEG 390 (412)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~ 390 (412)
........+... ......+.+++.+||+.||++||++.++.+.|+.
T Consensus 228 ~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 228 VISDDIEWPEGD--EALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred HHhcccCCCCcc--ccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 221111111110 1122347899999999999999997666666655
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-35 Score=272.50 Aligned_cols=231 Identities=24% Similarity=0.343 Sum_probs=175.8
Q ss_pred CcccceeeeecCceEEEEEEe-CCCcEEEEEecc-------------------------------CCccccceEEEecCc
Q 042435 144 YFHIRYCIGTGGYDSVYKAEL-PDGKVVALKKLH-------------------------------HSETEDSAFVVYSPQ 191 (412)
Q Consensus 144 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l~-------------------------------~~~~~~~~~~~~~~~ 191 (412)
+|...+.||+|+||.||+|.. .+|+.+|+|.++ |+++......+...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 467788999999999999975 468999999653 344444445567778
Q ss_pred eEEEEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCc
Q 042435 192 CMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTV 271 (412)
Q Consensus 192 ~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla 271 (412)
..++||||+++|+|.++++... .+++..+..++.|++.||.|||+. +++||||+|+||+++.++.++++|||++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~~~~ 155 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYG---RFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGIS 155 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeecccc
Confidence 8999999999999999887653 589999999999999999999998 9999999999999999999999999998
Q ss_pred cccCCCCC--CcccccccccccccccccCcc--cCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhc
Q 042435 272 RLLDVDSS--NRTLQAGTYGYIALELVYTMV--VTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQR 347 (412)
Q Consensus 272 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~--~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 347 (412)
+....... ......|+..|+|||.+.... ++.++|+||||+++||+++|..||..... .....+.....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~-------~~~~~~~~~~~ 228 (272)
T cd06629 156 KKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEA-------IAAMFKLGNKR 228 (272)
T ss_pred ccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcch-------HHHHHHhhccc
Confidence 76432211 122345788999999987654 78999999999999999999999863211 11111111111
Q ss_pred cCCccchh-hHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 348 LSPPINQK-IIQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 348 ~~~~~~~~-~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
.....+.. .......+.+++.+||+.+|++|||++|++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 229 SAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred cCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 11111111 01122348889999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-35 Score=270.42 Aligned_cols=229 Identities=23% Similarity=0.323 Sum_probs=178.1
Q ss_pred CcccceeeeecCceEEEEEEeC-CCcEEEEEecc-----------------------CCccccceEEEecCceEEEEEEe
Q 042435 144 YFHIRYCIGTGGYDSVYKAELP-DGKVVALKKLH-----------------------HSETEDSAFVVYSPQCMFFIYEY 199 (412)
Q Consensus 144 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~-----------------------~~~~~~~~~~~~~~~~~~lv~ey 199 (412)
+|++.+.||+|+||.||+|... +|..+|+|.+. |+++......+......++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 4788899999999999999774 58899999753 44444445557778889999999
Q ss_pred ccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCC-cEEEeecCCccccCCCC
Q 042435 200 MERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNL-EAFVADFGTVRLLDVDS 278 (412)
Q Consensus 200 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~-~~kl~DfGla~~~~~~~ 278 (412)
+++++|.+++..... ..+++..+..++.|++.||+|||+. +++|+||||+||++++++ .++++|||.+.......
T Consensus 81 ~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (257)
T cd08225 81 CDGGDLMKRINRQRG-VLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM 156 (257)
T ss_pred CCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhccCCc
Confidence 999999998865432 2479999999999999999999998 999999999999998875 56999999998665433
Q ss_pred CCcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccchhhHH
Q 042435 279 SNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKIIQ 358 (412)
Q Consensus 279 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 358 (412)
.......|++.|+|||+..+..++.++|+||||+++||+++|+.||.... ............... ... .
T Consensus 157 ~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-------~~~~~~~~~~~~~~~-~~~---~ 225 (257)
T cd08225 157 ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN-------LHQLVLKICQGYFAP-ISP---N 225 (257)
T ss_pred ccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc-------HHHHHHHHhcccCCC-CCC---C
Confidence 33333468899999999988889999999999999999999999986321 111112222221111 111 1
Q ss_pred HHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 359 DIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 359 ~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
....+.+++.+||..+|++|||+.|++++
T Consensus 226 ~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 226 FSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred CCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 12247889999999999999999999865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=268.92 Aligned_cols=230 Identities=27% Similarity=0.341 Sum_probs=176.5
Q ss_pred CcccceeeeecCceEEEEEEeC-CCcEEEEEecc-----------------------CCccccceEEEecCceEEEEEEe
Q 042435 144 YFHIRYCIGTGGYDSVYKAELP-DGKVVALKKLH-----------------------HSETEDSAFVVYSPQCMFFIYEY 199 (412)
Q Consensus 144 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~-----------------------~~~~~~~~~~~~~~~~~~lv~ey 199 (412)
+|+..+.||+|+||.||+|... +++.||+|.++ |+++......+...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 4788899999999999999764 68999999754 34444444556677889999999
Q ss_pred ccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCCC
Q 042435 200 MERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSS 279 (412)
Q Consensus 200 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 279 (412)
+++++|.+++.... .+++..+..++.+++.||+|||+. +++|+||+|+||++++++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~~---~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~ 154 (264)
T cd06626 81 CSGGTLEELLEHGR---ILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTT 154 (264)
T ss_pred CCCCcHHHHHhhcC---CCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccCCCCC
Confidence 99999999887643 478899999999999999999998 999999999999999999999999999887644322
Q ss_pred Cc----ccccccccccccccccCcc---cCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCcc
Q 042435 280 NR----TLQAGTYGYIALELVYTMV---VTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPI 352 (412)
Q Consensus 280 ~~----~~~~gt~~y~aPE~~~~~~---~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 352 (412)
.. ....++..|+|||++.+.. ++.++||||||+++||+++|+.||.... ..............+..
T Consensus 155 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~-------~~~~~~~~~~~~~~~~~ 227 (264)
T cd06626 155 TMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELD-------NEFQIMFHVGAGHKPPI 227 (264)
T ss_pred cccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCc-------chHHHHHHHhcCCCCCC
Confidence 21 1246788999999998766 8899999999999999999999986321 11111111111111111
Q ss_pred chhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 353 NQKIIQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 353 ~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
+. .......+.+++.+||+.+|++|||+.|++.+
T Consensus 228 ~~-~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~ 261 (264)
T cd06626 228 PD-SLQLSPEGKDFLDRCLESDPKKRPTASELLQH 261 (264)
T ss_pred Cc-ccccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 11 11112347789999999999999999998753
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-35 Score=280.99 Aligned_cols=176 Identities=19% Similarity=0.275 Sum_probs=145.0
Q ss_pred cceeeeec--CceEEEEEEe-CCCcEEEEEec-----------------------cCCccccceEEEecCceEEEEEEec
Q 042435 147 IRYCIGTG--GYDSVYKAEL-PDGKVVALKKL-----------------------HHSETEDSAFVVYSPQCMFFIYEYM 200 (412)
Q Consensus 147 ~~~~lG~G--~~g~Vy~~~~-~~~~~vAvK~l-----------------------~~~~~~~~~~~~~~~~~~~lv~ey~ 200 (412)
+.++||+| +||+||++.. .+|+.||+|++ +|+++......+..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 45789999 7899999976 57899999965 4677777777788889999999999
Q ss_pred cCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCCC-
Q 042435 201 ERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSS- 279 (412)
Q Consensus 201 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~- 279 (412)
++|+|.+++..... ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.++++||+..........
T Consensus 82 ~~~~l~~~~~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~ 157 (327)
T cd08227 82 AYGSAKDLICTHFM-DGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQR 157 (327)
T ss_pred CCCcHHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhcccccccc
Confidence 99999998865322 1489999999999999999999998 999999999999999999999999986543321110
Q ss_pred ------CcccccccccccccccccC--cccCcccccHHHHHHHHHHHhCCCCccc
Q 042435 280 ------NRTLQAGTYGYIALELVYT--MVVTEKCVIYSFGVVALEVLMGTHPGEL 326 (412)
Q Consensus 280 ------~~~~~~gt~~y~aPE~~~~--~~~s~ksDv~S~Gvil~elltg~~P~~~ 326 (412)
......++..|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 212 (327)
T cd08227 158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD 212 (327)
T ss_pred ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 0122346778999999875 4588999999999999999999999963
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=273.37 Aligned_cols=230 Identities=24% Similarity=0.303 Sum_probs=178.7
Q ss_pred cCcccceeeeecCceEEEEEEeC-CCcEEEEEecc----------------------CCccccceEEEecCceEEEEEEe
Q 042435 143 EYFHIRYCIGTGGYDSVYKAELP-DGKVVALKKLH----------------------HSETEDSAFVVYSPQCMFFIYEY 199 (412)
Q Consensus 143 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~----------------------~~~~~~~~~~~~~~~~~~lv~ey 199 (412)
++|+..+.||+|+||.||++... +++.+|+|.+. |+++......+......++++||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 36778889999999999999875 68999999653 34444445557777899999999
Q ss_pred ccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHh-CCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCC
Q 042435 200 MERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHH-DCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDS 278 (412)
Q Consensus 200 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~-~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~ 278 (412)
+++++|.+++.... ..++......++.|++.||+|||+ . +++|+||||+||+++.++.++|+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~ 155 (265)
T cd06605 81 MDGGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL 155 (265)
T ss_pred cCCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhhHHHH
Confidence 99999999887643 258889999999999999999998 6 99999999999999999999999999987653222
Q ss_pred CCcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhcc---CCccchh
Q 042435 279 SNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRL---SPPINQK 355 (412)
Q Consensus 279 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~ 355 (412)
.. ...++..|+|||...+..++.++||||||+++|+|++|+.||..... ......+...... .+..+..
T Consensus 156 ~~--~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~ 227 (265)
T cd06605 156 AK--TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPEND------PPDGIFELLQYIVNEPPPRLPSG 227 (265)
T ss_pred hh--cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccc------ccccHHHHHHHHhcCCCCCCChh
Confidence 11 25688899999999988999999999999999999999999863211 0111112221111 1111111
Q ss_pred hHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 356 IIQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 356 ~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
.....+.+++.+||..||++|||+.|++.+
T Consensus 228 --~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 228 --KFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred --hcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 123347899999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-35 Score=275.24 Aligned_cols=239 Identities=19% Similarity=0.265 Sum_probs=174.1
Q ss_pred cCcccceeeeecCceEEEEEEeC-CCcEEEEEecc----------------------CCccccceEEEecCceEEEEEEe
Q 042435 143 EYFHIRYCIGTGGYDSVYKAELP-DGKVVALKKLH----------------------HSETEDSAFVVYSPQCMFFIYEY 199 (412)
Q Consensus 143 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~----------------------~~~~~~~~~~~~~~~~~~lv~ey 199 (412)
++|++.+.||+|++|.||+|... +++.||+|.+. |+++.....++...+..++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 67889999999999999999775 68999999753 44455555667788899999999
Q ss_pred ccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCCC
Q 042435 200 MERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSS 279 (412)
Q Consensus 200 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 279 (412)
+++ +|.+++..... .+++.....++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++.......
T Consensus 85 ~~~-~L~~~~~~~~~--~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 158 (291)
T cd07844 85 LDT-DLKQYMDDCGG--GLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK 158 (291)
T ss_pred CCC-CHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccccccCCCCc
Confidence 974 89888765432 588999999999999999999998 999999999999999999999999999875433222
Q ss_pred CcccccccccccccccccC-cccCcccccHHHHHHHHHHHhCCCCccccccccc---------CCCCcchhhHHhh----
Q 042435 280 NRTLQAGTYGYIALELVYT-MVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSS---------SSGPKIMLIDILY---- 345 (412)
Q Consensus 280 ~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~---------~~~~~~~~~~~~~---- 345 (412)
......++..|+|||++.+ ..++.++||||||+++|||++|+.||........ .............
T Consensus 159 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (291)
T cd07844 159 TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEF 238 (291)
T ss_pred cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcccc
Confidence 2233356889999998865 4578899999999999999999999863210000 0000000000000
Q ss_pred --hccCCccchh------hHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 346 --QRLSPPINQK------IIQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 346 --~~~~~~~~~~------~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
.......... .......+.+++.+|++.+|++|||+.|++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~ 288 (291)
T cd07844 239 KPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKH 288 (291)
T ss_pred ccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence 0000000000 00011347789999999999999999998763
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=274.82 Aligned_cols=238 Identities=24% Similarity=0.252 Sum_probs=174.4
Q ss_pred CcccceeeeecCceEEEEEEeC-CCcEEEEEeccC--------------------------CccccceEEEecCceEEEE
Q 042435 144 YFHIRYCIGTGGYDSVYKAELP-DGKVVALKKLHH--------------------------SETEDSAFVVYSPQCMFFI 196 (412)
Q Consensus 144 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~--------------------------~~~~~~~~~~~~~~~~~lv 196 (412)
+|+..+.||+|+||.||+|... +++.||+|.++. +++......+.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4778889999999999999764 689999997643 3333334446667889999
Q ss_pred EEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCC
Q 042435 197 YEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDV 276 (412)
Q Consensus 197 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~ 276 (412)
|||+ +|+|.+++.... ..+++..+..++.|+++||+|||++ +++|+||||+||+++.++.++|+|||+++....
T Consensus 81 ~e~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~ 154 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGS 154 (298)
T ss_pred Eccc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence 9999 899999987643 2589999999999999999999998 999999999999999999999999999987654
Q ss_pred CCCCcccccccccccccccccC-cccCcccccHHHHHHHHHHHhCCCCccccccccc--------CCCCcchh------h
Q 042435 277 DSSNRTLQAGTYGYIALELVYT-MVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSS--------SSGPKIML------I 341 (412)
Q Consensus 277 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~--------~~~~~~~~------~ 341 (412)
.........+++.|+|||.+.+ ..++.++|||||||++|||++|..||........ ........ .
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (298)
T cd07841 155 PNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLP 234 (298)
T ss_pred CCccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhccccc
Confidence 4333334456788999998854 4578899999999999999999777652211000 00000000 0
Q ss_pred HHhhhccCCcc--chhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 342 DILYQRLSPPI--NQKIIQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 342 ~~~~~~~~~~~--~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
.........+. ..........+.+++.+||+.||++|||+.|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 235 DYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred ccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 00000000000 00001112357899999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=273.38 Aligned_cols=241 Identities=21% Similarity=0.231 Sum_probs=173.3
Q ss_pred hhcCcccceeeeecCceEEEEEEe-CCCcEEEEEecc----------------------CCccccceEEEecCceEEEEE
Q 042435 141 ATEYFHIRYCIGTGGYDSVYKAEL-PDGKVVALKKLH----------------------HSETEDSAFVVYSPQCMFFIY 197 (412)
Q Consensus 141 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l~----------------------~~~~~~~~~~~~~~~~~~lv~ 197 (412)
++++|.+.+.||+|+||.||+|.. .+++.||+|.++ |+++......+..++..++|+
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 567899999999999999999976 468999999763 334444445566778899999
Q ss_pred EeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCC
Q 042435 198 EYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVD 277 (412)
Q Consensus 198 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~ 277 (412)
||++ ++|.+++.... ..+.+..+..++.|++.||+|||+. +++|+||||+||+++.++.++|+|||+++.....
T Consensus 83 e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 156 (291)
T cd07870 83 EYMH-TDLAQYMIQHP--GGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSIP 156 (291)
T ss_pred eccc-CCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccccccccCCC
Confidence 9996 67766654332 2478888899999999999999998 9999999999999999999999999998765433
Q ss_pred CCCcccccccccccccccccCc-ccCcccccHHHHHHHHHHHhCCCCcccccccccC--------CCCcchhh-------
Q 042435 278 SSNRTLQAGTYGYIALELVYTM-VVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSS--------SGPKIMLI------- 341 (412)
Q Consensus 278 ~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~--------~~~~~~~~------- 341 (412)
........++..|+|||.+.+. .++.++||||||+++|||++|+.||+........ ..+.....
T Consensus 157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (291)
T cd07870 157 SQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLP 236 (291)
T ss_pred CCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcc
Confidence 3223334578899999998753 5788999999999999999999998632110000 00000000
Q ss_pred ---HHhhhccCCccchh---hHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 342 ---DILYQRLSPPINQK---IIQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 342 ---~~~~~~~~~~~~~~---~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
........+..... .......+.+++.+|+..||++|||+.|++.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h 288 (291)
T cd07870 237 NYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH 288 (291)
T ss_pred cccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence 00000000000000 00112347789999999999999999998764
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=267.60 Aligned_cols=229 Identities=25% Similarity=0.394 Sum_probs=175.7
Q ss_pred cccceeeeecCceEEEEEEeCC-----CcEEEEEecc----------------------CCccccceEEEecCceEEEEE
Q 042435 145 FHIRYCIGTGGYDSVYKAELPD-----GKVVALKKLH----------------------HSETEDSAFVVYSPQCMFFIY 197 (412)
Q Consensus 145 f~~~~~lG~G~~g~Vy~~~~~~-----~~~vAvK~l~----------------------~~~~~~~~~~~~~~~~~~lv~ 197 (412)
|++.+.||+|+||.||++...+ +..||+|.++ |+++......+...+..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 3567889999999999998753 4889999764 333344444566778899999
Q ss_pred EeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCC
Q 042435 198 EYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVD 277 (412)
Q Consensus 198 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~ 277 (412)
||+++++|.+++...... .+++.++..++.|++.||+|||+. +++|+||||+||++++++.++++|||+++.....
T Consensus 81 e~~~~~~l~~~~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 156 (258)
T smart00219 81 EYMEGGDLLDYLRKNRPK-ELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDD 156 (258)
T ss_pred eccCCCCHHHHHHhhhhc-cCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCceecccc
Confidence 999999999998764421 289999999999999999999998 9999999999999999999999999999866543
Q ss_pred CCCcc-cccccccccccccccCcccCcccccHHHHHHHHHHHh-CCCCcccccccccCCCCcchhhHHhhhccCCccchh
Q 042435 278 SSNRT-LQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLM-GTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQK 355 (412)
Q Consensus 278 ~~~~~-~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 355 (412)
..... ...+++.|+|||...+..++.++||||+|++++||++ |..||... ......+.............
T Consensus 157 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~--------~~~~~~~~~~~~~~~~~~~~ 228 (258)
T smart00219 157 DYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGM--------SNEEVLEYLKKGYRLPKPEN 228 (258)
T ss_pred cccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC--------CHHHHHHHHhcCCCCCCCCc
Confidence 22111 2336789999999988889999999999999999998 78887621 11111122221111111111
Q ss_pred hHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHH
Q 042435 356 IIQDIILVSTIALACLRSKPKSRPTMQRISQEL 388 (412)
Q Consensus 356 ~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L 388 (412)
....+.+++.+||..||++|||+.|+++.|
T Consensus 229 ---~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 229 ---CPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred ---CCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 233488899999999999999999998764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=267.17 Aligned_cols=228 Identities=22% Similarity=0.330 Sum_probs=176.2
Q ss_pred CcccceeeeecCceEEEEEEe-CCCcEEEEEecc-----------------------CCccccceEEEecCceEEEEEEe
Q 042435 144 YFHIRYCIGTGGYDSVYKAEL-PDGKVVALKKLH-----------------------HSETEDSAFVVYSPQCMFFIYEY 199 (412)
Q Consensus 144 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l~-----------------------~~~~~~~~~~~~~~~~~~lv~ey 199 (412)
+|+..+.||+|+||.||++.. .+++.+|+|.+. |+++......+...+..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 478889999999999999976 468899999753 44444444456667889999999
Q ss_pred ccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCC-CcEEEeecCCccccCCCC
Q 042435 200 MERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSN-LEAFVADFGTVRLLDVDS 278 (412)
Q Consensus 200 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~-~~~kl~DfGla~~~~~~~ 278 (412)
+++++|.+++..... ..+++..+..++.+++.||+|||++ +++|+||||+||+++++ ..++++|||+++......
T Consensus 81 ~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (256)
T cd08220 81 APGGTLAEYIQKRCN-SLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS 156 (256)
T ss_pred CCCCCHHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc
Confidence 999999999876432 2489999999999999999999998 99999999999999854 568999999998664332
Q ss_pred CCcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccchhhHH
Q 042435 279 SNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKIIQ 358 (412)
Q Consensus 279 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 358 (412)
......++..|+|||.+.+..++.++||||||+++|+|++|+.||... .............. .+....
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~-------~~~~~~~~~~~~~~-~~~~~~--- 224 (256)
T cd08220 157 -KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAA-------NLPALVLKIMSGTF-APISDR--- 224 (256)
T ss_pred -cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccC-------chHHHHHHHHhcCC-CCCCCC---
Confidence 222346788999999998888999999999999999999999998632 11111122221111 111111
Q ss_pred HHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 359 DIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 359 ~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
....+.+++.+||+.||++|||+.|++++
T Consensus 225 ~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 225 YSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred cCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 12247889999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=273.12 Aligned_cols=224 Identities=23% Similarity=0.276 Sum_probs=180.0
Q ss_pred cCcccceeeeecCceEEEEEEeC-CCcEEEEEec------------------------cCCccccceEEEecCceEEEEE
Q 042435 143 EYFHIRYCIGTGGYDSVYKAELP-DGKVVALKKL------------------------HHSETEDSAFVVYSPQCMFFIY 197 (412)
Q Consensus 143 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l------------------------~~~~~~~~~~~~~~~~~~~lv~ 197 (412)
++|++.+.||+|+||.||++... +++.+|+|.+ +|+++......+...+..++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 46889999999999999999774 6899999964 3667777777788888999999
Q ss_pred EeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCC
Q 042435 198 EYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVD 277 (412)
Q Consensus 198 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~ 277 (412)
||+++++|.+++.... .+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~~~~~~---~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 154 (290)
T cd05580 81 EYVPGGELFSHLRKSG---RFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR 154 (290)
T ss_pred ecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCccccCCC
Confidence 9999999999887653 588999999999999999999998 9999999999999999999999999999865433
Q ss_pred CCCcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccchhhH
Q 042435 278 SSNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKII 357 (412)
Q Consensus 278 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 357 (412)
.....+++.|+|||.+.+...+.++||||||+++|||++|+.||.... .............. .+...
T Consensus 155 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-------~~~~~~~~~~~~~~--~~~~~- 221 (290)
T cd05580 155 ---TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDN-------PIQIYEKILEGKVR--FPSFF- 221 (290)
T ss_pred ---CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC-------HHHHHHHHhcCCcc--CCccC-
Confidence 233468899999999988888999999999999999999999986321 11111122211111 11111
Q ss_pred HHHHHHHHHHHhcCcCCCCCCC-----CHHHHHHH
Q 042435 358 QDIILVSTIALACLRSKPKSRP-----TMQRISQE 387 (412)
Q Consensus 358 ~~~~~~~~l~~~Cl~~dP~~RP-----s~~evl~~ 387 (412)
...+.+++.+||..||.+|| +++|++++
T Consensus 222 --~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~ 254 (290)
T cd05580 222 --SPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNH 254 (290)
T ss_pred --CHHHHHHHHHHccCCHHHccCcccCCHHHHHcC
Confidence 23477899999999999999 77777654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=274.40 Aligned_cols=241 Identities=19% Similarity=0.199 Sum_probs=170.7
Q ss_pred cCcccceeeeecCceEEEEEEeC-CCcEEEEEecc------------------------CCccccceEEEecCce-----
Q 042435 143 EYFHIRYCIGTGGYDSVYKAELP-DGKVVALKKLH------------------------HSETEDSAFVVYSPQC----- 192 (412)
Q Consensus 143 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~------------------------~~~~~~~~~~~~~~~~----- 192 (412)
++|++.+.||+|+||.||+|... +++.||+|.++ |+++......+...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 46889999999999999999764 68999999753 2333333333443333
Q ss_pred EEEEEEeccCCceeeeeccCcc--cccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecC-CCcEEEeecC
Q 042435 193 MFFIYEYMERGSLFCVLRDDDE--AIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNS-NLEAFVADFG 269 (412)
Q Consensus 193 ~~lv~ey~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~-~~~~kl~DfG 269 (412)
.++||||+++ +|.+++..... ...+++..+..++.||+.||+|||+. +++||||||+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeecc
Confidence 7999999985 78887754321 23589999999999999999999998 9999999999999998 8999999999
Q ss_pred CccccCCCCCCcccccccccccccccccC-cccCcccccHHHHHHHHHHHhCCCCccccccccc--------CCCCcchh
Q 042435 270 TVRLLDVDSSNRTLQAGTYGYIALELVYT-MVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSS--------SSGPKIML 340 (412)
Q Consensus 270 la~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~--------~~~~~~~~ 340 (412)
+++.............+++.|+|||++.+ ..++.++||||||+++|||++|..||........ ........
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (295)
T cd07837 157 LGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVW 236 (295)
T ss_pred cceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhC
Confidence 98865433332333456889999998865 4578999999999999999999999863211000 00000000
Q ss_pred hHH------h-hhccCCccc-hhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 341 IDI------L-YQRLSPPIN-QKIIQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 341 ~~~------~-~~~~~~~~~-~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
... . .+...+... .........+.+++.+||+.||++||+++|++.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 237 PGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred cchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 000 0 000000000 0001123347889999999999999999999864
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=289.58 Aligned_cols=225 Identities=25% Similarity=0.341 Sum_probs=181.0
Q ss_pred CcccceeeeecCceEEEEEEe-CCCcEEEEEec------------------------cCCccccceEEEecCceEEEEEE
Q 042435 144 YFHIRYCIGTGGYDSVYKAEL-PDGKVVALKKL------------------------HHSETEDSAFVVYSPQCMFFIYE 198 (412)
Q Consensus 144 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l------------------------~~~~~~~~~~~~~~~~~~~lv~e 198 (412)
-|...+.||.|+||.||-|+. .+.++||||++ +|+|.....+.+......|||||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME 106 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME 106 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence 355667899999999999965 67899999975 68888888888888888999999
Q ss_pred eccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCC
Q 042435 199 YMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDS 278 (412)
Q Consensus 199 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~ 278 (412)
||- |+-.+++.-..+ ++....+..|..+.+.||+|||++ +.||||||..|||+++.+.+||+|||.|....+.
T Consensus 107 YCl-GSAsDlleVhkK--plqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA- 179 (948)
T KOG0577|consen 107 YCL-GSASDLLEVHKK--PLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASIMAPA- 179 (948)
T ss_pred HHh-ccHHHHHHHHhc--cchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchhhcCch-
Confidence 994 587777765543 488888999999999999999999 9999999999999999999999999999865433
Q ss_pred CCccccccccccccccccc---CcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccchh
Q 042435 279 SNRTLQAGTYGYIALELVY---TMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQK 355 (412)
Q Consensus 279 ~~~~~~~gt~~y~aPE~~~---~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 355 (412)
..++|||.|||||++. .+.|+-|+||||+|++..||...++|.-.+... ..+.. +...-+|....
T Consensus 180 ---nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAM-------SALYH-IAQNesPtLqs- 247 (948)
T KOG0577|consen 180 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-------SALYH-IAQNESPTLQS- 247 (948)
T ss_pred ---hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHH-------HHHHH-HHhcCCCCCCC-
Confidence 3578999999999985 567999999999999999999999996532110 01111 22222232222
Q ss_pred hHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHH
Q 042435 356 IIQDIILVSTIALACLRSKPKSRPTMQRISQEL 388 (412)
Q Consensus 356 ~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L 388 (412)
.+....+..++..|+++-|.+|||.++++++-
T Consensus 248 -~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~ 279 (948)
T KOG0577|consen 248 -NEWSDYFRNFVDSCLQKIPQERPTSEELLKHR 279 (948)
T ss_pred -chhHHHHHHHHHHHHhhCcccCCcHHHHhhcc
Confidence 23344588999999999999999999998874
|
|
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=272.79 Aligned_cols=227 Identities=23% Similarity=0.329 Sum_probs=177.3
Q ss_pred cccceeeeecCceEEEEEEe-CCCcEEEEEec---------------------cCCccccceEEEecCceEEEEEEeccC
Q 042435 145 FHIRYCIGTGGYDSVYKAEL-PDGKVVALKKL---------------------HHSETEDSAFVVYSPQCMFFIYEYMER 202 (412)
Q Consensus 145 f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l---------------------~~~~~~~~~~~~~~~~~~~lv~ey~~~ 202 (412)
|...+.||+|++|.||++.. .+++.+|+|++ +|+++......+...+..++++||+++
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~ 100 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG 100 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence 44457999999999999976 46889999965 345555555566778889999999999
Q ss_pred CceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCCCCcc
Q 042435 203 GSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRT 282 (412)
Q Consensus 203 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 282 (412)
++|.+++... .+++..+..++.|++.||+|||++ +++||||+|+||+++.++.++++|||++...........
T Consensus 101 ~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~~ 173 (285)
T cd06648 101 GALTDIVTHT----RMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRK 173 (285)
T ss_pred CCHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhccCCcccc
Confidence 9999988763 488999999999999999999998 999999999999999999999999998876544333333
Q ss_pred cccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccchhhHHHHHH
Q 042435 283 LQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKIIQDIIL 362 (412)
Q Consensus 283 ~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 362 (412)
...|+..|+|||...+..++.++||||||+++|||++|+.||.... ... ....+.....+.. .........
T Consensus 174 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~-------~~~-~~~~~~~~~~~~~-~~~~~~~~~ 244 (285)
T cd06648 174 SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEP-------PLQ-AMKRIRDNLPPKL-KNLHKVSPR 244 (285)
T ss_pred cccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCC-------HHH-HHHHHHhcCCCCC-cccccCCHH
Confidence 4568899999999988889999999999999999999999986311 111 1111111111111 111112234
Q ss_pred HHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 363 VSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 363 ~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
+.+++.+||+.+|++||++.+++++
T Consensus 245 l~~li~~~l~~~p~~Rpt~~~il~~ 269 (285)
T cd06648 245 LRSFLDRMLVRDPAQRATAAELLNH 269 (285)
T ss_pred HHHHHHHHcccChhhCcCHHHHccC
Confidence 8899999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=271.56 Aligned_cols=239 Identities=21% Similarity=0.245 Sum_probs=173.2
Q ss_pred CcccceeeeecCceEEEEEEeC-CCcEEEEEecc-----------------------CCccccceEEEecCceEEEEEEe
Q 042435 144 YFHIRYCIGTGGYDSVYKAELP-DGKVVALKKLH-----------------------HSETEDSAFVVYSPQCMFFIYEY 199 (412)
Q Consensus 144 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~-----------------------~~~~~~~~~~~~~~~~~~lv~ey 199 (412)
+|+..+.||+|++|.||+|... +++.||||+++ |+++......+...+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 5888899999999999999774 68999999664 44444445556778889999999
Q ss_pred ccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCCC
Q 042435 200 MERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSS 279 (412)
Q Consensus 200 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 279 (412)
++ ++|.+++..... ..+++..+..++.|++.||+|||+. +++||||+|+||+++.++.+||+|||+++.......
T Consensus 81 ~~-~~l~~~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~ 155 (284)
T cd07860 81 LH-QDLKKFMDASPL-SGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 155 (284)
T ss_pred cc-cCHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc
Confidence 96 588887765332 2589999999999999999999998 999999999999999999999999999876544333
Q ss_pred CcccccccccccccccccCcc-cCcccccHHHHHHHHHHHhCCCCccccccccc-------CCCCcch----hhHHhh--
Q 042435 280 NRTLQAGTYGYIALELVYTMV-VTEKCVIYSFGVVALEVLMGTHPGELLLSLSS-------SSGPKIM----LIDILY-- 345 (412)
Q Consensus 280 ~~~~~~gt~~y~aPE~~~~~~-~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~-------~~~~~~~----~~~~~~-- 345 (412)
......++..|+|||...+.. ++.++||||||+++|||+||+.||........ ...+... ..+...
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd07860 156 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYK 235 (284)
T ss_pred ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHH
Confidence 333445788999999887644 68899999999999999999999853211000 0000000 000000
Q ss_pred hccCCccch---h-hHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 346 QRLSPPINQ---K-IIQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 346 ~~~~~~~~~---~-~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
......... . .......+.+++.+||+.||++|||++|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 236 PSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred hhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 000000000 0 00112236789999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=270.75 Aligned_cols=226 Identities=19% Similarity=0.264 Sum_probs=164.0
Q ss_pred eeeecCceEEEEEEeCCC---cEEEEEec----------------------cCCccccceEEEecCceEEEEEEeccCCc
Q 042435 150 CIGTGGYDSVYKAELPDG---KVVALKKL----------------------HHSETEDSAFVVYSPQCMFFIYEYMERGS 204 (412)
Q Consensus 150 ~lG~G~~g~Vy~~~~~~~---~~vAvK~l----------------------~~~~~~~~~~~~~~~~~~~lv~ey~~~gs 204 (412)
.||+|+||.||+|...++ ..+++|.+ +|+++......+......++||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 589999999999975433 34566643 46666666777788888999999999999
Q ss_pred eeeeeccCcc-cccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCC--CCc
Q 042435 205 LFCVLRDDDE-AIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDS--SNR 281 (412)
Q Consensus 205 L~~~l~~~~~-~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~--~~~ 281 (412)
|.++++.... ....++.....++.|+++||+|||+. +++||||||+|||++.++.++|+|||++....... ...
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence 9999875432 22466777889999999999999998 99999999999999999999999999986432211 112
Q ss_pred ccccccccccccccccC-------cccCcccccHHHHHHHHHHHh-CCCCcccccccccCCCCcchhhHHhhhc----cC
Q 042435 282 TLQAGTYGYIALELVYT-------MVVTEKCVIYSFGVVALEVLM-GTHPGELLLSLSSSSGPKIMLIDILYQR----LS 349 (412)
Q Consensus 282 ~~~~gt~~y~aPE~~~~-------~~~s~ksDv~S~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~----~~ 349 (412)
....++..|+|||++.. ..++.++||||||+++|||++ |..||.... ............ ..
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~-------~~~~~~~~~~~~~~~~~~ 231 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLS-------DREVLNHVIKDQQVKLFK 231 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCC-------HHHHHHHHHhhcccccCC
Confidence 33467889999998743 245789999999999999997 566775221 111111111111 11
Q ss_pred CccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHh
Q 042435 350 PPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELE 389 (412)
Q Consensus 350 ~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~ 389 (412)
+..... ....+.+++..|| .+|++||+++||++.|.
T Consensus 232 ~~~~~~---~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 232 PQLELP---YSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CccCCC---CcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 111111 1223677888999 67999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=272.36 Aligned_cols=234 Identities=28% Similarity=0.394 Sum_probs=183.2
Q ss_pred HhhcCcccceeeeecCceEEEEEEeC-CCcEEEEEecc--------------------CCccccceEEEecCceEEEEEE
Q 042435 140 DATEYFHIRYCIGTGGYDSVYKAELP-DGKVVALKKLH--------------------HSETEDSAFVVYSPQCMFFIYE 198 (412)
Q Consensus 140 ~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~--------------------~~~~~~~~~~~~~~~~~~lv~e 198 (412)
+.++.|+..+.||+|++|.||+|... +++.+|+|.++ |+++......+...+..++++|
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 95 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME 95 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence 56777888999999999999999875 68899999764 3444444555677789999999
Q ss_pred eccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCC
Q 042435 199 YMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDS 278 (412)
Q Consensus 199 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~ 278 (412)
|+++++|.+++.... ..+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++.......
T Consensus 96 ~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 170 (286)
T cd06614 96 YMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK 170 (286)
T ss_pred ccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhhhhccch
Confidence 999999999997653 2589999999999999999999998 99999999999999999999999999987654433
Q ss_pred CCcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccchhhHH
Q 042435 279 SNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKIIQ 358 (412)
Q Consensus 279 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 358 (412)
.......++..|+|||.+.+..++.++|+||||+++|||++|+.||.... .......+....... . .....
T Consensus 171 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~-------~~~~~~~~~~~~~~~-~-~~~~~ 241 (286)
T cd06614 171 SKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREP-------PLRALFLITTKGIPP-L-KNPEK 241 (286)
T ss_pred hhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCC-------HHHHHHHHHhcCCCC-C-cchhh
Confidence 33334457889999999988889999999999999999999999986321 111111111111111 1 11111
Q ss_pred HHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 359 DIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 359 ~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
....+.+++.+||+.+|.+||++.+++++
T Consensus 242 ~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 270 (286)
T cd06614 242 WSPEFKDFLNKCLVKDPEKRPSAEELLQH 270 (286)
T ss_pred CCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 22347889999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=268.58 Aligned_cols=233 Identities=24% Similarity=0.353 Sum_probs=171.8
Q ss_pred cccceeeeecCceEEEEEEeC----CCcEEEEEecc-----------------------CCccccceEEEecC------c
Q 042435 145 FHIRYCIGTGGYDSVYKAELP----DGKVVALKKLH-----------------------HSETEDSAFVVYSP------Q 191 (412)
Q Consensus 145 f~~~~~lG~G~~g~Vy~~~~~----~~~~vAvK~l~-----------------------~~~~~~~~~~~~~~------~ 191 (412)
|.+.+.||+|+||.||+|.+. +++.||||.+. |+++......+... .
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 566789999999999999753 36889999653 44444444433222 1
Q ss_pred eEEEEEEeccCCceeeeeccCc---ccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeec
Q 042435 192 CMFFIYEYMERGSLFCVLRDDD---EAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADF 268 (412)
Q Consensus 192 ~~~lv~ey~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Df 268 (412)
..++++||+++|+|.+++.... ....+++...+.++.|++.||+|||+. +|+||||||+||++++++.+|++||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECcc
Confidence 3478999999999987764321 123478899999999999999999998 9999999999999999999999999
Q ss_pred CCccccCCCCC--CcccccccccccccccccCcccCcccccHHHHHHHHHHHh-CCCCcccccccccCCCCcchhhHHhh
Q 042435 269 GTVRLLDVDSS--NRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLM-GTHPGELLLSLSSSSGPKIMLIDILY 345 (412)
Q Consensus 269 Gla~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~ 345 (412)
|+++....... ......+++.|++||......++.++||||||+++|||++ |+.||.... .........
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~--------~~~~~~~~~ 229 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVE--------NSEIYNYLI 229 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCC--------HHHHHHHHH
Confidence 99986543221 1122345678999999988889999999999999999999 888875221 111111111
Q ss_pred hccCCccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhcC
Q 042435 346 QRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELEGK 391 (412)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 391 (412)
......... .....+.+++.+||+.+|++|||+.|+++.|+++
T Consensus 230 ~~~~~~~~~---~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 230 KGNRLKQPP---DCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred cCCcCCCCC---CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 111111111 1123488999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=271.03 Aligned_cols=239 Identities=23% Similarity=0.286 Sum_probs=175.4
Q ss_pred cCcccceeeeecCceEEEEEEeC-CCcEEEEEecc-----------------------CCccccceEEEecCceEEEEEE
Q 042435 143 EYFHIRYCIGTGGYDSVYKAELP-DGKVVALKKLH-----------------------HSETEDSAFVVYSPQCMFFIYE 198 (412)
Q Consensus 143 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~-----------------------~~~~~~~~~~~~~~~~~~lv~e 198 (412)
++|++.+.||+|+||.||+|... +++.||+|+++ |+++......+...+..+++||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 36889999999999999999875 58899999653 4444444555667788999999
Q ss_pred eccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCC
Q 042435 199 YMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDS 278 (412)
Q Consensus 199 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~ 278 (412)
|++++.+..+..... .+++..+..++.|++.||+|||+. +++|+||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~~~~l~~~~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 154 (288)
T cd07833 81 YVERTLLELLEASPG---GLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARP 154 (288)
T ss_pred cCCCCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccCCCc
Confidence 999877765554332 488999999999999999999998 99999999999999999999999999998765443
Q ss_pred C-CcccccccccccccccccCc-ccCcccccHHHHHHHHHHHhCCCCcccccccc---------cCCCCcch--h--hHH
Q 042435 279 S-NRTLQAGTYGYIALELVYTM-VVTEKCVIYSFGVVALEVLMGTHPGELLLSLS---------SSSGPKIM--L--IDI 343 (412)
Q Consensus 279 ~-~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~---------~~~~~~~~--~--~~~ 343 (412)
. ......++..|+|||++.+. .++.++||||||+++|||++|+.||....... ....+... . ...
T Consensus 155 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd07833 155 ASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPR 234 (288)
T ss_pred cccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcc
Confidence 2 22345678899999999887 78999999999999999999999986321000 00000000 0 000
Q ss_pred hhh-ccCCccchhhH------HHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 344 LYQ-RLSPPINQKII------QDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 344 ~~~-~~~~~~~~~~~------~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
... ........... .....+.+++.+||..+|++|||+++++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 235 FAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred ccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence 000 00000000000 013458899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=268.25 Aligned_cols=223 Identities=22% Similarity=0.264 Sum_probs=170.0
Q ss_pred eeeeecCceEEEEEEe-CCCcEEEEEecc-------------------------CCccccceEEEecCceEEEEEEeccC
Q 042435 149 YCIGTGGYDSVYKAEL-PDGKVVALKKLH-------------------------HSETEDSAFVVYSPQCMFFIYEYMER 202 (412)
Q Consensus 149 ~~lG~G~~g~Vy~~~~-~~~~~vAvK~l~-------------------------~~~~~~~~~~~~~~~~~~lv~ey~~~ 202 (412)
+.||+|+||.||+|.. .+++.||+|.++ |+++......+...+..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 4689999999999976 468999999763 33333444456677889999999999
Q ss_pred CceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCCCCcc
Q 042435 203 GSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRT 282 (412)
Q Consensus 203 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 282 (412)
++|.+++.... .+++..+..++.|++.||.|||+. +++||||+|+||+++.++.++|+|||+++.... ..
T Consensus 82 ~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----~~ 151 (260)
T cd05611 82 GDCASLIKTLG---GLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE----NK 151 (260)
T ss_pred CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceeccc----cc
Confidence 99999887543 478899999999999999999998 999999999999999999999999999875432 22
Q ss_pred cccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccchhhHHHHHH
Q 042435 283 LQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKIIQDIIL 362 (412)
Q Consensus 283 ~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 362 (412)
...++..|+|||.+.+..++.++||||||+++|||++|..||... ................+. .........
T Consensus 152 ~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~-------~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 223 (260)
T cd05611 152 KFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAE-------TPDAVFDNILSRRINWPE-EVKEFCSPE 223 (260)
T ss_pred cCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCC-------CHHHHHHHHHhcccCCCC-cccccCCHH
Confidence 345788999999998888899999999999999999999998632 111111111111111110 001112234
Q ss_pred HHHHHHhcCcCCCCCCCCHHHHHHHHh
Q 042435 363 VSTIALACLRSKPKSRPTMQRISQELE 389 (412)
Q Consensus 363 ~~~l~~~Cl~~dP~~RPs~~evl~~L~ 389 (412)
+.+++.+||+.||++||++.++.+.|.
T Consensus 224 ~~~~i~~~l~~~p~~R~~~~~~~~~l~ 250 (260)
T cd05611 224 AVDLINRLLCMDPAKRLGANGYQEIKS 250 (260)
T ss_pred HHHHHHHHccCCHHHccCCCcHHHHHc
Confidence 889999999999999997765555443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=267.91 Aligned_cols=231 Identities=23% Similarity=0.363 Sum_probs=177.1
Q ss_pred CcccceeeeecCceEEEEEEe-CCCcEEEEEecc---------------------------CCccccceEEEecCceEEE
Q 042435 144 YFHIRYCIGTGGYDSVYKAEL-PDGKVVALKKLH---------------------------HSETEDSAFVVYSPQCMFF 195 (412)
Q Consensus 144 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l~---------------------------~~~~~~~~~~~~~~~~~~l 195 (412)
+|+..+.||+|+||.||+|.. .+++.||+|.++ |+++......+...+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 477889999999999999975 578999999763 4444455555777889999
Q ss_pred EEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCC-cEEEeecCCcccc
Q 042435 196 IYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNL-EAFVADFGTVRLL 274 (412)
Q Consensus 196 v~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~-~~kl~DfGla~~~ 274 (412)
|+||+++++|.+++.... .+++..+..++.|++.||+|||+. +++|+||||+||+++.++ .++|+|||.+...
T Consensus 81 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~ 154 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYG---AFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARL 154 (268)
T ss_pred EEeccCCCcHHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence 999999999999887543 588999999999999999999998 999999999999998775 5999999998766
Q ss_pred CCCCC----CcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCC
Q 042435 275 DVDSS----NRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSP 350 (412)
Q Consensus 275 ~~~~~----~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 350 (412)
..... ......++..|+|||.+.+..++.++||||+|+++||+++|..||..... ........+.......+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~----~~~~~~~~~~~~~~~~~ 230 (268)
T cd06630 155 AAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKH----SNHLALIFKIASATTAP 230 (268)
T ss_pred ccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCC----cchHHHHHHHhccCCCC
Confidence 43311 11234678899999999888899999999999999999999999863210 00001111111111111
Q ss_pred ccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 351 PINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 351 ~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
..+. .....+.+++.+|+..+|++||++.|++++
T Consensus 231 ~~~~---~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~ 264 (268)
T cd06630 231 SIPE---HLSPGLRDVTLRCLELQPEDRPPSRELLKH 264 (268)
T ss_pred CCch---hhCHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence 1111 122347889999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=270.95 Aligned_cols=221 Identities=20% Similarity=0.271 Sum_probs=167.8
Q ss_pred eeeecCceEEEEEEe-CCCcEEEEEeccCC---------------------------ccccceEEEecCceEEEEEEecc
Q 042435 150 CIGTGGYDSVYKAEL-PDGKVVALKKLHHS---------------------------ETEDSAFVVYSPQCMFFIYEYME 201 (412)
Q Consensus 150 ~lG~G~~g~Vy~~~~-~~~~~vAvK~l~~~---------------------------~~~~~~~~~~~~~~~~lv~ey~~ 201 (412)
.||+|+||.||+|.. .+++.||+|.+... ++......+...+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 489999999999976 46899999976432 22222333556778999999999
Q ss_pred CCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCCCCc
Q 042435 202 RGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNR 281 (412)
Q Consensus 202 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 281 (412)
+|+|.+++.... .+++..+..++.|+++||+|||+. +++||||||+||+++.++.++|+|||+++...... .
T Consensus 81 g~~L~~~l~~~~---~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~--~ 152 (278)
T cd05606 81 GGDLHYHLSQHG---VFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--P 152 (278)
T ss_pred CCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccCccC--C
Confidence 999988876543 589999999999999999999998 99999999999999999999999999987553222 2
Q ss_pred ccccccccccccccccCc-ccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccchhhHHHH
Q 042435 282 TLQAGTYGYIALELVYTM-VVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKIIQDI 360 (412)
Q Consensus 282 ~~~~gt~~y~aPE~~~~~-~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 360 (412)
....|+..|+|||.+.+. .++.++||||+|+++|||++|+.||...... ....... .........+.. ..
T Consensus 153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~-----~~~~~~~-~~~~~~~~~~~~---~s 223 (278)
T cd05606 153 HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK-----DKHEIDR-MTLTMAVELPDS---FS 223 (278)
T ss_pred cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCcc-----chHHHHH-HhhccCCCCCCc---CC
Confidence 234689999999998754 6889999999999999999999998732110 0001111 111111111111 12
Q ss_pred HHHHHHHHhcCcCCCCCCC-----CHHHHHHH
Q 042435 361 ILVSTIALACLRSKPKSRP-----TMQRISQE 387 (412)
Q Consensus 361 ~~~~~l~~~Cl~~dP~~RP-----s~~evl~~ 387 (412)
..+.+++.+|+..+|++|| ++.|++++
T Consensus 224 ~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~ 255 (278)
T cd05606 224 PELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH 255 (278)
T ss_pred HHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence 3478899999999999999 99999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=282.28 Aligned_cols=230 Identities=22% Similarity=0.309 Sum_probs=175.9
Q ss_pred cCcccceeeeecCceEEEEEEeCCCcEEEEEecc------------------------CCccccceEEEecCceEEEEEE
Q 042435 143 EYFHIRYCIGTGGYDSVYKAELPDGKVVALKKLH------------------------HSETEDSAFVVYSPQCMFFIYE 198 (412)
Q Consensus 143 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~l~------------------------~~~~~~~~~~~~~~~~~~lv~e 198 (412)
..|++.+.||+||.+.||++...+.+.+|+|++. +.++.....+...++.+|+|||
T Consensus 361 ~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE 440 (677)
T KOG0596|consen 361 REYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVME 440 (677)
T ss_pred chhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEee
Confidence 3588889999999999999999888999999652 3344445555566889999999
Q ss_pred eccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCC
Q 042435 199 YMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDS 278 (412)
Q Consensus 199 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~ 278 (412)
|=+ -+|..+|+..... ...| .+..+..|++.++.++|.+ +|||.||||.|.|+- .|.+||+|||+|..+..+.
T Consensus 441 ~Gd-~DL~kiL~k~~~~-~~~~-~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~DT 513 (677)
T KOG0596|consen 441 CGD-IDLNKILKKKKSI-DPDW-FLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLV-KGRLKLIDFGIANAIQPDT 513 (677)
T ss_pred ccc-ccHHHHHHhccCC-CchH-HHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEE-eeeEEeeeechhcccCccc
Confidence 874 5899999876532 3445 6778999999999999999 999999999999985 5789999999999887654
Q ss_pred CC--cccccccccccccccccCcc-----------cCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhh
Q 042435 279 SN--RTLQAGTYGYIALELVYTMV-----------VTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILY 345 (412)
Q Consensus 279 ~~--~~~~~gt~~y~aPE~~~~~~-----------~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~ 345 (412)
.. ....+||+.||+||.+.... .++++||||+|||||+|+.|+.||....... ..+..+.+
T Consensus 514 TsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~------aKl~aI~~ 587 (677)
T KOG0596|consen 514 TSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQI------AKLHAITD 587 (677)
T ss_pred cceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHH------HHHHhhcC
Confidence 43 35678999999999986432 5679999999999999999999997432111 11223333
Q ss_pred hccCCccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 346 QRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
+...-+.+.... ...+.+++..||.+||++|||+.|++++
T Consensus 588 P~~~Iefp~~~~--~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 588 PNHEIEFPDIPE--NDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred CCccccccCCCC--chHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 322111111111 1127899999999999999999999976
|
|
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=271.93 Aligned_cols=237 Identities=21% Similarity=0.227 Sum_probs=173.0
Q ss_pred cCcccceeeeecCceEEEEEEeC-CCcEEEEEecc-----------------------CCccccceEEEecC--ceEEEE
Q 042435 143 EYFHIRYCIGTGGYDSVYKAELP-DGKVVALKKLH-----------------------HSETEDSAFVVYSP--QCMFFI 196 (412)
Q Consensus 143 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~-----------------------~~~~~~~~~~~~~~--~~~~lv 196 (412)
++|++.+.||+|+||.||+|... +++.+|+|.++ |+++......+... ...++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 57888899999999999999875 58899999764 33433334444445 789999
Q ss_pred EEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCC
Q 042435 197 YEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDV 276 (412)
Q Consensus 197 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~ 276 (412)
|||++ ++|.+++..... .+++.....++.|++.||+|||+. +++|+||||+||+++.++.++|+|||+++....
T Consensus 85 ~e~~~-~~L~~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 158 (293)
T cd07843 85 MEYVE-HDLKSLMETMKQ--PFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGS 158 (293)
T ss_pred ehhcC-cCHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence 99997 488887765432 489999999999999999999998 999999999999999999999999999986654
Q ss_pred CCCCcccccccccccccccccCc-ccCcccccHHHHHHHHHHHhCCCCccccccccc--------CCCCcchhhHH----
Q 042435 277 DSSNRTLQAGTYGYIALELVYTM-VVTEKCVIYSFGVVALEVLMGTHPGELLLSLSS--------SSGPKIMLIDI---- 343 (412)
Q Consensus 277 ~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~--------~~~~~~~~~~~---- 343 (412)
.........++..|+|||.+.+. .++.++|+||||+++|||++|..||........ ...........
T Consensus 159 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (293)
T cd07843 159 PLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELP 238 (293)
T ss_pred CccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccc
Confidence 43333344678899999988754 468899999999999999999999863211000 00000000000
Q ss_pred ----------hhhccCCccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 344 ----------LYQRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 344 ----------~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
....+....+.. .....+.+++.+||+.||++|||+.|++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~l~~~p~~R~t~~ell~~ 290 (293)
T cd07843 239 GAKKKTFTKYPYNQLRKKFPAL--SLSDNGFDLLNRLLTYDPAKRISAEDALKH 290 (293)
T ss_pred hhcccccccccchhhhcccccc--CCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence 000000000000 012347789999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=270.68 Aligned_cols=237 Identities=25% Similarity=0.269 Sum_probs=176.5
Q ss_pred cCcccceeeeecCceEEEEEEe-CCCcEEEEEec----------------------cCCccccceEEEec--CceEEEEE
Q 042435 143 EYFHIRYCIGTGGYDSVYKAEL-PDGKVVALKKL----------------------HHSETEDSAFVVYS--PQCMFFIY 197 (412)
Q Consensus 143 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l----------------------~~~~~~~~~~~~~~--~~~~~lv~ 197 (412)
++|+..+.||.|++|.||++.. .+++.+|+|.+ +|+++......+.. ....++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 4688889999999999999987 46889999965 44555554444433 44789999
Q ss_pred EeccCCceeeeeccCc-ccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCC
Q 042435 198 EYMERGSLFCVLRDDD-EAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDV 276 (412)
Q Consensus 198 ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~ 276 (412)
||+++++|.+++.... ....+++.....++.|++.||+|||+. +++|+||+|+||++++++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 9999999988765321 123578899999999999999999998 999999999999999999999999999875432
Q ss_pred CCCCcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccc---
Q 042435 277 DSSNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPIN--- 353 (412)
Q Consensus 277 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 353 (412)
... ....++..|+|||.+.+..++.++||||||+++|||++|+.||+.... .... .......+.....+...
T Consensus 158 ~~~--~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--~~~~-~~~~~~~~~~~~~~~~~~~~ 232 (287)
T cd06621 158 SLA--GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGE--PPLG-PIELLSYIVNMPNPELKDEP 232 (287)
T ss_pred ccc--ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccC--CCCC-hHHHHHHHhcCCchhhccCC
Confidence 221 234578899999999888999999999999999999999999874321 0001 11111111111111000
Q ss_pred hhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 354 QKIIQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 354 ~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
.........+.+++.+||+.+|++|||+.|++++
T Consensus 233 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~ 266 (287)
T cd06621 233 GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEH 266 (287)
T ss_pred CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence 0001122347899999999999999999999985
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-34 Score=272.05 Aligned_cols=228 Identities=25% Similarity=0.325 Sum_probs=173.8
Q ss_pred hhcCcccceeeeecCceEEEEEEeC-CCcEEEEEec------------------------cCCccccceEEEecCceEEE
Q 042435 141 ATEYFHIRYCIGTGGYDSVYKAELP-DGKVVALKKL------------------------HHSETEDSAFVVYSPQCMFF 195 (412)
Q Consensus 141 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l------------------------~~~~~~~~~~~~~~~~~~~l 195 (412)
..+.|+..+.||+|+||.||+|... +++.||+|.+ +|+++......+...+..++
T Consensus 13 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~l 92 (307)
T cd06607 13 PEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWL 92 (307)
T ss_pred cchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEE
Confidence 3456888899999999999999774 6899999965 34555555566778888999
Q ss_pred EEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccC
Q 042435 196 IYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLD 275 (412)
Q Consensus 196 v~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~ 275 (412)
|+||++ |++.+++.... ..+++..+..++.|++.||.|||+. +++||||+|+||++++++.++|+|||++....
T Consensus 93 v~e~~~-g~l~~~~~~~~--~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~ 166 (307)
T cd06607 93 VMEYCL-GSASDILEVHK--KPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLVS 166 (307)
T ss_pred EHHhhC-CCHHHHHHHcc--cCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCcceecC
Confidence 999997 56766654322 2489999999999999999999998 99999999999999999999999999987653
Q ss_pred CCCCCccccccccccccccccc---CcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCcc
Q 042435 276 VDSSNRTLQAGTYGYIALELVY---TMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPI 352 (412)
Q Consensus 276 ~~~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 352 (412)
.. ....++..|+|||++. ...++.++||||||+++|||+||+.||..... ........ ....+..
T Consensus 167 ~~----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~-------~~~~~~~~-~~~~~~~ 234 (307)
T cd06607 167 PA----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-------MSALYHIA-QNDSPTL 234 (307)
T ss_pred CC----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccH-------HHHHHHHh-cCCCCCC
Confidence 32 2345788999999874 45688899999999999999999999863210 00011111 1111111
Q ss_pred chhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHH
Q 042435 353 NQKIIQDIILVSTIALACLRSKPKSRPTMQRISQEL 388 (412)
Q Consensus 353 ~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L 388 (412)
. .......+.+++.+||+.||++||++.+++.+.
T Consensus 235 ~--~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 268 (307)
T cd06607 235 S--SNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHR 268 (307)
T ss_pred C--chhhCHHHHHHHHHHhcCChhhCcCHHHHhcCh
Confidence 0 111233488999999999999999999998763
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=269.35 Aligned_cols=240 Identities=20% Similarity=0.267 Sum_probs=175.4
Q ss_pred CcccceeeeecCceEEEEEEeC-CCcEEEEEecc----------------------CCccccceEEEecCceEEEEEEec
Q 042435 144 YFHIRYCIGTGGYDSVYKAELP-DGKVVALKKLH----------------------HSETEDSAFVVYSPQCMFFIYEYM 200 (412)
Q Consensus 144 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~----------------------~~~~~~~~~~~~~~~~~~lv~ey~ 200 (412)
+|+..+.||+|++|.||+|... +|+.||+|.++ |+++......+...+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 5888999999999999999875 68999999653 445555555677788899999999
Q ss_pred cCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCCCC
Q 042435 201 ERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSN 280 (412)
Q Consensus 201 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 280 (412)
++ +|.+++........+++..+..++.|++.||+|||+. +++||||||+||++++++.++++|||+++........
T Consensus 81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~ 156 (284)
T cd07836 81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNT 156 (284)
T ss_pred Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCccc
Confidence 85 8888776544333589999999999999999999998 9999999999999999999999999999765433333
Q ss_pred cccccccccccccccccCc-ccCcccccHHHHHHHHHHHhCCCCccccccccc-------C-CCCcchhhHHhh-hccCC
Q 042435 281 RTLQAGTYGYIALELVYTM-VVTEKCVIYSFGVVALEVLMGTHPGELLLSLSS-------S-SGPKIMLIDILY-QRLSP 350 (412)
Q Consensus 281 ~~~~~gt~~y~aPE~~~~~-~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~-------~-~~~~~~~~~~~~-~~~~~ 350 (412)
.....++..|++||++.+. .++.++||||||+++|||++|+.||........ . ......+..... +....
T Consensus 157 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd07836 157 FSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKP 236 (284)
T ss_pred cccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhcc
Confidence 3344578899999988654 578899999999999999999999863211000 0 000000000000 00000
Q ss_pred cc---chhh-----HHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 351 PI---NQKI-----IQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 351 ~~---~~~~-----~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
.. .... ......+.+++.+|++.||.+||++.|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 281 (284)
T cd07836 237 TFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH 281 (284)
T ss_pred cccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 00 0000 0112347789999999999999999999864
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=267.81 Aligned_cols=227 Identities=21% Similarity=0.252 Sum_probs=176.6
Q ss_pred CcccceeeeecCceEEEEEEeC-CCcEEEEEecc------------------------CCccccceEEEecCceEEEEEE
Q 042435 144 YFHIRYCIGTGGYDSVYKAELP-DGKVVALKKLH------------------------HSETEDSAFVVYSPQCMFFIYE 198 (412)
Q Consensus 144 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~------------------------~~~~~~~~~~~~~~~~~~lv~e 198 (412)
+|++.+.||+|+||.||+|... +++.||+|.+. |+++......+..+...++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 5888999999999999999875 58999999653 4444444444667888999999
Q ss_pred eccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCC
Q 042435 199 YMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDS 278 (412)
Q Consensus 199 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~ 278 (412)
|+++++|.+++.... .+++.....++.|+++||.|||+. +++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~l~~~~---~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 154 (258)
T cd05578 81 LLLGGDLRYHLSQKV---KFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT 154 (258)
T ss_pred CCCCCCHHHHHHhcC---CcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccccccCCCc
Confidence 999999999887652 588999999999999999999998 99999999999999999999999999987654332
Q ss_pred CCcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccchhhHH
Q 042435 279 SNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKIIQ 358 (412)
Q Consensus 279 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 358 (412)
......|+..|+|||.+.+..++.++|+||||+++|+|++|+.||...... ........... .....+. .
T Consensus 155 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-----~~~~~~~~~~~-~~~~~~~---~ 224 (258)
T cd05578 155 -LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT-----IRDQIRAKQET-ADVLYPA---T 224 (258)
T ss_pred -cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc-----HHHHHHHHhcc-ccccCcc---c
Confidence 223456888999999998888999999999999999999999998733110 01111111111 1111111 1
Q ss_pred HHHHHHHHHHhcCcCCCCCCCCH--HHHHH
Q 042435 359 DIILVSTIALACLRSKPKSRPTM--QRISQ 386 (412)
Q Consensus 359 ~~~~~~~l~~~Cl~~dP~~RPs~--~evl~ 386 (412)
....+.+++.+||+.||.+||++ +|+++
T Consensus 225 ~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~ 254 (258)
T cd05578 225 WSTEAIDAINKLLERDPQKRLGDNLKDLKN 254 (258)
T ss_pred CcHHHHHHHHHHccCChhHcCCccHHHHhc
Confidence 22347899999999999999999 66553
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=281.99 Aligned_cols=232 Identities=25% Similarity=0.328 Sum_probs=185.3
Q ss_pred cccceeeeecCceEEEEEEeCC---C--cEEEEEe----------------------ccCCccccceEEEecCceEEEEE
Q 042435 145 FHIRYCIGTGGYDSVYKAELPD---G--KVVALKK----------------------LHHSETEDSAFVVYSPQCMFFIY 197 (412)
Q Consensus 145 f~~~~~lG~G~~g~Vy~~~~~~---~--~~vAvK~----------------------l~~~~~~~~~~~~~~~~~~~lv~ 197 (412)
....++||.|.||.||+|.+.+ | -.||||. ++|+++.+..++|. .+..|+||
T Consensus 391 Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~-e~P~Wivm 469 (974)
T KOG4257|consen 391 ITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCV-EQPMWIVM 469 (974)
T ss_pred ccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeee-ccceeEEE
Confidence 3445789999999999997632 3 3578883 57888888888876 46689999
Q ss_pred EeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCC
Q 042435 198 EYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVD 277 (412)
Q Consensus 198 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~ 277 (412)
|.++.|.|..+|+.... .++......++.||+.||+|||+. ..|||||..+|||+.....+|++|||+++.+..+
T Consensus 470 EL~~~GELr~yLq~nk~--sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~ 544 (974)
T KOG4257|consen 470 ELAPLGELREYLQQNKD--SLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADFGLSRYLEDD 544 (974)
T ss_pred ecccchhHHHHHHhccc--cchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecccchhhhcccc
Confidence 99999999999987654 488888899999999999999999 9999999999999999999999999999988765
Q ss_pred CCCc-ccccccccccccccccCcccCcccccHHHHHHHHHHHh-CCCCcccccccccCCCCcchhhHHhhhccCCccchh
Q 042435 278 SSNR-TLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLM-GTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQK 355 (412)
Q Consensus 278 ~~~~-~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 355 (412)
.... +...-.+.|||||.+...+++.+||||-|||++||++. |..||.... .... ...+...-+.|.++
T Consensus 545 ~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvk-------NsDV-I~~iEnGeRlP~P~- 615 (974)
T KOG4257|consen 545 AYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVK-------NSDV-IGHIENGERLPCPP- 615 (974)
T ss_pred chhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCcccccc-------ccce-EEEecCCCCCCCCC-
Confidence 4433 33344678999999999999999999999999999987 999998431 1111 11122222222222
Q ss_pred hHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhcCCC
Q 042435 356 IIQDIILVSTIALACLRSKPKSRPTMQRISQELEGKTP 393 (412)
Q Consensus 356 ~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 393 (412)
.+...+..++.+||+.||.+||++.|+...|+++..
T Consensus 616 --nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 616 --NCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred --CCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 333448899999999999999999999999877654
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=266.77 Aligned_cols=230 Identities=22% Similarity=0.247 Sum_probs=172.5
Q ss_pred cccceeeeecCceEEEEEEeC-CCcEEEEEecc--------------------------CCccccceEEEecCce-----
Q 042435 145 FHIRYCIGTGGYDSVYKAELP-DGKVVALKKLH--------------------------HSETEDSAFVVYSPQC----- 192 (412)
Q Consensus 145 f~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~--------------------------~~~~~~~~~~~~~~~~----- 192 (412)
|++.+.||+|+||.||+|..+ +++.||+|+++ |+++......+...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 567889999999999999886 48999999774 2333333444555554
Q ss_pred EEEEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCcc
Q 042435 193 MFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVR 272 (412)
Q Consensus 193 ~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~ 272 (412)
.+++|||++ ++|.+++..... ..+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++.
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~~~-~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~~~ 155 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKCPK-PGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLAR 155 (287)
T ss_pred eEEEehhcc-cCHHHHHHHccC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccCcce
Confidence 899999997 488887765432 2489999999999999999999998 99999999999999999999999999998
Q ss_pred ccCCCCCCcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhh-------
Q 042435 273 LLDVDSSNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILY------- 345 (412)
Q Consensus 273 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~------- 345 (412)
....... .....++..|+|||.+.+..++.++|+||||+++|||++|+.||..... ......+.+
T Consensus 156 ~~~~~~~-~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~ 227 (287)
T cd07838 156 IYSFEMA-LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSE-------ADQLDKIFDVIGLPSE 227 (287)
T ss_pred eccCCcc-cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCCh-------HHHHHHHHHHcCCCCh
Confidence 7643322 1233578899999999988899999999999999999999998863211 000111110
Q ss_pred ---------------hccCCccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 346 ---------------QRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 346 ---------------~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
.................+.+++.+||+.||++||++.|++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~ 284 (287)
T cd07838 228 EEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH 284 (287)
T ss_pred HhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence 000010011111223457889999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=286.21 Aligned_cols=223 Identities=24% Similarity=0.336 Sum_probs=177.4
Q ss_pred ceeeeecCceEEEEEEe-CCCcEEE-------------------------EEeccCCccccceEEEecC--ceEEEEEEe
Q 042435 148 RYCIGTGGYDSVYKAEL-PDGKVVA-------------------------LKKLHHSETEDSAFVVYSP--QCMFFIYEY 199 (412)
Q Consensus 148 ~~~lG~G~~g~Vy~~~~-~~~~~vA-------------------------vK~l~~~~~~~~~~~~~~~--~~~~lv~ey 199 (412)
..+||+|+|-+||||.. .+|..|| +|-|+|+|+.+......+. .+.-+|+|.
T Consensus 45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL 124 (632)
T KOG0584|consen 45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITEL 124 (632)
T ss_pred hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeec
Confidence 35799999999999955 3465554 6678999999988776554 458899999
Q ss_pred ccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCC-CcEEEeecCCccccCCCC
Q 042435 200 MERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSN-LEAFVADFGTVRLLDVDS 278 (412)
Q Consensus 200 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~-~~~kl~DfGla~~~~~~~ 278 (412)
|..|+|+.|++..+ .++.....+|++||++||.|||++ .|+|+|||||.+||+++.+ |.+||+|.|+|+......
T Consensus 125 ~TSGtLr~Y~kk~~---~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~ 200 (632)
T KOG0584|consen 125 FTSGTLREYRKKHR---RVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH 200 (632)
T ss_pred ccCCcHHHHHHHhc---cCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhccc
Confidence 99999999998776 588889999999999999999998 7899999999999999854 899999999999775443
Q ss_pred CCcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccchhhHH
Q 042435 279 SNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKIIQ 358 (412)
Q Consensus 279 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 358 (412)
. ....|||.|||||+.. ..|++..||||||++++||+|+..||..- .....+..-+...+.|.... ...
T Consensus 201 a--ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC-------~n~AQIYKKV~SGiKP~sl~-kV~ 269 (632)
T KOG0584|consen 201 A--KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSEC-------TNPAQIYKKVTSGIKPAALS-KVK 269 (632)
T ss_pred c--ceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhh-------CCHHHHHHHHHcCCCHHHhh-ccC
Confidence 2 3378999999999876 78999999999999999999999998732 11112222222233221111 011
Q ss_pred HHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 359 DIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 359 ~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
...+.+++.+|+.. .++|||+.|++++
T Consensus 270 -dPevr~fIekCl~~-~~~R~sa~eLL~d 296 (632)
T KOG0584|consen 270 -DPEVREFIEKCLAT-KSERLSAKELLKD 296 (632)
T ss_pred -CHHHHHHHHHHhcC-chhccCHHHHhhC
Confidence 23489999999999 9999999999875
|
|
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-34 Score=268.12 Aligned_cols=238 Identities=24% Similarity=0.313 Sum_probs=175.0
Q ss_pred CcccceeeeecCceEEEEEEe-CCCcEEEEEecc-----------------------CCccccceEEEecCceEEEEEEe
Q 042435 144 YFHIRYCIGTGGYDSVYKAEL-PDGKVVALKKLH-----------------------HSETEDSAFVVYSPQCMFFIYEY 199 (412)
Q Consensus 144 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l~-----------------------~~~~~~~~~~~~~~~~~~lv~ey 199 (412)
+|++.+.||+|+||.||+|.. .+|+.||+|++. |+++......+......++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 478889999999999999987 468999999753 44455555556778889999999
Q ss_pred ccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCCC
Q 042435 200 MERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSS 279 (412)
Q Consensus 200 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 279 (412)
+ +++|.+++.... ..+++.++..++.|++.||+|||+. +++|+||||+||+++.++.++++|||++........
T Consensus 81 ~-~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 154 (286)
T cd07832 81 M-PSDLSEVLRDEE--RPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP 154 (286)
T ss_pred c-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC
Confidence 9 999999886543 2589999999999999999999998 999999999999999999999999999886644321
Q ss_pred -CcccccccccccccccccCc-ccCcccccHHHHHHHHHHHhCCCCcccccccc------cC-CCCcc-h------hhHH
Q 042435 280 -NRTLQAGTYGYIALELVYTM-VVTEKCVIYSFGVVALEVLMGTHPGELLLSLS------SS-SGPKI-M------LIDI 343 (412)
Q Consensus 280 -~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~------~~-~~~~~-~------~~~~ 343 (412)
......++..|+|||.+.+. .++.++||||+|+++|||+||..||....... .. ..+.. . +.+.
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T cd07832 155 RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDY 234 (286)
T ss_pred CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchh
Confidence 22345688999999998654 46889999999999999999987775221000 00 00000 0 0000
Q ss_pred ---hhhccCC-ccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 344 ---LYQRLSP-PINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 344 ---~~~~~~~-~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
....... +...........+.+++.+|++.||++|||+++++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 235 NKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred hcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0000000 0000000112458899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=269.56 Aligned_cols=238 Identities=21% Similarity=0.224 Sum_probs=172.9
Q ss_pred cccceeeeecCceEEEEEEe-CCCcEEEEEecc-----------------------CCccccceEEEecCceEEEEEEec
Q 042435 145 FHIRYCIGTGGYDSVYKAEL-PDGKVVALKKLH-----------------------HSETEDSAFVVYSPQCMFFIYEYM 200 (412)
Q Consensus 145 f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l~-----------------------~~~~~~~~~~~~~~~~~~lv~ey~ 200 (412)
|++.+.||+|++|.||+|.. .+|+.||+|++. |+++......+...+..+++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 56778999999999999976 479999999764 344444445577788999999999
Q ss_pred cCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCCCC
Q 042435 201 ERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSN 280 (412)
Q Consensus 201 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 280 (412)
+ ++|.+++..... ..+++..+..++.|+++||+|||+. +++||||+|+||+++.++.++|+|||+++........
T Consensus 81 ~-~~l~~~~~~~~~-~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~ 155 (283)
T cd07835 81 D-LDLKKYMDSSPL-TGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT 155 (283)
T ss_pred C-cCHHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccc
Confidence 5 689888765432 2489999999999999999999998 9999999999999999999999999999765433333
Q ss_pred cccccccccccccccccCc-ccCcccccHHHHHHHHHHHhCCCCccccccccc-------CCCCcch-------hhHHhh
Q 042435 281 RTLQAGTYGYIALELVYTM-VVTEKCVIYSFGVVALEVLMGTHPGELLLSLSS-------SSGPKIM-------LIDILY 345 (412)
Q Consensus 281 ~~~~~gt~~y~aPE~~~~~-~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~-------~~~~~~~-------~~~~~~ 345 (412)
.....++..|+|||++.+. .++.++||||||+++|||++|+.||........ ...+... ..+...
T Consensus 156 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (283)
T cd07835 156 YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKP 235 (283)
T ss_pred cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhh
Confidence 3334568899999987654 578899999999999999999999863211000 0000000 000000
Q ss_pred hc--cC-CccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 346 QR--LS-PPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 346 ~~--~~-~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
.. .. .............+.+++.+||+.||++|||++|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 236 TFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred hcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 00 00 00000001111347789999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-34 Score=261.01 Aligned_cols=229 Identities=28% Similarity=0.396 Sum_probs=178.1
Q ss_pred CcccceeeeecCceEEEEEEeC-CCcEEEEEeccC---------------------CccccceEEEecCceEEEEEEecc
Q 042435 144 YFHIRYCIGTGGYDSVYKAELP-DGKVVALKKLHH---------------------SETEDSAFVVYSPQCMFFIYEYME 201 (412)
Q Consensus 144 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~---------------------~~~~~~~~~~~~~~~~~lv~ey~~ 201 (412)
+|+..+.||+|++|.||++... +++.+++|+++. +++......+......++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 4778899999999999999875 689999997643 333333445666788999999999
Q ss_pred CCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCCCCc
Q 042435 202 RGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNR 281 (412)
Q Consensus 202 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 281 (412)
+++|.+++.... ..+++..+..++.|++.||+|||+. +++||||+|+||++++++.++|+|||.+........ .
T Consensus 81 ~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-~ 154 (253)
T cd05122 81 GGSLKDLLKSTN--QTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA-R 154 (253)
T ss_pred CCcHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecccccccccccc-c
Confidence 999999887653 2589999999999999999999998 999999999999999999999999999886654332 3
Q ss_pred ccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccchhhHHHHH
Q 042435 282 TLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKIIQDII 361 (412)
Q Consensus 282 ~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 361 (412)
....++..|+|||.+.+..++.++||||||+++|+|++|+.||.... ....... ......+.. ........
T Consensus 155 ~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-------~~~~~~~-~~~~~~~~~-~~~~~~~~ 225 (253)
T cd05122 155 NTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELP-------PMKALFK-IATNGPPGL-RNPEKWSD 225 (253)
T ss_pred cceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCc-------hHHHHHH-HHhcCCCCc-CcccccCH
Confidence 34568889999999988889999999999999999999999986321 1111111 111111111 11111123
Q ss_pred HHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 362 LVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 362 ~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
.+.+++.+||+.||++|||+.|++++
T Consensus 226 ~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 226 EFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred HHHHHHHHHccCChhhCCCHHHHhcC
Confidence 48899999999999999999999864
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=271.02 Aligned_cols=223 Identities=23% Similarity=0.344 Sum_probs=174.2
Q ss_pred eeeeecCceEEEEEEe-CCCcEEEEEecc---------------------CCccccceEEEecCceEEEEEEeccCCcee
Q 042435 149 YCIGTGGYDSVYKAEL-PDGKVVALKKLH---------------------HSETEDSAFVVYSPQCMFFIYEYMERGSLF 206 (412)
Q Consensus 149 ~~lG~G~~g~Vy~~~~-~~~~~vAvK~l~---------------------~~~~~~~~~~~~~~~~~~lv~ey~~~gsL~ 206 (412)
.+||+|+||.||++.. .+++.||+|++. |+++......+...+..++||||+++++|.
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 105 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 105 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence 5799999999999977 478999999753 445555555677788999999999999999
Q ss_pred eeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCCCCcccccc
Q 042435 207 CVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAG 286 (412)
Q Consensus 207 ~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~g 286 (412)
+++... .+++.....++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++..............|
T Consensus 106 ~~~~~~----~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 178 (292)
T cd06657 106 DIVTHT----RMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVG 178 (292)
T ss_pred HHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceeccccccccccccc
Confidence 877543 378999999999999999999998 9999999999999999999999999998765433333334568
Q ss_pred cccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccchhhHHHHHHHHHH
Q 042435 287 TYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKIIQDIILVSTI 366 (412)
Q Consensus 287 t~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 366 (412)
+..|+|||.+.+..++.++|+||||+++|||++|+.||.... ................ .........+.++
T Consensus 179 ~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~--------~~~~~~~~~~~~~~~~-~~~~~~~~~l~~l 249 (292)
T cd06657 179 TPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP--------PLKAMKMIRDNLPPKL-KNLHKVSPSLKGF 249 (292)
T ss_pred CccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHhhCCccc-CCcccCCHHHHHH
Confidence 899999999988889999999999999999999999986211 1111112222221111 0111112347788
Q ss_pred HHhcCcCCCCCCCCHHHHHHH
Q 042435 367 ALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 367 ~~~Cl~~dP~~RPs~~evl~~ 387 (412)
+.+||+.||.+||++.+++++
T Consensus 250 i~~~l~~~P~~R~~~~~ll~~ 270 (292)
T cd06657 250 LDRLLVRDPAQRATAAELLKH 270 (292)
T ss_pred HHHHHhCCcccCcCHHHHhcC
Confidence 999999999999999999884
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=266.09 Aligned_cols=235 Identities=21% Similarity=0.237 Sum_probs=170.4
Q ss_pred cccceeeeecCceEEEEEEe-CCCcEEEEEecc-----------------------CCccccceEEEecC--ceEEEEEE
Q 042435 145 FHIRYCIGTGGYDSVYKAEL-PDGKVVALKKLH-----------------------HSETEDSAFVVYSP--QCMFFIYE 198 (412)
Q Consensus 145 f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l~-----------------------~~~~~~~~~~~~~~--~~~~lv~e 198 (412)
|++.+.||+|+||.||+|.. .+++.||+|+++ |+++......+.+. +..++|+|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 56778999999999999976 468999999753 34444445556665 78999999
Q ss_pred eccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCC
Q 042435 199 YMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDS 278 (412)
Q Consensus 199 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~ 278 (412)
|++ |+|.+.+.... ..++|.++..++.|++.||+|||+. +++||||||+||+++. +.+||+|||+++......
T Consensus 81 ~~~-~~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~ 153 (282)
T cd07831 81 LMD-MNLYELIKGRK--RPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGIYSKP 153 (282)
T ss_pred cCC-ccHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEecccccccccCC
Confidence 996 58877776533 2589999999999999999999998 9999999999999999 999999999998654332
Q ss_pred CCccccccccccccccccc-CcccCcccccHHHHHHHHHHHhCCCCcccccccc------cC-CCCcchhhHHhhhc--c
Q 042435 279 SNRTLQAGTYGYIALELVY-TMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLS------SS-SGPKIMLIDILYQR--L 348 (412)
Q Consensus 279 ~~~~~~~gt~~y~aPE~~~-~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~------~~-~~~~~~~~~~~~~~--~ 348 (412)
. .....++..|+|||.+. +..++.++|||||||++|||++|..||....... .. .............. .
T Consensus 154 ~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (282)
T cd07831 154 P-YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHM 232 (282)
T ss_pred C-cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccc
Confidence 2 12345788999999765 4557889999999999999999999986321100 00 00000000000000 0
Q ss_pred CCcc--------chhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 349 SPPI--------NQKIIQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 349 ~~~~--------~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
.... ..........+.+++.+||+.+|++||++++++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 233 NYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred cccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 0000 00001123458899999999999999999999865
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-36 Score=309.17 Aligned_cols=234 Identities=26% Similarity=0.313 Sum_probs=187.6
Q ss_pred HHhhcCcccceeeeecCceEEEEEEe-CCCcEEEEEe-----------------------ccCCccccceEEEecCceEE
Q 042435 139 IDATEYFHIRYCIGTGGYDSVYKAEL-PDGKVVALKK-----------------------LHHSETEDSAFVVYSPQCMF 194 (412)
Q Consensus 139 ~~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~-----------------------l~~~~~~~~~~~~~~~~~~~ 194 (412)
...+-+|.-...||.|.||.||-|.. .+|+..|+|. ++|+|+++..++-...+..+
T Consensus 1231 snV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~ 1310 (1509)
T KOG4645|consen 1231 SNVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVY 1310 (1509)
T ss_pred ccceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHH
Confidence 34556788888999999999999965 6788899883 57999999999999999999
Q ss_pred EEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCcccc
Q 042435 195 FIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLL 274 (412)
Q Consensus 195 lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~ 274 (412)
|.||||++|+|.+.+...+ -.+......+..|++.|++|||++ ||||||+||.||+++.++.+|++|||.|..+
T Consensus 1311 IFMEyC~~GsLa~ll~~gr---i~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki 1384 (1509)
T KOG4645|consen 1311 IFMEYCEGGSLASLLEHGR---IEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVKI 1384 (1509)
T ss_pred HHHHHhccCcHHHHHHhcc---hhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeEe
Confidence 9999999999999987654 355555666889999999999999 9999999999999999999999999999877
Q ss_pred CCCCCC----cccccccccccccccccCcc---cCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhc
Q 042435 275 DVDSSN----RTLQAGTYGYIALELVYTMV---VTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQR 347 (412)
Q Consensus 275 ~~~~~~----~~~~~gt~~y~aPE~~~~~~---~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 347 (412)
...... .....||+.|||||++.+.. ...+.||||+||+++||+||+.||... +.+..++-.+...
T Consensus 1385 ~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~-------dne~aIMy~V~~g 1457 (1509)
T KOG4645|consen 1385 KNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAEL-------DNEWAIMYHVAAG 1457 (1509)
T ss_pred cCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhc-------cchhHHHhHHhcc
Confidence 654322 23467999999999997643 456899999999999999999998733 2223333333333
Q ss_pred cCCccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHH
Q 042435 348 LSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQEL 388 (412)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L 388 (412)
-.|+.+.. ....-.+++.+|+..||+.|.++.|++++-
T Consensus 1458 h~Pq~P~~---ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~ 1495 (1509)
T KOG4645|consen 1458 HKPQIPER---LSSEGRDFLEHCLEQDPKMRWTASQLLEHA 1495 (1509)
T ss_pred CCCCCchh---hhHhHHHHHHHHHhcCchhhhHHHHHHHhh
Confidence 34444433 233467899999999999999999887764
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-34 Score=270.01 Aligned_cols=232 Identities=21% Similarity=0.259 Sum_probs=173.0
Q ss_pred cCcccceeeeecCceEEEEEEeCC-CcEEEEEecc-----------------------CCccccceEEEecCceEEEEEE
Q 042435 143 EYFHIRYCIGTGGYDSVYKAELPD-GKVVALKKLH-----------------------HSETEDSAFVVYSPQCMFFIYE 198 (412)
Q Consensus 143 ~~f~~~~~lG~G~~g~Vy~~~~~~-~~~vAvK~l~-----------------------~~~~~~~~~~~~~~~~~~lv~e 198 (412)
++|++.+.||+|+||.||+|...+ ++.||||.++ |+++......+......+++||
T Consensus 15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e 94 (296)
T cd06618 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME 94 (296)
T ss_pred chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEee
Confidence 568888999999999999998864 8999999764 3344444555777888999999
Q ss_pred eccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCC
Q 042435 199 YMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDS 278 (412)
Q Consensus 199 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~ 278 (412)
|++ ++|.+++..... .+++..+..++.|++.||+|||+.+ +++||||+|+||++++++.+||+|||++.......
T Consensus 95 ~~~-~~l~~l~~~~~~--~l~~~~~~~i~~~i~~~l~~lH~~~--~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~ 169 (296)
T cd06618 95 LMS-TCLDKLLKRIQG--PIPEDILGKMTVAIVKALHYLKEKH--GVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSK 169 (296)
T ss_pred ccC-cCHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhhC--CEecCCCcHHHEEEcCCCCEEECccccchhccCCC
Confidence 985 466665544222 5899999999999999999999732 89999999999999999999999999987654322
Q ss_pred CCcccccccccccccccccCcc----cCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccch
Q 042435 279 SNRTLQAGTYGYIALELVYTMV----VTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQ 354 (412)
Q Consensus 279 ~~~~~~~gt~~y~aPE~~~~~~----~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 354 (412)
. .....++..|+|||.+.+.. ++.++||||||+++|||++|+.||.... ............... ....
T Consensus 170 ~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~------~~~~~~~~~~~~~~~-~~~~ 241 (296)
T cd06618 170 A-KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCK------TEFEVLTKILQEEPP-SLPP 241 (296)
T ss_pred c-ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcch------hHHHHHHHHhcCCCC-CCCC
Confidence 1 22335788999999987553 7889999999999999999999986311 001111122222111 1100
Q ss_pred hhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHH
Q 042435 355 KIIQDIILVSTIALACLRSKPKSRPTMQRISQEL 388 (412)
Q Consensus 355 ~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L 388 (412)
. ......+.+++.+||+.||++||++.+++++-
T Consensus 242 ~-~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~ 274 (296)
T cd06618 242 N-EGFSPDFCSFVDLCLTKDHRKRPKYRELLQHP 274 (296)
T ss_pred C-CCCCHHHHHHHHHHccCChhhCCCHHHHhcCh
Confidence 0 01223478899999999999999999998763
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=270.34 Aligned_cols=241 Identities=23% Similarity=0.261 Sum_probs=171.7
Q ss_pred hhcCcccceeeeecCceEEEEEEe-CCCcEEEEEecc-----------------------CCccccceEEEecC--ceEE
Q 042435 141 ATEYFHIRYCIGTGGYDSVYKAEL-PDGKVVALKKLH-----------------------HSETEDSAFVVYSP--QCMF 194 (412)
Q Consensus 141 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l~-----------------------~~~~~~~~~~~~~~--~~~~ 194 (412)
..++|++.+.||+|+||.||+|.. .+|+.||+|.++ |+++......+... +..+
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIF 84 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEE
Confidence 346799999999999999999977 468999999764 22333333333322 5689
Q ss_pred EEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCcccc
Q 042435 195 FIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLL 274 (412)
Q Consensus 195 lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~ 274 (412)
+||||+.+ +|.+++.... ..+++.++..++.|++.||+|||+. +++||||||+||++++++.+||+|||+++..
T Consensus 85 lv~e~~~~-~l~~~l~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~ 158 (309)
T cd07845 85 LVMEYCEQ-DLASLLDNMP--TPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLARTY 158 (309)
T ss_pred EEEecCCC-CHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccceeeec
Confidence 99999964 7877776432 2589999999999999999999998 9999999999999999999999999999876
Q ss_pred CCCCCCcccccccccccccccccC-cccCcccccHHHHHHHHHHHhCCCCcccccccc------cC--CCCcchhhHHh-
Q 042435 275 DVDSSNRTLQAGTYGYIALELVYT-MVVTEKCVIYSFGVVALEVLMGTHPGELLLSLS------SS--SGPKIMLIDIL- 344 (412)
Q Consensus 275 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~------~~--~~~~~~~~~~~- 344 (412)
...........++..|+|||.+.+ ..++.++||||||+++|||++|+.||....... .. ...........
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (309)
T cd07845 159 GLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSD 238 (309)
T ss_pred CCccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhc
Confidence 543333333346788999999865 457899999999999999999999986321100 00 00000000000
Q ss_pred ----hh-ccCCccchh----hHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 345 ----YQ-RLSPPINQK----IIQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 345 ----~~-~~~~~~~~~----~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
.. ......... .......+.+++.+|++.||++|||++|++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 239 LPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred ccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 00 000000000 00113347789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=260.72 Aligned_cols=230 Identities=27% Similarity=0.350 Sum_probs=180.0
Q ss_pred CcccceeeeecCceEEEEEEeC-CCcEEEEEecc-----------------------CCccccceEEEecCceEEEEEEe
Q 042435 144 YFHIRYCIGTGGYDSVYKAELP-DGKVVALKKLH-----------------------HSETEDSAFVVYSPQCMFFIYEY 199 (412)
Q Consensus 144 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~-----------------------~~~~~~~~~~~~~~~~~~lv~ey 199 (412)
+|++.+.||+|+||.||++... +++.+|+|++. |+++......+......++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4788899999999999999774 68999999764 33444444456667889999999
Q ss_pred ccCCceeeeeccCc-ccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCC
Q 042435 200 MERGSLFCVLRDDD-EAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDS 278 (412)
Q Consensus 200 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~ 278 (412)
+++++|.+++.... ....+++..+..++.+++.||+|||+. +++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 99999999887642 123689999999999999999999998 99999999999999999999999999998665443
Q ss_pred CCcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccchhhHH
Q 042435 279 SNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKIIQ 358 (412)
Q Consensus 279 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 358 (412)
.......|++.|+|||...+..++.++|+||+|+++++|++|+.||.... ........... ...+.+. .
T Consensus 158 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~-------~~~~~~~~~~~-~~~~~~~---~ 226 (258)
T cd08215 158 DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGEN-------LLELALKILKG-QYPPIPS---Q 226 (258)
T ss_pred ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCc-------HHHHHHHHhcC-CCCCCCC---C
Confidence 23334568889999999988889999999999999999999999986321 11111111111 1111111 1
Q ss_pred HHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 359 DIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 359 ~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
....+.+++.+||..+|++|||+.|++++
T Consensus 227 ~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 227 YSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 22347889999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-34 Score=268.15 Aligned_cols=234 Identities=22% Similarity=0.300 Sum_probs=175.7
Q ss_pred CcccceeeeecCceEEEEEEe----CCCcEEEEEecc--------------------------CCccccceEEEecCceE
Q 042435 144 YFHIRYCIGTGGYDSVYKAEL----PDGKVVALKKLH--------------------------HSETEDSAFVVYSPQCM 193 (412)
Q Consensus 144 ~f~~~~~lG~G~~g~Vy~~~~----~~~~~vAvK~l~--------------------------~~~~~~~~~~~~~~~~~ 193 (412)
+|++.+.||+|+||.||++.. .+++.||||.++ |+++......+..+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 477889999999999999964 357889999764 23333334445667788
Q ss_pred EEEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccc
Q 042435 194 FFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRL 273 (412)
Q Consensus 194 ~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~ 273 (412)
++||||+++|+|.+++.... .+++.....++.|+++||+|||+. +++||||||+||+++.++.++|+|||+++.
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg~~~~ 154 (288)
T cd05583 81 HLILDYVNGGELFTHLYQRE---HFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSKE 154 (288)
T ss_pred EEEEecCCCCcHHHHHhhcC---CcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECccccc
Confidence 99999999999998886543 488999999999999999999988 999999999999999999999999999876
Q ss_pred cCCCCCC-cccccccccccccccccCcc--cCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCC
Q 042435 274 LDVDSSN-RTLQAGTYGYIALELVYTMV--VTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSP 350 (412)
Q Consensus 274 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~--~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 350 (412)
....... .....|+..|+|||...+.. .+.++||||||+++|||++|..||...... .............. +
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~----~~~~~~~~~~~~~~-~ 229 (288)
T cd05583 155 FLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQ----NSQSEISRRILKSK-P 229 (288)
T ss_pred cccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCccc----chHHHHHHHHHccC-C
Confidence 5433221 22345889999999987655 788999999999999999999998622100 00011111111111 1
Q ss_pred ccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhcC
Q 042435 351 PINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELEGK 391 (412)
Q Consensus 351 ~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 391 (412)
+.+.. ....+.+++.+||+.||++|||+.++.+.|+..
T Consensus 230 ~~~~~---~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~ 267 (288)
T cd05583 230 PFPKT---MSAEARDFIQKLLEKDPKKRLGANGADEIKNHP 267 (288)
T ss_pred CCCcc---cCHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence 11111 122378899999999999999998888777664
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=259.36 Aligned_cols=228 Identities=24% Similarity=0.307 Sum_probs=180.3
Q ss_pred hcCcccceeeeecCceEEEEEEe-CCCcEEEEEeccCCccccc------------------------eEEEecCceEEEE
Q 042435 142 TEYFHIRYCIGTGGYDSVYKAEL-PDGKVVALKKLHHSETEDS------------------------AFVVYSPQCMFFI 196 (412)
Q Consensus 142 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l~~~~~~~~------------------------~~~~~~~~~~~lv 196 (412)
.++|+..++||+|.||+|-.++- .+++.+|+|.++..-+... ...+++.+.+|.|
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV 246 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV 246 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence 46788899999999999999966 4799999998865433322 2236778899999
Q ss_pred EEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCC
Q 042435 197 YEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDV 276 (412)
Q Consensus 197 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~ 276 (412)
|||..||.|+-+|...+ .++.....-+-..|+.||.|||++ +||.||||.+|.|+|.++.+||+|||+++.--.
T Consensus 247 MeyanGGeLf~HLsrer---~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~ 320 (516)
T KOG0690|consen 247 MEYANGGELFFHLSRER---VFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFGLCKEEIK 320 (516)
T ss_pred EEEccCceEeeehhhhh---cccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecccchhccc
Confidence 99999999999887654 477777778899999999999998 999999999999999999999999999986544
Q ss_pred CCCCcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccchhh
Q 042435 277 DSSNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKI 356 (412)
Q Consensus 277 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 356 (412)
........+||+.|+|||++....|+.+.|.|.+||++|||++|+.||... ..+..+.-++-..+..|. ..
T Consensus 321 ~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~-------dh~kLFeLIl~ed~kFPr--~l 391 (516)
T KOG0690|consen 321 YGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNK-------DHEKLFELILMEDLKFPR--TL 391 (516)
T ss_pred ccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCccccc-------chhHHHHHHHhhhccCCc--cC
Confidence 445567789999999999999999999999999999999999999999732 122222223333333332 11
Q ss_pred HHHHHHHHHHHHhcCcCCCCCCC-----CHHHHHHH
Q 042435 357 IQDIILVSTIALACLRSKPKSRP-----TMQRISQE 387 (412)
Q Consensus 357 ~~~~~~~~~l~~~Cl~~dP~~RP-----s~~evl~~ 387 (412)
.. ....|+...+.+||.+|. .+.||.++
T Consensus 392 s~---eAktLLsGLL~kdP~kRLGgGpdDakEi~~h 424 (516)
T KOG0690|consen 392 SP---EAKTLLSGLLKKDPKKRLGGGPDDAKEIMRH 424 (516)
T ss_pred CH---HHHHHHHHHhhcChHhhcCCCchhHHHHHhh
Confidence 22 256677889999999995 45566543
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=271.28 Aligned_cols=232 Identities=22% Similarity=0.242 Sum_probs=169.9
Q ss_pred CcccceeeeecCceEEEEEEe-CCCcEEEEEecc-----------------------CCccccceEEEecCceEEEEEEe
Q 042435 144 YFHIRYCIGTGGYDSVYKAEL-PDGKVVALKKLH-----------------------HSETEDSAFVVYSPQCMFFIYEY 199 (412)
Q Consensus 144 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l~-----------------------~~~~~~~~~~~~~~~~~~lv~ey 199 (412)
+|+..+.||+|+||.||++.. .+++.+|+|.+. |+++......+..+...+++|||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 455667899999999999976 468999999753 45555555667777888999999
Q ss_pred ccCCceeeeec---cCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCC
Q 042435 200 MERGSLFCVLR---DDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDV 276 (412)
Q Consensus 200 ~~~gsL~~~l~---~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~ 276 (412)
+.. ++.++.. .. ....+++.....++.+++.||+|||+.+ +++||||||+||+++.++.++|+|||+++....
T Consensus 85 ~~~-~l~~l~~~~~~~-~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd06616 85 MDI-SLDKFYKYVYEV-LKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD 160 (288)
T ss_pred ccC-CHHHHHHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence 864 5544322 11 1135899999999999999999999742 899999999999999999999999999876543
Q ss_pred CCCCcccccccccccccccccCc---ccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccc
Q 042435 277 DSSNRTLQAGTYGYIALELVYTM---VVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPIN 353 (412)
Q Consensus 277 ~~~~~~~~~gt~~y~aPE~~~~~---~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 353 (412)
.. ......|+..|+|||++.+. .++.++|||||||++|||++|+.||..... ......+..... .+...
T Consensus 161 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~------~~~~~~~~~~~~-~~~~~ 232 (288)
T cd06616 161 SI-AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS------VFDQLTQVVKGD-PPILS 232 (288)
T ss_pred CC-ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch------HHHHHhhhcCCC-CCcCC
Confidence 22 12233688899999998765 688999999999999999999999863210 000111111110 01100
Q ss_pred -hhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 354 -QKIIQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 354 -~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
.........+.+++.+||+.||++|||++||+++
T Consensus 233 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 233 NSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred CcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1101123348899999999999999999999876
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-34 Score=266.95 Aligned_cols=223 Identities=22% Similarity=0.269 Sum_probs=168.7
Q ss_pred eeecCceEEEEEEe-CCCcEEEEEecc------------------------CCccccceEEEecCceEEEEEEeccCCce
Q 042435 151 IGTGGYDSVYKAEL-PDGKVVALKKLH------------------------HSETEDSAFVVYSPQCMFFIYEYMERGSL 205 (412)
Q Consensus 151 lG~G~~g~Vy~~~~-~~~~~vAvK~l~------------------------~~~~~~~~~~~~~~~~~~lv~ey~~~gsL 205 (412)
||+|+||+||++.. .+|+.+|+|.+. |+++......+...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 68999999999965 468999999653 44444455556777889999999999999
Q ss_pred eeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCCCCccccc
Q 042435 206 FCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQA 285 (412)
Q Consensus 206 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 285 (412)
.+++..... ..+++..+..++.|++.||.|||+. +++||||+|+||++++++.++|+|||++...... .......
T Consensus 81 ~~~l~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~-~~~~~~~ 155 (277)
T cd05577 81 KYHIYNVGE-PGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG-KKIKGRA 155 (277)
T ss_pred HHHHHHcCc-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhccC-Ccccccc
Confidence 988865432 2589999999999999999999998 9999999999999999999999999998765432 2223346
Q ss_pred ccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccchhhHHHHHHHHH
Q 042435 286 GTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKIIQDIILVST 365 (412)
Q Consensus 286 gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 365 (412)
++..|+|||++.+..++.++||||||+++|+|++|+.||...... .....+...... .....+.. ....+.+
T Consensus 156 ~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~~~~~-~~~~~~~~---~~~~~~~ 227 (277)
T cd05577 156 GTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEK----VEKEELKRRTLE-MAVEYPDK---FSPEAKD 227 (277)
T ss_pred CCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCccc----ccHHHHHhcccc-ccccCCcc---CCHHHHH
Confidence 788999999998888999999999999999999999998632110 000001110000 01111111 1234788
Q ss_pred HHHhcCcCCCCCCC-----CHHHHHH
Q 042435 366 IALACLRSKPKSRP-----TMQRISQ 386 (412)
Q Consensus 366 l~~~Cl~~dP~~RP-----s~~evl~ 386 (412)
++.+||+.||++|| ++.++++
T Consensus 228 li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 228 LCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred HHHHHccCChhHccCCCcccHHHHHh
Confidence 99999999999999 6666765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=263.59 Aligned_cols=221 Identities=24% Similarity=0.322 Sum_probs=172.3
Q ss_pred eeecCceEEEEEEeC-CCcEEEEEec------------------------cCCccccceEEEecCceEEEEEEeccCCce
Q 042435 151 IGTGGYDSVYKAELP-DGKVVALKKL------------------------HHSETEDSAFVVYSPQCMFFIYEYMERGSL 205 (412)
Q Consensus 151 lG~G~~g~Vy~~~~~-~~~~vAvK~l------------------------~~~~~~~~~~~~~~~~~~~lv~ey~~~gsL 205 (412)
||.|+||.||+|... +++.+|+|.+ +|+++......+..+...++++||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 689999999999875 4899999965 345555555567778889999999999999
Q ss_pred eeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCCCCccccc
Q 042435 206 FCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQA 285 (412)
Q Consensus 206 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 285 (412)
.+++.... .+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||+++...... ......
T Consensus 81 ~~~l~~~~---~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~-~~~~~~ 153 (262)
T cd05572 81 WTILRDRG---LFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ-KTWTFC 153 (262)
T ss_pred HHHHhhcC---CCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc-cccccc
Confidence 99987653 488999999999999999999998 99999999999999999999999999998764432 223346
Q ss_pred ccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccchhhHHHHHHHHH
Q 042435 286 GTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKIIQDIILVST 365 (412)
Q Consensus 286 gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 365 (412)
++..|+|||.+.+..++.++|+||||+++|||++|..||..... ........+.........+... ...+.+
T Consensus 154 ~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~---~~~~~~ 225 (262)
T cd05572 154 GTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDE-----DPMEIYNDILKGNGKLEFPNYI---DKAAKD 225 (262)
T ss_pred CCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCC-----CHHHHHHHHhccCCCCCCCccc---CHHHHH
Confidence 78899999999888899999999999999999999999873210 0111112222111111111111 234889
Q ss_pred HHHhcCcCCCCCCCC-----HHHHHH
Q 042435 366 IALACLRSKPKSRPT-----MQRISQ 386 (412)
Q Consensus 366 l~~~Cl~~dP~~RPs-----~~evl~ 386 (412)
++.+||+.+|++||+ ++|+++
T Consensus 226 ~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 226 LIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred HHHHHccCChhhCcCCcccCHHHHhc
Confidence 999999999999999 777765
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=268.78 Aligned_cols=230 Identities=23% Similarity=0.300 Sum_probs=175.1
Q ss_pred cccceeeeecCceEEEEEEe-CCCcEEEEEecc------------------------CCccccceEEEecCceEEEEEEe
Q 042435 145 FHIRYCIGTGGYDSVYKAEL-PDGKVVALKKLH------------------------HSETEDSAFVVYSPQCMFFIYEY 199 (412)
Q Consensus 145 f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l~------------------------~~~~~~~~~~~~~~~~~~lv~ey 199 (412)
|+..+.||+|+||.||+|.. .+++.||+|.+. |+++......+..++..++||||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 106 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY 106 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence 66778999999999999976 468999999764 34444445556777889999999
Q ss_pred ccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCCC
Q 042435 200 MERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSS 279 (412)
Q Consensus 200 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 279 (412)
++ |+|.+.+.... ..++|.++..++.|++.||.|||+. +++||||+|+||+++.++.++|+|||++......
T Consensus 107 ~~-g~l~~~~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~-- 178 (317)
T cd06635 107 CL-GSASDLLEVHK--KPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPA-- 178 (317)
T ss_pred CC-CCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCccccCCc--
Confidence 96 57777664332 2589999999999999999999998 9999999999999999999999999998754322
Q ss_pred Cccccccccccccccccc---CcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccchhh
Q 042435 280 NRTLQAGTYGYIALELVY---TMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKI 356 (412)
Q Consensus 280 ~~~~~~gt~~y~aPE~~~---~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 356 (412)
....|+..|+|||++. ...++.++|||||||++|||++|+.||... ........+...........
T Consensus 179 --~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~-------~~~~~~~~~~~~~~~~~~~~-- 247 (317)
T cd06635 179 --NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM-------NAMSALYHIAQNESPTLQSN-- 247 (317)
T ss_pred --ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCc-------cHHHHHHHHHhccCCCCCCc--
Confidence 2346788999999974 456889999999999999999999997632 11111112222211111111
Q ss_pred HHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhcCCCC
Q 042435 357 IQDIILVSTIALACLRSKPKSRPTMQRISQELEGKTPM 394 (412)
Q Consensus 357 ~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~ 394 (412)
.....+.+++.+||+.+|.+||++.++++++-.....
T Consensus 248 -~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~ 284 (317)
T cd06635 248 -EWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRER 284 (317)
T ss_pred -cccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccC
Confidence 1223478899999999999999999999987655443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=260.25 Aligned_cols=229 Identities=27% Similarity=0.346 Sum_probs=179.3
Q ss_pred CcccceeeeecCceEEEEEEeC-CCcEEEEEecc-----------------------CCccccceEEEecC--ceEEEEE
Q 042435 144 YFHIRYCIGTGGYDSVYKAELP-DGKVVALKKLH-----------------------HSETEDSAFVVYSP--QCMFFIY 197 (412)
Q Consensus 144 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~-----------------------~~~~~~~~~~~~~~--~~~~lv~ 197 (412)
+|+..+.||+|++|.||+|... +++.|++|.++ |+++......+... ...++++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4778899999999999999875 68999999753 34444444455556 7899999
Q ss_pred EeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCC
Q 042435 198 EYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVD 277 (412)
Q Consensus 198 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~ 277 (412)
||+++++|.+++.... .+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||.+......
T Consensus 81 e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 154 (260)
T cd06606 81 EYVSGGSLSSLLKKFG---KLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDI 154 (260)
T ss_pred EecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEecccc
Confidence 9999999999987654 589999999999999999999998 9999999999999999999999999998876544
Q ss_pred CC--CcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccchh
Q 042435 278 SS--NRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQK 355 (412)
Q Consensus 278 ~~--~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 355 (412)
.. ......++..|+|||...+...+.++||||||+++++|++|..||.... ..................+..
T Consensus 155 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~------~~~~~~~~~~~~~~~~~~~~~ 228 (260)
T cd06606 155 ETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG------NPMAALYKIGSSGEPPEIPEH 228 (260)
T ss_pred cccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC------chHHHHHhccccCCCcCCCcc
Confidence 32 1334568889999999988889999999999999999999999987321 000111111111111111111
Q ss_pred hHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 356 IIQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 356 ~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
. ...+.+++.+|++.||++||++.|++++
T Consensus 229 ~---~~~l~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 229 L---SEEAKDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred c---CHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence 1 2348889999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=259.55 Aligned_cols=227 Identities=26% Similarity=0.408 Sum_probs=178.1
Q ss_pred CcccceeeeecCceEEEEEEeC-CCcEEEEEecc-----------------------CCccccceEEEecCceEEEEEEe
Q 042435 144 YFHIRYCIGTGGYDSVYKAELP-DGKVVALKKLH-----------------------HSETEDSAFVVYSPQCMFFIYEY 199 (412)
Q Consensus 144 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~-----------------------~~~~~~~~~~~~~~~~~~lv~ey 199 (412)
+|++.+.||+|++|.||++... +++.||+|.+. |+++......+...+..+++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4778899999999999999764 68899999764 33334444456677889999999
Q ss_pred ccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCCC
Q 042435 200 MERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSS 279 (412)
Q Consensus 200 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 279 (412)
+++++|.+++.... .+++..+..++.|++.||.|||+. +++||||||+||+++.++.++|+|||++........
T Consensus 81 ~~~~~L~~~~~~~~---~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (254)
T cd06627 81 AENGSLRQIIKKFG---PFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK 154 (254)
T ss_pred CCCCcHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccceecCCCcc
Confidence 99999998887553 589999999999999999999998 999999999999999999999999999987655443
Q ss_pred CcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccchhhHHH
Q 042435 280 NRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKIIQD 359 (412)
Q Consensus 280 ~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 359 (412)
......++..|+|||...+..++.++||||+|+++|+|++|+.||.... .......... ...+..+...
T Consensus 155 ~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~-------~~~~~~~~~~-~~~~~~~~~~--- 223 (254)
T cd06627 155 DDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLN-------PMAALFRIVQ-DDHPPLPEGI--- 223 (254)
T ss_pred cccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCcc-------HHHHHHHHhc-cCCCCCCCCC---
Confidence 3344568899999999988778999999999999999999999986321 1111111111 1111111111
Q ss_pred HHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 360 IILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 360 ~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
...+.+++.+||..+|++|||+.|++.+
T Consensus 224 ~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 251 (254)
T cd06627 224 SPELKDFLMQCFQKDPNLRPTAKQLLKH 251 (254)
T ss_pred CHHHHHHHHHHHhCChhhCcCHHHHhcC
Confidence 2347789999999999999999999853
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=273.99 Aligned_cols=244 Identities=23% Similarity=0.285 Sum_probs=173.7
Q ss_pred hhcCcccceeeeecCceEEEEEEe-CCCcEEEEEecc----------------------CCccccceEEEec-----Cce
Q 042435 141 ATEYFHIRYCIGTGGYDSVYKAEL-PDGKVVALKKLH----------------------HSETEDSAFVVYS-----PQC 192 (412)
Q Consensus 141 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l~----------------------~~~~~~~~~~~~~-----~~~ 192 (412)
.+++|++.+.||+|+||.||+|.. .+|+.||+|.++ |+++......+.. ...
T Consensus 3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 82 (336)
T cd07849 3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND 82 (336)
T ss_pred cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence 357899999999999999999975 568999999764 3333333333222 245
Q ss_pred EEEEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCcc
Q 042435 193 MFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVR 272 (412)
Q Consensus 193 ~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~ 272 (412)
.++++||+++ +|.+++... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 83 ~~lv~e~~~~-~l~~~~~~~----~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~ 154 (336)
T cd07849 83 VYIVQELMET-DLYKLIKTQ----HLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLAR 154 (336)
T ss_pred EEEEehhccc-CHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECccccee
Confidence 7999999964 777766543 489999999999999999999998 99999999999999999999999999987
Q ss_pred ccCCCCCC---cccccccccccccccccC-cccCcccccHHHHHHHHHHHhCCCCcccccccc------c--CCCCcchh
Q 042435 273 LLDVDSSN---RTLQAGTYGYIALELVYT-MVVTEKCVIYSFGVVALEVLMGTHPGELLLSLS------S--SSGPKIML 340 (412)
Q Consensus 273 ~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~------~--~~~~~~~~ 340 (412)
........ .....|+..|+|||.+.+ ..++.++|||||||++|||++|+.||....... . ........
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~ 234 (336)
T cd07849 155 IADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDL 234 (336)
T ss_pred eccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHH
Confidence 65432211 123467899999998654 568899999999999999999999985321000 0 00000001
Q ss_pred hHHhhh-------ccC--Cccc--hhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH--HhcCC
Q 042435 341 IDILYQ-------RLS--PPIN--QKIIQDIILVSTIALACLRSKPKSRPTMQRISQE--LEGKT 392 (412)
Q Consensus 341 ~~~~~~-------~~~--~~~~--~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~--L~~~~ 392 (412)
..+... ... .... .........+.+++.+||+.||++|||+.|++++ ++...
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~ 299 (336)
T cd07849 235 NCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYH 299 (336)
T ss_pred HHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccC
Confidence 100000 000 0000 0001123347899999999999999999999988 55443
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-35 Score=284.60 Aligned_cols=227 Identities=24% Similarity=0.346 Sum_probs=182.5
Q ss_pred ccceeeeecCceEEEEEEeC--CCc--EEEEEec----------------------cCCccccceEEEecCceEEEEEEe
Q 042435 146 HIRYCIGTGGYDSVYKAELP--DGK--VVALKKL----------------------HHSETEDSAFVVYSPQCMFFIYEY 199 (412)
Q Consensus 146 ~~~~~lG~G~~g~Vy~~~~~--~~~--~vAvK~l----------------------~~~~~~~~~~~~~~~~~~~lv~ey 199 (412)
...++||+|.||.|++|.|. +|+ .||||.+ +|++..+.++++.+ ....+|+|.
T Consensus 113 ~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~EL 191 (1039)
T KOG0199|consen 113 KLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFEL 191 (1039)
T ss_pred HHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhh
Confidence 44578999999999999884 344 5899954 57777788888776 778999999
Q ss_pred ccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCCC
Q 042435 200 MERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSS 279 (412)
Q Consensus 200 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 279 (412)
++.|+|.+.|+.. ....+-......++.|||.|+.||.++ ++|||||..+|+|+-..-.+||+|||+.+.+..+..
T Consensus 192 aplGSLldrLrka-~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned 267 (1039)
T KOG0199|consen 192 APLGSLLDRLRKA-KKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLMRALGENED 267 (1039)
T ss_pred cccchHHHHHhhc-cccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccceeccCCCCc
Confidence 9999999999883 233577888899999999999999999 999999999999999999999999999998866544
Q ss_pred Ccc---cccccccccccccccCcccCcccccHHHHHHHHHHHh-CCCCcccccccccCCCCcchhhHHhhhccCCccchh
Q 042435 280 NRT---LQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLM-GTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQK 355 (412)
Q Consensus 280 ~~~---~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 355 (412)
... ...-.+.|.|||.+....++.+||||+|||++|||+| |..||-.. ....+.+.++....-+.+..
T Consensus 268 ~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~--------~g~qIL~~iD~~erLpRPk~ 339 (1039)
T KOG0199|consen 268 MYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGC--------RGIQILKNIDAGERLPRPKY 339 (1039)
T ss_pred ceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCC--------CHHHHHHhccccccCCCCCC
Confidence 331 2234578999999999999999999999999999999 78887522 12223444444433333444
Q ss_pred hHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHH
Q 042435 356 IIQDIILVSTIALACLRSKPKSRPTMQRISQEL 388 (412)
Q Consensus 356 ~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L 388 (412)
+.+ .+++++..||..+|++|||+..|.+.+
T Consensus 340 cse---dIY~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 340 CSE---DIYQIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred ChH---HHHHHHHHhccCCccccccHHHHHHhH
Confidence 444 489999999999999999999997444
|
|
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=261.62 Aligned_cols=228 Identities=21% Similarity=0.259 Sum_probs=173.2
Q ss_pred cCcccceeeeecCceEEEEEEe-CCCcEEEEEecc--------------------------CCccccceEEEec--CceE
Q 042435 143 EYFHIRYCIGTGGYDSVYKAEL-PDGKVVALKKLH--------------------------HSETEDSAFVVYS--PQCM 193 (412)
Q Consensus 143 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l~--------------------------~~~~~~~~~~~~~--~~~~ 193 (412)
.+|++.+.||+|+||.||+|.. .+++.||+|.+. |+++......+.. ....
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 4789999999999999999976 468999999652 3333333333333 3467
Q ss_pred EEEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccc
Q 042435 194 FFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRL 273 (412)
Q Consensus 194 ~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~ 273 (412)
++++||+++++|.+++.... .+++.....++.|++.||.|||+. +++|+||||+||+++.++.++|+|||+++.
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~---~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~ 155 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYG---ALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKR 155 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECccccccc
Confidence 89999999999998886543 478889999999999999999998 999999999999999999999999999986
Q ss_pred cCCCC---CCcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCC
Q 042435 274 LDVDS---SNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSP 350 (412)
Q Consensus 274 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 350 (412)
..... .......++..|+|||.+.+..++.++|+|||||++||+++|+.||... .......+.......+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~-------~~~~~~~~~~~~~~~~ 228 (264)
T cd06653 156 IQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEY-------EAMAAIFKIATQPTKP 228 (264)
T ss_pred cccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCcc-------CHHHHHHHHHcCCCCC
Confidence 53211 1112346889999999998888999999999999999999999998632 1111122222111112
Q ss_pred ccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 351 PINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 351 ~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
..+.. ....+.+++.+||. +|..||+..+++++
T Consensus 229 ~~p~~---~~~~~~~~i~~~l~-~~~~r~~~~~~~~~ 261 (264)
T cd06653 229 MLPDG---VSDACRDFLKQIFV-EEKRRPTAEFLLRH 261 (264)
T ss_pred CCCcc---cCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence 11222 22347889999999 57999999998764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=273.86 Aligned_cols=239 Identities=26% Similarity=0.328 Sum_probs=174.2
Q ss_pred hhcCcccceeeeecCceEEEEEEeC-CCcEEEEEec------------------------cCCccccceEEEec--CceE
Q 042435 141 ATEYFHIRYCIGTGGYDSVYKAELP-DGKVVALKKL------------------------HHSETEDSAFVVYS--PQCM 193 (412)
Q Consensus 141 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l------------------------~~~~~~~~~~~~~~--~~~~ 193 (412)
..++|++.+.||+|+||.||+|... +++.+|+|++ +|+++......+.. ....
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 3567888999999999999999775 6889999965 45555555555443 3468
Q ss_pred EEEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccc
Q 042435 194 FFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRL 273 (412)
Q Consensus 194 ~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~ 273 (412)
++||||++ ++|.+++... .++|..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 85 ~lv~e~~~-~~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~~~~ 156 (337)
T cd07852 85 YLVFEYME-TDLHAVIRAN----ILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARS 156 (337)
T ss_pred EEEecccc-cCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccchhc
Confidence 99999997 5888877654 488999999999999999999998 999999999999999999999999999986
Q ss_pred cCCCCC-----CcccccccccccccccccC-cccCcccccHHHHHHHHHHHhCCCCccccccccc--------CCCCcch
Q 042435 274 LDVDSS-----NRTLQAGTYGYIALELVYT-MVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSS--------SSGPKIM 339 (412)
Q Consensus 274 ~~~~~~-----~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~--------~~~~~~~ 339 (412)
...... ......|+..|+|||.+.+ ..++.++||||||+++|||+||+.||........ .......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 236 (337)
T cd07852 157 LSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAED 236 (337)
T ss_pred cccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence 543321 1233468899999998764 4578899999999999999999999853211000 0000000
Q ss_pred h--------hHHhhh---ccCCccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 340 L--------IDILYQ---RLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 340 ~--------~~~~~~---~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
. .+.+.. ....+...........+.+++.+||+.||++|||+.+++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 237 IESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 0 000000 00000000000112347899999999999999999999986
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=267.07 Aligned_cols=240 Identities=21% Similarity=0.241 Sum_probs=171.2
Q ss_pred cCcccceeeeecCceEEEEEEeC-CCcEEEEEecc-----------------------CCccccceEEEecCceEEEEEE
Q 042435 143 EYFHIRYCIGTGGYDSVYKAELP-DGKVVALKKLH-----------------------HSETEDSAFVVYSPQCMFFIYE 198 (412)
Q Consensus 143 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~-----------------------~~~~~~~~~~~~~~~~~~lv~e 198 (412)
++|++.+.||+|++|.||+|... +|+.||+|.++ |+++......+...+..++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 57889999999999999999774 68999999653 3444444555777889999999
Q ss_pred eccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecC-CCcEEEeecCCccccCCC
Q 042435 199 YMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNS-NLEAFVADFGTVRLLDVD 277 (412)
Q Consensus 199 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~-~~~~kl~DfGla~~~~~~ 277 (412)
|++ ++|.+++..... ..+++.....++.|++.||+|||++ +++||||+|+||+++. ++.+||+|||++......
T Consensus 82 ~~~-~~l~~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~ 156 (294)
T PLN00009 82 YLD-LDLKKHMDSSPD-FAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP 156 (294)
T ss_pred ccc-ccHHHHHHhCCC-CCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence 996 577776654332 2367888889999999999999998 9999999999999985 567999999999765433
Q ss_pred CCCcccccccccccccccccC-cccCcccccHHHHHHHHHHHhCCCCccccccccc-------CCCC-cc------hhhH
Q 042435 278 SSNRTLQAGTYGYIALELVYT-MVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSS-------SSGP-KI------MLID 342 (412)
Q Consensus 278 ~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~-------~~~~-~~------~~~~ 342 (412)
........+++.|+|||++.+ ..++.++||||||+++|||+||+.||........ ...+ .. ...+
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (294)
T PLN00009 157 VRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPD 236 (294)
T ss_pred ccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchh
Confidence 322334467889999998865 4578899999999999999999999863211000 0000 00 0000
Q ss_pred Hhh--hccCCccc-hhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 343 ILY--QRLSPPIN-QKIIQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 343 ~~~--~~~~~~~~-~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
... +....... .........+.+++.+|++.+|++||++.+++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 237 YKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred hhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000 00000000 0001112347889999999999999999999864
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=260.79 Aligned_cols=228 Identities=25% Similarity=0.288 Sum_probs=178.9
Q ss_pred CcccceeeeecCceEEEEEEe-CCCcEEEEEecc-----------------------CCccccceEEEecCceEEEEEEe
Q 042435 144 YFHIRYCIGTGGYDSVYKAEL-PDGKVVALKKLH-----------------------HSETEDSAFVVYSPQCMFFIYEY 199 (412)
Q Consensus 144 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l~-----------------------~~~~~~~~~~~~~~~~~~lv~ey 199 (412)
+|++.+.||+|+||.||++.. .+++.+|+|.+. |+++......+......++|+||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 478889999999999999965 468899999754 33344334445667889999999
Q ss_pred ccCCceeeeeccCcc-cccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCC
Q 042435 200 MERGSLFCVLRDDDE-AIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDS 278 (412)
Q Consensus 200 ~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~ 278 (412)
+++++|.+++..... ...+++..+..++.|++.||+|||+. +++|+||+|+||++++++.+|++|||+++.....
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~- 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKN- 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence 999999998865321 23589999999999999999999998 9999999999999999999999999999876544
Q ss_pred CCcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccchhhHH
Q 042435 279 SNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKIIQ 358 (412)
Q Consensus 279 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 358 (412)
......++..|+|||...+..++.++|+||||+++|||++|+.||.... .............++... .
T Consensus 157 -~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~--------~~~~~~~~~~~~~~~~~~---~ 224 (256)
T cd08530 157 -MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARS--------MQDLRYKVQRGKYPPIPP---I 224 (256)
T ss_pred -CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHhcCCCCCCch---h
Confidence 2223457889999999998889999999999999999999999986321 111112222222222211 2
Q ss_pred HHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 359 DIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 359 ~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
....+.+++.+|++.+|++||++.|++++
T Consensus 225 ~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 225 YSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred hCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 23448899999999999999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=266.25 Aligned_cols=230 Identities=25% Similarity=0.336 Sum_probs=172.1
Q ss_pred CcccceeeeecCceEEEEEEe----CCCcEEEEEecc--------------------------CCccccceEEEecCceE
Q 042435 144 YFHIRYCIGTGGYDSVYKAEL----PDGKVVALKKLH--------------------------HSETEDSAFVVYSPQCM 193 (412)
Q Consensus 144 ~f~~~~~lG~G~~g~Vy~~~~----~~~~~vAvK~l~--------------------------~~~~~~~~~~~~~~~~~ 193 (412)
+|++.+.||+|+||.||++.. .+|+.||+|.++ |+++......+..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 478889999999999999976 368999999764 23333344445667788
Q ss_pred EEEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccc
Q 042435 194 FFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRL 273 (412)
Q Consensus 194 ~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~ 273 (412)
++||||+++++|.+++.... .+++.....++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++.
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 154 (290)
T cd05613 81 HLILDYINGGELFTHLSQRE---RFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKE 154 (290)
T ss_pred EEEEecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCcccee
Confidence 99999999999999887543 478889999999999999999998 999999999999999999999999999986
Q ss_pred cCCCCC-CcccccccccccccccccCc--ccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCC
Q 042435 274 LDVDSS-NRTLQAGTYGYIALELVYTM--VVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSP 350 (412)
Q Consensus 274 ~~~~~~-~~~~~~gt~~y~aPE~~~~~--~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 350 (412)
...... ......|+..|+|||.+... .++.++||||||+++|||++|+.||.... .......+.+...... +
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~----~~~~~~~~~~~~~~~~-~ 229 (290)
T cd05613 155 FHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDG----EKNSQAEISRRILKSE-P 229 (290)
T ss_pred cccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCC----ccccHHHHHHHhhccC-C
Confidence 543221 12234688999999998753 46789999999999999999999986210 0000011111111111 1
Q ss_pred ccchhhHHHHHHHHHHHHhcCcCCCCCCC-----CHHHHHHH
Q 042435 351 PINQKIIQDIILVSTIALACLRSKPKSRP-----TMQRISQE 387 (412)
Q Consensus 351 ~~~~~~~~~~~~~~~l~~~Cl~~dP~~RP-----s~~evl~~ 387 (412)
+.+.. ....+.+++.+||+.||++|| ++++++++
T Consensus 230 ~~~~~---~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 230 PYPQE---MSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred CCCcc---CCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 11111 123478899999999999997 67777665
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-34 Score=290.55 Aligned_cols=244 Identities=20% Similarity=0.206 Sum_probs=164.3
Q ss_pred hhcCcccceeeeecCceEEEEEEeC-C----CcEEEEEeccCCcccc-----------------ce-E----E-EecCce
Q 042435 141 ATEYFHIRYCIGTGGYDSVYKAELP-D----GKVVALKKLHHSETED-----------------SA-F----V-VYSPQC 192 (412)
Q Consensus 141 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~----~~~vAvK~l~~~~~~~-----------------~~-~----~-~~~~~~ 192 (412)
..++|++.+.||+|+||.||+|.+. + +..||+|++....... .. . . ......
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e~~~~e~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 209 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEIWMNERVRRACPNSCADFVYGFLEPVSSKKEDE 209 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhHHHHHHHHHhhchhhHHHHHHhhhcccccccCCc
Confidence 5678999999999999999999874 4 6899999875321110 00 0 0 245667
Q ss_pred EEEEEEeccCCceeeeeccCccc-----------------ccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCE
Q 042435 193 MFFIYEYMERGSLFCVLRDDDEA-----------------IELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNI 255 (412)
Q Consensus 193 ~~lv~ey~~~gsL~~~l~~~~~~-----------------~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NI 255 (412)
.++||||+++++|.+++...... .......+..++.|++.||+|||++ +|+||||||+||
T Consensus 210 ~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDLKP~NI 286 (566)
T PLN03225 210 YWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDVKPQNI 286 (566)
T ss_pred eEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcCCHHHE
Confidence 89999999999999888653210 0112234567999999999999998 999999999999
Q ss_pred EecC-CCcEEEeecCCccccCCCC-CCcccccccccccccccccCc----------------------ccCcccccHHHH
Q 042435 256 LLNS-NLEAFVADFGTVRLLDVDS-SNRTLQAGTYGYIALELVYTM----------------------VVTEKCVIYSFG 311 (412)
Q Consensus 256 Ll~~-~~~~kl~DfGla~~~~~~~-~~~~~~~gt~~y~aPE~~~~~----------------------~~s~ksDv~S~G 311 (412)
|++. ++.+||+|||+++.+.... .......+++.|+|||.+... .++.++||||||
T Consensus 287 Ll~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlG 366 (566)
T PLN03225 287 IFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAG 366 (566)
T ss_pred EEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHH
Confidence 9985 5799999999998654332 222445789999999965322 234567999999
Q ss_pred HHHHHHHhCCCCcccccc-----cccCCCCcchhhHHhhhccCCccchhh---HHHHHHHHHHHHhcCcCCCCCCCCHHH
Q 042435 312 VVALEVLMGTHPGELLLS-----LSSSSGPKIMLIDILYQRLSPPINQKI---IQDIILVSTIALACLRSKPKSRPTMQR 383 (412)
Q Consensus 312 vil~elltg~~P~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~~Cl~~dP~~RPs~~e 383 (412)
|++|||+++..|++.... +.........+.........+...... ........+|+.+|++.||++|||+.|
T Consensus 367 viL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~ta~e 446 (566)
T PLN03225 367 LIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRISAKA 446 (566)
T ss_pred HHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccCCCHHH
Confidence 999999998877652110 000000000011111111000000000 000112458999999999999999999
Q ss_pred HHHH
Q 042435 384 ISQE 387 (412)
Q Consensus 384 vl~~ 387 (412)
++++
T Consensus 447 ~L~H 450 (566)
T PLN03225 447 ALAH 450 (566)
T ss_pred HhCC
Confidence 9986
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=271.01 Aligned_cols=227 Identities=22% Similarity=0.322 Sum_probs=189.7
Q ss_pred cCcccceeeeecCceEEEEEEe-CCCcEEEEEec-----------------------cCCccccceEEEecCceEEEEEE
Q 042435 143 EYFHIRYCIGTGGYDSVYKAEL-PDGKVVALKKL-----------------------HHSETEDSAFVVYSPQCMFFIYE 198 (412)
Q Consensus 143 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l-----------------------~~~~~~~~~~~~~~~~~~~lv~e 198 (412)
.-|++.+.||+|.|+.|-.|++ -+|+.||||.+ +|+|+++.+.+..+...+|||+|
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE 97 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE 97 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence 3477778899999999999965 68999999965 58999999999999999999999
Q ss_pred eccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEec-CCCcEEEeecCCccccCCC
Q 042435 199 YMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLN-SNLEAFVADFGTVRLLDVD 277 (412)
Q Consensus 199 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~-~~~~~kl~DfGla~~~~~~ 277 (412)
.=.+|+|++|+-.+.++ +......+++.||+.|+.|+|+. .+|||||||+|+.+- .-|-+||.|||++-.+.+.
T Consensus 98 LGD~GDl~DyImKHe~G--l~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG 172 (864)
T KOG4717|consen 98 LGDGGDLFDYIMKHEEG--LNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG 172 (864)
T ss_pred ecCCchHHHHHHhhhcc--ccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeeccccccCCCc
Confidence 99999999999877653 88888999999999999999988 899999999998775 5688999999999776554
Q ss_pred CCCcccccccccccccccccCcccC-cccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccchhh
Q 042435 278 SSNRTLQAGTYGYIALELVYTMVVT-EKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKI 356 (412)
Q Consensus 278 ~~~~~~~~gt~~y~aPE~~~~~~~s-~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 356 (412)
. .....+|+..|-|||++.+..|+ ++.||||+|||||.|++|+.||+. ....+.+..+++-...-| ...
T Consensus 173 ~-kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqe-------ANDSETLTmImDCKYtvP--shv 242 (864)
T KOG4717|consen 173 K-KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQE-------ANDSETLTMIMDCKYTVP--SHV 242 (864)
T ss_pred c-hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCcccc-------ccchhhhhhhhcccccCc--hhh
Confidence 3 34556899999999999999887 579999999999999999999983 233344455555544332 222
Q ss_pred HHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 357 IQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 357 ~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
.....+|+..|+..||++|.+.+||...
T Consensus 243 ---S~eCrdLI~sMLvRdPkkRAslEeI~s~ 270 (864)
T KOG4717|consen 243 ---SKECRDLIQSMLVRDPKKRASLEEIVST 270 (864)
T ss_pred ---hHHHHHHHHHHHhcCchhhccHHHHhcc
Confidence 2347899999999999999999999865
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=266.53 Aligned_cols=225 Identities=24% Similarity=0.348 Sum_probs=182.6
Q ss_pred HHHHHhhcCcccceeeeecCceEEEEEEeC-CCcEEEEEeccCCccccceEE-------------------------Eec
Q 042435 136 ENLIDATEYFHIRYCIGTGGYDSVYKAELP-DGKVVALKKLHHSETEDSAFV-------------------------VYS 189 (412)
Q Consensus 136 ~~l~~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~-------------------------~~~ 189 (412)
.+...++ +|....+||+|+||.|..|..+ +.+.+|||.++..-+.+...+ +++
T Consensus 343 ~d~i~~t-DFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQT 421 (683)
T KOG0696|consen 343 RDRIKAT-DFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQT 421 (683)
T ss_pred ccceeec-ccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhh
Confidence 3344444 5888999999999999999664 578999999876544332221 456
Q ss_pred CceEEEEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecC
Q 042435 190 PQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFG 269 (412)
Q Consensus 190 ~~~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG 269 (412)
-+.+|.||||+.+|+|--.+++-+ .+..+...-+|.+||-||-|||++ +|+.||||..||++|.++.+||+|||
T Consensus 422 mDRLyFVMEyvnGGDLMyhiQQ~G---kFKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFG 495 (683)
T KOG0696|consen 422 MDRLYFVMEYVNGGDLMYHIQQVG---KFKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFG 495 (683)
T ss_pred hhheeeEEEEecCchhhhHHHHhc---ccCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeecc
Confidence 678999999999999988777654 477788889999999999999999 99999999999999999999999999
Q ss_pred CccccCCCCCCcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccC
Q 042435 270 TVRLLDVDSSNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLS 349 (412)
Q Consensus 270 la~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 349 (412)
+++.--.......+.+||+.|+|||++...+|+...|.|||||+||||+.|+.||+ ...+.+.+..+.+....
T Consensus 496 mcKEni~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFd-------GeDE~elF~aI~ehnvs 568 (683)
T KOG0696|consen 496 MCKENIFDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD-------GEDEDELFQAIMEHNVS 568 (683)
T ss_pred cccccccCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCC-------CCCHHHHHHHHHHccCc
Confidence 99865555555667899999999999999999999999999999999999999998 33455556666666655
Q ss_pred CccchhhHHHHHHHHHHHHhcCcCCCCCCC
Q 042435 350 PPINQKIIQDIILVSTIALACLRSKPKSRP 379 (412)
Q Consensus 350 ~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RP 379 (412)
.+. .... +..++....+.+.|.+|.
T Consensus 569 yPK--slSk---EAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 569 YPK--SLSK---EAVAICKGLLTKHPGKRL 593 (683)
T ss_pred Ccc--cccH---HHHHHHHHHhhcCCcccc
Confidence 432 2222 256777888899999995
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=263.16 Aligned_cols=223 Identities=23% Similarity=0.349 Sum_probs=171.6
Q ss_pred eeecCceEEEEEEeC-CCcEEEEEecc------------------------CCccccceEEEecCceEEEEEEeccCCce
Q 042435 151 IGTGGYDSVYKAELP-DGKVVALKKLH------------------------HSETEDSAFVVYSPQCMFFIYEYMERGSL 205 (412)
Q Consensus 151 lG~G~~g~Vy~~~~~-~~~~vAvK~l~------------------------~~~~~~~~~~~~~~~~~~lv~ey~~~gsL 205 (412)
||+|+||.||++... +|+.+|+|.+. |+++......+......++++||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999886 49999999764 34444444446677889999999999999
Q ss_pred eeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCCC------
Q 042435 206 FCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSS------ 279 (412)
Q Consensus 206 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~------ 279 (412)
.+++.... .+++..+..++.|++.||+|||+. +++|+||+|+||++++++.++|+|||++........
T Consensus 81 ~~~l~~~~---~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 154 (265)
T cd05579 81 ASLLENVG---SLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDD 154 (265)
T ss_pred HHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccc
Confidence 99887644 589999999999999999999998 999999999999999999999999999875433211
Q ss_pred --CcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccchhhH
Q 042435 280 --NRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKII 357 (412)
Q Consensus 280 --~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 357 (412)
......++..|+|||.......+.++||||||+++||+++|+.||... ................+. ..
T Consensus 155 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~-------~~~~~~~~~~~~~~~~~~--~~- 224 (265)
T cd05579 155 EKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGE-------TPEEIFQNILNGKIEWPE--DV- 224 (265)
T ss_pred cccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCC-------CHHHHHHHHhcCCcCCCc--cc-
Confidence 223346788999999998888999999999999999999999998632 111111112211111111 11
Q ss_pred HHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHh
Q 042435 358 QDIILVSTIALACLRSKPKSRPTMQRISQELE 389 (412)
Q Consensus 358 ~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~ 389 (412)
.....+.+++.+||+.+|++|||+.++.+.|+
T Consensus 225 ~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 225 EVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred cCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 01234789999999999999999966655554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-33 Score=261.89 Aligned_cols=237 Identities=23% Similarity=0.317 Sum_probs=172.1
Q ss_pred cccceeeeecCceEEEEEEeC-CCcEEEEEecc-----------------------CCccccceEEEecCceEEEEEEec
Q 042435 145 FHIRYCIGTGGYDSVYKAELP-DGKVVALKKLH-----------------------HSETEDSAFVVYSPQCMFFIYEYM 200 (412)
Q Consensus 145 f~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~-----------------------~~~~~~~~~~~~~~~~~~lv~ey~ 200 (412)
|++.+.||+|+||+||+|... +++.||+|++. |+++......+..++..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 567889999999999999875 58899999763 333444444466678899999999
Q ss_pred cCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCCCC
Q 042435 201 ERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSN 280 (412)
Q Consensus 201 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 280 (412)
+|+|.+++..... ..+++.++..++.|++.+|.|||++ +++|+||+|+||++++++.++|+|||+++.......
T Consensus 81 -~~~l~~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~- 154 (283)
T cd07830 81 -EGNLYQLMKDRKG-KPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP- 154 (283)
T ss_pred -CCCHHHHHHhccc-ccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceeccCCCC-
Confidence 7899888765432 2589999999999999999999998 999999999999999999999999999986543222
Q ss_pred ccccccccccccccccc-CcccCcccccHHHHHHHHHHHhCCCCcccccccc---------cCCCCc----c-hhhHHhh
Q 042435 281 RTLQAGTYGYIALELVY-TMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLS---------SSSGPK----I-MLIDILY 345 (412)
Q Consensus 281 ~~~~~gt~~y~aPE~~~-~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~---------~~~~~~----~-~~~~~~~ 345 (412)
.....++..|+|||++. ...++.++|+||||++++||++|+.||....... ...... . .......
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd07830 155 YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLG 234 (283)
T ss_pred cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccc
Confidence 22345788999999875 4457899999999999999999999985321100 000000 0 0000000
Q ss_pred hccCCc----cchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 346 QRLSPP----INQKIIQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 346 ~~~~~~----~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
...... ...........+.+++.+||+.||++|||++|++.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 235 FRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred ccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 000000 000000112348899999999999999999999864
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-35 Score=282.38 Aligned_cols=233 Identities=24% Similarity=0.330 Sum_probs=182.1
Q ss_pred hhcCcccceeeeecCceEEEEEEeCCCc-EEEEEec---------------------cCCccccceEEEecCceEEEEEE
Q 042435 141 ATEYFHIRYCIGTGGYDSVYKAELPDGK-VVALKKL---------------------HHSETEDSAFVVYSPQCMFFIYE 198 (412)
Q Consensus 141 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~-~vAvK~l---------------------~~~~~~~~~~~~~~~~~~~lv~e 198 (412)
..+.|++...||.|+||.||||..++.. ..|.|.+ +|+.++.....++..+.+++..|
T Consensus 30 P~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliE 109 (1187)
T KOG0579|consen 30 PRDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIE 109 (1187)
T ss_pred HHHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEe
Confidence 3445777788999999999999876533 3444543 56666666666778889999999
Q ss_pred eccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCC
Q 042435 199 YMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDS 278 (412)
Q Consensus 199 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~ 278 (412)
||.||-...++-+-. ..|+..++..+++|++.||.|||++ +|+|||||..|||++-+|.++|+|||.+.......
T Consensus 110 FC~GGAVDaimlEL~--r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~ 184 (1187)
T KOG0579|consen 110 FCGGGAVDAIMLELG--RVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTR 184 (1187)
T ss_pred ecCCchHhHHHHHhc--cccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccchhHH
Confidence 999999988776544 3589999999999999999999999 99999999999999999999999999986554444
Q ss_pred CCccccccccccccccccc-----CcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccc
Q 042435 279 SNRTLQAGTYGYIALELVY-----TMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPIN 353 (412)
Q Consensus 279 ~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 353 (412)
.....+.||++|||||+.. ..+|+.++||||||++|.||..+.+|-... .+...+..+.... ||..
T Consensus 185 qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhel-------npMRVllKiaKSe--PPTL 255 (1187)
T KOG0579|consen 185 QKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHEL-------NPMRVLLKIAKSE--PPTL 255 (1187)
T ss_pred hhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCcccc-------chHHHHHHHhhcC--CCcc
Confidence 5556789999999999875 467999999999999999999999995522 2222222222211 1111
Q ss_pred hhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 354 QKIIQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 354 ~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
.........+.+++.+|+..||..||++.+++++
T Consensus 256 lqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 256 LQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred cCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence 2223344458899999999999999999999876
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=264.47 Aligned_cols=227 Identities=24% Similarity=0.352 Sum_probs=177.7
Q ss_pred cCcccceeeeecCceEEEEEEeC-CCcEEEEEecc-------------------------CCccccceEEEecCceEEEE
Q 042435 143 EYFHIRYCIGTGGYDSVYKAELP-DGKVVALKKLH-------------------------HSETEDSAFVVYSPQCMFFI 196 (412)
Q Consensus 143 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~-------------------------~~~~~~~~~~~~~~~~~~lv 196 (412)
++|.+.+.||+|+||.||+|... +++.||+|.+. |+++......+...+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 47889999999999999999774 79999999764 33333334445667889999
Q ss_pred EEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCC
Q 042435 197 YEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDV 276 (412)
Q Consensus 197 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~ 276 (412)
|||+++++|.+++.... .+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++++|||++.....
T Consensus 81 ~e~~~~~~L~~~l~~~~---~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~ 154 (280)
T cd05581 81 LEYAPNGELLQYIRKYG---SLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDP 154 (280)
T ss_pred EcCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCccccccCC
Confidence 99999999999987654 599999999999999999999998 999999999999999999999999999876543
Q ss_pred CCC--------------------CcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCC
Q 042435 277 DSS--------------------NRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGP 336 (412)
Q Consensus 277 ~~~--------------------~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~ 336 (412)
... ......++..|+|||......++.++||||||++++|+++|+.||.... .
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~-------~ 227 (280)
T cd05581 155 NSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSN-------E 227 (280)
T ss_pred ccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCcc-------H
Confidence 221 1123457889999999988889999999999999999999999987321 1
Q ss_pred cchhhHHhhhccCCccchhhHHHHHHHHHHHHhcCcCCCCCCCCH----HHHHHH
Q 042435 337 KIMLIDILYQRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTM----QRISQE 387 (412)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~----~evl~~ 387 (412)
.............. +... ...+.+++.+||+.+|++||++ +|++++
T Consensus 228 ~~~~~~~~~~~~~~--~~~~---~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~ 277 (280)
T cd05581 228 YLTFQKILKLEYSF--PPNF---PPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH 277 (280)
T ss_pred HHHHHHHHhcCCCC--CCcc---CHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence 11112222111111 1111 2237899999999999999999 887754
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=296.70 Aligned_cols=181 Identities=23% Similarity=0.343 Sum_probs=132.2
Q ss_pred eEEEEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCc
Q 042435 192 CMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTV 271 (412)
Q Consensus 192 ~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla 271 (412)
.+||-||||+.-.|.++++.+... -.-...++++.+|+.||+|+|+. +||||||||.||++|++..+||+|||+|
T Consensus 670 ~LYIQMEyCE~~ll~~iI~~N~~~--~~~d~~wrLFreIlEGLaYIH~~---giIHRDLKP~NIFLd~~~~VKIGDFGLA 744 (1351)
T KOG1035|consen 670 ILYIQMEYCEKTLLRDIIRRNHFN--SQRDEAWRLFREILEGLAYIHDQ---GIIHRDLKPRNIFLDSRNSVKIGDFGLA 744 (1351)
T ss_pred EEEEEHhhhhhhHHHHHHHhcccc--hhhHHHHHHHHHHHHHHHHHHhC---ceeeccCCcceeEEcCCCCeeecccccc
Confidence 468999999998888887765421 03456678999999999999999 9999999999999999999999999999
Q ss_pred cccC------------------CCCCCcccccccccccccccccCc---ccCcccccHHHHHHHHHHHhCCCCccccccc
Q 042435 272 RLLD------------------VDSSNRTLQAGTYGYIALELVYTM---VVTEKCVIYSFGVVALEVLMGTHPGELLLSL 330 (412)
Q Consensus 272 ~~~~------------------~~~~~~~~~~gt~~y~aPE~~~~~---~~s~ksDv~S~Gvil~elltg~~P~~~~~~~ 330 (412)
+... .+....+...||.-|+|||++.+. .|+.|+|+||+||+++||+.- |...
T Consensus 745 t~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~yP---F~Ts--- 818 (1351)
T KOG1035|consen 745 TDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEMLYP---FGTS--- 818 (1351)
T ss_pred hhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccchhhhHHHHHHHHHHhcc---CCch---
Confidence 8721 011234567899999999999764 499999999999999999853 4311
Q ss_pred ccCCCCcchhhHHhhhccCCccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 331 SSSSGPKIMLIDILYQRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
......+...-+..++.+ ..........-.+++.++++.||.+|||+.|+++.
T Consensus 819 ---MERa~iL~~LR~g~iP~~-~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~s 871 (1351)
T KOG1035|consen 819 ---MERASILTNLRKGSIPEP-ADFFDPEHPEEASLIRWLLSHDPSKRPTATELLNS 871 (1351)
T ss_pred ---HHHHHHHHhcccCCCCCC-cccccccchHHHHHHHHHhcCCCccCCCHHHHhhc
Confidence 000111112222222222 11122333345688999999999999999999864
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=266.25 Aligned_cols=240 Identities=19% Similarity=0.272 Sum_probs=169.5
Q ss_pred hcCcccceeeeecCceEEEEEEeC-CCcEEEEEecc-----------------------CCccccceEEEecC-------
Q 042435 142 TEYFHIRYCIGTGGYDSVYKAELP-DGKVVALKKLH-----------------------HSETEDSAFVVYSP------- 190 (412)
Q Consensus 142 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~-----------------------~~~~~~~~~~~~~~------- 190 (412)
.++|++.+.||+|+||.||+|... +++.||||.+. |+++.....++...
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 457999999999999999999764 68999999653 44444444444333
Q ss_pred -ceEEEEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecC
Q 042435 191 -QCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFG 269 (412)
Q Consensus 191 -~~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG 269 (412)
...++||||+.+ +|.+++.... ..+++.+...++.|++.||+|||++ +++|+||||+||+++.++.+||+|||
T Consensus 91 ~~~~~lv~e~~~~-~l~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg 164 (310)
T cd07865 91 KGSFYLVFEFCEH-DLAGLLSNKN--VKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFG 164 (310)
T ss_pred CceEEEEEcCCCc-CHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEECcCC
Confidence 345999999964 7877765442 2489999999999999999999998 99999999999999999999999999
Q ss_pred CccccCCCCCC----cccccccccccccccccCc-ccCcccccHHHHHHHHHHHhCCCCcccccccc-------------
Q 042435 270 TVRLLDVDSSN----RTLQAGTYGYIALELVYTM-VVTEKCVIYSFGVVALEVLMGTHPGELLLSLS------------- 331 (412)
Q Consensus 270 la~~~~~~~~~----~~~~~gt~~y~aPE~~~~~-~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~------------- 331 (412)
++......... .....++..|+|||.+.+. .++.++||||||+++|||+||+.||.......
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (310)
T cd07865 165 LARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSIT 244 (310)
T ss_pred CcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 99765432211 1234577889999988664 47889999999999999999999986321100
Q ss_pred cCCCCcchhhHHhhh-ccCCccchhhHH------HHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 332 SSSGPKIMLIDILYQ-RLSPPINQKIIQ------DIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 332 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~------~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
....+.....+..+. ............ ....+.+++.+||..||++|||++|++++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 245 PEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred hhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 000000000000000 000000000000 11236789999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=255.84 Aligned_cols=228 Identities=20% Similarity=0.300 Sum_probs=160.3
Q ss_pred ccceeeeecCceEEEEEEeC-CCcEEEEEeccCCccc-c-------ceEEEecCceEEEE---------------EEecc
Q 042435 146 HIRYCIGTGGYDSVYKAELP-DGKVVALKKLHHSETE-D-------SAFVVYSPQCMFFI---------------YEYME 201 (412)
Q Consensus 146 ~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~~~~-~-------~~~~~~~~~~~~lv---------------~ey~~ 201 (412)
+....||.|+.|.|++++.+ +|...|||.++..... . ...++...++.|+| ||.|.
T Consensus 95 ~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs 174 (391)
T KOG0983|consen 95 ENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMS 174 (391)
T ss_pred hhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHH
Confidence 34456999999999999774 5899999988643221 1 11123334455555 33331
Q ss_pred CCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCCCCc
Q 042435 202 RGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNR 281 (412)
Q Consensus 202 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 281 (412)
- -+..+++... .++++...-++...+.+||.||.+++ +|+|||+||+|||+|+.|++|+||||++..+.... ..
T Consensus 175 ~-C~ekLlkrik--~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk-Ah 248 (391)
T KOG0983|consen 175 T-CAEKLLKRIK--GPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK-AH 248 (391)
T ss_pred H-HHHHHHHHhc--CCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeeccc-cc
Confidence 1 2222232221 13566666678888999999999876 99999999999999999999999999998765433 33
Q ss_pred cccccccccccccccc---CcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccchhhHH
Q 042435 282 TLQAGTYGYIALELVY---TMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKIIQ 358 (412)
Q Consensus 282 ~~~~gt~~y~aPE~~~---~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 358 (412)
+...|.+.|||||.+. ...|+.++||||||+.++||.||+.||... ..+-..+..+++ ..++.. .....
T Consensus 249 trsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c------~tdFe~ltkvln-~ePP~L-~~~~g 320 (391)
T KOG0983|consen 249 TRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGC------KTDFEVLTKVLN-EEPPLL-PGHMG 320 (391)
T ss_pred ccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCC------CccHHHHHHHHh-cCCCCC-CcccC
Confidence 4557999999999986 346889999999999999999999998732 111122333333 222222 11112
Q ss_pred HHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 359 DIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 359 ~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
....+.+++..|+.+|+.+||...+++++
T Consensus 321 FSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 321 FSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred cCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 34458899999999999999999998875
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=289.35 Aligned_cols=238 Identities=25% Similarity=0.348 Sum_probs=188.3
Q ss_pred hhcCcccceeeeecCceEEEEEEeC--------CCcEEEEEec-----------------------cCCccccceEEEec
Q 042435 141 ATEYFHIRYCIGTGGYDSVYKAELP--------DGKVVALKKL-----------------------HHSETEDSAFVVYS 189 (412)
Q Consensus 141 ~~~~f~~~~~lG~G~~g~Vy~~~~~--------~~~~vAvK~l-----------------------~~~~~~~~~~~~~~ 189 (412)
..++..+.+.||+|.||.|++|... ....||||.+ +|+|+....+.|..
T Consensus 294 ~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~ 373 (609)
T KOG0200|consen 294 PRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQ 373 (609)
T ss_pred chhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeecc
Confidence 3344556679999999999999652 1457999976 47788888888988
Q ss_pred CceEEEEEEeccCCceeeeeccCc-------c----c--ccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEE
Q 042435 190 PQCMFFIYEYMERGSLFCVLRDDD-------E----A--IELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNIL 256 (412)
Q Consensus 190 ~~~~~lv~ey~~~gsL~~~l~~~~-------~----~--~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NIL 256 (412)
.+..++|+||++.|+|.++|+..+ . . ..++....+.++.|||.|++||++. +++||||..+|||
T Consensus 374 ~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAaRNVL 450 (609)
T KOG0200|consen 374 DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAARNVL 450 (609)
T ss_pred CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---CccchhhhhhhEE
Confidence 999999999999999999998765 0 0 1388899999999999999999999 9999999999999
Q ss_pred ecCCCcEEEeecCCccccCCCCCCc-ccccc--cccccccccccCcccCcccccHHHHHHHHHHHh-CCCCccccccccc
Q 042435 257 LNSNLEAFVADFGTVRLLDVDSSNR-TLQAG--TYGYIALELVYTMVVTEKCVIYSFGVVALEVLM-GTHPGELLLSLSS 332 (412)
Q Consensus 257 l~~~~~~kl~DfGla~~~~~~~~~~-~~~~g--t~~y~aPE~~~~~~~s~ksDv~S~Gvil~ellt-g~~P~~~~~~~~~ 332 (412)
+..+..+||+|||+++......... ....| ...|||||.+....|+.|+|||||||+|||++| |..||...
T Consensus 451 i~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~----- 525 (609)
T KOG0200|consen 451 ITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGI----- 525 (609)
T ss_pred ecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCC-----
Confidence 9999999999999999654433322 22222 456999999999999999999999999999999 88887631
Q ss_pred CCCCcchhhHHhhhccCCccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhcC
Q 042435 333 SSGPKIMLIDILYQRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELEGK 391 (412)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 391 (412)
.....+.+.+....+...+... ...+.+++..||+.+|++||++.++.+.++..
T Consensus 526 --~~~~~l~~~l~~G~r~~~P~~c---~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~ 579 (609)
T KOG0200|consen 526 --PPTEELLEFLKEGNRMEQPEHC---SDEIYDLMKSCWNADPEDRPTFSECVEFFEKH 579 (609)
T ss_pred --CcHHHHHHHHhcCCCCCCCCCC---CHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence 1112223344443333323333 33488999999999999999999999999884
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=256.44 Aligned_cols=238 Identities=23% Similarity=0.296 Sum_probs=185.8
Q ss_pred hhcCcccc-eeeeecCceEEEEEEe-CCCcEEEEEecc-----------------CCccccceEE----EecCceEEEEE
Q 042435 141 ATEYFHIR-YCIGTGGYDSVYKAEL-PDGKVVALKKLH-----------------HSETEDSAFV----VYSPQCMFFIY 197 (412)
Q Consensus 141 ~~~~f~~~-~~lG~G~~g~Vy~~~~-~~~~~vAvK~l~-----------------~~~~~~~~~~----~~~~~~~~lv~ 197 (412)
.|++|.+. ++||-|-.|.|-.+.. .+++.+|+|.+. |++++....+ +....++.+||
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVm 138 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDSPKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVM 138 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcCHHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeee
Confidence 35556654 5799999999999966 579999999874 3444443333 33457889999
Q ss_pred EeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEec---CCCcEEEeecCCcccc
Q 042435 198 EYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLN---SNLEAFVADFGTVRLL 274 (412)
Q Consensus 198 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~---~~~~~kl~DfGla~~~ 274 (412)
|+|+||.|++.+++++.. .++..+.-.|+.||+.|+.|||+. +|.||||||+|+|.. .|...||+|||+|+..
T Consensus 139 E~meGGeLfsriq~~g~~-afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t 214 (400)
T KOG0604|consen 139 ECMEGGELFSRIQDRGDQ-AFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKET 214 (400)
T ss_pred ecccchHHHHHHHHcccc-cchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEeccccccccc
Confidence 999999999999877643 589999999999999999999999 999999999999995 4567999999999965
Q ss_pred CCCCCCcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccch
Q 042435 275 DVDSSNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQ 354 (412)
Q Consensus 275 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 354 (412)
.. .....+.+-|+.|.|||++...+|+..+|+||+||++|-|++|.+||.......- ....-..+.......+ .+
T Consensus 215 ~~-~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~ai---spgMk~rI~~gqy~FP-~p 289 (400)
T KOG0604|consen 215 QE-PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI---SPGMKRRIRTGQYEFP-EP 289 (400)
T ss_pred CC-CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccC---ChhHHhHhhccCccCC-Ch
Confidence 43 2334556789999999999999999999999999999999999999984433211 1122222222222222 24
Q ss_pred hhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 355 KIIQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 355 ~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
++.+......+++...+..+|.+|.|+.|++++
T Consensus 290 EWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h 322 (400)
T KOG0604|consen 290 EWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH 322 (400)
T ss_pred hHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence 455556678899999999999999999999876
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=271.20 Aligned_cols=237 Identities=23% Similarity=0.240 Sum_probs=171.3
Q ss_pred hhcCcccceeeeecCceEEEEEEe-CCCcEEEEEecc-----------------------CCccccceEEEec------C
Q 042435 141 ATEYFHIRYCIGTGGYDSVYKAEL-PDGKVVALKKLH-----------------------HSETEDSAFVVYS------P 190 (412)
Q Consensus 141 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l~-----------------------~~~~~~~~~~~~~------~ 190 (412)
..++|+..+.||+|+||.||+|.. .+++.||+|.+. |+++......+.. .
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 457899999999999999999976 478999999864 3333333333322 2
Q ss_pred ceEEEEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCC
Q 042435 191 QCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGT 270 (412)
Q Consensus 191 ~~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGl 270 (412)
...++||||+. ++|.+.+.. .+++.....++.|++.||+|||+. +++||||||+||+++.++.+||+|||+
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~-----~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~Dfg~ 164 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQM-----DLDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 164 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCcc
Confidence 35799999996 477776643 278888999999999999999998 999999999999999999999999999
Q ss_pred ccccCCCCCCcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccc-------cCCCCcchhhH-
Q 042435 271 VRLLDVDSSNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLS-------SSSGPKIMLID- 342 (412)
Q Consensus 271 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~-------~~~~~~~~~~~- 342 (412)
++....... .....++..|+|||.+.+..++.++|||||||++|+|++|+.||....... ....+.....+
T Consensus 165 ~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (353)
T cd07850 165 ARTAGTSFM-MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSR 243 (353)
T ss_pred ceeCCCCCC-CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence 986543322 223457889999999999899999999999999999999999986321100 00000000000
Q ss_pred -------Hhhhcc---------------CCccc-hhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 343 -------ILYQRL---------------SPPIN-QKIIQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 343 -------~~~~~~---------------~~~~~-~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
...... .+... .........+.+++.+||+.||++|||+.|++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 244 LQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred hhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000000 00000 0000123347899999999999999999999976
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=272.84 Aligned_cols=245 Identities=20% Similarity=0.213 Sum_probs=175.4
Q ss_pred hcCcccceeeeecCceEEEEEEe-CCCcEEEEEeccC-----------------------CccccceEEEecC-----ce
Q 042435 142 TEYFHIRYCIGTGGYDSVYKAEL-PDGKVVALKKLHH-----------------------SETEDSAFVVYSP-----QC 192 (412)
Q Consensus 142 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l~~-----------------------~~~~~~~~~~~~~-----~~ 192 (412)
.+.|.+.+.||+|+||.||+|.. .+++.||||.++. +++......+... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 45789999999999999999976 4689999997643 3333222222221 35
Q ss_pred EEEEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCcc
Q 042435 193 MFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVR 272 (412)
Q Consensus 193 ~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~ 272 (412)
.++|+||+. ++|.+++.... .+++.....++.|++.||.|||++ +++||||||+||+++.++.+||+|||+++
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~ 156 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSSQ---TLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLAR 156 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCcccc
Confidence 799999996 68888776543 589999999999999999999998 99999999999999999999999999998
Q ss_pred ccCCCCCCcccccccccccccccccC-cccCcccccHHHHHHHHHHHhCCCCccccccc---------ccCCC-------
Q 042435 273 LLDVDSSNRTLQAGTYGYIALELVYT-MVVTEKCVIYSFGVVALEVLMGTHPGELLLSL---------SSSSG------- 335 (412)
Q Consensus 273 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~---------~~~~~------- 335 (412)
.............++..|+|||.+.. ..++.++|||||||++|||++|+.||...... .....
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (337)
T cd07858 157 TTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFI 236 (337)
T ss_pred ccCCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhc
Confidence 65443222234467889999998764 46889999999999999999999998632100 00000
Q ss_pred CcchhhHHhhhccC---CccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH--HhcCCC
Q 042435 336 PKIMLIDILYQRLS---PPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQE--LEGKTP 393 (412)
Q Consensus 336 ~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~--L~~~~~ 393 (412)
.............. .............+.+++.+||+.||++|||++|++++ ++....
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~ 299 (337)
T cd07858 237 RNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHD 299 (337)
T ss_pred CchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcC
Confidence 00000111110000 00000011123447899999999999999999999988 655443
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-33 Score=264.81 Aligned_cols=179 Identities=24% Similarity=0.370 Sum_probs=144.0
Q ss_pred CcccceeeeecCceEEEEEEeC---CCcEEEEEeccC------------------------CccccceEEEecC--ceEE
Q 042435 144 YFHIRYCIGTGGYDSVYKAELP---DGKVVALKKLHH------------------------SETEDSAFVVYSP--QCMF 194 (412)
Q Consensus 144 ~f~~~~~lG~G~~g~Vy~~~~~---~~~~vAvK~l~~------------------------~~~~~~~~~~~~~--~~~~ 194 (412)
.|++.+.||+|+||.||+|... +++.||+|.+.. +++......+... +..+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 4778899999999999999874 478999997643 4444455556666 7899
Q ss_pred EEEEeccCCceeeeeccCcc--cccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecC----CCcEEEeec
Q 042435 195 FIYEYMERGSLFCVLRDDDE--AIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNS----NLEAFVADF 268 (412)
Q Consensus 195 lv~ey~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~----~~~~kl~Df 268 (412)
+||||+++ +|.+++..... ...++......++.|++.||+|||+. +++||||||+||+++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999975 66665543221 12578889999999999999999998 9999999999999999 999999999
Q ss_pred CCccccCCCCC---CcccccccccccccccccC-cccCcccccHHHHHHHHHHHhCCCCccc
Q 042435 269 GTVRLLDVDSS---NRTLQAGTYGYIALELVYT-MVVTEKCVIYSFGVVALEVLMGTHPGEL 326 (412)
Q Consensus 269 Gla~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~S~Gvil~elltg~~P~~~ 326 (412)
|+++....... ......++..|+|||++.+ ..++.++||||||+++|||++|+.||..
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~ 218 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKG 218 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcC
Confidence 99986543322 1223467889999998765 4578999999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-33 Score=261.84 Aligned_cols=237 Identities=25% Similarity=0.342 Sum_probs=171.0
Q ss_pred cccceeeeecCceEEEEEEeC-CCcEEEEEeccC-----------------------CccccceEEEecC--ceEEEEEE
Q 042435 145 FHIRYCIGTGGYDSVYKAELP-DGKVVALKKLHH-----------------------SETEDSAFVVYSP--QCMFFIYE 198 (412)
Q Consensus 145 f~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~-----------------------~~~~~~~~~~~~~--~~~~lv~e 198 (412)
|++.+.||+|+||.||+|... +++.+|+|.++. +++......+... +..++|+|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 567889999999999999875 588999998753 3333334445555 78999999
Q ss_pred eccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCC
Q 042435 199 YMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDS 278 (412)
Q Consensus 199 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~ 278 (412)
|+++ +|.+++.... ..+++..+..++.|++.||+|||+. +++|+||||+||++++++.++|+|||++.......
T Consensus 81 ~~~~-~l~~~~~~~~--~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~ 154 (287)
T cd07840 81 YMDH-DLTGLLDSPE--VKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRN 154 (287)
T ss_pred cccc-cHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeeccCCC
Confidence 9975 8888776542 2589999999999999999999998 99999999999999999999999999998664432
Q ss_pred C-CcccccccccccccccccC-cccCcccccHHHHHHHHHHHhCCCCcccccccc---------cCCCCc--chhhHH-h
Q 042435 279 S-NRTLQAGTYGYIALELVYT-MVVTEKCVIYSFGVVALEVLMGTHPGELLLSLS---------SSSGPK--IMLIDI-L 344 (412)
Q Consensus 279 ~-~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~---------~~~~~~--~~~~~~-~ 344 (412)
. ......++..|+|||.+.+ ..++.++||||||+++|||+||+.||+...... ...... ....+. .
T Consensus 155 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd07840 155 SADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPW 234 (287)
T ss_pred cccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchh
Confidence 1 1233456788999998764 457899999999999999999999986321100 000000 000000 0
Q ss_pred hhcc--CCccch---hhH-H-HHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 345 YQRL--SPPINQ---KII-Q-DIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 345 ~~~~--~~~~~~---~~~-~-~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
.... ...... ... . ....+.+++.+||+.+|++||++++++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 235 FENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred hhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 0000 000000 000 0 13457899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=262.00 Aligned_cols=237 Identities=21% Similarity=0.262 Sum_probs=173.0
Q ss_pred cccceeeeecCceEEEEEEeC-CCcEEEEEeccCC-----------------------ccccceEEEecCceEEEEEEec
Q 042435 145 FHIRYCIGTGGYDSVYKAELP-DGKVVALKKLHHS-----------------------ETEDSAFVVYSPQCMFFIYEYM 200 (412)
Q Consensus 145 f~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~-----------------------~~~~~~~~~~~~~~~~lv~ey~ 200 (412)
|++.+.||+|++|.||+|... +++.+|+|.++.. ++......+..++..++|+||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 566789999999999999774 6899999976433 2333333456678899999999
Q ss_pred cCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCCCC
Q 042435 201 ERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSN 280 (412)
Q Consensus 201 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 280 (412)
++ +|.+++.... ..+++.++..++.|++.||+|||+. +++|+||||+||+++.++.++|+|||.+.........
T Consensus 81 ~~-~l~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~ 154 (283)
T cd05118 81 DT-DLYKLIKDRQ--RGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRP 154 (283)
T ss_pred CC-CHHHHHHhhc--ccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCccc
Confidence 75 8887776543 2589999999999999999999998 9999999999999999999999999999876544322
Q ss_pred cccccccccccccccccCc-ccCcccccHHHHHHHHHHHhCCCCccccccccc-------CCCC-cc---hhhH---Hh-
Q 042435 281 RTLQAGTYGYIALELVYTM-VVTEKCVIYSFGVVALEVLMGTHPGELLLSLSS-------SSGP-KI---MLID---IL- 344 (412)
Q Consensus 281 ~~~~~gt~~y~aPE~~~~~-~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~-------~~~~-~~---~~~~---~~- 344 (412)
.....++..|+|||.+.+. .++.++|+||||+++|+|+||+.||........ .... .. ...+ ..
T Consensus 155 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd05118 155 YTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYK 234 (283)
T ss_pred ccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhh
Confidence 2334578899999998776 788999999999999999999999853211000 0000 00 0000 00
Q ss_pred --hhc-cCCccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 345 --YQR-LSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 345 --~~~-~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
.+. ...............+.+++.+||+.||.+||++.+++.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 235 FSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred hhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 000 0000001111223458899999999999999999999864
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-33 Score=264.36 Aligned_cols=242 Identities=24% Similarity=0.296 Sum_probs=170.5
Q ss_pred HhhcCcccceeeeecCceEEEEEEeC-CCcEEEEEeccC-----------------------CccccceEEEecC-----
Q 042435 140 DATEYFHIRYCIGTGGYDSVYKAELP-DGKVVALKKLHH-----------------------SETEDSAFVVYSP----- 190 (412)
Q Consensus 140 ~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~-----------------------~~~~~~~~~~~~~----- 190 (412)
...++|++.+.||+|+||.||+|..+ +|+.||+|.++. +++......+.+.
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 34578999999999999999999875 589999997743 3333333333332
Q ss_pred -----ceEEEEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEE
Q 042435 191 -----QCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFV 265 (412)
Q Consensus 191 -----~~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl 265 (412)
...++|+||+++ ++.+.+.... ..+++..+..++.|++.||+|||+. +|+|+||||+||++++++.+||
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~kl 157 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESGL--VHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIKL 157 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcEEe
Confidence 378999999976 6666655432 2589999999999999999999998 9999999999999999999999
Q ss_pred eecCCccccCCCCC-CcccccccccccccccccC-cccCcccccHHHHHHHHHHHhCCCCccccccccc--------CCC
Q 042435 266 ADFGTVRLLDVDSS-NRTLQAGTYGYIALELVYT-MVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSS--------SSG 335 (412)
Q Consensus 266 ~DfGla~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~--------~~~ 335 (412)
+|||++........ ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||........ ...
T Consensus 158 ~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~ 237 (302)
T cd07864 158 ADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSP 237 (302)
T ss_pred CcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence 99999986644332 1122346788999998764 4578899999999999999999999863211000 000
Q ss_pred CcchhhHHhhh----------ccCCccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 336 PKIMLIDILYQ----------RLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 336 ~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
......++... ................+.+++.+||+.||++||++++++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 238 CPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred ChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 00000000000 00000000000112348899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=270.09 Aligned_cols=240 Identities=22% Similarity=0.252 Sum_probs=172.5
Q ss_pred hcCcccceeeeecCceEEEEEEe-CCCcEEEEEeccCC-----------------------ccccceEEEe----cCceE
Q 042435 142 TEYFHIRYCIGTGGYDSVYKAEL-PDGKVVALKKLHHS-----------------------ETEDSAFVVY----SPQCM 193 (412)
Q Consensus 142 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l~~~-----------------------~~~~~~~~~~----~~~~~ 193 (412)
.++|++.+.||+|+||.||+|.. .+|+.||+|++... ++......+. .....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 47899999999999999999976 46999999987532 2222222221 33568
Q ss_pred EEEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccc
Q 042435 194 FFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRL 273 (412)
Q Consensus 194 ~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~ 273 (412)
++||||+. |+|.+++.... .+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||+++.
T Consensus 84 ~lv~e~~~-~~l~~~~~~~~---~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~ 156 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSDQ---PLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARG 156 (334)
T ss_pred EEEEehhh-hhHHHHhccCC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEeccccccee
Confidence 99999995 68888876543 489999999999999999999998 999999999999999999999999999976
Q ss_pred cCCCCCC----cccccccccccccccccC-cccCcccccHHHHHHHHHHHhCCCCcccccccc------c--CCCCcc--
Q 042435 274 LDVDSSN----RTLQAGTYGYIALELVYT-MVVTEKCVIYSFGVVALEVLMGTHPGELLLSLS------S--SSGPKI-- 338 (412)
Q Consensus 274 ~~~~~~~----~~~~~gt~~y~aPE~~~~-~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~------~--~~~~~~-- 338 (412)
....... .....|+..|+|||.+.+ ..++.++||||||+++|||++|+.||....... . ...+..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~ 236 (334)
T cd07855 157 LSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVL 236 (334)
T ss_pred ecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhh
Confidence 5432211 123468889999998765 458899999999999999999999986321100 0 000000
Q ss_pred ------hhhHHhhhc---cCCccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHH
Q 042435 339 ------MLIDILYQR---LSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQEL 388 (412)
Q Consensus 339 ------~~~~~~~~~---~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L 388 (412)
......... ...+...........+.+++.+||+.+|++|||+++++.+-
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~ 295 (334)
T cd07855 237 NRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHP 295 (334)
T ss_pred hhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhCh
Confidence 000001000 00000000011234588999999999999999999998853
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=260.47 Aligned_cols=229 Identities=22% Similarity=0.277 Sum_probs=170.6
Q ss_pred CcccceeeeecCceEEEEEEeCC-CcEEEEEec--------------------------cCCccccceEEEecCceEEEE
Q 042435 144 YFHIRYCIGTGGYDSVYKAELPD-GKVVALKKL--------------------------HHSETEDSAFVVYSPQCMFFI 196 (412)
Q Consensus 144 ~f~~~~~lG~G~~g~Vy~~~~~~-~~~vAvK~l--------------------------~~~~~~~~~~~~~~~~~~~lv 196 (412)
+|.+.+.||+|+||.||++.... +..+++|.+ +|+++......+......++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 47888999999999999997643 333444432 234443333345567788999
Q ss_pred EEeccCCceeeeeccCc-ccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccC
Q 042435 197 YEYMERGSLFCVLRDDD-EAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLD 275 (412)
Q Consensus 197 ~ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~ 275 (412)
|||+++++|.+++.... ....+++..++.++.|++.||.|||+. +++|+||||+||++++ +.++|+|||+++...
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccCceeecC
Confidence 99999999998876422 223589999999999999999999998 9999999999999975 569999999988764
Q ss_pred CCCCCcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccchh
Q 042435 276 VDSSNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQK 355 (412)
Q Consensus 276 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 355 (412)
..........|++.|+|||...+..++.++|+||||+++|+|++|..||.... ......... ....+..+
T Consensus 157 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~-------~~~~~~~~~-~~~~~~~~-- 226 (260)
T cd08222 157 GSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN-------FLSVVLRIV-EGPTPSLP-- 226 (260)
T ss_pred CCcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc-------HHHHHHHHH-cCCCCCCc--
Confidence 44333344568889999999988888999999999999999999999986211 111111111 11111111
Q ss_pred hHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 356 IIQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 356 ~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
......+.+++.+||+.||++||++.|++++
T Consensus 227 -~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 227 -ETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred -chhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 1222347889999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=294.82 Aligned_cols=235 Identities=26% Similarity=0.314 Sum_probs=179.4
Q ss_pred HHHHHhhcCcccceeeeecCceEEEEEEeC-CCcEEEEEeccCCccc------------------------cceEEEecC
Q 042435 136 ENLIDATEYFHIRYCIGTGGYDSVYKAELP-DGKVVALKKLHHSETE------------------------DSAFVVYSP 190 (412)
Q Consensus 136 ~~l~~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~~~~------------------------~~~~~~~~~ 190 (412)
.++.-..++|++.++||+|+||.|..++++ +++++|+|+++..... ..+..+.++
T Consensus 68 ~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~ 147 (1317)
T KOG0612|consen 68 KELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDE 147 (1317)
T ss_pred HHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCc
Confidence 455566789999999999999999999874 6899999988652221 122237788
Q ss_pred ceEEEEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCC
Q 042435 191 QCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGT 270 (412)
Q Consensus 191 ~~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGl 270 (412)
.++|+|||||+||+|-.++.... .++..-...++..|+-||.-||+. |+|||||||+|||+|.+|++||+|||.
T Consensus 148 ~~LYlVMdY~pGGDlltLlSk~~---~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLADFGs 221 (1317)
T KOG0612|consen 148 RYLYLVMDYMPGGDLLTLLSKFD---RLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLADFGS 221 (1317)
T ss_pred cceEEEEecccCchHHHHHhhcC---CChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeeccchh
Confidence 99999999999999999998765 366666667889999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCCc-cccccccccccccccc----C-cccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHh
Q 042435 271 VRLLDVDSSNR-TLQAGTYGYIALELVY----T-MVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDIL 344 (412)
Q Consensus 271 a~~~~~~~~~~-~~~~gt~~y~aPE~~~----~-~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 344 (412)
+-.+..+.... ...+|||.|++||++. + +.|++.+|.||+||++|||+.|..||....-+ .....++
T Consensus 222 Clkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslv-------eTY~KIm 294 (1317)
T KOG0612|consen 222 CLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLV-------ETYGKIM 294 (1317)
T ss_pred HHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHH-------HHHHHHh
Confidence 87776554443 5668999999999986 3 67899999999999999999999999732111 0111122
Q ss_pred hh--ccCCccchhhHHHHHHHHHHHHhcCcCCCCCCCC---HHHHHHH
Q 042435 345 YQ--RLSPPINQKIIQDIILVSTIALACLRSKPKSRPT---MQRISQE 387 (412)
Q Consensus 345 ~~--~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs---~~evl~~ 387 (412)
+- .+..|. .........+|+.+.+. +|+.|.. ++|+-.|
T Consensus 295 ~hk~~l~FP~---~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~H 338 (1317)
T KOG0612|consen 295 NHKESLSFPD---ETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNH 338 (1317)
T ss_pred chhhhcCCCc---ccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhC
Confidence 11 222221 11123346677766554 8888887 8888765
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=269.27 Aligned_cols=243 Identities=23% Similarity=0.237 Sum_probs=176.1
Q ss_pred CcccceeeeecCceEEEEEEeC-CCcEEEEEeccCC-----------------------ccccceEEEecC-----ceEE
Q 042435 144 YFHIRYCIGTGGYDSVYKAELP-DGKVVALKKLHHS-----------------------ETEDSAFVVYSP-----QCMF 194 (412)
Q Consensus 144 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~-----------------------~~~~~~~~~~~~-----~~~~ 194 (412)
+|++.+.||+|+||.||+|... +++.||+|++... ++.....++... ...+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 4788899999999999999875 5899999976542 222222223333 3689
Q ss_pred EEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCcccc
Q 042435 195 FIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLL 274 (412)
Q Consensus 195 lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~ 274 (412)
++|||++ ++|.+++.... .+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||++...
T Consensus 81 lv~e~~~-~~l~~~l~~~~---~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~~~~ 153 (330)
T cd07834 81 IVTELME-TDLHKVIKSPQ---PLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGV 153 (330)
T ss_pred EEecchh-hhHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence 9999997 48888876543 589999999999999999999998 9999999999999999999999999999876
Q ss_pred CCCC---CCcccccccccccccccccCc-ccCcccccHHHHHHHHHHHhCCCCcccccccc---------cC-C------
Q 042435 275 DVDS---SNRTLQAGTYGYIALELVYTM-VVTEKCVIYSFGVVALEVLMGTHPGELLLSLS---------SS-S------ 334 (412)
Q Consensus 275 ~~~~---~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~---------~~-~------ 334 (412)
.... .......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||....... .. .
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 233 (330)
T cd07834 154 DPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKF 233 (330)
T ss_pred cccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhh
Confidence 5443 123344678899999999877 78999999999999999999999986321100 00 0
Q ss_pred CCcchhhHHhhhccCC-c--cchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH--HhcCCC
Q 042435 335 GPKIMLIDILYQRLSP-P--INQKIIQDIILVSTIALACLRSKPKSRPTMQRISQE--LEGKTP 393 (412)
Q Consensus 335 ~~~~~~~~~~~~~~~~-~--~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~--L~~~~~ 393 (412)
.......+.+...... . ...........+.+++.+||+.+|++|||+++++++ +++...
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~ 297 (330)
T cd07834 234 ITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHD 297 (330)
T ss_pred ccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcc
Confidence 0000001111100000 0 000001122347899999999999999999999986 555544
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-33 Score=264.79 Aligned_cols=230 Identities=23% Similarity=0.306 Sum_probs=173.4
Q ss_pred cCcccceeeeecCceEEEEEEeC-CCcEEEEEecc------------------------CCccccceEEEecCceEEEEE
Q 042435 143 EYFHIRYCIGTGGYDSVYKAELP-DGKVVALKKLH------------------------HSETEDSAFVVYSPQCMFFIY 197 (412)
Q Consensus 143 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~------------------------~~~~~~~~~~~~~~~~~~lv~ 197 (412)
+.|+..+.||+|+||.||+|... +++.+|+|.+. |+++......+......++||
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 34666788999999999999864 68899999753 344444555567778899999
Q ss_pred EeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCC
Q 042435 198 EYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVD 277 (412)
Q Consensus 198 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~ 277 (412)
||+. |++.+++.... ..+++.++..++.|++.||.|||+. +++||||||+||+++.++.++|+|||++......
T Consensus 95 e~~~-~~l~~~~~~~~--~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 168 (308)
T cd06634 95 EYCL-GSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 168 (308)
T ss_pred EccC-CCHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcccceeecCc
Confidence 9996 57777664332 2488999999999999999999998 9999999999999999999999999998765432
Q ss_pred CCCccccccccccccccccc---CcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccch
Q 042435 278 SSNRTLQAGTYGYIALELVY---TMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQ 354 (412)
Q Consensus 278 ~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 354 (412)
....++..|+|||.+. ...++.++|||||||++|||++|+.||.... ............ .+....
T Consensus 169 ----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-------~~~~~~~~~~~~-~~~~~~ 236 (308)
T cd06634 169 ----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN-------AMSALYHIAQNE-SPALQS 236 (308)
T ss_pred ----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCcccc-------HHHHHHHHhhcC-CCCcCc
Confidence 2345788999999874 3567889999999999999999999976321 111111111111 111101
Q ss_pred hhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhcCC
Q 042435 355 KIIQDIILVSTIALACLRSKPKSRPTMQRISQELEGKT 392 (412)
Q Consensus 355 ~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 392 (412)
......+.+++.+||+.+|++||++.+++++..-..
T Consensus 237 --~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~ 272 (308)
T cd06634 237 --GHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 272 (308)
T ss_pred --ccccHHHHHHHHHHhhCCcccCCCHHHHhhCccccc
Confidence 112234788999999999999999999998855443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=284.75 Aligned_cols=244 Identities=18% Similarity=0.188 Sum_probs=169.8
Q ss_pred HhhcCcccceeeeecCceEEEEEEeCC--CcEE------------------E--------------------EEeccCCc
Q 042435 140 DATEYFHIRYCIGTGGYDSVYKAELPD--GKVV------------------A--------------------LKKLHHSE 179 (412)
Q Consensus 140 ~~~~~f~~~~~lG~G~~g~Vy~~~~~~--~~~v------------------A--------------------vK~l~~~~ 179 (412)
...++|++.+.||+|+||+||++..+. +... + ++.++|++
T Consensus 145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hpn 224 (501)
T PHA03210 145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHEN 224 (501)
T ss_pred hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCC
Confidence 345789999999999999999986421 1111 1 12357889
Q ss_pred cccceEEEecCceEEEEEEeccCCceeeeeccCcc--cccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEe
Q 042435 180 TEDSAFVVYSPQCMFFIYEYMERGSLFCVLRDDDE--AIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILL 257 (412)
Q Consensus 180 ~~~~~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl 257 (412)
+.....++...+..++|+|++. ++|.+++..... .......+...++.|++.||+|||++ +|+||||||+|||+
T Consensus 225 Iv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NILl 300 (501)
T PHA03210 225 ILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFL 300 (501)
T ss_pred cCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEE
Confidence 9888888888999999999985 567666543321 11233456778999999999999998 99999999999999
Q ss_pred cCCCcEEEeecCCccccCCCCCC-cccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCC-cccccc------
Q 042435 258 NSNLEAFVADFGTVRLLDVDSSN-RTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHP-GELLLS------ 329 (412)
Q Consensus 258 ~~~~~~kl~DfGla~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P-~~~~~~------ 329 (412)
+.++.+||+|||+++.+...... .....||..|+|||++.+..++.++|||||||++|||++|..+ +.....
T Consensus 301 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~ 380 (501)
T PHA03210 301 NCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQL 380 (501)
T ss_pred CCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHH
Confidence 99999999999999876543222 2345799999999999999999999999999999999998754 321100
Q ss_pred ------cc--cCCCC--cchhhHHhhhccCCccchhh---H---HHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 330 ------LS--SSSGP--KIMLIDILYQRLSPPINQKI---I---QDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 330 ------~~--~~~~~--~~~~~~~~~~~~~~~~~~~~---~---~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
+. ....+ ...+.+.+............ . .....+.+++.+|++.||++|||+.|++++
T Consensus 381 ~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 381 LKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred HHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 00 00000 00011111100000000000 0 011236677889999999999999999875
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=262.00 Aligned_cols=223 Identities=24% Similarity=0.305 Sum_probs=169.7
Q ss_pred cccceeeeecCceEEEEEEe-CCCcEEEEEecc------------------------CCccccceEEEecCceEEEEEEe
Q 042435 145 FHIRYCIGTGGYDSVYKAEL-PDGKVVALKKLH------------------------HSETEDSAFVVYSPQCMFFIYEY 199 (412)
Q Consensus 145 f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l~------------------------~~~~~~~~~~~~~~~~~~lv~ey 199 (412)
|...+.||+|+||.||+|.. .+++.||+|.+. |+++......+.+.+..++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 55567899999999999976 468899999753 45555556667788889999999
Q ss_pred ccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCCC
Q 042435 200 MERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSS 279 (412)
Q Consensus 200 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 279 (412)
+. |++.+++.... ..+++.++..++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++.....
T Consensus 103 ~~-~~l~~~l~~~~--~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~--- 173 (313)
T cd06633 103 CL-GSASDLLEVHK--KPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSSP--- 173 (313)
T ss_pred CC-CCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCcccCC---
Confidence 96 57777665432 2589999999999999999999998 999999999999999999999999999864321
Q ss_pred Cccccccccccccccccc---CcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccchhh
Q 042435 280 NRTLQAGTYGYIALELVY---TMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKI 356 (412)
Q Consensus 280 ~~~~~~gt~~y~aPE~~~---~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 356 (412)
.....|+..|+|||++. ...++.++|||||||++|||++|..||.... ............. +....
T Consensus 174 -~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~-------~~~~~~~~~~~~~-~~~~~-- 242 (313)
T cd06633 174 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN-------AMSALYHIAQNDS-PTLQS-- 242 (313)
T ss_pred -CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-------hHHHHHHHHhcCC-CCCCc--
Confidence 22346888999999974 4568889999999999999999999986321 1111111111111 11100
Q ss_pred HHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 357 IQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 357 ~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
......+.+++.+||+.+|.+||++.+++++
T Consensus 243 ~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 243 NEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred cccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0111237789999999999999999999975
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=265.95 Aligned_cols=233 Identities=21% Similarity=0.285 Sum_probs=168.9
Q ss_pred eeeeec--CceEEEEEEe-CCCcEEEEEec-----------------------cCCccccceEEEecCceEEEEEEeccC
Q 042435 149 YCIGTG--GYDSVYKAEL-PDGKVVALKKL-----------------------HHSETEDSAFVVYSPQCMFFIYEYMER 202 (412)
Q Consensus 149 ~~lG~G--~~g~Vy~~~~-~~~~~vAvK~l-----------------------~~~~~~~~~~~~~~~~~~~lv~ey~~~ 202 (412)
..||+| +||+||++.. .+|+.||+|.+ +|+++.....++..++..++|+||+++
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 346666 9999999976 47999999964 467777777778888899999999999
Q ss_pred CceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCCCC--
Q 042435 203 GSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSN-- 280 (412)
Q Consensus 203 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~-- 280 (412)
|+|.+++..... ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.++++||+.+.........
T Consensus 84 ~~l~~~l~~~~~-~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (328)
T cd08226 84 GSANSLLKTYFP-EGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAK 159 (328)
T ss_pred CCHHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccc
Confidence 999988875432 2488899999999999999999988 9999999999999999999999999865332211110
Q ss_pred -----cccccccccccccccccCc--ccCcccccHHHHHHHHHHHhCCCCcccccccc-------cCCC-Cc------ch
Q 042435 281 -----RTLQAGTYGYIALELVYTM--VVTEKCVIYSFGVVALEVLMGTHPGELLLSLS-------SSSG-PK------IM 339 (412)
Q Consensus 281 -----~~~~~gt~~y~aPE~~~~~--~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~-------~~~~-~~------~~ 339 (412)
.....++..|+|||++.+. .++.++|||||||++|||++|+.||....... .... +. ..
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (328)
T cd08226 160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCE 239 (328)
T ss_pred ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchh
Confidence 0112345679999998763 47889999999999999999999986321100 0000 00 00
Q ss_pred hh------------------------HHhhhccCCccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHH
Q 042435 340 LI------------------------DILYQRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQEL 388 (412)
Q Consensus 340 ~~------------------------~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L 388 (412)
.. ......... .........+.+++.+||+.||++|||++|++++-
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~ 309 (328)
T cd08226 240 ESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRT---PSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHA 309 (328)
T ss_pred hhhhccchhhhhcccccchhccccccccccccccc---hhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCH
Confidence 00 000000000 01112334588999999999999999999998653
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-33 Score=268.19 Aligned_cols=240 Identities=22% Similarity=0.250 Sum_probs=169.7
Q ss_pred hcCcccceeeeecCceEEEEEEe-CCCcEEEEEeccC-----------------------CccccceEEEecC------c
Q 042435 142 TEYFHIRYCIGTGGYDSVYKAEL-PDGKVVALKKLHH-----------------------SETEDSAFVVYSP------Q 191 (412)
Q Consensus 142 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l~~-----------------------~~~~~~~~~~~~~------~ 191 (412)
.++|...+.||+|+||.||+|.. .+|+.||+|+++. +++......+... .
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 47899999999999999999976 4689999997643 3333333333222 3
Q ss_pred eEEEEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCc
Q 042435 192 CMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTV 271 (412)
Q Consensus 192 ~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla 271 (412)
..++|+||+.. +|..+.. ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++
T Consensus 94 ~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~dfg~~ 164 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIMG-----HPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGLA 164 (342)
T ss_pred eEEEEeccccc-CHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCCCC
Confidence 46899999964 6655432 1488999999999999999999998 9999999999999999999999999998
Q ss_pred cccCCCCCCcccccccccccccccccC-cccCcccccHHHHHHHHHHHhCCCCccccccccc-------CCCCcchhhH-
Q 042435 272 RLLDVDSSNRTLQAGTYGYIALELVYT-MVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSS-------SSGPKIMLID- 342 (412)
Q Consensus 272 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~-------~~~~~~~~~~- 342 (412)
+..... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||........ ...+.....+
T Consensus 165 ~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (342)
T cd07879 165 RHADAE---MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQK 241 (342)
T ss_pred cCCCCC---CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence 764322 223457889999999876 4688999999999999999999999863210000 0000000000
Q ss_pred --------Hhhhcc--C-CccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH--HhcCCC
Q 042435 343 --------ILYQRL--S-PPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQE--LEGKTP 393 (412)
Q Consensus 343 --------~~~~~~--~-~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~--L~~~~~ 393 (412)
...... . .............+.+++.+||+.||++||+++|++.+ ++...+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~ 305 (342)
T cd07879 242 LEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD 305 (342)
T ss_pred hcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence 000000 0 00000000112347799999999999999999999976 666554
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=266.92 Aligned_cols=246 Identities=21% Similarity=0.227 Sum_probs=176.6
Q ss_pred cccHHHHHHhhcCcccceeeeecCceEEEEEEe-CCCcEEEEEecc-----------------------CCccccceEEE
Q 042435 132 KILYENLIDATEYFHIRYCIGTGGYDSVYKAEL-PDGKVVALKKLH-----------------------HSETEDSAFVV 187 (412)
Q Consensus 132 ~~~~~~l~~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l~-----------------------~~~~~~~~~~~ 187 (412)
+-...++..++++|++.+.||+|+||.||+|.. .+++.||+|+++ |+++......+
T Consensus 6 ~~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~ 85 (345)
T cd07877 6 QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVF 85 (345)
T ss_pred hhHHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeee
Confidence 334567788899999999999999999999965 578999999763 34444433333
Q ss_pred ec------CceEEEEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCC
Q 042435 188 YS------PQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNL 261 (412)
Q Consensus 188 ~~------~~~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~ 261 (412)
.. ....+++++++ +++|.+++... .+++..+..++.|+++||+|||+. +++||||||+||++++++
T Consensus 86 ~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~ 157 (345)
T cd07877 86 TPARSLEEFNDVYLVTHLM-GADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDC 157 (345)
T ss_pred eecccccccccEEEEehhc-ccCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCC
Confidence 22 23467888887 77888777543 489999999999999999999998 999999999999999999
Q ss_pred cEEEeecCCccccCCCCCCcccccccccccccccccC-cccCcccccHHHHHHHHHHHhCCCCccccccccc--------
Q 042435 262 EAFVADFGTVRLLDVDSSNRTLQAGTYGYIALELVYT-MVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSS-------- 332 (412)
Q Consensus 262 ~~kl~DfGla~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~-------- 332 (412)
.+||+|||+++..... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||........
T Consensus 158 ~~kl~dfg~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~ 234 (345)
T cd07877 158 ELKILDFGLARHTDDE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 234 (345)
T ss_pred CEEEeccccccccccc---ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence 9999999998754322 223467889999998865 5688899999999999999999999853211000
Q ss_pred CCCCcch--------hhHHhh---hccCCccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHH
Q 042435 333 SSGPKIM--------LIDILY---QRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQEL 388 (412)
Q Consensus 333 ~~~~~~~--------~~~~~~---~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L 388 (412)
....... ...... .................+.+++.+|++.||.+||++.+++++=
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~ 301 (345)
T cd07877 235 GTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 301 (345)
T ss_pred CCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcCh
Confidence 0000000 000000 0000000000001123478999999999999999999998763
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=263.26 Aligned_cols=236 Identities=19% Similarity=0.192 Sum_probs=166.3
Q ss_pred cceeeeecCceEEEEEEeCCCcEEEEEecc-----------------------CCccccceEEEecCceEEEEEEeccCC
Q 042435 147 IRYCIGTGGYDSVYKAELPDGKVVALKKLH-----------------------HSETEDSAFVVYSPQCMFFIYEYMERG 203 (412)
Q Consensus 147 ~~~~lG~G~~g~Vy~~~~~~~~~vAvK~l~-----------------------~~~~~~~~~~~~~~~~~~lv~ey~~~g 203 (412)
+.+.+|.|+++.||++.. +++.||||+++ |+++......+...+..+++|||+++|
T Consensus 6 i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~ 84 (314)
T cd08216 6 IGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYG 84 (314)
T ss_pred hhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCC
Confidence 344455666666666655 78999999753 445555555677788899999999999
Q ss_pred ceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCCC----
Q 042435 204 SLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSS---- 279 (412)
Q Consensus 204 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~---- 279 (412)
+|.+++..... ..+++.....++.|++.||+|||++ +|+||||||+||+++.++.+|++|||.+........
T Consensus 85 ~l~~~l~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~ 160 (314)
T cd08216 85 SCEDLLKTHFP-EGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRV 160 (314)
T ss_pred CHHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeeccccccccc
Confidence 99998875432 2478889999999999999999998 999999999999999999999999998865432211
Q ss_pred ---CcccccccccccccccccC--cccCcccccHHHHHHHHHHHhCCCCccccccccc------CCCC----cch-----
Q 042435 280 ---NRTLQAGTYGYIALELVYT--MVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSS------SSGP----KIM----- 339 (412)
Q Consensus 280 ---~~~~~~gt~~y~aPE~~~~--~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~------~~~~----~~~----- 339 (412)
......++..|+|||++.. ..++.++|||||||++|||++|+.||........ .... ...
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (314)
T cd08216 161 VHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYE 240 (314)
T ss_pred cccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhc
Confidence 1123456788999999865 3578899999999999999999999973211000 0000 000
Q ss_pred --hhH----HhhhccCC-ccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 340 --LID----ILYQRLSP-PINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 340 --~~~----~~~~~~~~-~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
..+ ........ ............+.+++.+||+.||++|||++|++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 241 DSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred CCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 000 00000000 0000011122357889999999999999999999875
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=263.19 Aligned_cols=240 Identities=22% Similarity=0.244 Sum_probs=168.0
Q ss_pred hcCcccceeeeecCceEEEEEEeC-CCcEEEEEecc-----------------------CCccccceEEEe--------c
Q 042435 142 TEYFHIRYCIGTGGYDSVYKAELP-DGKVVALKKLH-----------------------HSETEDSAFVVY--------S 189 (412)
Q Consensus 142 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~-----------------------~~~~~~~~~~~~--------~ 189 (412)
.++|++.+.||+|+||.||+|... +++.+|+|++. |+++......+. .
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 578999999999999999999764 68999999753 333333322222 2
Q ss_pred CceEEEEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecC
Q 042435 190 PQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFG 269 (412)
Q Consensus 190 ~~~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG 269 (412)
....++|+||+.+ +|...+.... ..+++..+..++.|+++||+|||+. +++|+||||+||++++++.++|+|||
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~~--~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg 160 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENPS--VKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFG 160 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhccc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcCc
Confidence 3357999999965 6666555432 2589999999999999999999998 99999999999999999999999999
Q ss_pred CccccCCCCCC-----------cccccccccccccccccCc-ccCcccccHHHHHHHHHHHhCCCCccccccccc-----
Q 042435 270 TVRLLDVDSSN-----------RTLQAGTYGYIALELVYTM-VVTEKCVIYSFGVVALEVLMGTHPGELLLSLSS----- 332 (412)
Q Consensus 270 la~~~~~~~~~-----------~~~~~gt~~y~aPE~~~~~-~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~----- 332 (412)
+++........ .....+++.|+|||.+.+. .++.++||||||+++|||++|+.||........
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~ 240 (311)
T cd07866 161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIF 240 (311)
T ss_pred cchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 99765432211 1223567889999987654 578999999999999999999999863211000
Q ss_pred ---CCCCcchhh------H----HhhhccCCccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 333 ---SSGPKIMLI------D----ILYQRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 333 ---~~~~~~~~~------~----~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
......... . .......+............+.+++.+|++.||++|||+.|++.+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~ 308 (311)
T cd07866 241 KLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH 308 (311)
T ss_pred HHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence 000000000 0 000000000000001111347899999999999999999998864
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=265.93 Aligned_cols=240 Identities=22% Similarity=0.254 Sum_probs=174.8
Q ss_pred HHHHhhcCcccceeeeecCceEEEEEEe-CCCcEEEEEecc-----------------------CCccccceEEEec-Cc
Q 042435 137 NLIDATEYFHIRYCIGTGGYDSVYKAEL-PDGKVVALKKLH-----------------------HSETEDSAFVVYS-PQ 191 (412)
Q Consensus 137 ~l~~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l~-----------------------~~~~~~~~~~~~~-~~ 191 (412)
++...+++|++.+.||+|+||.||+|.. .+++.||+|++. |+++......+.. ..
T Consensus 4 ~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 83 (328)
T cd07856 4 TVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLE 83 (328)
T ss_pred ceeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCC
Confidence 4556789999999999999999999975 479999999652 4444444444443 55
Q ss_pred eEEEEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCc
Q 042435 192 CMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTV 271 (412)
Q Consensus 192 ~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla 271 (412)
..++++||+ +++|.++++.. .+++.....++.|+++||+|||+. +++||||+|+||++++++.++|+|||.+
T Consensus 84 ~~~lv~e~~-~~~L~~~~~~~----~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~~ 155 (328)
T cd07856 84 DIYFVTELL-GTDLHRLLTSR----PLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLA 155 (328)
T ss_pred cEEEEeehh-ccCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCccccc
Confidence 789999999 56888777643 378888889999999999999998 9999999999999999999999999998
Q ss_pred cccCCCCCCcccccccccccccccccC-cccCcccccHHHHHHHHHHHhCCCCcccccccc------c--CCCCcc----
Q 042435 272 RLLDVDSSNRTLQAGTYGYIALELVYT-MVVTEKCVIYSFGVVALEVLMGTHPGELLLSLS------S--SSGPKI---- 338 (412)
Q Consensus 272 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~------~--~~~~~~---- 338 (412)
...... .....++..|+|||.+.+ ..++.++||||||+++|||+||+.||....... . ...+..
T Consensus 156 ~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (328)
T cd07856 156 RIQDPQ---MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINT 232 (328)
T ss_pred cccCCC---cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 754322 123457889999998765 568999999999999999999999986321100 0 000000
Q ss_pred ----hhhHHhhhc-c--CCccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 339 ----MLIDILYQR-L--SPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 339 ----~~~~~~~~~-~--~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
...+..... . ..+...........+.+++.+||+.+|++|||+++++.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 233 ICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred ccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000000000 0 000000001112458899999999999999999999877
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-33 Score=271.77 Aligned_cols=224 Identities=25% Similarity=0.316 Sum_probs=178.0
Q ss_pred hhcCcccceeeeecCceEEEEEEe-CCCcEEEEEecc------------------CCccccceEEEecCceEEEEEEecc
Q 042435 141 ATEYFHIRYCIGTGGYDSVYKAEL-PDGKVVALKKLH------------------HSETEDSAFVVYSPQCMFFIYEYME 201 (412)
Q Consensus 141 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l~------------------~~~~~~~~~~~~~~~~~~lv~ey~~ 201 (412)
.++.|.....+|.|+|+.|-++.. .+++..++|.+. |+++.....++.++.+.|+|||++.
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~ 399 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLD 399 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccccccccccchhhhhcCCCcceeecceecCCceeeeeehhcc
Confidence 367888889999999999988865 568888888763 5566666677888889999999999
Q ss_pred CCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEe-cCCCcEEEeecCCccccCCCCCC
Q 042435 202 RGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILL-NSNLEAFVADFGTVRLLDVDSSN 280 (412)
Q Consensus 202 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl-~~~~~~kl~DfGla~~~~~~~~~ 280 (412)
+|-+.+.+..... .. ..+..|+.+++.|+.|||++ +++||||||+|||+ ++.++++|+|||.++.....
T Consensus 400 g~ell~ri~~~~~---~~-~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~--- 469 (612)
T KOG0603|consen 400 GGELLRRIRSKPE---FC-SEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS--- 469 (612)
T ss_pred ccHHHHHHHhcch---hH-HHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEechhhhCchh---
Confidence 9887766655431 22 66778999999999999998 99999999999999 58899999999999876554
Q ss_pred cccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccchhhHHHH
Q 042435 281 RTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKIIQDI 360 (412)
Q Consensus 281 ~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 360 (412)
....+-|..|.|||++....|++++|+||||++||||++|+.||... +.. .++......++.. ....
T Consensus 470 ~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~--------P~~--~ei~~~i~~~~~s---~~vS 536 (612)
T KOG0603|consen 470 CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAH--------PAG--IEIHTRIQMPKFS---ECVS 536 (612)
T ss_pred hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccC--------Cch--HHHHHhhcCCccc---cccC
Confidence 22345678999999999999999999999999999999999998732 111 2222222222221 1222
Q ss_pred HHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 361 ILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 361 ~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
....+|+.+||+.||.+||+|+++..+
T Consensus 537 ~~AKdLl~~LL~~dP~~Rl~~~~i~~h 563 (612)
T KOG0603|consen 537 DEAKDLLQQLLQVDPALRLGADEIGAH 563 (612)
T ss_pred HHHHHHHHHhccCChhhCcChhhhccC
Confidence 347899999999999999999999865
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=258.58 Aligned_cols=237 Identities=21% Similarity=0.240 Sum_probs=172.0
Q ss_pred cccceeeeecCceEEEEEEeC-CCcEEEEEeccCCc-----------------------cccceEEEecCceEEEEEEec
Q 042435 145 FHIRYCIGTGGYDSVYKAELP-DGKVVALKKLHHSE-----------------------TEDSAFVVYSPQCMFFIYEYM 200 (412)
Q Consensus 145 f~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~~-----------------------~~~~~~~~~~~~~~~lv~ey~ 200 (412)
|+..+.||+|+||.||+|... +++.+|+|.++... +......+...+..++|+||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 556688999999999999875 59999999775432 222223355667899999999
Q ss_pred cCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCCCC
Q 042435 201 ERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSN 280 (412)
Q Consensus 201 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 280 (412)
+ ++|.+++.... ..+++..+..++.|++.||+|||+. +++||||+|+||++++++.++|+|||+++........
T Consensus 81 ~-~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~ 154 (282)
T cd07829 81 D-MDLKKYLDKRP--GPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRT 154 (282)
T ss_pred C-cCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCCCccc
Confidence 7 58998887653 2589999999999999999999998 9999999999999999999999999999876543333
Q ss_pred cccccccccccccccccCc-ccCcccccHHHHHHHHHHHhCCCCccccccccc--------CCCCcchhhHH-----hhh
Q 042435 281 RTLQAGTYGYIALELVYTM-VVTEKCVIYSFGVVALEVLMGTHPGELLLSLSS--------SSGPKIMLIDI-----LYQ 346 (412)
Q Consensus 281 ~~~~~gt~~y~aPE~~~~~-~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~--------~~~~~~~~~~~-----~~~ 346 (412)
.....++..|+|||.+.+. .++.++||||||+++||+++|+.||........ ........... ...
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (282)
T cd07829 155 YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKP 234 (282)
T ss_pred cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccc
Confidence 3334567889999998766 789999999999999999999999863211000 00000000000 000
Q ss_pred cc---CCccc-hhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 347 RL---SPPIN-QKIIQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 347 ~~---~~~~~-~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
.. ..... .........+.+++.+||..||++||++.+++.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 279 (282)
T cd07829 235 TFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH 279 (282)
T ss_pred cccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence 00 00000 0000112348899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=264.95 Aligned_cols=231 Identities=23% Similarity=0.197 Sum_probs=168.4
Q ss_pred cCcc-cceeeeecCceEEEEEEeC-CCcEEEEEeccCC-----------------------------------ccccceE
Q 042435 143 EYFH-IRYCIGTGGYDSVYKAELP-DGKVVALKKLHHS-----------------------------------ETEDSAF 185 (412)
Q Consensus 143 ~~f~-~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~-----------------------------------~~~~~~~ 185 (412)
++|. +.+.||+|+||.||+|... +++.||+|.++.. ++.....
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 3454 3567999999999999764 6899999976432 2222333
Q ss_pred EEecCceEEEEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEE
Q 042435 186 VVYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFV 265 (412)
Q Consensus 186 ~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl 265 (412)
.+...+..++||||++ |+|.+++.... .+++.....++.|++.||+|||+. +++||||||+||+++.++.++|
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~---~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~~kl 160 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDRKI---RLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICKI 160 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCCEEE
Confidence 4566778999999996 68888876533 488999999999999999999998 9999999999999999999999
Q ss_pred eecCCccccCC--------------CCCCcccccccccccccccccCc-ccCcccccHHHHHHHHHHHhCCCCccccccc
Q 042435 266 ADFGTVRLLDV--------------DSSNRTLQAGTYGYIALELVYTM-VVTEKCVIYSFGVVALEVLMGTHPGELLLSL 330 (412)
Q Consensus 266 ~DfGla~~~~~--------------~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~S~Gvil~elltg~~P~~~~~~~ 330 (412)
+|||+++.... .........++..|+|||.+.+. .++.++||||||+++|||++|+.||......
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~ 240 (335)
T PTZ00024 161 ADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEI 240 (335)
T ss_pred CCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 99999876541 11111233467889999998764 4688999999999999999999998632110
Q ss_pred ccCCCCcchhhHHhh-----------------------hccCCccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 331 SSSSGPKIMLIDILY-----------------------QRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 331 ~~~~~~~~~~~~~~~-----------------------~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
.....+.. .................+.+++.+||+.+|++|||++|++.+
T Consensus 241 -------~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~ 313 (335)
T PTZ00024 241 -------DQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKH 313 (335)
T ss_pred -------HHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence 00000000 000000000001112347899999999999999999999974
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=274.75 Aligned_cols=178 Identities=29% Similarity=0.394 Sum_probs=153.1
Q ss_pred cccceeeeecCceEEEEEEe-CCCcEEEEEe----------------------ccCCccccceEEEec------CceEEE
Q 042435 145 FHIRYCIGTGGYDSVYKAEL-PDGKVVALKK----------------------LHHSETEDSAFVVYS------PQCMFF 195 (412)
Q Consensus 145 f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~----------------------l~~~~~~~~~~~~~~------~~~~~l 195 (412)
|...+.||+|+||.||+|+. .+|+.||||. ++|+|++....+-.+ .....+
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl 94 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL 94 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence 45567899999999999985 5799999993 567787776555332 346789
Q ss_pred EEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEec--C--CCcEEEeecCCc
Q 042435 196 IYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLN--S--NLEAFVADFGTV 271 (412)
Q Consensus 196 v~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~--~--~~~~kl~DfGla 271 (412)
|||||.+|||+..|+.......|+..+.+.++.+++.||.|||++ +|+||||||.||++- + .-.-||+|||.|
T Consensus 95 vmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A 171 (732)
T KOG4250|consen 95 VMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA 171 (732)
T ss_pred EEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence 999999999999999887777899999999999999999999998 999999999999982 3 334799999999
Q ss_pred cccCCCCCCccccccccccccccccc-CcccCcccccHHHHHHHHHHHhCCCCccc
Q 042435 272 RLLDVDSSNRTLQAGTYGYIALELVY-TMVVTEKCVIYSFGVVALEVLMGTHPGEL 326 (412)
Q Consensus 272 ~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~ksDv~S~Gvil~elltg~~P~~~ 326 (412)
+.++.+. ......||..|.+||... ...|+...|.|||||++||++||..||..
T Consensus 172 rel~d~s-~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p 226 (732)
T KOG4250|consen 172 RELDDNS-LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIP 226 (732)
T ss_pred ccCCCCC-eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCc
Confidence 9876654 556678999999999998 48899999999999999999999999963
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.6e-32 Score=263.73 Aligned_cols=237 Identities=20% Similarity=0.231 Sum_probs=167.3
Q ss_pred CcccceeeeecCceEEEEEEeC-C--CcEEEEEecc------------------------CCccccceEEEe----cCce
Q 042435 144 YFHIRYCIGTGGYDSVYKAELP-D--GKVVALKKLH------------------------HSETEDSAFVVY----SPQC 192 (412)
Q Consensus 144 ~f~~~~~lG~G~~g~Vy~~~~~-~--~~~vAvK~l~------------------------~~~~~~~~~~~~----~~~~ 192 (412)
+|++.+.||+|+||.||++... + +..||+|++. |+++........ ....
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4788899999999999999874 3 7899999764 333333222211 1245
Q ss_pred EEEEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCcc
Q 042435 193 MFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVR 272 (412)
Q Consensus 193 ~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~ 272 (412)
.++++||+. ++|.+++.... .+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~a~ 153 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSGQ---PLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLAR 153 (332)
T ss_pred EEEEEeccc-CCHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence 788899985 68888876543 589999999999999999999998 99999999999999999999999999998
Q ss_pred ccCCCCC----CcccccccccccccccccC-cccCcccccHHHHHHHHHHHhCCCCccccccccc--------CCCCcch
Q 042435 273 LLDVDSS----NRTLQAGTYGYIALELVYT-MVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSS--------SSGPKIM 339 (412)
Q Consensus 273 ~~~~~~~----~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~--------~~~~~~~ 339 (412)
....... ......|+..|+|||...+ ..++.++|||||||++|++++|+.||........ .......
T Consensus 154 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 233 (332)
T cd07857 154 GFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEET 233 (332)
T ss_pred ecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 6543221 1123468899999998765 4688999999999999999999999863211000 0000000
Q ss_pred hhHHhhh-----------ccCCccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 340 LIDILYQ-----------RLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 340 ~~~~~~~-----------~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
...+..+ ................+.+++.+|++.||++|||+.|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~ 292 (332)
T cd07857 234 LSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH 292 (332)
T ss_pred HHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 0000000 00000000000112348899999999999999999999755
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.4e-32 Score=250.60 Aligned_cols=218 Identities=24% Similarity=0.341 Sum_probs=169.2
Q ss_pred eeecCceEEEEEEeC-CCcEEEEEeccCC------------------------ccccceEEEecCceEEEEEEeccCCce
Q 042435 151 IGTGGYDSVYKAELP-DGKVVALKKLHHS------------------------ETEDSAFVVYSPQCMFFIYEYMERGSL 205 (412)
Q Consensus 151 lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~------------------------~~~~~~~~~~~~~~~~lv~ey~~~gsL 205 (412)
||+|+||.||++... +++.+|+|.++.. ++......+..++..++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 689999999999875 5899999976432 222233346677889999999999999
Q ss_pred eeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCCCCccccc
Q 042435 206 FCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQA 285 (412)
Q Consensus 206 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 285 (412)
.+++.... .+++.....++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++..............
T Consensus 81 ~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~ 154 (250)
T cd05123 81 FSHLSKEG---RFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFC 154 (250)
T ss_pred HHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCc
Confidence 99887553 489999999999999999999998 999999999999999999999999999886644332334456
Q ss_pred ccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccchhhHHHHHHHHH
Q 042435 286 GTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKIIQDIILVST 365 (412)
Q Consensus 286 gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 365 (412)
++..|+|||...+...+.++|+||||+++||+++|+.||... ............... .+... ...+.+
T Consensus 155 ~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~-------~~~~~~~~~~~~~~~--~~~~~---~~~l~~ 222 (250)
T cd05123 155 GTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAE-------DRKEIYEKILKDPLR--FPEFL---SPEARD 222 (250)
T ss_pred CCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCC-------CHHHHHHHHhcCCCC--CCCCC---CHHHHH
Confidence 888999999998888899999999999999999999998632 111111222221111 11111 233788
Q ss_pred HHHhcCcCCCCCCCCH---HHHHH
Q 042435 366 IALACLRSKPKSRPTM---QRISQ 386 (412)
Q Consensus 366 l~~~Cl~~dP~~RPs~---~evl~ 386 (412)
++.+||..||++||++ +++.+
T Consensus 223 ~i~~~l~~~p~~R~~~~~~~~l~~ 246 (250)
T cd05123 223 LISGLLQKDPTKRLGSGGAEEIKA 246 (250)
T ss_pred HHHHHhcCCHhhCCCcccHHHHHh
Confidence 9999999999999999 55543
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.1e-32 Score=284.28 Aligned_cols=125 Identities=25% Similarity=0.402 Sum_probs=109.7
Q ss_pred hcCcccceeeeecCceEEEEEEeC-CCcEEEEEecc------------------------CCccccceEEEecCceEEEE
Q 042435 142 TEYFHIRYCIGTGGYDSVYKAELP-DGKVVALKKLH------------------------HSETEDSAFVVYSPQCMFFI 196 (412)
Q Consensus 142 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~------------------------~~~~~~~~~~~~~~~~~~lv 196 (412)
.++|.+.+.||+|+||.||+|... +++.||||.++ |+++......+...+..++|
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 367899999999999999999875 68999999763 45555556667778899999
Q ss_pred EEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCcc
Q 042435 197 YEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVR 272 (412)
Q Consensus 197 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~ 272 (412)
|||+++++|.+++.... .+++...+.++.||+.||+|||.+ +|+||||||+|||++.++.+||+|||+++
T Consensus 83 mEy~~g~~L~~li~~~~---~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 83 MEYLIGGDVKSLLHIYG---YFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EeCCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 99999999999886543 478889999999999999999998 99999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.1e-32 Score=274.89 Aligned_cols=242 Identities=24% Similarity=0.372 Sum_probs=197.7
Q ss_pred ccHHHHHHhhcCcccceeeeecCceEEEEEEe-CCCcEEEEEec---------------------cCCccccceEEEe--
Q 042435 133 ILYENLIDATEYFHIRYCIGTGGYDSVYKAEL-PDGKVVALKKL---------------------HHSETEDSAFVVY-- 188 (412)
Q Consensus 133 ~~~~~l~~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l---------------------~~~~~~~~~~~~~-- 188 (412)
+.++.+.+.++-|++.+.||.|.+|.||+++. ++++.+|+|.+ +|+|.....+++.
T Consensus 9 ~~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~ 88 (953)
T KOG0587|consen 9 IDLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKK 88 (953)
T ss_pred cchhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEe
Confidence 44667778889999999999999999999965 57888999865 4666666665543
Q ss_pred ---cCceEEEEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEE
Q 042435 189 ---SPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFV 265 (412)
Q Consensus 189 ---~~~~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl 265 (412)
.++.+|||||||.+||..+++++.. +..+.|..+..|++.++.||.+||.+ .++|||+|-.|||++.++.+|+
T Consensus 89 ~~~~~DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~VKL 164 (953)
T KOG0587|consen 89 DPGNGDQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEVKL 164 (953)
T ss_pred cCCCCCeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcEEE
Confidence 3678999999999999999988765 45699999999999999999999998 9999999999999999999999
Q ss_pred eecCCccccCCCCCCcccccccccccccccccC-----cccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchh
Q 042435 266 ADFGTVRLLDVDSSNRTLQAGTYGYIALELVYT-----MVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIML 340 (412)
Q Consensus 266 ~DfGla~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~ 340 (412)
+|||++..++.....+.+..||+.|||||++.. ..|+..+|+||+|++..||--|.+|+.++... .
T Consensus 165 vDFGvSaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPm-------r-- 235 (953)
T KOG0587|consen 165 VDFGVSAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPM-------R-- 235 (953)
T ss_pred eeeeeeeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchh-------h--
Confidence 999999988877777778899999999999864 34777999999999999999999997643211 1
Q ss_pred hHHhhhccCCccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 341 IDILYQRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 341 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
.-+..++-+++..........++.+++..|+.+|-++||++.+++++
T Consensus 236 aLF~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 236 ALFLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred hhccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 11112222333333344556679999999999999999999998765
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.9e-32 Score=264.56 Aligned_cols=237 Identities=21% Similarity=0.231 Sum_probs=170.0
Q ss_pred HhhcCcccceeeeecCceEEEEEEeC-CCcEEEEEeccCCc-----------------------cccceEEEecC-----
Q 042435 140 DATEYFHIRYCIGTGGYDSVYKAELP-DGKVVALKKLHHSE-----------------------TEDSAFVVYSP----- 190 (412)
Q Consensus 140 ~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~~-----------------------~~~~~~~~~~~----- 190 (412)
+..++|++.+.||+|+||.||+|... +++.||+|++.... +......+...
T Consensus 12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07851 12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED 91 (343)
T ss_pred cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence 45678999999999999999999874 58899999875431 11111112222
Q ss_pred -ceEEEEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecC
Q 042435 191 -QCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFG 269 (412)
Q Consensus 191 -~~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG 269 (412)
...++|+||+ +++|.+++... .+++..+..++.|+++||+|||+. +++||||||+||++++++.++|+|||
T Consensus 92 ~~~~~lv~e~~-~~~L~~~~~~~----~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~dfg 163 (343)
T cd07851 92 FQDVYLVTHLM-GADLNNIVKCQ----KLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFG 163 (343)
T ss_pred cccEEEEEecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEcccc
Confidence 2489999999 56898887653 489999999999999999999998 99999999999999999999999999
Q ss_pred CccccCCCCCCcccccccccccccccccC-cccCcccccHHHHHHHHHHHhCCCCcccccccc------c--CCCCcc--
Q 042435 270 TVRLLDVDSSNRTLQAGTYGYIALELVYT-MVVTEKCVIYSFGVVALEVLMGTHPGELLLSLS------S--SSGPKI-- 338 (412)
Q Consensus 270 la~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~------~--~~~~~~-- 338 (412)
++...... .....++..|+|||.+.+ ..++.++||||||+++||+++|+.||....... . ......
T Consensus 164 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 240 (343)
T cd07851 164 LARHTDDE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELL 240 (343)
T ss_pred cccccccc---ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHH
Confidence 99865432 223457889999998765 467889999999999999999999986321100 0 000000
Q ss_pred ------hhhHHhhhccCC---ccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 339 ------MLIDILYQRLSP---PINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 339 ------~~~~~~~~~~~~---~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
............ ............+.+++.+||+.||++|||+.|++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 241 QKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred hhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 000000000000 0000000113458899999999999999999999875
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.1e-32 Score=262.88 Aligned_cols=238 Identities=23% Similarity=0.279 Sum_probs=170.7
Q ss_pred HHhhcCcccceeeeecCceEEEEEEe-CCCcEEEEEecc-----------------------CCccccceEEEecC----
Q 042435 139 IDATEYFHIRYCIGTGGYDSVYKAEL-PDGKVVALKKLH-----------------------HSETEDSAFVVYSP---- 190 (412)
Q Consensus 139 ~~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l~-----------------------~~~~~~~~~~~~~~---- 190 (412)
-...++|++.+.||+|+||.||+|.. .+++.||||++. |+++.....++...
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07880 11 WEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLD 90 (343)
T ss_pred hccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccc
Confidence 34567899999999999999999975 579999999763 33433333333322
Q ss_pred --ceEEEEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeec
Q 042435 191 --QCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADF 268 (412)
Q Consensus 191 --~~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Df 268 (412)
...++||||+ +++|.+++... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++++||
T Consensus 91 ~~~~~~lv~e~~-~~~l~~~~~~~----~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~df 162 (343)
T cd07880 91 RFHDFYLVMPFM-GTDLGKLMKHE----KLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDF 162 (343)
T ss_pred ccceEEEEEecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeec
Confidence 2468999999 67888777543 489999999999999999999998 9999999999999999999999999
Q ss_pred CCccccCCCCCCcccccccccccccccccC-cccCcccccHHHHHHHHHHHhCCCCccccccccc-------CCCCcchh
Q 042435 269 GTVRLLDVDSSNRTLQAGTYGYIALELVYT-MVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSS-------SSGPKIML 340 (412)
Q Consensus 269 Gla~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~-------~~~~~~~~ 340 (412)
|++...... .....++..|+|||.+.+ ..++.++|+||||+++|++++|+.||........ .......+
T Consensus 163 g~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 239 (343)
T cd07880 163 GLARQTDSE---MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEF 239 (343)
T ss_pred ccccccccC---ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence 999865332 223457889999998875 4588899999999999999999999863211000 00000000
Q ss_pred hHHhh--------hccCCccchh----hHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 341 IDILY--------QRLSPPINQK----IIQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 341 ~~~~~--------~~~~~~~~~~----~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
...+. ..+....... .......+.+++.+|++.||++|||+.+++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~ 298 (343)
T cd07880 240 VQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAH 298 (343)
T ss_pred HHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000 0000000000 00112247799999999999999999999843
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.2e-32 Score=250.38 Aligned_cols=203 Identities=21% Similarity=0.165 Sum_probs=158.2
Q ss_pred cCceEEEEEEe-CCCcEEEEEeccC----------------CccccceEEEecCceEEEEEEeccCCceeeeeccCcccc
Q 042435 154 GGYDSVYKAEL-PDGKVVALKKLHH----------------SETEDSAFVVYSPQCMFFIYEYMERGSLFCVLRDDDEAI 216 (412)
Q Consensus 154 G~~g~Vy~~~~-~~~~~vAvK~l~~----------------~~~~~~~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~~ 216 (412)
|.+|.||++.. .+++.+|+|+++. +++......+...+..++||||+++|+|.+++....
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--- 80 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSSEYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFL--- 80 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchhhhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHHhc---
Confidence 89999999976 5789999998753 333444444667788999999999999998886543
Q ss_pred cCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCCCCcccccccccccccccc
Q 042435 217 ELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTYGYIALELV 296 (412)
Q Consensus 217 ~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~gt~~y~aPE~~ 296 (412)
.+++.....++.|++.||+|||+. +++||||||+||+++.++.++++|||.+....... ....++..|+|||..
T Consensus 81 ~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~---~~~~~~~~y~aPE~~ 154 (237)
T cd05576 81 NIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC---DGEAVENMYCAPEVG 154 (237)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhcccccc---ccCCcCccccCCccc
Confidence 489999999999999999999998 99999999999999999999999999876543321 223456789999999
Q ss_pred cCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccchhhHHHHHHHHHHHHhcCcCCCC
Q 042435 297 YTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKIIQDIILVSTIALACLRSKPK 376 (412)
Q Consensus 297 ~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~ 376 (412)
.+..++.++||||+|+++|||++|+.|+...... ........++ .. ....+.+++.+|++.||+
T Consensus 155 ~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~---------~~~~~~~~~~----~~---~~~~~~~li~~~l~~dp~ 218 (237)
T cd05576 155 GISEETEACDWWSLGAILFELLTGKTLVECHPSG---------INTHTTLNIP----EW---VSEEARSLLQQLLQFNPT 218 (237)
T ss_pred CCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh---------cccccccCCc----cc---CCHHHHHHHHHHccCCHH
Confidence 8888899999999999999999999886521100 0000000011 11 122377899999999999
Q ss_pred CCCCH
Q 042435 377 SRPTM 381 (412)
Q Consensus 377 ~RPs~ 381 (412)
+||++
T Consensus 219 ~R~~~ 223 (237)
T cd05576 219 ERLGA 223 (237)
T ss_pred HhcCC
Confidence 99997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-32 Score=263.04 Aligned_cols=238 Identities=21% Similarity=0.209 Sum_probs=165.9
Q ss_pred hcCcccceeeeecCceEEEEEEe-CCCcEEEEEecc---------------------CCccccceEEEe-----------
Q 042435 142 TEYFHIRYCIGTGGYDSVYKAEL-PDGKVVALKKLH---------------------HSETEDSAFVVY----------- 188 (412)
Q Consensus 142 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l~---------------------~~~~~~~~~~~~----------- 188 (412)
..+|.+.+.||.|+||.||+|.. .+|+.||+|.+. |+++......+.
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 36789999999999999999976 468999999763 333332222111
Q ss_pred ---cCceEEEEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEec-CCCcEE
Q 042435 189 ---SPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLN-SNLEAF 264 (412)
Q Consensus 189 ---~~~~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~-~~~~~k 264 (412)
.....++||||++ ++|.+++... .+++.....++.|++.||.|||+. +++||||||+||+++ ++..++
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~~~k 155 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLEQG----PLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLVLK 155 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCceEE
Confidence 1235789999997 5887777543 488999999999999999999998 999999999999997 456789
Q ss_pred EeecCCccccCCCCCC---cccccccccccccccccC-cccCcccccHHHHHHHHHHHhCCCCccccccccc-------C
Q 042435 265 VADFGTVRLLDVDSSN---RTLQAGTYGYIALELVYT-MVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSS-------S 333 (412)
Q Consensus 265 l~DfGla~~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~-------~ 333 (412)
++|||+++........ .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||........ .
T Consensus 156 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~ 235 (342)
T cd07854 156 IGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESV 235 (342)
T ss_pred ECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence 9999999765432111 122357889999998654 5678899999999999999999999963211000 0
Q ss_pred CCC-c---chh----hHHhhhccCCc---cchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 334 SGP-K---IML----IDILYQRLSPP---INQKIIQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 334 ~~~-~---~~~----~~~~~~~~~~~---~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
... . ... ........... ...........+.+++.+||+.||++|||++|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h 300 (342)
T cd07854 236 PVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH 300 (342)
T ss_pred CCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence 000 0 000 00000000000 000000112347789999999999999999999864
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-32 Score=264.62 Aligned_cols=230 Identities=24% Similarity=0.327 Sum_probs=186.4
Q ss_pred HhhcCcccceeeeecCceEEEEEEe-CCCcEEEEEe-----------------------ccCCccccceEEEecCceEEE
Q 042435 140 DATEYFHIRYCIGTGGYDSVYKAEL-PDGKVVALKK-----------------------LHHSETEDSAFVVYSPQCMFF 195 (412)
Q Consensus 140 ~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~-----------------------l~~~~~~~~~~~~~~~~~~~l 195 (412)
.-...|.+...||+|.|+.|..|.. .++..||||. +.|+++++...+......+|+
T Consensus 53 ~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lyl 132 (596)
T KOG0586|consen 53 NSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYL 132 (596)
T ss_pred ccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEE
Confidence 3456789999999999999999976 4689999994 468999999999999999999
Q ss_pred EEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccC
Q 042435 196 IYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLD 275 (412)
Q Consensus 196 v~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~ 275 (412)
||||+.+|.+++++..+.. ........++.|+.+|++|||++ .|+|||||.+|||++.++++||+|||++..+.
T Consensus 133 V~eya~~ge~~~yl~~~gr---~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~ 206 (596)
T KOG0586|consen 133 VMEYASGGELFDYLVKHGR---MKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFSTFFD 206 (596)
T ss_pred EEEeccCchhHHHHHhccc---chhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccccceeec
Confidence 9999999999999987763 44477788999999999999999 99999999999999999999999999999877
Q ss_pred CCCCCcccccccccccccccccCcccC-cccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccch
Q 042435 276 VDSSNRTLQAGTYGYIALELVYTMVVT-EKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQ 354 (412)
Q Consensus 276 ~~~~~~~~~~gt~~y~aPE~~~~~~~s-~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 354 (412)
... .....+|++.|.|||++.+..|. +++|+||+|+++|-|+.|..||+...-. ..-..++.....-+..
T Consensus 207 ~~~-~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk-------~Lr~rvl~gk~rIp~~- 277 (596)
T KOG0586|consen 207 YGL-MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLK-------ELRPRVLRGKYRIPFY- 277 (596)
T ss_pred ccc-cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccc-------cccchheeeeecccce-
Confidence 433 33456899999999999988765 6899999999999999999999832100 0001122222222211
Q ss_pred hhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHH
Q 042435 355 KIIQDIILVSTIALACLRSKPKSRPTMQRISQEL 388 (412)
Q Consensus 355 ~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L 388 (412)
.. ....+++.+++-.+|.+|++++++.++-
T Consensus 278 -ms---~dce~lLrk~lvl~Pskr~~~dqim~~~ 307 (596)
T KOG0586|consen 278 -MS---CDCEDLLRKFLVLNPSKRGPCDQIMKDR 307 (596)
T ss_pred -ee---chhHHHHHHhhccCccccCCHHHhhhhc
Confidence 11 1256788899999999999999998763
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-32 Score=250.48 Aligned_cols=243 Identities=18% Similarity=0.238 Sum_probs=187.7
Q ss_pred HHHHHHhhcCcccceeeeecCceEEEEEEeCC------CcEEEEEe----------------------ccCCccccceEE
Q 042435 135 YENLIDATEYFHIRYCIGTGGYDSVYKAELPD------GKVVALKK----------------------LHHSETEDSAFV 186 (412)
Q Consensus 135 ~~~l~~~~~~f~~~~~lG~G~~g~Vy~~~~~~------~~~vAvK~----------------------l~~~~~~~~~~~ 186 (412)
.+++.-...+++...++-+|.||.||+|.|.+ .+.|-+|. +.|+|......+
T Consensus 276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V 355 (563)
T KOG1024|consen 276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGV 355 (563)
T ss_pred HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence 35555556678888899999999999996643 33455553 357787777776
Q ss_pred Ee-cCceEEEEEEeccCCceeeeec-----cCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCC
Q 042435 187 VY-SPQCMFFIYEYMERGSLFCVLR-----DDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSN 260 (412)
Q Consensus 187 ~~-~~~~~~lv~ey~~~gsL~~~l~-----~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~ 260 (412)
+. +.+..+.+|.++.-|+|..+|. +......++-.+...++.|++.|++|||.+ +++|.||..+|+++|+.
T Consensus 356 ~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvIdd~ 432 (563)
T KOG1024|consen 356 SIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVIDDQ 432 (563)
T ss_pred EeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---Ccccchhhhhcceehhh
Confidence 54 4567889999999999999998 333445678888899999999999999999 99999999999999999
Q ss_pred CcEEEeecCCccccCCCCCCc--ccccccccccccccccCcccCcccccHHHHHHHHHHHh-CCCCcccccccccCCCCc
Q 042435 261 LEAFVADFGTVRLLDVDSSNR--TLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLM-GTHPGELLLSLSSSSGPK 337 (412)
Q Consensus 261 ~~~kl~DfGla~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~ellt-g~~P~~~~~~~~~~~~~~ 337 (412)
.++||+|=.+++.+-+.+.+. ...-.+..||+||.+....|+.++|||||||+||||+| |+.|+... ++.
T Consensus 433 LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeI-------DPf 505 (563)
T KOG1024|consen 433 LQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEI-------DPF 505 (563)
T ss_pred eeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCcccc-------CHH
Confidence 999999999998765544332 22234678999999999999999999999999999998 99998633 222
Q ss_pred chhhHHhhhccCCccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhcC
Q 042435 338 IMLIDILYQRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELEGK 391 (412)
Q Consensus 338 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 391 (412)
.+...+....+-..+-.+++ +++.++..||+.+|++||+++|++.-|.+-
T Consensus 506 -Em~~ylkdGyRlaQP~NCPD---eLf~vMacCWallpeeRPsf~Qlv~cLseF 555 (563)
T KOG1024|consen 506 -EMEHYLKDGYRLAQPFNCPD---ELFTVMACCWALLPEERPSFSQLVICLSEF 555 (563)
T ss_pred -HHHHHHhccceecCCCCCcH---HHHHHHHHHHhcCcccCCCHHHHHHHHHHH
Confidence 22333333222221223333 488999999999999999999999988753
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-32 Score=247.49 Aligned_cols=182 Identities=24% Similarity=0.316 Sum_probs=147.6
Q ss_pred HhhcCcccceeeeecCceEEEEEEeCC-----CcEEEEEec-----------------------cCCccccceEEEec-C
Q 042435 140 DATEYFHIRYCIGTGGYDSVYKAELPD-----GKVVALKKL-----------------------HHSETEDSAFVVYS-P 190 (412)
Q Consensus 140 ~~~~~f~~~~~lG~G~~g~Vy~~~~~~-----~~~vAvK~l-----------------------~~~~~~~~~~~~~~-~ 190 (412)
+....|+....||+|.||.||||.-.+ .+.+|+|++ +|+|+.....++.+ +
T Consensus 21 e~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d 100 (438)
T KOG0666|consen 21 EDLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHD 100 (438)
T ss_pred HHHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccC
Confidence 445678889999999999999995432 347899975 45555555555444 7
Q ss_pred ceEEEEEEeccCCceeeeeccCc--ccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCC----CcEE
Q 042435 191 QCMFFIYEYMERGSLFCVLRDDD--EAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSN----LEAF 264 (412)
Q Consensus 191 ~~~~lv~ey~~~gsL~~~l~~~~--~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~----~~~k 264 (412)
..+++++||.+. +|..+++-++ ....++-.....|+.||+.|+.|||++ =|+||||||.|||+..+ |.+|
T Consensus 101 ~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~VK 176 (438)
T KOG0666|consen 101 KKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRVK 176 (438)
T ss_pred ceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCeeE
Confidence 789999999976 9998887553 234688888999999999999999998 79999999999999877 9999
Q ss_pred EeecCCccccCCCCCC---cccccccccccccccccCc-ccCcccccHHHHHHHHHHHhCCCCcc
Q 042435 265 VADFGTVRLLDVDSSN---RTLQAGTYGYIALELVYTM-VVTEKCVIYSFGVVALEVLMGTHPGE 325 (412)
Q Consensus 265 l~DfGla~~~~~~~~~---~~~~~gt~~y~aPE~~~~~-~~s~ksDv~S~Gvil~elltg~~P~~ 325 (412)
|+|+|+++.+...-.. ....+-|++|+|||.+.+. .||.+.||||.|||+.||+|-++-|.
T Consensus 177 IaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~ 241 (438)
T KOG0666|consen 177 IADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFK 241 (438)
T ss_pred eecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCcccc
Confidence 9999999987654322 2345679999999999875 58999999999999999999766553
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-31 Score=265.81 Aligned_cols=241 Identities=14% Similarity=0.159 Sum_probs=163.1
Q ss_pred hhcCcccceeeeecCceEEEEEEe-----------------CCCcEEEEEeccCCccc----------------------
Q 042435 141 ATEYFHIRYCIGTGGYDSVYKAEL-----------------PDGKVVALKKLHHSETE---------------------- 181 (412)
Q Consensus 141 ~~~~f~~~~~lG~G~~g~Vy~~~~-----------------~~~~~vAvK~l~~~~~~---------------------- 181 (412)
..++|++.++||+|+||.||+|.+ ..++.||||+++.....
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 467899999999999999999964 23568999997532110
Q ss_pred ------------------cceEEE--------ecCceEEEEEEeccCCceeeeeccCcc---------------------
Q 042435 182 ------------------DSAFVV--------YSPQCMFFIYEYMERGSLFCVLRDDDE--------------------- 214 (412)
Q Consensus 182 ------------------~~~~~~--------~~~~~~~lv~ey~~~gsL~~~l~~~~~--------------------- 214 (412)
.....+ ...+..+|||||+++|+|.++++....
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 000001 123568999999999999988864210
Q ss_pred cccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCCCC-ccccccccccccc
Q 042435 215 AIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSN-RTLQAGTYGYIAL 293 (412)
Q Consensus 215 ~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~-~~~~~gt~~y~aP 293 (412)
...++|..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++........ .....+++.|+||
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aP 379 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPP 379 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeCh
Confidence 12357888999999999999999998 9999999999999999999999999999765432211 1222347899999
Q ss_pred ccccCcc--------------------c--CcccccHHHHHHHHHHHhCCC-CcccccccccCCCC-cchhhH---Hhhh
Q 042435 294 ELVYTMV--------------------V--TEKCVIYSFGVVALEVLMGTH-PGELLLSLSSSSGP-KIMLID---ILYQ 346 (412)
Q Consensus 294 E~~~~~~--------------------~--s~ksDv~S~Gvil~elltg~~-P~~~~~~~~~~~~~-~~~~~~---~~~~ 346 (412)
|.+.... + ..+.||||+||++|||++|.. |+............ ...... ....
T Consensus 380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~ 459 (507)
T PLN03224 380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQ 459 (507)
T ss_pred hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhccc
Confidence 9875322 1 124799999999999999885 66432111100000 000000 0001
Q ss_pred ccCCccchhhHHHHHHHHHHHHhcCcCCC---CCCCCHHHHHHH
Q 042435 347 RLSPPINQKIIQDIILVSTIALACLRSKP---KSRPTMQRISQE 387 (412)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP---~~RPs~~evl~~ 387 (412)
....+ ..........+++.+++..+| .+|+|++|+++|
T Consensus 460 ~~~~~---~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 460 KYDFS---LLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred CCCcc---cccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 11111 111122347789999998766 689999999876
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-32 Score=254.36 Aligned_cols=238 Identities=19% Similarity=0.255 Sum_probs=174.1
Q ss_pred hcCcccceeeeecCceEEEEEEe-CCCcEEEEEeccCCcc--------------------cc------ceEEEecCceEE
Q 042435 142 TEYFHIRYCIGTGGYDSVYKAEL-PDGKVVALKKLHHSET--------------------ED------SAFVVYSPQCMF 194 (412)
Q Consensus 142 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l~~~~~--------------------~~------~~~~~~~~~~~~ 194 (412)
++.|.+...+|+|.||.|-.+.. ..+..||||.++.-.. .. ....+...++.+
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghiC 167 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHIC 167 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCceE
Confidence 78899999999999999999954 4589999997642110 00 011134567889
Q ss_pred EEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecC---------------
Q 042435 195 FIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNS--------------- 259 (412)
Q Consensus 195 lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~--------------- 259 (412)
+|+|.+ |-|+++++.++.. .+++..++..++.|++++++|||+. +++|-||||+|||+.+
T Consensus 168 ivfell-G~S~~dFlk~N~y-~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~~~~~~k~~~~~ 242 (415)
T KOG0671|consen 168 IVFELL-GLSTFDFLKENNY-IPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYFKTYNPKKKVCF 242 (415)
T ss_pred EEEecc-ChhHHHHhccCCc-cccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceEEEeccCCccce
Confidence 999998 5699999987653 3588899999999999999999999 9999999999999932
Q ss_pred -----CCcEEEeecCCccccCCCCCCcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccc---
Q 042435 260 -----NLEAFVADFGTVRLLDVDSSNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLS--- 331 (412)
Q Consensus 260 -----~~~~kl~DfGla~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~--- 331 (412)
+..++++|||.|+.-... .+..+.|..|.|||++.+-.++.++||||+||||.|+.||..-|+......
T Consensus 243 ~r~~ks~~I~vIDFGsAtf~~e~---hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHLa 319 (415)
T KOG0671|consen 243 IRPLKSTAIKVIDFGSATFDHEH---HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEHLA 319 (415)
T ss_pred eccCCCcceEEEecCCcceeccC---cceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHHHH
Confidence 235899999999864332 356688999999999999999999999999999999999998886322100
Q ss_pred -----cCCCCcchhhHH-----hh-hcc-----------------CCccc---hhhHHHHHHHHHHHHhcCcCCCCCCCC
Q 042435 332 -----SSSGPKIMLIDI-----LY-QRL-----------------SPPIN---QKIIQDIILVSTIALACLRSKPKSRPT 380 (412)
Q Consensus 332 -----~~~~~~~~~~~~-----~~-~~~-----------------~~~~~---~~~~~~~~~~~~l~~~Cl~~dP~~RPs 380 (412)
....+...+... .. ..+ ..+.. .....+...+++|+.+++..||.+|+|
T Consensus 320 MMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiT 399 (415)
T KOG0671|consen 320 MMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRIT 399 (415)
T ss_pred HHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCcccccc
Confidence 000000000000 00 000 00000 011233456999999999999999999
Q ss_pred HHHHHHH
Q 042435 381 MQRISQE 387 (412)
Q Consensus 381 ~~evl~~ 387 (412)
+.|++.+
T Consensus 400 l~EAL~H 406 (415)
T KOG0671|consen 400 LREALSH 406 (415)
T ss_pred HHHHhcC
Confidence 9999865
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-31 Score=241.29 Aligned_cols=226 Identities=21% Similarity=0.319 Sum_probs=176.2
Q ss_pred cCcccceeeeecCceEEEEEEe-CCCcEEEEEeccCCccccc-------------------------eEEEecCceEEEE
Q 042435 143 EYFHIRYCIGTGGYDSVYKAEL-PDGKVVALKKLHHSETEDS-------------------------AFVVYSPQCMFFI 196 (412)
Q Consensus 143 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l~~~~~~~~-------------------------~~~~~~~~~~~lv 196 (412)
++|++..+||+|+|++|..+++ ++.+.+|+|.++..-.... ...+.+...+++|
T Consensus 250 ~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffv 329 (593)
T KOG0695|consen 250 QDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFV 329 (593)
T ss_pred ccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEE
Confidence 5799999999999999999987 4688999998765322221 1124567788999
Q ss_pred EEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCC
Q 042435 197 YEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDV 276 (412)
Q Consensus 197 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~ 276 (412)
.||.++|+|--+++.++ .++.....-+...|.-||.|||+. ||+.||||..|+|+|..+.+|++|+|+.+.--.
T Consensus 330 ieyv~ggdlmfhmqrqr---klpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdygmcke~l~ 403 (593)
T KOG0695|consen 330 IEYVNGGDLMFHMQRQR---KLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLG 403 (593)
T ss_pred EEEecCcceeeehhhhh---cCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccchhhcCCC
Confidence 99999999987777655 588888888999999999999999 999999999999999999999999999986544
Q ss_pred CCCCcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCC-CcchhhHHhhhccCCccchh
Q 042435 277 DSSNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSG-PKIMLIDILYQRLSPPINQK 355 (412)
Q Consensus 277 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 355 (412)
.....++.+||+.|+|||++.+..|....|.|++||+++||+.|+.||+..-....... +...+.-++.+.++-|.
T Consensus 404 ~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiripr--- 480 (593)
T KOG0695|consen 404 PGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRIPR--- 480 (593)
T ss_pred CCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcccccc---
Confidence 55556778999999999999999999999999999999999999999985432111111 11112222233333221
Q ss_pred hHHHHHHHHHHHHhcCcCCCCCCC
Q 042435 356 IIQDIILVSTIALACLRSKPKSRP 379 (412)
Q Consensus 356 ~~~~~~~~~~l~~~Cl~~dP~~RP 379 (412)
....+...++..-+.+||.+|.
T Consensus 481 --slsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 481 --SLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred --eeehhhHHHHHHhhcCCcHHhc
Confidence 1223456677888999999985
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.3e-34 Score=249.95 Aligned_cols=229 Identities=22% Similarity=0.285 Sum_probs=167.9
Q ss_pred eeeeecCceEEEEEEe-CCCcEEEEEeccCCcc-----------------------ccceEEEecCceEEEEEEeccCCc
Q 042435 149 YCIGTGGYDSVYKAEL-PDGKVVALKKLHHSET-----------------------EDSAFVVYSPQCMFFIYEYMERGS 204 (412)
Q Consensus 149 ~~lG~G~~g~Vy~~~~-~~~~~vAvK~l~~~~~-----------------------~~~~~~~~~~~~~~lv~ey~~~gs 204 (412)
..||.|+||+|+|-.+ +.|+..|||+++..+. ++..+.++.++..|+.||.|. -|
T Consensus 70 g~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd-~S 148 (361)
T KOG1006|consen 70 GEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMD-IS 148 (361)
T ss_pred HHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHh-hh
Confidence 5699999999999966 5799999999865544 333444677888999999995 46
Q ss_pred eeeeeccCc--ccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCCCCcc
Q 042435 205 LFCVLRDDD--EAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRT 282 (412)
Q Consensus 205 L~~~l~~~~--~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 282 (412)
|..+...-. ....++....-.|..-.+.||.||-+.. .|+|||+||+|||+|..|.+||||||++..+..+ ...+
T Consensus 149 lDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~S-iAkT 225 (361)
T KOG1006|consen 149 LDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDS-IAKT 225 (361)
T ss_pred HHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHHH-HHhh
Confidence 655443211 1224677767777778899999998764 8999999999999999999999999998766432 2334
Q ss_pred cccccccccccccccC--cccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCc-cchhhHHH
Q 042435 283 LQAGTYGYIALELVYT--MVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPP-INQKIIQD 359 (412)
Q Consensus 283 ~~~gt~~y~aPE~~~~--~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 359 (412)
...|...|||||.+.. ..|+.+|||||+|++|||+.||+.|+....++ -..+..++....+.- ........
T Consensus 226 ~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~sv------feql~~Vv~gdpp~l~~~~~~~~~ 299 (361)
T KOG1006|consen 226 VDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSV------FEQLCQVVIGDPPILLFDKECVHY 299 (361)
T ss_pred hccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHH------HHHHHHHHcCCCCeecCccccccc
Confidence 5578899999999863 34899999999999999999999998743221 111222222211110 01222234
Q ss_pred HHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 360 IILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 360 ~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
...+..++..|+.+|-++||+..++.++
T Consensus 300 s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 300 SFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred CHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 4568889999999999999999988654
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.6e-32 Score=253.30 Aligned_cols=233 Identities=26% Similarity=0.367 Sum_probs=175.6
Q ss_pred CcccceeeeecCceEEEEE-EeCCCcEEEEEe----------------------------ccCCccccceEE-EecCceE
Q 042435 144 YFHIRYCIGTGGYDSVYKA-ELPDGKVVALKK----------------------------LHHSETEDSAFV-VYSPQCM 193 (412)
Q Consensus 144 ~f~~~~~lG~G~~g~Vy~~-~~~~~~~vAvK~----------------------------l~~~~~~~~~~~-~~~~~~~ 193 (412)
+|-..++||+|||+.|||| ++...+-||||. ++|+.++..+.. ..+.+.+
T Consensus 464 RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsF 543 (775)
T KOG1151|consen 464 RYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSF 543 (775)
T ss_pred HHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccc
Confidence 4666789999999999999 456678899984 356666665544 3467788
Q ss_pred EEEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEec---CCCcEEEeecCC
Q 042435 194 FFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLN---SNLEAFVADFGT 270 (412)
Q Consensus 194 ~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~---~~~~~kl~DfGl 270 (412)
|-|+|||+|.+|.-+|+.+. .++......|+.||+.||.||.+. .++|+|-||||.|||+- ..+.+||+|||+
T Consensus 544 CTVLEYceGNDLDFYLKQhk---lmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDFGL 619 (775)
T KOG1151|consen 544 CTVLEYCEGNDLDFYLKQHK---LMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDFGL 619 (775)
T ss_pred eeeeeecCCCchhHHHHhhh---hhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeecch
Confidence 99999999999999998776 578899999999999999999987 78999999999999994 458899999999
Q ss_pred ccccCCCCCC-------cccccccccccccccccCc----ccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcch
Q 042435 271 VRLLDVDSSN-------RTLQAGTYGYIALELVYTM----VVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIM 339 (412)
Q Consensus 271 a~~~~~~~~~-------~~~~~gt~~y~aPE~~~~~----~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~ 339 (412)
++.++.+... .+...||.+|++||.+.-+ .++.|.||||.|||+|.++.|+.||....+-.......
T Consensus 620 SKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeN-- 697 (775)
T KOG1151|consen 620 SKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQEN-- 697 (775)
T ss_pred hhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhh--
Confidence 9998765433 2446799999999988643 47889999999999999999999997432211110000
Q ss_pred hhHHhhh-ccCCccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 340 LIDILYQ-RLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 340 ~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
.++.. .+..|..+ ........++.+|++..-++|....++..+
T Consensus 698 --TIlkAtEVqFP~KP---vVsseAkaFIRRCLaYRKeDR~DV~qLA~d 741 (775)
T KOG1151|consen 698 --TILKATEVQFPPKP---VVSSEAKAFIRRCLAYRKEDRIDVQQLACD 741 (775)
T ss_pred --chhcceeccCCCCC---ccCHHHHHHHHHHHHhhhhhhhhHHHHccC
Confidence 01100 11111111 112236788999999999999888877643
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.4e-32 Score=256.71 Aligned_cols=224 Identities=23% Similarity=0.302 Sum_probs=172.9
Q ss_pred ceeeeecCceEEEEEEe-CCCcEEEEEec-----------------------cCCccccceEEEecCceEEEEEEeccCC
Q 042435 148 RYCIGTGGYDSVYKAEL-PDGKVVALKKL-----------------------HHSETEDSAFVVYSPQCMFFIYEYMERG 203 (412)
Q Consensus 148 ~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l-----------------------~~~~~~~~~~~~~~~~~~~lv~ey~~~g 203 (412)
.++||+|.||+||-|.+ ++|+.||||.+ +|+.++.....+.+++.+++|||-+. |
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~-G 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLH-G 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhc-c
Confidence 47899999999999966 68999999965 46777777777999999999999995 4
Q ss_pred ceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCC---CcEEEeecCCccccCCCCCC
Q 042435 204 SLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSN---LEAFVADFGTVRLLDVDSSN 280 (412)
Q Consensus 204 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~---~~~kl~DfGla~~~~~~~~~ 280 (412)
+..+.+-....+ .|+...-..++.||+.||.|||.+ +|+|+||||+|||+.+. -++||||||+|+.+.... -
T Consensus 648 DMLEMILSsEkg-RL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks-F 722 (888)
T KOG4236|consen 648 DMLEMILSSEKG-RLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS-F 722 (888)
T ss_pred hHHHHHHHhhcc-cchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeecchhh-h
Confidence 655444333222 477777788899999999999999 99999999999999643 579999999999876543 3
Q ss_pred cccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccchhhHHHH
Q 042435 281 RTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKIIQDI 360 (412)
Q Consensus 281 ~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 360 (412)
+...+||+.|+|||++....|...-|+||.|||+|--++|..||... +.+.+.+....-.-.+..+.+..
T Consensus 723 RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEd----------EdIndQIQNAaFMyPp~PW~eis 792 (888)
T KOG4236|consen 723 RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNED----------EDINDQIQNAAFMYPPNPWSEIS 792 (888)
T ss_pred hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCc----------cchhHHhhccccccCCCchhhcC
Confidence 34568999999999999999999999999999999999999999732 22233332211111112233333
Q ss_pred HHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 361 ILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 361 ~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
....+++...++..-++|-|.+.-+.+
T Consensus 793 ~~AidlIn~LLqVkm~kRysvdk~lsh 819 (888)
T KOG4236|consen 793 PEAIDLINNLLQVKMRKRYSVDKSLSH 819 (888)
T ss_pred HHHHHHHHHHHHHHHHHhcchHhhccc
Confidence 457788888888888888888765543
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.1e-31 Score=236.38 Aligned_cols=242 Identities=20% Similarity=0.296 Sum_probs=180.1
Q ss_pred cHHHHHHhhcCcccceeeeecCceEEEEEE-eCCCcEEEEEecc----------------------CCccccceEEEecC
Q 042435 134 LYENLIDATEYFHIRYCIGTGGYDSVYKAE-LPDGKVVALKKLH----------------------HSETEDSAFVVYSP 190 (412)
Q Consensus 134 ~~~~l~~~~~~f~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~l~----------------------~~~~~~~~~~~~~~ 190 (412)
+|+|+-..|+ +.||+|+|+.|--+. ..+|..+|||.+. |.|+......+.++
T Consensus 74 ~F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd 148 (463)
T KOG0607|consen 74 KFEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDD 148 (463)
T ss_pred hHHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhccc
Confidence 3567766665 679999999998884 5789999999874 44555555557788
Q ss_pred ceEEEEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCC---cEEEee
Q 042435 191 QCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNL---EAFVAD 267 (412)
Q Consensus 191 ~~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~---~~kl~D 267 (412)
..+|||||-|.||+|..+++++. .++.....++..+|+.||.|||.+ +|.||||||+|||-.... -+||+|
T Consensus 149 ~~FYLVfEKm~GGplLshI~~~~---~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKiCD 222 (463)
T KOG0607|consen 149 TRFYLVFEKMRGGPLLSHIQKRK---HFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKICD 222 (463)
T ss_pred ceEEEEEecccCchHHHHHHHhh---hccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceeeec
Confidence 89999999999999999888765 588899999999999999999999 999999999999996543 489999
Q ss_pred cCCccccCCC-------CCCccccccccccccccccc-----CcccCcccccHHHHHHHHHHHhCCCCcccccccccCCC
Q 042435 268 FGTVRLLDVD-------SSNRTLQAGTYGYIALELVY-----TMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSG 335 (412)
Q Consensus 268 fGla~~~~~~-------~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~ 335 (412)
|.+..-+... .....+.+|+..|||||+.. ...|+.++|.||+|||+|-|++|..||...-...-...
T Consensus 223 fDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWd 302 (463)
T KOG0607|consen 223 FDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWD 302 (463)
T ss_pred cccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCcc
Confidence 9886543221 11224567899999999863 34588999999999999999999999975432111111
Q ss_pred C---cchhhHH----hh-hccCCccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 336 P---KIMLIDI----LY-QRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 336 ~---~~~~~~~----~~-~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
. -....+. +. .....| ..++..-.....+++...+..||.+|-++.+++++
T Consensus 303 rGe~Cr~CQ~~LFesIQEGkYeFP-dkdWahIS~eakdlisnLlvrda~~rlsa~~vlnh 361 (463)
T KOG0607|consen 303 RGEVCRVCQNKLFESIQEGKYEFP-DKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNH 361 (463)
T ss_pred CCCccHHHHHHHHHHHhccCCcCC-hhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCC
Confidence 1 1111111 11 122222 23344444557889999999999999999999883
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.6e-32 Score=237.01 Aligned_cols=239 Identities=20% Similarity=0.282 Sum_probs=173.6
Q ss_pred CcccceeeeecCceEEEEEEeC-CCcEEEEEe-----------------------ccCCccccceEEEe--------cCc
Q 042435 144 YFHIRYCIGTGGYDSVYKAELP-DGKVVALKK-----------------------LHHSETEDSAFVVY--------SPQ 191 (412)
Q Consensus 144 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~-----------------------l~~~~~~~~~~~~~--------~~~ 191 (412)
.|+-..+||+|.||+||+|+.+ +|+.||+|+ ++|+++.....+|. ...
T Consensus 18 ~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~ 97 (376)
T KOG0669|consen 18 KYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRA 97 (376)
T ss_pred HHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccc
Confidence 3555678999999999999774 578889884 35666655444433 234
Q ss_pred eEEEEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCc
Q 042435 192 CMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTV 271 (412)
Q Consensus 192 ~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla 271 (412)
.+|+|+++|+. +|..+|.+.. ..++..++.+++.++..||.|+|.. .|+|||+|++|+|++.++.+||+|||++
T Consensus 98 t~ylVf~~ceh-DLaGlLsn~~--vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADFGla 171 (376)
T KOG0669|consen 98 TFYLVFDFCEH-DLAGLLSNRK--VRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADFGLA 171 (376)
T ss_pred eeeeeHHHhhh-hHHHHhcCcc--ccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeeccccc
Confidence 58999999976 8998887654 3588899999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCC----cccccccccccccccccCc-ccCcccccHHHHHHHHHHHhCCCCccccc-------------ccccC
Q 042435 272 RLLDVDSSN----RTLQAGTYGYIALELVYTM-VVTEKCVIYSFGVVALEVLMGTHPGELLL-------------SLSSS 333 (412)
Q Consensus 272 ~~~~~~~~~----~~~~~gt~~y~aPE~~~~~-~~s~ksDv~S~Gvil~elltg~~P~~~~~-------------~~~~~ 333 (412)
+.+...... .+..+-|.+|.+||.+.+. .|+++.|||..||++.||+||.+-++... +....
T Consensus 172 r~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tke 251 (376)
T KOG0669|consen 172 RAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKE 251 (376)
T ss_pred cceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcc
Confidence 866443221 2344568999999998864 58999999999999999999998775221 11112
Q ss_pred CCCcchhhHHhhhccCCccchh----hHHHH------HHHHHHHHhcCcCCCCCCCCHHHHHHHH
Q 042435 334 SGPKIMLIDILYQRLSPPINQK----IIQDI------ILVSTIALACLRSKPKSRPTMQRISQEL 388 (412)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~----~~~~~------~~~~~l~~~Cl~~dP~~RPs~~evl~~L 388 (412)
.++...-.........+|.+.. ..+.. ....+++..++..||.+||++++++++-
T Consensus 252 vWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~ 316 (376)
T KOG0669|consen 252 VWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHD 316 (376)
T ss_pred cCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchh
Confidence 2222111111111111111111 11111 1367889999999999999999998875
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-31 Score=253.36 Aligned_cols=226 Identities=21% Similarity=0.341 Sum_probs=176.3
Q ss_pred CcccceeeeecCceEEEEEEeCCCc-EEEEEeccCCccccceE------------------------EEecCceEEEEEE
Q 042435 144 YFHIRYCIGTGGYDSVYKAELPDGK-VVALKKLHHSETEDSAF------------------------VVYSPQCMFFIYE 198 (412)
Q Consensus 144 ~f~~~~~lG~G~~g~Vy~~~~~~~~-~vAvK~l~~~~~~~~~~------------------------~~~~~~~~~lv~e 198 (412)
+++....||-||||.|=.+...... .+|+|.++...++.... .+.+...+|+.||
T Consensus 421 dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmE 500 (732)
T KOG0614|consen 421 DLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLME 500 (732)
T ss_pred hhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHH
Confidence 3455567999999999999775433 48999887665554321 1556778899999
Q ss_pred eccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCC
Q 042435 199 YMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDS 278 (412)
Q Consensus 199 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~ 278 (412)
-|-||.|+..|++.. .++..+..-++..+.+|++|||.+ +||.|||||+|.++|.+|.+||.|||+|+.+..+.
T Consensus 501 aClGGElWTiLrdRg---~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~ 574 (732)
T KOG0614|consen 501 ACLGGELWTILRDRG---SFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGR 574 (732)
T ss_pred hhcCchhhhhhhhcC---CcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehhhHHHhccCC
Confidence 999999999999876 578888888999999999999999 99999999999999999999999999999887665
Q ss_pred CCcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCC-ccchhhH
Q 042435 279 SNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSP-PINQKII 357 (412)
Q Consensus 279 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 357 (412)
... +.+||+.|.|||++.....+.+.|.||+|+++|||+||++||... .+. .....+-+.+.. ..+....
T Consensus 575 KTw-TFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~-------dpm-ktYn~ILkGid~i~~Pr~I~ 645 (732)
T KOG0614|consen 575 KTW-TFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGV-------DPM-KTYNLILKGIDKIEFPRRIT 645 (732)
T ss_pred cee-eecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCC-------chH-HHHHHHHhhhhhhhcccccc
Confidence 544 469999999999999999999999999999999999999999832 221 122222222211 1112222
Q ss_pred HHHHHHHHHHHhcCcCCCCCCCC-----HHHHHHH
Q 042435 358 QDIILVSTIALACLRSKPKSRPT-----MQRISQE 387 (412)
Q Consensus 358 ~~~~~~~~l~~~Cl~~dP~~RPs-----~~evl~~ 387 (412)
. ...+++.+....+|.+|.. +.||-+|
T Consensus 646 k---~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH 677 (732)
T KOG0614|consen 646 K---TATDLIKKLCRDNPTERLGYQKGGINDIKKH 677 (732)
T ss_pred h---hHHHHHHHHHhcCcHhhhccccCChHHHHhh
Confidence 2 2567888888899999975 6676655
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-30 Score=217.85 Aligned_cols=174 Identities=22% Similarity=0.344 Sum_probs=148.4
Q ss_pred CcccceeeeecCceEEEEEEe-CCCcEEEEEec-----------------------cCCccccceEEEecCceEEEEEEe
Q 042435 144 YFHIRYCIGTGGYDSVYKAEL-PDGKVVALKKL-----------------------HHSETEDSAFVVYSPQCMFFIYEY 199 (412)
Q Consensus 144 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l-----------------------~~~~~~~~~~~~~~~~~~~lv~ey 199 (412)
+|+..++||+|.||+||||+. .+++.||+|++ +|.|+++...+...+...-+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 456668899999999999976 46899999964 577777777778888899999999
Q ss_pred ccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCCC
Q 042435 200 MERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSS 279 (412)
Q Consensus 200 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 279 (412)
|.. +|..+.....+ .++......++.|+.+||.|+|++ ++.||||||.|.|++.+++.|++|||+++.+.....
T Consensus 83 cdq-dlkkyfdslng--~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgipvr 156 (292)
T KOG0662|consen 83 CDQ-DLKKYFDSLNG--DLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR 156 (292)
T ss_pred hhH-HHHHHHHhcCC--cCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCCceE
Confidence 965 88877765443 488899999999999999999999 999999999999999999999999999997765544
Q ss_pred CcccccccccccccccccCcc-cCcccccHHHHHHHHHHHhCCCC
Q 042435 280 NRTLQAGTYGYIALELVYTMV-VTEKCVIYSFGVVALEVLMGTHP 323 (412)
Q Consensus 280 ~~~~~~gt~~y~aPE~~~~~~-~s~ksDv~S~Gvil~elltg~~P 323 (412)
..+...-|.+|.+|.++.+.. |++..|+||-|||+.|+.....|
T Consensus 157 cysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrp 201 (292)
T KOG0662|consen 157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP 201 (292)
T ss_pred eeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCC
Confidence 455567799999999998754 89999999999999999874444
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-31 Score=264.79 Aligned_cols=227 Identities=24% Similarity=0.315 Sum_probs=171.9
Q ss_pred cccceeeeecCceE-EEEEEeCCCcEEEEEec-------------------cCCccccceEEEecCceEEEEEEeccCCc
Q 042435 145 FHIRYCIGTGGYDS-VYKAELPDGKVVALKKL-------------------HHSETEDSAFVVYSPQCMFFIYEYMERGS 204 (412)
Q Consensus 145 f~~~~~lG~G~~g~-Vy~~~~~~~~~vAvK~l-------------------~~~~~~~~~~~~~~~~~~~lv~ey~~~gs 204 (412)
|...+++|.|+.|+ ||+|.+ +|+.||||++ .|+|+.+....-.+.+..|+..|.|. .+
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~-~s 588 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLEEFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA-CS 588 (903)
T ss_pred eccHHHcccCCCCcEEEEEee-CCceehHHHHhhHhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh-hh
Confidence 44456789999885 699998 7899999987 57888887777788899999999995 59
Q ss_pred eeeeeccCc-ccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecC-----CCcEEEeecCCccccCCCC
Q 042435 205 LFCVLRDDD-EAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNS-----NLEAFVADFGTVRLLDVDS 278 (412)
Q Consensus 205 L~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~-----~~~~kl~DfGla~~~~~~~ 278 (412)
|.+++.... +.....-.....+..|+++||++||+. +||||||||.||||+. ...++|+|||+++.+..+.
T Consensus 589 L~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~ 665 (903)
T KOG1027|consen 589 LQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGK 665 (903)
T ss_pred HHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEecccccccccCCCc
Confidence 999987741 111111134467889999999999997 9999999999999975 3578999999999887654
Q ss_pred CC---cccccccccccccccccCcccCcccccHHHHHHHHHHHhC-CCCcccccccccCCCCcchhhHHhhhccCCccch
Q 042435 279 SN---RTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMG-THPGELLLSLSSSSGPKIMLIDILYQRLSPPINQ 354 (412)
Q Consensus 279 ~~---~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg-~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 354 (412)
.. .....||.+|+|||++....-+.+.||||+||++|..++| ..||...... -..++.....-....
T Consensus 666 sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R---------~~NIl~~~~~L~~L~ 736 (903)
T KOG1027|consen 666 SSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLER---------QANILTGNYTLVHLE 736 (903)
T ss_pred chhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHh---------hhhhhcCccceeeec
Confidence 33 3456799999999999988888899999999999999985 8999743211 011111111100000
Q ss_pred hhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 355 KIIQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 355 ~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
...++ ...+|+.+|++.||..||++.+|+.|
T Consensus 737 ~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~H 767 (903)
T KOG1027|consen 737 PLPDC--EAKDLISRMLNPDPQLRPSATDVLNH 767 (903)
T ss_pred cCchH--HHHHHHHHhcCCCcccCCCHHHHhCC
Confidence 11111 47899999999999999999999865
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-29 Score=230.37 Aligned_cols=217 Identities=26% Similarity=0.330 Sum_probs=166.8
Q ss_pred CceEEEEEEeC-CCcEEEEEeccCCcc----------------------ccceEEEecCceEEEEEEeccCCceeeeecc
Q 042435 155 GYDSVYKAELP-DGKVVALKKLHHSET----------------------EDSAFVVYSPQCMFFIYEYMERGSLFCVLRD 211 (412)
Q Consensus 155 ~~g~Vy~~~~~-~~~~vAvK~l~~~~~----------------------~~~~~~~~~~~~~~lv~ey~~~gsL~~~l~~ 211 (412)
+||.||+|... +|+.+|+|.+..... ......+......++++||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999886 489999998764432 2222235556789999999999999998865
Q ss_pred CcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCCCCccccccccccc
Q 042435 212 DDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTYGYI 291 (412)
Q Consensus 212 ~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~gt~~y~ 291 (412)
.. .+++..+..++.+++.++.|||+. +++|+||+|+||++++++.++++|||.+....... ......++..|+
T Consensus 81 ~~---~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~ 153 (244)
T smart00220 81 RG---RLSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG-LLTTFVGTPEYM 153 (244)
T ss_pred cc---CCCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc-ccccccCCcCCC
Confidence 43 288999999999999999999998 99999999999999999999999999998765432 223446788999
Q ss_pred ccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccchhhHHHHHHHHHHHHhcC
Q 042435 292 ALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKIIQDIILVSTIALACL 371 (412)
Q Consensus 292 aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl 371 (412)
+||......++.++||||||++++++++|..||... .......+.......... .........+.+++.+||
T Consensus 154 ~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~-------~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~i~~~l 225 (244)
T smart00220 154 APEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGD-------DQLLELFKKIGKPKPPFP-PPEWKISPEAKDLIRKLL 225 (244)
T ss_pred CHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCC-------CcHHHHHHHHhccCCCCc-cccccCCHHHHHHHHHHc
Confidence 999998888899999999999999999999998631 111122222222211111 100002234888999999
Q ss_pred cCCCCCCCCHHHHHH
Q 042435 372 RSKPKSRPTMQRISQ 386 (412)
Q Consensus 372 ~~dP~~RPs~~evl~ 386 (412)
..+|++||++.++++
T Consensus 226 ~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 226 VKDPEKRLTAEEALQ 240 (244)
T ss_pred cCCchhccCHHHHhh
Confidence 999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.9e-30 Score=218.82 Aligned_cols=182 Identities=25% Similarity=0.322 Sum_probs=142.0
Q ss_pred hhcCcccceeeeecCceEEEEEEe-CCCcEEEEEeccC-----------------------CccccceEEEecCceEEEE
Q 042435 141 ATEYFHIRYCIGTGGYDSVYKAEL-PDGKVVALKKLHH-----------------------SETEDSAFVVYSPQCMFFI 196 (412)
Q Consensus 141 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l~~-----------------------~~~~~~~~~~~~~~~~~lv 196 (412)
..++......||+|++|.|=+-++ .+|+..|+|+++. +..+.+.+........++.
T Consensus 44 ~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIc 123 (282)
T KOG0984|consen 44 PADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWIC 123 (282)
T ss_pred chhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEe
Confidence 334445567799999999988866 5799999998743 2222233334566778999
Q ss_pred EEeccCCceeeeeccC-cccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccC
Q 042435 197 YEYMERGSLFCVLRDD-DEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLD 275 (412)
Q Consensus 197 ~ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~ 275 (412)
||.|.- ||..+.++- ..+..++....-+|+..+.+||.|||++- .++|||+||+|||++.++++|+||||++..+.
T Consensus 124 ME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~ 200 (282)
T KOG0984|consen 124 MELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISGYLV 200 (282)
T ss_pred HHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccceeeh
Confidence 999954 776655432 12235778888899999999999999874 89999999999999999999999999998765
Q ss_pred CCCCCccccccccccccccccc----CcccCcccccHHHHHHHHHHHhCCCCccc
Q 042435 276 VDSSNRTLQAGTYGYIALELVY----TMVVTEKCVIYSFGVVALEVLMGTHPGEL 326 (412)
Q Consensus 276 ~~~~~~~~~~gt~~y~aPE~~~----~~~~s~ksDv~S~Gvil~elltg~~P~~~ 326 (412)
.+- ..+...|.-.|||||.+. ...|+.||||||+|+.+.||.+++.||+.
T Consensus 201 dSi-Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~ 254 (282)
T KOG0984|consen 201 DSI-AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYES 254 (282)
T ss_pred hhh-HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccc
Confidence 332 233456888999999875 34689999999999999999999999873
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.7e-29 Score=240.91 Aligned_cols=186 Identities=23% Similarity=0.324 Sum_probs=149.2
Q ss_pred HHHHHHhh---cCcccceeeeecCceEEEEEEe-CCCcEEEEEeccCC------------------------ccccceEE
Q 042435 135 YENLIDAT---EYFHIRYCIGTGGYDSVYKAEL-PDGKVVALKKLHHS------------------------ETEDSAFV 186 (412)
Q Consensus 135 ~~~l~~~~---~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l~~~------------------------~~~~~~~~ 186 (412)
|--|+++. .-|...+-||-|+||+|.++.. ++...+|+|.|+.. -+++....
T Consensus 618 YiRLkRaKMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyyS 697 (1034)
T KOG0608|consen 618 YIRLKRAKMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYS 697 (1034)
T ss_pred HHHHHHhhccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEE
Confidence 34444443 3477788999999999999954 55778899977532 22334445
Q ss_pred EecCceEEEEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEe
Q 042435 187 VYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVA 266 (412)
Q Consensus 187 ~~~~~~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~ 266 (412)
+.+++++|+||||++||++-.+|-..+ -+.+.....++.++..|+++.|.. |+|||||||+|||||.+|.+||+
T Consensus 698 FQDkdnLYFVMdYIPGGDmMSLLIrmg---IFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLT 771 (1034)
T KOG0608|consen 698 FQDKDNLYFVMDYIPGGDMMSLLIRMG---IFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLT 771 (1034)
T ss_pred eccCCceEEEEeccCCccHHHHHHHhc---cCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeee
Confidence 788999999999999999988876554 366777777888999999999999 99999999999999999999999
Q ss_pred ecCCccccC---------CCCC---------------------------------CcccccccccccccccccCcccCcc
Q 042435 267 DFGTVRLLD---------VDSS---------------------------------NRTLQAGTYGYIALELVYTMVVTEK 304 (412)
Q Consensus 267 DfGla~~~~---------~~~~---------------------------------~~~~~~gt~~y~aPE~~~~~~~s~k 304 (412)
|||++.-+. .+.. .....+||+.|+|||++....++.-
T Consensus 772 DFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~ 851 (1034)
T KOG0608|consen 772 DFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQL 851 (1034)
T ss_pred eccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCcccc
Confidence 999975321 0000 0012469999999999999999999
Q ss_pred cccHHHHHHHHHHHhCCCCccc
Q 042435 305 CVIYSFGVVALEVLMGTHPGEL 326 (412)
Q Consensus 305 sDv~S~Gvil~elltg~~P~~~ 326 (412)
+|.||.|||||||+.|+.||..
T Consensus 852 cdwws~gvil~em~~g~~pf~~ 873 (1034)
T KOG0608|consen 852 CDWWSVGVILYEMLVGQPPFLA 873 (1034)
T ss_pred chhhHhhHHHHHHhhCCCCccC
Confidence 9999999999999999999963
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1e-28 Score=241.67 Aligned_cols=234 Identities=24% Similarity=0.330 Sum_probs=183.8
Q ss_pred HhhcCcccceeeeecCceEEEEEEe-CCCcEEEEEecc---------------------CCccccceEEEecCceEEEEE
Q 042435 140 DATEYFHIRYCIGTGGYDSVYKAEL-PDGKVVALKKLH---------------------HSETEDSAFVVYSPQCMFFIY 197 (412)
Q Consensus 140 ~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l~---------------------~~~~~~~~~~~~~~~~~~lv~ 197 (412)
+..++|+....+|+|+||.|||++. ..++..|+|.++ |+|+....+.+...+..++.|
T Consensus 12 nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicM 91 (829)
T KOG0576|consen 12 NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICM 91 (829)
T ss_pred CCccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEE
Confidence 4557899999999999999999976 568889988764 455555555556677889999
Q ss_pred EeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCC
Q 042435 198 EYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVD 277 (412)
Q Consensus 198 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~ 277 (412)
|||.+|+|.+..+... .++..++..+.+...+||+|||+. +-+|||||-.|||+++.+.+|++|||.+..+...
T Consensus 92 EycgggslQdiy~~Tg---plselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsaqitat 165 (829)
T KOG0576|consen 92 EYCGGGSLQDIYHVTG---PLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSAQITAT 165 (829)
T ss_pred EecCCCcccceeeecc---cchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchhhhhhh
Confidence 9999999999888665 688889999999999999999998 8899999999999999999999999999887766
Q ss_pred CCCccccccccccccccccc---CcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccch
Q 042435 278 SSNRTLQAGTYGYIALELVY---TMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQ 354 (412)
Q Consensus 278 ~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 354 (412)
...+....||+.|||||+.. .+.|..++|||+.|+...|+-.-+.|.... .+...+.-.-.....++...
T Consensus 166 i~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdl-------hpmr~l~LmTkS~~qpp~lk 238 (829)
T KOG0576|consen 166 IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDL-------HPMRALFLMTKSGFQPPTLK 238 (829)
T ss_pred hhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCccccc-------chHHHHHHhhccCCCCCccc
Confidence 66667789999999999874 466889999999999999998777663211 11111111112222333223
Q ss_pred hhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHH
Q 042435 355 KIIQDIILVSTIALACLRSKPKSRPTMQRISQ 386 (412)
Q Consensus 355 ~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~ 386 (412)
+.......+.+++..|+.++|++||+++.++.
T Consensus 239 Dk~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 239 DKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred CCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 33334445889999999999999999987654
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.1e-29 Score=222.13 Aligned_cols=239 Identities=24% Similarity=0.240 Sum_probs=167.3
Q ss_pred cccceeeeecCceEEEEEEe-CCCcEEEEEeccC-----------------------CccccceEEEec-----CceEEE
Q 042435 145 FHIRYCIGTGGYDSVYKAEL-PDGKVVALKKLHH-----------------------SETEDSAFVVYS-----PQCMFF 195 (412)
Q Consensus 145 f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l~~-----------------------~~~~~~~~~~~~-----~~~~~l 195 (412)
.+..+-||-|+||.||.+.. ++|+.||+|++.+ .|......+..- -+++|+
T Consensus 55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV 134 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV 134 (449)
T ss_pred CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence 34457899999999999966 5799999998743 332222222111 135678
Q ss_pred EEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccC
Q 042435 196 IYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLD 275 (412)
Q Consensus 196 v~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~ 275 (412)
++|.|.. +|.+++-... .++-..+.-+.+||++||.|||+. +|.||||||.|.|+++|...||||||+++..+
T Consensus 135 ~TELmQS-DLHKIIVSPQ---~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLARvee 207 (449)
T KOG0664|consen 135 LTELMQS-DLHKIIVSPQ---ALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLARTWD 207 (449)
T ss_pred HHHHHHh-hhhheeccCC---CCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecccccccccc
Confidence 8999954 8988886544 577778888999999999999998 99999999999999999999999999999765
Q ss_pred CCC-CCcccccccccccccccccCc-ccCcccccHHHHHHHHHHHhCCCCccccccccc--------CCCCcc-------
Q 042435 276 VDS-SNRTLQAGTYGYIALELVYTM-VVTEKCVIYSFGVVALEVLMGTHPGELLLSLSS--------SSGPKI------- 338 (412)
Q Consensus 276 ~~~-~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~--------~~~~~~------- 338 (412)
.+. .+.+...-|..|.|||++.+. .|+.+.||||.|||+.|++.++.-|+....+.. .....+
T Consensus 208 ~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACE 287 (449)
T KOG0664|consen 208 QRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACE 287 (449)
T ss_pred hhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhh
Confidence 443 334556678899999999875 599999999999999999988877763211100 000000
Q ss_pred -hhhHHhhhccCCccchh------hHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhc
Q 042435 339 -MLIDILYQRLSPPINQK------IIQDIILVSTIALACLRSKPKSRPTMQRISQELEG 390 (412)
Q Consensus 339 -~~~~~~~~~~~~~~~~~------~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~ 390 (412)
.-..++.....++..+. ..........+...++..||++|.+..+.+.++..
T Consensus 288 GAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~ 346 (449)
T KOG0664|consen 288 GAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYL 346 (449)
T ss_pred hhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccc
Confidence 01111222222211000 00111124567778899999999999998887643
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-27 Score=209.40 Aligned_cols=165 Identities=21% Similarity=0.135 Sum_probs=124.6
Q ss_pred CceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCCCCcc
Q 042435 203 GSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRT 282 (412)
Q Consensus 203 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 282 (412)
|+|.++++... ..++|.++..++.|+++||+|||++ + ||+||+++.++.+|+ ||+++......
T Consensus 1 GsL~~~l~~~~--~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~~---- 63 (176)
T smart00750 1 VSLADILEVRG--RPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPEQ---- 63 (176)
T ss_pred CcHHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecccc----
Confidence 67888887533 2599999999999999999999988 4 999999999999999 99988654322
Q ss_pred cccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCC--ccchhhHHHH
Q 042435 283 LQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSP--PINQKIIQDI 360 (412)
Q Consensus 283 ~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~ 360 (412)
..||+.|+|||++.+..++.++|||||||++|||+||+.||...... .............. ..........
T Consensus 64 -~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~ 136 (176)
T smart00750 64 -SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEEREL------SAILEILLNGMPADDPRDRSNLESVS 136 (176)
T ss_pred -CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchh------cHHHHHHHHHhccCCccccccHHHHH
Confidence 26889999999999999999999999999999999999998632111 11111222111111 0000111111
Q ss_pred --HHHHHHHHhcCcCCCCCCCCHHHHHHHHhcC
Q 042435 361 --ILVSTIALACLRSKPKSRPTMQRISQELEGK 391 (412)
Q Consensus 361 --~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 391 (412)
..+.+++.+||+.||++||++.|+++++...
T Consensus 137 ~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 137 AARSFADFMRVCASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred hhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence 2488999999999999999999999998655
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.1e-28 Score=230.72 Aligned_cols=245 Identities=18% Similarity=0.199 Sum_probs=181.7
Q ss_pred ccHHHHHHhhcCcccceeeeecCceEEEEEEe-CCCcEEEEEeccCCccccceEE-------------------------
Q 042435 133 ILYENLIDATEYFHIRYCIGTGGYDSVYKAEL-PDGKVVALKKLHHSETEDSAFV------------------------- 186 (412)
Q Consensus 133 ~~~~~l~~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l~~~~~~~~~~~------------------------- 186 (412)
+.+.|+.+ +.|.+....|+|-|++|.+|.. ..|..||||.++...+....+.
T Consensus 424 v~igE~LD--~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r 501 (752)
T KOG0670|consen 424 VRIGELLD--SRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFR 501 (752)
T ss_pred Eehhhhhc--ceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHH
Confidence 34455543 5688889999999999999966 4588999999976654433221
Q ss_pred -EecCceEEEEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCC-CcEE
Q 042435 187 -VYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSN-LEAF 264 (412)
Q Consensus 187 -~~~~~~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~-~~~k 264 (412)
+...+++|||+|-+. -+|.++|...+....|....+..++.|+.-||..|-.. +|+|.||||.|||+++. ..+|
T Consensus 502 ~F~hknHLClVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~k~iLK 577 (752)
T KOG0670|consen 502 HFKHKNHLCLVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNESKNILK 577 (752)
T ss_pred HhhhcceeEEEehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccCcceee
Confidence 556789999999884 58999998877666788899999999999999999987 99999999999999854 6789
Q ss_pred EeecCCccccCCCCCCcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCccccc----------------
Q 042435 265 VADFGTVRLLDVDSSNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLL---------------- 328 (412)
Q Consensus 265 l~DfGla~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~---------------- 328 (412)
|||||.|.....+.. +...-+..|.|||++.+-+|+...|+||.||+||||.||+.-|..-.
T Consensus 578 LCDfGSA~~~~enei--tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p 655 (752)
T KOG0670|consen 578 LCDFGSASFASENEI--TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFP 655 (752)
T ss_pred eccCccccccccccc--cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCc
Confidence 999999987654322 22334568999999999999999999999999999999986653100
Q ss_pred ------------cc--------------c--------cCCCCcchhhHHhhhccCCccchhhHHHHHHHHHHHHhcCcCC
Q 042435 329 ------------SL--------------S--------SSSGPKIMLIDILYQRLSPPINQKIIQDIILVSTIALACLRSK 374 (412)
Q Consensus 329 ------------~~--------------~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~d 374 (412)
.+ . ....+...+...+... +..+.........+.+|+..|+..|
T Consensus 656 ~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~--q~~~deq~~~~~~~rdLLdkml~Ld 733 (752)
T KOG0670|consen 656 NKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAV--QRLPDEQPKIVQQLRDLLDKMLILD 733 (752)
T ss_pred HHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhcc--CCCCchhHHHHHHHHHHHHHHhccC
Confidence 00 0 0000000111111110 1112333445567999999999999
Q ss_pred CCCCCCHHHHHHH
Q 042435 375 PKSRPTMQRISQE 387 (412)
Q Consensus 375 P~~RPs~~evl~~ 387 (412)
|++|.|..+.++|
T Consensus 734 P~KRit~nqAL~H 746 (752)
T KOG0670|consen 734 PEKRITVNQALKH 746 (752)
T ss_pred hhhcCCHHHHhcC
Confidence 9999999998875
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.7e-27 Score=225.98 Aligned_cols=113 Identities=24% Similarity=0.429 Sum_probs=89.2
Q ss_pred hcCcccceeeeecCceEEEEEE-eCCCcEEEEEeccCC----------------------ccccceEE----------Ee
Q 042435 142 TEYFHIRYCIGTGGYDSVYKAE-LPDGKVVALKKLHHS----------------------ETEDSAFV----------VY 188 (412)
Q Consensus 142 ~~~f~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~l~~~----------------------~~~~~~~~----------~~ 188 (412)
..+|.+.++||-|.|++||++. ..+.+.||+|+.+.. +......+ ..
T Consensus 77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp 156 (590)
T KOG1290|consen 77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP 156 (590)
T ss_pred CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence 3679999999999999999994 467889999976421 11111111 23
Q ss_pred cCceEEEEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEec
Q 042435 189 SPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLN 258 (412)
Q Consensus 189 ~~~~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~ 258 (412)
.+.++++|+|++ |-+|..++...... .++...+.+|++||+.||.|||..| +|+|-||||+|||+.
T Consensus 157 NG~HVCMVfEvL-GdnLLklI~~s~Yr-Glpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 157 NGQHVCMVFEVL-GDNLLKLIKYSNYR-GLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLC 222 (590)
T ss_pred CCcEEEEEehhh-hhHHHHHHHHhCCC-CCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeee
Confidence 467899999999 66888887654322 4888999999999999999999998 999999999999993
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.6e-28 Score=258.69 Aligned_cols=179 Identities=17% Similarity=0.203 Sum_probs=130.4
Q ss_pred CceEEEEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecC----------
Q 042435 190 PQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNS---------- 259 (412)
Q Consensus 190 ~~~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~---------- 259 (412)
...++.++||+ +++|.+++.... ..+++.+++.++.||++||+|||++ +|+||||||+|||++.
T Consensus 52 ~~~~~~~~e~~-~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~---gIvHrDlKP~NiLl~~~~~~k~~d~~ 125 (793)
T PLN00181 52 DDSIVRALECE-DVSLRQWLDNPD--RSVDAFECFHVFRQIVEIVNAAHSQ---GIVVHNVRPSCFVMSSFNHVSFIESA 125 (793)
T ss_pred cchhhhhhccC-CccHHHHHhccc--ccccHHHHHHHHHHHHHHHHHHHhC---CeeeccCCchhEEEcccCcEEEeecc
Confidence 34678889988 569999997543 2489999999999999999999998 9999999999999954
Q ss_pred ---------CCcEEEeecCCccccCCCC----------------CCcccccccccccccccccCcccCcccccHHHHHHH
Q 042435 260 ---------NLEAFVADFGTVRLLDVDS----------------SNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVA 314 (412)
Q Consensus 260 ---------~~~~kl~DfGla~~~~~~~----------------~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil 314 (412)
++.+|++|||+++...... .......||+.|||||++.+..++.++|||||||+|
T Consensus 126 ~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~sDVwSlGviL 205 (793)
T PLN00181 126 SCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNGSSSNCASDVYRLGVLL 205 (793)
T ss_pred ccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhccCCCCchhhhhhHHHHH
Confidence 4556677777765421100 001123578899999999999999999999999999
Q ss_pred HHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 315 LEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 315 ~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
|||++|..|+.... ..+........++. ..........++.+||+.||.+||+|.|++++
T Consensus 206 ~ELl~~~~~~~~~~---------~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~L~~~P~~Rps~~eil~h 265 (793)
T PLN00181 206 FELFCPVSSREEKS---------RTMSSLRHRVLPPQ----ILLNWPKEASFCLWLLHPEPSCRPSMSELLQS 265 (793)
T ss_pred HHHhhCCCchhhHH---------HHHHHHHHhhcChh----hhhcCHHHHHHHHHhCCCChhhCcChHHHhhc
Confidence 99999988865211 11111111111111 11112235678889999999999999999875
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=3e-26 Score=204.29 Aligned_cols=190 Identities=32% Similarity=0.515 Sum_probs=157.7
Q ss_pred eeecCceEEEEEEeCC-CcEEEEEeccCCccc----------------------cceEEEecCceEEEEEEeccCCceee
Q 042435 151 IGTGGYDSVYKAELPD-GKVVALKKLHHSETE----------------------DSAFVVYSPQCMFFIYEYMERGSLFC 207 (412)
Q Consensus 151 lG~G~~g~Vy~~~~~~-~~~vAvK~l~~~~~~----------------------~~~~~~~~~~~~~lv~ey~~~gsL~~ 207 (412)
||+|++|.||++...+ ++.+++|.+...... ............++++||+++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999998854 899999987655431 12223445578899999999999999
Q ss_pred eeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecC-CCcEEEeecCCccccCCCCCCcccccc
Q 042435 208 VLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNS-NLEAFVADFGTVRLLDVDSSNRTLQAG 286 (412)
Q Consensus 208 ~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~-~~~~kl~DfGla~~~~~~~~~~~~~~g 286 (412)
++.... ..+++..+..++.++++++++||+. +++|+||+|.||+++. +..++|+|||.+..............+
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~ 155 (215)
T cd00180 81 LLKENE--GKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVG 155 (215)
T ss_pred HHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcccC
Confidence 887542 2488999999999999999999998 9999999999999998 899999999999865443322333457
Q ss_pred cccccccccccCc-ccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccchhhHHHHHHHHH
Q 042435 287 TYGYIALELVYTM-VVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKIIQDIILVST 365 (412)
Q Consensus 287 t~~y~aPE~~~~~-~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 365 (412)
...|++||..... ..+.++|+|++|++++++ ..+.+
T Consensus 156 ~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-------------------------------------------~~~~~ 192 (215)
T cd00180 156 TPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-------------------------------------------PELKD 192 (215)
T ss_pred CCCccChhHhcccCCCCchhhhHHHHHHHHHH-------------------------------------------HHHHH
Confidence 8899999998877 788999999999999998 23778
Q ss_pred HHHhcCcCCCCCCCCHHHHHHHH
Q 042435 366 IALACLRSKPKSRPTMQRISQEL 388 (412)
Q Consensus 366 l~~~Cl~~dP~~RPs~~evl~~L 388 (412)
++..|++.||++||++.++++++
T Consensus 193 ~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 193 LIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred HHHHHhhCCcccCcCHHHHhhCC
Confidence 89999999999999999998753
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.2e-27 Score=208.50 Aligned_cols=231 Identities=20% Similarity=0.299 Sum_probs=162.9
Q ss_pred hhcCcccceeeeecCceEEEEEEeC-CCcEEEEEeccCCcccc---------------------ceE-EEecCceEEEEE
Q 042435 141 ATEYFHIRYCIGTGGYDSVYKAELP-DGKVVALKKLHHSETED---------------------SAF-VVYSPQCMFFIY 197 (412)
Q Consensus 141 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~~~~~---------------------~~~-~~~~~~~~~lv~ 197 (412)
..+.|.+.+.+|+|.||.+-.++++ ..+.+++|.+..+.... ... .+.+.+..+.++
T Consensus 22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q 101 (378)
T KOG1345|consen 22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ 101 (378)
T ss_pred hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence 3456889999999999999999875 57789999775443221 111 155667888999
Q ss_pred EeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEec--CCCcEEEeecCCccccC
Q 042435 198 EYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLN--SNLEAFVADFGTVRLLD 275 (412)
Q Consensus 198 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~--~~~~~kl~DfGla~~~~ 275 (412)
||+|.|+|.+-+...+ +......+++.|+++|+.|+|++ ++||||||.+|||+- +...+|+||||..+...
T Consensus 102 E~aP~gdL~snv~~~G----igE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g 174 (378)
T KOG1345|consen 102 EFAPRGDLRSNVEAAG----IGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFGLTRKVG 174 (378)
T ss_pred ccCccchhhhhcCccc----ccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeecccccccC
Confidence 9999999998776643 77778889999999999999999 999999999999993 45689999999987543
Q ss_pred CCCCCcccccccccccccccccC-----cccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCC
Q 042435 276 VDSSNRTLQAGTYGYIALELVYT-----MVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSP 350 (412)
Q Consensus 276 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 350 (412)
... ....-+..|.+||.... -...+.+|+|.||++++.++||..||+...... .+-.....+. ++..+
T Consensus 175 ~tV---~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d---~~Y~~~~~w~-~rk~~ 247 (378)
T KOG1345|consen 175 TTV---KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMD---KPYWEWEQWL-KRKNP 247 (378)
T ss_pred cee---hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccC---chHHHHHHHh-cccCc
Confidence 221 11223456889987653 235678999999999999999999998322111 1111122222 22222
Q ss_pred ccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHH
Q 042435 351 PINQKIIQDIILVSTIALACLRSKPKSRPTMQRIS 385 (412)
Q Consensus 351 ~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl 385 (412)
..+.........+.++..+-+..+|++|=...++.
T Consensus 248 ~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~k 282 (378)
T KOG1345|consen 248 ALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAK 282 (378)
T ss_pred cCchhhcccCHHHHHHHHHhcCCcccccchhHHHH
Confidence 22222223334467778888999999984444443
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.8e-27 Score=212.10 Aligned_cols=234 Identities=24% Similarity=0.248 Sum_probs=163.2
Q ss_pred CcccceeeeecCceEEEEEE-eCCCcEEEEEeccCC-----------------------ccccceEEEe------cCceE
Q 042435 144 YFHIRYCIGTGGYDSVYKAE-LPDGKVVALKKLHHS-----------------------ETEDSAFVVY------SPQCM 193 (412)
Q Consensus 144 ~f~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~l~~~-----------------------~~~~~~~~~~------~~~~~ 193 (412)
+|.-...+|.|.- .|..+. .-.++.||+|++..+ |+.....++. .-...
T Consensus 18 Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~ 96 (369)
T KOG0665|consen 18 RYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEV 96 (369)
T ss_pred eeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhH
Confidence 4555567888887 555553 346889999987543 2222211111 12356
Q ss_pred EEEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccc
Q 042435 194 FFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRL 273 (412)
Q Consensus 194 ~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~ 273 (412)
|+|||||. ++|.+.+.. .++-.+...|..|++.|+.|||+. +|+||||||+||++..+..+||.|||+|+.
T Consensus 97 y~v~e~m~-~nl~~vi~~-----elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg~ar~ 167 (369)
T KOG0665|consen 97 YLVMELMD-ANLCQVILM-----ELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFGLART 167 (369)
T ss_pred HHHHHhhh-hHHHHHHHH-----hcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccchhhcc
Confidence 99999995 588887762 477788889999999999999999 999999999999999999999999999986
Q ss_pred cCCCCCCcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCccccccc-------ccCCCCcchhhH----
Q 042435 274 LDVDSSNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSL-------SSSSGPKIMLID---- 342 (412)
Q Consensus 274 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~-------~~~~~~~~~~~~---- 342 (412)
-... -..+....|..|.|||++.+..+.+..||||.||++.||++|+.-|.....+ .....+.....+
T Consensus 168 e~~~-~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~ 246 (369)
T KOG0665|consen 168 EDTD-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQP 246 (369)
T ss_pred cCcc-cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhH
Confidence 4433 2345567889999999999988999999999999999999998766421100 000001111100
Q ss_pred -------------------HhhhccCCccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHH
Q 042435 343 -------------------ILYQRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQEL 388 (412)
Q Consensus 343 -------------------~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L 388 (412)
.+....-+............+.+++.+||-.||++|.+++++++|=
T Consensus 247 ~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HP 311 (369)
T KOG0665|consen 247 TVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHP 311 (369)
T ss_pred HHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCC
Confidence 0000000000111112233478899999999999999999999873
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.2e-26 Score=201.08 Aligned_cols=237 Identities=16% Similarity=0.185 Sum_probs=171.8
Q ss_pred hhcCcccceeeeecCceEEEEEE-eCCCcEEEEEecc-------------------CCccccceEEEecC--ceEEEEEE
Q 042435 141 ATEYFHIRYCIGTGGYDSVYKAE-LPDGKVVALKKLH-------------------HSETEDSAFVVYSP--QCMFFIYE 198 (412)
Q Consensus 141 ~~~~f~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~l~-------------------~~~~~~~~~~~~~~--~~~~lv~e 198 (412)
..++|++.+++|+|.+++||.|. ..+++.++||.++ ++|+.....+..++ ....||+|
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE 115 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFE 115 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhh
Confidence 34679999999999999999995 4678899999774 45555555555443 45689999
Q ss_pred eccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecC-CCcEEEeecCCccccCCC
Q 042435 199 YMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNS-NLEAFVADFGTVRLLDVD 277 (412)
Q Consensus 199 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~-~~~~kl~DfGla~~~~~~ 277 (412)
|..+.+...+.. .++...+..++.++++||.|+|+. ||+|||+||.|+++|. .-+.+|+|+|+|.+..+.
T Consensus 116 ~v~n~Dfk~ly~------tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~ 186 (338)
T KOG0668|consen 116 YVNNTDFKQLYP------TLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 186 (338)
T ss_pred hhccccHHHHhh------hhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecchHhhcCCC
Confidence 999887765543 477788889999999999999999 9999999999999984 567999999999988765
Q ss_pred CCCcccccccccccccccccC-cccCcccccHHHHHHHHHHHhCCCCccccccc-------ccCC--------------C
Q 042435 278 SSNRTLQAGTYGYIALELVYT-MVVTEKCVIYSFGVVALEVLMGTHPGELLLSL-------SSSS--------------G 335 (412)
Q Consensus 278 ~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~-------~~~~--------------~ 335 (412)
.... ....+..|.-||.+.. ..|+..-|+|||||++..|+..+.||-...+- +.-. .
T Consensus 187 ~eYn-VRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~ 265 (338)
T KOG0668|consen 187 KEYN-VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQID 265 (338)
T ss_pred ceee-eeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccC
Confidence 4432 3356778899998865 45888999999999999999999998421100 0000 0
Q ss_pred CcchhhHHhhhccCCccchh-----hHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 336 PKIMLIDILYQRLSPPINQK-----IIQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
-.....+++....+.+.... ..-....+.+++.+.+..|..+|||+.|.+.+
T Consensus 266 Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H 322 (338)
T KOG0668|consen 266 LDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH 322 (338)
T ss_pred CChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence 00111222222111111100 00112347889999999999999999998765
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.3e-25 Score=198.88 Aligned_cols=176 Identities=31% Similarity=0.442 Sum_probs=145.9
Q ss_pred cccceeeeecCceEEEEEEeCC-CcEEEEEeccCCc----------------------cccceEEEecCceEEEEEEecc
Q 042435 145 FHIRYCIGTGGYDSVYKAELPD-GKVVALKKLHHSE----------------------TEDSAFVVYSPQCMFFIYEYME 201 (412)
Q Consensus 145 f~~~~~lG~G~~g~Vy~~~~~~-~~~vAvK~l~~~~----------------------~~~~~~~~~~~~~~~lv~ey~~ 201 (412)
|++.+.||+|++|.||++...+ ++.+|+|.+.... +......+......++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 5667899999999999998865 8999999875432 2222333555678899999999
Q ss_pred CCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCC-CC
Q 042435 202 RGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDS-SN 280 (412)
Q Consensus 202 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~-~~ 280 (412)
+++|.+++..... .+++.....++.+++.++.|||+. +++|+|++|+||+++.++.++|+|||.+....... ..
T Consensus 81 ~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~ 155 (225)
T smart00221 81 GGDLFDYLRKKGG--KLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAAL 155 (225)
T ss_pred CCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccccc
Confidence 9999998876542 178999999999999999999998 99999999999999999999999999988765432 12
Q ss_pred cccccccccccccccc-cCcccCcccccHHHHHHHHHHHhCCCCcc
Q 042435 281 RTLQAGTYGYIALELV-YTMVVTEKCVIYSFGVVALEVLMGTHPGE 325 (412)
Q Consensus 281 ~~~~~gt~~y~aPE~~-~~~~~s~ksDv~S~Gvil~elltg~~P~~ 325 (412)
.....++..|++||.. ....++.++|+||||++++||++|+.||.
T Consensus 156 ~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~ 201 (225)
T smart00221 156 LKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFS 201 (225)
T ss_pred ccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCcc
Confidence 2334677889999998 66778889999999999999999999986
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.9e-26 Score=213.18 Aligned_cols=181 Identities=27% Similarity=0.362 Sum_probs=142.9
Q ss_pred HHHHHhhcCcccceeeeecCceEEEEEEeC----CCcEEEEEeccCC--------------------ccccceEEEecCc
Q 042435 136 ENLIDATEYFHIRYCIGTGGYDSVYKAELP----DGKVVALKKLHHS--------------------ETEDSAFVVYSPQ 191 (412)
Q Consensus 136 ~~l~~~~~~f~~~~~lG~G~~g~Vy~~~~~----~~~~vAvK~l~~~--------------------~~~~~~~~~~~~~ 191 (412)
+++....+.|...++||+|.|++||++... ..+.||+|.+... ++.........++
T Consensus 29 q~~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd 108 (418)
T KOG1167|consen 29 QDIPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSPSRILNELEMLYRLGGSDNIIKLNGCFRNND 108 (418)
T ss_pred hhhhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCchHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence 345556678999999999999999999653 4778999987432 2222223355678
Q ss_pred eEEEEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecC-CCcEEEeecCC
Q 042435 192 CMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNS-NLEAFVADFGT 270 (412)
Q Consensus 192 ~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~-~~~~kl~DfGl 270 (412)
...+|+||++.-+..+++. .++...+..++..+..||+++|++ ||||||+||+|+|.+. .+.-.|.|||+
T Consensus 109 ~v~ivlp~~~H~~f~~l~~------~l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~LvDFgL 179 (418)
T KOG1167|consen 109 QVAIVLPYFEHDRFRDLYR------SLSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVLVDFGL 179 (418)
T ss_pred eeEEEecccCccCHHHHHh------cCCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceEEechh
Confidence 8999999999988877775 377888999999999999999999 9999999999999984 46678999999
Q ss_pred ccccC-----------------C--CC-------------------------CCcccccccccccccccccC-cccCccc
Q 042435 271 VRLLD-----------------V--DS-------------------------SNRTLQAGTYGYIALELVYT-MVVTEKC 305 (412)
Q Consensus 271 a~~~~-----------------~--~~-------------------------~~~~~~~gt~~y~aPE~~~~-~~~s~ks 305 (412)
|...+ . .. .......||++|.|||++.. ...+++.
T Consensus 180 A~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qttai 259 (418)
T KOG1167|consen 180 AQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAI 259 (418)
T ss_pred HHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCcc
Confidence 87221 0 00 00112369999999999875 4578899
Q ss_pred ccHHHHHHHHHHHhCCCCcc
Q 042435 306 VIYSFGVVALEVLMGTHPGE 325 (412)
Q Consensus 306 Dv~S~Gvil~elltg~~P~~ 325 (412)
||||.|||++-+++++.||-
T Consensus 260 Diws~GVI~Lslls~~~PFf 279 (418)
T KOG1167|consen 260 DIWSAGVILLSLLSRRYPFF 279 (418)
T ss_pred ceeeccceeehhhccccccc
Confidence 99999999999999999984
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.1e-25 Score=213.38 Aligned_cols=175 Identities=21% Similarity=0.244 Sum_probs=150.3
Q ss_pred cCcccceeeeecCceEEEEEEeC-CCcEEEEEec--------------------------------cCCccccceEEEec
Q 042435 143 EYFHIRYCIGTGGYDSVYKAELP-DGKVVALKKL--------------------------------HHSETEDSAFVVYS 189 (412)
Q Consensus 143 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l--------------------------------~~~~~~~~~~~~~~ 189 (412)
.+|...+.+|+|+||.|+.|.++ +...|+||.+ .|+|+.+....+.+
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 35888899999999999999775 4678889954 26777777778889
Q ss_pred CceEEEEEEecc-CCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeec
Q 042435 190 PQCMFFIYEYME-RGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADF 268 (412)
Q Consensus 190 ~~~~~lv~ey~~-~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Df 268 (412)
++..||+||--. +-+|++++.-.. .++......|+.||+.|+++||+. +|||||||-+|+.++.+|-+||+||
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE~kp---~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~klidf 714 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIEFKP---RMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFVKLIDF 714 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhhccC---ccchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeEEEeec
Confidence 999999999764 558899887654 588999999999999999999999 9999999999999999999999999
Q ss_pred CCccccCCCCCCcccccccccccccccccCcccC-cccccHHHHHHHHHHHhCCCCcc
Q 042435 269 GTVRLLDVDSSNRTLQAGTYGYIALELVYTMVVT-EKCVIYSFGVVALEVLMGTHPGE 325 (412)
Q Consensus 269 Gla~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s-~ksDv~S~Gvil~elltg~~P~~ 325 (412)
|.+...... ......||..|.|||++.+..|- ...|||++|++||.++....||.
T Consensus 715 gsaa~~ksg--pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 715 GSAAYTKSG--PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred cchhhhcCC--CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 998765432 34557899999999999988875 56999999999999999999875
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.5e-24 Score=190.09 Aligned_cols=226 Identities=19% Similarity=0.269 Sum_probs=174.1
Q ss_pred ceeeeecCceEEEEEEeCCCcEE----------------------EEEeccCCccccceEEEecCceEEEEEEeccCCce
Q 042435 148 RYCIGTGGYDSVYKAELPDGKVV----------------------ALKKLHHSETEDSAFVVYSPQCMFFIYEYMERGSL 205 (412)
Q Consensus 148 ~~~lG~G~~g~Vy~~~~~~~~~v----------------------AvK~l~~~~~~~~~~~~~~~~~~~lv~ey~~~gsL 205 (412)
..+|.+...|+.|+|+|+.+..| +++.+.|+|+....+.|..+....++..||+.|+|
T Consensus 195 ~tkl~e~hsgelwrgrwqgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gsl 274 (448)
T KOG0195|consen 195 ITKLAESHSGELWRGRWQGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGSL 274 (448)
T ss_pred hhhhccCCCcccccccccCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchHH
Confidence 34688899999999999655444 23456788888888889999999999999999999
Q ss_pred eeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEe--ecCCccccCCCCCCccc
Q 042435 206 FCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVA--DFGTVRLLDVDSSNRTL 283 (412)
Q Consensus 206 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~--DfGla~~~~~~~~~~~~ 283 (412)
+.+|++...- ..+-.+..+++.++|+|++|||+. .+-|.--.|.+..+++|++.+++|+ |--++-. ...
T Consensus 275 ynvlhe~t~v-vvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarismad~kfsfq-------e~g 345 (448)
T KOG0195|consen 275 YNVLHEQTSV-VVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQ-------EVG 345 (448)
T ss_pred HHHHhcCccE-EEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheecccceeeee-------ccc
Confidence 9999987543 477889999999999999999987 4455566799999999999998885 4222211 111
Q ss_pred ccccccccccccccCcccC---cccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccchhhHHHH
Q 042435 284 QAGTYGYIALELVYTMVVT---EKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKIIQDI 360 (412)
Q Consensus 284 ~~gt~~y~aPE~~~~~~~s---~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 360 (412)
..-++.||+||.++..+.+ .++|+|||++++||+.|+..||.... +.+.-..+..+.++..+++.....
T Consensus 346 r~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadls-------pmecgmkialeglrv~ippgis~h- 417 (448)
T KOG0195|consen 346 RAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLS-------PMECGMKIALEGLRVHIPPGISRH- 417 (448)
T ss_pred cccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCC-------chhhhhhhhhccccccCCCCccHH-
Confidence 2346889999999876544 47999999999999999999998432 222234444555555555544443
Q ss_pred HHHHHHHHhcCcCCCCCCCCHHHHHHHHhcCC
Q 042435 361 ILVSTIALACLRSKPKSRPTMQRISQELEGKT 392 (412)
Q Consensus 361 ~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 392 (412)
+.+++.-|+..||.+||.+..|+-.||++.
T Consensus 418 --m~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 418 --MNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred --HHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 667778899999999999999999999864
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1e-21 Score=188.84 Aligned_cols=238 Identities=19% Similarity=0.189 Sum_probs=168.3
Q ss_pred CcccceeeeecCceEEEEEEeCCC--cEEEEEeccCCc-------------------------cccceEEE-ecCceEEE
Q 042435 144 YFHIRYCIGTGGYDSVYKAELPDG--KVVALKKLHHSE-------------------------TEDSAFVV-YSPQCMFF 195 (412)
Q Consensus 144 ~f~~~~~lG~G~~g~Vy~~~~~~~--~~vAvK~l~~~~-------------------------~~~~~~~~-~~~~~~~l 195 (412)
+|.+.+.||+|+||.||++..... ..+|+|...... ........ ..+...++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 799999999999999999986543 578888643211 11111112 24567899
Q ss_pred EEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCC-----CcEEEeecCC
Q 042435 196 IYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSN-----LEAFVADFGT 270 (412)
Q Consensus 196 v~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~-----~~~kl~DfGl 270 (412)
||+.+ +.+|.++..... ...++..+.+.|+.|++.+|++||+. |++||||||+|+++... ..+.+.|||+
T Consensus 99 VM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl 173 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLLDFGL 173 (322)
T ss_pred EEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence 99988 779998775444 34689999999999999999999999 99999999999999754 4689999999
Q ss_pred cc--ccCCCC--------CCcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchh
Q 042435 271 VR--LLDVDS--------SNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIML 340 (412)
Q Consensus 271 a~--~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~ 340 (412)
++ ...... .......||..|+++....+...+.+.|+||++.++.|+..|..||....... .....
T Consensus 174 ar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~----~~~~~ 249 (322)
T KOG1164|consen 174 ARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTD----LKSKF 249 (322)
T ss_pred CccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccc----hHHHH
Confidence 98 321111 11223459999999999999999999999999999999999999986332110 01111
Q ss_pred hHHhhhccCCccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhcCCC
Q 042435 341 IDILYQRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELEGKTP 393 (412)
Q Consensus 341 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 393 (412)
.................. .+.++...+-..+..++|....+.+.|+....
T Consensus 250 ~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~ 299 (322)
T KOG1164|consen 250 EKDPRKLLTDRFGDLKPE---EFAKILEYIDSLDYEDKPDYEKLAELLKDVFD 299 (322)
T ss_pred HHHhhhhccccccCCChH---HHHHHHHHhhccCCcCCCCHHHHHHHHHHHHH
Confidence 111111111100011112 24455555666899999999999998866543
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.1e-21 Score=192.62 Aligned_cols=214 Identities=24% Similarity=0.394 Sum_probs=162.4
Q ss_pred EeccCCccccceEEEecCceEEEEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCc-EEeCCC
Q 042435 173 KKLHHSETEDSAFVVYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSI-VHRDIS 251 (412)
Q Consensus 173 K~l~~~~~~~~~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~i-vHrDlk 251 (412)
|.+.|.|.....+.+.++...+.|.+||..|+|.+.+.... ..++|.-...+.++++.||+|+|+. +| .|+.++
T Consensus 2 ~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~--~~~d~~F~~s~~rdi~~Gl~ylh~s---~i~~hg~l~ 76 (484)
T KOG1023|consen 2 RQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNED--IKLDYFFILSFIRDISKGLAYLHNS---PIGYHGALK 76 (484)
T ss_pred cccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccc--cCccHHHHHHHHHHHHHHHHHHhcC---cceeeeeec
Confidence 56789999999999999999999999999999999998743 4699999999999999999999976 44 999999
Q ss_pred CCCEEecCCCcEEEeecCCccccCC--CCCCcccccccccccccccccCc-------ccCcccccHHHHHHHHHHHhCCC
Q 042435 252 SNNILLNSNLEAFVADFGTVRLLDV--DSSNRTLQAGTYGYIALELVYTM-------VVTEKCVIYSFGVVALEVLMGTH 322 (412)
Q Consensus 252 p~NILl~~~~~~kl~DfGla~~~~~--~~~~~~~~~gt~~y~aPE~~~~~-------~~s~ksDv~S~Gvil~elltg~~ 322 (412)
++|+++|..+.+|++|||+...... .........-..-|.|||.+... ..+.++||||||++++|+++.+.
T Consensus 77 s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~ 156 (484)
T KOG1023|consen 77 SSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSG 156 (484)
T ss_pred cccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccC
Confidence 9999999999999999999876642 11111222234579999998753 14678999999999999999999
Q ss_pred CcccccccccCCCCcchhhHHhhhc---cCCccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhcCCCCC
Q 042435 323 PGELLLSLSSSSGPKIMLIDILYQR---LSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELEGKTPMK 395 (412)
Q Consensus 323 P~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~~ 395 (412)
||+...... .+.+.+..+.... ..|...... +....+..++..||..+|++||++++|-..++.+....
T Consensus 157 ~~~~~~~~~---~~~eii~~~~~~~~~~~rP~i~~~~-e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~~ 228 (484)
T KOG1023|consen 157 PFDLRNLVE---DPDEIILRVKKGGSNPFRPSIELLN-ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKGG 228 (484)
T ss_pred ccccccccC---ChHHHHHHHHhcCCCCcCcchhhhh-hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcccc
Confidence 998432111 1112222222201 122211111 22235888999999999999999999999998887653
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.7e-21 Score=170.38 Aligned_cols=240 Identities=18% Similarity=0.202 Sum_probs=170.7
Q ss_pred HHHHHhhcCcccceeeeecCceEEEEEEe-CCCcEEEEEec----cCCcccc----------------ceEEEecCceEE
Q 042435 136 ENLIDATEYFHIRYCIGTGGYDSVYKAEL-PDGKVVALKKL----HHSETED----------------SAFVVYSPQCMF 194 (412)
Q Consensus 136 ~~l~~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l----~~~~~~~----------------~~~~~~~~~~~~ 194 (412)
.++.. .+.|.+.++||+|+||.+|.|.. .+|+.||||.- +|+.... ......+.+...
T Consensus 9 ~~~iv-~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynv 87 (341)
T KOG1163|consen 9 EELIV-GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNV 87 (341)
T ss_pred hhhee-ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCcchhHHHHHHHHhccCCCCchhhhhccccccce
Confidence 34433 35699999999999999999954 78999999963 3433221 122245567778
Q ss_pred EEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecC---CCcEEEeecCCc
Q 042435 195 FIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNS---NLEAFVADFGTV 271 (412)
Q Consensus 195 lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~---~~~~kl~DfGla 271 (412)
+|||.+ +.+|.+++.-.. ..++..+.+-++-|++.-++|+|.+ +.+||||||+|.|..- ..++.++|||+|
T Consensus 88 lVMdLL-GPsLEdLfnfC~--R~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLa 161 (341)
T KOG1163|consen 88 LVMDLL-GPSLEDLFNFCS--RRFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLA 161 (341)
T ss_pred eeeecc-CccHHHHHHHHh--hhhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEeccch
Confidence 999998 779988876433 2588899999999999999999999 8999999999999963 356889999999
Q ss_pred cccCCCCC-------CcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHh
Q 042435 272 RLLDVDSS-------NRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDIL 344 (412)
Q Consensus 272 ~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 344 (412)
+.+..... ......||..|.+-....+...+.+.|+=|+|.+|...--|..||+...... .......+.
T Consensus 162 Kky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~t----k~QKyEkI~ 237 (341)
T KOG1163|consen 162 KKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAAT----KKQKYEKIS 237 (341)
T ss_pred hhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhh----HHHHHHHHH
Confidence 87643221 1234579999999888888888999999999999999999999998543211 111222333
Q ss_pred hhccCCccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHH
Q 042435 345 YQRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQ 386 (412)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~ 386 (412)
...+..+...-+...+.++.-.+..|-..--++-|...-+.+
T Consensus 238 EkK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrq 279 (341)
T KOG1163|consen 238 EKKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQ 279 (341)
T ss_pred HhhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHH
Confidence 333333322222222333555666777777777776544433
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.85 E-value=4.7e-22 Score=203.63 Aligned_cols=232 Identities=19% Similarity=0.233 Sum_probs=160.4
Q ss_pred ccceeeeecCceEEEEEEe-CCCcEEEEEecc---------------------------CCccccceEEEecCceEEEEE
Q 042435 146 HIRYCIGTGGYDSVYKAEL-PDGKVVALKKLH---------------------------HSETEDSAFVVYSPQCMFFIY 197 (412)
Q Consensus 146 ~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l~---------------------------~~~~~~~~~~~~~~~~~~lv~ 197 (412)
...+++|.|++|.|+.... ...+..+.|..+ |+++........+.....-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 3457899999998777743 334444444322 222211111122223334449
Q ss_pred EeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCC
Q 042435 198 EYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVD 277 (412)
Q Consensus 198 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~ 277 (412)
|||++ +|+.++.... .++...+..++.|+..|++|+|+. +|.|||+|++|++++.++.+||+|||.+......
T Consensus 401 E~~~~-Dlf~~~~~~~---~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~ 473 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSNG---KLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASVFRYP 473 (601)
T ss_pred hcccH-HHHHHHhccc---ccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCcceeeccC
Confidence 99999 9999887652 477788889999999999999999 9999999999999999999999999998765433
Q ss_pred CC----CcccccccccccccccccCcccCc-ccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCcc
Q 042435 278 SS----NRTLQAGTYGYIALELVYTMVVTE-KCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPI 352 (412)
Q Consensus 278 ~~----~~~~~~gt~~y~aPE~~~~~~~s~-ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 352 (412)
.. ......|+-.|+|||.+.+..|++ ..||||.|+++..|++|+.||.....-.... ...............
T Consensus 474 ~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~---~~~~~~~~~~~~~~~ 550 (601)
T KOG0590|consen 474 WEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF---KTNNYSDQRNIFEGP 550 (601)
T ss_pred cchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch---hhhccccccccccCh
Confidence 22 235568999999999999999886 5999999999999999999987432111100 000000000111111
Q ss_pred chhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 353 NQKIIQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 353 ~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
..-..........++.++++.||.+|.|+++|++.
T Consensus 551 ~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d 585 (601)
T KOG0590|consen 551 NRLLSLLPRETRIIIYRMLQLDPTKRITIEQILND 585 (601)
T ss_pred HHHHHhchhhHHHHHHHHccCChhheecHHHHhhC
Confidence 11122223346778899999999999999999864
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=6.5e-21 Score=183.73 Aligned_cols=145 Identities=16% Similarity=0.133 Sum_probs=108.9
Q ss_pred HHHhhcCcccceeeeecCceEEEEEEeC--CCcEEEEEeccCC--------------------------ccccceEEEec
Q 042435 138 LIDATEYFHIRYCIGTGGYDSVYKAELP--DGKVVALKKLHHS--------------------------ETEDSAFVVYS 189 (412)
Q Consensus 138 l~~~~~~f~~~~~lG~G~~g~Vy~~~~~--~~~~vAvK~l~~~--------------------------~~~~~~~~~~~ 189 (412)
.....++|.+.+.||+|+||+||+|.+. +++.||||++... ++.. ....
T Consensus 13 ~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~---~l~~ 89 (365)
T PRK09188 13 IPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVP---QLLA 89 (365)
T ss_pred cccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCc---EEEE
Confidence 3345678999999999999999999764 5788899985421 1111 0122
Q ss_pred CceEEEEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCC-CCCCEEecCCCcEEEeec
Q 042435 190 PQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDI-SSNNILLNSNLEAFVADF 268 (412)
Q Consensus 190 ~~~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDl-kp~NILl~~~~~~kl~Df 268 (412)
.+..++||||+++++|... .. .. ...++.++++||+|||++ +|+|||| ||+|||++.++.+||+||
T Consensus 90 ~~~~~LVmE~~~G~~L~~~-~~------~~---~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ikLiDF 156 (365)
T PRK09188 90 TGKDGLVRGWTEGVPLHLA-RP------HG---DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAAVIDF 156 (365)
T ss_pred cCCcEEEEEccCCCCHHHh-Cc------cc---hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEEEEEC
Confidence 3568999999999999632 11 11 135788999999999998 9999999 999999999999999999
Q ss_pred CCccccCCCCCC--------cccccccccccccccccC
Q 042435 269 GTVRLLDVDSSN--------RTLQAGTYGYIALELVYT 298 (412)
Q Consensus 269 Gla~~~~~~~~~--------~~~~~gt~~y~aPE~~~~ 298 (412)
|+++.+...... .....+++.|+|||.+..
T Consensus 157 GlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 157 QLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred ccceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 999876443211 134567888999999863
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=9.6e-21 Score=172.67 Aligned_cols=179 Identities=17% Similarity=0.241 Sum_probs=145.8
Q ss_pred cCcccceeeeecCceEEEEEE-eCCCcEEEEEecc--------------------CCccccceEEEecCceEEEEEEecc
Q 042435 143 EYFHIRYCIGTGGYDSVYKAE-LPDGKVVALKKLH--------------------HSETEDSAFVVYSPQCMFFIYEYME 201 (412)
Q Consensus 143 ~~f~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~l~--------------------~~~~~~~~~~~~~~~~~~lv~ey~~ 201 (412)
-+|.++++||+|+||..+.|. +-+++.||||.-. .+.+........++.+..||+|.+
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL- 106 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL- 106 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEeccccCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh-
Confidence 369999999999999999995 4689999999531 122222333344556678999998
Q ss_pred CCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecC-----CCcEEEeecCCccccCC
Q 042435 202 RGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNS-----NLEAFVADFGTVRLLDV 276 (412)
Q Consensus 202 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~-----~~~~kl~DfGla~~~~~ 276 (412)
|.||++++.-.+ ..++..++..+|.|+..-++|+|++ .+|.|||||+|.||.. ...+.++|||+|+.+..
T Consensus 107 GPSLEDLFD~Cg--R~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrD 181 (449)
T KOG1165|consen 107 GPSLEDLFDLCG--RRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRD 181 (449)
T ss_pred CcCHHHHHHHhc--CcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEeccchhhhcC
Confidence 779988876443 3589999999999999999999999 9999999999999963 34588999999997744
Q ss_pred CCC-------CcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccc
Q 042435 277 DSS-------NRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELL 327 (412)
Q Consensus 277 ~~~-------~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~ 327 (412)
... ......||.+||+-....+...+.+.|+=|+|-+++..+-|..||+..
T Consensus 182 p~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGL 239 (449)
T KOG1165|consen 182 PKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGL 239 (449)
T ss_pred ccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccc
Confidence 322 124567999999999999999999999999999999999999999854
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.83 E-value=1e-19 Score=172.49 Aligned_cols=234 Identities=26% Similarity=0.352 Sum_probs=169.7
Q ss_pred cccceeeeecCceEEEEEEeCCCcEEEEEeccCC-------------------------ccccceEEEecCceEEEEEEe
Q 042435 145 FHIRYCIGTGGYDSVYKAELPDGKVVALKKLHHS-------------------------ETEDSAFVVYSPQCMFFIYEY 199 (412)
Q Consensus 145 f~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~l~~~-------------------------~~~~~~~~~~~~~~~~lv~ey 199 (412)
|.....||.|+||.||++... ..+|+|.+... ++.............+++++|
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 667789999999999999886 78888876432 233333334445557999999
Q ss_pred ccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCC-cEEEeecCCccccCCCC
Q 042435 200 MERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNL-EAFVADFGTVRLLDVDS 278 (412)
Q Consensus 200 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~-~~kl~DfGla~~~~~~~ 278 (412)
+.++++.+++........+.......++.|++.++.|+|+. +++|||+||+||+++... .++++|||.++......
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 99999996655432112478888999999999999999999 899999999999999888 79999999998554433
Q ss_pred C------CcccccccccccccccccC---cccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccC
Q 042435 279 S------NRTLQAGTYGYIALELVYT---MVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLS 349 (412)
Q Consensus 279 ~------~~~~~~gt~~y~aPE~~~~---~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 349 (412)
. ......||..|+|||...+ ..++...|+||+|++++++++|..||...... .......+.+.....
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~----~~~~~~~~~~~~~~~ 232 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS----SATSQTLKIILELPT 232 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc----ccHHHHHHHHHhcCC
Confidence 2 2355689999999999987 57888999999999999999999996632110 001112222222221
Q ss_pred C----ccchhh-HHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 350 P----PINQKI-IQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 350 ~----~~~~~~-~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
+ ...... ......+.+++..|+..+|..|.+..+....
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 233 PSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred cccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 1 111100 0111347788899999999999998887764
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.83 E-value=8.7e-22 Score=190.06 Aligned_cols=174 Identities=26% Similarity=0.381 Sum_probs=133.4
Q ss_pred eEEEEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCc
Q 042435 192 CMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTV 271 (412)
Q Consensus 192 ~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla 271 (412)
+.|+.|++|...+|.+||...+.....+|...+.++.|++.|++| + +.+|+|+||.||....+.++||.|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhhhe
Confidence 468999999999999999877666678899999999999999999 5 8999999999999999999999999998
Q ss_pred cccCCCC------CCcccccccccccccccccCcccCcccccHHHHHHHHHHHh-CCCCcccccccccCCCCcchhhHHh
Q 042435 272 RLLDVDS------SNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLM-GTHPGELLLSLSSSSGPKIMLIDIL 344 (412)
Q Consensus 272 ~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~ 344 (412)
....... ...+...||..||+||.+.+..|+.|+||||+|++|+|+++ =..+++. ...+.++-
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er----------~~t~~d~r 473 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFER----------IATLTDIR 473 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHH----------HHhhhhhh
Confidence 7654433 12355689999999999999999999999999999999997 2222221 11122222
Q ss_pred hhccCCccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHH
Q 042435 345 YQRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRIS 385 (412)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl 385 (412)
+..+++. ...+...-..++.+++...|.+||++.++.
T Consensus 474 ~g~ip~~----~~~d~p~e~~ll~~lls~~p~~RP~~~~~~ 510 (516)
T KOG1033|consen 474 DGIIPPE----FLQDYPEEYTLLQQLLSPSPEERPSAIEVA 510 (516)
T ss_pred cCCCChH----HhhcCcHHHHHHHHhcCCCcccCchHHHHh
Confidence 2222221 122222245788899999999999655543
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.81 E-value=7.7e-20 Score=162.01 Aligned_cols=120 Identities=19% Similarity=0.235 Sum_probs=91.9
Q ss_pred ceeeeecCceEEEEEEeCCCcEEEEEeccCCccc------------cc-------------------e----------EE
Q 042435 148 RYCIGTGGYDSVYKAELPDGKVVALKKLHHSETE------------DS-------------------A----------FV 186 (412)
Q Consensus 148 ~~~lG~G~~g~Vy~~~~~~~~~vAvK~l~~~~~~------------~~-------------------~----------~~ 186 (412)
...||+|+||.||+|...+|+.||||.++..... .. + .+
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 3679999999999998889999999998643210 00 0 00
Q ss_pred ----EecCceEEEEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHH-HhCCCCCcEEeCCCCCCEEecCCC
Q 042435 187 ----VYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYL-HHDCTPSIVHRDISSNNILLNSNL 261 (412)
Q Consensus 187 ----~~~~~~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~L-H~~~~~~ivHrDlkp~NILl~~~~ 261 (412)
.......++||||++++++....... ..+++.....++.|++.+|.|+ |+. +|+||||||+||+++ ++
T Consensus 82 ~~p~~~~~~~~~iVmE~i~g~~l~~~~~~~---~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIli~-~~ 154 (190)
T cd05147 82 PCPEPILLKSHVLVMEFIGDDGWAAPRLKD---APLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLLYH-DG 154 (190)
T ss_pred CCCcEEEecCCEEEEEEeCCCCCcchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEE-CC
Confidence 01112238999999987776543222 2488899999999999999999 677 999999999999998 47
Q ss_pred cEEEeecCCcccc
Q 042435 262 EAFVADFGTVRLL 274 (412)
Q Consensus 262 ~~kl~DfGla~~~ 274 (412)
.++|+|||+|...
T Consensus 155 ~v~LiDFG~a~~~ 167 (190)
T cd05147 155 KLYIIDVSQSVEH 167 (190)
T ss_pred cEEEEEccccccC
Confidence 8999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=2e-20 Score=192.79 Aligned_cols=228 Identities=22% Similarity=0.261 Sum_probs=160.7
Q ss_pred CcccceeeeecCceEEEEEEeCCCcEEEEEeccC------------------------CccccceEEEecCceEEEEEEe
Q 042435 144 YFHIRYCIGTGGYDSVYKAELPDGKVVALKKLHH------------------------SETEDSAFVVYSPQCMFFIYEY 199 (412)
Q Consensus 144 ~f~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~l~~------------------------~~~~~~~~~~~~~~~~~lv~ey 199 (412)
++...+.||++.|=+|.+|+.+.|. |+||++-. +|......+..+....|||-+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 5777789999999999999998888 78887632 2222222223344556788888
Q ss_pred ccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCcccc--CCC
Q 042435 200 MERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLL--DVD 277 (412)
Q Consensus 200 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~--~~~ 277 (412)
..+ +|+|.+.-+. -+...+..-|+.|+..||..+|.. +|+|||||.+|||++.-..+.|+||.--|.. ..+
T Consensus 103 vkh-nLyDRlSTRP---FL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeD 175 (1431)
T KOG1240|consen 103 VKH-NLYDRLSTRP---FLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFASFKPTYLPED 175 (1431)
T ss_pred Hhh-hhhhhhccch---HHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccccCCccCCCC
Confidence 865 8999887654 477778888999999999999999 9999999999999999999999999765532 111
Q ss_pred C-CCccc----ccccccccccccccCc----------c-cCcccccHHHHHHHHHHHh-CCCCcccccccccCCCCcchh
Q 042435 278 S-SNRTL----QAGTYGYIALELVYTM----------V-VTEKCVIYSFGVVALEVLM-GTHPGELLLSLSSSSGPKIML 340 (412)
Q Consensus 278 ~-~~~~~----~~gt~~y~aPE~~~~~----------~-~s~ksDv~S~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~ 340 (412)
. ..... ...-..|.|||.+... . .+++-||||+||++.|+++ |++||..-+-..-........
T Consensus 176 NPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~~~~~~ 255 (1431)
T KOG1240|consen 176 NPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSGNADDP 255 (1431)
T ss_pred CcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhccCccCH
Confidence 1 11111 1223479999987531 1 5678999999999999998 688887332211111111111
Q ss_pred hHHhhhccCCccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhc
Q 042435 341 IDILYQRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELEG 390 (412)
Q Consensus 341 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~ 390 (412)
...+.+ +.. ..+..++..|++.||++|-++++.++.-++
T Consensus 256 e~~Le~-Ied----------~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG 294 (1431)
T KOG1240|consen 256 EQLLEK-IED----------VSLRNLILSMIQRDPSKRLSAEDYLQKYRG 294 (1431)
T ss_pred HHHHHh-CcC----------ccHHHHHHHHHccCchhccCHHHHHHhhhc
Confidence 111111 111 126788999999999999999999987444
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.79 E-value=2.1e-19 Score=166.44 Aligned_cols=211 Identities=18% Similarity=0.234 Sum_probs=133.1
Q ss_pred cccceeeeecCceEEEEEEeC-CCcEEEEEeccCCccccc-----------------------------eE-----E---
Q 042435 145 FHIRYCIGTGGYDSVYKAELP-DGKVVALKKLHHSETEDS-----------------------------AF-----V--- 186 (412)
Q Consensus 145 f~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~~~~~~-----------------------------~~-----~--- 186 (412)
+...+.||.|+++.||.+... +|+.+|||.+.-+..... .+ .
T Consensus 14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i 93 (288)
T PF14531_consen 14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI 93 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence 455689999999999999774 599999996532210000 00 0
Q ss_pred ------EecC---c-----eEEEEEEeccCCceeeeeccC---c-ccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEe
Q 042435 187 ------VYSP---Q-----CMFFIYEYMERGSLFCVLRDD---D-EAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHR 248 (412)
Q Consensus 187 ------~~~~---~-----~~~lv~ey~~~gsL~~~l~~~---~-~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHr 248 (412)
.... . ..+++|+-+ .+||.+++..- . ....+....++.+..|+++.+++||+. |++|+
T Consensus 94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVHg 169 (288)
T PF14531_consen 94 PGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVHG 169 (288)
T ss_dssp TTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEES
T ss_pred cCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEec
Confidence 0001 1 236677777 45887765421 1 112345667788889999999999999 99999
Q ss_pred CCCCCCEEecCCCcEEEeecCCccccCCCCCCcccccccccccccccccC--------cccCcccccHHHHHHHHHHHhC
Q 042435 249 DISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTYGYIALELVYT--------MVVTEKCVIYSFGVVALEVLMG 320 (412)
Q Consensus 249 Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~s~ksDv~S~Gvil~elltg 320 (412)
||||+|++++.+|.++|+||+........ ......+..|.+||.... -.++.+.|.|++|+++|.|++|
T Consensus 170 di~~~nfll~~~G~v~Lg~F~~~~r~g~~---~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~ 246 (288)
T PF14531_consen 170 DIKPENFLLDQDGGVFLGDFSSLVRAGTR---YRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCG 246 (288)
T ss_dssp T-SGGGEEE-TTS-EEE--GGGEEETTEE---EEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHS
T ss_pred ccceeeEEEcCCCCEEEcChHHHeecCce---eeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHc
Confidence 99999999999999999999876543221 111334577999997643 2578899999999999999999
Q ss_pred CCCcccccccccCCCCcchhhHHhhhccCCccchhhHHHHHHHHHHHHhcCcCCCCCC
Q 042435 321 THPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKIIQDIILVSTIALACLRSKPKSR 378 (412)
Q Consensus 321 ~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~R 378 (412)
+.||+........ .. ... .+. +....+..|+..+++.||.+|
T Consensus 247 ~lPf~~~~~~~~~---~~--------~f~--~C~---~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 247 RLPFGLSSPEADP---EW--------DFS--RCR---DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp S-STCCCGGGSTS---GG--------GGT--TSS------HHHHHHHHHHT-SSGGGS
T ss_pred cCCCCCCCccccc---cc--------cch--hcC---CcCHHHHHHHHHHccCCcccC
Confidence 9999843211111 00 111 011 233348889999999999988
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.7e-19 Score=168.13 Aligned_cols=181 Identities=20% Similarity=0.284 Sum_probs=123.5
Q ss_pred CceEEEEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEe--cCCC--cEEE
Q 042435 190 PQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILL--NSNL--EAFV 265 (412)
Q Consensus 190 ~~~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl--~~~~--~~kl 265 (412)
+..+|+||.-.+. +|..++.... .+...+.-++.|+++|+.|||.+ +|.|||+|++|||+ |+|. ...|
T Consensus 315 ~~tlylvMkrY~~-tLr~yl~~~~----~s~r~~~~~laQlLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVv 386 (598)
T KOG4158|consen 315 PKTLYLVMKRYRQ-TLREYLWTRH----RSYRTGRVILAQLLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVV 386 (598)
T ss_pred CceEEEehhcchh-hHHHHHhcCC----CchHHHHHHHHHHHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEE
Confidence 4567899987755 8888886553 55566667889999999999999 99999999999999 4444 4678
Q ss_pred eecCCccccCCC------CCCcccccccccccccccccCcc-----c-CcccccHHHHHHHHHHHhCCCCcccccccccC
Q 042435 266 ADFGTVRLLDVD------SSNRTLQAGTYGYIALELVYTMV-----V-TEKCVIYSFGVVALEVLMGTHPGELLLSLSSS 333 (412)
Q Consensus 266 ~DfGla~~~~~~------~~~~~~~~gt~~y~aPE~~~~~~-----~-s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~ 333 (412)
+|||.+-.-+.. .+......|.-.-||||+....+ . -.|+|.|+.|.+.||+++...||...-..
T Consensus 387 aDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem--- 463 (598)
T KOG4158|consen 387 ADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEM--- 463 (598)
T ss_pred cccceeeeccccccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchh---
Confidence 999986432211 11123345777889999986432 1 14899999999999999999999731000
Q ss_pred CCCcchhhHHhhhccCCccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHH
Q 042435 334 SGPKIMLIDILYQRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQEL 388 (412)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L 388 (412)
.- .... ..+...++.++.. ...+.+++...++.||++||+..-..+.|
T Consensus 464 ~L---~~r~-Yqe~qLPalp~~v---pp~~rqlV~~lL~r~pskRvsp~iAANvl 511 (598)
T KOG4158|consen 464 LL---DTRT-YQESQLPALPSRV---PPVARQLVFDLLKRDPSKRVSPNIAANVL 511 (598)
T ss_pred ee---chhh-hhhhhCCCCcccC---ChHHHHHHHHHhcCCccccCCccHHHhHH
Confidence 00 0011 1111122222222 22377888899999999999876665554
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.79 E-value=9.8e-19 Score=155.23 Aligned_cols=120 Identities=23% Similarity=0.283 Sum_probs=92.2
Q ss_pred ceeeeecCceEEEEEEeCCCcEEEEEeccCCccccc---------------------------------e--------E-
Q 042435 148 RYCIGTGGYDSVYKAELPDGKVVALKKLHHSETEDS---------------------------------A--------F- 185 (412)
Q Consensus 148 ~~~lG~G~~g~Vy~~~~~~~~~vAvK~l~~~~~~~~---------------------------------~--------~- 185 (412)
...||+|+||.||+|...+|+.||||.++....... . .
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 467999999999999887899999998875421000 0 0
Q ss_pred ---EEecCceEEEEEEeccCCceeee-eccCcccccCCHHHHHHHHHHHHHHHHHHHh-CCCCCcEEeCCCCCCEEecCC
Q 042435 186 ---VVYSPQCMFFIYEYMERGSLFCV-LRDDDEAIELNWTRRMNIVKSVAHALSYLHH-DCTPSIVHRDISSNNILLNSN 260 (412)
Q Consensus 186 ---~~~~~~~~~lv~ey~~~gsL~~~-l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~-~~~~~ivHrDlkp~NILl~~~ 260 (412)
........++||||++++++... +... .++......++.|++.++.++|+ . +|+||||||+||+++ +
T Consensus 82 ~~p~~~~~~~~~lVmE~~~g~~~~~~~l~~~----~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NIll~-~ 153 (190)
T cd05145 82 PVPEPILLKKNVLVMEFIGDDGSPAPRLKDV----PLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNILYH-D 153 (190)
T ss_pred CCceEEEecCCEEEEEEecCCCchhhhhhhc----cCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhEEEE-C
Confidence 00001123899999998755432 3221 46778889999999999999999 7 999999999999999 7
Q ss_pred CcEEEeecCCccccC
Q 042435 261 LEAFVADFGTVRLLD 275 (412)
Q Consensus 261 ~~~kl~DfGla~~~~ 275 (412)
+.++|+|||+++...
T Consensus 154 ~~~~liDFG~a~~~~ 168 (190)
T cd05145 154 GKPYIIDVSQAVELD 168 (190)
T ss_pred CCEEEEEcccceecC
Confidence 899999999998654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.77 E-value=2.7e-18 Score=179.87 Aligned_cols=177 Identities=23% Similarity=0.263 Sum_probs=146.3
Q ss_pred hhcCcccceeeeecCceEEEEEEeCCCcEEEEEeccCCccccceEE---------------------EecCceEEEEEEe
Q 042435 141 ATEYFHIRYCIGTGGYDSVYKAELPDGKVVALKKLHHSETEDSAFV---------------------VYSPQCMFFIYEY 199 (412)
Q Consensus 141 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~---------------------~~~~~~~~lv~ey 199 (412)
..+.|.+.+.||+|+||+||+|...+|+.||+|.=+.++.-..+.. ....+.-+||+||
T Consensus 696 ~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv~ey 775 (974)
T KOG1166|consen 696 GGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEFYICLQVMERLKPQMLPSIMHISSAHVFQNASVLVSEY 775 (974)
T ss_pred cceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCceeeeehHHHHHhhchhhhcchHHHHHHHccCCcceeeeec
Confidence 3456888899999999999999988899999997666554332221 2234556899999
Q ss_pred ccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEec-------CCCcEEEeecCCcc
Q 042435 200 MERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLN-------SNLEAFVADFGTVR 272 (412)
Q Consensus 200 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~-------~~~~~kl~DfGla~ 272 (412)
.+.|+|.+++.... .++|...+.+..|+++-++.||.. +|||+||||+|.||. ++..++|+|||.+-
T Consensus 776 ~~~Gtlld~~N~~~---~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~si 849 (974)
T KOG1166|consen 776 SPYGTLLDLINTNK---VMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSI 849 (974)
T ss_pred cccccHHHhhccCC---CCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccceEEEecccce
Confidence 99999999998443 589999999999999999999999 999999999999993 34568999999986
Q ss_pred ccCC--CCCCcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCC
Q 042435 273 LLDV--DSSNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHP 323 (412)
Q Consensus 273 ~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P 323 (412)
.+.. +........+|-.+-++|+..+..++...|.|.++.+++-|+.|+.-
T Consensus 850 Dm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~ 902 (974)
T KOG1166|consen 850 DMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM 902 (974)
T ss_pred eeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence 5432 22334556788899999999999999999999999999999999854
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.2e-19 Score=178.49 Aligned_cols=203 Identities=24% Similarity=0.328 Sum_probs=152.2
Q ss_pred eeecCceEEEEEEe----CCCcEEEEEeccCCc------------------------cccceEEEecCceEEEEEEeccC
Q 042435 151 IGTGGYDSVYKAEL----PDGKVVALKKLHHSE------------------------TEDSAFVVYSPQCMFFIYEYMER 202 (412)
Q Consensus 151 lG~G~~g~Vy~~~~----~~~~~vAvK~l~~~~------------------------~~~~~~~~~~~~~~~lv~ey~~~ 202 (412)
+|+|+||.|+.++- +.|..+|+|.++... .......+..+...+++++|..+
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rg 81 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRG 81 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhccc
Confidence 68999999998732 457778888664322 22222335667778999999999
Q ss_pred CceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCCCCcc
Q 042435 203 GSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRT 282 (412)
Q Consensus 203 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 282 (412)
|+|...+.... .++......+...++-+++++|+. +|+|||+|++||+++.+|.+++.|||+++..-.....
T Consensus 82 g~lft~l~~~~---~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~-- 153 (612)
T KOG0603|consen 82 GDLFTRLSKEV---MFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA-- 153 (612)
T ss_pred chhhhccccCC---chHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHhhhhc--
Confidence 99988887654 466666677788899999999998 9999999999999999999999999999865433222
Q ss_pred cccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccchhhHHHHHH
Q 042435 283 LQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKIIQDIIL 362 (412)
Q Consensus 283 ~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 362 (412)
+||..|||||+.. .....+|.||||++++||+||..||.. ..+..+....+..+ . +....
T Consensus 154 --cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~-----------~~~~~Il~~~~~~p--~---~l~~~ 213 (612)
T KOG0603|consen 154 --CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG-----------DTMKRILKAELEMP--R---ELSAE 213 (612)
T ss_pred --ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch-----------HHHHHHhhhccCCc--h---hhhHH
Confidence 8999999999987 456789999999999999999999873 22333333222221 2 22223
Q ss_pred HHHHHHhcCcCCCCCCCCH
Q 042435 363 VSTIALACLRSKPKSRPTM 381 (412)
Q Consensus 363 ~~~l~~~Cl~~dP~~RPs~ 381 (412)
..++...+...+|..|--.
T Consensus 214 a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 214 ARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred HHHHHHHHHhhCHHHHhcc
Confidence 5667778888888888644
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.9e-18 Score=155.43 Aligned_cols=167 Identities=14% Similarity=0.116 Sum_probs=117.9
Q ss_pred eeeeccCccccHHHHHH--hhcCcccceeeeecCceEEEEEEeCCCcEEEEEeccCCccccc------------------
Q 042435 124 FSVWNYDGKILYENLID--ATEYFHIRYCIGTGGYDSVYKAELPDGKVVALKKLHHSETEDS------------------ 183 (412)
Q Consensus 124 ~~~~~~~~~~~~~~l~~--~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~l~~~~~~~~------------------ 183 (412)
+.++-.+....|.++.+ ..++|+..+++|.|+||.||.+.. ++..+|+|.++.......
T Consensus 10 ~~~~~~~~~~~~~~~~~~~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~ 88 (232)
T PRK10359 10 YTVFYKDNDNKYKEIFDDFLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQ 88 (232)
T ss_pred eEEEecCCcccHHHHHHHHhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHH
Confidence 34444445555656543 357899999999999999999866 577899998853221111
Q ss_pred ------------eEEEe--------cCceEEEEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCC
Q 042435 184 ------------AFVVY--------SPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTP 243 (412)
Q Consensus 184 ------------~~~~~--------~~~~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~ 243 (412)
..... .....+++|||++|.+|.++.. ++. ....+++.++..+|+.
T Consensus 89 l~rL~~~GI~~~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~~lH~~--- 154 (232)
T PRK10359 89 TDRVRSEGLASLNDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMPE-------ISE----DVKAKIKASIESLHQH--- 154 (232)
T ss_pred HHHHHHCCCCcceEeeeecccccccccCCeEEEEEEECCccHHHhhh-------ccH----HHHHHHHHHHHHHHHc---
Confidence 11111 1235789999999999977631 222 2456899999999999
Q ss_pred CcEEeCCCCCCEEecCCCcEEEeecCCccccCCCCCCcccccccccccccccccCcccCcccccHHHHHHHHHHH
Q 042435 244 SIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVL 318 (412)
Q Consensus 244 ~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~ell 318 (412)
+++|||+||+||+++.++ ++++|||..+........ ..+.....+..++|+||||+++.-..
T Consensus 155 gi~H~Dikp~Nili~~~g-i~liDfg~~~~~~e~~a~------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 155 GMVSGDPHKGNFIVSKNG-LRIIDLSGKRCTAQRKAK------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred CCccCCCChHHEEEeCCC-EEEEECCCcccccchhhH------------HHHHHHhHhcccccccceeEeehHHH
Confidence 999999999999999888 999999988654321111 01233445667999999999887654
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.4e-18 Score=179.06 Aligned_cols=207 Identities=21% Similarity=0.259 Sum_probs=145.1
Q ss_pred hcCcccceeeeecCceEEEEEEeC-CCcEEEEEeccCCccccceEEEecCceEEEEEEeccCCceeeeeccCcccccCCH
Q 042435 142 TEYFHIRYCIGTGGYDSVYKAELP-DGKVVALKKLHHSETEDSAFVVYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNW 220 (412)
Q Consensus 142 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~~~l~~ 220 (412)
..+|+..+.|..|+||.||..+++ ..+.+|+ +++..++.-.. +....+..+.| |+-...++..+. ++
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~-kiNkq~lilRn-ilt~a~npfvv------gDc~tllk~~g~---lP- 149 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAM-KINKQNLILRN-ILTFAGNPFVV------GDCATLLKNIGP---LP- 149 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhh-cccccchhhhc-cccccCCccee------chhhhhcccCCC---Cc-
Confidence 468999999999999999999875 4678999 55555544332 11222333333 455555544331 21
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCC---------------CCccccc
Q 042435 221 TRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDS---------------SNRTLQA 285 (412)
Q Consensus 221 ~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~---------------~~~~~~~ 285 (412)
.+++.+++|||+. +|+|||+||+|.++..-+.+|++|||+++...... ......+
T Consensus 150 -------vdmvla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvc 219 (1205)
T KOG0606|consen 150 -------VDMVLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVC 219 (1205)
T ss_pred -------chhhHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchHHHHHHhhhcccc
Confidence 1227899999998 99999999999999999999999999987542111 0113458
Q ss_pred ccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccchhhHHHHHHHHH
Q 042435 286 GTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKIIQDIILVST 365 (412)
Q Consensus 286 gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 365 (412)
||+.|+|||++....|....|.|++|+|+||.+-|..||... .+++.+..++...+.-+ +.......++.+
T Consensus 220 gTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGd-------tpeelfg~visd~i~wp--E~dea~p~Ea~d 290 (1205)
T KOG0606|consen 220 GTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGD-------TPEELFGQVISDDIEWP--EEDEALPPEAQD 290 (1205)
T ss_pred CCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCC-------CHHHHHhhhhhhhcccc--ccCcCCCHHHHH
Confidence 999999999999999999999999999999999999998732 22232333332222211 111122334778
Q ss_pred HHHhcCcCCCCCCC
Q 042435 366 IALACLRSKPKSRP 379 (412)
Q Consensus 366 l~~~Cl~~dP~~RP 379 (412)
++.+.++.+|..|-
T Consensus 291 li~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 291 LIEQLLRQNPLCRL 304 (1205)
T ss_pred HHHHHHHhChHhhc
Confidence 88999999999994
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.72 E-value=2.8e-17 Score=150.54 Aligned_cols=124 Identities=23% Similarity=0.217 Sum_probs=95.9
Q ss_pred CcccceeeeecCceEEEEEE--eCCCcEEEEEeccCCcccc----------c---------------------------e
Q 042435 144 YFHIRYCIGTGGYDSVYKAE--LPDGKVVALKKLHHSETED----------S---------------------------A 184 (412)
Q Consensus 144 ~f~~~~~lG~G~~g~Vy~~~--~~~~~~vAvK~l~~~~~~~----------~---------------------------~ 184 (412)
.|++.+.||+|+||.||+|. ..+|+.||+|.++...... . .
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 47788999999999999998 5689999999886542100 0 0
Q ss_pred --EE----EecCceEEEEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCC-cEEeCCCCCCEEe
Q 042435 185 --FV----VYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPS-IVHRDISSNNILL 257 (412)
Q Consensus 185 --~~----~~~~~~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~-ivHrDlkp~NILl 257 (412)
.. .......++||||+++++|........ .+...+...++.|++.++++||++ + ++||||||+||++
T Consensus 109 ~~~i~~p~~~~~~~~~lV~E~~~g~~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~Dikp~NIli 182 (237)
T smart00090 109 EAGVPVPKPIAWRRNVLVMEFIGGDGLPAPRLKDV---EPEEEEEFELYDDILEEMRKLYKE---GELVHGDLSEYNILV 182 (237)
T ss_pred hcCCCCCeeeEecCceEEEEEecCCcccccccccC---CcchHHHHHHHHHHHHHHHHHHhc---CCEEeCCCChhhEEE
Confidence 00 111234589999999988876543222 345556778999999999999999 8 9999999999999
Q ss_pred cCCCcEEEeecCCcccc
Q 042435 258 NSNLEAFVADFGTVRLL 274 (412)
Q Consensus 258 ~~~~~~kl~DfGla~~~ 274 (412)
+ +++++++|||.+...
T Consensus 183 ~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 183 H-DGKVVIIDVSQSVEL 198 (237)
T ss_pred E-CCCEEEEEChhhhcc
Confidence 9 889999999998753
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.2e-16 Score=141.15 Aligned_cols=162 Identities=9% Similarity=0.047 Sum_probs=114.6
Q ss_pred ccceeeeecCceEEEEEEeCCCcEEEEEeccCCc--------------------------cccceEEEecCceEEEEEEe
Q 042435 146 HIRYCIGTGGYDSVYKAELPDGKVVALKKLHHSE--------------------------TEDSAFVVYSPQCMFFIYEY 199 (412)
Q Consensus 146 ~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~l~~~~--------------------------~~~~~~~~~~~~~~~lv~ey 199 (412)
.+...|++|+||+||.+.. .+..++.+.+.... +.... .-+..+++|||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll----~~~~~~lvmey 79 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLL----HWDGRHLDRSY 79 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEE----EEcCEEEEEee
Confidence 4567899999999998766 66777766543211 11111 12456999999
Q ss_pred ccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCC-CCCCEEecCCCcEEEeecCCccccCCCC
Q 042435 200 MERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDI-SSNNILLNSNLEAFVADFGTVRLLDVDS 278 (412)
Q Consensus 200 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDl-kp~NILl~~~~~~kl~DfGla~~~~~~~ 278 (412)
+++.+|.+.+.. ....++.|++.+|+++|++ +|+|||| ||+|||++.++.++|+|||++.......
T Consensus 80 I~G~~L~~~~~~----------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~ 146 (218)
T PRK12274 80 LAGAAMYQRPPR----------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRA 146 (218)
T ss_pred ecCccHHhhhhh----------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCceecCCcc
Confidence 999888654321 1134778999999999999 9999999 7999999999999999999998554332
Q ss_pred CC-------------cccccccccccccccccCc-ccC-cccccHHHHHHHHHHHhCCCCcc
Q 042435 279 SN-------------RTLQAGTYGYIALELVYTM-VVT-EKCVIYSFGVVALEVLMGTHPGE 325 (412)
Q Consensus 279 ~~-------------~~~~~gt~~y~aPE~~~~~-~~s-~ksDv~S~Gvil~elltg~~P~~ 325 (412)
.. ......++.|++|+...-. ..+ ...+.++-|.-+|.++|+..|..
T Consensus 147 ~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~ 208 (218)
T PRK12274 147 RWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHW 208 (218)
T ss_pred hHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcc
Confidence 10 0112346677777654321 233 45677899999999999998843
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.7e-16 Score=141.83 Aligned_cols=128 Identities=22% Similarity=0.256 Sum_probs=97.0
Q ss_pred HHHHHhhcCcccceeeeecCceEEEEEEeCCCcEEEEEeccCCccc-----c----------------------c-----
Q 042435 136 ENLIDATEYFHIRYCIGTGGYDSVYKAELPDGKVVALKKLHHSETE-----D----------------------S----- 183 (412)
Q Consensus 136 ~~l~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~l~~~~~~-----~----------------------~----- 183 (412)
.++......|.+.+.||+|+||.||++..++|+.||||.++..... . .
T Consensus 8 ~~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 87 (198)
T cd05144 8 HTLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAAL 87 (198)
T ss_pred HHHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHH
Confidence 3444444457888999999999999999888999999976432200 0 0
Q ss_pred -----e----EEEecCceEEEEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCC
Q 042435 184 -----A----FVVYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNN 254 (412)
Q Consensus 184 -----~----~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~N 254 (412)
. .........++||||+++++|...... .....++.+++.++.++|+. +++||||||+|
T Consensus 88 ~~l~~~~i~v~~~~~~~~~~lv~e~~~g~~L~~~~~~---------~~~~~~~~~i~~~l~~lh~~---gi~H~Dl~p~N 155 (198)
T cd05144 88 KALYEEGFPVPKPIDWNRHAVVMEYIDGVELYRVRVL---------EDPEEVLDEILEEIVKAYKH---GIIHGDLSEFN 155 (198)
T ss_pred HHHHHcCCCCCceeecCCceEEEEEeCCcchhhcccc---------ccHHHHHHHHHHHHHHHHHC---CCCcCCCCccc
Confidence 0 001123456899999999998765431 23456889999999999998 99999999999
Q ss_pred EEecCCCcEEEeecCCccccC
Q 042435 255 ILLNSNLEAFVADFGTVRLLD 275 (412)
Q Consensus 255 ILl~~~~~~kl~DfGla~~~~ 275 (412)
|+++++++++|+|||.+....
T Consensus 156 ill~~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 156 ILVDDDEKIYIIDWPQMVSTD 176 (198)
T ss_pred EEEcCCCcEEEEECCccccCC
Confidence 999999999999999986543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.63 E-value=1.1e-15 Score=137.77 Aligned_cols=113 Identities=19% Similarity=0.380 Sum_probs=91.2
Q ss_pred eeeeecCceEEEEEEeCCCcEEEEEeccCC-----------------------------ccccceEEEecCceEEEEEEe
Q 042435 149 YCIGTGGYDSVYKAELPDGKVVALKKLHHS-----------------------------ETEDSAFVVYSPQCMFFIYEY 199 (412)
Q Consensus 149 ~~lG~G~~g~Vy~~~~~~~~~vAvK~l~~~-----------------------------~~~~~~~~~~~~~~~~lv~ey 199 (412)
+.||+|++|.||+|.+ +|..+++|..... ++......+...+..+++|||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5789999999999988 6778899964321 111122234456678899999
Q ss_pred ccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccc
Q 042435 200 MERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRL 273 (412)
Q Consensus 200 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~ 273 (412)
+++++|.+++... .+ .+..++.+++.+|.++|+. +++|||++|.||+++ ++.++++|||.++.
T Consensus 81 ~~G~~L~~~~~~~------~~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSN------GM-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhc------cH-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999998887542 22 7888999999999999998 999999999999999 78999999998864
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.61 E-value=1.7e-15 Score=135.31 Aligned_cols=109 Identities=20% Similarity=0.383 Sum_probs=85.9
Q ss_pred eeeecCceEEEEEEeCCCcEEEEEeccCCc-----------------------------cccceEEEecCceEEEEEEec
Q 042435 150 CIGTGGYDSVYKAELPDGKVVALKKLHHSE-----------------------------TEDSAFVVYSPQCMFFIYEYM 200 (412)
Q Consensus 150 ~lG~G~~g~Vy~~~~~~~~~vAvK~l~~~~-----------------------------~~~~~~~~~~~~~~~lv~ey~ 200 (412)
.||+|+||.||+|.+ +|..+++|...... +..........+..++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 389999999999986 67889999753211 111112234455678999999
Q ss_pred cCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccc
Q 042435 201 ERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRL 273 (412)
Q Consensus 201 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~ 273 (412)
++++|.+++.... . .++.+++.+|.++|+. +++|+|++|.||+++ ++.++++|||+++.
T Consensus 80 ~g~~l~~~~~~~~----~------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEGN----D------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhcH----H------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 9999987764322 0 7899999999999998 999999999999999 78999999999874
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.61 E-value=2.2e-15 Score=133.19 Aligned_cols=119 Identities=23% Similarity=0.258 Sum_probs=87.8
Q ss_pred ceeeeecCceEEEEEEeCCCcEEEEEeccCCccccc--eE----------------------------------------
Q 042435 148 RYCIGTGGYDSVYKAELPDGKVVALKKLHHSETEDS--AF---------------------------------------- 185 (412)
Q Consensus 148 ~~~lG~G~~g~Vy~~~~~~~~~vAvK~l~~~~~~~~--~~---------------------------------------- 185 (412)
.+.||+|+||.||+|...+|+.||||.++....... ..
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 467999999999999888899999998765321100 00
Q ss_pred -EEecCceEEEEEEeccCCceeee-eccCcccccCCHHHHHHHHHHHHHHHHHHHh-CCCCCcEEeCCCCCCEEecCCCc
Q 042435 186 -VVYSPQCMFFIYEYMERGSLFCV-LRDDDEAIELNWTRRMNIVKSVAHALSYLHH-DCTPSIVHRDISSNNILLNSNLE 262 (412)
Q Consensus 186 -~~~~~~~~~lv~ey~~~gsL~~~-l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~-~~~~~ivHrDlkp~NILl~~~~~ 262 (412)
........++||||++++++... +.... .. .....++.+++.++.++|. . +++||||||+||+++ ++.
T Consensus 82 ~~~~~~~~~~lv~e~~~g~~~~~~~l~~~~----~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Nili~-~~~ 152 (187)
T cd05119 82 PKPIDLNRHVLVMEFIGGDGIPAPRLKDVR----LL-EDPEELYDQILELMRKLYREA---GLVHGDLSEYNILVD-DGK 152 (187)
T ss_pred CceEecCCCEEEEEEeCCCCccChhhhhhh----hc-ccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhEEEE-CCc
Confidence 01111245899999998654321 21111 11 5567899999999999998 6 999999999999999 899
Q ss_pred EEEeecCCccccC
Q 042435 263 AFVADFGTVRLLD 275 (412)
Q Consensus 263 ~kl~DfGla~~~~ 275 (412)
++++|||.+....
T Consensus 153 ~~liDfg~a~~~~ 165 (187)
T cd05119 153 VYIIDVPQAVEID 165 (187)
T ss_pred EEEEECccccccc
Confidence 9999999987543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.59 E-value=5.6e-15 Score=132.38 Aligned_cols=115 Identities=17% Similarity=0.140 Sum_probs=84.6
Q ss_pred ccceeeeecCceEEEEEEeCCCcEEEEEecc--------------------------CCccccceEEEecCc---e-EEE
Q 042435 146 HIRYCIGTGGYDSVYKAELPDGKVVALKKLH--------------------------HSETEDSAFVVYSPQ---C-MFF 195 (412)
Q Consensus 146 ~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~l~--------------------------~~~~~~~~~~~~~~~---~-~~l 195 (412)
.....||+|+||.||. +++....+||++. |+++.+..+++.++. . ..+
T Consensus 5 ~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~ 82 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV 82 (210)
T ss_pred CCcceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence 3457899999999996 4333333688643 466666666666653 3 337
Q ss_pred EEEe--ccCCceeeeeccCcccccCCHHHHHHHHHHHHHHH-HHHHhCCCCCcEEeCCCCCCEEecC----CCcEEEeec
Q 042435 196 IYEY--MERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHAL-SYLHHDCTPSIVHRDISSNNILLNS----NLEAFVADF 268 (412)
Q Consensus 196 v~ey--~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL-~~LH~~~~~~ivHrDlkp~NILl~~----~~~~kl~Df 268 (412)
|+|| +++|+|.+++.+.. ++.. ..++.+++.++ +|||++ +|+||||||+|||++. +..++|+||
T Consensus 83 I~e~~G~~~~tL~~~l~~~~----~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~LiDg 153 (210)
T PRK10345 83 IADFDGKPSITLTEFAEQCR----YEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPVVCDN 153 (210)
T ss_pred EecCCCCcchhHHHHHHccc----ccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEEEEEC
Confidence 8999 66899999996532 4444 35677888787 999999 9999999999999973 348999995
Q ss_pred CCc
Q 042435 269 GTV 271 (412)
Q Consensus 269 Gla 271 (412)
+-+
T Consensus 154 ~G~ 156 (210)
T PRK10345 154 IGE 156 (210)
T ss_pred CCC
Confidence 444
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.59 E-value=2.4e-15 Score=154.26 Aligned_cols=119 Identities=20% Similarity=0.313 Sum_probs=89.4
Q ss_pred HHhhcCcccceeeeecCceEEEEEEeCCCcEEEEEe-cc----------------------------CCccccceEEEec
Q 042435 139 IDATEYFHIRYCIGTGGYDSVYKAELPDGKVVALKK-LH----------------------------HSETEDSAFVVYS 189 (412)
Q Consensus 139 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~-l~----------------------------~~~~~~~~~~~~~ 189 (412)
......|...+.||+|+||.||+|.+.+... ++|+ .. +.++.........
T Consensus 329 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~~-v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~ 407 (535)
T PRK09605 329 EEVKRRKIPDHLIGKGAEADIKKGEYLGRDA-VIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVD 407 (535)
T ss_pred cccccccCccceeccCCcEEEEEEeecCccc-eeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEe
Confidence 3344556678899999999999998855443 3332 11 1111222223444
Q ss_pred CceEEEEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecC
Q 042435 190 PQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFG 269 (412)
Q Consensus 190 ~~~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG 269 (412)
.+..++||||+++++|.+++. ....++.+++++|.|||+. +++|||+||+|||+ +++.++|+|||
T Consensus 408 ~~~~~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~liDFG 472 (535)
T PRK09605 408 PEEKTIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLIDFG 472 (535)
T ss_pred CCCCEEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEEeCc
Confidence 566789999999999987664 3467899999999999998 99999999999999 57899999999
Q ss_pred Cccc
Q 042435 270 TVRL 273 (412)
Q Consensus 270 la~~ 273 (412)
+++.
T Consensus 473 la~~ 476 (535)
T PRK09605 473 LGKY 476 (535)
T ss_pred cccc
Confidence 9975
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.46 E-value=1.1e-14 Score=149.69 Aligned_cols=234 Identities=20% Similarity=0.248 Sum_probs=161.5
Q ss_pred hcCcccceeeeecCceEEEEEEeC--CCcEEEEEecc------------------------CCccccceEEEecCceEEE
Q 042435 142 TEYFHIRYCIGTGGYDSVYKAELP--DGKVVALKKLH------------------------HSETEDSAFVVYSPQCMFF 195 (412)
Q Consensus 142 ~~~f~~~~~lG~G~~g~Vy~~~~~--~~~~vAvK~l~------------------------~~~~~~~~~~~~~~~~~~l 195 (412)
...|.+.+-||+|+|+.|-..... ....+|+|.+. |.+...........+..++
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~ 98 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL 98 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence 345666777999999999877552 34456666543 3333333333455677899
Q ss_pred EEEeccCCceeeee-ccCcccccCCHHHHHHHHHHHHHHHHHHH-hCCCCCcEEeCCCCCCEEecCCC-cEEEeecCCcc
Q 042435 196 IYEYMERGSLFCVL-RDDDEAIELNWTRRMNIVKSVAHALSYLH-HDCTPSIVHRDISSNNILLNSNL-EAFVADFGTVR 272 (412)
Q Consensus 196 v~ey~~~gsL~~~l-~~~~~~~~l~~~~~~~i~~~ia~gL~~LH-~~~~~~ivHrDlkp~NILl~~~~-~~kl~DfGla~ 272 (412)
+.+|..+|++.+.+ ..... ..+....-.++.|+..++.|+| +. ++.|||+||+|.+++..+ ..+++|||+|.
T Consensus 99 ~~~~s~g~~~f~~i~~~~~~--~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~~At 173 (601)
T KOG0590|consen 99 SLSYSDGGSLFSKISHPDST--GTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFGLAT 173 (601)
T ss_pred ccCcccccccccccccCCcc--CCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCchhhc
Confidence 99999999999888 43321 2444556678999999999999 77 999999999999999999 99999999998
Q ss_pred ccCC-CCC--Ccccccc-cccccccccccCc-ccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhc
Q 042435 273 LLDV-DSS--NRTLQAG-TYGYIALELVYTM-VVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQR 347 (412)
Q Consensus 273 ~~~~-~~~--~~~~~~g-t~~y~aPE~~~~~-~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 347 (412)
.... ... ......| ++.|+|||...+. ...+..|+||.|+++.-+++|..|++....... ....+....
T Consensus 174 ~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~------~~~~~~~~~ 247 (601)
T KOG0590|consen 174 AYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDG------RYSSWKSNK 247 (601)
T ss_pred cccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccc------cceeecccc
Confidence 7655 222 2244567 9999999999874 456789999999999999999999874321111 111111111
Q ss_pred cCCccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 348 LSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
..... .....-.....++..+++..+|+.|.+.+++-..
T Consensus 248 ~~~~~-~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d 286 (601)
T KOG0590|consen 248 GRFTQ-LPWNSISDQAHDLLHKILKENPSNRLSIEELKLD 286 (601)
T ss_pred ccccc-CccccCChhhhhcccccccCCchhcccccccccc
Confidence 00000 0001111235677788888999999998887543
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.43 E-value=1.9e-12 Score=109.26 Aligned_cols=116 Identities=20% Similarity=0.163 Sum_probs=90.4
Q ss_pred cceeeeecCceEEEEEEeCCCcEEEEEeccCCcc---------------------ccceEEEecCceEEEEEEeccCCce
Q 042435 147 IRYCIGTGGYDSVYKAELPDGKVVALKKLHHSET---------------------EDSAFVVYSPQCMFFIYEYMERGSL 205 (412)
Q Consensus 147 ~~~~lG~G~~g~Vy~~~~~~~~~vAvK~l~~~~~---------------------~~~~~~~~~~~~~~lv~ey~~~gsL 205 (412)
+.+.||+|.++.||++...+ ..+++|..+.... ..........+..++++||++++++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~ 80 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREKGADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETL 80 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCchhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeec
Confidence 35789999999999999854 7899998755431 0011112233468999999988777
Q ss_pred eeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccc
Q 042435 206 FCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRL 273 (412)
Q Consensus 206 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~ 273 (412)
..+ ++.....++.+++++++++|.....+++|+|++|+||++++.+.++++|||.++.
T Consensus 81 ~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 81 DEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 643 4566777899999999999986555799999999999999989999999998864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.41 E-value=9e-13 Score=131.33 Aligned_cols=118 Identities=25% Similarity=0.299 Sum_probs=88.0
Q ss_pred eeeeecCceEEEEEEeCCCcEEEEEeccCCccccc----------------------e----------------------
Q 042435 149 YCIGTGGYDSVYKAELPDGKVVALKKLHHSETEDS----------------------A---------------------- 184 (412)
Q Consensus 149 ~~lG~G~~g~Vy~~~~~~~~~vAvK~l~~~~~~~~----------------------~---------------------- 184 (412)
+.||+|++|.||+|++++|+.||||..+.. +... .
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~-i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPG-IEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCC-cHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 679999999999999999999999986432 1000 0
Q ss_pred -----------------EE-----E-ecCceEEEEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHH-HHHHHHhC
Q 042435 185 -----------------FV-----V-YSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAH-ALSYLHHD 240 (412)
Q Consensus 185 -----------------~~-----~-~~~~~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~-gL~~LH~~ 240 (412)
.+ + ......+|||||++|++|.++...... .. .+..++..++. .+..+|..
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~--~~---~~~~ia~~~~~~~l~ql~~~ 276 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA--GL---DRKALAENLARSFLNQVLRD 276 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc--CC---CHHHHHHHHHHHHHHHHHhC
Confidence 00 0 012345799999999999887643211 12 23456666666 46788887
Q ss_pred CCCCcEEeCCCCCCEEecCCCcEEEeecCCccccC
Q 042435 241 CTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLD 275 (412)
Q Consensus 241 ~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~ 275 (412)
+++|+|++|.||+++.+++++++|||++..+.
T Consensus 277 ---g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 277 ---GFFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred ---CceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 99999999999999999999999999998764
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.39 E-value=1.1e-12 Score=120.39 Aligned_cols=114 Identities=18% Similarity=0.286 Sum_probs=83.6
Q ss_pred ceeee-ecCceEEEEEEeCCCcEEEEEeccCCccc------------------------------------cceEEEe-c
Q 042435 148 RYCIG-TGGYDSVYKAELPDGKVVALKKLHHSETE------------------------------------DSAFVVY-S 189 (412)
Q Consensus 148 ~~~lG-~G~~g~Vy~~~~~~~~~vAvK~l~~~~~~------------------------------------~~~~~~~-~ 189 (412)
...|| .||.|+||++... +..++||++...+.. ....... .
T Consensus 36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 35788 8999999999884 778888877543210 0000011 1
Q ss_pred Cc---eEEEEEEeccC-CceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEE
Q 042435 190 PQ---CMFFIYEYMER-GSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFV 265 (412)
Q Consensus 190 ~~---~~~lv~ey~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl 265 (412)
.. ..++|+||+++ .+|.+++... .++.. .+.+++.++.+||+. ||+||||||.|||++.++.++|
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~----~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~v~L 183 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQEA----PLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDPDGKFWL 183 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhcC----CCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCCEEE
Confidence 11 23599999997 6888777543 24433 357899999999999 9999999999999998889999
Q ss_pred eecCCccc
Q 042435 266 ADFGTVRL 273 (412)
Q Consensus 266 ~DfGla~~ 273 (412)
+|||.++.
T Consensus 184 IDfg~~~~ 191 (239)
T PRK01723 184 IDFDRGEL 191 (239)
T ss_pred EECCCccc
Confidence 99998875
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.27 E-value=4.3e-12 Score=116.47 Aligned_cols=183 Identities=21% Similarity=0.270 Sum_probs=123.0
Q ss_pred CceEEEEEEeccCCceeeeeccCcc-cccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeec
Q 042435 190 PQCMFFIYEYMERGSLFCVLRDDDE-AIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADF 268 (412)
Q Consensus 190 ~~~~~lv~ey~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Df 268 (412)
.....++.|||..|++..+|+.... ...+....-.+++.||..||.|||+. .|+|+|+++..+-|++..++-+|+.-
T Consensus 144 ~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-~PpiihgnlTc~tifiq~ngLIkig~- 221 (458)
T KOG1266|consen 144 KPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-DPPIIHGNLTCDTIFIQHNGLIKIGS- 221 (458)
T ss_pred ccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-CCccccCCcchhheeecCCceEEecc-
Confidence 3456789999999999999986542 23455556678999999999999985 88999999999999999888777642
Q ss_pred CCccccCCC-----CCCcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCC-cccccccccCCCCcchhhH
Q 042435 269 GTVRLLDVD-----SSNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHP-GELLLSLSSSSGPKIMLID 342 (412)
Q Consensus 269 Gla~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P-~~~~~~~~~~~~~~~~~~~ 342 (412)
+-....... ........+-++|.+||+-.....+.++|||+||...+||..+..- ..... ....+.....
T Consensus 222 ~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailEiq~tnseS----~~~~ee~ia~ 297 (458)
T KOG1266|consen 222 VAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILEIQSTNSES----KVEVEENIAN 297 (458)
T ss_pred cCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHheeccCCCcc----eeehhhhhhh
Confidence 111111110 1111233467899999988777778899999999999999877532 11000 0001111111
Q ss_pred HhhhccCCccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHh
Q 042435 343 ILYQRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELE 389 (412)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~ 389 (412)
.+.. +..+. -.+++..|++..|..||+|.+++.|.-
T Consensus 298 ~i~~-len~l----------qr~~i~kcl~~eP~~rp~ar~llfHpl 333 (458)
T KOG1266|consen 298 VIIG-LENGL----------QRGSITKCLEGEPNGRPDARLLLFHPL 333 (458)
T ss_pred heee-ccCcc----------ccCcCcccccCCCCCCcchhhhhcCce
Confidence 1111 11000 124567899999999999999887653
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.21 E-value=1.5e-11 Score=121.69 Aligned_cols=225 Identities=24% Similarity=0.224 Sum_probs=150.8
Q ss_pred cccceeeee--cCceEEEEEEe---CCCcEEEEEeccCC------------------------ccccceEEEecCceEEE
Q 042435 145 FHIRYCIGT--GGYDSVYKAEL---PDGKVVALKKLHHS------------------------ETEDSAFVVYSPQCMFF 195 (412)
Q Consensus 145 f~~~~~lG~--G~~g~Vy~~~~---~~~~~vAvK~l~~~------------------------~~~~~~~~~~~~~~~~l 195 (412)
|.+...+|. |.+|.||.+.. .++..+|+|+=+++ +...........+..++
T Consensus 116 ~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lfi 195 (524)
T KOG0601|consen 116 FPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILFI 195 (524)
T ss_pred cccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCccee
Confidence 555678999 99999999976 46888999973322 22222223556677888
Q ss_pred EEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHH----HHHHHHhCCCCCcEEeCCCCCCEEecCC-CcEEEeecCC
Q 042435 196 IYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAH----ALSYLHHDCTPSIVHRDISSNNILLNSN-LEAFVADFGT 270 (412)
Q Consensus 196 v~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~----gL~~LH~~~~~~ivHrDlkp~NILl~~~-~~~kl~DfGl 270 (412)
-+|++. .+|..+.+.... .++.........+... ||.++|+. +++|-|+||.||+...+ ...+++|||+
T Consensus 196 qtE~~~-~sl~~~~~~~~~--~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s~~~~df~~ 269 (524)
T KOG0601|consen 196 QTELCG-ESLQSYCHTPCN--FLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTSCKLTDFGL 269 (524)
T ss_pred eecccc-chhHHhhhcccc--cCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccceeecCCcce
Confidence 899885 577776655432 2444445555556556 99999988 99999999999999998 8899999999
Q ss_pred ccccCCCCCCc-----ccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhh
Q 042435 271 VRLLDVDSSNR-----TLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILY 345 (412)
Q Consensus 271 a~~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~ 345 (412)
...+....-.. ....|...|++||... ..++..+|+||+|.+..|..++..+........... +....
T Consensus 270 v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~-----~r~~~- 342 (524)
T KOG0601|consen 270 VSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQ-----LRQGY- 342 (524)
T ss_pred eEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCCCCccc-----ccccc-
Confidence 98776543222 2225777899999874 467889999999999999999876644220000000 00000
Q ss_pred hccCCccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 346 QRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
+..+ ....-...+...+..+++.+|..|++...+.++
T Consensus 343 --ip~e---~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l 379 (524)
T KOG0601|consen 343 --IPLE---FCEGGSSSLRSVTSQMLDEDPRLRLTAQILTAL 379 (524)
T ss_pred --Cchh---hhcCcchhhhhHHHHhcCcchhhhhHHHHHhcc
Confidence 1110 010111123447778999999999988877543
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.20 E-value=1.5e-11 Score=124.33 Aligned_cols=124 Identities=21% Similarity=0.227 Sum_probs=81.7
Q ss_pred hcCcccceeeeecCceEEEEEEeCC-CcEEEEEeccCCccc------------------------cc--e-----E----
Q 042435 142 TEYFHIRYCIGTGGYDSVYKAELPD-GKVVALKKLHHSETE------------------------DS--A-----F---- 185 (412)
Q Consensus 142 ~~~f~~~~~lG~G~~g~Vy~~~~~~-~~~vAvK~l~~~~~~------------------------~~--~-----~---- 185 (412)
-..|+. +.||+|++|.||+|++++ |+.||||..+..-.. .. . +
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 345776 789999999999999987 999999987632100 00 0 0
Q ss_pred ------------------EEec-------------CceEEEEEEeccCCceeee--eccCcccccCCHHHHHHHHHHHHH
Q 042435 186 ------------------VVYS-------------PQCMFFIYEYMERGSLFCV--LRDDDEAIELNWTRRMNIVKSVAH 232 (412)
Q Consensus 186 ------------------~~~~-------------~~~~~lv~ey~~~gsL~~~--l~~~~~~~~l~~~~~~~i~~~ia~ 232 (412)
.+.. ....+|||||++|+++.++ +...+ .+. ..++...+.
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g----~d~---~~la~~~v~ 270 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAG----TDM---KLLAERGVE 270 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcC----CCH---HHHHHHHHH
Confidence 0111 2234699999999999764 22211 111 112222211
Q ss_pred -HHHHHHhCCCCCcEEeCCCCCCEEecCCC----cEEEeecCCccccCC
Q 042435 233 -ALSYLHHDCTPSIVHRDISSNNILLNSNL----EAFVADFGTVRLLDV 276 (412)
Q Consensus 233 -gL~~LH~~~~~~ivHrDlkp~NILl~~~~----~~kl~DfGla~~~~~ 276 (412)
-+.-++.. |++|+|+||.||+++.++ ++++.|||++..++.
T Consensus 271 ~~~~Qif~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 271 VFFTQVFRD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred HHHHHHHhC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 12223345 999999999999999887 999999999987643
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.10 E-value=3.3e-10 Score=98.15 Aligned_cols=112 Identities=17% Similarity=0.263 Sum_probs=80.4
Q ss_pred eeeeecCceEEEEEEeCCCcEEEEEeccCCcc--cc-----------------ceEEEecCceEEEEEEeccCCceeeee
Q 042435 149 YCIGTGGYDSVYKAELPDGKVVALKKLHHSET--ED-----------------SAFVVYSPQCMFFIYEYMERGSLFCVL 209 (412)
Q Consensus 149 ~~lG~G~~g~Vy~~~~~~~~~vAvK~l~~~~~--~~-----------------~~~~~~~~~~~~lv~ey~~~gsL~~~l 209 (412)
+.++.|.++.||++... ++.+++|....... .. ...........++||||+++.++.+.-
T Consensus 4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~~~~~~~lv~e~i~G~~l~~~~ 82 (170)
T cd05151 4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYFDPETGVLITEFIEGSELLTED 82 (170)
T ss_pred eecCCcccCceEEEEEC-CeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEEeCCCCeEEEEecCCCcccccc
Confidence 56889999999999874 77899998654321 00 011122333468999999998876430
Q ss_pred ccCcccccCCHHHHHHHHHHHHHHHHHHHhCC--CCCcEEeCCCCCCEEecCCCcEEEeecCCccc
Q 042435 210 RDDDEAIELNWTRRMNIVKSVAHALSYLHHDC--TPSIVHRDISSNNILLNSNLEAFVADFGTVRL 273 (412)
Q Consensus 210 ~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~--~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~ 273 (412)
. ....++.+++++|+.||+.. ...++|+|++|.||+++ ++.++++||+.+..
T Consensus 83 --------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 83 --------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred --------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 0 11235678999999999872 22369999999999999 66899999998763
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.07 E-value=7.8e-10 Score=97.61 Aligned_cols=118 Identities=20% Similarity=0.215 Sum_probs=81.1
Q ss_pred eeeeecCceEEEEEEeCC-------CcEEEEEeccCCcc------------ccce--EE---------------------
Q 042435 149 YCIGTGGYDSVYKAELPD-------GKVVALKKLHHSET------------EDSA--FV--------------------- 186 (412)
Q Consensus 149 ~~lG~G~~g~Vy~~~~~~-------~~~vAvK~l~~~~~------------~~~~--~~--------------------- 186 (412)
..||.|.-+.||.|...+ +..+|||..+.... .+.. ..
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999997643 57999996542110 0000 00
Q ss_pred ----------EecCceEEEEEEeccCCceee-eeccCcccccCCHHHHHHHHHHHHHHHHHH-HhCCCCCcEEeCCCCCC
Q 042435 187 ----------VYSPQCMFFIYEYMERGSLFC-VLRDDDEAIELNWTRRMNIVKSVAHALSYL-HHDCTPSIVHRDISSNN 254 (412)
Q Consensus 187 ----------~~~~~~~~lv~ey~~~gsL~~-~l~~~~~~~~l~~~~~~~i~~~ia~gL~~L-H~~~~~~ivHrDlkp~N 254 (412)
...-...++||||+.++.+.. .+++. .++..+...+..+++.+|..+ |.. +++|+||++.|
T Consensus 83 l~~~Gv~vP~pi~~~~~~lvME~Ig~~~~~~~~Lkd~----~~~~~~~~~i~~~i~~~l~~l~H~~---glVHGDLs~~N 155 (197)
T cd05146 83 MQKAGIPCPEVVVLKKHVLVMSFIGDDQVPAPKLKDA----KLNDEEMKNAYYQVLSMMKQLYKEC---NLVHADLSEYN 155 (197)
T ss_pred HHHcCCCCCeEEEecCCEEEEEEcCCCCccchhhhcc----ccCHHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHH
Confidence 111244589999997654422 22221 244455667789999999999 777 99999999999
Q ss_pred EEecCCCcEEEeecCCcccc
Q 042435 255 ILLNSNLEAFVADFGTVRLL 274 (412)
Q Consensus 255 ILl~~~~~~kl~DfGla~~~ 274 (412)
|+++ ++.+.++|||.+-..
T Consensus 156 IL~~-~~~v~iIDF~qav~~ 174 (197)
T cd05146 156 MLWH-DGKVWFIDVSQSVEP 174 (197)
T ss_pred EEEE-CCcEEEEECCCceeC
Confidence 9997 468999999987643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.06 E-value=7.3e-11 Score=116.79 Aligned_cols=229 Identities=20% Similarity=0.194 Sum_probs=153.2
Q ss_pred HHhhcCcccceeeeecCceEEEEEEe--CCCcEEEEEeccCCcc------------------------ccceEEEecCce
Q 042435 139 IDATEYFHIRYCIGTGGYDSVYKAEL--PDGKVVALKKLHHSET------------------------EDSAFVVYSPQC 192 (412)
Q Consensus 139 ~~~~~~f~~~~~lG~G~~g~Vy~~~~--~~~~~vAvK~l~~~~~------------------------~~~~~~~~~~~~ 192 (412)
...+.+|.....||.|.|+.||+... .++..+++|.+...-. ............
T Consensus 261 s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~ 340 (524)
T KOG0601|consen 261 SCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQ 340 (524)
T ss_pred eeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccc
Confidence 34456788999999999999999854 4688999996643211 111111233445
Q ss_pred EEEEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCC-CcEEEeecCCc
Q 042435 193 MFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSN-LEAFVADFGTV 271 (412)
Q Consensus 193 ~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~-~~~kl~DfGla 271 (412)
.|+-.|||+++++..... -...++...++++..|++.++.++|+. .++|+|+||+||++..+ +..++.|||.+
T Consensus 341 ~~ip~e~~~~~s~~l~~~---~~~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~~~~~~~~ 414 (524)
T KOG0601|consen 341 GYIPLEFCEGGSSSLRSV---TSQMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSKLGDFGCW 414 (524)
T ss_pred ccCchhhhcCcchhhhhH---HHHhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhhccccccc
Confidence 678889999988765442 122477778889999999999999988 99999999999999876 78889999998
Q ss_pred cccCCCCCCccccccccccc--ccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccC
Q 042435 272 RLLDVDSSNRTLQAGTYGYI--ALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLS 349 (412)
Q Consensus 272 ~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 349 (412)
+.+.... ......-++. +++......+..+.|++|||..+.|.+++..--... .....+ .....
T Consensus 415 t~~~~~~---~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~----------~~~~~i-~~~~~ 480 (524)
T KOG0601|consen 415 TRLAFSS---GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESG----------VQSLTI-RSGDT 480 (524)
T ss_pred cccceec---ccccccccccccchhhccccccccccccccccccccccccCcccCccc----------ccceee-ecccc
Confidence 6432111 1112223333 555555667888999999999999999987432110 001111 11111
Q ss_pred CccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhcC
Q 042435 350 PPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELEGK 391 (412)
Q Consensus 350 ~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 391 (412)
+..+... ..+..+...+...++..||.+.+...+.+-.
T Consensus 481 p~~~~~~----~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~ 518 (524)
T KOG0601|consen 481 PNLPGLK----LQLQVLLKVMINPDRKRRPSAVELSLHSEFY 518 (524)
T ss_pred cCCCchH----HhhhhhhhhhcCCccccchhhhhhcccchhh
Confidence 1111111 2255677788899999999998887665543
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.99 E-value=1.4e-10 Score=120.91 Aligned_cols=227 Identities=20% Similarity=0.228 Sum_probs=149.3
Q ss_pred hhcCcccceeeeecCceEEEEEEeC-CCcEEEEEeccC---------------Cccc---cceEE------EecCceEEE
Q 042435 141 ATEYFHIRYCIGTGGYDSVYKAELP-DGKVVALKKLHH---------------SETE---DSAFV------VYSPQCMFF 195 (412)
Q Consensus 141 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~---------------~~~~---~~~~~------~~~~~~~~l 195 (412)
..++|.+.+-+-+|.++.++.+.-. .|...+.|.... .++. ..-++ .......+|
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L 881 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL 881 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence 4466777778889999999887432 233333332110 1110 01111 123456789
Q ss_pred EEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccC
Q 042435 196 IYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLD 275 (412)
Q Consensus 196 v~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~ 275 (412)
+++|..+++|...|+.... .+..-.......+..+++|||.. .+.|+|++|.|++...++..+++|||......
T Consensus 882 ~~~~~~~~~~~Skl~~~~~---~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg 955 (1205)
T KOG0606|consen 882 VGHYLNGGDLPSKLHNSGC---LSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVG 955 (1205)
T ss_pred hhHHhccCCchhhhhcCCC---cccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCccccccccc
Confidence 9999999999998887652 23223334556677899999987 79999999999999999999999998432210
Q ss_pred C---------------------C-----C-----CCcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCc
Q 042435 276 V---------------------D-----S-----SNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPG 324 (412)
Q Consensus 276 ~---------------------~-----~-----~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~ 324 (412)
. . . .......||+.|.+||...+......+|.|++|++++|.++|..||
T Consensus 956 ~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~ 1035 (1205)
T KOG0606|consen 956 LIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPF 1035 (1205)
T ss_pred cccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCC
Confidence 0 0 0 0012346899999999999999999999999999999999999998
Q ss_pred ccccccccCCCCcchhhHHhhhccCCccchhhHHHHHHHHHHHHhcCcCCCCCCCCHH
Q 042435 325 ELLLSLSSSSGPKIMLIDILYQRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQ 382 (412)
Q Consensus 325 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ 382 (412)
... .++..+..+....+..+ ....+....+.+++...+..+|.+|-.+.
T Consensus 1036 na~-------tpq~~f~ni~~~~~~~p--~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1036 NAE-------TPQQIFENILNRDIPWP--EGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred CCc-------chhhhhhccccCCCCCC--CCccccChhhhhhhhhhhccCchhccCcc
Confidence 732 22223333333332222 11222223356677778888888886655
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.93 E-value=3.3e-09 Score=90.88 Aligned_cols=109 Identities=24% Similarity=0.425 Sum_probs=81.9
Q ss_pred eeeecCceEEEEEEeCCCcEEEEEe-----ccCCcccc------------------------ceEEEecCceEEEEEEec
Q 042435 150 CIGTGGYDSVYKAELPDGKVVALKK-----LHHSETED------------------------SAFVVYSPQCMFFIYEYM 200 (412)
Q Consensus 150 ~lG~G~~g~Vy~~~~~~~~~vAvK~-----l~~~~~~~------------------------~~~~~~~~~~~~lv~ey~ 200 (412)
.+++|+-+.+|.+.+.+ ..+++|. .+|+.+.. ......+++...|+|||.
T Consensus 3 ~i~~GAEa~i~~~~~~g-~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I 81 (204)
T COG3642 3 LIKQGAEAIIYLTDFLG-LPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYI 81 (204)
T ss_pred hhhCCcceeEEeeeccC-cceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEe
Confidence 57899999999998744 4466662 23332221 122355677788999999
Q ss_pred cCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccc
Q 042435 201 ERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRL 273 (412)
Q Consensus 201 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~ 273 (412)
++-.|.+.+... +..++..+-.-+.-||.. +|+|+||.++||++.++. +.++|||++..
T Consensus 82 ~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 82 EGELLKDALEEA----------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred CChhHHHHHHhc----------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 988888777543 245677788888999999 999999999999998654 99999999874
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.90 E-value=1.6e-09 Score=112.96 Aligned_cols=67 Identities=27% Similarity=0.391 Sum_probs=51.5
Q ss_pred eechhhccCCC-ceeeCCC-CCCCCCCCEEeCccccccccCCCCCc---CC-CCcccccCcCCCCCCCCCCccc
Q 042435 3 VLLAFLSISAA-CSGVVEE-EPSSPSFLKSDMSFNNLDGEIPTYLR---DN-PPKSFVGNKGLCGHVQGFLSCF 70 (412)
Q Consensus 3 ~~~~~l~~~~~-~~G~ip~-~~~~~~l~~~~ls~N~l~G~iP~~~~---~~-~~~~~~gn~~lcg~~~~~~~c~ 70 (412)
..|++|||+.| ++|.+|+ +.++++|+.||||+|+|+|.+|..+. .+ ....+.+|+++||.+. +..|.
T Consensus 466 ~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p~-l~~C~ 538 (623)
T PLN03150 466 TSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPG-LRACG 538 (623)
T ss_pred CCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCcccccCChHHhhccccCceEEecCCccccCCCC-CCCCc
Confidence 46788888888 8888877 78888888888888888888887322 22 4567889999998653 46685
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.87 E-value=1.3e-08 Score=102.07 Aligned_cols=161 Identities=19% Similarity=0.208 Sum_probs=116.8
Q ss_pred eeeecCceEEEEEEeCCCcEE-----E---EEeccCCccccceEEEecCceEEEEEEeccCCceeeeeccCcccccCCHH
Q 042435 150 CIGTGGYDSVYKAELPDGKVV-----A---LKKLHHSETEDSAFVVYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWT 221 (412)
Q Consensus 150 ~lG~G~~g~Vy~~~~~~~~~v-----A---vK~l~~~~~~~~~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~ 221 (412)
.-..|++-.||.....+++.+ | +|.++|+++.............|||+|-+. .|..++.+ +...
T Consensus 33 ~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~------l~~~ 104 (690)
T KOG1243|consen 33 RKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE------LGKE 104 (690)
T ss_pred eeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH------hHHH
Confidence 445688889999888777322 2 567899999998888888889999999874 45555543 2234
Q ss_pred HHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCCCCcccccccccccccccccCccc
Q 042435 222 RRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTYGYIALELVYTMVV 301 (412)
Q Consensus 222 ~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 301 (412)
....-+.||+.||.|||+.| +++|++|.-+.|+++..|+-||++|-++...............-..|..|+.+....
T Consensus 105 ~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~s~- 181 (690)
T KOG1243|consen 105 EVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDPSE- 181 (690)
T ss_pred HHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcCccc-
Confidence 45557899999999999876 899999999999999999999999987754332221111111122355665443222
Q ss_pred CcccccHHHHHHHHHHHhCCC
Q 042435 302 TEKCVIYSFGVVALEVLMGTH 322 (412)
Q Consensus 302 s~ksDv~S~Gvil~elltg~~ 322 (412)
-..|.|-||++++|++.|..
T Consensus 182 -~s~D~~~Lg~li~el~ng~~ 201 (690)
T KOG1243|consen 182 -WSIDSWGLGCLIEELFNGSL 201 (690)
T ss_pred -cchhhhhHHHHHHHHhCccc
Confidence 24699999999999999943
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.85 E-value=1.2e-08 Score=87.21 Aligned_cols=122 Identities=17% Similarity=0.311 Sum_probs=87.8
Q ss_pred cceeeeecCceEEEEEEeCCCcEEEEE-----eccCCccccc------------------------eEEEecCceEEEEE
Q 042435 147 IRYCIGTGGYDSVYKAELPDGKVVALK-----KLHHSETEDS------------------------AFVVYSPQCMFFIY 197 (412)
Q Consensus 147 ~~~~lG~G~~g~Vy~~~~~~~~~vAvK-----~l~~~~~~~~------------------------~~~~~~~~~~~lv~ 197 (412)
....+-+|+-+.|+++.+ .|+...|| +.+||..... ..++.+...-.|+|
T Consensus 11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 457899999999999998 57776666 3455543321 12244566678999
Q ss_pred EeccC-CceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCC---CcEEEeecCCccc
Q 042435 198 EYMER-GSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSN---LEAFVADFGTVRL 273 (412)
Q Consensus 198 ey~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~---~~~kl~DfGla~~ 273 (412)
||.++ .++.+++....... ........++..|-+.+.-||.+ .|+|+||..+||++..+ ..+.++|||++..
T Consensus 90 E~~~g~~~vk~~i~~~~~~~-~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDE-SEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EeccchhHHHHHHHHHccCc-ccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeecchhc
Confidence 99976 36777766543221 22223367888899999999999 99999999999999544 4468999999863
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.81 E-value=7.5e-08 Score=86.96 Aligned_cols=121 Identities=21% Similarity=0.259 Sum_probs=88.9
Q ss_pred eeeeecCceEEEEEEeCCCcEEEEEeccCCccc------------------------cceEEEecC---ceEEEEEEecc
Q 042435 149 YCIGTGGYDSVYKAELPDGKVVALKKLHHSETE------------------------DSAFVVYSP---QCMFFIYEYME 201 (412)
Q Consensus 149 ~~lG~G~~g~Vy~~~~~~~~~vAvK~l~~~~~~------------------------~~~~~~~~~---~~~~lv~ey~~ 201 (412)
+.|+.|..+.||++...+|+.+++|........ ......... +..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 568999999999998877789999986543210 001111111 25689999999
Q ss_pred CCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCC----------------------------------------
Q 042435 202 RGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDC---------------------------------------- 241 (412)
Q Consensus 202 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~---------------------------------------- 241 (412)
+.++.+.+... .++..++..++.+++++|..||+..
T Consensus 84 G~~l~~~~~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (223)
T cd05154 84 GRVLRDRLLRP----ELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER 159 (223)
T ss_pred CEecCCCCCCC----CCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence 98887765321 3677778888889999998888531
Q ss_pred -------------CCCcEEeCCCCCCEEecC--CCcEEEeecCCccc
Q 042435 242 -------------TPSIVHRDISSNNILLNS--NLEAFVADFGTVRL 273 (412)
Q Consensus 242 -------------~~~ivHrDlkp~NILl~~--~~~~kl~DfGla~~ 273 (412)
...++|+|++|.||+++. +..+.++||+.+..
T Consensus 160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 235799999999999998 56688999998763
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.78 E-value=8.1e-08 Score=91.70 Aligned_cols=197 Identities=15% Similarity=0.231 Sum_probs=127.2
Q ss_pred EEEEEEeccCC-ceeeeeccC---cccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeec
Q 042435 193 MFFIYEYMERG-SLFCVLRDD---DEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADF 268 (412)
Q Consensus 193 ~~lv~ey~~~g-sL~~~l~~~---~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Df 268 (412)
.-+.|..+++- -...+++.. ......+|...++.+..+|.+.+-||++ |.+-+|++++|+|++++..+.+.|-
T Consensus 85 iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVds 161 (637)
T COG4248 85 IGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDS 161 (637)
T ss_pred eEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEcc
Confidence 45666666542 122333221 1223589999999999999999999999 9999999999999999999999874
Q ss_pred CCccccCCCCCCccccccccccccccccc-----CcccCcccccHHHHHHHHHHHhC-CCCcccccccccCCCCcc-hh-
Q 042435 269 GTVRLLDVDSSNRTLQAGTYGYIALELVY-----TMVVTEKCVIYSFGVVALEVLMG-THPGELLLSLSSSSGPKI-ML- 340 (412)
Q Consensus 269 Gla~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDv~S~Gvil~elltg-~~P~~~~~~~~~~~~~~~-~~- 340 (412)
..-.. ..+.......+|...|.+||... +-.-+...|-|.+||++++++.| +.||..+........+-+ .+
T Consensus 162 Dsfqi-~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia 240 (637)
T COG4248 162 DSFQI-NANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIA 240 (637)
T ss_pred cceee-ccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhh
Confidence 32221 12233334567889999999765 33456789999999999999886 999986543322222111 00
Q ss_pred ----hHHhh--hcc-CCccchhhHHHHHHHHHHHHhcCcCC--CCCCCCHHHHHHHHhcCCC
Q 042435 341 ----IDILY--QRL-SPPINQKIIQDIILVSTIALACLRSK--PKSRPTMQRISQELEGKTP 393 (412)
Q Consensus 341 ----~~~~~--~~~-~~~~~~~~~~~~~~~~~l~~~Cl~~d--P~~RPs~~evl~~L~~~~~ 393 (412)
...-+ ... +++......-....+..+..+|+... +.-|||++..+..|.+..+
T Consensus 241 ~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~ 302 (637)
T COG4248 241 HGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQ 302 (637)
T ss_pred cceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHH
Confidence 01111 111 11111111112233666777888643 5689999999998876654
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.66 E-value=4.8e-08 Score=85.87 Aligned_cols=74 Identities=26% Similarity=0.417 Sum_probs=48.0
Q ss_pred eEEEEEEecc--CCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHH-HhCCCCCcEEeCCCCCCEEecCCCcEEEeec
Q 042435 192 CMFFIYEYME--RGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYL-HHDCTPSIVHRDISSNNILLNSNLEAFVADF 268 (412)
Q Consensus 192 ~~~lv~ey~~--~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~L-H~~~~~~ivHrDlkp~NILl~~~~~~kl~Df 268 (412)
...|||||++ +..+. .+.... ++......++.+++..+..+ |.. +|+|+||.+.||+++++ .+.++||
T Consensus 80 ~~~ivME~I~~~G~~~~-~l~~~~----~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~~~iIDf 150 (188)
T PF01163_consen 80 RNVIVMEYIGEDGVPLP-RLKDVD----LSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-KVYIIDF 150 (188)
T ss_dssp TTEEEEE--EETTEEGG-CHHHCG----GGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-CEEE--G
T ss_pred CCEEEEEecCCCccchh-hHHhcc----ccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-eEEEEec
Confidence 3479999998 43333 333221 22344556778888866664 666 99999999999999887 9999999
Q ss_pred CCcccc
Q 042435 269 GTVRLL 274 (412)
Q Consensus 269 Gla~~~ 274 (412)
|.+...
T Consensus 151 ~qav~~ 156 (188)
T PF01163_consen 151 GQAVDS 156 (188)
T ss_dssp TTEEET
T ss_pred Ccceec
Confidence 987643
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.63 E-value=1.1e-08 Score=102.99 Aligned_cols=150 Identities=20% Similarity=0.200 Sum_probs=96.4
Q ss_pred HHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCCCC---------ccccccccccccccccc
Q 042435 227 VKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSN---------RTLQAGTYGYIALELVY 297 (412)
Q Consensus 227 ~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~---------~~~~~gt~~y~aPE~~~ 297 (412)
+.+++.|+.|+|.. .++||++|.|++|.++..+..||+.|+++-........ .....-...|.|||++.
T Consensus 105 l~~v~dgl~flh~s--Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~ 182 (700)
T KOG2137|consen 105 LGNVADGLAFLHRS--AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL 182 (700)
T ss_pred hhcccchhhhhccC--cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence 34566999999976 48999999999999999999999999987544331111 01123356799999999
Q ss_pred CcccCcccccHHHHHHHHHHHhCCCC-cccccccccCCCCcchhhHHhhhccCCccchhhHHHHHHHHHHHHhcCcCCCC
Q 042435 298 TMVVTEKCVIYSFGVVALEVLMGTHP-GELLLSLSSSSGPKIMLIDILYQRLSPPINQKIIQDIILVSTIALACLRSKPK 376 (412)
Q Consensus 298 ~~~~s~ksDv~S~Gvil~elltg~~P-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~ 376 (412)
....+.++|+||+|+++|-+..|..+ +.......... ......+.-........ ..++.+=+.+.+..++.
T Consensus 183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~-~~~~~~~~~~~~~s~~~-------p~el~~~l~k~l~~~~~ 254 (700)
T KOG2137|consen 183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYS-FSRNLLNAGAFGYSNNL-------PSELRESLKKLLNGDSA 254 (700)
T ss_pred cccccccccceeeeeEEEEEecCCcchhhccCCcchhh-hhhcccccccccccccC-------cHHHHHHHHHHhcCCcc
Confidence 98889999999999999999854443 32110000000 00000000000111111 12255566788999999
Q ss_pred CCCCHHHHHH
Q 042435 377 SRPTMQRISQ 386 (412)
Q Consensus 377 ~RPs~~evl~ 386 (412)
-||++.++..
T Consensus 255 ~rp~~~~l~~ 264 (700)
T KOG2137|consen 255 VRPTLDLLLS 264 (700)
T ss_pred cCcchhhhhc
Confidence 9997776643
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.54 E-value=3.8e-07 Score=82.92 Aligned_cols=116 Identities=25% Similarity=0.263 Sum_probs=78.1
Q ss_pred cccceeeeecCceEEEEEEeCCCcEEEEEeccCCccc-------------cceEE-------------------------
Q 042435 145 FHIRYCIGTGGYDSVYKAELPDGKVVALKKLHHSETE-------------DSAFV------------------------- 186 (412)
Q Consensus 145 f~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~l~~~~~~-------------~~~~~------------------------- 186 (412)
..+++.||-|.-+.||.|..+.|..+|||.=+..... .....
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 4566899999999999999999999999953221000 00000
Q ss_pred ---EecCceEEEEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcE
Q 042435 187 ---VYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEA 263 (412)
Q Consensus 187 ---~~~~~~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~ 263 (412)
....+...+||||.++-.|...- ++-...-.++..|..-+.-.-.. |+||+|+++=||++++++.+
T Consensus 173 VP~P~~~nRHaVvMe~ieG~eL~~~r--------~~~en~~~il~~il~~~~~~~~~---GiVHGDlSefNIlV~~dg~~ 241 (304)
T COG0478 173 VPKPIAWNRHAVVMEYIEGVELYRLR--------LDVENPDEILDKILEEVRKAYRR---GIVHGDLSEFNILVTEDGDI 241 (304)
T ss_pred CCCccccccceeeeehcccceeeccc--------CcccCHHHHHHHHHHHHHHHHHc---CccccCCchheEEEecCCCE
Confidence 12345678999999886665432 11222223444444444433345 99999999999999999999
Q ss_pred EEeecCCc
Q 042435 264 FVADFGTV 271 (412)
Q Consensus 264 kl~DfGla 271 (412)
.++||--+
T Consensus 242 ~vIDwPQ~ 249 (304)
T COG0478 242 VVIDWPQA 249 (304)
T ss_pred EEEeCccc
Confidence 99999544
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.45 E-value=7.2e-07 Score=89.99 Aligned_cols=123 Identities=23% Similarity=0.276 Sum_probs=83.5
Q ss_pred CcccceeeeecCceEEEEEEeCCCcEEEEEeccCCccccc---------------------------e------------
Q 042435 144 YFHIRYCIGTGGYDSVYKAELPDGKVVALKKLHHSETEDS---------------------------A------------ 184 (412)
Q Consensus 144 ~f~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~l~~~~~~~~---------------------------~------------ 184 (412)
.|+. +-|+.++-|.||+|++++|+.||||..+.. +... .
T Consensus 127 eF~~-~PiAsASIaQVH~A~L~sG~~VAVKVqrPg-i~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ 204 (517)
T COG0661 127 EFEP-EPIASASIAQVHRAVLKSGEEVAVKVQRPG-IRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLRE 204 (517)
T ss_pred HcCC-CchhhhhHhhheeEEecCCCEEEEEecCCC-hHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHH
Confidence 3443 678999999999999999999999975421 1000 0
Q ss_pred ---------------------------EEEe-cCceEEEEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHH-HH
Q 042435 185 ---------------------------FVVY-SPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHA-LS 235 (412)
Q Consensus 185 ---------------------------~~~~-~~~~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~g-L~ 235 (412)
.++. -.....|+|||++|-.+.+...-... ..+ +..++..++++ +.
T Consensus 205 ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~--g~d---~k~ia~~~~~~f~~ 279 (517)
T COG0661 205 ELDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSA--GID---RKELAELLVRAFLR 279 (517)
T ss_pred HhCHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhc--CCC---HHHHHHHHHHHHHH
Confidence 0011 13456899999999888877422211 133 22344443333 23
Q ss_pred HHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCC
Q 042435 236 YLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDV 276 (412)
Q Consensus 236 ~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~ 276 (412)
.+-.. +++|.|..|.||+++.+++..+.|||+...+..
T Consensus 280 q~~~d---gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 280 QLLRD---GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred HHHhc---CccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 33334 899999999999999999999999999887654
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.37 E-value=5.7e-07 Score=83.74 Aligned_cols=78 Identities=24% Similarity=0.210 Sum_probs=63.0
Q ss_pred eEEEEEEeccCC-ceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecC-------CCcE
Q 042435 192 CMFFIYEYMERG-SLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNS-------NLEA 263 (412)
Q Consensus 192 ~~~lv~ey~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~-------~~~~ 263 (412)
..++|+|++++- +|.+++..... ...+...+..++.+++..+.-||.. ||+|+|++++|||++. +..+
T Consensus 109 ~s~LVte~l~~~~sL~~~~~~~~~-~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~~~~ 184 (268)
T PRK15123 109 TSFIITEDLAPTISLEDYCADWAT-NPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREEDLKL 184 (268)
T ss_pred eeEEEEeeCCCCccHHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCCCceE
Confidence 478999999875 78877753211 1345567778999999999999999 9999999999999975 5788
Q ss_pred EEeecCCccc
Q 042435 264 FVADFGTVRL 273 (412)
Q Consensus 264 kl~DfGla~~ 273 (412)
.++||+.++.
T Consensus 185 ~LIDl~r~~~ 194 (268)
T PRK15123 185 SVIDLHRAQI 194 (268)
T ss_pred EEEECCcccc
Confidence 9999998753
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.26 E-value=1.3e-06 Score=78.44 Aligned_cols=76 Identities=22% Similarity=0.430 Sum_probs=63.5
Q ss_pred eEEEEEEeccCC-ceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCC---cEEEee
Q 042435 192 CMFFIYEYMERG-SLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNL---EAFVAD 267 (412)
Q Consensus 192 ~~~lv~ey~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~---~~kl~D 267 (412)
..++|+|++++. +|.+++.... ..+...+..++.+++..++-||+. +|+|+|+++.|||++.+. .+.++|
T Consensus 91 ~s~lite~l~~~~~L~~~~~~~~---~~~~~~~~~ll~~l~~~i~~lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lID 164 (206)
T PF06293_consen 91 RSYLITEALPGAQDLRDLLQQWE---QLDPSQRRELLRALARLIAKLHDA---GIYHGDLNPSNILVDPDDGQYRFYLID 164 (206)
T ss_pred eEEEEEEeCCCcccHHHHHHhhc---ccchhhHHHHHHHHHHHHHHHHHC---cCCCCCCCcccEEEeCCCCceeEEEEc
Confidence 458999999874 7888776532 145566788999999999999999 999999999999998776 889999
Q ss_pred cCCccc
Q 042435 268 FGTVRL 273 (412)
Q Consensus 268 fGla~~ 273 (412)
|+-++.
T Consensus 165 ld~~~~ 170 (206)
T PF06293_consen 165 LDRMRF 170 (206)
T ss_pred chhcee
Confidence 987764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.24 E-value=2.3e-06 Score=86.10 Aligned_cols=120 Identities=19% Similarity=0.154 Sum_probs=78.2
Q ss_pred eeeeecCceEEEEEEeCCCcEEEEEeccCCccccce--------------------------------------------
Q 042435 149 YCIGTGGYDSVYKAELPDGKVVALKKLHHSETEDSA-------------------------------------------- 184 (412)
Q Consensus 149 ~~lG~G~~g~Vy~~~~~~~~~vAvK~l~~~~~~~~~-------------------------------------------- 184 (412)
+-||.-+.|.||+|++++|+.||||+-+. .+....
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P-~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHP-GLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCc-ChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 57999999999999999999999996321 111100
Q ss_pred ----------------------EE-EecCceEEEEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCC
Q 042435 185 ----------------------FV-VYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDC 241 (412)
Q Consensus 185 ----------------------~~-~~~~~~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~ 241 (412)
.+ ........|+||||+|..+.+.-.-.. ..++-.....-+.+...-+-+-|
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~--~gi~~~~i~~~l~~~~~~qIf~~--- 320 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDK--RGISPHDILNKLVEAYLEQIFKT--- 320 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHH--cCCCHHHHHHHHHHHHHHHHHhc---
Confidence 00 111235689999999988876532111 12444433333322221122222
Q ss_pred CCCcEEeCCCCCCEEec----CCCcEEEeecCCccccCC
Q 042435 242 TPSIVHRDISSNNILLN----SNLEAFVADFGTVRLLDV 276 (412)
Q Consensus 242 ~~~ivHrDlkp~NILl~----~~~~~kl~DfGla~~~~~ 276 (412)
|.+|+|-.|.||+++ .++.+.+-|||+...+..
T Consensus 321 --GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 321 --GFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred --CCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 899999999999998 367899999999876543
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.23 E-value=6.1e-06 Score=73.58 Aligned_cols=125 Identities=19% Similarity=0.248 Sum_probs=86.4
Q ss_pred ccHHHHHH--hhcCcccceeeeecCceEEEEEEeCCCcEEEEEeccCCccccc---------------------------
Q 042435 133 ILYENLID--ATEYFHIRYCIGTGGYDSVYKAELPDGKVVALKKLHHSETEDS--------------------------- 183 (412)
Q Consensus 133 ~~~~~l~~--~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~l~~~~~~~~--------------------------- 183 (412)
..|.+|.+ ..++|...+++-......|.+-.. +|+.+++|..+..+....
T Consensus 19 ~~y~~l~~~i~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~ 97 (229)
T PF06176_consen 19 EKYLELGEKILDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGF 97 (229)
T ss_pred hHHHHHHHHHHhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCc
Confidence 34555533 356788888888888888887777 678899996543221110
Q ss_pred ------eEE-----EecCceEEEEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCC
Q 042435 184 ------AFV-----VYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISS 252 (412)
Q Consensus 184 ------~~~-----~~~~~~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp 252 (412)
..+ +.-....+++|||++|..|.+... ++. .++..+..++.-+|.. |++|+|..|
T Consensus 98 ~~~~~~yl~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~-------i~e----~~~~ki~~~ikqlH~~---G~~HGD~hp 163 (229)
T PF06176_consen 98 TEPADPYLAAEKKIFRYTSSYVLLMEYIEGVELNDIED-------IDE----DLAEKIVEAIKQLHKH---GFYHGDPHP 163 (229)
T ss_pred cccccceeeeeeeeccceeEEEEEEEEecCeecccchh-------cCH----HHHHHHHHHHHHHHHc---CCccCCCCc
Confidence 001 112244578999999988876532 222 2456677889999999 999999999
Q ss_pred CCEEecCCCcEEEeecCCccc
Q 042435 253 NNILLNSNLEAFVADFGTVRL 273 (412)
Q Consensus 253 ~NILl~~~~~~kl~DfGla~~ 273 (412)
.|++++++ .++++||+..+.
T Consensus 164 gNFlv~~~-~i~iID~~~k~~ 183 (229)
T PF06176_consen 164 GNFLVSNN-GIRIIDTQGKRM 183 (229)
T ss_pred CcEEEECC-cEEEEECccccc
Confidence 99999854 599999986653
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.19 E-value=1.4e-05 Score=72.22 Aligned_cols=136 Identities=24% Similarity=0.283 Sum_probs=90.2
Q ss_pred cccHHHHHHhhcCcccceee---eecCceEEEEEEeCCCcEEEEEeccCCccccce----------------------EE
Q 042435 132 KILYENLIDATEYFHIRYCI---GTGGYDSVYKAELPDGKVVALKKLHHSETEDSA----------------------FV 186 (412)
Q Consensus 132 ~~~~~~l~~~~~~f~~~~~l---G~G~~g~Vy~~~~~~~~~vAvK~l~~~~~~~~~----------------------~~ 186 (412)
..+++.|....+...+.... ++|.-+.||+|...++..+|||..+........ ..
T Consensus 34 ~~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~ 113 (268)
T COG1718 34 KRTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFA 113 (268)
T ss_pred hHHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHH
Confidence 45667777777777666654 467777999999888999999976532111000 00
Q ss_pred ---------------------EecCceEEEEEEeccCCc-eeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCC
Q 042435 187 ---------------------VYSPQCMFFIYEYMERGS-LFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPS 244 (412)
Q Consensus 187 ---------------------~~~~~~~~lv~ey~~~gs-L~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ 244 (412)
-..-....|||||+.... -.-.|.+- .+.......+..++++.+.-|-..+ +
T Consensus 114 W~~kEf~NL~R~~eAGVrvP~Pi~~~~nVLvMEfIg~~g~pAP~LkDv----~~e~~e~~~~~~~~v~~~~~l~~~a--~ 187 (268)
T COG1718 114 WARKEFRNLKRAYEAGVRVPEPIAFRNNVLVMEFIGDDGLPAPRLKDV----PLELEEAEGLYEDVVEYMRRLYKEA--G 187 (268)
T ss_pred HHHHHHHHHHHHHHcCCCCCCceeecCCeEEEEeccCCCCCCCCcccC----CcCchhHHHHHHHHHHHHHHHHHhc--C
Confidence 011223479999996431 11122221 1222245667778888888777632 9
Q ss_pred cEEeCCCCCCEEecCCCcEEEeecCCcccc
Q 042435 245 IVHRDISSNNILLNSNLEAFVADFGTVRLL 274 (412)
Q Consensus 245 ivHrDlkp~NILl~~~~~~kl~DfGla~~~ 274 (412)
+||+||+.=|||+. ++.+.++|+|-|-..
T Consensus 188 LVHgDLSEyNiL~~-~~~p~iID~~QaV~~ 216 (268)
T COG1718 188 LVHGDLSEYNILVH-DGEPYIIDVSQAVTI 216 (268)
T ss_pred cccccchhhheEEE-CCeEEEEECcccccc
Confidence 99999999999999 889999999977543
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.16 E-value=5.5e-05 Score=74.51 Aligned_cols=148 Identities=18% Similarity=0.316 Sum_probs=106.4
Q ss_pred CceEEEEEEe-CCCcEEEEEecc---------------------CCccccceEEE----ecCceEEEEEEeccC-Cceee
Q 042435 155 GYDSVYKAEL-PDGKVVALKKLH---------------------HSETEDSAFVV----YSPQCMFFIYEYMER-GSLFC 207 (412)
Q Consensus 155 ~~g~Vy~~~~-~~~~~vAvK~l~---------------------~~~~~~~~~~~----~~~~~~~lv~ey~~~-gsL~~ 207 (412)
--.+.||+.. .||..|++|+++ |.|++....++ ..+..+++||+|.|+ ++|.+
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d 367 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD 367 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence 3457799954 589999999982 22332222222 235578999999985 56765
Q ss_pred eeccCc------------ccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccC
Q 042435 208 VLRDDD------------EAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLD 275 (412)
Q Consensus 208 ~l~~~~------------~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~ 275 (412)
+..... .....+....+.++.|+..||.++|+. |+.-+-|.+.+||++++.+++|+..|+...+.
T Consensus 368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~ 444 (655)
T KOG3741|consen 368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDVLQ 444 (655)
T ss_pred HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceeeec
Confidence 432211 123467788999999999999999998 99999999999999999999999988876654
Q ss_pred CCCCCcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCC
Q 042435 276 VDSSNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTH 322 (412)
Q Consensus 276 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~ 322 (412)
.+... | +. --.+-|.=.||.+++.|.||..
T Consensus 445 ~d~~~------------~--le---~~Qq~D~~~lG~ll~aLAt~~~ 474 (655)
T KOG3741|consen 445 EDPTE------------P--LE---SQQQNDLRDLGLLLLALATGTE 474 (655)
T ss_pred CCCCc------------c--hh---HHhhhhHHHHHHHHHHHhhccc
Confidence 44310 0 11 1235688899999999999963
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.02 E-value=3.7e-05 Score=68.33 Aligned_cols=117 Identities=18% Similarity=0.119 Sum_probs=83.3
Q ss_pred eeecCceEEEEEEeCCCcEEEEEecc--------CCccccce-------------------EEEe------cCceEEEEE
Q 042435 151 IGTGGYDSVYKAELPDGKVVALKKLH--------HSETEDSA-------------------FVVY------SPQCMFFIY 197 (412)
Q Consensus 151 lG~G~~g~Vy~~~~~~~~~vAvK~l~--------~~~~~~~~-------------------~~~~------~~~~~~lv~ 197 (412)
-|+||.+-|++..+ +|+.+-+|+-. ++...... -++. ..-..+||+
T Consensus 26 ~~rgG~SgV~r~~~-~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 26 YRRNGMSGVQCVER-NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred cCCCCcceEEEEEe-CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 47799999999887 44578889653 22211000 0000 122468999
Q ss_pred EeccC-CceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCc--EEEeecCCcc
Q 042435 198 EYMER-GSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLE--AFVADFGTVR 272 (412)
Q Consensus 198 ey~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~--~kl~DfGla~ 272 (412)
|-+++ -+|.+++.+..-. +.+...+..+..+++..++-||+. ++.|+|+.+.||+++.++. ++++||--++
T Consensus 105 e~L~g~~~L~~~l~~~~~~-~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 105 EDMAGFISIADWYAQHAVS-PYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred EeCCCCccHHHHHhcCCcC-CcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 97763 4787777554211 356777889999999999999999 9999999999999986666 8999997665
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.79 E-value=3.6e-05 Score=85.19 Aligned_cols=41 Identities=34% Similarity=0.436 Sum_probs=32.2
Q ss_pred eechhhccCCC-ceeeCCC-CCCCCCCCEEeCccccccccCCC
Q 042435 3 VLLAFLSISAA-CSGVVEE-EPSSPSFLKSDMSFNNLDGEIPT 43 (412)
Q Consensus 3 ~~~~~l~~~~~-~~G~ip~-~~~~~~l~~~~ls~N~l~G~iP~ 43 (412)
..|++|||+.| ++|.+|. +.++++|+.||||+|+++|.+|.
T Consensus 523 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~ 565 (968)
T PLN00113 523 KKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPK 565 (968)
T ss_pred cCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCCh
Confidence 35777888888 8888876 67788888888888888888886
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.65 E-value=4.7e-06 Score=83.72 Aligned_cols=175 Identities=18% Similarity=0.118 Sum_probs=117.0
Q ss_pred HhhcCcccceeeeecCceEEEEEEeCCCcEEEEEe----------------ccCCc-cccceEEEecCceEEEEEEeccC
Q 042435 140 DATEYFHIRYCIGTGGYDSVYKAELPDGKVVALKK----------------LHHSE-TEDSAFVVYSPQCMFFIYEYMER 202 (412)
Q Consensus 140 ~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~----------------l~~~~-~~~~~~~~~~~~~~~lv~ey~~~ 202 (412)
+.+.-+..-+-+++|+++++||.+-...+....+. .++++ .......+..+...+++++|+..
T Consensus 239 Dk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~ 318 (829)
T KOG0576|consen 239 DKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQTLSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICST 318 (829)
T ss_pred CCccchHHHHHHHHHHhcCCCccCCChhhheeceeeccchhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcC
Confidence 33444444456789999999998653222222332 24444 22223334455677889999977
Q ss_pred C-ceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCCCCc
Q 042435 203 G-SLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNR 281 (412)
Q Consensus 203 g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 281 (412)
| +-..-.... ...+...+...+...-.++++++|+. .-+|+| ||+..+ ...+..||+.+..+.... ..
T Consensus 319 ~rs~~~~~~~s--e~~~~~~~~~~~~r~et~~l~~l~~~---~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~-~~ 387 (829)
T KOG0576|consen 319 GRSSALEMTVS--EIALEQYQFAYPLRKETRPLAELHSS---YKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM-KP 387 (829)
T ss_pred CccccccCChh--hHhhhhhhhhhhhhhhcccccccccc---cccCcc----cccccc-cccccccccCCcccCccc-cc
Confidence 6 222111111 11244445556666778899999976 458998 887765 678999999988765543 33
Q ss_pred ccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcc
Q 042435 282 TLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGE 325 (412)
Q Consensus 282 ~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~ 325 (412)
....+++.|+|||+...+.+..+.|+|+.|+--.++--|-.|-.
T Consensus 388 ~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~ 431 (829)
T KOG0576|consen 388 RTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS 431 (829)
T ss_pred ccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence 45678999999999999999999999999998778877777643
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.50 E-value=0.00042 Score=61.10 Aligned_cols=81 Identities=23% Similarity=0.365 Sum_probs=62.6
Q ss_pred EEEEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCcc
Q 042435 193 MFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVR 272 (412)
Q Consensus 193 ~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~ 272 (412)
.++|.||.+.+++......-..-..-+|..|.+||.++++.+.++++.....+.-.|++++|+-+++++++|++|...+.
T Consensus 31 ~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~~lcDv~~~nfgv~~~~~lk~iDld~v~ 110 (188)
T PF12260_consen 31 RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFFYLCDVSPDNFGVNDDGRLKLIDLDDVF 110 (188)
T ss_pred CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcEEEeecchHHeEEeCCCcEEEEechhcc
Confidence 36788999877665321110111247899999999999999999998654468889999999999999999999987665
Q ss_pred c
Q 042435 273 L 273 (412)
Q Consensus 273 ~ 273 (412)
.
T Consensus 111 ~ 111 (188)
T PF12260_consen 111 V 111 (188)
T ss_pred h
Confidence 3
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B | Back alignment and domain information |
|---|
Probab=97.45 E-value=4.2e-05 Score=50.17 Aligned_cols=37 Identities=19% Similarity=0.216 Sum_probs=30.8
Q ss_pred echhhccCCC-ceeeCCC-CCCCCCCCEEeCccccccccCC
Q 042435 4 LLAFLSISAA-CSGVVEE-EPSSPSFLKSDMSFNNLDGEIP 42 (412)
Q Consensus 4 ~~~~l~~~~~-~~G~ip~-~~~~~~l~~~~ls~N~l~G~iP 42 (412)
.|++|+|+.| ++ .||+ +.+|+.|+.||+|+|+++ .+|
T Consensus 2 ~L~~L~l~~N~i~-~l~~~l~~l~~L~~L~l~~N~i~-~i~ 40 (44)
T PF12799_consen 2 NLEELDLSNNQIT-DLPPELSNLPNLETLNLSNNPIS-DIS 40 (44)
T ss_dssp T-SEEEETSSS-S-SHGGHGTTCTTSSEEEETSSCCS-BEG
T ss_pred cceEEEccCCCCc-ccCchHhCCCCCCEEEecCCCCC-CCc
Confidence 4899999999 87 6777 999999999999999998 444
|
... |
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.43 E-value=0.00013 Score=76.55 Aligned_cols=42 Identities=26% Similarity=0.358 Sum_probs=38.2
Q ss_pred eechhhccCCC-ceeeCCC-CCCCCCCCEEeCccccccccCCCC
Q 042435 3 VLLAFLSISAA-CSGVVEE-EPSSPSFLKSDMSFNNLDGEIPTY 44 (412)
Q Consensus 3 ~~~~~l~~~~~-~~G~ip~-~~~~~~l~~~~ls~N~l~G~iP~~ 44 (412)
..|+.|||+.| ++|.||. +.++++|+.||||+|+|+|.+|..
T Consensus 442 ~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~ 485 (623)
T PLN03150 442 RHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPES 485 (623)
T ss_pred CCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchH
Confidence 46889999999 9999986 889999999999999999999973
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=97.43 E-value=0.0022 Score=58.30 Aligned_cols=29 Identities=17% Similarity=0.376 Sum_probs=25.6
Q ss_pred CCcEEeCCCCCCEEecCCCcEEEeecCCcc
Q 042435 243 PSIVHRDISSNNILLNSNLEAFVADFGTVR 272 (412)
Q Consensus 243 ~~ivHrDlkp~NILl~~~~~~kl~DfGla~ 272 (412)
+.++|+|+.|.||++++++ +.++||+.+.
T Consensus 153 ~~~~HgD~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 153 STCLHGDFQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred CceEecCCCCCcEEEcCCC-cEEEechhcC
Confidence 3578999999999999877 9999998775
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=97.27 E-value=0.0022 Score=57.88 Aligned_cols=123 Identities=17% Similarity=0.143 Sum_probs=66.6
Q ss_pred eeeeecCceEEEEEEeCCCcEEEEEeccCC-------------------cc--ccceEEE---ecCceEEEEEEeccCCc
Q 042435 149 YCIGTGGYDSVYKAELPDGKVVALKKLHHS-------------------ET--EDSAFVV---YSPQCMFFIYEYMERGS 204 (412)
Q Consensus 149 ~~lG~G~~g~Vy~~~~~~~~~vAvK~l~~~-------------------~~--~~~~~~~---~~~~~~~lv~ey~~~gs 204 (412)
+.++.|..+.||+....+ ..+++|..... .. ....... ......+++|+++++.+
T Consensus 3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g~~ 81 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRPPDAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPGRP 81 (239)
T ss_dssp EEEEESSSSEEEEEEETT-SEEEEEEESSHHHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESSEE
T ss_pred ccCCCCCeeeEEEEEECC-cEEEEEEeCCCCCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEecccc
Confidence 578999999999999977 68999976443 01 0111111 12234689999999887
Q ss_pred eee----------------ee---ccCc-ccccCCHHH---------HHHH------------HHHHHH-HHHHHHh---
Q 042435 205 LFC----------------VL---RDDD-EAIELNWTR---------RMNI------------VKSVAH-ALSYLHH--- 239 (412)
Q Consensus 205 L~~----------------~l---~~~~-~~~~l~~~~---------~~~i------------~~~ia~-gL~~LH~--- 239 (412)
+.. .+ +... ......+.. .... ...+.. .++.++.
T Consensus 82 ~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (239)
T PF01636_consen 82 LDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEALLP 161 (239)
T ss_dssp HHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhhhc
Confidence 766 00 0110 000011110 0000 111222 3333332
Q ss_pred -CCCCCcEEeCCCCCCEEec-CCCcEEEeecCCcc
Q 042435 240 -DCTPSIVHRDISSNNILLN-SNLEAFVADFGTVR 272 (412)
Q Consensus 240 -~~~~~ivHrDlkp~NILl~-~~~~~kl~DfGla~ 272 (412)
.....++|+|+.|.||+++ +++.+.|+||+.+.
T Consensus 162 ~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 162 KPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp CCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred cCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 1245799999999999999 55666799998765
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.10 E-value=0.00097 Score=57.29 Aligned_cols=114 Identities=20% Similarity=0.209 Sum_probs=68.3
Q ss_pred ccceeeeecCceEEEEEEeCCCcEEEEEeccCCccccce-----------E-----EEecCceEEEEEEeccCCceeeee
Q 042435 146 HIRYCIGTGGYDSVYKAELPDGKVVALKKLHHSETEDSA-----------F-----VVYSPQCMFFIYEYMERGSLFCVL 209 (412)
Q Consensus 146 ~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~l~~~~~~~~~-----------~-----~~~~~~~~~lv~ey~~~gsL~~~l 209 (412)
...+.||+|++|.||+|.+. |..+|+|.-++....... . ..+.-+..++.|||..|-.|.++-
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~ds~r~~l~kEakiLeil~g~~~~p~vy~yg~~~i~me~i~G~~L~~~~ 103 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEWR-GGEVALKVRRRDSPRRNLEKEAKILEILAGEGVTPEVYFYGEDFIRMEYIDGRPLGKLE 103 (201)
T ss_pred hhhhhhhcccccEEEEeecc-CceEEEEEecCCcchhhHHHHHHHHHHhhhcCCCceEEEechhhhhhhhhcCcchhhhh
Confidence 34567999999999999995 457888876554322110 0 122223345669999887776543
Q ss_pred ccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCC-CCCEEecCCCcEEEeecCCccc
Q 042435 210 RDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDIS-SNNILLNSNLEAFVADFGTVRL 273 (412)
Q Consensus 210 ~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlk-p~NILl~~~~~~kl~DfGla~~ 273 (412)
... +-.+. ..++..---|-.. ||-|+.|. |..+++-.+..+.|+||--|+.
T Consensus 104 ~~~------~rk~l----~~vlE~a~~LD~~---GI~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 104 IGG------DRKHL----LRVLEKAYKLDRL---GIEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred hcc------cHHHH----HHHHHHHHHHHHh---ccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 321 12222 2333332223333 88888886 4444444455999999988874
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.96 E-value=0.00075 Score=63.37 Aligned_cols=113 Identities=16% Similarity=0.204 Sum_probs=78.4
Q ss_pred cccceeeeecCceEEEEEEeCCCcEEEEEecc-----------------CCccccceE----------------------
Q 042435 145 FHIRYCIGTGGYDSVYKAELPDGKVVALKKLH-----------------HSETEDSAF---------------------- 185 (412)
Q Consensus 145 f~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~l~-----------------~~~~~~~~~---------------------- 185 (412)
+.+++.||-|.-+.||.+...+|++.++|.-+ +.....-..
T Consensus 94 ~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gfp 173 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGFP 173 (465)
T ss_pred hhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCCC
Confidence 67789999999999999999999999998321 111000000
Q ss_pred --EEecCceEEEEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcE
Q 042435 186 --VVYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEA 263 (412)
Q Consensus 186 --~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~ 263 (412)
...+.+..++|||++.+-.|.+.-+-. +.++...-+.++ +.-|-.+ |+||+|..-=||+++++..+
T Consensus 174 VPkpiD~~RH~Vvmelv~g~Pl~~v~~v~------d~~~ly~~lm~~---Iv~la~~---GlIHgDFNEFNimv~dd~~i 241 (465)
T KOG2268|consen 174 VPKPIDHNRHCVVMELVDGYPLRQVRHVE------DPPTLYDDLMGL---IVRLANH---GLIHGDFNEFNIMVKDDDKI 241 (465)
T ss_pred CCCcccccceeeHHHhhcccceeeeeecC------ChHHHHHHHHHH---HHHHHHc---CceecccchheeEEecCCCE
Confidence 023456779999999998887754322 223332222222 3334445 99999999999999999999
Q ss_pred EEeecC
Q 042435 264 FVADFG 269 (412)
Q Consensus 264 kl~DfG 269 (412)
+++||-
T Consensus 242 ~vIDFP 247 (465)
T KOG2268|consen 242 VVIDFP 247 (465)
T ss_pred EEeech
Confidence 999995
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=96.89 E-value=0.009 Score=52.88 Aligned_cols=32 Identities=31% Similarity=0.546 Sum_probs=29.2
Q ss_pred cCcccceeeeecCc-eEEEEEEeCCCcEEEEEec
Q 042435 143 EYFHIRYCIGTGGY-DSVYKAELPDGKVVALKKL 175 (412)
Q Consensus 143 ~~f~~~~~lG~G~~-g~Vy~~~~~~~~~vAvK~l 175 (412)
.+++..+.||.|.. |.|||++. +|+.+|+|.+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf 69 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLF 69 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEe
Confidence 77888999999999 99999999 6789999984
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.83 E-value=0.01 Score=56.90 Aligned_cols=31 Identities=19% Similarity=0.301 Sum_probs=26.4
Q ss_pred CCCcEEeCCCCCCEEecCCCcEEEeecCCcc
Q 042435 242 TPSIVHRDISSNNILLNSNLEAFVADFGTVR 272 (412)
Q Consensus 242 ~~~ivHrDlkp~NILl~~~~~~kl~DfGla~ 272 (412)
..+++|+|+.|.||+++++...-|+||+.+.
T Consensus 186 p~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 186 PRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred CcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 4589999999999999876556799999775
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=96.82 E-value=0.012 Score=53.94 Aligned_cols=30 Identities=20% Similarity=0.272 Sum_probs=26.4
Q ss_pred CCcEEeCCCCCCEEecCCCcEEEeecCCcc
Q 042435 243 PSIVHRDISSNNILLNSNLEAFVADFGTVR 272 (412)
Q Consensus 243 ~~ivHrDlkp~NILl~~~~~~kl~DfGla~ 272 (412)
+.++|+|+.|.||+++++....|+||+.+.
T Consensus 163 ~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 163 LVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred eEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 468999999999999987778899998765
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=96.80 E-value=0.0062 Score=57.64 Aligned_cols=124 Identities=16% Similarity=0.125 Sum_probs=71.1
Q ss_pred ceeeeecCceEEEEEEeCCCcEEEEEeccCCccccce------------E--------------EEecCceEEEEEEecc
Q 042435 148 RYCIGTGGYDSVYKAELPDGKVVALKKLHHSETEDSA------------F--------------VVYSPQCMFFIYEYME 201 (412)
Q Consensus 148 ~~~lG~G~~g~Vy~~~~~~~~~vAvK~l~~~~~~~~~------------~--------------~~~~~~~~~lv~ey~~ 201 (412)
.+.+..|....+|+....+ ..+++|........... . .....+..+.+++|++
T Consensus 19 i~~i~~G~~n~~y~v~~~~-~~~vLr~~~~~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~i~ 97 (296)
T cd05153 19 FEGISAGIENTNYFVTTDS-GRYVLTLFEKVSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVEFLA 97 (296)
T ss_pred eecccCccccceEEEEeCC-CcEEEEEcCCCChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEEeCC
Confidence 4567778888999987754 46888876531111000 0 0122345689999999
Q ss_pred CCceeee----e----------ccCcc--------cccCCHHHHHH----------HHHHHHHHHHHHHh----CCCCCc
Q 042435 202 RGSLFCV----L----------RDDDE--------AIELNWTRRMN----------IVKSVAHALSYLHH----DCTPSI 245 (412)
Q Consensus 202 ~gsL~~~----l----------~~~~~--------~~~l~~~~~~~----------i~~~ia~gL~~LH~----~~~~~i 245 (412)
|..+... . +.... .....|..... ....+...+.++.. ....++
T Consensus 98 G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~~l 177 (296)
T cd05153 98 GEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLPRGV 177 (296)
T ss_pred CCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCCCcC
Confidence 8776431 0 00000 01123332210 11123344555543 123479
Q ss_pred EEeCCCCCCEEecCCCcEEEeecCCcc
Q 042435 246 VHRDISSNNILLNSNLEAFVADFGTVR 272 (412)
Q Consensus 246 vHrDlkp~NILl~~~~~~kl~DfGla~ 272 (412)
+|+|+.|.||+++++....|.||+.+.
T Consensus 178 ~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 178 IHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred CccCcCcccEEEeCCceEEEeehhhhc
Confidence 999999999999987777899998765
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=96.78 E-value=0.0038 Score=67.46 Aligned_cols=169 Identities=14% Similarity=0.126 Sum_probs=107.8
Q ss_pred EEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCC---CEEecCCCcEEEe--ecCCc
Q 042435 197 YEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSN---NILLNSNLEAFVA--DFGTV 271 (412)
Q Consensus 197 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~---NILl~~~~~~kl~--DfGla 271 (412)
.||+..-++...+..-. ..+..+.+.+..+..+||+|+|+. ...|.-+..+ +--.+.++...++ ||+.+
T Consensus 265 ~~~~s~~~~~~~~q~v~---~i~~~~~r~~~~~~~~GL~~~h~~---~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss 338 (1351)
T KOG1035|consen 265 QEICSKVELRSLLQSVG---SIPLETLRILHQKLLEGLAYLHSL---SLEHVVLSASSSKESTVDGEGVVAISLSDFDSS 338 (1351)
T ss_pred HhhcCccchHHHHhhcc---ccCHHHHHHHHHHHhhhHHHHHHh---ccceeEEecccccccccCccceeecchhhhccc
Confidence 45666656655555433 467778888999999999999988 5555555444 4444556666666 88877
Q ss_pred cccCCCCCCcccccccccccccccccCcccCc--ccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccC
Q 042435 272 RLLDVDSSNRTLQAGTYGYIALELVYTMVVTE--KCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLS 349 (412)
Q Consensus 272 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~--ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 349 (412)
+.+....... ....+..|.+||......++. ..|+|.+|.....+..|..+-... ......+ .
T Consensus 339 ~~l~d~~~~~-~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~~~~~~i~~~~----------~~~~~~l----~ 403 (1351)
T KOG1035|consen 339 KPLPDNEKSF-SDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQLSQGEDISEKS----------AVPVSLL----D 403 (1351)
T ss_pred ccCCCcccch-hhcCccccccccccccccchhhhhhHHHHHHHHHhhhhhcCcccccc----------cchhhhh----c
Confidence 7654332222 223445677888776665544 479999999999999887652210 0001111 1
Q ss_pred CccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhcCCC
Q 042435 350 PPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELEGKTP 393 (412)
Q Consensus 350 ~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 393 (412)
.. .. . ...+...+|+..++++|+++.+++.+.-.-.+
T Consensus 404 ~~-~~---~---~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~~ 440 (1351)
T KOG1035|consen 404 VL-ST---S---ELLDALPKCLDEDSEERLSALELLTHPFLRFP 440 (1351)
T ss_pred cc-cc---h---hhhhhhhhhcchhhhhccchhhhhhchhcccc
Confidence 00 00 0 24566679999999999999999988654433
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.63 E-value=0.012 Score=53.71 Aligned_cols=30 Identities=23% Similarity=0.297 Sum_probs=26.5
Q ss_pred CCcEEeCCCCCCEEecC-CCcEEEeecCCcc
Q 042435 243 PSIVHRDISSNNILLNS-NLEAFVADFGTVR 272 (412)
Q Consensus 243 ~~ivHrDlkp~NILl~~-~~~~kl~DfGla~ 272 (412)
..++|+|+.+.|||+++ +..+.++||-.|.
T Consensus 170 ~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~ 200 (235)
T cd05157 170 IVFCHNDLLSGNIIYNEEKNSVKFIDYEYAG 200 (235)
T ss_pred EEEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence 46899999999999997 5789999998775
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=96.51 E-value=0.00014 Score=79.88 Aligned_cols=136 Identities=13% Similarity=0.013 Sum_probs=101.0
Q ss_pred CceEEEEEEeccCCceeeeeccCcc-cccCCHHHHHHHHHHHHHHHHHHHhCC--CCCcEEeCCCCCCEEecCCCcEEEe
Q 042435 190 PQCMFFIYEYMERGSLFCVLRDDDE-AIELNWTRRMNIVKSVAHALSYLHHDC--TPSIVHRDISSNNILLNSNLEAFVA 266 (412)
Q Consensus 190 ~~~~~lv~ey~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~gL~~LH~~~--~~~ivHrDlkp~NILl~~~~~~kl~ 266 (412)
..+.+..++|+..|++.+.+-...+ ...++..-......+...+..-+|+.. ..-.+|++||+-|.++..+..+|+.
T Consensus 1303 s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~g 1382 (2724)
T KOG1826|consen 1303 STEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLG 1382 (2724)
T ss_pred ChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCCccccc
Confidence 3455788999999999988765432 223333333333333355555555542 2246899999999999999999999
Q ss_pred ecCCccccCCCCCCcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcc
Q 042435 267 DFGTVRLLDVDSSNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGE 325 (412)
Q Consensus 267 DfGla~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~ 325 (412)
++|+.+...+.........+++.|+.|+......++.++|+|..|+.+|+...|..+|-
T Consensus 1383 k~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~~n~~fi 1441 (2724)
T KOG1826|consen 1383 KGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSDGNAYFI 1441 (2724)
T ss_pred ccccccccCchHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhcccHHHH
Confidence 99999965555545566678899999999888889988999999999999988877753
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=96.41 E-value=0.019 Score=54.74 Aligned_cols=42 Identities=26% Similarity=0.425 Sum_probs=32.1
Q ss_pred HHHHHHHHh----CCCCCcEEeCCCCCCEEecCCCcEEEeecCCcc
Q 042435 231 AHALSYLHH----DCTPSIVHRDISSNNILLNSNLEAFVADFGTVR 272 (412)
Q Consensus 231 a~gL~~LH~----~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~ 272 (412)
.+.++++.. ....+++|+|+.+.||+++++....|+||+.+.
T Consensus 171 ~~~~~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 171 DKELDYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred HHHHHHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 345555543 234589999999999999988767899998764
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=96.38 E-value=0.034 Score=60.48 Aligned_cols=43 Identities=19% Similarity=0.319 Sum_probs=30.4
Q ss_pred HHHHHHHhCCC--------CCcEEeCCCCCCEEecCC-Cc-EEEeecCCcccc
Q 042435 232 HALSYLHHDCT--------PSIVHRDISSNNILLNSN-LE-AFVADFGTVRLL 274 (412)
Q Consensus 232 ~gL~~LH~~~~--------~~ivHrDlkp~NILl~~~-~~-~kl~DfGla~~~ 274 (412)
..+.+|..+.. +.++|+|+++.||+++.+ .. .-|.||.++..-
T Consensus 206 ~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~G 258 (822)
T PLN02876 206 ELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTLG 258 (822)
T ss_pred HHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeeccccC
Confidence 34567755422 359999999999999853 33 468999987643
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=96.36 E-value=0.0025 Score=44.84 Aligned_cols=44 Identities=27% Similarity=0.291 Sum_probs=34.5
Q ss_pred echhhccCCC-ceeeCCC-CCCCCCCCEEeCccccccccCCCCCcCC
Q 042435 4 LLAFLSISAA-CSGVVEE-EPSSPSFLKSDMSFNNLDGEIPTYLRDN 48 (412)
Q Consensus 4 ~~~~l~~~~~-~~G~ip~-~~~~~~l~~~~ls~N~l~G~iP~~~~~~ 48 (412)
.|++|+|+.| ++...+. +.++++|+.||+|+|+++. ||...|..
T Consensus 2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~-i~~~~f~~ 47 (61)
T PF13855_consen 2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTS-IPPDAFSN 47 (61)
T ss_dssp TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESE-EETTTTTT
T ss_pred cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCc-cCHHHHcC
Confidence 4789999999 8855555 7899999999999999975 45443443
|
... |
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=96.33 E-value=0.002 Score=45.37 Aligned_cols=35 Identities=26% Similarity=0.263 Sum_probs=30.5
Q ss_pred eechhhccCCC-ceeeCCC-CCCCCCCCEEeCccccc
Q 042435 3 VLLAFLSISAA-CSGVVEE-EPSSPSFLKSDMSFNNL 37 (412)
Q Consensus 3 ~~~~~l~~~~~-~~G~ip~-~~~~~~l~~~~ls~N~l 37 (412)
-.|++|||+.| ++...|. +.++++|+.|++++|+|
T Consensus 25 ~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 25 PNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 46899999999 8766666 78999999999999986
|
... |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=96.32 E-value=0.038 Score=52.48 Aligned_cols=28 Identities=14% Similarity=0.220 Sum_probs=21.9
Q ss_pred CCCcEEeCCCCCCEEecCC-Cc-EEEeecC
Q 042435 242 TPSIVHRDISSNNILLNSN-LE-AFVADFG 269 (412)
Q Consensus 242 ~~~ivHrDlkp~NILl~~~-~~-~kl~DfG 269 (412)
.+.++|||+.+.||+++.+ +. +.|.|..
T Consensus 192 ~psLlHGDlw~gNvl~~~~~~~i~~liDPa 221 (297)
T PRK10593 192 NCVLVHGNFTLRSMLKDPRSDQLLAMLNPG 221 (297)
T ss_pred CCeeEeCCCCcccEEECCCCCceEEEECch
Confidence 4678999999999999854 33 6677754
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=96.02 E-value=0.038 Score=51.12 Aligned_cols=30 Identities=13% Similarity=0.169 Sum_probs=25.8
Q ss_pred CCcEEeCCCCCCEEecCCCcEEEeecCCccc
Q 042435 243 PSIVHRDISSNNILLNSNLEAFVADFGTVRL 273 (412)
Q Consensus 243 ~~ivHrDlkp~NILl~~~~~~kl~DfGla~~ 273 (412)
+.++|+|+.|.||++++++ +.++||..+..
T Consensus 146 ~~l~H~Dl~~~Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 146 LAPLHMDVHAYNLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred CeeecCCCCcCcEEEeCCC-CEEEeccccCc
Confidence 3589999999999999876 78999988763
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PF00560 LRR_1: Leucine Rich Repeat; InterPro: IPR001611 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape [] | Back alignment and domain information |
|---|
Probab=95.91 E-value=0.0029 Score=34.66 Aligned_cols=18 Identities=39% Similarity=0.434 Sum_probs=15.6
Q ss_pred CCCEEeCccccccccCCCC
Q 042435 26 SFLKSDMSFNNLDGEIPTY 44 (412)
Q Consensus 26 ~l~~~~ls~N~l~G~iP~~ 44 (412)
+|+.||+|+|+|+ +||..
T Consensus 1 ~L~~Ldls~n~l~-~ip~~ 18 (22)
T PF00560_consen 1 NLEYLDLSGNNLT-SIPSS 18 (22)
T ss_dssp TESEEEETSSEES-EEGTT
T ss_pred CccEEECCCCcCE-eCChh
Confidence 5789999999999 89974
|
LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. ; GO: 0005515 protein binding; PDB: 4ECO_B 2A0Z_A 3ULU_A 1ZIW_A 3ULV_A 1DCE_C 1LTX_A 3J0A_B 3A79_B 4FCG_A .... |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.74 E-value=0.053 Score=52.16 Aligned_cols=120 Identities=24% Similarity=0.393 Sum_probs=82.3
Q ss_pred ccceeeeecCceEEEEEEeCCCcEEEEEeccCCccc--------cceE-----EEe------------------------
Q 042435 146 HIRYCIGTGGYDSVYKAELPDGKVVALKKLHHSETE--------DSAF-----VVY------------------------ 188 (412)
Q Consensus 146 ~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~l~~~~~~--------~~~~-----~~~------------------------ 188 (412)
++..+|..|.-+.||.|.-.+|..+|||..+.+-.+ .-.+ .|.
T Consensus 147 ~inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a 226 (520)
T KOG2270|consen 147 EINGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA 226 (520)
T ss_pred ecccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence 344678899999999999999999999976532111 0000 111
Q ss_pred ---cC-----ceEEEEEEeccCCce-eeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecC
Q 042435 189 ---SP-----QCMFFIYEYMERGSL-FCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNS 259 (412)
Q Consensus 189 ---~~-----~~~~lv~ey~~~gsL-~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~ 259 (412)
.+ ....|||+|+..-.. .-.|++ ..++......+-.+++.-+.-|-+.| ++||.||.-=|+|+-
T Consensus 227 GIP~PePIlLk~hVLVM~FlGrdgw~aPkLKd----~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Lyh- 299 (520)
T KOG2270|consen 227 GIPCPEPILLKNHVLVMEFLGRDGWAAPKLKD----ASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLYH- 299 (520)
T ss_pred CCCCCCceeeecceEeeeeccCCCCcCccccc----ccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheEE-
Confidence 11 123799999953211 112222 23666667777788888888888777 899999999999985
Q ss_pred CCcEEEeecCCcc
Q 042435 260 NLEAFVADFGTVR 272 (412)
Q Consensus 260 ~~~~kl~DfGla~ 272 (412)
++.+.++|-+-+-
T Consensus 300 dG~lyiIDVSQSV 312 (520)
T KOG2270|consen 300 DGKLYIIDVSQSV 312 (520)
T ss_pred CCEEEEEEccccc
Confidence 5789999987654
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=95.70 E-value=0.064 Score=52.88 Aligned_cols=30 Identities=20% Similarity=0.313 Sum_probs=25.4
Q ss_pred CCcEEeCCCCCCEEecCCCcEEEeecCCccc
Q 042435 243 PSIVHRDISSNNILLNSNLEAFVADFGTVRL 273 (412)
Q Consensus 243 ~~ivHrDlkp~NILl~~~~~~kl~DfGla~~ 273 (412)
..++|||+.+.||++.++ .++++||-++..
T Consensus 223 ~~l~HgDl~~gni~~~~~-~~~viD~E~a~~ 252 (401)
T PRK09550 223 EALLHGDLHTGSIFVTEE-ETKVIDPEFAFY 252 (401)
T ss_pred CceeeccCCcccEEeeCC-CcEEEecccccc
Confidence 468999999999999766 689999987653
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=95.67 E-value=0.036 Score=50.62 Aligned_cols=30 Identities=30% Similarity=0.537 Sum_probs=25.5
Q ss_pred CCcEEeCCCCCCEEecCCCcEEEeecCCcc
Q 042435 243 PSIVHRDISSNNILLNSNLEAFVADFGTVR 272 (412)
Q Consensus 243 ~~ivHrDlkp~NILl~~~~~~kl~DfGla~ 272 (412)
+.++|+|+.+.||+++++...-|+||+.+.
T Consensus 164 ~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~ 193 (235)
T cd05155 164 PVWFHGDLAPGNLLVQDGRLSAVIDFGCLG 193 (235)
T ss_pred ceEEeCCCCCCcEEEECCCEEEEEeCcccC
Confidence 458999999999999876556799999875
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=95.51 E-value=0.16 Score=45.03 Aligned_cols=112 Identities=21% Similarity=0.294 Sum_probs=67.4
Q ss_pred ceeeeecCceEEEEEEeCCCcEEEEEeccCCc-------------------------------------------cccce
Q 042435 148 RYCIGTGGYDSVYKAELPDGKVVALKKLHHSE-------------------------------------------TEDSA 184 (412)
Q Consensus 148 ~~~lG~G~~g~Vy~~~~~~~~~vAvK~l~~~~-------------------------------------------~~~~~ 184 (412)
...||+|+.=.||. ++++....||.++... +....
T Consensus 6 ~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 6 SDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred CcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 45799999999986 3445556667655443 11122
Q ss_pred EEEecCceEEEEEEeccC--C----ceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEec
Q 042435 185 FVVYSPQCMFFIYEYMER--G----SLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLN 258 (412)
Q Consensus 185 ~~~~~~~~~~lv~ey~~~--g----sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~ 258 (412)
+...++...-+|+|.+.+ | +|.+++.+.. ++. . +...+-+-..||-++ .|+.+|++|.||++.
T Consensus 84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~----~~~-~---~~~~L~~f~~~l~~~---~Iv~~dl~~~NIv~~ 152 (199)
T PF10707_consen 84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKEGG----LTE-E---LRQALDEFKRYLLDH---HIVIRDLNPHNIVVQ 152 (199)
T ss_pred EEEecCCceEEEEEEEECCCCCcCccHHHHHHcCC----ccH-H---HHHHHHHHHHHHHHc---CCeecCCCcccEEEE
Confidence 335556666788887643 2 3444443322 333 2 233333445677766 899999999999995
Q ss_pred CC---C-cEEEee-cCCcc
Q 042435 259 SN---L-EAFVAD-FGTVR 272 (412)
Q Consensus 259 ~~---~-~~kl~D-fGla~ 272 (412)
.. . .+.|+| ||-..
T Consensus 153 ~~~~~~~~lvlIDG~G~~~ 171 (199)
T PF10707_consen 153 RRDSGEFRLVLIDGLGEKE 171 (199)
T ss_pred ecCCCceEEEEEeCCCCcc
Confidence 32 2 577888 55443
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=94.31 E-value=0.19 Score=48.41 Aligned_cols=54 Identities=22% Similarity=0.302 Sum_probs=46.7
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCcccc
Q 042435 218 LNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLL 274 (412)
Q Consensus 218 l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~ 274 (412)
-.|.+.+.++.+.+.-++-+..+. +.-|||+.-.|||++ +|++.|+||-+++.-
T Consensus 318 ~~~~e~lsff~s~~sil~~lekkf--~fehrnlt~~niLId-~GnvtLIDfklsRl~ 371 (488)
T COG5072 318 DRSEEELSFFWSCISILDILEKKF--PFEHRNLTLDNILID-EGNVTLIDFKLSRLS 371 (488)
T ss_pred ccHHHHHHHHHHHHHHHhhhhhcC--Ccccccccccceeee-cCceEEEEeeeeecc
Confidence 578899999998888777777653 789999999999999 999999999999853
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=93.08 E-value=0.44 Score=46.24 Aligned_cols=30 Identities=23% Similarity=0.332 Sum_probs=24.8
Q ss_pred CCcEEeCCCCCCEEecCCCcEEEeecCCccc
Q 042435 243 PSIVHRDISSNNILLNSNLEAFVADFGTVRL 273 (412)
Q Consensus 243 ~~ivHrDlkp~NILl~~~~~~kl~DfGla~~ 273 (412)
..++|||+.+.||+++++ .++++|+.++..
T Consensus 192 ~~llHGDl~~gNi~~~~~-~~~~iD~e~~~~ 221 (370)
T TIGR01767 192 ETLLHGDLHSGSIFVSEH-ETKVIDPEFAFY 221 (370)
T ss_pred ceeeeccCCcccEEEcCC-CCEEEcCccccc
Confidence 368999999999999765 478999987653
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=93.05 E-value=0.76 Score=43.36 Aligned_cols=27 Identities=30% Similarity=0.449 Sum_probs=19.0
Q ss_pred CCCcEEeCCCCCCEEecCCCcEEEeec
Q 042435 242 TPSIVHRDISSNNILLNSNLEAFVADF 268 (412)
Q Consensus 242 ~~~ivHrDlkp~NILl~~~~~~kl~Df 268 (412)
.|-++|+||-+.|++.+.++++.|.|=
T Consensus 187 ~PsLlHGDLW~GN~~~~~~g~p~l~DP 213 (288)
T PF03881_consen 187 KPSLLHGDLWSGNVGFDADGEPVLFDP 213 (288)
T ss_dssp --EEE-SS-SGGGEEEETTE-EEE-S-
T ss_pred CceeeEcCccccceeecCCCCceeecc
Confidence 567999999999999999988999883
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=92.94 E-value=0.23 Score=47.05 Aligned_cols=32 Identities=25% Similarity=0.352 Sum_probs=27.7
Q ss_pred CCCCcEEeCCCCCCEEecCC----CcEEEeecCCcc
Q 042435 241 CTPSIVHRDISSNNILLNSN----LEAFVADFGTVR 272 (412)
Q Consensus 241 ~~~~ivHrDlkp~NILl~~~----~~~kl~DfGla~ 272 (412)
....++|+|+.+.||+++++ +.+.++||..+.
T Consensus 177 ~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~ 212 (302)
T cd05156 177 SPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS 212 (302)
T ss_pred CCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence 34578999999999999874 789999998875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=92.82 E-value=0.094 Score=51.18 Aligned_cols=59 Identities=19% Similarity=0.228 Sum_probs=39.7
Q ss_pred EEEEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHH-hCCCCCcEEeCCCCCCEEec
Q 042435 193 MFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLH-HDCTPSIVHRDISSNNILLN 258 (412)
Q Consensus 193 ~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH-~~~~~~ivHrDlkp~NILl~ 258 (412)
..++-+|+++-++..++.... .+...+.+++.--+.|+--+- -. +.+|.|+.|.||++-
T Consensus 320 ~vl~E~~~~Gl~v~~~v~~~~----~pe~l~kkva~lg~~AllkMl~vD---NFvHaDlHPGNVlir 379 (565)
T KOG1236|consen 320 LVLVETYERGLSVLRFVKWKS----QPEALVKKVAKLGVNALLKMLIVD---NFVHADLHPGNVLIR 379 (565)
T ss_pred ceeeeeccccccHHhhhhccc----ChHHHHHHHHHHHHHHHHHHHHhh---cceecccCCCcEEEE
Confidence 356777888888877776543 233445556655556654332 22 799999999999994
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=92.80 E-value=0.42 Score=53.24 Aligned_cols=31 Identities=26% Similarity=0.499 Sum_probs=25.9
Q ss_pred CCCcEEeCCCCCCEEecCCC--cEE-EeecCCcc
Q 042435 242 TPSIVHRDISSNNILLNSNL--EAF-VADFGTVR 272 (412)
Q Consensus 242 ~~~ivHrDlkp~NILl~~~~--~~k-l~DfGla~ 272 (412)
..++||+|+.+.|||++.+. ++. |+|||-+.
T Consensus 202 p~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~ 235 (1013)
T PRK06148 202 PAQVIHNDANDYNILVDADDGERISGLIDFGDAV 235 (1013)
T ss_pred CcceECCCCCcccEEEcCCCCcceEEEEECcccc
Confidence 44799999999999998775 454 89999875
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=92.20 E-value=0.062 Score=57.37 Aligned_cols=38 Identities=18% Similarity=0.023 Sum_probs=20.1
Q ss_pred chhhccCCC-ceeeCCC-CCCCCCCCEEeCccccccccCCC
Q 042435 5 LAFLSISAA-CSGVVEE-EPSSPSFLKSDMSFNNLDGEIPT 43 (412)
Q Consensus 5 ~~~l~~~~~-~~G~ip~-~~~~~~l~~~~ls~N~l~G~iP~ 43 (412)
|+.|+|+.| ++ .||. +.++++|..|||++|+|+|.+|.
T Consensus 424 L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~~~ 463 (788)
T PRK15387 424 LLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQ 463 (788)
T ss_pred hhhhhhccCccc-ccChHHhhccCCCeEECCCCCCCchHHH
Confidence 344444444 33 3444 44555666666666666666554
|
|
| >PF13504 LRR_7: Leucine rich repeat; PDB: 3OJA_B 3G06_A 1OOK_G 1QYY_G 1SQ0_B 1P9A_G 1GWB_A 1P8V_A 1M0Z_A 1U0N_D | Back alignment and domain information |
|---|
Probab=91.69 E-value=0.1 Score=26.48 Aligned_cols=14 Identities=36% Similarity=0.501 Sum_probs=9.6
Q ss_pred CCCCEEeCcccccc
Q 042435 25 PSFLKSDMSFNNLD 38 (412)
Q Consensus 25 ~~l~~~~ls~N~l~ 38 (412)
++|++|+||+|+|+
T Consensus 1 ~~L~~L~l~~n~L~ 14 (17)
T PF13504_consen 1 PNLRTLDLSNNRLT 14 (17)
T ss_dssp TT-SEEEETSS--S
T ss_pred CccCEEECCCCCCC
Confidence 47899999999986
|
... |
| >PF03109 ABC1: ABC1 family; InterPro: IPR004147 This entry includes ABC1 from yeast [] and AarF from Escherichia coli [] | Back alignment and domain information |
|---|
Probab=91.11 E-value=0.055 Score=43.81 Aligned_cols=30 Identities=27% Similarity=0.289 Sum_probs=27.1
Q ss_pred ceeeeecCceEEEEEEeCCCcEEEEEeccC
Q 042435 148 RYCIGTGGYDSVYKAELPDGKVVALKKLHH 177 (412)
Q Consensus 148 ~~~lG~G~~g~Vy~~~~~~~~~vAvK~l~~ 177 (412)
.+-||.|+.|.||+|++++|+.||||..+.
T Consensus 16 ~~PlasASiaQVh~a~l~~g~~VaVKV~rP 45 (119)
T PF03109_consen 16 PEPLASASIAQVHRARLKDGEEVAVKVQRP 45 (119)
T ss_pred cchhhheehhhheeeeecccchhhhhhcch
Confidence 367999999999999999999999998764
|
These proteins have a nuclear or mitochondrial subcellular location in eukaryotes. The exact molecular functions of these proteins is not clear, however yeast ABC1 suppresses a cytochrome b mRNA translation defect and is essential for the electron transfer in the bc 1 complex [] and E. coli AarF is required for ubiquinone production []. It has been suggested that members of the ABC1 family are novel chaperonins []. These proteins are unrelated to the ABC transporter proteins. |
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=90.61 E-value=0.57 Score=45.07 Aligned_cols=28 Identities=25% Similarity=0.564 Sum_probs=25.1
Q ss_pred cEEeCCCCCCEEecCCCc-EEEeecCCcc
Q 042435 245 IVHRDISSNNILLNSNLE-AFVADFGTVR 272 (412)
Q Consensus 245 ivHrDlkp~NILl~~~~~-~kl~DfGla~ 272 (412)
++|+|+.|.||+++++.. ..+.||+-+.
T Consensus 199 iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 199 IIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred eeecCCCccceeEcCCCCeeeEEEccccc
Confidence 899999999999998875 8899999765
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=90.56 E-value=0.55 Score=44.56 Aligned_cols=30 Identities=33% Similarity=0.523 Sum_probs=25.7
Q ss_pred CCCcEEeCCCCCCEEecCCCcEEEeecCCcc
Q 042435 242 TPSIVHRDISSNNILLNSNLEAFVADFGTVR 272 (412)
Q Consensus 242 ~~~ivHrDlkp~NILl~~~~~~kl~DfGla~ 272 (412)
..+++|+|+.+.||+++. +.+.++||+.+.
T Consensus 186 ~~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 186 IRGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred cCceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 357899999999999987 578899998664
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=90.47 E-value=0.25 Score=44.34 Aligned_cols=75 Identities=15% Similarity=0.165 Sum_probs=51.6
Q ss_pred HHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCCCCcccccccccccccccccCcccCcccccHHH
Q 042435 231 AHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTYGYIALELVYTMVVTEKCVIYSF 310 (412)
Q Consensus 231 a~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~ 310 (412)
.+.|.-.|+. ..+.+|+|..|+||+-|..|.+||.|=+.-- ..+..|.--|+ ...|+++.+-+|
T Consensus 151 i~~L~~fH~~-~~~~lHGD~np~NiM~D~~G~lKlVDP~~Ll------------~~~V~~vN~~Y---~~lT~~aE~~~f 214 (308)
T PF07387_consen 151 IKDLMDFHSE-NQHCLHGDCNPDNIMCDKFGYLKLVDPVCLL------------ENQVNMVNIEY---ESLTQEAEVKVF 214 (308)
T ss_pred HHHHHHhhcc-CCCeecCCCChhheeecCCCCEEecChhhhh------------hheeeEEeeec---cccChHHHHHHH
Confidence 3678888965 4589999999999999999999999865321 11222332121 234667788888
Q ss_pred HHHHHHHHhCC
Q 042435 311 GVVALEVLMGT 321 (412)
Q Consensus 311 Gvil~elltg~ 321 (412)
=.-+++++...
T Consensus 215 v~s~l~~v~~~ 225 (308)
T PF07387_consen 215 VKSCLKLVEKQ 225 (308)
T ss_pred HHHHHHHHHHH
Confidence 77777777643
|
The function of this family is unknown. |
| >PF08693 SKG6: Transmembrane alpha-helix domain; InterPro: IPR014805 SKG6 and AXL2 are membrane proteins that show polarised intracellular localisation [, ] | Back alignment and domain information |
|---|
Probab=90.08 E-value=0.19 Score=31.75 Aligned_cols=29 Identities=10% Similarity=0.202 Sum_probs=15.6
Q ss_pred ccceeeehhhHHHHHHHHHHHHHHHHHhh
Q 042435 77 PSFILSVKIFLPLTPILAFTIFGFILLLK 105 (412)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 105 (412)
....+++.++++++++++++++.+++++|
T Consensus 9 ~~vaIa~~VvVPV~vI~~vl~~~l~~~~r 37 (40)
T PF08693_consen 9 NTVAIAVGVVVPVGVIIIVLGAFLFFWYR 37 (40)
T ss_pred ceEEEEEEEEechHHHHHHHHHHhheEEe
Confidence 34445556666666655555444444444
|
This entry represents the highly conserved transmembrane alpha-helical domain found in these proteins [, ]. The full-length AXL2 protein has a negative regulatory function in cytokinesis []. |
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=89.79 E-value=0.081 Score=53.95 Aligned_cols=49 Identities=24% Similarity=0.318 Sum_probs=0.0
Q ss_pred chhhccCCC-ceeeCCCCCCCCCCCEEeCccccccccCCCCCcCC-CCcccc
Q 042435 5 LAFLSISAA-CSGVVEEEPSSPSFLKSDMSFNNLDGEIPTYLRDN-PPKSFV 54 (412)
Q Consensus 5 ~~~l~~~~~-~~G~ip~~~~~~~l~~~~ls~N~l~G~iP~~~~~~-~~~~~~ 54 (412)
|+.||||+| +.-....|..-.++..||||||++. +||..+|-+ ...-|.
T Consensus 105 Lt~lDLShNqL~EvP~~LE~AKn~iVLNLS~N~Ie-tIPn~lfinLtDLLfL 155 (1255)
T KOG0444|consen 105 LTILDLSHNQLREVPTNLEYAKNSIVLNLSYNNIE-TIPNSLFINLTDLLFL 155 (1255)
T ss_pred ceeeecchhhhhhcchhhhhhcCcEEEEcccCccc-cCCchHHHhhHhHhhh
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST 
Original result of BLAST against Protein Data Bank
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() | |
| Query | 412 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 6e-26 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 2e-25 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 9e-14 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-13 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 6e-13 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 7e-13 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 1e-11 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 1e-11 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 5e-10 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 6e-09 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 6e-09 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 6e-09 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 1e-08 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 2e-08 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-08 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-08 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 3e-08 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 3e-08 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 3e-08 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 3e-08 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 3e-08 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-08 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 3e-08 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 3e-08 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 4e-08 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 5e-08 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 5e-08 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 5e-08 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 5e-08 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 6e-08 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 6e-08 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 6e-08 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 8e-08 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 9e-08 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 9e-08 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 9e-08 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-07 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 1e-07 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 1e-07 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-07 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 1e-07 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 1e-07 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-07 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-07 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-07 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-07 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-07 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 3e-07 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-07 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-07 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-06 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-06 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 1e-06 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-06 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 2e-06 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 3e-06 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 3e-06 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 3e-06 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 3e-06 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 4e-06 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 4e-06 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 4e-06 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 4e-06 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-06 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-06 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 4e-06 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 4e-06 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 5e-06 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 5e-06 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 5e-06 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 5e-06 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 5e-06 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 5e-06 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 6e-06 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 6e-06 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 6e-06 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 6e-06 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 7e-06 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 7e-06 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 7e-06 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 7e-06 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 8e-06 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 8e-06 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 8e-06 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 8e-06 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 8e-06 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 8e-06 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 8e-06 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 8e-06 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 9e-06 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 9e-06 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 9e-06 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 9e-06 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 9e-06 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 9e-06 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 1e-05 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 1e-05 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 1e-05 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-05 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 1e-05 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 1e-05 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-05 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 1e-05 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 1e-05 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 1e-05 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 1e-05 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 1e-05 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 1e-05 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 1e-05 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-05 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 1e-05 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 1e-05 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 1e-05 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 1e-05 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 1e-05 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 1e-05 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 1e-05 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-05 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-05 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 2e-05 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-05 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-05 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-05 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 3e-05 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 3e-05 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 3e-05 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 3e-05 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 3e-05 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 4e-05 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 4e-05 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 4e-05 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 5e-05 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 5e-05 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 5e-05 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 5e-05 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 5e-05 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 5e-05 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 5e-05 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 6e-05 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 6e-05 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 6e-05 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 7e-05 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 7e-05 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 9e-05 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 1e-04 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-04 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 1e-04 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 1e-04 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 1e-04 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-04 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 1e-04 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-04 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-04 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-04 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-04 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-04 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-04 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-04 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-04 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 3e-04 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 3e-04 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-04 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-04 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 3e-04 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-04 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 3e-04 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 3e-04 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 3e-04 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 3e-04 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 3e-04 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-04 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 4e-04 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 4e-04 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 4e-04 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 5e-04 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 5e-04 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 6e-04 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 6e-04 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 7e-04 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 7e-04 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 7e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST 
Original result of RPS-BLAST against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 412 | |||
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 1e-63 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 8e-52 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 2e-51 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 4e-50 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 1e-46 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 1e-44 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 2e-41 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 2e-39 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 2e-39 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 7e-39 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 8e-39 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 5e-38 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 7e-37 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 3e-36 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 2e-35 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 5e-33 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 4e-31 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 1e-30 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 3e-24 | |
| 4apc_A | 350 | Serine/threonine-protein kinase NEK1; transferase; | 1e-23 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 1e-23 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 5e-23 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 2e-22 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 2e-21 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 6e-21 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 6e-21 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 1e-20 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 1e-20 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 2e-20 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 2e-20 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 3e-20 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 4e-20 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 5e-20 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 5e-20 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 1e-19 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 1e-19 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 4e-19 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 5e-19 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 8e-19 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 2e-18 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 2e-18 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 2e-18 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 3e-18 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 6e-18 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 7e-18 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 8e-18 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 8e-18 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 9e-18 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 9e-18 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 2e-17 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 2e-17 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 2e-17 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 4e-17 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 6e-17 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 7e-17 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 7e-17 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 7e-17 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 8e-17 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 1e-16 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 1e-16 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 2e-16 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 3e-16 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 6e-16 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 6e-16 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 7e-16 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 1e-15 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 3e-15 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 4e-15 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 5e-15 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 5e-15 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 5e-15 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 6e-15 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 7e-15 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 7e-15 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 1e-14 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 1e-14 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 1e-14 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 1e-14 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 2e-14 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 2e-14 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 2e-14 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 2e-14 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 2e-14 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 3e-14 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 3e-14 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 3e-14 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 3e-14 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 4e-14 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 4e-14 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 6e-14 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 6e-14 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 8e-14 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 8e-14 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 9e-14 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 1e-13 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 3e-13 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 6e-13 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 6e-13 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 7e-13 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 2e-12 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 3e-12 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 3e-12 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 3e-12 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 6e-12 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 8e-12 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 1e-11 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 1e-11 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 2e-11 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 3e-11 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 3e-11 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 4e-11 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 6e-11 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 9e-11 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 9e-11 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 9e-11 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 9e-11 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 1e-10 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 1e-10 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 2e-10 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 2e-10 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 2e-10 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 2e-10 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 2e-10 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 3e-10 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 3e-10 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 3e-10 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 3e-10 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 4e-10 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 4e-10 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 4e-10 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 4e-10 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 5e-10 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 5e-10 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 8e-10 | |
| 1uu3_A | 310 | HPDK1, 3-phosphoinositide dependent protein kinase | 8e-10 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 9e-10 | |
| 3zzw_A | 289 | Tyrosine-protein kinase transmembrane receptor RO; | 1e-09 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 1e-09 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 2e-09 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 2e-09 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 3e-09 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 3e-09 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 4e-09 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 5e-09 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 5e-09 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 1e-08 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 1e-08 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 1e-08 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 1e-08 | |
| 3pvu_A | 695 | Beta-adrenergic receptor kinase 1; transferase, se | 1e-08 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 1e-08 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 2e-08 | |
| 3v5q_A | 297 | NT-3 growth factor receptor; kinase domain, kinase | 2e-08 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 2e-08 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 2e-08 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 3e-08 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 3e-08 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 3e-08 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 4e-08 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 4e-08 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 6e-08 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 6e-08 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 6e-08 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 9e-08 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 1e-07 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 1e-07 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 1e-07 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 1e-07 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 2e-07 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 2e-07 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 2e-07 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 2e-07 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 2e-07 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 2e-07 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 3e-07 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 3e-07 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 4e-07 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 6e-07 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 7e-07 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 9e-07 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 1e-06 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 2e-06 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 2e-06 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 3e-06 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 3e-06 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 3e-06 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 4e-06 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 4e-06 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 6e-06 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 7e-06 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 7e-06 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 9e-06 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 1e-05 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 2e-05 | |
| 3g51_A | 325 | Ribosomal protein S6 kinase alpha-3; N-terminal ki | 2e-05 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 2e-05 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 2e-05 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 2e-05 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 2e-05 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 3e-05 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 4e-05 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 4e-05 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 4e-05 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 6e-05 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 7e-05 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 1e-04 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 1e-04 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 1e-04 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 1e-04 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 2e-04 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 2e-04 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 2e-04 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 3e-04 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 4e-04 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 4e-04 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 4e-04 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 5e-04 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 6e-04 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 8e-04 |
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 206 bits (526), Expect = 1e-63
Identities = 91/315 (28%), Positives = 140/315 (44%), Gaps = 50/315 (15%)
Query: 135 YENLIDATEYFHIRYCIGTGGYDSVYKAELPDGKVVALKKLHHSET--EDSAFVV----- 187
L A++ F + +G GG+ VYK L DG +VA+K+L T + F
Sbjct: 22 LRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMI 81
Query: 188 -------------YSPQCM-----FFIYEYMERGSL-FCVLRDDDEAIELNWTRRMNIVK 228
+ CM +Y YM GS+ C+ + L+W +R I
Sbjct: 82 SMAVHRNLLRLRGF---CMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIAL 138
Query: 229 SVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSN-RTLQAGT 287
A L+YLH C P I+HRD+ + NILL+ EA V DFG +L+D ++ T GT
Sbjct: 139 GSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGT 198
Query: 288 YGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLID---IL 344
G+IA E + T +EK ++ +GV+ LE++ G +L + +ML+D L
Sbjct: 199 IGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDD---DVMLLDWVKGL 255
Query: 345 YQ----------RLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELEGKTPM 394
+ L + ++ +I V AL C +S P RP M + + LEG
Sbjct: 256 LKEKKLEALVDVDLQGNYKDEEVEQLIQV---ALLCTQSSPMERPKMSEVVRMLEGDGLA 312
Query: 395 KKGLKEISIPEMRNQ 409
++ +E EM Q
Sbjct: 313 ER-WEEWQKEEMFRQ 326
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 175 bits (445), Expect = 8e-52
Identities = 78/304 (25%), Positives = 119/304 (39%), Gaps = 61/304 (20%)
Query: 135 YENLIDATEYFHIRYC------IGTGGYDSVYKAELPDGKVVALKKLHHSETEDSA---- 184
+ L + T F R +G GG+ VYK + + VA+KKL +
Sbjct: 17 FYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQ 75
Query: 185 -FVV--------------------YSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRR 223
F + +Y YM GSL L D L+W R
Sbjct: 76 QFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMR 135
Query: 224 MNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDS----S 279
I + A+ +++LH + +HRDI S NILL+ A ++DFG R + + +
Sbjct: 136 CKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMT 192
Query: 280 NRTLQAGTYGYIALELVY-TMVVTEKCVIYSFGVVALEVLMG------THPGELLLS--- 329
+R GT Y+A E +T K IYSFGVV LE++ G +LLL
Sbjct: 193 SRI--VGTTAYMAPE--ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKE 248
Query: 330 -LSSSSGPKIMLIDILYQRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQEL 388
+ ID +N + + ++A CL K RP ++++ Q L
Sbjct: 249 EIEDEEKTIEDYID-------KKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLL 301
Query: 389 EGKT 392
+ T
Sbjct: 302 QEMT 305
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 174 bits (443), Expect = 2e-51
Identities = 84/304 (27%), Positives = 119/304 (39%), Gaps = 58/304 (19%)
Query: 135 YENLIDATEYFHIRYCIGTGGYDSVYKAELPDGKVVALKKLHHS----ETEDSAFVV--- 187
+L +AT F ++ IG G + VYK L DG VALK+ E F
Sbjct: 31 LVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEE---FETEIE 87
Query: 188 ---------------YSPQC-----MFFIYEYMERGSLFCVLRDDDEAIE-LNWTRRMNI 226
+ C M IY+YME G+L L D ++W +R+ I
Sbjct: 88 TLSFCRHPHLVSLIGF---CDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEI 144
Query: 227 VKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNR--TLQ 284
A L YLH T +I+HRD+ S NILL+ N + DFG + T+
Sbjct: 145 CIGAARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVV 201
Query: 285 AGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGP-------- 336
GT GYI E +TEK +YSFGVV EVL + S
Sbjct: 202 KGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSA----IVQSLPREMVNLAEWAV 257
Query: 337 ----KIMLIDILYQRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELEGKT 392
L I+ L+ I + + A+ CL + RP+M + +LE
Sbjct: 258 ESHNNGQLEQIVDPNLADKIRPE---SLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYAL 314
Query: 393 PMKK 396
+++
Sbjct: 315 RLQE 318
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 171 bits (434), Expect = 4e-50
Identities = 58/304 (19%), Positives = 112/304 (36%), Gaps = 54/304 (17%)
Query: 135 YENLIDATEYFHIRYCIGTGGYDSVYKAELPDGKVVALKKLHHSETEDSAF--------- 185
ENL + + G + V+KA+ + VA+K + +
Sbjct: 16 TENLYFQSMPLQLLEVKARGRFGCVWKAQ-LLNEYVAVKIFPIQDKQSWQNEYEVYSLPG 74
Query: 186 -----VV----------YSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSV 230
++ ++ I + E+GSL L+ + ++W +I +++
Sbjct: 75 MKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN----VVSWNELCHIAETM 130
Query: 231 AHALSYLHHD-------CTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSS--NR 281
A L+YLH D P+I HRDI S N+LL +NL A +ADFG + S +
Sbjct: 131 ARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDT 190
Query: 282 TLQAGTYGYIALE-----LVYTMVVTEKCVIYSFGVVALEVLMGTHPG-------ELLLS 329
Q GT Y+A E + + + +Y+ G+V E+ L
Sbjct: 191 HGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFE 250
Query: 330 LSSSSGPKI--MLIDILYQRLSPPINQKIIQDIIL--VSTIALACLRSKPKSRPTMQRIS 385
P + M +++++ P + + + + C ++R + +
Sbjct: 251 EEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVG 310
Query: 386 QELE 389
+ +
Sbjct: 311 ERIT 314
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 1e-46
Identities = 64/275 (23%), Positives = 120/275 (43%), Gaps = 38/275 (13%)
Query: 136 ENLIDATEYFHIRYCIGTGGYDSVYKAELPDGKVVALKKLHHSETEDSAF---------- 185
++ID E + +G G + V KA+ K VA+K++ SE+E AF
Sbjct: 2 LHMIDYKE-IEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIE-SESERKAFIVELRQLSRV 58
Query: 186 ----------VVYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALS 235
+P C+ + EY E GSL+ VL + M+ + ++
Sbjct: 59 NHPNIVKLYGACLNPVCL--VMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVA 116
Query: 236 YLHHDCTPSIVHRDISSNNILLNSNLEAF-VADFGTVRLLDVDSSNRTLQAGTYGYIALE 294
YLH +++HRD+ N+LL + + DFGT + ++ T G+ ++A E
Sbjct: 117 YLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI---QTHMTNNKGSAAWMAPE 173
Query: 295 LVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQ 354
+ +EKC ++S+G++ EV+ P + + GP ++ ++ PP+ +
Sbjct: 174 VFEGSNYSEKCDVFSWGIILWEVITRRKPFDEI------GGPAFRIMWAVHNGTRPPLIK 227
Query: 355 KIIQDIILVSTIALACLRSKPKSRPTMQRISQELE 389
+ + I ++ C P RP+M+ I + +
Sbjct: 228 NLPKPI---ESLMTRCWSKDPSQRPSMEEIVKIMT 259
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 1e-44
Identities = 67/274 (24%), Positives = 116/274 (42%), Gaps = 36/274 (13%)
Query: 139 IDATEYFHIRYCIGTGGYDSVYKAELPDGKVVALKKLHHSETEDSAF------------- 185
I + +I+ IG G + +V++AE G VA+K L +
Sbjct: 34 IPWCD-LNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRL 91
Query: 186 ----------VVYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALS 235
V P + + EY+ RGSL+ +L +L+ RR+++ VA ++
Sbjct: 92 RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMN 151
Query: 236 YLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTYGYIALEL 295
YLH+ P IVHR++ S N+L++ V DFG RL + AGT ++A E+
Sbjct: 152 YLHN-RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEV 210
Query: 296 VYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQK 355
+ EK +YSFGV+ E+ P L + +++ + ++ I +
Sbjct: 211 LRDEPSNEKSDVYSFGVILWELATLQQPWGNL------NPAQVVA-AVGFKCKRLEIPRN 263
Query: 356 IIQDIILVSTIALACLRSKPKSRPTMQRISQELE 389
+ + + I C ++P RP+ I L
Sbjct: 264 LNPQV---AAIIEGCWTNEPWKRPSFATIMDLLR 294
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 2e-41
Identities = 68/287 (23%), Positives = 111/287 (38%), Gaps = 53/287 (18%)
Query: 139 IDATEYFHIRYCIGTGGYDSVYKAE-LPDGKVVALKKLHHSETEDSAF------------ 185
+ E IG GG+ V+K + D VVA+K L ++E
Sbjct: 16 LADNE-IEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREV 74
Query: 186 ----------------VVYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKS 229
++++P M + E++ G L+ L D +A + W+ ++ ++
Sbjct: 75 FIMSNLNHPNIVKLYGLMHNPPRM--VMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLD 130
Query: 230 VAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAF-----VADFGTVRLLDVDSSNRTLQ 284
+A + Y+ + P IVHRD+ S NI L S E VADFG + +
Sbjct: 131 IALGIEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSV---SGL 186
Query: 285 AGTYGYIALELVYT--MVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLID 342
G + ++A E + TEK YSF ++ +L G P + S G +
Sbjct: 187 LGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEY-----SYGKIKFINM 241
Query: 343 ILYQRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELE 389
I + L P I + + + C PK RP I +EL
Sbjct: 242 IREEGLRPTIPEDCPPRL---RNVIELCWSGDPKKRPHFSYIVKELS 285
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 2e-39
Identities = 59/328 (17%), Positives = 110/328 (33%), Gaps = 65/328 (19%)
Query: 135 YENLIDATEYFHIRYCIGTGGYDSVYKAELPDGKVVALKKLHHS-------ETE------ 181
+ + IG G Y +VYK L D + VA+K + E
Sbjct: 5 ASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQNFINEKNIYRVPL 63
Query: 182 ------------DSAFVVYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKS 229
D + EY GSL L +W + S
Sbjct: 64 MEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH----TSDWVSSCRLAHS 119
Query: 230 VAHALSYLHHD------CTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNR-- 281
V L+YLH + P+I HRD++S N+L+ ++ ++DFG L + R
Sbjct: 120 VTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPG 179
Query: 282 ------TLQAGTYGYIA-------LELVYTMVVTEKCVIYSFGVVALEVLMGT------- 321
+ GT Y+A + L ++ +Y+ G++ E+ M
Sbjct: 180 EEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGE 239
Query: 322 --HPGELLLSLSSSSGPKI--MLIDILYQRLSPPINQKIIQDIILVSTIA---LACLRSK 374
++ + P M + + ++ P + ++ + V ++ C
Sbjct: 240 SVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQD 299
Query: 375 PKSRPTMQRISQELEGKTPMKKGLKEIS 402
++R T Q + + + + K +S
Sbjct: 300 AEARLTAQXAEERMAELMMIWERNKSVS 327
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 2e-39
Identities = 64/284 (22%), Positives = 109/284 (38%), Gaps = 51/284 (17%)
Query: 139 IDATEYFHIRYCIGTGGYDSVYKAELPDGKVVALKKLHHSETEDSAF------------- 185
ID E + IG GG+ VY+A G VA+K H ED +
Sbjct: 4 IDFAE-LTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFA 61
Query: 186 ------------VVYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHA 233
V + + E+ G L VL + +N +A
Sbjct: 62 MLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGK----RIPPDILVNWAVQIARG 117
Query: 234 LSYLHHDCTPSIVHRDISSNNILLNSNLEAF--------VADFGTVRLLDVDSSNRTLQA 285
++YLH + I+HRD+ S+NIL+ +E + DFG R + + A
Sbjct: 118 MNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLARE--WHRTTKMSAA 175
Query: 286 GTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILY 345
G Y ++A E++ + ++ ++S+GV+ E+L G P + L+ + +
Sbjct: 176 GAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLA-------VAYGVAM 228
Query: 346 QRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELE 389
+L+ PI + + + C P SRP+ I +L
Sbjct: 229 NKLALPIPSTCPEPF---AKLMEDCWNPDPHSRPSFTNILDQLT 269
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 7e-39
Identities = 66/291 (22%), Positives = 111/291 (38%), Gaps = 58/291 (19%)
Query: 150 CIGTGGYDSVYKAELPDGKVVALKKLHHSETEDSAFV----VYS---------------- 189
C+G G Y V++ G+ VA+K S ++ ++ +Y+
Sbjct: 15 CVGKGRYGEVWRGSW-QGENVAVKIF--SSRDEKSWFRETELYNTVMLRHENILGFIASD 71
Query: 190 ------PQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHD--- 240
++ I Y E GSL+ L+ L+ + IV S+A L++LH +
Sbjct: 72 MTSRHSSTQLWLITHYHEMGSLYDYLQLT----TLDTVSCLRIVLSIASGLAHLHIEIFG 127
Query: 241 --CTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSS----NRTLQAGTYGYIALE 294
P+I HRD+ S NIL+ N + +AD G + ++ + GT Y+A E
Sbjct: 128 TQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPE 187
Query: 295 L------VYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLS------SSSGPKI--ML 340
+ V ++ I++FG+V EV ++ + P M
Sbjct: 188 VLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMR 247
Query: 341 IDILYQRLSPPINQKIIQDIILVSTIAL--ACLRSKPKSRPTMQRISQELE 389
+ + P I + D L S L C P +R T RI + L
Sbjct: 248 KVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLT 298
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 8e-39
Identities = 66/308 (21%), Positives = 107/308 (34%), Gaps = 55/308 (17%)
Query: 131 GKILYENLIDATEYFHIRYCIGTGGYDSVYKAELPDGKVVALKKLHHSETEDSAF----- 185
G L A + + IG G Y V+ + G+ VA+K +E
Sbjct: 26 GLPLLVQRTIAKQ-IQMVKQIGKGRYGEVWMGKW-RGEKVAVKVFFTTEEASWFRETEIY 83
Query: 186 ---------VV----------YSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNI 226
++ S ++ I +Y E GSL+ L+ L+ + +
Sbjct: 84 QTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKST----TLDAKSMLKL 139
Query: 227 VKSVAHALSYLH-----HDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNR 281
S L +LH P+I HRD+ S NIL+ N +AD G D++
Sbjct: 140 AYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEV 199
Query: 282 TL----QAGTYGYIALELVYTMV------VTEKCVIYSFGVVALEVLMGTHPGELLLSLS 331
+ + GT Y+ E++ + +YSFG++ EV G ++
Sbjct: 200 DIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQ 259
Query: 332 ------SSSGPKI--MLIDILYQRLSPPINQKIIQDIILVSTIAL--ACLRSKPKSRPTM 381
S P M + ++L P + D L L C P SR T
Sbjct: 260 LPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTA 319
Query: 382 QRISQELE 389
R+ + L
Sbjct: 320 LRVKKTLA 327
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 7e-37
Identities = 63/290 (21%), Positives = 106/290 (36%), Gaps = 56/290 (19%)
Query: 150 CIGTGGYDSVYKAELPDGKVVALKKLHHSETEDSAFV---VY------------------ 188
IG G + V++ + G+ VA+K S E S F +Y
Sbjct: 49 SIGKGRFGEVWRGKW-RGEEVAVKIFS-SREERSWFREAEIYQTVMLRHENILGFIAADN 106
Query: 189 ----SPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHD---- 240
+ ++ + +Y E GSLF L + + + S A L++LH +
Sbjct: 107 KDNGTWTQLWLVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGT 162
Query: 241 -CTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTL----QAGTYGYIALEL 295
P+I HRD+ S NIL+ N +AD G D + + + GT Y+A E+
Sbjct: 163 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV 222
Query: 296 ------VYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLS--------LSSSSGPKIMLI 341
+ ++ IY+ G+V E+ G + + S + M
Sbjct: 223 LDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRK 282
Query: 342 DILYQRLSPPINQKIIQDIILVSTIAL--ACLRSKPKSRPTMQRISQELE 389
+ Q+L P I + L + C + +R T RI + L
Sbjct: 283 VVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 332
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 3e-36
Identities = 62/277 (22%), Positives = 114/277 (41%), Gaps = 54/277 (19%)
Query: 151 IGTGGYDSVYKAEL-PDGKVVALKKLHHSETED-SAF--------------------VVY 188
+G G + K G+V+ +K+L + E F V+Y
Sbjct: 18 LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77
Query: 189 SPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHR 248
+ + FI EY++ G+L +++ D + W++R++ K +A ++YLH + +I+HR
Sbjct: 78 KDKRLNFITEYIKGGTLRGIIKSMDS--QYPWSQRVSFAKDIASGMAYLH---SMNIIHR 132
Query: 249 DISSNNILLNSNLEAFVADFGTVRLLDVDSSN--------------RTLQAGTYGYIALE 294
D++S+N L+ N VADFG RL+ + + R G ++A E
Sbjct: 133 DLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPE 192
Query: 295 LVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPIN- 353
++ EK ++SFG+V E++ + L + G + + P N
Sbjct: 193 MINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFG---LNVRGFL-DRYCPPNC 248
Query: 354 -QKIIQDIILVSTIALACLRSKPKSRPTMQRISQELE 389
I + C P+ RP+ ++ LE
Sbjct: 249 PPSFFP-------ITVRCCDLDPEKRPSFVKLEHWLE 278
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 2e-35
Identities = 43/279 (15%), Positives = 90/279 (32%), Gaps = 47/279 (16%)
Query: 139 IDATEYFHIRYCIGTGGYDSVYKAELPDGKVVALKKLHHSETEDSAF------------- 185
ID + + + ++K G + +K L +
Sbjct: 7 IDFKQ-LNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIF 64
Query: 186 ----------VVYSPQC--MFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHA 233
SP I +M GSL+ VL + ++ ++ + +A
Sbjct: 65 SHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEG-TNFVVDQSQAVKFALDMARG 123
Query: 234 LSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTYGYIAL 293
+++LH P I ++S +++++ ++ A ++ S + ++A
Sbjct: 124 MAFLHT-LEPLIPRHALNSRSVMIDEDMTARISMADVKF-----SFQSPGRMYAPAWVAP 177
Query: 294 ELV---YTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSP 350
E + ++SF V+ E++ P L + + + + L P
Sbjct: 178 EALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADL-------SNMEIGMKVALEGLRP 230
Query: 351 PINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELE 389
I I + S + C+ P RP I LE
Sbjct: 231 TIPPGISPHV---SKLMKICMNEDPAKRPKFDMIVPILE 266
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 5e-33
Identities = 60/316 (18%), Positives = 116/316 (36%), Gaps = 69/316 (21%)
Query: 139 IDATEYFHIRYCIGTGGYDSVYKAELPDGKVVALKKLHHSETEDSAF------------- 185
I + I IG G + VY G+V A++ + +
Sbjct: 30 IPFEQ-LEIGELIGKGRFGQVYHGRW-HGEV-AIRLIDIERDNEDQLKAFKREVMAYRQT 86
Query: 186 ----------VVYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALS 235
SP + I + +L+ V+RD I L+ + I + + +
Sbjct: 87 RHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAK--IVLDVNKTRQIAQEIVKGMG 144
Query: 236 YLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNR-----TLQAGTYGY 290
YLH I+H+D+ S N+ + N + + DFG + V + R +Q G +
Sbjct: 145 YLH---AKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCH 200
Query: 291 IALELVYTMVV---------TEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLI 341
+A E++ + ++ +++ G + E+ P + P +I
Sbjct: 201 LAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQ--------PAEAII 252
Query: 342 DILYQRLSPPINQ----KIIQDIILVSTIALACLRSKPKSRPTMQRISQELEGKTPMKKG 397
+ + P ++Q K I DI+ L C + + RPT ++ LE + K
Sbjct: 253 WQMGTGMKPNLSQIGMGKEISDIL------LFCWAFEQEERPTFTKLMDMLE---KLPKR 303
Query: 398 LKEISIPE--MRNQEM 411
+ +S P ++ E+
Sbjct: 304 NRRLSHPGHFWKSAEL 319
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 1e-30
Identities = 59/279 (21%), Positives = 114/279 (40%), Gaps = 43/279 (15%)
Query: 139 IDATEYFHIRYCIGTGGYDSVYKAELPDGKVVALKKL---HHSETEDSAFV--------- 186
I + + IG+G + +VYK + G V A+K L + + AF
Sbjct: 21 IPDGQ-ITVGQRIGSGSFGTVYKGKW-HGDV-AVKMLNVTAPTPQQLQAFKNEVGVLRKT 77
Query: 187 ----------VYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSY 236
+ + + ++ E SL+ L + + + ++I + A + Y
Sbjct: 78 RHVNILLFMGYSTAPQLAIVTQWCEGSSLYHHLHASET--KFEMKKLIDIARQTARGMDY 135
Query: 237 LHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLD--VDSSNRTLQAGTYGYIALE 294
LH SI+HRD+ SNNI L+ + + DFG S +G+ ++A E
Sbjct: 136 LH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPE 192
Query: 295 LV---YTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPP 351
++ + + + +Y+FG+V E++ G P + + +I+++ + P
Sbjct: 193 VIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNI-------NNRDQIIEMVGRGSLSP 245
Query: 352 INQKIIQDI-ILVSTIALACLRSKPKSRPTMQRISQELE 389
K+ + + + CL+ K RP+ RI E+E
Sbjct: 246 DLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIE 284
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 3e-24
Identities = 54/279 (19%), Positives = 97/279 (34%), Gaps = 65/279 (23%)
Query: 145 FHIRYCIGTGGYDSVYKAE-LPDGKVVALK-----------------KLHH--------- 177
F IG+GG+ V+KA+ DGK +K KL H
Sbjct: 13 FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGC 72
Query: 178 ------SETEDSAFVVYSPQCMFFIY-EYMERGSLFCVLRDD-----DEAIELNWTRRMN 225
S S FI E+ ++G+L + D+ + L ++
Sbjct: 73 WDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQI- 131
Query: 226 IVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQA 285
+ Y+H + +++RD+ +NI L + + DFG V L D
Sbjct: 132 -----TKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTR-SK 182
Query: 286 GTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILY 345
GT Y++ E + + ++ +Y+ G++ E+L D+
Sbjct: 183 GTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKF---------FTDLRD 233
Query: 346 QRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRI 384
+S ++K + ++ L KP+ RP I
Sbjct: 234 GIISDIFDKK-EKTLL------QKLLSKKPEDRPNTSEI 265
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 1e-23
Identities = 57/300 (19%), Positives = 107/300 (35%), Gaps = 59/300 (19%)
Query: 143 EYFHIRYCIGTGGYDSVYKAE-LPDGKVVALKKLH------------HSETE-----DSA 184
E + IG G + + DG+ +K+++ E
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 185 FVV------YSPQCMFFIYEYMERGSLFCVLRDD-----DEAIELNWTRRMNIVKSVAHA 233
+V ++ + +Y E G LF + E L+W ++ A
Sbjct: 84 NIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQI------CLA 137
Query: 234 LSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTYGYIAL 293
L ++H I+HRDI S NI L + + DFG R+L+ GT Y++
Sbjct: 138 LKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSP 194
Query: 294 ELVYTMVVTEKCVIYSFGVVALEVLMGTHP--GELLLSLSSSSGPKIMLIDILYQRLSPP 351
E+ K I++ G V E+ H + +L KI+ PP
Sbjct: 195 EICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVL----KIISGSF------PP 244
Query: 352 INQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELEGKTP-MKKGLKEISIPEMRNQE 410
++ D+ ++ + P+ RP++ I + + K +++ P++ +E
Sbjct: 245 VSLHYSYDL---RSLVSQLFKRNPRDRPSVNSILE-----KGFIAKRIEKFLSPQLIAEE 296
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 1e-23
Identities = 54/274 (19%), Positives = 91/274 (33%), Gaps = 61/274 (22%)
Query: 144 YFHIRYCIGTGGYDSVYKA-ELPDGKVVA-----------------------LKKLHH-- 177
+ IG G + +VYK + VA LK L H
Sbjct: 27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPN 86
Query: 178 ------SETEDSAFVVYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVA 231
S +C+ + E M G+L L+ + + + +
Sbjct: 87 IVRFYDSWESTVK----GKKCIVLVTELMTSGTLKTYLKRFKV---MKIKVLRSWCRQIL 139
Query: 232 HALSYLHHDCTPSIVHRDISSNNILLNSNL-EAFVADFGTVRLLDVDSSNRTLQAGTYGY 290
L +LH TP I+HRD+ +NI + + D G L S + + GT +
Sbjct: 140 KGLQFLH-TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR-ASFAKAVI-GTPEF 196
Query: 291 IALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSP 350
+A E +Y E +Y+FG+ LE+ +P S + + + P
Sbjct: 197 MAPE-MYEEKYDESVDVYAFGMCMLEMATSEYPY-------SECQNAAQIYRRVTSGVKP 248
Query: 351 PINQKII----QDIILVSTIALACLRSKPKSRPT 380
K+ ++II C+R R +
Sbjct: 249 ASFDKVAIPEVKEII------EGCIRQNKDERYS 276
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 5e-23
Identities = 62/279 (22%), Positives = 99/279 (35%), Gaps = 56/279 (20%)
Query: 143 EYFHIRYCIGTGGYDSVYKAE-LPDGKVVALKKLH-----HSETEDS------------- 183
E + + Y IGTG Y K DGK++ K+L +E +
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 184 -------AFVVYSPQCMFFIYEYMERGSLFCVLRDD-------DEAIELNWTRRMNIVKS 229
+ + ++ + EY E G L V+ DE L ++
Sbjct: 66 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQL----- 120
Query: 230 VAHALSYLH--HDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGT 287
AL H D +++HRD+ N+ L+ + DFG R+L+ D+S GT
Sbjct: 121 -TLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGT 179
Query: 288 YGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHP--GELLLSLSSSSGPKIMLIDILY 345
Y++ E + M EK I+S G + E+ P L+ KI
Sbjct: 180 PYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAG----KIREGKF-- 233
Query: 346 QRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRI 384
I + + L I L K RP+++ I
Sbjct: 234 ----RRIPYRYSDE--LNEIIT-RMLNLKDYHRPSVEEI 265
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 2e-22
Identities = 59/312 (18%), Positives = 113/312 (36%), Gaps = 71/312 (22%)
Query: 142 TEYFHIRYCIGTGGYDSVYKAE-LPDGKVVALKK----------------------LHHS 178
T++ I+ C+G GG+ V++A+ D A+K+ L H
Sbjct: 5 TDFEPIQ-CLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHP 63
Query: 179 ---------ETEDSAFVVYSPQCMFFIY---EYMERGSLFCVLRDDDEAIELNWTRRMNI 226
+++ + ++Y + + +L + E + ++I
Sbjct: 64 GIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHI 123
Query: 227 VKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDS-------- 278
+A A+ +LH + ++HRD+ +NI + V DFG V +D D
Sbjct: 124 FLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTP 180
Query: 279 ----SNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSS 334
+ T Q GT Y++ E ++ + K I+S G++ ELL S+
Sbjct: 181 MPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILF---------ELLYPFSTQM 231
Query: 335 GPKIMLIDILYQRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQ-------E 387
L D+ + PP+ + + L P RP I + +
Sbjct: 232 ERVRTLTDVRNLKF-PPLFTQKYPCE---YVMVQDMLSPSPMERPEAINIIENAVFEDLD 287
Query: 388 LEGKTPMKKGLK 399
GKT +++ +
Sbjct: 288 FPGKTVLRQRSR 299
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 92.6 bits (230), Expect = 6e-21
Identities = 54/207 (26%), Positives = 87/207 (42%), Gaps = 36/207 (17%)
Query: 143 EYFHIRYCIGTGGYDSVYKAEL-PDGKVVALKKLHHSETE----------------DSAF 185
+ F +G G V+K P G V+A K +H +S +
Sbjct: 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 92
Query: 186 VV------YSPQCMFFIYEYMERGSLFCVLRDD---DEAIELNWTRRMNIVKSVAHALSY 236
+V YS + E+M+ GSL VL+ E I + +V L+Y
Sbjct: 93 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQI------LGKVSIAVIKGLTY 146
Query: 237 LHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTYGYIALELV 296
L I+HRD+ +NIL+NS E + DFG L +DS + GT Y++ E +
Sbjct: 147 LREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQL-IDSMANSF-VGTRSYMSPERL 202
Query: 297 YTMVVTEKCVIYSFGVVALEVLMGTHP 323
+ + I+S G+ +E+ +G +P
Sbjct: 203 QGTHYSVQSDIWSMGLSLVEMAVGRYP 229
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 6e-21
Identities = 54/280 (19%), Positives = 85/280 (30%), Gaps = 72/280 (25%)
Query: 143 EYFHIRYCIGTGGYDSVYKA-ELPDGKVVALKKLH------------------HSETEDS 183
+ F +G G Y V+K DG++ A+K+ H +
Sbjct: 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQH 116
Query: 184 AFVV------YSPQCMFFIYEYMERGSLFCVLRDD----DEAIELNWTRRMNIVKSVAHA 233
V ++ E SL EA + R A
Sbjct: 117 PCCVRLEQAWEEGGILYLQTELCG-PSLQQHCEAWGASLPEAQVWGYLR------DTLLA 169
Query: 234 LSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTYGYIAL 293
L++LH +VH D+ NI L + DFG + L + Q G Y+A
Sbjct: 170 LAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEV-QEGDPRYMAP 225
Query: 294 ELV---YTMVVTEKCVIYSFGVVALEVLMGTHP---GELLLSLSSSSGPKIMLIDILYQR 347
EL+ Y ++S G+ LEV GE L
Sbjct: 226 ELLQGSY----GTAADVFSLGLTILEVACNMELPHGGEGWQQLRQG-------------Y 268
Query: 348 LSPPINQKI---IQDIILVSTIALACLRSKPKSRPTMQRI 384
L P + ++ ++ + L PK R T + +
Sbjct: 269 LPPEFTAGLSSELRSVL------VMMLEPDPKLRATAEAL 302
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 1e-20
Identities = 51/278 (18%), Positives = 93/278 (33%), Gaps = 57/278 (20%)
Query: 145 FHIRYCIGTGGYDSVYKAE-LPDGKVVALKKLHHSETEDSA------------------F 185
F I IG G + VY+A L DG VALKK+ + D+
Sbjct: 34 FRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 93
Query: 186 VV------YSPQCMFFIYEYMERGSLFCVLRDD-------DEAIELNWTRRMNIVKSVAH 232
V+ + + E + G L +++ E + ++
Sbjct: 94 VIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQL------CS 147
Query: 233 ALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTYGYIA 292
AL ++H ++HRDI N+ + + + D G R ++ GT Y++
Sbjct: 148 ALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMS 204
Query: 293 LELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPI 352
E ++ K I+S G + E+ P L + Q PP+
Sbjct: 205 PERIHENGYNFKSDIWSLGCLLYEMAALQSP------FYGDKMNLYSLCKKIEQCDYPPL 258
Query: 353 NQKI----IQDIILVSTIALACLRSKPKSRPTMQRISQ 386
++ ++ C+ P+ RP + +
Sbjct: 259 PSDHYSEELRQLV------NMCINPDPEKRPDVTYVYD 290
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 1e-20
Identities = 69/273 (25%), Positives = 107/273 (39%), Gaps = 59/273 (21%)
Query: 140 DATEYFHIRYCIGTGGYDSVYKA-ELPDGKVVALKKLHHSETED---------------- 182
D E F IG G + V+K + KVVA+K + E ED
Sbjct: 19 DPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCD 78
Query: 183 SAFVV------YSPQCMFFIYEYMERGSLFCVLRD---DDEAIELNWTRRMNIVKSVAHA 233
S +V ++ I EY+ GS +L D+ I I++ +
Sbjct: 79 SPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIAT-------ILREILKG 131
Query: 234 LSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTYGYIAL 293
L YLH + +HRDI + N+LL+ + E +ADFG L R GT ++A
Sbjct: 132 LDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAP 188
Query: 294 ELVYTMVVTEKCVIYSFGVVALEVLMGT------HPGELLLSLSSSSGPKIMLIDILYQR 347
E++ K I+S G+ A+E+ G HP ++L + ++ P L
Sbjct: 189 EVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPT------LEGN 242
Query: 348 LSPPINQKIIQDIILVSTIALACLRSKPKSRPT 380
S P+ + + CL +P RPT
Sbjct: 243 YSKPLKEFVEA-----------CLNKEPSFRPT 264
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 2e-20
Identities = 59/296 (19%), Positives = 107/296 (36%), Gaps = 78/296 (26%)
Query: 145 FHIRYCIGTGGYDSVYKA-ELPDGKVVALKKLHHSETE--------------DSAFVV-- 187
F +G G + V KA D + A+KK+ H+E + + +VV
Sbjct: 8 FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRY 67
Query: 188 -----------------YSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSV 230
+F EY E G+L+ ++ ++ + + R + + +
Sbjct: 68 YAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWR--LFRQI 125
Query: 231 AHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLD--------------V 276
ALSY+H I+HRD+ NI ++ + + DFG + +
Sbjct: 126 LEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPG 182
Query: 277 DSSNRTLQAGTYGYIALELV-----YTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLS 331
S N T GT Y+A E++ Y EK +YS G++ E++ G +++
Sbjct: 183 SSDNLTSAIGTAMYVATEVLDGTGHY----NEKIDMYSLGIIFFEMIYPFSTGMERVNIL 238
Query: 332 SSSGPKIMLIDILYQRLSPPINQKI---IQDIILVSTIALACLRSKPKSRPTMQRI 384
K+ + I P + + II + P RP + +
Sbjct: 239 K----KLRSVSI---EFPPDFDDNKMKVEKKII------RLLIDHDPNKRPGARTL 281
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 2e-20
Identities = 49/295 (16%), Positives = 98/295 (33%), Gaps = 69/295 (23%)
Query: 143 EYFHIRYCIGTGGYDSVYKAE-LPDGKVVALKKLHHSETE-------------------- 181
+++ +G GG+ V E L DG ALK++ E +
Sbjct: 29 KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNI 88
Query: 182 ----DSAFVVYSPQCMFFIY-EYMERGSLFCVLR---------DDDEAIELNWTRRMNIV 227
+ ++ + +RG+L+ + +D+ + ++
Sbjct: 89 LRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQI--------LWLL 140
Query: 228 KSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRT----- 282
+ L +H HRD+ NILL + + D G++ +
Sbjct: 141 LGICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTL 197
Query: 283 ----LQAGTYGYIALELVYT---MVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSG 335
Q T Y A EL V+ E+ ++S G V ++ G P +
Sbjct: 198 QDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYD------MVFQ 251
Query: 336 PKIMLIDILYQRLSPPINQKIIQDII-LVSTIALACLRSKPKSRPTMQRISQELE 389
+ + +LS P + + + L++ + + P RP + + +LE
Sbjct: 252 KGDSVALAVQNQLSIPQSPRHSSALWQLLN----SMMTVDPHQRPHIPLLLSQLE 302
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 90.5 bits (224), Expect = 3e-20
Identities = 27/294 (9%), Positives = 61/294 (20%), Gaps = 73/294 (24%)
Query: 151 IGTGGYDSVYKA-ELPDGKVVALKKLHHSETEDSAFV----------------------- 186
+ G V+ ++ + ALK + +
Sbjct: 70 LRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARD 129
Query: 187 ---------------------------VYSPQCMFFIYEYMERGSLFCVLRDDDEAIE-- 217
Y+ + L + D
Sbjct: 130 RRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFR 188
Query: 218 --LNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLD 275
+ + + L +VH + +N+ + + + D +
Sbjct: 189 GDEGILALHILTAQLIRLAANLQSK---GLVHGHFTPDNLFIMPDGRLMLGDVSALW--- 242
Query: 276 VDSSNRTLQAGTYGYIALELVY--TMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSS 333
+ + Y E + T T + G+ V P L+
Sbjct: 243 KVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKG 302
Query: 334 SGPKIMLIDILYQRLSPPINQKI---IQDIILVSTIALACLRSKPKSRPTMQRI 384
S + L L+ + ++ +I L + R
Sbjct: 303 SWKRPSLRVPGTDSLAFGSCTPLPDFVKTLI------GRFLNFDRRRRLLPLEA 350
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 4e-20
Identities = 62/270 (22%), Positives = 96/270 (35%), Gaps = 59/270 (21%)
Query: 148 RY----CIGTGGYDSVYKAELPD---GKVVALKKLHHSETEDSAFV-------------- 186
RY +G GG +VY AE D VA+K + E +
Sbjct: 12 RYKIVDKLGGGGMSTVYLAE--DTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLS 69
Query: 187 ------VY----SPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSY 236
+ C + + EY+E +L + L+ +N + + +
Sbjct: 70 HQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGP---LSVDTAINFTNQILDGIKH 126
Query: 237 LHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQA-GTYGYIALEL 295
H IVHRDI NIL++SN + DFG + L S +T GT Y + E
Sbjct: 127 AHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQ 183
Query: 296 VYTMVVTEKCVIYSFGVVALEVLMGTHP--GELLLSLSSSSGPKIMLIDILYQRLS---P 350
E IYS G+V E+L+G P GE + I + + P
Sbjct: 184 AKGEATDECTDIYSIGIVLYEMLVGEPPFNGE---------TA----VSIAIKHIQDSVP 230
Query: 351 PINQKIIQDI-ILVSTIALACLRSKPKSRP 379
+ + +DI +S + L +R
Sbjct: 231 NVTTDVRKDIPQSLSNVILRATEKDKANRY 260
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 5e-20
Identities = 48/207 (23%), Positives = 79/207 (38%), Gaps = 36/207 (17%)
Query: 145 FHIRYCIGTGGYDSVYKAELPD---GKVVALKKLHHSETEDSAFV--------------- 186
+ +R +G GG VY+AE D ++VALK + + + D F
Sbjct: 36 YRLRRLVGRGGMGDVYEAE--DTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQE 93
Query: 187 -----VY---SPQCMFFIY-EYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYL 237
++ ++ + L +LR L R + IV+ + AL
Sbjct: 94 PHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGP---LAPPRAVAIVRQIGSALDAA 150
Query: 238 HHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQA-GTYGYIALELV 296
H HRD+ NIL++++ A++ DFG + + GT Y+A E
Sbjct: 151 HAA---GATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERF 207
Query: 297 YTMVVTEKCVIYSFGVVALEVLMGTHP 323
T + IY+ V E L G+ P
Sbjct: 208 SESHATYRADIYALTCVLYECLTGSPP 234
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 5e-20
Identities = 52/263 (19%), Positives = 93/263 (35%), Gaps = 51/263 (19%)
Query: 151 IGTGGYDSVYKA-ELPDGKVVALKKLHHSETE-----------------DSAFVV----- 187
+G+G V+K G V+A+K++ S + D ++V
Sbjct: 33 MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGT 92
Query: 188 -YSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIV 246
+ +F E M + R I + + ++ AL YL ++
Sbjct: 93 FITNTDVFIAMELMGTCAEKLKKRMQG-PIPERILGK--MTVAIVKALYYLKEK--HGVI 147
Query: 247 HRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTYGYIALELVYTMVVTE--- 303
HRD+ +NILL+ + + DFG L VD + AG Y+A E + T+
Sbjct: 148 HRDVKPSNILLDERGQIKLCDFGISGRL-VDDKAKDRSAGCAAYMAPERIDPPDPTKPDY 206
Query: 304 --KCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQ---RLSPPIN-QKII 357
+ ++S G+ +E+ G P + +L +L + L +
Sbjct: 207 DIRADVWSLGISLVELATGQFP------YKNCKTDFEVLTKVLQEEPPLLPGHMGFSGDF 260
Query: 358 QDIILVSTIALACLRSKPKSRPT 380
Q + CL + RP
Sbjct: 261 QSFV------KDCLTKDHRKRPK 277
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 1e-19
Identities = 58/267 (21%), Positives = 102/267 (38%), Gaps = 58/267 (21%)
Query: 151 IGTGGYDSVYKA-ELPDGKVVALKKLHHSETE-----------------DSAFVV----- 187
+G G Y V K +P G+++A+K++ + D F V
Sbjct: 15 LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 74
Query: 188 -YSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMN------IVKSVAHALSYLHHD 240
+ ++ E M+ SL D ++ + + I S+ AL +LH
Sbjct: 75 LFREGDVWICMELMD-TSL-----DKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSK 128
Query: 241 CTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTYGYIALELVYTMV 300
S++HRD+ +N+L+N+ + + DFG L VD + + AG Y+A E + +
Sbjct: 129 L--SVIHRDVKPSNVLINALGQVKMCDFGISGYL-VDDVAKDIDAGCKPYMAPERINPEL 185
Query: 301 V----TEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQ---RLSPPIN 353
+ K I+S G+ +E+ + P S P L ++ + +L
Sbjct: 186 NQKGYSVKSDIWSLGITMIELAILRFP------YDSWGTPFQQLKQVVEEPSPQLPADKF 239
Query: 354 QKIIQDIILVSTIALACLRSKPKSRPT 380
D CL+ K RPT
Sbjct: 240 SAEFVDFT------SQCLKKNSKERPT 260
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 1e-19
Identities = 58/283 (20%), Positives = 97/283 (34%), Gaps = 63/283 (22%)
Query: 139 IDATEYFHIRYCIGTGGYDSVYKA-ELPDGKVVALKKLHHSETE---------------- 181
A + + IG G Y SV K P G+++A+K++ + E
Sbjct: 19 FTAEDLKDLG-EIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRS 77
Query: 182 -DSAFVV------YSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMN------IVK 228
D ++V + + E M S + + + I
Sbjct: 78 SDCPYIVQFYGALFREGDCWICMELMS-TSFDKFYKY----VYSVLDDVIPEEILGKITL 132
Query: 229 SVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTY 288
+ AL++L + I+HRDI +NILL+ + + DFG L VDS +T AG
Sbjct: 133 ATVKALNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFGISGQL-VDSIAKTRDAGCR 189
Query: 289 GYIALELVYTMVV----TEKCVIYSFGVVALEVLMGTHP-------GELLLSLSSSSGPK 337
Y+A E + + ++S G+ E+ G P + L + P+
Sbjct: 190 PYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQ 249
Query: 338 IMLIDILYQRLSPPINQKIIQDIILVSTIALACLRSKPKSRPT 380
L + + SP + CL RP
Sbjct: 250 --LSNSEEREFSPSFINFVNL-----------CLTKDESKRPK 279
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 4e-19
Identities = 59/275 (21%), Positives = 103/275 (37%), Gaps = 64/275 (23%)
Query: 148 RY----CIGTGGYDSVYKAELPD---GKVVALKKLHHSETEDSAFV-------------- 186
RY +G GG V+ A D + VA+K L D +F
Sbjct: 13 RYELGEILGFGGMSEVHLAR--DLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 187 ------VY--------SPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAH 232
VY + + + EY++ +L ++ + + R + ++
Sbjct: 71 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQ 127
Query: 233 ALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQA---GTYG 289
AL++ H + I+HRD+ NI++++ V DFG R + ++ T A GT
Sbjct: 128 ALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 184
Query: 290 YIALELVYTMVVTEKCVIYSFGVVALEVLMGTHP--GELLLSLSSSSGPKIMLIDILYQR 347
Y++ E V + +YS G V EVL G P G+ P + + YQ
Sbjct: 185 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGD---------SP----VSVAYQH 231
Query: 348 LS--PPINQKIIQDI-ILVSTIALACLRSKPKSRP 379
+ P + + + + L L P++R
Sbjct: 232 VREDPIPPSARHEGLSADLDAVVLKALAKNPENRY 266
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 87.0 bits (215), Expect = 5e-19
Identities = 28/225 (12%), Positives = 67/225 (29%), Gaps = 47/225 (20%)
Query: 142 TEYFHIRYCIGTGGYDSVYKAE------LPDGKVVALKKL-------------------- 175
++ ++ + +G G + VY+A + + LK
Sbjct: 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKP 123
Query: 176 --HHSETEDSAFVVYSPQCMFFIYEYMERGSLFCVLRDDDEAIE--LNWTRRMNIVKSVA 231
H + + ++ + E G+L + E + ++ +
Sbjct: 124 SMQHMFMKFYSAHLF-QNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRML 182
Query: 232 HALSYLHHDCTPSIVHRDISSNNILLNSNLEAF-----------VADFGTVRLLDVDSSN 280
+ + +H I+H DI +N +L + + D G + +
Sbjct: 183 YMIEQVH---DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKG 239
Query: 281 RTLQA--GTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHP 323
A T G+ +E++ + + +L GT+
Sbjct: 240 TIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYM 284
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 86.8 bits (215), Expect = 8e-19
Identities = 59/280 (21%), Positives = 108/280 (38%), Gaps = 68/280 (24%)
Query: 145 FHIRYCIGTGGYDSVYKAELPDGKVVALK---------------------------KLHH 177
F + +G G ++ + D + VA+K +
Sbjct: 26 FCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIRYFC 85
Query: 178 SETEDSAFVVYSPQCMFFIYEYMERGSLF-CVLRDDDEAIELNWTRRMNIVKSVAHALSY 236
+E +D F + E +L V + D + L + +++ L++
Sbjct: 86 TE-KDRQFQ-------YIAIELCA-ATLQEYVEQKDFAHLGL---EPITLLQQTTSGLAH 133
Query: 237 LHHDCTPSIVHRDISSNNILL-----NSNLEAFVADFGTVRLLDVDSS---NRTLQAGTY 288
LH +IVHRD+ +NIL+ + ++A ++DFG + L V R+ GT
Sbjct: 134 LHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTE 190
Query: 289 GYIALELV---YTMVVTEKCVIYSFGVVALEVL-MGTHP-GELLLSLSSSSGPKIMLIDI 343
G+IA E++ T I+S G V V+ G+HP G+ S I+L
Sbjct: 191 GWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGK-----SLQRQANILLGAC 245
Query: 344 LYQRLSPPINQKII-QDIILVSTIALACLRSKPKSRPTMQ 382
L P ++ +I +++I + P+ RP+ +
Sbjct: 246 SLDCLHPEKHEDVIARELI------EKMIAMDPQKRPSAK 279
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 2e-18
Identities = 56/287 (19%), Positives = 108/287 (37%), Gaps = 69/287 (24%)
Query: 143 EYFHIRYCIGTGGYDSVYKA-ELPDGKVVALK--KLHHSETE--------------DSAF 185
+ + ++ IG+G V A P + VA+K L +T
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 186 VV------YSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMN------IVKSVAHA 233
+V ++ + + + GS+ +++ E + ++ I++ V
Sbjct: 75 IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHK-SGVLDESTIATILREVLEG 133
Query: 234 LSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFG-----TVRLLDVDSSNRTLQAGTY 288
L YLH + +HRD+ + NILL + +ADFG + R GT
Sbjct: 134 LEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTP 190
Query: 289 GYIALELVYTMVVTE------KCVIYSFGVVALEVLMGT------HPGELLLSLSSSSGP 336
++A E V+ + K I+SFG+ A+E+ G P ++L+ + P
Sbjct: 191 CWMAPE-----VMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPP 245
Query: 337 KI---MLIDILYQRLSPPINQKIIQDIILVSTIALACLRSKPKSRPT 380
+ + + ++ + ++S CL+ P+ RPT
Sbjct: 246 SLETGVQDKEMLKKYGKSFRK-------MIS----LCLQKDPEKRPT 281
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 2e-18
Identities = 53/278 (19%), Positives = 89/278 (32%), Gaps = 66/278 (23%)
Query: 140 DATEYFHIRYCIGTGGYDSVYKA-ELPDGKVVA----------------LKKLHH----- 177
+ + + +G G + V++ + G A L
Sbjct: 55 EEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEELVACAGLSSPRIVP 114
Query: 178 ---SETEDSAFVVYSPQCMFFIYEYMERGSLFCVLRDD---DEAIELNWTRRMNIVKSVA 231
+ E ++ M E +E GSL +++ E L +
Sbjct: 115 LYGAVREGPWVNIF----M----ELLEGGSLGQLIKQMGCLPEDRALYYLG------QAL 160
Query: 232 HALSYLHHDCTPSIVHRDISSNNILLNSN-LEAFVADFGTVRLLDVDSSNRTLQA----- 285
L YLH I+H D+ ++N+LL+S+ A + DFG L D ++L
Sbjct: 161 EGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIP 217
Query: 286 GTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILY 345
GT ++A E+V K I+S + L +L G HP + + L
Sbjct: 218 GTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHP------WTQYFRGPLCLKIASE 271
Query: 346 QRLSPPINQKI---IQDIILVSTIALACLRSKPKSRPT 380
I I LR +P R +
Sbjct: 272 PPPIREIPPSCAPLTAQAI------QEGLRKEPVHRAS 303
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 86.7 bits (214), Expect = 2e-18
Identities = 59/296 (19%), Positives = 99/296 (33%), Gaps = 50/296 (16%)
Query: 151 IGTGGYDSVYKA-ELPDGKVVA----------------------LKKLHHS------ETE 181
+GTGG+ V + G+ VA +KKL+H E
Sbjct: 22 LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVP 81
Query: 182 DSAFVVYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDC 241
D + EY E G L L + L ++ ++ AL YLH +
Sbjct: 82 DGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN- 140
Query: 242 TPSIVHRDISSNNILLNSNLEAF---VADFGTVRLLDVDSSNRTLQAGTYGYIALELVYT 298
I+HRD+ NI+L + + D G + LD GT Y+A EL+
Sbjct: 141 --RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEF-VGTLQYLAPELLEQ 197
Query: 299 MVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPIN--QKI 356
T +SFG +A E + G P + + + ++ + I +
Sbjct: 198 KKYTVTVDYWSFGTLAFECITGFRPFL-------PNWQPVQWHGKVREKSNEHIVVYDDL 250
Query: 357 IQDIILVSTIALACLRSKPKSRPTMQRISQELEGKTPMKKGLKEISIPEMRNQEMF 412
+ S + S + + + L ++G + P+ N F
Sbjct: 251 TGAVKFSSVLPTPNHLSGILAGKLERWLQCMLM-WHQRQRG----TDPQNPNVGCF 301
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 3e-18
Identities = 62/272 (22%), Positives = 98/272 (36%), Gaps = 65/272 (23%)
Query: 148 RYCIGTGGYDSVYKA-ELPDGKVVA---------------------LKKLHH-------- 177
R +G G Y VY +L + +A K L H
Sbjct: 27 RVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLG 86
Query: 178 SETEDSAFVVYSPQCMFFIY-EYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSY 236
S +E+ I+ E + GSL +LR ++ N K + L Y
Sbjct: 87 SFSENG---------FIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKY 137
Query: 237 LHHDCTPSIVHRDISSNNILLNS-NLEAFVADFGT-VRLLDVDSSNRTLQAGTYGYIALE 294
LH + IVHRDI +N+L+N+ + ++DFGT RL ++ T GT Y+A E
Sbjct: 138 LHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFT-GTLQYMAPE 193
Query: 295 LVYTMVV--TEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPI 352
++ + I+S G +E+ G P P+ + + ++ P I
Sbjct: 194 IIDKGPRGYGKAADIWSLGCTIIEMATGKPP------FYELGEPQAAMFKVGMFKVHPEI 247
Query: 353 NQKIIQDIILVSTIA----LACLRSKPKSRPT 380
+ + S A L C P R
Sbjct: 248 PESM-------SAEAKAFILKCFEPDPDKRAC 272
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 6e-18
Identities = 63/292 (21%), Positives = 102/292 (34%), Gaps = 71/292 (24%)
Query: 136 ENLIDATEYFHIRYCIGTGGYDSVYKA-ELPDGKVVALKKLHHSETEDS----------- 183
L D F + +G G Y VYK + G++ A+K + + E+
Sbjct: 17 SALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKK 76
Query: 184 ------------AFVVYSPQC----MFFIYEYMERGSLFCVLRDDDEAIELNWTRRMN-- 225
AF+ +P ++ + E+ GS+ + I+ +
Sbjct: 77 YSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSV-------TDLIKNTKGNTLKEE 129
Query: 226 ----IVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNR 281
I + + LS+LH ++HRDI N+LL N E + DFG LD R
Sbjct: 130 WIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRR 186
Query: 282 TLQAGTYGYIALELVYTMVVTE-----KCVIYSFGVVALEVLMG------THPGELLLSL 330
GT ++A E++ + K ++S G+ A+E+ G HP L +
Sbjct: 187 NTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI 246
Query: 331 SSSSGPKIMLIDILYQRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQ 382
+ P RL K Q I CL RP +
Sbjct: 247 PRNPAP----------RLKSKKWSKKFQSFIES------CLVKNHSQRPATE 282
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 83.0 bits (205), Expect = 7e-18
Identities = 41/227 (18%), Positives = 78/227 (34%), Gaps = 28/227 (12%)
Query: 172 LKKLHHSETEDSAFVVYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVA 231
+ T ++ + + +L + + ++I +A
Sbjct: 115 MDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIA 174
Query: 232 HALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSS------------ 279
A+ +LH ++HRD+ +NI + V DFG V +D D
Sbjct: 175 EAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYA 231
Query: 280 NRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIM 339
T Q GT Y++ E ++ + K I+S G++ E+L + +
Sbjct: 232 THTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERVRI--------- 282
Query: 340 LIDILYQRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQ 386
+ D+ + QK Q+ ++V L P RP I +
Sbjct: 283 ITDVRNLKFPLLFTQKYPQEHMMVQ----DMLSPSPTERPEATDIIE 325
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 8e-18
Identities = 65/267 (24%), Positives = 106/267 (39%), Gaps = 46/267 (17%)
Query: 140 DATEYFHIRYCIGTGGYDSVYKA-ELPDGKVVALKKLHHSETE-------------DSAF 185
E F + +G G Y SVYKA G++VA+K++ DS
Sbjct: 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPH 85
Query: 186 VV------YSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHH 239
VV + ++ + EY GS+ ++R ++ + + I++S L YLH
Sbjct: 86 VVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIAT--ILQSTLKGLEYLHF 143
Query: 240 DCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTYGYIALELVYTM 299
+HRDI + NILLN+ A +ADFG L + R GT ++A E++ +
Sbjct: 144 M---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEI 200
Query: 300 VVTEKCVIYSFGVVALEVLMG------THPGELLLSLSSSSGPKIMLIDILYQRLSPPIN 353
I+S G+ A+E+ G HP + + ++ P + S
Sbjct: 201 GYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPE----LWSDNFT 256
Query: 354 QKIIQDIILVSTIALACLRSKPKSRPT 380
+ Q CL P+ R T
Sbjct: 257 DFVKQ-----------CLVKSPEQRAT 272
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 8e-18
Identities = 56/275 (20%), Positives = 110/275 (40%), Gaps = 62/275 (22%)
Query: 140 DATEYFHIRYCIGTGGYDSVYKA-ELPDGKVVALKKLHHSETED---------------S 183
D + + IG G +VY A ++ G+ VA+++++ + +
Sbjct: 17 DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKN 76
Query: 184 AFVV------YSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMN------IVKSVA 231
+V ++ + EY+ GSL V+ M+ + +
Sbjct: 77 PNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT----------ETCMDEGQIAAVCRECL 126
Query: 232 HALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTYGYI 291
AL +LH + ++HRDI S+NILL + + DFG + + S R+ GT ++
Sbjct: 127 QALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWM 183
Query: 292 ALELVYTMVVTEKCVIYSFGVVALEVLMG------THPGELLLSLSSSSGPKIMLIDILY 345
A E+V K I+S G++A+E++ G +P L ++++ P++ +
Sbjct: 184 APEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPE--- 240
Query: 346 QRLSPPINQKIIQDIILVSTIALACLRSKPKSRPT 380
+LS + + CL + R +
Sbjct: 241 -KLSAIFRDFLNR-----------CLEMDVEKRGS 263
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 84.5 bits (209), Expect = 9e-18
Identities = 46/212 (21%), Positives = 74/212 (34%), Gaps = 53/212 (25%)
Query: 148 RY----CIGTGGYDSVYKAE---LPDGKVVALKKLHHSETEDSAFV-------------- 186
+Y CI GG +Y A + +G+ V LK L HS D+
Sbjct: 81 QYEVKGCIAHGGLGWIYLALDRNV-NGRPVVLKGLVHSG--DAEAQAMAMAERQFLAEVV 137
Query: 187 ------VY---------SPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVA 231
++ + + EY+ SL +L + + +
Sbjct: 138 HPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEIL 192
Query: 232 HALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTYGYI 291
ALSYLH +V+ D+ NI+L + + D G V + +S GT G+
Sbjct: 193 PALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAVSRI--NSFGYLY--GTPGFQ 244
Query: 292 ALELVYTMVVTEKCVIYSFGVVALEVLMGTHP 323
A E+V T T IY+ G + +
Sbjct: 245 APEIVRTG-PTVATDIYTVGRTLAALTLDLPT 275
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 9e-18
Identities = 57/269 (21%), Positives = 107/269 (39%), Gaps = 50/269 (18%)
Query: 140 DATEYFHIRYCIGTGGYDSVYKA-ELPDGKVVALKKLHHSETED---------------S 183
D IG G V A E G+ VA+K + + +
Sbjct: 42 DPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQH 101
Query: 184 AFVV------YSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYL 237
VV + ++ + E+++ G+L ++ + LN + + ++V AL+YL
Sbjct: 102 FNVVEMYKSYLVGEELWVLMEFLQGGALTDIVS----QVRLNEEQIATVCEAVLQALAYL 157
Query: 238 HHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTYGYIALELVY 297
H ++HRDI S++ILL + ++DFG + D R GT ++A E++
Sbjct: 158 H---AQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVIS 214
Query: 298 TMVVTEKCVIYSFGVVALEVLMG------THPGELLLSLSSSSGPKIMLIDILYQRLSPP 351
+ + I+S G++ +E++ G P + + L S PK+ ++SP
Sbjct: 215 RSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSH----KVSPV 270
Query: 352 INQKIIQDIILVSTIALACLRSKPKSRPT 380
+ + + L P+ R T
Sbjct: 271 LRDFLER-----------MLVRDPQERAT 288
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 2e-17
Identities = 51/282 (18%), Positives = 88/282 (31%), Gaps = 60/282 (21%)
Query: 143 EYFHIRYCIGTGGYDSVYKAELPDGKV-VALKKLH--HSETEDSAF-------------- 185
E + IG G + V+ L VA+K + F
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPN 173
Query: 186 ------VVYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHH 239
V Q ++ + E ++ G LR + L + +V A + YL
Sbjct: 174 IVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGA--RLRVKTLLQMVGDAAAGMEYLES 231
Query: 240 DCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTYGYI-----ALE 294
+HRD+++ N L+ ++DFG R +G + A E
Sbjct: 232 K---CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAA---SGGLRQVPVKWTAPE 285
Query: 295 LVYTMVVTEKCVIYSFGVVALEVLM-GTHPGELLLSLSSSSGPKIMLIDILYQ-----RL 348
+ + + ++SFG++ E G P P + RL
Sbjct: 286 ALNYGRYSSESDVWSFGILLWETFSLGASP-----------YPNLSNQQTREFVEKGGRL 334
Query: 349 SPPIN-QKIIQDIILVSTIALACLRSKPKSRPTMQRISQELE 389
P + ++ C +P RP+ I QEL+
Sbjct: 335 PCPELCPDAVFRLM------EQCWAYEPGQRPSFSTIYQELQ 370
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 2e-17
Identities = 47/279 (16%), Positives = 96/279 (34%), Gaps = 57/279 (20%)
Query: 145 FHIRYCIGTGGYDSVYKAELPDGKVVALKKLHHSETEDSAF------------------- 185
+ I IG+GG V++ ++ A+K ++ E ++
Sbjct: 30 YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK 89
Query: 186 ------VVYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHH 239
+ Q ++ + E L L+ ++I+ + K++ A+ +H
Sbjct: 90 IIRLYDYEITDQYIYMVMECGN-IDLNSWLKKK-KSIDPWERKS--YWKNMLEAVHTIHQ 145
Query: 240 DCTPSIVHRDISSNNILL-NSNLEAFVADFGTVRLLDVDSSN--RTLQAGTYGYIALELV 296
IVH D+ N L+ + L+ + DFG + D+++ + Q GT Y+ E +
Sbjct: 146 H---GIVHSDLKPANFLIVDGMLK--LIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAI 200
Query: 297 -----------YTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILY 345
++ K ++S G + + G P L I+
Sbjct: 201 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP------FQQIINQISKLHAIID 254
Query: 346 QRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRI 384
+D L + CL+ PK R ++ +
Sbjct: 255 PNHEIEFPDIPEKD--LQDVL-KCCLKRDPKQRISIPEL 290
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 2e-17
Identities = 53/274 (19%), Positives = 104/274 (37%), Gaps = 53/274 (19%)
Query: 140 DATEYFHIRYCIGTGGYDSVYKA-ELPDGKVVALKKLHHSETED---------------S 183
D E + I +G G + VYKA G + A K + E+
Sbjct: 16 DPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDH 75
Query: 184 AFVV------YSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYL 237
++V Y ++ + E+ G++ ++ + D + + + + + AL++L
Sbjct: 76 PYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQV--VCRQMLEALNFL 133
Query: 238 HHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTYGYIALELVY 297
H I+HRD+ + N+L+ + +ADFG R GT ++A E+V
Sbjct: 134 HSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVM 190
Query: 298 TMVVTE-----KCVIYSFGVVALEVLMG------THPGELLLSLSSSSGPKIMLIDILYQ 346
+ + K I+S G+ +E+ +P +LL ++ S P ++
Sbjct: 191 CETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPS---- 246
Query: 347 RLSPPINQKIIQDIILVSTIALACLRSKPKSRPT 380
+ S + L P++RP+
Sbjct: 247 KWSVEFRDFLKI-----------ALDKNPETRPS 269
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 4e-17
Identities = 51/289 (17%), Positives = 95/289 (32%), Gaps = 73/289 (25%)
Query: 145 FHIRYCIGTGGYDSVYKA-ELPDGKVVALKKLH------------------HSETEDSAF 185
FH IG+G + SV+K + DG + A+K+ H+ +
Sbjct: 13 FHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSH 72
Query: 186 VV--YS----PQCMFFIYEYMERGSLFCVLRDDDEAIE-LNWTRRMNIVKSVAHALSYLH 238
VV +S M EY GSL + ++ + +++ V L Y+H
Sbjct: 73 VVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH 132
Query: 239 HDCTPSIVHRDISSNNILLNSNLEAFV-------------------ADFGTVRLLDVDSS 279
S+VH DI +NI ++ D G V + S
Sbjct: 133 SM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRI----S 185
Query: 280 NRTLQAGTYGYIALELV-YTMVVTEKCVIYSFGVVALEVLMGTHP---GELLLSLSSSSG 335
+ ++ G ++A E++ K I++ + + G+ +
Sbjct: 186 SPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHEIRQGRL 245
Query: 336 PKIMLIDILYQRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRI 384
P+I Q LS +++ + P+ RP+ +
Sbjct: 246 PRI------PQVLSQE-----FTELL------KVMIHPDPERRPSAMAL 277
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 6e-17
Identities = 47/281 (16%), Positives = 96/281 (34%), Gaps = 57/281 (20%)
Query: 143 EYFHIRYCIGTGGYDSVYKAELPDGKVVALKKLHHSETEDSAF----------------- 185
+ I IG+GG V++ ++ A+K ++ E ++
Sbjct: 9 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 68
Query: 186 --------VVYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYL 237
+ Q ++ + E L L+ ++I+ + K++ A+ +
Sbjct: 69 DKIIRLYDYEITDQYIYMVMECGN-IDLNSWLKKK-KSIDPWERKS--YWKNMLEAVHTI 124
Query: 238 HHDCTPSIVHRDISSNNILL-NSNLEAFVADFGTVRLLDVDSSN--RTLQAGTYGYIALE 294
H IVH D+ N L+ + L+ + DFG + D+++ + Q GT Y+ E
Sbjct: 125 HQH---GIVHSDLKPANFLIVDGMLK--LIDFGIANQMQPDTTSVVKDSQVGTVNYMPPE 179
Query: 295 LV-----------YTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDI 343
+ ++ K ++S G + + G P L I
Sbjct: 180 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP------FQQIINQISKLHAI 233
Query: 344 LYQRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRI 384
+ +D L + CL+ PK R ++ +
Sbjct: 234 IDPNHEIEFPDIPEKD--LQDVL-KCCLKRDPKQRISIPEL 271
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 80.2 bits (198), Expect = 7e-17
Identities = 52/314 (16%), Positives = 102/314 (32%), Gaps = 64/314 (20%)
Query: 145 FHIRYCIGTGGYDSVYKAE-LPDGKVVALKKL--HHSETEDSAF---------------- 185
+R + GG+ VY+A+ + G+ ALK+L + E +
Sbjct: 30 LRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIV 89
Query: 186 -----------VVYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHAL 234
+ Q F + + +G L L+ + L+ + I A+
Sbjct: 90 QFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAV 149
Query: 235 SYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQA--------- 285
++H P I+HRD+ N+LL++ + DFG+ +
Sbjct: 150 QHMHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEI 208
Query: 286 ---GTYGYIALELVYTM---VVTEKCVIYSFGVVALEVLMGTHP--GELLLSLSSSSGPK 337
T Y E++ + EK I++ G + + HP L + +
Sbjct: 209 TRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVNGK--- 265
Query: 338 IMLIDILYQRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELEGKTPMKKG 397
Y + +I A L+ P+ R ++ + +L+ +
Sbjct: 266 -------YSIPPHDTQYTVFHSLI------RAMLQVNPEERLSIAEVVHQLQEIAAARNV 312
Query: 398 LKEISIPEMRNQEM 411
+ I E+ Q
Sbjct: 313 NPKSPITELLEQNG 326
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 81.5 bits (201), Expect = 7e-17
Identities = 61/273 (22%), Positives = 109/273 (39%), Gaps = 46/273 (16%)
Query: 143 EYFHIRYCIGTGGYDSVYKAELPDGKVVALKKLHHSETEDSAFV---------------- 186
E + +G G + V+ VA+K L AF+
Sbjct: 267 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQ 326
Query: 187 ---VYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTP 243
V S + ++ + EYM +GSL L+ + L + +++ +A ++Y+
Sbjct: 327 LYAVVSEEPIYIVTEYMSKGSLLDFLKGETGK-YLRLPQLVDMAAQIASGMAYVERM--- 382
Query: 244 SIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAG-TYGYIALELVYTMVVT 302
+ VHRD+ + NIL+ NL VADFG RL++ + A + A E T
Sbjct: 383 NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 442
Query: 303 EKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQ-----RLSPPIN-QKI 356
K ++SFG++ E+ + P ++ ++L Q R+ P +
Sbjct: 443 IKSDVWSFGILLTEL----------TTKGRVPYPGMVNREVLDQVERGYRMPCPPECPES 492
Query: 357 IQDIILVSTIALACLRSKPKSRPTMQRISQELE 389
+ D++ C R +P+ RPT + + LE
Sbjct: 493 LHDLM------CQCWRKEPEERPTFEYLQAFLE 519
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 81.0 bits (200), Expect = 7e-17
Identities = 61/273 (22%), Positives = 110/273 (40%), Gaps = 46/273 (16%)
Query: 143 EYFHIRYCIGTGGYDSVYKAELPDGKVVALKKLHHSETEDSAFV---------------- 186
E + +G G + V+ VA+K L AF+
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQ 243
Query: 187 ---VYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTP 243
V S + ++ + EYM +GSL L+ + L + +++ +A ++Y+
Sbjct: 244 LYAVVSEEPIYIVTEYMSKGSLLDFLKGETGK-YLRLPQLVDMAAQIASGMAYVERM--- 299
Query: 244 SIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDS-SNRTLQAGTYGYIALELVYTMVVT 302
+ VHRD+ + NIL+ NL VADFG RL++ + + R + A E T
Sbjct: 300 NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 359
Query: 303 EKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQ-----RLSPPIN-QKI 356
K ++SFG++ E+ + P ++ ++L Q R+ P +
Sbjct: 360 IKSDVWSFGILLTEL----------TTKGRVPYPGMVNREVLDQVERGYRMPCPPECPES 409
Query: 357 IQDIILVSTIALACLRSKPKSRPTMQRISQELE 389
+ D++ C R +P+ RPT + + LE
Sbjct: 410 LHDLM------CQCWRKEPEERPTFEYLQAFLE 436
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 80.7 bits (199), Expect = 8e-17
Identities = 45/295 (15%), Positives = 102/295 (34%), Gaps = 57/295 (19%)
Query: 136 ENLIDATEYFHIRYCIGTG--GYDSVYKA-ELPDGKVVALKK--LHHSETED-------- 182
+ + + + IG G +V A P G+ V +++ L E
Sbjct: 18 SSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGEL 77
Query: 183 -------SAFVV------YSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMN---- 225
+V + ++ + +M GS + I ++ MN
Sbjct: 78 HVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAK-------DLICTHFMDGMNELAI 130
Query: 226 --IVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFG-TVRLLDVDSSNRT 282
I++ V AL Y+HH VHR + +++IL++ + + +++ + ++ R
Sbjct: 131 AYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRV 187
Query: 283 LQAGTYGYI------ALELVYTMVV--TEKCVIYSFGVVALEVLMG------THPGELLL 328
+ + + E++ + K IYS G+ A E+ G ++LL
Sbjct: 188 VHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLL 247
Query: 329 SLSSSSGPKIMLIDILYQRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQR 383
+ + P ++ + + + + L ++ + R P+
Sbjct: 248 EKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPY 302
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 80.6 bits (199), Expect = 1e-16
Identities = 57/275 (20%), Positives = 104/275 (37%), Gaps = 48/275 (17%)
Query: 143 EYFHIRYCIGTGGYDSVYKAELPDGKV-VALKKLHHSETEDSAF---------------- 185
+++ +G G Y VY+ + VA+K L E F
Sbjct: 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLV 279
Query: 186 ----VVYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDC 241
V + I E+M G+L LR+ + E++ + + ++ A+ YL
Sbjct: 280 QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVSAVVLLYMATQISSAMEYLEKK- 337
Query: 242 TPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDS-SNRTLQAGTYGYIALELVYTMV 300
+ +HR++++ N L+ N VADFG RL+ D+ + + A E +
Sbjct: 338 --NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNK 395
Query: 301 VTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQ-----RLSPPIN-Q 354
+ K +++FGV+ E+ + S P I L + R+ P
Sbjct: 396 FSIKSDVWAFGVLLWEI----------ATYGMSPYPGIDLSQVYELLEKDYRMERPEGCP 445
Query: 355 KIIQDIILVSTIALACLRSKPKSRPTMQRISQELE 389
+ + +++ AC + P RP+ I Q E
Sbjct: 446 EKVYELM------RACWQWNPSDRPSFAEIHQAFE 474
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 80.8 bits (199), Expect = 1e-16
Identities = 66/397 (16%), Positives = 129/397 (32%), Gaps = 58/397 (14%)
Query: 27 FLKSDMSFNNLDGEIPTYLRDNPPKSFVGNKGLCGHVQGFLSCFQRHRLAPSFILSVKIF 86
+ F+ L + YL+ K C + + P+ +
Sbjct: 222 CIPEGTKFDTLWQLV-EYLKLKADGLIYCLKEACPNSSASNASGAAAPTLPA--HPSTLT 278
Query: 87 LPLTPILAFTIFGFILLLKGKSENLKLVTRAAKNGDVFSVWNYDGKILYENL-IDATEYF 145
P I G+ + K S ++ ++ + L +
Sbjct: 279 HPQRRIDTLNSDGYTPEPARITSPDKPRPMPMDTSVFESPFSDPEELKDKKLFLKRDNLL 338
Query: 146 HIRYCIGTGGYDSVYKAELPDGKV---VALKKLH--HSETEDSAFV-------------- 186
+G G + SV + K VA+K L + + +
Sbjct: 339 IADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYI 398
Query: 187 -----VYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYL--HH 239
V + + + E G L L E E+ + ++ V+ + YL +
Sbjct: 399 VRLIGVCQAEALMLVMEMAGGGPLHKFLVGKRE--EIPVSNVAELLHQVSMGMKYLEEKN 456
Query: 240 DCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTYGYI---ALELV 296
VHR++++ N+LL + A ++DFG + L D S T ++ + A E +
Sbjct: 457 -----FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECI 511
Query: 297 YTMVVTEKCVIYSFGVVALEVLM-GTHPGELLLSLSSSSGPKIM-LIDILYQRLSPPIN- 353
+ + ++S+GV E L G P + + GP++M I+ R+ P
Sbjct: 512 NFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM------KGPEVMAFIEQGK-RMECPPEC 564
Query: 354 -QKIIQDIILVSTIALACLRSKPKSRPTMQRISQELE 389
++ + C K + RP + Q +
Sbjct: 565 PPELYA-------LMSDCWIYKWEDRPDFLTVEQRMR 594
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 79.5 bits (196), Expect = 2e-16
Identities = 46/279 (16%), Positives = 94/279 (33%), Gaps = 57/279 (20%)
Query: 145 FHIRYCIGTGGYDSVYKAELPDGKVVALKKLHHSETEDSAF------------------- 185
+ I IG+GG V++ ++ A+K ++ E ++
Sbjct: 58 YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK 117
Query: 186 ------VVYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHH 239
+ Q ++ + E L L+ ++I+ + K++ A+ +H
Sbjct: 118 IIRLYDYEITDQYIYMVMECGN-IDLNSWLKKK-KSIDPWERKS--YWKNMLEAVHTIHQ 173
Query: 240 DCTPSIVHRDISSNNILL-NSNLEAFVADFGTVRLLDVDSSNRTL--QAGTYGYIALELV 296
IVH D+ N L+ + L+ + DFG + D+++ Q G Y+ E +
Sbjct: 174 H---GIVHSDLKPANFLIVDGMLK--LIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAI 228
Query: 297 -----------YTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILY 345
++ K ++S G + + G P L I+
Sbjct: 229 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP------FQQIINQISKLHAIID 282
Query: 346 QRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRI 384
+D L + CL+ PK R ++ +
Sbjct: 283 PNHEIEFPDIPEKD--LQDVL-KCCLKRDPKQRISIPEL 318
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 3e-16
Identities = 54/277 (19%), Positives = 101/277 (36%), Gaps = 63/277 (22%)
Query: 151 IGTGGYDSVYKAEL--PDGKV---VALKKLH--HSETEDSAFV----------------- 186
+G+G + +VYK KV VA+K+L S + +
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 187 --VYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYL--HHDCT 242
+ + I + M G L +R+ + I +N +A ++YL
Sbjct: 83 LGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQ--YLLNWCVQIAKGMNYLEDRR--- 137
Query: 243 PSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAG------TYGYIALELV 296
+VHRD+++ N+L+ + + DFG +LL + + G ALE +
Sbjct: 138 --LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM----ALESI 191
Query: 297 YTMVVTEKCVIYSFGVVALEVLM-GTHPGELLLSLSSSSGPKIM-LIDILYQRLSPPIN- 353
+ T + ++S+GV E++ G+ P + + +I +++ RL P
Sbjct: 192 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI------PASEISSILEKGE-RLPQPPIC 244
Query: 354 -QKIIQDIILVSTIALACLRSKPKSRPTMQRISQELE 389
+ I C SRP + + E
Sbjct: 245 TIDVYM-------IMRKCWMIDADSRPKFRELIIEFS 274
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 77.1 bits (190), Expect = 6e-16
Identities = 45/222 (20%), Positives = 81/222 (36%), Gaps = 49/222 (22%)
Query: 143 EYFHIRYCIGTGGYDSVYKA-ELPDGKVVA----------------------LKKLHHS- 178
+ + +G G +V++ G + A LKKL+H
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 179 -----ETEDSAFVVYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHA 233
E+ + + I E+ GSL+ VL + A L + + +++ V
Sbjct: 69 IVKLFAIEEET----TTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGG 124
Query: 234 LSYLHHDCTPSIVHRDISSNNILLNSNLEAF----VADFGTVRLLDVDSSNRTLQAGTYG 289
+++L + IVHR+I NI+ + + DFG R L+ D +L GT
Sbjct: 125 MNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSL-YGTEE 180
Query: 290 YIALELVYTMVV--------TEKCVIYSFGVVALEVLMGTHP 323
Y+ ++ V+ ++S GV G+ P
Sbjct: 181 YLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 6e-16
Identities = 55/209 (26%), Positives = 88/209 (42%), Gaps = 43/209 (20%)
Query: 145 FHIRYCIGTGGYDSVYKA-ELPDGKVVALKKLHHSETEDSA------------------F 185
F I +G G + +VY A E ++ALK L ++ E +
Sbjct: 11 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 70
Query: 186 VV------YSPQCMFFIYEYMERGSLFCVLR-----DDDEAIELNWTRRMNIVKSVAHAL 234
++ + ++ I EY G+++ L+ D+ + +A+AL
Sbjct: 71 ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRT------AT--YITELANAL 122
Query: 235 SYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTYGYIALE 294
SY H ++HRDI N+LL S E +ADFG SS RT GT Y+ E
Sbjct: 123 SYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVH--APSSRRTDLCGTLDYLPPE 177
Query: 295 LVYTMVVTEKCVIYSFGVVALEVLMGTHP 323
++ + EK ++S GV+ E L+G P
Sbjct: 178 MIEGRMHDEKVDLWSLGVLCYEFLVGKPP 206
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 7e-16
Identities = 53/284 (18%), Positives = 101/284 (35%), Gaps = 54/284 (19%)
Query: 139 IDATEYFHIRYCIGTGGYDSVYKAEL--PDGKV-VALKKLHHSETEDS--AFV------- 186
+ +G G + SV + ++ VA+K L + +
Sbjct: 6 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMH 65
Query: 187 ------------VYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHAL 234
V + + + E G L L E E+ + ++ V+ +
Sbjct: 66 QLDNPYIVRLIGVCQAEALMLVMEMAGGGPLHKFLVGKRE--EIPVSNVAELLHQVSMGM 123
Query: 235 SYL--HHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTYGYI- 291
YL + VHRD+++ N+LL + A ++DFG + L D S T ++ +
Sbjct: 124 KYLEEKN-----FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLK 178
Query: 292 --ALELVYTMVVTEKCVIYSFGVVALEVLM-GTHPGELLLSLSSSSGPKIM-LIDILYQR 347
A E + + + ++S+GV E L G P + + GP++M I+ R
Sbjct: 179 WYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM------KGPEVMAFIEQGK-R 231
Query: 348 LSPPIN--QKIIQDIILVSTIALACLRSKPKSRPTMQRISQELE 389
+ P ++ + C K + RP + Q +
Sbjct: 232 MECPPECPPELYA-------LMSDCWIYKWEDRPDFLTVEQRMR 268
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 1e-15
Identities = 52/290 (17%), Positives = 100/290 (34%), Gaps = 55/290 (18%)
Query: 143 EYFHIRYCIGTGGYDSVYKAELP-----DGKVVALKKL--HHSETEDSAF---------- 185
+ +G G + V G+ VA+K L +
Sbjct: 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNL 80
Query: 186 ----------VVYSPQC--MFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHA 233
+ + I E++ GSL L + ++N +++ +
Sbjct: 81 YHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKN--KINLKQQLKYAVQICKG 138
Query: 234 LSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTYGYI-- 291
+ YL + VHRD+++ N+L+ S + + DFG + ++ D T++ +
Sbjct: 139 MDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFW 195
Query: 292 -ALELVYTMVVTEKCVIYSFGVVALEVLM-GTHPGELLLSLSSSSGP--KIM----LIDI 343
A E + ++SFGV E+L + GP M L++
Sbjct: 196 YAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNT 255
Query: 344 LYQ--RLSPPIN--QKIIQDIILVSTIALACLRSKPKSRPTMQRISQELE 389
L + RL P N ++ Q + C +P +R + Q + + E
Sbjct: 256 LKEGKRLPCPPNCPDEVYQ-------LMRKCWEFQPSNRTSFQNLIEGFE 298
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 3e-15
Identities = 50/275 (18%), Positives = 99/275 (36%), Gaps = 60/275 (21%)
Query: 140 DATEYFHIRYCIGTGGYDSVYKA-ELPDGKVVALKK--LHHSETED-------------- 182
D + F IG G + +VY A ++ + +VVA+KK ++ +
Sbjct: 51 DPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQK 110
Query: 183 --SAFVV------YSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHAL 234
+ + + EY GS +L + ++ + L
Sbjct: 111 LRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAA--VTHGALQGL 167
Query: 235 SYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTYGYIALE 294
+YLH +++HRD+ + NILL+ + DFG+ ++ + GT ++A E
Sbjct: 168 AYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIM----APANSFVGTPYWMAPE 220
Query: 295 LVYTMVVTE---KCVIYSFGVVALEVLMG------THPGELLLSLSSSSGPKIMLIDILY 345
++ M + K ++S G+ +E+ + L ++ + P +
Sbjct: 221 VILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQ-----S 275
Query: 346 QRLSPPINQKIIQDIILVSTIALACLRSKPKSRPT 380
S + CL+ P+ RPT
Sbjct: 276 GHWSEYFRNFVDS-----------CLQKIPQDRPT 299
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 75.3 bits (185), Expect = 4e-15
Identities = 45/222 (20%), Positives = 81/222 (36%), Gaps = 49/222 (22%)
Query: 143 EYFHIRYCIGTGGYDSVYKA-ELPDGKVVA----------------------LKKLHHS- 178
+ + +G G +V++ G + A LKKL+H
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 179 -----ETEDSAFVVYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHA 233
E+ + + I E+ GSL+ VL + A L + + +++ V
Sbjct: 69 IVKLFAIEEET----TTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGG 124
Query: 234 LSYLHHDCTPSIVHRDISSNNILLNSNLEAF----VADFGTVRLLDVDSSNRTLQAGTYG 289
+++L + IVHR+I NI+ + + DFG R L+ D +L GT
Sbjct: 125 MNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSL-YGTEE 180
Query: 290 YIALELVYTMVV--------TEKCVIYSFGVVALEVLMGTHP 323
Y+ ++ V+ ++S GV G+ P
Sbjct: 181 YLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 5e-15
Identities = 41/203 (20%), Positives = 76/203 (37%), Gaps = 41/203 (20%)
Query: 151 IGTGGYDSVYKA-ELPDGKVVALKKLHHSETEDSAF------------------------ 185
+G GG+ ++ + +V A K + S
Sbjct: 49 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 186 VVYSPQCMFFIYEYMERGSLFCVLR-----DDDEAIELNWTRRMNIVKSVAHALSYLHHD 240
+F + E R SL + + + EA R ++ + YLH +
Sbjct: 109 FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEA------RY--YLRQIVLGCQYLHRN 160
Query: 241 CTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTYGYIALELVYTMV 300
++HRD+ N+ LN +LE + DFG ++ D + + GT YIA E++
Sbjct: 161 R---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKG 217
Query: 301 VTEKCVIYSFGVVALEVLMGTHP 323
+ + ++S G + +L+G P
Sbjct: 218 HSFEVDVWSIGCIMYTLLVGKPP 240
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 5e-15
Identities = 57/276 (20%), Positives = 120/276 (43%), Gaps = 52/276 (18%)
Query: 143 EYFHIRYCIGTGGYDSVYKAELPDGKVVALKKLHHSETEDSAFV---------------- 186
E + +G G + V+ A VA+K + AF+
Sbjct: 188 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVK 247
Query: 187 ---VYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTP 243
V + + ++ I E+M +GSL L+ D+ + + + ++ +A ++++
Sbjct: 248 LHAVVTKEPIYIITEFMAKGSLLDFLKSDEGS-KQPLPKLIDFSAQIAEGMAFIEQR--- 303
Query: 244 SIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTYGYI---ALELVYTMV 300
+ +HRD+ + NIL++++L +ADFG R+++ + T + G I A E +
Sbjct: 304 NYIHRDLRAANILVSASLVCKIADFGLARVIEDNE--YTAREGAKFPIKWTAPEAINFGS 361
Query: 301 VTEKCVIYSFGVVALEVLM-GTHPGELLLSLSSSSGPKIMLIDILYQ-----RLSPPIN- 353
T K ++SFG++ +E++ G P P + +++ R+ P N
Sbjct: 362 FTIKSDVWSFGILLMEIVTYGRIP-----------YPGMSNPEVIRALERGYRMPRPENC 410
Query: 354 QKIIQDIILVSTIALACLRSKPKSRPTMQRISQELE 389
+ + +I+ + C +++P+ RPT + I L+
Sbjct: 411 PEELYNIM------MRCWKNRPEERPTFEYIQSVLD 440
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 75.2 bits (185), Expect = 5e-15
Identities = 53/303 (17%), Positives = 107/303 (35%), Gaps = 67/303 (22%)
Query: 136 ENLIDATEYFHIRYC----IGTGGYDSVYKAELPDGKVVALKKLHHSETEDSA------- 184
N+ + + +G G +V G+ VA+K++ + +
Sbjct: 4 ANIPNFEQSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALMEIKLLT 63
Query: 185 -----------FVVY-SPQCMFFIYEYMERGSLF--CVLRDDDEAIELNWTRR--MNIVK 228
+ + + ++ E +L ++ + +++++
Sbjct: 64 ESDDHPNVIRYYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLR 122
Query: 229 SVAHALSYLHHDCTPSIVHRDISSNNILLNS-------------NLEAFVADFGTVRLLD 275
+A +++LH I+HRD+ NIL+++ NL ++DFG + LD
Sbjct: 123 QIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLD 179
Query: 276 VDSSNRTLQ----AGTYGYIALEL-------VYTMVVTEKCVIYSFGVVALEVL-MGTHP 323
S+ +GT G+ A EL +T I+S G V +L G HP
Sbjct: 180 SGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHP 239
Query: 324 -GELLLSLSSSSGPKIMLIDILYQRLSPPINQKIIQDII-LVSTIALACLRSKPKSRPTM 381
G+ S I+ + ++ +I + L+S + P RPT
Sbjct: 240 FGD-----KYSRESNIIRGIFSLDEMKCLHDRSLIAEATDLIS----QMIDHDPLKRPTA 290
Query: 382 QRI 384
++
Sbjct: 291 MKV 293
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 6e-15
Identities = 53/275 (19%), Positives = 102/275 (37%), Gaps = 59/275 (21%)
Query: 151 IGTGGYDSVYKAEL--PDGKV---VALKKLH--HSETEDSAFV----------------- 186
+G+G + +VYK KV VA+K+L S + +
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 187 --VYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPS 244
+ + I + M G L +R+ + + +N +A ++YL
Sbjct: 83 LGICLTSTVQLITQLMPFGCLLDYVREHKD--NIGSQYLLNWCVQIAKGMNYLEDRR--- 137
Query: 245 IVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAG------TYGYIALELVYT 298
+VHRD+++ N+L+ + + DFG +LL + + G ALE +
Sbjct: 138 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM----ALESILH 193
Query: 299 MVVTEKCVIYSFGVVALEVLM-GTHPGELLLSLSSSSGPKIM-LIDILYQRLSPPIN--Q 354
+ T + ++S+GV E++ G+ P + + +I +++ RL P
Sbjct: 194 RIYTHQSDVWSYGVTVWELMTFGSKPYDGI------PASEISSILEKGE-RLPQPPICTI 246
Query: 355 KIIQDIILVSTIALACLRSKPKSRPTMQRISQELE 389
+ I + C SRP + + E
Sbjct: 247 DVYM-------IMVKCWMIDADSRPKFRELIIEFS 274
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 7e-15
Identities = 41/203 (20%), Positives = 76/203 (37%), Gaps = 41/203 (20%)
Query: 151 IGTGGYDSVYKA-ELPDGKVVALKKLHHSETEDSAF------------------------ 185
+G GG+ ++ + +V A K + S
Sbjct: 23 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 186 VVYSPQCMFFIYEYMERGSLFCVLR-----DDDEAIELNWTRRMNIVKSVAHALSYLHHD 240
+F + E R SL + + + EA R ++ + YLH +
Sbjct: 83 FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEA------RY--YLRQIVLGCQYLHRN 134
Query: 241 CTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTYGYIALELVYTMV 300
++HRD+ N+ LN +LE + DFG ++ D + + GT YIA E++
Sbjct: 135 R---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKG 191
Query: 301 VTEKCVIYSFGVVALEVLMGTHP 323
+ + ++S G + +L+G P
Sbjct: 192 HSFEVDVWSIGCIMYTLLVGKPP 214
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 7e-15
Identities = 73/308 (23%), Positives = 113/308 (36%), Gaps = 72/308 (23%)
Query: 143 EYFHIRYCIGTGGYDSVYKAEL--PDGK--VVALKKLHHSETEDSA--F----------- 185
I +G G + V L P K VA+K L TE F
Sbjct: 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFD 104
Query: 186 ---------VVYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSY 236
VV + + + EYME GSL LR D + + + +++ +A + Y
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA--QFTVIQLVGMLRGIASGMKY 162
Query: 237 LHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTYGYI---AL 293
L VHRD+++ NIL+NSNL V+DFG R+L+ D G I +
Sbjct: 163 LS---DMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSP 219
Query: 294 ELVYTMVVTEKCVIYSFGVVALEVLM-GTHPGELLLSLSSSSGPKIMLIDILYQRLSPPI 352
E + T ++S+G+V EV+ G P Y +S
Sbjct: 220 EAIAYRKFTSASDVWSYGIVLWEVMSYGERP---------------------YWEMS--- 255
Query: 353 NQKIIQDI-------------ILVSTIALACLRSKPKSRPTMQRISQELEGKTPMKKGLK 399
NQ +I+ + + + L C + +RP ++I L+ LK
Sbjct: 256 NQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGSLK 315
Query: 400 EISIPEMR 407
I+ R
Sbjct: 316 IITSAAAR 323
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 1e-14
Identities = 58/290 (20%), Positives = 102/290 (35%), Gaps = 55/290 (18%)
Query: 143 EYFHIRYCIGTGGYDSVYKAELP-----DGKVVALKKLHH-SETEDSAF----------- 185
+ +G G + SV G+VVA+KKL H +E F
Sbjct: 10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ 69
Query: 186 ---------VVYSPQC--MFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHAL 234
V YS + I EY+ GSL L+ E I+ + + + +
Sbjct: 70 HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHI--KLLQYTSQICKGM 127
Query: 235 SYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTYGYI--- 291
YL T +HRD+++ NIL+ + + DFG ++L D ++ I
Sbjct: 128 EYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWY 184
Query: 292 ALELVYTMVVTEKCVIYSFGVVALEVLM-GTHPGELLLSLSSSSG----PKIMLIDILYQ 346
A E + + ++SFGVV E+ G ++++ ++
Sbjct: 185 APESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL 244
Query: 347 -----RLSPPIN--QKIIQDIILVSTIALACLRSKPKSRPTMQRISQELE 389
RL P +I I C + RP+ + ++ ++
Sbjct: 245 LKNNGRLPRPDGCPDEIYM-------IMTECWNNNVNQRPSFRDLALRVD 287
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 1e-14
Identities = 58/290 (20%), Positives = 102/290 (35%), Gaps = 55/290 (18%)
Query: 143 EYFHIRYCIGTGGYDSVYKAELP-----DGKVVALKKLHH-SETEDSAF----------- 185
+ +G G + SV G+VVA+KKL H +E F
Sbjct: 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ 100
Query: 186 ---------VVYSPQC--MFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHAL 234
V YS + I EY+ GSL L+ E I+ + + + +
Sbjct: 101 HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHI--KLLQYTSQICKGM 158
Query: 235 SYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTYGYI--- 291
YL T +HRD+++ NIL+ + + DFG ++L D ++ I
Sbjct: 159 EYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWY 215
Query: 292 ALELVYTMVVTEKCVIYSFGVVALEVLM-GTHPGELLLSLSSSSG----PKIMLIDILYQ 346
A E + + ++SFGVV E+ G ++++ ++
Sbjct: 216 APESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL 275
Query: 347 -----RLSPPIN--QKIIQDIILVSTIALACLRSKPKSRPTMQRISQELE 389
RL P +I I C + RP+ + ++ ++
Sbjct: 276 LKNNGRLPRPDGCPDEIYM-------IMTECWNNNVNQRPSFRDLALRVD 318
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 72.6 bits (179), Expect = 1e-14
Identities = 61/290 (21%), Positives = 100/290 (34%), Gaps = 73/290 (25%)
Query: 139 IDATEYFHIRYCIGTGGYDSVYKAELPDGKVVALKKLHHSETEDSAF------------- 185
ID +E IG+G + V+ + VA+K + + F
Sbjct: 5 IDPSE-LTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHP 63
Query: 186 -------VVYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYL- 237
V + + E+ME G L LR + + V ++YL
Sbjct: 64 KLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRG--LFAAETLLGMCLDVCEGMAYLE 121
Query: 238 -HHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTYGYI---AL 293
++HRD+++ N L+ N V+DFG R V T GT + +
Sbjct: 122 EAC-----VIHRDLAARNCLVGENQVIKVSDFGMTR--FVLDDQYTSSTGTKFPVKWASP 174
Query: 294 ELVYTMVVTEKCVIYSFGVVALEVLM-GTHPGELLLSLSSSSGPKIMLIDILYQRLSPPI 352
E+ + K ++SFGV+ EV G P Y+ S
Sbjct: 175 EVFSFSRYSSKSDVWSFGVLMWEVFSEGKIP---------------------YENRS--- 210
Query: 353 NQKIIQDI-------------ILVSTIALACLRSKPKSRPTMQRISQELE 389
N ++++DI V I C R +P+ RP R+ ++L
Sbjct: 211 NSEVVEDISTGFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLA 260
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 72.6 bits (179), Expect = 1e-14
Identities = 60/290 (20%), Positives = 97/290 (33%), Gaps = 73/290 (25%)
Query: 139 IDATEYFHIRYCIGTGGYDSVYKAELPDGKVVALKKLHHSETEDSAF------------- 185
ID + +GTG + V + VA+K + + F
Sbjct: 21 IDPKD-LTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHE 79
Query: 186 -------VVYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYL- 237
V + +F I EYM G L LR+ + + + K V A+ YL
Sbjct: 80 KLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRH--RFQTQQLLEMCKDVCEAMEYLE 137
Query: 238 -HHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTYGYI---AL 293
+HRD+++ N L+N V+DFG R V T G+ +
Sbjct: 138 SKQ-----FLHRDLAARNCLVNDQGVVKVSDFGLSR--YVLDDEYTSSVGSKFPVRWSPP 190
Query: 294 ELVYTMVVTEKCVIYSFGVVALEVLM-GTHPGELLLSLSSSSGPKIMLIDILYQRLSPPI 352
E++ + K I++FGV+ E+ G P Y+R +
Sbjct: 191 EVLMYSKFSSKSDIWAFGVLMWEIYSLGKMP---------------------YERFT--- 226
Query: 353 NQKIIQDII-------------LVSTIALACLRSKPKSRPTMQRISQELE 389
N + + I V TI +C K RPT + + +
Sbjct: 227 NSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNIL 276
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 2e-14
Identities = 58/281 (20%), Positives = 102/281 (36%), Gaps = 54/281 (19%)
Query: 151 IGTGGYDSVYKAELP-----DGKVVALKKLHHSETE-DSAF------------------- 185
+G G + SV G +VA+K+L HS + F
Sbjct: 31 LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 90
Query: 186 -VVYSPQC--MFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCT 242
V Y P + + EY+ G L L+ ++ + R + + + YL +
Sbjct: 91 GVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDAS--RLLLYSSQICKGMEYLG---S 145
Query: 243 PSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTYGYI---ALELVYTM 299
VHRD+++ NIL+ S +ADFG +LL +D ++ I A E +
Sbjct: 146 RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDN 205
Query: 300 VVTEKCVIYSFGVVALEVLM-GTHP---GELLLSLSSSSGPKIMLIDILYQ-----RLSP 350
+ + + ++SFGVV E+ L + L +L RL
Sbjct: 206 IFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEGQRLPA 265
Query: 351 PIN--QKIIQDIILVSTIALACLRSKPKSRPTMQRISQELE 389
P ++ + + C P+ RP+ + +L+
Sbjct: 266 PPACPAEVHE-------LMKLCWAPSPQDRPSFSALGPQLD 299
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 2e-14
Identities = 72/291 (24%), Positives = 114/291 (39%), Gaps = 73/291 (25%)
Query: 143 EYFHIRYCIGTGGYDSVYKAEL--PDGKV---VALKKLHH--SETEDSAF---------- 185
+ IG G + VYK L GK VA+K L +E + F
Sbjct: 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 103
Query: 186 ----------VVYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALS 235
V+ + M I EYME G+L LR+ D E + + + +++ +A +
Sbjct: 104 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDG--EFSVLQLVGMLRGIAAGMK 161
Query: 236 YLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTYGYI---A 292
YL + + VHRD+++ NIL+NSNL V+DFG R+L+ D +G I A
Sbjct: 162 YLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTA 218
Query: 293 LELVYTMVVTEKCVIYSFGVVALEVLM-GTHPGELLLSLSSSSGPKIMLIDILYQRLSPP 351
E + T ++SFG+V EV+ G P Y LS
Sbjct: 219 PEAISYRKFTSASDVWSFGIVMWEVMTYGERP---------------------YWELS-- 255
Query: 352 INQKIIQDI-------------ILVSTIALACLRSKPKSRPTMQRISQELE 389
N ++++ I + + + C + + RP I L+
Sbjct: 256 -NHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILD 305
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 73.6 bits (180), Expect = 2e-14
Identities = 30/297 (10%), Positives = 71/297 (23%), Gaps = 84/297 (28%)
Query: 151 IGTGGYDSVYKAE-LPDGKVVALKKLHHSETEDSAFV----------------------- 186
+G + +A G+ + + +E S +
Sbjct: 86 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145
Query: 187 -------------------------VYSPQCMFFIYEYMER--GSLFCVLRDDDEAIELN 219
+ + R +L +
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205
Query: 220 ----WTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLD 275
R+ + V L+ LHH +VH + +I+L+ F+ F +
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 262
Query: 276 VDSSNRTLQA-GTYGYIALELVY-----TMVVTEKCVIYSFGVVALEVLMGTHP--GELL 327
+ + + A ++ ++T ++ G+ + P +
Sbjct: 263 ASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAA 322
Query: 328 LSLSSSSGPKIMLIDILYQRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRI 384
L S I + P ++ ++ LR + R +
Sbjct: 323 LGGS----EWIFRSCK---NIPQP-----VRALL------EGFLRYPKEDRLLPLQA 361
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 2e-14
Identities = 49/311 (15%), Positives = 102/311 (32%), Gaps = 63/311 (20%)
Query: 128 NYDGKI--LYENLIDATE----YFHIRYCIGTGGYDSVYKAEL-----PDGKVVALKKL- 175
++ G + L++ D T Y +G G + V G++VA+K L
Sbjct: 10 HHHGALEVLFQGPGDPTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALK 69
Query: 176 -HHSETEDSAF--------------------VVYSPQC--MFFIYEYMERGSLFCVLRDD 212
S + + + EY+ GSL L
Sbjct: 70 ADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRH 129
Query: 213 DEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVR 272
+ + + + + ++YLH +HRD+++ N+LL+++ + DFG +
Sbjct: 130 ----SIGLAQLLLFAQQICEGMAYLH---AQHYIHRDLAARNVLLDNDRLVKIGDFGLAK 182
Query: 273 LLDVDSSNRTLQAGTYGYI---ALELVYTMVVTEKCVIYSFGVVALEVLM-GTHPGELLL 328
+ ++ + A E + ++SFGV E+L
Sbjct: 183 AVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPT 242
Query: 329 SLSSSSG---PKIMLIDILY-----QRLSPPIN--QKIIQDIILVSTIALACLRSKPKSR 378
G ++ ++ + +RL P ++ + C ++ R
Sbjct: 243 KFLELIGIAQGQMTVLRLTELLERGERLPRPDKCPAEVYH-------LMKNCWETEASFR 295
Query: 379 PTMQRISQELE 389
PT + + L+
Sbjct: 296 PTFENLIPILK 306
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 2e-14
Identities = 66/291 (22%), Positives = 101/291 (34%), Gaps = 53/291 (18%)
Query: 138 LIDATEYFHIRYCIGTGGYDSVYKAEL--PDGKV--VALKKLH----HSETEDSAFV--- 186
LI + + +G G + V + E P GK VA+K L F+
Sbjct: 14 LIGEKD-LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREV 72
Query: 187 ----------------VYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSV 230
V M + E GSL LR L V
Sbjct: 73 NAMHSLDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLG--TLSRYAVQV 130
Query: 231 AHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGT--- 287
A + YL +HRD+++ N+LL + + DFG +R L + + +Q
Sbjct: 131 AEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVP 187
Query: 288 YGYIALELVYTMVVTEKCVIYSFGVVALEVLM-GTHPGELLLSLSSSSGPKIM-LIDILY 345
+ + A E + T + + FGV E+ G P L +G +I+ ID
Sbjct: 188 FAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL------NGSQILHKIDKEG 241
Query: 346 QRLSPPIN--QKIIQDIILVSTIALACLRSKPKSRPTMQRISQELEGKTPM 394
+RL P + Q I + + C KP+ RPT + L P
Sbjct: 242 ERLPRPEDCPQDIYN-------VMVQCWAHKPEDRPTFVALRDFLLEAQPT 285
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 3e-14
Identities = 51/284 (17%), Positives = 99/284 (34%), Gaps = 68/284 (23%)
Query: 143 EYFHIRYCIGTGGYDSVYKAELPDGKVVALKKLHHSETEDSAF----------------- 185
E + +G+G + V + VA+K + + F
Sbjct: 8 EEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVK 67
Query: 186 ---VVYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCT 242
V ++ + EY+ G L LR + L ++ + + V +++L
Sbjct: 68 FYGVCSKEYPIYIVTEYISNGCLLNYLRSHGK--GLEPSQLLEMCYDVCEGMAFLESH-- 123
Query: 243 PSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTYGYI---ALELVYTM 299
+HRD+++ N L++ +L V+DFG R V GT + A E+ +
Sbjct: 124 -QFIHRDLAARNCLVDRDLCVKVSDFGMTR--YVLDDQYVSSVGTKFPVKWSAPEVFHYF 180
Query: 300 VVTEKCVIYSFGVVALEVLM-GTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKIIQ 358
+ K +++FG++ EV G P Y + N +++
Sbjct: 181 KYSSKSDVWAFGILMWEVFSLGKMP---------------------YDLYT---NSEVVL 216
Query: 359 DII-------------LVSTIALACLRSKPKSRPTMQRISQELE 389
+ + I +C P+ RPT Q++ +E
Sbjct: 217 KVSQGHRLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIE 260
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 3e-14
Identities = 57/276 (20%), Positives = 110/276 (39%), Gaps = 52/276 (18%)
Query: 143 EYFHIRYCIGTGGYDSVYKAELPDGKVVALKKLHHSETEDSAFV---------------- 186
E + +G G + V+ VA+K L AF+
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVR 72
Query: 187 ---VYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTP 243
V + + ++ I EYME GSL L+ +L + +++ +A ++++
Sbjct: 73 LYAVVTQEPIYIITEYMENGSLVDFLKTPSGI-KLTINKLLDMAAQIAEGMAFIEER--- 128
Query: 244 SIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGT---YGYIALELVYTMV 300
+ +HRD+ + NIL++ L +ADFG R ++ + T + G + A E +
Sbjct: 129 NYIHRDLRAANILVSDTLSCKIADFGLAR--LIEDNEYTAREGAKFPIKWTAPEAINYGT 186
Query: 301 VTEKCVIYSFGVVALEVLM-GTHPGELLLSLSSSSGPKIMLIDILYQ-----RLSPPIN- 353
T K ++SFG++ E++ G P P + +++ R+ P N
Sbjct: 187 FTIKSDVWSFGILLTEIVTHGRIP-----------YPGMTNPEVIQNLERGYRMVRPDNC 235
Query: 354 QKIIQDIILVSTIALACLRSKPKSRPTMQRISQELE 389
+ + ++ C + +P+ RPT + LE
Sbjct: 236 PEELYQLM------RLCWKERPEDRPTFDYLRSVLE 265
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 72.7 bits (178), Expect = 3e-14
Identities = 39/302 (12%), Positives = 79/302 (26%), Gaps = 93/302 (30%)
Query: 151 IGTGGYDSVYKA-ELPDGKVVALKKLHHSETEDSAFV----------------------- 186
+G + +A + G+ + + +E S +
Sbjct: 81 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 140
Query: 187 ----------------------------VYSPQCMFFIYEYME--RGSLFCVLRDDDEAI 216
FF+Y M+ + VL
Sbjct: 141 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 200
Query: 217 E-LNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLD 275
+ L R+ + V L+ LHH +VH + +I+L+ F+ F +
Sbjct: 201 KSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 257
Query: 276 VDSSNRTLQAGTYGYIALELVYTMV-----------VTEKCVIYSFGVVALEVLMGTHP- 323
R + + + G+ EL +T ++ G+V + P
Sbjct: 258 ----ARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPI 313
Query: 324 -GELLLSLSSSSGPKIMLIDILYQRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQ 382
+ L S I + P ++ ++ LR + R
Sbjct: 314 TKDAALGGSE----WIFRSCK---NIPQP-----VRALL------EGFLRYPKEDRLLPL 355
Query: 383 RI 384
+
Sbjct: 356 QA 357
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 3e-14
Identities = 69/292 (23%), Positives = 105/292 (35%), Gaps = 76/292 (26%)
Query: 143 EYFHIRYCIGTGGYDSVYKAEL--PDGKV--VALKKLHH--SETEDSAF----------- 185
HI IG+G V L P + VA+K L +E + F
Sbjct: 49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFD 108
Query: 186 ---------VVYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSY 236
VV + + EYME GSL LR D + + + +++ V + Y
Sbjct: 109 HPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDG--QFTIMQLVGMLRGVGAGMRY 166
Query: 237 LHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTYGYI----- 291
L VHRD+++ N+L++SNL V+DFG R+L+ D G G I
Sbjct: 167 LS---DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTG--GKIPIRWT 221
Query: 292 ALELVYTMVVTEKCVIYSFGVVALEVLM-GTHPGELLLSLSSSSGPKIMLIDILYQRLSP 350
A E + + ++SFGVV EVL G P Y ++
Sbjct: 222 APEAIAFRTFSSASDVWSFGVVMWEVLAYGERP---------------------YWNMT- 259
Query: 351 PINQKIIQDI-------------ILVSTIALACLRSKPKSRPTMQRISQELE 389
N+ +I + + + L C RP +I L+
Sbjct: 260 --NRDVISSVEEGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLD 309
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 71.0 bits (175), Expect = 4e-14
Identities = 41/204 (20%), Positives = 74/204 (36%), Gaps = 42/204 (20%)
Query: 151 IGTGGYDSVYKA-ELPDGKVVALKKLHHSETEDSAF------------------------ 185
+G G + VY+A + G VA+K + +
Sbjct: 19 LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78
Query: 186 VVYSPQCMFFIYEYMERGSLFCVLR------DDDEAIELNWTRRMNIVKSVAHALSYLHH 239
++ + E G + L+ ++EA R + + + YLH
Sbjct: 79 YFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEA------RH--FMHQIITGMLYLHS 130
Query: 240 DCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTYGYIALELVYTM 299
I+HRD++ +N+LL N+ +ADFG L + GT YI+ E+
Sbjct: 131 HG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRS 187
Query: 300 VVTEKCVIYSFGVVALEVLMGTHP 323
+ ++S G + +L+G P
Sbjct: 188 AHGLESDVWSLGCMFYTLLIGRPP 211
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 72.1 bits (177), Expect = 4e-14
Identities = 54/279 (19%), Positives = 95/279 (34%), Gaps = 64/279 (22%)
Query: 151 IGTGGYDSVYKAELPDGK----VVALKKLH--HSETEDSAF------------------- 185
IG G + VY L D A+K L+ E S F
Sbjct: 97 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 156
Query: 186 -VVYSPQC-MFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTP 243
+ + + YM+ G L +R++ + + VA + +L
Sbjct: 157 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKFLASK--- 211
Query: 244 SIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTYGYI-----ALELVYT 298
VHRD+++ N +L+ VADFG R + + T + ALE + T
Sbjct: 212 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV-HNKTGAKLPVKWMALESLQT 270
Query: 299 MVVTEKCVIYSFGVVALEVLM-------GTHPGELLLSLSSSSGPKIMLIDILYQRLSPP 351
T K ++SFGV+ E++ + ++ + L +RL P
Sbjct: 271 QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG------------RRLLQP 318
Query: 352 IN-QKIIQDIILVSTIALACLRSKPKSRPTMQRISQELE 389
+ +++ L C K + RP+ + +
Sbjct: 319 EYCPDPLYEVM------LKCWHPKAEMRPSFSELVSRIS 351
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 70.7 bits (174), Expect = 6e-14
Identities = 50/209 (23%), Positives = 82/209 (39%), Gaps = 43/209 (20%)
Query: 145 FHIRYCIGTGGYDSVYKA-ELPDGKVVALKKLHHSETEDSA------------------- 184
F I +G G + +VY A E + ++ALK L S+ E
Sbjct: 16 FDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPN 75
Query: 185 -----FVVYSPQCMFFIYEYMERGSLFCVLR-----DDDEAIELNWTRRMNIVKSVAHAL 234
+ + ++ + E+ RG L+ L+ D+ + ++ +A AL
Sbjct: 76 ILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRS------AT--FMEELADAL 127
Query: 235 SYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTYGYIALE 294
Y H ++HRDI N+L+ E +ADFG S R GT Y+ E
Sbjct: 128 HYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVH--APSLRRRTMCGTLDYLPPE 182
Query: 295 LVYTMVVTEKCVIYSFGVVALEVLMGTHP 323
++ EK ++ GV+ E L+G P
Sbjct: 183 MIEGKTHDEKVDLWCAGVLCYEFLVGMPP 211
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 6e-14
Identities = 52/212 (24%), Positives = 84/212 (39%), Gaps = 38/212 (17%)
Query: 145 FHIRYCIGTGGYDSVYKAELPD-GKVVALKKLH-----------HSETE-------DSAF 185
F I IG G + V ++ G+V A+K ++ E D +
Sbjct: 63 FEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRW 122
Query: 186 VV---YS---PQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHH 239
+ ++ ++ + EY G L +L E I R + + V A+ +H
Sbjct: 123 ITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMAR-FYLAEIVM-AIDSVH- 179
Query: 240 DCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQA-GTYGYIALELVYT 298
VHRDI +NILL+ +ADFG+ L D + R+L A GT Y++ E++
Sbjct: 180 --RLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQA 237
Query: 299 MVVTEKCVIY-------SFGVVALEVLMGTHP 323
+ Y + GV A E+ G P
Sbjct: 238 VGGGPGTGSYGPECDWWALGVFAYEMFYGQTP 269
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 70.3 bits (173), Expect = 8e-14
Identities = 61/280 (21%), Positives = 103/280 (36%), Gaps = 58/280 (20%)
Query: 143 EYFHIRYCIGTGGYDSVYKAELPDGKV-VALKKLHHSETEDSAF---------------- 185
+++ +G G Y VY+ + VA+K L E F
Sbjct: 13 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLV 72
Query: 186 ----VVYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDC 241
V + I E+M G+L LR+ + E++ + + ++ A+ YL
Sbjct: 73 QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVSAVVLLYMATQISSAMEYLE--- 128
Query: 242 TPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTYGYI-----ALELV 296
+ +HRD+++ N L+ N VADFG RL+ D T A A E +
Sbjct: 129 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD----TYTAHAGAKFPIKWTAPESL 184
Query: 297 YTMVVTEKCVIYSFGVVALEVLM-GTHPGELLLSLSSSSGPKIMLIDILYQ-----RLSP 350
+ K +++FGV+ E+ G P P I L + R+
Sbjct: 185 AYNKFSIKSDVWAFGVLLWEIATYGMSP-----------YPGIDLSQVYELLEKDYRMER 233
Query: 351 PIN-QKIIQDIILVSTIALACLRSKPKSRPTMQRISQELE 389
P + + +++ AC + P RP+ I Q E
Sbjct: 234 PEGCPEKVYELM------RACWQWNPSDRPSFAEIHQAFE 267
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 8e-14
Identities = 55/280 (19%), Positives = 93/280 (33%), Gaps = 66/280 (23%)
Query: 151 IGTGGYDSVYKAELPDGK----VVALKKLH--HSETEDSAF------------------- 185
IG G + VY L D A+K L+ E S F
Sbjct: 33 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 92
Query: 186 -VVYSPQC-MFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTP 243
+ + + YM+ G L +R++ + VA + YL +
Sbjct: 93 GICLRSEGSPLVVLPYMKHGDLRNFIRNETH--NPTVKDLIGFGLQVAKGMKYLA---SK 147
Query: 244 SIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTYGYI-----ALELVYT 298
VHRD+++ N +L+ VADFG R + T + ALE + T
Sbjct: 148 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSV-HNKTGAKLPVKWMALESLQT 206
Query: 299 MVVTEKCVIYSFGVVALEVLM-------GTHPGELLLSLSSSSGPKIMLIDILYQRLSPP 351
T K ++SFGV+ E++ + ++ + L +RL P
Sbjct: 207 QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG------------RRLLQP 254
Query: 352 IN--QKIIQDIILVSTIALACLRSKPKSRPTMQRISQELE 389
+ + + L C K + RP+ + +
Sbjct: 255 EYCPDPLYE-------VMLKCWHPKAEMRPSFSELVSRIS 287
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 9e-14
Identities = 57/290 (19%), Positives = 101/290 (34%), Gaps = 64/290 (22%)
Query: 138 LIDATEYFHIRYCIGTGGYDSVYKAEL-PDGK----VVALK--KLHHSETEDSAFV---- 186
+ TE +G+G + +V+K P+G+ V +K + A
Sbjct: 9 IFKETE-LRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHML 67
Query: 187 ---------------VYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVA 231
+ + + +Y+ GSL +R A+ +N +A
Sbjct: 68 AIGSLDHAHIVRLLGLCPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQ--LLLNWGVQIA 125
Query: 232 HALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAG----- 286
+ YL +VHR++++ N+LL S + VADFG LL D
Sbjct: 126 KGMYYLE---EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIK 182
Query: 287 -TYGYIALELVYTMVVTEKCVIYSFGVVALEVLM-GTHPGELLLSLSSSSGPKIMLIDIL 344
ALE ++ T + ++S+GV E++ G P + L ++
Sbjct: 183 WM----ALESIHFGKYTHQSDVWSYGVTVWELMTFGAEP-----------YAGLRLAEVP 227
Query: 345 YQ-----RLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELE 389
RL+ P I V + + C RPT + ++ E
Sbjct: 228 DLLEKGERLAQPQICTID-----VYMVMVKCWMIDENIRPTFKELANEFT 272
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 1e-13
Identities = 60/282 (21%), Positives = 95/282 (33%), Gaps = 70/282 (24%)
Query: 151 IGTGGYDSVYKAELPDGK----VVALKKLH--HSETEDSAF------------------- 185
IG G + VY E D A+K L + AF
Sbjct: 29 IGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALI 88
Query: 186 -VVYSPQCMFFI-YEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYL--HHDC 241
++ P+ + + YM G L +R ++ VA + YL
Sbjct: 89 GIMLPPEGLPHVLLPYMCHGDLLQFIRSPQR--NPTVKDLISFGLQVARGMEYLAEQK-- 144
Query: 242 TPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTYG------YIALEL 295
VHRD+++ N +L+ + VADFG R D+ + ALE
Sbjct: 145 ---FVHRDLAARNCMLDESFTVKVADFGLAR--DILDREYYSVQQHRHARLPVKWTALES 199
Query: 296 VYTMVVTEKCVIYSFGVVALEVLM-------GTHPGELLLSLSSSSGPKIMLIDILYQRL 348
+ T T K ++SFGV+ E+L P +L L+ +RL
Sbjct: 200 LQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQG------------RRL 247
Query: 349 SPPIN-QKIIQDIILVSTIALACLRSKPKSRPTMQRISQELE 389
P + ++ C + P RPT + + E+E
Sbjct: 248 PQPEYCPDSLYQVM------QQCWEADPAVRPTFRVLVGEVE 283
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 3e-13
Identities = 50/273 (18%), Positives = 99/273 (36%), Gaps = 56/273 (20%)
Query: 151 IGTGGYDSVYKAELPDGKV---VALKKLHHSETEDSA---FV------------------ 186
+G+G + +V K KV VA+K L + + + +
Sbjct: 25 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84
Query: 187 -VYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYL--HHDCTP 243
+ + + E E G L L+ + + + +V V+ + YL +
Sbjct: 85 GICEAESWMLVMEMAELGPLNKYLQQNRH---VKDKNIIELVHQVSMGMKYLEESN---- 137
Query: 244 SIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGT---YGYIALELVYTMV 300
VHRD+++ N+LL + A ++DFG + L D + Q + A E +
Sbjct: 138 -FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK 196
Query: 301 VTEKCVIYSFGVVALEVLM-GTHPGELLLSLSSSSGPKIM-LIDILYQRLSPPIN--QKI 356
+ K ++SFGV+ E G P + G ++ +++ R+ P +++
Sbjct: 197 FSSKSDVWSFGVLMWEAFSYGQKPYRGM------KGSEVTAMLEKGE-RMGCPAGCPREM 249
Query: 357 IQDIILVSTIALACLRSKPKSRPTMQRISQELE 389
+ C ++RP + L
Sbjct: 250 YD-------LMNLCWTYDVENRPGFAAVELRLR 275
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 6e-13
Identities = 50/223 (22%), Positives = 81/223 (36%), Gaps = 41/223 (18%)
Query: 131 GKILYENLIDATEYFHIRYCIGTGGYDSVYKA-ELPDGKVVALK-----KLHHSETED-- 182
G + +E + +G+G Y V + A+K + S
Sbjct: 25 GMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLL 84
Query: 183 ---------------SAFVVY-SPQCMFFIYEYMERGSLFCVLRDDDEAIEL-NWTRRM- 224
+ + + + + E + G LF DE I +
Sbjct: 85 EEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELF------DEIIHRMKFNEVDA 138
Query: 225 -NIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAF---VADFGTVRLLDVDSSN 280
I+K V ++YLH +IVHRD+ N+LL S + + DFG + + +
Sbjct: 139 AVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE-NQKK 194
Query: 281 RTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHP 323
+ GT YIA E V EKC ++S GV+ +L G P
Sbjct: 195 MKERLGTAYYIAPE-VLRKKYDEKCDVWSIGVILFILLAGYPP 236
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 6e-13
Identities = 53/213 (24%), Positives = 85/213 (39%), Gaps = 47/213 (22%)
Query: 145 FHIRYCIGTGGYDSVYKAELPD-GKVVALKKLH-----------HSETE-------DSAF 185
F I IG G + V + D K+ A+K ++ + E + F
Sbjct: 17 FEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPF 76
Query: 186 VV---YS---PQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRM--NIVK----SVAHA 233
+V YS + MF + + + G L L+ + VK + A
Sbjct: 77 LVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQN---------VHFKEETVKLFICELVMA 127
Query: 234 LSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTYGYIAL 293
L YL + I+HRD+ +NILL+ + + DF +L ++ T+ AGT Y+A
Sbjct: 128 LDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTM-AGTKPYMAP 183
Query: 294 ELVYTMVVTE--KCV-IYSFGVVALEVLMGTHP 323
E+ + V +S GV A E+L G P
Sbjct: 184 EMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 7e-13
Identities = 56/290 (19%), Positives = 99/290 (34%), Gaps = 77/290 (26%)
Query: 151 IGTGGYDSVYKAELPDGK----VVALKKL---HHSETEDSAFV----------------- 186
+G G + SV +A+L VA+K L + ++ F+
Sbjct: 31 LGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKL 90
Query: 187 ---------VYSPQCMFFIYEYMERGSLFCVLRD---DDEAIELNWTRRMNIVKSVAHAL 234
I +M+ G L L + L + + +A +
Sbjct: 91 VGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGM 150
Query: 235 SYL--HHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTYGYI- 291
YL + +HRD+++ N +L ++ VADFG R + S + + G +
Sbjct: 151 EYLSSRN-----FIHRDLAARNCMLAEDMTVCVADFGLSR--KIYSGD-YYRQGCASKLP 202
Query: 292 ----ALELVYTMVVTEKCVIYSFGVVALEVLM-------GTHPGELLLSLSSSSGPKIML 340
ALE + + T +++FGV E++ G E+ L
Sbjct: 203 VKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGG------- 255
Query: 341 IDILYQRLSPPIN-QKIIQDIILVSTIALACLRSKPKSRPTMQRISQELE 389
RL P + + D++ C + PK RP+ + ELE
Sbjct: 256 -----NRLKQPPECMEEVYDLM------YQCWSADPKQRPSFTCLRMELE 294
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 67.5 bits (165), Expect = 2e-12
Identities = 54/212 (25%), Positives = 87/212 (41%), Gaps = 40/212 (18%)
Query: 145 FHIRYCIGTGGYDSVYKAELPD-GKVVALKKLH-----------HSETE-------DSAF 185
F I IG G + V +L + KV A+K L+ E DS +
Sbjct: 76 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKW 135
Query: 186 VV---YS---PQCMFFIYEYMERGSLFCVLRDDDEAIELNWTR--RMNIVKSVAHALSYL 237
+ Y+ ++ + +Y G L +L ++ + R +V A+ +
Sbjct: 136 ITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVI----AIDSV 191
Query: 238 HHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQA-GTYGYIALELV 296
H VHRDI +NIL++ N +ADFG+ L D + ++ A GT YI+ E++
Sbjct: 192 H---QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEIL 248
Query: 297 YTMVVTEK-----CVIYSFGVVALEVLMGTHP 323
M + C +S GV E+L G P
Sbjct: 249 QAMEGGKGRYGPECDWWSLGVCMYEMLYGETP 280
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 3e-12
Identities = 57/289 (19%), Positives = 100/289 (34%), Gaps = 76/289 (26%)
Query: 151 IGTGGYDSVYKAELPDGK----VVA---LKKLHHSETEDSAF------------------ 185
+G G + SV + L VA +K + S+ E F
Sbjct: 42 LGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRL 101
Query: 186 --VVY--SPQCMFFIY---EYMERGSLFCVLR---DDDEAIELNWTRRMNIVKSVAHALS 235
V S Q + +M+ G L L + + + + +A +
Sbjct: 102 LGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGME 161
Query: 236 YL--HHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTYGYI-- 291
YL + +HRD+++ N +L ++ VADFG + + S + + G +
Sbjct: 162 YLSNRN-----FLHRDLAARNCMLRDDMTVCVADFGLSK--KIYSGD-YYRQGRIAKMPV 213
Query: 292 ---ALELVYTMVVTEKCVIYSFGVVALEVLM-------GTHPGELLLSLSSSSGPKIMLI 341
A+E + V T K +++FGV E+ G E+ L
Sbjct: 214 KWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHG-------- 265
Query: 342 DILYQRLSPPIN-QKIIQDIILVSTIALACLRSKPKSRPTMQRISQELE 389
RL P + + +I+ +C R+ P RPT + +LE
Sbjct: 266 ----HRLKQPEDCLDELYEIM------YSCWRTDPLDRPTFSVLRLQLE 304
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 67.2 bits (164), Expect = 3e-12
Identities = 55/284 (19%), Positives = 98/284 (34%), Gaps = 79/284 (27%)
Query: 151 IGTGGYDSVYKAEL--PDGKV--VALKKLH--HSETEDSAFV------------------ 186
IG G + V++ P+ VA+K S++ F+
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 187 -VYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLH-HDCTPS 244
V + ++ I E G L L+ +++L + ++ AL+YL
Sbjct: 458 GVITENPVWIIMELCTLGELRSFLQVRKFSLDL--ASLILYAYQLSTALAYLESKRF--- 512
Query: 245 IVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTYGYI-----ALELVYTM 299
VHRDI++ N+L++SN + DFG R ++ + + + G + A E +
Sbjct: 513 -VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKA----SKGKLPIKWMAPESINFR 567
Query: 300 VVTEKCVIYSFGVVALEVLM-GTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKIIQ 358
T ++ FGV E+LM G P +Q + N +I
Sbjct: 568 RFTSASDVWMFGVCMWEILMHGVKP---------------------FQGVK---NNDVIG 603
Query: 359 DI-------------ILVSTIALACLRSKPKSRPTMQRISQELE 389
I + ++ C P RP + +L
Sbjct: 604 RIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLS 647
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 3e-12
Identities = 56/275 (20%), Positives = 105/275 (38%), Gaps = 54/275 (19%)
Query: 143 EYFHIRYCIGTGGYDSVYKAELPDGKVVALKKLHHSETEDS------------------- 183
+ + IG G + V + G VA+K + + T +
Sbjct: 193 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQL 251
Query: 184 -AFVVYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYL-HHDC 241
+V ++ + EYM +GSL LR + L + V A+ YL ++
Sbjct: 252 LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRS-VLGGDCLLKFSLDVCEAMEYLEGNNF 310
Query: 242 TPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTYGYIALELVYTMVV 301
VHRD+++ N+L++ + A V+DFG + L + A E +
Sbjct: 311 ----VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL---PVKWTAPEALREKKF 363
Query: 302 TEKCVIYSFGVVALEVLM-GTHPGELLLSLSSSSGPKIMLIDILYQ-----RLSPPIN-Q 354
+ K ++SFG++ E+ G P P+I L D++ + ++ P
Sbjct: 364 STKSDVWSFGILLWEIYSFGRVP-----------YPRIPLKDVVPRVEKGYKMDAPDGCP 412
Query: 355 KIIQDIILVSTIALACLRSKPKSRPTMQRISQELE 389
+ D++ C +RPT ++ ++LE
Sbjct: 413 PAVYDVM------KNCWHLDAATRPTFLQLREQLE 441
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 6e-12
Identities = 46/215 (21%), Positives = 81/215 (37%), Gaps = 42/215 (19%)
Query: 140 DATEYFHIRYCIGTGGYDSVYKA-ELPDGKVVALK-----KLHHSETEDS---------- 183
++ + + +G G + V + G+ A+K ++ ++S
Sbjct: 23 IFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQ 82
Query: 184 --------AFVVY-SPQCMFFIYEYMERGSLFCVLRDDDEAIEL-NWTRRM--NIVKSVA 231
+ + + + E G LF DE I ++ I++ V
Sbjct: 83 LDHPNIMKLYEFFEDKGYFYLVGEVYTGGELF------DEIISRKRFSEVDAARIIRQVL 136
Query: 232 HALSYLHHDCTPSIVHRDISSNNILLNSNLEAF---VADFGTVRLLDVDSSNRTLQAGTY 288
++Y+H + IVHRD+ N+LL S + + DFG + + GT
Sbjct: 137 SGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDK-IGTA 192
Query: 289 GYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHP 323
YIA E V EKC ++S GV+ +L G P
Sbjct: 193 YYIAPE-VLHGTYDEKCDVWSTGVILYILLSGCPP 226
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 8e-12
Identities = 56/282 (19%), Positives = 96/282 (34%), Gaps = 75/282 (26%)
Query: 151 IGTGGYDSVYKAEL--PDGKV--VALKKLH--HSETEDSAFV------------------ 186
IG G + V++ P+ VA+K S++ F+
Sbjct: 23 IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82
Query: 187 -VYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYL-HHDCTPS 244
V + ++ I E G L L+ +++L + ++ AL+YL
Sbjct: 83 GVITENPVWIIMELCTLGELRSFLQVRKYSLDLA--SLILYAYQLSTALAYLESKRF--- 137
Query: 245 IVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTYGYI---ALELVYTMVV 301
VHRDI++ N+L++SN + DFG R ++ S + I A E +
Sbjct: 138 -VHRDIAARNVLVSSNDCVKLGDFGLSR--YMEDSTYYKASKGKLPIKWMAPESINFRRF 194
Query: 302 TEKCVIYSFGVVALEVLM-GTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKIIQDI 360
T ++ FGV E+LM G P +Q + N +I I
Sbjct: 195 TSASDVWMFGVCMWEILMHGVKP---------------------FQGVK---NNDVIGRI 230
Query: 361 -------------ILVSTIALACLRSKPKSRPTMQRISQELE 389
+ ++ C P RP + +L
Sbjct: 231 ENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLS 272
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 64.1 bits (157), Expect = 1e-11
Identities = 51/283 (18%), Positives = 91/283 (32%), Gaps = 77/283 (27%)
Query: 151 IGTGGYDSVYKAEL--PDGKV--VALKKLHHSETEDS--AFV------------------ 186
+G G + VY+ G+ VA+K T D+ F+
Sbjct: 20 LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 79
Query: 187 -VYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYL--HHDCTP 243
+ + + I E G L L + ++++ + + A++YL +
Sbjct: 80 GIIEEEPTWIIMELYPYGELGHYLERNKNSLKV--LTLVLYSLQICKAMAYLESIN---- 133
Query: 244 SIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTYGYI---ALELVYTMV 300
VHRDI+ NIL+ S + DFG R ++ + + T I + E +
Sbjct: 134 -CVHRDIAVRNILVASPECVKLGDFGLSR--YIEDEDYYKASVTRLPIKWMSPESINFRR 190
Query: 301 VTEKCVIYSFGVVALEVLM-GTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKIIQD 359
T ++ F V E+L G P + L N+ +I
Sbjct: 191 FTTASDVWMFAVCMWEILSFGKQP---------------------FFWLE---NKDVIGV 226
Query: 360 I-------------ILVSTIALACLRSKPKSRPTMQRISQELE 389
+ ++ T+ C P RP + L
Sbjct: 227 LEKGDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLS 269
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 64.8 bits (158), Expect = 1e-11
Identities = 35/145 (24%), Positives = 62/145 (42%), Gaps = 11/145 (7%)
Query: 186 VVYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMN-----IVKSVAHALSYLHHD 240
++ + ++ IYEYME S+ + I+KSV ++ SY+H++
Sbjct: 111 IITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNE 170
Query: 241 CTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTYGYIALELVYT-- 298
+I HRD+ +NIL++ N ++DFG + D + GTY ++ E
Sbjct: 171 K--NICHRDVKPSNILMDKNGRVKLSDFGESEYMV-DKKIKGS-RGTYEFMPPEFFSNES 226
Query: 299 MVVTEKCVIYSFGVVALEVLMGTHP 323
K I+S G+ + P
Sbjct: 227 SYNGAKVDIWSLGICLYVMFYNVVP 251
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 63.0 bits (154), Expect = 2e-11
Identities = 51/289 (17%), Positives = 96/289 (33%), Gaps = 82/289 (28%)
Query: 143 EYFHIRYCIGTGGYDSVYKAELPDGKVVALKKLHHSETEDS------------------- 183
+ + IG G + V + G VA+K + + T +
Sbjct: 21 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQL 79
Query: 184 -AFVVYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYL-HHDC 241
+V ++ + EYM +GSL LR + L + V A+ YL ++
Sbjct: 80 LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRS-VLGGDCLLKFSLDVCEAMEYLEGNNF 138
Query: 242 TPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTL-------QAGTYGYIALE 294
VHRD+++ N+L++ + A V+DFG + L +A
Sbjct: 139 ----VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREK----- 189
Query: 295 LVYTMVVTEKCVIYSFGVVALEVLM-GTHPGELLLSLSSSSGPKIMLIDILYQRLSPPIN 353
+ K ++SFG++ E+ G P Y R+
Sbjct: 190 -----KFSTKSDVWSFGILLWEIYSFGRVP---------------------YPRIP---L 220
Query: 354 QKIIQDII-------------LVSTIALACLRSKPKSRPTMQRISQELE 389
+ ++ + V + C RP+ ++ ++LE
Sbjct: 221 KDVVPRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLE 269
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 3e-11
Identities = 45/304 (14%), Positives = 96/304 (31%), Gaps = 80/304 (26%)
Query: 133 ILYENLIDATEYFHIRYCIGTGGYDSVYKAEL--------PDGKVVALKKLHH-SETEDS 183
+ ++ I + +G G + ++K V LK L
Sbjct: 1 VFHK--IRNED-LIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSE 57
Query: 184 AF--------------------VVYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRR 223
+F V + E+++ GSL L+ + I + W +
Sbjct: 58 SFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILW--K 115
Query: 224 MNIVKSVAHALSYL--HHDCTPSIVHRDISSNNILLNSNLEAF--------VADFGTVRL 273
+ + K +A A+ +L + ++H ++ + NILL + ++D G
Sbjct: 116 LEVAKQLAAAMHFLEENT-----LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISIT 170
Query: 274 LDVDSSNRTLQAGTYGYI-----ALE-LVYTMVVTEKCVIYSFGVVALEVLM-GTHPGEL 326
+ E + + +SFG E+ G P
Sbjct: 171 VLPKD---------ILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKP--- 218
Query: 327 LLSLSSSSGPKIM-LIDILYQRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRIS 385
LS+ + + + + +L P ++ + C+ +P RP+ + I
Sbjct: 219 ---LSALDSQRKLQFYEDRH-QLPAPKAAELAN-------LINNCMDYEPDHRPSFRAII 267
Query: 386 QELE 389
++L
Sbjct: 268 RDLN 271
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 3e-11
Identities = 52/214 (24%), Positives = 82/214 (38%), Gaps = 41/214 (19%)
Query: 140 DATEYFHIRYCIGTGGYDSVYKA-ELPDGKVVALK-----KLHHSETED----------- 182
E ++I +G G + V K + + A+K + +T
Sbjct: 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKL 78
Query: 183 ------SAFVVY-SPQCMFFIYEYMERGSLFCVLRDDDEAIEL-NWTRRM--NIVKSVAH 232
F + + + E G LF DE I+ ++ I+K V
Sbjct: 79 DHPNIMKLFEILEDSSSFYIVGELYTGGELF------DEIIKRKRFSEHDAARIIKQVFS 132
Query: 233 ALSYLHHDCTPSIVHRDISSNNILLNSNLEAF---VADFGTVRLLDVDSSNRTLQAGTYG 289
++Y+H +IVHRD+ NILL S + + DFG ++ + GT
Sbjct: 133 GITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDR-IGTAY 188
Query: 290 YIALELVYTMVVTEKCVIYSFGVVALEVLMGTHP 323
YIA E V EKC ++S GV+ +L GT P
Sbjct: 189 YIAPE-VLRGTYDEKCDVWSAGVILYILLSGTPP 221
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 4e-11
Identities = 60/311 (19%), Positives = 111/311 (35%), Gaps = 78/311 (25%)
Query: 151 IGTGGYDSVYKAELPDGK------VVALKKL--HHSETEDSAF----------------- 185
+G G + VY+ VA+K + S E F
Sbjct: 33 LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92
Query: 186 ---VVYSPQCMFFIYEYMERGSLFCVLR-------DDDEAIELNWTRRMNIVKSVAHALS 235
VV Q I E M RG L LR ++ + ++ + + +A ++
Sbjct: 93 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMA 152
Query: 236 YL--HHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTYGYI-- 291
YL + VHRD+++ N ++ + + DFG R D+ ++ + G G +
Sbjct: 153 YLNANK-----FVHRDLAARNCMVAEDFTVKIGDFGMTR--DIYETD-YYRKGGKGLLPV 204
Query: 292 ---ALELVYTMVVTEKCVIYSFGVVALEVLM-GTHP------GELLLSLSSSSGPKIMLI 341
+ E + V T ++SFGVV E+ P ++L +
Sbjct: 205 RWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEG-------- 256
Query: 342 DILYQRLSPPIN-QKIIQDIILVSTIALACLRSKPKSRPTMQRISQELEGKTPMKKGLKE 400
L P N ++ +++ C + PK RP+ I ++ + M+ G +E
Sbjct: 257 ----GLLDKPDNCPDMLFELM------RMCWQYNPKMRPSFLEIISSIKEE--MEPGFRE 304
Query: 401 ISIPEMRNQEM 411
+S ++
Sbjct: 305 VSFYYSEENKL 315
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 61.7 bits (150), Expect = 6e-11
Identities = 32/264 (12%), Positives = 65/264 (24%), Gaps = 75/264 (28%)
Query: 148 RY----CIGTGGYDSVYKAELPD---GKVVALKKLHHSETEDSAFV-------------- 186
RY G ++A D + VAL + +
Sbjct: 32 RYRLLIFHGGVPPLQFWQAL--DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRID 89
Query: 187 ------VY----SPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSY 236
V + + E++ GSL V + + ++S+A A
Sbjct: 90 KPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVADT-----SPSPVGAIRAMQSLAAAADA 144
Query: 237 LHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTYGYIALELV 296
H + + + ++ + + +A T+ +
Sbjct: 145 AHRA---GVALSIDHPSRVRVSIDGDVVLAYPATMPDANPQDD----------------- 184
Query: 297 YTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKI 356
I G +L+ P L + + P I
Sbjct: 185 ----------IRGIGASLYALLVNRWP----LPEAGVRSGLAPAERDTAGQPIEP--ADI 228
Query: 357 IQDI-ILVSTIALACLRSKPKSRP 379
+DI +S +A ++ R
Sbjct: 229 DRDIPFQISAVAARSVQGDGGIRS 252
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 61.8 bits (151), Expect = 9e-11
Identities = 34/150 (22%), Positives = 59/150 (39%), Gaps = 41/150 (27%)
Query: 151 IGTGGYDSVYKA-ELPDGKVVALKK--LHHSETEDSAF---------------------- 185
+G G + +VYKA + ++VA+KK L H
Sbjct: 18 LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 77
Query: 186 --VVYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAH----ALSYLHH 239
+ ++++ME L +++D+ + + +K+ L YLH
Sbjct: 78 LDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLT------PSHIKAYMLMTLQGLEYLHQ 130
Query: 240 DCTPSIVHRDISSNNILLNSNLEAFVADFG 269
I+HRD+ NN+LL+ N +ADFG
Sbjct: 131 H---WILHRDLKPNNLLLDENGVLKLADFG 157
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 62.5 bits (152), Expect = 9e-11
Identities = 46/208 (22%), Positives = 79/208 (37%), Gaps = 30/208 (14%)
Query: 140 DATEYFHIRYCIGTGGYDSVYKA-ELPDGKVVALKKLHHSETEDSAFV------------ 186
+++ I +GTG + V++ E G A K + D V
Sbjct: 154 HVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRH 213
Query: 187 --------VY-SPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYL 237
+ M IYE+M G LF + DE +++ + ++ V L ++
Sbjct: 214 PTLVNLHDAFEDDNEMVMIYEFMSGGELFE--KVADEHNKMSEDEAVEYMRQVCKGLCHM 271
Query: 238 HHDCTPSIVHRDISSNNILLNSNLEAFV--ADFGTVRLLDVDSSNRTLQAGTYGYIALEL 295
H + + VH D+ NI+ + + DFG LD S + GT + A E+
Sbjct: 272 HEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT-TGTAEFAAPEV 327
Query: 296 VYTMVVTEKCVIYSFGVVALEVLMGTHP 323
V ++S GV++ +L G P
Sbjct: 328 AEGKPVGYYTDMWSVGVLSYILLSGLSP 355
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 61.4 bits (150), Expect = 9e-11
Identities = 36/147 (24%), Positives = 61/147 (41%), Gaps = 39/147 (26%)
Query: 151 IGTGGYDSVYKAELPDGKVVALKKLHHSETEDSAF------------------------V 186
IG G Y VYKA+ G+ ALKK+ E ED V
Sbjct: 10 IGEGTYGVVYKAQNNYGETFALKKIR-LEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 187 VYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAH----ALSYLHHDCT 242
+++ + + ++E++++ L +L + +E KS ++Y H
Sbjct: 69 IHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLE------SVTAKSFLLQLLNGIAYCHDRR- 120
Query: 243 PSIVHRDISSNNILLNSNLEAFVADFG 269
++HRD+ N+L+N E +ADFG
Sbjct: 121 --VLHRDLKPQNLLINREGELKIADFG 145
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 61.4 bits (150), Expect = 9e-11
Identities = 37/147 (25%), Positives = 68/147 (46%), Gaps = 39/147 (26%)
Query: 151 IGTGGYDSVYKAELPDGKVVALKKLHHSETEDSAF------------------------V 186
+G G Y VYKA+ G++VALK++ + ED V
Sbjct: 29 VGEGTYGVVYKAKDSQGRIVALKRIR-LDAEDEGIPSTAIREISLLKELHHPNIVSLIDV 87
Query: 187 VYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAH----ALSYLHHDCT 242
++S +C+ ++E+ME+ L VL ++ ++ + +K + +++ H
Sbjct: 88 IHSERCLTLVFEFMEK-DLKKVLDENKTGLQ------DSQIKIYLYQLLRGVAHCHQHR- 139
Query: 243 PSIVHRDISSNNILLNSNLEAFVADFG 269
I+HRD+ N+L+NS+ +ADFG
Sbjct: 140 --ILHRDLKPQNLLINSDGALKLADFG 164
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 1e-10
Identities = 45/210 (21%), Positives = 78/210 (37%), Gaps = 34/210 (16%)
Query: 140 DATEYFHIRYCIGTGGYDSVYKA-ELPDGKVVALKKLHHSETEDSAFV------------ 186
+Y+ I +G+G + V++ E G+V K ++ D V
Sbjct: 48 SVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHH 107
Query: 187 --------VY-SPQCMFFIYEYMERGSLF--CVLRDDDEAIELNWTRRMNIVKSVAHALS 235
+ M I E++ G LF E +++ +N ++ L
Sbjct: 108 PKLINLHDAFEDKYEMVLILEFLSGGELFDRIA----AEDYKMSEAEVINYMRQACEGLK 163
Query: 236 YLHHDCTPSIVHRDISSNNILLNSNLEAFV--ADFGTVRLLDVDSSNRTLQAGTYGYIAL 293
++H SIVH DI NI+ + + V DFG L+ D + T + A
Sbjct: 164 HMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVT-TATAEFAAP 219
Query: 294 ELVYTMVVTEKCVIYSFGVVALEVLMGTHP 323
E+V V +++ GV+ +L G P
Sbjct: 220 EIVDREPVGFYTDMWAIGVLGYVLLSGLSP 249
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 61.0 bits (149), Expect = 1e-10
Identities = 33/148 (22%), Positives = 61/148 (41%), Gaps = 40/148 (27%)
Query: 151 IGTGGYDSVYKA-ELPDGKVVALKKLHHSETEDSAF------------------------ 185
IG G Y +V+KA ++VALK++ + +D
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRVRL-DDDDEGVPSSALREICLLKELKHKNIVRLHD 68
Query: 186 VVYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAH----ALSYLHHDC 241
V++S + + ++E+ ++ L + ++ IVKS L + H
Sbjct: 69 VLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLD------PEIVKSFLFQLLKGLGFCHSRN 121
Query: 242 TPSIVHRDISSNNILLNSNLEAFVADFG 269
++HRD+ N+L+N N E +A+FG
Sbjct: 122 ---VLHRDLKPQNLLINRNGELKLANFG 146
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 60.2 bits (147), Expect = 2e-10
Identities = 35/148 (23%), Positives = 62/148 (41%), Gaps = 39/148 (26%)
Query: 151 IGTGGYDSVYKA-ELPDGKVVALKKLHHSETEDSAF------------------------ 185
IG G Y VYKA G+VVALKK+ +TE
Sbjct: 11 IGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEGVPSTAIREISLLKELNHPNIVKLLD 69
Query: 186 VVYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAH----ALSYLHHDC 241
V+++ ++ ++E++ + L + D + + ++KS L++ H
Sbjct: 70 VIHTENKLYLVFEFLHQ-DLKKFM-DASALTGIP----LPLIKSYLFQLLQGLAFCHSHR 123
Query: 242 TPSIVHRDISSNNILLNSNLEAFVADFG 269
++HRD+ N+L+N+ +ADFG
Sbjct: 124 ---VLHRDLKPQNLLINTEGAIKLADFG 148
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 60.3 bits (147), Expect = 2e-10
Identities = 37/150 (24%), Positives = 64/150 (42%), Gaps = 39/150 (26%)
Query: 151 IGTGGYDSVYKAELPD-GKVVALKKLHHSETED----SAF-------------------V 186
+G G Y +VYK + +VALK++ E E+ +A +
Sbjct: 10 LGEGTYATVYKGKSKLTDNLVALKEIR-LEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 68
Query: 187 VYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAH----ALSYLHHDCT 242
+++ + + ++EY+++ L L D I M+ VK L+Y H
Sbjct: 69 IHTEKSLTLVFEYLDK-DLKQYLDDCGNIIN------MHNVKLFLFQLLRGLAYCHR--- 118
Query: 243 PSIVHRDISSNNILLNSNLEAFVADFGTVR 272
++HRD+ N+L+N E +ADFG R
Sbjct: 119 QKVLHRDLKPQNLLINERGELKLADFGLAR 148
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 60.3 bits (147), Expect = 2e-10
Identities = 33/147 (22%), Positives = 61/147 (41%), Gaps = 34/147 (23%)
Query: 151 IGTGGYDSVYKA-ELPDGKVVALKKLHHSETED----SAF-------------------V 186
+G G Y +VYK G VALK++ ++E+ +A V
Sbjct: 13 LGNGTYATVYKGLNKTTGVYVALKEVK-LDSEEGTPSTAIREISLMKELKHENIVRLYDV 71
Query: 187 VYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAH----ALSYLHHDCT 242
+++ + ++E+M+ L + D +N+VK L++ H +
Sbjct: 72 IHTENKLTLVFEFMDN-DLKKYM-DSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN-- 127
Query: 243 PSIVHRDISSNNILLNSNLEAFVADFG 269
I+HRD+ N+L+N + + DFG
Sbjct: 128 -KILHRDLKPQNLLINKRGQLKLGDFG 153
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 2e-10
Identities = 48/222 (21%), Positives = 81/222 (36%), Gaps = 52/222 (23%)
Query: 142 TEYFHIRYCIGTGGYDSVYKA-ELPDGKVVALK-----KLHHSETEDSAFV--------- 186
+ + + +G+G V A E K VA++ K ++
Sbjct: 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEI 193
Query: 187 --------------VYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNW-----TRRMNIV 227
+ + + + E ME G LF D+ + +
Sbjct: 194 LKKLNHPCIIKIKNFFDAEDYYIVLELMEGGELF------DKVVGNKRLKEATCKL--YF 245
Query: 228 KSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAF---VADFGTVRLLDVDSSNRTLQ 284
+ A+ YLH + I+HRD+ N+LL+S E + DFG ++L S RTL
Sbjct: 246 YQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTL- 301
Query: 285 AGTYGYIALELVYTMVV---TEKCVIYSFGVVALEVLMGTHP 323
GT Y+A E++ ++ +S GV+ L G P
Sbjct: 302 CGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 343
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 2e-10
Identities = 59/293 (20%), Positives = 104/293 (35%), Gaps = 80/293 (27%)
Query: 151 IGTGGYDSVYKAELPDGK------VVALKKLH-HSETEDSAF------------------ 185
+G G + V+ AE + +VA+K L SE+ F
Sbjct: 49 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 186 --VVYSPQCMFFIYEYMERGSLFCVLR------------DDDEAIELNWTRRMNIVKSVA 231
V + + ++EYM G L LR +D L + + + VA
Sbjct: 109 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 168
Query: 232 HALSYL--HHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTYG 289
+ YL H VHRD+++ N L+ L + DFG R D+ S++ + G
Sbjct: 169 AGMVYLAGLH-----FVHRDLATRNCLVGQGLVVKIGDFGMSR--DIYSTDYY-RVGGRT 220
Query: 290 YI-----ALELVYTMVVTEKCVIYSFGVVALEVL-MGTHP------GELLLSLSSSSGPK 337
+ E + T + ++SFGVV E+ G P E + ++
Sbjct: 221 MLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQG---- 276
Query: 338 IMLIDILYQRLSPPIN-QKIIQDIILVSTIALACLRSKPKSRPTMQRISQELE 389
+ L P + I+ C + +P+ R +++ + L+
Sbjct: 277 --------RELERPRACPPEVYAIM------RGCWQREPQQRHSIKDVHARLQ 315
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 3e-10
Identities = 62/290 (21%), Positives = 102/290 (35%), Gaps = 78/290 (26%)
Query: 151 IGTGGYDSVYKAELPDGK------VVALKKL--HHSETEDSAF----------------- 185
+G G + VY+ ++ VA+K L SE ++ F
Sbjct: 38 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 186 ---VVYSPQCMFFIYEYMERGSLFCVLR----DDDEAIELNWTRRMNIVKSVAHALSYL- 237
V F + E M G L LR + L +++ + +A YL
Sbjct: 98 CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157
Query: 238 -HHDCTPSIVHRDISSNNILLNSNLEAFV---ADFGTVRLLDVDSSNRTLQAGTYGYI-- 291
+H +HRDI++ N LL V DFG R D+ ++ + G +
Sbjct: 158 ENH-----FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR--DIYRASYY-RKGGCAMLPV 209
Query: 292 ---ALELVYTMVVTEKCVIYSFGVVALEVL-MGTHP------GELLLSLSSSSGPKIMLI 341
E + T K +SFGV+ E+ +G P E+L ++S
Sbjct: 210 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSG-------- 261
Query: 342 DILYQRLSPPIN--QKIIQDIILVSTIALACLRSKPKSRPTMQRISQELE 389
R+ PP N + + I C + +P+ RP I + +E
Sbjct: 262 ----GRMDPPKNCPGPVYR-------IMTQCWQHQPEDRPNFAIILERIE 300
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 60.3 bits (147), Expect = 3e-10
Identities = 33/156 (21%), Positives = 62/156 (39%), Gaps = 46/156 (29%)
Query: 151 IGTGGYDSVYKA-ELPDGKVVALKKLHHSETEDSAF------------------------ 185
+G G Y VYKA + + VA+K++ E E+
Sbjct: 42 LGEGTYGEVYKAIDTVTNETVAIKRIRL-EHEEEGVPGTAIREVSLLKELQHRNIIELKS 100
Query: 186 VVYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAH----ALSYLHHDC 241
V++ + I+EY E L + D+ +++ M ++KS + +++ H
Sbjct: 101 VIHHNHRLHLIFEYAEN-DLKKYM---DKNPDVS----MRVIKSFLYQLINGVNFCHS-- 150
Query: 242 TPSIVHRDISSNNILLNSNLEAF-----VADFGTVR 272
+HRD+ N+LL+ + + + DFG R
Sbjct: 151 -RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR 185
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 59.9 bits (146), Expect = 3e-10
Identities = 32/148 (21%), Positives = 57/148 (38%), Gaps = 40/148 (27%)
Query: 151 IGTGGYDSVYKA-ELPDGKVVALKKLHHSETEDSAF------------------------ 185
IG G Y V+K G++VA+KK SE +D
Sbjct: 11 IGEGSYGVVFKCRNRDTGQIVAIKKFLESE-DDPVIKKIALREIRMLKQLKHPNLVNLLE 69
Query: 186 VVYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAH----ALSYLHHDC 241
V + + ++EY + ++ L + ++VKS+ A+++ H
Sbjct: 70 VFRRKRRLHLVFEYCDH-TVLHELDRYQRGVP------EHLVKSITWQTLQAVNFCHKH- 121
Query: 242 TPSIVHRDISSNNILLNSNLEAFVADFG 269
+ +HRD+ NIL+ + + DFG
Sbjct: 122 --NCIHRDVKPENILITKHSVIKLCDFG 147
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 3e-10
Identities = 36/209 (17%), Positives = 74/209 (35%), Gaps = 46/209 (22%)
Query: 142 TEYFHIRYCIGTGGYDSVYKA-ELPDGKVVALK-----KLHHSETEDSAFV--------- 186
+ + + IG G + V + G+ A+K K S + +
Sbjct: 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHM 82
Query: 187 -----------VY-SPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRM-------NIV 227
Y S ++ ++E+M+ L E ++ + + +
Sbjct: 83 LKHPHIVELLETYSSDGMLYMVFEFMDGADLC------FEIVKRADAGFVYSEAVASHYM 136
Query: 228 KSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAF---VADFGTVRLLDVDSSNRTLQ 284
+ + AL Y H + +I+HRD+ + +LL S + + FG L +
Sbjct: 137 RQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGR 193
Query: 285 AGTYGYIALELVYTMVVTEKCVIYSFGVV 313
GT ++A E+V + ++ GV+
Sbjct: 194 VGTPHFMAPEVVKREPYGKPVDVWGCGVI 222
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 4e-10
Identities = 52/211 (24%), Positives = 86/211 (40%), Gaps = 41/211 (19%)
Query: 145 FHIRYCIGTGGYDSVYKAELPD-GKVVALKKLH-----------HSETE-------DSAF 185
+ + IG G + V KV A+K L E +S +
Sbjct: 71 YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPW 130
Query: 186 VV---YS---PQCMFFIYEYMERGSLFCVLRDDDEAIELNWTR--RMNIVKSVAHALSYL 237
VV Y+ + ++ + EYM G L ++ + D + W R +V AL +
Sbjct: 131 VVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD--VPEKWARFYTAEVVL----ALDAI 184
Query: 238 HHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQA-GTYGYIALELV 296
H +HRD+ +N+LL+ + +ADFGT ++ + R A GT YI+ E++
Sbjct: 185 HSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVL 241
Query: 297 YTMVVTEK----CVIYSFGVVALEVLMGTHP 323
+ C +S GV E+L+G P
Sbjct: 242 KSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 272
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 4e-10
Identities = 62/290 (21%), Positives = 101/290 (34%), Gaps = 78/290 (26%)
Query: 151 IGTGGYDSVYKAELPDGK------VVALKKL--HHSETEDSAF----------------- 185
+G G + VY+ ++ VA+K L SE ++ F
Sbjct: 79 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138
Query: 186 ---VVYSPQCMFFIYEYMERGSLFCVLR----DDDEAIELNWTRRMNIVKSVAHALSYL- 237
V F + E M G L LR + L +++ + +A YL
Sbjct: 139 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 198
Query: 238 -HHDCTPSIVHRDISSNNILLNSNLEAFV---ADFGTVRLLDVDSSNRTLQAGTYGYI-- 291
+H +HRDI++ N LL V DFG R D+ + + G +
Sbjct: 199 ENH-----FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR--DIYRAGYY-RKGGCAMLPV 250
Query: 292 ---ALELVYTMVVTEKCVIYSFGVVALEVL-MGTHP------GELLLSLSSSSGPKIMLI 341
E + T K +SFGV+ E+ +G P E+L ++S
Sbjct: 251 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSG-------- 302
Query: 342 DILYQRLSPPIN--QKIIQDIILVSTIALACLRSKPKSRPTMQRISQELE 389
R+ PP N + + I C + +P+ RP I + +E
Sbjct: 303 ----GRMDPPKNCPGPVYR-------IMTQCWQHQPEDRPNFAIILERIE 341
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 4e-10
Identities = 39/194 (20%), Positives = 70/194 (36%), Gaps = 42/194 (21%)
Query: 151 IGTGGYDSVYKA-ELPDGKVVALKKLHHSETEDSAFV--------------------VY- 188
+G G + V+K E G +A K + +D V +
Sbjct: 97 LGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFE 156
Query: 189 SPQCMFFIYEYMERGSLF--CVLRDDD----EAIELNWTRRMNIVKSVAHALSYLHHDCT 242
S + + EY++ G LF + + + I +K + + ++H
Sbjct: 157 SKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILF--------MKQICEGIRHMHQM-- 206
Query: 243 PSIVHRDISSNNILLNSNLEAFV--ADFGTVRLLDVDSSNRTLQAGTYGYIALELVYTMV 300
I+H D+ NIL + + DFG R + GT ++A E+V
Sbjct: 207 -YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVN-FGTPEFLAPEVVNYDF 264
Query: 301 VTEKCVIYSFGVVA 314
V+ ++S GV+A
Sbjct: 265 VSFPTDMWSVGVIA 278
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 59.5 bits (145), Expect = 4e-10
Identities = 29/153 (18%), Positives = 55/153 (35%), Gaps = 40/153 (26%)
Query: 151 IGTGGYDSVYKA-ELPDGKVVALKKLHHSETEDSAF------------------------ 185
+G G Y V K G++VA+KK +D
Sbjct: 33 VGEGSYGMVMKCRNKDTGRIVAIKKFL-ESDDDKMVKKIAMREIKLLKQLRHENLVNLLE 91
Query: 186 VVYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAH----ALSYLHHDC 241
V + + ++E+++ ++ L ++ +V+ + + H
Sbjct: 92 VCKKKKRWYLVFEFVDH-TILDDLELFPNGLD------YQVVQKYLFQIINGIGFCHSH- 143
Query: 242 TPSIVHRDISSNNILLNSNLEAFVADFGTVRLL 274
+I+HRDI NIL++ + + DFG R L
Sbjct: 144 --NIIHRDIKPENILVSQSGVVKLCDFGFARTL 174
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 5e-10
Identities = 35/204 (17%), Positives = 78/204 (38%), Gaps = 39/204 (19%)
Query: 140 DATEYFHIRYCIGTGGYDSVYKA-ELPDGKVVALK-----KLHHSETED----------- 182
TE + + +G G + V + ++ G+ A KL + +
Sbjct: 8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLL 67
Query: 183 ------SAFVVY-SPQCMFFIYEYMERGSLFCVLRDDDEAIEL-NWTRRM--NIVKSVAH 232
+ I++ + G LF ++ + ++ + ++ +
Sbjct: 68 KHPNIVRLHDSISEEGHHYLIFDLVTGGELF------EDIVAREYYSEADASHCIQQILE 121
Query: 233 ALSYLHHDCTPSIVHRDISSNNILLNSNLEAF---VADFGTVRLLDVDSSNRTLQAGTYG 289
A+ + H +VHR++ N+LL S L+ +ADFG ++ + AGT G
Sbjct: 122 AVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPG 178
Query: 290 YIALELVYTMVVTEKCVIYSFGVV 313
Y++ E++ + +++ GV+
Sbjct: 179 YLSPEVLRKDPYGKPVDLWACGVI 202
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 5e-10
Identities = 54/234 (23%), Positives = 79/234 (33%), Gaps = 52/234 (22%)
Query: 131 GKILYENLIDATEYFHIRYCIGTGGYDSVYKA-ELPDGKVVALK-----KLHHSETEDSA 184
G + + E + +G+G Y V E A+K + D
Sbjct: 24 GMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDN 83
Query: 185 FV----------------------------VY-SPQCMFFIYEYMERGSLFCVLRDDDEA 215
V+ + + + E+ E G LF ++
Sbjct: 84 KNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELF------EQI 137
Query: 216 IEL-NWTRRM--NIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAF---VADFG 269
I + NI+K + + YLH +IVHRDI NILL + + DFG
Sbjct: 138 INRHKFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLNIKIVDFG 194
Query: 270 TVRLLDVDSSNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHP 323
D R GT YIA E V EKC ++S GV+ +L G P
Sbjct: 195 LSSFFSKDYKLRDR-LGTAYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCGYPP 246
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 8e-10
Identities = 68/311 (21%), Positives = 112/311 (36%), Gaps = 87/311 (27%)
Query: 151 IGTGGYDSVYKAELPDGKV---VALKKL--HHSETEDSAF-------------------- 185
IG G + V KA + + A+K++ + S+ + F
Sbjct: 33 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 92
Query: 186 -VVYSPQCMFFIYEYMERGSLFCVLR-------------DDDEAIELNWTRRMNIVKSVA 231
++ EY G+L LR + A L+ + ++ VA
Sbjct: 93 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 152
Query: 232 HALSYL--HHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTYG 289
+ YL +HRD+++ NIL+ N A +ADFG R +V T G
Sbjct: 153 RGMDYLSQKQ-----FIHRDLAARNILVGENYVAKIADFGLSRGQEV------YVKKTMG 201
Query: 290 YI-----ALE-LVYTMVVTEKCVIYSFGVVALEVL-MGTHP------GELLLSLSSSSGP 336
+ A+E L Y+ V T ++S+GV+ E++ +G P EL L G
Sbjct: 202 RLPVRWMAIESLNYS-VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL--PQG- 257
Query: 337 KIMLIDILYQRLSPPIN--QKIIQDIILVSTIALACLRSKPKSRPTMQRISQELEGKTPM 394
RL P+N ++ + C R KP RP+ +I L
Sbjct: 258 ---------YRLEKPLNCDDEVYD-------LMRQCWREKPYERPSFAQILVSLNRMLEE 301
Query: 395 KKGLKEISIPE 405
+K ++ E
Sbjct: 302 RKTYVNTTLYE 312
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 8e-10
Identities = 48/217 (22%), Positives = 84/217 (38%), Gaps = 55/217 (25%)
Query: 145 FHIRYCIGTGGYDSVYKA-ELPDGKVVALK-----------KLHHSETE-------DSAF 185
F +G G + +V A EL + A+K K+ + E D F
Sbjct: 32 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 91
Query: 186 VV---YS---PQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKS------VAHA 233
V ++ + ++F Y + G L +R + + + A
Sbjct: 92 FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK---------IGSFDETCTRFYTAEIVSA 142
Query: 234 LSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQA--GTYGYI 291
L YLH I+HRD+ NILLN ++ + DFGT ++L +S + GT Y+
Sbjct: 143 LEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYV 199
Query: 292 ALELV----YTMVVTEKCV-IYSFGVVALEVLMGTHP 323
+ EL+ K +++ G + +++ G P
Sbjct: 200 SPELLTEKSAC-----KSSDLWALGCIIYQLVAGLPP 231
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 9e-10
Identities = 47/210 (22%), Positives = 87/210 (41%), Gaps = 36/210 (17%)
Query: 130 DGKILYENLIDATEYFHIRYCIGTGGYDSVYKA-ELPDGKVVALKKLHHSETEDSAF--- 185
D I N +++F + +G G VY+ + K ALK L + +
Sbjct: 40 DYWIDGSNRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEI 99
Query: 186 ----------VVY------SPQCMFFIYEYMERGSLFCVLRDDDEAIEL-NWTRRM--NI 226
++ +P + + E + G LF D +E ++ R +
Sbjct: 100 GVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELF------DRIVEKGYYSERDAADA 153
Query: 227 VKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAF---VADFGTVRLLDVDSSNRTL 283
VK + A++YLH + IVHRD+ N+L + +ADFG ++++ +T+
Sbjct: 154 VKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTV 210
Query: 284 QAGTYGYIALELVYTMVVTEKCVIYSFGVV 313
GT GY A E++ + ++S G++
Sbjct: 211 -CGTPGYCAPEILRGCAYGPEVDMWSVGII 239
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 58.0 bits (141), Expect = 1e-09
Identities = 56/295 (18%), Positives = 96/295 (32%), Gaps = 82/295 (27%)
Query: 151 IGTGGYDSVYKAELPDGK------VVALKKL--HHSETEDSAF----------------- 185
+G + VYK L VA+K L F
Sbjct: 17 LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 76
Query: 186 ---VVYSPQCMFFIYEYMERGSLFCVLR-------------DDDEAIELNWTRRMNIVKS 229
VV Q + I+ Y G L L D L +++V
Sbjct: 77 LLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQ 136
Query: 230 VAHALSYL--HHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGT 287
+A + YL HH +VH+D+++ N+L+ L ++D G R +V +++ +
Sbjct: 137 IAAGMEYLSSHH-----VVHKDLATRNVLVYDKLNVKISDLGLFR--EVYAAD-YYKLLG 188
Query: 288 YGYI-----ALELVYTMVVTEKCVIYSFGVVALEVLM-GTHP------GELLLSLSSSSG 335
+ A E + + I+S+GVV EV G P +++ + +
Sbjct: 189 NSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRNR-- 246
Query: 336 PKIMLIDILYQRLSPPIN-QKIIQDIILVSTIALACLRSKPKSRPTMQRISQELE 389
Q L P + + ++ + C P RP + I L
Sbjct: 247 ----------QVLPCPDDCPAWVYALM------IECWNEFPSRRPRFKDIHSRLR 285
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 58.0 bits (141), Expect = 1e-09
Identities = 48/205 (23%), Positives = 79/205 (38%), Gaps = 47/205 (22%)
Query: 142 TEYFHIRYCIGTGGYDSVYKA-ELPDGKVVALK-----KLHHSETED------------- 182
E ++I +G G + V K + + A+K + +T
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 183 ----SAFVVY-SPQCMFFIYEYMERGSLFCVLRDDDEAIEL-NWTRRM--NIVKSVAHAL 234
F + + + E G LF DE I+ ++ I+K V +
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGELF------DEIIKRKRFSEHDAARIIKQVFSGI 134
Query: 235 SYLHHDCTPSIVHRDISSNNILLNSNLEAF---VADFGTVRLLDVDSSNRTLQAGTYGYI 291
+Y+H +IVHRD+ NILL S + + DFG ++ + GT YI
Sbjct: 135 TYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDR-IGTAYYI 190
Query: 292 ALELV---YTMVVTEKCVIYSFGVV 313
A E++ Y EKC ++S GV+
Sbjct: 191 APEVLRGTY----DEKCDVWSAGVI 211
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 58.3 bits (141), Expect = 2e-09
Identities = 35/164 (21%), Positives = 68/164 (41%), Gaps = 38/164 (23%)
Query: 144 YFHIRYCIGTGGYDSVYKA---ELPDGKVVALKKLHHSETEDSA---------------- 184
+ + +G G Y VYKA + D K ALK++ + SA
Sbjct: 22 FEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVI 81
Query: 185 -----FVVYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMN--IVKSVAH----A 233
F+ ++ + ++ +++Y E L+ +++ + ++ +VKS+ +
Sbjct: 82 SLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDG 140
Query: 234 LSYLHHDCTPSIVHRDISSNNILLNSNLEAF----VADFGTVRL 273
+ YLH + ++HRD+ NIL+ +AD G RL
Sbjct: 141 IHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARL 181
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 58.0 bits (141), Expect = 2e-09
Identities = 38/192 (19%), Positives = 69/192 (35%), Gaps = 65/192 (33%)
Query: 151 IGTGGYDSVYKA-ELPDGKVVALKK-----------------------LHHS-------- 178
IG G + V+KA G+ VALKK L H
Sbjct: 25 IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 84
Query: 179 ETEDSAFVVYSPQCMFFIYEYME---RGSLFCVLRDDDEAIELNWTRRMNIVKSVAH--- 232
++ ++ ++++ E G L + ++ ++ +K V
Sbjct: 85 CRTKASPYNRCKGSIYLVFDFCEHDLAGLL------SNVLVKFT----LSEIKRVMQMLL 134
Query: 233 -ALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTYGYI 291
L Y+H + I+HRD+ + N+L+ + +ADFG R + +++ +
Sbjct: 135 NGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNR------- 184
Query: 292 ALELVYT-MVVT 302
YT VVT
Sbjct: 185 -----YTNRVVT 191
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 3e-09
Identities = 34/202 (16%), Positives = 79/202 (39%), Gaps = 40/202 (19%)
Query: 142 TEYFHIRYCIGTGGYDSVYKA-ELPDGKVVALK-----KLHHSETED------------- 182
++ + ++ +G G + V + G A K KL + +
Sbjct: 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 87
Query: 183 ----SAFVVY-SPQCMFFIYEYMERGSLFCVLRDDDEAIEL-NWTRRM--NIVKSVAHAL 234
+ +++ + G LF ++ + ++ + ++ + ++
Sbjct: 88 PNIVRLHDSIQEESFHYLVFDLVTGGELF------EDIVAREFYSEADASHCIQQILESI 141
Query: 235 SYLHHDCTPSIVHRDISSNNILLNSNLEAF---VADFGTVRLLDVDSSNRTLQAGTYGYI 291
+Y H + IVHR++ N+LL S + +ADFG ++ + AGT GY+
Sbjct: 142 AYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGF-AGTPGYL 197
Query: 292 ALELVYTMVVTEKCVIYSFGVV 313
+ E++ ++ I++ GV+
Sbjct: 198 SPEVLKKDPYSKPVDIWACGVI 219
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 3e-09
Identities = 39/189 (20%), Positives = 71/189 (37%), Gaps = 35/189 (18%)
Query: 151 IGTGGYDSVYKA-ELPDGKVVALK-----KLHHSETEDSA-------------FVVY-SP 190
+G G + K + A+K +++ E +A V+
Sbjct: 19 LGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVKLHEVFHDQ 78
Query: 191 QCMFFIYEYMERGSLFCVLRDDDEAIEL-NWTRRM--NIVKSVAHALSYLHHDCTPSIVH 247
F + E + G LF + + +++ I++ + A+S++H +VH
Sbjct: 79 LHTFLVMELLNGGELF------ERIKKKKHFSETEASYIMRKLVSAVSHMHDV---GVVH 129
Query: 248 RDISSNNILLNSNLEAF---VADFGTVRLLDVDSSNRTLQAGTYGYIALELVYTMVVTEK 304
RD+ N+L + + DFG RL D+ T Y A EL+ E
Sbjct: 130 RDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNGYDES 189
Query: 305 CVIYSFGVV 313
C ++S GV+
Sbjct: 190 CDLWSLGVI 198
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 56.4 bits (137), Expect = 4e-09
Identities = 37/158 (23%), Positives = 57/158 (36%), Gaps = 48/158 (30%)
Query: 151 IGTGGYDSVYKA-ELPDGKVVALKKLH-HSETEDSAF----------------------- 185
IG G Y +VYKA + G VALK + +
Sbjct: 17 IGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNV 76
Query: 186 -----VVYSPQC-----MFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAH--- 232
V + + + ++E++++ L L D L +K +
Sbjct: 77 VRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYL-DKAPPPGLP----AETIKDLMRQFL 130
Query: 233 -ALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFG 269
L +LH +C IVHRD+ NIL+ S +ADFG
Sbjct: 131 RGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFG 165
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 56.0 bits (136), Expect = 5e-09
Identities = 34/202 (16%), Positives = 79/202 (39%), Gaps = 40/202 (19%)
Query: 142 TEYFHIRYCIGTGGYDSVYKA-ELPDGKVVALK-----KLHHSETED------------- 182
++ + ++ +G G + V + G A K KL + +
Sbjct: 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 183 ----SAFVVY-SPQCMFFIYEYMERGSLFCVLRDDDEAIEL-NWTRRM--NIVKSVAHAL 234
+ +++ + G LF ++ + ++ + ++ + ++
Sbjct: 65 PNIVRLHDSIQEESFHYLVFDLVTGGELF------EDIVAREFYSEADASHCIQQILESI 118
Query: 235 SYLHHDCTPSIVHRDISSNNILLNSNLEAF---VADFGTVRLLDVDSSNRTLQAGTYGYI 291
+Y H + IVHR++ N+LL S + +ADFG ++ + AGT GY+
Sbjct: 119 AYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGF-AGTPGYL 174
Query: 292 ALELVYTMVVTEKCVIYSFGVV 313
+ E++ ++ I++ GV+
Sbjct: 175 SPEVLKKDPYSKPVDIWACGVI 196
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 56.0 bits (136), Expect = 5e-09
Identities = 43/202 (21%), Positives = 82/202 (40%), Gaps = 39/202 (19%)
Query: 140 DATEYFHIRYCIGTGGYDSVYKA-ELPDGKVVALKKLHHSETEDSAFV------------ 186
+ + F +G+G + V+ + GK+ ALK + S + +
Sbjct: 6 NIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKH 65
Query: 187 --------VY-SPQCMFFIYEYMERGSLFCVLRDDDEAIEL-NWTRRM--NIVKSVAHAL 234
+Y S + + + + G LF D +E +T + +++ V A+
Sbjct: 66 ENIVTLEDIYESTTHYYLVMQLVSGGELF------DRILERGVYTEKDASLVIQQVLSAV 119
Query: 235 SYLHHDCTPSIVHRDISSNNILLNSNLEAF---VADFGTVRLLDVDSSNRTLQAGTYGYI 291
YLH + IVHRD+ N+L + E + DFG ++ + + GT GY+
Sbjct: 120 KYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKM--EQNGIMSTACGTPGYV 174
Query: 292 ALELVYTMVVTEKCVIYSFGVV 313
A E++ ++ +S GV+
Sbjct: 175 APEVLAQKPYSKAVDCWSIGVI 196
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 55.3 bits (134), Expect = 1e-08
Identities = 44/199 (22%), Positives = 75/199 (37%), Gaps = 47/199 (23%)
Query: 151 IGTGGYDSVYKA-ELPDGKVVALK--KLHHSETEDSAFV--------------------- 186
+G G + V + G+ A K K + A +
Sbjct: 37 LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96
Query: 187 VY-SPQCMFFIYEYMERGSLF--CVLRDDD-----EAIELNWTRRMNIVKSVAHALSYLH 238
VY + + I EY G +F C+ + + I L +K + + YLH
Sbjct: 97 VYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRL--------IKQILEGVYYLH 148
Query: 239 HDCTPSIVHRDISSNNILLNSNLEAF---VADFGTVRLLDVDSSNRTLQAGTYGYIALEL 295
+ +IVH D+ NILL+S + DFG R + R + GT Y+A E+
Sbjct: 149 QN---NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREI-MGTPEYLAPEI 204
Query: 296 VYTMVVTEKCVIYSFGVVA 314
+ +T +++ G++A
Sbjct: 205 LNYDPITTATDMWNIGIIA 223
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 54.9 bits (133), Expect = 1e-08
Identities = 46/207 (22%), Positives = 76/207 (36%), Gaps = 44/207 (21%)
Query: 140 DATEYFHIRYCIGTGGYDSVYKA-ELPDGKVVALKKLHHSETEDSA-------------- 184
+ F + +G+G + V+ E G +K ++ ++
Sbjct: 19 TIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLD 78
Query: 185 -------FVVY-SPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRM-------NIVKS 229
F V+ M+ + E E G L + + + ++K
Sbjct: 79 HPNIIKIFEVFEDYHNMYIVMETCEGGELL------ERIVSAQARGKALSEGYVAELMKQ 132
Query: 230 VAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAF---VADFGTVRLLDVDSSNRTLQAG 286
+ +AL+Y H +VH+D+ NIL + DFG L D + AG
Sbjct: 133 MMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNA-AG 188
Query: 287 TYGYIALELVYTMVVTEKCVIYSFGVV 313
T Y+A E V+ VT KC I+S GVV
Sbjct: 189 TALYMAPE-VFKRDVTFKCDIWSAGVV 214
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 55.2 bits (133), Expect = 1e-08
Identities = 54/263 (20%), Positives = 88/263 (33%), Gaps = 75/263 (28%)
Query: 133 ILYENLIDATEYFHIRYCIGTGGYDSVYKA-ELPDGKVVALK-----KLHHSETEDSAFV 186
+L++ + +H++ IG G Y V A E + A+K K+ +D +
Sbjct: 16 FQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERI 75
Query: 187 --------------------VY-SPQCMFFIYEYMERGSLF------------------- 206
VY Q + + E G L
Sbjct: 76 KTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVV 135
Query: 207 ------CVLRDDDEAIELNWTRRM------------NIVKSVAHALSYLHHDCTPSIVHR 248
C +++ R NI++ + AL YLH+ I HR
Sbjct: 136 KTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---GICHR 192
Query: 249 DISSNNILLNSNLEAFV--ADFGTVRLLDVDSSNRTLQ----AGTYGYIALELVYTMV-- 300
DI N L ++N + DFG + ++ AGT ++A E++ T
Sbjct: 193 DIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNES 252
Query: 301 VTEKCVIYSFGVVALEVLMGTHP 323
KC +S GV+ +LMG P
Sbjct: 253 YGPKCDAWSAGVLLHLLLMGAVP 275
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 1e-08
Identities = 59/293 (20%), Positives = 102/293 (34%), Gaps = 78/293 (26%)
Query: 151 IGTGGYDSVYKAELPD------GKVVALKKL--HHSETEDSAF----------------- 185
+G G + V +A VA+K L E A
Sbjct: 54 LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 186 ----VVYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRR-----------MNIVKSV 230
+ I EY G L LR +E + ++ V
Sbjct: 114 NLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQV 173
Query: 231 AHALSYL--HHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTY 288
A +++L + +HRD+++ N+LL + A + DFG R + DS+
Sbjct: 174 AQGMAFLASKN-----CIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYI---VKGN 225
Query: 289 GYI-----ALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDI 343
+ A E ++ V T + ++S+G++ E + SL + P I++
Sbjct: 226 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWE----------IFSLGLNPYPGILVNSK 275
Query: 344 LYQ------RLSPPIN-QKIIQDIILVSTIALACLRSKPKSRPTMQRISQELE 389
Y+ +++ P K I I+ AC +P RPT Q+I L+
Sbjct: 276 FYKLVKDGYQMAQPAFAPKNIYSIM------QACWALEPTHRPTFQQICSFLQ 322
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 55.7 bits (134), Expect = 1e-08
Identities = 54/213 (25%), Positives = 84/213 (39%), Gaps = 43/213 (20%)
Query: 143 EYFHIRYCIGTGGYDSVYKAELPD-GKVVALKKLH-----------HSETE--------- 181
F + IG GG+ VY D GK+ A+K L + E
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 182 -DSAFVV---YS---PQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNI-VKSVAHA 233
D F+V Y+ P + FI + M G L L E M +
Sbjct: 249 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSE----ADMRFYAAEIILG 304
Query: 234 LSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQA--GTYGYI 291
L ++H+ +V+RD+ NILL+ + ++D G L D S + A GT+GY+
Sbjct: 305 LEHMHNR---FVVYRDLKPANILLDEHGHVRISDLG----LACDFSKKKPHASVGTHGYM 357
Query: 292 ALELVYTMVVTEKCVIY-SFGVVALEVLMGTHP 323
A E++ V + + S G + ++L G P
Sbjct: 358 APEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 54.5 bits (132), Expect = 1e-08
Identities = 40/205 (19%), Positives = 70/205 (34%), Gaps = 45/205 (21%)
Query: 140 DATEYFHIRYCIGTGGYDSVYKA-ELPDGKVVALKKLHHSETEDSAFV------------ 186
D +Y+ + IG G + V A + A KK+ ED
Sbjct: 6 DINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDH 65
Query: 187 --------VY-SPQCMFFIYEYMERGSLFCVLRDDDEAIEL-NWTRRM--NIVKSVAHAL 234
+ ++ + E G LF + + + I+K V A+
Sbjct: 66 PNIIRLYETFEDNTDIYLVMELCTGGELF------ERVVHKRVFRESDAARIMKDVLSAV 119
Query: 235 SYLHHDCTPSIVHRDISSNNILLNSNLEAF---VADFGTVRLLDVDSSNRTLQAGTYGYI 291
+Y H ++ HRD+ N L ++ + DFG RT GT Y+
Sbjct: 120 AYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTK-VGTPYYV 175
Query: 292 ALELV---YTMVVTEKCVIYSFGVV 313
+ +++ Y +C +S GV+
Sbjct: 176 SPQVLEGLY----GPECDEWSAGVM 196
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 2e-08
Identities = 41/209 (19%), Positives = 81/209 (38%), Gaps = 35/209 (16%)
Query: 131 GKILYENLIDATEYFHIRYCIGTGGYDSVYKA-ELPDGKVVALKKLHHSETEDSAFV--- 186
+ L+ N I T+ + ++ IG G Y + A+K + S+ + + +
Sbjct: 10 VQQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEIL 69
Query: 187 --------------VY-SPQCMFFIYEYMERGSLFCVLRDDDEAIEL-NWTRRM--NIVK 228
VY + ++ + E M+ G L D+ + ++ R ++
Sbjct: 70 LRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELL------DKILRQKFFSEREASAVLF 123
Query: 229 SVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAF----VADFGTVRLLDVDSSNRTLQ 284
++ + YLH +VHRD+ +NIL + DFG + L ++
Sbjct: 124 TITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTP 180
Query: 285 AGTYGYIALELVYTMVVTEKCVIYSFGVV 313
T ++A E++ C I+S GV+
Sbjct: 181 CYTANFVAPEVLERQGYDAACDIWSLGVL 209
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 2e-08
Identities = 62/295 (21%), Positives = 111/295 (37%), Gaps = 83/295 (28%)
Query: 151 IGTGGYDSVYKAELPDGK------VVALKKLH-HSETEDSAF------------------ 185
+G G + V+ AE + +VA+K L + F
Sbjct: 23 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 186 --VVYSPQCMFFIYEYMERGSLFCVLR-------------DDDEAIELNWTRRMNIVKSV 230
V + ++EYM+ G L LR EL ++ ++I +
Sbjct: 83 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 142
Query: 231 AHALSYL--HHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTY 288
A + YL H VHRD+++ N L+ +NL + DFG R DV S++ + G +
Sbjct: 143 ASGMVYLASQH-----FVHRDLATRNCLVGANLLVKIGDFGMSR--DVYSTDYY-RVGGH 194
Query: 289 GYI-----ALE-LVYTMVVTEKCVIYSFGVVALEVL-MGTHP------GELLLSLSSSSG 335
+ E ++Y T + ++SFGV+ E+ G P E++ ++
Sbjct: 195 TMLPIRWMPPESIMYR-KFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQG-- 251
Query: 336 PKIMLIDILYQRLSPPIN-QKIIQDIILVSTIALACLRSKPKSRPTMQRISQELE 389
+ L P K + D++ L C + +P+ R ++ I + L
Sbjct: 252 ----------RVLERPRVCPKEVYDVM------LGCWQREPQQRLNIKEIYKILH 290
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 2e-08
Identities = 53/297 (17%), Positives = 92/297 (30%), Gaps = 83/297 (27%)
Query: 151 IGTGGYDSVYKAEL------PDGKVVALKKL--HHSETEDSAFV---------------- 186
+G G + V +A+ + VA+K L + +E A +
Sbjct: 35 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 187 --------VYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKS--------- 229
P + I E+ + G+L LR ++ K
Sbjct: 95 NLLGACTKPGGPLMV--IVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152
Query: 230 ----VAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQA 285
VA + +L + +HRD+++ NILL+ + DFG R + D
Sbjct: 153 YSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV---R 206
Query: 286 GTYGYI-----ALELVYTMVVTEKCVIYSFGVVALEVLM-------GTHPGELLLSLSSS 333
+ A E ++ V T + ++SFGV+ E+ G E
Sbjct: 207 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKE 266
Query: 334 SGPKIMLIDILYQRLSPPIN-QKIIQDIILVSTIALACLRSKPKSRPTMQRISQELE 389
R+ P + + L C +P RPT + + L
Sbjct: 267 GT-----------RMRAPDYTTPEMYQTM------LDCWHGEPSQRPTFSELVEHLG 306
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 2e-08
Identities = 46/216 (21%), Positives = 75/216 (34%), Gaps = 60/216 (27%)
Query: 142 TEYFHIRYCIGTGGYDSVYKA-ELPDGKVVALK-----KLHHSETEDSAFV--------- 186
+ + + +G+G V A E K VA+K K ++
Sbjct: 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 68
Query: 187 --------------VYSPQCMFFIYEYMERGSLFCVLRDD---------DEAIELNWTRR 223
+ + + + E ME G LF D
Sbjct: 69 LKKLNHPCIIKIKNFFDAEDYYIVLELMEGGELF----DKVVGNKRLKEATC-------- 116
Query: 224 MNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAF---VADFGTVRLLDVDSSN 280
+ A+ YLH + I+HRD+ N+LL+S E + DFG ++L S
Sbjct: 117 KLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLM 173
Query: 281 RTLQAGTYGYIALELVYTMVV---TEKCVIYSFGVV 313
RTL GT Y+A E++ ++ +S GV+
Sbjct: 174 RTL-CGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVI 208
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 3e-08
Identities = 58/301 (19%), Positives = 103/301 (34%), Gaps = 91/301 (30%)
Query: 151 IGTGGYDSVYKAELPDGK--------VVALKKL--HHSETEDSAFV-------------- 186
+G G + V AE VA+K L +E + S V
Sbjct: 89 LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 148
Query: 187 ---------VYSPQCMFFIYEYMERGSLFCVLR-------------DDDEAIELNWTRRM 224
P + I EY +G+L LR + ++ + +
Sbjct: 149 IINLLGACTQDGPLYV--IVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 206
Query: 225 NIVKSVAHALSYL--HHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRT 282
+ +A + YL +HRD+++ N+L+ N +ADFG R ++ +
Sbjct: 207 SCTYQLARGMEYLASQK-----CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYK- 260
Query: 283 LQAGTYGYI-----ALELVYTMVVTEKCVIYSFGVVALEVLM-------GTHPGELLLSL 330
T G + A E ++ V T + ++SFGV+ E+ G EL L
Sbjct: 261 --KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL 318
Query: 331 SSSSGPKIMLIDILYQRLSPPIN--QKIIQDIILVSTIALACLRSKPKSRPTMQRISQEL 388
R+ P N ++ + C + P RPT +++ ++L
Sbjct: 319 KEG------------HRMDKPANCTNELYM-------MMRDCWHAVPSQRPTFKQLVEDL 359
Query: 389 E 389
+
Sbjct: 360 D 360
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 53.7 bits (130), Expect = 3e-08
Identities = 34/157 (21%), Positives = 58/157 (36%), Gaps = 48/157 (30%)
Query: 151 IGTGGYDSVYKA--ELPDGKVVALKKLHHSETEDSAF----------------------- 185
IG G Y V+KA G+ VALK++ +T +
Sbjct: 19 IGEGAYGKVFKARDLKNGGRFVALKRVRV-QTGEEGMPLSTIREVAVLRHLETFEHPNVV 77
Query: 186 ----VVYSPQC-----MFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAH---- 232
V + + ++E++++ L L D + +K +
Sbjct: 78 RLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYL-DKVPEPGVP----TETIKDMMFQLLR 131
Query: 233 ALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFG 269
L +LH +VHRD+ NIL+ S+ + +ADFG
Sbjct: 132 GLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFG 165
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 54.4 bits (131), Expect = 3e-08
Identities = 49/210 (23%), Positives = 78/210 (37%), Gaps = 42/210 (20%)
Query: 145 FHIRYCIGTGGYDSVYKAELPD-GKVVALKKL-----------HHSETE-------DSAF 185
F +G G + V + G+ A+K L H+ TE F
Sbjct: 150 FEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPF 209
Query: 186 VV---YS---PQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNI-VKSVAHALSYLH 238
+ YS + F+ EY G LF L + E R + AL YLH
Sbjct: 210 LTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSE----DRARFYGAEIVSALDYLH 265
Query: 239 HDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQ-AGTYGYIALELV- 296
+ ++V+RD+ N++L+ + + DFG + + GT Y+A E++
Sbjct: 266 SEK--NVVYRDLKLENLMLDKDGHIKITDFGLCK-EGIKDGATMKTFCGTPEYLAPEVLE 322
Query: 297 ---YTMVVTEKCVIYSFGVVALEVLMGTHP 323
Y V + GVV E++ G P
Sbjct: 323 DNDYGRAV----DWWGLGVVMYEMMCGRLP 348
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 54.4 bits (131), Expect = 4e-08
Identities = 47/210 (22%), Positives = 78/210 (37%), Gaps = 38/210 (18%)
Query: 143 EYFHIRYCIGTGGYDSVYKAELPD-GKVVALKKLH-----------HSETE-------DS 183
F +G GG+ V ++ GK+ A KKL + E +S
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS 243
Query: 184 AFVVY------SPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYL 237
FVV + + + M G L + +A R + + L L
Sbjct: 244 RFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAG-FPEARAVFYAAEICCGLEDL 302
Query: 238 HHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTYGYIALELV- 296
H + IV+RD+ NILL+ + ++D G + + + GT GY+A E+V
Sbjct: 303 HRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGR-VGTVGYMAPEVVK 358
Query: 297 ---YTMVVTEKCVIYSFGVVALEVLMGTHP 323
YT ++ G + E++ G P
Sbjct: 359 NERYTFSPD----WWALGCLLYEMIAGQSP 384
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 4e-08
Identities = 41/221 (18%), Positives = 76/221 (34%), Gaps = 49/221 (22%)
Query: 140 DATEYFHIRYCIGTGGYDSVYKA-ELPDGKVVALK-----KLHHSETEDSAFVVY----- 188
+++ I +G+G + V K E G A K + S +
Sbjct: 9 KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSI 68
Query: 189 -----------------SPQCMFFIYEYMERGSLF--CVLRD---DDEAIELNWTRRMNI 226
+ + I E + G LF ++ ++EA
Sbjct: 69 LRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSF-------- 120
Query: 227 VKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAF----VADFGTVRLLDVDSSNRT 282
+K + ++YLH I H D+ NI+L + DFG ++ +
Sbjct: 121 IKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN 177
Query: 283 LQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHP 323
+ GT ++A E+V + + ++S GV+ +L G P
Sbjct: 178 I-FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 53.6 bits (129), Expect = 6e-08
Identities = 40/164 (24%), Positives = 65/164 (39%), Gaps = 46/164 (28%)
Query: 151 IGTGGYDSVYKAEL-PDGKVVALKK-----------------LHH-----------SETE 181
IG G + VY+A+L G++VA+KK L H S E
Sbjct: 62 IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGE 121
Query: 182 DSAFVVYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAH----ALSYL 237
V + + +Y+ +++ V R A T + VK + +L+Y+
Sbjct: 122 KKDEV-----YLNLVLDYVPE-TVYRVARHYSRA---KQTLPVIYVKLYMYQLFRSLAYI 172
Query: 238 HHDCTPSIVHRDISSNNILLNSNLEAF-VADFGTVRLLDVDSSN 280
H + I HRDI N+LL+ + + DFG+ + L N
Sbjct: 173 H---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN 213
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 6e-08
Identities = 57/298 (19%), Positives = 104/298 (34%), Gaps = 85/298 (28%)
Query: 151 IGTGGYDSVYKAELPDGK--------VVALKKL--HHSETEDSAF--------------- 185
+G G + V AE VA+K L +E + S
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 186 ------VVYSPQCMFFIYEYMERGSLFCVLR-------------DDDEAIELNWTRRMNI 226
++ I EY +G+L LR + ++ + ++
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 227 VKSVAHALSYL--HHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQ 284
+A + YL +HRD+++ N+L+ N +ADFG R ++ +
Sbjct: 163 TYQLARGMEYLASQK-----CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYK--- 214
Query: 285 AGTYGYI-----ALELVYTMVVTEKCVIYSFGVVALEVL-MGTHP------GELLLSLSS 332
T G + A E ++ V T + ++SFGV+ E+ +G P EL L
Sbjct: 215 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKE 274
Query: 333 SSGPKIMLIDILYQRLSPPIN-QKIIQDIILVSTIALACLRSKPKSRPTMQRISQELE 389
R+ P N + ++ C + P RPT +++ ++L+
Sbjct: 275 G------------HRMDKPANCTNELYMMM------RDCWHAVPSQRPTFKQLVEDLD 314
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 53.0 bits (128), Expect = 6e-08
Identities = 42/222 (18%), Positives = 72/222 (32%), Gaps = 59/222 (26%)
Query: 140 DATEYFHIRYCIGTGGYDSVYKA-ELPDGKVVA--------------------LKKLHHS 178
+ E + I +G G + V++ E K L H
Sbjct: 2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHR 61
Query: 179 ---------ETEDSAFVVYSPQCMFFIYEYMERGSLF--CVLRDD----DEAIELNWTRR 223
E+ + + I+E++ +F E +
Sbjct: 62 NILHLHESFESMEE---------LVMIFEFISGLDIFERINTSAFELNEREIV------- 105
Query: 224 MNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFV--ADFGTVRLLDVDSSNR 281
+ V V AL +LH +I H DI NI+ + + + +FG R L + R
Sbjct: 106 -SYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFR 161
Query: 282 TLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHP 323
L Y A E+ VV+ ++S G + +L G +P
Sbjct: 162 LL-FTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINP 202
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 9e-08
Identities = 43/213 (20%), Positives = 79/213 (37%), Gaps = 51/213 (23%)
Query: 142 TEYFHIRYCIGTGGYDSVYKA-ELPDGKVVALK-----KLHHSETEDSAFV--------- 186
E + + +G G V + P K A+K E+ +
Sbjct: 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 75
Query: 187 ----------------VY-SPQCMFFIYEYMERGSLFCVLRDDDEAIEL-NWTRRM--NI 226
Y + F +++ M++G LF D E + + I
Sbjct: 76 ILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELF------DYLTEKVTLSEKETRKI 129
Query: 227 VKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAG 286
++++ + LH +IVHRD+ NILL+ ++ + DFG LD R + G
Sbjct: 130 MRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREV-CG 185
Query: 287 TYGYIALELVYTMVV------TEKCVIYSFGVV 313
T Y+A E++ + ++ ++S GV+
Sbjct: 186 TPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVI 218
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 1e-07
Identities = 60/295 (20%), Positives = 100/295 (33%), Gaps = 78/295 (26%)
Query: 151 IGTGGYDSVYKAELPDGK------VVALKKL--HHSETEDSAF----------------- 185
+G G + V +A VA+K L TE A
Sbjct: 31 LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 90
Query: 186 ----VVYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKS------------ 229
I EY G L LR ++ + T +
Sbjct: 91 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 150
Query: 230 ---VAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAG 286
VA +++L + + +HRD+++ NILL + DFG R + DS+
Sbjct: 151 SYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYV---VK 204
Query: 287 TYGYI-----ALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLI 341
+ A E ++ V T + ++S+G+ E+ SL SS P + +
Sbjct: 205 GNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWEL----------FSLGSSPYPGMPVD 254
Query: 342 DILYQ------RLSPPIN-QKIIQDIILVSTIALACLRSKPKSRPTMQRISQELE 389
Y+ R+ P + + DI+ C + P RPT ++I Q +E
Sbjct: 255 SKFYKMIKEGFRMLSPEHAPAEMYDIM------KTCWDADPLKRPTFKQIVQLIE 303
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 1e-07
Identities = 39/212 (18%), Positives = 73/212 (34%), Gaps = 49/212 (23%)
Query: 140 DATEYFHIRYCIGTGGYDSVYKA-ELPDGKVVALK-----KLHHSETEDSAFVVY----- 188
+++ I +G+G + V K E G A K + S S +
Sbjct: 9 KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSI 68
Query: 189 -----------------SPQCMFFIYEYMERGSLF--CVLRD---DDEAIELNWTRRMNI 226
+ + I E + G LF ++ ++EA
Sbjct: 69 LRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSF-------- 120
Query: 227 VKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAF----VADFGTVRLLDVDSSNRT 282
+K + ++YLH I H D+ NI+L + DFG ++ +
Sbjct: 121 IKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN 177
Query: 283 LQAGTYGYIALELVYTMVVTEKCVIYSFGVVA 314
+ GT ++A E+V + + ++S GV+
Sbjct: 178 I-FGTPEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 1e-07
Identities = 42/205 (20%), Positives = 70/205 (34%), Gaps = 48/205 (23%)
Query: 143 EYFHIRYCIGTGGYDSVYKA-ELPDGKVVALKKLHHSET--------------------- 180
+Y +G G V + + ALK L
Sbjct: 62 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIV 121
Query: 181 ---EDSAFVVYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRM------NIVKSVA 231
E+ +C+ + E ++ G LF I+ + I+KS+
Sbjct: 122 DVYENL---YAGRKCLLIVMECLDGGELF-------SRIQDRGDQAFTEREASEIMKSIG 171
Query: 232 HALSYLHHDCTPSIVHRDISSNNILLNSNLEAF---VADFGTVRLLDVDSSNRTLQAGTY 288
A+ YLH +I HRD+ N+L S + DFG + +S T T
Sbjct: 172 EAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTP-CYTP 227
Query: 289 GYIALELVYTMVVTEKCVIYSFGVV 313
Y+A E++ + C ++S GV+
Sbjct: 228 YYVAPEVLGPEKYDKSCDMWSLGVI 252
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 52.5 bits (126), Expect = 1e-07
Identities = 47/212 (22%), Positives = 85/212 (40%), Gaps = 39/212 (18%)
Query: 143 EYFHIRYCIGTGGYDSVYKAELPD-GKVVALKKLH-----------HSETE-------DS 183
++F +G GG+ V+ ++ GK+ A KKL+ + E S
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 184 AFVV---YS---PQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKS-VAHALSY 236
F+V Y+ + + M G + + + DE R + + L +
Sbjct: 245 RFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEH 304
Query: 237 LHHDCTPSIVHRDISSNNILLNSNLEAFVADFG-TVRLLDVDSSNRTLQAGTYGYIALEL 295
LH +I++RD+ N+LL+ + ++D G V L + + AGT G++A EL
Sbjct: 305 LHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGY-AGTPGFMAPEL 360
Query: 296 V----YTMVVTEKCVIYSFGVVALEVLMGTHP 323
+ Y V ++ GV E++ P
Sbjct: 361 LLGEEYDFSVD----YFALGVTLYEMIAARGP 388
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 2e-07
Identities = 54/294 (18%), Positives = 106/294 (36%), Gaps = 77/294 (26%)
Query: 151 IGTGGYDSVYKAELPDGK--------VVALKKL--HHSETEDSAF--------------- 185
+G G + V AE VA+K L +E + S
Sbjct: 77 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 186 ------VVYSPQCMFFIYEYMERGSLFCVLR-------------DDDEAIELNWTRRMNI 226
++ I EY +G+L L+ + +L+ ++
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196
Query: 227 VKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAG 286
VA + YL + +HRD+++ N+L+ + +ADFG R + +
Sbjct: 197 AYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK---KT 250
Query: 287 TYGYI-----ALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLI 341
T G + A E ++ + T + ++SFGV+ E+ +L S P + +
Sbjct: 251 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI----------FTLGGSPYPGVPVE 300
Query: 342 DILYQ-----RLSPPIN-QKIIQDIILVSTIALACLRSKPKSRPTMQRISQELE 389
++ R+ P N + ++ C + P RPT +++ ++L+
Sbjct: 301 ELFKLLKEGHRMDKPSNCTNELYMMM------RDCWHAVPSQRPTFKQLVEDLD 348
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 2e-07
Identities = 45/214 (21%), Positives = 75/214 (35%), Gaps = 54/214 (25%)
Query: 145 FHIRYCIGTGGYDSVYKAEL-PDGKVVALKKLH-----------HSETE-------DSAF 185
F +GTG + V + G A+K L H+ E + F
Sbjct: 43 FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 186 VVY------SPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKS------VAHA 233
+V ++ + EY+ G +F LR R + + +
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI---------GRFSEPHARFYAAQIVLT 153
Query: 234 LSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTYGYIAL 293
YLH +++RD+ N+L++ V DFG + V TL GT +A
Sbjct: 154 FEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAK--RVKGRTWTL-CGTPEALAP 207
Query: 294 ELV----YTMVVTEKCVIYSFGVVALEVLMGTHP 323
E++ Y V ++ GV+ E+ G P
Sbjct: 208 EIILSKGYNKAVD----WWALGVLIYEMAAGYPP 237
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 51.0 bits (123), Expect = 2e-07
Identities = 40/212 (18%), Positives = 76/212 (35%), Gaps = 49/212 (23%)
Query: 140 DATEYFHIRYCIGTGGYDSVYKA-ELPDGKVVALK-----KLHHSETEDSAFVVY----- 188
+++ + +G+G + V K + GK A K +L S S +
Sbjct: 2 MVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNI 61
Query: 189 -----------------SPQCMFFIYEYMERGSLF--CVLRD---DDEAIELNWTRRMNI 226
+ + I E + G LF ++ +DEA +
Sbjct: 62 LREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQF-------- 113
Query: 227 VKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAF----VADFGTVRLLDVDSSNRT 282
+K + + YLH I H D+ NI+L + DFG ++ + +
Sbjct: 114 LKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKN 170
Query: 283 LQAGTYGYIALELVYTMVVTEKCVIYSFGVVA 314
+ GT ++A E+V + + ++S GV+
Sbjct: 171 I-FGTPEFVAPEIVNYEPLGLEADMWSIGVIT 201
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 2e-07
Identities = 41/212 (19%), Positives = 75/212 (35%), Gaps = 49/212 (23%)
Query: 140 DATEYFHIRYCIGTGGYDSVYKA-ELPDGKVVALK-----KLHHSETEDSAFVVY----- 188
+ +Y+ +G+G + V K E G A K + S S +
Sbjct: 8 NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSI 67
Query: 189 -----------------SPQCMFFIYEYMERGSLF--CVLRD---DDEAIELNWTRRMNI 226
+ + I E + G LF ++ ++EA E
Sbjct: 68 LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEF-------- 119
Query: 227 VKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAF----VADFGTVRLLDVDSSNRT 282
+K + + + YLH I H D+ NI+L + DFG +D + +
Sbjct: 120 LKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN 176
Query: 283 LQAGTYGYIALELVYTMVVTEKCVIYSFGVVA 314
+ GT ++A E+V + + ++S GV+
Sbjct: 177 I-FGTPEFVAPEIVNYEPLGLEADMWSIGVIT 207
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 2e-07
Identities = 39/208 (18%), Positives = 68/208 (32%), Gaps = 58/208 (27%)
Query: 151 IGTGGYDSVYKA-ELPDGKVVALKKLHHSETEDSAFV---------------------VY 188
+G G + V L + A+K + + V +
Sbjct: 21 LGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFF 80
Query: 189 -SPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRM-------NIVKSVAHALSYLHHD 240
+ ++E M GS+ I RR +V+ VA AL +LH
Sbjct: 81 EEEDRFYLVFEKMRGGSIL-------SHIH---KRRHFNELEASVVVQDVASALDFLH-- 128
Query: 241 CTPSIVHRDISSNNILLNSNLEAF---VADFGTVRLLDVDSSNRTLQ-------AGTYGY 290
I HRD+ NIL + + DF + ++ + G+ Y
Sbjct: 129 -NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEY 187
Query: 291 IALELVYTMVVT-----EKCVIYSFGVV 313
+A E+V ++C ++S GV+
Sbjct: 188 MAPEVVEAFSEEASIYDKRCDLWSLGVI 215
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 2e-07
Identities = 35/163 (21%), Positives = 63/163 (38%), Gaps = 45/163 (27%)
Query: 151 IGTGGYDSVYKAELPDGKVVALKK-----------------LHH-----------SETED 182
IG G + V++A+L + VA+KK + H S +
Sbjct: 48 IGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDK 107
Query: 183 SAFVVYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAH----ALSYLH 238
V + + EY+ +++ R + T M ++K + +L+Y+H
Sbjct: 108 KDEV-----FLNLVLEYVPE-TVYRASRHYAKL---KQTMPMLLIKLYMYQLLRSLAYIH 158
Query: 239 HDCTPSIVHRDISSNNILLNSNLEAF-VADFGTVRLLDVDSSN 280
+ I HRDI N+LL+ + DFG+ ++L N
Sbjct: 159 ---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPN 198
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 3e-07
Identities = 62/304 (20%), Positives = 106/304 (34%), Gaps = 92/304 (30%)
Query: 151 IGTGGYDSVYKAELPDGK------VVALKKL--HHSETEDSAF----------------- 185
IG G + V++A P +VA+K L S + F
Sbjct: 55 IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114
Query: 186 ---VVYSPQCMFFIYEYMERGSLFCVLR---------------------DDDEAIELNWT 221
V + M ++EYM G L LR L+
Sbjct: 115 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCA 174
Query: 222 RRMNIVKSVAHALSYL--HHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSS 279
++ I + VA ++YL VHRD+++ N L+ N+ +ADFG R ++ S+
Sbjct: 175 EQLCIARQVAAGMAYLSERK-----FVHRDLATRNCLVGENMVVKIADFGLSR--NIYSA 227
Query: 280 NRTLQAGTYGYI-----ALE-LVYTMVVTEKCVIYSFGVVALEVL-MGTHP------GEL 326
+ +A I E + Y T + ++++GVV E+ G P E+
Sbjct: 228 D-YYKADGNDAIPIRWMPPESIFYN-RYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEV 285
Query: 327 LLSLSSSSGPKIMLIDILYQRLSPPIN-QKIIQDIILVSTIALACLRSKPKSRPTMQRIS 385
+ + G L+ P N + +++ C P RP+ I
Sbjct: 286 IYYV--RDG----------NILACPENCPLELYNLM------RLCWSKLPADRPSFCSIH 327
Query: 386 QELE 389
+ L+
Sbjct: 328 RILQ 331
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 3e-07
Identities = 44/199 (22%), Positives = 72/199 (36%), Gaps = 53/199 (26%)
Query: 151 IGTGGYDSVYKA-ELPDGKVVALK------------KLHHSET------------EDSAF 185
+G G V + G+ ALK H + E+
Sbjct: 37 LGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDHHWQASGGPHIVCILDVYENMH- 95
Query: 186 VVYSPQCMFFIYEYMERGSLFCVLRDDDEAI----ELNWTRRM--NIVKSVAHALSYLHH 239
+ +C+ I E ME G LF I + +T R I++ + A+ +LH
Sbjct: 96 --HGKRCLLIIMECMEGGELF-------SRIQERGDQAFTEREAAEIMRDIGTAIQFLHS 146
Query: 240 DCTPSIVHRDISSNNILLNSNLEAF---VADFGTVRLLDVDSSNRTLQ--AGTYGYIALE 294
+I HRD+ N+L S + + DFG + LQ T Y+A E
Sbjct: 147 H---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETT----QNALQTPCYTPYYVAPE 199
Query: 295 LVYTMVVTEKCVIYSFGVV 313
++ + C ++S GV+
Sbjct: 200 VLGPEKYDKSCDMWSLGVI 218
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 50.3 bits (121), Expect = 4e-07
Identities = 64/304 (21%), Positives = 106/304 (34%), Gaps = 92/304 (30%)
Query: 151 IGTGGYDSVYKAELPDGK------VVALKKL--HHSETEDSAF----------------- 185
+G G + V KA K VA+K L + S +E
Sbjct: 31 LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 186 ---VVYSPQCMFFIYEYMERGSLFCVLR---------------------DDDEAIELNWT 221
+ I EY + GSL LR D + L
Sbjct: 91 LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150
Query: 222 RRMNIVKSVAHALSYL--HHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSS 279
++ ++ + YL +VHRD+++ NIL+ + ++DFG R + + S
Sbjct: 151 DLISFAWQISQGMQYLAEMK-----LVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDS 205
Query: 280 NRTLQAGTYGYI-----ALE-LVYTMVVTEKCVIYSFGVVALEVLM-------GTHPGEL 326
+ G I A+E L + T + ++SFGV+ E++ G P L
Sbjct: 206 YV---KRSQGRIPVKWMAIESLFDH-IYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERL 261
Query: 327 LLSLSSSSGPKIMLIDILYQRLSPPIN-QKIIQDIILVSTIALACLRSKPKSRPTMQRIS 385
L +G R+ P N + + ++ L C + +P RP IS
Sbjct: 262 FNLL--KTG----------HRMERPDNCSEEMYRLM------LQCWKQEPDKRPVFADIS 303
Query: 386 QELE 389
++LE
Sbjct: 304 KDLE 307
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 49.9 bits (119), Expect = 6e-07
Identities = 37/172 (21%), Positives = 66/172 (38%), Gaps = 34/172 (19%)
Query: 230 VAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTYG 289
VA + +L + +HRD+++ NILL+ + DFG R + D
Sbjct: 202 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV---RKGDA 255
Query: 290 YI-----ALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDIL 344
+ A E ++ V T + ++SFGV+ E + SL +S P + + +
Sbjct: 256 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWE----------IFSLGASPYPGVKIDEEF 305
Query: 345 YQ------RLSPPIN-QKIIQDIILVSTIALACLRSKPKSRPTMQRISQELE 389
+ R+ P + + L C +P RPT + + L
Sbjct: 306 CRRLKEGTRMRAPDYTTPEMYQTM------LDCWHGEPSQRPTFSELVEHLG 351
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 49.9 bits (118), Expect = 7e-07
Identities = 17/144 (11%), Positives = 42/144 (29%), Gaps = 13/144 (9%)
Query: 179 ETEDSAFVVYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLH 238
+ + + +F + E+ G + + +I+ + +L+
Sbjct: 123 GSANDRPDFFKDDQLFIVLEFEFGGIDL----EQMRTKLSSLATAKSILHQLTASLAVAE 178
Query: 239 HDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTYGYIALELVYT 298
HRD+ N+LL + + + S + Y LE
Sbjct: 179 ASL--RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLE---- 232
Query: 299 MVVTEKCVIYSFGVVALEVLMGTH 322
+ V++ + ++ G
Sbjct: 233 ---RDGIVVFCDVSMDEDLFTGDG 253
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 9e-07
Identities = 53/205 (25%), Positives = 80/205 (39%), Gaps = 54/205 (26%)
Query: 151 IGTGGYDSVYKA-ELPDGKVVALK-----KLHHSETEDSAFV------------------ 186
IG G V + G A+K S +
Sbjct: 102 IGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPH 161
Query: 187 ------VY-SPQCMFFIYEYMERGSLFCVLRDDDEAIELNW-----TRRMNIVKSVAHAL 234
Y S MF +++ M +G LF D E TR I++S+ A+
Sbjct: 162 IITLIDSYESSSFMFLVFDLMRKGELF------DYLTEKVALSEKETRS--IMRSLLEAV 213
Query: 235 SYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTYGYIALE 294
S+LH + +IVHRD+ NILL+ N++ ++DFG L+ R L GT GY+A E
Sbjct: 214 SFLHAN---NIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLREL-CGTPGYLAPE 269
Query: 295 -LVYTMVVTEK-----CVIYSFGVV 313
L +M T +++ GV+
Sbjct: 270 ILKCSMDETHPGYGKEVDLWACGVI 294
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 49.1 bits (117), Expect = 1e-06
Identities = 42/226 (18%), Positives = 73/226 (32%), Gaps = 63/226 (27%)
Query: 142 TEYFHIRYCIGTGGYDSVYKA-ELPDGKVVALKKLHHSETEDSAF--------------- 185
+ + IR+ IGTG Y V +A + + +VVA+KK+ ED
Sbjct: 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKIL-RVFEDLIDCKRILREIAILNRLN 110
Query: 186 ---------VVYSPQCMFF-----IYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVA 231
+V F + E + + R + +
Sbjct: 111 HDHVVKVLDIVIPKDVEKFDELYVVLEIAD--------------SDFKKLFRTPVYLTEL 156
Query: 232 H----------ALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNR 281
H + Y+H + I+HRD+ N L+N + V DFG R +D +
Sbjct: 157 HIKTLLYNLLVGVKYVH---SAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGN 213
Query: 282 TLQAGTYGYIALELVYTMVVTEKCVIYSFGVV-----ALEVLMGTH 322
+ + + LV + VV A E+++
Sbjct: 214 SQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQE 259
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 2e-06
Identities = 33/167 (19%), Positives = 59/167 (35%), Gaps = 46/167 (27%)
Query: 151 IGTGGYDSVYKA-ELPDGKVVALKK--------------------LHH-----------S 178
G G + +V E G VA+KK LHH +
Sbjct: 31 AGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYT 90
Query: 179 ETEDSAFVVYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKS----VAHAL 234
E +Y + + EY+ +L R+ ++K + ++
Sbjct: 91 LGERDRRDIY----LNVVMEYVPD-TLHRCCRN---YYRRQVAPPPILIKVFLFQLIRSI 142
Query: 235 SYLHHDCTPSIVHRDISSNNILLN-SNLEAFVADFGTVRLLDVDSSN 280
LH + ++ HRDI +N+L+N ++ + DFG+ + L N
Sbjct: 143 GCLHLP-SVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPN 188
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 2e-06
Identities = 52/302 (17%), Positives = 95/302 (31%), Gaps = 87/302 (28%)
Query: 151 IGTGGYDSVYKAELPDGK------VVALKKL--HHSETEDSAF----------------- 185
+G+G + V A VA+K L +E A
Sbjct: 53 LGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIV 112
Query: 186 ----VVYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKS------------ 229
++ I+EY G L LR E + N +
Sbjct: 113 NLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFE 172
Query: 230 --------VAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNR 281
VA + +L S VHRD+++ N+L+ + DFG R + DS+
Sbjct: 173 DLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYV 229
Query: 282 TLQAGTYGYI-----ALELVYTMVVTEKCVIYSFGVVALEVL-MGTHP-------GELLL 328
+ A E ++ + T K ++S+G++ E+ +G +P
Sbjct: 230 ---VRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYK 286
Query: 329 SLSSSSGPKIMLIDILYQRLSPPIN-QKIIQDIILVSTIALACLRSKPKSRPTMQRISQE 387
+ +G ++ P + I I+ +C + RP+ ++
Sbjct: 287 LI--QNG----------FKMDQPFYATEEIYIIM------QSCWAFDSRKRPSFPNLTSF 328
Query: 388 LE 389
L
Sbjct: 329 LG 330
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 47.6 bits (114), Expect = 3e-06
Identities = 31/143 (21%), Positives = 55/143 (38%), Gaps = 35/143 (24%)
Query: 169 VVALKKLHH-----------SETEDSAFVVYSPQCMFFIYEYMERGSLFCVLRDD----D 213
+ LKKL H ED ++ ++E + +G + V D
Sbjct: 87 IAILKKLDHPNVVKLVEVLDDPNEDH---------LYMVFELVNQGPVMEVPTLKPLSED 137
Query: 214 EAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRL 273
+A R + + + YLH+ I+HRDI +N+L+ + +ADFG
Sbjct: 138 QA------RF--YFQDLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSNE 186
Query: 274 LDVDSSNRTLQAGTYGYIALELV 296
+ + GT ++A E +
Sbjct: 187 FKGSDALLSNTVGTPAFMAPESL 209
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 3e-06
Identities = 32/182 (17%), Positives = 58/182 (31%), Gaps = 43/182 (23%)
Query: 134 LYENLIDATEYFHIRYCIGTGGYDSVYKAELPDGKVVALKKLHHSETEDSAF-------- 185
L L + ++ I +G Y +V +G VA+K++ ++ ++
Sbjct: 13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFL 72
Query: 186 ------------------------VVYSPQCMFF-----IYEYMERGSLFCVLRDDDEAI 216
+ + + E M L V+ D I
Sbjct: 73 CKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQR--I 129
Query: 217 ELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDV 276
++ + + L LH +VHRD+ NILL N + + DF R
Sbjct: 130 VISPQHIQYFMYHILLGLHVLH---EAGVVHRDLHPGNILLADNNDITICDFNLAREDTA 186
Query: 277 DS 278
D+
Sbjct: 187 DA 188
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 3e-06
Identities = 47/212 (22%), Positives = 85/212 (40%), Gaps = 46/212 (21%)
Query: 145 FHI--RY----CIGTGGYDSVYKA-ELPDGKVVALKK--------------------LHH 177
F + RY IG+G V A + + VA+KK +
Sbjct: 21 FTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKC 80
Query: 178 SETED--SAFVVYSPQC-------MFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVK 228
++ V++PQ ++ + E M+ +L V++ + L+ R ++
Sbjct: 81 VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQME-----LDHERMSYLLY 134
Query: 229 SVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTY 288
+ + +LH + I+HRD+ +NI++ S+ + DFG R S T T
Sbjct: 135 QMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG-TSFMMTPYVVTR 190
Query: 289 GYIALELVYTMVVTEKCVIYSFGVVALEVLMG 320
Y A E++ M E I+S G + E++ G
Sbjct: 191 YYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 222
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 4e-06
Identities = 39/145 (26%), Positives = 62/145 (42%), Gaps = 20/145 (13%)
Query: 186 VVYSPQCMFFIYEYMERGSLFCVLR-----DDDEAIELNWTRRMNIVKSVAHALSYLHHD 240
V+ + + ++ I EY G +F L + EA R + + A+ Y H
Sbjct: 82 VIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEA------RS--KFRQIVSAVQYCHQK 133
Query: 241 CTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTYGYIALELVYTMV 300
IVHRD+ + N+LL++++ +ADFG V G Y A EL
Sbjct: 134 R---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDA-FCGAPPYAAPELFQGKK 189
Query: 301 VTEKCV-IYSFGVVALEVLM-GTHP 323
V ++S GV+ L L+ G+ P
Sbjct: 190 YDGPEVDVWSLGVI-LYTLVSGSLP 213
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 47.5 bits (113), Expect = 4e-06
Identities = 44/209 (21%), Positives = 81/209 (38%), Gaps = 40/209 (19%)
Query: 142 TEYFHIRYCIGTGGYDSVYKA-ELPDGKVVALKK--------------------LHHSET 180
+ + IG+G V A + + VA+KK +
Sbjct: 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 120
Query: 181 ED--SAFVVYSPQCMF-------FIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVA 231
++ S V++PQ + E M+ +L V++ + L+ R ++ +
Sbjct: 121 KNIISLLNVFTPQKTLEEFQDVYLVMELMD-ANLCQVIQME-----LDHERMSYLLYQML 174
Query: 232 HALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTYGYI 291
+ +LH + I+HRD+ +NI++ S+ + DFG R S T T Y
Sbjct: 175 CGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG-TSFMMTPYVVTRYYR 230
Query: 292 ALELVYTMVVTEKCVIYSFGVVALEVLMG 320
A E++ M E I+S G + E++
Sbjct: 231 APEVILGMGYKENVDIWSVGCIMGEMVRH 259
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 6e-06
Identities = 34/156 (21%), Positives = 52/156 (33%), Gaps = 48/156 (30%)
Query: 151 IGTGGYDSVYKAE-LPDGKVVALK-----KLHHSETEDSAF------------------- 185
+G+GG+ SVY + D VA+K ++ +
Sbjct: 51 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110
Query: 186 -----VVYSPQCMFFIYEYME-RGSLF--CVLR---DDDEAIELNWTRRMNIVKSVAHAL 234
P I E E LF R ++ A R V A+
Sbjct: 111 IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELA------RS--FFWQVLEAV 162
Query: 235 SYLHHDCTPSIVHRDISSNNILLNSN-LEAFVADFG 269
+ H+ ++HRDI NIL++ N E + DFG
Sbjct: 163 RHCHNC---GVLHRDIKDENILIDLNRGELKLIDFG 195
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 46.8 bits (112), Expect = 7e-06
Identities = 48/204 (23%), Positives = 75/204 (36%), Gaps = 43/204 (21%)
Query: 151 IGTGGYDSVYKAELPD-GKVVALKKLH-----------HSETE-------DSAFVV---Y 188
+G G + V G+ A+K L H+ TE F+ Y
Sbjct: 13 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 72
Query: 189 S---PQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKS-VAHALSYLHHDCTPS 244
+ + F+ EY G LF L + E R + + AL YLH
Sbjct: 73 AFQTHDRLCFVMEYANGGELFFHLSRERVFTE----ERARFYGAEIVSALEYLHSR---D 125
Query: 245 IVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQ-AGTYGYIALELV----YTM 299
+V+RDI N++L+ + + DFG + + GT Y+A E++ Y
Sbjct: 126 VVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKTFCGTPEYLAPEVLEDNDYGR 184
Query: 300 VVTEKCVIYSFGVVALEVLMGTHP 323
V + GVV E++ G P
Sbjct: 185 AV----DWWGLGVVMYEMMCGRLP 204
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 47.2 bits (113), Expect = 7e-06
Identities = 19/50 (38%), Positives = 25/50 (50%), Gaps = 3/50 (6%)
Query: 15 SGVVEEEPSSPSFLKS-DMSFNNLDGEIPTY--LRDNPPKSFVGNKGLCG 61
G + + S+ + L D+S NNL G IP PP F+ N GLCG
Sbjct: 693 DGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCG 742
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 46.7 bits (111), Expect = 9e-06
Identities = 36/185 (19%), Positives = 62/185 (33%), Gaps = 62/185 (33%)
Query: 142 TEYFHIRYCIGTGGYDSVYKA-ELPDGKVVALKKLHHSETEDSAF--------------- 185
+ + I++ IG G Y VY A + K VA+KK++ F
Sbjct: 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVN------RMFEDLIDCKRILREITI 78
Query: 186 --------------VVYSPQCMFF--IYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKS 229
++ + F +Y +E + D D L + I +
Sbjct: 79 LNRLKSDYIIRLYDLIIPDDLLKFDELYIVLE-------IADSD----LKKLFKTPIFLT 127
Query: 230 VAH----------ALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSS 279
H +++H I+HRD+ N LLN + V DFG R ++ +
Sbjct: 128 EEHIKTILYNLLLGENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKD 184
Query: 280 NRTLQ 284
+
Sbjct: 185 TNIVN 189
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 46.1 bits (109), Expect = 1e-05
Identities = 34/158 (21%), Positives = 60/158 (37%), Gaps = 47/158 (29%)
Query: 143 EYFHIRYCI----GTGGYDSVYKAE-LPDGKVVALK--------------------KLHH 177
+ F+ RY + G G + +V+ + + K VA+K + +
Sbjct: 33 DLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRN 92
Query: 178 SETEDS----------AFVVYSP----QCMFFIYEYMERGSLFCVLRD-DDEAIELNWTR 222
S+ D F + CM ++E + L + + + + L +
Sbjct: 93 SDPNDPNREMVVQLLDDFKISGVNGTHICM--VFEVL-GHHLLKWIIKSNYQGLPLPCVK 149
Query: 223 RMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSN 260
+ I++ V L YLH C I+H DI NILL+ N
Sbjct: 150 K--IIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVN 183
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 45.3 bits (108), Expect = 2e-05
Identities = 42/176 (23%), Positives = 70/176 (39%), Gaps = 42/176 (23%)
Query: 151 IGTGGYDSVYKAE-LPDGKVVALK-----KLHHSETEDSAF------------------- 185
+G G + V E G VA+K K+ +
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 186 VVYSPQCMFFIYEYMERGSLF--CVLR---DDDEAIELNWTRRMNIVKSVAHALSYLHHD 240
V+ +P F + EY+ G LF ++ EA RR + + + A+ Y H
Sbjct: 79 VISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEA------RR--LFQQILSAVDYCHRH 130
Query: 241 CTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTYGYIALELV 296
+VHRD+ N+LL++++ A +ADFG ++ RT G+ Y A E++
Sbjct: 131 ---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRT-SCGSPNYAAPEVI 182
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 45.2 bits (108), Expect = 2e-05
Identities = 52/222 (23%), Positives = 85/222 (38%), Gaps = 65/222 (29%)
Query: 145 FHIRYCIGTGGYDSVYKAELP----DGKVVALKKLH----------HSETE-------DS 183
F + +G G + V+ + ++ A+K L ++ E +
Sbjct: 26 FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNH 85
Query: 184 AFVV---YS---PQCMFFIYEYMERGSLFCVLRDD---DE------AIELNWTRRMNIVK 228
F+V Y+ ++ I +++ G LF L + E EL
Sbjct: 86 PFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAEL---------- 135
Query: 229 SVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRL--LDVDSSNRTLQ-A 285
A AL +LH I++RD+ NILL+ + DFG L +D +
Sbjct: 136 --ALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFG---LSKESIDHEKKAYSFC 187
Query: 286 GTYGYIALELV----YTMVVTEKCVIYSFGVVALEVLMGTHP 323
GT Y+A E+V +T +SFGV+ E+L GT P
Sbjct: 188 GTVEYMAPEVVNRRGHTQSAD----WWSFGVLMFEMLTGTLP 225
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 2e-05
Identities = 28/158 (17%), Positives = 48/158 (30%), Gaps = 50/158 (31%)
Query: 151 IGTGGYDSVYKAE-LPDGKVVALK-----KLHHSETEDSAFVVY---------------- 188
+G GG+ +V+ L D VA+K ++ +
Sbjct: 39 LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98
Query: 189 ----------SPQCMFFIYEYMERGS-LF--CVLR---DDDEAIELNWTRRMNIVKSVAH 232
+ + + E LF + + + R V
Sbjct: 99 GVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPS------RC--FFGQVVA 150
Query: 233 ALSYLHHDCTPSIVHRDISSNNILLNS-NLEAFVADFG 269
A+ + H +VHRDI NIL++ A + DFG
Sbjct: 151 AIQHCHSR---GVVHRDIKDENILIDLRRGCAKLIDFG 185
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 45.5 bits (108), Expect = 2e-05
Identities = 35/182 (19%), Positives = 58/182 (31%), Gaps = 48/182 (26%)
Query: 151 IGTGGYDSVYKAE-LPDGKVVALK-----KLHHSETEDSAF------------------- 185
+G+G + V+ A K V +K K+ +
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 186 -----VVYSPQCMFFIYEYMERGS-LF--CVLR---DDDEAIELNWTRRMNIVKSVAHAL 234
+ + + E G LF D+ A I + + A+
Sbjct: 92 IKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLA------SY--IFRQLVSAV 143
Query: 235 SYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTYGYIALE 294
YL I+HRDI NI++ + + DFG+ L+ T GT Y A E
Sbjct: 144 GYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTF-CGTIEYCAPE 199
Query: 295 LV 296
++
Sbjct: 200 VL 201
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 45.3 bits (108), Expect = 2e-05
Identities = 34/167 (20%), Positives = 64/167 (38%), Gaps = 36/167 (21%)
Query: 142 TEYFHIRYCIGTGGYDSVYKA-ELPDGKVVALKKLHHSETEDSA------------F--- 185
+ IG G Y V A + + VA+KK+ E + F
Sbjct: 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 85
Query: 186 -------VVYSPQCMFF-----IYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHA 233
++ +P + + ME L+ +L+ L+ + +
Sbjct: 86 NIIGINDIIRAPTIEQMKDVYIVQDLME-TDLYKLLKTQH----LSNDHICYFLYQILRG 140
Query: 234 LSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSN 280
L Y+H + +++HRD+ +N+LLN+ + + DFG R+ D D +
Sbjct: 141 LKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH 184
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 44.9 bits (107), Expect = 2e-05
Identities = 39/181 (21%), Positives = 69/181 (38%), Gaps = 42/181 (23%)
Query: 145 FHI--RY----CIGTGGYDSVYKA-ELPDGKVVALKKLHHSETEDSA------------F 185
++I + +G G Y V A P G++VA+KK+ + A F
Sbjct: 7 YNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHF 66
Query: 186 ----------VVYSPQCMFF-----IYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSV 230
+ F I E M+ L V+ L+ +
Sbjct: 67 KHENIITIFNIQRPDSFENFNEVYIIQELMQT-DLHRVISTQM----LSDDHIQYFIYQT 121
Query: 231 AHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTYGY 290
A+ LH +++HRD+ +N+L+NSN + V DFG R++D +++ + G
Sbjct: 122 LRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSG 178
Query: 291 I 291
+
Sbjct: 179 M 179
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 45.2 bits (107), Expect = 3e-05
Identities = 34/149 (22%), Positives = 59/149 (39%), Gaps = 41/149 (27%)
Query: 151 IGTGGYDSVYKAE-LPDGKVVALK-----KLHHSETEDSAF------------------- 185
+G G + V + G VA+K K+ +
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83
Query: 186 VVYSPQCMFFIYEYMERGSLF--CVLR---DDDEAIELNWTRRMNIVKSVAHALSYLHHD 240
V+ +P +F + EY+ G LF D+ E+ RR + + + + Y H
Sbjct: 84 VISTPSDIFMVMEYVSGGELFDYICKNGRLDEKES------RR--LFQQILSGVDYCHRH 135
Query: 241 CTPSIVHRDISSNNILLNSNLEAFVADFG 269
+VHRD+ N+LL++++ A +ADFG
Sbjct: 136 M---VVHRDLKPENVLLDAHMNAKIADFG 161
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 44.4 bits (106), Expect = 4e-05
Identities = 59/214 (27%), Positives = 87/214 (40%), Gaps = 54/214 (25%)
Query: 145 FHIRYCIGTGGYDSVYKAEL-PDGKVVALKKLH-----------HSETE-------DSAF 185
F I +GTG + V+ +G+ A+K L H+ E F
Sbjct: 8 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 67
Query: 186 VV---YS---PQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKS------VAHA 233
++ + Q +F I +Y+E G LF +LR +R + V A
Sbjct: 68 IIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKS---------QRFPNPVAKFYAAEVCLA 118
Query: 234 LSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTYGYIAL 293
L YLH I++RD+ NILL+ N + DFG + V TL GT YIA
Sbjct: 119 LEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKY--VPDVTYTL-CGTPDYIAP 172
Query: 294 ELV----YTMVVTEKCVIYSFGVVALEVLMGTHP 323
E+V Y + +SFG++ E+L G P
Sbjct: 173 EVVSTKPYNKSID----WWSFGILIYEMLAGYTP 202
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 44.1 bits (105), Expect = 4e-05
Identities = 18/39 (46%), Positives = 23/39 (58%), Gaps = 3/39 (7%)
Query: 26 SFLKS-DMSFNNLDGEIPT--YLRDNPPKSFVGNKGLCG 61
FL S ++SFNNL GEIP L+ ++ NK LCG
Sbjct: 268 KFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCG 306
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 4e-05
Identities = 35/168 (20%), Positives = 62/168 (36%), Gaps = 38/168 (22%)
Query: 140 DATEYFHIRYCIGTGGYDSVYKA-ELPDGKVVALKK--------------------LHHS 178
+ + +G+G Y +V A + G VA+KK L H
Sbjct: 22 EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHM 81
Query: 179 ETED--SAFVVYSPQC-------MFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKS 229
E+ V++P + + +M L +++ + L R +V
Sbjct: 82 RHENVIGLLDVFTPDETLDDFTDFYLVMPFMGT-DLGKLMKHEK----LGEDRIQFLVYQ 136
Query: 230 VAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVD 277
+ L Y+H I+HRD+ N+ +N + E + DFG R D +
Sbjct: 137 MLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE 181
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 6e-05
Identities = 34/166 (20%), Positives = 66/166 (39%), Gaps = 39/166 (23%)
Query: 142 TEYFHIRYCIGTGGYDSVYKA-ELPDGKVVALKK--------------------LHHSET 180
+ + +G+G Y SV A + G+ VA+KK L H +
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQH 82
Query: 181 ED--SAFVVYSPQC-------MFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVA 231
E+ V++P + + +M+ L ++ ++ + + +V +
Sbjct: 83 ENVIGLLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIMG-----LKFSEEKIQYLVYQML 136
Query: 232 HALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVD 277
L Y+H + +VHRD+ N+ +N + E + DFG R D +
Sbjct: 137 KGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE 179
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 43.9 bits (103), Expect = 7e-05
Identities = 47/210 (22%), Positives = 81/210 (38%), Gaps = 42/210 (20%)
Query: 145 FHIRYCIGTGGYDSVYKAELPD-GKVVALKKLH-----------HSETE--------DSA 184
F+ +G G + V +E ++ A+K L + E
Sbjct: 343 FNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPP 402
Query: 185 FVV---YSPQCM---FFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLH 238
F+ Q M +F+ EY+ G L ++ E + +A L +L
Sbjct: 403 FLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKE---PHAVFYAAEIAIGLFFLQ 459
Query: 239 HDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQ-AGTYGYIALELV- 296
I++RD+ +N++L+S +ADFG + ++ T GT YIA E++
Sbjct: 460 SK---GIIYRDLKLDNVMLDSEGHIKIADFGMCK-ENIWDGVTTKTFCGTPDYIAPEIIA 515
Query: 297 ---YTMVVTEKCVIYSFGVVALEVLMGTHP 323
Y V ++FGV+ E+L G P
Sbjct: 516 YQPYGKSVD----WWAFGVLLYEMLAGQAP 541
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 42.6 bits (101), Expect = 1e-04
Identities = 27/120 (22%), Positives = 44/120 (36%), Gaps = 27/120 (22%)
Query: 189 SPQCMFFIYEYMERGS--LFCVLRDDDEAIELNWTRRMNIVKSVAH--------ALSYLH 238
Q M+ + EY G + D E +R + AH L YLH
Sbjct: 79 EKQKMYMVMEYCVCGMQEML------DSVPE----KRFPV--CQAHGYFCQLIDGLEYLH 126
Query: 239 HDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQ--AGTYGYIALELV 296
IVH+DI N+LL + ++ G L +++ T + G+ + E+
Sbjct: 127 SQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIA 183
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 1e-04
Identities = 33/160 (20%), Positives = 52/160 (32%), Gaps = 45/160 (28%)
Query: 143 EYFHIRYCIGTGGYDSVYKA-ELPDGKVVALKKLHHSET--------------------- 180
+Y +G G V + + ALK L
Sbjct: 18 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIV 77
Query: 181 ---EDSAFVVYSPQCMFFIYEYMERGSLFCVLRDDDEAIE---LNWTRRM--NIVKSVAH 232
E+ +C+ + E ++ G LF + +T R I+KS+
Sbjct: 78 DVYENL---YAGRKCLLIVMECLDGGELF------SRIQDRGDQAFTEREASEIMKSIGE 128
Query: 233 ALSYLHHDCTPSIVHRDISSNNILLNSNLEAF---VADFG 269
A+ YLH +I HRD+ N+L S + DFG
Sbjct: 129 AIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFG 165
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 42.6 bits (101), Expect = 1e-04
Identities = 40/179 (22%), Positives = 66/179 (36%), Gaps = 51/179 (28%)
Query: 145 FHI--RY----CIGTGGYDSVYKA-ELPDGKVVALKK---------------------LH 176
F + RY +G GG V+ A + K VA+KK L
Sbjct: 7 FDLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLD 66
Query: 177 H--------------SETEDSAFVVYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTR 222
H S+ D + ++ + EYME L VL L
Sbjct: 67 HDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYME-TDLANVLEQGP----LLEEH 121
Query: 223 RMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNS-NLEAFVADFGTVRLLDVDSSN 280
+ + L Y+H + +++HRD+ N+ +N+ +L + DFG R++D S+
Sbjct: 122 ARLFMYQLLRGLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSH 177
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 42.2 bits (100), Expect = 1e-04
Identities = 39/178 (21%), Positives = 59/178 (33%), Gaps = 45/178 (25%)
Query: 151 IGTGGYDSVYKAE-LPDGKVVALKKLHHSETEDSAF----------------------VV 187
+G G Y V A + VA+K + D
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 188 YSPQCMFFIYEYMERGSLFCVLRDD-----DEAIELNWTRRM--NIVKSVAHALSYLHHD 240
+ EY G LF + D +A +R ++ + YLH
Sbjct: 75 REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDA------QRFFHQLM----AGVVYLHGI 124
Query: 241 CTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQA--GTYGYIALELV 296
I HRDI N+LL+ ++DFG + ++ R L GT Y+A EL+
Sbjct: 125 ---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 2e-04
Identities = 32/196 (16%), Positives = 56/196 (28%), Gaps = 60/196 (30%)
Query: 142 TEYFHIRYCIGTGGYDSVYKA-ELPDGKVVALKK-----------------LHH------ 177
++ + + +GTG + V + ++ GK ALKK L H
Sbjct: 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHVNIIKL 65
Query: 178 -------SETEDSAFVVYSPQCMFFIYEYMERGSLFCVLRDDDEAIELN----------- 219
+ E V+ + + LN
Sbjct: 66 VDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLH 125
Query: 220 ----WTRRMNIVKSVAH----------ALSYLHHDCTPSIVHRDISSNNILLNSNLEAF- 264
R + A+ ++H + I HRDI N+L+NS
Sbjct: 126 KVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH---SLGICHRDIKPQNLLVNSKDNTLK 182
Query: 265 VADFGTVRLLDVDSSN 280
+ DFG+ + L +
Sbjct: 183 LCDFGSAKKLIPSEPS 198
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 42.1 bits (100), Expect = 2e-04
Identities = 51/221 (23%), Positives = 82/221 (37%), Gaps = 61/221 (27%)
Query: 145 FHIRYCIGTGGYDSVYKAELP----DGKVVALKKL------------HHSETE------- 181
F + +G GGY V++ GK+ A+K L H++ E
Sbjct: 19 FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV 78
Query: 182 DSAFVV---YSPQCM---FFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKS------ 229
F+V Y+ Q + I EY+ G LF L + +
Sbjct: 79 KHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLERE---------GIFMEDTACFYLAE 129
Query: 230 VAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRL--LDVDSSNRTLQ-AG 286
++ AL +LH I++RD+ NI+LN + DFG L + T G
Sbjct: 130 ISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFG---LCKESIHDGTVTHTFCG 183
Query: 287 TYGYIALELV----YTMVVTEKCVIYSFGVVALEVLMGTHP 323
T Y+A E++ + V +S G + ++L G P
Sbjct: 184 TIEYMAPEILMRSGHNRAVD----WWSLGALMYDMLTGAPP 220
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 2e-04
Identities = 57/222 (25%), Positives = 83/222 (37%), Gaps = 59/222 (26%)
Query: 145 FHIRYCIGTGGYDSVYKAELPDGK----VVALKKLH------------HSETE------- 181
F + +GTG Y V+ G + A+K L H+ TE
Sbjct: 56 FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 115
Query: 182 -DSAFVV---YSPQCM---FFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKS----- 229
S F+V Y+ Q I +Y+ G LF L R +
Sbjct: 116 RQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQR---------ERFTEHEVQIYVG 166
Query: 230 -VAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQ-AGT 287
+ AL +LH I++RDI NILL+SN + DFG + D + R GT
Sbjct: 167 EIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGT 223
Query: 288 YGYIALELV------YTMVVTEKCVIYSFGVVALEVLMGTHP 323
Y+A ++V + V +S GV+ E+L G P
Sbjct: 224 IEYMAPDIVRGGDSGHDKAVD----WWSLGVLMYELLTGASP 261
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 3e-04
Identities = 14/43 (32%), Positives = 23/43 (53%), Gaps = 3/43 (6%)
Query: 233 ALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLD 275
L Y+H + I+HRD+ +N+ +N + E + DFG R
Sbjct: 144 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTA 183
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 41.0 bits (97), Expect = 4e-04
Identities = 51/210 (24%), Positives = 86/210 (40%), Gaps = 42/210 (20%)
Query: 145 FHIRYCIGTGGYDSVYKAELPD-GKVVALKKLH-----------HSETE--------DSA 184
F + +G G + V+ AE + A+K L + E +
Sbjct: 19 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 78
Query: 185 FVV---YS---PQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLH 238
F+ + + +FF+ EY+ G L ++ + +R + L +LH
Sbjct: 79 FLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDL---SRATFYAAEIILGLQFLH 135
Query: 239 HDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRL-LDVDSSNRTLQAGTYGYIALELV- 296
IV+RD+ +NILL+ + +ADFG + + D+ T GT YIA E++
Sbjct: 136 SK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTF-CGTPDYIAPEILL 191
Query: 297 ---YTMVVTEKCVIYSFGVVALEVLMGTHP 323
Y V +SFGV+ E+L+G P
Sbjct: 192 GQKYNHSVD----WWSFGVLLYEMLIGQSP 217
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 41.1 bits (97), Expect = 4e-04
Identities = 57/219 (26%), Positives = 85/219 (38%), Gaps = 60/219 (27%)
Query: 145 FHIRYCIGTGGYDSVYKAELPD-GKVVALKKL-----------HHSETE--------DSA 184
FH IG G + V A A+K L H +E
Sbjct: 40 FHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHP 99
Query: 185 FVV---YSPQCM---FFIYEYMERGSLFCVLRDD---DE------AIELNWTRRMNIVKS 229
F+V +S Q +F+ +Y+ G LF L+ + E A E
Sbjct: 100 FLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAE------------ 147
Query: 230 VAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQ-AGTY 288
+A AL YLH +IV+RD+ NILL+S + DFG + +++ ++ T GT
Sbjct: 148 IASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCK-ENIEHNSTTSTFCGTP 203
Query: 289 GYIALELV----YTMVVTEKCVIYSFGVVALEVLMGTHP 323
Y+A E++ Y V + G V E+L G P
Sbjct: 204 EYLAPEVLHKQPYDRTVD----WWCLGAVLYEMLYGLPP 238
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 41.1 bits (97), Expect = 4e-04
Identities = 39/178 (21%), Positives = 59/178 (33%), Gaps = 45/178 (25%)
Query: 151 IGTGGYDSVYKAE-LPDGKVVALKKLHHSETEDSAF----------------------VV 187
+G G Y V A + VA+K + D
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 188 YSPQCMFFIYEYMERGSLFCVLRDD-----DEAIELNWTRRM--NIVKSVAHALSYLHHD 240
+ EY G LF + D +A +R ++ + YLH
Sbjct: 75 REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDA------QRFFHQLM----AGVVYLHGI 124
Query: 241 CTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQA--GTYGYIALELV 296
I HRDI N+LL+ ++DFG + ++ R L GT Y+A EL+
Sbjct: 125 ---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 5e-04
Identities = 19/76 (25%), Positives = 27/76 (35%), Gaps = 9/76 (11%)
Query: 233 ALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTYGYIA 292
+ YLH + ++HRD+ +NILLN+ VADFG R +
Sbjct: 121 VIKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENT 177
Query: 293 LELVYTM------VVT 302
V T
Sbjct: 178 ENFDDDQPILTDYVAT 193
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 40.7 bits (96), Expect = 6e-04
Identities = 48/204 (23%), Positives = 80/204 (39%), Gaps = 42/204 (20%)
Query: 151 IGTGGYDSVYKAELPD-GKVVALKKLH-----------HSETE--------DSAFVV--- 187
+G G + V A + + G + A+K L + TE + F+
Sbjct: 31 LGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLF 90
Query: 188 YSPQCM---FFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPS 244
Q FF+ E++ G L ++ E R + AL +LH
Sbjct: 91 CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDE---ARARFYAAEIISALMFLHDK---G 144
Query: 245 IVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQ-AGTYGYIALELV----YTM 299
I++RD+ +N+LL+ +ADFG + + + T GT YIA E++ Y
Sbjct: 145 IIYRDLKLDNVLLDHEGHCKLADFGMCK-EGICNGVTTATFCGTPDYIAPEILQEMLYGP 203
Query: 300 VVTEKCVIYSFGVVALEVLMGTHP 323
V ++ GV+ E+L G P
Sbjct: 204 AVD----WWAMGVLLYEMLCGHAP 223
|
Structure Templates Detected by HHsearch 
Original result of HHsearch against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 412 | |||
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.94 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.91 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.87 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.74 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.66 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.96 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 98.94 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.84 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.68 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.42 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 98.25 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.06 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.78 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 97.74 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 97.51 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 97.41 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 97.39 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.35 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.3 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 97.27 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 97.11 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 97.1 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 97.09 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 97.02 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 96.99 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 96.87 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 96.82 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 96.77 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 96.73 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 96.69 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 96.66 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 96.63 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 96.58 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 96.54 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 96.52 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 96.44 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 96.43 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 96.42 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 96.39 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 96.25 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 96.23 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 96.21 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 96.2 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 96.2 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 96.19 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 96.16 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 96.13 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 96.11 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 96.1 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 96.0 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 95.92 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 95.91 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 95.91 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 95.9 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 95.79 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 95.74 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 95.72 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 95.7 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 95.69 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 95.69 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 95.66 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 95.6 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 95.51 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 95.47 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 95.42 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 95.41 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 95.35 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 95.33 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 95.31 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 95.29 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 95.24 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 95.23 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 95.22 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 95.15 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 95.09 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 95.09 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 95.05 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 95.05 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 95.05 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 95.02 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 95.0 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 94.96 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 94.96 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 94.89 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 94.85 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 94.85 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 94.84 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 94.79 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 94.79 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 94.7 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 94.57 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 94.52 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 94.51 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 94.46 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 94.45 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 94.42 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 94.42 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 94.39 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 94.36 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 94.29 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 94.24 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 94.23 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 94.15 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 94.12 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 94.11 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 94.11 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 94.1 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 94.08 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 94.04 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 94.0 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 93.98 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 93.96 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 93.92 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 93.79 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 93.7 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 93.64 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 93.56 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 93.44 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 93.43 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 93.41 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 93.38 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 93.35 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 93.31 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 93.3 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 93.27 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 93.18 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 93.17 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 93.15 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 93.12 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 93.1 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 93.09 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 93.04 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 92.72 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 92.61 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 92.47 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 92.47 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 92.23 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 92.18 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 91.93 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 91.93 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 91.87 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 91.8 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 91.76 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 91.69 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 91.59 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 91.42 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 91.4 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 91.22 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 90.68 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 90.46 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 90.43 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 90.32 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 90.01 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 89.78 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 89.4 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 89.25 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 89.03 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 88.66 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 87.9 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 87.88 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 87.87 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 87.83 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 87.61 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 86.9 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 86.61 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 84.79 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 84.77 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 83.53 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 83.19 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 82.57 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 80.95 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 80.14 |
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-53 Score=405.05 Aligned_cols=236 Identities=22% Similarity=0.307 Sum_probs=194.2
Q ss_pred cCcccceeeeecCceEEEEEEeC------CCcEEEEEec----------------------cCCccccceEEEecCceEE
Q 042435 143 EYFHIRYCIGTGGYDSVYKAELP------DGKVVALKKL----------------------HHSETEDSAFVVYSPQCMF 194 (412)
Q Consensus 143 ~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vAvK~l----------------------~~~~~~~~~~~~~~~~~~~ 194 (412)
+++++.+.||+|+||+||+|.+. +++.||||++ +|+|++...+++.+++..+
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~ 105 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS 105 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence 34667789999999999999873 4689999964 6899999999999999999
Q ss_pred EEEEeccCCceeeeeccCc-------------ccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCC
Q 042435 195 FIYEYMERGSLFCVLRDDD-------------EAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNL 261 (412)
Q Consensus 195 lv~ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~ 261 (412)
+|||||++|+|.++|.... ....++|.+++.|+.|||+||+|||++ +|+||||||+|||+++++
T Consensus 106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NILl~~~~ 182 (308)
T 4gt4_A 106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKL 182 (308)
T ss_dssp EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGG
T ss_pred EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceEECCCC
Confidence 9999999999999996432 123599999999999999999999998 999999999999999999
Q ss_pred cEEEeecCCccccCCCC--CCcccccccccccccccccCcccCcccccHHHHHHHHHHHh-CCCCcccccccccCCCCcc
Q 042435 262 EAFVADFGTVRLLDVDS--SNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLM-GTHPGELLLSLSSSSGPKI 338 (412)
Q Consensus 262 ~~kl~DfGla~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~ellt-g~~P~~~~~~~~~~~~~~~ 338 (412)
.+||+|||+++...... .......||+.|||||++.+..++.++|||||||++|||+| |+.||... ...
T Consensus 183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~--------~~~ 254 (308)
T 4gt4_A 183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGY--------SNQ 254 (308)
T ss_dssp CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTC--------CHH
T ss_pred CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCC--------CHH
Confidence 99999999998764432 22344679999999999999999999999999999999999 89998732 112
Q ss_pred hhhHHhhhccCCccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhcCC
Q 042435 339 MLIDILYQRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELEGKT 392 (412)
Q Consensus 339 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 392 (412)
.+.+.+......+.+...+ ..+.+++.+||+.||++||||.||+++|+++.
T Consensus 255 ~~~~~i~~~~~~~~p~~~~---~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~ 305 (308)
T 4gt4_A 255 DVVEMIRNRQVLPCPDDCP---AWVYALMIECWNEFPSRRPRFKDIHSRLRAWG 305 (308)
T ss_dssp HHHHHHHTTCCCCCCTTCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred HHHHHHHcCCCCCCcccch---HHHHHHHHHHcCCChhHCcCHHHHHHHHHhcc
Confidence 2333333333333333332 34889999999999999999999999999864
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-53 Score=406.14 Aligned_cols=239 Identities=23% Similarity=0.324 Sum_probs=189.6
Q ss_pred cCcccceeeeecCceEEEEEEeC------CCcEEEEEec---------------------cCCccccceEEEecCceEEE
Q 042435 143 EYFHIRYCIGTGGYDSVYKAELP------DGKVVALKKL---------------------HHSETEDSAFVVYSPQCMFF 195 (412)
Q Consensus 143 ~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vAvK~l---------------------~~~~~~~~~~~~~~~~~~~l 195 (412)
++|.+.++||+|+||+||+|++. +++.||||++ +|+|++...+++.+++..+|
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 46778899999999999999874 4789999964 68999999999999999999
Q ss_pred EEEeccCCceeeeeccCcc------------cccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcE
Q 042435 196 IYEYMERGSLFCVLRDDDE------------AIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEA 263 (412)
Q Consensus 196 v~ey~~~gsL~~~l~~~~~------------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~ 263 (412)
|||||++|+|.++++.... ...++|.+++.|+.|||+||+|||++ +|+||||||+|||+++++.+
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEECCCCcE
Confidence 9999999999999876431 23599999999999999999999998 99999999999999999999
Q ss_pred EEeecCCccccCCCCC--CcccccccccccccccccCcccCcccccHHHHHHHHHHHh-CCCCcccccccccCCCCcchh
Q 042435 264 FVADFGTVRLLDVDSS--NRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLM-GTHPGELLLSLSSSSGPKIML 340 (412)
Q Consensus 264 kl~DfGla~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~ 340 (412)
||+|||+++....... ......||+.|||||++.+..++.++|||||||++|||+| |+.||... .. ..+
T Consensus 198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~-------~~-~~~ 269 (329)
T 4aoj_A 198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQL-------SN-TEA 269 (329)
T ss_dssp EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSS-------CH-HHH
T ss_pred EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCC-------CH-HHH
Confidence 9999999987644322 2244579999999999999999999999999999999999 89998732 11 122
Q ss_pred hHHhhhccCCccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhcCCCCC
Q 042435 341 IDILYQRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELEGKTPMK 395 (412)
Q Consensus 341 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~~ 395 (412)
.+.+......+.+.... ..+.+|+.+||+.||++||||+||+++|+.+.+.+
T Consensus 270 ~~~i~~g~~~~~p~~~~---~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~p 321 (329)
T 4aoj_A 270 IDCITQGRELERPRACP---PEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAP 321 (329)
T ss_dssp HHHHHHTCCCCCCTTCC---HHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHSC
T ss_pred HHHHHcCCCCCCccccc---HHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhCC
Confidence 23333322233233322 34789999999999999999999999999886543
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-53 Score=403.61 Aligned_cols=237 Identities=24% Similarity=0.350 Sum_probs=193.2
Q ss_pred cCcccceeeeecCceEEEEEEeC------CCcEEEEEec---------------------cCCccccceEEEecCceEEE
Q 042435 143 EYFHIRYCIGTGGYDSVYKAELP------DGKVVALKKL---------------------HHSETEDSAFVVYSPQCMFF 195 (412)
Q Consensus 143 ~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vAvK~l---------------------~~~~~~~~~~~~~~~~~~~l 195 (412)
++|.+.+.||+|+||+||+|++. +++.||||++ +|+|++...+++.+++..++
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 92 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 92 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 56888999999999999999864 4789999964 69999999999999999999
Q ss_pred EEEeccCCceeeeeccCc----------ccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEE
Q 042435 196 IYEYMERGSLFCVLRDDD----------EAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFV 265 (412)
Q Consensus 196 v~ey~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl 265 (412)
|||||++|+|.++|+... ....++|.+++.|+.|||+||+|||++ +|+||||||+|||+++++.+||
T Consensus 93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~~~~Ki 169 (299)
T 4asz_A 93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKI 169 (299)
T ss_dssp EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCCCcEEE
Confidence 999999999999997542 123699999999999999999999998 9999999999999999999999
Q ss_pred eecCCccccCCCCCCc--ccccccccccccccccCcccCcccccHHHHHHHHHHHh-CCCCcccccccccCCCCcchhhH
Q 042435 266 ADFGTVRLLDVDSSNR--TLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLM-GTHPGELLLSLSSSSGPKIMLID 342 (412)
Q Consensus 266 ~DfGla~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~ 342 (412)
+|||+|+......... ....||+.|||||++.+..++.++|||||||++|||+| |+.||... ... .+..
T Consensus 170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~-------~~~-~~~~ 241 (299)
T 4asz_A 170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQL-------SNN-EVIE 241 (299)
T ss_dssp CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS-------CHH-HHHH
T ss_pred CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC-------CHH-HHHH
Confidence 9999998664433222 23468999999999999999999999999999999999 89998732 111 2222
Q ss_pred HhhhccCCccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhcCCC
Q 042435 343 ILYQRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELEGKTP 393 (412)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 393 (412)
.+.....++.+...+ ..+.+++.+||+.||++||||+||.+.|+++.+
T Consensus 242 ~i~~~~~~~~p~~~~---~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~ 289 (299)
T 4asz_A 242 CITQGRVLQRPRTCP---QEVYELMLGCWQREPHMRKNIKGIHTLLQNLAK 289 (299)
T ss_dssp HHHHTCCCCCCTTCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHcCCCCCCCccch---HHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 232222222223322 348899999999999999999999999987654
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-52 Score=397.72 Aligned_cols=235 Identities=22% Similarity=0.346 Sum_probs=183.9
Q ss_pred cCcccceeeeecCceEEEEEEeCCCcEEEEEec-----------------------cCCccccceEEEecCceEEEEEEe
Q 042435 143 EYFHIRYCIGTGGYDSVYKAELPDGKVVALKKL-----------------------HHSETEDSAFVVYSPQCMFFIYEY 199 (412)
Q Consensus 143 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~l-----------------------~~~~~~~~~~~~~~~~~~~lv~ey 199 (412)
+++.+.++||+|+||+||+|++++ .||||.+ +|+|++...+++. .+..+|||||
T Consensus 36 ~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~-~~~~~iVmEy 112 (307)
T 3omv_A 36 SEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMT-KDNLAIVTQW 112 (307)
T ss_dssp TSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEEC
T ss_pred HHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-CCeEEEEEEc
Confidence 567888999999999999998854 5899954 6888888887765 4668999999
Q ss_pred ccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCC-
Q 042435 200 MERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDS- 278 (412)
Q Consensus 200 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~- 278 (412)
|++|+|.++|+.... .++|.+++.|+.|||+||+|||++ +|+||||||+|||+++++.+||+|||+|+......
T Consensus 113 ~~gGsL~~~l~~~~~--~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~ 187 (307)
T 3omv_A 113 CEGSSLYKHLHVQET--KFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSG 187 (307)
T ss_dssp CSSCBHHHHHHTSCC--CCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCSSCBC------
T ss_pred CCCCCHHHHHhhcCC--CCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeeccCceecccCCc
Confidence 999999999976532 599999999999999999999998 99999999999999999999999999998765332
Q ss_pred -CCcccccccccccccccccC---cccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCc-cc
Q 042435 279 -SNRTLQAGTYGYIALELVYT---MVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPP-IN 353 (412)
Q Consensus 279 -~~~~~~~gt~~y~aPE~~~~---~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~ 353 (412)
.......||+.|||||++.+ ..|+.++|||||||++|||+||+.||... .....+...+......+ ..
T Consensus 188 ~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~-------~~~~~~~~~~~~~~~~p~~~ 260 (307)
T 3omv_A 188 SQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHI-------NNRDQIIFMVGRGYASPDLS 260 (307)
T ss_dssp ------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTC-------CCHHHHHHHHHTTCCCCCST
T ss_pred ceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCC-------ChHHHHHHHHhcCCCCCCcc
Confidence 22345689999999999863 46899999999999999999999999732 11222233333222211 11
Q ss_pred hhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhcCC
Q 042435 354 QKIIQDIILVSTIALACLRSKPKSRPTMQRISQELEGKT 392 (412)
Q Consensus 354 ~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 392 (412)
.........+.+++.+||+.||++||||.||+++|+.+.
T Consensus 261 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~ 299 (307)
T 3omv_A 261 KLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQ 299 (307)
T ss_dssp TSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHH
T ss_pred cccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 111122334889999999999999999999999998764
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-52 Score=392.63 Aligned_cols=246 Identities=24% Similarity=0.341 Sum_probs=189.8
Q ss_pred cCcccceeeeecCceEEEEEEeCCCcEEEEEec--------------------cCCccccceEEEecCc----eEEEEEE
Q 042435 143 EYFHIRYCIGTGGYDSVYKAELPDGKVVALKKL--------------------HHSETEDSAFVVYSPQ----CMFFIYE 198 (412)
Q Consensus 143 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~l--------------------~~~~~~~~~~~~~~~~----~~~lv~e 198 (412)
++|.+.+.||+|+||+||+|++ +|+.||||++ +|+|+....+++..++ ..+||||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~E 81 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD 81 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEec
Confidence 4577889999999999999998 6899999964 6889998888877543 6899999
Q ss_pred eccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhC-----CCCCcEEeCCCCCCEEecCCCcEEEeecCCccc
Q 042435 199 YMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHD-----CTPSIVHRDISSNNILLNSNLEAFVADFGTVRL 273 (412)
Q Consensus 199 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~-----~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~ 273 (412)
||++|+|.++++.. .++|..+.+++.|+++||+|||++ +.++|+||||||+|||++.++++||+|||+|+.
T Consensus 82 y~~~gsL~~~l~~~----~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~ 157 (303)
T 3hmm_A 82 YHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 157 (303)
T ss_dssp CCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred CCCCCcHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCcc
Confidence 99999999999764 489999999999999999999986 256899999999999999999999999999987
Q ss_pred cCCCCCC----cccccccccccccccccCc------ccCcccccHHHHHHHHHHHhCCCCccccccccc-------CCCC
Q 042435 274 LDVDSSN----RTLQAGTYGYIALELVYTM------VVTEKCVIYSFGVVALEVLMGTHPGELLLSLSS-------SSGP 336 (412)
Q Consensus 274 ~~~~~~~----~~~~~gt~~y~aPE~~~~~------~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~-------~~~~ 336 (412)
....... .....||+.|||||++.+. .++.++|||||||++|||+||+.|+........ ....
T Consensus 158 ~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~ 237 (303)
T 3hmm_A 158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 237 (303)
T ss_dssp EETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred ccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccch
Confidence 6543322 2345799999999998654 478899999999999999999888753211100 0000
Q ss_pred cchhhH-HhhhccCCccchh--hHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhcCCC
Q 042435 337 KIMLID-ILYQRLSPPINQK--IIQDIILVSTIALACLRSKPKSRPTMQRISQELEGKTP 393 (412)
Q Consensus 337 ~~~~~~-~~~~~~~~~~~~~--~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 393 (412)
...+.. +......++.+.. ..+....+.+++.+||+.||++||||.||++.|+++.+
T Consensus 238 ~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~ 297 (303)
T 3hmm_A 238 VEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297 (303)
T ss_dssp HHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence 111111 2233333333222 12334458899999999999999999999999988754
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-52 Score=395.06 Aligned_cols=236 Identities=22% Similarity=0.249 Sum_probs=192.0
Q ss_pred hhcCcccceeeeecCceEEEEEEe-CCCcEEEEEec----------------cCCccccceEEEecCceEEEEEEeccCC
Q 042435 141 ATEYFHIRYCIGTGGYDSVYKAEL-PDGKVVALKKL----------------HHSETEDSAFVVYSPQCMFFIYEYMERG 203 (412)
Q Consensus 141 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l----------------~~~~~~~~~~~~~~~~~~~lv~ey~~~g 203 (412)
..+.|++.++||+|+||+||+|+. .+|+.||||++ +|+|++....++.+++..|||||||++|
T Consensus 56 ~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg 135 (336)
T 4g3f_A 56 EVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGG 135 (336)
T ss_dssp TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTTC
T ss_pred chhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCC
Confidence 346788899999999999999987 46999999964 6899999999999999999999999999
Q ss_pred ceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCC-cEEEeecCCccccCCCCCC--
Q 042435 204 SLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNL-EAFVADFGTVRLLDVDSSN-- 280 (412)
Q Consensus 204 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~-~~kl~DfGla~~~~~~~~~-- 280 (412)
+|.++++... .+++.....++.||+.||+|||++ +|+||||||+|||++.++ .+||+|||+|+.+......
T Consensus 136 ~L~~~l~~~~---~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~ 209 (336)
T 4g3f_A 136 SLGQLIKQMG---CLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKS 209 (336)
T ss_dssp BHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTTCEEC--------
T ss_pred cHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccc
Confidence 9999997543 599999999999999999999998 999999999999999887 6999999999976543221
Q ss_pred ---cccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCC-ccchhh
Q 042435 281 ---RTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSP-PINQKI 356 (412)
Q Consensus 281 ---~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 356 (412)
....+||+.|||||++.+..|+.++|||||||++|||+||+.||... ........+....... ..+..
T Consensus 210 ~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~-------~~~~~~~~i~~~~~~~~~~~~~- 281 (336)
T 4g3f_A 210 LLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQY-------FRGPLCLKIASEPPPIREIPPS- 281 (336)
T ss_dssp ----CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTT-------CCSCCHHHHHHSCCGGGGSCTT-
T ss_pred eecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCC-------CHHHHHHHHHcCCCCchhcCcc-
Confidence 23357999999999999999999999999999999999999999732 1222233333322111 11111
Q ss_pred HHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhcCC
Q 042435 357 IQDIILVSTIALACLRSKPKSRPTMQRISQELEGKT 392 (412)
Q Consensus 357 ~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 392 (412)
....+.+++.+||+.||++|||+.|++++|....
T Consensus 282 --~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l 315 (336)
T 4g3f_A 282 --CAPLTAQAIQEGLRKEPVHRASAMELRRKVGKAL 315 (336)
T ss_dssp --SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --CCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHH
Confidence 2234788999999999999999999999886553
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-51 Score=394.75 Aligned_cols=229 Identities=24% Similarity=0.357 Sum_probs=192.6
Q ss_pred cCcccceeeeecCceEEEEEEe-CCCcEEEEEec---------------------cCCccccceEEEecCceEEEEEEec
Q 042435 143 EYFHIRYCIGTGGYDSVYKAEL-PDGKVVALKKL---------------------HHSETEDSAFVVYSPQCMFFIYEYM 200 (412)
Q Consensus 143 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l---------------------~~~~~~~~~~~~~~~~~~~lv~ey~ 200 (412)
+.|++.+.||+|+||+||+|.. .+|+.||||++ +|+|++....++.+++..|||||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 5689999999999999999977 47999999964 6889999999999999999999999
Q ss_pred cCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCCCC
Q 042435 201 ERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSN 280 (412)
Q Consensus 201 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 280 (412)
++|+|.+++... .+++.+...++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+.+......
T Consensus 154 ~gg~L~~~l~~~----~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~ 226 (346)
T 4fih_A 154 EGGALTDIVTHT----RMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR 226 (346)
T ss_dssp TTEEHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCC
T ss_pred CCCcHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCceecCCCCCc
Confidence 999999988754 489999999999999999999999 9999999999999999999999999999987665555
Q ss_pred cccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccchhhHHHH
Q 042435 281 RTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKIIQDI 360 (412)
Q Consensus 281 ~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 360 (412)
....+||+.|||||++.+..|+.++|||||||++|||++|+.||... ........+.....+.. .......
T Consensus 227 ~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~--------~~~~~~~~i~~~~~~~~-~~~~~~s 297 (346)
T 4fih_A 227 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE--------PPLKAMKMIRDNLPPRL-KNLHKVS 297 (346)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS--------CHHHHHHHHHHSSCCCC-SCGGGSC
T ss_pred ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc--------CHHHHHHHHHcCCCCCC-CccccCC
Confidence 56678999999999999999999999999999999999999999732 11112222222222211 1111222
Q ss_pred HHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 361 ILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 361 ~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
..+.+++.+||+.||++|||++|++++
T Consensus 298 ~~~~dli~~~L~~dP~~R~ta~e~l~H 324 (346)
T 4fih_A 298 PSLKGFLDRLLVRDPAQRATAAELLKH 324 (346)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred HHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 347899999999999999999999875
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-51 Score=398.74 Aligned_cols=242 Identities=21% Similarity=0.284 Sum_probs=196.9
Q ss_pred HHHhhcCcccceeeeecCceEEEEEEeCC------CcEEEEEec-----------------------cCCccccceEEEe
Q 042435 138 LIDATEYFHIRYCIGTGGYDSVYKAELPD------GKVVALKKL-----------------------HHSETEDSAFVVY 188 (412)
Q Consensus 138 l~~~~~~f~~~~~lG~G~~g~Vy~~~~~~------~~~vAvK~l-----------------------~~~~~~~~~~~~~ 188 (412)
.+-..++|++.+.||+|+||+||+|.+.. ++.||||++ +|+|++...++|.
T Consensus 59 wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~ 138 (353)
T 4ase_A 59 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACT 138 (353)
T ss_dssp HBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEE
Confidence 33455789999999999999999997642 468999965 3478888888886
Q ss_pred cC-ceEEEEEEeccCCceeeeeccCcc-------------cccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCC
Q 042435 189 SP-QCMFFIYEYMERGSLFCVLRDDDE-------------AIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNN 254 (412)
Q Consensus 189 ~~-~~~~lv~ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~N 254 (412)
.. +..++|||||++|+|.++|+.... ...++|.+++.++.|||+||+|||++ +|+||||||+|
T Consensus 139 ~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHRDLK~~N 215 (353)
T 4ase_A 139 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARN 215 (353)
T ss_dssp CTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGG
T ss_pred ecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecCccCccc
Confidence 64 568999999999999999975432 23489999999999999999999999 99999999999
Q ss_pred EEecCCCcEEEeecCCccccCCCCCC--cccccccccccccccccCcccCcccccHHHHHHHHHHHh-CCCCcccccccc
Q 042435 255 ILLNSNLEAFVADFGTVRLLDVDSSN--RTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLM-GTHPGELLLSLS 331 (412)
Q Consensus 255 ILl~~~~~~kl~DfGla~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~ellt-g~~P~~~~~~~~ 331 (412)
||+++++.+||+|||+|+........ .....||+.|||||++.+..|+.++|||||||++|||+| |+.||...
T Consensus 216 ILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~---- 291 (353)
T 4ase_A 216 ILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV---- 291 (353)
T ss_dssp EEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC----
T ss_pred eeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCC----
Confidence 99999999999999999976544332 244578999999999999999999999999999999998 99998732
Q ss_pred cCCCCcchhhHHhhhccCCccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhcCC
Q 042435 332 SSSGPKIMLIDILYQRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELEGKT 392 (412)
Q Consensus 332 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 392 (412)
.....+...+.....++.+..... .+.+++.+||+.||++|||+.||+++|+++.
T Consensus 292 ---~~~~~~~~~i~~g~~~~~p~~~~~---~~~~li~~c~~~dP~~RPt~~eil~~L~~ll 346 (353)
T 4ase_A 292 ---KIDEEFCRRLKEGTRMRAPDYTTP---EMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 346 (353)
T ss_dssp ---CCSHHHHHHHHHTCCCCCCTTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---CHHHHHHHHHHcCCCCCCCccCCH---HHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 222234444444444333333322 4788999999999999999999999998764
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-52 Score=397.77 Aligned_cols=230 Identities=21% Similarity=0.337 Sum_probs=185.5
Q ss_pred cCcccceeeeecCceEEEEEEe-CCCcEEEEEec-----------------------cCCccccceEEEecCceEEEEEE
Q 042435 143 EYFHIRYCIGTGGYDSVYKAEL-PDGKVVALKKL-----------------------HHSETEDSAFVVYSPQCMFFIYE 198 (412)
Q Consensus 143 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l-----------------------~~~~~~~~~~~~~~~~~~~lv~e 198 (412)
++|++.+.||+|+||+||+|+. .+|+.||||++ +|+|++....++.+++..|+|||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 6899999999999999999976 57999999964 68899999999999999999999
Q ss_pred eccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCC
Q 042435 199 YMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDS 278 (412)
Q Consensus 199 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~ 278 (412)
||++|+|.+++..... ..+++.+...|+.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+......
T Consensus 104 y~~gg~L~~~i~~~~~-~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~ 179 (350)
T 4b9d_A 104 YCEGGDLFKRINAQKG-VLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV 179 (350)
T ss_dssp CCTTCBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTEESCCCHHH
T ss_pred CCCCCcHHHHHHHcCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcccccceeecCCc
Confidence 9999999999975432 2478899999999999999999999 99999999999999999999999999998765432
Q ss_pred CCcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccchhhHH
Q 042435 279 SNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKIIQ 358 (412)
Q Consensus 279 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 358 (412)
......+||+.|||||++.+..|+.++|||||||++|||+||+.||... .....+..+......+ .+...
T Consensus 180 ~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~-------~~~~~~~~i~~~~~~~-~~~~~-- 249 (350)
T 4b9d_A 180 ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAG-------SMKNLVLKIISGSFPP-VSLHY-- 249 (350)
T ss_dssp HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS-------SHHHHHHHHHHTCCCC-CCTTS--
T ss_pred ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc-------CHHHHHHHHHcCCCCC-CCccC--
Confidence 2334567999999999999999999999999999999999999999732 1122233333333222 22222
Q ss_pred HHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 359 DIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 359 ~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
...+.+++.+||+.||++|||++|++++
T Consensus 250 -s~~~~~li~~~L~~dP~~R~s~~e~l~h 277 (350)
T 4b9d_A 250 -SYDLRSLVSQLFKRNPRDRPSVNSILEK 277 (350)
T ss_dssp -CHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -CHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 2237899999999999999999999874
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-50 Score=396.07 Aligned_cols=230 Identities=23% Similarity=0.355 Sum_probs=192.9
Q ss_pred hcCcccceeeeecCceEEEEEEe-CCCcEEEEEec---------------------cCCccccceEEEecCceEEEEEEe
Q 042435 142 TEYFHIRYCIGTGGYDSVYKAEL-PDGKVVALKKL---------------------HHSETEDSAFVVYSPQCMFFIYEY 199 (412)
Q Consensus 142 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l---------------------~~~~~~~~~~~~~~~~~~~lv~ey 199 (412)
.+.|++.+.||+|+||.||+|.. .+|+.||||++ +|+|++....++.+++.+||||||
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy 229 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 229 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence 35699999999999999999977 46999999964 688999999999999999999999
Q ss_pred ccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCCC
Q 042435 200 MERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSS 279 (412)
Q Consensus 200 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 279 (412)
|++|+|.+++... .+++.++..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+.+.....
T Consensus 230 ~~gG~L~~~i~~~----~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~ 302 (423)
T 4fie_A 230 LEGGALTDIVTHT----RMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP 302 (423)
T ss_dssp CTTEEHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC
T ss_pred CCCCcHHHHHhcc----CCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccceECCCCCc
Confidence 9999999998654 489999999999999999999999 999999999999999999999999999998766655
Q ss_pred CcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccchhhHHH
Q 042435 280 NRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKIIQD 359 (412)
Q Consensus 280 ~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 359 (412)
.....+||+.|||||++.+..|+.++|||||||++|||++|+.||... ........+.....+.. ......
T Consensus 303 ~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~--------~~~~~~~~i~~~~~~~~-~~~~~~ 373 (423)
T 4fie_A 303 RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE--------PPLKAMKMIRDNLPPRL-KNLHKV 373 (423)
T ss_dssp CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS--------CHHHHHHHHHHSCCCCC-SCTTSS
T ss_pred cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc--------CHHHHHHHHHcCCCCCC-cccccC
Confidence 566778999999999999999999999999999999999999999732 11112222222222211 111112
Q ss_pred HHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 360 IILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 360 ~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
...+.+|+.+||+.||++|||+.|++++
T Consensus 374 s~~~~dli~~~L~~dP~~R~ta~ell~H 401 (423)
T 4fie_A 374 SPSLKGFLDRLLVRDPAQRATAAELLKH 401 (423)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred CHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 2347899999999999999999999885
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-50 Score=377.31 Aligned_cols=227 Identities=22% Similarity=0.309 Sum_probs=179.2
Q ss_pred cccceeeeecCceEEEEEEe-CCCcEEEEEec-----------------------cCCccccceEEEec----CceEEEE
Q 042435 145 FHIRYCIGTGGYDSVYKAEL-PDGKVVALKKL-----------------------HHSETEDSAFVVYS----PQCMFFI 196 (412)
Q Consensus 145 f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l-----------------------~~~~~~~~~~~~~~----~~~~~lv 196 (412)
|+..++||+|+||+||+|.+ .+++.||+|++ +|+|++....++.+ .+.+|+|
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv 107 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence 35667899999999999977 46899999954 68899888877643 4568999
Q ss_pred EEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecC-CCcEEEeecCCccccC
Q 042435 197 YEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNS-NLEAFVADFGTVRLLD 275 (412)
Q Consensus 197 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~-~~~~kl~DfGla~~~~ 275 (412)
||||++|+|.+++.... .+++..+..++.||+.||+|||++ .++|+||||||+|||++. ++.+||+|||+|+...
T Consensus 108 mEy~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~ylH~~-~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~ 183 (290)
T 3fpq_A 108 TELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp EECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EeCCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC-CCCEEecccChhheeEECCCCCEEEEeCcCCEeCC
Confidence 99999999999997543 589999999999999999999998 223999999999999984 7899999999998643
Q ss_pred CCCCCcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccchh
Q 042435 276 VDSSNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQK 355 (412)
Q Consensus 276 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 355 (412)
. ......+||+.|||||++.+ .|+.++|||||||++|||+||+.||... .....+...+.....+....
T Consensus 184 ~--~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~-------~~~~~~~~~i~~~~~~~~~~- 252 (290)
T 3fpq_A 184 A--SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSEC-------QNAAQIYRRVTSGVKPASFD- 252 (290)
T ss_dssp T--TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTC-------SSHHHHHHHHTTTCCCGGGG-
T ss_pred C--CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCC-------CcHHHHHHHHHcCCCCCCCC-
Confidence 2 23345689999999998865 6999999999999999999999999632 11112222232222221111
Q ss_pred hHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 356 IIQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 356 ~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
......+.+++.+||+.||++|||++|+++|
T Consensus 253 -~~~~~~~~~li~~~L~~dP~~R~s~~e~l~H 283 (290)
T 3fpq_A 253 -KVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp -GCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred -ccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1112247889999999999999999999875
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-50 Score=380.98 Aligned_cols=227 Identities=23% Similarity=0.318 Sum_probs=185.9
Q ss_pred cCcccceeeeecCceEEEEEEe----CCCcEEEEEec-----------------------cCCccccceEEEecCceEEE
Q 042435 143 EYFHIRYCIGTGGYDSVYKAEL----PDGKVVALKKL-----------------------HHSETEDSAFVVYSPQCMFF 195 (412)
Q Consensus 143 ~~f~~~~~lG~G~~g~Vy~~~~----~~~~~vAvK~l-----------------------~~~~~~~~~~~~~~~~~~~l 195 (412)
++|++.+.||+|+||+||+|+. .+++.||||.+ +|+|++....++.+++..|+
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 5799999999999999999975 24789999954 57888888888899999999
Q ss_pred EEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccC
Q 042435 196 IYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLD 275 (412)
Q Consensus 196 v~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~ 275 (412)
|||||++|+|.+++.... .+++.+...++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+|+...
T Consensus 104 vmEy~~gg~L~~~l~~~~---~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~ 177 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKEV---MFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESI 177 (304)
T ss_dssp EECCCTTCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESSEEEEC--
T ss_pred EEEcCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEecccccceecc
Confidence 999999999999997643 589999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCCcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccchh
Q 042435 276 VDSSNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQK 355 (412)
Q Consensus 276 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 355 (412)
.........+||+.|||||++.+..|+.++||||+||++|||+||+.||... ........+.......+ ..
T Consensus 178 ~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~-------~~~~~~~~i~~~~~~~p--~~ 248 (304)
T 3ubd_A 178 DHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGK-------DRKETMTMILKAKLGMP--QF 248 (304)
T ss_dssp ---CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCS-------SHHHHHHHHHHCCCCCC--TT
T ss_pred CCCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCc-------CHHHHHHHHHcCCCCCC--Cc
Confidence 4444445678999999999999999999999999999999999999999732 11222233333333222 22
Q ss_pred hHHHHHHHHHHHHhcCcCCCCCCCC-----HHHHHHH
Q 042435 356 IIQDIILVSTIALACLRSKPKSRPT-----MQRISQE 387 (412)
Q Consensus 356 ~~~~~~~~~~l~~~Cl~~dP~~RPs-----~~evl~~ 387 (412)
.. ..+.+++.+||+.||++||| ++|+++|
T Consensus 249 ~s---~~~~~li~~~L~~dP~~R~ta~~~~~~eil~H 282 (304)
T 3ubd_A 249 LS---PEAQSLLRMLFKRNPANRLGAGPDGVEEIKRH 282 (304)
T ss_dssp SC---HHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTS
T ss_pred CC---HHHHHHHHHHcccCHHHCCCCCcCCHHHHHcC
Confidence 22 23788999999999999998 4677653
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-50 Score=381.85 Aligned_cols=226 Identities=22% Similarity=0.351 Sum_probs=190.3
Q ss_pred cCcccceeeeecCceEEEEEEe-CCCcEEEEEec------------------------cCCccccceEEEecCceEEEEE
Q 042435 143 EYFHIRYCIGTGGYDSVYKAEL-PDGKVVALKKL------------------------HHSETEDSAFVVYSPQCMFFIY 197 (412)
Q Consensus 143 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l------------------------~~~~~~~~~~~~~~~~~~~lv~ 197 (412)
++|++.+.||+|+||+||+|+. .+|+.||||.+ +|+++.+....+.+++..|+||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 5799999999999999999976 57999999954 6889999999999999999999
Q ss_pred EeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCC
Q 042435 198 EYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVD 277 (412)
Q Consensus 198 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~ 277 (412)
|||++|+|.+++.... .+++.....++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+.+...
T Consensus 112 Ey~~gG~L~~~i~~~~---~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~ 185 (311)
T 4aw0_A 112 SYAKNGELLKYIRKIG---SFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 185 (311)
T ss_dssp CCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred ecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcCCceecCCC
Confidence 9999999999997543 589999999999999999999999 9999999999999999999999999999987543
Q ss_pred C--CCcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccchh
Q 042435 278 S--SNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQK 355 (412)
Q Consensus 278 ~--~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 355 (412)
. ......+||+.|||||++.+..|+.++||||+||++|||+||+.||... ........+.......+ ..
T Consensus 186 ~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~-------~~~~~~~~i~~~~~~~p--~~ 256 (311)
T 4aw0_A 186 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG-------NEGLIFAKIIKLEYDFP--EK 256 (311)
T ss_dssp TTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCS-------SHHHHHHHHHHTCCCCC--TT
T ss_pred CCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC-------CHHHHHHHHHcCCCCCC--cc
Confidence 2 2334568999999999999999999999999999999999999999732 11222333333333222 22
Q ss_pred hHHHHHHHHHHHHhcCcCCCCCCCCHHHHHH
Q 042435 356 IIQDIILVSTIALACLRSKPKSRPTMQRISQ 386 (412)
Q Consensus 356 ~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~ 386 (412)
.. ..+.+++.+||+.||++|||++|++.
T Consensus 257 ~s---~~~~dli~~lL~~dp~~R~t~~e~~~ 284 (311)
T 4aw0_A 257 FF---PKARDLVEKLLVLDATKRLGCEEMEG 284 (311)
T ss_dssp CC---HHHHHHHHHHSCSSGGGSTTSGGGTC
T ss_pred cC---HHHHHHHHHHccCCHhHCcChHHHcC
Confidence 22 23788999999999999999998743
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-49 Score=368.45 Aligned_cols=225 Identities=22% Similarity=0.310 Sum_probs=174.1
Q ss_pred cCcccceeeeecCceEEEEEEe-CCCcEEEEEec------------------------cCCccccceEEEecCceEEEEE
Q 042435 143 EYFHIRYCIGTGGYDSVYKAEL-PDGKVVALKKL------------------------HHSETEDSAFVVYSPQCMFFIY 197 (412)
Q Consensus 143 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l------------------------~~~~~~~~~~~~~~~~~~~lv~ 197 (412)
++|++.+.||+|+||+||+|.. .+|+.||||.+ +|+|+.+...++.+++..|+||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 6899999999999999999976 46999999954 5888888888899999999999
Q ss_pred EeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCC
Q 042435 198 EYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVD 277 (412)
Q Consensus 198 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~ 277 (412)
||+ +|+|.+++.... .+++.+...++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+|+.....
T Consensus 93 Ey~-~g~L~~~l~~~~---~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~ 165 (275)
T 3hyh_A 93 EYA-GNELFDYIVQRD---KMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG 165 (275)
T ss_dssp ECC-CEEHHHHHHHSC---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSSCC------
T ss_pred eCC-CCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecCCCeecCCC
Confidence 999 689999887654 599999999999999999999999 9999999999999999999999999999875433
Q ss_pred CCCcccccccccccccccccCccc-CcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccchhh
Q 042435 278 SSNRTLQAGTYGYIALELVYTMVV-TEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKI 356 (412)
Q Consensus 278 ~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 356 (412)
. ......||+.|||||++.+..+ +.++||||+||++|||+||+.||... ........+....... +...
T Consensus 166 ~-~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~-------~~~~~~~~i~~~~~~~--p~~~ 235 (275)
T 3hyh_A 166 N-FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDE-------SIPVLFKNISNGVYTL--PKFL 235 (275)
T ss_dssp ----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCS-------SHHHHHHHHHHTCCCC--CTTS
T ss_pred C-ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCC-------CHHHHHHHHHcCCCCC--CCCC
Confidence 2 2345689999999999998876 57999999999999999999999732 1111122222222221 1222
Q ss_pred HHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 357 IQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 357 ~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
...+.+++.+||+.||++|||++|++++
T Consensus 236 ---s~~~~~li~~~L~~dP~~R~s~~eil~h 263 (275)
T 3hyh_A 236 ---SPGAAGLIKRMLIVNPLNRISIHEIMQD 263 (275)
T ss_dssp ---CHHHHHHHHHHSCSSGGGSCCHHHHHHC
T ss_pred ---CHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 2237889999999999999999999885
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=369.62 Aligned_cols=229 Identities=22% Similarity=0.304 Sum_probs=172.6
Q ss_pred cCcccceeeeecCceEEEEEEe-CCCcEEEEEec----------------------cCCccccceEEEecCc--------
Q 042435 143 EYFHIRYCIGTGGYDSVYKAEL-PDGKVVALKKL----------------------HHSETEDSAFVVYSPQ-------- 191 (412)
Q Consensus 143 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l----------------------~~~~~~~~~~~~~~~~-------- 191 (412)
++|++.+.||+|+||+||+|+. .+|+.||||++ +|+|+++....+.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 5699999999999999999976 47999999964 6888888777654332
Q ss_pred ----eEEEEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEee
Q 042435 192 ----CMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVAD 267 (412)
Q Consensus 192 ----~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~D 267 (412)
..|+|||||++|+|.+++.........++...+.++.||+.||+|||++ +|+||||||+|||++.++.+||+|
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~vKl~D 161 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGD 161 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcEEEcc
Confidence 4799999999999999998765444577888899999999999999999 999999999999999999999999
Q ss_pred cCCccccCCCCCC------------cccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCC
Q 042435 268 FGTVRLLDVDSSN------------RTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSG 335 (412)
Q Consensus 268 fGla~~~~~~~~~------------~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~ 335 (412)
||+|+........ ....+||+.|||||++.+..|+.++|||||||++|||++ ||....
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~------- 231 (299)
T 4g31_A 162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM------- 231 (299)
T ss_dssp CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH-------
T ss_pred CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc-------
Confidence 9999876543211 133579999999999999999999999999999999996 765211
Q ss_pred CcchhhHHhhhccCCccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 336 PKIMLIDILYQRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
. ....+........++........+.+++.+||+.||++|||+.|++++
T Consensus 232 --~-~~~~~~~~~~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 280 (299)
T 4g31_A 232 --E-RVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIEN 280 (299)
T ss_dssp --H-HHHHHHHHHTTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred --H-HHHHHHHHhcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 0 011111111111122223333446789999999999999999999874
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-46 Score=359.21 Aligned_cols=182 Identities=26% Similarity=0.366 Sum_probs=155.7
Q ss_pred HHHHHHhhcCcccceeeeecCceEEEEEEeC----CCcEEEEEec--------------------cCCccccceEEEecC
Q 042435 135 YENLIDATEYFHIRYCIGTGGYDSVYKAELP----DGKVVALKKL--------------------HHSETEDSAFVVYSP 190 (412)
Q Consensus 135 ~~~l~~~~~~f~~~~~lG~G~~g~Vy~~~~~----~~~~vAvK~l--------------------~~~~~~~~~~~~~~~ 190 (412)
++.+.+..+.|++.+.||+|+||+||+|+.+ +++.||+|++ +|+++.....++.+.
T Consensus 13 ~~~~p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~ 92 (361)
T 4f9c_A 13 YEAVPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHPIRIAAELQCLTVAGGQDNVMGVKYCFRKN 92 (361)
T ss_dssp HHHSGGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSCHHHHHHHHHHHHHTCSBTTBCCCSEEEEET
T ss_pred HHhcCCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccCHHHHHHHHHHHHHhcCCCCCceEEEEEEEC
Confidence 3444556788999999999999999999652 4789999964 478888888889999
Q ss_pred ceEEEEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCC-CcEEEeecC
Q 042435 191 QCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSN-LEAFVADFG 269 (412)
Q Consensus 191 ~~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~-~~~kl~DfG 269 (412)
+..|+|||||++|+|.+++. .+++.+...++.|++.||+|||++ +|+||||||+|||++.+ +.+||+|||
T Consensus 93 ~~~~lvmE~~~g~~L~~~~~------~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl~DFG 163 (361)
T 4f9c_A 93 DHVVIAMPYLEHESFLDILN------SLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALVDFG 163 (361)
T ss_dssp TEEEEEEECCCCCCHHHHHT------TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred CEEEEEEeCCCcccHHHHHc------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEECcCC
Confidence 99999999999999999884 388999999999999999999999 99999999999999876 799999999
Q ss_pred CccccCCCCC----------------------------CcccccccccccccccccCc-ccCcccccHHHHHHHHHHHhC
Q 042435 270 TVRLLDVDSS----------------------------NRTLQAGTYGYIALELVYTM-VVTEKCVIYSFGVVALEVLMG 320 (412)
Q Consensus 270 la~~~~~~~~----------------------------~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~S~Gvil~elltg 320 (412)
+|+....... .....+||+.|+|||++.+. .++.++||||+||++|||+||
T Consensus 164 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G 243 (361)
T 4f9c_A 164 LAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSG 243 (361)
T ss_dssp TCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHT
T ss_pred CCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHC
Confidence 9986532211 11334799999999999875 489999999999999999999
Q ss_pred CCCcc
Q 042435 321 THPGE 325 (412)
Q Consensus 321 ~~P~~ 325 (412)
+.||.
T Consensus 244 ~~Pf~ 248 (361)
T 4f9c_A 244 RYPFY 248 (361)
T ss_dssp CSSSS
T ss_pred CCCCC
Confidence 99995
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=361.20 Aligned_cols=238 Identities=21% Similarity=0.254 Sum_probs=179.9
Q ss_pred hcCcccceeeeecCceEEEEEEe-CCCcEEEEEec-----------------------cCCccccceEEEec------Cc
Q 042435 142 TEYFHIRYCIGTGGYDSVYKAEL-PDGKVVALKKL-----------------------HHSETEDSAFVVYS------PQ 191 (412)
Q Consensus 142 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l-----------------------~~~~~~~~~~~~~~------~~ 191 (412)
.++|++.+.||+|+||+||+|.. .+|+.||||++ +|+|++....++.. .+
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 35799999999999999999976 57999999965 57777777766543 36
Q ss_pred eEEEEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCc
Q 042435 192 CMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTV 271 (412)
Q Consensus 192 ~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla 271 (412)
..|+|||||+ |+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|
T Consensus 133 ~~~ivmE~~~-g~L~~~i~~~~---~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFGla 205 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQIIHSSQ---PLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMA 205 (398)
T ss_dssp CEEEEEECCS-EEHHHHHTSSS---CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEEeCCC-CCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeeccee
Confidence 7899999995 78999887654 599999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCC----CCCcccccccccccccccccCc-ccCcccccHHHHHHHHHHHhCCCCcccccccc--------cCCCCc-
Q 042435 272 RLLDVD----SSNRTLQAGTYGYIALELVYTM-VVTEKCVIYSFGVVALEVLMGTHPGELLLSLS--------SSSGPK- 337 (412)
Q Consensus 272 ~~~~~~----~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~--------~~~~~~- 337 (412)
+.+... .......+||+.|||||++.+. .++.++||||+||++|||++|+.||....... ......
T Consensus 206 ~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~ 285 (398)
T 4b99_A 206 RGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPA 285 (398)
T ss_dssp BCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGG
T ss_pred eecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChH
Confidence 876432 1223456899999999998775 56899999999999999999999996321000 000000
Q ss_pred -------chhhHHhhhccCCccchhh----HHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 338 -------IMLIDILYQRLSPPINQKI----IQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 338 -------~~~~~~~~~~~~~~~~~~~----~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
....... .......+... ......+.+|+.+||..||++|||+.|+++|
T Consensus 286 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 345 (398)
T 4b99_A 286 VIQAVGAERVRAYI-QSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH 345 (398)
T ss_dssp GTC-----CHHHHH-HSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred Hhhhhhhhhhhhhh-hcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0000000 01111000000 0112347899999999999999999999886
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-45 Score=372.99 Aligned_cols=228 Identities=20% Similarity=0.267 Sum_probs=186.7
Q ss_pred hcCcccceeeeecCceEEEEEEe-CCCcEEEEEec---------------------------cCCccccceEEEecCceE
Q 042435 142 TEYFHIRYCIGTGGYDSVYKAEL-PDGKVVALKKL---------------------------HHSETEDSAFVVYSPQCM 193 (412)
Q Consensus 142 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l---------------------------~~~~~~~~~~~~~~~~~~ 193 (412)
.++|++.++||+|+||+||+|+. .+|+.||||.+ +|++++.....+.+.+.+
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 36899999999999999999977 46999999964 478888888899999999
Q ss_pred EEEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccc
Q 042435 194 FFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRL 273 (412)
Q Consensus 194 ~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~ 273 (412)
|+|||||+||+|.++|.... .+++.....++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+.
T Consensus 268 ylVmEy~~GGdL~~~l~~~~---~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL~DFGlA~~ 341 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLSQHG---VFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACD 341 (689)
T ss_dssp EEEECCCCSCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEecccceeee
Confidence 99999999999999997643 589999999999999999999998 999999999999999999999999999987
Q ss_pred cCCCCCCcccccccccccccccccC-cccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcch-hhHHhhhccCCc
Q 042435 274 LDVDSSNRTLQAGTYGYIALELVYT-MVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIM-LIDILYQRLSPP 351 (412)
Q Consensus 274 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 351 (412)
..... ....+||+.|||||++.. ..|+.++|+||+||++|||++|+.||.... ...... ...+.......
T Consensus 342 ~~~~~--~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~-----~~~~~~i~~~i~~~~~~~- 413 (689)
T 3v5w_A 342 FSKKK--PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHK-----TKDKHEIDRMTLTMAVEL- 413 (689)
T ss_dssp CSSCC--CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGG-----CCCHHHHHHHHHHCCCCC-
T ss_pred cCCCC--CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC-----hHHHHHHHHhhcCCCCCC-
Confidence 65432 234689999999999974 579999999999999999999999997321 111111 11222222221
Q ss_pred cchhhHHHHHHHHHHHHhcCcCCCCCCCC-----HHHHHHH
Q 042435 352 INQKIIQDIILVSTIALACLRSKPKSRPT-----MQRISQE 387 (412)
Q Consensus 352 ~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs-----~~evl~~ 387 (412)
+.... ..+.+|+.+||+.||++|++ ++||.+|
T Consensus 414 -p~~~S---~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~H 450 (689)
T 3v5w_A 414 -PDSFS---PELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 450 (689)
T ss_dssp -CTTSC---HHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTS
T ss_pred -CccCC---HHHHHHHHHHccCCHhHCCCCCCCCHHHHhcC
Confidence 12222 23789999999999999998 6888764
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=345.73 Aligned_cols=262 Identities=31% Similarity=0.512 Sum_probs=210.9
Q ss_pred CccccHHHHHHhhcCcccceeeeecCceEEEEEEeCCCcEEEEEec----------------------cCCccccceEEE
Q 042435 130 DGKILYENLIDATEYFHIRYCIGTGGYDSVYKAELPDGKVVALKKL----------------------HHSETEDSAFVV 187 (412)
Q Consensus 130 ~~~~~~~~l~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~l----------------------~~~~~~~~~~~~ 187 (412)
...+++.++...+++|++.+.||+|+||.||+|...+|+.||||++ +|+++.....++
T Consensus 17 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 96 (326)
T 3uim_A 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 96 (326)
T ss_dssp CEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEE
T ss_pred cceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEE
Confidence 3468889999999999999999999999999999888999999965 466777777788
Q ss_pred ecCceEEEEEEeccCCceeeeeccCcc-cccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEe
Q 042435 188 YSPQCMFFIYEYMERGSLFCVLRDDDE-AIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVA 266 (412)
Q Consensus 188 ~~~~~~~lv~ey~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~ 266 (412)
...+..++||||+++|+|.+++..... ...++|..+..++.|++.||+|||+++.++|+||||||+|||++.++.+||+
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~ 176 (326)
T 3uim_A 97 MTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVG 176 (326)
T ss_dssp CCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEEC
T ss_pred ecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEec
Confidence 888999999999999999999976542 3359999999999999999999999877899999999999999999999999
Q ss_pred ecCCccccCCCCCC-cccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCccccccccc----------CCC
Q 042435 267 DFGTVRLLDVDSSN-RTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSS----------SSG 335 (412)
Q Consensus 267 DfGla~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~----------~~~ 335 (412)
|||+++........ .....||+.|+|||++.+..++.++||||||+++|||+||+.||+....... ...
T Consensus 177 Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 256 (326)
T 3uim_A 177 DFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL 256 (326)
T ss_dssp CCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTT
T ss_pred cCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHh
Confidence 99999876543322 2345699999999999888899999999999999999999999963211100 000
Q ss_pred CcchhhHHhhhccCCccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhcCCCC
Q 042435 336 PKIMLIDILYQRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELEGKTPM 394 (412)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~ 394 (412)
.........+....... .......+.+++.+||+.||++|||+.|++++|++....
T Consensus 257 ~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~~ 312 (326)
T 3uim_A 257 KEKKLEALVDVDLQGNY---KDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLA 312 (326)
T ss_dssp SSCCSTTSSCTTCTTSC---CHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSCS
T ss_pred hchhhhhhcChhhcccc---CHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcchh
Confidence 01111111222222221 234445689999999999999999999999999986543
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-44 Score=366.79 Aligned_cols=232 Identities=21% Similarity=0.257 Sum_probs=189.7
Q ss_pred hcCcccceeeeecCceEEEEEEe-CCCcEEEEEec---------------------cCCccccceEEEecCceEEEEEEe
Q 042435 142 TEYFHIRYCIGTGGYDSVYKAEL-PDGKVVALKKL---------------------HHSETEDSAFVVYSPQCMFFIYEY 199 (412)
Q Consensus 142 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l---------------------~~~~~~~~~~~~~~~~~~~lv~ey 199 (412)
.++|++.+.||+|+||.||+|.. .+|+.||+|.+ +|+++.....++.+.+..|+||||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 36899999999999999999977 47999999954 688999999999999999999999
Q ss_pred ccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCC--CcEEEeecCCccccCCC
Q 042435 200 MERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSN--LEAFVADFGTVRLLDVD 277 (412)
Q Consensus 200 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~--~~~kl~DfGla~~~~~~ 277 (412)
|++|+|.+++..... .+++.+...++.||+.||+|||++ +|+||||||+|||++.+ +.+||+|||+|+.+...
T Consensus 236 ~~gg~L~~~i~~~~~--~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~ 310 (573)
T 3uto_A 236 MSGGELFEKVADEHN--KMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 310 (573)
T ss_dssp CCCCBHHHHHTCTTS--CEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT
T ss_pred cCCCcHHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeeccceeEccCC
Confidence 999999998865432 488999999999999999999999 99999999999999854 89999999999987543
Q ss_pred CCCcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccchhhH
Q 042435 278 SSNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKII 357 (412)
Q Consensus 278 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 357 (412)
. .....+||+.|||||++.+..|+.++||||+||++|||++|+.||... .....+..+.......+. ....
T Consensus 311 ~-~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~-------~~~~~~~~i~~~~~~~~~-~~~~ 381 (573)
T 3uto_A 311 Q-SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGE-------NDDETLRNVKSCDWNMDD-SAFS 381 (573)
T ss_dssp S-EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCS-------SHHHHHHHHHTTCCCCCS-GGGT
T ss_pred C-ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc-------CHHHHHHHHHhCCCCCCc-cccc
Confidence 3 234458999999999999999999999999999999999999999732 111222222222222111 1111
Q ss_pred HHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 358 QDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 358 ~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
.....+.+|+.+||+.||++|||+.|+++|
T Consensus 382 ~~s~~~~dli~~~L~~dp~~R~t~~e~l~H 411 (573)
T 3uto_A 382 GISEDGKDFIRKLLLADPNTRMTIHQALEH 411 (573)
T ss_dssp TSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 122347899999999999999999999885
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=339.26 Aligned_cols=258 Identities=31% Similarity=0.427 Sum_probs=203.1
Q ss_pred cccHHHHHHhhcCcccceeeeecCceEEEEEEeCCCcEEEEEec---------------------cCCccccceEEEecC
Q 042435 132 KILYENLIDATEYFHIRYCIGTGGYDSVYKAELPDGKVVALKKL---------------------HHSETEDSAFVVYSP 190 (412)
Q Consensus 132 ~~~~~~l~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~l---------------------~~~~~~~~~~~~~~~ 190 (412)
++.+.++..++++|++.+.||+|+||.||+|.+.+++.||||++ +|+++......+...
T Consensus 28 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 107 (321)
T 2qkw_B 28 RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDER 107 (321)
T ss_dssp --CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCT
T ss_pred eecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCC
Confidence 45667778899999999999999999999999988999999964 577777777888888
Q ss_pred ceEEEEEEeccCCceeeeeccCcc-cccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecC
Q 042435 191 QCMFFIYEYMERGSLFCVLRDDDE-AIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFG 269 (412)
Q Consensus 191 ~~~~lv~ey~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG 269 (412)
+..++||||+++|+|.+++..... ...++|..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||
T Consensus 108 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg 184 (321)
T 2qkw_B 108 NEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFG 184 (321)
T ss_dssp TCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEECCCT
T ss_pred CeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEEeecc
Confidence 999999999999999999876532 23589999999999999999999998 99999999999999999999999999
Q ss_pred CccccCCCC--CCcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCC--------Ccch
Q 042435 270 TVRLLDVDS--SNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSG--------PKIM 339 (412)
Q Consensus 270 la~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~--------~~~~ 339 (412)
+++...... .......||+.|+|||++.+..++.++||||||+++|||+||+.||........... ....
T Consensus 185 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 264 (321)
T 2qkw_B 185 ISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQ 264 (321)
T ss_dssp TCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTC
T ss_pred cccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhcccccc
Confidence 998654322 122344689999999999888999999999999999999999999863211000000 0000
Q ss_pred hhHHhhhccCCccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhcCCCCC
Q 042435 340 LIDILYQRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELEGKTPMK 395 (412)
Q Consensus 340 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~~ 395 (412)
+.+.+++..... ........+.+++.+||+.||++|||+.|++++|+.+....
T Consensus 265 ~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~~ 317 (321)
T 2qkw_B 265 LEQIVDPNLADK---IRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQ 317 (321)
T ss_dssp CCSSSSSSCTTC---SCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred HHHhcChhhccc---cCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhcc
Confidence 001111111111 12344556889999999999999999999999999876543
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-43 Score=335.10 Aligned_cols=245 Identities=28% Similarity=0.395 Sum_probs=186.6
Q ss_pred HHHHHhhcCcccceeeeecCceEEEEEEeCCCcEEEEEec-----------------------cCCccccceEEEecCce
Q 042435 136 ENLIDATEYFHIRYCIGTGGYDSVYKAELPDGKVVALKKL-----------------------HHSETEDSAFVVYSPQC 192 (412)
Q Consensus 136 ~~l~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~l-----------------------~~~~~~~~~~~~~~~~~ 192 (412)
.++....++|++.+.||+|+||.||+|+. +|+.||||.+ +|+++......+...+.
T Consensus 30 ~~~~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 108 (309)
T 3p86_A 30 DDMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPN 108 (309)
T ss_dssp --CBCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTC
T ss_pred ccccCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCc
Confidence 33444467899999999999999999987 6889999964 46777777888888889
Q ss_pred EEEEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCC--cEEeCCCCCCEEecCCCcEEEeecCC
Q 042435 193 MFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPS--IVHRDISSNNILLNSNLEAFVADFGT 270 (412)
Q Consensus 193 ~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~--ivHrDlkp~NILl~~~~~~kl~DfGl 270 (412)
.++||||+++|+|.+++........+++..++.++.|++.||+|||++ + |+||||||+||+++.++.+||+|||+
T Consensus 109 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~ 185 (309)
T 3p86_A 109 LSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKVCDFGL 185 (309)
T ss_dssp CEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEECCCC-
T ss_pred eEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEECCCCC
Confidence 999999999999999998765444599999999999999999999998 7 99999999999999999999999999
Q ss_pred ccccCCCCCCcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCC
Q 042435 271 VRLLDVDSSNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSP 350 (412)
Q Consensus 271 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 350 (412)
++.............||+.|+|||++.+..++.++||||||+++|||+||+.||... ................
T Consensus 186 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~-------~~~~~~~~~~~~~~~~ 258 (309)
T 3p86_A 186 SRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNL-------NPAQVVAAVGFKCKRL 258 (309)
T ss_dssp ----------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTS-------CHHHHHHHHHHSCCCC
T ss_pred CccccccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-------CHHHHHHHHHhcCCCC
Confidence 986544433344567999999999999999999999999999999999999998732 1111111111111111
Q ss_pred ccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhcCCCC
Q 042435 351 PINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELEGKTPM 394 (412)
Q Consensus 351 ~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~ 394 (412)
..+... ...+.+++.+||+.||++|||+.|+++.|+.+...
T Consensus 259 ~~~~~~---~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~ 299 (309)
T 3p86_A 259 EIPRNL---NPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS 299 (309)
T ss_dssp CCCTTS---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred CCCccC---CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 212222 22378899999999999999999999999887653
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=329.03 Aligned_cols=230 Identities=23% Similarity=0.315 Sum_probs=189.8
Q ss_pred hhcCcccceeeeecCceEEEEEEe-CCCcEEEEEec---------------------cCCccccceEEEecCceEEEEEE
Q 042435 141 ATEYFHIRYCIGTGGYDSVYKAEL-PDGKVVALKKL---------------------HHSETEDSAFVVYSPQCMFFIYE 198 (412)
Q Consensus 141 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l---------------------~~~~~~~~~~~~~~~~~~~lv~e 198 (412)
..++|++.+.||+|+||+||+|.. .+++.||||.+ +|+++......+...+..++|||
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 97 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEE
Confidence 346799999999999999999976 57999999964 57888888888888999999999
Q ss_pred eccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCC
Q 042435 199 YMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDS 278 (412)
Q Consensus 199 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~ 278 (412)
|+++|+|.+++... .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 98 ~~~~~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 170 (297)
T 3fxz_A 98 YLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (297)
T ss_dssp CCTTCBHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred CCCCCCHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc
Confidence 99999999998754 389999999999999999999999 99999999999999999999999999998776655
Q ss_pred CCcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhcc-CCccchhhH
Q 042435 279 SNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRL-SPPINQKII 357 (412)
Q Consensus 279 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 357 (412)
.......||+.|+|||++.+..++.++|||||||++|||+||+.||.... ............. ....+.
T Consensus 171 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~-------~~~~~~~~~~~~~~~~~~~~--- 240 (297)
T 3fxz_A 171 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN-------PLRALYLIATNGTPELQNPE--- 240 (297)
T ss_dssp CCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSC-------HHHHHHHHHHHCSCCCSCGG---
T ss_pred cccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC-------HHHHHHHHHhCCCCCCCCcc---
Confidence 55556689999999999999999999999999999999999999986321 1111111111111 111111
Q ss_pred HHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 358 QDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 358 ~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
.....+.+++.+||+.||++|||++|++++
T Consensus 241 ~~~~~~~~li~~~l~~dp~~Rps~~ell~h 270 (297)
T 3fxz_A 241 KLSAIFRDFLNRCLEMDVEKRGSAKELLQH 270 (297)
T ss_dssp GSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 122347889999999999999999999875
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=331.11 Aligned_cols=241 Identities=23% Similarity=0.328 Sum_probs=195.7
Q ss_pred ccccHHHHHHhhcC----------cccceeeeecCceEEEEEEeC-CCcEEEEEec---------------------cCC
Q 042435 131 GKILYENLIDATEY----------FHIRYCIGTGGYDSVYKAELP-DGKVVALKKL---------------------HHS 178 (412)
Q Consensus 131 ~~~~~~~l~~~~~~----------f~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l---------------------~~~ 178 (412)
+.++++++..+++. |+..+.||+|+||.||+|... +|+.||||.+ +|+
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ 102 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF 102 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence 46788898888864 777889999999999999875 7999999964 467
Q ss_pred ccccceEEEecCceEEEEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEec
Q 042435 179 ETEDSAFVVYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLN 258 (412)
Q Consensus 179 ~~~~~~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~ 258 (412)
++......+...+..++||||+++|+|.+++... .+++..+..++.|++.||+|||+. +|+||||||+||+++
T Consensus 103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~ 175 (321)
T 2c30_A 103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV----RLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSILLT 175 (321)
T ss_dssp TBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEC
T ss_pred CcceEEEEEEECCEEEEEEecCCCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEC
Confidence 7777777888889999999999999999988654 489999999999999999999998 999999999999999
Q ss_pred CCCcEEEeecCCccccCCCCCCcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcc
Q 042435 259 SNLEAFVADFGTVRLLDVDSSNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKI 338 (412)
Q Consensus 259 ~~~~~kl~DfGla~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~ 338 (412)
.++.+||+|||+++.............||+.|+|||++.+..++.++||||||+++|||++|+.||.... . .
T Consensus 176 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~-------~-~ 247 (321)
T 2c30_A 176 LDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDS-------P-V 247 (321)
T ss_dssp TTCCEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC-------H-H
T ss_pred CCCcEEEeeeeeeeecccCccccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-------H-H
Confidence 9999999999999876654444455689999999999999999999999999999999999999986321 1 1
Q ss_pred hhhHHhhhccCCccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 339 MLIDILYQRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 339 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
.....+.....+.. .........+.+++.+||+.||++|||+.|++++
T Consensus 248 ~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 248 QAMKRLRDSPPPKL-KNSHKVSPVLRDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp HHHHHHHHSSCCCC-TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHHHhcCCCCCc-CccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11111222111111 1111122347889999999999999999999986
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-43 Score=331.16 Aligned_cols=239 Identities=24% Similarity=0.357 Sum_probs=184.4
Q ss_pred hcCcccceeeeecCceEEEEEEeCCCcEEEEEec--------------------cCCccccceEEEec----CceEEEEE
Q 042435 142 TEYFHIRYCIGTGGYDSVYKAELPDGKVVALKKL--------------------HHSETEDSAFVVYS----PQCMFFIY 197 (412)
Q Consensus 142 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~l--------------------~~~~~~~~~~~~~~----~~~~~lv~ 197 (412)
.++|++.+.||+|+||+||+|.. +++.||||.+ +|+++......+.. ....++||
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv~ 85 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLIT 85 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGGGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccccchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEeh
Confidence 46899999999999999999988 7899999964 57777776655332 45689999
Q ss_pred EeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHH--------hCCCCCcEEeCCCCCCEEecCCCcEEEeecC
Q 042435 198 EYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLH--------HDCTPSIVHRDISSNNILLNSNLEAFVADFG 269 (412)
Q Consensus 198 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH--------~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG 269 (412)
||+++|+|.++++.. .+++..+..++.|++.||+||| +. +|+||||||+|||++.++.+||+|||
T Consensus 86 e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg 158 (301)
T 3q4u_A 86 HYHEMGSLYDYLQLT----TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNGQCCIADLG 158 (301)
T ss_dssp CCCTTCBHHHHHTTC----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTSCEEECCCT
T ss_pred hhccCCCHHHHHhhc----ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCCCEEEeeCC
Confidence 999999999999654 4899999999999999999999 66 99999999999999999999999999
Q ss_pred CccccCCCCCC----cccccccccccccccccCc------ccCcccccHHHHHHHHHHHhC----------CCCcccccc
Q 042435 270 TVRLLDVDSSN----RTLQAGTYGYIALELVYTM------VVTEKCVIYSFGVVALEVLMG----------THPGELLLS 329 (412)
Q Consensus 270 la~~~~~~~~~----~~~~~gt~~y~aPE~~~~~------~~s~ksDv~S~Gvil~elltg----------~~P~~~~~~ 329 (412)
+++........ .....||+.|+|||++.+. .++.++|||||||++|||+|| +.||.....
T Consensus 159 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~ 238 (301)
T 3q4u_A 159 LAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVP 238 (301)
T ss_dssp TCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSC
T ss_pred CeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCC
Confidence 99765443322 1234799999999999876 566799999999999999999 667652211
Q ss_pred cccCCCCcchhhHHhh-hccCCccch--hhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhcC
Q 042435 330 LSSSSGPKIMLIDILY-QRLSPPINQ--KIIQDIILVSTIALACLRSKPKSRPTMQRISQELEGK 391 (412)
Q Consensus 330 ~~~~~~~~~~~~~~~~-~~~~~~~~~--~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 391 (412)
............. ....+..+. ........+.+++.+||+.||++|||+.|+++.|+++
T Consensus 239 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 239 ---NDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp ---SSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred ---CCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 0011111111111 111111111 1123345688999999999999999999999999875
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-42 Score=323.85 Aligned_cols=254 Identities=28% Similarity=0.433 Sum_probs=201.3
Q ss_pred ccccHHHHHHhhcCcccc------eeeeecCceEEEEEEeCCCcEEEEEec-------------------------cCCc
Q 042435 131 GKILYENLIDATEYFHIR------YCIGTGGYDSVYKAELPDGKVVALKKL-------------------------HHSE 179 (412)
Q Consensus 131 ~~~~~~~l~~~~~~f~~~------~~lG~G~~g~Vy~~~~~~~~~vAvK~l-------------------------~~~~ 179 (412)
..+++.++..++++|... +.||+|+||.||+|.. +++.||+|++ +|++
T Consensus 13 ~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 91 (307)
T 2nru_A 13 HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHEN 91 (307)
T ss_dssp EECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTT
T ss_pred CcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCC
Confidence 367899999999999887 8999999999999987 6889999964 4667
Q ss_pred cccceEEEecCceEEEEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecC
Q 042435 180 TEDSAFVVYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNS 259 (412)
Q Consensus 180 ~~~~~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~ 259 (412)
+.....++...+..++||||+++|+|.+++........++|..+..++.|++.||+|||++ +++||||||+||+++.
T Consensus 92 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nili~~ 168 (307)
T 2nru_A 92 LVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDE 168 (307)
T ss_dssp BCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECT
T ss_pred eEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEcC
Confidence 7777777888889999999999999999987654444699999999999999999999999 9999999999999999
Q ss_pred CCcEEEeecCCccccCCCCCC--cccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccC----
Q 042435 260 NLEAFVADFGTVRLLDVDSSN--RTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSS---- 333 (412)
Q Consensus 260 ~~~~kl~DfGla~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~---- 333 (412)
++.+||+|||+++........ .....||+.|+|||.+.+ .++.++||||||+++|||++|+.||.........
T Consensus 169 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~ 247 (307)
T 2nru_A 169 AFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIK 247 (307)
T ss_dssp TCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHH
T ss_pred CCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHH
Confidence 999999999999865443222 233568999999998865 5889999999999999999999998743211000
Q ss_pred ---CCCcchhhHHhhhccCCccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhcCCC
Q 042435 334 ---SGPKIMLIDILYQRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELEGKTP 393 (412)
Q Consensus 334 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 393 (412)
......+.+.++.... .........+.+++.+||+.||++|||+.|++++|+++..
T Consensus 248 ~~~~~~~~~~~~~~~~~~~----~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~ 306 (307)
T 2nru_A 248 EEIEDEEKTIEDYIDKKMN----DADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306 (307)
T ss_dssp HHHHTTSCCHHHHSCSSCS----CCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred HHhhhhhhhhhhhcccccc----ccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence 0000011122222221 1122334458899999999999999999999999998753
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=336.59 Aligned_cols=237 Identities=22% Similarity=0.332 Sum_probs=191.9
Q ss_pred hcCcccceeeeecCceEEEEEEe--------CCCcEEEEEec-----------------------cCCccccceEEEecC
Q 042435 142 TEYFHIRYCIGTGGYDSVYKAEL--------PDGKVVALKKL-----------------------HHSETEDSAFVVYSP 190 (412)
Q Consensus 142 ~~~f~~~~~lG~G~~g~Vy~~~~--------~~~~~vAvK~l-----------------------~~~~~~~~~~~~~~~ 190 (412)
.++|++.+.||+|+||.||+|.. .++..||||.+ +|+++......+...
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 46799999999999999999975 24568999965 578888888888889
Q ss_pred ceEEEEEEeccCCceeeeeccCcc-------------cccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEe
Q 042435 191 QCMFFIYEYMERGSLFCVLRDDDE-------------AIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILL 257 (412)
Q Consensus 191 ~~~~lv~ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl 257 (412)
+..++||||+++|+|.+++..... ...+++..++.++.|++.||+|||++ +|+||||||+|||+
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll 236 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLV 236 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEE
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchhhEEE
Confidence 999999999999999999875431 12489999999999999999999999 99999999999999
Q ss_pred cCCCcEEEeecCCccccCCCCC--CcccccccccccccccccCcccCcccccHHHHHHHHHHHh-CCCCcccccccccCC
Q 042435 258 NSNLEAFVADFGTVRLLDVDSS--NRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLM-GTHPGELLLSLSSSS 334 (412)
Q Consensus 258 ~~~~~~kl~DfGla~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~ellt-g~~P~~~~~~~~~~~ 334 (412)
+.++.+||+|||+++....... ......+|+.|+|||++.+..++.++|||||||++|||+| |+.||...
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~------- 309 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI------- 309 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC-------
T ss_pred CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCC-------
Confidence 9999999999999986644322 2233457889999999999999999999999999999999 99998732
Q ss_pred CCcchhhHHhhhccCCccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhcCC
Q 042435 335 GPKIMLIDILYQRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELEGKT 392 (412)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 392 (412)
....+...+........+... ...+.+++.+||+.||++|||+.|+++.|+++.
T Consensus 310 -~~~~~~~~~~~~~~~~~~~~~---~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il 363 (370)
T 2psq_A 310 -PVEELFKLLKEGHRMDKPANC---TNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 363 (370)
T ss_dssp -CGGGHHHHHHTTCCCCCCTTS---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -CHHHHHHHHhcCCCCCCCCCC---CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 111222333332222222222 224788999999999999999999999998864
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=323.76 Aligned_cols=238 Identities=25% Similarity=0.407 Sum_probs=191.8
Q ss_pred hcCcccceeeeecCceEEEEEEe-CCCcEEEEEec---------------------cCCccccceEEEecCceEEEEEEe
Q 042435 142 TEYFHIRYCIGTGGYDSVYKAEL-PDGKVVALKKL---------------------HHSETEDSAFVVYSPQCMFFIYEY 199 (412)
Q Consensus 142 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l---------------------~~~~~~~~~~~~~~~~~~~lv~ey 199 (412)
.++|.+.+.||+|+||+||+|.. .+++.||+|++ +|+++......+...+..++||||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY 88 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence 35788999999999999999987 46899999953 688888888889999999999999
Q ss_pred ccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCCC
Q 042435 200 MERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSS 279 (412)
Q Consensus 200 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 279 (412)
+++|+|.+++..... .+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.......
T Consensus 89 ~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 163 (310)
T 3s95_A 89 IKGGTLRGIIKSMDS--QYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKT 163 (310)
T ss_dssp CTTCBHHHHHHHCCT--TSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTCEECC----
T ss_pred cCCCcHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccceecccccc
Confidence 999999999976432 589999999999999999999999 999999999999999999999999999987643322
Q ss_pred Cc--------------ccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhh
Q 042435 280 NR--------------TLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILY 345 (412)
Q Consensus 280 ~~--------------~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~ 345 (412)
.. ....||+.|+|||++.+..++.++||||||+++|||++|..|+....... ............
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~--~~~~~~~~~~~~ 241 (310)
T 3s95_A 164 QPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRT--MDFGLNVRGFLD 241 (310)
T ss_dssp ----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBC--TTSSBCHHHHHH
T ss_pred cccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhH--HHHhhhhhcccc
Confidence 11 14579999999999999999999999999999999999999986322111 111111222222
Q ss_pred hccCCccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhcCCC
Q 042435 346 QRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELEGKTP 393 (412)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 393 (412)
.......+ ..+.+++.+||+.||++|||+.|+++.|+.+..
T Consensus 242 ~~~~~~~~-------~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~ 282 (310)
T 3s95_A 242 RYCPPNCP-------PSFFPITVRCCDLDPEKRPSFVKLEHWLETLRM 282 (310)
T ss_dssp HTCCTTCC-------TTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ccCCCCCC-------HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 22222211 127789999999999999999999999988754
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-42 Score=318.57 Aligned_cols=237 Identities=21% Similarity=0.284 Sum_probs=191.7
Q ss_pred hcCcccceeeeecCceEEEEEEeCCCcEEEEEec--------------------cCCccccceEEEecCceEEEEEEecc
Q 042435 142 TEYFHIRYCIGTGGYDSVYKAELPDGKVVALKKL--------------------HHSETEDSAFVVYSPQCMFFIYEYME 201 (412)
Q Consensus 142 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~l--------------------~~~~~~~~~~~~~~~~~~~lv~ey~~ 201 (412)
.++|++.+.||+|+||.||+|...++..||+|.+ +|+++......+...+..++||||++
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYIS 86 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEccC
Confidence 4678999999999999999999988889999964 56777777888888889999999999
Q ss_pred CCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCCCC-
Q 042435 202 RGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSN- 280 (412)
Q Consensus 202 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~- 280 (412)
+|+|.+++.... ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++........
T Consensus 87 ~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~ 161 (268)
T 3sxs_A 87 NGCLLNYLRSHG--KGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVS 161 (268)
T ss_dssp TCBHHHHHHHHG--GGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEEE
T ss_pred CCcHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccceecchhhhhc
Confidence 999999987643 2489999999999999999999999 9999999999999999999999999999865443221
Q ss_pred cccccccccccccccccCcccCcccccHHHHHHHHHHHh-CCCCcccccccccCCCCcchhhHHhhhccCCccchhhHHH
Q 042435 281 RTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLM-GTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKIIQD 359 (412)
Q Consensus 281 ~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 359 (412)
.....+|+.|+|||.+.+..++.++||||||+++|||+| |+.||.... ... .............+...
T Consensus 162 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~-------~~~-~~~~~~~~~~~~~~~~~--- 230 (268)
T 3sxs_A 162 SVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYT-------NSE-VVLKVSQGHRLYRPHLA--- 230 (268)
T ss_dssp CCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSC-------HHH-HHHHHHTTCCCCCCTTS---
T ss_pred ccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccC-------hHH-HHHHHHcCCCCCCCCcC---
Confidence 223456778999999998889999999999999999999 999986321 111 11111111111111111
Q ss_pred HHHHHHHHHhcCcCCCCCCCCHHHHHHHHhcCCCC
Q 042435 360 IILVSTIALACLRSKPKSRPTMQRISQELEGKTPM 394 (412)
Q Consensus 360 ~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~ 394 (412)
...+.+++.+||+.||++|||+.|++++|+.+.+.
T Consensus 231 ~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (268)
T 3sxs_A 231 SDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK 265 (268)
T ss_dssp CHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred hHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence 12378899999999999999999999999998764
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=327.75 Aligned_cols=228 Identities=22% Similarity=0.305 Sum_probs=188.1
Q ss_pred hcCcccceeeeecCceEEEEEEeC-CCcEEEEEec------------------------cCCccccceEEEecCceEEEE
Q 042435 142 TEYFHIRYCIGTGGYDSVYKAELP-DGKVVALKKL------------------------HHSETEDSAFVVYSPQCMFFI 196 (412)
Q Consensus 142 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l------------------------~~~~~~~~~~~~~~~~~~~lv 196 (412)
.++|++.+.||+|+||.||+|+.. +|+.||+|.+ +|+++......+...+..++|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 367999999999999999999874 6999999965 467777778888899999999
Q ss_pred EEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCC
Q 042435 197 YEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDV 276 (412)
Q Consensus 197 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~ 276 (412)
|||+++|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 84 ~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 157 (337)
T 1o6l_A 84 MEYANGGELFFHLSRER---VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp EECCTTCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred EeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeeccchhhccc
Confidence 99999999998886543 589999999999999999999999 999999999999999999999999999986544
Q ss_pred CCCCcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccchhh
Q 042435 277 DSSNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKI 356 (412)
Q Consensus 277 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 356 (412)
.........||+.|+|||++.+..++.++|||||||++|||++|+.||... ........+.......+ ...
T Consensus 158 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~-------~~~~~~~~i~~~~~~~p--~~~ 228 (337)
T 1o6l_A 158 DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ-------DHERLFELILMEEIRFP--RTL 228 (337)
T ss_dssp TTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCS-------SHHHHHHHHHHCCCCCC--TTS
T ss_pred CCCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCC-------CHHHHHHHHHcCCCCCC--CCC
Confidence 444445568999999999999999999999999999999999999998632 11111222222222221 111
Q ss_pred HHHHHHHHHHHHhcCcCCCCCCC-----CHHHHHHH
Q 042435 357 IQDIILVSTIALACLRSKPKSRP-----TMQRISQE 387 (412)
Q Consensus 357 ~~~~~~~~~l~~~Cl~~dP~~RP-----s~~evl~~ 387 (412)
...+.+++.+||+.||++|| +++|++++
T Consensus 229 ---s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 229 ---SPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp ---CHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred ---CHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 22378899999999999999 89999875
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-42 Score=329.90 Aligned_cols=238 Identities=27% Similarity=0.361 Sum_probs=189.7
Q ss_pred cCcccceeeeecCceEEEEEEeC----CCcEEEEEec----------------------cCCccccceEEEecCceEEEE
Q 042435 143 EYFHIRYCIGTGGYDSVYKAELP----DGKVVALKKL----------------------HHSETEDSAFVVYSPQCMFFI 196 (412)
Q Consensus 143 ~~f~~~~~lG~G~~g~Vy~~~~~----~~~~vAvK~l----------------------~~~~~~~~~~~~~~~~~~~lv 196 (412)
++|++.+.||+|+||.||+|.+. .+..||||.+ +|+++.....++...+..++|
T Consensus 49 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 128 (325)
T 3kul_A 49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIV 128 (325)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEE
T ss_pred hHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEE
Confidence 56888999999999999999874 3556999965 577788888888888999999
Q ss_pred EEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCC
Q 042435 197 YEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDV 276 (412)
Q Consensus 197 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~ 276 (412)
|||+++|+|.++++.... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 129 ~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 203 (325)
T 3kul_A 129 TEYMENGSLDTFLRTHDG--QFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLED 203 (325)
T ss_dssp EECCTTCBHHHHHHTTTT--CSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCSSCEECC-
T ss_pred eeCCCCCcHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCCCccccccc
Confidence 999999999999965432 589999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCCc---ccccccccccccccccCcccCcccccHHHHHHHHHHHh-CCCCcccccccccCCCCcchhhHHhhhccCCcc
Q 042435 277 DSSNR---TLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLM-GTHPGELLLSLSSSSGPKIMLIDILYQRLSPPI 352 (412)
Q Consensus 277 ~~~~~---~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 352 (412)
..... ....+|+.|+|||++.+..++.++||||||+++|||++ |+.||... ........+......+.
T Consensus 204 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~--------~~~~~~~~~~~~~~~~~ 275 (325)
T 3kul_A 204 DPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNM--------TNRDVISSVEEGYRLPA 275 (325)
T ss_dssp ---CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTS--------CHHHHHHHHHTTCCCCC
T ss_pred CccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccC--------CHHHHHHHHHcCCCCCC
Confidence 32221 22346778999999998899999999999999999999 99998632 11112222222222222
Q ss_pred chhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhcCCCCCC
Q 042435 353 NQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELEGKTPMKK 396 (412)
Q Consensus 353 ~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~~~ 396 (412)
+... ...+.+++.+||+.||++|||+.|+++.|+++....+
T Consensus 276 ~~~~---~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~ 316 (325)
T 3kul_A 276 PMGC---PHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPE 316 (325)
T ss_dssp CTTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC
T ss_pred CCCc---CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCcc
Confidence 2222 2247889999999999999999999999998865544
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=334.29 Aligned_cols=235 Identities=21% Similarity=0.328 Sum_probs=186.5
Q ss_pred hcCcccceeeeecCceEEEEEEeC-CCcEEEEEec-------------------------cCCccccceEEEecCceEEE
Q 042435 142 TEYFHIRYCIGTGGYDSVYKAELP-DGKVVALKKL-------------------------HHSETEDSAFVVYSPQCMFF 195 (412)
Q Consensus 142 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l-------------------------~~~~~~~~~~~~~~~~~~~l 195 (412)
.++|++.++||+|+||.||+|+.. +++.||+|.+ +|+++......+.+.+..++
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 467999999999999999999875 5889999965 46777777788888999999
Q ss_pred EEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccC
Q 042435 196 IYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLD 275 (412)
Q Consensus 196 v~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~ 275 (412)
||||+++|+|..++.... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 131 V~E~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFGla~~~~ 204 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQRQR---KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 204 (396)
T ss_dssp EEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEEcCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEeecceeeecc
Confidence 999999999998887543 589999999999999999999999 99999999999999999999999999998644
Q ss_pred CCCCCcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCC-Ccc-hhhHHhhhccCCccc
Q 042435 276 VDSSNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSG-PKI-MLIDILYQRLSPPIN 353 (412)
Q Consensus 276 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~-~~~-~~~~~~~~~~~~~~~ 353 (412)
.........+||+.|+|||++.+..++.++|||||||++|||++|+.||........... ... ....+.......+
T Consensus 205 ~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p-- 282 (396)
T 4dc2_A 205 RPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP-- 282 (396)
T ss_dssp CTTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCCC--
T ss_pred cCCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCCC--
Confidence 444445567899999999999999999999999999999999999999963211110000 111 1122222222221
Q ss_pred hhhHHHHHHHHHHHHhcCcCCCCCCCCH------HHHHHH
Q 042435 354 QKIIQDIILVSTIALACLRSKPKSRPTM------QRISQE 387 (412)
Q Consensus 354 ~~~~~~~~~~~~l~~~Cl~~dP~~RPs~------~evl~~ 387 (412)
... ...+.+++.+||+.||++||++ .|++++
T Consensus 283 ~~~---s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~H 319 (396)
T 4dc2_A 283 RSL---SVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 319 (396)
T ss_dssp TTS---CHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHS
T ss_pred CcC---CHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcC
Confidence 221 2237889999999999999985 666654
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-42 Score=333.70 Aligned_cols=228 Identities=23% Similarity=0.346 Sum_probs=183.6
Q ss_pred hcCcccceeeeecCceEEEEEEeC-CCcEEEEEec-------------------------cCCccccceEEEecCceEEE
Q 042435 142 TEYFHIRYCIGTGGYDSVYKAELP-DGKVVALKKL-------------------------HHSETEDSAFVVYSPQCMFF 195 (412)
Q Consensus 142 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l-------------------------~~~~~~~~~~~~~~~~~~~l 195 (412)
.++|++.+.||+|+||.||+|+.. +|+.||||.+ +|+++......+.+.+..++
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 101 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF 101 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence 478999999999999999999874 6899999964 47788888888889999999
Q ss_pred EEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccC
Q 042435 196 IYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLD 275 (412)
Q Consensus 196 v~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~ 275 (412)
||||+++|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 102 v~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~DFG~a~~~~ 175 (353)
T 3txo_A 102 VMEFVNGGDLMFHIQKSR---RFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGI 175 (353)
T ss_dssp EEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred EEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEccccceeecc
Confidence 999999999999887543 589999999999999999999999 99999999999999999999999999998654
Q ss_pred CCCCCcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccchh
Q 042435 276 VDSSNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQK 355 (412)
Q Consensus 276 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 355 (412)
.........+||+.|+|||++.+..++.++|||||||++|||++|+.||... ........+.......+ ..
T Consensus 176 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~-------~~~~~~~~i~~~~~~~p--~~ 246 (353)
T 3txo_A 176 CNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAE-------NEDDLFEAILNDEVVYP--TW 246 (353)
T ss_dssp C---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCS-------SHHHHHHHHHHCCCCCC--TT
T ss_pred cCCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCC-------CHHHHHHHHHcCCCCCC--CC
Confidence 4444445568999999999999889999999999999999999999999732 11222233333333222 11
Q ss_pred hHHHHHHHHHHHHhcCcCCCCCCCCH------HHHHHH
Q 042435 356 IIQDIILVSTIALACLRSKPKSRPTM------QRISQE 387 (412)
Q Consensus 356 ~~~~~~~~~~l~~~Cl~~dP~~RPs~------~evl~~ 387 (412)
. ...+.+++.+||+.||++||++ .|++++
T Consensus 247 ~---~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~h 281 (353)
T 3txo_A 247 L---HEDATGILKSFMTKNPTMRLGSLTQGGEHAILRH 281 (353)
T ss_dssp S---CHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTS
T ss_pred C---CHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhC
Confidence 1 1237789999999999999998 777653
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-42 Score=328.81 Aligned_cols=248 Identities=22% Similarity=0.329 Sum_probs=189.3
Q ss_pred hhcCcccceeeeecCceEEEEEEeCCCcEEEEEec--------------------cCCccccceEEEecC----ceEEEE
Q 042435 141 ATEYFHIRYCIGTGGYDSVYKAELPDGKVVALKKL--------------------HHSETEDSAFVVYSP----QCMFFI 196 (412)
Q Consensus 141 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~l--------------------~~~~~~~~~~~~~~~----~~~~lv 196 (412)
..++|++.+.||+|+||.||+|++. ++.||||++ +|+++......+... ...++|
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv 100 (322)
T 3soc_A 22 QSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI 100 (322)
T ss_dssp TTEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred chhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCchHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence 3467999999999999999999885 799999964 577777777776653 347999
Q ss_pred EEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhC-------CCCCcEEeCCCCCCEEecCCCcEEEeecC
Q 042435 197 YEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHD-------CTPSIVHRDISSNNILLNSNLEAFVADFG 269 (412)
Q Consensus 197 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~-------~~~~ivHrDlkp~NILl~~~~~~kl~DfG 269 (412)
|||+++|+|.++++.. .++|..+..++.|++.||+|||+. +.++|+||||||+|||++.++.+||+|||
T Consensus 101 ~e~~~~g~L~~~l~~~----~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg 176 (322)
T 3soc_A 101 TAFHEKGSLSDFLKAN----VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFG 176 (322)
T ss_dssp EECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCT
T ss_pred EecCCCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCC
Confidence 9999999999999754 389999999999999999999975 23489999999999999999999999999
Q ss_pred CccccCCCCC--CcccccccccccccccccC-----cccCcccccHHHHHHHHHHHhCCCCccccccccc--------CC
Q 042435 270 TVRLLDVDSS--NRTLQAGTYGYIALELVYT-----MVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSS--------SS 334 (412)
Q Consensus 270 la~~~~~~~~--~~~~~~gt~~y~aPE~~~~-----~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~--------~~ 334 (412)
+++....... ......||+.|+|||++.+ ..++.++|||||||++|||+||+.||........ ..
T Consensus 177 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~ 256 (322)
T 3soc_A 177 LALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQH 256 (322)
T ss_dssp TCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSS
T ss_pred cccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccC
Confidence 9987654332 2234579999999999876 4567789999999999999999999864211100 00
Q ss_pred CCcchhhHHh-hhccCCccchh--hHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhcCCC
Q 042435 335 GPKIMLIDIL-YQRLSPPINQK--IIQDIILVSTIALACLRSKPKSRPTMQRISQELEGKTP 393 (412)
Q Consensus 335 ~~~~~~~~~~-~~~~~~~~~~~--~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 393 (412)
.......+.. .....+..... .......+.+++.+||+.||++|||+.|+++.|+++..
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~ 318 (322)
T 3soc_A 257 PSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQR 318 (322)
T ss_dssp CCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 0111111111 11222211111 11233458899999999999999999999999988753
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-42 Score=336.42 Aligned_cols=236 Identities=22% Similarity=0.303 Sum_probs=190.9
Q ss_pred hhcCcccceeeeecCceEEEEEEeC-CCcEEEEEec----------------------cCCccccceEEEecCceEEEEE
Q 042435 141 ATEYFHIRYCIGTGGYDSVYKAELP-DGKVVALKKL----------------------HHSETEDSAFVVYSPQCMFFIY 197 (412)
Q Consensus 141 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l----------------------~~~~~~~~~~~~~~~~~~~lv~ 197 (412)
..++|.+.+.||+|+||.||+|.+. +++.||||.+ +|+++.....++...+..++||
T Consensus 112 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 191 (377)
T 3cbl_A 112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVM 191 (377)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred chHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEE
Confidence 3467899999999999999999885 7899999964 4677777788888888999999
Q ss_pred EeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCC
Q 042435 198 EYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVD 277 (412)
Q Consensus 198 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~ 277 (412)
||+++|+|.++++... ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 192 e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~ 266 (377)
T 3cbl_A 192 ELVQGGDFLTFLRTEG--ARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEADG 266 (377)
T ss_dssp ECCTTCBHHHHHHHHG--GGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECTTS
T ss_pred EcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCCCceecCCC
Confidence 9999999999987543 2589999999999999999999999 9999999999999999999999999999864332
Q ss_pred CCC--cccccccccccccccccCcccCcccccHHHHHHHHHHHh-CCCCcccccccccCCCCcchhhHHhhhccCCccch
Q 042435 278 SSN--RTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLM-GTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQ 354 (412)
Q Consensus 278 ~~~--~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 354 (412)
... .....+++.|+|||.+.+..++.++|||||||++|||+| |..||.... .....+.+......+.+.
T Consensus 267 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~--------~~~~~~~~~~~~~~~~~~ 338 (377)
T 3cbl_A 267 VYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLS--------NQQTREFVEKGGRLPCPE 338 (377)
T ss_dssp EEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSC--------HHHHHHHHHTTCCCCCCT
T ss_pred ceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC--------HHHHHHHHHcCCCCCCCC
Confidence 111 112235778999999998899999999999999999998 999987321 112223333332222222
Q ss_pred hhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhcCC
Q 042435 355 KIIQDIILVSTIALACLRSKPKSRPTMQRISQELEGKT 392 (412)
Q Consensus 355 ~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 392 (412)
... ..+.+++.+||+.||++|||+.++++.|+++.
T Consensus 339 ~~~---~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~ 373 (377)
T 3cbl_A 339 LCP---DAVFRLMEQCWAYEPGQRPSFSTIYQELQSIR 373 (377)
T ss_dssp TCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCC---HHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence 222 23788999999999999999999999998764
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-42 Score=322.54 Aligned_cols=241 Identities=24% Similarity=0.300 Sum_probs=187.7
Q ss_pred hcCcccceeeeecCceEEEEEEe-CCCcEEEEEec------------------------cCCccccceEEEecCceEEEE
Q 042435 142 TEYFHIRYCIGTGGYDSVYKAEL-PDGKVVALKKL------------------------HHSETEDSAFVVYSPQCMFFI 196 (412)
Q Consensus 142 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l------------------------~~~~~~~~~~~~~~~~~~~lv 196 (412)
.++|++.+.||+|+||.||+|.. .+++.||+|.+ +|+++......+...+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 35799999999999999999976 46899999964 577788888888889999999
Q ss_pred EEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCC
Q 042435 197 YEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDV 276 (412)
Q Consensus 197 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~ 276 (412)
|||+++|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++....
T Consensus 90 ~e~~~g~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 163 (294)
T 4eqm_A 90 MEYIEGPTLSEYIESHG---PLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSE 163 (294)
T ss_dssp EECCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCSSSTTC--
T ss_pred EeCCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCCCcccccc
Confidence 99999999999987543 589999999999999999999999 999999999999999999999999999987654
Q ss_pred CCC-CcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccchh
Q 042435 277 DSS-NRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQK 355 (412)
Q Consensus 277 ~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 355 (412)
... ......||+.|+|||.+.+..++.++||||||+++|||+||+.||.... ....................
T Consensus 164 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~-------~~~~~~~~~~~~~~~~~~~~ 236 (294)
T 4eqm_A 164 TSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGET-------AVSIAIKHIQDSVPNVTTDV 236 (294)
T ss_dssp -----------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSC-------HHHHHHHHHSSCCCCHHHHS
T ss_pred ccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC-------hHHHHHHHhhccCCCcchhc
Confidence 322 2234569999999999999999999999999999999999999987321 11111111111111100000
Q ss_pred hHHHHHHHHHHHHhcCcCCCCCCC-CHHHHHHHHhcCCCCC
Q 042435 356 IIQDIILVSTIALACLRSKPKSRP-TMQRISQELEGKTPMK 395 (412)
Q Consensus 356 ~~~~~~~~~~l~~~Cl~~dP~~RP-s~~evl~~L~~~~~~~ 395 (412)
.......+.+++.+||+.||++|| +++++.+.|+......
T Consensus 237 ~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~ 277 (294)
T 4eqm_A 237 RKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHEN 277 (294)
T ss_dssp CTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSS
T ss_pred ccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhc
Confidence 011123478899999999999998 9999999999886543
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-42 Score=327.53 Aligned_cols=228 Identities=22% Similarity=0.339 Sum_probs=187.5
Q ss_pred hhcCcccceeeeecCceEEEEEEe-CCCcEEEEEec-----------------------cCCccccceEEEecCceEEEE
Q 042435 141 ATEYFHIRYCIGTGGYDSVYKAEL-PDGKVVALKKL-----------------------HHSETEDSAFVVYSPQCMFFI 196 (412)
Q Consensus 141 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l-----------------------~~~~~~~~~~~~~~~~~~~lv 196 (412)
..++|++.+.||+|+||.||+|.. .+|+.||||++ +|+++.....++...+..++|
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 92 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLI 92 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence 346899999999999999999987 67999999964 578888888888899999999
Q ss_pred EEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCC
Q 042435 197 YEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDV 276 (412)
Q Consensus 197 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~ 276 (412)
|||+++|+|.+++.... .+++.....++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 93 ~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 166 (328)
T 3fe3_A 93 MEYASGGEVFDYLVAHG---RMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTV 166 (328)
T ss_dssp ECCCTTCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTCCGGGSS
T ss_pred EECCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeeccCceecCC
Confidence 99999999999886543 589999999999999999999999 999999999999999999999999999986654
Q ss_pred CCCCcccccccccccccccccCcccC-cccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccchh
Q 042435 277 DSSNRTLQAGTYGYIALELVYTMVVT-EKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQK 355 (412)
Q Consensus 277 ~~~~~~~~~gt~~y~aPE~~~~~~~s-~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 355 (412)
.. ......||+.|+|||++.+..++ .++|||||||++|||++|+.||... ........+.......+ ..
T Consensus 167 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~-------~~~~~~~~i~~~~~~~p--~~ 236 (328)
T 3fe3_A 167 GG-KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQ-------NLKELRERVLRGKYRIP--FY 236 (328)
T ss_dssp SC-GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCS-------SHHHHHHHHHHCCCCCC--TT
T ss_pred CC-ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCC-------CHHHHHHHHHhCCCCCC--CC
Confidence 32 33456799999999999887765 7999999999999999999999732 11111122222222221 11
Q ss_pred hHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 356 IIQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 356 ~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
. ...+.+++.+||+.||++|||++|++++
T Consensus 237 ~---s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 237 M---STDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp S---CHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred C---CHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 1 2237789999999999999999999876
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=328.70 Aligned_cols=224 Identities=21% Similarity=0.226 Sum_probs=178.8
Q ss_pred cCcccceeeeecCceEEEEEEeC-CCcEEEEEec------------------------cCCccccceEEEecCceEEEEE
Q 042435 143 EYFHIRYCIGTGGYDSVYKAELP-DGKVVALKKL------------------------HHSETEDSAFVVYSPQCMFFIY 197 (412)
Q Consensus 143 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l------------------------~~~~~~~~~~~~~~~~~~~lv~ 197 (412)
++|++.++||+|+||+||+|... +|+.||||++ +|+++......+...+..++||
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~ 136 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT 136 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence 67999999999999999999875 7999999975 5778888888888999999999
Q ss_pred EeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCC
Q 042435 198 EYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVD 277 (412)
Q Consensus 198 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~ 277 (412)
||+ +++|.+++.... ..++|..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 137 e~~-~~~L~~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~ 210 (311)
T 3p1a_A 137 ELC-GPSLQQHCEAWG--ASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA 210 (311)
T ss_dssp ECC-CCBHHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCTTCEECC--
T ss_pred ecc-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccceeeeecccC
Confidence 999 679988876543 2599999999999999999999998 9999999999999999999999999999865433
Q ss_pred CCCcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccchhhH
Q 042435 278 SSNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKII 357 (412)
Q Consensus 278 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 357 (412)
. ......||+.|+|||++.+ .++.++|||||||++|||++|..|+..... ...+......+. ...
T Consensus 211 ~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~----------~~~~~~~~~~~~---~~~ 275 (311)
T 3p1a_A 211 G-AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG----------WQQLRQGYLPPE---FTA 275 (311)
T ss_dssp -----CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH----------HHHHTTTCCCHH---HHT
T ss_pred C-CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH----------HHHHhccCCCcc---ccc
Confidence 2 2334569999999998876 789999999999999999999766542111 111111111111 111
Q ss_pred HHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 358 QDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 358 ~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
.....+.+++.+||+.||++|||++|++++
T Consensus 276 ~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 305 (311)
T 3p1a_A 276 GLSSELRSVLVMMLEPDPKLRATAEALLAL 305 (311)
T ss_dssp TSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHhC
Confidence 122348899999999999999999999874
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=319.82 Aligned_cols=229 Identities=21% Similarity=0.266 Sum_probs=177.8
Q ss_pred hcCcccceeeeecCceEEEEEEe-CCCcEEEEEecc--------------------------------------------
Q 042435 142 TEYFHIRYCIGTGGYDSVYKAEL-PDGKVVALKKLH-------------------------------------------- 176 (412)
Q Consensus 142 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l~-------------------------------------------- 176 (412)
.++|++.+.||+|+||.||+|.. .+++.||||.++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 36799999999999999999976 468999999763
Q ss_pred ---CCccccceEEEec--CceEEEEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCC
Q 042435 177 ---HSETEDSAFVVYS--PQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDIS 251 (412)
Q Consensus 177 ---~~~~~~~~~~~~~--~~~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlk 251 (412)
|+++.....++.. .+..++||||+++|+|.+++... .+++..+..++.|++.||+|||++ +|+|||||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlk 164 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLK----PLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIK 164 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCSS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCC
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCC
Confidence 4455555555554 56889999999999999876543 489999999999999999999999 99999999
Q ss_pred CCCEEecCCCcEEEeecCCccccCCCCCCcccccccccccccccccCcc---cCcccccHHHHHHHHHHHhCCCCccccc
Q 042435 252 SNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTYGYIALELVYTMV---VTEKCVIYSFGVVALEVLMGTHPGELLL 328 (412)
Q Consensus 252 p~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~s~ksDv~S~Gvil~elltg~~P~~~~~ 328 (412)
|+||+++.++.+||+|||+++.............||+.|+|||.+.+.. ++.++|||||||++|||++|+.||....
T Consensus 165 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 244 (298)
T 2zv2_A 165 PSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER 244 (298)
T ss_dssp GGGEEECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred HHHEEECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCcc
Confidence 9999999999999999999987655444444567999999999997654 4788999999999999999999986321
Q ss_pred ccccCCCCcchhhHHhhhccCCccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 329 SLSSSSGPKIMLIDILYQRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 329 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
.......+.......+..... ...+.+++.+||+.||++|||+.|++++
T Consensus 245 -------~~~~~~~~~~~~~~~~~~~~~---~~~l~~li~~~l~~dp~~R~s~~e~l~h 293 (298)
T 2zv2_A 245 -------IMCLHSKIKSQALEFPDQPDI---AEDLKDLITRMLDKNPESRIVVPEIKLH 293 (298)
T ss_dssp -------HHHHHHHHHHCCCCCCSSSCC---CHHHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred -------HHHHHHHHhcccCCCCCcccc---CHHHHHHHHHHhhcChhhCCCHHHHhcC
Confidence 011111112222221111111 2237889999999999999999999764
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-42 Score=328.39 Aligned_cols=248 Identities=24% Similarity=0.365 Sum_probs=188.5
Q ss_pred HhhcCcccceeeeecCceEEEEEEeCCCcEEEEEec--------------------cCCccccceEEEecC----ceEEE
Q 042435 140 DATEYFHIRYCIGTGGYDSVYKAELPDGKVVALKKL--------------------HHSETEDSAFVVYSP----QCMFF 195 (412)
Q Consensus 140 ~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~l--------------------~~~~~~~~~~~~~~~----~~~~l 195 (412)
...++|++.+.||+|+||.||+|+.. ++.||||.+ +|+++......+... ...++
T Consensus 34 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~l 112 (337)
T 3mdy_A 34 TIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYL 112 (337)
T ss_dssp THHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEEE
T ss_pred ccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEeccccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceEE
Confidence 44578999999999999999999885 899999964 677887777776665 78999
Q ss_pred EEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCC-----CCCcEEeCCCCCCEEecCCCcEEEeecCC
Q 042435 196 IYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDC-----TPSIVHRDISSNNILLNSNLEAFVADFGT 270 (412)
Q Consensus 196 v~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~-----~~~ivHrDlkp~NILl~~~~~~kl~DfGl 270 (412)
||||+++|+|.++++.. .+++..+..++.|++.||+|||+++ .++|+||||||+|||++.++.+||+|||+
T Consensus 113 v~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~ 188 (337)
T 3mdy_A 113 ITDYHENGSLYDYLKST----TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 188 (337)
T ss_dssp EECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred EEeccCCCcHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeCCC
Confidence 99999999999999654 4899999999999999999999752 34899999999999999999999999999
Q ss_pred ccccCCCCCC----cccccccccccccccccCcccCcc------cccHHHHHHHHHHHhCC----------CCccccccc
Q 042435 271 VRLLDVDSSN----RTLQAGTYGYIALELVYTMVVTEK------CVIYSFGVVALEVLMGT----------HPGELLLSL 330 (412)
Q Consensus 271 a~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~s~k------sDv~S~Gvil~elltg~----------~P~~~~~~~ 330 (412)
++........ .....||+.|+|||++.+...+.+ +|||||||++|||+||. .||.....
T Consensus 189 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~- 267 (337)
T 3mdy_A 189 AVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVP- 267 (337)
T ss_dssp CEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSC-
T ss_pred ceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcC-
Confidence 9765443222 124579999999999987766654 99999999999999994 44432110
Q ss_pred ccCCCCcchhhHHh-hhccCCccchh--hHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhcCCCCC
Q 042435 331 SSSSGPKIMLIDIL-YQRLSPPINQK--IIQDIILVSTIALACLRSKPKSRPTMQRISQELEGKTPMK 395 (412)
Q Consensus 331 ~~~~~~~~~~~~~~-~~~~~~~~~~~--~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~~ 395 (412)
............ .....+..+.. .......+.+++.+||+.||++|||+.|++++|+++.+..
T Consensus 268 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~ 333 (337)
T 3mdy_A 268 --SDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQ 333 (337)
T ss_dssp --SSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred --CCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhc
Confidence 001111111111 11222222111 1234455889999999999999999999999999886543
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-42 Score=333.96 Aligned_cols=245 Identities=21% Similarity=0.283 Sum_probs=193.9
Q ss_pred HHHHHHhhcCcccceeeeecCceEEEEEEe------CCCcEEEEEec-----------------------cCCccccceE
Q 042435 135 YENLIDATEYFHIRYCIGTGGYDSVYKAEL------PDGKVVALKKL-----------------------HHSETEDSAF 185 (412)
Q Consensus 135 ~~~l~~~~~~f~~~~~lG~G~~g~Vy~~~~------~~~~~vAvK~l-----------------------~~~~~~~~~~ 185 (412)
..+.....++|++.+.||+|+||.||+|.+ .+++.||||++ +|+++.....
T Consensus 14 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~ 93 (359)
T 3vhe_A 14 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG 93 (359)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeee
Confidence 455556778999999999999999999974 34689999975 4677777777
Q ss_pred EEecCc-eEEEEEEeccCCceeeeeccCcc--------------------------------------------------
Q 042435 186 VVYSPQ-CMFFIYEYMERGSLFCVLRDDDE-------------------------------------------------- 214 (412)
Q Consensus 186 ~~~~~~-~~~lv~ey~~~gsL~~~l~~~~~-------------------------------------------------- 214 (412)
.+...+ ..++||||+++|+|.+++.....
T Consensus 94 ~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (359)
T 3vhe_A 94 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSL 173 (359)
T ss_dssp EECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC--------------------------------------------
T ss_pred eeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccccc
Confidence 776654 48999999999999999876432
Q ss_pred -------------cccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCCC--
Q 042435 215 -------------AIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSS-- 279 (412)
Q Consensus 215 -------------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~-- 279 (412)
...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.......
T Consensus 174 ~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 250 (359)
T 3vhe_A 174 SDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV 250 (359)
T ss_dssp ----------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCE
T ss_pred chhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeecccccch
Confidence 11288999999999999999999999 999999999999999999999999999986644322
Q ss_pred CcccccccccccccccccCcccCcccccHHHHHHHHHHHh-CCCCcccccccccCCCCcchhhHHhhhccCCccchhhHH
Q 042435 280 NRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLM-GTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKIIQ 358 (412)
Q Consensus 280 ~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 358 (412)
......||+.|+|||++.+..++.++||||||+++|||+| |+.||... .........+........+....
T Consensus 251 ~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~-------~~~~~~~~~~~~~~~~~~~~~~~- 322 (359)
T 3vhe_A 251 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV-------KIDEEFCRRLKEGTRMRAPDYTT- 322 (359)
T ss_dssp EC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC-------CCSHHHHHHHHHTCCCCCCTTCC-
T ss_pred hccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCcc-------chhHHHHHHHHcCCCCCCCCCCC-
Confidence 2234568899999999999999999999999999999998 99998632 11222333333332222222222
Q ss_pred HHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhcCC
Q 042435 359 DIILVSTIALACLRSKPKSRPTMQRISQELEGKT 392 (412)
Q Consensus 359 ~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 392 (412)
..+.+++.+||+.||++|||+.|++++|+++.
T Consensus 323 --~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~ 354 (359)
T 3vhe_A 323 --PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 354 (359)
T ss_dssp --HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --HHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence 23788999999999999999999999998764
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-42 Score=334.60 Aligned_cols=240 Identities=14% Similarity=0.195 Sum_probs=183.6
Q ss_pred hhcCcccceeeeecCceEEEEEEeCC------CcEEEEEec--------------------------------cCCcccc
Q 042435 141 ATEYFHIRYCIGTGGYDSVYKAELPD------GKVVALKKL--------------------------------HHSETED 182 (412)
Q Consensus 141 ~~~~f~~~~~lG~G~~g~Vy~~~~~~------~~~vAvK~l--------------------------------~~~~~~~ 182 (412)
..++|++.+.||+|+||.||+|.+.+ ++.||||.+ +|+++..
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 45689999999999999999998754 478999974 2667777
Q ss_pred ceEEEecC----ceEEEEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEec
Q 042435 183 SAFVVYSP----QCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLN 258 (412)
Q Consensus 183 ~~~~~~~~----~~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~ 258 (412)
....+... ...++||||+ +++|.+++.... ..+++..++.++.|++.||+|||++ +|+||||||+|||++
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~--~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Nill~ 186 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANA--KRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLLN 186 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEE
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHEEEe
Confidence 66665543 5589999999 999999987642 2599999999999999999999999 999999999999998
Q ss_pred --CCCcEEEeecCCccccCCCCCC-------cccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccc
Q 042435 259 --SNLEAFVADFGTVRLLDVDSSN-------RTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLS 329 (412)
Q Consensus 259 --~~~~~kl~DfGla~~~~~~~~~-------~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~ 329 (412)
.++.+||+|||+++.+...... .....||+.|+|||++.+..++.++|||||||++|||+||+.||.....
T Consensus 187 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~ 266 (364)
T 3op5_A 187 YKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLK 266 (364)
T ss_dssp SSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTT
T ss_pred cCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcccccc
Confidence 8899999999999866432211 1334599999999999999999999999999999999999999973210
Q ss_pred cccCC-----CCcchhhHHhhhccCCccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhcCC
Q 042435 330 LSSSS-----GPKIMLIDILYQRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELEGKT 392 (412)
Q Consensus 330 ~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 392 (412)
..... .......+..+..+... .....+.+++..||+.||++||++.++++.|+++.
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~ 328 (364)
T 3op5_A 267 DPKYVRDSKIRYRENIASLMDKCFPAA------NAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGL 328 (364)
T ss_dssp CHHHHHHHHHHHHHCHHHHHHHHSCTT------CCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHhhhhHHHHHHHhcccc------cCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Confidence 00000 00000111111111100 11234788999999999999999999999997654
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-42 Score=318.66 Aligned_cols=234 Identities=22% Similarity=0.309 Sum_probs=190.3
Q ss_pred cCcccceeeeecCceEEEEEEeCCCcEEEEEec--------------------cCCccccceEEEecCceEEEEEEeccC
Q 042435 143 EYFHIRYCIGTGGYDSVYKAELPDGKVVALKKL--------------------HHSETEDSAFVVYSPQCMFFIYEYMER 202 (412)
Q Consensus 143 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~l--------------------~~~~~~~~~~~~~~~~~~~lv~ey~~~ 202 (412)
++|++.+.||+|+||.||+|...+++.||+|++ +|+++......+.+.+..++||||+++
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 89 (269)
T 4hcu_A 10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEH 89 (269)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTT
T ss_pred hhceeeheecCCCccEEEEEEecCCCeEEEEEecccccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCCC
Confidence 578999999999999999999988999999964 567777777888888899999999999
Q ss_pred CceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCC-CCc
Q 042435 203 GSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDS-SNR 281 (412)
Q Consensus 203 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~-~~~ 281 (412)
|+|.+++..... .+++..+..++.|++.||+|||++ +++||||||+||+++.++.+||+|||+++...... ...
T Consensus 90 ~~L~~~l~~~~~--~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 164 (269)
T 4hcu_A 90 GCLSDYLRTQRG--LFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS 164 (269)
T ss_dssp CBHHHHHHTTTT--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHST
T ss_pred CcHHHHHHhcCc--ccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEeccccccccccccccccc
Confidence 999999976442 489999999999999999999999 99999999999999999999999999998654321 112
Q ss_pred ccccccccccccccccCcccCcccccHHHHHHHHHHHh-CCCCcccccccccCCCCcchhhHHhhhccCCccchhhHHHH
Q 042435 282 TLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLM-GTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKIIQDI 360 (412)
Q Consensus 282 ~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 360 (412)
....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||... ......+.+........+... .
T Consensus 165 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~--------~~~~~~~~~~~~~~~~~~~~~---~ 233 (269)
T 4hcu_A 165 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR--------SNSEVVEDISTGFRLYKPRLA---S 233 (269)
T ss_dssp TSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC--------CHHHHHHHHHTTCCCCCCTTS---C
T ss_pred cCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCC--------CHHHHHHHHhcCccCCCCCcC---C
Confidence 33456788999999998899999999999999999999 99998732 111122222222222211211 2
Q ss_pred HHHHHHHHhcCcCCCCCCCCHHHHHHHHhcCC
Q 042435 361 ILVSTIALACLRSKPKSRPTMQRISQELEGKT 392 (412)
Q Consensus 361 ~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 392 (412)
..+.+++.+||+.||++|||+.|++++|+++.
T Consensus 234 ~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~ 265 (269)
T 4hcu_A 234 THVYQIMNHCWRERPEDRPAFSRLLRQLAEIA 265 (269)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHHHHccCCcccCcCHHHHHHHHHHHH
Confidence 23788999999999999999999999998865
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=329.18 Aligned_cols=230 Identities=23% Similarity=0.339 Sum_probs=186.9
Q ss_pred HHhhcCcccceeeeecCceEEEEEEeC-CCcEEEEEec-------------------------cCCccccceEEEecCce
Q 042435 139 IDATEYFHIRYCIGTGGYDSVYKAELP-DGKVVALKKL-------------------------HHSETEDSAFVVYSPQC 192 (412)
Q Consensus 139 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l-------------------------~~~~~~~~~~~~~~~~~ 192 (412)
....++|++.+.||+|+||.||+|+.+ +|+.||||.+ +|+++......+.+.+.
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~ 92 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN 92 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence 345678999999999999999999875 6899999964 57777788888889999
Q ss_pred EEEEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCcc
Q 042435 193 MFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVR 272 (412)
Q Consensus 193 ~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~ 272 (412)
.++||||+++|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 93 ~~lv~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~ 166 (345)
T 1xjd_A 93 LFFVMEYLNGGDLMYHIQSCH---KFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCK 166 (345)
T ss_dssp EEEEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred EEEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEeEChhhh
Confidence 999999999999999987543 589999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCCcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCcc
Q 042435 273 LLDVDSSNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPI 352 (412)
Q Consensus 273 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 352 (412)
.............||+.|+|||++.+..++.++|||||||++|||++|+.||... ........+.......
T Consensus 167 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~-------~~~~~~~~i~~~~~~~-- 237 (345)
T 1xjd_A 167 ENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQ-------DEEELFHSIRMDNPFY-- 237 (345)
T ss_dssp CCCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS-------SHHHHHHHHHHCCCCC--
T ss_pred hcccCCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCC-------CHHHHHHHHHhCCCCC--
Confidence 6544444445668999999999999999999999999999999999999998732 1111122222222211
Q ss_pred chhhHHHHHHHHHHHHhcCcCCCCCCCCHH-HHHH
Q 042435 353 NQKIIQDIILVSTIALACLRSKPKSRPTMQ-RISQ 386 (412)
Q Consensus 353 ~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~-evl~ 386 (412)
+... ...+.+++.+||+.||++||++. |+.+
T Consensus 238 p~~~---s~~~~~li~~lL~~dp~~R~~~~~~i~~ 269 (345)
T 1xjd_A 238 PRWL---EKEAKDLLVKLFVREPEKRLGVRGDIRQ 269 (345)
T ss_dssp CTTS---CHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred Cccc---CHHHHHHHHHHhcCCHhHcCCChHHHHc
Confidence 1111 22378899999999999999997 6653
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-41 Score=323.06 Aligned_cols=230 Identities=21% Similarity=0.292 Sum_probs=181.2
Q ss_pred hcCcccceeeeecCceEEEEEEeC-CCcEEEEEec----------------------cCCccccceEEEecCc-------
Q 042435 142 TEYFHIRYCIGTGGYDSVYKAELP-DGKVVALKKL----------------------HHSETEDSAFVVYSPQ------- 191 (412)
Q Consensus 142 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l----------------------~~~~~~~~~~~~~~~~------- 191 (412)
.++|++.+.||+|+||.||+|... +|+.||||++ +|+++......+.+..
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 467999999999999999999885 7999999965 4666666655543322
Q ss_pred --------------------------------------------------eEEEEEEeccCCceeeeeccCcccccCCHH
Q 042435 192 --------------------------------------------------CMFFIYEYMERGSLFCVLRDDDEAIELNWT 221 (412)
Q Consensus 192 --------------------------------------------------~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~ 221 (412)
..++||||+++|+|.+++.........++.
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 164 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence 379999999999999999876655567888
Q ss_pred HHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCCC------------Cccccccccc
Q 042435 222 RRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSS------------NRTLQAGTYG 289 (412)
Q Consensus 222 ~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~------------~~~~~~gt~~ 289 (412)
.++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++....... ......||+.
T Consensus 165 ~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 241 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred HHHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence 8999999999999999999 999999999999999999999999999987654321 1233569999
Q ss_pred ccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccchhhHHHHHHHHHHHHh
Q 042435 290 YIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKIIQDIILVSTIALA 369 (412)
Q Consensus 290 y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 369 (412)
|+|||++.+..++.++||||||+++|||++|..|+... ............+.........+.+++.+
T Consensus 242 y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~-------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 308 (332)
T 3qd2_B 242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER-------------VRIITDVRNLKFPLLFTQKYPQEHMMVQD 308 (332)
T ss_dssp GSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH-------------HHHHHHHHTTCCCHHHHHHCHHHHHHHHH
T ss_pred ccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH-------------HHHHHHhhccCCCcccccCChhHHHHHHH
Confidence 99999999999999999999999999999998875421 11111111111122223333457889999
Q ss_pred cCcCCCCCCCCHHHHHHH
Q 042435 370 CLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 370 Cl~~dP~~RPs~~evl~~ 387 (412)
||+.||++|||+.|++++
T Consensus 309 ~l~~~p~~Rps~~~~l~~ 326 (332)
T 3qd2_B 309 MLSPSPTERPEATDIIEN 326 (332)
T ss_dssp HHCSSGGGSCCHHHHHHS
T ss_pred HccCCCCcCCCHHHHhhc
Confidence 999999999999999875
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=323.15 Aligned_cols=232 Identities=22% Similarity=0.245 Sum_probs=186.7
Q ss_pred hcCcccceeeeecCceEEEEEEeC-CCcEEEEEec----------------------cCCccccceEEEecCceEEEEEE
Q 042435 142 TEYFHIRYCIGTGGYDSVYKAELP-DGKVVALKKL----------------------HHSETEDSAFVVYSPQCMFFIYE 198 (412)
Q Consensus 142 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l----------------------~~~~~~~~~~~~~~~~~~~lv~e 198 (412)
.++|++.+.||+|+||.||+|... +++.||||.+ +|+++......+...+..++|||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 468999999999999999999775 7999999964 56777777888888999999999
Q ss_pred eccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCC
Q 042435 199 YMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDS 278 (412)
Q Consensus 199 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~ 278 (412)
|+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 86 ~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 159 (323)
T 3tki_A 86 YCSGGELFDRIEPDI---GMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159 (323)
T ss_dssp CCTTEEGGGGSBTTT---BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred cCCCCcHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeeccceeccCC
Confidence 999999999987654 589999999999999999999998 99999999999999999999999999998654322
Q ss_pred --CCcccccccccccccccccCccc-CcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccchh
Q 042435 279 --SNRTLQAGTYGYIALELVYTMVV-TEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQK 355 (412)
Q Consensus 279 --~~~~~~~gt~~y~aPE~~~~~~~-s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 355 (412)
.......||+.|+|||++.+..+ +.++|||||||++|||++|+.||.... ................+....
T Consensus 160 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~------~~~~~~~~~~~~~~~~~~~~~ 233 (323)
T 3tki_A 160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS------DSCQEYSDWKEKKTYLNPWKK 233 (323)
T ss_dssp EECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSC------TTSHHHHHHHTTCTTSTTGGG
T ss_pred cccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCc------hHHHHHHHHhcccccCCcccc
Confidence 22234579999999999987765 778999999999999999999997321 111112222222221111111
Q ss_pred hHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHH
Q 042435 356 IIQDIILVSTIALACLRSKPKSRPTMQRISQEL 388 (412)
Q Consensus 356 ~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L 388 (412)
....+.+++.+||+.||++|||+.|++++-
T Consensus 234 ---~~~~~~~li~~~L~~dP~~R~t~~eil~h~ 263 (323)
T 3tki_A 234 ---IDSAPLALLHKILVENPSARITIPDIKKDR 263 (323)
T ss_dssp ---SCHHHHHHHHHHSCSSTTTSCCHHHHTTCT
T ss_pred ---CCHHHHHHHHHHccCChhhCcCHHHHhhCh
Confidence 223377899999999999999999998763
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=327.86 Aligned_cols=242 Identities=21% Similarity=0.290 Sum_probs=194.4
Q ss_pred HhhcCcccceeeeecCceEEEEEEe------CCCcEEEEEec-----------------------cCCccccceEEEecC
Q 042435 140 DATEYFHIRYCIGTGGYDSVYKAEL------PDGKVVALKKL-----------------------HHSETEDSAFVVYSP 190 (412)
Q Consensus 140 ~~~~~f~~~~~lG~G~~g~Vy~~~~------~~~~~vAvK~l-----------------------~~~~~~~~~~~~~~~ 190 (412)
-..++|++.+.||+|+||.||+|.. .+++.||+|.+ +|+++......+...
T Consensus 42 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 121 (344)
T 1rjb_A 42 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS 121 (344)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred cCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeC
Confidence 3457899999999999999999985 24668999964 577788888888888
Q ss_pred ceEEEEEEeccCCceeeeeccCccc--------------------ccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCC
Q 042435 191 QCMFFIYEYMERGSLFCVLRDDDEA--------------------IELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDI 250 (412)
Q Consensus 191 ~~~~lv~ey~~~gsL~~~l~~~~~~--------------------~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDl 250 (412)
+..++||||+++|+|.+++...... ..+++..++.++.|++.||+|||++ +|+||||
T Consensus 122 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Di 198 (344)
T 1rjb_A 122 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDL 198 (344)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTC
T ss_pred CccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCC
Confidence 9999999999999999998764321 2379999999999999999999999 9999999
Q ss_pred CCCCEEecCCCcEEEeecCCccccCCCCCC--cccccccccccccccccCcccCcccccHHHHHHHHHHHh-CCCCcccc
Q 042435 251 SSNNILLNSNLEAFVADFGTVRLLDVDSSN--RTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLM-GTHPGELL 327 (412)
Q Consensus 251 kp~NILl~~~~~~kl~DfGla~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~ellt-g~~P~~~~ 327 (412)
||+||+++.++.+||+|||+++........ .....||+.|+|||.+.+..++.++||||||+++|||+| |..||...
T Consensus 199 kp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 278 (344)
T 1rjb_A 199 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI 278 (344)
T ss_dssp SGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred ChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccC
Confidence 999999999999999999999866543322 234467889999999988899999999999999999998 99998732
Q ss_pred cccccCCCCcchhhHHhhhccCCccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhcCCCC
Q 042435 328 LSLSSSSGPKIMLIDILYQRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELEGKTPM 394 (412)
Q Consensus 328 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~ 394 (412)
.........+......+.+... ...+.+++.+||+.||++|||+.|++++|+.+...
T Consensus 279 -------~~~~~~~~~~~~~~~~~~~~~~---~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 335 (344)
T 1rjb_A 279 -------PVDANFYKLIQNGFKMDQPFYA---TEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLAD 335 (344)
T ss_dssp -------CCSHHHHHHHHTTCCCCCCTTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred -------CcHHHHHHHHhcCCCCCCCCCC---CHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 1222233334333333222222 22378899999999999999999999999988754
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-42 Score=334.03 Aligned_cols=235 Identities=26% Similarity=0.370 Sum_probs=179.3
Q ss_pred cCcccceeeeecCceEEEEEEeC----CCcEEEEEec----------------------cCCccccceEEEecCceEEEE
Q 042435 143 EYFHIRYCIGTGGYDSVYKAELP----DGKVVALKKL----------------------HHSETEDSAFVVYSPQCMFFI 196 (412)
Q Consensus 143 ~~f~~~~~lG~G~~g~Vy~~~~~----~~~~vAvK~l----------------------~~~~~~~~~~~~~~~~~~~lv 196 (412)
++|++.+.||+|+||.||+|... ++..||||.+ +|+++.....++...+..++|
T Consensus 45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 124 (373)
T 2qol_A 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV 124 (373)
T ss_dssp GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEE
Confidence 57999999999999999999874 5778999965 477888888888888999999
Q ss_pred EEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCC
Q 042435 197 YEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDV 276 (412)
Q Consensus 197 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~ 276 (412)
|||+++|+|.++++... ..+++.++..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 125 ~e~~~~~sL~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 199 (373)
T 2qol_A 125 TEYMENGSLDSFLRKHD--AQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRVLED 199 (373)
T ss_dssp EECCTTCBHHHHHHTTT--TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EeCCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcCcccccccc
Confidence 99999999999997653 2589999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCCc---ccccccccccccccccCcccCcccccHHHHHHHHHHHh-CCCCcccccccccCCCCcchhhHHhhhccCCcc
Q 042435 277 DSSNR---TLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLM-GTHPGELLLSLSSSSGPKIMLIDILYQRLSPPI 352 (412)
Q Consensus 277 ~~~~~---~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 352 (412)
..... ....+++.|+|||++.+..++.++||||||+++|||++ |+.||... ......+.+......+.
T Consensus 200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~--------~~~~~~~~i~~~~~~~~ 271 (373)
T 2qol_A 200 DPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEM--------SNQDVIKAVDEGYRLPP 271 (373)
T ss_dssp --------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTC--------CHHHHHHHHHTTEECCC
T ss_pred CCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCC--------CHHHHHHHHHcCCCCCC
Confidence 32211 22245778999999998899999999999999999998 99998632 11122233333222221
Q ss_pred chhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhcCCC
Q 042435 353 NQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELEGKTP 393 (412)
Q Consensus 353 ~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 393 (412)
+.. ....+.+++.+||+.||++||++.|+++.|+++..
T Consensus 272 ~~~---~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~ 309 (373)
T 2qol_A 272 PMD---CPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIR 309 (373)
T ss_dssp CTT---CBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred Ccc---ccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHh
Confidence 222 22347889999999999999999999999988754
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-42 Score=339.85 Aligned_cols=240 Identities=22% Similarity=0.287 Sum_probs=191.8
Q ss_pred cHHHHHHhhcCcccceeeeecCceEEEEEEeC-CCcEEEEEec------------------------cCCccccceEEEe
Q 042435 134 LYENLIDATEYFHIRYCIGTGGYDSVYKAELP-DGKVVALKKL------------------------HHSETEDSAFVVY 188 (412)
Q Consensus 134 ~~~~l~~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l------------------------~~~~~~~~~~~~~ 188 (412)
.+.++...+++|++.++||+|+||+||+|+.. +++.||+|++ +|+++......+.
T Consensus 65 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 144 (437)
T 4aw2_A 65 KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQ 144 (437)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence 45666677899999999999999999999875 5889999965 4677777788889
Q ss_pred cCceEEEEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeec
Q 042435 189 SPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADF 268 (412)
Q Consensus 189 ~~~~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Df 268 (412)
+.+..++||||+++|+|.+++..... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+||
T Consensus 145 ~~~~~~lV~Ey~~gg~L~~~l~~~~~--~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~vkL~DF 219 (437)
T 4aw2_A 145 DDNNLYLVMDYYVGGDLLTLLSKFED--RLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADF 219 (437)
T ss_dssp CSSEEEEEECCCTTCBHHHHHHTTTT--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCC
T ss_pred eCCEEEEEEecCCCCcHHHHHHHccC--CCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCEEEcch
Confidence 99999999999999999999976322 489999999999999999999998 9999999999999999999999999
Q ss_pred CCccccCCCCCC-ccccccccccccccccc-----CcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhH
Q 042435 269 GTVRLLDVDSSN-RTLQAGTYGYIALELVY-----TMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLID 342 (412)
Q Consensus 269 Gla~~~~~~~~~-~~~~~gt~~y~aPE~~~-----~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~ 342 (412)
|+++........ .....||+.|+|||++. ...++.++|||||||++|||++|+.||... ........
T Consensus 220 Gla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~-------~~~~~~~~ 292 (437)
T 4aw2_A 220 GSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAE-------SLVETYGK 292 (437)
T ss_dssp TTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCS-------SHHHHHHH
T ss_pred hhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCC-------ChhHHHHh
Confidence 999866543332 23457999999999987 567899999999999999999999999732 11112222
Q ss_pred Hhhh--ccCCccchhhHHHHHHHHHHHHhcCcCCCCC--CCCHHHHHHH
Q 042435 343 ILYQ--RLSPPINQKIIQDIILVSTIALACLRSKPKS--RPTMQRISQE 387 (412)
Q Consensus 343 ~~~~--~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~--RPs~~evl~~ 387 (412)
++.. ....+ .........+.+++.+|+..+|++ ||+++|++++
T Consensus 293 i~~~~~~~~~p--~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 293 IMNHKERFQFP--TQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp HHTHHHHCCCC--SSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred hhhccccccCC--cccccCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence 2221 11111 110011223788999999888888 9999999876
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=323.18 Aligned_cols=234 Identities=22% Similarity=0.234 Sum_probs=190.4
Q ss_pred hhcCcccceeeeecCceEEEEEEeC-CCcEEEEEec--------------------cCCccccceEEEecCceEEEEEEe
Q 042435 141 ATEYFHIRYCIGTGGYDSVYKAELP-DGKVVALKKL--------------------HHSETEDSAFVVYSPQCMFFIYEY 199 (412)
Q Consensus 141 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l--------------------~~~~~~~~~~~~~~~~~~~lv~ey 199 (412)
..++|++.+.||+|+||.||+|... +++.||+|.+ +|+++......+.+.+..++||||
T Consensus 3 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 82 (321)
T 1tki_A 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence 3578999999999999999999774 6889999954 588888888889999999999999
Q ss_pred ccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecC--CCcEEEeecCCccccCCC
Q 042435 200 MERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNS--NLEAFVADFGTVRLLDVD 277 (412)
Q Consensus 200 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~--~~~~kl~DfGla~~~~~~ 277 (412)
+++|+|.+++.... ..+++..+..++.|++.||+|||++ +|+||||||+|||++. ++.+||+|||+++.....
T Consensus 83 ~~g~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~ 157 (321)
T 1tki_A 83 ISGLDIFERINTSA--FELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp CCCCBHHHHHTSSS--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred CCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC
Confidence 99999999987543 2489999999999999999999999 9999999999999987 789999999999876543
Q ss_pred CCCcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccchhhH
Q 042435 278 SSNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKII 357 (412)
Q Consensus 278 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 357 (412)
. ......||+.|+|||++.+..++.++|||||||++|||++|..||... ........+.......+ .....
T Consensus 158 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~-------~~~~~~~~i~~~~~~~~-~~~~~ 228 (321)
T 1tki_A 158 D-NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAE-------TNQQIIENIMNAEYTFD-EEAFK 228 (321)
T ss_dssp C-EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCS-------SHHHHHHHHHHTCCCCC-HHHHT
T ss_pred C-ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCC-------CHHHHHHHHHcCCCCCC-hhhhc
Confidence 2 234457899999999999888999999999999999999999998632 11112222333222221 11111
Q ss_pred HHHHHHHHHHHhcCcCCCCCCCCHHHHHHHH
Q 042435 358 QDIILVSTIALACLRSKPKSRPTMQRISQEL 388 (412)
Q Consensus 358 ~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L 388 (412)
.....+.+++.+||+.||++|||+.|++++-
T Consensus 229 ~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp 259 (321)
T 1tki_A 229 EISIEAMDFVDRLLVKERKSRMTASEALQHP 259 (321)
T ss_dssp TSCHHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred cCCHHHHHHHHHHcCCChhHCcCHHHHhcCh
Confidence 2233488999999999999999999999864
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-41 Score=326.24 Aligned_cols=228 Identities=21% Similarity=0.299 Sum_probs=186.4
Q ss_pred hcCcccceeeeecCceEEEEEEeC-CCcEEEEEec-------------------------cCCccccceEEEecCceEEE
Q 042435 142 TEYFHIRYCIGTGGYDSVYKAELP-DGKVVALKKL-------------------------HHSETEDSAFVVYSPQCMFF 195 (412)
Q Consensus 142 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l-------------------------~~~~~~~~~~~~~~~~~~~l 195 (412)
.++|++.+.||+|+||.||+|+.. +|+.||||.+ +|+++......+.+.+..++
T Consensus 19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 98 (353)
T 2i0e_A 19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 98 (353)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEE
Confidence 468999999999999999999875 4889999965 35666667777888899999
Q ss_pred EEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccC
Q 042435 196 IYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLD 275 (412)
Q Consensus 196 v~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~ 275 (412)
||||+++|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 99 v~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 172 (353)
T 2i0e_A 99 VMEYVNGGDLMYHIQQVG---RFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENI 172 (353)
T ss_dssp EEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEeCCcccccc
Confidence 999999999999987543 589999999999999999999999 99999999999999999999999999998654
Q ss_pred CCCCCcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccchh
Q 042435 276 VDSSNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQK 355 (412)
Q Consensus 276 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 355 (412)
..........||+.|+|||++.+..++.++|||||||++|||++|+.||... ........+.......+ ..
T Consensus 173 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~-------~~~~~~~~i~~~~~~~p--~~ 243 (353)
T 2i0e_A 173 WDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE-------DEDELFQSIMEHNVAYP--KS 243 (353)
T ss_dssp CTTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCS-------SHHHHHHHHHHCCCCCC--TT
T ss_pred cCCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCC-------CHHHHHHHHHhCCCCCC--CC
Confidence 4444445568999999999999999999999999999999999999998732 11122233333332222 11
Q ss_pred hHHHHHHHHHHHHhcCcCCCCCCCC-----HHHHHHH
Q 042435 356 IIQDIILVSTIALACLRSKPKSRPT-----MQRISQE 387 (412)
Q Consensus 356 ~~~~~~~~~~l~~~Cl~~dP~~RPs-----~~evl~~ 387 (412)
. ...+.+++.+||+.||++||+ ++|++++
T Consensus 244 ~---s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h 277 (353)
T 2i0e_A 244 M---SKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 277 (353)
T ss_dssp S---CHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred C---CHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 1 223788999999999999995 5777765
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-41 Score=336.03 Aligned_cols=234 Identities=18% Similarity=0.198 Sum_probs=189.0
Q ss_pred HhhcCcccceeeeecCceEEEEEEe-CCCcEEEEEec-----------------------cCCccccceEEEecCceEEE
Q 042435 140 DATEYFHIRYCIGTGGYDSVYKAEL-PDGKVVALKKL-----------------------HHSETEDSAFVVYSPQCMFF 195 (412)
Q Consensus 140 ~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l-----------------------~~~~~~~~~~~~~~~~~~~l 195 (412)
...++|++.+.||+|+||.||+|.. .+|+.+|+|.+ +|+++......+.+.+..++
T Consensus 8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 87 (444)
T 3soa_A 8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYL 87 (444)
T ss_dssp HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEE
T ss_pred cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEE
Confidence 3467899999999999999999976 57899999953 67888888888999999999
Q ss_pred EEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEec---CCCcEEEeecCCcc
Q 042435 196 IYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLN---SNLEAFVADFGTVR 272 (412)
Q Consensus 196 v~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~---~~~~~kl~DfGla~ 272 (412)
||||+++|+|.+.+.... .+++..+..++.|++.||+|||++ +|+||||||+|||++ .++.+||+|||+++
T Consensus 88 v~E~~~gg~L~~~i~~~~---~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL~DFG~a~ 161 (444)
T 3soa_A 88 IFDLVTGGELFEDIVARE---YYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAI 161 (444)
T ss_dssp EECCCBCCBHHHHHHHCS---CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEECCCSSCB
T ss_pred EEEeCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEEccCceeE
Confidence 999999999998887654 589999999999999999999999 999999999999998 46789999999998
Q ss_pred ccCCCCCCcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCcc
Q 042435 273 LLDVDSSNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPI 352 (412)
Q Consensus 273 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 352 (412)
.............||+.|+|||++.+..++.++||||+||++|||++|..||... ........+.......+.
T Consensus 162 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~-------~~~~~~~~i~~~~~~~~~ 234 (444)
T 3soa_A 162 EVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDE-------DQHRLYQQIKAGAYDFPS 234 (444)
T ss_dssp CCCTTCCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCS-------SHHHHHHHHHHTCCCCCT
T ss_pred EecCCCceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCc-------cHHHHHHHHHhCCCCCCc
Confidence 7765544445568999999999999989999999999999999999999998632 111112222222222111
Q ss_pred chhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 353 NQKIIQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 353 ~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
.........+.+++.+||+.||++|||+.|++++
T Consensus 235 -~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 235 -PEWDTVTPEAKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp -TTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred -cccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 1111122347899999999999999999999885
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=314.98 Aligned_cols=233 Identities=25% Similarity=0.387 Sum_probs=178.2
Q ss_pred hcCcccceeeeecCceEEEEEEeCCCcEEEEEec-------------------------cCCccccceEEEecCceEEEE
Q 042435 142 TEYFHIRYCIGTGGYDSVYKAELPDGKVVALKKL-------------------------HHSETEDSAFVVYSPQCMFFI 196 (412)
Q Consensus 142 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~l-------------------------~~~~~~~~~~~~~~~~~~~lv 196 (412)
.++|++.+.||+|+||.||+|.+. ++.||||.+ +|+++......+...+..++|
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV 84 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 357899999999999999999984 889999964 466777777778888899999
Q ss_pred EEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecC--------CCcEEEeec
Q 042435 197 YEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNS--------NLEAFVADF 268 (412)
Q Consensus 197 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~--------~~~~kl~Df 268 (412)
|||+++++|.+++... .+++..+..++.|++.||+|||++...+++||||||+||+++. ++.+||+||
T Consensus 85 ~e~~~~~~L~~~~~~~----~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df 160 (271)
T 3dtc_A 85 MEFARGGPLNRVLSGK----RIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF 160 (271)
T ss_dssp EECCTTEEHHHHHTSS----CCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred EEcCCCCCHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence 9999999999988644 4899999999999999999999982223999999999999985 678999999
Q ss_pred CCccccCCCCCCcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhcc
Q 042435 269 GTVRLLDVDSSNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRL 348 (412)
Q Consensus 269 Gla~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 348 (412)
|+++...... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||.... .............
T Consensus 161 g~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~-------~~~~~~~~~~~~~ 231 (271)
T 3dtc_A 161 GLAREWHRTT--KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGID-------GLAVAYGVAMNKL 231 (271)
T ss_dssp CC---------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSC-------HHHHHHHHHTSCC
T ss_pred Cccccccccc--ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-------HHHHHHhhhcCCC
Confidence 9998654332 224578999999999998889999999999999999999999987321 1111122222222
Q ss_pred CCccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhcC
Q 042435 349 SPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELEGK 391 (412)
Q Consensus 349 ~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 391 (412)
..+.+... ...+.+++.+||+.||++|||+.|++++|+++
T Consensus 232 ~~~~~~~~---~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 232 ALPIPSTC---PEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp CCCCCTTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred CCCCCccc---CHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 22222222 22378899999999999999999999999864
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=340.43 Aligned_cols=241 Identities=22% Similarity=0.374 Sum_probs=193.2
Q ss_pred HHHhhcCcccceeeeecCceEEEEEEeCCCcEEEEEec--------------------cCCccccceEEEecCceEEEEE
Q 042435 138 LIDATEYFHIRYCIGTGGYDSVYKAELPDGKVVALKKL--------------------HHSETEDSAFVVYSPQCMFFIY 197 (412)
Q Consensus 138 l~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~l--------------------~~~~~~~~~~~~~~~~~~~lv~ 197 (412)
.....++|++.+.||+|+||.||+|.+.++..||||.+ +|+++.....++. .+..++||
T Consensus 183 ~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~ 261 (454)
T 1qcf_A 183 WEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIIT 261 (454)
T ss_dssp SBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred eeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEE
Confidence 34456789999999999999999999988999999965 4667777666654 67789999
Q ss_pred EeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCC
Q 042435 198 EYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVD 277 (412)
Q Consensus 198 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~ 277 (412)
||+++|+|.++++.... ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 262 e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~ 337 (454)
T 1qcf_A 262 EFMAKGSLLDFLKSDEG-SKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDN 337 (454)
T ss_dssp CCCTTCBHHHHHHSHHH-HTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCH
T ss_pred eecCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCCCceEcCCC
Confidence 99999999999975432 2588999999999999999999999 9999999999999999999999999999875432
Q ss_pred C-CCcccccccccccccccccCcccCcccccHHHHHHHHHHHh-CCCCcccccccccCCCCcchhhHHhhhccCCccchh
Q 042435 278 S-SNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLM-GTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQK 355 (412)
Q Consensus 278 ~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 355 (412)
. .......+|+.|+|||++....++.++|||||||++|||+| |+.||.... .......+......+.+..
T Consensus 338 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~--------~~~~~~~i~~~~~~~~~~~ 409 (454)
T 1qcf_A 338 EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMS--------NPEVIRALERGYRMPRPEN 409 (454)
T ss_dssp HHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC--------HHHHHHHHHHTCCCCCCTT
T ss_pred ceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCC--------HHHHHHHHHcCCCCCCCCC
Confidence 1 11123346789999999998899999999999999999999 999987321 1112222333322222222
Q ss_pred hHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhcCCCC
Q 042435 356 IIQDIILVSTIALACLRSKPKSRPTMQRISQELEGKTPM 394 (412)
Q Consensus 356 ~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~ 394 (412)
. ...+.+++.+||+.||++|||+++|++.|+++...
T Consensus 410 ~---~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~ 445 (454)
T 1qcf_A 410 C---PEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTA 445 (454)
T ss_dssp S---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSS
T ss_pred C---CHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhc
Confidence 2 22478999999999999999999999999998654
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=318.81 Aligned_cols=242 Identities=15% Similarity=0.151 Sum_probs=188.6
Q ss_pred hcCcccceeeeecCceEEEEEEe-CCCcEEEEEec--------------------cCCccccceEEEecCceEEEEEEec
Q 042435 142 TEYFHIRYCIGTGGYDSVYKAEL-PDGKVVALKKL--------------------HHSETEDSAFVVYSPQCMFFIYEYM 200 (412)
Q Consensus 142 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l--------------------~~~~~~~~~~~~~~~~~~~lv~ey~ 200 (412)
.++|++.+.||+|+||.||+|.. .+|+.||||.+ +|+++......+......++||||+
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~ 88 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL 88 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEec
Confidence 35799999999999999999986 67999999975 3445555566677888999999999
Q ss_pred cCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCc-----EEEeecCCccccC
Q 042435 201 ERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLE-----AFVADFGTVRLLD 275 (412)
Q Consensus 201 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~-----~kl~DfGla~~~~ 275 (412)
+++|.+++.... ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++. +||+|||+++...
T Consensus 89 -~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~ 162 (298)
T 1csn_A 89 -GPSLEDLLDLCG--RKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 162 (298)
T ss_dssp -CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred -CCCHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEEEECccccccc
Confidence 999999997543 2489999999999999999999998 9999999999999987765 9999999998765
Q ss_pred CCCC-------CcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhcc
Q 042435 276 VDSS-------NRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRL 348 (412)
Q Consensus 276 ~~~~-------~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 348 (412)
.... ......||+.|+|||++.+..++.++||||||+++|||++|+.||..... .........+.....
T Consensus 163 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~----~~~~~~~~~~~~~~~ 238 (298)
T 1csn_A 163 DPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKA----ATNKQKYERIGEKKQ 238 (298)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCS----CCHHHHHHHHHHHHH
T ss_pred cccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhc----cccHHHHHHHHhhcc
Confidence 4322 12445799999999999999999999999999999999999999974210 001111111111111
Q ss_pred CCccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhcCCC
Q 042435 349 SPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELEGKTP 393 (412)
Q Consensus 349 ~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 393 (412)
..+...........+.+++.+||+.||++|||+++|++.|+++..
T Consensus 239 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~ 283 (298)
T 1csn_A 239 STPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLE 283 (298)
T ss_dssp HSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred CccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHH
Confidence 111111111122348899999999999999999999999988754
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-41 Score=325.40 Aligned_cols=232 Identities=21% Similarity=0.247 Sum_probs=186.2
Q ss_pred hhcCcccceeeeecCceEEEEEEeC-CCcEEEEEec---------------------------cCCccccceEEEecCce
Q 042435 141 ATEYFHIRYCIGTGGYDSVYKAELP-DGKVVALKKL---------------------------HHSETEDSAFVVYSPQC 192 (412)
Q Consensus 141 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l---------------------------~~~~~~~~~~~~~~~~~ 192 (412)
..+.|++.+.||+|+||.||+|... +|+.||+|.+ +|+++.....++.+.+.
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 89 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD 89 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence 3567999999999999999999874 6899999965 35666667777888899
Q ss_pred EEEEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCC----cEEEeec
Q 042435 193 MFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNL----EAFVADF 268 (412)
Q Consensus 193 ~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~----~~kl~Df 268 (412)
.++||||+++|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+|||++.++ .+||+||
T Consensus 90 ~~lv~e~~~gg~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~~vkl~DF 163 (361)
T 2yab_A 90 VVLILELVSGGELFDFLAQKE---SLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (361)
T ss_dssp EEEEEECCCSCBHHHHHTTCS---CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred EEEEEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCccCEEEEec
Confidence 999999999999999987643 589999999999999999999999 999999999999998776 7999999
Q ss_pred CCccccCCCCCCcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhcc
Q 042435 269 GTVRLLDVDSSNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRL 348 (412)
Q Consensus 269 Gla~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 348 (412)
|+++...... ......||+.|+|||++.+..++.++|||||||++|||++|..||... ........+.....
T Consensus 164 G~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~-------~~~~~~~~i~~~~~ 235 (361)
T 2yab_A 164 GLAHEIEDGV-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD-------TKQETLANITAVSY 235 (361)
T ss_dssp SSCEECCTTC-CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCS-------SHHHHHHHHHTTCC
T ss_pred CCceEcCCCC-ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCC-------CHHHHHHHHHhcCC
Confidence 9998765432 233457999999999999989999999999999999999999998632 11111222222222
Q ss_pred CCccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 349 SPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 349 ~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
..+ ..........+.+++.+||..||++|||+.|++++
T Consensus 236 ~~~-~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h 273 (361)
T 2yab_A 236 DFD-EEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (361)
T ss_dssp CCC-HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CCC-chhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 111 01111122347899999999999999999999864
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-41 Score=318.97 Aligned_cols=234 Identities=24% Similarity=0.310 Sum_probs=183.8
Q ss_pred hhcCcccceeeeecCceEEEEEEeCCCcEEEEEec-----------------------cCCccccceEEEecCceEEEEE
Q 042435 141 ATEYFHIRYCIGTGGYDSVYKAELPDGKVVALKKL-----------------------HHSETEDSAFVVYSPQCMFFIY 197 (412)
Q Consensus 141 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~l-----------------------~~~~~~~~~~~~~~~~~~~lv~ 197 (412)
..++|++.+.||+|+||+||+|...+|+.||+|++ +|+++.....++...+..++||
T Consensus 19 l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 98 (311)
T 3niz_A 19 LMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVF 98 (311)
T ss_dssp SSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEE
T ss_pred hHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEE
Confidence 35789999999999999999999988999999964 5777888888888899999999
Q ss_pred EeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCC
Q 042435 198 EYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVD 277 (412)
Q Consensus 198 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~ 277 (412)
||+++ +|.+++..... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 99 e~~~~-~l~~~~~~~~~--~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~ 172 (311)
T 3niz_A 99 EFMEK-DLKKVLDENKT--GLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIP 172 (311)
T ss_dssp ECCSE-EHHHHHHTCTT--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEETTSC
T ss_pred cCCCC-CHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCcCceecCCC
Confidence 99974 88777765432 489999999999999999999999 9999999999999999999999999999876554
Q ss_pred CCCcccccccccccccccccC-cccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhh----------
Q 042435 278 SSNRTLQAGTYGYIALELVYT-MVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQ---------- 346 (412)
Q Consensus 278 ~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~---------- 346 (412)
........||+.|+|||++.+ ..++.++|||||||++|||++|+.||.... .......+...
T Consensus 173 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-------~~~~~~~i~~~~~~~~~~~~~ 245 (311)
T 3niz_A 173 VRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVT-------DDDQLPKIFSILGTPNPREWP 245 (311)
T ss_dssp CC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS-------TTTHHHHHHHHHCCCCTTTSG
T ss_pred cccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCC-------hHHHHHHHHHHHCCCChHHhh
Confidence 444455678999999999876 568999999999999999999999996321 11111111100
Q ss_pred -----------ccC---C-ccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 347 -----------RLS---P-PINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 347 -----------~~~---~-~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
... . +...........+.+++.+||+.||++|||++|++++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 301 (311)
T 3niz_A 246 QVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH 301 (311)
T ss_dssp GGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred hhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 000 0 0000000112347899999999999999999999874
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-41 Score=325.33 Aligned_cols=235 Identities=22% Similarity=0.329 Sum_probs=185.6
Q ss_pred hcCcccceeeeecCceEEEEEEeC-CCcEEEEEec-------------------------cCCccccceEEEecCceEEE
Q 042435 142 TEYFHIRYCIGTGGYDSVYKAELP-DGKVVALKKL-------------------------HHSETEDSAFVVYSPQCMFF 195 (412)
Q Consensus 142 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l-------------------------~~~~~~~~~~~~~~~~~~~l 195 (412)
.++|++.+.||+|+||.||+|+.. +++.||+|.+ +|+++......+.+.+..++
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 87 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 87 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence 357999999999999999999875 6899999964 46777777778888999999
Q ss_pred EEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccC
Q 042435 196 IYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLD 275 (412)
Q Consensus 196 v~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~ 275 (412)
||||+++|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 88 v~e~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~ 161 (345)
T 3a8x_A 88 VIEYVNGGDLMFHMQRQR---KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 161 (345)
T ss_dssp EECCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCGGGCBCSC
T ss_pred EEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEecccccccc
Confidence 999999999999887543 589999999999999999999999 99999999999999999999999999998644
Q ss_pred CCCCCcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCC-CCcchh-hHHhhhccCCccc
Q 042435 276 VDSSNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSS-GPKIML-IDILYQRLSPPIN 353 (412)
Q Consensus 276 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~-~~~~~~-~~~~~~~~~~~~~ 353 (412)
..........||+.|+|||++.+..++.++|||||||++|||++|+.||.......... .....+ ..+.......+
T Consensus 162 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p-- 239 (345)
T 3a8x_A 162 RPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP-- 239 (345)
T ss_dssp CTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCCCC--
T ss_pred CCCCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCCCC--
Confidence 33334455689999999999999999999999999999999999999996321110000 001111 12222222211
Q ss_pred hhhHHHHHHHHHHHHhcCcCCCCCCCCH------HHHHHH
Q 042435 354 QKIIQDIILVSTIALACLRSKPKSRPTM------QRISQE 387 (412)
Q Consensus 354 ~~~~~~~~~~~~l~~~Cl~~dP~~RPs~------~evl~~ 387 (412)
... ...+.+++.+||+.||++||++ .|++++
T Consensus 240 ~~~---s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~h 276 (345)
T 3a8x_A 240 RSL---SVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 276 (345)
T ss_dssp TTS---CHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTS
T ss_pred CCC---CHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcC
Confidence 111 2237889999999999999995 677654
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-41 Score=329.46 Aligned_cols=238 Identities=21% Similarity=0.307 Sum_probs=192.7
Q ss_pred hcCcccceeeeecCceEEEEEEeC--------CCcEEEEEec-----------------------cCCccccceEEEecC
Q 042435 142 TEYFHIRYCIGTGGYDSVYKAELP--------DGKVVALKKL-----------------------HHSETEDSAFVVYSP 190 (412)
Q Consensus 142 ~~~f~~~~~lG~G~~g~Vy~~~~~--------~~~~vAvK~l-----------------------~~~~~~~~~~~~~~~ 190 (412)
.++|.+.+.||+|+||.||+|... ++..||||++ +|+++......+...
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 147 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 147 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence 468999999999999999999752 3468999964 577888888888889
Q ss_pred ceEEEEEEeccCCceeeeeccCcc-------------cccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEe
Q 042435 191 QCMFFIYEYMERGSLFCVLRDDDE-------------AIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILL 257 (412)
Q Consensus 191 ~~~~lv~ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl 257 (412)
+..++||||+++|+|.+++..... ...+++..++.++.|++.||+|||+. +|+||||||+|||+
T Consensus 148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll 224 (382)
T 3tt0_A 148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLV 224 (382)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEE
T ss_pred CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCcceEEE
Confidence 999999999999999999875431 12489999999999999999999999 99999999999999
Q ss_pred cCCCcEEEeecCCccccCCCC--CCcccccccccccccccccCcccCcccccHHHHHHHHHHHh-CCCCcccccccccCC
Q 042435 258 NSNLEAFVADFGTVRLLDVDS--SNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLM-GTHPGELLLSLSSSS 334 (412)
Q Consensus 258 ~~~~~~kl~DfGla~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~ellt-g~~P~~~~~~~~~~~ 334 (412)
+.++.+||+|||+++...... .......+|+.|+|||++.+..++.++|||||||++|||++ |..||...
T Consensus 225 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~------- 297 (382)
T 3tt0_A 225 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV------- 297 (382)
T ss_dssp CTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC-------
T ss_pred cCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC-------
Confidence 999999999999998765432 22234467889999999999999999999999999999999 99998632
Q ss_pred CCcchhhHHhhhccCCccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhcCCC
Q 042435 335 GPKIMLIDILYQRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELEGKTP 393 (412)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 393 (412)
....+.+.+........+... ...+.+++.+||+.||++|||+.|++++|+++..
T Consensus 298 -~~~~~~~~~~~~~~~~~~~~~---~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 352 (382)
T 3tt0_A 298 -PVEELFKLLKEGHRMDKPSNC---TNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 352 (382)
T ss_dssp -CHHHHHHHHHTTCCCCCCSSC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -CHHHHHHHHHcCCCCCCCccC---CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 111223333332222222222 2237889999999999999999999999988754
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-41 Score=316.49 Aligned_cols=244 Identities=16% Similarity=0.212 Sum_probs=185.0
Q ss_pred HhhcCcccceeeeecCceEEEEEEe-CCCcEEEEEecc-------------------CCcccc-ceEEEecCceEEEEEE
Q 042435 140 DATEYFHIRYCIGTGGYDSVYKAEL-PDGKVVALKKLH-------------------HSETED-SAFVVYSPQCMFFIYE 198 (412)
Q Consensus 140 ~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l~-------------------~~~~~~-~~~~~~~~~~~~lv~e 198 (412)
...++|++.+.||+|+||.||+|.. .+++.||||.+. |++... ........+..++|||
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 4hgt_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp -----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred ccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEE
Confidence 3457899999999999999999986 678999999642 233222 2333456778899999
Q ss_pred eccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEe---cCCCcEEEeecCCccccC
Q 042435 199 YMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILL---NSNLEAFVADFGTVRLLD 275 (412)
Q Consensus 199 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl---~~~~~~kl~DfGla~~~~ 275 (412)
|+ +++|.+++..... .+++..+..++.|++.||+|||++ +|+||||||+||++ +.++.+||+|||+++...
T Consensus 86 ~~-~~~L~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~ 159 (296)
T 4hgt_A 86 LL-GPSLEDLFNFCSR--KFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp CC-CCBHHHHHHHTTS--CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred cc-CCCHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEecCccceecc
Confidence 99 9999999874332 489999999999999999999999 99999999999999 788999999999998765
Q ss_pred CCCC-------CcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhcc
Q 042435 276 VDSS-------NRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRL 348 (412)
Q Consensus 276 ~~~~-------~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 348 (412)
.... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||..... ...............
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~----~~~~~~~~~~~~~~~ 235 (296)
T 4hgt_A 160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKA----ATKRQKYERISEKKM 235 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCC----SSSSSHHHHHHHHHH
T ss_pred CcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccch----hhhhhhhhhhhcccc
Confidence 4322 12345789999999999999999999999999999999999999974311 111122222222222
Q ss_pred CCccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhcCCC
Q 042435 349 SPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELEGKTP 393 (412)
Q Consensus 349 ~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 393 (412)
..+...........+.+++.+||+.||++|||+.++++.|+++..
T Consensus 236 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~ 280 (296)
T 4hgt_A 236 STPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 280 (296)
T ss_dssp HSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHH
T ss_pred cchhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHH
Confidence 222111111112348899999999999999999999999988754
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-41 Score=326.24 Aligned_cols=234 Identities=18% Similarity=0.237 Sum_probs=187.3
Q ss_pred hcCcccceeeeecCceEEEEEEe-CCCcEEEEEec--------------------------cCCccccceEEEecCceEE
Q 042435 142 TEYFHIRYCIGTGGYDSVYKAEL-PDGKVVALKKL--------------------------HHSETEDSAFVVYSPQCMF 194 (412)
Q Consensus 142 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l--------------------------~~~~~~~~~~~~~~~~~~~ 194 (412)
.+.|++.+.||+|+||.||+|.. .+|+.||||.+ +|+++......+...+..+
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 35799999999999999999976 46899999954 5778888888888899999
Q ss_pred EEEEeccCCceeeeeccCc-ccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCc---EEEeecCC
Q 042435 195 FIYEYMERGSLFCVLRDDD-EAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLE---AFVADFGT 270 (412)
Q Consensus 195 lv~ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~---~kl~DfGl 270 (412)
+||||+++|+|.+++.... ....+++..+..++.|++.||+|||++ +|+||||||+|||++.++. +||+|||+
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 9999999999988775432 223489999999999999999999999 9999999999999976554 99999999
Q ss_pred ccccCCCCCCcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCC
Q 042435 271 VRLLDVDSSNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSP 350 (412)
Q Consensus 271 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 350 (412)
++.............||+.|+|||++.+..++.++|||||||++|||++|+.||.... ......+.......
T Consensus 180 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~--------~~~~~~i~~~~~~~ 251 (351)
T 3c0i_A 180 AIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK--------ERLFEGIIKGKYKM 251 (351)
T ss_dssp CEECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH--------HHHHHHHHHTCCCC
T ss_pred eeEecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH--------HHHHHHHHcCCCCC
Confidence 9876654443445679999999999999999999999999999999999999987321 11122222222221
Q ss_pred ccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 351 PINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 351 ~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
. ..........+.+++.+||+.||++|||+.|++++
T Consensus 252 ~-~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 287 (351)
T 3c0i_A 252 N-PRQWSHISESAKDLVRRMLMLDPAERITVYEALNH 287 (351)
T ss_dssp C-HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred C-ccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 1 11111123348899999999999999999999864
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=317.55 Aligned_cols=243 Identities=19% Similarity=0.252 Sum_probs=188.4
Q ss_pred cCcccceeeeecCceEEEEEEeC-CCcEEEEEec----------------------cCCccccceEEEecCc--eEEEEE
Q 042435 143 EYFHIRYCIGTGGYDSVYKAELP-DGKVVALKKL----------------------HHSETEDSAFVVYSPQ--CMFFIY 197 (412)
Q Consensus 143 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l----------------------~~~~~~~~~~~~~~~~--~~~lv~ 197 (412)
++|.+.+.||+|+||.||+|... +++.||||.+ +|+++.....++.... ..++||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (319)
T 4euu_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (319)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEE
Confidence 57999999999999999999875 5899999975 4566666666665544 789999
Q ss_pred EeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEe----cCCCcEEEeecCCccc
Q 042435 198 EYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILL----NSNLEAFVADFGTVRL 273 (412)
Q Consensus 198 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl----~~~~~~kl~DfGla~~ 273 (412)
||+++|+|.+++........+++.++..++.|++.||+|||+. +|+||||||+||++ +.++.+||+|||+++.
T Consensus 89 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~ 165 (319)
T 4euu_A 89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165 (319)
T ss_dssp ECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECCCTTCEE
T ss_pred eCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEccCCCcee
Confidence 9999999999998765444599999999999999999999999 99999999999999 7888899999999987
Q ss_pred cCCCCCCccccccccccccccccc--------CcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhh
Q 042435 274 LDVDSSNRTLQAGTYGYIALELVY--------TMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILY 345 (412)
Q Consensus 274 ~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~ 345 (412)
...... .....||+.|+|||++. +..++.++|||||||++|||+||+.||...... ......+..+..
T Consensus 166 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---~~~~~~~~~~~~ 241 (319)
T 4euu_A 166 LEDDEQ-FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGP---RRNKEVMYKIIT 241 (319)
T ss_dssp CCTTCC-BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCG---GGCHHHHHHHHH
T ss_pred cCCCCc-eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcc---chhHHHHHHHhc
Confidence 654332 23457999999999986 567899999999999999999999999632110 000111112221
Q ss_pred hccC--------------------CccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhcCC
Q 042435 346 QRLS--------------------PPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELEGKT 392 (412)
Q Consensus 346 ~~~~--------------------~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 392 (412)
.... +............+.+++.+||+.||++|||++|++++..+..
T Consensus 242 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~ 308 (319)
T 4euu_A 242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL 308 (319)
T ss_dssp HCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHT
T ss_pred CCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHh
Confidence 1110 0001112233445889999999999999999999999997654
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=325.96 Aligned_cols=245 Identities=22% Similarity=0.300 Sum_probs=192.4
Q ss_pred HHHhhcCcccceeeeecCceEEEEEEeC------CCcEEEEEec----------------------cCCccccceEEEec
Q 042435 138 LIDATEYFHIRYCIGTGGYDSVYKAELP------DGKVVALKKL----------------------HHSETEDSAFVVYS 189 (412)
Q Consensus 138 l~~~~~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vAvK~l----------------------~~~~~~~~~~~~~~ 189 (412)
+....++|++.+.||+|+||.||+|... +++.||||.+ +|+++......+..
T Consensus 42 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 121 (343)
T 1luf_A 42 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV 121 (343)
T ss_dssp TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred eEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcc
Confidence 3345688999999999999999999874 3589999965 46777777888888
Q ss_pred CceEEEEEEeccCCceeeeeccCcc---------------------cccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEe
Q 042435 190 PQCMFFIYEYMERGSLFCVLRDDDE---------------------AIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHR 248 (412)
Q Consensus 190 ~~~~~lv~ey~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHr 248 (412)
.+..++||||+++|+|.+++..... ...+++.+++.++.|++.||+|||++ +|+||
T Consensus 122 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~ivH~ 198 (343)
T 1luf_A 122 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHR 198 (343)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCS
T ss_pred CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecC
Confidence 8999999999999999999875321 13589999999999999999999999 99999
Q ss_pred CCCCCCEEecCCCcEEEeecCCccccCCCC--CCcccccccccccccccccCcccCcccccHHHHHHHHHHHh-CCCCcc
Q 042435 249 DISSNNILLNSNLEAFVADFGTVRLLDVDS--SNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLM-GTHPGE 325 (412)
Q Consensus 249 Dlkp~NILl~~~~~~kl~DfGla~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~ellt-g~~P~~ 325 (412)
||||+||+++.++.+||+|||+++...... .......+|+.|+|||.+.+..++.++||||||+++|||+| |..||.
T Consensus 199 Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 278 (343)
T 1luf_A 199 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY 278 (343)
T ss_dssp CCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred CCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCC
Confidence 999999999999999999999997654322 12234567899999999998889999999999999999999 999986
Q ss_pred cccccccCCCCcchhhHHhhhccCCccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhcCCCCCC
Q 042435 326 LLLSLSSSSGPKIMLIDILYQRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELEGKTPMKK 396 (412)
Q Consensus 326 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~~~ 396 (412)
.. .. ......+........+... ...+.+++.+||+.||++|||+.|++++|+++....+
T Consensus 279 ~~-------~~-~~~~~~~~~~~~~~~~~~~---~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~~ 338 (343)
T 1luf_A 279 GM-------AH-EEVIYYVRDGNILACPENC---PLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERAE 338 (343)
T ss_dssp TS-------CH-HHHHHHHHTTCCCCCCTTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC---
T ss_pred CC-------Ch-HHHHHHHhCCCcCCCCCCC---CHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhhh
Confidence 32 11 1111222111111111221 2247889999999999999999999999999987554
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=317.46 Aligned_cols=236 Identities=23% Similarity=0.297 Sum_probs=188.3
Q ss_pred hhcCcccceeeeecCceEEEEEEeCCCcEEEEEec--------------------cCCccccceEEEecCceEEEEEEec
Q 042435 141 ATEYFHIRYCIGTGGYDSVYKAELPDGKVVALKKL--------------------HHSETEDSAFVVYSPQCMFFIYEYM 200 (412)
Q Consensus 141 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~l--------------------~~~~~~~~~~~~~~~~~~~lv~ey~ 200 (412)
..++|++.+.||+|+||.||+|.+.++..||+|.+ +|+++......+...+..++||||+
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 101 (283)
T 3gen_A 22 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 101 (283)
T ss_dssp CGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCC
T ss_pred CHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEecc
Confidence 35679999999999999999999998899999965 4677777777888889999999999
Q ss_pred cCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCC-C
Q 042435 201 ERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDS-S 279 (412)
Q Consensus 201 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~-~ 279 (412)
++|+|.+++..... .+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++...... .
T Consensus 102 ~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 176 (283)
T 3gen_A 102 ANGCLLNYLREMRH--RFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT 176 (283)
T ss_dssp TTCBHHHHHHCGGG--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHH
T ss_pred CCCcHHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEccccccccccccccc
Confidence 99999999976432 489999999999999999999999 99999999999999999999999999998654321 1
Q ss_pred CcccccccccccccccccCcccCcccccHHHHHHHHHHHh-CCCCcccccccccCCCCcchhhHHhhhccCCccchhhHH
Q 042435 280 NRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLM-GTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKIIQ 358 (412)
Q Consensus 280 ~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 358 (412)
......+|+.|+|||.+.+..++.++||||||+++|||+| |+.||.... .....+.+........+....
T Consensus 177 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~--------~~~~~~~~~~~~~~~~~~~~~- 247 (283)
T 3gen_A 177 SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT--------NSETAEHIAQGLRLYRPHLAS- 247 (283)
T ss_dssp STTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSC--------HHHHHHHHHTTCCCCCCTTCC-
T ss_pred cccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccC--------hhHHHHHHhcccCCCCCCcCC-
Confidence 1223456788999999998889999999999999999998 999987321 111222222222222112211
Q ss_pred HHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhcCC
Q 042435 359 DIILVSTIALACLRSKPKSRPTMQRISQELEGKT 392 (412)
Q Consensus 359 ~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 392 (412)
..+.+++.+||+.||++|||+.|++++|+++.
T Consensus 248 --~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~ 279 (283)
T 3gen_A 248 --EKVYTIMYSCWHEKADERPTFKILLSNILDVM 279 (283)
T ss_dssp --HHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --HHHHHHHHHHccCChhHCcCHHHHHHHHHHHh
Confidence 23788999999999999999999999998764
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-41 Score=328.40 Aligned_cols=224 Identities=25% Similarity=0.313 Sum_probs=181.4
Q ss_pred hcCcccceeeeecCceEEEEEEeC-CCcEEEEEec-------------------------cCCccccceEEEecCceEEE
Q 042435 142 TEYFHIRYCIGTGGYDSVYKAELP-DGKVVALKKL-------------------------HHSETEDSAFVVYSPQCMFF 195 (412)
Q Consensus 142 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l-------------------------~~~~~~~~~~~~~~~~~~~l 195 (412)
.++|++.+.||+|+||.||+|+.. +++.||||.+ +|+++......+.+.+..|+
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 467999999999999999999875 5889999965 34555555666788889999
Q ss_pred EEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccC
Q 042435 196 IYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLD 275 (412)
Q Consensus 196 v~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~ 275 (412)
||||+++|+|.+++.... .+++.....++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 117 v~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~DFG~a~~~~ 190 (373)
T 2r5t_A 117 VLDYINGGELFYHLQRER---CFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENI 190 (373)
T ss_dssp EEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCBCGGGB
T ss_pred EEeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEeeCccccccc
Confidence 999999999999887543 588899999999999999999999 99999999999999999999999999998654
Q ss_pred CCCCCcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccchh
Q 042435 276 VDSSNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQK 355 (412)
Q Consensus 276 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 355 (412)
..........||+.|+|||++.+..++.++|||||||++|||++|+.||... ........+.......+ ..
T Consensus 191 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~-------~~~~~~~~i~~~~~~~~--~~ 261 (373)
T 2r5t_A 191 EHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSR-------NTAEMYDNILNKPLQLK--PN 261 (373)
T ss_dssp CCCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCS-------BHHHHHHHHHHSCCCCC--SS
T ss_pred cCCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCC-------CHHHHHHHHHhcccCCC--CC
Confidence 4444445668999999999999999999999999999999999999998632 11122223333322221 11
Q ss_pred hHHHHHHHHHHHHhcCcCCCCCCCCHHH
Q 042435 356 IIQDIILVSTIALACLRSKPKSRPTMQR 383 (412)
Q Consensus 356 ~~~~~~~~~~l~~~Cl~~dP~~RPs~~e 383 (412)
. ...+.+++.+||+.||++||++.+
T Consensus 262 ~---~~~~~~li~~lL~~dp~~R~~~~~ 286 (373)
T 2r5t_A 262 I---TNSARHLLEGLLQKDRTKRLGAKD 286 (373)
T ss_dssp S---CHHHHHHHHHHTCSSGGGSTTTTT
T ss_pred C---CHHHHHHHHHHcccCHHhCCCCCC
Confidence 1 123788999999999999999853
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=334.15 Aligned_cols=240 Identities=22% Similarity=0.277 Sum_probs=190.2
Q ss_pred ccHHHHHHhhcCcccceeeeecCceEEEEEEeC-CCcEEEEEec------------------------cCCccccceEEE
Q 042435 133 ILYENLIDATEYFHIRYCIGTGGYDSVYKAELP-DGKVVALKKL------------------------HHSETEDSAFVV 187 (412)
Q Consensus 133 ~~~~~l~~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l------------------------~~~~~~~~~~~~ 187 (412)
+.+.++....++|++.+.||+|+||+||+|+.+ +|+.||||++ +|+++......+
T Consensus 51 ~~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~ 130 (412)
T 2vd5_A 51 VRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAF 130 (412)
T ss_dssp HHHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred hhhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEE
Confidence 345566667899999999999999999999874 7999999975 466777777788
Q ss_pred ecCceEEEEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEee
Q 042435 188 YSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVAD 267 (412)
Q Consensus 188 ~~~~~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~D 267 (412)
.+.+..|+||||+++|+|.+++.... ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|
T Consensus 131 ~~~~~~~lVmE~~~gg~L~~~l~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~vkL~D 205 (412)
T 2vd5_A 131 QDENYLYLVMEYYVGGDLLTLLSKFG--ERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLAD 205 (412)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHHHS--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECC
T ss_pred eeCCEEEEEEcCCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCEEEee
Confidence 88999999999999999999997532 2489999999999999999999998 999999999999999999999999
Q ss_pred cCCccccCCCCCC-ccccccccccccccccc-------CcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcch
Q 042435 268 FGTVRLLDVDSSN-RTLQAGTYGYIALELVY-------TMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIM 339 (412)
Q Consensus 268 fGla~~~~~~~~~-~~~~~gt~~y~aPE~~~-------~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~ 339 (412)
||+++........ .....||+.|+|||++. ...++.++|||||||++|||++|+.||... .....
T Consensus 206 FGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~-------~~~~~ 278 (412)
T 2vd5_A 206 FGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYAD-------STAET 278 (412)
T ss_dssp CTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCS-------SHHHH
T ss_pred chhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCC-------CHHHH
Confidence 9999876544332 23457999999999987 357899999999999999999999998732 11111
Q ss_pred hhHHhhh--ccCCccchhhHHHHHHHHHHHHhcCcCCCCCC---CCHHHHHHH
Q 042435 340 LIDILYQ--RLSPPINQKIIQDIILVSTIALACLRSKPKSR---PTMQRISQE 387 (412)
Q Consensus 340 ~~~~~~~--~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~R---Ps~~evl~~ 387 (412)
...+... ....+. ........+.+++.+||. +|++| |+++|++++
T Consensus 279 ~~~i~~~~~~~~~p~--~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H 328 (412)
T 2vd5_A 279 YGKIVHYKEHLSLPL--VDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH 328 (412)
T ss_dssp HHHHHTHHHHCCCC------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred HHHHHhcccCcCCCc--cccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence 2222221 111110 001112347889999999 99998 699999876
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-41 Score=321.36 Aligned_cols=234 Identities=23% Similarity=0.312 Sum_probs=183.0
Q ss_pred cCcccceeeeecCceEEEEEEeC-CCcE----EEEEec----------------------cCCccccceEEEecCceEEE
Q 042435 143 EYFHIRYCIGTGGYDSVYKAELP-DGKV----VALKKL----------------------HHSETEDSAFVVYSPQCMFF 195 (412)
Q Consensus 143 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~----vAvK~l----------------------~~~~~~~~~~~~~~~~~~~l 195 (412)
++|++.+.||+|+||.||+|.+. +++. ||+|.+ +|+++.....++. .+..++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~ 91 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL 91 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence 56889999999999999999864 4443 788854 4666666666554 567899
Q ss_pred EEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccC
Q 042435 196 IYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLD 275 (412)
Q Consensus 196 v~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~ 275 (412)
||||+++|+|.+++..... .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 92 v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 166 (325)
T 3kex_A 92 VTQYLPLGSLLDHVRQHRG--ALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLLP 166 (325)
T ss_dssp EEECCTTCBSHHHHHSSGG--GSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCSGGGGSC
T ss_pred EEEeCCCCCHHHHHHHccc--cCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCCcccccC
Confidence 9999999999999876532 589999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCC--CcccccccccccccccccCcccCcccccHHHHHHHHHHHh-CCCCcccccccccCCCCcchhhHHhhhccCCcc
Q 042435 276 VDSS--NRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLM-GTHPGELLLSLSSSSGPKIMLIDILYQRLSPPI 352 (412)
Q Consensus 276 ~~~~--~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 352 (412)
.... ......||..|+|||++.+..++.++||||||+++|||+| |+.||... . .....+.+........
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~-------~-~~~~~~~~~~~~~~~~ 238 (325)
T 3kex_A 167 PDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGL-------R-LAEVPDLLEKGERLAQ 238 (325)
T ss_dssp CCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTS-------C-TTHHHHHHHTTCBCCC
T ss_pred cccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCcccc-------C-HHHHHHHHHcCCCCCC
Confidence 4332 2244567889999999998899999999999999999999 99998732 1 1122233322221111
Q ss_pred chhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhcCCC
Q 042435 353 NQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELEGKTP 393 (412)
Q Consensus 353 ~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 393 (412)
+... ...+.+++.+||+.||++|||+.|++++|+.+..
T Consensus 239 ~~~~---~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~ 276 (325)
T 3kex_A 239 PQIC---TIDVYMVMVKCWMIDENIRPTFKELANEFTRMAR 276 (325)
T ss_dssp CTTB---CTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred CCcC---cHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 1111 1237789999999999999999999999988754
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=319.69 Aligned_cols=231 Identities=22% Similarity=0.269 Sum_probs=185.1
Q ss_pred hcCcccceeeeecCceEEEEEEeC-CCcEEEEEec---------------------------cCCccccceEEEecCceE
Q 042435 142 TEYFHIRYCIGTGGYDSVYKAELP-DGKVVALKKL---------------------------HHSETEDSAFVVYSPQCM 193 (412)
Q Consensus 142 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l---------------------------~~~~~~~~~~~~~~~~~~ 193 (412)
.+.|++.+.||+|+||.||+|... +|+.||+|.+ +|+++.....++...+..
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 456999999999999999999874 6899999965 356666777778888999
Q ss_pred EEEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCC----cEEEeecC
Q 042435 194 FFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNL----EAFVADFG 269 (412)
Q Consensus 194 ~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~----~~kl~DfG 269 (412)
++||||+++|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++ .+||+|||
T Consensus 90 ~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg 163 (326)
T 2y0a_A 90 ILILELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFG 163 (326)
T ss_dssp EEEEECCCSCBHHHHHTTSS---CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEEcCCCCCHHHHHHhcC---CcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCCEEEEECC
Confidence 99999999999999987643 589999999999999999999998 999999999999998877 89999999
Q ss_pred CccccCCCCCCcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccC
Q 042435 270 TVRLLDVDSSNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLS 349 (412)
Q Consensus 270 la~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 349 (412)
+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||... ........+......
T Consensus 164 ~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~-------~~~~~~~~~~~~~~~ 235 (326)
T 2y0a_A 164 LAHKIDFGN-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD-------TKQETLANVSAVNYE 235 (326)
T ss_dssp TCEECCTTS-CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCS-------SHHHHHHHHHHTCCC
T ss_pred CCeECCCCC-ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCC-------CHHHHHHHHHhcCCC
Confidence 998765332 223457999999999999889999999999999999999999998622 111111122211111
Q ss_pred CccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 350 PPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 350 ~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
.+ ..........+.+++.+||+.||++|||+.|++++
T Consensus 236 ~~-~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 236 FE-DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp CC-HHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred cC-ccccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 11 11111122347899999999999999999999985
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-41 Score=334.85 Aligned_cols=228 Identities=22% Similarity=0.304 Sum_probs=185.0
Q ss_pred hcCcccceeeeecCceEEEEEEe-CCCcEEEEEec------------------------cCCccccceEEEecCceEEEE
Q 042435 142 TEYFHIRYCIGTGGYDSVYKAEL-PDGKVVALKKL------------------------HHSETEDSAFVVYSPQCMFFI 196 (412)
Q Consensus 142 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l------------------------~~~~~~~~~~~~~~~~~~~lv 196 (412)
.++|++.+.||+|+||.||+|.. .+|+.||||.+ +|+++......+...+..++|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 46799999999999999999976 56899999964 466777777778888999999
Q ss_pred EEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHh-CCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccC
Q 042435 197 YEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHH-DCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLD 275 (412)
Q Consensus 197 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~-~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~ 275 (412)
|||+++|+|.+++.... .+++..+..++.|++.||+|||+ . +|+||||||+|||++.++.+||+|||+++...
T Consensus 227 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 300 (446)
T 4ejn_A 227 MEYANGGELFFHLSRER---VFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGI 300 (446)
T ss_dssp ECCCSSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECCCCCCCTTC
T ss_pred EeeCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEccCCCceecc
Confidence 99999999998886543 58999999999999999999998 7 99999999999999999999999999998654
Q ss_pred CCCCCcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccchh
Q 042435 276 VDSSNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQK 355 (412)
Q Consensus 276 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 355 (412)
..........||+.|+|||++.+..++.++|||||||++|||++|+.||... ........+.......+ ..
T Consensus 301 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~-------~~~~~~~~i~~~~~~~p--~~ 371 (446)
T 4ejn_A 301 KDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ-------DHEKLFELILMEEIRFP--RT 371 (446)
T ss_dssp C-----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCS-------SHHHHHHHHHHCCCCCC--TT
T ss_pred CCCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCC-------CHHHHHHHHHhCCCCCC--cc
Confidence 4444445568999999999999999999999999999999999999998632 11111222222222221 11
Q ss_pred hHHHHHHHHHHHHhcCcCCCCCCC-----CHHHHHHH
Q 042435 356 IIQDIILVSTIALACLRSKPKSRP-----TMQRISQE 387 (412)
Q Consensus 356 ~~~~~~~~~~l~~~Cl~~dP~~RP-----s~~evl~~ 387 (412)
. ...+.+++.+||+.||++|| +++|++++
T Consensus 372 ~---~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~h 405 (446)
T 4ejn_A 372 L---GPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQH 405 (446)
T ss_dssp S---CHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred C---CHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhC
Confidence 1 12378899999999999999 99999874
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-41 Score=318.85 Aligned_cols=238 Identities=24% Similarity=0.360 Sum_probs=191.6
Q ss_pred hhcCcccceeeeecCceEEEEEEe------CCCcEEEEEec----------------------cCCccccceEEEecCce
Q 042435 141 ATEYFHIRYCIGTGGYDSVYKAEL------PDGKVVALKKL----------------------HHSETEDSAFVVYSPQC 192 (412)
Q Consensus 141 ~~~~f~~~~~lG~G~~g~Vy~~~~------~~~~~vAvK~l----------------------~~~~~~~~~~~~~~~~~ 192 (412)
..++|.+.+.||+|+||.||+|.. .+++.||+|.+ +|+++......+...+.
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 100 (314)
T 2ivs_A 21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGP 100 (314)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCc
Confidence 356799999999999999999975 34589999965 46777777888888899
Q ss_pred EEEEEEeccCCceeeeeccCcc---------------------cccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCC
Q 042435 193 MFFIYEYMERGSLFCVLRDDDE---------------------AIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDIS 251 (412)
Q Consensus 193 ~~lv~ey~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlk 251 (412)
.++||||+++|+|.+++..... ...+++..+..++.|++.||+|||++ +|+|||||
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dik 177 (314)
T 2ivs_A 101 LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRDLA 177 (314)
T ss_dssp CEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEECCCCS
T ss_pred eEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCcccccc
Confidence 9999999999999999875431 12489999999999999999999999 99999999
Q ss_pred CCCEEecCCCcEEEeecCCccccCCCCCC--cccccccccccccccccCcccCcccccHHHHHHHHHHHh-CCCCccccc
Q 042435 252 SNNILLNSNLEAFVADFGTVRLLDVDSSN--RTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLM-GTHPGELLL 328 (412)
Q Consensus 252 p~NILl~~~~~~kl~DfGla~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~ellt-g~~P~~~~~ 328 (412)
|+||+++.++.+||+|||+++........ .....+|+.|+|||.+.+..++.++||||||+++|||+| |+.||...
T Consensus 178 p~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~- 256 (314)
T 2ivs_A 178 ARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI- 256 (314)
T ss_dssp GGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTC-
T ss_pred hheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCC-
Confidence 99999999999999999999866443221 233457889999999998889999999999999999999 99998632
Q ss_pred ccccCCCCcchhhHHhhhccCCccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhcCC
Q 042435 329 SLSSSSGPKIMLIDILYQRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELEGKT 392 (412)
Q Consensus 329 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 392 (412)
......+.+........+... ...+.+++.+||+.||++|||+.|++++|+++.
T Consensus 257 -------~~~~~~~~~~~~~~~~~~~~~---~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~ 310 (314)
T 2ivs_A 257 -------PPERLFNLLKTGHRMERPDNC---SEEMYRLMLQCWKQEPDKRPVFADISKDLEKMM 310 (314)
T ss_dssp -------CGGGHHHHHHTTCCCCCCTTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -------CHHHHHHHhhcCCcCCCCccC---CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 112223333332222222222 224789999999999999999999999998764
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=314.67 Aligned_cols=243 Identities=16% Similarity=0.211 Sum_probs=187.0
Q ss_pred hhcCcccceeeeecCceEEEEEEe-CCCcEEEEEecc-------------------CCccc-cceEEEecCceEEEEEEe
Q 042435 141 ATEYFHIRYCIGTGGYDSVYKAEL-PDGKVVALKKLH-------------------HSETE-DSAFVVYSPQCMFFIYEY 199 (412)
Q Consensus 141 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l~-------------------~~~~~-~~~~~~~~~~~~~lv~ey 199 (412)
..++|++.+.||+|+||.||+|.. .+|+.||||.+. |++.. .........+..++||||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~ 86 (296)
T 3uzp_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 86 (296)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcchhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEe
Confidence 357899999999999999999986 679999999753 22222 223334567788999999
Q ss_pred ccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEe---cCCCcEEEeecCCccccCC
Q 042435 200 MERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILL---NSNLEAFVADFGTVRLLDV 276 (412)
Q Consensus 200 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl---~~~~~~kl~DfGla~~~~~ 276 (412)
+ +++|.+++.... ..+++..+..++.|++.||+|||++ +|+||||||+||++ +.++.+||+|||+++....
T Consensus 87 ~-~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 160 (296)
T 3uzp_A 87 L-GPSLEDLFNFCS--RKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 160 (296)
T ss_dssp C-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred c-CCCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccc
Confidence 9 899999987433 2589999999999999999999999 99999999999999 4889999999999987654
Q ss_pred CCC-------CcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccC
Q 042435 277 DSS-------NRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLS 349 (412)
Q Consensus 277 ~~~-------~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 349 (412)
... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||..... .........+......
T Consensus 161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~----~~~~~~~~~~~~~~~~ 236 (296)
T 3uzp_A 161 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKA----ATKRQKYERISEKKMS 236 (296)
T ss_dssp TTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCC----SSSSSHHHHHHHHHHH
T ss_pred cccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCc----hhhhhhhhhhcccccC
Confidence 332 12345799999999999999999999999999999999999999974211 1111222222222222
Q ss_pred CccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhcCCC
Q 042435 350 PPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELEGKTP 393 (412)
Q Consensus 350 ~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 393 (412)
.+...........+.+++.+||+.||++|||+.++++.|+++..
T Consensus 237 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~ 280 (296)
T 3uzp_A 237 TPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 280 (296)
T ss_dssp SCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHH
T ss_pred CchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHH
Confidence 21111111112348899999999999999999999999988754
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-41 Score=324.04 Aligned_cols=238 Identities=16% Similarity=0.205 Sum_probs=180.7
Q ss_pred hcCcccceeeeecCceEEEEEEeC----CCcEEEEEec--------------------------------cCCccccceE
Q 042435 142 TEYFHIRYCIGTGGYDSVYKAELP----DGKVVALKKL--------------------------------HHSETEDSAF 185 (412)
Q Consensus 142 ~~~f~~~~~lG~G~~g~Vy~~~~~----~~~~vAvK~l--------------------------------~~~~~~~~~~ 185 (412)
.++|++.+.||+|+||.||+|... ++..+|+|.+ +|+++.....
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 367999999999999999999875 5788999965 4566666666
Q ss_pred EEec----CceEEEEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCC
Q 042435 186 VVYS----PQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNL 261 (412)
Q Consensus 186 ~~~~----~~~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~ 261 (412)
.+.. ....++||||+ +++|.+++.... .+++..++.++.|++.||+|||++ +|+||||||+|||++.++
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~ 188 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNG---TFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYKN 188 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGGG---BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEESSS
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEEccCC
Confidence 6655 67899999999 999999997654 599999999999999999999999 999999999999998777
Q ss_pred --cEEEeecCCccccCCCC-------CCcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCccccccccc
Q 042435 262 --EAFVADFGTVRLLDVDS-------SNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSS 332 (412)
Q Consensus 262 --~~kl~DfGla~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~ 332 (412)
.+||+|||+++.+.... .......||+.|+|||++.+..++.++|||||||++|||+||+.||....
T Consensus 189 ~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~---- 264 (345)
T 2v62_A 189 PDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNL---- 264 (345)
T ss_dssp TTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGT----
T ss_pred CCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccc----
Confidence 99999999998664321 11244579999999999999899999999999999999999999996310
Q ss_pred CCCCcchhhHHhhhccCCccchhhH------HHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhcCCC
Q 042435 333 SSGPKIMLIDILYQRLSPPINQKII------QDIILVSTIALACLRSKPKSRPTMQRISQELEGKTP 393 (412)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 393 (412)
........ .........+.... .....+.+++.+||+.||++|||+.++++.|+....
T Consensus 265 --~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 328 (345)
T 2v62_A 265 --KDPVAVQT-AKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI 328 (345)
T ss_dssp --TCHHHHHH-HHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred --cccHHHHH-HHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence 11111111 11111001111100 112248899999999999999999999999998764
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-41 Score=324.65 Aligned_cols=237 Identities=19% Similarity=0.245 Sum_probs=188.1
Q ss_pred HhhcCcccceeeeecCceEEEEEEeC-CCcEEEEEec------------------cCCccccceEEEecCceEEEEEEec
Q 042435 140 DATEYFHIRYCIGTGGYDSVYKAELP-DGKVVALKKL------------------HHSETEDSAFVVYSPQCMFFIYEYM 200 (412)
Q Consensus 140 ~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l------------------~~~~~~~~~~~~~~~~~~~lv~ey~ 200 (412)
...++|++.+.||+|+||.||+|... +|+.||||.+ +|+++......+.+.+..++||||+
T Consensus 19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~ 98 (342)
T 2qr7_A 19 QFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELM 98 (342)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCCCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred CccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeCC
Confidence 34577999999999999999999774 6899999965 5788888888899999999999999
Q ss_pred cCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCC----CcEEEeecCCccccCC
Q 042435 201 ERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSN----LEAFVADFGTVRLLDV 276 (412)
Q Consensus 201 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~----~~~kl~DfGla~~~~~ 276 (412)
++|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+|||+.++ +.+||+|||+++....
T Consensus 99 ~gg~L~~~i~~~~---~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~ 172 (342)
T 2qr7_A 99 KGGELLDKILRQK---FFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRA 172 (342)
T ss_dssp CSCBHHHHHHTCT---TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBC
T ss_pred CCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcC
Confidence 9999999887654 589999999999999999999999 99999999999998433 3599999999987655
Q ss_pred CCCCcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccchhh
Q 042435 277 DSSNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKI 356 (412)
Q Consensus 277 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 356 (412)
.........||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..........+.......+. ...
T Consensus 173 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~----~~~~~~~~~~i~~~~~~~~~-~~~ 247 (342)
T 2qr7_A 173 ENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGP----DDTPEEILARIGSGKFSLSG-GYW 247 (342)
T ss_dssp TTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSST----TSCHHHHHHHHHHCCCCCCS-TTT
T ss_pred CCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCC----cCCHHHHHHHHccCCcccCc-ccc
Confidence 5444455679999999999988889999999999999999999999987321 00111111222222221110 111
Q ss_pred HHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 357 IQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 357 ~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
......+.+++.+||+.||++|||+.|++++
T Consensus 248 ~~~s~~~~~li~~~L~~dP~~R~t~~~il~h 278 (342)
T 2qr7_A 248 NSVSDTAKDLVSKMLHVDPHQRLTAALVLRH 278 (342)
T ss_dssp TTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred ccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 1122347889999999999999999999875
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-41 Score=332.52 Aligned_cols=237 Identities=22% Similarity=0.310 Sum_probs=191.2
Q ss_pred HHHHHHhhcCcccceeeeecCceEEEEEEeC-CCcEEEEEec------------------------cCCccccceEEEec
Q 042435 135 YENLIDATEYFHIRYCIGTGGYDSVYKAELP-DGKVVALKKL------------------------HHSETEDSAFVVYS 189 (412)
Q Consensus 135 ~~~l~~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l------------------------~~~~~~~~~~~~~~ 189 (412)
+.++....++|++.+.||+|+||+||+|+.. +++.||+|.+ +|+++......+.+
T Consensus 61 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 140 (410)
T 3v8s_A 61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 140 (410)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred HHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE
Confidence 3556667789999999999999999999875 5899999964 57788888888899
Q ss_pred CceEEEEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecC
Q 042435 190 PQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFG 269 (412)
Q Consensus 190 ~~~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG 269 (412)
.+..++||||+++|+|.++++.. .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||
T Consensus 141 ~~~~~lV~E~~~gg~L~~~l~~~----~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFG 213 (410)
T 3v8s_A 141 DRYLYMVMEYMPGGDLVNLMSNY----DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFG 213 (410)
T ss_dssp SSEEEEEECCCTTEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred CCEEEEEEeCCCCCcHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEEeccc
Confidence 99999999999999999988654 488999999999999999999999 99999999999999999999999999
Q ss_pred CccccCCCCC-CcccccccccccccccccCcc----cCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHh
Q 042435 270 TVRLLDVDSS-NRTLQAGTYGYIALELVYTMV----VTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDIL 344 (412)
Q Consensus 270 la~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~----~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 344 (412)
+++....... ......||+.|+|||++.+.. ++.++|||||||++|||++|+.||... ........+.
T Consensus 214 ~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~-------~~~~~~~~i~ 286 (410)
T 3v8s_A 214 TCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD-------SLVGTYSKIM 286 (410)
T ss_dssp TCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCS-------SHHHHHHHHH
T ss_pred eeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCC-------ChhhHHHHHH
Confidence 9987654322 223567999999999997655 889999999999999999999999732 1112222232
Q ss_pred hhc--cCCccchhhHHHHHHHHHHHHhcCcCCCCC--CCCHHHHHHHH
Q 042435 345 YQR--LSPPINQKIIQDIILVSTIALACLRSKPKS--RPTMQRISQEL 388 (412)
Q Consensus 345 ~~~--~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~--RPs~~evl~~L 388 (412)
... ...+..... ...+.+++.+||..+|++ ||+++||++|-
T Consensus 287 ~~~~~~~~p~~~~~---s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp 331 (410)
T 3v8s_A 287 NHKNSLTFPDDNDI---SKEAKNLICAFLTDREVRLGRNGVEEIKRHL 331 (410)
T ss_dssp THHHHCCCCTTCCC---CHHHHHHHHHHSSCGGGCTTSSCHHHHHTSG
T ss_pred hccccccCCCcccc---cHHHHHHHHHHccChhhhCCCCCHHHHhcCc
Confidence 221 221111111 223788999999999988 99999999873
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-41 Score=322.43 Aligned_cols=234 Identities=23% Similarity=0.382 Sum_probs=184.4
Q ss_pred cCcccceeeeecCceEEEEEEeC-CCc----EEEEEec----------------------cCCccccceEEEecCceEEE
Q 042435 143 EYFHIRYCIGTGGYDSVYKAELP-DGK----VVALKKL----------------------HHSETEDSAFVVYSPQCMFF 195 (412)
Q Consensus 143 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~----~vAvK~l----------------------~~~~~~~~~~~~~~~~~~~l 195 (412)
++|++.+.||+|+||.||+|.+. +++ .||+|.+ +|+++.....++... ..++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~ 93 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 93 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS-SEEE
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-CeEE
Confidence 56899999999999999999863 444 3688864 567777777777664 4789
Q ss_pred EEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccC
Q 042435 196 IYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLD 275 (412)
Q Consensus 196 v~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~ 275 (412)
|+||+++|+|.+++..... .+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 94 v~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~ 168 (327)
T 3poz_A 94 ITQLMPFGCLLDYVREHKD--NIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp EEECCTTCBHHHHHHHSTT--SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTHHHHHT
T ss_pred EEEecCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCcceeEcc
Confidence 9999999999999876432 589999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCC--cccccccccccccccccCcccCcccccHHHHHHHHHHHh-CCCCcccccccccCCCCcchhhHHhhhccCCcc
Q 042435 276 VDSSN--RTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLM-GTHPGELLLSLSSSSGPKIMLIDILYQRLSPPI 352 (412)
Q Consensus 276 ~~~~~--~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 352 (412)
..... .....+|+.|+|||++.+..++.++|||||||++|||+| |+.||... ........+......+.
T Consensus 169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~--------~~~~~~~~~~~~~~~~~ 240 (327)
T 3poz_A 169 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI--------PASEISSILEKGERLPQ 240 (327)
T ss_dssp TTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC--------CGGGHHHHHHTTCCCCC
T ss_pred CCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCC--------CHHHHHHHHHcCCCCCC
Confidence 43322 233456889999999999999999999999999999999 99998732 12223334433332222
Q ss_pred chhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhcCCC
Q 042435 353 NQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELEGKTP 393 (412)
Q Consensus 353 ~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 393 (412)
+... ...+.+++.+||+.||++|||+.|++++|+.+..
T Consensus 241 ~~~~---~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~ 278 (327)
T 3poz_A 241 PPIC---TIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp CTTB---CHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred CccC---CHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 2222 2247889999999999999999999999987654
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-41 Score=339.93 Aligned_cols=238 Identities=23% Similarity=0.314 Sum_probs=194.8
Q ss_pred hhcCcccceeeeecCceEEEEEEeCC-CcEEEEEec--------------------cCCccccceEEEecCceEEEEEEe
Q 042435 141 ATEYFHIRYCIGTGGYDSVYKAELPD-GKVVALKKL--------------------HHSETEDSAFVVYSPQCMFFIYEY 199 (412)
Q Consensus 141 ~~~~f~~~~~lG~G~~g~Vy~~~~~~-~~~vAvK~l--------------------~~~~~~~~~~~~~~~~~~~lv~ey 199 (412)
..++|++.+.||+|+||.||+|.+.. +..||||.+ +|+++.....++...+..++||||
T Consensus 218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~ 297 (495)
T 1opk_A 218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 297 (495)
T ss_dssp CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEc
Confidence 45678899999999999999998864 889999965 577888888889889999999999
Q ss_pred ccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCCC
Q 042435 200 MERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSS 279 (412)
Q Consensus 200 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 279 (412)
+++|+|.++++.... ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.......
T Consensus 298 ~~~g~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 373 (495)
T 1opk_A 298 MTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTY 373 (495)
T ss_dssp CTTCBHHHHHHHSCT-TTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCE
T ss_pred cCCCCHHHHHHhcCc-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecccceeccCCce
Confidence 999999999975432 2589999999999999999999999 999999999999999999999999999987643321
Q ss_pred -CcccccccccccccccccCcccCcccccHHHHHHHHHHHh-CCCCcccccccccCCCCcchhhHHhhhccCCccchhhH
Q 042435 280 -NRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLM-GTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKII 357 (412)
Q Consensus 280 -~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 357 (412)
......+++.|+|||++.+..++.++|||||||++|||+| |+.||... ......+.+......+.+....
T Consensus 374 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~--------~~~~~~~~~~~~~~~~~~~~~~ 445 (495)
T 1opk_A 374 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI--------DLSQVYELLEKDYRMERPEGCP 445 (495)
T ss_dssp ECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTC--------CGGGHHHHHHTTCCCCCCTTCC
T ss_pred eecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCC--------CHHHHHHHHHcCCCCCCCCCCC
Confidence 1223456789999999998899999999999999999999 99998732 1112333343333332222222
Q ss_pred HHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhcCCC
Q 042435 358 QDIILVSTIALACLRSKPKSRPTMQRISQELEGKTP 393 (412)
Q Consensus 358 ~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 393 (412)
..+.+++.+||+.||++|||+.|+++.|+.+..
T Consensus 446 ---~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~ 478 (495)
T 1opk_A 446 ---EKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 478 (495)
T ss_dssp ---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCS
T ss_pred ---HHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHh
Confidence 247889999999999999999999999998864
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-41 Score=323.08 Aligned_cols=240 Identities=15% Similarity=0.131 Sum_probs=187.9
Q ss_pred hcCcccceeeeecCceEEEEEEe-CCCcEEEEEec--------------------cCCccccceEEEecCceEEEEEEec
Q 042435 142 TEYFHIRYCIGTGGYDSVYKAEL-PDGKVVALKKL--------------------HHSETEDSAFVVYSPQCMFFIYEYM 200 (412)
Q Consensus 142 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l--------------------~~~~~~~~~~~~~~~~~~~lv~ey~ 200 (412)
.++|++.+.||+|+||.||+|.. .+|+.||||.+ +|+++......+...+..++||||+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~ 87 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL 87 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC
Confidence 36799999999999999999986 57999999965 5667777777788888999999999
Q ss_pred cCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCc-----EEEeecCCccccC
Q 042435 201 ERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLE-----AFVADFGTVRLLD 275 (412)
Q Consensus 201 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~-----~kl~DfGla~~~~ 275 (412)
+++|.+++.... ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++. +||+|||+++...
T Consensus 88 -~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~ 161 (330)
T 2izr_A 88 -GPSLEDLFDLCD--RTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYI 161 (330)
T ss_dssp -CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESB
T ss_pred -CCCHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEEEcccceeee
Confidence 999999987542 2599999999999999999999999 9999999999999998887 9999999998764
Q ss_pred CCCCC-------cccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhcc
Q 042435 276 VDSSN-------RTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRL 348 (412)
Q Consensus 276 ~~~~~-------~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 348 (412)
..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..........+.....
T Consensus 162 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~----~~~~~~~~~~i~~~~~ 237 (330)
T 2izr_A 162 DPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLK----ADTLKERYQKIGDTKR 237 (330)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCC----CSSHHHHHHHHHHHHH
T ss_pred cCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccc----cccHHHHHHHHHhhhc
Confidence 33221 235679999999999999999999999999999999999999997321 0000011111111111
Q ss_pred CCccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhcCC
Q 042435 349 SPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELEGKT 392 (412)
Q Consensus 349 ~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 392 (412)
..+......... .+.+++..||+.||.+||+++++.+.|+++.
T Consensus 238 ~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~ 280 (330)
T 2izr_A 238 ATPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLF 280 (330)
T ss_dssp HSCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred cCCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHH
Confidence 111100000112 5889999999999999999999999997653
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=333.88 Aligned_cols=233 Identities=22% Similarity=0.321 Sum_probs=186.9
Q ss_pred hhcCcccceeeeecCceEEEEEEeCCCcEEEEEec-------------------cCCccccceEEEecCc-eEEEEEEec
Q 042435 141 ATEYFHIRYCIGTGGYDSVYKAELPDGKVVALKKL-------------------HHSETEDSAFVVYSPQ-CMFFIYEYM 200 (412)
Q Consensus 141 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~l-------------------~~~~~~~~~~~~~~~~-~~~lv~ey~ 200 (412)
..++|++.+.||+|+||.||+|.+. |+.||||.+ +|+++.....++...+ ..++||||+
T Consensus 191 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~ 269 (450)
T 1k9a_A 191 NMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 269 (450)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCTTSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECC
T ss_pred ChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCchHHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEec
Confidence 3467899999999999999999984 789999965 4677777777766554 799999999
Q ss_pred cCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCCCC
Q 042435 201 ERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSN 280 (412)
Q Consensus 201 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 280 (412)
++|+|.++++.... ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 270 ~~g~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~--- 342 (450)
T 1k9a_A 270 AKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--- 342 (450)
T ss_dssp TTCBHHHHHHHHCT-TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred CCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCccccccc---
Confidence 99999999976432 2378999999999999999999999 9999999999999999999999999999854322
Q ss_pred cccccccccccccccccCcccCcccccHHHHHHHHHHHh-CCCCcccccccccCCCCcchhhHHhhhccCCccchhhHHH
Q 042435 281 RTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLM-GTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKIIQD 359 (412)
Q Consensus 281 ~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 359 (412)
.....+++.|+|||.+.+..++.++|||||||++|||+| |+.||... .... ....+......+.+...
T Consensus 343 ~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~-------~~~~-~~~~i~~~~~~~~p~~~--- 411 (450)
T 1k9a_A 343 QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI-------PLKD-VVPRVEKGYKMDAPDGC--- 411 (450)
T ss_dssp ----CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTS-------CTTT-HHHHHHTTCCCCCCTTC---
T ss_pred ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC-------CHHH-HHHHHHcCCCCCCCCcC---
Confidence 122357889999999999999999999999999999998 99998732 1111 22223232222222222
Q ss_pred HHHHHHHHHhcCcCCCCCCCCHHHHHHHHhcCC
Q 042435 360 IILVSTIALACLRSKPKSRPTMQRISQELEGKT 392 (412)
Q Consensus 360 ~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 392 (412)
...+.+++.+||+.||++|||+.++++.|+++.
T Consensus 412 ~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~ 444 (450)
T 1k9a_A 412 PPAVYDVMKNCWHLDAATRPTFLQLREQLEHIR 444 (450)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 234788999999999999999999999998865
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=324.77 Aligned_cols=232 Identities=19% Similarity=0.258 Sum_probs=187.0
Q ss_pred hhcCcccceeeeecCceEEEEEEeC-CCcEEEEEec-----------------------cCCccccceEEEecCceEEEE
Q 042435 141 ATEYFHIRYCIGTGGYDSVYKAELP-DGKVVALKKL-----------------------HHSETEDSAFVVYSPQCMFFI 196 (412)
Q Consensus 141 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l-----------------------~~~~~~~~~~~~~~~~~~~lv 196 (412)
..++|++.+.||+|+||.||+|... +|+.||+|.+ +|+++......+.+.+..++|
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 106 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 106 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 3568999999999999999999774 6899999964 578888888888999999999
Q ss_pred EEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCC---CcEEEeecCCccc
Q 042435 197 YEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSN---LEAFVADFGTVRL 273 (412)
Q Consensus 197 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~---~~~kl~DfGla~~ 273 (412)
|||+++|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+|||++.+ +.+||+|||+++.
T Consensus 107 ~e~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~ 180 (362)
T 2bdw_A 107 FDLVTGGELFEDIVARE---FYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIE 180 (362)
T ss_dssp ECCCCSCBHHHHHTTCS---CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEECCCTTCBC
T ss_pred EecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEeecCcceE
Confidence 99999999998887553 589999999999999999999999 99999999999999865 4599999999987
Q ss_pred cCCCCCCcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccc
Q 042435 274 LDVDSSNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPIN 353 (412)
Q Consensus 274 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 353 (412)
..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||... ........+.......+.
T Consensus 181 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~-------~~~~~~~~i~~~~~~~~~- 251 (362)
T 2bdw_A 181 VNDSE-AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDE-------DQHRLYAQIKAGAYDYPS- 251 (362)
T ss_dssp CTTCC-SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS-------SHHHHHHHHHHTCCCCCT-
T ss_pred ecCCc-ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCC-------CHHHHHHHHHhCCCCCCc-
Confidence 65332 233457999999999999989999999999999999999999998632 111112222222222111
Q ss_pred hhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 354 QKIIQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 354 ~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
.........+.+++.+||+.||++|||+.|++++
T Consensus 252 ~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 252 PEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp TGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred ccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 1111122347899999999999999999999876
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=326.15 Aligned_cols=243 Identities=21% Similarity=0.279 Sum_probs=193.5
Q ss_pred HHHHhhcCcccceeeeecCceEEEEEEeCC------CcEEEEEec-----------------------cCCccccceEEE
Q 042435 137 NLIDATEYFHIRYCIGTGGYDSVYKAELPD------GKVVALKKL-----------------------HHSETEDSAFVV 187 (412)
Q Consensus 137 ~l~~~~~~f~~~~~lG~G~~g~Vy~~~~~~------~~~vAvK~l-----------------------~~~~~~~~~~~~ 187 (412)
++....++|++.+.||+|+||.||+|.... ...||+|.+ +|+++......+
T Consensus 40 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 119 (333)
T 2i1m_A 40 KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGAC 119 (333)
T ss_dssp GGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 344456789999999999999999998642 348999964 578888888888
Q ss_pred ecCceEEEEEEeccCCceeeeeccCcc-----------cccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEE
Q 042435 188 YSPQCMFFIYEYMERGSLFCVLRDDDE-----------AIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNIL 256 (412)
Q Consensus 188 ~~~~~~~lv~ey~~~gsL~~~l~~~~~-----------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NIL 256 (412)
...+..++||||+++|+|.+++..... ...+++..++.++.|++.||+|||++ +|+||||||+||+
T Consensus 120 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl 196 (333)
T 2i1m_A 120 THGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVL 196 (333)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGCE
T ss_pred ecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccceEE
Confidence 889999999999999999999875421 12479999999999999999999999 9999999999999
Q ss_pred ecCCCcEEEeecCCccccCCCCCC--cccccccccccccccccCcccCcccccHHHHHHHHHHHh-CCCCcccccccccC
Q 042435 257 LNSNLEAFVADFGTVRLLDVDSSN--RTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLM-GTHPGELLLSLSSS 333 (412)
Q Consensus 257 l~~~~~~kl~DfGla~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~ellt-g~~P~~~~~~~~~~ 333 (412)
++.++.+||+|||+++........ .....+|+.|+|||.+.+..++.++||||||+++|||+| |..||...
T Consensus 197 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~------ 270 (333)
T 2i1m_A 197 LTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGI------ 270 (333)
T ss_dssp EEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC------
T ss_pred ECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCccc------
Confidence 999999999999999865443322 233457889999999988899999999999999999999 99998732
Q ss_pred CCCcchhhHHhhhccCCccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhcCC
Q 042435 334 SGPKIMLIDILYQRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELEGKT 392 (412)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 392 (412)
..................+... ...+.+++.+||+.||++|||+.|++++|+++.
T Consensus 271 -~~~~~~~~~~~~~~~~~~~~~~---~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~ 325 (333)
T 2i1m_A 271 -LVNSKFYKLVKDGYQMAQPAFA---PKNIYSIMQACWALEPTHRPTFQQICSFLQEQA 325 (333)
T ss_dssp -CSSHHHHHHHHHTCCCCCCTTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -chhHHHHHHHhcCCCCCCCCCC---CHHHHHHHHHHhccChhhCcCHHHHHHHHHHHH
Confidence 1122233333333322222222 223788999999999999999999999998764
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-41 Score=319.95 Aligned_cols=239 Identities=21% Similarity=0.318 Sum_probs=193.4
Q ss_pred hhcCcccceeeeecCceEEEEEEe------CCCcEEEEEec-----------------------cCCccccceEEEecCc
Q 042435 141 ATEYFHIRYCIGTGGYDSVYKAEL------PDGKVVALKKL-----------------------HHSETEDSAFVVYSPQ 191 (412)
Q Consensus 141 ~~~~f~~~~~lG~G~~g~Vy~~~~------~~~~~vAvK~l-----------------------~~~~~~~~~~~~~~~~ 191 (412)
..++|++.+.||+|+||.||+|.. .+++.||+|.+ +|+++......+...+
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 100 (313)
T 1t46_A 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG 100 (313)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCC
Confidence 456899999999999999999975 35789999964 5777888888888889
Q ss_pred eEEEEEEeccCCceeeeeccCcc---------------cccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEE
Q 042435 192 CMFFIYEYMERGSLFCVLRDDDE---------------AIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNIL 256 (412)
Q Consensus 192 ~~~lv~ey~~~gsL~~~l~~~~~---------------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NIL 256 (412)
..++||||+++|+|.+++..... ...+++..+..++.|++.||+|||++ +++||||||+||+
T Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil 177 (313)
T 1t46_A 101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNIL 177 (313)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEE
T ss_pred CcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEE
Confidence 99999999999999999875432 12489999999999999999999999 9999999999999
Q ss_pred ecCCCcEEEeecCCccccCCCCCC--cccccccccccccccccCcccCcccccHHHHHHHHHHHh-CCCCcccccccccC
Q 042435 257 LNSNLEAFVADFGTVRLLDVDSSN--RTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLM-GTHPGELLLSLSSS 333 (412)
Q Consensus 257 l~~~~~~kl~DfGla~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~ellt-g~~P~~~~~~~~~~ 333 (412)
++.++.+||+|||+++........ .....+|+.|+|||.+.+..++.++||||||+++|||+| |+.||...
T Consensus 178 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~------ 251 (313)
T 1t46_A 178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM------ 251 (313)
T ss_dssp EETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC------
T ss_pred EcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcc------
Confidence 999999999999999876544322 233457889999999988899999999999999999999 99998632
Q ss_pred CCCcchhhHHhhhccCCccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhcCC
Q 042435 334 SGPKIMLIDILYQRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELEGKT 392 (412)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 392 (412)
..................+... ...+.+++.+||+.||++|||+.|++++|+++.
T Consensus 252 -~~~~~~~~~~~~~~~~~~~~~~---~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 306 (313)
T 1t46_A 252 -PVDSKFYKMIKEGFRMLSPEHA---PAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI 306 (313)
T ss_dssp -CSSHHHHHHHHHTCCCCCCTTS---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -cchhHHHHHhccCCCCCCcccC---CHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence 1122233333333332222222 223788999999999999999999999998765
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=324.60 Aligned_cols=232 Identities=21% Similarity=0.271 Sum_probs=164.5
Q ss_pred eeeeecCceEEEEEEeC-CCcEEEEEec-------------------cCCccccceEEEecCceEEEEEEeccCCceeee
Q 042435 149 YCIGTGGYDSVYKAELP-DGKVVALKKL-------------------HHSETEDSAFVVYSPQCMFFIYEYMERGSLFCV 208 (412)
Q Consensus 149 ~~lG~G~~g~Vy~~~~~-~~~~vAvK~l-------------------~~~~~~~~~~~~~~~~~~~lv~ey~~~gsL~~~ 208 (412)
+.||+|+||.||+|... +++.||||.+ .|+++.....++.+....++||||+++|+|.++
T Consensus 17 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~ 96 (325)
T 3kn6_A 17 KPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFER 96 (325)
T ss_dssp CCSEEETTEEEEEEEETTTCCEEEEEEEEGGGHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHHHH
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEChhhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcHHHH
Confidence 78999999999999874 6899999965 288888888999999999999999999999999
Q ss_pred eccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCC---cEEEeecCCccccCCCCCCccccc
Q 042435 209 LRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNL---EAFVADFGTVRLLDVDSSNRTLQA 285 (412)
Q Consensus 209 l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~---~~kl~DfGla~~~~~~~~~~~~~~ 285 (412)
+.... .+++..+..++.|++.||+|||++ +|+||||||+|||++.++ .+||+|||+++.............
T Consensus 97 l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 170 (325)
T 3kn6_A 97 IKKKK---HFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPC 170 (325)
T ss_dssp HHHCS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTCEECCC---------
T ss_pred HHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCcccccC
Confidence 87653 589999999999999999999999 999999999999997655 899999999987655444445567
Q ss_pred ccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccchhhHHHHHHHHH
Q 042435 286 GTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKIIQDIILVST 365 (412)
Q Consensus 286 gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 365 (412)
||+.|+|||++.+..++.++||||||+++|||++|+.||..................+.......+ ..........+.+
T Consensus 171 ~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~-~~~~~~~s~~~~~ 249 (325)
T 3kn6_A 171 FTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFE-GEAWKNVSQEAKD 249 (325)
T ss_dssp -------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCC-SHHHHTSCHHHHH
T ss_pred CCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCC-cccccCCCHHHHH
Confidence 899999999999999999999999999999999999999743211000000111111111111111 1111222345889
Q ss_pred HHHhcCcCCCCCCCCHHHHHHH
Q 042435 366 IALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 366 l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
++.+||+.||++|||++|++++
T Consensus 250 li~~~L~~dP~~Rpt~~ell~h 271 (325)
T 3kn6_A 250 LIQGLLTVDPNKRLKMSGLRYN 271 (325)
T ss_dssp HHHHHHCCCTTTCCCTTTSTTC
T ss_pred HHHHHCCCChhHCCCHHHHhcC
Confidence 9999999999999999999865
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=322.54 Aligned_cols=234 Identities=23% Similarity=0.310 Sum_probs=178.4
Q ss_pred HhhcCcccceeeeecCceEEEEEEeC-CCcEEEEEec-------------------cCCccccceEEEecCceEEEEEEe
Q 042435 140 DATEYFHIRYCIGTGGYDSVYKAELP-DGKVVALKKL-------------------HHSETEDSAFVVYSPQCMFFIYEY 199 (412)
Q Consensus 140 ~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l-------------------~~~~~~~~~~~~~~~~~~~lv~ey 199 (412)
...++|++.+.||+|+||.||+|... +++.||||.+ +|+++.....++...+..++||||
T Consensus 50 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 129 (349)
T 2w4o_A 50 ALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLEL 129 (349)
T ss_dssp CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC----------CHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred cccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccchhHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEe
Confidence 34578999999999999999999875 5889999964 467777777888889999999999
Q ss_pred ccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecC---CCcEEEeecCCccccCC
Q 042435 200 MERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNS---NLEAFVADFGTVRLLDV 276 (412)
Q Consensus 200 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~---~~~~kl~DfGla~~~~~ 276 (412)
+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||++. ++.+||+|||+++....
T Consensus 130 ~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~ 203 (349)
T 2w4o_A 130 VTGGELFDRIVEKG---YYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH 203 (349)
T ss_dssp CCSCBHHHHHTTCS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCCC-------
T ss_pred CCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccCccccccCc
Confidence 99999999887654 589999999999999999999999 9999999999999975 88999999999986543
Q ss_pred CCCCcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccchhh
Q 042435 277 DSSNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKI 356 (412)
Q Consensus 277 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 356 (412)
.. ......||+.|+|||++.+..++.++|||||||++|||++|+.||.... ........+........ ....
T Consensus 204 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~------~~~~~~~~i~~~~~~~~-~~~~ 275 (349)
T 2w4o_A 204 QV-LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDER------GDQFMFRRILNCEYYFI-SPWW 275 (349)
T ss_dssp ----------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTT------CHHHHHHHHHTTCCCCC-TTTT
T ss_pred cc-ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCc------ccHHHHHHHHhCCCccC-Cchh
Confidence 22 2234578999999999999899999999999999999999999986321 11111222222221111 0111
Q ss_pred HHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 357 IQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 357 ~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
......+.+++.+||+.||++|||+.|++++
T Consensus 276 ~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 276 DEVSLNAKDLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred hhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1122347899999999999999999999985
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-41 Score=324.60 Aligned_cols=186 Identities=19% Similarity=0.238 Sum_probs=161.7
Q ss_pred cccHHHHHHhhcCcccceeeeecCceEEEEEEe-CCCcEEEEEecc-------------------------CCccccceE
Q 042435 132 KILYENLIDATEYFHIRYCIGTGGYDSVYKAEL-PDGKVVALKKLH-------------------------HSETEDSAF 185 (412)
Q Consensus 132 ~~~~~~l~~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l~-------------------------~~~~~~~~~ 185 (412)
.+++.+-....++|++.++||+|+||.||+|.. .+++.||||.++ |+++.....
T Consensus 24 ~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~ 103 (360)
T 3llt_A 24 HFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHG 103 (360)
T ss_dssp SCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEE
T ss_pred eeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecccc
Confidence 445555556678999999999999999999987 578999999752 677778888
Q ss_pred EEecCceEEEEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecC------
Q 042435 186 VVYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNS------ 259 (412)
Q Consensus 186 ~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~------ 259 (412)
.+...+..++||||+ +++|.+++...... .+++..+..++.|++.||+|||++ +|+||||||+|||++.
T Consensus 104 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~ 178 (360)
T 3llt_A 104 KFMYYDHMCLIFEPL-GPSLYEIITRNNYN-GFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDPYFEKS 178 (360)
T ss_dssp EEEETTEEEEEECCC-CCBHHHHHHHTTTC-CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCTTCCEE
T ss_pred eeeECCeeEEEEcCC-CCCHHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEcccccccc
Confidence 888889999999999 89999998765322 489999999999999999999999 9999999999999975
Q ss_pred -------------------CCcEEEeecCCccccCCCCCCcccccccccccccccccCcccCcccccHHHHHHHHHHHhC
Q 042435 260 -------------------NLEAFVADFGTVRLLDVDSSNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMG 320 (412)
Q Consensus 260 -------------------~~~~kl~DfGla~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg 320 (412)
++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||+||
T Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g 255 (360)
T 3llt_A 179 LITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY---HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTG 255 (360)
T ss_dssp EEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC---CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHS
T ss_pred ccchhcccccccccccccCCCCEEEEeccCceecCCC---CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHC
Confidence 789999999999864432 2345789999999999999999999999999999999999
Q ss_pred CCCcc
Q 042435 321 THPGE 325 (412)
Q Consensus 321 ~~P~~ 325 (412)
+.||.
T Consensus 256 ~~pf~ 260 (360)
T 3llt_A 256 SLLFR 260 (360)
T ss_dssp SCSCC
T ss_pred CCCCC
Confidence 99996
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-41 Score=324.37 Aligned_cols=248 Identities=22% Similarity=0.334 Sum_probs=183.0
Q ss_pred hcCcccceeeeecCceEEEEEEeCCCcEEEEEec--------------------cCCccccceEEE-----ecCceEEEE
Q 042435 142 TEYFHIRYCIGTGGYDSVYKAELPDGKVVALKKL--------------------HHSETEDSAFVV-----YSPQCMFFI 196 (412)
Q Consensus 142 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~l--------------------~~~~~~~~~~~~-----~~~~~~~lv 196 (412)
.++|++.+.||+|+||.||+|+. +++.||||.+ +|+++......+ ......++|
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv 90 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLV 90 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEE
T ss_pred hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccchhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEEE
Confidence 46799999999999999999987 7899999974 456666554321 123467899
Q ss_pred EEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCC------CCCcEEeCCCCCCEEecCCCcEEEeecCC
Q 042435 197 YEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDC------TPSIVHRDISSNNILLNSNLEAFVADFGT 270 (412)
Q Consensus 197 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~------~~~ivHrDlkp~NILl~~~~~~kl~DfGl 270 (412)
|||+++|+|.+++.... .++..+..++.|++.||+|||+.+ .++|+||||||+|||++.++.+||+|||+
T Consensus 91 ~e~~~~g~L~~~l~~~~----~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG~ 166 (336)
T 3g2f_A 91 MEYYPNGSLXKYLSLHT----SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGL 166 (336)
T ss_dssp ECCCTTCBHHHHHHHCC----BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCTT
T ss_pred EecCCCCcHHHHHhhcc----cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeeccc
Confidence 99999999999996553 689999999999999999999763 33899999999999999999999999999
Q ss_pred ccccCCCC--------CCcccccccccccccccccC-------cccCcccccHHHHHHHHHHHhCCCCcccccccccCC-
Q 042435 271 VRLLDVDS--------SNRTLQAGTYGYIALELVYT-------MVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSS- 334 (412)
Q Consensus 271 a~~~~~~~--------~~~~~~~gt~~y~aPE~~~~-------~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~- 334 (412)
++...... .......||+.|+|||++.+ ..++.++|||||||++|||++|..|+..........
T Consensus 167 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~ 246 (336)
T 3g2f_A 167 SMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQM 246 (336)
T ss_dssp CEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCC
T ss_pred eeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHH
Confidence 98764321 11234469999999999976 467789999999999999999988764321111000
Q ss_pred --------CCc-chhhHHh-hhccCCccch---hhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhcCCCC
Q 042435 335 --------GPK-IMLIDIL-YQRLSPPINQ---KIIQDIILVSTIALACLRSKPKSRPTMQRISQELEGKTPM 394 (412)
Q Consensus 335 --------~~~-~~~~~~~-~~~~~~~~~~---~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~ 394 (412)
.+. ....... .....+..+. ........+.+++.+||+.||++|||+.|+++.|+++...
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~ 319 (336)
T 3g2f_A 247 AFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMI 319 (336)
T ss_dssp TTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred hhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHH
Confidence 000 0001111 1111111111 1112334588999999999999999999999999887643
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=327.13 Aligned_cols=238 Identities=22% Similarity=0.279 Sum_probs=177.9
Q ss_pred hcCcccc-eeeeecCceEEEEEEeC-CCcEEEEEec-----------------cCCccccceEEEec----CceEEEEEE
Q 042435 142 TEYFHIR-YCIGTGGYDSVYKAELP-DGKVVALKKL-----------------HHSETEDSAFVVYS----PQCMFFIYE 198 (412)
Q Consensus 142 ~~~f~~~-~~lG~G~~g~Vy~~~~~-~~~~vAvK~l-----------------~~~~~~~~~~~~~~----~~~~~lv~e 198 (412)
.++|.+. ++||+|+||+||+|... +|+.||||.+ +|+++.....++.. .+..++|||
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E 139 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVME 139 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcchhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEE
Confidence 3567665 68999999999999774 6899999975 46777776666543 667899999
Q ss_pred eccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecC---CCcEEEeecCCccccC
Q 042435 199 YMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNS---NLEAFVADFGTVRLLD 275 (412)
Q Consensus 199 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~---~~~~kl~DfGla~~~~ 275 (412)
|+++|+|.+++..... ..+++..+..++.|++.||+|||++ +|+||||||+|||++. ++.+||+|||+++...
T Consensus 140 ~~~gg~L~~~l~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~ 215 (400)
T 1nxk_A 140 CLDGGELFSRIQDRGD-QAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT 215 (400)
T ss_dssp CCCSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred eCCCCcHHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEEecccccccC
Confidence 9999999999976532 2589999999999999999999998 9999999999999987 7899999999998654
Q ss_pred CCCCCcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccchh
Q 042435 276 VDSSNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQK 355 (412)
Q Consensus 276 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 355 (412)
... ......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ........+.......+. ..
T Consensus 216 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~---~~~~~~~~i~~~~~~~~~-~~ 290 (400)
T 1nxk_A 216 SHN-SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA---ISPGMKTRIRMGQYEFPN-PE 290 (400)
T ss_dssp ------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCS---SCCSHHHHHHHTCCCCCT-TT
T ss_pred CCC-ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcccc---ccHHHHHHHHcCcccCCC-cc
Confidence 322 2345578999999999999999999999999999999999999997432111 011111222222222111 01
Q ss_pred hHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHH
Q 042435 356 IIQDIILVSTIALACLRSKPKSRPTMQRISQEL 388 (412)
Q Consensus 356 ~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L 388 (412)
.......+.+++.+||+.||++|||+.|++++-
T Consensus 291 ~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp 323 (400)
T 1nxk_A 291 WSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHP 323 (400)
T ss_dssp TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred cccCCHHHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence 111223478999999999999999999999863
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=319.19 Aligned_cols=244 Identities=21% Similarity=0.325 Sum_probs=184.6
Q ss_pred hcCcccceeeeecCceEEEEEEe-----CCCcEEEEEec---------------------cCCccccceEEEec--CceE
Q 042435 142 TEYFHIRYCIGTGGYDSVYKAEL-----PDGKVVALKKL---------------------HHSETEDSAFVVYS--PQCM 193 (412)
Q Consensus 142 ~~~f~~~~~lG~G~~g~Vy~~~~-----~~~~~vAvK~l---------------------~~~~~~~~~~~~~~--~~~~ 193 (412)
.++|++.+.||+|+||.||+|++ .+++.||||++ +|+++.....++.. ....
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 88 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence 36789999999999999999984 36899999965 46677666666644 3458
Q ss_pred EEEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccc
Q 042435 194 FFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRL 273 (412)
Q Consensus 194 ~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~ 273 (412)
++||||+++|+|.+++..... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 89 ~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~ 163 (295)
T 3ugc_A 89 KLIMEYLPYGSLRDYLQKHKE--RIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKV 163 (295)
T ss_dssp EEEEECCTTCBHHHHHHHCGG--GCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCSCC-
T ss_pred EEEEEeCCCCCHHHHHHhccc--ccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEccCccccc
Confidence 999999999999999976542 489999999999999999999998 999999999999999999999999999987
Q ss_pred cCCCCC---CcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCccccccc-----ccCCCCcc---hhhH
Q 042435 274 LDVDSS---NRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSL-----SSSSGPKI---MLID 342 (412)
Q Consensus 274 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~-----~~~~~~~~---~~~~ 342 (412)
...... ......++..|+|||.+.+..++.++||||||+++|||+||..|+...... ........ ...+
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (295)
T 3ugc_A 164 LPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE 243 (295)
T ss_dssp ------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHH
T ss_pred ccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHH
Confidence 644322 123345778899999999899999999999999999999999997632110 01111110 1112
Q ss_pred HhhhccCCccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhcCCC
Q 042435 343 ILYQRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELEGKTP 393 (412)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 393 (412)
.+......+.+... ...+.+++.+||+.||++|||+.|+++.|+++..
T Consensus 244 ~~~~~~~~~~~~~~---~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~ 291 (295)
T 3ugc_A 244 LLKNNGRLPRPDGC---PDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 291 (295)
T ss_dssp HHHTTCCCCCCTTC---CHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHhccCcCCCCcCc---CHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHH
Confidence 22222222222222 2348889999999999999999999999988753
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=330.75 Aligned_cols=239 Identities=22% Similarity=0.291 Sum_probs=190.5
Q ss_pred hcCcccceeeeecCceEEEEEEeC------CCcEEEEEec----------------------cCCccccceEEEecCceE
Q 042435 142 TEYFHIRYCIGTGGYDSVYKAELP------DGKVVALKKL----------------------HHSETEDSAFVVYSPQCM 193 (412)
Q Consensus 142 ~~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vAvK~l----------------------~~~~~~~~~~~~~~~~~~ 193 (412)
.++|++.+.||+|+||.||+|.+. +++.||||++ +|+++......+......
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 367999999999999999999853 4678999975 578888888888888899
Q ss_pred EEEEEeccCCceeeeeccCcc----cccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCC---cEEEe
Q 042435 194 FFIYEYMERGSLFCVLRDDDE----AIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNL---EAFVA 266 (412)
Q Consensus 194 ~lv~ey~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~---~~kl~ 266 (412)
++||||+++|+|.+++..... ...+++.+++.++.|++.||+|||++ +|+||||||+|||++.++ .+||+
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCceEEEC
Confidence 999999999999999875431 23589999999999999999999999 999999999999998544 59999
Q ss_pred ecCCccccCCC--CCCcccccccccccccccccCcccCcccccHHHHHHHHHHHh-CCCCcccccccccCCCCcchhhHH
Q 042435 267 DFGTVRLLDVD--SSNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLM-GTHPGELLLSLSSSSGPKIMLIDI 343 (412)
Q Consensus 267 DfGla~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~ 343 (412)
|||+++..... ........||+.|+|||++.+..++.++|||||||++|||+| |..||... ......+.
T Consensus 227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~--------~~~~~~~~ 298 (367)
T 3l9p_A 227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK--------SNQEVLEF 298 (367)
T ss_dssp CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC--------CHHHHHHH
T ss_pred CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC--------CHHHHHHH
Confidence 99999754322 122234567899999999998899999999999999999998 99998732 11122233
Q ss_pred hhhccCCccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhcCCCC
Q 042435 344 LYQRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELEGKTPM 394 (412)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~ 394 (412)
+........+... ...+.+++.+||+.||++|||+.|++++|+.+...
T Consensus 299 i~~~~~~~~~~~~---~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~ 346 (367)
T 3l9p_A 299 VTSGGRMDPPKNC---PGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 346 (367)
T ss_dssp HHTTCCCCCCTTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHcCCCCCCCccC---CHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhC
Confidence 3222222222222 22378899999999999999999999999887654
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=316.66 Aligned_cols=225 Identities=26% Similarity=0.314 Sum_probs=186.6
Q ss_pred hcCcccceeeeecCceEEEEEEeC-CCcEEEEEec------------------------cCCccccceEEEecCceEEEE
Q 042435 142 TEYFHIRYCIGTGGYDSVYKAELP-DGKVVALKKL------------------------HHSETEDSAFVVYSPQCMFFI 196 (412)
Q Consensus 142 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l------------------------~~~~~~~~~~~~~~~~~~~lv 196 (412)
.++|++.+.||+|+||.||+|+.. +|+.||+|.+ +|+++......+.+.+..++|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 367999999999999999999874 6999999964 577888888888899999999
Q ss_pred EEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCC
Q 042435 197 YEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDV 276 (412)
Q Consensus 197 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~ 276 (412)
|||+++|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 85 ~e~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~ 158 (318)
T 1fot_A 85 MDYIEGGELFSLLRKSQ---RFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPD 158 (318)
T ss_dssp ECCCCSCBHHHHHHHTS---SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred EeCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeecCcceecCC
Confidence 99999999999987643 589999999999999999999998 999999999999999999999999999986543
Q ss_pred CCCCcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccchhh
Q 042435 277 DSSNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKI 356 (412)
Q Consensus 277 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 356 (412)
. .....||+.|+|||++.+..++.++|||||||++|||++|+.||... ........+.......+ ...
T Consensus 159 ~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~-------~~~~~~~~i~~~~~~~p--~~~ 226 (318)
T 1fot_A 159 V---TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDS-------NTMKTYEKILNAELRFP--PFF 226 (318)
T ss_dssp C---BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCS-------SHHHHHHHHHHCCCCCC--TTS
T ss_pred c---cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCC-------CHHHHHHHHHhCCCCCC--CCC
Confidence 2 23457999999999999999999999999999999999999998632 11112223333332221 111
Q ss_pred HHHHHHHHHHHHhcCcCCCCCCC-----CHHHHHHH
Q 042435 357 IQDIILVSTIALACLRSKPKSRP-----TMQRISQE 387 (412)
Q Consensus 357 ~~~~~~~~~l~~~Cl~~dP~~RP-----s~~evl~~ 387 (412)
...+.+++.+||+.||++|| +++|++++
T Consensus 227 ---~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~h 259 (318)
T 1fot_A 227 ---NEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 259 (318)
T ss_dssp ---CHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred ---CHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence 12378899999999999999 89999865
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=318.92 Aligned_cols=228 Identities=24% Similarity=0.347 Sum_probs=180.2
Q ss_pred hcCcccceeeeecCceEEEEEEe----CCCcEEEEEec-------------------------cCCccccceEEEecCce
Q 042435 142 TEYFHIRYCIGTGGYDSVYKAEL----PDGKVVALKKL-------------------------HHSETEDSAFVVYSPQC 192 (412)
Q Consensus 142 ~~~f~~~~~lG~G~~g~Vy~~~~----~~~~~vAvK~l-------------------------~~~~~~~~~~~~~~~~~ 192 (412)
.++|++.+.||+|+||.||+|+. .+|+.||+|.+ +|+++......+...+.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 46799999999999999999987 47899999965 35566666667888889
Q ss_pred EEEEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCcc
Q 042435 193 MFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVR 272 (412)
Q Consensus 193 ~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~ 272 (412)
.++||||+++|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~ 169 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLEREG---IFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCK 169 (327)
T ss_dssp EEEEEECCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred EEEEEeCCCCCcHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEEeCCccc
Confidence 999999999999999886543 588999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCCcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCcc
Q 042435 273 LLDVDSSNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPI 352 (412)
Q Consensus 273 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 352 (412)
.............||+.|+|||++.+..++.++||||||+++|||++|+.||... ........+.......+
T Consensus 170 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~-------~~~~~~~~i~~~~~~~p- 241 (327)
T 3a62_A 170 ESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGE-------NRKKTIDKILKCKLNLP- 241 (327)
T ss_dssp ---------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCS-------SHHHHHHHHHHTCCCCC-
T ss_pred ccccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCC-------CHHHHHHHHHhCCCCCC-
Confidence 6543333334567999999999999989999999999999999999999998732 11112222333222221
Q ss_pred chhhHHHHHHHHHHHHhcCcCCCCCCC-----CHHHHHHH
Q 042435 353 NQKIIQDIILVSTIALACLRSKPKSRP-----TMQRISQE 387 (412)
Q Consensus 353 ~~~~~~~~~~~~~l~~~Cl~~dP~~RP-----s~~evl~~ 387 (412)
... ...+.+++.+||+.||++|| ++.|++++
T Consensus 242 -~~~---~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h 277 (327)
T 3a62_A 242 -PYL---TQEARDLLKKLLKRNAASRLGAGPGDAGEVQAH 277 (327)
T ss_dssp -TTS---CHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred -CCC---CHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence 111 12378899999999999999 78888775
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=316.98 Aligned_cols=238 Identities=23% Similarity=0.382 Sum_probs=180.0
Q ss_pred cCcccceeeeecCceEEEEEEeCCCcEEEEEec-------------------cCCccccceEEEecCceEEEEEEeccCC
Q 042435 143 EYFHIRYCIGTGGYDSVYKAELPDGKVVALKKL-------------------HHSETEDSAFVVYSPQCMFFIYEYMERG 203 (412)
Q Consensus 143 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~l-------------------~~~~~~~~~~~~~~~~~~~lv~ey~~~g 203 (412)
++|++.+.||+|+||.||+|.+ .++.||+|.+ +|+++......+. +..++||||+++|
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~~~~ 84 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAEGG 84 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEECSSTTHHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECCTTC
T ss_pred hHeeeeeEeecCCCceEEEEEE-CCeeEEEEEecChhHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcCCCC
Confidence 5688999999999999999988 4788999976 4666666555444 4579999999999
Q ss_pred ceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCc-EEEeecCCccccCCCCCCcc
Q 042435 204 SLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLE-AFVADFGTVRLLDVDSSNRT 282 (412)
Q Consensus 204 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~-~kl~DfGla~~~~~~~~~~~ 282 (412)
+|.+++........+++..++.++.|+++||+|||+.+..+|+||||||+||+++.++. +||+|||+++..... ..
T Consensus 85 ~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~---~~ 161 (307)
T 2eva_A 85 SLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH---MT 161 (307)
T ss_dssp BHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC------------
T ss_pred CHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc---cc
Confidence 99999987654445889999999999999999999943348999999999999988876 799999999755322 22
Q ss_pred cccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccchhhHHHHHH
Q 042435 283 LQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKIIQDIIL 362 (412)
Q Consensus 283 ~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 362 (412)
...||+.|+|||++.+..++.++||||||+++|||+||+.||.... ...............++..... ...
T Consensus 162 ~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~------~~~~~~~~~~~~~~~~~~~~~~---~~~ 232 (307)
T 2eva_A 162 NNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIG------GPAFRIMWAVHNGTRPPLIKNL---PKP 232 (307)
T ss_dssp ---CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTC------SSHHHHHHHHHTTCCCCCBTTC---CHH
T ss_pred cCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhC------ccHHHHHHHHhcCCCCCccccc---CHH
Confidence 3468999999999999999999999999999999999999987321 1111111111122222222222 223
Q ss_pred HHHHHHhcCcCCCCCCCCHHHHHHHHhcCCCCC
Q 042435 363 VSTIALACLRSKPKSRPTMQRISQELEGKTPMK 395 (412)
Q Consensus 363 ~~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~~ 395 (412)
+.+++.+||+.||++|||++|+++.|+.+....
T Consensus 233 l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 265 (307)
T 2eva_A 233 IESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYF 265 (307)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGC
T ss_pred HHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhc
Confidence 788999999999999999999999998876543
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-41 Score=334.72 Aligned_cols=240 Identities=24% Similarity=0.358 Sum_probs=186.9
Q ss_pred HhhcCcccceeeeecCceEEEEEEeCCCcEEEEEec--------------------cCCccccceEEEecCceEEEEEEe
Q 042435 140 DATEYFHIRYCIGTGGYDSVYKAELPDGKVVALKKL--------------------HHSETEDSAFVVYSPQCMFFIYEY 199 (412)
Q Consensus 140 ~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~l--------------------~~~~~~~~~~~~~~~~~~~lv~ey 199 (412)
...++|++.+.||+|+||.||+|.+.++..||||.+ +|+++.....++.. +..++||||
T Consensus 181 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~ 259 (452)
T 1fmk_A 181 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 259 (452)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred cChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehh
Confidence 345678999999999999999999988889999975 46677766666654 678999999
Q ss_pred ccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCCC
Q 042435 200 MERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSS 279 (412)
Q Consensus 200 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 279 (412)
+++|+|.+++..... ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.......
T Consensus 260 ~~~gsL~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 335 (452)
T 1fmk_A 260 MSKGSLLDFLKGETG-KYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 335 (452)
T ss_dssp CTTCBHHHHHSHHHH-TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC-------
T ss_pred hcCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCccceecCCCce
Confidence 999999999975322 2489999999999999999999999 999999999999999999999999999987643321
Q ss_pred -CcccccccccccccccccCcccCcccccHHHHHHHHHHHh-CCCCcccccccccCCCCcchhhHHhhhccCCccchhhH
Q 042435 280 -NRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLM-GTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKII 357 (412)
Q Consensus 280 -~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 357 (412)
......+++.|+|||.+.+..++.++||||||+++|||+| |+.||.... .....+.+......+.+...
T Consensus 336 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~--------~~~~~~~i~~~~~~~~~~~~- 406 (452)
T 1fmk_A 336 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV--------NREVLDQVERGYRMPCPPEC- 406 (452)
T ss_dssp -------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC--------HHHHHHHHHTTCCCCCCTTS-
T ss_pred ecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCC--------HHHHHHHHHcCCCCCCCCCC-
Confidence 2233457789999999998899999999999999999999 999986321 11122222222222222222
Q ss_pred HHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhcCCCCC
Q 042435 358 QDIILVSTIALACLRSKPKSRPTMQRISQELEGKTPMK 395 (412)
Q Consensus 358 ~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~~ 395 (412)
...+.+++.+||+.||++|||++++++.|+++....
T Consensus 407 --~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~ 442 (452)
T 1fmk_A 407 --PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 442 (452)
T ss_dssp --CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred --CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccC
Confidence 224788999999999999999999999999986543
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=309.64 Aligned_cols=231 Identities=18% Similarity=0.255 Sum_probs=184.5
Q ss_pred cCcccceeeeecCceEEEEEEeCCCcEEEEEec-----------------------cCCccccceEEEecC--ceEEEEE
Q 042435 143 EYFHIRYCIGTGGYDSVYKAELPDGKVVALKKL-----------------------HHSETEDSAFVVYSP--QCMFFIY 197 (412)
Q Consensus 143 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~l-----------------------~~~~~~~~~~~~~~~--~~~~lv~ 197 (412)
++|++.+.||+|+||.||+|.+. ++.||||.+ +|+++.....++... +..++||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (271)
T 3kmu_A 10 KQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT 88 (271)
T ss_dssp GGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEE
T ss_pred HHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeee
Confidence 57899999999999999999984 889999965 466666667777766 7889999
Q ss_pred EeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCC--cEEeCCCCCCEEecCCCcEEEeecCCccccC
Q 042435 198 EYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPS--IVHRDISSNNILLNSNLEAFVADFGTVRLLD 275 (412)
Q Consensus 198 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~--ivHrDlkp~NILl~~~~~~kl~DfGla~~~~ 275 (412)
||+++|+|.+++..... ..+++..+..++.|++.||+|||++ + ++||||||+||+++.++.++++|||++....
T Consensus 89 e~~~~~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~ 164 (271)
T 3kmu_A 89 HWMPYGSLYNVLHEGTN-FVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ 164 (271)
T ss_dssp ECCTTCBHHHHHHSCSS-CCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS
T ss_pred cccCCCcHHHHHhhccc-CCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcceeEEeccceeeec
Confidence 99999999999986542 2489999999999999999999998 7 9999999999999999999999888775432
Q ss_pred CCCCCcccccccccccccccccCcccCc---ccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCcc
Q 042435 276 VDSSNRTLQAGTYGYIALELVYTMVVTE---KCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPI 352 (412)
Q Consensus 276 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~---ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 352 (412)
. ....||+.|+|||.+.+..++. ++||||||+++|||++|+.||... ...............+..
T Consensus 165 ~-----~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~-------~~~~~~~~~~~~~~~~~~ 232 (271)
T 3kmu_A 165 S-----PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADL-------SNMEIGMKVALEGLRPTI 232 (271)
T ss_dssp C-----TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTS-------CHHHHHHHHHHSCCCCCC
T ss_pred c-----cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCcccc-------ChHHHHHHHHhcCCCCCC
Confidence 2 2346899999999998765544 799999999999999999998732 111112222323333222
Q ss_pred chhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhcCCC
Q 042435 353 NQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELEGKTP 393 (412)
Q Consensus 353 ~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 393 (412)
+.... ..+.+++.+||+.||++|||++|+++.|+++..
T Consensus 233 ~~~~~---~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 233 PPGIS---PHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp CTTCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred CCCCC---HHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 22222 237889999999999999999999999998753
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=316.40 Aligned_cols=234 Identities=24% Similarity=0.260 Sum_probs=180.8
Q ss_pred hhcCcccceeeeecCceEEEEEEe-CCCcEEEEEecc-----------------------------CCccccceEEEecC
Q 042435 141 ATEYFHIRYCIGTGGYDSVYKAEL-PDGKVVALKKLH-----------------------------HSETEDSAFVVYSP 190 (412)
Q Consensus 141 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l~-----------------------------~~~~~~~~~~~~~~ 190 (412)
.+++|++.+.||+|+||+||+|.. .+++.||||.++ |+++.....++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 367899999999999999999986 578999999763 67777776666554
Q ss_pred c-----eEEEEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEE
Q 042435 191 Q-----CMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFV 265 (412)
Q Consensus 191 ~-----~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl 265 (412)
. ..++||||+. |+|.+++...... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~-~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl 161 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAPPP-GLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKL 161 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCCTT-CSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTSCEEE
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhccCC-CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEE
Confidence 4 5899999996 6999988765432 389999999999999999999999 9999999999999999999999
Q ss_pred eecCCccccCCCCCCcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhh
Q 042435 266 ADFGTVRLLDVDSSNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILY 345 (412)
Q Consensus 266 ~DfGla~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~ 345 (412)
+|||+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+..
T Consensus 162 ~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-------~~~~~~i~~ 233 (308)
T 3g33_A 162 ADFGLARIYSYQM-ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSE-------ADQLGKIFD 233 (308)
T ss_dssp CSCSCTTTSTTCC-CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSH-------HHHHHHHHH
T ss_pred eeCccccccCCCc-ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHHH
Confidence 9999998664332 23456789999999999999999999999999999999999999863211 000111110
Q ss_pred h------------------ccC----CccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 346 Q------------------RLS----PPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 346 ~------------------~~~----~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
. ... .+...........+.+++.+||+.||++|||+.|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 297 (308)
T 3g33_A 234 LIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH 297 (308)
T ss_dssp HHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence 0 000 00000001112347889999999999999999999875
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=318.74 Aligned_cols=238 Identities=22% Similarity=0.329 Sum_probs=190.1
Q ss_pred hcCcccceeeeecCceEEEEEEeC--------CCcEEEEEec-----------------------cCCccccceEEEecC
Q 042435 142 TEYFHIRYCIGTGGYDSVYKAELP--------DGKVVALKKL-----------------------HHSETEDSAFVVYSP 190 (412)
Q Consensus 142 ~~~f~~~~~lG~G~~g~Vy~~~~~--------~~~~vAvK~l-----------------------~~~~~~~~~~~~~~~ 190 (412)
.++|++.+.||+|+||.||+|... +++.||+|.+ +|+++......+...
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 113 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 113 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence 468999999999999999999863 4778999975 577777778888888
Q ss_pred ceEEEEEEeccCCceeeeeccCcc-------------cccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEe
Q 042435 191 QCMFFIYEYMERGSLFCVLRDDDE-------------AIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILL 257 (412)
Q Consensus 191 ~~~~lv~ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl 257 (412)
+..++||||+++|+|.+++..... ...+++..++.++.|++.||+|||+. +|+||||||+||++
T Consensus 114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll 190 (334)
T 2pvf_A 114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLV 190 (334)
T ss_dssp SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEE
T ss_pred CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCccceEEE
Confidence 999999999999999999876431 12489999999999999999999999 99999999999999
Q ss_pred cCCCcEEEeecCCccccCCCCCC--cccccccccccccccccCcccCcccccHHHHHHHHHHHh-CCCCcccccccccCC
Q 042435 258 NSNLEAFVADFGTVRLLDVDSSN--RTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLM-GTHPGELLLSLSSSS 334 (412)
Q Consensus 258 ~~~~~~kl~DfGla~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~ellt-g~~P~~~~~~~~~~~ 334 (412)
+.++.+||+|||+++........ .....+|+.|+|||++.+..++.++||||||+++|||+| |+.||...
T Consensus 191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~------- 263 (334)
T 2pvf_A 191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI------- 263 (334)
T ss_dssp CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTC-------
T ss_pred cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcC-------
Confidence 99999999999999866543221 233456789999999988889999999999999999999 99998632
Q ss_pred CCcchhhHHhhhccCCccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhcCCC
Q 042435 335 GPKIMLIDILYQRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELEGKTP 393 (412)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 393 (412)
........+........+... ...+.+++.+||+.||++|||+.|+++.|+++..
T Consensus 264 -~~~~~~~~~~~~~~~~~~~~~---~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~ 318 (334)
T 2pvf_A 264 -PVEELFKLLKEGHRMDKPANC---TNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 318 (334)
T ss_dssp -CHHHHHHHHHHTCCCCCCTTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -CHHHHHHHHhcCCCCCCCccC---CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 111122222222222222222 2247889999999999999999999999998754
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=320.36 Aligned_cols=226 Identities=22% Similarity=0.332 Sum_probs=182.8
Q ss_pred hcCcccceeeeecCceEEEEEEe-CCCcEEEEEec------------------------cCCccccceEEEecCceEEEE
Q 042435 142 TEYFHIRYCIGTGGYDSVYKAEL-PDGKVVALKKL------------------------HHSETEDSAFVVYSPQCMFFI 196 (412)
Q Consensus 142 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l------------------------~~~~~~~~~~~~~~~~~~~lv 196 (412)
.++|.+.+.||+|+||.||+|.. .+++.||+|.+ +|+++.....++...+..++|
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 36799999999999999999986 67899999953 578888888889999999999
Q ss_pred EEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCC
Q 042435 197 YEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDV 276 (412)
Q Consensus 197 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~ 276 (412)
|||+ +|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+++....
T Consensus 88 ~E~~-~g~l~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~ 160 (336)
T 3h4j_B 88 IEYA-GGELFDYIVEKK---RMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTD 160 (336)
T ss_dssp ECCC-CEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSSCTBTTTT
T ss_pred EECC-CCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEeccceeccC
Confidence 9999 689988876543 589999999999999999999999 999999999999999999999999999986544
Q ss_pred CCCCcccccccccccccccccCccc-CcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccchh
Q 042435 277 DSSNRTLQAGTYGYIALELVYTMVV-TEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQK 355 (412)
Q Consensus 277 ~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 355 (412)
.. ......||+.|+|||++.+..+ +.++|||||||++|||++|+.||+...... ....+...... .+..
T Consensus 161 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~-------~~~~i~~~~~~--~p~~ 230 (336)
T 3h4j_B 161 GN-FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPN-------LFKKVNSCVYV--MPDF 230 (336)
T ss_dssp SB-TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTT-------CBCCCCSSCCC--CCTT
T ss_pred Cc-ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHH-------HHHHHHcCCCC--Cccc
Confidence 32 2234579999999999988776 689999999999999999999997421100 00000000011 1111
Q ss_pred hHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 356 IIQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 356 ~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
. ...+.+++.+||+.||++|||++|++++
T Consensus 231 ~---s~~~~~li~~~L~~dP~~Rpt~~eil~h 259 (336)
T 3h4j_B 231 L---SPGAQSLIRRMIVADPMQRITIQEIRRD 259 (336)
T ss_dssp S---CHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred C---CHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 1 1237789999999999999999999875
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-41 Score=319.72 Aligned_cols=244 Identities=22% Similarity=0.340 Sum_probs=177.9
Q ss_pred HHHHhhcCcccceeeeecCceEEEEEEeCCC----cEEEEEec-----------------------cCCccccceEEEec
Q 042435 137 NLIDATEYFHIRYCIGTGGYDSVYKAELPDG----KVVALKKL-----------------------HHSETEDSAFVVYS 189 (412)
Q Consensus 137 ~l~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~----~~vAvK~l-----------------------~~~~~~~~~~~~~~ 189 (412)
++....++|++.+.||+|+||.||+|..... ..||||.+ +|+++.....++..
T Consensus 17 ~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 96 (323)
T 3qup_A 17 DVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLR 96 (323)
T ss_dssp TTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEEC
T ss_pred hcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeec
Confidence 3444567899999999999999999987543 27999965 46677777777666
Q ss_pred CceE------EEEEEeccCCceeeeeccCcc---cccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCC
Q 042435 190 PQCM------FFIYEYMERGSLFCVLRDDDE---AIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSN 260 (412)
Q Consensus 190 ~~~~------~lv~ey~~~gsL~~~l~~~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~ 260 (412)
.+.. ++||||+++|+|.+++..... ...+++..+..++.|++.||+|||++ +|+||||||+||+++.+
T Consensus 97 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~ 173 (323)
T 3qup_A 97 SRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAED 173 (323)
T ss_dssp C-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTT
T ss_pred cccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCC
Confidence 5544 999999999999998864321 12589999999999999999999999 99999999999999999
Q ss_pred CcEEEeecCCccccCCCCC--CcccccccccccccccccCcccCcccccHHHHHHHHHHHh-CCCCcccccccccCCCCc
Q 042435 261 LEAFVADFGTVRLLDVDSS--NRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLM-GTHPGELLLSLSSSSGPK 337 (412)
Q Consensus 261 ~~~kl~DfGla~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~ellt-g~~P~~~~~~~~~~~~~~ 337 (412)
+.+||+|||+++....... ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||... ...
T Consensus 174 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~-------~~~ 246 (323)
T 3qup_A 174 MTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGI-------ENA 246 (323)
T ss_dssp SCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC-------CGG
T ss_pred CCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCcccc-------ChH
Confidence 9999999999986644322 1233456789999999999899999999999999999999 89998732 111
Q ss_pred chhhHHhhhccCCccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhcCCCC
Q 042435 338 IMLIDILYQRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELEGKTPM 394 (412)
Q Consensus 338 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~ 394 (412)
.....+........+... ...+.+++.+||+.||++|||+.|+++.|+++...
T Consensus 247 -~~~~~~~~~~~~~~~~~~---~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~ 299 (323)
T 3qup_A 247 -EIYNYLIGGNRLKQPPEC---MEEVYDLMYQCWSADPKQRPSFTCLRMELENILGH 299 (323)
T ss_dssp -GHHHHHHTTCCCCCCTTC---CHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred -HHHHHHhcCCCCCCCCcc---CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 122222222111111222 22478999999999999999999999999987643
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=319.75 Aligned_cols=225 Identities=19% Similarity=0.252 Sum_probs=186.1
Q ss_pred hcCcccceeeeecCceEEEEEEeC-CCcEEEEEec------------------------cCCccccceEEEecCceEEEE
Q 042435 142 TEYFHIRYCIGTGGYDSVYKAELP-DGKVVALKKL------------------------HHSETEDSAFVVYSPQCMFFI 196 (412)
Q Consensus 142 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l------------------------~~~~~~~~~~~~~~~~~~~lv 196 (412)
.++|++.+.||+|+||.||+|... +|+.||+|.+ +|+++......+.+.+..++|
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 119 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence 367999999999999999999874 6999999964 467777777888889999999
Q ss_pred EEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCC
Q 042435 197 YEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDV 276 (412)
Q Consensus 197 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~ 276 (412)
|||+++|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 120 ~e~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~ 193 (350)
T 1rdq_E 120 MEYVAGGEMFSHLRRIG---RFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp EECCTTCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred EcCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEcccccceeccC
Confidence 99999999999987543 589999999999999999999999 999999999999999999999999999986543
Q ss_pred CCCCcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccchhh
Q 042435 277 DSSNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKI 356 (412)
Q Consensus 277 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 356 (412)
. .....||+.|+|||++.+..++.++|||||||++|||++|+.||... ........+.......+ ...
T Consensus 194 ~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~-------~~~~~~~~i~~~~~~~p--~~~ 261 (350)
T 1rdq_E 194 R---TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD-------QPIQIYEKIVSGKVRFP--SHF 261 (350)
T ss_dssp C---BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS-------SHHHHHHHHHHCCCCCC--TTC
T ss_pred C---cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCC-------CHHHHHHHHHcCCCCCC--CCC
Confidence 2 23457999999999999999999999999999999999999998732 11112222333322221 111
Q ss_pred HHHHHHHHHHHHhcCcCCCCCCCC-----HHHHHHH
Q 042435 357 IQDIILVSTIALACLRSKPKSRPT-----MQRISQE 387 (412)
Q Consensus 357 ~~~~~~~~~l~~~Cl~~dP~~RPs-----~~evl~~ 387 (412)
...+.+++.+||+.||++||+ ++|++++
T Consensus 262 ---~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h 294 (350)
T 1rdq_E 262 ---SSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp ---CHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred ---CHHHHHHHHHHhhcCHHhccCCccCCHHHHHhC
Confidence 223788999999999999998 8888765
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=312.54 Aligned_cols=234 Identities=22% Similarity=0.319 Sum_probs=175.2
Q ss_pred hcCcccceeeeecCceEEEEEEeCC----CcEEEEEec----------------------cCCccccceEEEecCceEEE
Q 042435 142 TEYFHIRYCIGTGGYDSVYKAELPD----GKVVALKKL----------------------HHSETEDSAFVVYSPQCMFF 195 (412)
Q Consensus 142 ~~~f~~~~~lG~G~~g~Vy~~~~~~----~~~vAvK~l----------------------~~~~~~~~~~~~~~~~~~~l 195 (412)
.++|++.+.||+|+||.||+|.... +..||+|.+ +|+++.....++ ..+..++
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~~~l 92 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVWI 92 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-CSSSCEE
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEE-ccCccEE
Confidence 4679999999999999999997743 557999964 467777766665 4567899
Q ss_pred EEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccC
Q 042435 196 IYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLD 275 (412)
Q Consensus 196 v~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~ 275 (412)
||||+++|+|.+++.... ..+++..+..++.|++.||+|||++ +++||||||+||+++.++.+||+|||+++...
T Consensus 93 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 167 (281)
T 1mp8_A 93 IMELCTLGELRSFLQVRK--YSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 167 (281)
T ss_dssp EEECCTTEEHHHHHHHTT--TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC--------
T ss_pred EEecCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECccccccccC
Confidence 999999999999987543 2489999999999999999999999 99999999999999999999999999998764
Q ss_pred CCCC-CcccccccccccccccccCcccCcccccHHHHHHHHHHHh-CCCCcccccccccCCCCcchhhHHhhhccCCccc
Q 042435 276 VDSS-NRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLM-GTHPGELLLSLSSSSGPKIMLIDILYQRLSPPIN 353 (412)
Q Consensus 276 ~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 353 (412)
.... ......+|+.|+|||.+.+..++.++||||||+++|||++ |..||... .... ....+......+.+
T Consensus 168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~-------~~~~-~~~~i~~~~~~~~~ 239 (281)
T 1mp8_A 168 DSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV-------KNND-VIGRIENGERLPMP 239 (281)
T ss_dssp -----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTC-------CGGG-HHHHHHTTCCCCCC
T ss_pred cccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcC-------CHHH-HHHHHHcCCCCCCC
Confidence 4322 1233456789999999988899999999999999999997 99998732 1111 22222222112222
Q ss_pred hhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhcCC
Q 042435 354 QKIIQDIILVSTIALACLRSKPKSRPTMQRISQELEGKT 392 (412)
Q Consensus 354 ~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 392 (412)
... ...+.+++.+||+.||++|||+.|+++.|+++.
T Consensus 240 ~~~---~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 275 (281)
T 1mp8_A 240 PNC---PPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 275 (281)
T ss_dssp TTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCC---CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 222 223788999999999999999999999998764
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-40 Score=309.11 Aligned_cols=231 Identities=29% Similarity=0.413 Sum_probs=180.6
Q ss_pred hcCcccceeeeecCceEEEEEEe-CCCcEEEEEec----------------------------cCCccccceEEEecCce
Q 042435 142 TEYFHIRYCIGTGGYDSVYKAEL-PDGKVVALKKL----------------------------HHSETEDSAFVVYSPQC 192 (412)
Q Consensus 142 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l----------------------------~~~~~~~~~~~~~~~~~ 192 (412)
.++|++.+.||+|+||.||+|.. .+++.||+|.+ +|+++......+.+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 36799999999999999999987 57999999976 3455555555554443
Q ss_pred EEEEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCC--cEEeCCCCCCEEecCCCc-----EEE
Q 042435 193 MFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPS--IVHRDISSNNILLNSNLE-----AFV 265 (412)
Q Consensus 193 ~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~--ivHrDlkp~NILl~~~~~-----~kl 265 (412)
++||||+++|+|.+++.... ..+++..+..++.|++.||+|||++ + |+||||||+||+++.++. +||
T Consensus 97 -~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~~~~~~kl 170 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLDKA--HPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDENAPVCAKV 170 (287)
T ss_dssp -EEEEECCTTCBHHHHHHCTT--SCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTTCSCCEEE
T ss_pred -eEEEEecCCCCHHHHHhccc--CCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCCCceeEEe
Confidence 79999999999988886543 2589999999999999999999998 7 999999999999987776 999
Q ss_pred eecCCccccCCCCCCcccccccccccccccc--cCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcch-hhH
Q 042435 266 ADFGTVRLLDVDSSNRTLQAGTYGYIALELV--YTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIM-LID 342 (412)
Q Consensus 266 ~DfGla~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~-~~~ 342 (412)
+|||+++.... ......||+.|+|||++ ....++.++||||||+++|||++|+.||.... ..... ...
T Consensus 171 ~Dfg~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~------~~~~~~~~~ 241 (287)
T 4f0f_A 171 ADFGLSQQSVH---SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYS------YGKIKFINM 241 (287)
T ss_dssp CCCTTCBCCSS---CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCC------CCHHHHHHH
T ss_pred CCCCccccccc---cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCcccc------ccHHHHHHH
Confidence 99999975432 23445789999999998 45568899999999999999999999987321 11111 112
Q ss_pred HhhhccCCccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhcC
Q 042435 343 ILYQRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELEGK 391 (412)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 391 (412)
.......+..+... ...+.+++.+||+.||++|||++|+++.|+++
T Consensus 242 ~~~~~~~~~~~~~~---~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 242 IREEGLRPTIPEDC---PPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp HHHSCCCCCCCTTS---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred HhccCCCCCCCccc---CHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 22222222222222 22478999999999999999999999999864
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=313.81 Aligned_cols=239 Identities=22% Similarity=0.270 Sum_probs=177.4
Q ss_pred cCcccceeeeecCceEEEEEEeCCCcEEEEEec-----------------------cCCccccceEEEecCceEEEEEEe
Q 042435 143 EYFHIRYCIGTGGYDSVYKAELPDGKVVALKKL-----------------------HHSETEDSAFVVYSPQCMFFIYEY 199 (412)
Q Consensus 143 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~l-----------------------~~~~~~~~~~~~~~~~~~~lv~ey 199 (412)
++|++.+.||+|+||.||+|...+|+.||+|++ +|+++......+...+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 578999999999999999999888999999965 466777777778888999999999
Q ss_pred ccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCCC
Q 042435 200 MERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSS 279 (412)
Q Consensus 200 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 279 (412)
+++ +|.+++..... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.......
T Consensus 82 ~~~-~l~~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 155 (288)
T 1ob3_A 82 LDQ-DLKKLLDVCEG--GLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR 155 (288)
T ss_dssp CSE-EHHHHHHTSTT--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred cCC-CHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECccccccCcccc
Confidence 975 88888765432 488999999999999999999999 999999999999999999999999999987654333
Q ss_pred CcccccccccccccccccCc-ccCcccccHHHHHHHHHHHhCCCCcccccccc----------c---CCCCcchhhHHhh
Q 042435 280 NRTLQAGTYGYIALELVYTM-VVTEKCVIYSFGVVALEVLMGTHPGELLLSLS----------S---SSGPKIMLIDILY 345 (412)
Q Consensus 280 ~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~----------~---~~~~~~~~~~~~~ 345 (412)
......||+.|+|||++.+. .++.++|||||||++|||++|+.||....... . ...+........+
T Consensus 156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T 1ob3_A 156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD 235 (288)
T ss_dssp ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccccc
Confidence 34455789999999998764 58999999999999999999999986321100 0 0000000000000
Q ss_pred hccC----CccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 346 QRLS----PPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 346 ~~~~----~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
+... .+...........+.+++.+||+.||++|||+.|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 281 (288)
T 1ob3_A 236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (288)
T ss_dssp TTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 0000 00000000112347789999999999999999999864
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=312.64 Aligned_cols=233 Identities=18% Similarity=0.228 Sum_probs=179.4
Q ss_pred cCcccceeeeecCceEEEEEEeC-CCcEEEEEec-----------------------cCCccccceEEEecCceEEEEEE
Q 042435 143 EYFHIRYCIGTGGYDSVYKAELP-DGKVVALKKL-----------------------HHSETEDSAFVVYSPQCMFFIYE 198 (412)
Q Consensus 143 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l-----------------------~~~~~~~~~~~~~~~~~~~lv~e 198 (412)
++|++.+.||+|+||+||+|... +++.||+|++ +|+++.....++.+++..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 57999999999999999999874 6899999965 46777777778888999999999
Q ss_pred eccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCC
Q 042435 199 YMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDS 278 (412)
Q Consensus 199 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~ 278 (412)
|+++ ++.+.+.... ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++......
T Consensus 82 ~~~~-~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 155 (292)
T 3o0g_A 82 FCDQ-DLKKYFDSCN--GDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp CCSE-EHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCSCC
T ss_pred cCCC-CHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecCCcc
Confidence 9975 5555554322 2589999999999999999999999 99999999999999999999999999998775554
Q ss_pred CCcccccccccccccccccCcc-cCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhc----------
Q 042435 279 SNRTLQAGTYGYIALELVYTMV-VTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQR---------- 347 (412)
Q Consensus 279 ~~~~~~~gt~~y~aPE~~~~~~-~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~---------- 347 (412)
.......||+.|+|||++.+.. ++.++|||||||++|||++|..|+...... ......+....
T Consensus 156 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~------~~~~~~i~~~~~~~~~~~~~~ 229 (292)
T 3o0g_A 156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV------DDQLKRIFRLLGTPTEEQWPS 229 (292)
T ss_dssp SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSH------HHHHHHHHHHHCCCCTTTCTT
T ss_pred ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCH------HHHHHHHHHHhCCCChhhhhh
Confidence 4455567899999999997765 799999999999999999999886321100 00000000000
Q ss_pred --------cC------CccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 348 --------LS------PPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 348 --------~~------~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
.. .............+.+++.+||+.||++|||++|++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 283 (292)
T 3o0g_A 230 MTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp GGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 00 00000001112347799999999999999999999875
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-40 Score=320.71 Aligned_cols=228 Identities=21% Similarity=0.314 Sum_probs=183.8
Q ss_pred cCcccceeeeecCceEEEEEEeC-CCcEEEEEec------------------------cCCccccceEEEecCceEEEEE
Q 042435 143 EYFHIRYCIGTGGYDSVYKAELP-DGKVVALKKL------------------------HHSETEDSAFVVYSPQCMFFIY 197 (412)
Q Consensus 143 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l------------------------~~~~~~~~~~~~~~~~~~~lv~ 197 (412)
++|++.+.||+|+||.||+|... +++.||+|.+ +|+++......+.+.+..++||
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 94 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV 94 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 57999999999999999999774 5899999954 5788888888899999999999
Q ss_pred EeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCC
Q 042435 198 EYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVD 277 (412)
Q Consensus 198 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~ 277 (412)
||+++|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 95 e~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 168 (384)
T 4fr4_A 95 DLLLGGDLRYHLQQNV---HFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE 168 (384)
T ss_dssp CCCTTEEHHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred ecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEeccceeeeccCC
Confidence 9999999999987653 589999999999999999999999 9999999999999999999999999999876433
Q ss_pred CCCcccccccccccccccccC---cccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccch
Q 042435 278 SSNRTLQAGTYGYIALELVYT---MVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQ 354 (412)
Q Consensus 278 ~~~~~~~~gt~~y~aPE~~~~---~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 354 (412)
.......||+.|+|||++.. ..++.++|||||||++|||++|+.||.... ..........+..... ..+.
T Consensus 169 -~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~-----~~~~~~~~~~~~~~~~-~~p~ 241 (384)
T 4fr4_A 169 -TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRS-----STSSKEIVHTFETTVV-TYPS 241 (384)
T ss_dssp -CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCT-----TSCHHHHHHHHHHCCC-CCCT
T ss_pred -CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCC-----CccHHHHHHHHhhccc-CCCC
Confidence 23345679999999999864 458999999999999999999999996321 1111111121111111 1111
Q ss_pred hhHHHHHHHHHHHHhcCcCCCCCCCC-HHHHHH
Q 042435 355 KIIQDIILVSTIALACLRSKPKSRPT-MQRISQ 386 (412)
Q Consensus 355 ~~~~~~~~~~~l~~~Cl~~dP~~RPs-~~evl~ 386 (412)
.. ...+.+++.+||+.||++||+ ++++.+
T Consensus 242 ~~---s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 242 AW---SQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp TS---CHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred cC---CHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 21 223788999999999999998 777765
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-40 Score=322.26 Aligned_cols=232 Identities=21% Similarity=0.259 Sum_probs=186.4
Q ss_pred hcCcccceeeeecCceEEEEEEeC-CCcEEEEEec---------------------cCCccccceEEEecCceEEEEEEe
Q 042435 142 TEYFHIRYCIGTGGYDSVYKAELP-DGKVVALKKL---------------------HHSETEDSAFVVYSPQCMFFIYEY 199 (412)
Q Consensus 142 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l---------------------~~~~~~~~~~~~~~~~~~~lv~ey 199 (412)
.++|++.+.||+|+||.||+|... +|+.||+|.+ +|+++......+...+..++||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 467999999999999999999774 6899999964 578888888888899999999999
Q ss_pred ccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecC--CCcEEEeecCCccccCCC
Q 042435 200 MERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNS--NLEAFVADFGTVRLLDVD 277 (412)
Q Consensus 200 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~--~~~~kl~DfGla~~~~~~ 277 (412)
+++|+|.+++.... ..+++..+..++.|++.||+|||++ +|+||||||+|||++. ++.+||+|||+++.....
T Consensus 130 ~~gg~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~ 204 (387)
T 1kob_A 130 LSGGELFDRIAAED--YKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 204 (387)
T ss_dssp CCCCBHHHHTTCTT--CCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred CCCCcHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEecccceecCCC
Confidence 99999999887543 2489999999999999999999999 9999999999999974 578999999999876543
Q ss_pred CCCcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccchhhH
Q 042435 278 SSNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKII 357 (412)
Q Consensus 278 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 357 (412)
. ......||+.|+|||++.+..++.++|||||||++|||++|+.||.... .......+.......+. ....
T Consensus 205 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~-------~~~~~~~i~~~~~~~~~-~~~~ 275 (387)
T 1kob_A 205 E-IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGED-------DLETLQNVKRCDWEFDE-DAFS 275 (387)
T ss_dssp S-CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS-------HHHHHHHHHHCCCCCCS-STTT
T ss_pred c-ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCC-------HHHHHHHHHhCCCCCCc-cccc
Confidence 2 2334579999999999999999999999999999999999999987321 11111222221111110 1111
Q ss_pred HHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 358 QDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 358 ~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
.....+.+++.+||+.||++|||+.|++++
T Consensus 276 ~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 276 SVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp TSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred cCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 112347899999999999999999999986
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=309.50 Aligned_cols=234 Identities=22% Similarity=0.295 Sum_probs=188.7
Q ss_pred cCcccceeeeecCceEEEEEEeCCCcEEEEEec--------------------cCCccccceEEEecCceEEEEEEeccC
Q 042435 143 EYFHIRYCIGTGGYDSVYKAELPDGKVVALKKL--------------------HHSETEDSAFVVYSPQCMFFIYEYMER 202 (412)
Q Consensus 143 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~l--------------------~~~~~~~~~~~~~~~~~~~lv~ey~~~ 202 (412)
++|++.+.||+|+||.||+|...+++.||+|.+ +|+++......+...+..++||||+++
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 87 (267)
T 3t9t_A 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEH 87 (267)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCTT
T ss_pred hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCCC
Confidence 578899999999999999999988999999965 467777777778888899999999999
Q ss_pred CceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCC-CCc
Q 042435 203 GSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDS-SNR 281 (412)
Q Consensus 203 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~-~~~ 281 (412)
++|.+++..... .+++..+..++.|++.||+|||++ +++||||||+||+++.++.+||+|||+++...... ...
T Consensus 88 ~~L~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~ 162 (267)
T 3t9t_A 88 GCLSDYLRTQRG--LFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS 162 (267)
T ss_dssp CBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHST
T ss_pred CcHHHHHhhCcc--cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEccccccccccccccccc
Confidence 999999875432 489999999999999999999999 99999999999999999999999999998653321 111
Q ss_pred ccccccccccccccccCcccCcccccHHHHHHHHHHHh-CCCCcccccccccCCCCcchhhHHhhhccCCccchhhHHHH
Q 042435 282 TLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLM-GTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKIIQDI 360 (412)
Q Consensus 282 ~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 360 (412)
....++..|+|||++.+..++.++||||||+++|||++ |+.||.... .....+.+........+... .
T Consensus 163 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~--------~~~~~~~i~~~~~~~~~~~~---~ 231 (267)
T 3t9t_A 163 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS--------NSEVVEDISTGFRLYKPRLA---S 231 (267)
T ss_dssp TSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC--------HHHHHHHHHTTCCCCCCTTS---C
T ss_pred ccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCC--------HHHHHHHHhcCCcCCCCccC---c
Confidence 23456788999999988889999999999999999999 899986321 11112222222111111111 2
Q ss_pred HHHHHHHHhcCcCCCCCCCCHHHHHHHHhcCC
Q 042435 361 ILVSTIALACLRSKPKSRPTMQRISQELEGKT 392 (412)
Q Consensus 361 ~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 392 (412)
..+.+++.+||+.||++|||+.|++++|+++.
T Consensus 232 ~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~ 263 (267)
T 3t9t_A 232 THVYQIMNHCWRERPEDRPAFSRLLRQLAEIA 263 (267)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 23788999999999999999999999998875
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-40 Score=307.64 Aligned_cols=230 Identities=21% Similarity=0.342 Sum_probs=164.8
Q ss_pred hhcCcccceeeeecCceEEEEEEe-CCCcEEEEEec------------------------cCCccccceEEEecCceEEE
Q 042435 141 ATEYFHIRYCIGTGGYDSVYKAEL-PDGKVVALKKL------------------------HHSETEDSAFVVYSPQCMFF 195 (412)
Q Consensus 141 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l------------------------~~~~~~~~~~~~~~~~~~~l 195 (412)
..++|++.+.||+|+||.||+|.. .+|+.||+|.+ +|+++......+...+..++
T Consensus 9 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 88 (278)
T 3cok_A 9 KIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYL 88 (278)
T ss_dssp SGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEE
T ss_pred ccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEE
Confidence 346799999999999999999987 57999999964 57778788888888999999
Q ss_pred EEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccC
Q 042435 196 IYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLD 275 (412)
Q Consensus 196 v~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~ 275 (412)
||||+++++|.+++.... ..+++..+..++.|++.||+|||++ +++||||||+||+++.++.+||+|||++....
T Consensus 89 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~ 163 (278)
T 3cok_A 89 VLEMCHNGEMNRYLKNRV--KPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLK 163 (278)
T ss_dssp EEECCTTEEHHHHHHTCS--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEecCCCCcHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEeecceeecc
Confidence 999999999999987643 2589999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCCcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccchh
Q 042435 276 VDSSNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQK 355 (412)
Q Consensus 276 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 355 (412)
..........||+.|+|||.+.+..++.++||||||+++|||++|+.||..... .............. +..
T Consensus 164 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-------~~~~~~~~~~~~~~--~~~ 234 (278)
T 3cok_A 164 MPHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTV-------KNTLNKVVLADYEM--PSF 234 (278)
T ss_dssp ----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSC-------C-----CCSSCCCC--CTT
T ss_pred CCCCcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhH-------HHHHHHHhhcccCC--ccc
Confidence 443333445789999999999988899999999999999999999999873211 01111111111111 111
Q ss_pred hHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 356 IIQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 356 ~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
. ...+.+++.+||+.||++|||++|++++
T Consensus 235 ~---~~~~~~li~~~l~~dp~~Rps~~~~l~h 263 (278)
T 3cok_A 235 L---SIEAKDLIHQLLRRNPADRLSLSSVLDH 263 (278)
T ss_dssp S---CHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred c---CHHHHHHHHHHcccCHhhCCCHHHHhcC
Confidence 1 1237789999999999999999999874
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=318.60 Aligned_cols=245 Identities=20% Similarity=0.266 Sum_probs=193.3
Q ss_pred HHHHHHhhcCcccceeeeecCceEEEEEEeC------CCcEEEEEec----------------------cCCccccceEE
Q 042435 135 YENLIDATEYFHIRYCIGTGGYDSVYKAELP------DGKVVALKKL----------------------HHSETEDSAFV 186 (412)
Q Consensus 135 ~~~l~~~~~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vAvK~l----------------------~~~~~~~~~~~ 186 (412)
.+++....++|++.+.||+|+||.||+|... +++.||+|.+ +|+++......
T Consensus 17 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~ 96 (322)
T 1p4o_A 17 PDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGV 96 (322)
T ss_dssp CCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEE
T ss_pred hhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEE
Confidence 3455566788999999999999999999764 3788999965 46677777778
Q ss_pred EecCceEEEEEEeccCCceeeeeccCcc-------cccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecC
Q 042435 187 VYSPQCMFFIYEYMERGSLFCVLRDDDE-------AIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNS 259 (412)
Q Consensus 187 ~~~~~~~~lv~ey~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~ 259 (412)
+...+..++||||+++|+|.+++..... ...+++..++.++.|++.||+|||++ +|+||||||+||+++.
T Consensus 97 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIli~~ 173 (322)
T 1p4o_A 97 VSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAE 173 (322)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECT
T ss_pred EccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEEEcC
Confidence 8888899999999999999999875431 13478999999999999999999999 9999999999999999
Q ss_pred CCcEEEeecCCccccCCCCCC--cccccccccccccccccCcccCcccccHHHHHHHHHHHh-CCCCcccccccccCCCC
Q 042435 260 NLEAFVADFGTVRLLDVDSSN--RTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLM-GTHPGELLLSLSSSSGP 336 (412)
Q Consensus 260 ~~~~kl~DfGla~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~ellt-g~~P~~~~~~~~~~~~~ 336 (412)
++.+||+|||+++........ .....+|+.|+|||++.+..++.++||||||+++|||+| |+.||... .
T Consensus 174 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~-------~- 245 (322)
T 1p4o_A 174 DFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL-------S- 245 (322)
T ss_dssp TCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS-------C-
T ss_pred CCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccC-------C-
Confidence 999999999999865433221 123456889999999998889999999999999999999 88998632 1
Q ss_pred cchhhHHhhhccCCccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhcCCC
Q 042435 337 KIMLIDILYQRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELEGKTP 393 (412)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 393 (412)
.......+........+... ...+.+++.+||+.||++|||+.|++++|++...
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~---~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 246 NEQVLRFVMEGGLLDKPDNC---PDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp HHHHHHHHHTTCCCCCCTTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred HHHHHHHHHcCCcCCCCCCC---CHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 11112222111111111221 2237889999999999999999999999998754
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=315.66 Aligned_cols=245 Identities=21% Similarity=0.282 Sum_probs=192.1
Q ss_pred HHHHHHhhcCcccceeeeecCceEEEEEEe------CCCcEEEEEec-----------------------cCCccccceE
Q 042435 135 YENLIDATEYFHIRYCIGTGGYDSVYKAEL------PDGKVVALKKL-----------------------HHSETEDSAF 185 (412)
Q Consensus 135 ~~~l~~~~~~f~~~~~lG~G~~g~Vy~~~~------~~~~~vAvK~l-----------------------~~~~~~~~~~ 185 (412)
..+.....++|++.+.||+|+||.||+|.+ .+++.||||.+ +|+++.....
T Consensus 19 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 98 (316)
T 2xir_A 19 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG 98 (316)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEE
Confidence 344555668899999999999999999974 35789999975 3566666666
Q ss_pred EEecC-ceEEEEEEeccCCceeeeeccCccc-------------ccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCC
Q 042435 186 VVYSP-QCMFFIYEYMERGSLFCVLRDDDEA-------------IELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDIS 251 (412)
Q Consensus 186 ~~~~~-~~~~lv~ey~~~gsL~~~l~~~~~~-------------~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlk 251 (412)
.+... ...++||||+++|+|.+++...... ..+++..+..++.|++.||+|||++ +|+|||||
T Consensus 99 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dik 175 (316)
T 2xir_A 99 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLA 175 (316)
T ss_dssp EECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCSCCS
T ss_pred EEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---CcccccCc
Confidence 66654 4589999999999999998765421 1278999999999999999999999 99999999
Q ss_pred CCCEEecCCCcEEEeecCCccccCCCCCC--cccccccccccccccccCcccCcccccHHHHHHHHHHHh-CCCCccccc
Q 042435 252 SNNILLNSNLEAFVADFGTVRLLDVDSSN--RTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLM-GTHPGELLL 328 (412)
Q Consensus 252 p~NILl~~~~~~kl~DfGla~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~ellt-g~~P~~~~~ 328 (412)
|+||+++.++.+||+|||+++........ .....||+.|+|||++.+..++.++||||||+++|||+| |+.||...
T Consensus 176 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~- 254 (316)
T 2xir_A 176 ARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV- 254 (316)
T ss_dssp GGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC-
T ss_pred cceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCccc-
Confidence 99999999999999999999866443322 234567889999999998899999999999999999998 99998632
Q ss_pred ccccCCCCcchhhHHhhhccCCccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhcCC
Q 042435 329 SLSSSSGPKIMLIDILYQRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELEGKT 392 (412)
Q Consensus 329 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 392 (412)
.........+........+... ...+.+++.+||+.||++|||+.|++++|+++.
T Consensus 255 ------~~~~~~~~~~~~~~~~~~~~~~---~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 309 (316)
T 2xir_A 255 ------KIDEEFCRRLKEGTRMRAPDYT---TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 309 (316)
T ss_dssp ------CCSHHHHHHHHHTCCCCCCTTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ------chhHHHHHHhccCccCCCCCCC---CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 1112222333322222222221 223788999999999999999999999998765
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=312.33 Aligned_cols=237 Identities=24% Similarity=0.379 Sum_probs=174.7
Q ss_pred hcCcccceeeeecCceEEEEEEeCCCcEEEEEec-----------------------cCCccccceEEEecCceEEEEEE
Q 042435 142 TEYFHIRYCIGTGGYDSVYKAELPDGKVVALKKL-----------------------HHSETEDSAFVVYSPQCMFFIYE 198 (412)
Q Consensus 142 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~l-----------------------~~~~~~~~~~~~~~~~~~~lv~e 198 (412)
.++|++.+.||+|+||.||+|...+ .||+|.+ +|+++..... +...+..++|||
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~-~~~~~~~~lv~e 99 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG-YSTAPQLAIVTQ 99 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESSS--EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEE-EECSSSCEEEEE
T ss_pred ccceeeeeEecCCCCeEEEEEEEcC--ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEe-eccCCccEEEEE
Confidence 4679999999999999999998743 5999965 3555555554 345667899999
Q ss_pred eccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCC
Q 042435 199 YMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDS 278 (412)
Q Consensus 199 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~ 278 (412)
|+++++|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 100 ~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 174 (289)
T 3og7_A 100 WCEGSSLYHHLHASE--TKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWS 174 (289)
T ss_dssp CCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC---------
T ss_pred ecCCCcHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccceecccccccc
Confidence 999999999886543 2589999999999999999999999 99999999999999999999999999997654321
Q ss_pred --CCccccccccccccccccc---CcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhc-cCCcc
Q 042435 279 --SNRTLQAGTYGYIALELVY---TMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQR-LSPPI 352 (412)
Q Consensus 279 --~~~~~~~gt~~y~aPE~~~---~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~ 352 (412)
.......||+.|+|||.+. +..++.++||||||+++|||++|+.||... .......+.+... ..+..
T Consensus 175 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~-------~~~~~~~~~~~~~~~~~~~ 247 (289)
T 3og7_A 175 GSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNI-------NNRDQIIEMVGRGSLSPDL 247 (289)
T ss_dssp ---------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSC-------CCHHHHHHHHHHTSCCCCT
T ss_pred ccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCcccc-------chHHHHHHHhcccccCcch
Confidence 2223457899999999986 567888999999999999999999998732 1112222222222 11111
Q ss_pred chhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhcCCC
Q 042435 353 NQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELEGKTP 393 (412)
Q Consensus 353 ~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 393 (412)
..........+.+++.+||+.||++|||+.|+++.|+++..
T Consensus 248 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 248 SKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp TSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred hhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 11111222348899999999999999999999999998764
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-40 Score=344.67 Aligned_cols=229 Identities=21% Similarity=0.299 Sum_probs=186.7
Q ss_pred hhcCcccceeeeecCceEEEEEEeC-CCcEEEEEecc-------------------------CCccccceEEEecCceEE
Q 042435 141 ATEYFHIRYCIGTGGYDSVYKAELP-DGKVVALKKLH-------------------------HSETEDSAFVVYSPQCMF 194 (412)
Q Consensus 141 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~-------------------------~~~~~~~~~~~~~~~~~~ 194 (412)
..++|++.++||+|+||.||+|... +++.||||.++ |+++......+.+.+..|
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 3467999999999999999999874 68899999753 455555666677888999
Q ss_pred EEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCcccc
Q 042435 195 FIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLL 274 (412)
Q Consensus 195 lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~ 274 (412)
+||||+++|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 419 lV~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~DFGla~~~ 492 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQVG---RFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEN 492 (674)
T ss_dssp EEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEECCCTTCEEC
T ss_pred EEEeCcCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEeecceeecc
Confidence 9999999999999987643 589999999999999999999999 9999999999999999999999999999865
Q ss_pred CCCCCCcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccch
Q 042435 275 DVDSSNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQ 354 (412)
Q Consensus 275 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 354 (412)
...........||+.|+|||++.+..++.++|||||||++|||++|+.||... ........+.......+ .
T Consensus 493 ~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~-------~~~~~~~~i~~~~~~~p--~ 563 (674)
T 3pfq_A 493 IWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE-------DEDELFQSIMEHNVAYP--K 563 (674)
T ss_dssp CCTTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCS-------SHHHHHHHHHSSCCCCC--T
T ss_pred ccCCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCC-------CHHHHHHHHHhCCCCCC--c
Confidence 44444455678999999999999999999999999999999999999999732 11222333333333222 1
Q ss_pred hhHHHHHHHHHHHHhcCcCCCCCCCCH-----HHHHHH
Q 042435 355 KIIQDIILVSTIALACLRSKPKSRPTM-----QRISQE 387 (412)
Q Consensus 355 ~~~~~~~~~~~l~~~Cl~~dP~~RPs~-----~evl~~ 387 (412)
.. ...+.+++.+||+.||++||++ +||.++
T Consensus 564 ~~---s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h 598 (674)
T 3pfq_A 564 SM---SKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 598 (674)
T ss_dssp TS---CHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSS
T ss_pred cC---CHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcC
Confidence 22 2237889999999999999997 777653
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-40 Score=308.09 Aligned_cols=236 Identities=24% Similarity=0.359 Sum_probs=187.1
Q ss_pred hcCcccceeeeecCceEEEEEEeCCCcEEEEEec--------------------cCCccccceEEEecCceEEEEEEecc
Q 042435 142 TEYFHIRYCIGTGGYDSVYKAELPDGKVVALKKL--------------------HHSETEDSAFVVYSPQCMFFIYEYME 201 (412)
Q Consensus 142 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~l--------------------~~~~~~~~~~~~~~~~~~~lv~ey~~ 201 (412)
.++|++.+.||+|+||.||+|...+++.||+|.+ +|+++......+. .+..++||||++
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~ 90 (279)
T 1qpc_A 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYME 90 (279)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCT
T ss_pred HHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEecCC
Confidence 4679999999999999999999988889999965 4566666555544 556899999999
Q ss_pred CCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCCC-C
Q 042435 202 RGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSS-N 280 (412)
Q Consensus 202 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~-~ 280 (412)
+++|.+++..... ..+++..+..++.|++.||+|||++ +++||||||+||++++++.+||+|||+++....... .
T Consensus 91 ~~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 166 (279)
T 1qpc_A 91 NGSLVDFLKTPSG-IKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTA 166 (279)
T ss_dssp TCBHHHHTTSHHH-HTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEEC
T ss_pred CCCHHHHHhcCCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCcccccccCccccc
Confidence 9999999875432 2589999999999999999999999 999999999999999999999999999987654321 1
Q ss_pred cccccccccccccccccCcccCcccccHHHHHHHHHHHh-CCCCcccccccccCCCCcchhhHHhhhccCCccchhhHHH
Q 042435 281 RTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLM-GTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKIIQD 359 (412)
Q Consensus 281 ~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 359 (412)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.||.... .......+........+...
T Consensus 167 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~--------~~~~~~~~~~~~~~~~~~~~--- 235 (279)
T 1qpc_A 167 REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT--------NPEVIQNLERGYRMVRPDNC--- 235 (279)
T ss_dssp CTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC--------HHHHHHHHHTTCCCCCCTTC---
T ss_pred ccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccC--------HHHHHHHHhcccCCCCcccc---
Confidence 233456789999999988889999999999999999999 899986321 11122222222222111221
Q ss_pred HHHHHHHHHhcCcCCCCCCCCHHHHHHHHhcCCC
Q 042435 360 IILVSTIALACLRSKPKSRPTMQRISQELEGKTP 393 (412)
Q Consensus 360 ~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 393 (412)
...+.+++.+||+.||++|||+.++++.|+++..
T Consensus 236 ~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 269 (279)
T 1qpc_A 236 PEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (279)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHH
Confidence 2247889999999999999999999999987643
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=320.03 Aligned_cols=230 Identities=19% Similarity=0.272 Sum_probs=177.7
Q ss_pred hcCcccceeeeecCceEEEEEEeCCCcEEEEEecc-----------------------C--CccccceEEEecCceEEEE
Q 042435 142 TEYFHIRYCIGTGGYDSVYKAELPDGKVVALKKLH-----------------------H--SETEDSAFVVYSPQCMFFI 196 (412)
Q Consensus 142 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~l~-----------------------~--~~~~~~~~~~~~~~~~~lv 196 (412)
.+.|++.+.||+|+||.||++...+++.||||+++ | +++......+...+..++|
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 87 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 87 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence 45699999999999999999999899999999652 3 6677777778888999999
Q ss_pred EEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCC
Q 042435 197 YEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDV 276 (412)
Q Consensus 197 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~ 276 (412)
||| .+|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+|||++ ++.+||+|||+++....
T Consensus 88 ~e~-~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~ 159 (343)
T 3dbq_A 88 MEC-GNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 159 (343)
T ss_dssp ECC-CSEEHHHHHHHSC---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCCC--
T ss_pred EeC-CCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeecccccccCc
Confidence 995 5789999987654 589999999999999999999999 999999999999997 57899999999987654
Q ss_pred CCC--CcccccccccccccccccC-----------cccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHH
Q 042435 277 DSS--NRTLQAGTYGYIALELVYT-----------MVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDI 343 (412)
Q Consensus 277 ~~~--~~~~~~gt~~y~aPE~~~~-----------~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~ 343 (412)
... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.... .........
T Consensus 160 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~------~~~~~~~~~ 233 (343)
T 3dbq_A 160 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII------NQISKLHAI 233 (343)
T ss_dssp ----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCC------SHHHHHHHH
T ss_pred ccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhh------hHHHHHHHH
Confidence 332 2234579999999999864 678899999999999999999999987321 111112222
Q ss_pred hhhccCCccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHH
Q 042435 344 LYQRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQEL 388 (412)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L 388 (412)
.+.......+.... ..+.+++.+||+.||++|||+.|++++-
T Consensus 234 ~~~~~~~~~~~~~~---~~l~~li~~~L~~dp~~Rpt~~e~l~hp 275 (343)
T 3dbq_A 234 IDPNHEIEFPDIPE---KDLQDVLKCCLKRDPKQRISIPELLAHP 275 (343)
T ss_dssp HCTTSCCCCCCCSC---HHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred hcCCcccCCcccCC---HHHHHHHHHHcCCChhHCCCHHHHHhCc
Confidence 32222222212111 2377899999999999999999998764
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-41 Score=314.17 Aligned_cols=239 Identities=23% Similarity=0.305 Sum_probs=194.3
Q ss_pred HHhhcCcccceeeeecCceEEEEEEeC-CCcEEEEEec--------------------cCCccccceEEEecCceEEEEE
Q 042435 139 IDATEYFHIRYCIGTGGYDSVYKAELP-DGKVVALKKL--------------------HHSETEDSAFVVYSPQCMFFIY 197 (412)
Q Consensus 139 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l--------------------~~~~~~~~~~~~~~~~~~~lv~ 197 (412)
....++|++.+.||+|+||.||+|... +++.||+|.+ +|+++.....++...+..++||
T Consensus 9 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 88 (288)
T 3kfa_A 9 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 88 (288)
T ss_dssp BCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEE
T ss_pred cccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEE
Confidence 345678999999999999999999875 4889999964 5777777888888889999999
Q ss_pred EeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCC
Q 042435 198 EYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVD 277 (412)
Q Consensus 198 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~ 277 (412)
||+++|+|.+++..... ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 89 e~~~~~~L~~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 164 (288)
T 3kfa_A 89 EFMTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 164 (288)
T ss_dssp ECCTTEEHHHHHHHCCT-TTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSS
T ss_pred EcCCCCcHHHHHHhccc-CCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCccceeccCC
Confidence 99999999999875432 2589999999999999999999999 9999999999999999999999999999876543
Q ss_pred CCC-cccccccccccccccccCcccCcccccHHHHHHHHHHHh-CCCCcccccccccCCCCcchhhHHhhhccCCccchh
Q 042435 278 SSN-RTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLM-GTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQK 355 (412)
Q Consensus 278 ~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 355 (412)
... .....+|+.|+|||.+.+..++.++||||||+++|||++ |..||... ......+.+........+..
T Consensus 165 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~--------~~~~~~~~~~~~~~~~~~~~ 236 (288)
T 3kfa_A 165 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI--------DLSQVYELLEKDYRMERPEG 236 (288)
T ss_dssp SSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC--------CGGGHHHHHHTTCCCCCCTT
T ss_pred ccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--------CHHHHHHHHhccCCCCCCCC
Confidence 322 233457889999999998899999999999999999999 99998632 11222333333332222222
Q ss_pred hHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhcCC
Q 042435 356 IIQDIILVSTIALACLRSKPKSRPTMQRISQELEGKT 392 (412)
Q Consensus 356 ~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 392 (412)
.. ..+.+++.+||+.||++|||+.|+++.|+.+.
T Consensus 237 ~~---~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~ 270 (288)
T 3kfa_A 237 CP---EKVYELMRACWQWNPSDRPSFAEIHQAFETMF 270 (288)
T ss_dssp CC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CC---HHHHHHHHHHhCCChhhCcCHHHHHHHHHHHH
Confidence 22 24789999999999999999999999998764
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-40 Score=316.77 Aligned_cols=240 Identities=25% Similarity=0.273 Sum_probs=186.1
Q ss_pred HHHHhhcCcccceeeeecCceEEEEEEe-CCCcEEEEEec--------------------------cCCccccceEEEec
Q 042435 137 NLIDATEYFHIRYCIGTGGYDSVYKAEL-PDGKVVALKKL--------------------------HHSETEDSAFVVYS 189 (412)
Q Consensus 137 ~l~~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l--------------------------~~~~~~~~~~~~~~ 189 (412)
++.+..++|++.+.||+|+||.||+|.. .+++.||+|.+ +|+++.....++.+
T Consensus 20 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 99 (345)
T 3hko_A 20 SLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED 99 (345)
T ss_dssp CHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred hhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc
Confidence 4567788899999999999999999977 56889999954 57888888888999
Q ss_pred CceEEEEEEeccCCceeeeeccCc-------------------------------------ccccCCHHHHHHHHHHHHH
Q 042435 190 PQCMFFIYEYMERGSLFCVLRDDD-------------------------------------EAIELNWTRRMNIVKSVAH 232 (412)
Q Consensus 190 ~~~~~lv~ey~~~gsL~~~l~~~~-------------------------------------~~~~l~~~~~~~i~~~ia~ 232 (412)
.+..++||||+++|+|.+++.... ....+++..+..++.|++.
T Consensus 100 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~ 179 (345)
T 3hko_A 100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS 179 (345)
T ss_dssp SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHH
T ss_pred CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHH
Confidence 999999999999999998885210 0112456778889999999
Q ss_pred HHHHHHhCCCCCcEEeCCCCCCEEecCCC--cEEEeecCCccccCCCCC----CcccccccccccccccccC--cccCcc
Q 042435 233 ALSYLHHDCTPSIVHRDISSNNILLNSNL--EAFVADFGTVRLLDVDSS----NRTLQAGTYGYIALELVYT--MVVTEK 304 (412)
Q Consensus 233 gL~~LH~~~~~~ivHrDlkp~NILl~~~~--~~kl~DfGla~~~~~~~~----~~~~~~gt~~y~aPE~~~~--~~~s~k 304 (412)
||+|||+. +|+||||||+||+++.++ .+||+|||+++....... ......||+.|+|||++.+ ..++.+
T Consensus 180 ~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~ 256 (345)
T 3hko_A 180 ALHYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPK 256 (345)
T ss_dssp HHHHHHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTH
T ss_pred HHHHHHHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcH
Confidence 99999999 999999999999998766 899999999986543221 2245579999999999865 678999
Q ss_pred cccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHH
Q 042435 305 CVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRI 384 (412)
Q Consensus 305 sDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev 384 (412)
+||||||+++|||++|+.||... ........+.......+. .........+.+++.+||+.||++|||+.|+
T Consensus 257 ~DiwslG~il~el~~g~~pf~~~-------~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~ 328 (345)
T 3hko_A 257 CDAWSAGVLLHLLLMGAVPFPGV-------NDADTISQVLNKKLCFEN-PNYNVLSPLARDLLSNLLNRNVDERFDAMRA 328 (345)
T ss_dssp HHHHHHHHHHHHHHHSSCSSCCS-------SHHHHHHHHHHCCCCTTS-GGGGGSCHHHHHHHHHHSCSCTTTSCCHHHH
T ss_pred HHHHHHHHHHHHHHHCCCCCCCC-------ChHHHHHHHHhcccccCC-cccccCCHHHHHHHHHHcCCChhHCCCHHHH
Confidence 99999999999999999998632 111222333333332221 1111122347899999999999999999999
Q ss_pred HHH
Q 042435 385 SQE 387 (412)
Q Consensus 385 l~~ 387 (412)
+++
T Consensus 329 l~h 331 (345)
T 3hko_A 329 LQH 331 (345)
T ss_dssp HHS
T ss_pred hcC
Confidence 885
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=318.00 Aligned_cols=244 Identities=24% Similarity=0.338 Sum_probs=189.8
Q ss_pred HHhhcCcccceeeeecCceEEEEEEeCCCcEEEEEec--------------------cCCccccceEEEecCc----eEE
Q 042435 139 IDATEYFHIRYCIGTGGYDSVYKAELPDGKVVALKKL--------------------HHSETEDSAFVVYSPQ----CMF 194 (412)
Q Consensus 139 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~l--------------------~~~~~~~~~~~~~~~~----~~~ 194 (412)
....++|++.+.||+|+||.||+|.. +|+.||||.+ +|+++......+...+ ..+
T Consensus 38 ~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~ 116 (342)
T 1b6c_B 38 RTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW 116 (342)
T ss_dssp HHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGGGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEE
T ss_pred ccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCchhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeE
Confidence 34457899999999999999999988 5899999963 5777777777776665 789
Q ss_pred EEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHH--------hCCCCCcEEeCCCCCCEEecCCCcEEEe
Q 042435 195 FIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLH--------HDCTPSIVHRDISSNNILLNSNLEAFVA 266 (412)
Q Consensus 195 lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH--------~~~~~~ivHrDlkp~NILl~~~~~~kl~ 266 (412)
+||||+++|+|.+++... .+++..++.++.|++.||+||| +. +|+||||||+||+++.++.+||+
T Consensus 117 lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~NIll~~~~~~kL~ 189 (342)
T 1b6c_B 117 LVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKNILVKKNGTCCIA 189 (342)
T ss_dssp EEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGGEEECTTSCEEEC
T ss_pred EEEeecCCCcHHHHHhcc----CccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHHEEECCCCCEEEE
Confidence 999999999999999654 4899999999999999999999 66 99999999999999999999999
Q ss_pred ecCCccccCCCCCC----cccccccccccccccccCc------ccCcccccHHHHHHHHHHHhC----------CCCccc
Q 042435 267 DFGTVRLLDVDSSN----RTLQAGTYGYIALELVYTM------VVTEKCVIYSFGVVALEVLMG----------THPGEL 326 (412)
Q Consensus 267 DfGla~~~~~~~~~----~~~~~gt~~y~aPE~~~~~------~~s~ksDv~S~Gvil~elltg----------~~P~~~ 326 (412)
|||+++........ .....||+.|+|||++.+. .++.++||||||+++|||+|| +.||..
T Consensus 190 Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~ 269 (342)
T 1b6c_B 190 DLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD 269 (342)
T ss_dssp CCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred ECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccc
Confidence 99999876543321 2345789999999998765 344789999999999999999 667652
Q ss_pred ccccccCCCCcchhhHHh-hhccCCccchh--hHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhcCCC
Q 042435 327 LLSLSSSSGPKIMLIDIL-YQRLSPPINQK--IIQDIILVSTIALACLRSKPKSRPTMQRISQELEGKTP 393 (412)
Q Consensus 327 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~--~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 393 (412)
... .......+...+ .....+..+.. .......+.+++.+||+.||++|||+.|++++|+++.+
T Consensus 270 ~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~ 336 (342)
T 1b6c_B 270 LVP---SDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 336 (342)
T ss_dssp TSC---SSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cCc---CcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHH
Confidence 210 000111112222 22222222221 12334458899999999999999999999999998764
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=318.17 Aligned_cols=238 Identities=24% Similarity=0.328 Sum_probs=188.7
Q ss_pred HHHHHHhhcCcccceeeeecCceEEEEEEeC-CCcEEEEEec------------------------------cCCccccc
Q 042435 135 YENLIDATEYFHIRYCIGTGGYDSVYKAELP-DGKVVALKKL------------------------------HHSETEDS 183 (412)
Q Consensus 135 ~~~l~~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l------------------------------~~~~~~~~ 183 (412)
+.......++|++.+.||+|+||.||+|... +|+.||||.+ +|+++...
T Consensus 86 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 165 (365)
T 2y7j_A 86 WAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITL 165 (365)
T ss_dssp HHHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCE
T ss_pred chhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence 3445566788999999999999999999885 7999999964 46677777
Q ss_pred eEEEecCceEEEEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcE
Q 042435 184 AFVVYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEA 263 (412)
Q Consensus 184 ~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~ 263 (412)
...+......++||||+++|+|.+++.... .+++..+..++.|++.||+|||+. +++||||||+||+++.++.+
T Consensus 166 ~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~---~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~~i 239 (365)
T 2y7j_A 166 IDSYESSSFMFLVFDLMRKGELFDYLTEKV---ALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQI 239 (365)
T ss_dssp EEEEEBSSEEEEEECCCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCE
T ss_pred EEEEeeCCEEEEEEEeCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCE
Confidence 777888899999999999999999887543 589999999999999999999998 99999999999999999999
Q ss_pred EEeecCCccccCCCCCCcccccccccccccccccC------cccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCc
Q 042435 264 FVADFGTVRLLDVDSSNRTLQAGTYGYIALELVYT------MVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPK 337 (412)
Q Consensus 264 kl~DfGla~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~ 337 (412)
||+|||++....... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||... ...
T Consensus 240 kl~DfG~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~-------~~~ 311 (365)
T 2y7j_A 240 RLSDFGFSCHLEPGE-KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHR-------RQI 311 (365)
T ss_dssp EECCCTTCEECCTTC-CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCS-------SHH
T ss_pred EEEecCcccccCCCc-ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCC-------CHH
Confidence 999999998765432 2334579999999999863 35888999999999999999999998631 111
Q ss_pred chhhHHhhhccCCccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 338 IMLIDILYQRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 338 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
.....+........ ..........+.+++.+||+.||++|||+.|++++
T Consensus 312 ~~~~~i~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 360 (365)
T 2y7j_A 312 LMLRMIMEGQYQFS-SPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQH 360 (365)
T ss_dssp HHHHHHHHTCCCCC-HHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHHHhCCCCCC-CcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 11112222222111 11111122348899999999999999999999874
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=321.51 Aligned_cols=233 Identities=21% Similarity=0.274 Sum_probs=175.9
Q ss_pred hcCcccceeeeecCceEEEEEEeC-CCcEEEEEec--------------------cCCccccceEEEecCceEEEEEEec
Q 042435 142 TEYFHIRYCIGTGGYDSVYKAELP-DGKVVALKKL--------------------HHSETEDSAFVVYSPQCMFFIYEYM 200 (412)
Q Consensus 142 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l--------------------~~~~~~~~~~~~~~~~~~~lv~ey~ 200 (412)
.++|++.+.||+|+||.||++... +++.||||.+ +|+++.....++.+.+..++||||+
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 98 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYA 98 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeC
Confidence 467999999999999999999875 7999999964 5788888888889999999999999
Q ss_pred cCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCc--EEEeecCCccccCCCC
Q 042435 201 ERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLE--AFVADFGTVRLLDVDS 278 (412)
Q Consensus 201 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~--~kl~DfGla~~~~~~~ 278 (412)
++|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+|||++.++. +||+|||+++......
T Consensus 99 ~~~~L~~~l~~~~---~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~ 172 (361)
T 3uc3_A 99 SGGELYERICNAG---RFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 172 (361)
T ss_dssp CSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCCCC-------
T ss_pred CCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecCccccccccC
Confidence 9999999886543 589999999999999999999998 9999999999999987665 9999999997533222
Q ss_pred CCcccccccccccccccccCcccCcc-cccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccchhhH
Q 042435 279 SNRTLQAGTYGYIALELVYTMVVTEK-CVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKII 357 (412)
Q Consensus 279 ~~~~~~~gt~~y~aPE~~~~~~~s~k-sDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 357 (412)
......||+.|+|||++.+..++.+ +|||||||++|||++|+.||...... .........+.......+....
T Consensus 173 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~---~~~~~~~~~~~~~~~~~~~~~~-- 246 (361)
T 3uc3_A 173 -QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP---RDYRKTIQRILSVKYSIPDDIR-- 246 (361)
T ss_dssp ---------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----C---CCHHHHHHHHHTTCCCCCTTSC--
T ss_pred -CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccH---HHHHHHHHHHhcCCCCCCCcCC--
Confidence 2234579999999999988877655 89999999999999999999732110 0000111122222222111111
Q ss_pred HHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 358 QDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 358 ~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
....+.+++.+||+.||++|||+.|++++
T Consensus 247 -~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 247 -ISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp -CCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred -CCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 12237889999999999999999999986
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-40 Score=316.78 Aligned_cols=238 Identities=27% Similarity=0.374 Sum_probs=182.7
Q ss_pred cCcccceeeeecCceEEEEEEeCC-----CcEEEEEec----------------------cCCccccceEEEecCceEEE
Q 042435 143 EYFHIRYCIGTGGYDSVYKAELPD-----GKVVALKKL----------------------HHSETEDSAFVVYSPQCMFF 195 (412)
Q Consensus 143 ~~f~~~~~lG~G~~g~Vy~~~~~~-----~~~vAvK~l----------------------~~~~~~~~~~~~~~~~~~~l 195 (412)
++|.+.+.||+|+||.||+|.... +..||+|.+ +|+++......+...+..++
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 123 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 123 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence 457778999999999999997642 346999965 46777777778888899999
Q ss_pred EEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccC
Q 042435 196 IYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLD 275 (412)
Q Consensus 196 v~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~ 275 (412)
||||+++|+|.+++.... ..+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++...
T Consensus 124 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~ 198 (333)
T 1mqb_A 124 ITEYMENGALDKFLREKD--GEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 198 (333)
T ss_dssp EEECCTTEEHHHHHHHTT--TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred EEeCCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCCCcchhhc
Confidence 999999999999987543 2589999999999999999999999 99999999999999999999999999998764
Q ss_pred CCCCC---cccccccccccccccccCcccCcccccHHHHHHHHHHHh-CCCCcccccccccCCCCcchhhHHhhhccCCc
Q 042435 276 VDSSN---RTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLM-GTHPGELLLSLSSSSGPKIMLIDILYQRLSPP 351 (412)
Q Consensus 276 ~~~~~---~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 351 (412)
..... .....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.... .......+......+
T Consensus 199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~--------~~~~~~~~~~~~~~~ 270 (333)
T 1mqb_A 199 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS--------NHEVMKAINDGFRLP 270 (333)
T ss_dssp ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC--------HHHHHHHHHTTCCCC
T ss_pred cccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCC--------HHHHHHHHHCCCcCC
Confidence 43221 122346788999999998899999999999999999999 999986321 111222222222222
Q ss_pred cchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhcCCCCCC
Q 042435 352 INQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELEGKTPMKK 396 (412)
Q Consensus 352 ~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~~~ 396 (412)
.+... ...+.+++.+||+.||++||++.|+++.|+++.....
T Consensus 271 ~~~~~---~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~ 312 (333)
T 1mqb_A 271 TPMDC---PSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPD 312 (333)
T ss_dssp CCTTC---BHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGG
T ss_pred CcccC---CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcch
Confidence 22222 2237889999999999999999999999988765443
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=313.60 Aligned_cols=241 Identities=20% Similarity=0.300 Sum_probs=186.1
Q ss_pred cCcccceeeeecCceEEEEEEe-----CCCcEEEEEec----------------------cCCccccceEEEecC--ceE
Q 042435 143 EYFHIRYCIGTGGYDSVYKAEL-----PDGKVVALKKL----------------------HHSETEDSAFVVYSP--QCM 193 (412)
Q Consensus 143 ~~f~~~~~lG~G~~g~Vy~~~~-----~~~~~vAvK~l----------------------~~~~~~~~~~~~~~~--~~~ 193 (412)
+.|++.+.||+|+||.||+|.+ .+++.||+|.+ +|+++.....++... +..
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 4588899999999999999984 46899999975 456666666666655 668
Q ss_pred EEEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccc
Q 042435 194 FFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRL 273 (412)
Q Consensus 194 ~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~ 273 (412)
++||||+++|+|.+++.... ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.
T Consensus 101 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 175 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPKNK--NKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKA 175 (302)
T ss_dssp EEEEECCTTCBHHHHHHHHT--TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEEeCCCCcHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEECccccccc
Confidence 99999999999999985443 2489999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCC---CcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCccccccc----ccCCCCcc---hhhHH
Q 042435 274 LDVDSS---NRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSL----SSSSGPKI---MLIDI 343 (412)
Q Consensus 274 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~----~~~~~~~~---~~~~~ 343 (412)
...... ......||..|+|||.+.+..++.++||||||+++|||+||..|+...... ........ .....
T Consensus 176 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (302)
T 4e5w_A 176 IETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNT 255 (302)
T ss_dssp CCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHH
T ss_pred ccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHH
Confidence 654432 123456888899999999889999999999999999999999987532110 00001111 11112
Q ss_pred hhhccCCccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhcC
Q 042435 344 LYQRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELEGK 391 (412)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 391 (412)
.......+.+... ...+.+++.+||+.||++|||+.|+++.|+++
T Consensus 256 ~~~~~~~~~~~~~---~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 300 (302)
T 4e5w_A 256 LKEGKRLPCPPNC---PDEVYQLMRKCWEFQPSNRTSFQNLIEGFEAL 300 (302)
T ss_dssp HHTTCCCCCCTTC---CHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred HhccCCCCCCCCC---CHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHH
Confidence 2222222222222 23488999999999999999999999999875
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-40 Score=323.55 Aligned_cols=229 Identities=18% Similarity=0.270 Sum_probs=178.5
Q ss_pred cCcccceeeeecCceEEEEEEeCCCcEEEEEecc-------------------------CCccccceEEEecCceEEEEE
Q 042435 143 EYFHIRYCIGTGGYDSVYKAELPDGKVVALKKLH-------------------------HSETEDSAFVVYSPQCMFFIY 197 (412)
Q Consensus 143 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~l~-------------------------~~~~~~~~~~~~~~~~~~lv~ 197 (412)
++|++.+.||+|+||.||+|...+++.||||.++ |+++.....++...+..++||
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 4599999999999999999998889999999652 366777777788888999999
Q ss_pred EeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCC
Q 042435 198 EYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVD 277 (412)
Q Consensus 198 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~ 277 (412)
| +.+++|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||++ ++.+||+|||+++.....
T Consensus 136 E-~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~ 207 (390)
T 2zmd_A 136 E-CGNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 207 (390)
T ss_dssp E-CCSEEHHHHHHHCS---SCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCCSSSCCC---
T ss_pred e-cCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEecCccccccCC
Confidence 9 56889999987654 588999999999999999999998 999999999999996 578999999999876543
Q ss_pred CC--CcccccccccccccccccC-----------cccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHh
Q 042435 278 SS--NRTLQAGTYGYIALELVYT-----------MVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDIL 344 (412)
Q Consensus 278 ~~--~~~~~~gt~~y~aPE~~~~-----------~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 344 (412)
.. ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.... .....+..++
T Consensus 208 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~------~~~~~~~~~~ 281 (390)
T 2zmd_A 208 TTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII------NQISKLHAII 281 (390)
T ss_dssp ------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCC------CHHHHHHHHH
T ss_pred CccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhh------HHHHHHHHHh
Confidence 22 1234579999999999865 368899999999999999999999986321 1111223333
Q ss_pred hhccCCccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHH
Q 042435 345 YQRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQEL 388 (412)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L 388 (412)
........+... ...+.+++.+||+.||++|||+.|++++-
T Consensus 282 ~~~~~~~~~~~~---~~~~~~li~~~L~~dP~~Rps~~ell~hp 322 (390)
T 2zmd_A 282 DPNHEIEFPDIP---EKDLQDVLKCCLKRDPKQRISIPELLAHP 322 (390)
T ss_dssp CTTSCCCCCCCS---CHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred CccccCCCCccc---hHHHHHHHHHHcccChhhCCCHHHHhhCc
Confidence 332222221111 12378899999999999999999998763
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-40 Score=315.23 Aligned_cols=239 Identities=18% Similarity=0.219 Sum_probs=175.2
Q ss_pred cCcccceeeeecCceEEEEEEeC-CCcEEEEEec----------------------cCCccccceEEEecCceEEEEEEe
Q 042435 143 EYFHIRYCIGTGGYDSVYKAELP-DGKVVALKKL----------------------HHSETEDSAFVVYSPQCMFFIYEY 199 (412)
Q Consensus 143 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l----------------------~~~~~~~~~~~~~~~~~~~lv~ey 199 (412)
++|.+.+.||+|+||.||+|... +++.||+|.+ +|+++.....++...+..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 57999999999999999999875 7899999964 466677777778888999999999
Q ss_pred ccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCCC
Q 042435 200 MERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSS 279 (412)
Q Consensus 200 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 279 (412)
++ |+|.+++..... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.......
T Consensus 82 ~~-~~l~~~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~ 155 (324)
T 3mtl_A 82 LD-KDLKQYLDDCGN--IINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK 155 (324)
T ss_dssp CS-EEHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEEECC-----
T ss_pred cc-cCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCcccccccCCcc
Confidence 97 588888765432 489999999999999999999999 999999999999999999999999999986654444
Q ss_pred CcccccccccccccccccC-cccCcccccHHHHHHHHHHHhCCCCcccccccc-------------cCCCCcchh-hHHh
Q 042435 280 NRTLQAGTYGYIALELVYT-MVVTEKCVIYSFGVVALEVLMGTHPGELLLSLS-------------SSSGPKIML-IDIL 344 (412)
Q Consensus 280 ~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~-------------~~~~~~~~~-~~~~ 344 (412)
......||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... ....+.... ....
T Consensus 156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 235 (324)
T 3mtl_A 156 TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFK 235 (324)
T ss_dssp -------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHH
T ss_pred ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhc
Confidence 4445578999999999876 568999999999999999999999996321000 000000000 0000
Q ss_pred hhccCCcc----chhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 345 YQRLSPPI----NQKIIQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 345 ~~~~~~~~----~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
........ ..........+.+++.+||+.||++|||++|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 282 (324)
T 3mtl_A 236 TYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKH 282 (324)
T ss_dssp HTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred ccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 00000000 00000112347899999999999999999999884
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=322.84 Aligned_cols=233 Identities=22% Similarity=0.252 Sum_probs=175.4
Q ss_pred HhhcCcccceeeeecCceEEEEEEe-CCCcEEEEEec-----------------------------cCCccccceEEEec
Q 042435 140 DATEYFHIRYCIGTGGYDSVYKAEL-PDGKVVALKKL-----------------------------HHSETEDSAFVVYS 189 (412)
Q Consensus 140 ~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l-----------------------------~~~~~~~~~~~~~~ 189 (412)
...++|.+.+.||+|+||.||+|.. .+++.||||.+ +|+++.....++ .
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~-~ 210 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFF-D 210 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEE-E
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEE-e
Confidence 4567899999999999999999976 46899999964 355666555554 4
Q ss_pred CceEEEEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCC---CcEEEe
Q 042435 190 PQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSN---LEAFVA 266 (412)
Q Consensus 190 ~~~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~---~~~kl~ 266 (412)
.+..++||||+++|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+|||++.+ ..+||+
T Consensus 211 ~~~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kl~ 284 (419)
T 3i6u_A 211 AEDYYIVLELMEGGELFDKVVGNK---RLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKIT 284 (419)
T ss_dssp SSEEEEEEECCTTCBGGGGTSSSC---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSSCCEEEC
T ss_pred cCceEEEEEcCCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCcceEEEe
Confidence 556899999999999999887654 589999999999999999999999 99999999999999654 459999
Q ss_pred ecCCccccCCCCCCcccccccccccccccccC---cccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHH
Q 042435 267 DFGTVRLLDVDSSNRTLQAGTYGYIALELVYT---MVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDI 343 (412)
Q Consensus 267 DfGla~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~ 343 (412)
|||+++...... ......||+.|+|||++.+ ..++.++|||||||++|||+||+.||... .......+.
T Consensus 285 DFG~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~-------~~~~~~~~~ 356 (419)
T 3i6u_A 285 DFGHSKILGETS-LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEH-------RTQVSLKDQ 356 (419)
T ss_dssp CSSTTTSCC------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCC-------SSSCCHHHH
T ss_pred ecccceecCCCc-cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCC-------cchHHHHHH
Confidence 999998764332 2234579999999999853 56888999999999999999999998732 111122222
Q ss_pred hhhccCCccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 344 LYQRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
+........+.........+.+++.+||+.||++|||+.|++++
T Consensus 357 i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 400 (419)
T 3i6u_A 357 ITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH 400 (419)
T ss_dssp HHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HhcCCCCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 22222111111111223458899999999999999999999975
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=316.58 Aligned_cols=235 Identities=23% Similarity=0.374 Sum_probs=180.3
Q ss_pred hcCcccceeeeecCceEEEEEEeC-CCc----EEEEEec----------------------cCCccccceEEEecCceEE
Q 042435 142 TEYFHIRYCIGTGGYDSVYKAELP-DGK----VVALKKL----------------------HHSETEDSAFVVYSPQCMF 194 (412)
Q Consensus 142 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~----~vAvK~l----------------------~~~~~~~~~~~~~~~~~~~ 194 (412)
.++|++.+.||+|+||.||+|.+. +++ .||+|.+ +|+++.....++... ..+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-~~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS-SEE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC-Cce
Confidence 367999999999999999999863 444 3577754 466777766666654 488
Q ss_pred EEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCcccc
Q 042435 195 FIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLL 274 (412)
Q Consensus 195 lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~ 274 (412)
+|+||+++|+|.+++..... .+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 93 ~v~~~~~~g~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~ 167 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVREHKD--NIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp EEECCCSSCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTC----
T ss_pred EEEEecCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccCcceeEc
Confidence 99999999999999876432 489999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCC--cccccccccccccccccCcccCcccccHHHHHHHHHHHh-CCCCcccccccccCCCCcchhhHHhhhccCCc
Q 042435 275 DVDSSN--RTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLM-GTHPGELLLSLSSSSGPKIMLIDILYQRLSPP 351 (412)
Q Consensus 275 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 351 (412)
...... .....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||... ........+......+
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~--------~~~~~~~~~~~~~~~~ 239 (327)
T 3lzb_A 168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI--------PASEISSILEKGERLP 239 (327)
T ss_dssp ------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC--------CGGGHHHHHHTTCCCC
T ss_pred cCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCC--------CHHHHHHHHHcCCCCC
Confidence 443222 233456889999999999999999999999999999999 99998732 1222333333333222
Q ss_pred cchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhcCCC
Q 042435 352 INQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELEGKTP 393 (412)
Q Consensus 352 ~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 393 (412)
.+.... ..+.+++.+||+.||++|||+.|+++.|+++..
T Consensus 240 ~~~~~~---~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 278 (327)
T 3lzb_A 240 QPPICT---IDVYMIMRKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp CCTTBC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHT
T ss_pred CCccCC---HHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 222222 237889999999999999999999999988764
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-40 Score=306.57 Aligned_cols=232 Identities=19% Similarity=0.260 Sum_probs=185.2
Q ss_pred hhcCcccceeeeecCceEEEEEEeC-CCcEEEEEec-----------------------cCCccccceEEEecCceEEEE
Q 042435 141 ATEYFHIRYCIGTGGYDSVYKAELP-DGKVVALKKL-----------------------HHSETEDSAFVVYSPQCMFFI 196 (412)
Q Consensus 141 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l-----------------------~~~~~~~~~~~~~~~~~~~lv 196 (412)
..++|++.+.||+|+||.||+|... +++.||+|.+ +|+++......+...+..++|
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 83 (284)
T 3kk8_A 4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 83 (284)
T ss_dssp TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence 3578999999999999999999774 6899999964 577777778888889999999
Q ss_pred EEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCc---EEEeecCCccc
Q 042435 197 YEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLE---AFVADFGTVRL 273 (412)
Q Consensus 197 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~---~kl~DfGla~~ 273 (412)
|||+++|+|.+.+.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++. +||+|||++..
T Consensus 84 ~e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~ 157 (284)
T 3kk8_A 84 FDLVTGGELFEDIVARE---FYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIE 157 (284)
T ss_dssp ECCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred EecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEeeceeeEE
Confidence 99999999988776543 589999999999999999999999 9999999999999976655 99999999976
Q ss_pred cCCCCCCcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccc
Q 042435 274 LDVDSSNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPIN 353 (412)
Q Consensus 274 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 353 (412)
..... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||... ........+.......+.
T Consensus 158 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~-------~~~~~~~~~~~~~~~~~~- 228 (284)
T 3kk8_A 158 VNDSE-AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDE-------DQHRLYAQIKAGAYDYPS- 228 (284)
T ss_dssp CCSSC-BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS-------SHHHHHHHHHHTCCCCCT-
T ss_pred cccCc-cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCC-------chhHHHHHHHhccccCCc-
Confidence 54332 223457899999999999999999999999999999999999998632 111111222222221111
Q ss_pred hhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 354 QKIIQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 354 ~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
.........+.+++.+||+.||++|||+.|++++
T Consensus 229 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (284)
T 3kk8_A 229 PEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 262 (284)
T ss_dssp TTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred hhhcccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 1111122347899999999999999999999885
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=316.32 Aligned_cols=236 Identities=22% Similarity=0.313 Sum_probs=173.3
Q ss_pred hcCcccceeeeecCceEEEEEEe-CCCcEEEEEec------------------------cCCccccceEEEecCc----e
Q 042435 142 TEYFHIRYCIGTGGYDSVYKAEL-PDGKVVALKKL------------------------HHSETEDSAFVVYSPQ----C 192 (412)
Q Consensus 142 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l------------------------~~~~~~~~~~~~~~~~----~ 192 (412)
.++|++.+.||+|+||.||+|.. .+++.||||.+ +|+++......+.... .
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 46799999999999999999986 67899999975 3555555555444332 3
Q ss_pred EEEEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCcc
Q 042435 193 MFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVR 272 (412)
Q Consensus 193 ~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~ 272 (412)
.++||||+++|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++
T Consensus 91 ~~lv~e~~~g~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~ 164 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIAR 164 (311)
T ss_dssp EEEEEECCCEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCCSCC-
T ss_pred cEEEEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeeccCcc
Confidence 499999999999999987543 589999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCC---CcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccC
Q 042435 273 LLDVDSS---NRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLS 349 (412)
Q Consensus 273 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 349 (412)
....... ......||+.|+|||++.+..++.++||||||+++|||+||+.||... ...............
T Consensus 165 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~-------~~~~~~~~~~~~~~~ 237 (311)
T 3ork_A 165 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGD-------SPVSVAYQHVREDPI 237 (311)
T ss_dssp -----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS-------SHHHHHHHHHHCCCC
T ss_pred cccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC-------ChHHHHHHHhcCCCC
Confidence 6644322 123356899999999999999999999999999999999999998732 111111222222211
Q ss_pred CccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHH-HHHHhcC
Q 042435 350 PPINQKIIQDIILVSTIALACLRSKPKSRPTMQRI-SQELEGK 391 (412)
Q Consensus 350 ~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev-l~~L~~~ 391 (412)
++ ..........+.+++.+||+.||++||++.++ ...+...
T Consensus 238 ~~-~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 279 (311)
T 3ork_A 238 PP-SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 279 (311)
T ss_dssp CH-HHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred Cc-ccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence 11 01111122347889999999999999965554 4555443
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-40 Score=315.77 Aligned_cols=246 Identities=22% Similarity=0.317 Sum_probs=188.1
Q ss_pred cCcccceeeeecCceEEEEEEe-----CCCcEEEEEec---------------------cCCccccceEEEe--cCceEE
Q 042435 143 EYFHIRYCIGTGGYDSVYKAEL-----PDGKVVALKKL---------------------HHSETEDSAFVVY--SPQCMF 194 (412)
Q Consensus 143 ~~f~~~~~lG~G~~g~Vy~~~~-----~~~~~vAvK~l---------------------~~~~~~~~~~~~~--~~~~~~ 194 (412)
++|++.+.||+|+||.||+|.+ .+++.||||++ +|+++.....++. .....+
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 102 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR 102 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence 5789999999999999999984 46889999975 4566666666555 456789
Q ss_pred EEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCcccc
Q 042435 195 FIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLL 274 (412)
Q Consensus 195 lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~ 274 (412)
+||||+++|+|.+++..... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 103 lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 177 (327)
T 3lxl_A 103 LVMEYLPSGCLRDFLQRHRA--RLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLAKLL 177 (327)
T ss_dssp EEEECCTTCBHHHHHHHHGG--GCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCGGGCEEC
T ss_pred EEEeecCCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEcccccceec
Confidence 99999999999999875432 489999999999999999999998 9999999999999999999999999999876
Q ss_pred CCCCCC---cccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCccccccc----ccCCCCc---chhhHHh
Q 042435 275 DVDSSN---RTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSL----SSSSGPK---IMLIDIL 344 (412)
Q Consensus 275 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~----~~~~~~~---~~~~~~~ 344 (412)
...... .....||+.|+|||++.+..++.++||||||+++|||++|+.||...... ....... ....+..
T Consensus 178 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (327)
T 3lxl_A 178 PLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELL 257 (327)
T ss_dssp CTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHH
T ss_pred ccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHh
Confidence 543321 23346788899999999888999999999999999999999998632210 0000011 1122222
Q ss_pred hhccCCccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhcCCCCCC
Q 042435 345 YQRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELEGKTPMKK 396 (412)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~~~ 396 (412)
......+.+... ...+.+++.+||+.||++|||+.|++++|+.+.....
T Consensus 258 ~~~~~~~~~~~~---~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~ 306 (327)
T 3lxl_A 258 EEGQRLPAPPAC---PAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSR 306 (327)
T ss_dssp HTTCCCCCCTTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC-----
T ss_pred hcccCCCCCCcc---cHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhc
Confidence 222222222222 2347899999999999999999999999998876544
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=327.39 Aligned_cols=226 Identities=23% Similarity=0.366 Sum_probs=186.6
Q ss_pred cCcccceeeeecCceEEEEEEeC-CCcEEEEEec------------------------cCCccccceEEEecCceEEEEE
Q 042435 143 EYFHIRYCIGTGGYDSVYKAELP-DGKVVALKKL------------------------HHSETEDSAFVVYSPQCMFFIY 197 (412)
Q Consensus 143 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l------------------------~~~~~~~~~~~~~~~~~~~lv~ 197 (412)
++|.+.+.||+|+||.||+|... +|+.||||.+ +|+++.....++...+..++||
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 95 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM 95 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 57999999999999999999875 7999999964 5788888888889999999999
Q ss_pred EeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCC
Q 042435 198 EYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVD 277 (412)
Q Consensus 198 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~ 277 (412)
||+++|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 96 E~~~gg~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~ 169 (476)
T 2y94_A 96 EYVSGGELFDYICKNG---RLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG 169 (476)
T ss_dssp ECCSSEEHHHHTTSSS---SCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCCSSCEECCTT
T ss_pred eCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEeccchhhcccc
Confidence 9999999999987653 589999999999999999999998 9999999999999999999999999999876543
Q ss_pred CCCcccccccccccccccccCccc-CcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccchhh
Q 042435 278 SSNRTLQAGTYGYIALELVYTMVV-TEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKI 356 (412)
Q Consensus 278 ~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 356 (412)
. ......||+.|+|||++.+..+ +.++|||||||++|||++|+.||+.. ........+.......+ ...
T Consensus 170 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~-------~~~~~~~~i~~~~~~~p--~~~ 239 (476)
T 2y94_A 170 E-FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDD-------HVPTLFKKICDGIFYTP--QYL 239 (476)
T ss_dssp C-CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCS-------SSHHHHHHHHTTCCCCC--TTC
T ss_pred c-cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCC-------CHHHHHHHHhcCCcCCC--ccC
Confidence 2 2344579999999999988765 68999999999999999999999732 11112222222222211 111
Q ss_pred HHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 357 IQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 357 ~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
...+.+++.+||+.||++|||+.|++++
T Consensus 240 ---s~~~~~Li~~~L~~dP~~Rpt~~eil~h 267 (476)
T 2y94_A 240 ---NPSVISLLKHMLQVDPMKRATIKDIREH 267 (476)
T ss_dssp ---CHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred ---CHHHHHHHHHHcCCCchhCcCHHHHHhC
Confidence 1237889999999999999999999985
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=311.48 Aligned_cols=231 Identities=21% Similarity=0.246 Sum_probs=184.3
Q ss_pred hcCcccceeeeecCceEEEEEEeC-CCcEEEEEec---------------------------cCCccccceEEEecCceE
Q 042435 142 TEYFHIRYCIGTGGYDSVYKAELP-DGKVVALKKL---------------------------HHSETEDSAFVVYSPQCM 193 (412)
Q Consensus 142 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l---------------------------~~~~~~~~~~~~~~~~~~ 193 (412)
.++|++.+.||+|+||.||+|... +|+.||+|.+ +|+++......+...+..
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 467999999999999999999874 6899999965 356666666778888999
Q ss_pred EEEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCC----cEEEeecC
Q 042435 194 FFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNL----EAFVADFG 269 (412)
Q Consensus 194 ~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~----~~kl~DfG 269 (412)
++||||+++++|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++ .+||+|||
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg 164 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQKE---SLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (321)
T ss_dssp EEEECCCCSCBHHHHHHTCS---CEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCT
T ss_pred EEEEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcCCEEEccCc
Confidence 99999999999999987643 588999999999999999999999 999999999999999887 79999999
Q ss_pred CccccCCCCCCcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccC
Q 042435 270 TVRLLDVDSSNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLS 349 (412)
Q Consensus 270 la~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 349 (412)
+++...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||... ........+......
T Consensus 165 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~-------~~~~~~~~i~~~~~~ 236 (321)
T 2a2a_A 165 LAHEIEDGV-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD-------TKQETLANITSVSYD 236 (321)
T ss_dssp TCEECCTTC-CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCS-------SHHHHHHHHHTTCCC
T ss_pred cceecCccc-cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCC-------CHHHHHHHHHhcccc
Confidence 998765432 223456899999999999999999999999999999999999998632 111111111111111
Q ss_pred CccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 350 PPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 350 ~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
.+ ..........+.+++.+||+.||++|||+.|++++
T Consensus 237 ~~-~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 237 FD-EEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (321)
T ss_dssp CC-HHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred cC-hhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 11 01111122347899999999999999999999985
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=305.12 Aligned_cols=228 Identities=26% Similarity=0.353 Sum_probs=182.8
Q ss_pred hhcCcccceeeeecCceEEEEEEeC-CCcEEEEEec------------------------cCCccccceEEEecCceEEE
Q 042435 141 ATEYFHIRYCIGTGGYDSVYKAELP-DGKVVALKKL------------------------HHSETEDSAFVVYSPQCMFF 195 (412)
Q Consensus 141 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l------------------------~~~~~~~~~~~~~~~~~~~l 195 (412)
+.++|++.+.||+|+||.||+|... +++.||+|.+ +|+++......+...+..++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 86 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 86 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence 3578999999999999999999764 5789999964 57888888888889999999
Q ss_pred EEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccC
Q 042435 196 IYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLD 275 (412)
Q Consensus 196 v~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~ 275 (412)
||||+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++....
T Consensus 87 v~e~~~~~~l~~~l~~~~---~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~ 160 (279)
T 3fdn_A 87 ILEYAPLGTVYRELQKLS---KFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP 160 (279)
T ss_dssp EECCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSCCEESCC-
T ss_pred EEecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEeccccccCC
Confidence 999999999998886543 589999999999999999999998 99999999999999999999999999986543
Q ss_pred CCCCCcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccchh
Q 042435 276 VDSSNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQK 355 (412)
Q Consensus 276 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 355 (412)
.. ......||+.|+|||.+.+..++.++||||||+++|||++|+.||... ........+....... +..
T Consensus 161 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~-------~~~~~~~~~~~~~~~~--~~~ 229 (279)
T 3fdn_A 161 SS--RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN-------TYQETYKRISRVEFTF--PDF 229 (279)
T ss_dssp ---------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCS-------SHHHHHHHHHHTCCCC--CTT
T ss_pred cc--cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCC-------cHHHHHHHHHhCCCCC--CCc
Confidence 22 223457899999999999999999999999999999999999998732 1111111111111111 111
Q ss_pred hHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHH
Q 042435 356 IIQDIILVSTIALACLRSKPKSRPTMQRISQEL 388 (412)
Q Consensus 356 ~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L 388 (412)
. ...+.+++.+||+.||++|||+.|++++-
T Consensus 230 ~---~~~~~~li~~~l~~~p~~Rps~~e~l~h~ 259 (279)
T 3fdn_A 230 V---TEGARDLISRLLKHNPSQRPMLREVLEHP 259 (279)
T ss_dssp S---CHHHHHHHHHHCCSSGGGSCCHHHHHHCH
T ss_pred C---CHHHHHHHHHHhccChhhCCCHHHHhhCc
Confidence 1 12377899999999999999999999864
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-40 Score=314.34 Aligned_cols=235 Identities=19% Similarity=0.229 Sum_probs=168.9
Q ss_pred hcCcccceeeeecCceEEEEEEeC-CCcEEEEEec----------------------cCCccccceEEEecCceEEEEEE
Q 042435 142 TEYFHIRYCIGTGGYDSVYKAELP-DGKVVALKKL----------------------HHSETEDSAFVVYSPQCMFFIYE 198 (412)
Q Consensus 142 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l----------------------~~~~~~~~~~~~~~~~~~~lv~e 198 (412)
.++|++.+.||+|+||.||+|... +|+.||+|.+ +|+++.....++..++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 467999999999999999999774 6899999965 46777777778888899999999
Q ss_pred eccCCceeeeeccCc---ccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccC
Q 042435 199 YMERGSLFCVLRDDD---EAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLD 275 (412)
Q Consensus 199 y~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~ 275 (412)
|++ |+|.+++.... ....+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 998 69988876432 112489999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCCcccccccccccccccccC-cccCcccccHHHHHHHHHHHhCCCCccccccccc--------CCCCc---------
Q 042435 276 VDSSNRTLQAGTYGYIALELVYT-MVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSS--------SSGPK--------- 337 (412)
Q Consensus 276 ~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~--------~~~~~--------- 337 (412)
..........||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ .....
T Consensus 160 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 239 (317)
T 2pmi_A 160 IPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKL 239 (317)
T ss_dssp SCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGC
T ss_pred CCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhh
Confidence 44444445678999999999876 4689999999999999999999999863211000 00000
Q ss_pred ------------chhhHHhhhccCCccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 338 ------------IMLIDILYQRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 338 ------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
....+...+.... .....+.+++.+||+.||++|||+.|++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h 294 (317)
T 2pmi_A 240 PKYNPNIQQRPPRDLRQVLQPHTKE-------PLDGNLMDFLHGLLQLNPDMRLSAKQALHH 294 (317)
T ss_dssp TTCCTTCCCCCCCCSHHHHGGGCSS-------CCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hhcccccccccchhHHHhhcccccc-------cCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence 0000000000000 012248899999999999999999999875
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=310.32 Aligned_cols=238 Identities=21% Similarity=0.262 Sum_probs=177.5
Q ss_pred cCcccceeeeecCceEEEEEEeC-CCcEEEEEec-----------------------cCCccccceEEEecCceEEEEEE
Q 042435 143 EYFHIRYCIGTGGYDSVYKAELP-DGKVVALKKL-----------------------HHSETEDSAFVVYSPQCMFFIYE 198 (412)
Q Consensus 143 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l-----------------------~~~~~~~~~~~~~~~~~~~lv~e 198 (412)
++|++.+.||+|+||.||+|... +|+.||+|++ +|+++......+...+..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 67999999999999999999875 5999999964 57777778888888999999999
Q ss_pred eccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCC
Q 042435 199 YMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDS 278 (412)
Q Consensus 199 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~ 278 (412)
|+++++|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++......
T Consensus 83 ~~~~~~l~~~~~~~~---~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 156 (311)
T 4agu_A 83 YCDHTVLHELDRYQR---GVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPS 156 (311)
T ss_dssp CCSEEHHHHHHHTSS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred eCCCchHHHHHhhhc---CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc
Confidence 999999988876543 489999999999999999999999 99999999999999999999999999998765444
Q ss_pred CCcccccccccccccccccC-cccCcccccHHHHHHHHHHHhCCCCccccccccc--------CCCCcchhhHHh-----
Q 042435 279 SNRTLQAGTYGYIALELVYT-MVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSS--------SSGPKIMLIDIL----- 344 (412)
Q Consensus 279 ~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~--------~~~~~~~~~~~~----- 344 (412)
.......||+.|+|||++.+ ..++.++||||||+++|||++|+.||........ ..... ......
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 235 (311)
T 4agu_A 157 DYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIP-RHQQVFSTNQY 235 (311)
T ss_dssp ---------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCH-HHHHHHHTCGG
T ss_pred cccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccc-ccccccccccc
Confidence 44455678999999999876 6689999999999999999999999863211000 00000 000000
Q ss_pred -hh-ccCCcc-----chhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 345 -YQ-RLSPPI-----NQKIIQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 345 -~~-~~~~~~-----~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
.. ....+. ..........+.+++.+||+.||++|||++|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 236 FSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp GTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred cccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 00 000000 00001122347889999999999999999999976
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=323.11 Aligned_cols=177 Identities=28% Similarity=0.397 Sum_probs=143.3
Q ss_pred hhcCcccceeeeecCceEEEEEEe-CCCcEEEEEec------------------------cCCccccceEEEecC--ceE
Q 042435 141 ATEYFHIRYCIGTGGYDSVYKAEL-PDGKVVALKKL------------------------HHSETEDSAFVVYSP--QCM 193 (412)
Q Consensus 141 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l------------------------~~~~~~~~~~~~~~~--~~~ 193 (412)
..++|++.+.||+|+||.||+|.. .+|+.||||++ .|+++.....++... ...
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 86 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV 86 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence 457899999999999999999976 57999999965 277787777776543 478
Q ss_pred EEEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccc
Q 042435 194 FFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRL 273 (412)
Q Consensus 194 ~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~ 273 (412)
++|||||+ |+|.+++... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 87 ~lv~e~~~-~~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 158 (388)
T 3oz6_A 87 YLVFDYME-TDLHAVIRAN----ILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRS 158 (388)
T ss_dssp EEEEECCS-EEHHHHHHHT----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEecccC-cCHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEecCCccccc
Confidence 99999997 5888888653 489999999999999999999999 999999999999999999999999999986
Q ss_pred cCCC---------------------CCCcccccccccccccccccC-cccCcccccHHHHHHHHHHHhCCCCcc
Q 042435 274 LDVD---------------------SSNRTLQAGTYGYIALELVYT-MVVTEKCVIYSFGVVALEVLMGTHPGE 325 (412)
Q Consensus 274 ~~~~---------------------~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~S~Gvil~elltg~~P~~ 325 (412)
.... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~ 232 (388)
T 3oz6_A 159 FVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFP 232 (388)
T ss_dssp SSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred ccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCC
Confidence 5321 111234579999999999876 678999999999999999999999996
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=306.85 Aligned_cols=234 Identities=21% Similarity=0.270 Sum_probs=184.9
Q ss_pred cCcccce-eeeecCceEEEEEEeC---CCcEEEEEec----------------------cCCccccceEEEecCceEEEE
Q 042435 143 EYFHIRY-CIGTGGYDSVYKAELP---DGKVVALKKL----------------------HHSETEDSAFVVYSPQCMFFI 196 (412)
Q Consensus 143 ~~f~~~~-~lG~G~~g~Vy~~~~~---~~~~vAvK~l----------------------~~~~~~~~~~~~~~~~~~~lv 196 (412)
++|.+.. .||+|+||.||+|.+. +++.||+|.+ +|+++......+ ..+..++|
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv 87 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV 87 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence 4566666 9999999999999763 5788999975 456666666666 55678999
Q ss_pred EEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCC
Q 042435 197 YEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDV 276 (412)
Q Consensus 197 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~ 276 (412)
|||+++++|.+++.... ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++....
T Consensus 88 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 162 (287)
T 1u59_A 88 MEMAGGGPLHKFLVGKR--EEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGA 162 (287)
T ss_dssp EECCTTEEHHHHHTTCT--TTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred EEeCCCCCHHHHHHhCC--ccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECcccceeeecc
Confidence 99999999999986543 2489999999999999999999999 999999999999999999999999999987644
Q ss_pred CCCC---cccccccccccccccccCcccCcccccHHHHHHHHHHHh-CCCCcccccccccCCCCcchhhHHhhhccCCcc
Q 042435 277 DSSN---RTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLM-GTHPGELLLSLSSSSGPKIMLIDILYQRLSPPI 352 (412)
Q Consensus 277 ~~~~---~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 352 (412)
.... .....+|+.|+|||++.+..++.++||||||+++|||+| |+.||... . .......+........
T Consensus 163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~-------~-~~~~~~~i~~~~~~~~ 234 (287)
T 1u59_A 163 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM-------K-GPEVMAFIEQGKRMEC 234 (287)
T ss_dssp CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC-------C-THHHHHHHHTTCCCCC
T ss_pred CcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccC-------C-HHHHHHHHhcCCcCCC
Confidence 3221 223456889999999988889999999999999999999 99998732 1 1122222222222222
Q ss_pred chhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhcCCC
Q 042435 353 NQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELEGKTP 393 (412)
Q Consensus 353 ~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 393 (412)
+... ...+.+++.+||+.||++||++.|++++|+++..
T Consensus 235 ~~~~---~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 272 (287)
T 1u59_A 235 PPEC---PPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 272 (287)
T ss_dssp CTTC---CHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCc---CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 2222 2348889999999999999999999999987743
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=321.47 Aligned_cols=233 Identities=25% Similarity=0.360 Sum_probs=181.3
Q ss_pred hcCcccceeeeecCceEEEEEEe----CCCcEEEEEecc--------------------------CCccccceEEEecCc
Q 042435 142 TEYFHIRYCIGTGGYDSVYKAEL----PDGKVVALKKLH--------------------------HSETEDSAFVVYSPQ 191 (412)
Q Consensus 142 ~~~f~~~~~lG~G~~g~Vy~~~~----~~~~~vAvK~l~--------------------------~~~~~~~~~~~~~~~ 191 (412)
.++|++.+.||+|+||.||+|+. .+++.||||.++ |+++......+...+
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 36899999999999999999987 478999999753 556666666777888
Q ss_pred eEEEEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCc
Q 042435 192 CMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTV 271 (412)
Q Consensus 192 ~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla 271 (412)
..++||||+++|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~DfG~a 206 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQRE---RFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLS 206 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred eEEEEeecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEEEeeCCCC
Confidence 9999999999999999987543 589999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCC-CcccccccccccccccccC--cccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhcc
Q 042435 272 RLLDVDSS-NRTLQAGTYGYIALELVYT--MVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRL 348 (412)
Q Consensus 272 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~--~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 348 (412)
+....... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... ......+.......
T Consensus 207 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~----~~~~~~~~~~~~~~- 281 (355)
T 1vzo_A 207 KEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGE----KNSQAEISRRILKS- 281 (355)
T ss_dssp EECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTS----CCCHHHHHHHHHHC-
T ss_pred eecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCc----cchHHHHHHHHhcc-
Confidence 86543221 2234579999999999985 3478899999999999999999999863210 00111111111111
Q ss_pred CCccchhhHHHHHHHHHHHHhcCcCCCCCCC-----CHHHHHHHH
Q 042435 349 SPPINQKIIQDIILVSTIALACLRSKPKSRP-----TMQRISQEL 388 (412)
Q Consensus 349 ~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RP-----s~~evl~~L 388 (412)
.++.+... ...+.+++.+||+.||++|| +++|++++.
T Consensus 282 ~~~~~~~~---~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 282 EPPYPQEM---SALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp CCCCCTTS---CHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred CCCCCccc---CHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 11111211 22377899999999999999 999998875
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-40 Score=320.51 Aligned_cols=235 Identities=23% Similarity=0.315 Sum_probs=174.0
Q ss_pred CcccceeeeecCceEEEEEEeC--C--CcEEEEEec----------------------cCCccccceEEEec-CceEEEE
Q 042435 144 YFHIRYCIGTGGYDSVYKAELP--D--GKVVALKKL----------------------HHSETEDSAFVVYS-PQCMFFI 196 (412)
Q Consensus 144 ~f~~~~~lG~G~~g~Vy~~~~~--~--~~~vAvK~l----------------------~~~~~~~~~~~~~~-~~~~~lv 196 (412)
.|++.+.||+|+||.||+|.+. + +..||+|.+ +|+++.....++.. .+..++|
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv 169 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 169 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence 4677889999999999999763 2 246899965 46777777776544 5678999
Q ss_pred EEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCC
Q 042435 197 YEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDV 276 (412)
Q Consensus 197 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~ 276 (412)
|||+++|+|.++++.... .+++..+..++.|+++||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 170 ~e~~~~g~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~ 244 (373)
T 3c1x_A 170 LPYMKHGDLRNFIRNETH--NPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 244 (373)
T ss_dssp EECCTTCBHHHHHHCTTC--CCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EECCCCCCHHHHHhhccc--CCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeeccccccccc
Confidence 999999999999976432 478999999999999999999999 999999999999999999999999999986543
Q ss_pred CCC----CcccccccccccccccccCcccCcccccHHHHHHHHHHHh-CCCCcccccccccCCCCcchhhHHhhhccCCc
Q 042435 277 DSS----NRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLM-GTHPGELLLSLSSSSGPKIMLIDILYQRLSPP 351 (412)
Q Consensus 277 ~~~----~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 351 (412)
... ......+|+.|+|||.+.+..++.++||||||+++|||+| |..||... .... ....+.......
T Consensus 245 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~-------~~~~-~~~~~~~~~~~~ 316 (373)
T 3c1x_A 245 KEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV-------NTFD-ITVYLLQGRRLL 316 (373)
T ss_dssp -------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTS-------CSSC-HHHHHHTTCCCC
T ss_pred cccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCC-------CHHH-HHHHHHcCCCCC
Confidence 221 1233457889999999999999999999999999999999 66776522 1111 122222211111
Q ss_pred cchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhcCCCC
Q 042435 352 INQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELEGKTPM 394 (412)
Q Consensus 352 ~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~ 394 (412)
.+... ...+.+++.+||+.||++|||+.|+++.|+++...
T Consensus 317 ~p~~~---~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~ 356 (373)
T 3c1x_A 317 QPEYC---PDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 356 (373)
T ss_dssp CCTTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CCCCC---CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 11221 22378899999999999999999999999987543
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-40 Score=319.31 Aligned_cols=236 Identities=13% Similarity=0.095 Sum_probs=185.6
Q ss_pred HHhhcCcccceeeeecCceEEEEEE------eCCCcEEEEEecc---------------------CCccccceEEEecCc
Q 042435 139 IDATEYFHIRYCIGTGGYDSVYKAE------LPDGKVVALKKLH---------------------HSETEDSAFVVYSPQ 191 (412)
Q Consensus 139 ~~~~~~f~~~~~lG~G~~g~Vy~~~------~~~~~~vAvK~l~---------------------~~~~~~~~~~~~~~~ 191 (412)
....++|.+.+.||+|+||.||+|. ..+++.||||.++ |+++......+...+
T Consensus 61 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~ 140 (365)
T 3e7e_A 61 QLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQN 140 (365)
T ss_dssp ECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSS
T ss_pred EECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCC
Confidence 3446789999999999999999993 4568999999763 456666677788889
Q ss_pred eEEEEEEeccCCceeeeeccCc--ccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecC----------
Q 042435 192 CMFFIYEYMERGSLFCVLRDDD--EAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNS---------- 259 (412)
Q Consensus 192 ~~~lv~ey~~~gsL~~~l~~~~--~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~---------- 259 (412)
..++||||+++|+|.+++.... ....++|..++.++.|++.||+|||++ +|+||||||+|||++.
T Consensus 141 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~~~~~~~~ 217 (365)
T 3e7e_A 141 GSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDD 217 (365)
T ss_dssp CEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGTCC-----
T ss_pred CcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccccCcccccc
Confidence 9999999999999999997422 123599999999999999999999998 9999999999999988
Q ss_pred -CCcEEEeecCCccccCCC--CCCcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCC
Q 042435 260 -NLEAFVADFGTVRLLDVD--SSNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGP 336 (412)
Q Consensus 260 -~~~~kl~DfGla~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~ 336 (412)
++.+||+|||+++.+... ........||+.|+|||++.+..++.++|||||||++|||+||+.||......
T Consensus 218 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~------ 291 (365)
T 3e7e_A 218 LSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGG------ 291 (365)
T ss_dssp -CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETT------
T ss_pred ccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCC------
Confidence 899999999999765422 22234567999999999999999999999999999999999999998632110
Q ss_pred cchhhHHhhhccCCccchhhHHHHHHHHHHHHhcCcCCCCCC-CCHHHHHHHHhcCCC
Q 042435 337 KIMLIDILYQRLSPPINQKIIQDIILVSTIALACLRSKPKSR-PTMQRISQELEGKTP 393 (412)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~R-Ps~~evl~~L~~~~~ 393 (412)
... ......... . ...+.+++..|++.+|.+| |++.++.+.|++..+
T Consensus 292 ~~~----~~~~~~~~~---~---~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~ 339 (365)
T 3e7e_A 292 ECK----PEGLFRRLP---H---LDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQ 339 (365)
T ss_dssp EEE----ECSCCTTCS---S---HHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHH
T ss_pred cee----echhccccC---c---HHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHH
Confidence 000 001111110 0 1125678889999999999 688888888877643
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=308.27 Aligned_cols=229 Identities=26% Similarity=0.382 Sum_probs=186.7
Q ss_pred hcCcccceeeeecCceEEEEEEe-CCCcEEEEEec----------------------cCCccccceEEEecCceEEEEEE
Q 042435 142 TEYFHIRYCIGTGGYDSVYKAEL-PDGKVVALKKL----------------------HHSETEDSAFVVYSPQCMFFIYE 198 (412)
Q Consensus 142 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l----------------------~~~~~~~~~~~~~~~~~~~lv~e 198 (412)
.+.|++.+.||+|+||.||+|.. .+++.||+|.+ +|+++......+...+..++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 45689999999999999999976 56899999965 45667777777888889999999
Q ss_pred eccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCC
Q 042435 199 YMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDS 278 (412)
Q Consensus 199 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~ 278 (412)
|+++++|.+++... .+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++.......
T Consensus 101 ~~~~~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~ 173 (303)
T 3a7i_A 101 YLGGGSALDLLEPG----PLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ 173 (303)
T ss_dssp CCTTEEHHHHHTTS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECBTTB
T ss_pred eCCCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccceecCccc
Confidence 99999999988653 489999999999999999999999 99999999999999999999999999998765544
Q ss_pred CCcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccchhhHH
Q 042435 279 SNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKIIQ 358 (412)
Q Consensus 279 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 358 (412)
.......||+.|+|||++.+..++.++||||||+++|||++|+.||.... .......+.....+......
T Consensus 174 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--------~~~~~~~~~~~~~~~~~~~~-- 243 (303)
T 3a7i_A 174 IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELH--------PMKVLFLIPKNNPPTLEGNY-- 243 (303)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC--------HHHHHHHHHHSCCCCCCSSC--
T ss_pred cccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcC--------HHHHHHHhhcCCCCCCcccc--
Confidence 44455678999999999999999999999999999999999999986321 11111122222221111111
Q ss_pred HHHHHHHHHHhcCcCCCCCCCCHHHHHHHH
Q 042435 359 DIILVSTIALACLRSKPKSRPTMQRISQEL 388 (412)
Q Consensus 359 ~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L 388 (412)
...+.+++.+||+.||++|||+.|++++.
T Consensus 244 -~~~l~~li~~~l~~dp~~Rps~~~ll~~~ 272 (303)
T 3a7i_A 244 -SKPLKEFVEACLNKEPSFRPTAKELLKHK 272 (303)
T ss_dssp -CHHHHHHHHHHCCSSGGGSCCHHHHTTCH
T ss_pred -CHHHHHHHHHHcCCChhhCcCHHHHhhCh
Confidence 22378899999999999999999998864
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-40 Score=306.39 Aligned_cols=234 Identities=22% Similarity=0.344 Sum_probs=186.9
Q ss_pred hhcCcccceeeeecCceEEEEEEeC-CCcEEEEEec-----------------cCCccccceEEEec-------------
Q 042435 141 ATEYFHIRYCIGTGGYDSVYKAELP-DGKVVALKKL-----------------HHSETEDSAFVVYS------------- 189 (412)
Q Consensus 141 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l-----------------~~~~~~~~~~~~~~------------- 189 (412)
..++|++.+.||+|+||.||+|... +++.||+|.+ +|+++......+..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~ 88 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSS 88 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCSGGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---------
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEeccccHHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccccccc
Confidence 3467999999999999999999885 7999999965 46677666555432
Q ss_pred ---CceEEEEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEe
Q 042435 190 ---PQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVA 266 (412)
Q Consensus 190 ---~~~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~ 266 (412)
....++||||+++|+|.+++..... ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+
T Consensus 89 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~ 164 (284)
T 2a19_B 89 RSKTKCLFIQMEFCDKGTLEQWIEKRRG-EKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIG 164 (284)
T ss_dssp CCEEEEEEEEECCCCSCBHHHHHHHGGG-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEEC
T ss_pred ccCcceEEEEEeccCCCCHHHHHhhccC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEcCCCCEEEC
Confidence 4568999999999999999975432 2589999999999999999999999 99999999999999999999999
Q ss_pred ecCCccccCCCCCCcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhh
Q 042435 267 DFGTVRLLDVDSSNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQ 346 (412)
Q Consensus 267 DfGla~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 346 (412)
|||+++...... ......||+.|+|||.+.+..++.++||||||+++|||++|..|+..... ........
T Consensus 165 Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~---------~~~~~~~~ 234 (284)
T 2a19_B 165 DFGLVTSLKNDG-KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSK---------FFTDLRDG 234 (284)
T ss_dssp CCTTCEESSCCS-CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHHH---------HHHHHHTT
T ss_pred cchhheeccccc-cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHHH---------HHHHhhcc
Confidence 999998765432 22345689999999999998999999999999999999999998752210 11111111
Q ss_pred ccCCccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhcCCCCC
Q 042435 347 RLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELEGKTPMK 395 (412)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~~ 395 (412)
..... . ...+.+++.+||+.||++|||+.|++++|+.+....
T Consensus 235 ~~~~~----~---~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~ 276 (284)
T 2a19_B 235 IISDI----F---DKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSP 276 (284)
T ss_dssp CCCTT----S---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC--
T ss_pred ccccc----C---CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCC
Confidence 11111 1 123678999999999999999999999999887654
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-40 Score=313.62 Aligned_cols=242 Identities=20% Similarity=0.276 Sum_probs=187.1
Q ss_pred ccHHHHHHhhcCcccc-eeeeecCceEEEEEEeC-CCcEEEEEec------------------------cCCccccceEE
Q 042435 133 ILYENLIDATEYFHIR-YCIGTGGYDSVYKAELP-DGKVVALKKL------------------------HHSETEDSAFV 186 (412)
Q Consensus 133 ~~~~~l~~~~~~f~~~-~~lG~G~~g~Vy~~~~~-~~~~vAvK~l------------------------~~~~~~~~~~~ 186 (412)
+.++......+.|.+. +.||+|+||.||+|... +++.||+|.+ +|+++......
T Consensus 18 ~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~ 97 (327)
T 3lm5_A 18 LYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEV 97 (327)
T ss_dssp CCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEE
T ss_pred hHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEE
Confidence 4455566667778887 89999999999999775 6999999965 34677777778
Q ss_pred EecCceEEEEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecC---CCcE
Q 042435 187 VYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNS---NLEA 263 (412)
Q Consensus 187 ~~~~~~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~---~~~~ 263 (412)
+...+..++||||+++|+|.+++..... ..+++..+..++.|++.||+|||++ +|+||||||+||+++. ++.+
T Consensus 98 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~~~~~ 173 (327)
T 3lm5_A 98 YENTSEIILILEYAAGGEIFSLCLPELA-EMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDI 173 (327)
T ss_dssp EECSSEEEEEEECCTTEEGGGGGSSCC--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTTBCCE
T ss_pred EEeCCeEEEEEEecCCCcHHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCCCCcE
Confidence 8889999999999999999998865422 2589999999999999999999999 9999999999999987 7899
Q ss_pred EEeecCCccccCCCCCCcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHH
Q 042435 264 FVADFGTVRLLDVDSSNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDI 343 (412)
Q Consensus 264 kl~DfGla~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~ 343 (412)
||+|||+++...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||... ........+
T Consensus 174 kL~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~-------~~~~~~~~i 245 (327)
T 3lm5_A 174 KIVDFGMSRKIGHAC-ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGE-------DNQETYLNI 245 (327)
T ss_dssp EECCGGGCEEC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS-------SHHHHHHHH
T ss_pred EEeeCccccccCCcc-ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-------CchHHHHHH
Confidence 999999998764332 223457999999999999999999999999999999999999998632 111111122
Q ss_pred hhhccCCccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 344 LYQRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
.......+. .........+.+++.+||+.||++|||++|++++
T Consensus 246 ~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 246 SQVNVDYSE-ETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp HHTCCCCCT-TTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred HhcccccCc-hhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 211111111 1111122347889999999999999999999876
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=301.49 Aligned_cols=231 Identities=21% Similarity=0.247 Sum_probs=184.1
Q ss_pred hcCcccceeeeecCceEEEEEEeC-CCcEEEEEec----------------------cCCccccceEEEecCceEEEEEE
Q 042435 142 TEYFHIRYCIGTGGYDSVYKAELP-DGKVVALKKL----------------------HHSETEDSAFVVYSPQCMFFIYE 198 (412)
Q Consensus 142 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l----------------------~~~~~~~~~~~~~~~~~~~lv~e 198 (412)
.++|++.+.||+|+||.||+|... +++.||+|.+ +|+++......+...+..++|||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 467999999999999999999875 7899999964 46777777777888899999999
Q ss_pred eccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCC
Q 042435 199 YMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDS 278 (412)
Q Consensus 199 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~ 278 (412)
|+++++|.+++.... .+++..+..++.|++.||+|||++ +++||||||+||+++.++.+||+|||++.......
T Consensus 86 ~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 159 (276)
T 2yex_A 86 YCSGGELFDRIEPDI---GMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159 (276)
T ss_dssp CCTTEEGGGGSBTTT---BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred ecCCCcHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCCCccccCCCc
Confidence 999999999987543 589999999999999999999998 99999999999999999999999999998654322
Q ss_pred --CCcccccccccccccccccCccc-CcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccchh
Q 042435 279 --SNRTLQAGTYGYIALELVYTMVV-TEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQK 355 (412)
Q Consensus 279 --~~~~~~~gt~~y~aPE~~~~~~~-s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 355 (412)
.......||+.|+|||.+.+..+ +.++||||||+++|||++|+.||.... ........+.......+...
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~------~~~~~~~~~~~~~~~~~~~~- 232 (276)
T 2yex_A 160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS------DSCQEYSDWKEKKTYLNPWK- 232 (276)
T ss_dssp EECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSC------TTSHHHHHHHTTCTTSTTGG-
T ss_pred chhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCc------hHHHHHHHhhhcccccCchh-
Confidence 12234578999999999987665 779999999999999999999987321 11111222222111111111
Q ss_pred hHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 356 IIQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 356 ~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
.....+.+++.+||+.||++|||++|++++
T Consensus 233 --~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (276)
T 2yex_A 233 --KIDSAPLALLHKILVENPSARITIPDIKKD 262 (276)
T ss_dssp --GSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred --hcCHHHHHHHHHHCCCCchhCCCHHHHhcC
Confidence 112247789999999999999999999875
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=318.26 Aligned_cols=227 Identities=21% Similarity=0.222 Sum_probs=177.5
Q ss_pred cceeeeecCceEEEEEEe-CCCcEEEEEec---------------------cCCccccceEEEecCceEEEEEEeccCCc
Q 042435 147 IRYCIGTGGYDSVYKAEL-PDGKVVALKKL---------------------HHSETEDSAFVVYSPQCMFFIYEYMERGS 204 (412)
Q Consensus 147 ~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l---------------------~~~~~~~~~~~~~~~~~~~lv~ey~~~gs 204 (412)
..+.||+|+||.||+|.. .+|+.||+|.+ +|+++......+...+..++||||+++|+
T Consensus 93 ~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~ 172 (373)
T 2x4f_A 93 KTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGE 172 (373)
T ss_dssp EEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCE
T ss_pred cceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCc
Confidence 357899999999999976 56999999964 57888888888999999999999999999
Q ss_pred eeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEe--cCCCcEEEeecCCccccCCCCCCcc
Q 042435 205 LFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILL--NSNLEAFVADFGTVRLLDVDSSNRT 282 (412)
Q Consensus 205 L~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl--~~~~~~kl~DfGla~~~~~~~~~~~ 282 (412)
|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+|||+ +.++.+||+|||+++...... ...
T Consensus 173 L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~-~~~ 246 (373)
T 2x4f_A 173 LFDRIIDES--YNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE-KLK 246 (373)
T ss_dssp EHHHHHHTG--GGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC-BCC
T ss_pred HHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc-ccc
Confidence 998886543 2589999999999999999999999 99999999999999 567899999999998765432 223
Q ss_pred cccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccchhhHHHHHH
Q 042435 283 LQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKIIQDIIL 362 (412)
Q Consensus 283 ~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 362 (412)
...||+.|+|||++.+..++.++|||||||++|||++|+.||... ........+.......+. .........
T Consensus 247 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~-------~~~~~~~~i~~~~~~~~~-~~~~~~~~~ 318 (373)
T 2x4f_A 247 VNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGD-------NDAETLNNILACRWDLED-EEFQDISEE 318 (373)
T ss_dssp CCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCS-------SHHHHHHHHHHTCCCSCS-GGGTTSCHH
T ss_pred cccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCC-------CHHHHHHHHHhccCCCCh-hhhccCCHH
Confidence 446999999999999889999999999999999999999998632 111122233332222111 111112234
Q ss_pred HHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 363 VSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 363 ~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
+.+++.+||+.||++|||+.|++++
T Consensus 319 ~~~li~~~L~~dp~~Rps~~e~l~h 343 (373)
T 2x4f_A 319 AKEFISKLLIKEKSWRISASEALKH 343 (373)
T ss_dssp HHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred HHHHHHHHcCCChhhCCCHHHHhcC
Confidence 8899999999999999999999984
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=303.68 Aligned_cols=231 Identities=19% Similarity=0.264 Sum_probs=184.7
Q ss_pred hhcCcccceeeeecCceEEEEEEeC-CCcEEEEEec---------------------cCCccccceEEEecCceEEEEEE
Q 042435 141 ATEYFHIRYCIGTGGYDSVYKAELP-DGKVVALKKL---------------------HHSETEDSAFVVYSPQCMFFIYE 198 (412)
Q Consensus 141 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l---------------------~~~~~~~~~~~~~~~~~~~lv~e 198 (412)
..++|++.+.||+|+||.||+|... ++..||+|++ +|+++......+...+..++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME 86 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence 3467999999999999999999875 5779999964 57788888888889999999999
Q ss_pred eccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEe---cCCCcEEEeecCCccccC
Q 042435 199 YMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILL---NSNLEAFVADFGTVRLLD 275 (412)
Q Consensus 199 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl---~~~~~~kl~DfGla~~~~ 275 (412)
|+++++|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+||++ +.++.+||+|||++....
T Consensus 87 ~~~~~~L~~~~~~~~---~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~ 160 (277)
T 3f3z_A 87 LCTGGELFERVVHKR---VFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK 160 (277)
T ss_dssp CCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred ccCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEecccceecc
Confidence 999999998886543 589999999999999999999999 99999999999999 788999999999998765
Q ss_pred CCCCCcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccchh
Q 042435 276 VDSSNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQK 355 (412)
Q Consensus 276 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 355 (412)
... ......||+.|+|||.+.+. ++.++||||||+++|||++|+.||... ........+.......+ ...
T Consensus 161 ~~~-~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~-------~~~~~~~~~~~~~~~~~-~~~ 230 (277)
T 3f3z_A 161 PGK-MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAP-------TDSEVMLKIREGTFTFP-EKD 230 (277)
T ss_dssp TTS-CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCS-------SHHHHHHHHHHCCCCCC-HHH
T ss_pred Ccc-chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCC-------CHHHHHHHHHhCCCCCC-chh
Confidence 433 23345799999999998654 899999999999999999999998732 11111222222222221 111
Q ss_pred hHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 356 IIQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 356 ~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
.......+.+++.+||+.||++|||+.|++++
T Consensus 231 ~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h 262 (277)
T 3f3z_A 231 WLNVSPQAESLIRRLLTKSPKQRITSLQALEH 262 (277)
T ss_dssp HTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred hhcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11223358899999999999999999999864
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=306.44 Aligned_cols=235 Identities=24% Similarity=0.321 Sum_probs=183.5
Q ss_pred CcccceeeeecCceEEEEEEeC-C---CcEEEEEec----------------------cCCccccceEEEecCceE-EEE
Q 042435 144 YFHIRYCIGTGGYDSVYKAELP-D---GKVVALKKL----------------------HHSETEDSAFVVYSPQCM-FFI 196 (412)
Q Consensus 144 ~f~~~~~lG~G~~g~Vy~~~~~-~---~~~vAvK~l----------------------~~~~~~~~~~~~~~~~~~-~lv 196 (412)
.|+..++||+|+||.||+|.+. + +..||+|.+ +|+++......+...+.. ++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 4666789999999999999753 2 337999964 577777777777665554 999
Q ss_pred EEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCC
Q 042435 197 YEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDV 276 (412)
Q Consensus 197 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~ 276 (412)
|||+.+|+|.+++.... ..+++..+..++.|++.||+|||++ +++||||||+||+++.++.+||+|||+++....
T Consensus 102 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 176 (298)
T 3pls_A 102 LPYMCHGDLLQFIRSPQ--RNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDILD 176 (298)
T ss_dssp ECCCTTCBHHHHHHCTT--CCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTSSCTTTT
T ss_pred EecccCCCHHHHHhccc--cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCCcccccC
Confidence 99999999999997643 2589999999999999999999999 999999999999999999999999999986533
Q ss_pred CC----CCcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCcc
Q 042435 277 DS----SNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPI 352 (412)
Q Consensus 277 ~~----~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 352 (412)
.. .......+|+.|+|||.+.+..++.++||||||+++|||++|..|+... .........+......+.
T Consensus 177 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~-------~~~~~~~~~~~~~~~~~~ 249 (298)
T 3pls_A 177 REYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRH-------IDPFDLTHFLAQGRRLPQ 249 (298)
T ss_dssp GGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTT-------SCGGGHHHHHHTTCCCCC
T ss_pred CcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCcc-------CCHHHHHHHhhcCCCCCC
Confidence 21 1223456789999999999999999999999999999999966664311 111222333333222222
Q ss_pred chhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhcCCC
Q 042435 353 NQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELEGKTP 393 (412)
Q Consensus 353 ~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 393 (412)
+.... ..+.+++.+||+.||++|||+.|+++.|+++..
T Consensus 250 ~~~~~---~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~ 287 (298)
T 3pls_A 250 PEYCP---DSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVS 287 (298)
T ss_dssp CTTCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred Cccch---HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 22222 237889999999999999999999999988754
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=312.51 Aligned_cols=223 Identities=20% Similarity=0.312 Sum_probs=183.5
Q ss_pred HhhcCcccceeeeecCceEEEEEEe-CCCcEEEEEec-----------------------------cCCccccceEEEec
Q 042435 140 DATEYFHIRYCIGTGGYDSVYKAEL-PDGKVVALKKL-----------------------------HHSETEDSAFVVYS 189 (412)
Q Consensus 140 ~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l-----------------------------~~~~~~~~~~~~~~ 189 (412)
+..++|++.+.||+|+||.||+|.. .+++.||||.+ +|+++.....++..
T Consensus 21 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~ 100 (335)
T 3dls_A 21 EYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFEN 100 (335)
T ss_dssp HHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred ccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEee
Confidence 3457899999999999999999975 57899999965 35566666677888
Q ss_pred CceEEEEEEeccCC-ceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeec
Q 042435 190 PQCMFFIYEYMERG-SLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADF 268 (412)
Q Consensus 190 ~~~~~lv~ey~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Df 268 (412)
.+..++||||+.+| +|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+||
T Consensus 101 ~~~~~lv~e~~~~g~~l~~~~~~~~---~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Df 174 (335)
T 3dls_A 101 QGFFQLVMEKHGSGLDLFAFIDRHP---RLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDF 174 (335)
T ss_dssp SSEEEEEEECCTTSCBHHHHHHTCC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCC
T ss_pred CCEEEEEEEeCCCCccHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCcEEEeec
Confidence 89999999999877 9998887654 589999999999999999999999 9999999999999999999999999
Q ss_pred CCccccCCCCCCcccccccccccccccccCccc-CcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhc
Q 042435 269 GTVRLLDVDSSNRTLQAGTYGYIALELVYTMVV-TEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQR 347 (412)
Q Consensus 269 Gla~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 347 (412)
|+++...... ......||+.|+|||++.+..+ +.++||||||+++|||++|+.||..... .....
T Consensus 175 g~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-------------~~~~~ 240 (335)
T 3dls_A 175 GSAAYLERGK-LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE-------------TVEAA 240 (335)
T ss_dssp TTCEECCTTC-CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG-------------GTTTC
T ss_pred ccceECCCCC-ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH-------------HHhhc
Confidence 9998765433 2334579999999999988776 7899999999999999999999874211 11111
Q ss_pred cCCccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 348 LSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
...+. .. ...+.+++.+||+.||++|||+.|++++
T Consensus 241 ~~~~~--~~---~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 241 IHPPY--LV---SKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp CCCSS--CC---CHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred cCCCc--cc---CHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11111 11 1237889999999999999999999987
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-40 Score=314.36 Aligned_cols=242 Identities=24% Similarity=0.352 Sum_probs=180.4
Q ss_pred cccHHHHHHhhcCcccceeeeecCceEEEEEEe-CCCcEEEEEec---------------------cCCccccceEEEec
Q 042435 132 KILYENLIDATEYFHIRYCIGTGGYDSVYKAEL-PDGKVVALKKL---------------------HHSETEDSAFVVYS 189 (412)
Q Consensus 132 ~~~~~~l~~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l---------------------~~~~~~~~~~~~~~ 189 (412)
.+++.++....++|++.+.||+|+||.||+|.. .+|+.||||.+ +|+++......+..
T Consensus 13 ~~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 92 (326)
T 2x7f_A 13 EIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIK 92 (326)
T ss_dssp ---CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEE
T ss_pred hccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEee
Confidence 345566677889999999999999999999987 57899999975 46677666666554
Q ss_pred ------CceEEEEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcE
Q 042435 190 ------PQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEA 263 (412)
Q Consensus 190 ------~~~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~ 263 (412)
.+..++||||+++|+|.+++..... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+
T Consensus 93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~ 168 (326)
T 2x7f_A 93 KNPPGMDDQLWLVMEFCGAGSVTDLIKNTKG-NTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEV 168 (326)
T ss_dssp CC--CCCCEEEEEEECCTTEEHHHHHHHSGG-GCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCE
T ss_pred ccCccccceEEEEEEcCCCCcHHHHHHhccc-CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCCCE
Confidence 5688999999999999999876532 3589999999999999999999999 99999999999999999999
Q ss_pred EEeecCCccccCCCCCCccccccccccccccccc-----CcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcc
Q 042435 264 FVADFGTVRLLDVDSSNRTLQAGTYGYIALELVY-----TMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKI 338 (412)
Q Consensus 264 kl~DfGla~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~ 338 (412)
||+|||++..............||+.|+|||++. +..++.++||||||+++|||++|+.||.... ...
T Consensus 169 kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-------~~~ 241 (326)
T 2x7f_A 169 KLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH-------PMR 241 (326)
T ss_dssp EECCCTTTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSC-------HHH
T ss_pred EEeeCcCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCc-------HHH
Confidence 9999999987654333334557899999999987 5668899999999999999999999986321 111
Q ss_pred hhhHHhhhccCCccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 339 MLIDILYQRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 339 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
....+............. ...+.+++.+||+.||++|||+.|++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~---~~~l~~li~~~l~~dp~~Rps~~~ll~h 287 (326)
T 2x7f_A 242 ALFLIPRNPAPRLKSKKW---SKKFQSFIESCLVKNHSQRPATEQLMKH 287 (326)
T ss_dssp HHHHHHHSCCCCCSCSCS---CHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred HHHHhhcCccccCCcccc---CHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 111111111111111111 1237889999999999999999999884
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=304.87 Aligned_cols=236 Identities=21% Similarity=0.260 Sum_probs=182.5
Q ss_pred hhcCcccceeeeecCceEEEEEEeCC----CcEEEEEec----------------------cCCccccceEEEecCceEE
Q 042435 141 ATEYFHIRYCIGTGGYDSVYKAELPD----GKVVALKKL----------------------HHSETEDSAFVVYSPQCMF 194 (412)
Q Consensus 141 ~~~~f~~~~~lG~G~~g~Vy~~~~~~----~~~vAvK~l----------------------~~~~~~~~~~~~~~~~~~~ 194 (412)
..++|.+.+.||+|+||.||+|.+.+ +..||+|.+ +|+++.....++. .+..+
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~ 88 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIE-EEPTW 88 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEEC-SSSCE
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCCE
Confidence 35679999999999999999997642 346999975 4566666666554 45678
Q ss_pred EEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCcccc
Q 042435 195 FIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLL 274 (412)
Q Consensus 195 lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~ 274 (412)
+||||+++++|.+++.... ..+++..+..++.|++.||+|||++ +++||||||+||+++.++.+||+|||+++..
T Consensus 89 ~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 163 (281)
T 3cc6_A 89 IIMELYPYGELGHYLERNK--NSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLSRYI 163 (281)
T ss_dssp EEEECCTTCBHHHHHHHHT--TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCCCGGGCC
T ss_pred EEEecCCCCCHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCccCCCccc
Confidence 9999999999999986543 2489999999999999999999999 9999999999999999999999999999866
Q ss_pred CCCCC-CcccccccccccccccccCcccCcccccHHHHHHHHHHHh-CCCCcccccccccCCCCcchhhHHhhhccCCcc
Q 042435 275 DVDSS-NRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLM-GTHPGELLLSLSSSSGPKIMLIDILYQRLSPPI 352 (412)
Q Consensus 275 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 352 (412)
..... ......+|+.|+|||.+.+..++.++||||||+++|||+| |+.||... ........+......+.
T Consensus 164 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~--------~~~~~~~~~~~~~~~~~ 235 (281)
T 3cc6_A 164 EDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWL--------ENKDVIGVLEKGDRLPK 235 (281)
T ss_dssp ---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS--------CGGGHHHHHHHTCCCCC
T ss_pred ccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccC--------ChHHHHHHHhcCCCCCC
Confidence 44322 2233457889999999988889999999999999999998 99998622 11112222222222222
Q ss_pred chhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhcCCC
Q 042435 353 NQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELEGKTP 393 (412)
Q Consensus 353 ~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 393 (412)
+... ...+.+++.+||+.||++|||+.|++++|+++..
T Consensus 236 ~~~~---~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 273 (281)
T 3cc6_A 236 PDLC---PPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQ 273 (281)
T ss_dssp CTTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCC---CHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHH
Confidence 2222 2237889999999999999999999999987643
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=319.10 Aligned_cols=182 Identities=19% Similarity=0.266 Sum_probs=157.6
Q ss_pred hhcCcccceeeeec--CceEEEEEEeC-CCcEEEEEec-----------------------cCCccccceEEEecCceEE
Q 042435 141 ATEYFHIRYCIGTG--GYDSVYKAELP-DGKVVALKKL-----------------------HHSETEDSAFVVYSPQCMF 194 (412)
Q Consensus 141 ~~~~f~~~~~lG~G--~~g~Vy~~~~~-~~~~vAvK~l-----------------------~~~~~~~~~~~~~~~~~~~ 194 (412)
..++|++.+.||+| +||.||+|... +|+.||||++ +|+++.....++...+..+
T Consensus 23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 102 (389)
T 3gni_B 23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELW 102 (389)
T ss_dssp CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEE
Confidence 34679999999999 99999999875 7999999964 5788888888889999999
Q ss_pred EEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCcccc
Q 042435 195 FIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLL 274 (412)
Q Consensus 195 lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~ 274 (412)
+||||+++|+|.+++..... ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||.+...
T Consensus 103 lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~ 178 (389)
T 3gni_B 103 VVTSFMAYGSAKDLICTHFM-DGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSM 178 (389)
T ss_dssp EEEECCTTCBHHHHHHHTCT-TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEEEccCCCCHHHHHhhhcc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccccceee
Confidence 99999999999999876422 2489999999999999999999999 9999999999999999999999999988644
Q ss_pred CCCC-------CCcccccccccccccccccC--cccCcccccHHHHHHHHHHHhCCCCccc
Q 042435 275 DVDS-------SNRTLQAGTYGYIALELVYT--MVVTEKCVIYSFGVVALEVLMGTHPGEL 326 (412)
Q Consensus 275 ~~~~-------~~~~~~~gt~~y~aPE~~~~--~~~s~ksDv~S~Gvil~elltg~~P~~~ 326 (412)
.... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 179 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 239 (389)
T 3gni_B 179 ISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD 239 (389)
T ss_dssp EETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred ccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCC
Confidence 2211 11233478999999999987 5799999999999999999999999963
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=330.70 Aligned_cols=233 Identities=19% Similarity=0.264 Sum_probs=187.7
Q ss_pred hcCcccceeeeecCceEEEEEEeC-CCcEEEEEec------------------------cCCccccceEEEecCceEEEE
Q 042435 142 TEYFHIRYCIGTGGYDSVYKAELP-DGKVVALKKL------------------------HHSETEDSAFVVYSPQCMFFI 196 (412)
Q Consensus 142 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l------------------------~~~~~~~~~~~~~~~~~~~lv 196 (412)
.++|++.+.||+|+||.||+|... +|+.||+|.+ +|+++......+.+.+..++|
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 262 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 262 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence 467999999999999999999874 7999999964 577888888888899999999
Q ss_pred EEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCC
Q 042435 197 YEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDV 276 (412)
Q Consensus 197 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~ 276 (412)
|||+++|+|.+++..... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 263 mEy~~gg~L~~~l~~~~~-~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~ 338 (576)
T 2acx_A 263 LTLMNGGDLKFHIYHMGQ-AGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPE 338 (576)
T ss_dssp ECCCCSCBHHHHHHSSSS-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEcCCCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEecccceeccc
Confidence 999999999998876532 2489999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCCcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccchhh
Q 042435 277 DSSNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKI 356 (412)
Q Consensus 277 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 356 (412)
.. ......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+...+... ....+...
T Consensus 339 ~~-~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~----~~~~~~i~~~i~~~-~~~~p~~~ 412 (576)
T 2acx_A 339 GQ-TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKK----KIKREEVERLVKEV-PEEYSERF 412 (576)
T ss_dssp TC-CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSS----CCCHHHHHHHHHHC-CCCCCTTS
T ss_pred Cc-cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCccccc----chhHHHHHHHhhcc-cccCCccC
Confidence 32 23345899999999999998999999999999999999999999973210 00111122222111 11111111
Q ss_pred HHHHHHHHHHHHhcCcCCCCCCC-----CHHHHHHH
Q 042435 357 IQDIILVSTIALACLRSKPKSRP-----TMQRISQE 387 (412)
Q Consensus 357 ~~~~~~~~~l~~~Cl~~dP~~RP-----s~~evl~~ 387 (412)
...+.+++.+||+.||++|| +++|++++
T Consensus 413 ---s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H 445 (576)
T 2acx_A 413 ---SPQARSLCSQLLCKDPAERLGCRGGSAREVKEH 445 (576)
T ss_dssp ---CHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred ---CHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence 22478899999999999999 78998865
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-40 Score=307.55 Aligned_cols=231 Identities=18% Similarity=0.270 Sum_probs=182.4
Q ss_pred hcCcccceeeeecCceEEEEEEeCC-C-------cEEEEEec---------------------cCCccccceEEEecCce
Q 042435 142 TEYFHIRYCIGTGGYDSVYKAELPD-G-------KVVALKKL---------------------HHSETEDSAFVVYSPQC 192 (412)
Q Consensus 142 ~~~f~~~~~lG~G~~g~Vy~~~~~~-~-------~~vAvK~l---------------------~~~~~~~~~~~~~~~~~ 192 (412)
.++|.+.+.||+|+||.||+|.... + ..||+|.+ +|+++......+..++.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence 3578999999999999999997643 3 57999964 57788888888888899
Q ss_pred EEEEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCc--------EE
Q 042435 193 MFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLE--------AF 264 (412)
Q Consensus 193 ~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~--------~k 264 (412)
.++||||+++|+|.+++..... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++. +|
T Consensus 87 ~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~k 161 (289)
T 4fvq_A 87 NILVQEFVKFGSLDTYLKKNKN--CINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPPFIK 161 (289)
T ss_dssp CEEEEECCTTCBHHHHHHHTGG--GCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred CEEEEECCCCCCHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCcccccccceee
Confidence 9999999999999999976542 489999999999999999999999 9999999999999988877 99
Q ss_pred EeecCCccccCCCCCCcccccccccccccccccC-cccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHH
Q 042435 265 VADFGTVRLLDVDSSNRTLQAGTYGYIALELVYT-MVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDI 343 (412)
Q Consensus 265 l~DfGla~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~ 343 (412)
|+|||+++.... .....||+.|+|||++.+ ..++.++||||||+++|||++|..|+... .........
T Consensus 162 l~Dfg~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~-------~~~~~~~~~ 230 (289)
T 4fvq_A 162 LSDPGISITVLP----KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSA-------LDSQRKLQF 230 (289)
T ss_dssp ECCCCSCTTTSC----HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTT-------SCHHHHHHH
T ss_pred eccCcccccccC----ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccc-------cchHHHHHH
Confidence 999999875422 233468899999999987 67899999999999999999965553311 111111122
Q ss_pred hhhccCCccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhcCCC
Q 042435 344 LYQRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELEGKTP 393 (412)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 393 (412)
.......+ ... ...+.+++.+||+.||++|||+.|++++|+++..
T Consensus 231 ~~~~~~~~--~~~---~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~ 275 (289)
T 4fvq_A 231 YEDRHQLP--APK---AAELANLINNCMDYEPDHRPSFRAIIRDLNSLFT 275 (289)
T ss_dssp HHTTCCCC--CCS---SCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred hhccCCCC--CCC---CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 22111111 111 1127789999999999999999999999999875
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=336.97 Aligned_cols=239 Identities=24% Similarity=0.370 Sum_probs=190.4
Q ss_pred hhcCcccceeeeecCceEEEEEEeCCCcEEEEEec--------------------cCCccccceEEEecCceEEEEEEec
Q 042435 141 ATEYFHIRYCIGTGGYDSVYKAELPDGKVVALKKL--------------------HHSETEDSAFVVYSPQCMFFIYEYM 200 (412)
Q Consensus 141 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~l--------------------~~~~~~~~~~~~~~~~~~~lv~ey~ 200 (412)
..++|++.+.||+|+||.||+|.+.++..||||.+ +|+++.....++.. +..++||||+
T Consensus 265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~ 343 (535)
T 2h8h_A 265 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 343 (535)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred chhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehh
Confidence 45678899999999999999999988889999975 46677776666654 6789999999
Q ss_pred cCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCC-C
Q 042435 201 ERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDS-S 279 (412)
Q Consensus 201 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~-~ 279 (412)
++|+|.++++.... ..+++.+++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++...... .
T Consensus 344 ~~gsL~~~l~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 419 (535)
T 2h8h_A 344 SKGSLLDFLKGETG-KYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 419 (535)
T ss_dssp TTEEHHHHHSHHHH-TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHH
T ss_pred cCCcHHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEcccccceecCCCcee
Confidence 99999999975322 2489999999999999999999999 99999999999999999999999999998654321 1
Q ss_pred CcccccccccccccccccCcccCcccccHHHHHHHHHHHh-CCCCcccccccccCCCCcchhhHHhhhccCCccchhhHH
Q 042435 280 NRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLM-GTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKIIQ 358 (412)
Q Consensus 280 ~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 358 (412)
......++..|+|||++.+..++.++|||||||++|||+| |+.||.... .....+.+......+.+...
T Consensus 420 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~--------~~~~~~~i~~~~~~~~~~~~-- 489 (535)
T 2h8h_A 420 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV--------NREVLDQVERGYRMPCPPEC-- 489 (535)
T ss_dssp TTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCC--------HHHHHHHHHTTCCCCCCTTC--
T ss_pred cccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC--------HHHHHHHHHcCCCCCCCCCC--
Confidence 1123356789999999998899999999999999999999 999986321 11122222222222222222
Q ss_pred HHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhcCCCCC
Q 042435 359 DIILVSTIALACLRSKPKSRPTMQRISQELEGKTPMK 395 (412)
Q Consensus 359 ~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~~ 395 (412)
...+.+++.+||+.||++|||+++|++.|+.+....
T Consensus 490 -~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~ 525 (535)
T 2h8h_A 490 -PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 525 (535)
T ss_dssp -CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCC
T ss_pred -CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhcc
Confidence 224788999999999999999999999999986543
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-40 Score=322.70 Aligned_cols=245 Identities=19% Similarity=0.250 Sum_probs=189.1
Q ss_pred hcCcccceeeeecCceEEEEEEeC-CCcEEEEEec----------------------cCCccccceEEEecCc--eEEEE
Q 042435 142 TEYFHIRYCIGTGGYDSVYKAELP-DGKVVALKKL----------------------HHSETEDSAFVVYSPQ--CMFFI 196 (412)
Q Consensus 142 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l----------------------~~~~~~~~~~~~~~~~--~~~lv 196 (412)
.++|.+.++||+|+||.||+|... +|+.||||.+ +|+++.....++...+ ..++|
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 87 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence 357999999999999999999875 5999999975 4666776666666544 78999
Q ss_pred EEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEe----cCCCcEEEeecCCcc
Q 042435 197 YEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILL----NSNLEAFVADFGTVR 272 (412)
Q Consensus 197 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl----~~~~~~kl~DfGla~ 272 (412)
|||+++|+|.+++........+++..+..++.|++.||+|||+. +|+||||||+|||+ +.++.+||+|||+++
T Consensus 88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~ 164 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (396)
T ss_dssp ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence 99999999999998765444599999999999999999999999 99999999999999 778889999999998
Q ss_pred ccCCCCCCcccccccccccccccccC--------cccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHh
Q 042435 273 LLDVDSSNRTLQAGTYGYIALELVYT--------MVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDIL 344 (412)
Q Consensus 273 ~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 344 (412)
...... ......||+.|+|||++.+ ..++.++|||||||++|||+||+.||...... ......+..+.
T Consensus 165 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~---~~~~~~~~~~~ 240 (396)
T 4eut_A 165 ELEDDE-QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGP---RRNKEVMYKII 240 (396)
T ss_dssp ECCCGG-GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCT---TTCHHHHHHHH
T ss_pred EccCCC-ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcc---cchHHHHHHHh
Confidence 764332 2234569999999999864 56788999999999999999999999632110 01111111111
Q ss_pred hhccC--------------------CccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhcCCC
Q 042435 345 YQRLS--------------------PPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELEGKTP 393 (412)
Q Consensus 345 ~~~~~--------------------~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 393 (412)
..... +............+.+++.+||+.||++||++.|+++.++++..
T Consensus 241 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~ 309 (396)
T 4eut_A 241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH 309 (396)
T ss_dssp HSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHT
T ss_pred cCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhh
Confidence 11100 00011112334458899999999999999999999999987654
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=309.60 Aligned_cols=238 Identities=24% Similarity=0.317 Sum_probs=184.8
Q ss_pred hcCcccceeeeecCceEEEEEEeC-CCcEEEEEec-----------------------cCCccccceEEE--ecCceEEE
Q 042435 142 TEYFHIRYCIGTGGYDSVYKAELP-DGKVVALKKL-----------------------HHSETEDSAFVV--YSPQCMFF 195 (412)
Q Consensus 142 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l-----------------------~~~~~~~~~~~~--~~~~~~~l 195 (412)
.++|++.+.||+|+||.||+|... +++.||+|.+ +|+++......+ ......++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 468999999999999999999874 6899999965 466666666654 34678999
Q ss_pred EEEeccCCceeeeeccCcc-cccCCHHHHHHHHHHHHHHHHHHHhCCCCC-----cEEeCCCCCCEEecCCCcEEEeecC
Q 042435 196 IYEYMERGSLFCVLRDDDE-AIELNWTRRMNIVKSVAHALSYLHHDCTPS-----IVHRDISSNNILLNSNLEAFVADFG 269 (412)
Q Consensus 196 v~ey~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~-----ivHrDlkp~NILl~~~~~~kl~DfG 269 (412)
||||+++|+|.+++..... ...+++..+..++.|++.||+|||+. + ++||||||+||+++.++.+||+|||
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg 161 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQNVKLGDFG 161 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence 9999999999999875432 23489999999999999999999998 6 9999999999999999999999999
Q ss_pred CccccCCCCCCcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccC
Q 042435 270 TVRLLDVDSSNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLS 349 (412)
Q Consensus 270 la~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 349 (412)
+++.............||+.|+|||.+.+..++.++||||||+++|||++|+.||.... .......+.....
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--------~~~~~~~i~~~~~ 233 (279)
T 2w5a_A 162 LARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS--------QKELAGKIREGKF 233 (279)
T ss_dssp HHHHC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHTCC
T ss_pred hheeeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccC--------HHHHHHHHhhccc
Confidence 99876543322334578999999999998899999999999999999999999987321 1112222222211
Q ss_pred CccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhcCCC
Q 042435 350 PPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELEGKTP 393 (412)
Q Consensus 350 ~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 393 (412)
...+... ...+.+++.+||+.||++|||+.|+++++....+
T Consensus 234 ~~~~~~~---~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~ 274 (279)
T 2w5a_A 234 RRIPYRY---SDELNEIITRMLNLKDYHRPSVEEILENPLILEH 274 (279)
T ss_dssp CCCCTTS---CHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGG
T ss_pred ccCCccc---CHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhh
Confidence 1221221 2237889999999999999999999988765443
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=328.42 Aligned_cols=241 Identities=16% Similarity=0.222 Sum_probs=185.5
Q ss_pred hcCcccceeeeecCceEEEEEEe-CCCcEEEEEeccC--------------------CccccceEEEecCceEEEEEEec
Q 042435 142 TEYFHIRYCIGTGGYDSVYKAEL-PDGKVVALKKLHH--------------------SETEDSAFVVYSPQCMFFIYEYM 200 (412)
Q Consensus 142 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l~~--------------------~~~~~~~~~~~~~~~~~lv~ey~ 200 (412)
.++|++.++||+|+||.||+|.. .+++.||||.++. ..+..........+..++||||+
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~ 85 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL 85 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC
Confidence 46899999999999999999986 5799999996532 22233344456778889999999
Q ss_pred cCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEe---cCCCcEEEeecCCccccCCC
Q 042435 201 ERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILL---NSNLEAFVADFGTVRLLDVD 277 (412)
Q Consensus 201 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl---~~~~~~kl~DfGla~~~~~~ 277 (412)
+++|.+++.... ..+++..++.|+.||+.||+|||++ +|+||||||+|||+ +.++.+||+|||+++.....
T Consensus 86 -g~sL~~ll~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 159 (483)
T 3sv0_A 86 -GPSLEDLFNFCS--RKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159 (483)
T ss_dssp -CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred -CCCHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeCCcceeccCC
Confidence 999999987433 2599999999999999999999999 99999999999999 68899999999999876543
Q ss_pred CCC-------cccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCC
Q 042435 278 SSN-------RTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSP 350 (412)
Q Consensus 278 ~~~-------~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 350 (412)
... .....||+.|+|||++.+..++.++|||||||++|||++|+.||..... .........+.......
T Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~----~~~~~~~~~i~~~~~~~ 235 (483)
T 3sv0_A 160 STHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA----GTKKQKYEKISEKKVAT 235 (483)
T ss_dssp TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCC----SSHHHHHHHHHHHHHHS
T ss_pred ccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccc----hhHHHHHHHHhhccccc
Confidence 221 1255799999999999999999999999999999999999999974211 00011111222221111
Q ss_pred ccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhcCC
Q 042435 351 PINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELEGKT 392 (412)
Q Consensus 351 ~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 392 (412)
............+.+++..||+.||++||++.+|++.|+++.
T Consensus 236 ~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~ 277 (483)
T 3sv0_A 236 SIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLF 277 (483)
T ss_dssp CHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHH
T ss_pred cHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHH
Confidence 111111111234889999999999999999999999998763
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-40 Score=311.85 Aligned_cols=244 Identities=19% Similarity=0.227 Sum_probs=179.9
Q ss_pred hhcCcccceeeeecCceEEEEEEe-CCCcEEEEEec------------------------cCCccccceEEEecCceEEE
Q 042435 141 ATEYFHIRYCIGTGGYDSVYKAEL-PDGKVVALKKL------------------------HHSETEDSAFVVYSPQCMFF 195 (412)
Q Consensus 141 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l------------------------~~~~~~~~~~~~~~~~~~~l 195 (412)
..++|++.+.||+|+||.||+|.. .+|+.||+|++ +|+++......+...+..++
T Consensus 30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 109 (310)
T 2wqm_A 30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNI 109 (310)
T ss_dssp SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEE
Confidence 346799999999999999999976 57999999965 35667777777888899999
Q ss_pred EEEeccCCceeeeeccCc-ccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCcccc
Q 042435 196 IYEYMERGSLFCVLRDDD-EAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLL 274 (412)
Q Consensus 196 v~ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~ 274 (412)
||||+++|+|.+++.... ....+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++..
T Consensus 110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~ 186 (310)
T 2wqm_A 110 VLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFF 186 (310)
T ss_dssp EEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC------
T ss_pred EEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEeccceeee
Confidence 999999999999886432 123589999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCCcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhh-ccCCccc
Q 042435 275 DVDSSNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQ-RLSPPIN 353 (412)
Q Consensus 275 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 353 (412)
...........|++.|+|||.+.+..++.++||||||+++|||++|+.||.... .........+.. .......
T Consensus 187 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~------~~~~~~~~~~~~~~~~~~~~ 260 (310)
T 2wqm_A 187 SSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK------MNLYSLCKKIEQCDYPPLPS 260 (310)
T ss_dssp ------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---------CCHHHHHHHHHTTCSCCCCT
T ss_pred cCCCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccc------hhHHHHHHHhhcccCCCCcc
Confidence 544333344578999999999999999999999999999999999999986321 111111111111 1111111
Q ss_pred hhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhcCCCCCC
Q 042435 354 QKIIQDIILVSTIALACLRSKPKSRPTMQRISQELEGKTPMKK 396 (412)
Q Consensus 354 ~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~~~ 396 (412)
.. ....+.+++.+||+.||++|||+.++++.|+++.+..+
T Consensus 261 ~~---~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~ 300 (310)
T 2wqm_A 261 DH---YSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTA 300 (310)
T ss_dssp TT---SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred cc---cCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhh
Confidence 11 12237889999999999999999999999998875433
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=331.23 Aligned_cols=233 Identities=21% Similarity=0.307 Sum_probs=186.6
Q ss_pred cCcccceeeeecCceEEEEEEeC-CCcEEEEEec------------------------cCCccccceEEEecCceEEEEE
Q 042435 143 EYFHIRYCIGTGGYDSVYKAELP-DGKVVALKKL------------------------HHSETEDSAFVVYSPQCMFFIY 197 (412)
Q Consensus 143 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l------------------------~~~~~~~~~~~~~~~~~~~lv~ 197 (412)
++|.+.+.||+|+||.||+|+.. +|+.||+|++ +|+++......+.+.+..|+||
T Consensus 185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm 264 (543)
T 3c4z_A 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM 264 (543)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence 67999999999999999999874 6999999965 4677777777888899999999
Q ss_pred EeccCCceeeeeccCcc-cccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCC
Q 042435 198 EYMERGSLFCVLRDDDE-AIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDV 276 (412)
Q Consensus 198 ey~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~ 276 (412)
||+++|+|.+++..... ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 265 E~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~ 341 (543)
T 3c4z_A 265 TIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKA 341 (543)
T ss_dssp CCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeecceeeeccC
Confidence 99999999998875432 23589999999999999999999999 999999999999999999999999999987655
Q ss_pred CCCCcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccchhh
Q 042435 277 DSSNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKI 356 (412)
Q Consensus 277 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 356 (412)
.........||+.|+|||++.+..++.++|||||||++|||+||+.||..... ..........+.......+ ...
T Consensus 342 ~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~---~~~~~~~~~~i~~~~~~~p--~~~ 416 (543)
T 3c4z_A 342 GQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGE---KVENKELKQRVLEQAVTYP--DKF 416 (543)
T ss_dssp TCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTC---CCCHHHHHHHHHHCCCCCC--TTS
T ss_pred CCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCcc---chhHHHHHHHHhhcccCCC--ccc
Confidence 44444456899999999999999999999999999999999999999973210 0000111122222222211 111
Q ss_pred HHHHHHHHHHHHhcCcCCCCCCCCH-----HHHHH
Q 042435 357 IQDIILVSTIALACLRSKPKSRPTM-----QRISQ 386 (412)
Q Consensus 357 ~~~~~~~~~l~~~Cl~~dP~~RPs~-----~evl~ 386 (412)
...+.+++.+||+.||++||++ +|+.+
T Consensus 417 ---s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~ 448 (543)
T 3c4z_A 417 ---SPASKDFCEALLQKDPEKRLGFRDGSCDGLRT 448 (543)
T ss_dssp ---CHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred ---CHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence 2237889999999999999975 66765
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=311.82 Aligned_cols=239 Identities=26% Similarity=0.369 Sum_probs=187.1
Q ss_pred cCcccceeeeecCceEEEEEEeC-CCcE--EEEEec-----------------------cCCccccceEEEecCceEEEE
Q 042435 143 EYFHIRYCIGTGGYDSVYKAELP-DGKV--VALKKL-----------------------HHSETEDSAFVVYSPQCMFFI 196 (412)
Q Consensus 143 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~--vAvK~l-----------------------~~~~~~~~~~~~~~~~~~~lv 196 (412)
++|++.+.||+|+||.||+|... ++.. +|+|.+ +|+++......+...+..++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 67899999999999999999764 5654 488854 567777778888889999999
Q ss_pred EEeccCCceeeeeccCc-------------ccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcE
Q 042435 197 YEYMERGSLFCVLRDDD-------------EAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEA 263 (412)
Q Consensus 197 ~ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~ 263 (412)
|||+++|+|.+++.... ....+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEcCCCeE
Confidence 99999999999987653 123589999999999999999999999 99999999999999999999
Q ss_pred EEeecCCccccCCCCCCcccccccccccccccccCcccCcccccHHHHHHHHHHHh-CCCCcccccccccCCCCcchhhH
Q 042435 264 FVADFGTVRLLDVDSSNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLM-GTHPGELLLSLSSSSGPKIMLID 342 (412)
Q Consensus 264 kl~DfGla~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~ 342 (412)
||+|||+++...... ......+++.|+|||++.+..++.++||||||+++|||+| |+.||.... .....+
T Consensus 182 kL~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~--------~~~~~~ 252 (327)
T 1fvr_A 182 KIADFGLSRGQEVYV-KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT--------CAELYE 252 (327)
T ss_dssp EECCTTCEESSCEEC-CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC--------HHHHHH
T ss_pred EEcccCcCccccccc-cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCc--------HHHHHH
Confidence 999999987433221 1233457889999999988889999999999999999998 999986321 111222
Q ss_pred HhhhccCCccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhcCCCCCC
Q 042435 343 ILYQRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELEGKTPMKK 396 (412)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~~~ 396 (412)
.+........+... ...+.+++.+||+.||++|||+.|++++|+++....+
T Consensus 253 ~~~~~~~~~~~~~~---~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 303 (327)
T 1fvr_A 253 KLPQGYRLEKPLNC---DDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 303 (327)
T ss_dssp HGGGTCCCCCCTTB---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred HhhcCCCCCCCCCC---CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhc
Confidence 22222222111121 2247889999999999999999999999987755443
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=307.05 Aligned_cols=233 Identities=20% Similarity=0.267 Sum_probs=183.9
Q ss_pred hcCcccce-eeeecCceEEEEEEe---CCCcEEEEEec-----------------------cCCccccceEEEecCceEE
Q 042435 142 TEYFHIRY-CIGTGGYDSVYKAEL---PDGKVVALKKL-----------------------HHSETEDSAFVVYSPQCMF 194 (412)
Q Consensus 142 ~~~f~~~~-~lG~G~~g~Vy~~~~---~~~~~vAvK~l-----------------------~~~~~~~~~~~~~~~~~~~ 194 (412)
.++|.+.+ .||+|+||.||+|.+ .+++.||||.+ +|+++.....++ ..+..+
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~ 93 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM 93 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence 46788887 999999999999954 34788999965 456666666666 567789
Q ss_pred EEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCcccc
Q 042435 195 FIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLL 274 (412)
Q Consensus 195 lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~ 274 (412)
+||||+++++|.+++.... .+++..+..++.|++.||+|||++ +++||||||+||+++.++.+||+|||+++..
T Consensus 94 lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 167 (291)
T 1xbb_A 94 LVMEMAELGPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKAL 167 (291)
T ss_dssp EEEECCTTEEHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEEeCCCCCHHHHHHhCc---CCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEccCCcceee
Confidence 9999999999999987643 589999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCC---cccccccccccccccccCcccCcccccHHHHHHHHHHHh-CCCCcccccccccCCCCcchhhHHhhhccCC
Q 042435 275 DVDSSN---RTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLM-GTHPGELLLSLSSSSGPKIMLIDILYQRLSP 350 (412)
Q Consensus 275 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 350 (412)
...... .....+++.|+|||.+.+..++.++||||||+++|||+| |+.||.... .......+......
T Consensus 168 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~--------~~~~~~~~~~~~~~ 239 (291)
T 1xbb_A 168 RADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK--------GSEVTAMLEKGERM 239 (291)
T ss_dssp CTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCC--------HHHHHHHHHTTCCC
T ss_pred ccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCC--------HHHHHHHHHcCCCC
Confidence 543322 122346788999999988889999999999999999999 999987321 11122222222222
Q ss_pred ccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhcCC
Q 042435 351 PINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELEGKT 392 (412)
Q Consensus 351 ~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 392 (412)
..+... ...+.+++.+||+.||++|||+.|+++.|+++-
T Consensus 240 ~~~~~~---~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 278 (291)
T 1xbb_A 240 GCPAGC---PREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 278 (291)
T ss_dssp CCCTTC---CHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred CCCCCC---CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 222222 224888999999999999999999999998763
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=304.35 Aligned_cols=226 Identities=22% Similarity=0.285 Sum_probs=181.2
Q ss_pred hhcCcccceeeeecCceEEEEEEeC-CCcEEEEEec------------------------cCCccccceEEEecCceEEE
Q 042435 141 ATEYFHIRYCIGTGGYDSVYKAELP-DGKVVALKKL------------------------HHSETEDSAFVVYSPQCMFF 195 (412)
Q Consensus 141 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l------------------------~~~~~~~~~~~~~~~~~~~l 195 (412)
.+++|++.+.||+|+||.||+|... +++.||+|.+ +|+++......+...+..++
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l 88 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI 88 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 3577999999999999999999875 7999999964 57888888888888999999
Q ss_pred EEEeccCCceeeeeccCcc-cccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecC---------------
Q 042435 196 IYEYMERGSLFCVLRDDDE-AIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNS--------------- 259 (412)
Q Consensus 196 v~ey~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~--------------- 259 (412)
||||+++|+|.+++..... ...+++..+..++.|++.||+|||++ +|+||||||+||+++.
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~ 165 (289)
T 1x8b_A 89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDD 165 (289)
T ss_dssp EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC----------------
T ss_pred EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCccccccccccc
Confidence 9999999999999976432 13589999999999999999999999 9999999999999984
Q ss_pred ----CCcEEEeecCCccccCCCCCCcccccccccccccccccCc-ccCcccccHHHHHHHHHHHhCCCCcccccccccCC
Q 042435 260 ----NLEAFVADFGTVRLLDVDSSNRTLQAGTYGYIALELVYTM-VVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSS 334 (412)
Q Consensus 260 ----~~~~kl~DfGla~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~ 334 (412)
...+||+|||.+....... ...||+.|+|||.+.+. .++.++||||||+++|||++|..|+...
T Consensus 166 ~~~~~~~~kl~Dfg~~~~~~~~~----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~------- 234 (289)
T 1x8b_A 166 WASNKVMFKIGDLGHVTRISSPQ----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG------- 234 (289)
T ss_dssp ----CCCEEECCCTTCEETTCSC----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSS-------
T ss_pred ccCCceEEEEcccccccccCCcc----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcch-------
Confidence 4479999999998654332 23589999999999765 5678999999999999999998775421
Q ss_pred CCcchhhHHhhhccCCccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 335 GPKIMLIDILYQRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
.....+..... +..+.... ..+.+++.+||+.||++|||+.|++++
T Consensus 235 ---~~~~~~~~~~~-~~~~~~~~---~~~~~li~~~l~~dp~~Rps~~~ll~h 280 (289)
T 1x8b_A 235 ---DQWHEIRQGRL-PRIPQVLS---QEFTELLKVMIHPDPERRPSAMALVKH 280 (289)
T ss_dssp ---HHHHHHHTTCC-CCCSSCCC---HHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred ---hHHHHHHcCCC-CCCCcccC---HHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence 11122222221 11111111 237889999999999999999999875
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-40 Score=316.16 Aligned_cols=227 Identities=22% Similarity=0.306 Sum_probs=180.8
Q ss_pred hcCcccceeeeecCceEEEEEEe-CCCcEEEEEec------------------------cCCccccceEEEecCceEEEE
Q 042435 142 TEYFHIRYCIGTGGYDSVYKAEL-PDGKVVALKKL------------------------HHSETEDSAFVVYSPQCMFFI 196 (412)
Q Consensus 142 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l------------------------~~~~~~~~~~~~~~~~~~~lv 196 (412)
.+.|+..+.||+|+||.||+|.. .+|+.||||++ +|+++......+...+..++|
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 132 (348)
T 1u5q_A 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 132 (348)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence 45688999999999999999976 57999999964 467777778888889999999
Q ss_pred EEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCC
Q 042435 197 YEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDV 276 (412)
Q Consensus 197 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~ 276 (412)
|||++ |+|.+++.... ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 133 ~e~~~-g~l~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~ 206 (348)
T 1u5q_A 133 MEYCL-GSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 206 (348)
T ss_dssp EECCS-EEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred EecCC-CCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeeccCceecCC
Confidence 99997 68877775432 2589999999999999999999999 999999999999999999999999999986543
Q ss_pred CCCCccccccccccccccccc---CcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccc
Q 042435 277 DSSNRTLQAGTYGYIALELVY---TMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPIN 353 (412)
Q Consensus 277 ~~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 353 (412)
. ....||+.|+|||++. ...++.++|||||||++|||++|+.||.... .......+..........
T Consensus 207 ~----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~-------~~~~~~~~~~~~~~~~~~ 275 (348)
T 1u5q_A 207 A----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN-------AMSALYHIAQNESPALQS 275 (348)
T ss_dssp B----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC-------HHHHHHHHHHSCCCCCCC
T ss_pred C----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC-------hHHHHHHHHhcCCCCCCC
Confidence 2 2357899999999984 5678999999999999999999999986321 111112222221111111
Q ss_pred hhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHH
Q 042435 354 QKIIQDIILVSTIALACLRSKPKSRPTMQRISQEL 388 (412)
Q Consensus 354 ~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L 388 (412)
... ...+.+++.+||+.||++|||++|++++.
T Consensus 276 ~~~---~~~l~~li~~~l~~dP~~Rps~~~ll~h~ 307 (348)
T 1u5q_A 276 GHW---SEYFRNFVDSCLQKIPQDRPTSEVLLKHR 307 (348)
T ss_dssp TTS---CHHHHHHHHHHTCSSGGGSCCHHHHTTCH
T ss_pred CCC---CHHHHHHHHHHcccChhhCcCHHHHhhCh
Confidence 111 22377899999999999999999998764
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=310.38 Aligned_cols=243 Identities=21% Similarity=0.323 Sum_probs=180.8
Q ss_pred HHHHHhhcCcccceeeeecCceEEEEEEeC----CCcEEEEEec-----------------------cCCccccceEEEe
Q 042435 136 ENLIDATEYFHIRYCIGTGGYDSVYKAELP----DGKVVALKKL-----------------------HHSETEDSAFVVY 188 (412)
Q Consensus 136 ~~l~~~~~~f~~~~~lG~G~~g~Vy~~~~~----~~~~vAvK~l-----------------------~~~~~~~~~~~~~ 188 (412)
.++....++|.+.+.||+|+||.||+|... +++.||+|.+ +|+++.....++.
T Consensus 27 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 106 (313)
T 3brb_A 27 EDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCI 106 (313)
T ss_dssp TTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEE
T ss_pred HhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEe
Confidence 444455678999999999999999999763 3458999965 4666666666665
Q ss_pred cCc-----eEEEEEEeccCCceeeeeccCc---ccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCC
Q 042435 189 SPQ-----CMFFIYEYMERGSLFCVLRDDD---EAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSN 260 (412)
Q Consensus 189 ~~~-----~~~lv~ey~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~ 260 (412)
..+ ..++||||+++|+|.+++.... ....+++..++.++.|++.||.|||++ +|+||||||+||+++.+
T Consensus 107 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~ 183 (313)
T 3brb_A 107 EMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDD 183 (313)
T ss_dssp C-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECTT
T ss_pred eccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCC
Confidence 544 4599999999999999884321 223589999999999999999999998 99999999999999999
Q ss_pred CcEEEeecCCccccCCCCC--CcccccccccccccccccCcccCcccccHHHHHHHHHHHh-CCCCcccccccccCCCCc
Q 042435 261 LEAFVADFGTVRLLDVDSS--NRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLM-GTHPGELLLSLSSSSGPK 337 (412)
Q Consensus 261 ~~~kl~DfGla~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~ellt-g~~P~~~~~~~~~~~~~~ 337 (412)
+.+||+|||+++....... ......+++.|+|||.+.+..++.++||||||+++|||++ |..||... . .
T Consensus 184 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~-------~-~ 255 (313)
T 3brb_A 184 MTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGV-------Q-N 255 (313)
T ss_dssp SCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTC-------C-G
T ss_pred CcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccC-------C-H
Confidence 9999999999986643321 1233457889999999999999999999999999999999 88888632 1 1
Q ss_pred chhhHHhhhccCCccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhcCC
Q 042435 338 IMLIDILYQRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELEGKT 392 (412)
Q Consensus 338 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 392 (412)
....+.+........+... ...+.+++.+||+.||++|||+.+++++|+++.
T Consensus 256 ~~~~~~~~~~~~~~~~~~~---~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~ 307 (313)
T 3brb_A 256 HEMYDYLLHGHRLKQPEDC---LDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLL 307 (313)
T ss_dssp GGHHHHHHTTCCCCCBTTC---CHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHHcCCCCCCCccc---cHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 1122222222222222222 224788999999999999999999999998864
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=308.49 Aligned_cols=239 Identities=21% Similarity=0.256 Sum_probs=180.0
Q ss_pred hcCcccceeeeecCceEEEEEEeC-CCcEEEEEec------------------------cCCccccceEEEecCceEEEE
Q 042435 142 TEYFHIRYCIGTGGYDSVYKAELP-DGKVVALKKL------------------------HHSETEDSAFVVYSPQCMFFI 196 (412)
Q Consensus 142 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l------------------------~~~~~~~~~~~~~~~~~~~lv 196 (412)
.++|++.+.||+|+||.||+|... +++.||+|.+ +|+++.....++...+..++|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 478999999999999999999874 6899999965 466777777778888999999
Q ss_pred EEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCC
Q 042435 197 YEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDV 276 (412)
Q Consensus 197 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~ 276 (412)
|||+++++|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 113 ~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 186 (309)
T 2h34_A 113 MRLINGVDLAAMLRRQG---PLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATTD 186 (309)
T ss_dssp EECCCCEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSCCC------
T ss_pred EEecCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEecCccCccccc
Confidence 99999999999987543 589999999999999999999999 999999999999999999999999999976544
Q ss_pred CC-CCcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccchh
Q 042435 277 DS-SNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQK 355 (412)
Q Consensus 277 ~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 355 (412)
.. .......||+.|+|||.+.+..++.++||||||+++|||++|+.||..... ..+...+......+ ...
T Consensus 187 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--------~~~~~~~~~~~~~~-~~~ 257 (309)
T 2h34_A 187 EKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQL--------SVMGAHINQAIPRP-STV 257 (309)
T ss_dssp ----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHH--------HHHHHHHHSCCCCG-GGT
T ss_pred cccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchH--------HHHHHHhccCCCCc-ccc
Confidence 32 122345689999999999999999999999999999999999999873211 11112222211111 000
Q ss_pred hHHHHHHHHHHHHhcCcCCCCCCC-CHHHHHHHHhcCCCCC
Q 042435 356 IIQDIILVSTIALACLRSKPKSRP-TMQRISQELEGKTPMK 395 (412)
Q Consensus 356 ~~~~~~~~~~l~~~Cl~~dP~~RP-s~~evl~~L~~~~~~~ 395 (412)
.......+.+++.+||+.||++|| +++++++.|+......
T Consensus 258 ~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~ 298 (309)
T 2h34_A 258 RPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATA 298 (309)
T ss_dssp STTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC--
T ss_pred CCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhh
Confidence 111122377899999999999999 9999999999886543
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=305.98 Aligned_cols=228 Identities=21% Similarity=0.347 Sum_probs=186.9
Q ss_pred hcCcccceeeeecCceEEEEEEeC-CCcEEEEEec------------------------cCCccccceEEEecCceEEEE
Q 042435 142 TEYFHIRYCIGTGGYDSVYKAELP-DGKVVALKKL------------------------HHSETEDSAFVVYSPQCMFFI 196 (412)
Q Consensus 142 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l------------------------~~~~~~~~~~~~~~~~~~~lv 196 (412)
.++|.+.+.||+|+||.||+|... +++.||+|.+ +|+++......+...+..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 467899999999999999999875 5889999964 477777888888889999999
Q ss_pred EEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCC
Q 042435 197 YEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDV 276 (412)
Q Consensus 197 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~ 276 (412)
|||+++++|.+++.... .+++..+..++.|++.||+|||++ +++||||||+||+++.++.+||+|||+++....
T Consensus 94 ~e~~~~~~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 167 (294)
T 2rku_A 94 LELCRRRSLLELHKRRK---ALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 167 (294)
T ss_dssp EECCTTCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEeccCceeccc
Confidence 99999999998876533 589999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCCcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccchhh
Q 042435 277 DSSNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKI 356 (412)
Q Consensus 277 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 356 (412)
.........||+.|+|||.+.+..++.++||||||+++|||++|+.||.... .......+....... +...
T Consensus 168 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~-------~~~~~~~~~~~~~~~--~~~~ 238 (294)
T 2rku_A 168 DGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC-------LKETYLRIKKNEYSI--PKHI 238 (294)
T ss_dssp TTCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSS-------HHHHHHHHHTTCCCC--CTTS
T ss_pred CccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-------HHHHHHHHhhccCCC--cccc
Confidence 4444455679999999999998889999999999999999999999987321 111111222221111 1111
Q ss_pred HHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 357 IQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 357 ~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
...+.+++.+||+.||++|||++|++++
T Consensus 239 ---~~~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 239 ---NPVAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp ---CHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred ---CHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 1237789999999999999999999986
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-40 Score=314.28 Aligned_cols=235 Identities=21% Similarity=0.317 Sum_probs=169.0
Q ss_pred hhcCcccceeeeecCceEEEEEEe-CCCcEEEEEec----------------------cCCccccceEEE--------ec
Q 042435 141 ATEYFHIRYCIGTGGYDSVYKAEL-PDGKVVALKKL----------------------HHSETEDSAFVV--------YS 189 (412)
Q Consensus 141 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l----------------------~~~~~~~~~~~~--------~~ 189 (412)
...+|++.+.||+|+||.||+|.. .+++.||||++ .|+++......+ ..
T Consensus 26 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~ 105 (337)
T 3ll6_A 26 GELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTG 105 (337)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTS
T ss_pred cCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccC
Confidence 345799999999999999999986 47899999965 377887776665 34
Q ss_pred CceEEEEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCC--cEEeCCCCCCEEecCCCcEEEee
Q 042435 190 PQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPS--IVHRDISSNNILLNSNLEAFVAD 267 (412)
Q Consensus 190 ~~~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~--ivHrDlkp~NILl~~~~~~kl~D 267 (412)
....++||||+. |+|.+++........+++..+..++.|++.||+|||++ + |+||||||+|||++.++.+||+|
T Consensus 106 ~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~~~kl~D 181 (337)
T 3ll6_A 106 QAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQGTIKLCD 181 (337)
T ss_dssp SEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTSCEEBCC
T ss_pred CceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCCCEEEec
Confidence 456899999995 79988886533333599999999999999999999998 7 99999999999999999999999
Q ss_pred cCCccccCCCCCC------------cccccccccccccccc---cCcccCcccccHHHHHHHHHHHhCCCCccccccccc
Q 042435 268 FGTVRLLDVDSSN------------RTLQAGTYGYIALELV---YTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSS 332 (412)
Q Consensus 268 fGla~~~~~~~~~------------~~~~~gt~~y~aPE~~---~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~ 332 (412)
||+++........ .....||+.|+|||++ .+..++.++||||||+++|||+||+.||......
T Consensus 182 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-- 259 (337)
T 3ll6_A 182 FGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL-- 259 (337)
T ss_dssp CTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC--------
T ss_pred CccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHH--
Confidence 9999876543211 1134589999999998 5667899999999999999999999998732110
Q ss_pred CCCCcchhhHHhhhccCCccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhcCCC
Q 042435 333 SSGPKIMLIDILYQRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELEGKTP 393 (412)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 393 (412)
+........+...... ..+.+++.+||+.||++|||+.|++++|+.+..
T Consensus 260 ---------~~~~~~~~~~~~~~~~---~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~ 308 (337)
T 3ll6_A 260 ---------RIVNGKYSIPPHDTQY---TVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAA 308 (337)
T ss_dssp ---------------CCCCTTCCSS---GGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---------HhhcCcccCCcccccc---hHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 1111111111111111 126789999999999999999999999987754
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-40 Score=312.10 Aligned_cols=239 Identities=19% Similarity=0.255 Sum_probs=185.4
Q ss_pred cccceeeeecCceEEEEEEeC-----CCcEEEEEec----------------------cCCccccceEEEec--CceEEE
Q 042435 145 FHIRYCIGTGGYDSVYKAELP-----DGKVVALKKL----------------------HHSETEDSAFVVYS--PQCMFF 195 (412)
Q Consensus 145 f~~~~~lG~G~~g~Vy~~~~~-----~~~~vAvK~l----------------------~~~~~~~~~~~~~~--~~~~~l 195 (412)
|++.+.||+|+||.||++.+. +++.||||++ +|+++.....++.. ....++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 488999999999999998653 6889999975 45666666666655 467899
Q ss_pred EEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccC
Q 042435 196 IYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLD 275 (412)
Q Consensus 196 v~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~ 275 (412)
||||+++|+|.+++.... +++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 113 v~e~~~~~~L~~~l~~~~----~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 185 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPRHS----IGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 185 (318)
T ss_dssp EECCCTTCBHHHHGGGSC----CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECC
T ss_pred EEecccCCcHHHHHhhCC----CCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCcccccccc
Confidence 999999999999997653 89999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCC---cccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCccccccc----ccCCCC---cchhhHHhh
Q 042435 276 VDSSN---RTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSL----SSSSGP---KIMLIDILY 345 (412)
Q Consensus 276 ~~~~~---~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~----~~~~~~---~~~~~~~~~ 345 (412)
..... .....+|..|+|||.+.+..++.++||||||+++|||+||+.||...... ...... .....+.+.
T Consensus 186 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (318)
T 3lxp_A 186 EGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLE 265 (318)
T ss_dssp TTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHH
T ss_pred ccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHh
Confidence 43321 23346788899999999889999999999999999999999998632110 000000 011122222
Q ss_pred hccCCccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhcCCC
Q 042435 346 QRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELEGKTP 393 (412)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 393 (412)
.....+.+... ...+.+++.+||+.||++|||+.|+++.|+++.+
T Consensus 266 ~~~~~~~~~~~---~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~ 310 (318)
T 3lxp_A 266 RGERLPRPDKC---PAEVYHLMKNCWETEASFRPTFENLIPILKTVHE 310 (318)
T ss_dssp TTCCCCCCTTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cccCCCCCccc---cHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence 22222222222 2348899999999999999999999999988754
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=305.27 Aligned_cols=232 Identities=22% Similarity=0.322 Sum_probs=178.3
Q ss_pred hcCcccceeeeecCceEEEEEEeCCCcEEEEEec-------------------cCCccccceEEEec-CceEEEEEEecc
Q 042435 142 TEYFHIRYCIGTGGYDSVYKAELPDGKVVALKKL-------------------HHSETEDSAFVVYS-PQCMFFIYEYME 201 (412)
Q Consensus 142 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~l-------------------~~~~~~~~~~~~~~-~~~~~lv~ey~~ 201 (412)
.++|++.+.||+|+||.||+|.. +|+.||||.+ +|+++......+.. .+..++||||++
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 98 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA 98 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCT
T ss_pred hhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecCC
Confidence 46799999999999999999988 5889999965 45666666665544 347899999999
Q ss_pred CCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCCCCc
Q 042435 202 RGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNR 281 (412)
Q Consensus 202 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 281 (412)
+|+|.+++..... ..+++..+..++.|++.||+|||++ +++||||||+||+++.++.+||+|||+++..... .
T Consensus 99 ~~~L~~~l~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~---~ 171 (278)
T 1byg_A 99 KGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST---Q 171 (278)
T ss_dssp TEEHHHHHHHHHH-HHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC-----------
T ss_pred CCCHHHHHHhccc-ccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeecccccccccc---c
Confidence 9999999875432 2388999999999999999999999 9999999999999999999999999998754332 2
Q ss_pred ccccccccccccccccCcccCcccccHHHHHHHHHHHh-CCCCcccccccccCCCCcchhhHHhhhccCCccchhhHHHH
Q 042435 282 TLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLM-GTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKIIQDI 360 (412)
Q Consensus 282 ~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 360 (412)
....+++.|+|||.+.+..++.++||||||+++|||+| |+.||... ........+........+... .
T Consensus 172 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~--------~~~~~~~~~~~~~~~~~~~~~---~ 240 (278)
T 1byg_A 172 DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI--------PLKDVVPRVEKGYKMDAPDGC---P 240 (278)
T ss_dssp ----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTS--------CGGGHHHHHTTTCCCCCCTTC---C
T ss_pred cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCC--------CHHHHHHHHhcCCCCCCcccC---C
Confidence 23357889999999988889999999999999999998 99998632 111122222222222222222 2
Q ss_pred HHHHHHHHhcCcCCCCCCCCHHHHHHHHhcCC
Q 042435 361 ILVSTIALACLRSKPKSRPTMQRISQELEGKT 392 (412)
Q Consensus 361 ~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 392 (412)
..+.+++.+||+.||++|||+.|+++.|+++.
T Consensus 241 ~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~ 272 (278)
T 1byg_A 241 PAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 272 (278)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHHHHhcCChhhCCCHHHHHHHHHHHH
Confidence 24788999999999999999999999998875
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=305.95 Aligned_cols=236 Identities=23% Similarity=0.311 Sum_probs=181.1
Q ss_pred hcCcccceeeeecCceEEEEEEeCC----CcEEEEEec----------------------cCCccccceEEEe-cCceEE
Q 042435 142 TEYFHIRYCIGTGGYDSVYKAELPD----GKVVALKKL----------------------HHSETEDSAFVVY-SPQCMF 194 (412)
Q Consensus 142 ~~~f~~~~~lG~G~~g~Vy~~~~~~----~~~vAvK~l----------------------~~~~~~~~~~~~~-~~~~~~ 194 (412)
..+|++.+.||+|+||.||+|...+ ...+|+|.+ +|+++.....++. ..+..+
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 103 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 103 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence 3468888999999999999998643 236899964 5677777777654 456789
Q ss_pred EEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCcccc
Q 042435 195 FIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLL 274 (412)
Q Consensus 195 lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~ 274 (412)
+||||+++|+|.+++.... ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++..
T Consensus 104 ~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~ 178 (298)
T 3f66_A 104 VVLPYMKHGDLRNFIRNET--HNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDM 178 (298)
T ss_dssp EEEECCTTCBHHHHHHCTT--CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSCGGGCCC
T ss_pred EEEeCCCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECcccccccc
Confidence 9999999999999997643 2489999999999999999999999 9999999999999999999999999999865
Q ss_pred CCCC----CCcccccccccccccccccCcccCcccccHHHHHHHHHHHhC-CCCcccccccccCCCCcchhhHHhhhccC
Q 042435 275 DVDS----SNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMG-THPGELLLSLSSSSGPKIMLIDILYQRLS 349 (412)
Q Consensus 275 ~~~~----~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg-~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 349 (412)
.... .......+|+.|+|||.+.+..++.++||||||+++|||++| ..||... ............ ..
T Consensus 179 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~-------~~~~~~~~~~~~-~~ 250 (298)
T 3f66_A 179 YDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV-------NTFDITVYLLQG-RR 250 (298)
T ss_dssp SCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTS-------CTTTHHHHHHTT-CC
T ss_pred cccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccC-------CHHHHHHHHhcC-CC
Confidence 4322 122344678899999999988999999999999999999995 4555421 111111222221 11
Q ss_pred CccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhcCCC
Q 042435 350 PPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELEGKTP 393 (412)
Q Consensus 350 ~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 393 (412)
...+.... ..+.+++.+||+.||++|||+.|+++.|+++..
T Consensus 251 ~~~~~~~~---~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 291 (298)
T 3f66_A 251 LLQPEYCP---DPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 291 (298)
T ss_dssp CCCCTTCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCccCC---HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 11111111 237889999999999999999999999998754
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=302.82 Aligned_cols=230 Identities=21% Similarity=0.265 Sum_probs=180.5
Q ss_pred cCcccceeeeecCceEEEEEEeC-CCcEEEEEec---------------------------cCCccccceEEEecCceEE
Q 042435 143 EYFHIRYCIGTGGYDSVYKAELP-DGKVVALKKL---------------------------HHSETEDSAFVVYSPQCMF 194 (412)
Q Consensus 143 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l---------------------------~~~~~~~~~~~~~~~~~~~ 194 (412)
++|++.+.||+|+||.||+|... +++.||+|.+ +|+++......+...+..+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 56999999999999999999875 6899999964 3566666777788889999
Q ss_pred EEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCC----cEEEeecCC
Q 042435 195 FIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNL----EAFVADFGT 270 (412)
Q Consensus 195 lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~----~~kl~DfGl 270 (412)
+||||+++++|.+++.... .+++..+..++.|++.||+|||+. +++||||||+||+++.++ .+||+|||+
T Consensus 85 lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~ 158 (283)
T 3bhy_A 85 LILELVSGGELFDFLAEKE---SLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGI 158 (283)
T ss_dssp EEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEeecCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCceEEEeccc
Confidence 9999999999999986533 589999999999999999999999 999999999999998776 899999999
Q ss_pred ccccCCCCCCcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCC
Q 042435 271 VRLLDVDSSNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSP 350 (412)
Q Consensus 271 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 350 (412)
++...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||.... .......+.......
T Consensus 159 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-------~~~~~~~~~~~~~~~ 230 (283)
T 3bhy_A 159 AHKIEAGN-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGET-------KQETLTNISAVNYDF 230 (283)
T ss_dssp CEECC---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSS-------HHHHHHHHHTTCCCC
T ss_pred ceeccCCC-cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcc-------hHHHHHHhHhcccCC
Confidence 98654332 2234468999999999998899999999999999999999999986321 111111111111111
Q ss_pred ccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 351 PINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 351 ~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
+ ..........+.+++.+||+.||++|||+.|++++
T Consensus 231 ~-~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 266 (283)
T 3bhy_A 231 D-EEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEH 266 (283)
T ss_dssp C-HHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHC
T ss_pred c-chhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhC
Confidence 1 11111122347899999999999999999999974
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=308.69 Aligned_cols=244 Identities=20% Similarity=0.316 Sum_probs=186.6
Q ss_pred hcCcccceeeeecCceEEEEEEe-CCCcEEEEEec---------------------cCCccccceEEEe----cCceEEE
Q 042435 142 TEYFHIRYCIGTGGYDSVYKAEL-PDGKVVALKKL---------------------HHSETEDSAFVVY----SPQCMFF 195 (412)
Q Consensus 142 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l---------------------~~~~~~~~~~~~~----~~~~~~l 195 (412)
.++|++.+.||+|+||.||++.. .+++.||||++ +|+++......+. .....++
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 107 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL 107 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence 46799999999999999999987 67999999964 5777777766655 3457899
Q ss_pred EEEeccCCceeeeeccCc-ccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCcccc
Q 042435 196 IYEYMERGSLFCVLRDDD-EAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLL 274 (412)
Q Consensus 196 v~ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~ 274 (412)
||||+++|+|.+++.... ....+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++..
T Consensus 108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~ 184 (317)
T 2buj_A 108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMNQA 184 (317)
T ss_dssp EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence 999999999999887531 123589999999999999999999999 9999999999999999999999999998764
Q ss_pred CCCCCC---------cccccccccccccccccCcc---cCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhH
Q 042435 275 DVDSSN---------RTLQAGTYGYIALELVYTMV---VTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLID 342 (412)
Q Consensus 275 ~~~~~~---------~~~~~gt~~y~aPE~~~~~~---~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~ 342 (412)
...... .....||+.|+|||.+.+.. ++.++||||||+++|||++|+.||...... . .....
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-----~-~~~~~ 258 (317)
T 2buj_A 185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQK-----G-DSVAL 258 (317)
T ss_dssp CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHT-----T-SCHHH
T ss_pred ccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcc-----c-chhhH
Confidence 321111 12235799999999987543 788999999999999999999998632110 0 11112
Q ss_pred HhhhccCCccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhcCCCCCCC
Q 042435 343 ILYQRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELEGKTPMKKG 397 (412)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~~~~ 397 (412)
........+..... ...+.+++.+||+.||++|||+.|++++|+.+.+...+
T Consensus 259 ~~~~~~~~~~~~~~---~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~ 310 (317)
T 2buj_A 259 AVQNQLSIPQSPRH---SSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAPG 310 (317)
T ss_dssp HHHCC--CCCCTTS---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCCCC
T ss_pred HhhccCCCCccccC---CHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCCCC
Confidence 22222222111111 22488999999999999999999999999999865543
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=322.30 Aligned_cols=234 Identities=12% Similarity=0.035 Sum_probs=169.1
Q ss_pred hcCcccceeeeecCceEEEEEEeC-CCcEEEEEeccC--------------------------Cccccce-------EEE
Q 042435 142 TEYFHIRYCIGTGGYDSVYKAELP-DGKVVALKKLHH--------------------------SETEDSA-------FVV 187 (412)
Q Consensus 142 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~--------------------------~~~~~~~-------~~~ 187 (412)
..+|.+.+.||+|+||.||+|... +|+.||||+++. +++.... .++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 456999999999999999999864 789999997643 3322111 111
Q ss_pred ecC-----------------ceEEEEEEeccCCceeeeeccCcccccCCHHHH------HHHHHHHHHHHHHHHhCCCCC
Q 042435 188 YSP-----------------QCMFFIYEYMERGSLFCVLRDDDEAIELNWTRR------MNIVKSVAHALSYLHHDCTPS 244 (412)
Q Consensus 188 ~~~-----------------~~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~------~~i~~~ia~gL~~LH~~~~~~ 244 (412)
... ...++||||++ |+|.+++..... .+.+..+ ..++.|++.||+|||++ +
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~--~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~---~ 214 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF--VYVFRGDEGILALHILTAQLIRLAANLQSK---G 214 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH--SCCCCHHHHHHHHHHHHHHHHHHHHHHHHT---T
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc--ccchhhhhhhhhHHHHHHHHHHHHHHHHHC---C
Confidence 111 34899999998 899999976432 3566666 78889999999999999 9
Q ss_pred cEEeCCCCCCEEecCCCcEEEeecCCccccCCCCCCcccccccccccccccccC--cccCcccccHHHHHHHHHHHhCCC
Q 042435 245 IVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTYGYIALELVYT--MVVTEKCVIYSFGVVALEVLMGTH 322 (412)
Q Consensus 245 ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~ksDv~S~Gvil~elltg~~ 322 (412)
|+||||||+|||++.++.+||+|||+++.... ......+|+.|+|||++.+ ..++.++|||||||++|||+||+.
T Consensus 215 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~ 291 (371)
T 3q60_A 215 LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT---RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFL 291 (371)
T ss_dssp EEETTCSGGGEEECTTSCEEECCGGGEEETTC---EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSC
T ss_pred CccCcCCHHHEEECCCCCEEEEecceeeecCC---CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCC
Confidence 99999999999999999999999999986532 1224467799999999987 779999999999999999999999
Q ss_pred CcccccccccCCCCcchhhHHhhhccCCccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 323 PGELLLSLSSSSGPKIMLIDILYQRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 323 P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
||..........................+.... ....+.+++.+||+.||++|||+.|++++
T Consensus 292 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 353 (371)
T 3q60_A 292 PFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTP---LPDFVKTLIGRFLNFDRRRRLLPLEAMET 353 (371)
T ss_dssp STTBCCTTCTTCCCBCCTTSCCCCSCCCTTSSC---CCHHHHHHHHHHTCSSTTTCCCHHHHTTS
T ss_pred CCCCcCcccccchhhhhhhhccccccchhhccC---CCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 997432111111110000000011111111111 12247889999999999999999999753
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=335.42 Aligned_cols=233 Identities=20% Similarity=0.270 Sum_probs=180.4
Q ss_pred cCcccce-eeeecCceEEEEEEeC---CCcEEEEEec----------------------cCCccccceEEEecCceEEEE
Q 042435 143 EYFHIRY-CIGTGGYDSVYKAELP---DGKVVALKKL----------------------HHSETEDSAFVVYSPQCMFFI 196 (412)
Q Consensus 143 ~~f~~~~-~lG~G~~g~Vy~~~~~---~~~~vAvK~l----------------------~~~~~~~~~~~~~~~~~~~lv 196 (412)
+++.+.+ .||+|+||.||+|.+. ++..||||.+ +|+++.....++.. +..++|
T Consensus 335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv 413 (613)
T 2ozo_A 335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 413 (613)
T ss_dssp TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEE
T ss_pred cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEE
Confidence 3444444 7999999999999763 5678999975 45666666676655 569999
Q ss_pred EEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCC
Q 042435 197 YEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDV 276 (412)
Q Consensus 197 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~ 276 (412)
|||+++|+|.+++.... ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 414 ~E~~~~g~L~~~l~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~ 488 (613)
T 2ozo_A 414 MEMAGGGPLHKFLVGKR--EEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALGA 488 (613)
T ss_dssp EECCTTCBHHHHHTTCT--TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC-
T ss_pred EEeCCCCcHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCcccccC
Confidence 99999999999987543 2589999999999999999999999 999999999999999999999999999987643
Q ss_pred CCCC---cccccccccccccccccCcccCcccccHHHHHHHHHHHh-CCCCcccccccccCCCCcchhhHHhhhccCCcc
Q 042435 277 DSSN---RTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLM-GTHPGELLLSLSSSSGPKIMLIDILYQRLSPPI 352 (412)
Q Consensus 277 ~~~~---~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 352 (412)
.... .....+++.|+|||++.+..++.++|||||||++|||+| |+.||... . .....+.+......+.
T Consensus 489 ~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~-------~-~~~~~~~i~~~~~~~~ 560 (613)
T 2ozo_A 489 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM-------K-GPEVMAFIEQGKRMEC 560 (613)
T ss_dssp -------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC-------C-SHHHHHHHHTTCCCCC
T ss_pred CCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC-------C-HHHHHHHHHcCCCCCC
Confidence 3221 122345689999999998899999999999999999998 99998732 1 1122333333222222
Q ss_pred chhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhcCC
Q 042435 353 NQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELEGKT 392 (412)
Q Consensus 353 ~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 392 (412)
+... ...+.+++.+||+.||++||++.++++.|+.+.
T Consensus 561 p~~~---~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~ 597 (613)
T 2ozo_A 561 PPEC---PPELYALMSDCWIYKWEDRPDFLTVEQRMRACY 597 (613)
T ss_dssp CTTC---CHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHH
T ss_pred CCcC---CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 2222 234889999999999999999999999998753
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=304.56 Aligned_cols=232 Identities=23% Similarity=0.318 Sum_probs=180.2
Q ss_pred CcccceeeeecCceEEEEEEe-CCCcEEEEEec---------------------cCCccccceEEEecCceEEEEEEecc
Q 042435 144 YFHIRYCIGTGGYDSVYKAEL-PDGKVVALKKL---------------------HHSETEDSAFVVYSPQCMFFIYEYME 201 (412)
Q Consensus 144 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l---------------------~~~~~~~~~~~~~~~~~~~lv~ey~~ 201 (412)
+|....+||+|+||.||+|.. .+++.||+|.+ +|+++......+...+..++||||++
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 102 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP 102 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCC
Confidence 345556899999999999986 56889999964 57777777778888899999999999
Q ss_pred CCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecC-CCcEEEeecCCccccCCCCCC
Q 042435 202 RGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNS-NLEAFVADFGTVRLLDVDSSN 280 (412)
Q Consensus 202 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~-~~~~kl~DfGla~~~~~~~~~ 280 (412)
+++|.+++........+++..+..++.|++.||+|||++ +++||||||+||+++. ++.+||+|||+++........
T Consensus 103 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~ 179 (295)
T 2clq_A 103 GGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPC 179 (295)
T ss_dssp EEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC----
T ss_pred CCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeecccccccCCCCCc
Confidence 999999987654444577899999999999999999999 9999999999999987 899999999999876543333
Q ss_pred cccccccccccccccccCcc--cCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccchhhHH
Q 042435 281 RTLQAGTYGYIALELVYTMV--VTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKIIQ 358 (412)
Q Consensus 281 ~~~~~gt~~y~aPE~~~~~~--~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 358 (412)
.....||+.|+|||++.+.. ++.++||||||+++|||++|+.||..... ..............+..+...
T Consensus 180 ~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~~~~~~~~~~~~~~~~~~~~~-- 251 (295)
T 2clq_A 180 TETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGE------PQAAMFKVGMFKVHPEIPESM-- 251 (295)
T ss_dssp -CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSS------HHHHHHHHHHHCCCCCCCTTS--
T ss_pred ccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCc------hhHHHHhhccccccccccccC--
Confidence 34557899999999987643 78999999999999999999999863210 001111111111222222222
Q ss_pred HHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 359 DIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 359 ~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
...+.+++.+||+.||++|||+.|++++
T Consensus 252 -~~~~~~li~~~l~~dp~~Rps~~~ll~~ 279 (295)
T 2clq_A 252 -SAEAKAFILKCFEPDPDKRACANDLLVD 279 (295)
T ss_dssp -CHHHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred -CHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 2237889999999999999999999864
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=312.02 Aligned_cols=228 Identities=22% Similarity=0.359 Sum_probs=187.2
Q ss_pred hcCcccceeeeecCceEEEEEEeC-CCcEEEEEec------------------------cCCccccceEEEecCceEEEE
Q 042435 142 TEYFHIRYCIGTGGYDSVYKAELP-DGKVVALKKL------------------------HHSETEDSAFVVYSPQCMFFI 196 (412)
Q Consensus 142 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l------------------------~~~~~~~~~~~~~~~~~~~lv 196 (412)
.++|.+.+.||+|+||.||++... +++.||+|.+ +|+++......+.+.+..++|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 467999999999999999999875 5889999964 577788888888889999999
Q ss_pred EEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCC
Q 042435 197 YEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDV 276 (412)
Q Consensus 197 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~ 276 (412)
|||+++++|.+++.... .+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++....
T Consensus 120 ~e~~~~~~L~~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 193 (335)
T 2owb_A 120 LELCRRRSLLELHKRRK---ALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 193 (335)
T ss_dssp ECCCTTCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EecCCCCCHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeeccCceeccc
Confidence 99999999998876533 589999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCCcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccchhh
Q 042435 277 DSSNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKI 356 (412)
Q Consensus 277 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 356 (412)
.........||+.|+|||++.+..++.++||||||+++|||++|+.||.... .......+.......+ ...
T Consensus 194 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-------~~~~~~~~~~~~~~~~--~~~ 264 (335)
T 2owb_A 194 DGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC-------LKETYLRIKKNEYSIP--KHI 264 (335)
T ss_dssp TTCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSS-------HHHHHHHHHHTCCCCC--TTS
T ss_pred CcccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCC-------HHHHHHHHhcCCCCCC--ccC
Confidence 4444455679999999999998889999999999999999999999987321 1111112222221111 111
Q ss_pred HHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 357 IQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 357 ~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
...+.+++.+||+.||++|||+.|++++
T Consensus 265 ---~~~~~~li~~~l~~dp~~Rps~~ell~~ 292 (335)
T 2owb_A 265 ---NPVAASLIQKMLQTDPTARPTINELLND 292 (335)
T ss_dssp ---CHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred ---CHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1237789999999999999999999975
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=308.07 Aligned_cols=239 Identities=20% Similarity=0.280 Sum_probs=177.8
Q ss_pred hcCcccc-eeeeecCceEEEEEEe-CCCcEEEEEec----------------------cCCccccceEEEecCceEEEEE
Q 042435 142 TEYFHIR-YCIGTGGYDSVYKAEL-PDGKVVALKKL----------------------HHSETEDSAFVVYSPQCMFFIY 197 (412)
Q Consensus 142 ~~~f~~~-~~lG~G~~g~Vy~~~~-~~~~~vAvK~l----------------------~~~~~~~~~~~~~~~~~~~lv~ 197 (412)
.+.|++. +.||+|+||.||+|.. .+++.||||.+ +|+++......+...+..++||
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~ 90 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF 90 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence 3567774 7899999999999976 47999999964 4677777777888889999999
Q ss_pred EeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCc---EEEeecCCcccc
Q 042435 198 EYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLE---AFVADFGTVRLL 274 (412)
Q Consensus 198 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~---~kl~DfGla~~~ 274 (412)
||+++|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++. +||+|||+++..
T Consensus 91 e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~ 164 (316)
T 2ac3_A 91 EKMRGGSILSHIHKRR---HFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGI 164 (316)
T ss_dssp ECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECCTTCCC--
T ss_pred EcCCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEEccCcccc
Confidence 9999999999987543 589999999999999999999999 9999999999999987765 999999998765
Q ss_pred CCCCC-------CcccccccccccccccccC-----cccCcccccHHHHHHHHHHHhCCCCcccccccccCCCC------
Q 042435 275 DVDSS-------NRTLQAGTYGYIALELVYT-----MVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGP------ 336 (412)
Q Consensus 275 ~~~~~-------~~~~~~gt~~y~aPE~~~~-----~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~------ 336 (412)
..... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||............
T Consensus 165 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 244 (316)
T 2ac3_A 165 KLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPA 244 (316)
T ss_dssp -----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHH
T ss_pred ccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchh
Confidence 42211 1123469999999999875 56889999999999999999999999743111000000
Q ss_pred -cchh-hHHhhhccCCccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 337 -KIML-IDILYQRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 337 -~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
...+ ..+.......+ ..........+.+++.+||+.||++|||+.|++++
T Consensus 245 ~~~~~~~~i~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 296 (316)
T 2ac3_A 245 CQNMLFESIQEGKYEFP-DKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH 296 (316)
T ss_dssp HHHHHHHHHHHCCCCCC-HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHHHHHhccCcccC-chhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 0011 11111211111 11111122348899999999999999999999985
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-39 Score=320.77 Aligned_cols=236 Identities=21% Similarity=0.197 Sum_probs=174.1
Q ss_pred hcCcccceeeeecCceEEEEEEe-CCCcEEEEEec-----------------------cCCccccceEEEecC------c
Q 042435 142 TEYFHIRYCIGTGGYDSVYKAEL-PDGKVVALKKL-----------------------HHSETEDSAFVVYSP------Q 191 (412)
Q Consensus 142 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l-----------------------~~~~~~~~~~~~~~~------~ 191 (412)
.++|++.+.||+|+||.||+|.. .+|+.||||++ +|+++.....++... .
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 57899999999999999999976 46899999975 477777777776543 4
Q ss_pred eEEEEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCc
Q 042435 192 CMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTV 271 (412)
Q Consensus 192 ~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla 271 (412)
..++||||+++ +|.+.+.. .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 141 ~~~lv~E~~~~-~l~~~~~~-----~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DFG~a 211 (464)
T 3ttj_A 141 DVYLVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA 211 (464)
T ss_dssp EEEEEEECCSE-EHHHHHTS-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCCC
T ss_pred eEEEEEeCCCC-CHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEEEee
Confidence 67999999976 46555542 388999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCCcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCccccccccc--------CCC-------C
Q 042435 272 RLLDVDSSNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSS--------SSG-------P 336 (412)
Q Consensus 272 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~--------~~~-------~ 336 (412)
+...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||........ ... .
T Consensus 212 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~ 290 (464)
T 3ttj_A 212 RTAGTSF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 290 (464)
T ss_dssp -----CC-CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTS
T ss_pred eecCCCc-ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHc
Confidence 8764332 23446799999999999999999999999999999999999999963211000 000 0
Q ss_pred cchhhHHhhh---------------ccCCccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 337 KIMLIDILYQ---------------RLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 337 ~~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
.......... ...+............+.+++.+||+.||++|||++|++++
T Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 291 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp CHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred chhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000011110 00011111111123458899999999999999999999986
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-39 Score=306.28 Aligned_cols=234 Identities=26% Similarity=0.354 Sum_probs=181.5
Q ss_pred HhhcCcccceeeeecCceEEEEEEeC-CCcEEEEEec-------------------cCCccccceEEEecCceEEEEEEe
Q 042435 140 DATEYFHIRYCIGTGGYDSVYKAELP-DGKVVALKKL-------------------HHSETEDSAFVVYSPQCMFFIYEY 199 (412)
Q Consensus 140 ~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l-------------------~~~~~~~~~~~~~~~~~~~lv~ey 199 (412)
...++|++.+.||+|+||.||+|... +|+.||+|.+ +|+++......+...+..++||||
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 105 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEY 105 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSCCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeec
Confidence 34567999999999999999999875 5899999964 567777778888888999999999
Q ss_pred ccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCCC
Q 042435 200 MERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSS 279 (412)
Q Consensus 200 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 279 (412)
+++|+|.+++.... ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++........
T Consensus 106 ~~~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~ 180 (314)
T 3com_A 106 CGAGSVSDIIRLRN--KTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMA 180 (314)
T ss_dssp CTTEEHHHHHHHHT--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBS
T ss_pred CCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeecccchhhhhhcc
Confidence 99999999886322 2589999999999999999999999 999999999999999999999999999987654443
Q ss_pred CcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccchhhHHH
Q 042435 280 NRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKIIQD 359 (412)
Q Consensus 280 ~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 359 (412)
......||+.|+|||.+.+..++.++||||||+++|||++|+.||..... ............+.. ......
T Consensus 181 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--------~~~~~~~~~~~~~~~-~~~~~~ 251 (314)
T 3com_A 181 KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHP--------MRAIFMIPTNPPPTF-RKPELW 251 (314)
T ss_dssp CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCH--------HHHHHHHHHSCCCCC-SSGGGS
T ss_pred ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCh--------HHHHHHHhcCCCccc-CCcccC
Confidence 44456789999999999998999999999999999999999999873211 001111111111110 001111
Q ss_pred HHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 360 IILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 360 ~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
...+.+++.+||+.||++|||+.|++++
T Consensus 252 ~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (314)
T 3com_A 252 SDNFTDFVKQCLVKSPEQRATATQLLQH 279 (314)
T ss_dssp CHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 2347899999999999999999999874
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-40 Score=317.67 Aligned_cols=240 Identities=15% Similarity=0.172 Sum_probs=181.9
Q ss_pred hcCcccceeeeecCceEEEEEEeCC---------CcEEEEEecc----------------CCcccc--------------
Q 042435 142 TEYFHIRYCIGTGGYDSVYKAELPD---------GKVVALKKLH----------------HSETED-------------- 182 (412)
Q Consensus 142 ~~~f~~~~~lG~G~~g~Vy~~~~~~---------~~~vAvK~l~----------------~~~~~~-------------- 182 (412)
.++|++.+.||+|+||.||+|.... ++.||+|.++ |+++..
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i~ 120 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIP 120 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETTSTHHHHHHHHHHHCCHHHHHHHHHHTTCTTCSCC
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEecccchHHHHHHHHHHhcccchhhhhhhhccCCccCcc
Confidence 3679999999999999999998753 7899999764 333222
Q ss_pred -ceEEEe-cCceEEEEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCC
Q 042435 183 -SAFVVY-SPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSN 260 (412)
Q Consensus 183 -~~~~~~-~~~~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~ 260 (412)
....+. ..+..++||||+ +++|.+++..... ..+++..+..++.|++.||+|||++ +|+||||||+||+++.+
T Consensus 121 ~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIl~~~~ 195 (352)
T 2jii_A 121 TCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPK-HVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTAENIFVDPE 195 (352)
T ss_dssp CCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGG-GCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCGGGEEEETT
T ss_pred chhhccccCCcEEEEEecCC-CcCHHHHHHhCCc-CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEEcCC
Confidence 222333 367899999999 9999999986522 3599999999999999999999999 99999999999999998
Q ss_pred C--cEEEeecCCccccCCCCC-------CcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccc
Q 042435 261 L--EAFVADFGTVRLLDVDSS-------NRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLS 331 (412)
Q Consensus 261 ~--~~kl~DfGla~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~ 331 (412)
+ .+||+|||+++....... ......||+.|+|||++.+..++.++||||||+++|||++|+.||....
T Consensus 196 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~--- 272 (352)
T 2jii_A 196 DQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCL--- 272 (352)
T ss_dssp EEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT---
T ss_pred CCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCC---
Confidence 8 999999999986643221 1233479999999999999899999999999999999999999997431
Q ss_pred cCCCCcchhhHHhh---hccCCccchhh---HHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhcCCC
Q 042435 332 SSSGPKIMLIDILY---QRLSPPINQKI---IQDIILVSTIALACLRSKPKSRPTMQRISQELEGKTP 393 (412)
Q Consensus 332 ~~~~~~~~~~~~~~---~~~~~~~~~~~---~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 393 (412)
.....+..... .... ...... ......+.+++.+||+.||++|||++|+++.|+++..
T Consensus 273 ---~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 336 (352)
T 2jii_A 273 ---PNTEDIMKQKQKFVDKPG-PFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQ 336 (352)
T ss_dssp ---TCHHHHHHHHHHHHHSCC-CEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred ---cCHHHHHHHHHhccCChh-hhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHH
Confidence 01111111111 1111 000000 0012348889999999999999999999999988754
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=305.35 Aligned_cols=233 Identities=23% Similarity=0.293 Sum_probs=172.7
Q ss_pred hcCcccceeeeecCceEEEEEEe-CCCcEEEEEec-----------------------cCCccccceEEEecCceEEEEE
Q 042435 142 TEYFHIRYCIGTGGYDSVYKAEL-PDGKVVALKKL-----------------------HHSETEDSAFVVYSPQCMFFIY 197 (412)
Q Consensus 142 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l-----------------------~~~~~~~~~~~~~~~~~~~lv~ 197 (412)
.++|++.+.||+|+||.||+|.. .+|+.||+|++ +|+++......+...+..++||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~ 85 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM 85 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence 46799999999999999999987 57999999965 4677777788888899999999
Q ss_pred EeccCCceeeeeccCc-ccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCC
Q 042435 198 EYMERGSLFCVLRDDD-EAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDV 276 (412)
Q Consensus 198 ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~ 276 (412)
||++ |+|.+++.... ....+++..+..++.|++.||+|||+++ +++||||||+||+++.++.+||+|||+++....
T Consensus 86 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 162 (290)
T 3fme_A 86 ELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYLVD 162 (290)
T ss_dssp ECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHS--CCCCCCCSGGGCEECTTCCEEBCCC--------
T ss_pred ehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecCCcccccc
Confidence 9997 58877765421 1235999999999999999999999842 899999999999999999999999999986644
Q ss_pred CCCCcccccccccccccccc----cCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCcc
Q 042435 277 DSSNRTLQAGTYGYIALELV----YTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPI 352 (412)
Q Consensus 277 ~~~~~~~~~gt~~y~aPE~~----~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 352 (412)
.. ......||+.|+|||.+ .+..++.++||||||+++|||+||+.||... ...................
T Consensus 163 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~------~~~~~~~~~~~~~~~~~~~ 235 (290)
T 3fme_A 163 DV-AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSW------GTPFQQLKQVVEEPSPQLP 235 (290)
T ss_dssp --------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCC------SCHHHHHHHHHHSCCCCCC
T ss_pred cc-cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCcccc------CchHHHHHHHhccCCCCcc
Confidence 32 22334789999999996 5667899999999999999999999998631 1111112222222222111
Q ss_pred chhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 353 NQKIIQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 353 ~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
... ....+.+++.+||+.||++|||+.|++++
T Consensus 236 ~~~---~~~~~~~li~~~l~~~p~~Rpt~~e~l~h 267 (290)
T 3fme_A 236 ADK---FSAEFVDFTSQCLKKNSKERPTYPELMQH 267 (290)
T ss_dssp TTT---SCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred ccc---CCHHHHHHHHHHhhcChhhCcCHHHHHhC
Confidence 111 12237889999999999999999999873
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=312.65 Aligned_cols=234 Identities=19% Similarity=0.223 Sum_probs=174.1
Q ss_pred HhhcCcccceeeeecCceEEEEEEe-CCCcEEEEEec-----------------------cCCccccceEEEecCceEEE
Q 042435 140 DATEYFHIRYCIGTGGYDSVYKAEL-PDGKVVALKKL-----------------------HHSETEDSAFVVYSPQCMFF 195 (412)
Q Consensus 140 ~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l-----------------------~~~~~~~~~~~~~~~~~~~l 195 (412)
...++|++.+.||+|+||.||+|.. .+++.||||++ +|+++.....++...+..++
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 110 (329)
T 3gbz_A 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHL 110 (329)
T ss_dssp -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEE
Confidence 4457899999999999999999975 57899999965 46667777777888999999
Q ss_pred EEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEe-----cCCCcEEEeecCC
Q 042435 196 IYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILL-----NSNLEAFVADFGT 270 (412)
Q Consensus 196 v~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl-----~~~~~~kl~DfGl 270 (412)
||||++ |+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+|||+ +.++.+||+|||+
T Consensus 111 v~e~~~-~~L~~~~~~~~---~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~ 183 (329)
T 3gbz_A 111 IFEYAE-NDLKKYMDKNP---DVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGL 183 (329)
T ss_dssp EEECCS-EEHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEEECCTTH
T ss_pred EEecCC-CCHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEEECcCCC
Confidence 999997 59998887654 489999999999999999999999 99999999999999 4556699999999
Q ss_pred ccccCCCCCCcccccccccccccccccCc-ccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhh---
Q 042435 271 VRLLDVDSSNRTLQAGTYGYIALELVYTM-VVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQ--- 346 (412)
Q Consensus 271 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~--- 346 (412)
++.............||+.|+|||++.+. .++.++|||||||++|||++|+.||...... .....+...
T Consensus 184 a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-------~~~~~~~~~~~~ 256 (329)
T 3gbz_A 184 ARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEI-------DQLFKIFEVLGL 256 (329)
T ss_dssp HHHHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHHHCC
T ss_pred ccccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHH-------HHHHHHHHHhCC
Confidence 98765444444556789999999999874 4899999999999999999999998632110 001111000
Q ss_pred -----------------c---cCCccchhh--HHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 347 -----------------R---LSPPINQKI--IQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 347 -----------------~---~~~~~~~~~--~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
. ......... ......+.+++.+||+.||++|||++|++++
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 319 (329)
T 3gbz_A 257 PDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEH 319 (329)
T ss_dssp CCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCC
Confidence 0 000000000 0012347899999999999999999999874
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-39 Score=319.62 Aligned_cols=176 Identities=20% Similarity=0.213 Sum_probs=151.9
Q ss_pred hcCcccceeeeecCceEEEEEEe-CCCcEEEEEecc--------------------------CCccccceEEEecCceEE
Q 042435 142 TEYFHIRYCIGTGGYDSVYKAEL-PDGKVVALKKLH--------------------------HSETEDSAFVVYSPQCMF 194 (412)
Q Consensus 142 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l~--------------------------~~~~~~~~~~~~~~~~~~ 194 (412)
..+|++.+.||+|+||.||+|.. .+++.||||.++ |+++......+...+..+
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~ 175 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHIC 175 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEE
Confidence 45799999999999999999976 468999999763 335666666777889999
Q ss_pred EEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCc--EEEeecCCcc
Q 042435 195 FIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLE--AFVADFGTVR 272 (412)
Q Consensus 195 lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~--~kl~DfGla~ 272 (412)
+||||+. ++|.+++..... ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++. +||+|||+++
T Consensus 176 lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~ 250 (429)
T 3kvw_A 176 MTFELLS-MNLYELIKKNKF-QGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGSSC 250 (429)
T ss_dssp EEECCCC-CBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred EEEeccC-CCHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceEEeecccce
Confidence 9999996 689888876432 2489999999999999999999999 9999999999999998887 9999999997
Q ss_pred ccCCCCCCcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcc
Q 042435 273 LLDVDSSNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGE 325 (412)
Q Consensus 273 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~ 325 (412)
..... .....||+.|+|||++.+..++.++|||||||++|||+||+.||.
T Consensus 251 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~ 300 (429)
T 3kvw_A 251 YEHQR---VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLP 300 (429)
T ss_dssp ETTCC---CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred ecCCc---ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCC
Confidence 64332 234578999999999999999999999999999999999999986
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=303.28 Aligned_cols=231 Identities=24% Similarity=0.319 Sum_probs=176.2
Q ss_pred cCcccceeeeecCceEEEEEEe-CCCcEEEEEec----------------------cCCccccceEEEecCceEEEEEEe
Q 042435 143 EYFHIRYCIGTGGYDSVYKAEL-PDGKVVALKKL----------------------HHSETEDSAFVVYSPQCMFFIYEY 199 (412)
Q Consensus 143 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l----------------------~~~~~~~~~~~~~~~~~~~lv~ey 199 (412)
++|.+.+.||+|+||.||+|.. .+++.||+|.+ +|+++.....++...+..++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 101 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET 101 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence 5689999999999999999977 46899999964 577777778888889999999999
Q ss_pred ccCCceeeeeccCc-ccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEe---cCCCcEEEeecCCccccC
Q 042435 200 MERGSLFCVLRDDD-EAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILL---NSNLEAFVADFGTVRLLD 275 (412)
Q Consensus 200 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl---~~~~~~kl~DfGla~~~~ 275 (412)
+++|+|.+++.... ....+++..+..++.|++.||+|||+. +|+||||||+||++ +.++.+||+|||+++...
T Consensus 102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 178 (285)
T 3is5_A 102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK 178 (285)
T ss_dssp CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence 99999998886432 123589999999999999999999999 99999999999999 456889999999998654
Q ss_pred CCCCCcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccchh
Q 042435 276 VDSSNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQK 355 (412)
Q Consensus 276 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 355 (412)
... ......||+.|+|||.+. ..++.++||||||+++|||++|+.||.... ................. .
T Consensus 179 ~~~-~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~-------~~~~~~~~~~~~~~~~~--~ 247 (285)
T 3is5_A 179 SDE-HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTS-------LEEVQQKATYKEPNYAV--E 247 (285)
T ss_dssp ---------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSS-------HHHHHHHHHHCCCCCCC---
T ss_pred Ccc-cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCC-------HHHHHhhhccCCccccc--c
Confidence 332 233457899999999875 568899999999999999999999987321 00111111111111100 0
Q ss_pred hHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 356 IIQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 356 ~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
.......+.+++.+||+.||++|||+.|++++
T Consensus 248 ~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 279 (285)
T 3is5_A 248 CRPLTPQAVDLLKQMLTKDPERRPSAAQVLHH 279 (285)
T ss_dssp -CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred cCcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00012237789999999999999999999864
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-39 Score=323.64 Aligned_cols=230 Identities=22% Similarity=0.297 Sum_probs=184.4
Q ss_pred hcCcccceeeeecCceEEEEEEeC-CCcEEEEEec-----------------------cCCccccceEEEecCceEEEEE
Q 042435 142 TEYFHIRYCIGTGGYDSVYKAELP-DGKVVALKKL-----------------------HHSETEDSAFVVYSPQCMFFIY 197 (412)
Q Consensus 142 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l-----------------------~~~~~~~~~~~~~~~~~~~lv~ 197 (412)
.++|++.+.||+|+||+||+|... +++.||||.+ +|+++.....++......++||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 100 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence 467999999999999999999874 7999999964 5888888888899999999999
Q ss_pred EeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEec---CCCcEEEeecCCcccc
Q 042435 198 EYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLN---SNLEAFVADFGTVRLL 274 (412)
Q Consensus 198 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~---~~~~~kl~DfGla~~~ 274 (412)
||+++|+|.+.+.... .+++..+..++.|++.||+|||++ +|+||||||+|||++ .++.+||+|||+++..
T Consensus 101 e~~~~~~L~~~~~~~~---~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 174 (486)
T 3mwu_A 101 ELYTGGELFDEIIKRK---RFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF 174 (486)
T ss_dssp CCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTB
T ss_pred EcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEEECCcCeEC
Confidence 9999999988886543 589999999999999999999999 999999999999995 4567999999999866
Q ss_pred CCCCCCcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccch
Q 042435 275 DVDSSNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQ 354 (412)
Q Consensus 275 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 354 (412)
.... ......||+.|+|||++.+ .++.++||||+||++|||++|+.||... ........+.......+. +
T Consensus 175 ~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~-------~~~~~~~~i~~~~~~~~~-~ 244 (486)
T 3mwu_A 175 QQNT-KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGK-------NEYDILKRVETGKYAFDL-P 244 (486)
T ss_dssp CCC-----CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCS-------SHHHHHHHHHHTCCCSCS-G
T ss_pred CCCC-ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCC-------CHHHHHHHHHhCCCCCCC-c
Confidence 4432 2334579999999999875 5899999999999999999999998632 111112222222222211 1
Q ss_pred hhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 355 KIIQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 355 ~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
........+.+++.+||+.||++|||+.|++++
T Consensus 245 ~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 245 QWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp GGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred ccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 111222347899999999999999999999986
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-39 Score=300.12 Aligned_cols=225 Identities=24% Similarity=0.327 Sum_probs=183.9
Q ss_pred cCcccceeeeecCceEEEEEEeC-CCcEEEEEec------------------------cCCccccceEEEecCceEEEEE
Q 042435 143 EYFHIRYCIGTGGYDSVYKAELP-DGKVVALKKL------------------------HHSETEDSAFVVYSPQCMFFIY 197 (412)
Q Consensus 143 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l------------------------~~~~~~~~~~~~~~~~~~~lv~ 197 (412)
++|++.+.||+|+||.||+|... +++.||+|.+ +|+++......+...+..++||
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 93 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML 93 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence 67999999999999999999875 5889999964 4777777788888889999999
Q ss_pred EeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCC
Q 042435 198 EYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVD 277 (412)
Q Consensus 198 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~ 277 (412)
||+++|+|.+++.... .+++..+..++.|++.||+|||++ +++||||||+||+++.++.+||+|||++......
T Consensus 94 e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~ 167 (284)
T 2vgo_A 94 EFAPRGELYKELQKHG---RFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL 167 (284)
T ss_dssp CCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCCTTCEECSSS
T ss_pred EeCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEecccccccCccc
Confidence 9999999999887543 589999999999999999999998 9999999999999999999999999998755432
Q ss_pred CCCcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccchhhH
Q 042435 278 SSNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKII 357 (412)
Q Consensus 278 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 357 (412)
......|++.|+|||.+.+..++.++||||||+++|||++|+.||.... .......+....... +...
T Consensus 168 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-------~~~~~~~~~~~~~~~--~~~~- 235 (284)
T 2vgo_A 168 --RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPS-------HTETHRRIVNVDLKF--PPFL- 235 (284)
T ss_dssp --CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS-------HHHHHHHHHTTCCCC--CTTS-
T ss_pred --ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCC-------HhHHHHHHhccccCC--CCcC-
Confidence 2234578999999999999999999999999999999999999987321 111111222222111 1111
Q ss_pred HHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 358 QDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 358 ~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
...+.+++.+||+.||++|||++|++++
T Consensus 236 --~~~~~~li~~~l~~~p~~Rps~~~ll~h 263 (284)
T 2vgo_A 236 --SDGSKDLISKLLRYHPPQRLPLKGVMEH 263 (284)
T ss_dssp --CHHHHHHHHHHSCSSGGGSCCHHHHHTC
T ss_pred --CHHHHHHHHHHhhcCHhhCCCHHHHhhC
Confidence 1237889999999999999999999874
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=305.36 Aligned_cols=230 Identities=20% Similarity=0.279 Sum_probs=183.8
Q ss_pred hcCcccceeeeecCceEEEEEEeC-CCcEEEEEec---------------------cCCccccceEEEecCceEEEEEEe
Q 042435 142 TEYFHIRYCIGTGGYDSVYKAELP-DGKVVALKKL---------------------HHSETEDSAFVVYSPQCMFFIYEY 199 (412)
Q Consensus 142 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l---------------------~~~~~~~~~~~~~~~~~~~lv~ey 199 (412)
.++|.+.+.||+|+||.||+|... +|+.||+|.+ +|+++.....++...+..++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL 87 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence 467999999999999999999874 7999999965 466777777778888999999999
Q ss_pred ccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEe---cCCCcEEEeecCCccccCC
Q 042435 200 MERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILL---NSNLEAFVADFGTVRLLDV 276 (412)
Q Consensus 200 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl---~~~~~~kl~DfGla~~~~~ 276 (412)
+++|+|.+++.... .+++..+..++.|++.||+|||+. +++||||||+||++ +.++.+||+|||+++....
T Consensus 88 ~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 161 (304)
T 2jam_A 88 VSGGELFDRILERG---VYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN 161 (304)
T ss_dssp CCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC
T ss_pred CCCccHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccCCcceecCC
Confidence 99999998886543 589999999999999999999999 99999999999999 7889999999999975432
Q ss_pred CCCCcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccchhh
Q 042435 277 DSSNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKI 356 (412)
Q Consensus 277 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 356 (412)
. ......||+.|+|||.+.+..++.++||||||+++|||++|+.||... ........+.......+. ...
T Consensus 162 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~-------~~~~~~~~i~~~~~~~~~-~~~ 231 (304)
T 2jam_A 162 G--IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEE-------TESKLFEKIKEGYYEFES-PFW 231 (304)
T ss_dssp B--TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTS-------CHHHHHHHHHHCCCCCCT-TTT
T ss_pred C--ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCC-------CHHHHHHHHHcCCCCCCc-ccc
Confidence 2 223456899999999999999999999999999999999999998632 111111122222111110 111
Q ss_pred HHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 357 IQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 357 ~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
......+.+++.+||+.||++|||+.|++++
T Consensus 232 ~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (304)
T 2jam_A 232 DDISESAKDFICHLLEKDPNERYTCEKALSH 262 (304)
T ss_dssp TTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred ccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 1112347899999999999999999999975
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-39 Score=301.66 Aligned_cols=233 Identities=22% Similarity=0.260 Sum_probs=185.7
Q ss_pred HhhcCcccceeeeecCceEEEEEEeC-CCcEEEEEec-------------------------------cCCccccceEEE
Q 042435 140 DATEYFHIRYCIGTGGYDSVYKAELP-DGKVVALKKL-------------------------------HHSETEDSAFVV 187 (412)
Q Consensus 140 ~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l-------------------------------~~~~~~~~~~~~ 187 (412)
...++|++.+.||+|+||.||+|... +|+.||||.+ .|+++......+
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (298)
T 1phk_A 14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY 93 (298)
T ss_dssp -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence 34578999999999999999999874 6899999975 377777778888
Q ss_pred ecCceEEEEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEee
Q 042435 188 YSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVAD 267 (412)
Q Consensus 188 ~~~~~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~D 267 (412)
...+..++||||+++++|.+++.... .+++..+..++.|++.||+|||++ +++||||||+||+++.++.+||+|
T Consensus 94 ~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~d 167 (298)
T 1phk_A 94 ETNTFFFLVFDLMKKGELFDYLTEKV---TLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTD 167 (298)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECC
T ss_pred ccCCeEEEEEeccCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCCCcEEEec
Confidence 88899999999999999999987543 589999999999999999999999 999999999999999999999999
Q ss_pred cCCccccCCCCCCccccccccccccccccc------CcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhh
Q 042435 268 FGTVRLLDVDSSNRTLQAGTYGYIALELVY------TMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLI 341 (412)
Q Consensus 268 fGla~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~ 341 (412)
||++....... ......||+.|+|||++. ...++.++||||||+++|||++|+.||.... ......
T Consensus 168 fg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~-------~~~~~~ 239 (298)
T 1phk_A 168 FGFSCQLDPGE-KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK-------QMLMLR 239 (298)
T ss_dssp CTTCEECCTTC-CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS-------HHHHHH
T ss_pred ccchhhcCCCc-ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCcc-------HHHHHH
Confidence 99998765432 233457899999999885 4568899999999999999999999986321 111112
Q ss_pred HHhhhccCCccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 342 DILYQRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 342 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
.+.......+. .........+.+++.+||+.||++|||+.|++++
T Consensus 240 ~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (298)
T 1phk_A 240 MIMSGNYQFGS-PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 284 (298)
T ss_dssp HHHHTCCCCCT-TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred HHhcCCcccCc-ccccccCHHHHHHHHHHccCCcccCCCHHHHHhC
Confidence 22222222111 1111222348899999999999999999999864
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=311.70 Aligned_cols=237 Identities=21% Similarity=0.234 Sum_probs=179.4
Q ss_pred HHhhcCcccceeeeecCceEEEEEEeC-CCcEEEEEecc--------------------------CCccccceEEEecCc
Q 042435 139 IDATEYFHIRYCIGTGGYDSVYKAELP-DGKVVALKKLH--------------------------HSETEDSAFVVYSPQ 191 (412)
Q Consensus 139 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~--------------------------~~~~~~~~~~~~~~~ 191 (412)
....++|++.+.||+|+||.||+|... +|+.||||.++ |+++......+...+
T Consensus 6 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 85 (346)
T 1ua2_A 6 KSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKS 85 (346)
T ss_dssp -------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred HHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCC
Confidence 344578999999999999999999875 58999999753 566666667788888
Q ss_pred eEEEEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCc
Q 042435 192 CMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTV 271 (412)
Q Consensus 192 ~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla 271 (412)
..++||||+++ +|.+++.... ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++
T Consensus 86 ~~~lv~e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a 159 (346)
T 1ua2_A 86 NISLVFDFMET-DLEVIIKDNS--LVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLA 159 (346)
T ss_dssp CCEEEEECCSE-EHHHHHTTCC--SSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGG
T ss_pred ceEEEEEcCCC-CHHHHHHhcC--cCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEEEEecccc
Confidence 99999999975 8888776543 2488899999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCCcccccccccccccccccCc-ccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhc---
Q 042435 272 RLLDVDSSNRTLQAGTYGYIALELVYTM-VVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQR--- 347 (412)
Q Consensus 272 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~--- 347 (412)
+.............||+.|+|||++.+. .++.++|||||||++|||++|..||..... ...+..+....
T Consensus 160 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~-------~~~~~~i~~~~~~~ 232 (346)
T 1ua2_A 160 KSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSD-------LDQLTRIFETLGTP 232 (346)
T ss_dssp STTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHHHCCC
T ss_pred eeccCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCH-------HHHHHHHHHHcCCC
Confidence 8765544444556789999999998754 588999999999999999999999863211 00011111100
Q ss_pred ------------------cCCccc--hhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHH
Q 042435 348 ------------------LSPPIN--QKIIQDIILVSTIALACLRSKPKSRPTMQRISQEL 388 (412)
Q Consensus 348 ------------------~~~~~~--~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L 388 (412)
..+..+ .........+.+++.+||+.||++|||+.|++++-
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~ 293 (346)
T 1ua2_A 233 TEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMK 293 (346)
T ss_dssp CTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSG
T ss_pred ChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcCh
Confidence 000000 00011123488999999999999999999999874
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-39 Score=309.44 Aligned_cols=238 Identities=21% Similarity=0.276 Sum_probs=160.8
Q ss_pred hhcCcccc-eeeeecCceEEEEEEeC-CCcEEEEEec-----------------cCCccccceEEEec----CceEEEEE
Q 042435 141 ATEYFHIR-YCIGTGGYDSVYKAELP-DGKVVALKKL-----------------HHSETEDSAFVVYS----PQCMFFIY 197 (412)
Q Consensus 141 ~~~~f~~~-~~lG~G~~g~Vy~~~~~-~~~~vAvK~l-----------------~~~~~~~~~~~~~~----~~~~~lv~ 197 (412)
..++|.+. ++||+|+||.||+|... +|+.||||.+ .|+++.....++.. ....++||
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~ 105 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIM 105 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEEE
Confidence 45678885 46999999999999875 6999999976 45666666665544 45689999
Q ss_pred EeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecC---CCcEEEeecCCcccc
Q 042435 198 EYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNS---NLEAFVADFGTVRLL 274 (412)
Q Consensus 198 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~---~~~~kl~DfGla~~~ 274 (412)
||+++|+|.+++..... ..+++.++..++.|++.||+|||++ +|+||||||+||+++. ++.+||+|||+++..
T Consensus 106 e~~~gg~L~~~l~~~~~-~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~ 181 (336)
T 3fhr_A 106 ECMEGGELFSRIQERGD-QAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKET 181 (336)
T ss_dssp ECCTTEEHHHHHHTC-C-CCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred eccCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEeccccceec
Confidence 99999999999976532 2589999999999999999999999 9999999999999976 455999999999865
Q ss_pred CCCCCCcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccch
Q 042435 275 DVDSSNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQ 354 (412)
Q Consensus 275 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 354 (412)
... ......||+.|+|||++.+..++.++||||||+++|||++|+.||.......... .............+. .
T Consensus 182 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~---~~~~~~~~~~~~~~~-~ 255 (336)
T 3fhr_A 182 TQN--ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISP---GMKRRIRLGQYGFPN-P 255 (336)
T ss_dssp ------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC------------------------CCCT-T
T ss_pred ccc--ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhh---hHHHhhhccccccCc-h
Confidence 432 2234568999999999988899999999999999999999999986332110000 000001111111100 0
Q ss_pred hhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHH
Q 042435 355 KIIQDIILVSTIALACLRSKPKSRPTMQRISQEL 388 (412)
Q Consensus 355 ~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L 388 (412)
........+.+++.+||+.||++|||+.|++++-
T Consensus 256 ~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp 289 (336)
T 3fhr_A 256 EWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHP 289 (336)
T ss_dssp TSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSH
T ss_pred hhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence 0011223478899999999999999999999853
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-39 Score=306.40 Aligned_cols=231 Identities=23% Similarity=0.260 Sum_probs=177.2
Q ss_pred hcCcccceeeeecCceEEEEEEeC-CCcEEEEEecc-----------------------------CCccccceEEEecCc
Q 042435 142 TEYFHIRYCIGTGGYDSVYKAELP-DGKVVALKKLH-----------------------------HSETEDSAFVVYSPQ 191 (412)
Q Consensus 142 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~-----------------------------~~~~~~~~~~~~~~~ 191 (412)
.++|.+.+.||+|+||.||+|... +++.||||.++ |+++.....++.. +
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~ 87 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-E 87 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEES-S
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcC-C
Confidence 467999999999999999999774 68999999753 4555555555544 4
Q ss_pred eEEEEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCc---EEEeec
Q 042435 192 CMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLE---AFVADF 268 (412)
Q Consensus 192 ~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~---~kl~Df 268 (412)
..++||||+++|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++. +||+||
T Consensus 88 ~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Df 161 (322)
T 2ycf_A 88 DYYIVLELMEGGELFDKVVGNK---RLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDF 161 (322)
T ss_dssp SEEEEEECCTTEETHHHHSTTC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSSCCEEECCC
T ss_pred ceEEEEecCCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCCCeEEEccC
Confidence 4899999999999998887543 589999999999999999999999 9999999999999986654 999999
Q ss_pred CCccccCCCCCCccccccccccccccccc---CcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhh
Q 042435 269 GTVRLLDVDSSNRTLQAGTYGYIALELVY---TMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILY 345 (412)
Q Consensus 269 Gla~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~ 345 (412)
|+++...... ......||+.|+|||++. ...++.++||||||+++|||++|+.||... .......+.+.
T Consensus 162 g~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~-------~~~~~~~~~~~ 233 (322)
T 2ycf_A 162 GHSKILGETS-LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEH-------RTQVSLKDQIT 233 (322)
T ss_dssp TTCEECCCCH-HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCST-------TCSSCHHHHHH
T ss_pred ccceeccccc-ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCccc-------chHHHHHHHHH
Confidence 9998654321 123456899999999974 567889999999999999999999998732 11112222222
Q ss_pred hccCCccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 346 QRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
.......+.........+.+++.+||+.||++|||+.|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h 275 (322)
T 2ycf_A 234 SGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH 275 (322)
T ss_dssp HTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hCccccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhC
Confidence 221111111111223348899999999999999999999864
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=313.16 Aligned_cols=239 Identities=20% Similarity=0.286 Sum_probs=177.9
Q ss_pred hcCcccceeeeecCceEEEEEEeC-CCcEEEEEec-----------------------cCCccccceEEEecCceEEEEE
Q 042435 142 TEYFHIRYCIGTGGYDSVYKAELP-DGKVVALKKL-----------------------HHSETEDSAFVVYSPQCMFFIY 197 (412)
Q Consensus 142 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l-----------------------~~~~~~~~~~~~~~~~~~~lv~ 197 (412)
.++|++.+.||+|+||.||+|... +|+.||+|++ +|+++.....++...+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 103 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence 367999999999999999999875 5899999964 5777888888888899999999
Q ss_pred EeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCC
Q 042435 198 EYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVD 277 (412)
Q Consensus 198 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~ 277 (412)
||+++++|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 104 e~~~~~~l~~~~~~~~---~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 177 (331)
T 4aaa_A 104 EFVDHTILDDLELFPN---GLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 177 (331)
T ss_dssp ECCSEEHHHHHHHSTT---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred ecCCcchHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCCCceeecCC
Confidence 9999998888765443 489999999999999999999999 9999999999999999999999999999876554
Q ss_pred CCCcccccccccccccccccCc-ccCcccccHHHHHHHHHHHhCCCCccccccccc--------CCCCcchhhHHhhh--
Q 042435 278 SSNRTLQAGTYGYIALELVYTM-VVTEKCVIYSFGVVALEVLMGTHPGELLLSLSS--------SSGPKIMLIDILYQ-- 346 (412)
Q Consensus 278 ~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~--------~~~~~~~~~~~~~~-- 346 (412)
........||+.|+|||++.+. .++.++||||||+++|||++|+.||........ .... .........
T Consensus 178 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 256 (331)
T 4aaa_A 178 GEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLI-PRHQELFNKNP 256 (331)
T ss_dssp ------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCC-HHHHHHHHHCG
T ss_pred ccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCC-hhhhhHhhhcc
Confidence 4444556789999999998775 789999999999999999999999863211000 0000 000000000
Q ss_pred --------ccCC--ccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 347 --------RLSP--PINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 347 --------~~~~--~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
.... +...........+.+++.+||+.||++|||+.|++++
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 307 (331)
T 4aaa_A 257 VFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH 307 (331)
T ss_dssp GGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred ccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0000 0000001122348899999999999999999999875
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=310.44 Aligned_cols=239 Identities=23% Similarity=0.309 Sum_probs=185.6
Q ss_pred hcCcccceeeeecCceEEEEEEe------CCCcEEEEEec----------------------cCCccccceEEEecCceE
Q 042435 142 TEYFHIRYCIGTGGYDSVYKAEL------PDGKVVALKKL----------------------HHSETEDSAFVVYSPQCM 193 (412)
Q Consensus 142 ~~~f~~~~~lG~G~~g~Vy~~~~------~~~~~vAvK~l----------------------~~~~~~~~~~~~~~~~~~ 193 (412)
.++|++.+.||+|+||.||+|.+ .+++.||||.+ +|+++......+...+..
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 108 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence 46899999999999999999974 35779999975 577788888888888899
Q ss_pred EEEEEeccCCceeeeeccCcc----cccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecC---CCcEEEe
Q 042435 194 FFIYEYMERGSLFCVLRDDDE----AIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNS---NLEAFVA 266 (412)
Q Consensus 194 ~lv~ey~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~---~~~~kl~ 266 (412)
++||||+++|+|.+++..... ...+++..++.++.|++.||+|||++ +|+||||||+||+++. +..+||+
T Consensus 109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~~~kl~ 185 (327)
T 2yfx_A 109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIG 185 (327)
T ss_dssp EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcceEEEC
Confidence 999999999999999976531 13489999999999999999999999 9999999999999984 4569999
Q ss_pred ecCCccccCCCCC--CcccccccccccccccccCcccCcccccHHHHHHHHHHHh-CCCCcccccccccCCCCcchhhHH
Q 042435 267 DFGTVRLLDVDSS--NRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLM-GTHPGELLLSLSSSSGPKIMLIDI 343 (412)
Q Consensus 267 DfGla~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~ 343 (412)
|||+++....... ......||+.|+|||.+.+..++.++||||||+++|||+| |+.||... ......+.
T Consensus 186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~--------~~~~~~~~ 257 (327)
T 2yfx_A 186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK--------SNQEVLEF 257 (327)
T ss_dssp CCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC--------CHHHHHHH
T ss_pred ccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCc--------CHHHHHHH
Confidence 9999875533221 2234467899999999988899999999999999999998 99998632 11112222
Q ss_pred hhhccCCccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhcCCCC
Q 042435 344 LYQRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELEGKTPM 394 (412)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~ 394 (412)
+........+... ...+.+++.+||+.||++|||+.|++++|+.+...
T Consensus 258 ~~~~~~~~~~~~~---~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 305 (327)
T 2yfx_A 258 VTSGGRMDPPKNC---PGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 305 (327)
T ss_dssp HHTTCCCCCCTTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HhcCCCCCCCCCC---CHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcC
Confidence 2222121111222 22378899999999999999999999999877543
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=297.79 Aligned_cols=226 Identities=24% Similarity=0.365 Sum_probs=175.8
Q ss_pred cCcccceeeeecCceEEEEEEeC-CCcEEEEEec------------------------cCCccccceEEEecCceEEEEE
Q 042435 143 EYFHIRYCIGTGGYDSVYKAELP-DGKVVALKKL------------------------HHSETEDSAFVVYSPQCMFFIY 197 (412)
Q Consensus 143 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l------------------------~~~~~~~~~~~~~~~~~~~lv~ 197 (412)
++|.+.+.||+|+||.||+|... +|+.||||.+ +|+++......+...+..++||
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 90 (276)
T 2h6d_A 11 GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVM 90 (276)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEE
Confidence 57999999999999999999875 7999999964 4677777788888899999999
Q ss_pred EeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCC
Q 042435 198 EYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVD 277 (412)
Q Consensus 198 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~ 277 (412)
||+++++|.+++.... .+++..+..++.|++.||+|||++ +++||||||+||+++.++.+||+|||++......
T Consensus 91 e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~ 164 (276)
T 2h6d_A 91 EYVSGGELFDYICKHG---RVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG 164 (276)
T ss_dssp ECCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC-
T ss_pred eccCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeecccccccCCC
Confidence 9999999999987543 589999999999999999999999 9999999999999999999999999999865433
Q ss_pred CCCcccccccccccccccccCccc-CcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccchhh
Q 042435 278 SSNRTLQAGTYGYIALELVYTMVV-TEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKI 356 (412)
Q Consensus 278 ~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 356 (412)
. ......||+.|+|||.+.+..+ +.++||||||+++|||++|+.||.... .....+.+...... .+...
T Consensus 165 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~--------~~~~~~~~~~~~~~-~~~~~ 234 (276)
T 2h6d_A 165 E-FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEH--------VPTLFKKIRGGVFY-IPEYL 234 (276)
T ss_dssp -------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHCCCC-CCTTS
T ss_pred c-ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCc--------HHHHHHHhhcCccc-Cchhc
Confidence 2 2234468999999999987765 689999999999999999999986321 11112222221111 11111
Q ss_pred HHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 357 IQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 357 ~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
...+.+++.+||+.||++|||+.|++++
T Consensus 235 ---~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 235 ---NRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp ---CHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred ---CHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 1237789999999999999999999986
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=325.91 Aligned_cols=230 Identities=20% Similarity=0.289 Sum_probs=186.1
Q ss_pred hcCcccceeeeecCceEEEEEEeC-CCcEEEEEec------------------------cCCccccceEEEecCceEEEE
Q 042435 142 TEYFHIRYCIGTGGYDSVYKAELP-DGKVVALKKL------------------------HHSETEDSAFVVYSPQCMFFI 196 (412)
Q Consensus 142 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l------------------------~~~~~~~~~~~~~~~~~~~lv 196 (412)
.++|++.+.||+|+||.||+|... +|+.||||.+ +|+++.....++...+..++|
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 104 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV 104 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 457999999999999999999875 7999999964 577777888888889999999
Q ss_pred EEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEe---cCCCcEEEeecCCccc
Q 042435 197 YEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILL---NSNLEAFVADFGTVRL 273 (412)
Q Consensus 197 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl---~~~~~~kl~DfGla~~ 273 (412)
|||+++|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+|||+ +.++.+||+|||+++.
T Consensus 105 ~e~~~~~~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 178 (484)
T 3nyv_A 105 GEVYTGGELFDEIISRK---RFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTH 178 (484)
T ss_dssp ECCCCSCBHHHHHHTCS---CCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCTTHHHH
T ss_pred EecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEE
Confidence 99999999998887654 589999999999999999999999 99999999999999 5678999999999987
Q ss_pred cCCCCCCcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccc
Q 042435 274 LDVDSSNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPIN 353 (412)
Q Consensus 274 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 353 (412)
..... ......||+.|+|||++.+ .++.++||||+||++|||++|+.||... ........+.......+.
T Consensus 179 ~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~-------~~~~~~~~i~~~~~~~~~- 248 (484)
T 3nyv_A 179 FEASK-KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGA-------NEYDILKKVEKGKYTFEL- 248 (484)
T ss_dssp BCCCC-SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCS-------SHHHHHHHHHHCCCCCCS-
T ss_pred ccccc-ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCC-------CHHHHHHHHHcCCCCCCC-
Confidence 65433 3344579999999999866 6899999999999999999999998732 111122222222222221
Q ss_pred hhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 354 QKIIQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 354 ~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
+........+.+++.+||+.||++|||+.|++++
T Consensus 249 ~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 282 (484)
T 3nyv_A 249 PQWKKVSESAKDLIRKMLTYVPSMRISARDALDH 282 (484)
T ss_dssp GGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred cccccCCHHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence 1111223347899999999999999999999875
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=304.55 Aligned_cols=235 Identities=15% Similarity=0.163 Sum_probs=178.3
Q ss_pred cCcccceeeeecCceEEEEEEe-CCCcEEEEEecc-------------------CCccccceEEEec--CceEEEEEEec
Q 042435 143 EYFHIRYCIGTGGYDSVYKAEL-PDGKVVALKKLH-------------------HSETEDSAFVVYS--PQCMFFIYEYM 200 (412)
Q Consensus 143 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l~-------------------~~~~~~~~~~~~~--~~~~~lv~ey~ 200 (412)
++|++.+.||+|+||.||+|.. .+++.||||.++ |+++.....++.. ....++||||+
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~~ 115 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHV 115 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEECC
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEecc
Confidence 6799999999999999999976 579999999763 7777777777776 66789999999
Q ss_pred cCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCC-cEEEeecCCccccCCCCC
Q 042435 201 ERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNL-EAFVADFGTVRLLDVDSS 279 (412)
Q Consensus 201 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~-~~kl~DfGla~~~~~~~~ 279 (412)
++++|.+++. .+++..+..++.|++.||+|||++ +|+||||||+|||++.++ .+||+|||+++.......
T Consensus 116 ~~~~l~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~ 186 (330)
T 3nsz_A 116 NNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE 186 (330)
T ss_dssp CCCCHHHHGG------GCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTCC
T ss_pred CchhHHHHHH------hCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCCc
Confidence 9999988874 388899999999999999999999 999999999999999766 899999999987654332
Q ss_pred CcccccccccccccccccC-cccCcccccHHHHHHHHHHHhCCCCcccccccc--------------------c-CCCCc
Q 042435 280 NRTLQAGTYGYIALELVYT-MVVTEKCVIYSFGVVALEVLMGTHPGELLLSLS--------------------S-SSGPK 337 (412)
Q Consensus 280 ~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~--------------------~-~~~~~ 337 (412)
.....||..|+|||.+.+ ..++.++|||||||++|||++|+.||....... . .....
T Consensus 187 -~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 265 (330)
T 3nsz_A 187 -YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD 265 (330)
T ss_dssp -CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCC
T ss_pred -cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccccc
Confidence 334578999999999877 678999999999999999999999984211000 0 00000
Q ss_pred chhhHHhhhccCCcc-----chhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 338 IMLIDILYQRLSPPI-----NQKIIQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 338 ~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
....+.......... ..........+.+++.+||+.||++|||++|++++
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 320 (330)
T 3nsz_A 266 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 320 (330)
T ss_dssp THHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred cchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 000000000000000 00000012348899999999999999999999975
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=303.98 Aligned_cols=236 Identities=24% Similarity=0.323 Sum_probs=177.5
Q ss_pred hcCcccceeeeecCceEEEEEEeC--CCc--EEEEEec------------------------cCCccccceEEEecCceE
Q 042435 142 TEYFHIRYCIGTGGYDSVYKAELP--DGK--VVALKKL------------------------HHSETEDSAFVVYSPQCM 193 (412)
Q Consensus 142 ~~~f~~~~~lG~G~~g~Vy~~~~~--~~~--~vAvK~l------------------------~~~~~~~~~~~~~~~~~~ 193 (412)
.++|++.+.||+|+||.||+|.+. +++ .||+|.+ +|+++......+... ..
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP-PM 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SC
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccC-Cc
Confidence 357999999999999999999763 333 6899965 356666666666554 48
Q ss_pred EEEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccc
Q 042435 194 FFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRL 273 (412)
Q Consensus 194 ~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~ 273 (412)
++|+||+++|+|.+++.... ..+++..+..++.|++.||+|||++ +++||||||+||+++.++.+||+|||+++.
T Consensus 96 ~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~ 170 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKHQ--GHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRA 170 (291)
T ss_dssp EEEEECCTTCBHHHHHHHHG--GGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred eeeEecccCCCHHHHHHhcc--CCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEcccccccc
Confidence 99999999999999887543 2589999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCC---cccccccccccccccccCcccCcccccHHHHHHHHHHHh-CCCCcccccccccCCCCcchhhHHhhhccC
Q 042435 274 LDVDSSN---RTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLM-GTHPGELLLSLSSSSGPKIMLIDILYQRLS 349 (412)
Q Consensus 274 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 349 (412)
....... .....+|..|+|||.+.+..++.++||||||+++|||++ |+.||... ........+......
T Consensus 171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~-------~~~~~~~~~~~~~~~ 243 (291)
T 1u46_A 171 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL-------NGSQILHKIDKEGER 243 (291)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTC-------CHHHHHHHHHTSCCC
T ss_pred ccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccC-------CHHHHHHHHHccCCC
Confidence 6543322 123457889999999988889999999999999999999 99998632 111111222222222
Q ss_pred CccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhcCCC
Q 042435 350 PPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELEGKTP 393 (412)
Q Consensus 350 ~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 393 (412)
.+..... ...+.+++.+||+.||++|||+.++++.|+++.+
T Consensus 244 ~~~~~~~---~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 284 (291)
T 1u46_A 244 LPRPEDC---PQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP 284 (291)
T ss_dssp CCCCTTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred CCCCcCc---CHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence 2211222 2348889999999999999999999999998875
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-39 Score=323.76 Aligned_cols=230 Identities=22% Similarity=0.276 Sum_probs=181.0
Q ss_pred hcCcccceeeeecCceEEEEEEeC-CCcEEEEEec-----------------------cCCccccceEEEecCceEEEEE
Q 042435 142 TEYFHIRYCIGTGGYDSVYKAELP-DGKVVALKKL-----------------------HHSETEDSAFVVYSPQCMFFIY 197 (412)
Q Consensus 142 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l-----------------------~~~~~~~~~~~~~~~~~~~lv~ 197 (412)
.+.|++.+.||+|+||.||+|... +++.||+|.+ +|+++.....++......++||
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 457999999999999999999875 6899999964 5788888888899999999999
Q ss_pred EeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecC---CCcEEEeecCCcccc
Q 042435 198 EYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNS---NLEAFVADFGTVRLL 274 (412)
Q Consensus 198 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~---~~~~kl~DfGla~~~ 274 (412)
||+++|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+|||++. ++.+||+|||+++..
T Consensus 116 e~~~~g~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~ 189 (494)
T 3lij_A 116 ECYKGGELFDEIIHRM---KFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVF 189 (494)
T ss_dssp ECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred ecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEEECCCCeEC
Confidence 9999999988876543 589999999999999999999999 9999999999999975 455999999999876
Q ss_pred CCCCCCcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccch
Q 042435 275 DVDSSNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQ 354 (412)
Q Consensus 275 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 354 (412)
.... ......||+.|+|||++. ..++.++||||+||++|||++|+.||... ........+.......+. .
T Consensus 190 ~~~~-~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~-------~~~~~~~~i~~~~~~~~~-~ 259 (494)
T 3lij_A 190 ENQK-KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQ-------TDQEILRKVEKGKYTFDS-P 259 (494)
T ss_dssp BTTB-CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCS-------SHHHHHHHHHHTCCCCCS-G
T ss_pred CCCc-cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCC-------CHHHHHHHHHhCCCCCCc-h
Confidence 5432 233457999999999886 56899999999999999999999998732 111112222222222111 1
Q ss_pred hhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 355 KIIQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 355 ~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
........+.+++.+||+.||++|||+.|++++
T Consensus 260 ~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 292 (494)
T 3lij_A 260 EWKNVSEGAKDLIKQMLQFDSQRRISAQQALEH 292 (494)
T ss_dssp GGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred hcccCCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence 111222347899999999999999999999865
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=318.25 Aligned_cols=224 Identities=17% Similarity=0.131 Sum_probs=169.1
Q ss_pred HhhcCcccceeeeecCceEEEEEEe-CCCcEEEEEecc---------------------------CCccccce-------
Q 042435 140 DATEYFHIRYCIGTGGYDSVYKAEL-PDGKVVALKKLH---------------------------HSETEDSA------- 184 (412)
Q Consensus 140 ~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l~---------------------------~~~~~~~~------- 184 (412)
...++|++.+.||+|+||.||+|.. .+|+.||||.++ |+++....
T Consensus 70 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~ 149 (377)
T 3byv_A 70 ERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPF 149 (377)
T ss_dssp CCCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCS
T ss_pred CCCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhh
Confidence 3457899999999999999999986 569999999864 22222221
Q ss_pred EEEecCc-----------------eEEEEEEeccCCceeeeeccCcc----cccCCHHHHHHHHHHHHHHHHHHHhCCCC
Q 042435 185 FVVYSPQ-----------------CMFFIYEYMERGSLFCVLRDDDE----AIELNWTRRMNIVKSVAHALSYLHHDCTP 243 (412)
Q Consensus 185 ~~~~~~~-----------------~~~lv~ey~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~ 243 (412)
.++...+ ..++||||+ +|+|.+++..... ...++|..++.++.|++.||+|||++
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~--- 225 (377)
T 3byv_A 150 DLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY--- 225 (377)
T ss_dssp EEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---
T ss_pred hhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---
Confidence 2222222 378999999 6899999875421 12345688999999999999999999
Q ss_pred CcEEeCCCCCCEEecCCCcEEEeecCCccccCCCCCCcccccccccccccccccCc-----------ccCcccccHHHHH
Q 042435 244 SIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTYGYIALELVYTM-----------VVTEKCVIYSFGV 312 (412)
Q Consensus 244 ~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~s~ksDv~S~Gv 312 (412)
+|+||||||+|||++.++.+||+|||+++.... ......| +.|+|||++.+. .++.++|||||||
T Consensus 226 ~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~---~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~ 301 (377)
T 3byv_A 226 GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA---RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL 301 (377)
T ss_dssp TEECSCCCGGGEEECTTCCEEECCGGGCEETTC---EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHH
T ss_pred CeecCCCCHHHEEEcCCCCEEEEechhheecCC---cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHH
Confidence 999999999999999999999999999985322 2334567 999999999887 8999999999999
Q ss_pred HHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 313 VALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 313 il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
++|||+||+.||...... .....+. ... ... ...+.+++.+||+.||++|||+.|++++
T Consensus 302 il~elltg~~Pf~~~~~~-------~~~~~~~-~~~-~~~-------~~~~~~li~~~L~~dp~~Rpt~~e~l~h 360 (377)
T 3byv_A 302 VIYWIWCADLPITKDAAL-------GGSEWIF-RSC-KNI-------PQPVRALLEGFLRYPKEDRLLPLQAMET 360 (377)
T ss_dssp HHHHHHHSSCCC-------------CCSGGGG-SSC-CCC-------CHHHHHHHHHHTCSSGGGCCCHHHHHTS
T ss_pred HHHHHHHCCCCCcccccc-------cchhhhh-hhc-cCC-------CHHHHHHHHHHcCCCchhCCCHHHHhhC
Confidence 999999999998632110 1111111 111 111 1237789999999999999999999863
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=299.39 Aligned_cols=226 Identities=21% Similarity=0.293 Sum_probs=175.9
Q ss_pred CcccceeeeecCceEEEEEEe-CCCcEEEEEec-----------------------cCCccccceEEEec----CceEEE
Q 042435 144 YFHIRYCIGTGGYDSVYKAEL-PDGKVVALKKL-----------------------HHSETEDSAFVVYS----PQCMFF 195 (412)
Q Consensus 144 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l-----------------------~~~~~~~~~~~~~~----~~~~~l 195 (412)
.|.+.+.||+|+||.||+|.. .++..||+|.+ +|+++......+.. ....++
T Consensus 27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 106 (290)
T 1t4h_A 27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 106 (290)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEE
Confidence 477888999999999999976 46889999964 46677666655433 466899
Q ss_pred EEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCC--cEEeCCCCCCEEec-CCCcEEEeecCCcc
Q 042435 196 IYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPS--IVHRDISSNNILLN-SNLEAFVADFGTVR 272 (412)
Q Consensus 196 v~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~--ivHrDlkp~NILl~-~~~~~kl~DfGla~ 272 (412)
||||+++|+|.+++.... .+++..+..++.|++.||+|||+. + ++||||||+||+++ .++.+||+|||++.
T Consensus 107 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~ 180 (290)
T 1t4h_A 107 VTELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 180 (290)
T ss_dssp EEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred EEEecCCCCHHHHHHHcc---CCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEeeCCCcc
Confidence 999999999999987543 589999999999999999999998 6 99999999999997 78999999999997
Q ss_pred ccCCCCCCcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCcc
Q 042435 273 LLDVDSSNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPI 352 (412)
Q Consensus 273 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 352 (412)
..... ......||+.|+|||.+. ..++.++||||||+++|||++|+.||... ...............+..
T Consensus 181 ~~~~~--~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~-------~~~~~~~~~~~~~~~~~~ 250 (290)
T 1t4h_A 181 LKRAS--FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSEC-------QNAAQIYRRVTSGVKPAS 250 (290)
T ss_dssp GCCTT--SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTC-------SSHHHHHHHHTTTCCCGG
T ss_pred ccccc--ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCc-------CcHHHHHHHHhccCCccc
Confidence 54332 233457899999999876 45899999999999999999999998632 111111222222211111
Q ss_pred chhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 353 NQKIIQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 353 ~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
........+.+++.+||+.||++|||+.|++++
T Consensus 251 --~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 283 (290)
T 1t4h_A 251 --FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp --GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred --cCCCCCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 111112348899999999999999999999875
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=322.72 Aligned_cols=231 Identities=23% Similarity=0.282 Sum_probs=182.9
Q ss_pred hhcCcccceeeeecCceEEEEEEeC-CCcEEEEEec----------------------------------cCCccccceE
Q 042435 141 ATEYFHIRYCIGTGGYDSVYKAELP-DGKVVALKKL----------------------------------HHSETEDSAF 185 (412)
Q Consensus 141 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l----------------------------------~~~~~~~~~~ 185 (412)
..++|.+.+.||+|+||+||+|... +++.||+|.+ +|+++.....
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 4578999999999999999999874 6889999965 3677777777
Q ss_pred EEecCceEEEEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCC---c
Q 042435 186 VVYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNL---E 262 (412)
Q Consensus 186 ~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~---~ 262 (412)
++......++||||+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++ .
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~ 187 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIINRH---KFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLN 187 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESSTTCCSS
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecCCCCcc
Confidence 8888999999999999999998886543 589999999999999999999999 999999999999998765 6
Q ss_pred EEEeecCCccccCCCCCCcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhH
Q 042435 263 AFVADFGTVRLLDVDSSNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLID 342 (412)
Q Consensus 263 ~kl~DfGla~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~ 342 (412)
+||+|||+++...... ......||+.|+|||++. ..++.++||||+||++|||++|..||... ........
T Consensus 188 ~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~-------~~~~~~~~ 258 (504)
T 3q5i_A 188 IKIVDFGLSSFFSKDY-KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQ-------NDQDIIKK 258 (504)
T ss_dssp EEECCCTTCEECCTTS-CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCS-------SHHHHHHH
T ss_pred EEEEECCCCEEcCCCC-ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCC-------CHHHHHHH
Confidence 9999999998765432 234457999999999986 46899999999999999999999998732 11112222
Q ss_pred HhhhccCCccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 343 ILYQRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
+.......+. .........+.+++.+||+.||++|||++|++++
T Consensus 259 i~~~~~~~~~-~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h 302 (504)
T 3q5i_A 259 VEKGKYYFDF-NDWKNISDEAKELIKLMLTYDYNKRCTAEEALNS 302 (504)
T ss_dssp HHHCCCCCCH-HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHcCCCCCCc-cccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 2222222111 1111223348899999999999999999999875
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-39 Score=304.99 Aligned_cols=243 Identities=21% Similarity=0.324 Sum_probs=181.2
Q ss_pred HHHHHhhcCcccceeeeecCceEEEEEEeCCCcEEEEEec-----------------------cCCccccceEEEecCce
Q 042435 136 ENLIDATEYFHIRYCIGTGGYDSVYKAELPDGKVVALKKL-----------------------HHSETEDSAFVVYSPQC 192 (412)
Q Consensus 136 ~~l~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~l-----------------------~~~~~~~~~~~~~~~~~ 192 (412)
++..-..++|++.+.||+|+||.||+|...+ .+|+|.+ +|+++......+...+.
T Consensus 26 ~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 103 (319)
T 2y4i_B 26 QEWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPH 103 (319)
T ss_dssp GGSSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSC
T ss_pred ccccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCc
Confidence 3444456789999999999999999998854 4888865 35566666677888889
Q ss_pred EEEEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCcc
Q 042435 193 MFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVR 272 (412)
Q Consensus 193 ~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~ 272 (412)
.++||||+++++|.+++.... ..+++..+..++.|++.||+|||++ +++||||||+||+++ ++.+||+|||+++
T Consensus 104 ~~iv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~ 177 (319)
T 2y4i_B 104 LAIITSLCKGRTLYSVVRDAK--IVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDFGLFS 177 (319)
T ss_dssp EEEECBCCCSEEHHHHTTSSC--CCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECCCSCCC
T ss_pred eEEEeecccCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEeecCCcc
Confidence 999999999999999997653 2489999999999999999999999 999999999999998 6799999999987
Q ss_pred ccCCC-----CCCcccccccccccccccccC---------cccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcc
Q 042435 273 LLDVD-----SSNRTLQAGTYGYIALELVYT---------MVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKI 338 (412)
Q Consensus 273 ~~~~~-----~~~~~~~~gt~~y~aPE~~~~---------~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~ 338 (412)
..... ........||+.|+|||.+.+ ..++.++||||||+++|||++|+.||.... ..
T Consensus 178 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~--------~~ 249 (319)
T 2y4i_B 178 ISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQP--------AE 249 (319)
T ss_dssp ----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCC--------HH
T ss_pred ccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCC--------HH
Confidence 54321 122234468999999999864 357889999999999999999999987321 11
Q ss_pred hhhHHhhhccCCccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhcCCCCCC
Q 042435 339 MLIDILYQRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELEGKTPMKK 396 (412)
Q Consensus 339 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~~~ 396 (412)
.....+.....+..... .....+.+++.+||+.||++|||+.|+++.|+++.....
T Consensus 250 ~~~~~~~~~~~~~~~~~--~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~ 305 (319)
T 2y4i_B 250 AIIWQMGTGMKPNLSQI--GMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNR 305 (319)
T ss_dssp HHHHHHHTTCCCCCCCS--SCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC-----
T ss_pred HHHHHhccCCCCCCCcC--CCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhc
Confidence 11111111111111100 011237789999999999999999999999999876543
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-39 Score=308.84 Aligned_cols=243 Identities=21% Similarity=0.326 Sum_probs=185.9
Q ss_pred hcCcccceeeeecCceEEEEEEe-----CCCcEEEEEec---------------------cCCccccceEEEecC--ceE
Q 042435 142 TEYFHIRYCIGTGGYDSVYKAEL-----PDGKVVALKKL---------------------HHSETEDSAFVVYSP--QCM 193 (412)
Q Consensus 142 ~~~f~~~~~lG~G~~g~Vy~~~~-----~~~~~vAvK~l---------------------~~~~~~~~~~~~~~~--~~~ 193 (412)
.++|++.+.||+|+||.||+|.+ .+++.||||++ +|+++.....++... ...
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 119 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence 35689999999999999999984 46899999975 356666666655544 368
Q ss_pred EEEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccc
Q 042435 194 FFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRL 273 (412)
Q Consensus 194 ~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~ 273 (412)
++||||+++|+|.+++..... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 120 ~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~Dfg~~~~ 194 (326)
T 2w1i_A 120 KLIMEYLPYGSLRDYLQKHKE--RIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKV 194 (326)
T ss_dssp EEEECCCTTCBHHHHHHHSTT--SSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEECCCCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEecCcchhh
Confidence 999999999999999976532 489999999999999999999998 999999999999999999999999999987
Q ss_pred cCCCCCC---cccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccc-c---ccCCCCcc----hhhH
Q 042435 274 LDVDSSN---RTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLS-L---SSSSGPKI----MLID 342 (412)
Q Consensus 274 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~-~---~~~~~~~~----~~~~ 342 (412)
....... .....++..|+|||.+.+..++.++||||||+++|||+||..|+..... . ........ .+.+
T Consensus 195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (326)
T 2w1i_A 195 LPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE 274 (326)
T ss_dssp CCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHH
T ss_pred ccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHH
Confidence 6543321 1234567889999999888899999999999999999999999763210 0 00001101 1112
Q ss_pred HhhhccCCccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhcCC
Q 042435 343 ILYQRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELEGKT 392 (412)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 392 (412)
.+......+.+... ...+.+++.+||+.||++|||+.|+++.|+.+.
T Consensus 275 ~~~~~~~~~~~~~~---~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~ 321 (326)
T 2w1i_A 275 LLKNNGRLPRPDGC---PDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR 321 (326)
T ss_dssp HHHTTCCCCCCTTC---CHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred HhhcCCCCCCCCcc---cHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 22222222222222 234888999999999999999999999998764
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=308.74 Aligned_cols=240 Identities=18% Similarity=0.243 Sum_probs=175.9
Q ss_pred hcCcccceeeeecCceEEEEEEe-CCCcEEEEEec-----------------------cCCccccceEEEec--------
Q 042435 142 TEYFHIRYCIGTGGYDSVYKAEL-PDGKVVALKKL-----------------------HHSETEDSAFVVYS-------- 189 (412)
Q Consensus 142 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l-----------------------~~~~~~~~~~~~~~-------- 189 (412)
.++|++.+.||+|+||.||+|.. .+|+.||+|++ +|+++.....++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 46799999999999999999987 57999999965 35555555555544
Q ss_pred CceEEEEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecC
Q 042435 190 PQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFG 269 (412)
Q Consensus 190 ~~~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG 269 (412)
.+..++||||+++ +|.+.+..... .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||
T Consensus 96 ~~~~~lv~e~~~~-~l~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg 169 (351)
T 3mi9_A 96 KGSIYLVFDFCEH-DLAGLLSNVLV--KFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFG 169 (351)
T ss_dssp -CEEEEEEECCSE-EHHHHHHCTTS--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred CceEEEEEeccCC-CHHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEccch
Confidence 4568999999975 77776655432 489999999999999999999999 99999999999999999999999999
Q ss_pred CccccCCCC----CCcccccccccccccccccC-cccCcccccHHHHHHHHHHHhCCCCccccccc-------------c
Q 042435 270 TVRLLDVDS----SNRTLQAGTYGYIALELVYT-MVVTEKCVIYSFGVVALEVLMGTHPGELLLSL-------------S 331 (412)
Q Consensus 270 la~~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~-------------~ 331 (412)
+++...... .......||+.|+|||++.+ ..++.++|||||||++|||+||+.||...... .
T Consensus 170 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~ 249 (351)
T 3mi9_A 170 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT 249 (351)
T ss_dssp TCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred hcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence 998664321 22244578999999999876 45899999999999999999999998732110 0
Q ss_pred cCCCCcchhhHHhhhc-cCCccchhhHH------HHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 332 SSSGPKIMLIDILYQR-LSPPINQKIIQ------DIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 332 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~------~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
....+.....+..... ........... ....+.+++.+||+.||++|||++|++++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 250 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp TTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 0000000000000000 00000000000 12347899999999999999999999986
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-39 Score=334.36 Aligned_cols=225 Identities=21% Similarity=0.271 Sum_probs=177.2
Q ss_pred eeeeecCceEEEEEEe---CCCcEEEEEec-----------------------cCCccccceEEEecCceEEEEEEeccC
Q 042435 149 YCIGTGGYDSVYKAEL---PDGKVVALKKL-----------------------HHSETEDSAFVVYSPQCMFFIYEYMER 202 (412)
Q Consensus 149 ~~lG~G~~g~Vy~~~~---~~~~~vAvK~l-----------------------~~~~~~~~~~~~~~~~~~~lv~ey~~~ 202 (412)
+.||+|+||.||+|.+ ..++.||||.+ +|+++.....++. .+..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCCEEEEEEccCC
Confidence 4799999999999965 34688999965 4667777766665 4568999999999
Q ss_pred CceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCCC---
Q 042435 203 GSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSS--- 279 (412)
Q Consensus 203 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~--- 279 (412)
|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.......
T Consensus 454 g~L~~~l~~~~---~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 527 (635)
T 4fl3_A 454 GPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 527 (635)
T ss_dssp EEHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC------
T ss_pred CCHHHHHhhCC---CCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccc
Confidence 99999997543 589999999999999999999999 999999999999999999999999999987654322
Q ss_pred CcccccccccccccccccCcccCcccccHHHHHHHHHHHh-CCCCcccccccccCCCCcchhhHHhhhccCCccchhhHH
Q 042435 280 NRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLM-GTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKIIQ 358 (412)
Q Consensus 280 ~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 358 (412)
......+|+.|+|||++.+..++.++|||||||++|||++ |+.||... ......+.+......+.+....
T Consensus 528 ~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~--------~~~~~~~~i~~~~~~~~p~~~~- 598 (635)
T 4fl3_A 528 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM--------KGSEVTAMLEKGERMGCPAGCP- 598 (635)
T ss_dssp -------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC--------CHHHHHHHHHTTCCCCCCTTCC-
T ss_pred cccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC--------CHHHHHHHHHcCCCCCCCCCCC-
Confidence 1233456789999999998899999999999999999998 99998732 1112233333332222222222
Q ss_pred HHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhcC
Q 042435 359 DIILVSTIALACLRSKPKSRPTMQRISQELEGK 391 (412)
Q Consensus 359 ~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 391 (412)
..+.+++.+||+.||++|||+.+|++.|++.
T Consensus 599 --~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~ 629 (635)
T 4fl3_A 599 --REMYDLMNLCWTYDVENRPGFAAVELRLRNY 629 (635)
T ss_dssp --HHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred --HHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 3488999999999999999999999999864
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-39 Score=315.24 Aligned_cols=235 Identities=21% Similarity=0.232 Sum_probs=174.6
Q ss_pred hcCcccceeeeecCceEEEEEEeCCCcEEEEEec-----------------cCCccccceEEEecCc------eEEEEEE
Q 042435 142 TEYFHIRYCIGTGGYDSVYKAELPDGKVVALKKL-----------------HHSETEDSAFVVYSPQ------CMFFIYE 198 (412)
Q Consensus 142 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~l-----------------~~~~~~~~~~~~~~~~------~~~lv~e 198 (412)
..+|++.+.||+|+||.||+|+...+..||+|++ +|+++.....++.... ..++|||
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~e 118 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLE 118 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTSCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcchHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEEee
Confidence 3469999999999999999999977777999964 5778877777664332 3789999
Q ss_pred eccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEec-CCCcEEEeecCCccccCCC
Q 042435 199 YMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLN-SNLEAFVADFGTVRLLDVD 277 (412)
Q Consensus 199 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~-~~~~~kl~DfGla~~~~~~ 277 (412)
|++++.+............+++..+..++.|+++||+|||++ +|+||||||+|||++ .++.+||+|||+++.....
T Consensus 119 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~ 195 (394)
T 4e7w_A 119 YVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAG 195 (394)
T ss_dssp CCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred ccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCCCcccccCC
Confidence 998643332222111123589999999999999999999999 999999999999999 7999999999999876443
Q ss_pred CCCcccccccccccccccccCc-ccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhh-----------
Q 042435 278 SSNRTLQAGTYGYIALELVYTM-VVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILY----------- 345 (412)
Q Consensus 278 ~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~----------- 345 (412)
.. .....||+.|+|||++.+. .++.++|||||||++|||++|+.||...... ..+..+..
T Consensus 196 ~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~-------~~l~~i~~~~g~p~~~~~~ 267 (394)
T 4e7w_A 196 EP-NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGI-------DQLVEIIKVLGTPSREQIK 267 (394)
T ss_dssp CC-CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHHHCCCCHHHHH
T ss_pred CC-CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHHHhCCCCHHHHH
Confidence 32 2345789999999998764 5899999999999999999999999732110 00111110
Q ss_pred ---hc-----c---CCccchh--hHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 346 ---QR-----L---SPPINQK--IIQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 346 ---~~-----~---~~~~~~~--~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
+. . .+..... .......+.+++.+||+.||++|||+.|++++
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 268 TMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322 (394)
T ss_dssp HHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred hhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence 00 0 0000000 00012348899999999999999999999986
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=303.76 Aligned_cols=242 Identities=22% Similarity=0.265 Sum_probs=184.4
Q ss_pred HHhhcCcccceeeeecCceEEEEEEe--CCCcEEEEEec--------------------------cCCccccceEEEe--
Q 042435 139 IDATEYFHIRYCIGTGGYDSVYKAEL--PDGKVVALKKL--------------------------HHSETEDSAFVVY-- 188 (412)
Q Consensus 139 ~~~~~~f~~~~~lG~G~~g~Vy~~~~--~~~~~vAvK~l--------------------------~~~~~~~~~~~~~-- 188 (412)
..+.++|++.+.||+|+||.||+|.. .+|+.||+|.+ +|+++.....++.
T Consensus 7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~ 86 (326)
T 1blx_A 7 CRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVS 86 (326)
T ss_dssp CCGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEE
T ss_pred cCchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeec
Confidence 34568899999999999999999987 46889999964 3666666666655
Q ss_pred ---cCceEEEEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEE
Q 042435 189 ---SPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFV 265 (412)
Q Consensus 189 ---~~~~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl 265 (412)
.....++||||++ |+|.+++...... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~kl 161 (326)
T 1blx_A 87 RTDRETKLTLVFEHVD-QDLTTYLDKVPEP-GVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKL 161 (326)
T ss_dssp ECSSEEEEEEEEECCS-CBHHHHHHHSCTT-CSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEE
T ss_pred ccCCCceEEEEEecCC-CCHHHHHHhcccC-CCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCEEE
Confidence 5667899999997 6999988754322 489999999999999999999999 9999999999999999999999
Q ss_pred eecCCccccCCCCCCcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhh
Q 042435 266 ADFGTVRLLDVDSSNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILY 345 (412)
Q Consensus 266 ~DfGla~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~ 345 (412)
+|||+++...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||...... .....+..
T Consensus 162 ~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-------~~~~~i~~ 233 (326)
T 1blx_A 162 ADFGLARIYSFQM-ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV-------DQLGKILD 233 (326)
T ss_dssp CSCCSCCCCCGGG-GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-------HHHHHHHH
T ss_pred ecCcccccccCCC-CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHH-------HHHHHHHH
Confidence 9999998654322 223457899999999999989999999999999999999999998632110 00001100
Q ss_pred h----------------------ccCCccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH--HhcCCC
Q 042435 346 Q----------------------RLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQE--LEGKTP 393 (412)
Q Consensus 346 ~----------------------~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~--L~~~~~ 393 (412)
. ....+...........+.+++.+||+.||++|||+.|++++ +++...
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~ 305 (326)
T 1blx_A 234 VIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLER 305 (326)
T ss_dssp HHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred HcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccch
Confidence 0 00000000001112347789999999999999999999965 444443
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=309.89 Aligned_cols=248 Identities=21% Similarity=0.225 Sum_probs=178.4
Q ss_pred ccHHHHHHhhcCcccceeeeecCceEEEEEEeCCCcEEEEEec--------------------------------cCCcc
Q 042435 133 ILYENLIDATEYFHIRYCIGTGGYDSVYKAELPDGKVVALKKL--------------------------------HHSET 180 (412)
Q Consensus 133 ~~~~~l~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~l--------------------------------~~~~~ 180 (412)
....++....++|.+.+.||+|+||.||+|...+|+.||||++ +|+++
T Consensus 12 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 91 (362)
T 3pg1_A 12 DLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNI 91 (362)
T ss_dssp HHHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTB
T ss_pred HHHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCc
Confidence 3457888899999999999999999999999888999999965 35566
Q ss_pred ccceEEEe-----cCceEEEEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCE
Q 042435 181 EDSAFVVY-----SPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNI 255 (412)
Q Consensus 181 ~~~~~~~~-----~~~~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NI 255 (412)
.....++. .....++||||++ |+|.+++.... ..+++..+..++.|++.||+|||++ +|+||||||+||
T Consensus 92 v~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NI 165 (362)
T 3pg1_A 92 LGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQR--IVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNI 165 (362)
T ss_dssp CCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTT--SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGE
T ss_pred cceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChHHE
Confidence 66555552 3346899999997 68888776543 2589999999999999999999999 999999999999
Q ss_pred EecCCCcEEEeecCCccccCCCCCCcccccccccccccccccC-cccCcccccHHHHHHHHHHHhCCCCccccccccc--
Q 042435 256 LLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTYGYIALELVYT-MVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSS-- 332 (412)
Q Consensus 256 Ll~~~~~~kl~DfGla~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~-- 332 (412)
+++.++.+||+|||+++...... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||........
T Consensus 166 l~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~ 244 (362)
T 3pg1_A 166 LLADNNDITICDFNLAREDTADA-NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLN 244 (362)
T ss_dssp EECTTCCEEECCTTC----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred EEcCCCCEEEEecCccccccccc-ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 99999999999999997543322 2334578999999999876 6789999999999999999999999873210000
Q ss_pred ------CCCC--------cchhhHHhhhccCCccc----hhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 333 ------SSGP--------KIMLIDILYQRLSPPIN----QKIIQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 333 ------~~~~--------~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
.... .....+........... .........+.+++.+||+.||++|||+.|++++
T Consensus 245 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 317 (362)
T 3pg1_A 245 KIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317 (362)
T ss_dssp HHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence 0000 00000011011100000 0000112347899999999999999999999986
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-38 Score=303.81 Aligned_cols=233 Identities=23% Similarity=0.302 Sum_probs=182.4
Q ss_pred hcCcccceeeeecCceEEEEEEeCCCcEEEEEec--------------------------------------cCCccccc
Q 042435 142 TEYFHIRYCIGTGGYDSVYKAELPDGKVVALKKL--------------------------------------HHSETEDS 183 (412)
Q Consensus 142 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~l--------------------------------------~~~~~~~~ 183 (412)
.++|++.+.||+|+||.||+|.. +|+.||+|.+ +|+++...
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 46899999999999999999998 9999999964 35566666
Q ss_pred eEEEecCceEEEEEEeccCCceeee------eccCcccccCCHHHHHHHHHHHHHHHHHHHh-CCCCCcEEeCCCCCCEE
Q 042435 184 AFVVYSPQCMFFIYEYMERGSLFCV------LRDDDEAIELNWTRRMNIVKSVAHALSYLHH-DCTPSIVHRDISSNNIL 256 (412)
Q Consensus 184 ~~~~~~~~~~~lv~ey~~~gsL~~~------l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~-~~~~~ivHrDlkp~NIL 256 (412)
..++...+..++||||+++|+|.++ +.... ...+++..+..++.|++.||+|||+ . +++||||||+||+
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~p~Nil 184 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNY-TCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVKPSNIL 184 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSS-CCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCCGGGEE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhcc-ccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCChHhEE
Confidence 6778888999999999999999999 55421 2369999999999999999999998 7 9999999999999
Q ss_pred ecCCCcEEEeecCCccccCCCCCCcccccccccccccccccCc-ccCc-ccccHHHHHHHHHHHhCCCCcccccccccCC
Q 042435 257 LNSNLEAFVADFGTVRLLDVDSSNRTLQAGTYGYIALELVYTM-VVTE-KCVIYSFGVVALEVLMGTHPGELLLSLSSSS 334 (412)
Q Consensus 257 l~~~~~~kl~DfGla~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~-ksDv~S~Gvil~elltg~~P~~~~~~~~~~~ 334 (412)
++.++.+||+|||+++..... ......||+.|+|||.+.+. .++. ++||||||+++|||++|+.||.....
T Consensus 185 ~~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~----- 257 (348)
T 2pml_X 185 MDKNGRVKLSDFGESEYMVDK--KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKIS----- 257 (348)
T ss_dssp ECTTSCEEECCCTTCEECBTT--EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSC-----
T ss_pred EcCCCcEEEeccccccccccc--cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCc-----
Confidence 999999999999999865433 33445789999999999877 6666 99999999999999999999873211
Q ss_pred CCcchhhHHhhhccCCccc--------------hhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 335 GPKIMLIDILYQRLSPPIN--------------QKIIQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~--------------~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
.......+.......+.. .........+.+++.+||+.||++|||+.|++++
T Consensus 258 -~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h 323 (348)
T 2pml_X 258 -LVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH 323 (348)
T ss_dssp -SHHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred -HHHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 011111111111111100 0001122347899999999999999999999874
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-38 Score=301.77 Aligned_cols=238 Identities=17% Similarity=0.240 Sum_probs=178.2
Q ss_pred hcCcccceeeeecCceEEEEEEe--CCCcEEEEEeccC--------------------C------ccccceEEEecCceE
Q 042435 142 TEYFHIRYCIGTGGYDSVYKAEL--PDGKVVALKKLHH--------------------S------ETEDSAFVVYSPQCM 193 (412)
Q Consensus 142 ~~~f~~~~~lG~G~~g~Vy~~~~--~~~~~vAvK~l~~--------------------~------~~~~~~~~~~~~~~~ 193 (412)
.++|++.+.||+|+||.||+|.. .+++.||||.++. . ++......+...+..
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~ 92 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHI 92 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcE
Confidence 35799999999999999999976 3689999998642 1 244455567778899
Q ss_pred EEEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecC--------------
Q 042435 194 FFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNS-------------- 259 (412)
Q Consensus 194 ~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~-------------- 259 (412)
++||||+ +++|.+++..... ..+++..+..++.|++.||+|||++ +|+||||||+||+++.
T Consensus 93 ~lv~e~~-~~~l~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~ 167 (339)
T 1z57_A 93 CIVFELL-GLSTYDFIKENGF-LPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKIKRD 167 (339)
T ss_dssp EEEEECC-CCBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEEEC----CE
T ss_pred EEEEcCC-CCCHHHHHHhcCC-CCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccccccCCccccc
Confidence 9999999 8899998875532 2488999999999999999999999 9999999999999987
Q ss_pred -----CCcEEEeecCCccccCCCCCCcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCccccccccc--
Q 042435 260 -----NLEAFVADFGTVRLLDVDSSNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSS-- 332 (412)
Q Consensus 260 -----~~~~kl~DfGla~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~-- 332 (412)
++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||........
T Consensus 168 ~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~ 244 (339)
T 1z57_A 168 ERTLINPDIKVVDFGSATYDDEH---HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLA 244 (339)
T ss_dssp EEEESCCCEEECCCSSCEETTSC---CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHHH
T ss_pred cccccCCCceEeeCcccccCccc---cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence 668999999999864332 2345789999999999999999999999999999999999999863211000
Q ss_pred ------CCCCcc----------------------hhhHHhhhccCCc--cchhhHHHHHHHHHHHHhcCcCCCCCCCCHH
Q 042435 333 ------SSGPKI----------------------MLIDILYQRLSPP--INQKIIQDIILVSTIALACLRSKPKSRPTMQ 382 (412)
Q Consensus 333 ------~~~~~~----------------------~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ 382 (412)
...+.. ...........+. ...........+.+++.+||+.||++|||+.
T Consensus 245 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ 324 (339)
T 1z57_A 245 MMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLR 324 (339)
T ss_dssp HHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHH
T ss_pred HHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCHH
Confidence 000000 0000000000000 0000112234588999999999999999999
Q ss_pred HHHHH
Q 042435 383 RISQE 387 (412)
Q Consensus 383 evl~~ 387 (412)
|++++
T Consensus 325 ell~h 329 (339)
T 1z57_A 325 EALKH 329 (339)
T ss_dssp HHTTS
T ss_pred HHhcC
Confidence 99865
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=315.96 Aligned_cols=178 Identities=24% Similarity=0.293 Sum_probs=147.2
Q ss_pred hhcCcccceeeeecCceEEEEEEe-CCCcEEEEEec-----------------------cCCccccceEEEecC-----c
Q 042435 141 ATEYFHIRYCIGTGGYDSVYKAEL-PDGKVVALKKL-----------------------HHSETEDSAFVVYSP-----Q 191 (412)
Q Consensus 141 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l-----------------------~~~~~~~~~~~~~~~-----~ 191 (412)
..++|++.+.||+|+||.||+|.. .+++.||||++ +|+++.....++... +
T Consensus 24 i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 103 (432)
T 3n9x_A 24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFD 103 (432)
T ss_dssp CCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred ecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCC
Confidence 357899999999999999999976 46889999975 456666666665544 5
Q ss_pred eEEEEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCc
Q 042435 192 CMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTV 271 (412)
Q Consensus 192 ~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla 271 (412)
..|+||||++ |+|.+++.... .+++..+..++.||++||+|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 104 ~~~lv~e~~~-~~L~~~~~~~~---~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFGla 176 (432)
T 3n9x_A 104 ELYIVLEIAD-SDLKKLFKTPI---FLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLA 176 (432)
T ss_dssp CEEEEEECCS-EEHHHHHHSSC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEecCC-cCHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCCCc
Confidence 7899999996 59999887643 589999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCC----------------------Ccccccccccccccccc-cCcccCcccccHHHHHHHHHHHhCCCCcc
Q 042435 272 RLLDVDSS----------------------NRTLQAGTYGYIALELV-YTMVVTEKCVIYSFGVVALEVLMGTHPGE 325 (412)
Q Consensus 272 ~~~~~~~~----------------------~~~~~~gt~~y~aPE~~-~~~~~s~ksDv~S~Gvil~elltg~~P~~ 325 (412)
+....... ......||+.|+|||++ ....++.++|||||||++|||++|..||.
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 177 RTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp EEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred ccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 87643321 12456789999999986 56679999999999999999999766654
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=310.38 Aligned_cols=181 Identities=20% Similarity=0.236 Sum_probs=151.6
Q ss_pred HhhcCcccceeeeecCceEEEEEEeC-CCcEEEEEeccC---------------------Cc-----cccceEEEecCce
Q 042435 140 DATEYFHIRYCIGTGGYDSVYKAELP-DGKVVALKKLHH---------------------SE-----TEDSAFVVYSPQC 192 (412)
Q Consensus 140 ~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~---------------------~~-----~~~~~~~~~~~~~ 192 (412)
...++|++.+.||+|+||+||+|... +++.||||.++. ++ +......+...+.
T Consensus 51 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~ 130 (382)
T 2vx3_A 51 KWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNH 130 (382)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTE
T ss_pred EeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCc
Confidence 44678999999999999999999764 688999998742 21 3444455677889
Q ss_pred EEEEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEec--CCCcEEEeecCC
Q 042435 193 MFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLN--SNLEAFVADFGT 270 (412)
Q Consensus 193 ~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~--~~~~~kl~DfGl 270 (412)
.++||||++ |+|.+++..... ..+++..+..++.|++.||+|||++ ..+|+||||||+|||++ .++.+||+|||+
T Consensus 131 ~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~ 207 (382)
T 2vx3_A 131 LCLVFEMLS-YNLYDLLRNTNF-RGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGS 207 (382)
T ss_dssp EEEEEECCC-CBHHHHHHHTTT-SCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCTT
T ss_pred eEEEEecCC-CCHHHHHhhcCc-CCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEeccC
Confidence 999999996 599998876532 2489999999999999999999953 33899999999999994 578899999999
Q ss_pred ccccCCCCCCcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCccc
Q 042435 271 VRLLDVDSSNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGEL 326 (412)
Q Consensus 271 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~ 326 (412)
++..... .....||+.|+|||++.+..++.++|||||||++|||+||+.||..
T Consensus 208 a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~ 260 (382)
T 2vx3_A 208 SCQLGQR---IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSG 260 (382)
T ss_dssp CEETTCC---CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred ceecccc---cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 9876432 2345789999999999999999999999999999999999999973
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-38 Score=307.15 Aligned_cols=237 Identities=21% Similarity=0.194 Sum_probs=170.7
Q ss_pred hcCcccceeeeecCceEEEEEEe-CCCcEEEEEec-----------------------cCCccccceEEEecCc------
Q 042435 142 TEYFHIRYCIGTGGYDSVYKAEL-PDGKVVALKKL-----------------------HHSETEDSAFVVYSPQ------ 191 (412)
Q Consensus 142 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l-----------------------~~~~~~~~~~~~~~~~------ 191 (412)
.++|++.+.||+|+||.||+|.. .+++.||||++ +|+++.....++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 46899999999999999999976 46899999975 4666666666665543
Q ss_pred eEEEEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCc
Q 042435 192 CMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTV 271 (412)
Q Consensus 192 ~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla 271 (412)
..++||||+++ +|.+++.. .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 104 ~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 174 (371)
T 2xrw_A 104 DVYIVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA 174 (371)
T ss_dssp EEEEEEECCSE-EHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCC-
T ss_pred ceEEEEEcCCC-CHHHHHhh-----ccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEeecc
Confidence 78999999974 77777642 488999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCCcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccc------cC-CCCc-------
Q 042435 272 RLLDVDSSNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLS------SS-SGPK------- 337 (412)
Q Consensus 272 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~------~~-~~~~------- 337 (412)
+...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||....... .. ..+.
T Consensus 175 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 253 (371)
T 2xrw_A 175 RTAGTSF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKL 253 (371)
T ss_dssp ----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTS
T ss_pred ccccccc-ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHh
Confidence 8654322 2234578999999999999999999999999999999999999996321100 00 0000
Q ss_pred -chhhHHh---------------hhccCCccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHH
Q 042435 338 -IMLIDIL---------------YQRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQEL 388 (412)
Q Consensus 338 -~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L 388 (412)
....... .....+............+.+++.+||+.||++|||++|++++-
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp 320 (371)
T 2xrw_A 254 QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHP 320 (371)
T ss_dssp CHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSH
T ss_pred hhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCc
Confidence 0000000 00001111111122244588999999999999999999999863
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=319.89 Aligned_cols=173 Identities=27% Similarity=0.346 Sum_probs=134.8
Q ss_pred hcCcccceeeeecCceEEEEEEe-CCCcEEEEEec-----------------------cCCccccceEEEec-----Cce
Q 042435 142 TEYFHIRYCIGTGGYDSVYKAEL-PDGKVVALKKL-----------------------HHSETEDSAFVVYS-----PQC 192 (412)
Q Consensus 142 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l-----------------------~~~~~~~~~~~~~~-----~~~ 192 (412)
.++|++.+.||+|+||.||+|.. .+++.||||++ +|+++.....++.. ...
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 46899999999999999999976 47899999965 56777777766633 357
Q ss_pred EEEEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCcc
Q 042435 193 MFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVR 272 (412)
Q Consensus 193 ~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~ 272 (412)
.|+||||+ +|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 132 ~~lv~e~~-~~~L~~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFGla~ 204 (458)
T 3rp9_A 132 LYVVLEIA-DSDFKKLFRTPV---YLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLAR 204 (458)
T ss_dssp EEEEECCC-SEEHHHHHHSSC---CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred EEEEEecc-ccchhhhcccCC---CCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeecccccch
Confidence 89999998 568988887653 589999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCC---------------------------Ccccccccccccccccc-cCcccCcccccHHHHHHHHHHHhCC
Q 042435 273 LLDVDSS---------------------------NRTLQAGTYGYIALELV-YTMVVTEKCVIYSFGVVALEVLMGT 321 (412)
Q Consensus 273 ~~~~~~~---------------------------~~~~~~gt~~y~aPE~~-~~~~~s~ksDv~S~Gvil~elltg~ 321 (412)
....... ......||+.|+|||++ .+..++.++|||||||++|||+||.
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~ 281 (458)
T 3rp9_A 205 TVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMI 281 (458)
T ss_dssp CTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTS
T ss_pred hccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhc
Confidence 7642211 12345789999999976 4667999999999999999999943
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=309.20 Aligned_cols=240 Identities=21% Similarity=0.237 Sum_probs=168.8
Q ss_pred HHHHHhhcCcccceeeeecCceEEEEEEe-CCCcEEEEEec--------------------cCCccccceEEEecCc---
Q 042435 136 ENLIDATEYFHIRYCIGTGGYDSVYKAEL-PDGKVVALKKL--------------------HHSETEDSAFVVYSPQ--- 191 (412)
Q Consensus 136 ~~l~~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l--------------------~~~~~~~~~~~~~~~~--- 191 (412)
.......++|++.+.||+|+||.||+|.. .+|+.||||++ +|+++......+...+
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~ 95 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERD 95 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSC
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhcccccc
Confidence 45567778999999999999999999987 46899999964 5777777766654432
Q ss_pred ----eEEEEEEeccCCceeeeecc-CcccccCCHHHHHHHHHHHHHHHHHHH--hCCCCCcEEeCCCCCCEEecC-CCcE
Q 042435 192 ----CMFFIYEYMERGSLFCVLRD-DDEAIELNWTRRMNIVKSVAHALSYLH--HDCTPSIVHRDISSNNILLNS-NLEA 263 (412)
Q Consensus 192 ----~~~lv~ey~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~~ia~gL~~LH--~~~~~~ivHrDlkp~NILl~~-~~~~ 263 (412)
..++||||+++ +|...+.. ......+++..+..++.|++.||.||| +. +|+||||||+|||++. ++.+
T Consensus 96 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~~~~~ 171 (360)
T 3e3p_A 96 RRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEADGTL 171 (360)
T ss_dssp TTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETTTTEE
T ss_pred ccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCCCCcE
Confidence 37899999986 55443332 112235889999999999999999999 66 9999999999999996 8999
Q ss_pred EEeecCCccccCCCCCCcccccccccccccccccCcc-cCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhH
Q 042435 264 FVADFGTVRLLDVDSSNRTLQAGTYGYIALELVYTMV-VTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLID 342 (412)
Q Consensus 264 kl~DfGla~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~ 342 (412)
||+|||+++....... .....||+.|+|||++.+.. ++.++|||||||++|||++|+.||..... ......
T Consensus 172 kl~Dfg~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~-------~~~~~~ 243 (360)
T 3e3p_A 172 KLCDFGSAKKLSPSEP-NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNS-------AGQLHE 243 (360)
T ss_dssp EECCCTTCBCCCTTSC-CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHH
T ss_pred EEeeCCCceecCCCCC-cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCCh-------HHHHHH
Confidence 9999999987654332 23456899999999986654 89999999999999999999999973211 001111
Q ss_pred HhhhccCC---------------------ccc------hhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 343 ILYQRLSP---------------------PIN------QKIIQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 343 ~~~~~~~~---------------------~~~------~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
+......+ ... .........+.+++.+||+.||++|||+.|++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 315 (360)
T 3e3p_A 244 IVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH 315 (360)
T ss_dssp HHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred HHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 11000000 000 0000123458899999999999999999999986
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-39 Score=311.17 Aligned_cols=237 Identities=23% Similarity=0.276 Sum_probs=182.0
Q ss_pred hcCcccceeeeecCceEEEEEEeC-CCcEEEEEec----------------------cCCccccceEEEecCceEEEEEE
Q 042435 142 TEYFHIRYCIGTGGYDSVYKAELP-DGKVVALKKL----------------------HHSETEDSAFVVYSPQCMFFIYE 198 (412)
Q Consensus 142 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l----------------------~~~~~~~~~~~~~~~~~~~lv~e 198 (412)
.++|++.+.||+|+||.||+|... +++.||+|.+ +|+++......+...+..++|||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 357999999999999999999875 6899999964 56777788888888999999999
Q ss_pred eccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCC
Q 042435 199 YMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDS 278 (412)
Q Consensus 199 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~ 278 (412)
|+++|+|.+++.... .+++..+..++.|++.||+|||+.+ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 112 ~~~~~~L~~~l~~~~---~~~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~- 185 (360)
T 3eqc_A 112 HMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 185 (360)
T ss_dssp CCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH-
T ss_pred CCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHhC--CEEcCCccHHHEEECCCCCEEEEECCCCcccccc-
Confidence 999999999987543 5899999999999999999999832 7999999999999999999999999998754322
Q ss_pred CCcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccc---------------------------
Q 042435 279 SNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLS--------------------------- 331 (412)
Q Consensus 279 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~--------------------------- 331 (412)
......||+.|+|||++.+..++.++||||||+++|||++|+.||.......
T Consensus 186 -~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (360)
T 3eqc_A 186 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL 264 (360)
T ss_dssp -C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC---------------------
T ss_pred -cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcc
Confidence 1233478999999999999999999999999999999999999986321000
Q ss_pred ----cCCCCcchh---hHHhhhccCCccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 332 ----SSSGPKIML---IDILYQRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 332 ----~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
....+.... .+.......+..... .....+.+++.+||+.||++|||++|++++
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 325 (360)
T 3eqc_A 265 NKFGMDSRPPMAIFELLDYIVNEPPPKLPSG--VFSLEFQDFVNKCLIKNPAERADLKQLMVH 325 (360)
T ss_dssp ---------CCCHHHHHHHHHHSCCCCCCTT--TSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred cccccCCCCcccchhhhhHHhccCCCCCCcc--cccHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 000000000 111111111111110 112247899999999999999999999875
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=309.57 Aligned_cols=236 Identities=22% Similarity=0.258 Sum_probs=172.9
Q ss_pred hhcCcccceeeeecCceEEEEEEe-CCCcEEEEEec-----------------------cCCccccceEEEecC------
Q 042435 141 ATEYFHIRYCIGTGGYDSVYKAEL-PDGKVVALKKL-----------------------HHSETEDSAFVVYSP------ 190 (412)
Q Consensus 141 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l-----------------------~~~~~~~~~~~~~~~------ 190 (412)
..++|++.+.||+|+||.||+|.. .+|+.||||++ +|+++.....++...
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 102 (367)
T 1cm8_A 23 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 102 (367)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred ecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccC
Confidence 356899999999999999999977 57999999976 456666666666554
Q ss_pred ceEEEEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCC
Q 042435 191 QCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGT 270 (412)
Q Consensus 191 ~~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGl 270 (412)
...++||||+ +++|.+++... .+++..+..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||+
T Consensus 103 ~~~~lv~e~~-~~~L~~~~~~~----~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 174 (367)
T 1cm8_A 103 TDFYLVMPFM-GTDLGKLMKHE----KLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGL 174 (367)
T ss_dssp CCCEEEEECC-SEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred ceEEEEEecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEeeec
Confidence 3469999999 78999888653 489999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCCcccccccccccccccccC-cccCcccccHHHHHHHHHHHhCCCCccccccccc--------CCCCcc---
Q 042435 271 VRLLDVDSSNRTLQAGTYGYIALELVYT-MVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSS--------SSGPKI--- 338 (412)
Q Consensus 271 a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~--------~~~~~~--- 338 (412)
++..... .....+|+.|+|||++.+ ..++.++||||+||++|||++|+.||........ ...+..
T Consensus 175 a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~ 251 (367)
T 1cm8_A 175 ARQADSE---MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQ 251 (367)
T ss_dssp CEECCSS---CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred ccccccc---cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence 9875432 234578999999999877 6799999999999999999999999963211000 000000
Q ss_pred -----hhhHHhhhc--c-CCccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 339 -----MLIDILYQR--L-SPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 339 -----~~~~~~~~~--~-~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
.....+... . ..............+.+++.+||+.||++|||++|++++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h 308 (367)
T 1cm8_A 252 RLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 308 (367)
T ss_dssp TCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence 000000000 0 000000001112347899999999999999999999986
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=310.27 Aligned_cols=237 Identities=22% Similarity=0.231 Sum_probs=175.3
Q ss_pred HHhhcCcccceeeeecCceEEEEEEe-CCCcEEEEEec-----------------cCCccccceEEEe------------
Q 042435 139 IDATEYFHIRYCIGTGGYDSVYKAEL-PDGKVVALKKL-----------------HHSETEDSAFVVY------------ 188 (412)
Q Consensus 139 ~~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l-----------------~~~~~~~~~~~~~------------ 188 (412)
....++|++.+.||+|+||.||+|.. .+|+.||||++ +|+++......+.
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~ 82 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQP 82 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTSCCHHHHHHTTCCCTTBCCEEEEEEEC----------
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcchHHHHHHHHHHcCCCCccchhheeeecCccccccccc
Confidence 34567899999999999999999976 67999999964 5777777666553
Q ss_pred --------------------------cCceEEEEEEeccCCceeeeeccCc-ccccCCHHHHHHHHHHHHHHHHHHHhCC
Q 042435 189 --------------------------SPQCMFFIYEYMERGSLFCVLRDDD-EAIELNWTRRMNIVKSVAHALSYLHHDC 241 (412)
Q Consensus 189 --------------------------~~~~~~lv~ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~~LH~~~ 241 (412)
.....++||||++ |+|.+.+.... ....+++..+..++.|+++||+|||+.
T Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~- 160 (383)
T 3eb0_A 83 PDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL- 160 (383)
T ss_dssp ---------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT-
T ss_pred ccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC-
Confidence 2334889999998 58777765421 123589999999999999999999998
Q ss_pred CCCcEEeCCCCCCEEec-CCCcEEEeecCCccccCCCCCCcccccccccccccccccCc-ccCcccccHHHHHHHHHHHh
Q 042435 242 TPSIVHRDISSNNILLN-SNLEAFVADFGTVRLLDVDSSNRTLQAGTYGYIALELVYTM-VVTEKCVIYSFGVVALEVLM 319 (412)
Q Consensus 242 ~~~ivHrDlkp~NILl~-~~~~~kl~DfGla~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~S~Gvil~ellt 319 (412)
+|+||||||+|||++ .++.+||+|||+++....... .....||+.|+|||.+.+. .++.++||||+||++|||++
T Consensus 161 --gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~ 237 (383)
T 3eb0_A 161 --GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP-SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELIL 237 (383)
T ss_dssp --TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC-CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHH
T ss_pred --cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC-CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHh
Confidence 999999999999998 688999999999987644332 2345789999999998765 48999999999999999999
Q ss_pred CCCCcccccccccCCCCcchhhHHhhhccC------------------Ccc-chhh-----HHHHHHHHHHHHhcCcCCC
Q 042435 320 GTHPGELLLSLSSSSGPKIMLIDILYQRLS------------------PPI-NQKI-----IQDIILVSTIALACLRSKP 375 (412)
Q Consensus 320 g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~------------------~~~-~~~~-----~~~~~~~~~l~~~Cl~~dP 375 (412)
|+.||...... ..+..++...-. +.. .... ......+.+++.+||+.||
T Consensus 238 g~~pf~~~~~~-------~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 310 (383)
T 3eb0_A 238 GKPLFSGETSI-------DQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEP 310 (383)
T ss_dssp SSCSSCCSSHH-------HHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSG
T ss_pred CCCCCCCCChH-------HHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCCh
Confidence 99999732110 011111100000 000 0000 0012237899999999999
Q ss_pred CCCCCHHHHHHH
Q 042435 376 KSRPTMQRISQE 387 (412)
Q Consensus 376 ~~RPs~~evl~~ 387 (412)
++|||+.|++++
T Consensus 311 ~~R~t~~e~l~h 322 (383)
T 3eb0_A 311 DLRINPYEAMAH 322 (383)
T ss_dssp GGSCCHHHHHTS
T ss_pred hhCCCHHHHhcC
Confidence 999999999864
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=309.93 Aligned_cols=238 Identities=20% Similarity=0.210 Sum_probs=175.4
Q ss_pred hcCcccceeeeecCceEEEEEEe-CCCcEEEEEecc----------------------------CCccccceEEEe----
Q 042435 142 TEYFHIRYCIGTGGYDSVYKAEL-PDGKVVALKKLH----------------------------HSETEDSAFVVY---- 188 (412)
Q Consensus 142 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l~----------------------------~~~~~~~~~~~~---- 188 (412)
.++|++.+.||+|+||.||+|.. .+++.||||.++ |+++......+.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~ 115 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGV 115 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEET
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCC
Confidence 46799999999999999999976 568999999764 334555555444
Q ss_pred cCceEEEEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCC-------
Q 042435 189 SPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNL------- 261 (412)
Q Consensus 189 ~~~~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~------- 261 (412)
.....++||||+ +++|.+.+..... ..+++..+..++.|++.||+|||+++ +|+||||||+|||++.++
T Consensus 116 ~~~~~~lv~e~~-~~~l~~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~~~~~~~~~~ 191 (397)
T 1wak_A 116 NGTHICMVFEVL-GHHLLKWIIKSNY-QGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIRRLA 191 (397)
T ss_dssp TEEEEEEEECCC-CCBHHHHHHHTTT-SCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECCCHHHHHHHH
T ss_pred CCceEEEEEecc-CccHHHHHHhccc-CCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEeccchhhhhhh
Confidence 566899999999 5566665544321 24899999999999999999999864 899999999999998765
Q ss_pred ------------------------------------------cEEEeecCCccccCCCCCCcccccccccccccccccCc
Q 042435 262 ------------------------------------------EAFVADFGTVRLLDVDSSNRTLQAGTYGYIALELVYTM 299 (412)
Q Consensus 262 ------------------------------------------~~kl~DfGla~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 299 (412)
.+||+|||+++..... .....||+.|+|||++.+.
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~---~~~~~gt~~y~aPE~~~~~ 268 (397)
T 1wak_A 192 AEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH---FTEDIQTRQYRSLEVLIGS 268 (397)
T ss_dssp HHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC---SCSCCSCGGGCCHHHHHTS
T ss_pred hhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc---CccCCCCCcccCChhhcCC
Confidence 7999999999865433 2334789999999999999
Q ss_pred ccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccC--------------------------C--c
Q 042435 300 VVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLS--------------------------P--P 351 (412)
Q Consensus 300 ~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~--------------------------~--~ 351 (412)
.++.++|||||||++|||+||+.||......... ........+....-. . +
T Consensus 269 ~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 347 (397)
T 1wak_A 269 GYNTPADIWSTACMAFELATGDYLFEPHSGEEYT-RDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKP 347 (397)
T ss_dssp CCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSC-HHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCC
T ss_pred CCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccC-chHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCC
Confidence 9999999999999999999999999632110000 000000000000000 0 0
Q ss_pred ---------cchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 352 ---------INQKIIQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 352 ---------~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
...........+.+++.+||+.||++|||++|++++
T Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 392 (397)
T 1wak_A 348 WGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392 (397)
T ss_dssp CCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred cchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence 000012334458899999999999999999999874
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-39 Score=304.29 Aligned_cols=234 Identities=22% Similarity=0.299 Sum_probs=179.9
Q ss_pred HhhcCcccceeeeecCceEEEEEEeC-CCcEEEEEec---------------------cCCccccceEEEecCceEEEEE
Q 042435 140 DATEYFHIRYCIGTGGYDSVYKAELP-DGKVVALKKL---------------------HHSETEDSAFVVYSPQCMFFIY 197 (412)
Q Consensus 140 ~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l---------------------~~~~~~~~~~~~~~~~~~~lv~ 197 (412)
...+.|++.+.||+|+||.||+|... +++.||+|.+ +|+++......+...+..++||
T Consensus 16 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 95 (302)
T 2j7t_A 16 DPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMI 95 (302)
T ss_dssp CGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEE
T ss_pred CCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEE
Confidence 34578999999999999999999885 5899999964 5677777788888889999999
Q ss_pred EeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCC
Q 042435 198 EYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVD 277 (412)
Q Consensus 198 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~ 277 (412)
||+++++|.+++.... ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++......
T Consensus 96 e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 170 (302)
T 2j7t_A 96 EFCPGGAVDAIMLELD--RGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT 170 (302)
T ss_dssp ECCTTEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH
T ss_pred EeCCCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCCcccccc
Confidence 9999999998876532 2489999999999999999999999 9999999999999999999999999987543221
Q ss_pred CCCcccccccccccccccc-----cCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCcc
Q 042435 278 SSNRTLQAGTYGYIALELV-----YTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPI 352 (412)
Q Consensus 278 ~~~~~~~~gt~~y~aPE~~-----~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 352 (412)
........||+.|+|||++ ....++.++||||||+++|||++|+.||.... ................
T Consensus 171 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-------~~~~~~~~~~~~~~~~- 242 (302)
T 2j7t_A 171 LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELN-------PMRVLLKIAKSDPPTL- 242 (302)
T ss_dssp HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSC-------HHHHHHHHHHSCCCCC-
T ss_pred ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCC-------HHHHHHHHhccCCccc-
Confidence 1122334689999999998 36678899999999999999999999987321 1111111211111110
Q ss_pred chhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 353 NQKIIQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 353 ~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
.........+.+++.+||+.||++|||+.|++++
T Consensus 243 -~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 276 (302)
T 2j7t_A 243 -LTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEH 276 (302)
T ss_dssp -SSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTS
T ss_pred -CCccccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 0011112347889999999999999999999875
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=304.03 Aligned_cols=239 Identities=18% Similarity=0.273 Sum_probs=179.8
Q ss_pred ccHHHHHHhhcCcccceeeeecCceEEEEEEeCCCcEEEEEecc-------------------------CCccccceEEE
Q 042435 133 ILYENLIDATEYFHIRYCIGTGGYDSVYKAELPDGKVVALKKLH-------------------------HSETEDSAFVV 187 (412)
Q Consensus 133 ~~~~~l~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~l~-------------------------~~~~~~~~~~~ 187 (412)
+.++.+....++|++.+.||+|+||.||++...+++.||||.++ ++++......+
T Consensus 18 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~ 97 (313)
T 3cek_A 18 LYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE 97 (313)
T ss_dssp --CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEE
T ss_pred CCeeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEe
Confidence 33444445567899999999999999999999889999999752 35666666778
Q ss_pred ecCceEEEEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEee
Q 042435 188 YSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVAD 267 (412)
Q Consensus 188 ~~~~~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~D 267 (412)
...+..++||| +.+++|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+||++++ +.+||+|
T Consensus 98 ~~~~~~~lv~e-~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~-~~~kL~D 169 (313)
T 3cek_A 98 ITDQYIYMVME-CGNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD-GMLKLID 169 (313)
T ss_dssp ECSSEEEEEEC-CCSEEHHHHHHHCS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEET-TEEEECC
T ss_pred ecCCEEEEEEe-cCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEEC-CeEEEee
Confidence 88889999999 55789999987653 589999999999999999999999 9999999999999964 8999999
Q ss_pred cCCccccCCCCCC--cccccccccccccccccC-----------cccCcccccHHHHHHHHHHHhCCCCcccccccccCC
Q 042435 268 FGTVRLLDVDSSN--RTLQAGTYGYIALELVYT-----------MVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSS 334 (412)
Q Consensus 268 fGla~~~~~~~~~--~~~~~gt~~y~aPE~~~~-----------~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~ 334 (412)
||+++........ .....||+.|+|||.+.+ ..++.++||||||+++|||++|+.||....
T Consensus 170 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~------ 243 (313)
T 3cek_A 170 FGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII------ 243 (313)
T ss_dssp CSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCC------
T ss_pred ccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHH------
Confidence 9999876443221 234568999999999865 468889999999999999999999986321
Q ss_pred CCcchhhHHhhhccCCccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHH
Q 042435 335 GPKIMLIDILYQRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQEL 388 (412)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L 388 (412)
..................+.... ..+.+++.+||+.||++|||+.|++++-
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~---~~l~~li~~~l~~dp~~Rps~~ell~h~ 294 (313)
T 3cek_A 244 NQISKLHAIIDPNHEIEFPDIPE---KDLQDVLKCCLKRDPKQRISIPELLAHP 294 (313)
T ss_dssp SHHHHHHHHHCTTSCCCCCCCSC---HHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred HHHHHHHHHHhcccccCCcccch---HHHHHHHHHHccCCcccCcCHHHHhcCc
Confidence 01111222232222222111111 2378899999999999999999999763
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=301.08 Aligned_cols=237 Identities=23% Similarity=0.347 Sum_probs=173.7
Q ss_pred hhcCcccceeeeecCceEEEEEEe-CCCcEEEEEec----------------------cCCccccceEEEecCceEEEEE
Q 042435 141 ATEYFHIRYCIGTGGYDSVYKAEL-PDGKVVALKKL----------------------HHSETEDSAFVVYSPQCMFFIY 197 (412)
Q Consensus 141 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l----------------------~~~~~~~~~~~~~~~~~~~lv~ 197 (412)
..++|++.+.||+|+||.||+|.. .+++.||||.+ +|+++......+...+..++||
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 92 (303)
T 2vwi_A 13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVM 92 (303)
T ss_dssp CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEE
T ss_pred chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEe
Confidence 357899999999999999999976 46899999964 4666666677788888999999
Q ss_pred EeccCCceeeeeccC-----cccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCcc
Q 042435 198 EYMERGSLFCVLRDD-----DEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVR 272 (412)
Q Consensus 198 ey~~~gsL~~~l~~~-----~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~ 272 (412)
||+++|+|.+++... .....+++..+..++.|++.||+|||++ +++||||||+||+++.++.+||+|||+++
T Consensus 93 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~ 169 (303)
T 2vwi_A 93 KLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSA 169 (303)
T ss_dssp ECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCHHHH
T ss_pred hhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEEeccchh
Confidence 999999999988641 1123589999999999999999999999 99999999999999999999999999987
Q ss_pred ccCCCC-----CCcccccccccccccccccC-cccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhh
Q 042435 273 LLDVDS-----SNRTLQAGTYGYIALELVYT-MVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQ 346 (412)
Q Consensus 273 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 346 (412)
...... .......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||..... ..........
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-------~~~~~~~~~~ 242 (303)
T 2vwi_A 170 FLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPP-------MKVLMLTLQN 242 (303)
T ss_dssp HCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCG-------GGHHHHHHTS
T ss_pred eeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCch-------hhHHHHHhcc
Confidence 654321 11234568999999999875 5689999999999999999999999873211 1111111111
Q ss_pred ccCCccc-----hhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 347 RLSPPIN-----QKIIQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 347 ~~~~~~~-----~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
....... .........+.+++.+||+.||++|||+.|++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 288 (303)
T 2vwi_A 243 DPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRH 288 (303)
T ss_dssp SCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred CCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 1000000 0000111237889999999999999999999875
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=313.14 Aligned_cols=233 Identities=23% Similarity=0.301 Sum_probs=172.8
Q ss_pred cCcccceeeeecCceEEEEEEeC-CCcEEEEEec-----------------cCCccccceEEEec------CceEEEEEE
Q 042435 143 EYFHIRYCIGTGGYDSVYKAELP-DGKVVALKKL-----------------HHSETEDSAFVVYS------PQCMFFIYE 198 (412)
Q Consensus 143 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l-----------------~~~~~~~~~~~~~~------~~~~~lv~e 198 (412)
.+|++.+.||+|+||.||+|... +|+.||||++ +|+++.....++.. ....++|||
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e 133 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLD 133 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTTSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEeehh
Confidence 46889999999999999999875 6999999964 56777776665532 224679999
Q ss_pred eccCCceeeeeccC-cccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCC-CcEEEeecCCccccCC
Q 042435 199 YMERGSLFCVLRDD-DEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSN-LEAFVADFGTVRLLDV 276 (412)
Q Consensus 199 y~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~-~~~kl~DfGla~~~~~ 276 (412)
|+++ +|.+.+... .....+++..+..++.|+++||+|||++ +|+||||||+|||++.+ +.+||+|||+++....
T Consensus 134 ~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~ 209 (420)
T 1j1b_A 134 YVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR 209 (420)
T ss_dssp CCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred cccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccchhhhhccc
Confidence 9975 665555421 1123589999999999999999999998 99999999999999955 6789999999987644
Q ss_pred CCCCcccccccccccccccccCc-ccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhh----------
Q 042435 277 DSSNRTLQAGTYGYIALELVYTM-VVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILY---------- 345 (412)
Q Consensus 277 ~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~---------- 345 (412)
... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||...... ..+.+++.
T Consensus 210 ~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~-------~~l~~i~~~lg~p~~~~~ 281 (420)
T 1j1b_A 210 GEP-NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV-------DQLVEIIKVLGTPTREQI 281 (420)
T ss_dssp TCC-CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHHHCSCCHHHH
T ss_pred CCC-ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHHHhCCCCHHHH
Confidence 322 2345789999999998764 7899999999999999999999999632110 01111111
Q ss_pred ----hcc---C-Cccch-hh-----HHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 346 ----QRL---S-PPINQ-KI-----IQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 346 ----~~~---~-~~~~~-~~-----~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
+.. . +.... .. ......+.+|+.+||+.||++|||+.|++++
T Consensus 282 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h 337 (420)
T 1j1b_A 282 REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 337 (420)
T ss_dssp HHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence 000 0 00000 00 0112348899999999999999999999875
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=307.95 Aligned_cols=236 Identities=21% Similarity=0.236 Sum_probs=161.3
Q ss_pred hhcCcccceeeeecCceEEEEEEe-CCCcEEEEEec-----------------------cCCccccceEEEecC------
Q 042435 141 ATEYFHIRYCIGTGGYDSVYKAEL-PDGKVVALKKL-----------------------HHSETEDSAFVVYSP------ 190 (412)
Q Consensus 141 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l-----------------------~~~~~~~~~~~~~~~------ 190 (412)
..++|++.+.||+|+||.||+|.. .+|+.||||++ +|+++.....++...
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 106 (367)
T 2fst_X 27 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 106 (367)
T ss_dssp EETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred CCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccC
Confidence 357899999999999999999975 57899999976 356666666665443
Q ss_pred ceEEEEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCC
Q 042435 191 QCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGT 270 (412)
Q Consensus 191 ~~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGl 270 (412)
...++|+||+ +++|.+++... .+++..+..++.|+++||+|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 107 ~~~~lv~e~~-~~~L~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DFG~ 178 (367)
T 2fst_X 107 NDVYLVTHLM-GADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGL 178 (367)
T ss_dssp CCCEEEEECC-CEECC-----C----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC---
T ss_pred CeEEEEeccc-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeeccc
Confidence 5679999999 68999988753 489999999999999999999998 999999999999999999999999999
Q ss_pred ccccCCCCCCcccccccccccccccccC-cccCcccccHHHHHHHHHHHhCCCCccccccccc--------CCC------
Q 042435 271 VRLLDVDSSNRTLQAGTYGYIALELVYT-MVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSS--------SSG------ 335 (412)
Q Consensus 271 a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~--------~~~------ 335 (412)
++..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ ...
T Consensus 179 a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~ 255 (367)
T 2fst_X 179 ARHTADE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 255 (367)
T ss_dssp ---------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHT
T ss_pred ccccccc---CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 9865432 234578999999999876 6789999999999999999999999963211000 000
Q ss_pred --CcchhhHHhhhccCCc---cchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 336 --PKIMLIDILYQRLSPP---INQKIIQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 336 --~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
........+......+ ...........+.+++.+||+.||++|||+.|++++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 256 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp TCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 0000011111000000 000000112347899999999999999999999986
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=329.03 Aligned_cols=236 Identities=22% Similarity=0.304 Sum_probs=184.0
Q ss_pred HhhcCcccceeeeecCceEEEEEEeC----CCcEEEEEec----------------------cCCccccceEEEecCceE
Q 042435 140 DATEYFHIRYCIGTGGYDSVYKAELP----DGKVVALKKL----------------------HHSETEDSAFVVYSPQCM 193 (412)
Q Consensus 140 ~~~~~f~~~~~lG~G~~g~Vy~~~~~----~~~~vAvK~l----------------------~~~~~~~~~~~~~~~~~~ 193 (412)
...++|++.+.||+|+||.||+|.+. .+..||+|.+ +|+++.....++ ..+..
T Consensus 387 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~-~~~~~ 465 (656)
T 2j0j_A 387 IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPV 465 (656)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-CSSSC
T ss_pred cccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-ecCce
Confidence 34567899999999999999999874 2567999964 477777777766 45678
Q ss_pred EEEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccc
Q 042435 194 FFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRL 273 (412)
Q Consensus 194 ~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~ 273 (412)
++||||+++|+|.+++.... ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 466 ~lv~E~~~~g~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~DFG~a~~ 540 (656)
T 2j0j_A 466 WIIMELCTLGELRSFLQVRK--FSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRY 540 (656)
T ss_dssp EEEEECCTTCBHHHHHHHTT--TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCCCCS
T ss_pred EEEEEcCCCCcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEEecCCCee
Confidence 99999999999999987543 2489999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCC-cccccccccccccccccCcccCcccccHHHHHHHHHHHh-CCCCcccccccccCCCCcchhhHHhhhccCCc
Q 042435 274 LDVDSSN-RTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLM-GTHPGELLLSLSSSSGPKIMLIDILYQRLSPP 351 (412)
Q Consensus 274 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 351 (412)
....... .....+|+.|+|||++.+..++.++||||||+++|||++ |..||.... . ......+......+
T Consensus 541 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~-------~-~~~~~~i~~~~~~~ 612 (656)
T 2j0j_A 541 MEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK-------N-NDVIGRIENGERLP 612 (656)
T ss_dssp CCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC-------H-HHHHHHHHHTCCCC
T ss_pred cCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCC-------H-HHHHHHHHcCCCCC
Confidence 6443221 233456789999999988899999999999999999997 999987321 1 11122222222222
Q ss_pred cchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhcCC
Q 042435 352 INQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELEGKT 392 (412)
Q Consensus 352 ~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 392 (412)
.+... ...+.+++.+||+.||++|||+.|+++.|+++.
T Consensus 613 ~~~~~---~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il 650 (656)
T 2j0j_A 613 MPPNC---PPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 650 (656)
T ss_dssp CCTTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCccc---cHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 22222 224788999999999999999999999998764
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-38 Score=305.00 Aligned_cols=235 Identities=23% Similarity=0.268 Sum_probs=179.3
Q ss_pred HHHhhcCcccceeeeecCceEEEEEEe-CCCcEEEEEec----------------------cCCccccceEEEecC----
Q 042435 138 LIDATEYFHIRYCIGTGGYDSVYKAEL-PDGKVVALKKL----------------------HHSETEDSAFVVYSP---- 190 (412)
Q Consensus 138 l~~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l----------------------~~~~~~~~~~~~~~~---- 190 (412)
+....++|++.+.||+|+||.||+|.. .+++.||||++ +|+++.....++...
T Consensus 22 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 101 (364)
T 3qyz_A 22 VFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQ 101 (364)
T ss_dssp BCCCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTT
T ss_pred eccccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccc
Confidence 334567899999999999999999976 46889999975 466776666666543
Q ss_pred -ceEEEEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecC
Q 042435 191 -QCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFG 269 (412)
Q Consensus 191 -~~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG 269 (412)
...++||||++ |+|.+++... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||
T Consensus 102 ~~~~~iv~e~~~-~~L~~~l~~~----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg 173 (364)
T 3qyz_A 102 MKDVYIVQDLME-TDLYKLLKTQ----HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFG 173 (364)
T ss_dssp CCCEEEEEECCS-EEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCT
T ss_pred cceEEEEEcccC-cCHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCc
Confidence 46899999997 5898888654 489999999999999999999999 99999999999999999999999999
Q ss_pred CccccCCCCCC---cccccccccccccccccC-cccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhh
Q 042435 270 TVRLLDVDSSN---RTLQAGTYGYIALELVYT-MVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILY 345 (412)
Q Consensus 270 la~~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~ 345 (412)
+++........ .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... ......+..
T Consensus 174 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-------~~~~~~i~~ 246 (364)
T 3qyz_A 174 LARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY-------LDQLNHILG 246 (364)
T ss_dssp TCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSG-------GGHHHHHHH
T ss_pred ceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCCh-------HHHHHHHHH
Confidence 99866433221 234579999999998754 4589999999999999999999999963211 011111110
Q ss_pred h----------------------ccCCc----cchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 346 Q----------------------RLSPP----INQKIIQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 346 ~----------------------~~~~~----~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
. ..... ...........+.+++.+||+.||++|||+.|++++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 314 (364)
T 3qyz_A 247 ILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 314 (364)
T ss_dssp HHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HhCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0 00000 000001112347899999999999999999999986
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-38 Score=297.19 Aligned_cols=230 Identities=22% Similarity=0.376 Sum_probs=170.8
Q ss_pred hhcCcccceeeeecCceEEEEEEe-CCCcEEEEEec--------------------cCCccccceEEEec----------
Q 042435 141 ATEYFHIRYCIGTGGYDSVYKAEL-PDGKVVALKKL--------------------HHSETEDSAFVVYS---------- 189 (412)
Q Consensus 141 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l--------------------~~~~~~~~~~~~~~---------- 189 (412)
..++|++.+.||+|+||.||+|.. .+++.||||.+ +|+++......+..
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA 83 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence 356799999999999999999987 47999999964 46777666555432
Q ss_pred ---CceEEEEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEe
Q 042435 190 ---PQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVA 266 (412)
Q Consensus 190 ---~~~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~ 266 (412)
....++||||+++|+|.+++.... ..+++..+..++.|++.||+|||++ +++||||||+||+++.++.+||+
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~~kl~ 158 (303)
T 1zy4_A 84 VKKKSTLFIQMEYCENGTLYDLIHSEN--LNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIG 158 (303)
T ss_dssp --CEEEEEEEEECCCSCBHHHHHHHSC--GGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEEC
T ss_pred cccCCceEEEEecCCCCCHHHhhhccc--cccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCCEEEe
Confidence 467899999999999999997543 2478899999999999999999999 99999999999999999999999
Q ss_pred ecCCccccCCCC--------------CCcccccccccccccccccCc-ccCcccccHHHHHHHHHHHhCCCCcccccccc
Q 042435 267 DFGTVRLLDVDS--------------SNRTLQAGTYGYIALELVYTM-VVTEKCVIYSFGVVALEVLMGTHPGELLLSLS 331 (412)
Q Consensus 267 DfGla~~~~~~~--------------~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~ 331 (412)
|||+++...... .......||+.|+|||++.+. .++.++||||||+++|||++ ||.....
T Consensus 159 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~-- 233 (303)
T 1zy4_A 159 DFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGME-- 233 (303)
T ss_dssp CCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHH--
T ss_pred eCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchh--
Confidence 999998654221 112345689999999998764 68999999999999999998 4431100
Q ss_pred cCCCCcchhhHHhhh--ccCCccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 332 SSSGPKIMLIDILYQ--RLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 332 ~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
.......+... ..++.... .....+.+++.+||+.||++|||+.|++++
T Consensus 234 ----~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 234 ----RVNILKKLRSVSIEFPPDFDD---NKMKVEKKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp ----HHHHHHHHHSTTCCCCTTCCT---TTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred ----HHHHHHhccccccccCccccc---cchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence 00001111111 11111111 112337889999999999999999999975
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-38 Score=299.42 Aligned_cols=223 Identities=24% Similarity=0.308 Sum_probs=179.1
Q ss_pred HHhhcCcccceeeeecCceEEEEEEe-CCCcEEEEEecc-----------------------------CCccccceEEEe
Q 042435 139 IDATEYFHIRYCIGTGGYDSVYKAEL-PDGKVVALKKLH-----------------------------HSETEDSAFVVY 188 (412)
Q Consensus 139 ~~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l~-----------------------------~~~~~~~~~~~~ 188 (412)
....++|++.+.||+|+||.||+|.. .+++.||||.++ |+++......+.
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~ 118 (320)
T 3a99_A 39 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE 118 (320)
T ss_dssp -CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE
T ss_pred CCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe
Confidence 34467899999999999999999976 578999999763 355555566677
Q ss_pred cCceEEEEEEeccC-CceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEec-CCCcEEEe
Q 042435 189 SPQCMFFIYEYMER-GSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLN-SNLEAFVA 266 (412)
Q Consensus 189 ~~~~~~lv~ey~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~-~~~~~kl~ 266 (412)
..+..++|+||+.+ ++|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++ +++.+||+
T Consensus 119 ~~~~~~lv~e~~~~~~~L~~~l~~~~---~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~kL~ 192 (320)
T 3a99_A 119 RPDSFVLILERPEPVQDLFDFITERG---ALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLI 192 (320)
T ss_dssp CSSEEEEEEECCSSEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEEC
T ss_pred cCCcEEEEEEcCCCCccHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCCCCCEEEe
Confidence 88899999999976 89998887543 589999999999999999999998 999999999999999 78999999
Q ss_pred ecCCccccCCCCCCcccccccccccccccccCccc-CcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhh
Q 042435 267 DFGTVRLLDVDSSNRTLQAGTYGYIALELVYTMVV-TEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILY 345 (412)
Q Consensus 267 DfGla~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~ 345 (412)
|||+++..... ......||+.|+|||++.+..+ +.++||||||+++|||++|+.||.... +...
T Consensus 193 Dfg~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~-------------~~~~ 257 (320)
T 3a99_A 193 DFGSGALLKDT--VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-------------EIIR 257 (320)
T ss_dssp CCTTCEECCSS--CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-------------HHHH
T ss_pred eCccccccccc--cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh-------------hhhc
Confidence 99999876432 2234568999999999877665 678999999999999999999986321 1111
Q ss_pred hccCCccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 346 QRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
.....+ ... ...+.+++.+||+.||++|||++|++++
T Consensus 258 ~~~~~~--~~~---~~~~~~li~~~l~~dp~~Rps~~~ll~h 294 (320)
T 3a99_A 258 GQVFFR--QRV---SSECQHLIRWCLALRPSDRPTFEEIQNH 294 (320)
T ss_dssp CCCCCS--SCC---CHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred cccccc--ccC---CHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111111 111 1237789999999999999999999875
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=312.56 Aligned_cols=179 Identities=24% Similarity=0.382 Sum_probs=136.0
Q ss_pred cCccc-ceeeeecCceEEEEEEeC---CCcEEEEEec-------------------cCCccccceEEE--ecCceEEEEE
Q 042435 143 EYFHI-RYCIGTGGYDSVYKAELP---DGKVVALKKL-------------------HHSETEDSAFVV--YSPQCMFFIY 197 (412)
Q Consensus 143 ~~f~~-~~~lG~G~~g~Vy~~~~~---~~~~vAvK~l-------------------~~~~~~~~~~~~--~~~~~~~lv~ 197 (412)
+.|++ .++||+|+||.||+|... +++.||||++ +|+++.....++ ......++||
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~ 99 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLF 99 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEE
Confidence 34555 458999999999999875 5789999965 577777777776 4477899999
Q ss_pred EeccCCceeeeeccCc------ccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEe----cCCCcEEEee
Q 042435 198 EYMERGSLFCVLRDDD------EAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILL----NSNLEAFVAD 267 (412)
Q Consensus 198 ey~~~gsL~~~l~~~~------~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl----~~~~~~kl~D 267 (412)
||++ |+|.+++.... ....+++..+..++.|++.||+|||++ +|+||||||+|||+ +.++.+||+|
T Consensus 100 e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~D 175 (405)
T 3rgf_A 100 DYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIAD 175 (405)
T ss_dssp ECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTTCEEECC
T ss_pred eCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCCcEEEEE
Confidence 9996 58877775322 112489999999999999999999999 99999999999999 6788999999
Q ss_pred cCCccccCCCC---CCcccccccccccccccccCc-ccCcccccHHHHHHHHHHHhCCCCcc
Q 042435 268 FGTVRLLDVDS---SNRTLQAGTYGYIALELVYTM-VVTEKCVIYSFGVVALEVLMGTHPGE 325 (412)
Q Consensus 268 fGla~~~~~~~---~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~S~Gvil~elltg~~P~~ 325 (412)
||+++...... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||.
T Consensus 176 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~ 237 (405)
T 3rgf_A 176 MGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 237 (405)
T ss_dssp TTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTC
T ss_pred CCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCC
Confidence 99998765332 122445789999999998874 58999999999999999999999996
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-38 Score=312.71 Aligned_cols=231 Identities=21% Similarity=0.272 Sum_probs=170.2
Q ss_pred CcccceeeeecCceEEEEEEeCCCcEEEEEec-------------------cCCccccceEEEecCceEEEEEEeccCCc
Q 042435 144 YFHIRYCIGTGGYDSVYKAELPDGKVVALKKL-------------------HHSETEDSAFVVYSPQCMFFIYEYMERGS 204 (412)
Q Consensus 144 ~f~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~l-------------------~~~~~~~~~~~~~~~~~~~lv~ey~~~gs 204 (412)
.|...+.||+|+||+||.+...+|+.||||++ +|+++......+.+.+..++||||+. |+
T Consensus 16 ~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-gs 94 (434)
T 2rio_A 16 LVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LN 94 (434)
T ss_dssp CEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGGHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-EE
T ss_pred eeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHHHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-CC
Confidence 35556889999999998777778999999964 58888888888888999999999995 69
Q ss_pred eeeeeccCcccc-c---CCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCC-------------CcEEEee
Q 042435 205 LFCVLRDDDEAI-E---LNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSN-------------LEAFVAD 267 (412)
Q Consensus 205 L~~~l~~~~~~~-~---l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~-------------~~~kl~D 267 (412)
|.+++....... . .++..++.++.|++.||+|||++ +|+||||||+|||++.+ +.+||+|
T Consensus 95 L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~D 171 (434)
T 2rio_A 95 LQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISD 171 (434)
T ss_dssp HHHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECC
T ss_pred HHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCCCceEEEEcc
Confidence 999987654211 1 13334678999999999999999 99999999999999653 5899999
Q ss_pred cCCccccCCCCCC----cccccccccccccccccC-------cccCcccccHHHHHHHHHHHh-CCCCcccccccccCCC
Q 042435 268 FGTVRLLDVDSSN----RTLQAGTYGYIALELVYT-------MVVTEKCVIYSFGVVALEVLM-GTHPGELLLSLSSSSG 335 (412)
Q Consensus 268 fGla~~~~~~~~~----~~~~~gt~~y~aPE~~~~-------~~~s~ksDv~S~Gvil~ellt-g~~P~~~~~~~~~~~~ 335 (412)
||+++........ .....||+.|+|||++.+ ..++.++|||||||++|||+| |+.||....
T Consensus 172 FG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~------- 244 (434)
T 2rio_A 172 FGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKY------- 244 (434)
T ss_dssp CTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTT-------
T ss_pred cccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCch-------
Confidence 9999876543221 234579999999999865 568999999999999999999 999986321
Q ss_pred CcchhhHHhhhccCCcc--chhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 336 PKIMLIDILYQRLSPPI--NQKIIQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 336 ~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
. ....+.......+. ..........+.+++.+||+.||++|||+.|++++
T Consensus 245 ~--~~~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 296 (434)
T 2rio_A 245 S--RESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRH 296 (434)
T ss_dssp T--HHHHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred h--hHHHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhC
Confidence 0 11122222111110 01112233458899999999999999999999864
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-38 Score=293.65 Aligned_cols=231 Identities=23% Similarity=0.288 Sum_probs=181.3
Q ss_pred hhcCcccceeeeecCceEEEEEEeC-CCcEEEEEec-----------------------cCCccccceEEEecCceEEEE
Q 042435 141 ATEYFHIRYCIGTGGYDSVYKAELP-DGKVVALKKL-----------------------HHSETEDSAFVVYSPQCMFFI 196 (412)
Q Consensus 141 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l-----------------------~~~~~~~~~~~~~~~~~~~lv 196 (412)
..++|++.+.||+|+||.||+|... +++.||+|.+ +|+++......+...+..++|
T Consensus 20 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 99 (287)
T 2wei_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (287)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEE
Confidence 3468999999999999999999875 7899999975 466777777778888999999
Q ss_pred EEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCC---CcEEEeecCCccc
Q 042435 197 YEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSN---LEAFVADFGTVRL 273 (412)
Q Consensus 197 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~---~~~kl~DfGla~~ 273 (412)
+||+++++|.+++.... .+++..+..++.|++.||+|||++ +++||||||+||+++.+ ..+||+|||+++.
T Consensus 100 ~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~ 173 (287)
T 2wei_A 100 GELYTGGELFDEIIKRK---RFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173 (287)
T ss_dssp ECCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECSTTGGGT
T ss_pred EEccCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEEeccCccee
Confidence 99999999988876543 589999999999999999999999 99999999999999754 4799999999986
Q ss_pred cCCCCCCcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccc
Q 042435 274 LDVDSSNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPIN 353 (412)
Q Consensus 274 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 353 (412)
..... ......||+.|+|||.+.+ .++.++||||||+++|||++|+.||.... .......+.......+.
T Consensus 174 ~~~~~-~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~-------~~~~~~~~~~~~~~~~~- 243 (287)
T 2wei_A 174 FQQNT-KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKN-------EYDILKRVETGKYAFDL- 243 (287)
T ss_dssp BCCCS-SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSS-------HHHHHHHHHHCCCCCCS-
T ss_pred ecCCC-ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCC-------HHHHHHHHHcCCCCCCc-
Confidence 54332 2233468999999998865 48899999999999999999999986321 11111122222211111
Q ss_pred hhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 354 QKIIQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 354 ~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
.........+.+++.+||+.||++|||+.|++++
T Consensus 244 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 277 (287)
T 2wei_A 244 PQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (287)
T ss_dssp GGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred hhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcC
Confidence 1111122347899999999999999999999984
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=298.54 Aligned_cols=238 Identities=19% Similarity=0.227 Sum_probs=174.2
Q ss_pred hcCcccceeeeecCceEEEEEEeC-CC-cEEEEEeccCC--------------------c------cccceEEEecCceE
Q 042435 142 TEYFHIRYCIGTGGYDSVYKAELP-DG-KVVALKKLHHS--------------------E------TEDSAFVVYSPQCM 193 (412)
Q Consensus 142 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~-~~vAvK~l~~~--------------------~------~~~~~~~~~~~~~~ 193 (412)
.++|++.+.||+|+||.||+|... ++ +.||+|.++.. + +......+...+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 97 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHM 97 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeE
Confidence 468999999999999999999864 34 78999987431 1 33334456677889
Q ss_pred EEEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEe----------------
Q 042435 194 FFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILL---------------- 257 (412)
Q Consensus 194 ~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl---------------- 257 (412)
++||||+ +++|.+++..... ..+++..+..++.|++.||+|||++ +|+||||||+|||+
T Consensus 98 ~lv~e~~-~~~l~~~l~~~~~-~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~ 172 (355)
T 2eu9_A 98 CIAFELL-GKNTFEFLKENNF-QPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHKSCE 172 (355)
T ss_dssp EEEEECC-CCBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEEEECCC-CCC
T ss_pred EEEEecc-CCChHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeccccccccccccccc
Confidence 9999999 6677766654432 2489999999999999999999998 99999999999999
Q ss_pred ---cCCCcEEEeecCCccccCCCCCCcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccc---
Q 042435 258 ---NSNLEAFVADFGTVRLLDVDSSNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLS--- 331 (412)
Q Consensus 258 ---~~~~~~kl~DfGla~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~--- 331 (412)
+.++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 173 ~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~ 249 (355)
T 2eu9_A 173 EKSVKNTSIRVADFGSATFDHEH---HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLV 249 (355)
T ss_dssp EEEESCCCEEECCCTTCEETTSC---CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred ccccCCCcEEEeecCcccccccc---ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 56789999999999864332 234578999999999999999999999999999999999999996321100
Q ss_pred ---c--CCCCcch----------------------hhHHhhhccCCc--cchhhHHHHHHHHHHHHhcCcCCCCCCCCHH
Q 042435 332 ---S--SSGPKIM----------------------LIDILYQRLSPP--INQKIIQDIILVSTIALACLRSKPKSRPTMQ 382 (412)
Q Consensus 332 ---~--~~~~~~~----------------------~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ 382 (412)
. ...+... ..........+. ...........+.+++.+||+.||++|||+.
T Consensus 250 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ 329 (355)
T 2eu9_A 250 MMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLA 329 (355)
T ss_dssp HHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHH
T ss_pred HHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCHH
Confidence 0 0000000 000000000000 0000011233588999999999999999999
Q ss_pred HHHHH
Q 042435 383 RISQE 387 (412)
Q Consensus 383 evl~~ 387 (412)
|++++
T Consensus 330 e~l~h 334 (355)
T 2eu9_A 330 EALLH 334 (355)
T ss_dssp HHTTS
T ss_pred HHhcC
Confidence 99864
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-37 Score=292.45 Aligned_cols=229 Identities=21% Similarity=0.201 Sum_probs=175.1
Q ss_pred hcCcccceeeeecCceEEEEEEe-CCCcEEEEEec-------------------------cCCccccceEEE--ecCceE
Q 042435 142 TEYFHIRYCIGTGGYDSVYKAEL-PDGKVVALKKL-------------------------HHSETEDSAFVV--YSPQCM 193 (412)
Q Consensus 142 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l-------------------------~~~~~~~~~~~~--~~~~~~ 193 (412)
.++|++.+.||+|+||.||+|.. .+++.||+|.+ +|+++.....++ ...+..
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 46899999999999999999987 46899999965 466777766666 345678
Q ss_pred EEEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccc
Q 042435 194 FFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRL 273 (412)
Q Consensus 194 ~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~ 273 (412)
++||||++++ |.+++..... ..+++..+..++.|++.||+|||++ +++||||||+||+++.++.+||+|||++..
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~ 158 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVPE-KRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEA 158 (305)
T ss_dssp EEEEECCSEE-HHHHHHHSTT-CSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEehhccCC-HHHHHHhCcc-cccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeeccccccc
Confidence 9999999876 6666554322 2589999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCC--CCcccccccccccccccccCcc--cCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccC
Q 042435 274 LDVDS--SNRTLQAGTYGYIALELVYTMV--VTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLS 349 (412)
Q Consensus 274 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~--~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 349 (412)
..... .......||+.|+|||++.+.. ++.++||||||+++|||++|+.||.... .......+......
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-------~~~~~~~i~~~~~~ 231 (305)
T 2wtk_C 159 LHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN-------IYKLFENIGKGSYA 231 (305)
T ss_dssp CCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSS-------HHHHHHHHHHCCCC
T ss_pred cCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCch-------HHHHHHHHhcCCCC
Confidence 64322 2223456899999999987643 4789999999999999999999987321 11111111111111
Q ss_pred CccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 350 PPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 350 ~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
. +... ...+.+++.+||+.||++|||+.|++++
T Consensus 232 ~--~~~~---~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 232 I--PGDC---GPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp C--CSSS---CHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred C--CCcc---CHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 1 1111 2237789999999999999999999976
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-38 Score=310.81 Aligned_cols=232 Identities=23% Similarity=0.307 Sum_probs=171.9
Q ss_pred hhcCcccceeeeecCceEEEEEEeCCCcEEEEEec-------------------cCCccccceEEEecCceEEEEEEecc
Q 042435 141 ATEYFHIRYCIGTGGYDSVYKAELPDGKVVALKKL-------------------HHSETEDSAFVVYSPQCMFFIYEYME 201 (412)
Q Consensus 141 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~l-------------------~~~~~~~~~~~~~~~~~~~lv~ey~~ 201 (412)
...+|+..++||+|+||+||.....+|+.||||++ +|+++......+.+.+..++||||++
T Consensus 22 ~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~ 101 (432)
T 3p23_A 22 GKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA 101 (432)
T ss_dssp TTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred ccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC
Confidence 34568999999999999976666668999999964 57888888888888899999999996
Q ss_pred CCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEec-----CCCcEEEeecCCccccCC
Q 042435 202 RGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLN-----SNLEAFVADFGTVRLLDV 276 (412)
Q Consensus 202 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~-----~~~~~kl~DfGla~~~~~ 276 (412)
|+|.+++..... ...+..+..++.|++.||+|||++ +|+||||||+|||++ ....+||+|||+++....
T Consensus 102 -g~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~ 175 (432)
T 3p23_A 102 -ATLQEYVEQKDF--AHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAV 175 (432)
T ss_dssp -EEHHHHHHSSSC--CCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC--
T ss_pred -CCHHHHHHhcCC--CccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccC
Confidence 699998876542 244455678999999999999999 999999999999994 334688999999987654
Q ss_pred CC---CCccccccccccccccccc---CcccCcccccHHHHHHHHHHHh-CCCCcccccccccCCCCcchhhHHhhhccC
Q 042435 277 DS---SNRTLQAGTYGYIALELVY---TMVVTEKCVIYSFGVVALEVLM-GTHPGELLLSLSSSSGPKIMLIDILYQRLS 349 (412)
Q Consensus 277 ~~---~~~~~~~gt~~y~aPE~~~---~~~~s~ksDv~S~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 349 (412)
.. .......||+.|+|||++. ...++.++|||||||++|||+| |..||.... .. ..........
T Consensus 176 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~--------~~-~~~~~~~~~~ 246 (432)
T 3p23_A 176 GRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSL--------QR-QANILLGACS 246 (432)
T ss_dssp ----------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTT--------TH-HHHHHTTCCC
T ss_pred CCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhh--------HH-HHHHHhccCC
Confidence 32 2234457999999999997 4567889999999999999999 999986211 11 1111111111
Q ss_pred CccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 350 PPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 350 ~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
.............+.+++.+||+.||++|||+.|++++
T Consensus 247 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~h 284 (432)
T 3p23_A 247 LDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKH 284 (432)
T ss_dssp CTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhC
Confidence 11101111223347789999999999999999999853
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=296.29 Aligned_cols=225 Identities=23% Similarity=0.314 Sum_probs=173.8
Q ss_pred HHHHhhcCcccceeeeecCceEEEEEEe-CCCcEEEEEec-------------------------------cCCccccce
Q 042435 137 NLIDATEYFHIRYCIGTGGYDSVYKAEL-PDGKVVALKKL-------------------------------HHSETEDSA 184 (412)
Q Consensus 137 ~l~~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l-------------------------------~~~~~~~~~ 184 (412)
+.....++|++.+.||+|+||.||+|.. .+++.||||.+ +|+++....
T Consensus 25 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~ 104 (312)
T 2iwi_A 25 DREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLL 104 (312)
T ss_dssp --------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEE
T ss_pred chhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEE
Confidence 3344567899999999999999999976 56899999986 356666666
Q ss_pred EEEecCceEEEEEEe-ccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEec-CCCc
Q 042435 185 FVVYSPQCMFFIYEY-MERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLN-SNLE 262 (412)
Q Consensus 185 ~~~~~~~~~~lv~ey-~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~-~~~~ 262 (412)
.++...+..++|+|| +++++|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+||+++ .++.
T Consensus 105 ~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~ 178 (312)
T 2iwi_A 105 DWFETQEGFMLVLERPLPAQDLFDYITEKG---PLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRGC 178 (312)
T ss_dssp EEC-----CEEEEECCSSEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEETTTTE
T ss_pred EEEecCCeEEEEEEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeCCCCe
Confidence 667777889999999 78999999987543 589999999999999999999999 999999999999999 8899
Q ss_pred EEEeecCCccccCCCCCCcccccccccccccccccCcccC-cccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhh
Q 042435 263 AFVADFGTVRLLDVDSSNRTLQAGTYGYIALELVYTMVVT-EKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLI 341 (412)
Q Consensus 263 ~kl~DfGla~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s-~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~ 341 (412)
+||+|||+++..... ......||..|+|||++.+..+. .++||||||+++|||++|+.||....
T Consensus 179 ~kl~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------------- 243 (312)
T 2iwi_A 179 AKLIDFGSGALLHDE--PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ------------- 243 (312)
T ss_dssp EEECCCSSCEECCSS--CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-------------
T ss_pred EEEEEcchhhhcccC--cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH-------------
Confidence 999999999876543 23345689999999998766654 58999999999999999999987321
Q ss_pred HHhhhccCCccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 342 DILYQRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 342 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
+........+ ... ...+.+++.+||+.||++|||++|++++
T Consensus 244 ~~~~~~~~~~--~~~---~~~~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 244 EILEAELHFP--AHV---SPDCCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp HHHHTCCCCC--TTS---CHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred HHhhhccCCc--ccC---CHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1111211111 111 1237789999999999999999999985
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=301.76 Aligned_cols=233 Identities=18% Similarity=0.229 Sum_probs=175.7
Q ss_pred hcCcccceeeeecCceEEEEEEe-CCCcEEEEEecc-------------------------------CCccccceEEEec
Q 042435 142 TEYFHIRYCIGTGGYDSVYKAEL-PDGKVVALKKLH-------------------------------HSETEDSAFVVYS 189 (412)
Q Consensus 142 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l~-------------------------------~~~~~~~~~~~~~ 189 (412)
.++|++.+.||+|+||.||+|.. .+++.||||.++ |+++......+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~ 97 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 97 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhc
Confidence 35799999999999999999976 578999999874 3455555555543
Q ss_pred Cc----eEEEEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEec------C
Q 042435 190 PQ----CMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLN------S 259 (412)
Q Consensus 190 ~~----~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~------~ 259 (412)
.+ ..++||||+ +++|.+++..... ..+++..+..++.|++.||+|||+++ +|+||||||+|||++ .
T Consensus 98 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~--~ivH~Dikp~NIll~~~~~~~~ 173 (373)
T 1q8y_A 98 KGPNGVHVVMVFEVL-GENLLALIKKYEH-RGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPEN 173 (373)
T ss_dssp EETTEEEEEEEECCC-CEEHHHHHHHTTT-SCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEETTTT
T ss_pred cCCCCceEEEEEecC-CCCHHHHHHHhhc-cCCcHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChHHeEEeccCCCcC
Confidence 32 789999999 8899998875432 24899999999999999999999853 899999999999994 4
Q ss_pred CCcEEEeecCCccccCCCCCCcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcch
Q 042435 260 NLEAFVADFGTVRLLDVDSSNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIM 339 (412)
Q Consensus 260 ~~~~kl~DfGla~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~ 339 (412)
.+.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||+||+.||........ ......
T Consensus 174 ~~~~kl~Dfg~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~-~~~~~~ 249 (373)
T 1q8y_A 174 LIQIKIADLGNACWYDEH---YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSY-TKDDDH 249 (373)
T ss_dssp EEEEEECCCTTCEETTBC---CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC----------CHHHH
T ss_pred cceEEEcccccccccCCC---CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCccccc-CChHHH
Confidence 458999999999866432 2334789999999999999999999999999999999999999973211000 000000
Q ss_pred hhHH------------------------------------------hhhccCCccchhhHHHHHHHHHHHHhcCcCCCCC
Q 042435 340 LIDI------------------------------------------LYQRLSPPINQKIIQDIILVSTIALACLRSKPKS 377 (412)
Q Consensus 340 ~~~~------------------------------------------~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~ 377 (412)
+..+ ...... ........+.+++.+||+.||++
T Consensus 250 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~li~~~L~~dP~~ 324 (373)
T 1q8y_A 250 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYK-----FSKDEAKEISDFLSPMLQLDPRK 324 (373)
T ss_dssp HHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTC-----CCHHHHHHHHHHHGGGGCSSTTT
T ss_pred HHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhccc-----CCcchHHHHHHHHHHHhccCccc
Confidence 0111 001000 01233445889999999999999
Q ss_pred CCCHHHHHHH
Q 042435 378 RPTMQRISQE 387 (412)
Q Consensus 378 RPs~~evl~~ 387 (412)
|||++|++++
T Consensus 325 Rpt~~ell~h 334 (373)
T 1q8y_A 325 RADAGGLVNH 334 (373)
T ss_dssp CBCHHHHHTC
T ss_pred cCCHHHHhhC
Confidence 9999999985
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=296.59 Aligned_cols=238 Identities=20% Similarity=0.234 Sum_probs=169.6
Q ss_pred hcCcccceeeeecCceEEEEEEeC-CCcEEEEEec---------------------cCCccccceEEE------------
Q 042435 142 TEYFHIRYCIGTGGYDSVYKAELP-DGKVVALKKL---------------------HHSETEDSAFVV------------ 187 (412)
Q Consensus 142 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l---------------------~~~~~~~~~~~~------------ 187 (412)
.++|++.+.||+|+||.||+|... +++.||+|++ +|+++.....++
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 367899999999999999999875 4899999964 467776665554
Q ss_pred --ecCceEEEEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEec-CCCcEE
Q 042435 188 --YSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLN-SNLEAF 264 (412)
Q Consensus 188 --~~~~~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~-~~~~~k 264 (412)
......++||||++ |+|.+++... .+++..+..++.|++.||+|||++ +|+||||||+||+++ +++.+|
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~k 161 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLEQG----PLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLVLK 161 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTTEEE
T ss_pred cccccCceeEEeeccC-CCHHHHhhcC----CccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCeEE
Confidence 34467899999997 6999888653 488999999999999999999999 999999999999997 567999
Q ss_pred EeecCCccccCCCC---CCcccccccccccccccccC-cccCcccccHHHHHHHHHHHhCCCCccccccccc--------
Q 042435 265 VADFGTVRLLDVDS---SNRTLQAGTYGYIALELVYT-MVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSS-------- 332 (412)
Q Consensus 265 l~DfGla~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~-------- 332 (412)
|+|||+++...... .......+|..|+|||.+.+ ..++.++||||||+++|||++|+.||........
T Consensus 162 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~ 241 (320)
T 2i6l_A 162 IGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESI 241 (320)
T ss_dssp ECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHS
T ss_pred EccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence 99999998764322 12234467899999998865 6789999999999999999999999973211000
Q ss_pred CCCCcchhhHH-------hhhccCCc---cchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 333 SSGPKIMLIDI-------LYQRLSPP---INQKIIQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 333 ~~~~~~~~~~~-------~~~~~~~~---~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
.........+. .......+ ...........+.+++.+||+.||++|||+.|++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (320)
T 2i6l_A 242 PVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH 306 (320)
T ss_dssp CCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred CCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence 00000000000 00000000 000001112348899999999999999999999875
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=300.16 Aligned_cols=239 Identities=20% Similarity=0.233 Sum_probs=176.2
Q ss_pred hhcCcccceeeeecCceEEEEEEeC-CCcEEEEEec----------------------cCCccccceEEEecC-----ce
Q 042435 141 ATEYFHIRYCIGTGGYDSVYKAELP-DGKVVALKKL----------------------HHSETEDSAFVVYSP-----QC 192 (412)
Q Consensus 141 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l----------------------~~~~~~~~~~~~~~~-----~~ 192 (412)
..++|++.+.||+|+||.||+|... +|+.||||.+ +|+++.....++... ..
T Consensus 9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 88 (353)
T 2b9h_A 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE 88 (353)
T ss_dssp SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence 3578999999999999999999874 6899999975 356666655554432 67
Q ss_pred EEEEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCcc
Q 042435 193 MFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVR 272 (412)
Q Consensus 193 ~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~ 272 (412)
.++||||++ |+|.+++... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++
T Consensus 89 ~~lv~e~~~-~~L~~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (353)
T 2b9h_A 89 VYIIQELMQ-TDLHRVISTQ----MLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLAR 160 (353)
T ss_dssp EEEEECCCS-EEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEeccC-ccHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEeccccc
Confidence 899999997 5888887653 489999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCC----------cccccccccccccccccC-cccCcccccHHHHHHHHHHHhCCCCcccccccc---------c
Q 042435 273 LLDVDSSN----------RTLQAGTYGYIALELVYT-MVVTEKCVIYSFGVVALEVLMGTHPGELLLSLS---------S 332 (412)
Q Consensus 273 ~~~~~~~~----------~~~~~gt~~y~aPE~~~~-~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~---------~ 332 (412)
........ .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... .
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 240 (353)
T 2b9h_A 161 IIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIG 240 (353)
T ss_dssp ECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred ccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhC
Confidence 76432211 123468999999998754 678999999999999999999999986321100 0
Q ss_pred --------CCCCcchhhHHhhhccCCc---cchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 333 --------SSGPKIMLIDILYQRLSPP---INQKIIQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 333 --------~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
.........+........+ ...........+.+++.+||+.||++|||+.|++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (353)
T 2b9h_A 241 TPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH 306 (353)
T ss_dssp CCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0000000111111100000 000001122347899999999999999999999985
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=303.56 Aligned_cols=235 Identities=22% Similarity=0.250 Sum_probs=173.7
Q ss_pred hhcCcccceeeeecCceEEEEEEe-CCCcEEEEEec-----------------------cCCccccceEEEecCceE---
Q 042435 141 ATEYFHIRYCIGTGGYDSVYKAEL-PDGKVVALKKL-----------------------HHSETEDSAFVVYSPQCM--- 193 (412)
Q Consensus 141 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l-----------------------~~~~~~~~~~~~~~~~~~--- 193 (412)
..++|.+.+.||+|+||.||+|.. .+|+.||||++ +|+++.....++...+..
T Consensus 40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 119 (371)
T 4exu_A 40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 119 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence 356899999999999999999976 46899999975 466676667776665544
Q ss_pred ---EEEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCC
Q 042435 194 ---FFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGT 270 (412)
Q Consensus 194 ---~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGl 270 (412)
++||||+. ++|.+++.. .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+
T Consensus 120 ~~~~lv~e~~~-~~l~~~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg~ 190 (371)
T 4exu_A 120 YDFYLVMPFMQ-TDLQKIMGM-----EFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGL 190 (371)
T ss_dssp CCCEEEEECCC-EEHHHHTTS-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECSTTC
T ss_pred eeEEEEEcccc-ccHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEecCc
Confidence 99999997 588776642 389999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCCcccccccccccccccccC-cccCcccccHHHHHHHHHHHhCCCCccccccccc----------------C
Q 042435 271 VRLLDVDSSNRTLQAGTYGYIALELVYT-MVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSS----------------S 333 (412)
Q Consensus 271 a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~----------------~ 333 (412)
++..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ .
T Consensus 191 a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 267 (371)
T 4exu_A 191 ARHADAE---MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQ 267 (371)
T ss_dssp C-----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHT
T ss_pred ccccccC---cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHH
Confidence 9865432 234578999999999877 6789999999999999999999999973211000 0
Q ss_pred CCCcchhhHHhhhccCCccc---hhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 334 SGPKIMLIDILYQRLSPPIN---QKIIQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
.................+.. .........+.+++.+||+.||++|||+.|++++
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 268 KLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp TCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 00000000111110000000 0001113358899999999999999999999986
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-38 Score=300.36 Aligned_cols=233 Identities=21% Similarity=0.223 Sum_probs=160.1
Q ss_pred hcCcccceeeeecCceEEEEEEeC-CCcEEEEEec-----------------------cCCccccceEEEecCceEEEEE
Q 042435 142 TEYFHIRYCIGTGGYDSVYKAELP-DGKVVALKKL-----------------------HHSETEDSAFVVYSPQCMFFIY 197 (412)
Q Consensus 142 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l-----------------------~~~~~~~~~~~~~~~~~~~lv~ 197 (412)
.++|++.+.||+|+||.||+|... +|+.||||.+ +|+++......+...+..++||
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~ 100 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM 100 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence 367899999999999999999874 7899999965 4677777788888899999999
Q ss_pred EeccCCceeeeeccCc--ccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccC
Q 042435 198 EYMERGSLFCVLRDDD--EAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLD 275 (412)
Q Consensus 198 ey~~~gsL~~~l~~~~--~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~ 275 (412)
||+++ +|.+++.... ....+++..+..++.|++.||.|||+.. +|+||||||+||+++.++.+||+|||+++...
T Consensus 101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~ 177 (327)
T 3aln_A 101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFGISGQLV 177 (327)
T ss_dssp CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHH--SCCCSCCCGGGEEEETTTEEEECCCSSSCC--
T ss_pred eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccC--CEeECCCCHHHEEEcCCCCEEEccCCCceecc
Confidence 99975 7777665311 1235899999999999999999999842 79999999999999999999999999998664
Q ss_pred CCCCCcccccccccccccccc----cCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhh---cc
Q 042435 276 VDSSNRTLQAGTYGYIALELV----YTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQ---RL 348 (412)
Q Consensus 276 ~~~~~~~~~~gt~~y~aPE~~----~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~---~~ 348 (412)
... ......||+.|+|||++ .+..++.++||||||+++|||++|+.||........ ........ .+
T Consensus 178 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~------~~~~~~~~~~~~~ 250 (327)
T 3aln_A 178 DSI-AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD------QLTQVVKGDPPQL 250 (327)
T ss_dssp -----------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------------CCCCCSCCCCC
T ss_pred ccc-ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH------HHHHHhcCCCCCC
Confidence 332 22334689999999998 456789999999999999999999999874211100 00011110 01
Q ss_pred CCccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 349 SPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 349 ~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
....... ....+.+++.+||+.||++|||+.|++++
T Consensus 251 ~~~~~~~---~~~~l~~li~~~l~~dp~~Rps~~ell~h 286 (327)
T 3aln_A 251 SNSEERE---FSPSFINFVNLCLTKDESKRPKYKELLKH 286 (327)
T ss_dssp CCCSSCC---CCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred CCccccc---CCHHHHHHHHHHhhCChhhCcCHHHHHhC
Confidence 1100011 12237889999999999999999999764
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-37 Score=297.77 Aligned_cols=234 Identities=21% Similarity=0.240 Sum_probs=172.7
Q ss_pred hcCcccceeeeecCceEEEEEEe-CCCcEEEEEec-----------------------cCCccccceEEEecCce-----
Q 042435 142 TEYFHIRYCIGTGGYDSVYKAEL-PDGKVVALKKL-----------------------HHSETEDSAFVVYSPQC----- 192 (412)
Q Consensus 142 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l-----------------------~~~~~~~~~~~~~~~~~----- 192 (412)
.++|.+.+.||+|+||.||+|.. .+|+.||||.+ +|+++.....++...+.
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 46799999999999999999977 46999999975 45666666666655543
Q ss_pred -EEEEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCc
Q 042435 193 -MFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTV 271 (412)
Q Consensus 193 -~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla 271 (412)
.++||||++ |+|.+++.. .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++
T Consensus 103 ~~~lv~e~~~-~~l~~~~~~-----~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~ 173 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMGL-----KFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLA 173 (353)
T ss_dssp CCEEEEECCS-EEGGGTTTS-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECSTTCT
T ss_pred eEEEEecccc-CCHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeecccc
Confidence 499999997 588877643 389999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCCcccccccccccccccccC-cccCcccccHHHHHHHHHHHhCCCCccccccccc--------CCC-------
Q 042435 272 RLLDVDSSNRTLQAGTYGYIALELVYT-MVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSS--------SSG------- 335 (412)
Q Consensus 272 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~--------~~~------- 335 (412)
+..... .....||+.|+|||++.+ ..++.++||||||+++|||++|+.||........ ...
T Consensus 174 ~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 250 (353)
T 3coi_A 174 RHADAE---MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQK 250 (353)
T ss_dssp TC-----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTT
T ss_pred cCCCCC---ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHH
Confidence 865432 234578999999999876 6789999999999999999999999973211000 000
Q ss_pred -CcchhhHHhhhc---cCCccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 336 -PKIMLIDILYQR---LSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 336 -~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
............ ...............+.+++.+||+.||++|||+.|++++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 306 (353)
T 3coi_A 251 LNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306 (353)
T ss_dssp CSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 000000000000 0000000011122348899999999999999999999976
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=295.32 Aligned_cols=231 Identities=19% Similarity=0.245 Sum_probs=162.3
Q ss_pred hcCcccceeeeecCceEEEEEEeC-CCcEEEEEec-----------------------cCCccccceEEEecCceEEEEE
Q 042435 142 TEYFHIRYCIGTGGYDSVYKAELP-DGKVVALKKL-----------------------HHSETEDSAFVVYSPQCMFFIY 197 (412)
Q Consensus 142 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l-----------------------~~~~~~~~~~~~~~~~~~~lv~ 197 (412)
.++|++.+.||+|+||.||+|... +|+.||||.+ +|+++......+...+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 467899999999999999999874 7999999965 4677777788888899999999
Q ss_pred EeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHh-CCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCC
Q 042435 198 EYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHH-DCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDV 276 (412)
Q Consensus 198 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~-~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~ 276 (412)
||+ ++.+..+.... ...+++..+..++.|++.||+|||+ + +++||||||+||+++.++.+||+|||+++....
T Consensus 104 e~~-~~~~~~l~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 177 (318)
T 2dyl_A 104 ELM-GTCAEKLKKRM--QGPIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGQIKLCDFGISGRLVD 177 (318)
T ss_dssp CCC-SEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred ecc-CCcHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHhhC---CEEeCCCCHHHEEECCCCCEEEEECCCchhccC
Confidence 999 44444333321 1258999999999999999999998 5 899999999999999999999999999976543
Q ss_pred CCCCccccccccccccccccc-----CcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCc
Q 042435 277 DSSNRTLQAGTYGYIALELVY-----TMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPP 351 (412)
Q Consensus 277 ~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 351 (412)
.. ......||+.|+|||++. ...++.++||||||+++|||++|+.||.... ............. .+.
T Consensus 178 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------~~~~~~~~~~~~~-~~~ 249 (318)
T 2dyl_A 178 DK-AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCK------TDFEVLTKVLQEE-PPL 249 (318)
T ss_dssp ----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCC------SHHHHHHHHHHSC-CCC
T ss_pred Cc-cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCC------ccHHHHHHHhccC-CCC
Confidence 32 223456899999999984 4568899999999999999999999987321 1111112222211 111
Q ss_pred cchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 352 INQKIIQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 352 ~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
.+. .......+.+++.+||+.||.+|||+.|++++
T Consensus 250 ~~~-~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (318)
T 2dyl_A 250 LPG-HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEH 284 (318)
T ss_dssp CCS-SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred CCc-cCCCCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 110 00112237889999999999999999999874
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-37 Score=304.46 Aligned_cols=223 Identities=17% Similarity=0.122 Sum_probs=163.8
Q ss_pred HhhcCcccceeeeecCceEEEEEEe-CCCcEEEEEeccCCccccc----------------------------------e
Q 042435 140 DATEYFHIRYCIGTGGYDSVYKAEL-PDGKVVALKKLHHSETEDS----------------------------------A 184 (412)
Q Consensus 140 ~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l~~~~~~~~----------------------------------~ 184 (412)
..+.+|...++||+|+||.||+|.. .+|+.||||+++....... .
T Consensus 75 ~~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~ 154 (413)
T 3dzo_A 75 ERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPF 154 (413)
T ss_dssp SCCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCC
T ss_pred CCceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccch
Confidence 4455688889999999999999985 5799999998762211110 0
Q ss_pred EEE------------e-----cCceEEEEEEeccCCceeeeeccC----cccccCCHHHHHHHHHHHHHHHHHHHhCCCC
Q 042435 185 FVV------------Y-----SPQCMFFIYEYMERGSLFCVLRDD----DEAIELNWTRRMNIVKSVAHALSYLHHDCTP 243 (412)
Q Consensus 185 ~~~------------~-----~~~~~~lv~ey~~~gsL~~~l~~~----~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~ 243 (412)
... . .....+++|+++ +++|.+++... .....++|..++.++.|+++||+|||++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~--- 230 (413)
T 3dzo_A 155 DLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY--- 230 (413)
T ss_dssp EEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---
T ss_pred hhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---
Confidence 000 0 012356777766 67998888421 1123588999999999999999999999
Q ss_pred CcEEeCCCCCCEEecCCCcEEEeecCCccccCCCCCCcccccccccccccccc----------cCcccCcccccHHHHHH
Q 042435 244 SIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTYGYIALELV----------YTMVVTEKCVIYSFGVV 313 (412)
Q Consensus 244 ~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~s~ksDv~S~Gvi 313 (412)
+|+||||||+|||++.++.+||+|||+++..... .....| +.|+|||++ ....++.++|||||||+
T Consensus 231 ~iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~---~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvi 306 (413)
T 3dzo_A 231 GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS---AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLA 306 (413)
T ss_dssp TEECSCCCGGGEEECTTCCEEECCGGGCEETTEE---ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHH
T ss_pred CcccCCcccceEEEecCCeEEEEeccceeecCCc---cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHH
Confidence 9999999999999999999999999998865432 334467 999999999 56668899999999999
Q ss_pred HHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHH
Q 042435 314 ALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQ 386 (412)
Q Consensus 314 l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~ 386 (412)
+|||+||+.||...... .....+.... ... ...+.+++.+||+.||++|||+.|+++
T Consensus 307 l~elltg~~Pf~~~~~~-------~~~~~~~~~~--~~~-------~~~~~~li~~~l~~dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 307 IYWIWCADLPNTDDAAL-------GGSEWIFRSC--KNI-------PQPVRALLEGFLRYPKEDRLLPLQAME 363 (413)
T ss_dssp HHHHHHSSCCCCTTGGG-------SCSGGGGSSC--CCC-------CHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHHHCCCCCCCcchh-------hhHHHHHhhc--ccC-------CHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 99999999999733111 0111111110 111 123788999999999999999777654
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=281.40 Aligned_cols=216 Identities=23% Similarity=0.324 Sum_probs=163.1
Q ss_pred hcCcccc-eeeeecCceEEEEEEe-CCCcEEEEEec-----------------cCCccccceEEEec----CceEEEEEE
Q 042435 142 TEYFHIR-YCIGTGGYDSVYKAEL-PDGKVVALKKL-----------------HHSETEDSAFVVYS----PQCMFFIYE 198 (412)
Q Consensus 142 ~~~f~~~-~~lG~G~~g~Vy~~~~-~~~~~vAvK~l-----------------~~~~~~~~~~~~~~----~~~~~lv~e 198 (412)
.++|.+. +.||+|+||.||+|.. .+++.||+|.+ +|+++......+.. ....++|||
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e 95 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVME 95 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEC
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecccHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEe
Confidence 3567776 7899999999999977 57899999975 46777777666654 677899999
Q ss_pred eccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecC---CCcEEEeecCCccccC
Q 042435 199 YMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNS---NLEAFVADFGTVRLLD 275 (412)
Q Consensus 199 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~---~~~~kl~DfGla~~~~ 275 (412)
|+++|+|.+++..... ..+++..+..++.|++.||+|||++ +|+||||||+||+++. ++.+||+|||+++...
T Consensus 96 ~~~~~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~ 171 (299)
T 3m2w_A 96 CLDGGELFSRIQDRGD-QAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT 171 (299)
T ss_dssp CCCSCBHHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECT
T ss_pred ecCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEeccccccccc
Confidence 9999999999876432 2589999999999999999999999 9999999999999997 7899999999986432
Q ss_pred CCCCCcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccchh
Q 042435 276 VDSSNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQK 355 (412)
Q Consensus 276 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 355 (412)
+..++.++|||||||++|||+||+.||............ ...........+ ...
T Consensus 172 ----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~---~~~~~~~~~~~~-~~~ 225 (299)
T 3m2w_A 172 ----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM---KTRIRMGQYEFP-NPE 225 (299)
T ss_dssp ----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCS---CCSSCTTCCSSC-HHH
T ss_pred ----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHH---HHHHhhccccCC-chh
Confidence 234678999999999999999999999633211100000 000000011100 011
Q ss_pred hHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 356 IIQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 356 ~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
.......+.+++.+||+.||++|||+.|++++
T Consensus 226 ~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~h 257 (299)
T 3m2w_A 226 WSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 257 (299)
T ss_dssp HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccCCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 11123348899999999999999999999985
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-35 Score=309.68 Aligned_cols=217 Identities=23% Similarity=0.296 Sum_probs=170.5
Q ss_pred hcCcccceeeeecCceEEEEEEeC--CCcEEEEEec----------------------cCCccccceEEEecCce-----
Q 042435 142 TEYFHIRYCIGTGGYDSVYKAELP--DGKVVALKKL----------------------HHSETEDSAFVVYSPQC----- 192 (412)
Q Consensus 142 ~~~f~~~~~lG~G~~g~Vy~~~~~--~~~~vAvK~l----------------------~~~~~~~~~~~~~~~~~----- 192 (412)
.++|++.+.||+|+||.||+|... +|+.||||.+ +|+++.....++...+.
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 368999999999999999999875 6899999965 46777777766665444
Q ss_pred EEEEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCcc
Q 042435 193 MFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVR 272 (412)
Q Consensus 193 ~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~ 272 (412)
.|+||||+++++|.+++.. .++|.+++.++.|++.||+|||++ +|+||||||+|||++.+ .+||+|||+++
T Consensus 159 ~~lv~E~~~g~~L~~~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DFG~a~ 229 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAVS 229 (681)
T ss_dssp EEEEEECCCCEECC----C-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCCTTCE
T ss_pred eEEEEEeCCCCcHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEecccch
Confidence 7999999999999987754 489999999999999999999999 99999999999999876 89999999998
Q ss_pred ccCCCCCCcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCcc
Q 042435 273 LLDVDSSNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPI 352 (412)
Q Consensus 273 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 352 (412)
..... ....||+.|+|||++.+.. +.++|||||||++|||++|..||...... . +...
T Consensus 230 ~~~~~----~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~--~--------------~~~~- 287 (681)
T 2pzi_A 230 RINSF----GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVD--G--------------LPED- 287 (681)
T ss_dssp ETTCC----SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECS--S--------------CCTT-
T ss_pred hcccC----CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccc--c--------------cccc-
Confidence 75433 3457999999999987654 88999999999999999999887632100 0 0000
Q ss_pred chhhHHHHHHHHHHHHhcCcCCCCCCCC-HHHHHHHHhc
Q 042435 353 NQKIIQDIILVSTIALACLRSKPKSRPT-MQRISQELEG 390 (412)
Q Consensus 353 ~~~~~~~~~~~~~l~~~Cl~~dP~~RPs-~~evl~~L~~ 390 (412)
.........+.+++.+||+.||++||+ ++++...|.+
T Consensus 288 -~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 325 (681)
T 2pzi_A 288 -DPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG 325 (681)
T ss_dssp -CHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred -ccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence 011112234788999999999999995 6666665554
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=313.90 Aligned_cols=238 Identities=24% Similarity=0.271 Sum_probs=172.7
Q ss_pred hcCcccceeeeecCceEEEEEEe-CCCcEEEEEec----------------------cCCccccceEEEec------Cce
Q 042435 142 TEYFHIRYCIGTGGYDSVYKAEL-PDGKVVALKKL----------------------HHSETEDSAFVVYS------PQC 192 (412)
Q Consensus 142 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l----------------------~~~~~~~~~~~~~~------~~~ 192 (412)
.++|++.+.||+|+||.||+|.. .+|+.||||.+ +|+++.....++.. .+.
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 36899999999999999999977 46899999965 45666655554433 677
Q ss_pred EEEEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCc---EEEeecC
Q 042435 193 MFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLE---AFVADFG 269 (412)
Q Consensus 193 ~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~---~kl~DfG 269 (412)
.++||||+++|+|.+++........+++..+..++.|++.||+|||+. +|+||||||+||+++.++. +||+|||
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL~DFG 169 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLG 169 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEEcccc
Confidence 899999999999999998765444589999999999999999999998 9999999999999986654 9999999
Q ss_pred CccccCCCCCCcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCccccccc---ccCC----CCcchhhH
Q 042435 270 TVRLLDVDSSNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSL---SSSS----GPKIMLID 342 (412)
Q Consensus 270 la~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~---~~~~----~~~~~~~~ 342 (412)
+++...... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||...... .... .......+
T Consensus 170 ~a~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~ 248 (676)
T 3qa8_A 170 YAKELDQGE-LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYD 248 (676)
T ss_dssp CCCBTTSCC-CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCC
T ss_pred ccccccccc-ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhh
Confidence 998765433 223457999999999999999999999999999999999999998632100 0000 00000000
Q ss_pred Hhhh-----ccCCccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHH
Q 042435 343 ILYQ-----RLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQR 383 (412)
Q Consensus 343 ~~~~-----~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~e 383 (412)
.... ...+............+.+++.+||+.||++|||+.|
T Consensus 249 ~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~e 294 (676)
T 3qa8_A 249 DLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQ 294 (676)
T ss_dssp CCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTT
T ss_pred hhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHH
Confidence 0000 0000000111122345889999999999999999977
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-35 Score=275.31 Aligned_cols=211 Identities=13% Similarity=0.025 Sum_probs=161.0
Q ss_pred cCcccceeeeecCceEEEEEEeC-CCcEEEEEec------------------------cCCccccceEEEecCceEEEEE
Q 042435 143 EYFHIRYCIGTGGYDSVYKAELP-DGKVVALKKL------------------------HHSETEDSAFVVYSPQCMFFIY 197 (412)
Q Consensus 143 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l------------------------~~~~~~~~~~~~~~~~~~~lv~ 197 (412)
++|++.+.||+|+||.||+|... +++.||||.+ +|+++.....++...+..|+||
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 110 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA 110 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence 57999999999999999999875 5899999976 4566666677788888999999
Q ss_pred EeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCC
Q 042435 198 EYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVD 277 (412)
Q Consensus 198 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~ 277 (412)
||+++++|.++++.. ....+..+++.|++.||+|||++ +|+||||||+|||++.++.+||+++|
T Consensus 111 e~~~g~~L~~~l~~~-----~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~~-------- 174 (286)
T 3uqc_A 111 EWIRGGSLQEVADTS-----PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPA-------- 174 (286)
T ss_dssp ECCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSCC--------
T ss_pred EecCCCCHHHHHhcC-----CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEecc--------
Confidence 999999999998543 34456788999999999999999 99999999999999999999998554
Q ss_pred CCCcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccchhhH
Q 042435 278 SSNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKII 357 (412)
Q Consensus 278 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 357 (412)
|++| ++.++|||||||++|||+||+.||......... .............+ .....
T Consensus 175 ------------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~----~~~~~~~~~~~~~~-~~~~~ 230 (286)
T 3uqc_A 175 ------------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGL----APAERDTAGQPIEP-ADIDR 230 (286)
T ss_dssp ------------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCS----EECCBCTTSCBCCH-HHHCT
T ss_pred ------------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhh----HHHHHHhccCCCCh-hhccc
Confidence 3332 578999999999999999999999743211100 00000001111100 00001
Q ss_pred HHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhcCCCC
Q 042435 358 QDIILVSTIALACLRSKPKSRPTMQRISQELEGKTPM 394 (412)
Q Consensus 358 ~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~ 394 (412)
.....+.+++.+||+.||++| |+.|+++.|+++...
T Consensus 231 ~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~ 266 (286)
T 3uqc_A 231 DIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAV 266 (286)
T ss_dssp TSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC-
T ss_pred CCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhcc
Confidence 112237899999999999999 999999999987654
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-35 Score=282.20 Aligned_cols=221 Identities=17% Similarity=0.108 Sum_probs=165.3
Q ss_pred hcCcccceeeeecCceEEEEEEeCCCcEEEEEeccCCcc--------------------------------------ccc
Q 042435 142 TEYFHIRYCIGTGGYDSVYKAELPDGKVVALKKLHHSET--------------------------------------EDS 183 (412)
Q Consensus 142 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~l~~~~~--------------------------------------~~~ 183 (412)
.++|++.+.||+|+||+||+|+. +|+.||||+++.... ...
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 46789999999999999999988 789999998764321 111
Q ss_pred eEEE-----------------e-------------cCceEEEEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHH
Q 042435 184 AFVV-----------------Y-------------SPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHA 233 (412)
Q Consensus 184 ~~~~-----------------~-------------~~~~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~g 233 (412)
..+. . ..+..++||||+++|++.+.+... .+++..+..++.|++.|
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~~----~~~~~~~~~i~~qi~~a 173 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTK----LSSLATAKSILHQLTAS 173 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTTT----CCCHHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHhc----CCCHHHHHHHHHHHHHH
Confidence 1110 0 267899999999999877766542 48999999999999999
Q ss_pred HHHHH-hCCCCCcEEeCCCCCCEEecCCC--------------------cEEEeecCCccccCCCCCCcccccccccccc
Q 042435 234 LSYLH-HDCTPSIVHRDISSNNILLNSNL--------------------EAFVADFGTVRLLDVDSSNRTLQAGTYGYIA 292 (412)
Q Consensus 234 L~~LH-~~~~~~ivHrDlkp~NILl~~~~--------------------~~kl~DfGla~~~~~~~~~~~~~~gt~~y~a 292 (412)
|+||| ++ +|+||||||+|||++.++ .+||+|||+++..... ...||+.|+|
T Consensus 174 L~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-----~~~gt~~y~a 245 (336)
T 2vuw_A 174 LAVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-----IVVFCDVSMD 245 (336)
T ss_dssp HHHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-----EEECCCCTTC
T ss_pred HHHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-----cEEEeecccC
Confidence 99999 88 999999999999999876 8999999999876432 3479999999
Q ss_pred cccccCcccCcccccHHHHHH-HHHHHhCCCCcccccccccCCCCcchhhHHhhhcc-C-CccchhhHHHHHHHHHHHHh
Q 042435 293 LELVYTMVVTEKCVIYSFGVV-ALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRL-S-PPINQKIIQDIILVSTIALA 369 (412)
Q Consensus 293 PE~~~~~~~s~ksDv~S~Gvi-l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~-~-~~~~~~~~~~~~~~~~l~~~ 369 (412)
||++.+.. +.++||||++++ .+++++|..||....+.. ........... . .............+.+++.+
T Consensus 246 PE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~ 318 (336)
T 2vuw_A 246 EDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLH------YLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRT 318 (336)
T ss_dssp SGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHH------HHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHH
T ss_pred hhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhhhh------HHHHhhhhhhccCcccchhhhhhcCHHHHHHHHH
Confidence 99998766 889999998777 778899999986321110 00111111101 1 11112223344568999999
Q ss_pred cCcCCCCCCCCHHHHH-HH
Q 042435 370 CLRSKPKSRPTMQRIS-QE 387 (412)
Q Consensus 370 Cl~~dP~~RPs~~evl-~~ 387 (412)
||+.| |++|++ ++
T Consensus 319 ~L~~d-----sa~e~l~~H 332 (336)
T 2vuw_A 319 MLNFS-----SATDLLCQH 332 (336)
T ss_dssp GGGSS-----SHHHHHHHC
T ss_pred HhccC-----CHHHHHhcC
Confidence 99976 999988 54
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=9e-29 Score=253.73 Aligned_cols=165 Identities=16% Similarity=0.073 Sum_probs=113.4
Q ss_pred eeeecCceEEEEEE-eCCCcEEEEEec--------------------------------cCCccccceEEEecCceEEEE
Q 042435 150 CIGTGGYDSVYKAE-LPDGKVVALKKL--------------------------------HHSETEDSAFVVYSPQCMFFI 196 (412)
Q Consensus 150 ~lG~G~~g~Vy~~~-~~~~~~vAvK~l--------------------------------~~~~~~~~~~~~~~~~~~~lv 196 (412)
..+.|++|.+..++ ...|+.+|+|.+ .|+++.+....+.+++..|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 35566677666653 345889999966 355666677778889999999
Q ss_pred EEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCC
Q 042435 197 YEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDV 276 (412)
Q Consensus 197 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~ 276 (412)
|||++||+|.++|.... .++.. +|+.||+.||+|+|++ +||||||||+|||+++++.+||+|||+|+....
T Consensus 321 MEyv~G~~L~d~i~~~~---~l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~ 391 (569)
T 4azs_A 321 MEKLPGRLLSDMLAAGE---EIDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ 391 (569)
T ss_dssp EECCCSEEHHHHHHTTC---CCCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCCTTEESCC-
T ss_pred EecCCCCcHHHHHHhCC---CCCHH---HHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeecccCeeCCC
Confidence 99999999999998654 35543 4899999999999999 999999999999999999999999999997766
Q ss_pred CCCCcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCc
Q 042435 277 DSSNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPG 324 (412)
Q Consensus 277 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~ 324 (412)
........+||+.|||||++.+ .+..++|+||+|++++++.++..|+
T Consensus 392 ~~~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~~ 438 (569)
T 4azs_A 392 DCSWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSNW 438 (569)
T ss_dssp --CCSHHHHHHHHHHHHHHC------------------CCCCTTHHHH
T ss_pred CCccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccchh
Confidence 5555566789999999999875 4567899999999988877665443
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=2.2e-25 Score=227.30 Aligned_cols=163 Identities=12% Similarity=0.142 Sum_probs=127.6
Q ss_pred ccceeeeecCceEEEEEEeCCCcEEEEEec-----------------------------cCCccccceEEEecCceEEEE
Q 042435 146 HIRYCIGTGGYDSVYKAELPDGKVVALKKL-----------------------------HHSETEDSAFVVYSPQCMFFI 196 (412)
Q Consensus 146 ~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~l-----------------------------~~~~~~~~~~~~~~~~~~~lv 196 (412)
...+.||+|+||.||+|.. .++.+|+|+. +|+++......+...+..++|
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 3456899999999999955 5788888852 466666555555667778999
Q ss_pred EEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCC
Q 042435 197 YEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDV 276 (412)
Q Consensus 197 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~ 276 (412)
|||+++|+|.+++.. +..++.|+++||+|||++ +|+||||||+|||++. .+||+|||+++....
T Consensus 418 mE~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~ 481 (540)
T 3en9_A 418 MSYINGKLAKDVIED-----------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIIDFGLGKISNL 481 (540)
T ss_dssp EECCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECCCTTCEECCC
T ss_pred EECCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEECccCEECCC
Confidence 999999999998875 457899999999999999 9999999999999998 999999999997654
Q ss_pred CCCC-------cccccccccccccccccC--cccCcccccHHHHHHHHHHHhCCCCcc
Q 042435 277 DSSN-------RTLQAGTYGYIALELVYT--MVVTEKCVIYSFGVVALEVLMGTHPGE 325 (412)
Q Consensus 277 ~~~~-------~~~~~gt~~y~aPE~~~~--~~~s~ksDv~S~Gvil~elltg~~P~~ 325 (412)
.... .....||+.|+|||++.. ..|+..+|+||..+-.++.+.++.+|.
T Consensus 482 ~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 482 DEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred ccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 3211 134579999999999986 668888999999999998888776653
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=1.5e-22 Score=189.67 Aligned_cols=147 Identities=17% Similarity=0.151 Sum_probs=112.3
Q ss_pred HHHHHHhhcCcccceeeeecCceEEEEEEeCCCcEEEEEeccCCcc----------------------------------
Q 042435 135 YENLIDATEYFHIRYCIGTGGYDSVYKAELPDGKVVALKKLHHSET---------------------------------- 180 (412)
Q Consensus 135 ~~~l~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~l~~~~~---------------------------------- 180 (412)
+..+......|.+.+.||+|+||.||+|...+|+.||+|.++....
T Consensus 82 l~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l 161 (282)
T 1zar_A 82 LHRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKL 161 (282)
T ss_dssp HHHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhc
Confidence 3445556667888899999999999999888899999999853211
Q ss_pred --ccceEEEecCceEEEEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEec
Q 042435 181 --EDSAFVVYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLN 258 (412)
Q Consensus 181 --~~~~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~ 258 (412)
..... +.+.+..++||||+++|+|.+ +.. .....++.|++.||+|||+. +|+||||||+|||++
T Consensus 162 ~~~~v~~-~~~~~~~~lvmE~~~g~~L~~-l~~---------~~~~~i~~qi~~~l~~lH~~---giiHrDlkp~NILl~ 227 (282)
T 1zar_A 162 QGLAVPK-VYAWEGNAVLMELIDAKELYR-VRV---------ENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVS 227 (282)
T ss_dssp TTSSSCC-EEEEETTEEEEECCCCEEGGG-CCC---------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEE
T ss_pred cCCCcCe-EEeccceEEEEEecCCCcHHH-cch---------hhHHHHHHHHHHHHHHHHHC---CCEeCCCCHHHEEEE
Confidence 11122 223456799999999999988 432 12346999999999999998 999999999999999
Q ss_pred CCCcEEEeecCCccccCCCCCCcccccccccccccccccC----------cccCcccccHH
Q 042435 259 SNLEAFVADFGTVRLLDVDSSNRTLQAGTYGYIALELVYT----------MVVTEKCVIYS 309 (412)
Q Consensus 259 ~~~~~kl~DfGla~~~~~~~~~~~~~~gt~~y~aPE~~~~----------~~~s~ksDv~S 309 (412)
++.+||+|||+++. +..|+|||++.. ..+...+|+|.
T Consensus 228 -~~~vkl~DFG~a~~-------------~~~~~a~e~l~rdv~~i~~~f~~~~~~~~~~~~ 274 (282)
T 1zar_A 228 -EEGIWIIDFPQSVE-------------VGEEGWREILERDVRNIITYFSRTYRTEKDINS 274 (282)
T ss_dssp -TTEEEECCCTTCEE-------------TTSTTHHHHHHHHHHHHHHHHHHHHCCCCCHHH
T ss_pred -CCcEEEEECCCCeE-------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCChHH
Confidence 99999999999863 345788988753 34455566654
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.74 E-value=3.4e-18 Score=157.90 Aligned_cols=132 Identities=23% Similarity=0.210 Sum_probs=92.5
Q ss_pred HHHHHhhcCcccceeeeecCceEEEEEEe-CCCcE--EEEEeccCCccccc-------------------------eE--
Q 042435 136 ENLIDATEYFHIRYCIGTGGYDSVYKAEL-PDGKV--VALKKLHHSETEDS-------------------------AF-- 185 (412)
Q Consensus 136 ~~l~~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~--vAvK~l~~~~~~~~-------------------------~~-- 185 (412)
..+.....-|++.+.||+|+||.||+|.. .+|+. ||||.++....... ..
T Consensus 40 ~~~~~~~~~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 119 (258)
T 1zth_A 40 YKLSAKGYITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEK 119 (258)
T ss_dssp HHHHHTTSEEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHH
T ss_pred HHHHhCCCchhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHH
Confidence 33333333467889999999999999988 78989 99998643211000 00
Q ss_pred ------------E----EecCceEEEEEEeccC-CceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHH-hCCCCCcEE
Q 042435 186 ------------V----VYSPQCMFFIYEYMER-GSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLH-HDCTPSIVH 247 (412)
Q Consensus 186 ------------~----~~~~~~~~lv~ey~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH-~~~~~~ivH 247 (412)
+ .......++||||+.+ |.+...+..... ..++.....++.|++.||.||| +. +|+|
T Consensus 120 E~~~l~~l~~~~i~~p~~~~~~~~~lVmE~~g~~g~~~~~L~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~---givH 194 (258)
T 1zth_A 120 EFRNLERAKEAGVSVPQPYTYMKNVLLMEFIGEDELPAPTLVELGR--ELKELDVEGIFNDVVENVKRLYQEA---ELVH 194 (258)
T ss_dssp HHHHHHHHHHTTCCCCCEEEEETTEEEEECCEETTEECCBHHHHGG--GGGGSCHHHHHHHHHHHHHHHHHTS---CEEC
T ss_pred HHHHHHHHHhCCCCCCeEEEcCCCEEEEEecCCCCCccccHHHHhh--ccChHHHHHHHHHHHHHHHHHHHHC---CEEe
Confidence 0 1112345899999952 544333332111 1234466789999999999999 87 9999
Q ss_pred eCCCCCCEEecCCCcEEEeecCCcccc
Q 042435 248 RDISSNNILLNSNLEAFVADFGTVRLL 274 (412)
Q Consensus 248 rDlkp~NILl~~~~~~kl~DfGla~~~ 274 (412)
|||||+|||++. .++|+|||+|...
T Consensus 195 rDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 195 ADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp SSCSTTSEEESS--SEEECCCTTCEET
T ss_pred CCCCHHHEEEcC--cEEEEECcccccC
Confidence 999999999998 9999999999754
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.66 E-value=1.9e-16 Score=152.97 Aligned_cols=124 Identities=12% Similarity=0.125 Sum_probs=91.4
Q ss_pred HHHhhcCcccceeeeecCceEEEEEEeCCCcEEEEEeccCCccc-----cceEE--------------------------
Q 042435 138 LIDATEYFHIRYCIGTGGYDSVYKAELPDGKVVALKKLHHSETE-----DSAFV-------------------------- 186 (412)
Q Consensus 138 l~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~l~~~~~~-----~~~~~-------------------------- 186 (412)
+..-..-|++...||+|+||.||+|...+|+.||||.++..... .....
T Consensus 90 L~~rg~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~r 169 (397)
T 4gyi_A 90 HAARKDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKA 169 (397)
T ss_dssp HHHTTSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHCCCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHH
Confidence 33333449999999999999999999999999999987532110 00000
Q ss_pred ----------EecCceEEEEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEE
Q 042435 187 ----------VYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNIL 256 (412)
Q Consensus 187 ----------~~~~~~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NIL 256 (412)
.......+|||||+++++|.++.... ....++.|++.+|.|||++ +||||||||.|||
T Consensus 170 L~~~gv~vp~p~~~~~~~LVME~i~G~~L~~l~~~~---------~~~~l~~qll~~l~~lH~~---gIVHrDLKp~NIL 237 (397)
T 4gyi_A 170 LYEEGFPVPEPIAQSRHTIVMSLVDALPMRQVSSVP---------DPASLYADLIALILRLAKH---GLIHGDFNEFNIL 237 (397)
T ss_dssp HHHTTCSCCCEEEEETTEEEEECCSCEEGGGCCCCS---------CHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEE
T ss_pred HHhcCCCCCeeeeccCceEEEEecCCccHhhhcccH---------HHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEE
Confidence 00111236999999988887654321 2345789999999999998 9999999999999
Q ss_pred ecCCC----------cEEEeecCCccc
Q 042435 257 LNSNL----------EAFVADFGTVRL 273 (412)
Q Consensus 257 l~~~~----------~~kl~DfGla~~ 273 (412)
+++++ .+.|+||+-+-.
T Consensus 238 l~~dgd~~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 238 IREEKDAEDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp EEEEECSSCTTSEEEEEEECCCTTCEE
T ss_pred EeCCCCcccccccccceEEEEeCCccc
Confidence 98766 389999987653
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=98.96 E-value=2.2e-09 Score=98.50 Aligned_cols=127 Identities=13% Similarity=0.036 Sum_probs=92.7
Q ss_pred HHHHhhcCcccceeeeecCceEEEEEEeCCCcEEEEEeccCC----------------------ccccceEEEecCceEE
Q 042435 137 NLIDATEYFHIRYCIGTGGYDSVYKAELPDGKVVALKKLHHS----------------------ETEDSAFVVYSPQCMF 194 (412)
Q Consensus 137 ~l~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~l~~~----------------------~~~~~~~~~~~~~~~~ 194 (412)
.+....++|++...++.|+.+.||++... ++.+++|..... ............+..|
T Consensus 8 ~l~~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~ 86 (263)
T 3tm0_A 8 ELKKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN 86 (263)
T ss_dssp HHHHHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred HHHHHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceE
Confidence 34455677888888999999999999864 688999986531 1111223345567889
Q ss_pred EEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCC---------------------------------
Q 042435 195 FIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDC--------------------------------- 241 (412)
Q Consensus 195 lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~--------------------------------- 241 (412)
+||||++|.+|.+.+.. ......++.+++++|+.||+..
T Consensus 87 lv~e~i~G~~l~~~~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (263)
T 3tm0_A 87 LLMSEADGVLCSEEYED--------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW 158 (263)
T ss_dssp EEEECCSSEEHHHHCCT--------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGG
T ss_pred EEEEecCCeehhhccCC--------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccc
Confidence 99999999888764321 1223467899999999999810
Q ss_pred -----------------------CCCcEEeCCCCCCEEecCCCcEEEeecCCcc
Q 042435 242 -----------------------TPSIVHRDISSNNILLNSNLEAFVADFGTVR 272 (412)
Q Consensus 242 -----------------------~~~ivHrDlkp~NILl~~~~~~kl~DfGla~ 272 (412)
.+.++|+|++|.||+++++....|+||+.+.
T Consensus 159 ~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp STTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred cccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 1358999999999999876556799998764
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=98.94 E-value=2.2e-10 Score=121.61 Aligned_cols=67 Identities=31% Similarity=0.492 Sum_probs=59.6
Q ss_pred eechhhccCCC-ceeeCCC-CCCCCCCCEEeCccccccccCCC-CCcCC-CCcccccCcCCCCCCCCCCcccc
Q 042435 3 VLLAFLSISAA-CSGVVEE-EPSSPSFLKSDMSFNNLDGEIPT-YLRDN-PPKSFVGNKGLCGHVQGFLSCFQ 71 (412)
Q Consensus 3 ~~~~~l~~~~~-~~G~ip~-~~~~~~l~~~~ls~N~l~G~iP~-~~~~~-~~~~~~gn~~lcg~~~~~~~c~~ 71 (412)
..|++||||+| ++|.||. +.++++|+.||||+|+|+|+||. +.|.. +..+|.||++|||.+.. +|..
T Consensus 680 ~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g~iP~~~~~~~~~~~~~~gN~~Lcg~~l~--~C~~ 750 (768)
T 3rgz_A 680 RGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYPLP--RCDP 750 (768)
T ss_dssp TTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSSEEEEECCSSSSGGGSCGGGGCSCTEEESTTSC--CCCS
T ss_pred CCCCEEECCCCcccCcCChHHhCCCCCCEEECcCCcccccCCCchhhccCCHHHhcCCchhcCCCCc--CCCC
Confidence 46899999999 9999988 88999999999999999999998 56777 88999999999998864 7864
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.84 E-value=5.9e-09 Score=95.11 Aligned_cols=124 Identities=15% Similarity=0.077 Sum_probs=84.9
Q ss_pred HHHhhcCcccceeeeecCceEEEEEEeCCCcEEEEEeccCCc--------------------cccceEEEecCceEEEEE
Q 042435 138 LIDATEYFHIRYCIGTGGYDSVYKAELPDGKVVALKKLHHSE--------------------TEDSAFVVYSPQCMFFIY 197 (412)
Q Consensus 138 l~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~l~~~~--------------------~~~~~~~~~~~~~~~lv~ 197 (412)
+.+...++.+..+.+.|..+.||++...+|+.+++|...... ..........++..++||
T Consensus 15 l~~~~~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~ 94 (264)
T 1nd4_A 15 WVERLFGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSGALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLL 94 (264)
T ss_dssp GTTTTTTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSCTTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEE
T ss_pred HHHhcCCCceEecccCCCCceEEEEecCCCCeEEEEeCCcccchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEE
Confidence 334445566544444666799999988778889999754321 111222344456689999
Q ss_pred EeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCC------------------------------------
Q 042435 198 EYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDC------------------------------------ 241 (412)
Q Consensus 198 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~------------------------------------ 241 (412)
||++|.+|. ... .+ ...++.++++.|+.||+..
T Consensus 95 e~i~G~~l~--~~~------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (264)
T 1nd4_A 95 GEVPGQDLL--SSH------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQ 163 (264)
T ss_dssp ECCSSEETT--TSC------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGT
T ss_pred EecCCcccC--cCc------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhcc
Confidence 999998874 211 11 1256778888888888642
Q ss_pred -------------------CCCcEEeCCCCCCEEecCCCcEEEeecCCcc
Q 042435 242 -------------------TPSIVHRDISSNNILLNSNLEAFVADFGTVR 272 (412)
Q Consensus 242 -------------------~~~ivHrDlkp~NILl~~~~~~kl~DfGla~ 272 (412)
...++|+|++|.||+++++..+.|+||+.+.
T Consensus 164 ~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 164 GLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp TCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred CccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 1139999999999999877666799999875
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.68 E-value=8.6e-08 Score=92.12 Aligned_cols=120 Identities=17% Similarity=0.200 Sum_probs=86.0
Q ss_pred ceeeeecCceEEEEEEeCCCcEEEEEecc--CCcc------------------------ccceEEEecC---ceEEEEEE
Q 042435 148 RYCIGTGGYDSVYKAELPDGKVVALKKLH--HSET------------------------EDSAFVVYSP---QCMFFIYE 198 (412)
Q Consensus 148 ~~~lG~G~~g~Vy~~~~~~~~~vAvK~l~--~~~~------------------------~~~~~~~~~~---~~~~lv~e 198 (412)
.+.|+.|.++.||+....+ ..+++|+.. .... ......+.+. +..++|||
T Consensus 43 ~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme 121 (359)
T 3dxp_A 43 VEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIME 121 (359)
T ss_dssp EEECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEE
T ss_pred EEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEE
Confidence 4678999999999998754 678888775 2210 0111123333 34789999
Q ss_pred eccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCC-------------------------------------
Q 042435 199 YMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDC------------------------------------- 241 (412)
Q Consensus 199 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~------------------------------------- 241 (412)
|+++..+.+... ..++..++..++.++++.|+.||+..
T Consensus 122 ~v~G~~l~~~~~-----~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (359)
T 3dxp_A 122 FVSGRVLWDQSL-----PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPA 196 (359)
T ss_dssp CCCCBCCCCTTC-----TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHH
T ss_pred ecCCeecCCCcc-----ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChH
Confidence 999887754211 13677888899999999999999731
Q ss_pred ------------------CCCcEEeCCCCCCEEecCCCc--EEEeecCCccc
Q 042435 242 ------------------TPSIVHRDISSNNILLNSNLE--AFVADFGTVRL 273 (412)
Q Consensus 242 ------------------~~~ivHrDlkp~NILl~~~~~--~kl~DfGla~~ 273 (412)
.+.++|+|+++.||+++.++. +.|+||+.+..
T Consensus 197 ~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 197 MDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 247999999999999987653 68999998864
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.42 E-value=7.7e-08 Score=90.26 Aligned_cols=166 Identities=21% Similarity=0.174 Sum_probs=102.8
Q ss_pred eeeeecCceEEEEEEeCCCcEEEEEeccCC--------------------ccccceEEEe--cCc---eEEEEEEeccCC
Q 042435 149 YCIGTGGYDSVYKAELPDGKVVALKKLHHS--------------------ETEDSAFVVY--SPQ---CMFFIYEYMERG 203 (412)
Q Consensus 149 ~~lG~G~~g~Vy~~~~~~~~~vAvK~l~~~--------------------~~~~~~~~~~--~~~---~~~lv~ey~~~g 203 (412)
+.++.|....||+.. ..+++|..... .+........ ..+ ..|+||||++|.
T Consensus 26 ~~~~~G~~n~v~~v~----~~~vlR~~~~~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G~ 101 (304)
T 3sg8_A 26 EISGEGNDCIAYEIN----RDFIFKFPKHSRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKGV 101 (304)
T ss_dssp CEEEECSSEEEEEST----TSEEEEEESSHHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCCE
T ss_pred EecCCCCcceEEEEC----CEEEEEecCCcchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCCe
Confidence 568999999999864 45778864321 1100011111 122 348899999988
Q ss_pred ceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCC------------------------------------------
Q 042435 204 SLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDC------------------------------------------ 241 (412)
Q Consensus 204 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~------------------------------------------ 241 (412)
+|.+... ..++..++..++.++++.|+.||+..
T Consensus 102 ~l~~~~~-----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 176 (304)
T 3sg8_A 102 PLTPLLL-----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDF 176 (304)
T ss_dssp ECCHHHH-----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHH
T ss_pred ECCcccc-----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHH
Confidence 7754221 13677778888999999999988621
Q ss_pred -------------CCCcEEeCCCCCCEEecC--CCcEEEeecCCccccCCCCCCc--cc------------ccccccccc
Q 042435 242 -------------TPSIVHRDISSNNILLNS--NLEAFVADFGTVRLLDVDSSNR--TL------------QAGTYGYIA 292 (412)
Q Consensus 242 -------------~~~ivHrDlkp~NILl~~--~~~~kl~DfGla~~~~~~~~~~--~~------------~~gt~~y~a 292 (412)
.+.++|+|++|.||++++ ...+.|+||+.+..-.....-. .. .....+...
T Consensus 177 ~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~~~ 256 (304)
T 3sg8_A 177 YRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKHKD 256 (304)
T ss_dssp HHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTCSC
T ss_pred HHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCCCC
Confidence 135799999999999987 4567899999886532210000 00 000001111
Q ss_pred -cccccCcccCcccccHHHHHHHHHHHhCCCCcc
Q 042435 293 -LELVYTMVVTEKCVIYSFGVVALEVLMGTHPGE 325 (412)
Q Consensus 293 -PE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~ 325 (412)
|+.... .....+.|+++.++|.+.+|..+|-
T Consensus 257 ~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~~~ 288 (304)
T 3sg8_A 257 IPTVLEK--YRMKEKYWSFEKIIYGKEYGYMDWY 288 (304)
T ss_dssp HHHHHHH--HHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred cHHHHHH--HHHHHHHHHHHHHHHHHHcCCHHHH
Confidence 222111 1123589999999999999987754
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=98.25 E-value=3.4e-07 Score=86.27 Aligned_cols=65 Identities=28% Similarity=0.365 Sum_probs=54.9
Q ss_pred eechhhccCCC-ceeeCCC-CCCCCCCCEEeCccccccccCCCC-CcCC-CCcccccCcCCCCCCCCCCcc
Q 042435 3 VLLAFLSISAA-CSGVVEE-EPSSPSFLKSDMSFNNLDGEIPTY-LRDN-PPKSFVGNKGLCGHVQGFLSC 69 (412)
Q Consensus 3 ~~~~~l~~~~~-~~G~ip~-~~~~~~l~~~~ls~N~l~G~iP~~-~~~~-~~~~~~gn~~lcg~~~~~~~c 69 (412)
..|++|||+.| ++|.+|. +.++++|+.||+|+|+|+|.+|.. .+.+ ....+.+|+.+||.|.. .|
T Consensus 244 ~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~~~l~~L~~l~l~~N~~lc~~p~~--~C 312 (313)
T 1ogq_A 244 KNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSPLP--AC 312 (313)
T ss_dssp TTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTCSSSEEESTTSS--CC
T ss_pred CCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccccCCCCccccccChHHhcCCCCccCCCCC--CC
Confidence 46889999999 9999988 889999999999999999999983 3444 66778899999998753 46
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=97.51 E-value=0.00054 Score=63.95 Aligned_cols=117 Identities=16% Similarity=0.121 Sum_probs=73.3
Q ss_pred ceeeeecCceEEEEEEeCCCcEEEEEeccCC--------------------c--cccceEEE-ecCceEEEEEEeccCCc
Q 042435 148 RYCIGTGGYDSVYKAELPDGKVVALKKLHHS--------------------E--TEDSAFVV-YSPQCMFFIYEYMERGS 204 (412)
Q Consensus 148 ~~~lG~G~~g~Vy~~~~~~~~~vAvK~l~~~--------------------~--~~~~~~~~-~~~~~~~lv~ey~~~gs 204 (412)
.+.++.|....||+. |..+++|.-+.. . +....... ...+..++||||++|.+
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~~ 99 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPKSQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQI 99 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEESSHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSEE
T ss_pred eeecCCCcceeEEEE----CCEEEEEecCCchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCeE
Confidence 356888999999998 566778864221 0 11111122 23445789999999877
Q ss_pred eeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhC--------------------------------------------
Q 042435 205 LFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHD-------------------------------------------- 240 (412)
Q Consensus 205 L~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~-------------------------------------------- 240 (412)
+.+.... .++..++..++.++++.|+.||+.
T Consensus 100 l~~~~~~-----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ 174 (306)
T 3tdw_A 100 LGEDGMA-----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTL 174 (306)
T ss_dssp CHHHHHT-----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHH
T ss_pred Cchhhhh-----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHH
Confidence 7542110 133444445555555555555542
Q ss_pred -------------CCCCcEEeCCCCCCEEecC---CCcE-EEeecCCccc
Q 042435 241 -------------CTPSIVHRDISSNNILLNS---NLEA-FVADFGTVRL 273 (412)
Q Consensus 241 -------------~~~~ivHrDlkp~NILl~~---~~~~-kl~DfGla~~ 273 (412)
..+.++|+|++|.||+++. ++.+ .|+||+.+..
T Consensus 175 ~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 175 RFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 2335699999999999987 4554 7999998763
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=97.41 E-value=4.1e-05 Score=80.98 Aligned_cols=40 Identities=28% Similarity=0.490 Sum_probs=20.8
Q ss_pred echhhccCCC-ceeeCCC-CCCCCCCCEEeCccccccccCCC
Q 042435 4 LLAFLSISAA-CSGVVEE-EPSSPSFLKSDMSFNNLDGEIPT 43 (412)
Q Consensus 4 ~~~~l~~~~~-~~G~ip~-~~~~~~l~~~~ls~N~l~G~iP~ 43 (412)
.|++||||.| ++|.||. ++++++|+.||+|+|+|+|.||.
T Consensus 633 ~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~ 674 (768)
T 3rgz_A 633 SMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPD 674 (768)
T ss_dssp CCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCG
T ss_pred cccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCCh
Confidence 3445555555 5555544 44555555555555555555554
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=97.39 E-value=0.00073 Score=61.50 Aligned_cols=126 Identities=18% Similarity=0.158 Sum_probs=79.2
Q ss_pred HHhhcCcccceeeeecCce-EEEEEEeC-CCcEEEEEeccCC-------------------ccccceEEEecCceEEEEE
Q 042435 139 IDATEYFHIRYCIGTGGYD-SVYKAELP-DGKVVALKKLHHS-------------------ETEDSAFVVYSPQCMFFIY 197 (412)
Q Consensus 139 ~~~~~~f~~~~~lG~G~~g-~Vy~~~~~-~~~~vAvK~l~~~-------------------~~~~~~~~~~~~~~~~lv~ 197 (412)
.....+|+. +.+..|..| .||+.... ++..+++|+-... -+.+....+...+..++||
T Consensus 21 ~~~l~g~~~-~~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvm 99 (272)
T 4gkh_A 21 DADLYGYRW-ARDNVGQSGATIYRLYGKPNAPELFLKHGKGSVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLT 99 (272)
T ss_dssp HHHHTTCEE-EEEECSSSSCEEEEEECCTTCCCEEEEEEETHHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEE
T ss_pred hccccCCeE-EEccCCCcCCeEEEEEecCCCeEEEEEECCCCCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEE
Confidence 333444544 345556655 69998764 4667888864211 1222334456678899999
Q ss_pred EeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCC------------------------------------
Q 042435 198 EYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDC------------------------------------ 241 (412)
Q Consensus 198 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~------------------------------------ 241 (412)
|++++.++.+..... ......+..+++..|+-||...
T Consensus 100 e~l~G~~~~~~~~~~-------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (272)
T 4gkh_A 100 TAIPGKTAFQVLEEY-------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERN 172 (272)
T ss_dssp ECCCSEEHHHHHHHC-------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGT
T ss_pred EeeCCccccccccCC-------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhcccccc
Confidence 999987765433211 1122345555666666666421
Q ss_pred -------------------CCCcEEeCCCCCCEEecCCCcEEEeecCCcc
Q 042435 242 -------------------TPSIVHRDISSNNILLNSNLEAFVADFGTVR 272 (412)
Q Consensus 242 -------------------~~~ivHrDlkp~NILl~~~~~~kl~DfGla~ 272 (412)
.+.++|+|+.+.||+++++..+-|+||+.+.
T Consensus 173 ~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 173 GWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp TCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred chHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 1137999999999999987767799998775
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.35 E-value=0.00057 Score=65.01 Aligned_cols=31 Identities=23% Similarity=0.309 Sum_probs=25.8
Q ss_pred CCCcEEeCCCCCCEEecCCCcEEEeecCCcc
Q 042435 242 TPSIVHRDISSNNILLNSNLEAFVADFGTVR 272 (412)
Q Consensus 242 ~~~ivHrDlkp~NILl~~~~~~kl~DfGla~ 272 (412)
.+.++|+|+.+.||+++++..+.|+||+.+.
T Consensus 221 ~~~l~HgDl~~~Nil~~~~~~~~vIDwe~a~ 251 (357)
T 3ats_A 221 EPVLLWGDARVGNVLYRDFQPVAVLDWEMVA 251 (357)
T ss_dssp CCEEECSSCSGGGEEEETTEEEEECCGGGCE
T ss_pred CceEEeCCCCCCeEEEeCCcEEEEEcccccc
Confidence 3579999999999999964457899998775
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.30 E-value=0.00024 Score=66.91 Aligned_cols=31 Identities=35% Similarity=0.635 Sum_probs=27.6
Q ss_pred CCCcEEeCCCCCCEEecCCCcEEEeecCCcc
Q 042435 242 TPSIVHRDISSNNILLNSNLEAFVADFGTVR 272 (412)
Q Consensus 242 ~~~ivHrDlkp~NILl~~~~~~kl~DfGla~ 272 (412)
...++|+|+++.||+++.+..+.|+||+.+.
T Consensus 221 ~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 221 SPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp SCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred cCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 4589999999999999877889999999775
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=97.27 E-value=0.00019 Score=62.07 Aligned_cols=40 Identities=10% Similarity=0.095 Sum_probs=28.7
Q ss_pred echhhccCCC-ceeeCCC-CCCCCCCCEEeCccccccccCCC
Q 042435 4 LLAFLSISAA-CSGVVEE-EPSSPSFLKSDMSFNNLDGEIPT 43 (412)
Q Consensus 4 ~~~~l~~~~~-~~G~ip~-~~~~~~l~~~~ls~N~l~G~iP~ 43 (412)
.|++|+|+.| ++|.+|. +.++++|+.||+|+|+|++..|.
T Consensus 55 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~ 96 (192)
T 1w8a_A 55 HLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNK 96 (192)
T ss_dssp TCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSS
T ss_pred CCCEEECCCCCCCCcCHhHcCCcccCCEEECCCCcCCccCHH
Confidence 4677777777 7777665 66777777777777777776664
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=97.11 E-value=0.00031 Score=66.61 Aligned_cols=40 Identities=13% Similarity=-0.057 Sum_probs=29.8
Q ss_pred echhhccCC-C-ceeeCCC-CCCCCCCCEEeCccccccccCCC
Q 042435 4 LLAFLSISA-A-CSGVVEE-EPSSPSFLKSDMSFNNLDGEIPT 43 (412)
Q Consensus 4 ~~~~l~~~~-~-~~G~ip~-~~~~~~l~~~~ls~N~l~G~iP~ 43 (412)
.|+.|+|+. | +++..|. +.++++|+.||||+|+|+|..|.
T Consensus 32 ~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~ 74 (347)
T 2ifg_A 32 NLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPD 74 (347)
T ss_dssp CCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTT
T ss_pred CeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHH
Confidence 477788875 7 7776654 77788888888888888886664
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=97.10 E-value=0.00036 Score=59.10 Aligned_cols=39 Identities=10% Similarity=-0.020 Sum_probs=28.7
Q ss_pred echhhccCCC-ceeeCCC-CCCCCCCCEEeCccccccccCC
Q 042435 4 LLAFLSISAA-CSGVVEE-EPSSPSFLKSDMSFNNLDGEIP 42 (412)
Q Consensus 4 ~~~~l~~~~~-~~G~ip~-~~~~~~l~~~~ls~N~l~G~iP 42 (412)
.|++|+|+.| +++..|. +.++++|+.||||+|+|++-.|
T Consensus 31 ~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~ 71 (170)
T 3g39_A 31 TTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPA 71 (170)
T ss_dssp TCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCT
T ss_pred CCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccCh
Confidence 4677888888 7777766 6778888888888888875433
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.09 E-value=0.00022 Score=76.27 Aligned_cols=54 Identities=20% Similarity=0.166 Sum_probs=26.7
Q ss_pred chhhccCCC-ceeeCCCCCCCCCCCEEeCccccccccCCCCCcCC-CCcccccCcCCC
Q 042435 5 LAFLSISAA-CSGVVEEEPSSPSFLKSDMSFNNLDGEIPTYLRDN-PPKSFVGNKGLC 60 (412)
Q Consensus 5 ~~~l~~~~~-~~G~ip~~~~~~~l~~~~ls~N~l~G~iP~~~~~~-~~~~~~gn~~lc 60 (412)
|+.||||.| +++..|.... ++|+.||||+|+|+|.+|.. +.+ ....+.+|+-.|
T Consensus 506 L~~L~Ls~N~l~~l~~~~~~-~~L~~L~Ls~N~l~~~~~~~-~~~L~~l~l~~Np~~C 561 (844)
T 3j0a_A 506 LRGLSLNSNRLTVLSHNDLP-ANLEILDISRNQLLAPNPDV-FVSLSVLDITHNKFIC 561 (844)
T ss_dssp CSEEEEESCCCSSCCCCCCC-SCCCEEEEEEECCCCCCSCC-CSSCCEEEEEEECCCC
T ss_pred hheeECCCCCCCccChhhhh-ccccEEECCCCcCCCCChhH-hCCcCEEEecCCCccc
Confidence 444444444 4443333111 44555555555555555542 233 444566788777
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=97.02 E-value=0.00015 Score=62.83 Aligned_cols=58 Identities=9% Similarity=0.090 Sum_probs=43.5
Q ss_pred eechhhccCCC-ceeeCCC-CCCCCCCCEEeCccccccccCCCCC--cCC-CCcccccCcCCC
Q 042435 3 VLLAFLSISAA-CSGVVEE-EPSSPSFLKSDMSFNNLDGEIPTYL--RDN-PPKSFVGNKGLC 60 (412)
Q Consensus 3 ~~~~~l~~~~~-~~G~ip~-~~~~~~l~~~~ls~N~l~G~iP~~~--~~~-~~~~~~gn~~lc 60 (412)
..|++|+|+.| +++..|. +.++++|+.||+|+|+++|.+|..+ +.+ ..-.+.+|+--|
T Consensus 78 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c 140 (192)
T 1w8a_A 78 SHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNC 140 (192)
T ss_dssp TTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCC
T ss_pred ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccC
Confidence 46889999999 9998877 7889999999999999999888632 222 333444565444
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=96.99 E-value=0.00043 Score=61.30 Aligned_cols=40 Identities=8% Similarity=-0.086 Sum_probs=27.1
Q ss_pred echhhccCCC-ceeeCCC-CCCCCCCCEEeCccccccccCCC
Q 042435 4 LLAFLSISAA-CSGVVEE-EPSSPSFLKSDMSFNNLDGEIPT 43 (412)
Q Consensus 4 ~~~~l~~~~~-~~G~ip~-~~~~~~l~~~~ls~N~l~G~iP~ 43 (412)
.|++|+|+.| +++..|. +.++++|+.||+|+|++++..|.
T Consensus 82 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~ 123 (220)
T 2v70_A 82 GVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGND 123 (220)
T ss_dssp TCCEEECCSSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTT
T ss_pred CCCEEECCCCccCccCHhHhcCCcCCCEEECCCCcCCeECHh
Confidence 4667777777 6666655 56677777777777777766664
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=96.87 E-value=0.00074 Score=57.41 Aligned_cols=40 Identities=15% Similarity=0.005 Sum_probs=31.9
Q ss_pred echhhccCCC-ceeeCCC-CCCCCCCCEEeCccccccccCCCC
Q 042435 4 LLAFLSISAA-CSGVVEE-EPSSPSFLKSDMSFNNLDGEIPTY 44 (412)
Q Consensus 4 ~~~~l~~~~~-~~G~ip~-~~~~~~l~~~~ls~N~l~G~iP~~ 44 (412)
.|++|+|+.| +++.+|. +.++++|+.||||+|+|++ +|..
T Consensus 34 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-i~~~ 75 (174)
T 2r9u_A 34 DKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTA-IPTG 75 (174)
T ss_dssp TCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCC-CCTT
T ss_pred CCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCc-cChh
Confidence 4778888888 8887776 7788888888888888887 4543
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=96.82 E-value=0.00077 Score=57.33 Aligned_cols=40 Identities=15% Similarity=0.075 Sum_probs=29.6
Q ss_pred eechhhccCCC-ceeeCCC-CCCCCCCCEEeCccccccccCC
Q 042435 3 VLLAFLSISAA-CSGVVEE-EPSSPSFLKSDMSFNNLDGEIP 42 (412)
Q Consensus 3 ~~~~~l~~~~~-~~G~ip~-~~~~~~l~~~~ls~N~l~G~iP 42 (412)
..|++|||+.| +++..|. +.++++|+.||||+|+|++-.|
T Consensus 57 ~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~l~~l~~ 98 (174)
T 2r9u_A 57 VNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDNHLKSIPR 98 (174)
T ss_dssp TTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCT
T ss_pred cCCCEEECCCCCCCccChhHhCCcchhhEEECCCCccceeCH
Confidence 45788888888 7775555 5778888888888888885433
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=96.77 E-value=0.0028 Score=61.28 Aligned_cols=31 Identities=19% Similarity=0.303 Sum_probs=26.1
Q ss_pred CCCcEEeCCCCCCEEecCCCcEEEeecCCccc
Q 042435 242 TPSIVHRDISSNNILLNSNLEAFVADFGTVRL 273 (412)
Q Consensus 242 ~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~ 273 (412)
.+.++|+|+.|.||+++.+ .++++||..+..
T Consensus 226 ~~~L~HGDl~~~Nil~~~~-~~~lID~e~a~~ 256 (397)
T 2olc_A 226 AETLIHGDLHTGSIFASEH-ETKVIDPEFAFY 256 (397)
T ss_dssp CCEEECSCCSGGGEEECSS-CEEECCCTTCEE
T ss_pred CCceeeCCCCcCcEEEeCC-CeEEEeCccccc
Confidence 3479999999999999865 489999987764
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=96.73 E-value=0.0018 Score=59.65 Aligned_cols=32 Identities=25% Similarity=0.251 Sum_probs=27.6
Q ss_pred cccceeeeecCceEEEEEEeCCCcEEEEEecc
Q 042435 145 FHIRYCIGTGGYDSVYKAELPDGKVVALKKLH 176 (412)
Q Consensus 145 f~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~l~ 176 (412)
....+.+|.|..+.||+.+..||+.|.+|+-.
T Consensus 17 v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~ 48 (288)
T 3f7w_A 17 VAAVAERGHSHRWHLYRVELADGTPLFVKALP 48 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTSCEEEEEECC
T ss_pred eEEEEecCCCCCeEEEEEEECCCCEEEEEEeC
Confidence 44457799999999999999999999999754
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=96.69 E-value=0.0011 Score=57.47 Aligned_cols=41 Identities=20% Similarity=0.234 Sum_probs=31.3
Q ss_pred eechhhccCCC-ceeeCCC-CCCCCCCCEEeCccccccccCCC
Q 042435 3 VLLAFLSISAA-CSGVVEE-EPSSPSFLKSDMSFNNLDGEIPT 43 (412)
Q Consensus 3 ~~~~~l~~~~~-~~G~ip~-~~~~~~l~~~~ls~N~l~G~iP~ 43 (412)
..|++|||+.| +++..|. +.++++|+.||+|+|++++-.|.
T Consensus 54 ~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~ 96 (193)
T 2wfh_A 54 KHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRCIPPR 96 (193)
T ss_dssp TTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTT
T ss_pred cCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCccCEeCHH
Confidence 35778888888 7776655 77888888888888888876664
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=96.66 E-value=0.001 Score=58.77 Aligned_cols=41 Identities=10% Similarity=-0.091 Sum_probs=30.5
Q ss_pred eechhhccCCC-ceeeCCC-CCCCCCCCEEeCccccccccCCC
Q 042435 3 VLLAFLSISAA-CSGVVEE-EPSSPSFLKSDMSFNNLDGEIPT 43 (412)
Q Consensus 3 ~~~~~l~~~~~-~~G~ip~-~~~~~~l~~~~ls~N~l~G~iP~ 43 (412)
..|++|||+.| +++..+. +.++++|+.||+++|++++..|.
T Consensus 80 ~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~ 122 (220)
T 2v9t_B 80 RSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKINCLRVD 122 (220)
T ss_dssp SSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTT
T ss_pred cCCCEEECCCCcCCccCHhHccCCCCCCEEECCCCCCCEeCHH
Confidence 45788888888 7744444 57788888888888888877665
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=96.63 E-value=0.00046 Score=68.88 Aligned_cols=40 Identities=20% Similarity=0.097 Sum_probs=27.2
Q ss_pred eechhhccCCC-ceeeCCCCCCCCCCCEEeCccccccccCCC
Q 042435 3 VLLAFLSISAA-CSGVVEEEPSSPSFLKSDMSFNNLDGEIPT 43 (412)
Q Consensus 3 ~~~~~l~~~~~-~~G~ip~~~~~~~l~~~~ls~N~l~G~iP~ 43 (412)
..|++|||+.| ++|. |....+++|..||||+|+|+|..|.
T Consensus 169 ~~L~~L~Ls~N~l~~~-~~~~~l~~L~~L~Ls~N~l~~~~~~ 209 (487)
T 3oja_A 169 DTLEHLNLQYNFIYDV-KGQVVFAKLKTLDLSSNKLAFMGPE 209 (487)
T ss_dssp TTCCEEECTTSCCCEE-ECCCCCTTCCEEECCSSCCCEECGG
T ss_pred CcccEEecCCCccccc-cccccCCCCCEEECCCCCCCCCCHh
Confidence 35677777777 6666 4444577777777777777775443
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=96.58 E-value=0.00065 Score=63.52 Aligned_cols=42 Identities=26% Similarity=0.506 Sum_probs=36.5
Q ss_pred eechhhccCCC-ceeeCCC-CCCCCCCCEEeCccccccccCCCC
Q 042435 3 VLLAFLSISAA-CSGVVEE-EPSSPSFLKSDMSFNNLDGEIPTY 44 (412)
Q Consensus 3 ~~~~~l~~~~~-~~G~ip~-~~~~~~l~~~~ls~N~l~G~iP~~ 44 (412)
..|++|+|+.| ++|.+|. +.++++|+.||+|+|.++|.+|..
T Consensus 101 ~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~ 144 (313)
T 1ogq_A 101 TQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPS 144 (313)
T ss_dssp TTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGG
T ss_pred CCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCccCCcCChH
Confidence 45889999999 9999987 788999999999999999999863
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=96.54 E-value=0.0012 Score=67.34 Aligned_cols=40 Identities=25% Similarity=0.137 Sum_probs=26.5
Q ss_pred echhhccCCC-ceeeCCC-CCCCCCCCEEeCccccccccCCC
Q 042435 4 LLAFLSISAA-CSGVVEE-EPSSPSFLKSDMSFNNLDGEIPT 43 (412)
Q Consensus 4 ~~~~l~~~~~-~~G~ip~-~~~~~~l~~~~ls~N~l~G~iP~ 43 (412)
.|++||||.| +++.+|. +.++++|+.||||+|+|++-.|.
T Consensus 495 ~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~ 536 (635)
T 4g8a_A 495 NLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTF 536 (635)
T ss_dssp TCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCBCCCG
T ss_pred ccCEEECCCCccCCcChHHHcCCCCCCEEECCCCcCCCCChh
Confidence 4666777777 7766665 56667777777777777665553
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=96.52 E-value=0.017 Score=53.95 Aligned_cols=120 Identities=15% Similarity=0.166 Sum_probs=71.7
Q ss_pred ceeeeecCceEEEEEEeCCCcEEEEEeccCC---------------------ccccceEEEecCceEEEEEEeccCCcee
Q 042435 148 RYCIGTGGYDSVYKAELPDGKVVALKKLHHS---------------------ETEDSAFVVYSPQCMFFIYEYMERGSLF 206 (412)
Q Consensus 148 ~~~lG~G~~g~Vy~~~~~~~~~vAvK~l~~~---------------------~~~~~~~~~~~~~~~~lv~ey~~~gsL~ 206 (412)
.+.|+.|....+|+... ++..+++|..... ...+........+..++||||+++..+.
T Consensus 41 ~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~~~ 119 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLIND-EVQTVFVKINERSYRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSKNK 119 (312)
T ss_dssp EEEECCSSSSEEEEEES-SSCEEEEEEEEGGGHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCCCC
T ss_pred eEEeCCccceeeeEEEE-CCCeEEEEeCCcccHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCCCC
Confidence 46789999999999987 5678888964321 1112222344556789999999987653
Q ss_pred e-----------eeccCcc-------------------cccCCHHHHH---HHHH----------------HHHHHH-HH
Q 042435 207 C-----------VLRDDDE-------------------AIELNWTRRM---NIVK----------------SVAHAL-SY 236 (412)
Q Consensus 207 ~-----------~l~~~~~-------------------~~~l~~~~~~---~i~~----------------~ia~gL-~~ 236 (412)
. .|+.... ...-+|.... ++.. .+...+ ..
T Consensus 120 ~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l~~~ 199 (312)
T 3jr1_A 120 QSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIVADT 199 (312)
T ss_dssp TTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHHHHH
T ss_pred chhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHHHHH
Confidence 1 1111100 0012565422 1111 111111 23
Q ss_pred HHh-CCCCCcEEeCCCCCCEEecCCCcEEEeecC
Q 042435 237 LHH-DCTPSIVHRDISSNNILLNSNLEAFVADFG 269 (412)
Q Consensus 237 LH~-~~~~~ivHrDlkp~NILl~~~~~~kl~DfG 269 (412)
|.. ...+.++|+|+.+.|++++.++ +.|.|+.
T Consensus 200 L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 200 LSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred hccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 321 2356899999999999999876 8899973
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=96.44 E-value=0.0023 Score=54.13 Aligned_cols=41 Identities=15% Similarity=0.005 Sum_probs=33.1
Q ss_pred eechhhccCCC-ceeeCCC-CCCCCCCCEEeCccccccccCCC
Q 042435 3 VLLAFLSISAA-CSGVVEE-EPSSPSFLKSDMSFNNLDGEIPT 43 (412)
Q Consensus 3 ~~~~~l~~~~~-~~G~ip~-~~~~~~l~~~~ls~N~l~G~iP~ 43 (412)
..|++|+|+.| +++..|. +.++++|+.||+|+|++++..|.
T Consensus 52 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~ 94 (177)
T 2o6r_A 52 TQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQSLPNG 94 (177)
T ss_dssp TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTT
T ss_pred ccccEEECCCCcceEeChhHccCCCccCEEECCCCCccccCHH
Confidence 46889999999 8866655 67899999999999999976554
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.43 E-value=0.0063 Score=56.71 Aligned_cols=139 Identities=13% Similarity=0.124 Sum_probs=76.5
Q ss_pred ccHHHHHHhhcCccc-----ceeeeecCceEEEEEEeCCCcEEEEEeccCC-ccccc-----------------eEE---
Q 042435 133 ILYENLIDATEYFHI-----RYCIGTGGYDSVYKAELPDGKVVALKKLHHS-ETEDS-----------------AFV--- 186 (412)
Q Consensus 133 ~~~~~l~~~~~~f~~-----~~~lG~G~~g~Vy~~~~~~~~~vAvK~l~~~-~~~~~-----------------~~~--- 186 (412)
++.+++......|.+ .+.|+.|....+|+....+| .+++|..... ..... ...
T Consensus 7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~~~~~l~~e~~~l~~L~~~g~~vP~~~~~ 85 (322)
T 2ppq_A 7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRVEKNDLPFFLGLMQHLAAKGLSCPLPLPR 85 (322)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC---CCHHHHHHHHHHHHHHTTCCCCCBCCB
T ss_pred CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCCCHHHHHHHHHHHHHHHHCCCCCCcccCC
Confidence 455666666666655 23566788899999988666 5778876541 10000 000
Q ss_pred ------EecCceEEEEEEeccCCceeee--------------eccC----ccc-----ccCCHHHHHH------------
Q 042435 187 ------VYSPQCMFFIYEYMERGSLFCV--------------LRDD----DEA-----IELNWTRRMN------------ 225 (412)
Q Consensus 187 ------~~~~~~~~lv~ey~~~gsL~~~--------------l~~~----~~~-----~~l~~~~~~~------------ 225 (412)
....+..+++++|++|..+... ++.. ... ....|.....
T Consensus 86 ~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~ 165 (322)
T 2ppq_A 86 KDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKG 165 (322)
T ss_dssp TTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTT
T ss_pred CCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhh
Confidence 1113456899999988655321 1110 000 0012332111
Q ss_pred HHHHHHHHHHHHHhC----CCCCcEEeCCCCCCEEecCCCcEEEeecCCcc
Q 042435 226 IVKSVAHALSYLHHD----CTPSIVHRDISSNNILLNSNLEAFVADFGTVR 272 (412)
Q Consensus 226 i~~~ia~gL~~LH~~----~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~ 272 (412)
+...+...+++++.. ....++|+|+.+.||+++++....++||+.+.
T Consensus 166 l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 166 LREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp HHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 011244456666532 13479999999999999877556799998765
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=96.42 E-value=0.0012 Score=62.22 Aligned_cols=42 Identities=7% Similarity=-0.141 Sum_probs=37.5
Q ss_pred eechhhccCCC-ceeeCCC-CCCCCCCCEEeCccccccccCCCC
Q 042435 3 VLLAFLSISAA-CSGVVEE-EPSSPSFLKSDMSFNNLDGEIPTY 44 (412)
Q Consensus 3 ~~~~~l~~~~~-~~G~ip~-~~~~~~l~~~~ls~N~l~G~iP~~ 44 (412)
..|++|+|+.| +.|.+|. +.++++|+.|++++|++.|.+|..
T Consensus 229 ~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~ 272 (328)
T 4fcg_A 229 PKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLD 272 (328)
T ss_dssp TTCCEEECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTT
T ss_pred CCCCEEECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchh
Confidence 46889999998 9999987 789999999999999999999974
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=96.39 E-value=0.0025 Score=53.74 Aligned_cols=58 Identities=10% Similarity=0.014 Sum_probs=40.5
Q ss_pred eechhhccCCC-ceeeCCC-CCCCCCCCEEeCccccccccCCCCC--cCC-CCcccccCcCCC
Q 042435 3 VLLAFLSISAA-CSGVVEE-EPSSPSFLKSDMSFNNLDGEIPTYL--RDN-PPKSFVGNKGLC 60 (412)
Q Consensus 3 ~~~~~l~~~~~-~~G~ip~-~~~~~~l~~~~ls~N~l~G~iP~~~--~~~-~~~~~~gn~~lc 60 (412)
..|++|||+.| +++..|. +.++++|+.||||+|+|++-.|..+ +.+ ..-.+.+|+--|
T Consensus 54 ~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c 116 (170)
T 3g39_A 54 TQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDNQLKSIPRGAFDNLKSLTHIWLLNNPWDC 116 (170)
T ss_dssp TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCT
T ss_pred ccCCEEECCCCCcCccChhhccCCCCCCEEECCCCccCEeCHHHhcCCCCCCEEEeCCCCCCC
Confidence 46889999999 8876666 5789999999999999987555321 122 334445665555
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=96.25 E-value=0.0016 Score=66.19 Aligned_cols=37 Identities=16% Similarity=0.145 Sum_probs=24.7
Q ss_pred echhhccCCC-ceeeCCC-CCCCCCCCEEeCccccccccCC
Q 042435 4 LLAFLSISAA-CSGVVEE-EPSSPSFLKSDMSFNNLDGEIP 42 (412)
Q Consensus 4 ~~~~l~~~~~-~~G~ip~-~~~~~~l~~~~ls~N~l~G~iP 42 (412)
.|++||||.| ++ .||. +.++++|+.||||+|+|+| ||
T Consensus 464 ~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp 502 (567)
T 1dce_A 464 LVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD 502 (567)
T ss_dssp TCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG
T ss_pred cCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc
Confidence 4666777777 66 5655 6666777777777777766 56
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=96.23 E-value=0.0032 Score=58.56 Aligned_cols=43 Identities=23% Similarity=0.354 Sum_probs=29.8
Q ss_pred eechhhccCCC-ceeeCCC-CCCC---CCCCEEeCccccccccCCCCCc
Q 042435 3 VLLAFLSISAA-CSGVVEE-EPSS---PSFLKSDMSFNNLDGEIPTYLR 46 (412)
Q Consensus 3 ~~~~~l~~~~~-~~G~ip~-~~~~---~~l~~~~ls~N~l~G~iP~~~~ 46 (412)
..|++||||+| +++.+|+ +..+ ++|+.||+|+|+|+ .||..++
T Consensus 224 ~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~ 271 (310)
T 4glp_A 224 VQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGLP 271 (310)
T ss_dssp CCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCCC
T ss_pred CCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhhc
Confidence 45777888888 7777654 4444 57888888888887 6776444
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=96.21 E-value=0.0033 Score=56.49 Aligned_cols=40 Identities=10% Similarity=0.011 Sum_probs=28.0
Q ss_pred eechhhccCCC-ceeeCCC-CCCCCCCCEEeCccccccccCC
Q 042435 3 VLLAFLSISAA-CSGVVEE-EPSSPSFLKSDMSFNNLDGEIP 42 (412)
Q Consensus 3 ~~~~~l~~~~~-~~G~ip~-~~~~~~l~~~~ls~N~l~G~iP 42 (412)
..|++|+|+.| +++..|. +.++++|+.|++|+|+|++-.|
T Consensus 107 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~ 148 (251)
T 3m19_A 107 TQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPA 148 (251)
T ss_dssp TTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCT
T ss_pred CCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCH
Confidence 35777788877 7755555 5677777888888887775444
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=96.20 E-value=0.0031 Score=59.28 Aligned_cols=42 Identities=17% Similarity=0.049 Sum_probs=36.2
Q ss_pred eechhhccCCC-ceeeCCCCCCCCCCCEEeCccccccccCCCC
Q 042435 3 VLLAFLSISAA-CSGVVEEEPSSPSFLKSDMSFNNLDGEIPTY 44 (412)
Q Consensus 3 ~~~~~l~~~~~-~~G~ip~~~~~~~l~~~~ls~N~l~G~iP~~ 44 (412)
..|++|+|+.| ++|..+.+.++++|+.||+|+|++.|.+|..
T Consensus 206 ~~L~~L~L~~N~l~~l~~~l~~l~~L~~L~Ls~n~~~~~~p~~ 248 (328)
T 4fcg_A 206 QNLKSLKIRNSPLSALGPAIHHLPKLEELDLRGCTALRNYPPI 248 (328)
T ss_dssp TTCCEEEEESSCCCCCCGGGGGCTTCCEEECTTCTTCCBCCCC
T ss_pred CCCCEEEccCCCCCcCchhhccCCCCCEEECcCCcchhhhHHH
Confidence 46889999999 8875555889999999999999999999974
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=96.20 E-value=0.0039 Score=56.79 Aligned_cols=41 Identities=15% Similarity=0.211 Sum_probs=29.7
Q ss_pred eechhhccCCC-ceeeCCC-CCCCCCCCEEeCccccccccCCC
Q 042435 3 VLLAFLSISAA-CSGVVEE-EPSSPSFLKSDMSFNNLDGEIPT 43 (412)
Q Consensus 3 ~~~~~l~~~~~-~~G~ip~-~~~~~~l~~~~ls~N~l~G~iP~ 43 (412)
..|++|+|+.| +++..|. +.++++|+.||+|+|++++..|.
T Consensus 133 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~ 175 (272)
T 3rfs_A 133 TNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEG 175 (272)
T ss_dssp TTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTT
T ss_pred CCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCccCHH
Confidence 35778888888 7766655 57788888888888888865553
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=96.19 E-value=0.0029 Score=59.79 Aligned_cols=45 Identities=20% Similarity=0.199 Sum_probs=38.0
Q ss_pred ceechhhccCCC-ceeeCCC-CCCCCCCCEEeCccccccccCCCCCcC
Q 042435 2 IVLLAFLSISAA-CSGVVEE-EPSSPSFLKSDMSFNNLDGEIPTYLRD 47 (412)
Q Consensus 2 ~~~~~~l~~~~~-~~G~ip~-~~~~~~l~~~~ls~N~l~G~iP~~~~~ 47 (412)
+..|+.|||+.| ++|.+|. +.++++|+.||||+|+|++ +|...|.
T Consensus 55 l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~-~~~~~~~ 101 (347)
T 2ifg_A 55 LGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALES-LSWKTVQ 101 (347)
T ss_dssp CCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCSC-CCSTTTC
T ss_pred ccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCCCccce-eCHHHcc
Confidence 457999999999 9999987 7899999999999999996 5544343
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=96.16 E-value=0.0037 Score=53.93 Aligned_cols=37 Identities=14% Similarity=0.099 Sum_probs=21.4
Q ss_pred chhhccCCC-ceeeCCC-CCCCCCCCEEeCccccccccCC
Q 042435 5 LAFLSISAA-CSGVVEE-EPSSPSFLKSDMSFNNLDGEIP 42 (412)
Q Consensus 5 ~~~l~~~~~-~~G~ip~-~~~~~~l~~~~ls~N~l~G~iP 42 (412)
|++|+|+.| ++ .||. +.++++|+.||+|+|++++-.|
T Consensus 33 l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~ 71 (193)
T 2wfh_A 33 VTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSN 71 (193)
T ss_dssp CCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCT
T ss_pred CCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCH
Confidence 556666666 44 4443 5556666666666666665443
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=96.13 E-value=0.0037 Score=55.14 Aligned_cols=40 Identities=10% Similarity=0.101 Sum_probs=31.6
Q ss_pred echhhccCCC-ceeeCCC-CCCCCCCCEEeCccccccccCCC
Q 042435 4 LLAFLSISAA-CSGVVEE-EPSSPSFLKSDMSFNNLDGEIPT 43 (412)
Q Consensus 4 ~~~~l~~~~~-~~G~ip~-~~~~~~l~~~~ls~N~l~G~iP~ 43 (412)
.|+.|+|+.| +++..|. +.++++|+.||+|+|++++-.|.
T Consensus 33 ~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~ 74 (220)
T 2v9t_B 33 TITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPD 74 (220)
T ss_dssp TCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTT
T ss_pred CCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHH
Confidence 4778888888 7776664 77888888888888888887775
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=96.11 E-value=0.0037 Score=57.68 Aligned_cols=43 Identities=23% Similarity=0.217 Sum_probs=30.3
Q ss_pred eechhhccCCC-ceeeCCC-CCCCCCCCEEeCccccccccCCCCCc
Q 042435 3 VLLAFLSISAA-CSGVVEE-EPSSPSFLKSDMSFNNLDGEIPTYLR 46 (412)
Q Consensus 3 ~~~~~l~~~~~-~~G~ip~-~~~~~~l~~~~ls~N~l~G~iP~~~~ 46 (412)
..|++|+|+.| +++..|. +.++++|+.||+++|+|+ .+|...|
T Consensus 124 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~l~~~~~ 168 (290)
T 1p9a_G 124 GELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLT-ELPAGLL 168 (290)
T ss_dssp TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCS-CCCTTTT
T ss_pred CCCCEEECCCCCCCccChhhcccccCCCEEECCCCcCC-ccCHHHh
Confidence 35778888888 7765555 567888888888888887 4554333
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=96.10 E-value=0.0031 Score=56.01 Aligned_cols=41 Identities=17% Similarity=0.129 Sum_probs=34.7
Q ss_pred eechhhccCCC-ceeeCCC-CCCCCCCCEEeCccccccccCCCC
Q 042435 3 VLLAFLSISAA-CSGVVEE-EPSSPSFLKSDMSFNNLDGEIPTY 44 (412)
Q Consensus 3 ~~~~~l~~~~~-~~G~ip~-~~~~~~l~~~~ls~N~l~G~iP~~ 44 (412)
..|++|||+.| +++..|. +..+++|+.||+|+|+|+ .||..
T Consensus 88 ~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~ 130 (229)
T 3e6j_A 88 TQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRG 130 (229)
T ss_dssp TTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTT
T ss_pred CCcCEEECCCCcCCccChhHhCcchhhCeEeccCCccc-ccCcc
Confidence 46889999999 8876666 678999999999999999 78864
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=96.00 E-value=0.0051 Score=53.43 Aligned_cols=41 Identities=12% Similarity=0.112 Sum_probs=31.2
Q ss_pred eechhhccCCC-ceeeCCC-CCCCCCCCEEeCccccccccCCC
Q 042435 3 VLLAFLSISAA-CSGVVEE-EPSSPSFLKSDMSFNNLDGEIPT 43 (412)
Q Consensus 3 ~~~~~l~~~~~-~~G~ip~-~~~~~~l~~~~ls~N~l~G~iP~ 43 (412)
..|++|||+.| +++..+. +.++++|+.||+|+|++++..|.
T Consensus 76 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~ 118 (208)
T 2o6s_A 76 TSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDG 118 (208)
T ss_dssp TTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTT
T ss_pred CCcCEEECCCCcCCccCHhHhcCccCCCEEEcCCCcCcccCHh
Confidence 45788888888 7766555 67888888888888888865543
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=95.92 E-value=0.0037 Score=55.15 Aligned_cols=41 Identities=12% Similarity=0.050 Sum_probs=34.8
Q ss_pred eechhhccCCC-ceeeCCC-CCCCCCCCEEeCccccccccCCC
Q 042435 3 VLLAFLSISAA-CSGVVEE-EPSSPSFLKSDMSFNNLDGEIPT 43 (412)
Q Consensus 3 ~~~~~l~~~~~-~~G~ip~-~~~~~~l~~~~ls~N~l~G~iP~ 43 (412)
..|++|+|+.| +++..|. +.++++|+.||+|+|++++..|.
T Consensus 57 ~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~ 99 (220)
T 2v70_A 57 PQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLENVQHK 99 (220)
T ss_dssp TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCCCCGG
T ss_pred CCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCCccCccCHh
Confidence 45889999999 8888874 88999999999999999887664
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=95.91 E-value=0.0032 Score=51.58 Aligned_cols=37 Identities=11% Similarity=-0.032 Sum_probs=29.0
Q ss_pred echhhccCCC-ce-eeCCC-CCCCCCCCEEeCcccccccc
Q 042435 4 LLAFLSISAA-CS-GVVEE-EPSSPSFLKSDMSFNNLDGE 40 (412)
Q Consensus 4 ~~~~l~~~~~-~~-G~ip~-~~~~~~l~~~~ls~N~l~G~ 40 (412)
.|+.|+++.| ++ |.+|. +.++++|+.|++++|++++.
T Consensus 18 ~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~ 57 (149)
T 2je0_A 18 DVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI 57 (149)
T ss_dssp GCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC
T ss_pred cCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc
Confidence 4778888888 77 77776 57788888888888888775
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=95.91 E-value=0.031 Score=51.56 Aligned_cols=30 Identities=17% Similarity=0.288 Sum_probs=25.1
Q ss_pred CCcEEeCCCCCCEEecCCCcEEEeecCCccc
Q 042435 243 PSIVHRDISSNNILLNSNLEAFVADFGTVRL 273 (412)
Q Consensus 243 ~~ivHrDlkp~NILl~~~~~~kl~DfGla~~ 273 (412)
+.++|+|+.+.||+ ..++.+.++||..+..
T Consensus 173 ~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 173 LAACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp CEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred ceeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 35899999999999 5567789999988764
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=95.90 E-value=0.0015 Score=59.60 Aligned_cols=38 Identities=21% Similarity=0.159 Sum_probs=33.3
Q ss_pred eechhhccCCC-cee--eCCC-CCCCCCCCEEeCcccccccc
Q 042435 3 VLLAFLSISAA-CSG--VVEE-EPSSPSFLKSDMSFNNLDGE 40 (412)
Q Consensus 3 ~~~~~l~~~~~-~~G--~ip~-~~~~~~l~~~~ls~N~l~G~ 40 (412)
..|++||||.| ++| .+|. +..+++|+.||||+|+|++.
T Consensus 170 ~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~ 211 (267)
T 3rw6_A 170 PELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE 211 (267)
T ss_dssp TTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG
T ss_pred CCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc
Confidence 46899999999 988 6676 56899999999999999985
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=95.79 E-value=0.0042 Score=62.48 Aligned_cols=37 Identities=24% Similarity=0.192 Sum_probs=18.2
Q ss_pred chhhccCCC-ceeeCCCCCCCCCCCEEeCccccccccCC
Q 042435 5 LAFLSISAA-CSGVVEEEPSSPSFLKSDMSFNNLDGEIP 42 (412)
Q Consensus 5 ~~~l~~~~~-~~G~ip~~~~~~~l~~~~ls~N~l~G~iP 42 (412)
|++|||+.| ++ .||+...+++|+.||+|+|+|+|.+|
T Consensus 453 L~~L~Ls~N~l~-~ip~~~~l~~L~~L~Ls~N~l~~~~~ 490 (549)
T 2z81_A 453 LQELYISRNKLK-TLPDASLFPVLLVMKISRNQLKSVPD 490 (549)
T ss_dssp CCEEECCSSCCS-SCCCGGGCTTCCEEECCSSCCCCCCT
T ss_pred hcEEECCCCccC-cCCCcccCccCCEEecCCCccCCcCH
Confidence 444455555 44 34444444555555555555555444
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=95.74 E-value=0.0074 Score=50.95 Aligned_cols=40 Identities=10% Similarity=0.008 Sum_probs=32.7
Q ss_pred echhhccCCC-ceeeCCC-CCCCCCCCEEeCccccccccCCC
Q 042435 4 LLAFLSISAA-CSGVVEE-EPSSPSFLKSDMSFNNLDGEIPT 43 (412)
Q Consensus 4 ~~~~l~~~~~-~~G~ip~-~~~~~~l~~~~ls~N~l~G~iP~ 43 (412)
.|++|+|+.| +++..|. +.++++|+.||+++|++++-.|.
T Consensus 29 ~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~ 70 (177)
T 2o6r_A 29 SATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDG 70 (177)
T ss_dssp TCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTT
T ss_pred CCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChh
Confidence 5789999999 8876665 68899999999999999865443
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=95.72 E-value=0.0047 Score=63.64 Aligned_cols=39 Identities=18% Similarity=0.066 Sum_probs=26.1
Q ss_pred echhhccCCC-ceeeCCC-CCCCCCCCEEeC------ccccccccCCC
Q 042435 4 LLAFLSISAA-CSGVVEE-EPSSPSFLKSDM------SFNNLDGEIPT 43 (412)
Q Consensus 4 ~~~~l~~~~~-~~G~ip~-~~~~~~l~~~~l------s~N~l~G~iP~ 43 (412)
.|+.|||+.| ++| ||. +.++++|+.||+ |+|+++|.+|.
T Consensus 514 ~L~~L~Ls~N~l~~-ip~~~~~l~~L~~L~Ls~N~~ls~N~l~~~~p~ 560 (636)
T 4eco_A 514 YLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPE 560 (636)
T ss_dssp TCCEEECCSSCCSS-CCCGGGGCSSCCEEECCSCBCTTCCBCCCCCCT
T ss_pred CcCEEECCCCCCCC-cChhhhcCCCCCEEECCCCcccccCcccccChH
Confidence 4667777777 666 655 566777777777 45666777775
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=95.70 E-value=0.0066 Score=53.81 Aligned_cols=41 Identities=15% Similarity=0.017 Sum_probs=33.4
Q ss_pred eechhhccCCC-ceeeCCC-CCCCCCCCEEeCccccccccCCC
Q 042435 3 VLLAFLSISAA-CSGVVEE-EPSSPSFLKSDMSFNNLDGEIPT 43 (412)
Q Consensus 3 ~~~~~l~~~~~-~~G~ip~-~~~~~~l~~~~ls~N~l~G~iP~ 43 (412)
..|++|+|+.| +++..+. +.++++|+.||||+|+|++-.|.
T Consensus 64 ~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~ 106 (229)
T 3e6j_A 64 INLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLTVLPSA 106 (229)
T ss_dssp TTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTT
T ss_pred cCCcEEECCCCCCCCcChhhcccCCCcCEEECCCCcCCccChh
Confidence 46899999999 8554445 68999999999999999975553
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=95.69 E-value=0.0047 Score=56.50 Aligned_cols=42 Identities=19% Similarity=0.032 Sum_probs=33.4
Q ss_pred eechhhccCCC-ceeeCCC-CCCCCCCCEEeCccccccccCCCC
Q 042435 3 VLLAFLSISAA-CSGVVEE-EPSSPSFLKSDMSFNNLDGEIPTY 44 (412)
Q Consensus 3 ~~~~~l~~~~~-~~G~ip~-~~~~~~l~~~~ls~N~l~G~iP~~ 44 (412)
..|++|+|+.| +++..+. +.++++|+.||+++|.+++..|..
T Consensus 153 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~ 196 (285)
T 1ozn_A 153 GNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHA 196 (285)
T ss_dssp TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTT
T ss_pred CCccEEECCCCcccccCHHHhcCccccCEEECCCCcccccCHhH
Confidence 35788888888 7776665 778888888888888888887763
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=95.69 E-value=0.036 Score=48.54 Aligned_cols=102 Identities=22% Similarity=0.114 Sum_probs=62.4
Q ss_pred ceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCCCCccc
Q 042435 204 SLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTL 283 (412)
Q Consensus 204 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 283 (412)
+|.++|...+ .+++..+.+.++.|.+.+|.-+-.... + ..+=..|..|++..+|.+...+ ..+.
T Consensus 34 SL~eIL~~~~--~PlsEEqaWALc~Qc~~~L~~~~~~~~-~-~~~i~~~~~i~l~~dG~V~f~~-~~s~----------- 97 (229)
T 2yle_A 34 SLEEILRLYN--QPINEEQAWAVCYQCCGSLRAAARRRQ-P-RHRVRSAAQIRVWRDGAVTLAP-AADD----------- 97 (229)
T ss_dssp EHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTTC-C-CCCCCSGGGEEEETTSCEEECC-C--------------
T ss_pred cHHHHHHHcC--CCcCHHHHHHHHHHHHHHHHhhhhccc-C-CceecCCcceEEecCCceeccc-cccc-----------
Confidence 6777776544 369999999999999999876622101 1 1222345788898888887664 1110
Q ss_pred ccccccccccccccCcccCcccccHHHHHHHHHHHhCCCC
Q 042435 284 QAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHP 323 (412)
Q Consensus 284 ~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P 323 (412)
.....+.|||... ...+.+.=|||+|+++|.-+-=..|
T Consensus 98 -~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 98 -AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp ----------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred -ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence 1122456888763 3445778899999999998864433
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=95.66 E-value=0.0044 Score=51.85 Aligned_cols=36 Identities=11% Similarity=0.015 Sum_probs=19.2
Q ss_pred chhhccCCC-ce-eeCCC-CCCCCCCCEEeCcccccccc
Q 042435 5 LAFLSISAA-CS-GVVEE-EPSSPSFLKSDMSFNNLDGE 40 (412)
Q Consensus 5 ~~~l~~~~~-~~-G~ip~-~~~~~~l~~~~ls~N~l~G~ 40 (412)
|+.|+|+.| ++ |.+|. +..+++|+.||+++|.+++.
T Consensus 26 L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~ 64 (168)
T 2ell_A 26 VRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV 64 (168)
T ss_dssp CSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC
T ss_pred CCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh
Confidence 455555555 54 55544 34555555555555555543
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=95.60 E-value=0.004 Score=64.22 Aligned_cols=42 Identities=10% Similarity=0.037 Sum_probs=37.2
Q ss_pred eechhhccCCC-ceee-----------------CCC-CC--CCCCCCEEeCccccccccCCCC
Q 042435 3 VLLAFLSISAA-CSGV-----------------VEE-EP--SSPSFLKSDMSFNNLDGEIPTY 44 (412)
Q Consensus 3 ~~~~~l~~~~~-~~G~-----------------ip~-~~--~~~~l~~~~ls~N~l~G~iP~~ 44 (412)
..|++|||+.| ++|. ||+ +. ++++|+.|++++|+++|.+|..
T Consensus 206 ~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~ 268 (636)
T 4eco_A 206 TKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTF 268 (636)
T ss_dssp TTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTT
T ss_pred cCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCccChHH
Confidence 46899999999 9996 877 78 8999999999999999999974
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=95.51 E-value=0.0049 Score=62.66 Aligned_cols=38 Identities=16% Similarity=0.152 Sum_probs=30.8
Q ss_pred chhhccCCC-ceeeCCCCCCCCCCCEEeCccccccccCCCC
Q 042435 5 LAFLSISAA-CSGVVEEEPSSPSFLKSDMSFNNLDGEIPTY 44 (412)
Q Consensus 5 ~~~l~~~~~-~~G~ip~~~~~~~l~~~~ls~N~l~G~iP~~ 44 (412)
|++|+|+.| +++ ||.+.++++|+.||||+|+|+ .||..
T Consensus 443 L~~L~Ls~n~l~~-lp~~~~l~~L~~L~Ls~N~l~-~lp~~ 481 (567)
T 1dce_A 443 VRVLHLAHKDLTV-LCHLEQLLLVTHLDLSHNRLR-ALPPA 481 (567)
T ss_dssp CSEEECTTSCCSS-CCCGGGGTTCCEEECCSSCCC-CCCGG
T ss_pred ceEEEecCCCCCC-CcCccccccCcEeecCccccc-ccchh
Confidence 677888888 776 677888888888888888888 78863
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=95.47 E-value=0.0073 Score=56.18 Aligned_cols=43 Identities=21% Similarity=0.226 Sum_probs=31.0
Q ss_pred eechhhccCCC-ceeeCC--CCCCCCCCCEEeCccccccccCCCCCc
Q 042435 3 VLLAFLSISAA-CSGVVE--EEPSSPSFLKSDMSFNNLDGEIPTYLR 46 (412)
Q Consensus 3 ~~~~~l~~~~~-~~G~ip--~~~~~~~l~~~~ls~N~l~G~iP~~~~ 46 (412)
..|++|||+.| ++|.+| .+..+++|+.||+|+|+|+ .||..++
T Consensus 228 ~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~-~ip~~~~ 273 (312)
T 1wwl_A 228 VQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLP 273 (312)
T ss_dssp CCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCS-SCCSSCC
T ss_pred CCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccC-hhhhhcc
Confidence 36778888888 777664 3556778888888888887 7776444
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=95.42 E-value=0.013 Score=57.29 Aligned_cols=41 Identities=15% Similarity=0.092 Sum_probs=28.4
Q ss_pred eechhhccCCC-ceeeCCC-CCCCCCCCEEeCccccccccCCC
Q 042435 3 VLLAFLSISAA-CSGVVEE-EPSSPSFLKSDMSFNNLDGEIPT 43 (412)
Q Consensus 3 ~~~~~l~~~~~-~~G~ip~-~~~~~~l~~~~ls~N~l~G~iP~ 43 (412)
..|++|||+.| +++.+|. +.++++|+.||+|+|++++..|.
T Consensus 323 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~ 365 (455)
T 3v47_A 323 THLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQ 365 (455)
T ss_dssp TTCCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTT
T ss_pred ccCCEEECCCCccCCcChhHhcCcccCCEEECCCCcccccChh
Confidence 35677777777 6666555 56777777777777777776665
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=95.41 E-value=0.0048 Score=53.19 Aligned_cols=40 Identities=23% Similarity=0.088 Sum_probs=21.9
Q ss_pred echhhccCCC-ceeeCCC-CCCCCCCCEEeCccccccccCCC
Q 042435 4 LLAFLSISAA-CSGVVEE-EPSSPSFLKSDMSFNNLDGEIPT 43 (412)
Q Consensus 4 ~~~~l~~~~~-~~G~ip~-~~~~~~l~~~~ls~N~l~G~iP~ 43 (412)
.|++|+|+.| +++..|. +.++++|+.||+|+|++++..|.
T Consensus 89 ~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~ 130 (197)
T 4ezg_A 89 NLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILT 130 (197)
T ss_dssp TCCEEEEECTTCBGGGSCCCTTCTTCCEEECCSSBCBGGGHH
T ss_pred CCCEEEeECCccCcccChhhcCCCCCCEEEecCCccCcHhHH
Confidence 3555566655 5554433 55555666666666666554443
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=95.35 E-value=0.01 Score=60.33 Aligned_cols=40 Identities=18% Similarity=0.040 Sum_probs=25.4
Q ss_pred echhhccCCC-ceeeCCC-CCCCCCCCEEeCccccccccCCC
Q 042435 4 LLAFLSISAA-CSGVVEE-EPSSPSFLKSDMSFNNLDGEIPT 43 (412)
Q Consensus 4 ~~~~l~~~~~-~~G~ip~-~~~~~~l~~~~ls~N~l~G~iP~ 43 (412)
.|+.||||.| +++.+|. +.++++|+.||||+|+|++..|.
T Consensus 519 ~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~ 560 (635)
T 4g8a_A 519 SLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQ 560 (635)
T ss_dssp TCCEEECTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSS
T ss_pred CCCEEECCCCcCCCCChhHHhCCCCCCEEECCCCcCCCCCHH
Confidence 4666666666 6665554 55666666666666666666665
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=95.33 E-value=0.012 Score=59.25 Aligned_cols=41 Identities=17% Similarity=0.161 Sum_probs=28.1
Q ss_pred eechhhccCCC-ce-eeCCC-CCCCCCCCEEeCccccccccCCC
Q 042435 3 VLLAFLSISAA-CS-GVVEE-EPSSPSFLKSDMSFNNLDGEIPT 43 (412)
Q Consensus 3 ~~~~~l~~~~~-~~-G~ip~-~~~~~~l~~~~ls~N~l~G~iP~ 43 (412)
..|++|+|+.| ++ |.+|. +.++++|+.||+|+|++++..|.
T Consensus 445 ~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~ 488 (570)
T 2z63_A 445 SSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPT 488 (570)
T ss_dssp TTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTT
T ss_pred CcCcEEECcCCcCccccchhhhhcccCCCEEECCCCccccCChh
Confidence 35677777777 55 56665 66777777777777777776665
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=95.31 E-value=0.029 Score=52.92 Aligned_cols=31 Identities=23% Similarity=0.455 Sum_probs=27.3
Q ss_pred CCcEEeCCCCCCEEecCCCcEEEeecCCccc
Q 042435 243 PSIVHRDISSNNILLNSNLEAFVADFGTVRL 273 (412)
Q Consensus 243 ~~ivHrDlkp~NILl~~~~~~kl~DfGla~~ 273 (412)
..++|+|+.+.||++++++.+.++||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 4799999999999999878899999987753
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=95.29 E-value=0.011 Score=57.92 Aligned_cols=41 Identities=15% Similarity=-0.034 Sum_probs=29.8
Q ss_pred eechhhccCCC-ceeeCCC-CCCCCCCCEEeCccccccccCCC
Q 042435 3 VLLAFLSISAA-CSGVVEE-EPSSPSFLKSDMSFNNLDGEIPT 43 (412)
Q Consensus 3 ~~~~~l~~~~~-~~G~ip~-~~~~~~l~~~~ls~N~l~G~iP~ 43 (412)
..|+.|||+.| +++..|. +.++++|+.|++++|++++..|.
T Consensus 207 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~ 249 (440)
T 3zyj_A 207 IKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERN 249 (440)
T ss_dssp SSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTT
T ss_pred cccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChh
Confidence 35777888888 7777665 67777777777777777776654
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=95.24 E-value=0.012 Score=49.62 Aligned_cols=36 Identities=8% Similarity=-0.028 Sum_probs=28.0
Q ss_pred echhhccCCC-ceeeCCCCCCCCCCCEEeCcccccccc
Q 042435 4 LLAFLSISAA-CSGVVEEEPSSPSFLKSDMSFNNLDGE 40 (412)
Q Consensus 4 ~~~~l~~~~~-~~G~ip~~~~~~~l~~~~ls~N~l~G~ 40 (412)
.|++|||+.| +++. +.+.++++|+.||+|+|.+++-
T Consensus 43 ~L~~L~Ls~N~l~~~-~~l~~l~~L~~L~Ls~N~l~~~ 79 (176)
T 1a9n_A 43 QFDAIDFSDNEIRKL-DGFPLLRRLKTLLVNNNRICRI 79 (176)
T ss_dssp CCSEEECCSSCCCEE-CCCCCCSSCCEEECCSSCCCEE
T ss_pred CCCEEECCCCCCCcc-cccccCCCCCEEECCCCccccc
Confidence 5778888888 7765 6677888888888888888754
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=95.23 E-value=0.011 Score=57.93 Aligned_cols=41 Identities=15% Similarity=-0.084 Sum_probs=28.2
Q ss_pred eechhhccCCC-ceeeCCC-CCCCCCCCEEeCccccccccCCC
Q 042435 3 VLLAFLSISAA-CSGVVEE-EPSSPSFLKSDMSFNNLDGEIPT 43 (412)
Q Consensus 3 ~~~~~l~~~~~-~~G~ip~-~~~~~~l~~~~ls~N~l~G~iP~ 43 (412)
..|+.|||+.| +++..|. +.++++|+.|++++|++++..|.
T Consensus 218 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~ 260 (452)
T 3zyi_A 218 VGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERN 260 (452)
T ss_dssp TTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTT
T ss_pred ccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHH
Confidence 35677777777 7776655 66677777777777777766654
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=95.22 E-value=0.007 Score=61.67 Aligned_cols=41 Identities=22% Similarity=0.075 Sum_probs=32.0
Q ss_pred eechhhccCCC-ceeeCCC-CCCCCCCCEEeCccccccccCCC
Q 042435 3 VLLAFLSISAA-CSGVVEE-EPSSPSFLKSDMSFNNLDGEIPT 43 (412)
Q Consensus 3 ~~~~~l~~~~~-~~G~ip~-~~~~~~l~~~~ls~N~l~G~iP~ 43 (412)
..|++|||+.| +++.+|. +.++++|+.||+|+|++++.+|.
T Consensus 473 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~ 515 (606)
T 3vq2_A 473 TNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSS 515 (606)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGG
T ss_pred CCCCEEECCCCcCCccChhhhcccccCCEEECCCCcCCCcCHH
Confidence 45778888888 8887766 67788888888888888887775
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=95.15 E-value=0.011 Score=53.84 Aligned_cols=59 Identities=14% Similarity=-0.018 Sum_probs=43.7
Q ss_pred eechhhccCCC-ceeeCCC-CCCCCCCCEEeCccccccccCCCCC--cCC-CCcccccCcCCCC
Q 042435 3 VLLAFLSISAA-CSGVVEE-EPSSPSFLKSDMSFNNLDGEIPTYL--RDN-PPKSFVGNKGLCG 61 (412)
Q Consensus 3 ~~~~~l~~~~~-~~G~ip~-~~~~~~l~~~~ls~N~l~G~iP~~~--~~~-~~~~~~gn~~lcg 61 (412)
..|++|+|+.| +++..|. +.++++|+.||+++|+++|..|..+ +.+ ..-.+.+|+-.|.
T Consensus 157 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~ 220 (272)
T 3rfs_A 157 TNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCT 220 (272)
T ss_dssp TTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCC
T ss_pred ccCCEEECCCCCcCccCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCcccc
Confidence 46899999999 9877766 6899999999999999999776422 222 3344556765553
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=95.09 E-value=0.01 Score=54.71 Aligned_cols=40 Identities=25% Similarity=0.139 Sum_probs=32.2
Q ss_pred eechhhccCCC-ceeeCCC-CCCCCCCCEEeCccccccccCC
Q 042435 3 VLLAFLSISAA-CSGVVEE-EPSSPSFLKSDMSFNNLDGEIP 42 (412)
Q Consensus 3 ~~~~~l~~~~~-~~G~ip~-~~~~~~l~~~~ls~N~l~G~iP 42 (412)
..|++|||+.| +++..|. +.++++|+.||+|+|.+++..|
T Consensus 175 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~ 216 (306)
T 2z66_A 175 RNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDT 216 (306)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCS
T ss_pred cCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccCh
Confidence 35788889888 8887766 7788888888888888887555
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=95.09 E-value=0.016 Score=52.54 Aligned_cols=40 Identities=15% Similarity=0.079 Sum_probs=28.4
Q ss_pred eechhhccCCC-ceeeCCC-CCCCCCCCEEeCccccccccCC
Q 042435 3 VLLAFLSISAA-CSGVVEE-EPSSPSFLKSDMSFNNLDGEIP 42 (412)
Q Consensus 3 ~~~~~l~~~~~-~~G~ip~-~~~~~~l~~~~ls~N~l~G~iP 42 (412)
..|++|+|+.| +++..+. +.++++|+.|++++|.+++-.|
T Consensus 133 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~ 174 (270)
T 2o6q_A 133 TKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVPE 174 (270)
T ss_dssp TTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCT
T ss_pred cCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCcEeCh
Confidence 35777888888 7665544 6777888888888888776444
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=95.05 E-value=0.012 Score=48.05 Aligned_cols=40 Identities=23% Similarity=0.293 Sum_probs=35.6
Q ss_pred eechhhccCCC-ceeeCCCCCCCCCCCEEeCccccccccCCC
Q 042435 3 VLLAFLSISAA-CSGVVEEEPSSPSFLKSDMSFNNLDGEIPT 43 (412)
Q Consensus 3 ~~~~~l~~~~~-~~G~ip~~~~~~~l~~~~ls~N~l~G~iP~ 43 (412)
..|++|+|+.| +++. +.+.++++|+.||+|+|.+++.+|.
T Consensus 42 ~~L~~L~l~~n~l~~~-~~~~~l~~L~~L~Ls~n~i~~~~~~ 82 (149)
T 2je0_A 42 EELEFLSTINVGLTSI-ANLPKLNKLKKLELSDNRVSGGLEV 82 (149)
T ss_dssp TTCCEEECTTSCCCCC-TTCCCCTTCCEEECCSSCCCSCTHH
T ss_pred CCCcEEECcCCCCCCc-hhhhcCCCCCEEECCCCcccchHHH
Confidence 46899999999 8776 7788999999999999999998886
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=95.05 E-value=0.0072 Score=64.52 Aligned_cols=42 Identities=7% Similarity=0.074 Sum_probs=36.4
Q ss_pred eechhhccCCC-cee-----------------eCCC-CC--CCCCCCEEeCccccccccCCCC
Q 042435 3 VLLAFLSISAA-CSG-----------------VVEE-EP--SSPSFLKSDMSFNNLDGEIPTY 44 (412)
Q Consensus 3 ~~~~~l~~~~~-~~G-----------------~ip~-~~--~~~~l~~~~ls~N~l~G~iP~~ 44 (412)
..|++|||+.| ++| .||+ +. ++++|+.|+|++|+++|.+|..
T Consensus 448 ~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~ 510 (876)
T 4ecn_A 448 TKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDF 510 (876)
T ss_dssp TTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEESCTTCCSCCGG
T ss_pred CCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcCCCCCccChHH
Confidence 46889999999 999 4877 77 8999999999999999999963
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=95.05 E-value=0.015 Score=52.00 Aligned_cols=40 Identities=8% Similarity=0.043 Sum_probs=31.4
Q ss_pred echhhccCCC-ceeeCCC-CCCCCCCCEEeCccccccccCCC
Q 042435 4 LLAFLSISAA-CSGVVEE-EPSSPSFLKSDMSFNNLDGEIPT 43 (412)
Q Consensus 4 ~~~~l~~~~~-~~G~ip~-~~~~~~l~~~~ls~N~l~G~iP~ 43 (412)
.|+.|+|+.| +++..|. +.++++|+.||+|+|++++..|.
T Consensus 36 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~ 77 (251)
T 3m19_A 36 DTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAG 77 (251)
T ss_dssp TCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTT
T ss_pred CCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHh
Confidence 4678888888 8777765 77888888888888888886664
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=95.02 E-value=0.01 Score=62.10 Aligned_cols=40 Identities=18% Similarity=0.209 Sum_probs=29.9
Q ss_pred eechhhccCCC-ceeeCCC-CCCCCCCCEEeCccccccccCCCC
Q 042435 3 VLLAFLSISAA-CSGVVEE-EPSSPSFLKSDMSFNNLDGEIPTY 44 (412)
Q Consensus 3 ~~~~~l~~~~~-~~G~ip~-~~~~~~l~~~~ls~N~l~G~iP~~ 44 (412)
..|++|+|+.| ++ .||. +.++++|+.||||+|+|+ .||..
T Consensus 247 ~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~ 288 (727)
T 4b8c_D 247 DFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAE 288 (727)
T ss_dssp CSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSS
T ss_pred CCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChh
Confidence 45777888888 77 6766 777788888888888887 77763
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=95.00 E-value=0.017 Score=53.97 Aligned_cols=41 Identities=10% Similarity=0.021 Sum_probs=33.9
Q ss_pred echhhccCCC-ceeeCCC-CCCCCCCCEEeCccccccccCCCC
Q 042435 4 LLAFLSISAA-CSGVVEE-EPSSPSFLKSDMSFNNLDGEIPTY 44 (412)
Q Consensus 4 ~~~~l~~~~~-~~G~ip~-~~~~~~l~~~~ls~N~l~G~iP~~ 44 (412)
.|++|+|+.| +++..+. +.++++|+.||+++|++++..|..
T Consensus 53 ~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~ 95 (330)
T 1xku_A 53 DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGA 95 (330)
T ss_dssp TCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTT
T ss_pred CCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHH
Confidence 4788999999 8877764 788999999999999998877763
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=94.96 E-value=0.011 Score=63.17 Aligned_cols=41 Identities=17% Similarity=0.127 Sum_probs=32.1
Q ss_pred eechhhccCCC-ceeeCCC-CCCCCCCCEEeCcc------ccccccCCCC
Q 042435 3 VLLAFLSISAA-CSGVVEE-EPSSPSFLKSDMSF------NNLDGEIPTY 44 (412)
Q Consensus 3 ~~~~~l~~~~~-~~G~ip~-~~~~~~l~~~~ls~------N~l~G~iP~~ 44 (412)
..|+.|||+.| ++| ||. +.++++|+.||||+ |+++|.+|..
T Consensus 753 ~~L~~L~Ls~N~L~~-lp~~l~~L~~L~~L~Ls~N~~ls~N~l~~~ip~~ 801 (876)
T 4ecn_A 753 PYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTG 801 (876)
T ss_dssp TTCCEEECCSSCCSS-CCCGGGGCTTCCEEECCCCBCTTCCBCCCCCCTT
T ss_pred CCcCEEEeCCCCCCc-cchhhhcCCCCCEEECCCCCCcccccccccChHH
Confidence 45788888888 887 665 77888888888866 7788888864
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=94.96 E-value=0.0092 Score=62.52 Aligned_cols=39 Identities=15% Similarity=-0.019 Sum_probs=24.2
Q ss_pred echhhccCCC-ceeeCCC-CCCCCCCCEEeCccccccccCCCC
Q 042435 4 LLAFLSISAA-CSGVVEE-EPSSPSFLKSDMSFNNLDGEIPTY 44 (412)
Q Consensus 4 ~~~~l~~~~~-~~G~ip~-~~~~~~l~~~~ls~N~l~G~iP~~ 44 (412)
.|++|||+.| ++ .||. +.++++|+.|+||+|.|+ .||..
T Consensus 271 ~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~-~lp~~ 311 (727)
T 4b8c_D 271 NLRVLDLSHNRLT-SLPAELGSCFQLKYFYFFDNMVT-TLPWE 311 (727)
T ss_dssp TCCEEECTTSCCS-SCCSSGGGGTTCSEEECCSSCCC-CCCSS
T ss_pred CCCEEeCcCCcCC-ccChhhcCCCCCCEEECCCCCCC-ccChh
Confidence 4666666666 55 5554 566666666666666664 56653
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=94.89 E-value=0.014 Score=50.48 Aligned_cols=57 Identities=12% Similarity=0.023 Sum_probs=41.8
Q ss_pred eechhhccCCC-ceeeCCC-CCCCCCCCEEeCccccccccCCCCCcC---C-CCcccccCcCCC
Q 042435 3 VLLAFLSISAA-CSGVVEE-EPSSPSFLKSDMSFNNLDGEIPTYLRD---N-PPKSFVGNKGLC 60 (412)
Q Consensus 3 ~~~~~l~~~~~-~~G~ip~-~~~~~~l~~~~ls~N~l~G~iP~~~~~---~-~~~~~~gn~~lc 60 (412)
..|++|+|+.| +++..|. +.++++|+.||+++|++++..|. .+. + ..-.+.+|+-.|
T Consensus 100 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~l~~L~~L~l~~N~~~~ 162 (208)
T 2o6s_A 100 TQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDG-VFDRLTSLQYIWLHDNPWDC 162 (208)
T ss_dssp TTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTT-TTTTCTTCCEEECCSCCBCC
T ss_pred cCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHH-HhccCCCccEEEecCCCeec
Confidence 46899999999 8877666 78899999999999999975543 232 2 334455676555
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=94.85 E-value=0.0069 Score=51.14 Aligned_cols=40 Identities=18% Similarity=0.124 Sum_probs=34.0
Q ss_pred eechhhccCCC-ceeeCCCC-CCCCCCCEEeCccccccccCCC
Q 042435 3 VLLAFLSISAA-CSGVVEEE-PSSPSFLKSDMSFNNLDGEIPT 43 (412)
Q Consensus 3 ~~~~~l~~~~~-~~G~ip~~-~~~~~l~~~~ls~N~l~G~iP~ 43 (412)
..|++|||+.| +++..|.+ .++++|+.||+|+|++ +.+|.
T Consensus 64 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i-~~~~~ 105 (176)
T 1a9n_A 64 RRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSL-VELGD 105 (176)
T ss_dssp SSCCEEECCSSCCCEECSCHHHHCTTCCEEECCSCCC-CCGGG
T ss_pred CCCCEEECCCCcccccCcchhhcCCCCCEEECCCCcC-Ccchh
Confidence 46899999999 88766664 8899999999999999 55775
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=94.85 E-value=0.0087 Score=55.62 Aligned_cols=37 Identities=11% Similarity=0.099 Sum_probs=22.4
Q ss_pred echhhccCCC-ceeeCCC-C--CCCCCCCEEeCcccccccc
Q 042435 4 LLAFLSISAA-CSGVVEE-E--PSSPSFLKSDMSFNNLDGE 40 (412)
Q Consensus 4 ~~~~l~~~~~-~~G~ip~-~--~~~~~l~~~~ls~N~l~G~ 40 (412)
.|++|+|+.| ++|.+|. + .++++|+.||+|+|+++|.
T Consensus 96 ~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~ 136 (312)
T 1wwl_A 96 GLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATR 136 (312)
T ss_dssp CCCEEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSSS
T ss_pred CccEEEccCCcccchhHHHHHHhcCCCccEEEccCCCCcch
Confidence 4556666666 6666655 3 5566666666666666665
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=94.84 E-value=0.0089 Score=55.71 Aligned_cols=39 Identities=21% Similarity=0.100 Sum_probs=27.0
Q ss_pred eechhhccCCC-ceeeCCCCCCCCCCCEEeCccccccccCC
Q 042435 3 VLLAFLSISAA-CSGVVEEEPSSPSFLKSDMSFNNLDGEIP 42 (412)
Q Consensus 3 ~~~~~l~~~~~-~~G~ip~~~~~~~l~~~~ls~N~l~G~iP 42 (412)
..|++|+|+.| +++. |....+++|+.||+|+|++++-.|
T Consensus 169 ~~L~~L~L~~N~l~~~-~~~~~l~~L~~L~Ls~N~l~~l~~ 208 (317)
T 3o53_A 169 DTLEHLNLQYNFIYDV-KGQVVFAKLKTLDLSSNKLAFMGP 208 (317)
T ss_dssp TTCCEEECTTSCCCEE-ECCCCCTTCCEEECCSSCCCEECG
T ss_pred CcCCEEECCCCcCccc-ccccccccCCEEECCCCcCCcchh
Confidence 35777888888 6655 454457778888888888876444
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=94.79 E-value=0.018 Score=53.91 Aligned_cols=40 Identities=8% Similarity=-0.011 Sum_probs=31.4
Q ss_pred echhhccCCC-ceeeCCC-CCCCCCCCEEeCccccccccCCC
Q 042435 4 LLAFLSISAA-CSGVVEE-EPSSPSFLKSDMSFNNLDGEIPT 43 (412)
Q Consensus 4 ~~~~l~~~~~-~~G~ip~-~~~~~~l~~~~ls~N~l~G~iP~ 43 (412)
.|++|+|+.| +++..|. +.++++|+.||+++|++++..|.
T Consensus 55 ~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~ 96 (332)
T 2ft3_A 55 DTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEK 96 (332)
T ss_dssp TCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGG
T ss_pred CCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHh
Confidence 4678888888 7777664 77888888888888888877675
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=94.79 E-value=0.013 Score=55.47 Aligned_cols=45 Identities=13% Similarity=-0.034 Sum_probs=38.4
Q ss_pred echhhccCCC-ceeeCCC-CCCCCCCCEEeCccccccccCCCCCcCC
Q 042435 4 LLAFLSISAA-CSGVVEE-EPSSPSFLKSDMSFNNLDGEIPTYLRDN 48 (412)
Q Consensus 4 ~~~~l~~~~~-~~G~ip~-~~~~~~l~~~~ls~N~l~G~iP~~~~~~ 48 (412)
.|+.|+|+.| ++...+. +.++++|+.||||+|++.+.||...|.+
T Consensus 31 ~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~ 77 (350)
T 4ay9_X 31 NAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSN 77 (350)
T ss_dssp TCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCS
T ss_pred CCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhc
Confidence 5889999999 8855454 7899999999999999999999866655
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=94.70 E-value=0.0056 Score=62.38 Aligned_cols=42 Identities=21% Similarity=0.107 Sum_probs=37.1
Q ss_pred eechhhccCCC-ceeeCCC-CCCCCCCCEEeCccccccccCCCC
Q 042435 3 VLLAFLSISAA-CSGVVEE-EPSSPSFLKSDMSFNNLDGEIPTY 44 (412)
Q Consensus 3 ~~~~~l~~~~~-~~G~ip~-~~~~~~l~~~~ls~N~l~G~iP~~ 44 (412)
..|++|+|+.| +++.+|. +.++++|+.||+|+|+++|.+|..
T Consensus 476 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~ 519 (606)
T 3t6q_A 476 GRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEA 519 (606)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCGGGGGG
T ss_pred CCccEEECCCCccCccChhhhccccCCCEEECCCCccCcCChhH
Confidence 46889999999 9998877 889999999999999999988863
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=94.57 E-value=0.011 Score=61.11 Aligned_cols=34 Identities=18% Similarity=0.193 Sum_probs=18.0
Q ss_pred echhhccCCC-ceeeCCC--CCCCCCCCEEeCcccccc
Q 042435 4 LLAFLSISAA-CSGVVEE--EPSSPSFLKSDMSFNNLD 38 (412)
Q Consensus 4 ~~~~l~~~~~-~~G~ip~--~~~~~~l~~~~ls~N~l~ 38 (412)
.|++|||+.| ++ .||. +.++++|+.||+|+|+|+
T Consensus 537 ~L~~L~L~~N~l~-~i~~~~~~~l~~L~~L~Ls~N~l~ 573 (680)
T 1ziw_A 537 HLHILNLESNGFD-EIPVEVFKDLFELKIIDLGLNNLN 573 (680)
T ss_dssp TCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCC
T ss_pred CCCEEECCCCCCC-CCCHHHcccccCcceeECCCCCCC
Confidence 3555555555 44 3332 455555555555555555
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=94.52 E-value=0.013 Score=48.94 Aligned_cols=37 Identities=22% Similarity=0.214 Sum_probs=31.4
Q ss_pred eechhhccCCC-ceeeCCC-CCCCCCCCEEeCccccccc
Q 042435 3 VLLAFLSISAA-CSGVVEE-EPSSPSFLKSDMSFNNLDG 39 (412)
Q Consensus 3 ~~~~~l~~~~~-~~G~ip~-~~~~~~l~~~~ls~N~l~G 39 (412)
..|++|||+.| +++.+|. +.++++|+.||+|+|++++
T Consensus 71 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~ 109 (168)
T 2ell_A 71 PKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKD 109 (168)
T ss_dssp SSCCEEEEESCCCCSCCCHHHHHCTTCCEEECBSSSCCS
T ss_pred CCCCEEECcCCcCchHHHHHHhhCCCCCEEeccCCccCc
Confidence 46889999999 8888877 4568999999999999987
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=94.51 E-value=0.027 Score=53.54 Aligned_cols=37 Identities=24% Similarity=0.124 Sum_probs=19.4
Q ss_pred echhhccCCC-ceeeCCC-CCCCCCCCEEeCcccccccc
Q 042435 4 LLAFLSISAA-CSGVVEE-EPSSPSFLKSDMSFNNLDGE 40 (412)
Q Consensus 4 ~~~~l~~~~~-~~G~ip~-~~~~~~l~~~~ls~N~l~G~ 40 (412)
.|++|+|+.| +++..|. +.++++|+.||||+|+|++-
T Consensus 65 ~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~ 103 (361)
T 2xot_A 65 NLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHLHTL 103 (361)
T ss_dssp TCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEE
T ss_pred ccCEEECCCCcCCccChhhccCCCCCCEEECCCCcCCcC
Confidence 3455555555 5544443 45555555555555555543
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=94.46 E-value=0.031 Score=56.41 Aligned_cols=37 Identities=27% Similarity=0.384 Sum_probs=17.7
Q ss_pred echhhccCCC-ceeeCCC-CCCCCCCCEEeCccccccccCCC
Q 042435 4 LLAFLSISAA-CSGVVEE-EPSSPSFLKSDMSFNNLDGEIPT 43 (412)
Q Consensus 4 ~~~~l~~~~~-~~G~ip~-~~~~~~l~~~~ls~N~l~G~iP~ 43 (412)
.|+.|+|+.| ++|.+|. +. ++|+.||+|+|+++ .||.
T Consensus 429 ~L~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~-~ip~ 467 (562)
T 3a79_B 429 SILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPK 467 (562)
T ss_dssp TCCEEECCSSCCCGGGGSSCC--TTCSEEECCSSCCC-CCCT
T ss_pred cCCEEECCCCCCCcchhhhhc--CcCCEEECCCCcCc-ccCh
Confidence 3455555555 5554433 22 34555555555554 4444
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=94.45 E-value=0.093 Score=51.16 Aligned_cols=29 Identities=17% Similarity=0.212 Sum_probs=22.9
Q ss_pred eeeeecCceEEEEEEeCC--------CcEEEEEeccC
Q 042435 149 YCIGTGGYDSVYKAELPD--------GKVVALKKLHH 177 (412)
Q Consensus 149 ~~lG~G~~g~Vy~~~~~~--------~~~vAvK~l~~ 177 (412)
+.|+.|....||++...+ ++.+++|+...
T Consensus 79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~ 115 (429)
T 1nw1_A 79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN 115 (429)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS
T ss_pred EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCC
Confidence 568888899999998753 57888998744
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=94.42 E-value=0.023 Score=55.42 Aligned_cols=41 Identities=7% Similarity=-0.023 Sum_probs=32.1
Q ss_pred echhhccCCC-ceeeCCC-CCCCCCCCEEeCccccccccCCCC
Q 042435 4 LLAFLSISAA-CSGVVEE-EPSSPSFLKSDMSFNNLDGEIPTY 44 (412)
Q Consensus 4 ~~~~l~~~~~-~~G~ip~-~~~~~~l~~~~ls~N~l~G~iP~~ 44 (412)
.|++|||+.| +++.+|. +.++++|+.||+|+|.+++.+|..
T Consensus 31 ~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~ 73 (455)
T 3v47_A 31 HVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNN 73 (455)
T ss_dssp TCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTT
T ss_pred ccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcc
Confidence 4778888888 8877765 778888888888888888887753
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=94.42 E-value=0.02 Score=58.15 Aligned_cols=41 Identities=12% Similarity=0.026 Sum_probs=33.8
Q ss_pred eechhhccCCC-ceee-CCC-CCCCCCCCEEeCccccccccCCC
Q 042435 3 VLLAFLSISAA-CSGV-VEE-EPSSPSFLKSDMSFNNLDGEIPT 43 (412)
Q Consensus 3 ~~~~~l~~~~~-~~G~-ip~-~~~~~~l~~~~ls~N~l~G~iP~ 43 (412)
..|++|+|+.| ++|. +|. +.++++|+.||+|+|++++..|.
T Consensus 448 ~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~ 491 (606)
T 3vq2_A 448 TSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWG 491 (606)
T ss_dssp TTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTT
T ss_pred CCCCEEECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChh
Confidence 46888999999 8884 566 78889999999999999988876
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=94.39 E-value=0.014 Score=59.64 Aligned_cols=57 Identities=14% Similarity=0.086 Sum_probs=31.2
Q ss_pred chhhccCCC-ceeeCCCCCCCCCCCEEeCccccccccCCCCCcCC-CCcccccCcCCCCCC
Q 042435 5 LAFLSISAA-CSGVVEEEPSSPSFLKSDMSFNNLDGEIPTYLRDN-PPKSFVGNKGLCGHV 63 (412)
Q Consensus 5 ~~~l~~~~~-~~G~ip~~~~~~~l~~~~ls~N~l~G~iP~~~~~~-~~~~~~gn~~lcg~~ 63 (412)
|++|||+.| +++. ++..+++|..||+|+|.++|..+...+.. ....+.+|..+|+.+
T Consensus 326 L~~L~L~~N~l~~~--~~~~~~~L~~L~l~~N~~~~~~~~~~~~~~~~~~~~~~~~~C~~~ 384 (597)
T 3oja_B 326 LENLYLDHNSIVTL--KLSTHHTLKNLTLSHNDWDCNSLRALFRNVARPAVDDADQHCKID 384 (597)
T ss_dssp CSEEECCSSCCCCC--CCCTTCCCSEEECCSSCEEHHHHHHHTTTCCTTTBCCCCCCCCTT
T ss_pred CCEEECCCCCCCCc--ChhhcCCCCEEEeeCCCCCChhHHHHHHHHhhhccccccccCCcc
Confidence 444444444 3332 13445566666666666666544333444 555677888888754
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=94.36 E-value=0.025 Score=51.95 Aligned_cols=40 Identities=15% Similarity=0.032 Sum_probs=34.1
Q ss_pred eechhhccCCC-ceeeCCC-CCCCCCCCEEeCccccccccCC
Q 042435 3 VLLAFLSISAA-CSGVVEE-EPSSPSFLKSDMSFNNLDGEIP 42 (412)
Q Consensus 3 ~~~~~l~~~~~-~~G~ip~-~~~~~~l~~~~ls~N~l~G~iP 42 (412)
..|++|+|+.| +++..|. +.++++|+.|++++|+|++-.|
T Consensus 100 ~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~ 141 (290)
T 1p9a_G 100 PALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPP 141 (290)
T ss_dssp TTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCT
T ss_pred CCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccCh
Confidence 46899999999 8877766 8899999999999999996444
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=94.29 E-value=0.019 Score=57.17 Aligned_cols=40 Identities=18% Similarity=0.131 Sum_probs=21.9
Q ss_pred echhhccCCC-cee--eCCC-CCCCCCCCEEeCccccccccCCC
Q 042435 4 LLAFLSISAA-CSG--VVEE-EPSSPSFLKSDMSFNNLDGEIPT 43 (412)
Q Consensus 4 ~~~~l~~~~~-~~G--~ip~-~~~~~~l~~~~ls~N~l~G~iP~ 43 (412)
.|+.|+|+.| +++ .+|. +.++++|+.||+|+|.+++.+|.
T Consensus 349 ~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~ 392 (520)
T 2z7x_B 349 ELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKK 392 (520)
T ss_dssp SCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGG
T ss_pred CCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCccccc
Confidence 3555566665 554 3433 45555555566666665555554
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=94.24 E-value=0.02 Score=60.99 Aligned_cols=40 Identities=10% Similarity=0.086 Sum_probs=20.5
Q ss_pred echhhccCCC-ceeeCCC-CCCCCCCCEEeCccccccccCCC
Q 042435 4 LLAFLSISAA-CSGVVEE-EPSSPSFLKSDMSFNNLDGEIPT 43 (412)
Q Consensus 4 ~~~~l~~~~~-~~G~ip~-~~~~~~l~~~~ls~N~l~G~iP~ 43 (412)
.|++|||++| +++.+|. +.++++|+.||+|+|++++.+|.
T Consensus 74 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~ 115 (844)
T 3j0a_A 74 NLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLK 115 (844)
T ss_dssp TCCEEECTTCCCCEECTTSSCSCSSCCCEECTTCCCSSCCST
T ss_pred CCCEEECCCCcCcccCHhHccCCcccCEeeCcCCCCCccccc
Confidence 3455555555 5555444 44555555555555555554443
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=94.23 E-value=0.024 Score=55.84 Aligned_cols=38 Identities=26% Similarity=0.357 Sum_probs=28.9
Q ss_pred echhhccCCC-ceeeCCCCCCCCCCCEEeCccccccccCCC
Q 042435 4 LLAFLSISAA-CSGVVEEEPSSPSFLKSDMSFNNLDGEIPT 43 (412)
Q Consensus 4 ~~~~l~~~~~-~~G~ip~~~~~~~l~~~~ls~N~l~G~iP~ 43 (412)
.|++|+|+.| +++ +|++.++++|+.||+|+|+++| +|.
T Consensus 132 ~L~~L~L~~n~l~~-lp~~~~l~~L~~L~l~~N~l~~-lp~ 170 (454)
T 1jl5_A 132 LLEYLGVSNNQLEK-LPELQNSSFLKIIDVDNNSLKK-LPD 170 (454)
T ss_dssp TCCEEECCSSCCSS-CCCCTTCTTCCEEECCSSCCSC-CCC
T ss_pred CCCEEECcCCCCCC-CcccCCCCCCCEEECCCCcCcc-cCC
Confidence 4677788877 776 7777778888888888888876 664
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=94.15 E-value=0.035 Score=52.64 Aligned_cols=41 Identities=12% Similarity=-0.076 Sum_probs=35.2
Q ss_pred eechhhccCCC-ceeeCCC-CCCCCCCCEEeCccccccccCCC
Q 042435 3 VLLAFLSISAA-CSGVVEE-EPSSPSFLKSDMSFNNLDGEIPT 43 (412)
Q Consensus 3 ~~~~~l~~~~~-~~G~ip~-~~~~~~l~~~~ls~N~l~G~iP~ 43 (412)
..|++|||+.| +++..|. +.++++|+.|+||+|++++..|.
T Consensus 88 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~ 130 (361)
T 2xot_A 88 PNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRN 130 (361)
T ss_dssp TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTT
T ss_pred CCCCEEECCCCcCCcCCHHHhCCCcCCCEEECCCCcccEECHH
Confidence 46889999999 8887765 78899999999999999987775
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=94.12 E-value=0.03 Score=56.55 Aligned_cols=38 Identities=16% Similarity=-0.042 Sum_probs=18.7
Q ss_pred chhhccCCC-ceeeCCC-CCCCCCCCEEeCccccccccCC
Q 042435 5 LAFLSISAA-CSGVVEE-EPSSPSFLKSDMSFNNLDGEIP 42 (412)
Q Consensus 5 ~~~l~~~~~-~~G~ip~-~~~~~~l~~~~ls~N~l~G~iP 42 (412)
|++|||+.| +++..|. +.++++|+.||+|+|++++-.|
T Consensus 54 L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~ 93 (562)
T 3a79_B 54 TKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDF 93 (562)
T ss_dssp CCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECT
T ss_pred cCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCH
Confidence 445555555 4444432 4455555555555555554444
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=94.11 E-value=0.038 Score=50.31 Aligned_cols=41 Identities=7% Similarity=0.039 Sum_probs=34.0
Q ss_pred eechhhccCCC-ceeeCCC-CCCCCCCCEEeCccccccccCCC
Q 042435 3 VLLAFLSISAA-CSGVVEE-EPSSPSFLKSDMSFNNLDGEIPT 43 (412)
Q Consensus 3 ~~~~~l~~~~~-~~G~ip~-~~~~~~l~~~~ls~N~l~G~iP~ 43 (412)
..|++|+|+.| +++..+. +.++++|+.||+++|++++-.|.
T Consensus 129 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~ 171 (285)
T 1ozn_A 129 AALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPER 171 (285)
T ss_dssp TTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTT
T ss_pred cCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccCHH
Confidence 46889999999 8876665 78899999999999999865543
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=94.11 E-value=0.022 Score=56.09 Aligned_cols=41 Identities=20% Similarity=0.111 Sum_probs=32.7
Q ss_pred eechhhccCCC-ceeeCCC-CCCCCCCCEEeCccccccccCCC
Q 042435 3 VLLAFLSISAA-CSGVVEE-EPSSPSFLKSDMSFNNLDGEIPT 43 (412)
Q Consensus 3 ~~~~~l~~~~~-~~G~ip~-~~~~~~l~~~~ls~N~l~G~iP~ 43 (412)
..|+.|||+.| +++..+. +.++++|+.|++++|++++..|.
T Consensus 248 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~ 290 (477)
T 2id5_A 248 VYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPY 290 (477)
T ss_dssp TTCCEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTT
T ss_pred cccCeeECCCCcCCccChhhccccccCCEEECCCCccceECHH
Confidence 35788888888 8877765 77888888888888888887775
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=94.10 E-value=0.018 Score=57.29 Aligned_cols=39 Identities=15% Similarity=0.043 Sum_probs=32.6
Q ss_pred echhhccCCC-ceeeCCC-CCCCCCCCEEeCccccccccCC
Q 042435 4 LLAFLSISAA-CSGVVEE-EPSSPSFLKSDMSFNNLDGEIP 42 (412)
Q Consensus 4 ~~~~l~~~~~-~~G~ip~-~~~~~~l~~~~ls~N~l~G~iP 42 (412)
.|++|||+.| +++.+|. +.++++|+.||||+|.++|.+|
T Consensus 35 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~ 75 (487)
T 3oja_A 35 NVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD 75 (487)
T ss_dssp GCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE
T ss_pred CccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc
Confidence 5888999999 8887665 7888899999999999988776
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=94.08 E-value=0.0096 Score=58.69 Aligned_cols=39 Identities=23% Similarity=0.221 Sum_probs=30.9
Q ss_pred eechhhccCCC-ceeeCCCCCCCCCCCEEeCccccccc--cCCCC
Q 042435 3 VLLAFLSISAA-CSGVVEEEPSSPSFLKSDMSFNNLDG--EIPTY 44 (412)
Q Consensus 3 ~~~~~l~~~~~-~~G~ip~~~~~~~l~~~~ls~N~l~G--~iP~~ 44 (412)
..|++|+|+.| ++ .||. .+++|+.||+++|+++| .+|..
T Consensus 337 ~~L~~L~L~~N~l~-~lp~--~l~~L~~L~L~~N~l~~l~~ip~~ 378 (454)
T 1jl5_A 337 PRLERLIASFNHLA-EVPE--LPQNLKQLHVEYNPLREFPDIPES 378 (454)
T ss_dssp TTCCEEECCSSCCS-CCCC--CCTTCCEEECCSSCCSSCCCCCTT
T ss_pred CcCCEEECCCCccc-cccc--hhhhccEEECCCCCCCcCCCChHH
Confidence 35788888888 76 4766 47889999999999999 88864
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=94.04 E-value=0.019 Score=49.28 Aligned_cols=41 Identities=22% Similarity=0.247 Sum_probs=34.4
Q ss_pred eechhhccCCC-ceeeCCC-CCCCCCCCEEeCccccccccCCC
Q 042435 3 VLLAFLSISAA-CSGVVEE-EPSSPSFLKSDMSFNNLDGEIPT 43 (412)
Q Consensus 3 ~~~~~l~~~~~-~~G~ip~-~~~~~~l~~~~ls~N~l~G~iP~ 43 (412)
..|++|+|+.| +++.+|. +.++++|+.||+|+|.+-+.+|.
T Consensus 112 ~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~~~~~ 154 (197)
T 4ezg_A 112 TSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMP 154 (197)
T ss_dssp TTCCEEECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCCCCGG
T ss_pred CCCCEEEecCCccCcHhHHHHhhCCCCCEEEccCCCCccccHh
Confidence 46889999999 8887755 88899999999999996677774
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=94.00 E-value=0.025 Score=57.54 Aligned_cols=42 Identities=12% Similarity=0.038 Sum_probs=34.0
Q ss_pred eechhhccCCC-ceee-CC--C-CCCCCCCCEEeCccccccccCCCC
Q 042435 3 VLLAFLSISAA-CSGV-VE--E-EPSSPSFLKSDMSFNNLDGEIPTY 44 (412)
Q Consensus 3 ~~~~~l~~~~~-~~G~-ip--~-~~~~~~l~~~~ls~N~l~G~iP~~ 44 (412)
..|++|+|+.| ++|. +| . +.++++|+.||+|+|++++..|..
T Consensus 449 ~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~ 495 (606)
T 3t6q_A 449 PALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHA 495 (606)
T ss_dssp TTCCEEECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEECTTT
T ss_pred CCCCEEECCCCCCCccccccchhhccCCCccEEECCCCccCccChhh
Confidence 46889999999 7763 33 3 678999999999999999988863
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=93.98 E-value=0.033 Score=56.55 Aligned_cols=37 Identities=27% Similarity=0.364 Sum_probs=24.0
Q ss_pred eechhhccCCC-ceeeCCCCCCCCCCCEEeCccccccccCCC
Q 042435 3 VLLAFLSISAA-CSGVVEEEPSSPSFLKSDMSFNNLDGEIPT 43 (412)
Q Consensus 3 ~~~~~l~~~~~-~~G~ip~~~~~~~l~~~~ls~N~l~G~iP~ 43 (412)
..|++|||+.| ++| ||.+.+ +|+.||+|+|+|+| ||.
T Consensus 100 ~~L~~L~Ls~N~l~~-ip~l~~--~L~~L~Ls~N~l~~-lp~ 137 (571)
T 3cvr_A 100 ASLEYLDACDNRLST-LPELPA--SLKHLDVDNNQLTM-LPE 137 (571)
T ss_dssp TTCCEEECCSSCCSC-CCCCCT--TCCEEECCSSCCSC-CCC
T ss_pred CCCCEEEccCCCCCC-cchhhc--CCCEEECCCCcCCC-CCC
Confidence 34667777777 666 655433 67777777777766 665
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=93.96 E-value=0.023 Score=52.62 Aligned_cols=41 Identities=7% Similarity=-0.089 Sum_probs=27.7
Q ss_pred eechhhccCCC-ceeeCCC-----CCCCCCCCEEeCccccccccCCC
Q 042435 3 VLLAFLSISAA-CSGVVEE-----EPSSPSFLKSDMSFNNLDGEIPT 43 (412)
Q Consensus 3 ~~~~~l~~~~~-~~G~ip~-----~~~~~~l~~~~ls~N~l~G~iP~ 43 (412)
..|++|||+.| +++.+|. +..+++|+.|++|+|++++..|.
T Consensus 117 ~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~ 163 (310)
T 4glp_A 117 LALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCE 163 (310)
T ss_dssp BCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTT
T ss_pred CCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHH
Confidence 45777777777 7765552 23577777777777777666654
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=93.92 E-value=0.034 Score=56.42 Aligned_cols=36 Identities=19% Similarity=0.194 Sum_probs=31.5
Q ss_pred echhhccCCC-ceeeCCCCCCCCCCCEEeCccccccccCCC
Q 042435 4 LLAFLSISAA-CSGVVEEEPSSPSFLKSDMSFNNLDGEIPT 43 (412)
Q Consensus 4 ~~~~l~~~~~-~~G~ip~~~~~~~l~~~~ls~N~l~G~iP~ 43 (412)
.|++|||+.| ++ .|| ..+++|+.||+|+|+|+| ||.
T Consensus 81 ~L~~L~Ls~N~l~-~ip--~~l~~L~~L~Ls~N~l~~-ip~ 117 (571)
T 3cvr_A 81 QITVLEITQNALI-SLP--ELPASLEYLDACDNRLST-LPE 117 (571)
T ss_dssp TCSEEECCSSCCS-CCC--CCCTTCCEEECCSSCCSC-CCC
T ss_pred CCCEEECcCCCCc-ccc--cccCCCCEEEccCCCCCC-cch
Confidence 5889999999 77 688 567899999999999999 887
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=93.79 E-value=0.036 Score=51.03 Aligned_cols=42 Identities=17% Similarity=0.131 Sum_probs=35.4
Q ss_pred eechhhccCCC-cee-eCCC-CCCCCCCCEEeCccccccccCCCC
Q 042435 3 VLLAFLSISAA-CSG-VVEE-EPSSPSFLKSDMSFNNLDGEIPTY 44 (412)
Q Consensus 3 ~~~~~l~~~~~-~~G-~ip~-~~~~~~l~~~~ls~N~l~G~iP~~ 44 (412)
..|++|+|+.| +++ .+|. +.++++|+.||+|+|++++..|..
T Consensus 150 ~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~ 194 (306)
T 2z66_A 150 SSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTA 194 (306)
T ss_dssp TTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTT
T ss_pred cCCCEEECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHH
Confidence 46889999999 887 4566 789999999999999999987763
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=93.70 E-value=0.018 Score=57.40 Aligned_cols=39 Identities=23% Similarity=0.089 Sum_probs=21.7
Q ss_pred echhhccCCC-ceeeCCC-CCCCCCCCEEeCccccccccCCC
Q 042435 4 LLAFLSISAA-CSGVVEE-EPSSPSFLKSDMSFNNLDGEIPT 43 (412)
Q Consensus 4 ~~~~l~~~~~-~~G~ip~-~~~~~~l~~~~ls~N~l~G~iP~ 43 (412)
.|++|||+.| +++..|. +.++++|+.||+|+|+++ .||.
T Consensus 46 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~ 86 (520)
T 2z7x_B 46 KLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLV-KISC 86 (520)
T ss_dssp TCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSCCC-EEEC
T ss_pred cccEEecCCCccCCcChHHhhcccCCCEEecCCCcee-ecCc
Confidence 4555666666 5555543 555555666666655555 3553
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=93.64 E-value=0.032 Score=56.06 Aligned_cols=59 Identities=19% Similarity=0.095 Sum_probs=45.0
Q ss_pred eechhhccCCC-ceeeCCC-CCCCCCCCEEeCccccccccCCCCC--cCC-CCcccccCcCCCC
Q 042435 3 VLLAFLSISAA-CSGVVEE-EPSSPSFLKSDMSFNNLDGEIPTYL--RDN-PPKSFVGNKGLCG 61 (412)
Q Consensus 3 ~~~~~l~~~~~-~~G~ip~-~~~~~~l~~~~ls~N~l~G~iP~~~--~~~-~~~~~~gn~~lcg 61 (412)
..|++|||+.| +++.+|. +.++++|+.||+++|++++..|..+ +.+ ..-.+.+|+--|.
T Consensus 470 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~ 533 (570)
T 2z63_A 470 RNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCS 533 (570)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCC
T ss_pred cCCCEEECCCCccccCChhhhhcccCCCEEeCCCCcCCCCCHHHhhcccCCcEEEecCCcccCC
Confidence 46899999999 9999876 8899999999999999999877532 222 3344556765553
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=93.56 E-value=0.037 Score=51.66 Aligned_cols=40 Identities=10% Similarity=0.013 Sum_probs=26.2
Q ss_pred echhhccCCC-ceeeCCC-CCCCCCCCEEeCccccccccCCC
Q 042435 4 LLAFLSISAA-CSGVVEE-EPSSPSFLKSDMSFNNLDGEIPT 43 (412)
Q Consensus 4 ~~~~l~~~~~-~~G~ip~-~~~~~~l~~~~ls~N~l~G~iP~ 43 (412)
.|+.|+|+.| +++..|. +.++++|+.||+++|++++..|.
T Consensus 194 ~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~ 235 (332)
T 2ft3_A 194 TLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENG 235 (332)
T ss_dssp SCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTT
T ss_pred CCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChh
Confidence 4666777777 6666544 66677777777777777665553
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=93.44 E-value=0.0075 Score=51.99 Aligned_cols=39 Identities=13% Similarity=0.152 Sum_probs=31.5
Q ss_pred echhhccCCC-ceeeCCC-------CCCCCCCCEEeCccccccccCCC
Q 042435 4 LLAFLSISAA-CSGVVEE-------EPSSPSFLKSDMSFNNLDGEIPT 43 (412)
Q Consensus 4 ~~~~l~~~~~-~~G~ip~-------~~~~~~l~~~~ls~N~l~G~iP~ 43 (412)
.++.|+++.+ ++|.+|. +.++++|+.||+|+|++++ +|.
T Consensus 19 ~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~~ 65 (198)
T 1ds9_A 19 SVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-ISS 65 (198)
T ss_dssp CCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CCC
T ss_pred cccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-ccc
Confidence 4677888888 8898875 5567889999999999988 773
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=93.43 E-value=0.058 Score=52.77 Aligned_cols=40 Identities=5% Similarity=-0.065 Sum_probs=28.0
Q ss_pred echhhccCCC-ceeeCCC-CCCCCCCCEEeCccccccccCCC
Q 042435 4 LLAFLSISAA-CSGVVEE-EPSSPSFLKSDMSFNNLDGEIPT 43 (412)
Q Consensus 4 ~~~~l~~~~~-~~G~ip~-~~~~~~l~~~~ls~N~l~G~iP~ 43 (412)
.|++|||+.| +++..|. +.++++|+.||||+|++++..|.
T Consensus 76 ~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~ 117 (452)
T 3zyi_A 76 NTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVG 117 (452)
T ss_dssp TCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTT
T ss_pred CccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChh
Confidence 4667777777 7776655 67777777777777777766554
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=93.41 E-value=0.048 Score=52.14 Aligned_cols=41 Identities=15% Similarity=0.102 Sum_probs=32.0
Q ss_pred eechhhccCCC-ceeeCCC-CCCCCCCCEEeCccccccccCCC
Q 042435 3 VLLAFLSISAA-CSGVVEE-EPSSPSFLKSDMSFNNLDGEIPT 43 (412)
Q Consensus 3 ~~~~~l~~~~~-~~G~ip~-~~~~~~l~~~~ls~N~l~G~iP~ 43 (412)
..|++|+|+.| +++..|. +.++++|+.||+++|++++..|.
T Consensus 69 ~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~ 111 (390)
T 3o6n_A 69 RQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPH 111 (390)
T ss_dssp CCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTT
T ss_pred ccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHH
Confidence 35788888888 7777664 77888888888888888876665
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=93.38 E-value=0.034 Score=55.72 Aligned_cols=38 Identities=21% Similarity=0.136 Sum_probs=17.8
Q ss_pred chhhccCCC-ceeeCCC-CCCCCCCCEEeCccccccccCC
Q 042435 5 LAFLSISAA-CSGVVEE-EPSSPSFLKSDMSFNNLDGEIP 42 (412)
Q Consensus 5 ~~~l~~~~~-~~G~ip~-~~~~~~l~~~~ls~N~l~G~iP 42 (412)
|++|||+.| +++..|. +.++++|+.||+|+|++++..|
T Consensus 52 L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~ 91 (549)
T 2z81_A 52 LQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSS 91 (549)
T ss_dssp CCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCH
T ss_pred ccEEECCCCCcCccChhhccccccCCEEECCCCccCccCH
Confidence 444444444 4444433 4444445555555555444433
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=93.35 E-value=0.059 Score=52.49 Aligned_cols=40 Identities=18% Similarity=0.161 Sum_probs=31.7
Q ss_pred eechhhccCCC-ceeeCCCCCCCCCCCEEeCccccccccCCC
Q 042435 3 VLLAFLSISAA-CSGVVEEEPSSPSFLKSDMSFNNLDGEIPT 43 (412)
Q Consensus 3 ~~~~~l~~~~~-~~G~ip~~~~~~~l~~~~ls~N~l~G~iP~ 43 (412)
..|++|+|+.| ++ .+|.+.++++|+.||+|+|++++..|.
T Consensus 185 ~~L~~L~L~~n~l~-~~~~~~~l~~L~~L~Ls~N~l~~~~~~ 225 (440)
T 3zyj_A 185 SNLRYLNLAMCNLR-EIPNLTPLIKLDELDLSGNHLSAIRPG 225 (440)
T ss_dssp SSCCEEECTTSCCS-SCCCCTTCSSCCEEECTTSCCCEECTT
T ss_pred cccCeecCCCCcCc-cccccCCCcccCEEECCCCccCccChh
Confidence 46788888888 65 667788888888888888888887775
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=93.31 E-value=0.032 Score=50.46 Aligned_cols=36 Identities=6% Similarity=-0.039 Sum_probs=20.5
Q ss_pred echhhccCCC-ceeeCCCCCCCCCCCEEeCcccccccc
Q 042435 4 LLAFLSISAA-CSGVVEEEPSSPSFLKSDMSFNNLDGE 40 (412)
Q Consensus 4 ~~~~l~~~~~-~~G~ip~~~~~~~l~~~~ls~N~l~G~ 40 (412)
.|++|+|+.| ++ .+|.+..+++|+.|++|+|++++-
T Consensus 42 ~L~~L~l~~n~i~-~l~~l~~l~~L~~L~L~~N~i~~~ 78 (263)
T 1xeu_A 42 GVQNFNGDNSNIQ-SLAGMQFFTNLKELHLSHNQISDL 78 (263)
T ss_dssp TCSEEECTTSCCC-CCTTGGGCTTCCEEECCSSCCCCC
T ss_pred cCcEEECcCCCcc-cchHHhhCCCCCEEECCCCccCCC
Confidence 3556666666 43 345555566666666666666553
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=93.30 E-value=0.049 Score=49.31 Aligned_cols=40 Identities=15% Similarity=-0.056 Sum_probs=32.2
Q ss_pred echhhccCCC-ceeeCC-CCCCCCCCCEEeCccccccccCCC
Q 042435 4 LLAFLSISAA-CSGVVE-EEPSSPSFLKSDMSFNNLDGEIPT 43 (412)
Q Consensus 4 ~~~~l~~~~~-~~G~ip-~~~~~~~l~~~~ls~N~l~G~iP~ 43 (412)
.|++|||+.| +++..| .+.++++|+.||+|+|++++-.|.
T Consensus 29 ~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~ 70 (276)
T 2z62_A 29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDG 70 (276)
T ss_dssp TCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTT
T ss_pred CccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHH
Confidence 4788999998 888776 478888999999999998875553
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=93.27 E-value=0.064 Score=54.60 Aligned_cols=41 Identities=15% Similarity=0.102 Sum_probs=30.1
Q ss_pred eechhhccCCC-ceeeCCC-CCCCCCCCEEeCccccccccCCC
Q 042435 3 VLLAFLSISAA-CSGVVEE-EPSSPSFLKSDMSFNNLDGEIPT 43 (412)
Q Consensus 3 ~~~~~l~~~~~-~~G~ip~-~~~~~~l~~~~ls~N~l~G~iP~ 43 (412)
..|++|||+.| +++..|. +.++++|+.||||+|.+++..|.
T Consensus 75 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~ 117 (597)
T 3oja_B 75 RQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPH 117 (597)
T ss_dssp CCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTT
T ss_pred CCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHH
Confidence 35777888888 7777763 77778888888888888775554
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=93.18 E-value=0.035 Score=50.25 Aligned_cols=34 Identities=21% Similarity=0.202 Sum_probs=20.1
Q ss_pred echhhccCCC-ceeeCCCCCCCCCCCEEeCccccccc
Q 042435 4 LLAFLSISAA-CSGVVEEEPSSPSFLKSDMSFNNLDG 39 (412)
Q Consensus 4 ~~~~l~~~~~-~~G~ip~~~~~~~l~~~~ls~N~l~G 39 (412)
.|++|+|+.| +++ +|.+.. ++|+.|++|+|++++
T Consensus 86 ~L~~L~L~~N~l~~-l~~~~~-~~L~~L~L~~N~l~~ 120 (263)
T 1xeu_A 86 KLEELSVNRNRLKN-LNGIPS-ACLSRLFLDNNELRD 120 (263)
T ss_dssp SCCEEECCSSCCSC-CTTCCC-SSCCEEECCSSCCSB
T ss_pred CCCEEECCCCccCC-cCcccc-CcccEEEccCCccCC
Confidence 4666666666 554 444433 566666666666655
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=93.17 E-value=0.048 Score=49.35 Aligned_cols=53 Identities=15% Similarity=0.058 Sum_probs=36.5
Q ss_pred hhccCCC-ceeeCCCCCCCCCCCEEeCccccccccCCCCCcCC----CCcccccCcCCC
Q 042435 7 FLSISAA-CSGVVEEEPSSPSFLKSDMSFNNLDGEIPTYLRDN----PPKSFVGNKGLC 60 (412)
Q Consensus 7 ~l~~~~~-~~G~ip~~~~~~~l~~~~ls~N~l~G~iP~~~~~~----~~~~~~gn~~lc 60 (412)
+|||+.| +++..|......+|+.||+++|++++- |...+.. ..-.+.+|+--|
T Consensus 181 ~L~ls~n~l~~~~~~~~~~~~L~~L~L~~n~l~~~-~~~~~~~l~~L~~L~l~~N~~~c 238 (276)
T 2z62_A 181 SLDLSLNPMNFIQPGAFKEIRLKELALDTNQLKSV-PDGIFDRLTSLQKIWLHTNPWDC 238 (276)
T ss_dssp EEECCSSCCCEECTTSSCSCCEEEEECCSSCCSCC-CTTTTTTCCSCCEEECCSSCBCC
T ss_pred eeecCCCcccccCccccCCCcccEEECCCCceeec-CHhHhcccccccEEEccCCcccc
Confidence 7889999 887777755556899999999999864 4433332 334455676655
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=93.15 E-value=0.016 Score=54.38 Aligned_cols=40 Identities=15% Similarity=0.086 Sum_probs=31.9
Q ss_pred eechhhccCCC-ceeeCCCCCCCCCCCEEeCccccccccCCC
Q 042435 3 VLLAFLSISAA-CSGVVEEEPSSPSFLKSDMSFNNLDGEIPT 43 (412)
Q Consensus 3 ~~~~~l~~~~~-~~G~ip~~~~~~~l~~~~ls~N~l~G~iP~ 43 (412)
..|++|+|+.| +++ +|.+..+++|+.|++++|.+++..|.
T Consensus 265 ~~L~~L~l~~n~l~~-~~~~~~l~~L~~L~L~~n~l~~~~~~ 305 (347)
T 4fmz_A 265 TKLKMLNVGSNQISD-ISVLNNLSQLNSLFLNNNQLGNEDME 305 (347)
T ss_dssp TTCCEEECCSSCCCC-CGGGGGCTTCSEEECCSSCCCGGGHH
T ss_pred CCcCEEEccCCccCC-ChhhcCCCCCCEEECcCCcCCCcChh
Confidence 35788889888 666 46677888899999999988887775
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=93.12 E-value=0.032 Score=57.11 Aligned_cols=38 Identities=11% Similarity=0.110 Sum_probs=23.8
Q ss_pred echhhccCCC-ceeeCCCCCCCCCCCEEeCccccccccCC
Q 042435 4 LLAFLSISAA-CSGVVEEEPSSPSFLKSDMSFNNLDGEIP 42 (412)
Q Consensus 4 ~~~~l~~~~~-~~G~ip~~~~~~~l~~~~ls~N~l~G~iP 42 (412)
.|+.|+|+.| +++. +.+.++++|+.||||+|.|++..|
T Consensus 132 ~L~~L~Ls~N~l~~l-~~l~~l~~L~~L~Ls~N~l~~~~~ 170 (605)
T 1m9s_A 132 QLESLYLGNNKITDI-TVLSRLTKLDTLSLEDNQISDIVP 170 (605)
T ss_dssp TCSEEECCSSCCCCC-GGGGSCTTCSEEECCSSCCCCCGG
T ss_pred ccCEEECCCCccCCc-hhhcccCCCCEEECcCCcCCCchh
Confidence 4666666666 5553 456666666666666666666554
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=93.10 E-value=0.018 Score=53.59 Aligned_cols=39 Identities=15% Similarity=0.043 Sum_probs=32.9
Q ss_pred echhhccCCC-ceeeCCC-CCCCCCCCEEeCccccccccCC
Q 042435 4 LLAFLSISAA-CSGVVEE-EPSSPSFLKSDMSFNNLDGEIP 42 (412)
Q Consensus 4 ~~~~l~~~~~-~~G~ip~-~~~~~~l~~~~ls~N~l~G~iP 42 (412)
.|++|||+.| +++..|. +.++++|+.||+|+|++++..|
T Consensus 35 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~ 75 (317)
T 3o53_A 35 NVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD 75 (317)
T ss_dssp GCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE
T ss_pred CCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh
Confidence 5888999999 8887765 7888999999999999988766
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=93.09 E-value=0.033 Score=50.66 Aligned_cols=40 Identities=13% Similarity=0.041 Sum_probs=32.8
Q ss_pred eechhhccCCC-ceee--CCCCCCCCCCCEEeCccccccccCCC
Q 042435 3 VLLAFLSISAA-CSGV--VEEEPSSPSFLKSDMSFNNLDGEIPT 43 (412)
Q Consensus 3 ~~~~~l~~~~~-~~G~--ip~~~~~~~l~~~~ls~N~l~G~iP~ 43 (412)
..|++||||.| +++. +..+..+ +|+.|+|++|.+++.+|.
T Consensus 196 ~~L~~L~Ls~N~i~~~~~l~~l~~l-~L~~L~L~~Npl~~~~~~ 238 (267)
T 3rw6_A 196 PNLKILNLSGNELKSERELDKIKGL-KLEELWLDGNSLCDTFRD 238 (267)
T ss_dssp TTCCEEECTTSCCCSGGGGGGGTTS-CCSEEECTTSTTGGGCSS
T ss_pred CCCCEEECCCCccCCchhhhhcccC-CcceEEccCCcCccccCc
Confidence 46899999999 8774 3335455 999999999999999995
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=93.04 E-value=0.074 Score=49.51 Aligned_cols=42 Identities=19% Similarity=0.121 Sum_probs=28.9
Q ss_pred eechhhccCCC-ceeeCCC-CCCCCCCCEEeCccccccccCCCCC
Q 042435 3 VLLAFLSISAA-CSGVVEE-EPSSPSFLKSDMSFNNLDGEIPTYL 45 (412)
Q Consensus 3 ~~~~~l~~~~~-~~G~ip~-~~~~~~l~~~~ls~N~l~G~iP~~~ 45 (412)
..|++|+|+.| +++..|. +.++++|+.||+|+|+++ .+|...
T Consensus 76 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~ 119 (330)
T 1xku_A 76 KNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-ELPEKM 119 (330)
T ss_dssp TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCS-BCCSSC
T ss_pred CCCCEEECCCCcCCeeCHHHhcCCCCCCEEECCCCcCC-ccChhh
Confidence 34677777777 7766655 677777777777777776 566543
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=92.72 E-value=0.066 Score=48.34 Aligned_cols=41 Identities=12% Similarity=0.012 Sum_probs=33.6
Q ss_pred eechhhccCCC-ceeeCCC-CCCCCCCCEEeCccccccccCCC
Q 042435 3 VLLAFLSISAA-CSGVVEE-EPSSPSFLKSDMSFNNLDGEIPT 43 (412)
Q Consensus 3 ~~~~~l~~~~~-~~G~ip~-~~~~~~l~~~~ls~N~l~G~iP~ 43 (412)
..|++|+|+.| +++..+. +.++++|+.|++++|++++..|.
T Consensus 85 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~ 127 (270)
T 2o6q_A 85 KNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPR 127 (270)
T ss_dssp TTCCEEECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTT
T ss_pred CCCCEEECCCCcCCcCCHhHcccccCCCEEECCCCccCeeCHH
Confidence 46889999999 7766655 67899999999999999886664
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=92.61 E-value=0.024 Score=58.12 Aligned_cols=38 Identities=18% Similarity=0.023 Sum_probs=18.0
Q ss_pred chhhccCCC-ceeeCCC-CCCCCCCCEEeCccccccccCCC
Q 042435 5 LAFLSISAA-CSGVVEE-EPSSPSFLKSDMSFNNLDGEIPT 43 (412)
Q Consensus 5 ~~~l~~~~~-~~G~ip~-~~~~~~l~~~~ls~N~l~G~iP~ 43 (412)
|++|+|+.| ++ .||. +.++++|..|||++|.|+|.+|.
T Consensus 263 L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L~~N~l~~~~~~ 302 (622)
T 3g06_A 263 LLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQ 302 (622)
T ss_dssp CCEEECCSSCCC-SCCGGGGGSCTTCEEECCSCCCCHHHHH
T ss_pred CcEEeCCCCCCC-cCCHHHhhccccCEEEecCCCCCCcCHH
Confidence 444444444 44 3333 44445555555555555554443
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=92.47 E-value=0.03 Score=49.56 Aligned_cols=40 Identities=10% Similarity=-0.037 Sum_probs=29.5
Q ss_pred eechhhccCCC-ceeeC-CC-CCCCCCCCEEeCcc-ccccccCC
Q 042435 3 VLLAFLSISAA-CSGVV-EE-EPSSPSFLKSDMSF-NNLDGEIP 42 (412)
Q Consensus 3 ~~~~~l~~~~~-~~G~i-p~-~~~~~~l~~~~ls~-N~l~G~iP 42 (412)
..|++|+|+.| .-+.| |. +.++++|+.|++++ |++++--|
T Consensus 55 ~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~ 98 (239)
T 2xwt_C 55 PNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDP 98 (239)
T ss_dssp TTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECT
T ss_pred CCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCH
Confidence 45788999988 34445 43 67888999999998 88886444
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=92.47 E-value=0.066 Score=50.41 Aligned_cols=40 Identities=8% Similarity=0.028 Sum_probs=31.2
Q ss_pred echhhccCCC-ceeeCC-CCCCCCCCCEEeCccccccccCCC
Q 042435 4 LLAFLSISAA-CSGVVE-EEPSSPSFLKSDMSFNNLDGEIPT 43 (412)
Q Consensus 4 ~~~~l~~~~~-~~G~ip-~~~~~~~l~~~~ls~N~l~G~iP~ 43 (412)
.|++|||+.| +++..+ .+.++++|+.||+++|++++..|.
T Consensus 53 ~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~ 94 (353)
T 2z80_A 53 AVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEED 94 (353)
T ss_dssp TCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTT
T ss_pred cCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHh
Confidence 4778888888 777665 377888888888888888876664
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=92.23 E-value=0.085 Score=49.71 Aligned_cols=44 Identities=18% Similarity=0.185 Sum_probs=27.2
Q ss_pred echhhccCCC-ceeeCCC--CCCCCCCCEEeCccccccccCCCCCcCC
Q 042435 4 LLAFLSISAA-CSGVVEE--EPSSPSFLKSDMSFNNLDGEIPTYLRDN 48 (412)
Q Consensus 4 ~~~~l~~~~~-~~G~ip~--~~~~~~l~~~~ls~N~l~G~iP~~~~~~ 48 (412)
.|+.|+++.+ .-+.||+ +.++++|+.||+|+|+|+ .||...+.+
T Consensus 178 ~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~-~lp~~~~~~ 224 (350)
T 4ay9_X 178 QLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIH-SLPSYGLEN 224 (350)
T ss_dssp EEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCC-CCCSSSCTT
T ss_pred chhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcC-ccChhhhcc
Confidence 4566666653 5556654 567777777777777776 456543433
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=92.18 E-value=0.088 Score=54.27 Aligned_cols=41 Identities=15% Similarity=0.160 Sum_probs=34.8
Q ss_pred echhhccCCC-ceeeCCC-CCCCCCCCEEeCccccccccCCCC
Q 042435 4 LLAFLSISAA-CSGVVEE-EPSSPSFLKSDMSFNNLDGEIPTY 44 (412)
Q Consensus 4 ~~~~l~~~~~-~~G~ip~-~~~~~~l~~~~ls~N~l~G~iP~~ 44 (412)
.|+.|+|+.| +++..|. +.++++|+.||+|+|.++|.+|..
T Consensus 382 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~ 424 (680)
T 1ziw_A 382 PLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQ 424 (680)
T ss_dssp CCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCEEECCSG
T ss_pred cCceEECCCCCCCeEChhhhhCCCCCCEEeCCCCcCccccCcc
Confidence 5778888888 8888876 788999999999999999998863
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=91.93 E-value=0.086 Score=51.83 Aligned_cols=36 Identities=22% Similarity=0.164 Sum_probs=22.7
Q ss_pred echhhccCCC-ceeeCCCCCCCCCCCEEeCccccccccCC
Q 042435 4 LLAFLSISAA-CSGVVEEEPSSPSFLKSDMSFNNLDGEIP 42 (412)
Q Consensus 4 ~~~~l~~~~~-~~G~ip~~~~~~~l~~~~ls~N~l~G~iP 42 (412)
.|+.|+|+.| +++. ++.++++|+.||+|+|+|+| +|
T Consensus 192 ~L~~L~l~~N~l~~~--~l~~l~~L~~L~Ls~N~l~~-ip 228 (457)
T 3bz5_A 192 LLNRLNCDTNNITKL--DLNQNIQLTFLDCSSNKLTE-ID 228 (457)
T ss_dssp TCCEEECCSSCCSCC--CCTTCTTCSEEECCSSCCSC-CC
T ss_pred CCCEEECcCCcCCee--ccccCCCCCEEECcCCcccc-cC
Confidence 4566666666 5553 35566666666666666666 55
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=91.93 E-value=0.13 Score=48.44 Aligned_cols=40 Identities=25% Similarity=0.317 Sum_probs=32.7
Q ss_pred eechhhccCCC-ceeeCCC-CCCCCCCCEEeCccccccccCCC
Q 042435 3 VLLAFLSISAA-CSGVVEE-EPSSPSFLKSDMSFNNLDGEIPT 43 (412)
Q Consensus 3 ~~~~~l~~~~~-~~G~ip~-~~~~~~l~~~~ls~N~l~G~iP~ 43 (412)
..|++|+|+.| +++..|. +.++++|+.||+|+|++++ +|.
T Consensus 76 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~-~~~ 117 (353)
T 2z80_A 76 VNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSN-LSS 117 (353)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSS-CCH
T ss_pred CCCCEEECCCCccCccCHhhcCCCCCCCEEECCCCcCCc-CCH
Confidence 45888999999 8887766 7888999999999999985 554
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=91.87 E-value=0.097 Score=51.41 Aligned_cols=40 Identities=13% Similarity=0.135 Sum_probs=29.6
Q ss_pred echhhccCCC-ceeeCCC-CCCCCCCCEEeCccccccccCCC
Q 042435 4 LLAFLSISAA-CSGVVEE-EPSSPSFLKSDMSFNNLDGEIPT 43 (412)
Q Consensus 4 ~~~~l~~~~~-~~G~ip~-~~~~~~l~~~~ls~N~l~G~iP~ 43 (412)
.|++|||+.| +++..|. +.++++|+.|||++|++++..|.
T Consensus 33 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~ 74 (477)
T 2id5_A 33 ETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPG 74 (477)
T ss_dssp TCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTT
T ss_pred CCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChh
Confidence 4677788887 7777655 67777788888888877777665
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=91.80 E-value=0.033 Score=47.80 Aligned_cols=39 Identities=10% Similarity=0.083 Sum_probs=34.2
Q ss_pred eechhhccCCC-ceeeCCCCCCCCCCCEEeCccccccccCCC
Q 042435 3 VLLAFLSISAA-CSGVVEEEPSSPSFLKSDMSFNNLDGEIPT 43 (412)
Q Consensus 3 ~~~~~l~~~~~-~~G~ip~~~~~~~l~~~~ls~N~l~G~iP~ 43 (412)
..|++|+|+.| +++ +|.+.++++|+.||+++|+++ .+|.
T Consensus 48 ~~L~~L~ls~n~l~~-l~~~~~l~~L~~L~l~~n~l~-~l~~ 87 (198)
T 1ds9_A 48 KACKHLALSTNNIEK-ISSLSGMENLRILSLGRNLIK-KIEN 87 (198)
T ss_dssp TTCSEEECSEEEESC-CCCHHHHTTCCEEEEEEEEEC-SCSS
T ss_pred CCCCEEECCCCCCcc-ccccccCCCCCEEECCCCCcc-cccc
Confidence 46899999999 877 788888999999999999998 6886
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=91.76 E-value=0.066 Score=52.63 Aligned_cols=40 Identities=13% Similarity=0.096 Sum_probs=21.2
Q ss_pred echhhccCCC-ceeeCCC-CCCCC-------CCCEEeCccccccccCCC
Q 042435 4 LLAFLSISAA-CSGVVEE-EPSSP-------SFLKSDMSFNNLDGEIPT 43 (412)
Q Consensus 4 ~~~~l~~~~~-~~G~ip~-~~~~~-------~l~~~~ls~N~l~G~iP~ 43 (412)
.|++|+|+.| ++|..+. +.++. +|+.+|+|+|.+.|++|.
T Consensus 234 ~L~~L~l~~N~l~~~~~~~l~~L~~L~l~~n~L~~L~l~~n~~~~~~~~ 282 (457)
T 3bz5_A 234 QLTYFDCSVNPLTELDVSTLSKLTTLHCIQTDLLEIDLTHNTQLIYFQA 282 (457)
T ss_dssp TCSEEECCSSCCSCCCCTTCTTCCEEECTTCCCSCCCCTTCTTCCEEEC
T ss_pred CCCEEEeeCCcCCCcCHHHCCCCCEEeccCCCCCEEECCCCccCCcccc
Confidence 4566666666 6554332 33333 445555555555555553
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=91.69 E-value=0.1 Score=50.62 Aligned_cols=78 Identities=10% Similarity=-0.012 Sum_probs=47.2
Q ss_pred CCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCCCCccccc--ccccccccccccCc---ccCcccccHHHHHHHHH
Q 042435 242 TPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQA--GTYGYIALELVYTM---VVTEKCVIYSFGVVALE 316 (412)
Q Consensus 242 ~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~--gt~~y~aPE~~~~~---~~s~ksDv~S~Gvil~e 316 (412)
.+.++|+|++|.||+++.+. ++++||+.+..-..... ..... -...|.+|+..... ......++.+....+|+
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~D-la~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFD-IGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWN 308 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHH-HHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHH-HHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHH
Confidence 45899999999999998776 99999998874321100 00000 11345666544311 11223455677778888
Q ss_pred HHhCC
Q 042435 317 VLMGT 321 (412)
Q Consensus 317 lltg~ 321 (412)
.++++
T Consensus 309 ~y~~~ 313 (420)
T 2pyw_A 309 LFNKR 313 (420)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 77653
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=91.59 E-value=0.067 Score=49.08 Aligned_cols=39 Identities=10% Similarity=0.092 Sum_probs=30.4
Q ss_pred eechhhccCCC-ceeeCCCCCCCCCCCEEeCccccccccCC
Q 042435 3 VLLAFLSISAA-CSGVVEEEPSSPSFLKSDMSFNNLDGEIP 42 (412)
Q Consensus 3 ~~~~~l~~~~~-~~G~ip~~~~~~~l~~~~ls~N~l~G~iP 42 (412)
..|++|+|+.| +++. +.+.++++|+.||+|+|.+++..|
T Consensus 134 ~~L~~L~l~~n~l~~~-~~l~~l~~L~~L~L~~N~l~~~~~ 173 (291)
T 1h6t_A 134 PQLESLYLGNNKITDI-TVLSRLTKLDTLSLEDNQISDIVP 173 (291)
T ss_dssp TTCCEEECCSSCCCCC-GGGGGCTTCSEEECCSSCCCCCGG
T ss_pred CCCCEEEccCCcCCcc-hhhccCCCCCEEEccCCccccchh
Confidence 35788888888 6664 667788888888888888887655
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=91.42 E-value=0.13 Score=49.12 Aligned_cols=39 Identities=13% Similarity=0.096 Sum_probs=21.5
Q ss_pred echhhccCCC-ceeeCCC-CCCCCCCCEEeCccccccccCCC
Q 042435 4 LLAFLSISAA-CSGVVEE-EPSSPSFLKSDMSFNNLDGEIPT 43 (412)
Q Consensus 4 ~~~~l~~~~~-~~G~ip~-~~~~~~l~~~~ls~N~l~G~iP~ 43 (412)
.|++|+|+.| +++..|. +.++++|+.||+++|+++ .+|.
T Consensus 94 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~ 134 (390)
T 3o6n_A 94 TIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPR 134 (390)
T ss_dssp TCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-CCCT
T ss_pred CcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccC-cCCH
Confidence 3555666655 5555444 455556666666666555 3443
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=91.40 E-value=0.069 Score=54.55 Aligned_cols=37 Identities=16% Similarity=0.090 Sum_probs=25.4
Q ss_pred eechhhccCCC-ceeeCCCCCCCCCCCEEeCcccccccc
Q 042435 3 VLLAFLSISAA-CSGVVEEEPSSPSFLKSDMSFNNLDGE 40 (412)
Q Consensus 3 ~~~~~l~~~~~-~~G~ip~~~~~~~l~~~~ls~N~l~G~ 40 (412)
..|+.|+|+.| +++ +|.+.++++|+.|+||+|+|++.
T Consensus 109 ~~L~~L~Ls~N~l~~-l~~l~~l~~L~~L~Ls~N~l~~l 146 (605)
T 1m9s_A 109 KKLKSLSLEHNGISD-INGLVHLPQLESLYLGNNKITDI 146 (605)
T ss_dssp TTCCEEECTTSCCCC-CGGGGGCTTCSEEECCSSCCCCC
T ss_pred CCCCEEEecCCCCCC-CccccCCCccCEEECCCCccCCc
Confidence 35677777777 554 45566777777777777777764
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=91.22 E-value=0.071 Score=48.90 Aligned_cols=37 Identities=16% Similarity=0.090 Sum_probs=32.2
Q ss_pred eechhhccCCC-ceeeCCCCCCCCCCCEEeCcccccccc
Q 042435 3 VLLAFLSISAA-CSGVVEEEPSSPSFLKSDMSFNNLDGE 40 (412)
Q Consensus 3 ~~~~~l~~~~~-~~G~ip~~~~~~~l~~~~ls~N~l~G~ 40 (412)
..|++|+|+.| +++ +|.+.++++|+.|++|+|++++.
T Consensus 112 ~~L~~L~L~~n~i~~-~~~l~~l~~L~~L~l~~n~l~~~ 149 (291)
T 1h6t_A 112 KKLKSLSLEHNGISD-INGLVHLPQLESLYLGNNKITDI 149 (291)
T ss_dssp TTCCEEECTTSCCCC-CGGGGGCTTCCEEECCSSCCCCC
T ss_pred CCCCEEECCCCcCCC-ChhhcCCCCCCEEEccCCcCCcc
Confidence 46899999999 776 57788899999999999999885
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=90.68 E-value=0.083 Score=48.86 Aligned_cols=36 Identities=14% Similarity=0.136 Sum_probs=29.3
Q ss_pred eechhhccCCC-ceeeCCCCCCCCCCCEEeCccccccc
Q 042435 3 VLLAFLSISAA-CSGVVEEEPSSPSFLKSDMSFNNLDG 39 (412)
Q Consensus 3 ~~~~~l~~~~~-~~G~ip~~~~~~~l~~~~ls~N~l~G 39 (412)
..|++|+|+.| +++ +|.+.++++|+.||+|+|++++
T Consensus 85 ~~L~~L~L~~n~l~~-~~~~~~l~~L~~L~l~~n~l~~ 121 (308)
T 1h6u_A 85 TKITELELSGNPLKN-VSAIAGLQSIKTLDLTSTQITD 121 (308)
T ss_dssp CSCCEEECCSCCCSC-CGGGTTCTTCCEEECTTSCCCC
T ss_pred CCCCEEEccCCcCCC-chhhcCCCCCCEEECCCCCCCC
Confidence 46888899988 665 5677888888889999988887
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=90.46 E-value=0.033 Score=51.88 Aligned_cols=40 Identities=10% Similarity=-0.003 Sum_probs=32.9
Q ss_pred echhhccCCC-ceeeCCCCCCCCCCCEEeCcccccccc-CCC
Q 042435 4 LLAFLSISAA-CSGVVEEEPSSPSFLKSDMSFNNLDGE-IPT 43 (412)
Q Consensus 4 ~~~~l~~~~~-~~G~ip~~~~~~~l~~~~ls~N~l~G~-iP~ 43 (412)
.|+.|+++.| ++|.+|.+.++++|+.||+|+|++++. +|.
T Consensus 71 ~l~~L~l~~n~l~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~ 112 (336)
T 2ast_B 71 GVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHG 112 (336)
T ss_dssp TCSEEECTTCEECSCCCSCCCCBCCCEEECTTCEECHHHHHH
T ss_pred cceEEEcCCccccccchhhccCCCCCEEEccCCCcCHHHHHH
Confidence 4778888888 888887777888899999999988876 664
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=90.43 E-value=0.087 Score=51.73 Aligned_cols=36 Identities=14% Similarity=0.098 Sum_probs=23.4
Q ss_pred echhhccCCC-ceeeCCCCCCCCCCCEEeCcccccccc
Q 042435 4 LLAFLSISAA-CSGVVEEEPSSPSFLKSDMSFNNLDGE 40 (412)
Q Consensus 4 ~~~~l~~~~~-~~G~ip~~~~~~~l~~~~ls~N~l~G~ 40 (412)
.|+.|+|+.| ++|..| +..+++|+.|++++|.++|.
T Consensus 310 ~L~~L~L~~n~l~~~~~-~~~l~~L~~L~l~~n~l~~~ 346 (466)
T 1o6v_A 310 NLTYLTLYFNNISDISP-VSSLTKLQRLFFYNNKVSDV 346 (466)
T ss_dssp TCSEEECCSSCCSCCGG-GGGCTTCCEEECCSSCCCCC
T ss_pred CCCEEECcCCcCCCchh-hccCccCCEeECCCCccCCc
Confidence 4667777777 666554 55666666666666666664
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=90.32 E-value=0.28 Score=45.66 Aligned_cols=32 Identities=31% Similarity=0.432 Sum_probs=27.5
Q ss_pred CCCcEEeCCCCCCEEecCC----CcEEEeecCCccc
Q 042435 242 TPSIVHRDISSNNILLNSN----LEAFVADFGTVRL 273 (412)
Q Consensus 242 ~~~ivHrDlkp~NILl~~~----~~~kl~DfGla~~ 273 (412)
...++|+|+.+.||+++.+ ..+.|+||+.+..
T Consensus 182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 4579999999999999874 6789999998864
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=90.01 E-value=0.18 Score=51.66 Aligned_cols=32 Identities=19% Similarity=0.049 Sum_probs=16.8
Q ss_pred echhhccCCC-ceeeCCCCCCCCCCCEEeCcccccc
Q 042435 4 LLAFLSISAA-CSGVVEEEPSSPSFLKSDMSFNNLD 38 (412)
Q Consensus 4 ~~~~l~~~~~-~~G~ip~~~~~~~l~~~~ls~N~l~ 38 (412)
.|++|+|+.| +++ || ..+++|..||+|+|+|+
T Consensus 222 ~L~~L~Ls~N~L~~-lp--~~l~~L~~L~Ls~N~L~ 254 (622)
T 3g06_A 222 GLKELIVSGNRLTS-LP--VLPSELKELMVSGNRLT 254 (622)
T ss_dssp TCCEEECCSSCCSC-CC--CCCTTCCEEECCSSCCS
T ss_pred CCCEEEccCCccCc-CC--CCCCcCcEEECCCCCCC
Confidence 3555666666 554 44 23345555555555555
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=89.78 E-value=0.13 Score=47.45 Aligned_cols=36 Identities=6% Similarity=0.035 Sum_probs=23.1
Q ss_pred eechhhccCCC-ceeeCCCCCCCCCCCEEeCccccccc
Q 042435 3 VLLAFLSISAA-CSGVVEEEPSSPSFLKSDMSFNNLDG 39 (412)
Q Consensus 3 ~~~~~l~~~~~-~~G~ip~~~~~~~l~~~~ls~N~l~G 39 (412)
..|++|+|+.| +++. |.+.++++|+.|++|+|++++
T Consensus 129 ~~L~~L~l~~n~l~~~-~~l~~l~~L~~L~l~~n~l~~ 165 (308)
T 1h6u_A 129 SNLQVLYLDLNQITNI-SPLAGLTNLQYLSIGNAQVSD 165 (308)
T ss_dssp TTCCEEECCSSCCCCC-GGGGGCTTCCEEECCSSCCCC
T ss_pred CCCCEEECCCCccCcC-ccccCCCCccEEEccCCcCCC
Confidence 34667777777 5543 336666777777777777765
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=89.40 E-value=0.12 Score=50.79 Aligned_cols=38 Identities=18% Similarity=0.216 Sum_probs=24.3
Q ss_pred echhhccCCC-ceeeCCCCCCCCCCCEEeCccccccccCC
Q 042435 4 LLAFLSISAA-CSGVVEEEPSSPSFLKSDMSFNNLDGEIP 42 (412)
Q Consensus 4 ~~~~l~~~~~-~~G~ip~~~~~~~l~~~~ls~N~l~G~iP 42 (412)
.|+.|+|+.| +++..| +..+++|+.|++++|++++..|
T Consensus 266 ~L~~L~l~~n~l~~~~~-~~~l~~L~~L~L~~n~l~~~~~ 304 (466)
T 1o6v_A 266 KLTELKLGANQISNISP-LAGLTALTNLELNENQLEDISP 304 (466)
T ss_dssp TCSEEECCSSCCCCCGG-GTTCTTCSEEECCSSCCSCCGG
T ss_pred CCCEEECCCCccCcccc-ccCCCccCeEEcCCCcccCchh
Confidence 4667777777 665433 6666677777777777766443
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=89.25 E-value=0.15 Score=40.67 Aligned_cols=51 Identities=20% Similarity=0.243 Sum_probs=33.8
Q ss_pred hhccCCC-ce-eeCCC-CCCCCCCCEEeCccccccccCCCCCcCC-C---CcccccCcCCC
Q 042435 7 FLSISAA-CS-GVVEE-EPSSPSFLKSDMSFNNLDGEIPTYLRDN-P---PKSFVGNKGLC 60 (412)
Q Consensus 7 ~l~~~~~-~~-G~ip~-~~~~~~l~~~~ls~N~l~G~iP~~~~~~-~---~~~~~gn~~lc 60 (412)
.+|.|.+ ++ -.||. +. ++|+.||||+|+|+. ||...|.. + ...+.+|+-.|
T Consensus 12 ~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~-l~~~~f~~l~~L~~L~L~~NP~~C 69 (130)
T 3rfe_A 12 LVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTA-LPPGLLDALPALRTAHLGANPWRC 69 (130)
T ss_dssp EEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSS-CCTTTGGGCTTCCEEECCSSCCBC
T ss_pred EEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCc-cChhhhhhccccCEEEecCCCeec
Confidence 4566666 65 35564 43 469999999999985 77655544 2 33456787776
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=89.03 E-value=0.17 Score=44.51 Aligned_cols=39 Identities=10% Similarity=0.107 Sum_probs=32.8
Q ss_pred echhhccCCC-ceeeCCC-CCCCCCCCEEeCcccc-ccccCCC
Q 042435 4 LLAFLSISAA-CSGVVEE-EPSSPSFLKSDMSFNN-LDGEIPT 43 (412)
Q Consensus 4 ~~~~l~~~~~-~~G~ip~-~~~~~~l~~~~ls~N~-l~G~iP~ 43 (412)
.|++|+|+.| +++..|. +.++++|+.||+++|+ +++ ||.
T Consensus 32 ~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~-i~~ 73 (239)
T 2xwt_C 32 STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQ-LES 73 (239)
T ss_dssp TCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCE-ECT
T ss_pred cccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcce-eCH
Confidence 4789999999 9888774 8899999999999998 654 554
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=88.66 E-value=0.46 Score=45.68 Aligned_cols=29 Identities=28% Similarity=0.440 Sum_probs=24.4
Q ss_pred cEEeCCCCCCEEe------cCCCcEEEeecCCccc
Q 042435 245 IVHRDISSNNILL------NSNLEAFVADFGTVRL 273 (412)
Q Consensus 245 ivHrDlkp~NILl------~~~~~~kl~DfGla~~ 273 (412)
++|+|+.+.||++ +++..++++||-+|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 5799999999999 4567799999988763
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=87.90 E-value=0.14 Score=47.55 Aligned_cols=40 Identities=8% Similarity=0.040 Sum_probs=23.9
Q ss_pred echhhccCCC-ceee-CCC-CCCCCCCCEEeCccccccccCCC
Q 042435 4 LLAFLSISAA-CSGV-VEE-EPSSPSFLKSDMSFNNLDGEIPT 43 (412)
Q Consensus 4 ~~~~l~~~~~-~~G~-ip~-~~~~~~l~~~~ls~N~l~G~iP~ 43 (412)
.|++|||+.| +++. +|. +.++++|+.|++++|++++.+|.
T Consensus 94 ~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~ 136 (336)
T 2ast_B 94 RVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVN 136 (336)
T ss_dssp CCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHH
T ss_pred CCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHH
Confidence 4566666666 5554 444 45566666666666666665554
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=87.88 E-value=0.39 Score=38.25 Aligned_cols=36 Identities=8% Similarity=0.044 Sum_probs=29.1
Q ss_pred echhhccCCC-ceeeCCC-CCCCCCCCEEeCccccccc
Q 042435 4 LLAFLSISAA-CSGVVEE-EPSSPSFLKSDMSFNNLDG 39 (412)
Q Consensus 4 ~~~~l~~~~~-~~G~ip~-~~~~~~l~~~~ls~N~l~G 39 (412)
.|++|||+.| ++..-+. +..+++|..|+|++|-+.-
T Consensus 32 ~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~C 69 (130)
T 3rfe_A 32 DTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWRC 69 (130)
T ss_dssp TCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCBC
T ss_pred CCCEEECCCCcCCccChhhhhhccccCEEEecCCCeec
Confidence 5889999999 7764444 6789999999999998753
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=87.87 E-value=0.13 Score=48.01 Aligned_cols=37 Identities=14% Similarity=0.171 Sum_probs=31.4
Q ss_pred eechhhccCCC-ceeeCCCCCCCCCCCEEeCcccccccc
Q 042435 3 VLLAFLSISAA-CSGVVEEEPSSPSFLKSDMSFNNLDGE 40 (412)
Q Consensus 3 ~~~~~l~~~~~-~~G~ip~~~~~~~l~~~~ls~N~l~G~ 40 (412)
..|++|+|+.| +++ ++.+..+++|+.|++|+|++++.
T Consensus 243 ~~L~~L~l~~n~l~~-~~~~~~l~~L~~L~l~~n~l~~~ 280 (347)
T 4fmz_A 243 SQLTWLEIGTNQISD-INAVKDLTKLKMLNVGSNQISDI 280 (347)
T ss_dssp TTCCEEECCSSCCCC-CGGGTTCTTCCEEECCSSCCCCC
T ss_pred CCCCEEECCCCccCC-ChhHhcCCCcCEEEccCCccCCC
Confidence 46889999999 665 57788899999999999999874
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=87.83 E-value=0.056 Score=51.62 Aligned_cols=43 Identities=14% Similarity=0.137 Sum_probs=35.1
Q ss_pred eechhhccCCC-ceee----CCC-C--CCCCCCCEEeCccccccc----cCCCCC
Q 042435 3 VLLAFLSISAA-CSGV----VEE-E--PSSPSFLKSDMSFNNLDG----EIPTYL 45 (412)
Q Consensus 3 ~~~~~l~~~~~-~~G~----ip~-~--~~~~~l~~~~ls~N~l~G----~iP~~~ 45 (412)
..|++|||+.| +++. +|. + .++++|+.||||+|.+++ .+|..+
T Consensus 244 ~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l 298 (386)
T 2ca6_A 244 PNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVI 298 (386)
T ss_dssp TTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHH
T ss_pred CCcCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHH
Confidence 36899999999 8876 544 5 458999999999999999 588743
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=87.61 E-value=0.38 Score=44.47 Aligned_cols=30 Identities=27% Similarity=0.350 Sum_probs=25.4
Q ss_pred CCCcEEeCCCCCCEEecCCCcEEEeecCCccc
Q 042435 242 TPSIVHRDISSNNILLNSNLEAFVADFGTVRL 273 (412)
Q Consensus 242 ~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~ 273 (412)
...++|+|+++.||+++ + .+.++||+.+..
T Consensus 194 ~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 194 TVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred CeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 34689999999999999 4 899999987753
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=86.90 E-value=0.092 Score=50.05 Aligned_cols=40 Identities=13% Similarity=0.147 Sum_probs=31.2
Q ss_pred echhhccCCC-ce--e---eCC-CCCCCCCCCEEeCcccccc----ccCCC
Q 042435 4 LLAFLSISAA-CS--G---VVE-EEPSSPSFLKSDMSFNNLD----GEIPT 43 (412)
Q Consensus 4 ~~~~l~~~~~-~~--G---~ip-~~~~~~~l~~~~ls~N~l~----G~iP~ 43 (412)
.|++|+|+.| ++ | .+| .+.++++|+.||||+|.++ +.+|.
T Consensus 188 ~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~ 238 (386)
T 2ca6_A 188 LLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAI 238 (386)
T ss_dssp TCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHH
T ss_pred CcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHH
Confidence 5788889888 66 4 446 5778888899999999887 66775
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=86.61 E-value=0.67 Score=29.16 Aligned_cols=9 Identities=22% Similarity=0.604 Sum_probs=3.3
Q ss_pred HHHHHhhcc
Q 042435 99 GFILLLKGK 107 (412)
Q Consensus 99 ~~~~~~~~~ 107 (412)
++++++|+|
T Consensus 30 ~~~~~~RRr 38 (44)
T 2ks1_B 30 GIGLFMRRR 38 (44)
T ss_dssp HHHHHHHTT
T ss_pred HHHHHhhhh
Confidence 333333333
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=84.79 E-value=0.16 Score=48.00 Aligned_cols=33 Identities=27% Similarity=0.216 Sum_probs=14.7
Q ss_pred hccCCC-ceeeCCCC-CCCCCCCEEeCcccccccc
Q 042435 8 LSISAA-CSGVVEEE-PSSPSFLKSDMSFNNLDGE 40 (412)
Q Consensus 8 l~~~~~-~~G~ip~~-~~~~~l~~~~ls~N~l~G~ 40 (412)
++|+.| ++|.+|.+ ....+|+.||+|+|++++.
T Consensus 3 ~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~ 37 (362)
T 3goz_A 3 YKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSI 37 (362)
T ss_dssp EECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGS
T ss_pred cccccccchHHHHHHHhCCCCceEEEccCCCCChH
Confidence 344444 55544442 2223355555555554443
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=84.77 E-value=0.63 Score=43.94 Aligned_cols=29 Identities=24% Similarity=0.315 Sum_probs=24.3
Q ss_pred CCcEEeCCCCCCEEecCCCcEEEeecCCcc
Q 042435 243 PSIVHRDISSNNILLNSNLEAFVADFGTVR 272 (412)
Q Consensus 243 ~~ivHrDlkp~NILl~~~~~~kl~DfGla~ 272 (412)
..++|+|+.+.|||++++. +.++||..+.
T Consensus 212 ~~l~HgDl~~~Nil~~~~~-~~lID~e~a~ 240 (369)
T 3c5i_A 212 IVFCHNDLQENNIINTNKC-LRLIDFEYSG 240 (369)
T ss_dssp EEEECSCCCGGGEEECC-C-EEECCCTTCE
T ss_pred eEEEeCCCCcccEEecCCc-EEEEEecCCC
Confidence 4689999999999998654 8999998775
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=83.53 E-value=0.98 Score=44.27 Aligned_cols=27 Identities=11% Similarity=-0.012 Sum_probs=20.1
Q ss_pred eeeeecCceEEEEEEeCC-CcEEEEEec
Q 042435 149 YCIGTGGYDSVYKAELPD-GKVVALKKL 175 (412)
Q Consensus 149 ~~lG~G~~g~Vy~~~~~~-~~~vAvK~l 175 (412)
+.|+.|-...+|+....+ +..+++|..
T Consensus 114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~ 141 (458)
T 2qg7_A 114 QIINGGITNILIKVKDMSKQAKYLIRLY 141 (458)
T ss_dssp EEECC--CEEEEEEEETTTTEEEEEEEE
T ss_pred EEcCCCeEeEEEEEEECCCCceEEEEEC
Confidence 568889899999998865 477888875
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=83.19 E-value=0.71 Score=29.01 Aligned_cols=6 Identities=0% Similarity=0.174 Sum_probs=2.3
Q ss_pred HHHHhh
Q 042435 100 FILLLK 105 (412)
Q Consensus 100 ~~~~~~ 105 (412)
+++++|
T Consensus 31 ~~~~RR 36 (44)
T 2l2t_A 31 AVYVRR 36 (44)
T ss_dssp HHHHHT
T ss_pred HHHhhh
Confidence 333343
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=82.57 E-value=0.14 Score=48.39 Aligned_cols=40 Identities=18% Similarity=0.116 Sum_probs=30.8
Q ss_pred echhhccCCC-ceeeCC----C-CCCCC-CCCEEeCccccccccCCC
Q 042435 4 LLAFLSISAA-CSGVVE----E-EPSSP-SFLKSDMSFNNLDGEIPT 43 (412)
Q Consensus 4 ~~~~l~~~~~-~~G~ip----~-~~~~~-~l~~~~ls~N~l~G~iP~ 43 (412)
.|++||||.| +++..+ . +.+++ +|+.||+|+|++++..|.
T Consensus 23 ~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~ 69 (362)
T 3goz_A 23 GVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSD 69 (362)
T ss_dssp TCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHH
T ss_pred CceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHH
Confidence 3788999998 766654 3 56677 789999999998887664
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=80.95 E-value=0.17 Score=49.17 Aligned_cols=41 Identities=10% Similarity=-0.046 Sum_probs=30.1
Q ss_pred eechhhccCCC-ceeeCCC-CC-----CCCCCCEEeCccccccc----cCCC
Q 042435 3 VLLAFLSISAA-CSGVVEE-EP-----SSPSFLKSDMSFNNLDG----EIPT 43 (412)
Q Consensus 3 ~~~~~l~~~~~-~~G~ip~-~~-----~~~~l~~~~ls~N~l~G----~iP~ 43 (412)
..|++|||+.| +++..+. +. ..++|+.||+++|++++ .+|.
T Consensus 341 ~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~ 392 (461)
T 1z7x_W 341 RFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAA 392 (461)
T ss_dssp SSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHH
T ss_pred CCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCCChhhHHHHHH
Confidence 46888999999 7665422 32 26789999999999987 7775
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=80.14 E-value=2.8 Score=36.50 Aligned_cols=108 Identities=11% Similarity=0.058 Sum_probs=71.0
Q ss_pred EEecCceEEEEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHH-HHHhCCCCCcEEeCCCCCCEEecCCCcEE
Q 042435 186 VVYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALS-YLHHDCTPSIVHRDISSNNILLNSNLEAF 264 (412)
Q Consensus 186 ~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~-~LH~~~~~~ivHrDlkp~NILl~~~~~~k 264 (412)
+..+.+.+.+.|+--+++.=+..+ ..++...+++++..++.-.. +++ .-+|--|.|+||++|.++.++
T Consensus 56 I~~~eD~~~i~y~~~~~~~~f~~i------~~~~~~eKlrll~nl~~L~~~~~~-----~r~tf~l~P~NL~f~~~~~p~ 124 (219)
T 4ano_A 56 IDVSEDEVKVVIKPPSSFLTFAAI------RKTTLLSRIRAAIHLVSKVKHHSA-----RRLIFIVCPENLMFNRALEPF 124 (219)
T ss_dssp EEECSSEEEEEEECCTTCEEHHHH------HTSCHHHHHHHHHHHHHHHSSCCS-----SSEECCCCGGGEEECTTCCEE
T ss_pred EEEeCCEEEEEEEcCcccCcHHHH------HhcCHHHHHHHHHHHHHHHHHhhh-----CceeEEEeCceEEEeCCCcEE
Confidence 345566666666654333222222 24778889999988877666 555 458999999999999999999
Q ss_pred EeecCCccccCCCCCCcccccccccccccccccCcccCccccc-HHHHHHHHHHHhCCCCcccc
Q 042435 265 VADFGTVRLLDVDSSNRTLQAGTYGYIALELVYTMVVTEKCVI-YSFGVVALEVLMGTHPGELL 327 (412)
Q Consensus 265 l~DfGla~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv-~S~Gvil~elltg~~P~~~~ 327 (412)
+.-.|+-..+ +|.-. + ..|. -++=+++..++.++..|+..
T Consensus 125 i~hRGi~~~l-----------------pP~e~-----~-ee~fl~qyKali~all~~K~~Fe~l 165 (219)
T 4ano_A 125 FLHVGVKESL-----------------PPDEW-----D-DERLLREVKATVLALTEGEYRFDEY 165 (219)
T ss_dssp ESCCEETTTB-----------------SSCSC-----C-HHHHHHHHHHHHHHHTTCSSCHHHH
T ss_pred EEEcCCcccC-----------------CCCCC-----C-HHHHHHHHHHHHHHHHcCCCCHHHH
Confidence 9988764432 23211 1 1232 25677888888898887743
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| 412 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-44 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 8e-44 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 7e-41 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-40 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 3e-39 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 4e-39 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-38 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 3e-38 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 7e-38 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 8e-38 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 9e-37 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-36 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-36 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-36 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 5e-36 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 6e-36 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 6e-36 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 4e-35 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 1e-34 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 3e-34 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 4e-34 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 8e-34 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 1e-33 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-33 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 4e-33 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-32 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-32 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-32 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 8e-32 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 8e-32 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-31 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 3e-31 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 4e-31 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 7e-31 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 4e-30 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 6e-30 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 9e-30 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 8e-29 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 7e-28 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 1e-27 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 3e-27 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 5e-27 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 3e-26 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 5e-26 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 4e-25 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 7e-25 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 4e-24 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 1e-23 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-23 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 4e-23 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 5e-23 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-22 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-22 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 3e-22 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 7e-22 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-21 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 3e-19 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 7e-19 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 7e-16 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 5e-14 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-13 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 3e-13 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 3e-12 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 0.001 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (388), Expect = 2e-44
Identities = 55/273 (20%), Positives = 110/273 (40%), Gaps = 42/273 (15%)
Query: 145 FHIRYCIGTGGYDSVYKAELPDGKVVALKKLHHSETEDSA-------------------- 184
+ IG+G + +VYK + VA+K L+ +
Sbjct: 10 ITVGQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67
Query: 185 --FVVYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCT 242
+ + + ++ E SL+ L + + + ++I + A + YLH
Sbjct: 68 LFMGYSTAPQLAIVTQWCEGSSLYHHLHIIET--KFEMIKLIDIARQTAQGMDYLHA--- 122
Query: 243 PSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQ--AGTYGYIALELVYTM- 299
SI+HRD+ SNNI L+ +L + DFG + S + + +G+ ++A E++
Sbjct: 123 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 182
Query: 300 --VVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKII 357
+ + +Y+FG+V E++ G P S+ + +I ++ + P K+
Sbjct: 183 KNPYSFQSDVYAFGIVLYELMTGQLP-------YSNINNRDQIIFMVGRGYLSPDLSKVR 235
Query: 358 QDII-LVSTIALACLRSKPKSRPTMQRISQELE 389
+ + + CL+ K RP +I +E
Sbjct: 236 SNCPKAMKRLMAECLKKKRDERPLFPQILASIE 268
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (383), Expect = 8e-44
Identities = 54/267 (20%), Positives = 102/267 (38%), Gaps = 34/267 (12%)
Query: 143 EYFHIRYCIGTGGYDSVYKAELPDGKVVALKKLHHSETEDSAFV---------------- 186
E + +G G + V+ VA+K L AF+
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVR 72
Query: 187 ---VYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTP 243
V + + ++ I EYME GSL L+ I+L + +++ +A ++++
Sbjct: 73 LYAVVTQEPIYIITEYMENGSLVDFLK-TPSGIKLTINKLLDMAAQIAEGMAFIEERN-- 129
Query: 244 SIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSN-RTLQAGTYGYIALELVYTMVVT 302
+HRD+ + NIL++ L +ADFG RL++ + R + A E + T
Sbjct: 130 -YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFT 188
Query: 303 EKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKIIQDIIL 362
K ++SFG++ E++ +I L + +++
Sbjct: 189 IKSDVWSFGILLTEIVTHGRI-------PYPGMTNPEVIQNLERGYRMVRPDNCPEELY- 240
Query: 363 VSTIALACLRSKPKSRPTMQRISQELE 389
+ C + +P+ RPT + LE
Sbjct: 241 --QLMRLCWKERPEDRPTFDYLRSVLE 265
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (364), Expect = 7e-41
Identities = 57/267 (21%), Positives = 102/267 (38%), Gaps = 34/267 (12%)
Query: 143 EYFHIRYCIGTGGYDSVYKAELPDGKVVALKKLHHSETEDSAFV---------------- 186
E + +G G + V+ VA+K L AF+
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQ 76
Query: 187 ---VYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTP 243
V S + ++ + EYM +GSL L+ + + +++ +A ++Y+
Sbjct: 77 LYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYL-RLPQLVDMAAQIASGMAYVERMN-- 133
Query: 244 SIVHRDISSNNILLNSNLEAFVADFGTVRLL-DVDSSNRTLQAGTYGYIALELVYTMVVT 302
VHRD+ + NIL+ NL VADFG RL+ D + + R + A E T
Sbjct: 134 -YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 192
Query: 303 EKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKIIQDIIL 362
K ++SFG++ E+ ++D + + P + + +
Sbjct: 193 IKSDVWSFGILLTELTTKGRV-------PYPGMVNREVLDQVERGYRMPCPPECPESLH- 244
Query: 363 VSTIALACLRSKPKSRPTMQRISQELE 389
+ C R +P+ RPT + + LE
Sbjct: 245 --DLMCQCWRKEPEERPTFEYLQAFLE 269
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (360), Expect = 2e-40
Identities = 56/269 (20%), Positives = 103/269 (38%), Gaps = 40/269 (14%)
Query: 145 FHIRYCIGTGGYDSVYKAE-LPDGKVVALKKLHHSETEDS-------------------- 183
+ + Y IGTG Y K DGK++ K+L + ++
Sbjct: 6 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI 65
Query: 184 -----AFVVYSPQCMFFIYEYMERGSLFCVLRDDDEAIE-LNWTRRMNIVKSVAHALSYL 237
+ + ++ + EY E G L V+ + + L+ + ++ + AL
Sbjct: 66 VRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKEC 125
Query: 238 H--HDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTYGYIALEL 295
H D +++HRD+ N+ L+ + DFG R+L+ D+S GT Y++ E
Sbjct: 126 HRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQ 185
Query: 296 VYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQK 355
+ M EK I+S G + E+ P ++ K + I + I +
Sbjct: 186 MNRMSYNEKSDIWSLGCLLYELCALMPP-------FTAFSQKELAGKIREGKF-RRIPYR 237
Query: 356 IIQDIILVSTIALACLRSKPKSRPTMQRI 384
++ I L K RP+++ I
Sbjct: 238 YSDELN---EIITRMLNLKDYHRPSVEEI 263
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (351), Expect = 3e-39
Identities = 47/273 (17%), Positives = 95/273 (34%), Gaps = 37/273 (13%)
Query: 138 LIDATEYFHIRYCIGTGGYDSVYKAELPDGKVVALKKLHHSETEDSAF------------ 185
+ID +E ++ IG+G + V+ + VA+K + + F
Sbjct: 1 VIDPSELTFVQ-EIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSH 59
Query: 186 --------VVYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYL 237
V + ++E+ME G L LR + + V +
Sbjct: 60 PKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFA--AETLLGMCLDVCEGM--- 114
Query: 238 HHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQ-AGTYGYIALELV 296
+ ++HRD+++ N L+ N V+DFG R + D + + + E+
Sbjct: 115 AYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVF 174
Query: 297 YTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKI 356
+ K ++SFGV+ EV + +++ + +
Sbjct: 175 SFSRYSSKSDVWSFGVLMWEVFSEGKI-------PYENRSNSEVVEDISTGFRLYKPRLA 227
Query: 357 IQDIILVSTIALACLRSKPKSRPTMQRISQELE 389
+ I C + +P+ RP R+ ++L
Sbjct: 228 STHVY---QIMNHCWKERPEDRPAFSRLLRQLA 257
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 139 bits (352), Expect = 4e-39
Identities = 60/289 (20%), Positives = 109/289 (37%), Gaps = 42/289 (14%)
Query: 145 FHIRYCIGTGGYDSVYKAELPD-GKVVALKKLHHSETEDSAF------------------ 185
+++ +G G Y VY+ VA+K L E F
Sbjct: 19 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQL 78
Query: 186 --VVYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTP 243
V + I E+M G+L LR+ + E++ + + ++ A+ YL
Sbjct: 79 LGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYLEK---K 134
Query: 244 SIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQA-GTYGYIALELVYTMVVT 302
+ +HRD+++ N L+ N VADFG RL+ D+ A + A E + +
Sbjct: 135 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS 194
Query: 303 EKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKIIQDIIL 362
K +++FGV+ E+ + LS + ++L + + + +
Sbjct: 195 IKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-------VYELLEKDYRMERPEGCPEKVY- 246
Query: 363 VSTIALACLRSKPKSRPTMQRISQELEGKTPMKKGLKEISIPEMRNQEM 411
+ AC + P RP+ I Q E +E SI + +E+
Sbjct: 247 --ELMRACWQWNPSDRPSFAEIHQAFE------TMFQESSISDEVEKEL 287
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (346), Expect = 2e-38
Identities = 50/287 (17%), Positives = 100/287 (34%), Gaps = 53/287 (18%)
Query: 145 FHIRYCIGTGGYDSVYKAELPDGKVVALKKLHHSETEDS--------------------A 184
+ IG G + V + G VA+K + + T +
Sbjct: 9 LKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLG 67
Query: 185 FVVYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPS 244
+V ++ + EYM +GSL LR ++ L + V A+ YL +
Sbjct: 68 VIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYLEG---NN 123
Query: 245 IVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTYGYIALELVYTMVVTEK 304
VHRD+++ N+L++ + A V+DFG + SS + + A E + + K
Sbjct: 124 FVHRDLAARNVLVSEDNVAKVSDFGLTKEA---SSTQDTGKLPVKWTAPEALREKKFSTK 180
Query: 305 CVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKIIQDIILVS 364
++SFG++ E+ + L ++ + + +
Sbjct: 181 SDVWSFGILLWEIYSFGRVPYPRIPLKD-------VVPRVEKGYKMDAPDGCPPAVY--- 230
Query: 365 TIALACLRSKPKSRPTMQRISQELEGKTPMKKGLKEISIPEMRNQEM 411
+ C RP+ ++ ++LE ++ E+
Sbjct: 231 EVMKNCWHLDAAMRPSFLQLREQLE---------------HIKTHEL 262
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (344), Expect = 3e-38
Identities = 56/273 (20%), Positives = 99/273 (36%), Gaps = 39/273 (14%)
Query: 139 IDATEYFHIRYCIGTGGYDSVYKAELPDGKVVALKKLHHSETEDSAF------------- 185
ID + ++ +GTG + V + VA+K + + F
Sbjct: 1 IDPKDLTFLK-ELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHE 59
Query: 186 -------VVYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLH 238
V + +F I EYM G L LR+ + + + K V A+ YL
Sbjct: 60 KLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRH--RFQTQQLLEMCKDVCEAMEYLE 117
Query: 239 HDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLL-DVDSSNRTLQAGTYGYIALELVY 297
+HRD+++ N L+N V+DFG R + D + ++ + E++
Sbjct: 118 SKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLM 174
Query: 298 TMVVTEKCVIYSFGVVALEVL-MGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKI 356
+ K I++FGV+ E+ +G P E + + Q L
Sbjct: 175 YSKFSSKSDIWAFGVLMWEIYSLGKMPYERF--------TNSETAEHIAQGLRLYRPHLA 226
Query: 357 IQDIILVSTIALACLRSKPKSRPTMQRISQELE 389
+ + TI +C K RPT + + +
Sbjct: 227 SEKVY---TIMYSCWHEKADERPTFKILLSNIL 256
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (344), Expect = 7e-38
Identities = 59/289 (20%), Positives = 104/289 (35%), Gaps = 54/289 (18%)
Query: 150 CIGTGGYDSVYKAELPDGKVVALKKLHHSETEDSAFVV---------------------- 187
IG G + V++ + G+ VA+K E
Sbjct: 10 SIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNK 68
Query: 188 --YSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDC---- 241
+ ++ + +Y E GSLF L + + + S A L++LH +
Sbjct: 69 DNGTWTQLWLVSDYHEHGSLFDYLNRYT----VTVEGMIKLALSTASGLAHLHMEIVGTQ 124
Query: 242 -TPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSN----RTLQAGTYGYIALELV 296
P+I HRD+ S NIL+ N +AD G D + + GT Y+A E++
Sbjct: 125 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVL 184
Query: 297 YTMV------VTEKCVIYSFGVVALEVLMGTHPGELLLSLS--------SSSGPKIMLID 342
+ ++ IY+ G+V E+ G + S + M
Sbjct: 185 DDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKV 244
Query: 343 ILYQRLSPPINQKI--IQDIILVSTIALACLRSKPKSRPTMQRISQELE 389
+ Q+L P I + + + +++ I C + +R T RI + L
Sbjct: 245 VCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 293
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (344), Expect = 8e-38
Identities = 51/294 (17%), Positives = 95/294 (32%), Gaps = 58/294 (19%)
Query: 143 EYFHIRYCIGTGGYDSVYKAEL------PDGKVVALKKLHHSETEDSAF----------- 185
+G G + V +A VA+K L S
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 186 ------------VVYSPQCMFFIYEYMERGSLFCVLRD---------------DDEAIEL 218
I EY G L LR +D+ + L
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 219 NWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDS 278
+ ++ VA +++L + +HRD+++ NILL + DFG R + DS
Sbjct: 143 DLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199
Query: 279 SN--RTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGP 336
+ + ++A E ++ V T + ++S+G+ E+ + + S
Sbjct: 200 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS---- 255
Query: 337 KIMLIDILYQRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELEG 390
++ + + ++ I C + P RPT ++I Q +E
Sbjct: 256 --KFYKMIKEGFRMLSPEHAPAEMY---DIMKTCWDADPLKRPTFKQIVQLIEK 304
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 133 bits (336), Expect = 9e-37
Identities = 52/296 (17%), Positives = 96/296 (32%), Gaps = 64/296 (21%)
Query: 145 FHIRYCIGTGGYDSVYKAELP------DGKVVALKKLHHSETEDSA-------------- 184
IG G + V++A P +VA+K L + D
Sbjct: 15 IEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFD 74
Query: 185 --------FVVYSPQCMFFIYEYMERGSLFCVLRD---------------------DDEA 215
V + M ++EYM G L LR
Sbjct: 75 NPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGP 134
Query: 216 IELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLD 275
L+ ++ I + VA ++YL VHRD+++ N L+ N+ +ADFG R +
Sbjct: 135 PPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRNIY 191
Query: 276 VDSSNR--TLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSS 333
+ A ++ E ++ T + ++++GVV E+ ++
Sbjct: 192 SADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEE- 250
Query: 334 SGPKIMLIDILYQRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELE 389
+I + + ++ + C P RP+ I + L+
Sbjct: 251 ------VIYYVRDGNILACPENCPLELY---NLMRLCWSKLPADRPSFCSIHRILQ 297
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (333), Expect = 1e-36
Identities = 62/266 (23%), Positives = 105/266 (39%), Gaps = 47/266 (17%)
Query: 145 FHIRYCIGTGGYDSVYKAELP-DGKVVALKKLHHSETEDSAF------------------ 185
F I +G G + +VY A ++ALK L ++ E +
Sbjct: 8 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 67
Query: 186 ------VVYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHH 239
+ ++ I EY G+++ L+ + + R + +A+ALSY H
Sbjct: 68 ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANALSYCHS 124
Query: 240 DCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTYGYIALELVYTM 299
++HRDI N+LL S E +ADFG SS RT GT Y+ E++
Sbjct: 125 ---KRVIHRDIKPENLLLGSAGELKIADFGWSV--HAPSSRRTTLCGTLDYLPPEMIEGR 179
Query: 300 VVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPIN-QKIIQ 358
+ EK ++S GV+ E L+G P ++ + I + P + +
Sbjct: 180 MHDEKVDLWSLGVLCYEFLVGKPP-------FEANTYQETYKRISRVEFTFPDFVTEGAR 232
Query: 359 DIILVSTIALACLRSKPKSRPTMQRI 384
D+I L+ P RP ++ +
Sbjct: 233 DLI------SRLLKHNPSQRPMLREV 252
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (337), Expect = 1e-36
Identities = 61/299 (20%), Positives = 103/299 (34%), Gaps = 62/299 (20%)
Query: 141 ATEYFHIRYCIGTGGYDSVYKAE-LPDGKVVALKKLHHSETE----------------DS 183
+ F +G G V+K P G V+A K +H +S
Sbjct: 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 63
Query: 184 AFVV------YSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYL 237
++V YS + E+M+ GSL VL+ + + +V L+YL
Sbjct: 64 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGLTYL 120
Query: 238 HHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTYGYIALELVY 297
I+HRD+ +NIL+NS E + DFG L S GT Y++ E +
Sbjct: 121 REKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI--DSMANSFVGTRSYMSPERLQ 176
Query: 298 TMVVTEKCVIYSFGVVALEVLMGTHP------------------GELLLSLSSSSGPKIM 339
+ + I+S G+ +E+ +G +P G+ + P
Sbjct: 177 GTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 236
Query: 340 LIDILYQRLSPPINQKIIQDIILVSTIAL--------------ACLRSKPKSRPTMQRI 384
L P +++ I+ L CL P R ++++
Sbjct: 237 LSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQL 295
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (333), Expect = 2e-36
Identities = 51/267 (19%), Positives = 92/267 (34%), Gaps = 44/267 (16%)
Query: 151 IGTGGYDSVYKAEL---PDGKVVALKKLHHSETEDSA---------------------FV 186
+G G + SV + VA+K L +
Sbjct: 17 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 76
Query: 187 VYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIV 246
V + + + E G L L E E+ + ++ V+ + YL + V
Sbjct: 77 VCQAEALMLVMEMAGGGPLHKFLVGKRE--EIPVSNVAELLHQVSMGMKYLEE---KNFV 131
Query: 247 HRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQ---AGTYGYIALELVYTMVVTE 303
HRD+++ N+LL + A ++DFG + L D S T + + A E + +
Sbjct: 132 HRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSS 191
Query: 304 KCVIYSFGVVALEVL-MGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKIIQDIIL 362
+ ++S+GV E L G P GP++M + Q + ++
Sbjct: 192 RSDVWSYGVTMWEALSYGQKP------YKKMKGPEVM--AFIEQGKRMECPPECPPELY- 242
Query: 363 VSTIALACLRSKPKSRPTMQRISQELE 389
+ C K + RP + Q +
Sbjct: 243 --ALMSDCWIYKWEDRPDFLTVEQRMR 267
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (330), Expect = 5e-36
Identities = 48/270 (17%), Positives = 89/270 (32%), Gaps = 45/270 (16%)
Query: 144 YFHIRYCIGTGGYDSVYKAELPD-GKVVALKKLHHSETEDSA------------------ 184
+ IG G + +VYK + VA +L + S
Sbjct: 10 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPN 69
Query: 185 ---------FVVYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALS 235
V +C+ + E M G+L L+ + + + + L
Sbjct: 70 IVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV---MKIKVLRSWCRQILKGLQ 126
Query: 236 YLHHDCTPSIVHRDISSNNILLNS-NLEAFVADFGTVRLLDVDSSNRTLQAGTYGYIALE 294
+LH P I+HRD+ +NI + + D G L + GT ++A E
Sbjct: 127 FLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAV--IGTPEFMAPE 183
Query: 295 LVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQ 354
+Y E +Y+FG+ LE+ +P S + + ++
Sbjct: 184 -MYEEKYDESVDVYAFGMCMLEMATSEYP------YSECQNAAQIYRRVTSGVKPASFDK 236
Query: 355 KIIQDIILVSTIALACLRSKPKSRPTMQRI 384
I ++ I C+R R +++ +
Sbjct: 237 VAIPEVK---EIIEGCIRQNKDERYSIKDL 263
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 131 bits (331), Expect = 6e-36
Identities = 67/295 (22%), Positives = 105/295 (35%), Gaps = 55/295 (18%)
Query: 135 YENLIDATEYFH---------IRYCIGTGGYDSVYKAELP----DGKVVALKKLHHSETE 181
+E+ +A F I IG G + V L VA+K L TE
Sbjct: 9 FEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTE 68
Query: 182 DSA----------------------FVVYSPQCMFFIYEYMERGSLFCVLRDDDEAIELN 219
VV + I E+ME GSL LR +D
Sbjct: 69 KQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF--T 126
Query: 220 WTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSS 279
+ + +++ +A + YL VHRD+++ NIL+NSNL V+DFG R L+ D+S
Sbjct: 127 VIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS 183
Query: 280 NRTL-----QAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSS 334
+ T + A E + T ++S+G+V EV+
Sbjct: 184 DPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGER-------PYWD 236
Query: 335 GPKIMLIDILYQRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELE 389
+I+ + Q P + + L C + RP +I L+
Sbjct: 237 MTNQDVINAIEQDYRLPPPMDCPSALH---QLMLDCWQKDRNHRPKFGQIVNTLD 288
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (330), Expect = 6e-36
Identities = 57/291 (19%), Positives = 112/291 (38%), Gaps = 46/291 (15%)
Query: 140 DATEYFHIRYCIGTGGYDSVYKA-ELPDGKVVALKKLHHSETEDSAF------------- 185
D + + IG G +VY A ++ G+ VA+++++ +
Sbjct: 17 DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKN 76
Query: 186 --------VVYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYL 237
++ + EY+ GSL V+ + + + + + AL +L
Sbjct: 77 PNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM----DEGQIAAVCRECLQALEFL 132
Query: 238 HHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTYGYIALELVY 297
H + ++HRDI S+NILL + + DFG + + S R+ GT ++A E+V
Sbjct: 133 HSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVT 189
Query: 298 TMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKII 357
K I+S G++A+E++ G P + + + + + +K+
Sbjct: 190 RKAYGPKVDIWSLGIMAIEMIEGEPP------YLNENPLRALYLIATNGTPELQNPEKLS 243
Query: 358 QDIILVSTIALACLRSKPKSRPTMQ--------RISQELEGKTPMKKGLKE 400
CL + R + + +I++ L TP+ KE
Sbjct: 244 AIFR---DFLNRCLDMDVEKRGSAKELLQHQFLKIAKPLSSLTPLIAAAKE 291
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (324), Expect = 4e-35
Identities = 50/280 (17%), Positives = 102/280 (36%), Gaps = 44/280 (15%)
Query: 135 YENL---IDATEYFHIRYCIGTGGYDSVYKAELPD-GKVVALKKLHHSETEDSA------ 184
YE++ ++ +++ I +G G + VYKA+ + + A K + E+
Sbjct: 1 YEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEI 60
Query: 185 ---------------FVVYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKS 229
Y ++ + E+ G++ V+ + + L ++ + K
Sbjct: 61 DILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERP--LTESQIQVVCKQ 118
Query: 230 VAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTYG 289
AL+YLH I+HRD+ + NIL + + +ADFG R GT
Sbjct: 119 TLDALNYLHD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPY 175
Query: 290 YIALELVYTMV-----VTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDIL 344
++A E+V K ++S G+ +E+ P + +++L
Sbjct: 176 WMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPP------HHELNPMRVLLKIAK 229
Query: 345 YQRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRI 384
+ + + + CL +R T ++
Sbjct: 230 SEPPTLAQPSRWSSNFK---DFLKKCLEKNVDARWTTSQL 266
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (324), Expect = 1e-34
Identities = 49/298 (16%), Positives = 89/298 (29%), Gaps = 63/298 (21%)
Query: 143 EYFHIRYCIGTGGYDSVYKAELPD------GKVVALKKLHH--SETEDSAF--------- 185
E +G+G + V A VA+K L +E A
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96
Query: 186 ------------VVYSPQCMFFIYEYMERGSLFCVLRDDDEAIE---------------- 217
++ I+EY G L LR E
Sbjct: 97 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156
Query: 218 ----LNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRL 273
L + + VA + +L S VHRD+++ N+L+ + DFG R
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARD 213
Query: 274 LDVDSSNRTLQ--AGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLS 331
+ DS+ ++A E ++ + T K ++S+G++ E+
Sbjct: 214 IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVN------PY 267
Query: 332 SSSGPKIMLIDILYQRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELE 389
++ ++I I +C + RP+ ++ L
Sbjct: 268 PGIPVDANFYKLIQNGFKMDQPFYATEEIY---IIMQSCWAFDSRKRPSFPNLTSFLG 322
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (317), Expect = 3e-34
Identities = 48/268 (17%), Positives = 93/268 (34%), Gaps = 46/268 (17%)
Query: 151 IGTGGYDSVYKAELPD---GKVVALKKLHHSETEDSA----------------------F 185
+G+G + +V K K VA+K L + + +
Sbjct: 15 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 74
Query: 186 VVYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSI 245
+ + + E E G L L+ + + + +V V+ + YL +
Sbjct: 75 GICEAESWMLVMEMAELGPLNKYLQQNRH---VKDKNIIELVHQVSMGMKYLEE---SNF 128
Query: 246 VHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQ---AGTYGYIALELVYTMVVT 302
VHRD+++ N+LL + A ++DFG + L D + Q + A E + +
Sbjct: 129 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS 188
Query: 303 EKCVIYSFGVVALEVLM-GTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKIIQDII 361
K ++SFGV+ E G P G ++ +L + +++
Sbjct: 189 SKSDVWSFGVLMWEAFSYGQKP------YRGMKGSEVT--AMLEKGERMGCPAGCPREMY 240
Query: 362 LVSTIALACLRSKPKSRPTMQRISQELE 389
+ C ++RP + L
Sbjct: 241 ---DLMNLCWTYDVENRPGFAAVELRLR 265
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (316), Expect = 4e-34
Identities = 58/279 (20%), Positives = 92/279 (32%), Gaps = 41/279 (14%)
Query: 145 FHIRYCIGTGGYDSVYKAE-LPDGKVVALKKLHHSETEDSA------------------- 184
+ + +G G Y V A + VA+K + D
Sbjct: 7 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 66
Query: 185 ---FVVYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDC 241
+ EY G LF + D I + + + YLH
Sbjct: 67 KFYGHRREGNIQYLFLEYCSGGELFDRIEPD---IGMPEPDAQRFFHQLMAGVVYLHG-- 121
Query: 242 TPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQ--AGTYGYIALELVYTM 299
I HRDI N+LL+ ++DFG + ++ R L GT Y+A EL+
Sbjct: 122 -IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 180
Query: 300 -VVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKIIQ 358
E ++S G+V +L G P S D ++ +KI
Sbjct: 181 EFHAEPVDVWSCGIVLTAMLAGELP------WDQPSDSCQEYSDWKEKKTYLNPWKKIDS 234
Query: 359 DIILVSTIALACLRSKPKSRPTMQRISQELEGKTPMKKG 397
+ + L P +R T+ I ++ P+KKG
Sbjct: 235 APL---ALLHKILVENPSARITIPDIKKDRWYNKPLKKG 270
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 125 bits (316), Expect = 8e-34
Identities = 50/275 (18%), Positives = 96/275 (34%), Gaps = 48/275 (17%)
Query: 140 DATEYFHIRYCIGTGGYDSVYKAE-LPDGKVVALKKLHHSETEDSAF------------- 185
D + F IG G + +VY A + + +VVA+KK+ +S + +
Sbjct: 12 DPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQK 71
Query: 186 -----------VVYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHAL 234
+ + EY + + L + L
Sbjct: 72 LRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP---LQEVEIAAVTHGALQGL 128
Query: 235 SYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTYGYIALE 294
+YLH +++HRD+ + NILL+ + DFG+ ++ +S GT ++A E
Sbjct: 129 AYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANS----FVGTPYWMAPE 181
Query: 295 LVYTM---VVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPP 351
++ M K ++S G+ +E+ P + L I
Sbjct: 182 VILAMDEGQYDGKVDVWSLGITCIELAERKPPLF-------NMNAMSALYHIAQNESPAL 234
Query: 352 INQKIIQDIILVSTIALACLRSKPKSRPTMQRISQ 386
+ + +CL+ P+ RPT + + +
Sbjct: 235 QSGHWSEYFR---NFVDSCLQKIPQDRPTSEVLLK 266
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (314), Expect = 1e-33
Identities = 65/290 (22%), Positives = 106/290 (36%), Gaps = 45/290 (15%)
Query: 143 EYFHIRYCIGTGGYDSVYKAELPDG-----KVVALKKLHHSETEDSA------------- 184
+ IG G + VYK L VA+K L TE
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66
Query: 185 ---------FVVYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALS 235
V+ + M I EYME G+L LR+ D E + + + +++ +A +
Sbjct: 67 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKD--GEFSVLQLVGMLRGIAAGM- 123
Query: 236 YLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSN---RTLQAGTYGYIA 292
+ + VHRD+++ NIL+NSNL V+DFG R+L+ D + + A
Sbjct: 124 --KYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTA 181
Query: 293 LELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPI 352
E + T ++SFG+V EV+ LS ++ + P
Sbjct: 182 PEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE-------VMKAINDGFRLPT 234
Query: 353 NQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELEGKTPMKKGLKEIS 402
I + + C + + RP I L+ LK ++
Sbjct: 235 PMDCPSAIY---QLMMQCWQQERARRPKFADIVSILDKLIRAPDSLKTLA 281
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (314), Expect = 2e-33
Identities = 56/301 (18%), Positives = 104/301 (34%), Gaps = 53/301 (17%)
Query: 145 FHIRYCIGTGGYDSVYKAELPDG---KVVALKKLHHSETEDSA----------------- 184
+ IG G + V KA + A+K++ ++D
Sbjct: 12 IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHP 71
Query: 185 ------FVVYSPQCMFFIYEYMERGSLFCVLR-------------DDDEAIELNWTRRMN 225
++ EY G+L LR + A L+ + ++
Sbjct: 72 NIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 131
Query: 226 IVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQA 285
VA + YL +HRD+++ NIL+ N A +ADFG R + +T+
Sbjct: 132 FAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQE-VYVKKTMGR 187
Query: 286 GTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILY 345
++A+E + V T ++S+GV+ E++ ++ + L + L
Sbjct: 188 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE-------LYEKLP 240
Query: 346 QRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELEGKTPMKKGLKEISIPE 405
Q ++ + C R KP RP+ +I L +K ++ E
Sbjct: 241 QGYRLEKPLNCDDEVY---DLMRQCWREKPYERPSFAQILVSLNRMLEERKTYVNTTLYE 297
Query: 406 M 406
Sbjct: 298 K 298
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (312), Expect = 4e-33
Identities = 54/280 (19%), Positives = 107/280 (38%), Gaps = 44/280 (15%)
Query: 138 LIDATEYFHIRYCIGTGGYDSVYKAE-LPDGKV----VALKKLHHSETEDSA-------- 184
++ TE+ I+ +G+G + +VYK +P+G+ VA+K+L + + +
Sbjct: 5 ILKETEFKKIK-VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 63
Query: 185 -------------FVVYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVA 231
+ + I + M G L +R+ + I +N +A
Sbjct: 64 VMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNI--GSQYLLNWCVQIA 121
Query: 232 HALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQ--AGTYG 289
++YL +VHRD+++ N+L+ + + DFG +LL + +
Sbjct: 122 KGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 178
Query: 290 YIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLS 349
++ALE + + T + ++S+GV E++ P + IL +
Sbjct: 179 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSK-------PYDGIPASEISSILEKGER 231
Query: 350 PPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELE 389
P D+ I + C SRP + + E
Sbjct: 232 LPQPPICTIDVY---MIMVKCWMIDADSRPKFRELIIEFS 268
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (307), Expect = 2e-32
Identities = 53/297 (17%), Positives = 103/297 (34%), Gaps = 52/297 (17%)
Query: 143 EYFHIRYCIGTGGYDSVYKAEL------PDGKVVALKKLHHSETEDSA------------ 184
E + +G G + VY+ VA+K ++ + +
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79
Query: 185 ----------FVVYSPQCMFFIYEYMERGSLFCVLR-------DDDEAIELNWTRRMNIV 227
VV Q I E M RG L LR ++ + ++ + +
Sbjct: 80 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139
Query: 228 KSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQA-- 285
+A ++YL+ + VHRD+++ N ++ + + DFG R + R
Sbjct: 140 GEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196
Query: 286 GTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILY 345
+++ E + V T ++SFGVV E+ LS ++ +
Sbjct: 197 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ-------VLRFVM 249
Query: 346 QRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELEGKTPMKKGLKEIS 402
+ + + C + PK RP+ I ++ + M+ G +E+S
Sbjct: 250 EGGLLDKPDNCPDMLF---ELMRMCWQYNPKMRPSFLEIISSIKEE--MEPGFREVS 301
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (306), Expect = 2e-32
Identities = 49/292 (16%), Positives = 88/292 (30%), Gaps = 57/292 (19%)
Query: 143 EYFHIRYCIGTGGYDSVYKA------ELPDGKVVALKKLHHSETEDSA------------ 184
+ + +G G + V +A + + VA+K L T
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 185 ------------FVVYSPQCMFFIYEYMERGSLFCVLR-------------DDDEAIELN 219
+ I E+ + G+L LR +D L
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 220 WTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSS 279
+ VA + +L +HRD+++ NILL+ + DFG R + D
Sbjct: 133 LEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189
Query: 280 N--RTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPK 337
+ ++A E ++ V T + ++SFGV+ E+
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS------PYPGVKID 243
Query: 338 IMLIDILYQRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELE 389
L + ++ L C +P RPT + + L
Sbjct: 244 EEFCRRLKEGTRMRAPDYTTPEMY---QTMLDCWHGEPSQRPTFSELVEHLG 292
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (307), Expect = 2e-32
Identities = 50/277 (18%), Positives = 89/277 (32%), Gaps = 46/277 (16%)
Query: 144 YFHIRYCIGTGGYDSVYKAELPDGK----VVALKKLHHSETEDSA--------------- 184
H IG G + VY L D A+K L+
Sbjct: 28 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 87
Query: 185 --------FVVYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSY 236
+ S + YM+ G L +R++ + + +
Sbjct: 88 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKG----- 142
Query: 237 LHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDS----SNRTLQAGTYGYIA 292
+ + VHRD+++ N +L+ VADFG R + N+T ++A
Sbjct: 143 MKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 202
Query: 293 LELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPI 352
LE + T T K ++SFGV+ E++ P ++ + L Q
Sbjct: 203 LESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD-------ITVYLLQGRRLLQ 255
Query: 353 NQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELE 389
+ + + L C K + RP+ + +
Sbjct: 256 PEYCPDPLY---EVMLKCWHPKAEMRPSFSELVSRIS 289
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (301), Expect = 8e-32
Identities = 50/275 (18%), Positives = 90/275 (32%), Gaps = 47/275 (17%)
Query: 145 FHIRYCIGTGGYDSVYKA-ELPDGKVVALKKLHHSETEDSAF------------------ 185
F +G G + +V A EL + A+K L
Sbjct: 10 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 69
Query: 186 ------VVYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHH 239
+ ++F Y + G L +R + T + AL YLH
Sbjct: 70 FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS---FDETCTRFYTAEIVSALEYLHG 126
Query: 240 DCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQ--AGTYGYIALELVY 297
I+HRD+ NILLN ++ + DFGT ++L +S GT Y++ EL+
Sbjct: 127 ---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLT 183
Query: 298 TMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPIN-QKI 356
+ +++ G + +++ G P + ++ I+ P
Sbjct: 184 EKSACKSSDLWALGCIIYQLVAGLPPFR-------AGNEYLIFQKIIKLEYDFPEKFFPK 236
Query: 357 IQDIILVSTIALACLRSKPKSRPTMQRISQELEGK 391
+D++ L R + + K
Sbjct: 237 ARDLV------EKLLVLDATKRLGCEEMEGYGPLK 265
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (300), Expect = 8e-32
Identities = 54/275 (19%), Positives = 86/275 (31%), Gaps = 44/275 (16%)
Query: 145 FHIRYCIGTGGYDSVYKAELP----DGKVVALKKLHHSETEDSAFV-------------- 186
+ +G G + V + E VA+K L +
Sbjct: 10 LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD 69
Query: 187 ---------VYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYL 237
V M + E GSL LR L R VA + YL
Sbjct: 70 HRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSR--YAVQVAEGMGYL 127
Query: 238 HHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQ---AGTYGYIALE 294
+HRD+++ N+LL + + DFG +R L + + +Q + + A E
Sbjct: 128 ESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE 184
Query: 295 LVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQ 354
+ T + + FGV E+ +L I + P +
Sbjct: 185 SLKTRTFSHASDTWMFGVTLWEMFTYGQE------PWIGLNGSQILHKIDKEGERLPRPE 238
Query: 355 KIIQDIILVSTIALACLRSKPKSRPTMQRISQELE 389
QDI + + C KP+ RPT + L
Sbjct: 239 DCPQDIY---NVMVQCWAHKPEDRPTFVALRDFLL 270
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (300), Expect = 1e-31
Identities = 49/293 (16%), Positives = 97/293 (33%), Gaps = 59/293 (20%)
Query: 143 EYFHIRYCIGTGGYDSVYKAELP--------DGKVVALKKLHHSETEDSA---------- 184
+ + +G G + V AE VA+K L TE
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 185 -------------FVVYSPQCMFFIYEYMERGSLFCVLR-------------DDDEAIEL 218
++ I EY +G+L L+ + +L
Sbjct: 73 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132
Query: 219 NWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDS 278
+ ++ VA + YL +HRD+++ N+L+ + +ADFG R +
Sbjct: 133 SSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189
Query: 279 SNRTLQA--GTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGP 336
+ ++A E ++ + T + ++SFGV+ E+ P
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS-------PYPGVP 242
Query: 337 KIMLIDILYQRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELE 389
L +L + ++ + C + P RPT +++ ++L+
Sbjct: 243 VEELFKLLKEGHRMDKPSNCTNELY---MMMRDCWHAVPSQRPTFKQLVEDLD 292
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (299), Expect = 3e-31
Identities = 57/292 (19%), Positives = 106/292 (36%), Gaps = 47/292 (16%)
Query: 143 EYFHIRYCIGTGGYDSVYKA-ELPDGKVVALKKLHHSETEDSAF---------------- 185
E + I +G G + V++ E K K + T+
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNIL 64
Query: 186 ----VVYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDC 241
S + + I+E++ +F + A ELN ++ V V AL +LH
Sbjct: 65 HLHESFESMEELVMIFEFISGLDIFERINT--SAFELNEREIVSYVHQVCEALQFLHS-- 120
Query: 242 TPSIVHRDISSNNILLNSNLEAFV--ADFGTVRLLDVDSSNRTLQAGTYGYIALELVYTM 299
+I H DI NI+ + + + +FG R L + R L Y A E+
Sbjct: 121 -HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLF-TAPEYYAPEVHQHD 178
Query: 300 VVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPP--INQKII 357
VV+ ++S G + +L G +P + + ++ +I+ + ++I
Sbjct: 179 VVSTATDMWSLGTLVYVLLSGINPFL-------AETNQQIIENIMNAEYTFDEEAFKEIS 231
Query: 358 QDIILVSTIALACLRSKPKSRPTMQRISQELEGKTP-MKKGLKEISIPEMRN 408
+ + L + KSR T Q P +K+ ++ +S +R
Sbjct: 232 IEAM---DFVDRLLVKERKSRMTASEALQH-----PWLKQKIERVSTKVIRT 275
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (295), Expect = 4e-31
Identities = 50/274 (18%), Positives = 92/274 (33%), Gaps = 43/274 (15%)
Query: 143 EYFHIRYCIGTGGYDSVYKAELPD----GKVVALKKLHHSETEDSA-------------- 184
E + CIG G + V++ VA+K + ++
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66
Query: 185 -------FVVYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYL 237
V + ++ I E G L L+ + ++ AL+YL
Sbjct: 67 HPHIVKLIGVITENPVWIIMELCTLGELRSF--LQVRKYSLDLASLILYAYQLSTALAYL 124
Query: 238 HHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQ-AGTYGYIALELV 296
VHRDI++ N+L++SN + DFG R ++ + + + ++A E +
Sbjct: 125 ES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESI 181
Query: 297 YTMVVTEKCVIYSFGVVALEVLM-GTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQK 355
T ++ FGV E+LM G P + +I + P+
Sbjct: 182 NFRRFTSASDVWMFGVCMWEILMHGVKPFQ--------GVKNNDVIGRIENGERLPMPPN 233
Query: 356 IIQDIILVSTIALACLRSKPKSRPTMQRISQELE 389
+ ++ C P RP + +L
Sbjct: 234 CPPTLY---SLMTKCWAYDPSRRPRFTELKAQLS 264
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 119 bits (298), Expect = 7e-31
Identities = 57/290 (19%), Positives = 104/290 (35%), Gaps = 45/290 (15%)
Query: 123 VFSVWNYD----GKILYENLIDATEYFHIRYCIGTGGYDSVYKA-ELPDGKVVALKKLHH 177
VF +W +I +++++D ++ I +GTG + V++ E G A K +
Sbjct: 5 VFDIWKQYYPQPVEIKHDHVLD---HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMT 61
Query: 178 SETEDSAF---------------------VVYSPQCMFFIYEYMERGSLFCVLRDDDEAI 216
D M IYE+M G LF + D E
Sbjct: 62 PHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVAD--EHN 119
Query: 217 ELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNS--NLEAFVADFGTVRLL 274
+++ + ++ V L ++H + VH D+ NI+ + + E + DFG L
Sbjct: 120 KMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHL 176
Query: 275 DVDSSNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSS 334
D S + GT + A E+ V ++S GV++ +L G P +
Sbjct: 177 DPKQSVKVTT-GTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFG-----GEND 230
Query: 335 GPKIMLIDILYQRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRI 384
+ + + I +D L + P +R T+ +
Sbjct: 231 DETLRNVKSCDWNMDDSAFSGISEDGK---DFIRKLLLADPNTRMTIHQA 277
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 115 bits (290), Expect = 4e-30
Identities = 59/303 (19%), Positives = 107/303 (35%), Gaps = 43/303 (14%)
Query: 135 YENLIDATEYFHIRYCIGTGGYDSVYKAE-LPDGKVVALKKLHHSETEDSAF-------- 185
++ D + + R +GTG + V AE K+VA+K + E
Sbjct: 1 WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAV 60
Query: 186 --------------VVYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVA 231
+ S ++ I + + G LF + + ++ V
Sbjct: 61 LHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGF---YTERDASRLIFQVL 117
Query: 232 HALSYLHHDCTPSIVHRDISSNNILL---NSNLEAFVADFGTVRLLDVDSSNRTLQAGTY 288
A+ YLH IVHRD+ N+L + + + ++DFG ++ D S T GT
Sbjct: 118 DAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTA-CGTP 173
Query: 289 GYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRL 348
GY+A E++ ++ +S GV+A +L G P + I
Sbjct: 174 GYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFY-----DENDAKLFEQILKAEYEF 228
Query: 349 SPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQE--LEGKTPMKKGLKEISIPEM 406
P I + P+ R T ++ Q + G T + K + + ++
Sbjct: 229 DSPYWDDISDSAK---DFIRHLMEKDPEKRFTCEQALQHPWIAGDTALDKNIHQSVSEQI 285
Query: 407 RNQ 409
+
Sbjct: 286 KKN 288
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 116 bits (291), Expect = 6e-30
Identities = 47/266 (17%), Positives = 89/266 (33%), Gaps = 38/266 (14%)
Query: 143 EYFHIRYCIGTGGYDSVYKA-ELPDGKVVALKKLHHSETEDSAF---------------- 185
+Y+ I +G+G + V++ E G+V K ++ D
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 88
Query: 186 -----VVYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHD 240
M I E++ G LF + +D +++ +N ++ L ++H
Sbjct: 89 INLHDAFEDKYEMVLILEFLSGGELFDRIAAED--YKMSEAEVINYMRQACEGLKHMHE- 145
Query: 241 CTPSIVHRDISSNNILLNSNLEAFV--ADFGTVRLLDVDSSNRTLQAGTYGYIALELVYT 298
SIVH DI NI+ + + V DFG L+ + T + A E+V
Sbjct: 146 --HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLN-PDEIVKVTTATAEFAAPEIVDR 202
Query: 299 MVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKIIQ 358
V +++ GV+ +L G P + + +
Sbjct: 203 EPVGFYTDMWAIGVLGYVLLSGLSPFA-----GEDDLETLQNVKRCDWEFDEDAFSSVSP 257
Query: 359 DIILVSTIALACLRSKPKSRPTMQRI 384
+ L+ +P+ R T+
Sbjct: 258 EAK---DFIKNLLQKEPRKRLTVHDA 280
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (288), Expect = 9e-30
Identities = 50/264 (18%), Positives = 95/264 (35%), Gaps = 44/264 (16%)
Query: 145 FHIRYCIGTGGYDSVYKAE-LPDGKVVALKKLHHSETEDSAF------------------ 185
F + +G G + V+ AE + A+K L
Sbjct: 4 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 63
Query: 186 -------VVYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLH 238
+ + +FF+ EY+ G L ++ + + +R + L +LH
Sbjct: 64 FLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK---FDLSRATFYAAEIILGLQFLH 120
Query: 239 HDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTYGYIALELVYT 298
IV+RD+ +NILL+ + +ADFG + + + GT YIA E++
Sbjct: 121 S---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLG 177
Query: 299 MVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKIIQ 358
+SFGV+ E+L+G P ++ + P +K +
Sbjct: 178 QKYNHSVDWWSFGVLLYEMLIGQSP------FHGQDEEELFHSIRMDNPFYPRWLEKEAK 231
Query: 359 DIILVSTIALACLRSKPKSRPTMQ 382
D++ + +P+ R ++
Sbjct: 232 DLL------VKLFVREPEKRLGVR 249
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 113 bits (284), Expect = 8e-29
Identities = 49/272 (18%), Positives = 86/272 (31%), Gaps = 46/272 (16%)
Query: 145 FHIRYCIGTGGYDSVYKAELPD-GKVVALKKLHHSETEDSAF------------------ 185
F + IG GG+ VY D GK+ A+K L +
Sbjct: 6 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 65
Query: 186 ---------VVYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSY 236
++P + FI + M G L L E + L +
Sbjct: 66 CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSE---ADMRFYAAEIILGLEH 122
Query: 237 LHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTYGYIALE-L 295
+H+ +V+RD+ NILL+ + ++D G D GT+GY+A E L
Sbjct: 123 MHN---RFVVYRDLKPANILLDEHGHVRISDLGLAC--DFSKKKPHASVGTHGYMAPEVL 177
Query: 296 VYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQK 355
+ +S G + ++L G P ID + ++ +
Sbjct: 178 QKGVAYDSSADWFSLGCMLFKLLRGHSP------FRQHKTKDKHEIDRMTLTMAVELPDS 231
Query: 356 IIQDIILVSTIALACLRSKPKSRPTMQRISQE 387
++ ++ L+ R +
Sbjct: 232 FSPELR---SLLEGLLQRDVNRRLGCLGRGAQ 260
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (275), Expect = 7e-28
Identities = 54/269 (20%), Positives = 97/269 (36%), Gaps = 38/269 (14%)
Query: 143 EYFHIRYCIGTGGYDSVYKAE-LPDGKVVALKKLH-----------HSETEDSAFVV--- 187
+Y +G G V + + ALK L H +V
Sbjct: 12 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIV 71
Query: 188 -------YSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHD 240
+C+ + E ++ G LF ++D + I+KS+ A+ YLH
Sbjct: 72 DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGD-QAFTEREASEIMKSIGEAIQYLHS- 129
Query: 241 CTPSIVHRDISSNNILLNSNLE---AFVADFGTVRLLDVDSSNRTLQAGTYGYIALELVY 297
+I HRD+ N+L S + DFG + +S T T Y+A E++
Sbjct: 130 --INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPC-YTPYYVAPEVLG 186
Query: 298 TMVVTEKCVIYSFGVVALEVLMGTHP--GELLLSLSSSSGPKIMLIDILYQRLSPPINQK 355
+ C ++S GV+ +L G P L++S +I + + +
Sbjct: 187 PEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSE 246
Query: 356 IIQDIILVSTIALACLRSKPKSRPTMQRI 384
++ +I L+++P R T+
Sbjct: 247 EVKMLI------RNLLKTEPTQRMTITEF 269
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 108 bits (271), Expect = 1e-27
Identities = 35/276 (12%), Positives = 81/276 (29%), Gaps = 41/276 (14%)
Query: 145 FHIRYCIGTGGYDSVYKAE-LPDGKVVALKKLHHSETEDSA------------------- 184
+ + IG+G + +Y + G+ VA+K
Sbjct: 9 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTI 68
Query: 185 -FVVYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTP 243
+ + E + + + + + + + Y+H
Sbjct: 69 RWCGAEGDYNVMVMELLGPSLEDLFNFCSRK---FSLKTVLLLADQMISRIEYIHS---K 122
Query: 244 SIVHRDISSNNILLNS---NLEAFVADFGTVRLLDVDSSN-------RTLQAGTYGYIAL 293
+ +HRD+ +N L+ ++ DFG + ++ GT Y ++
Sbjct: 123 NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASI 182
Query: 294 ELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPIN 353
+ + + + S G V + + G L ++ + I +++S PI
Sbjct: 183 NTHLGIEQSRRDDLESLGYVLMYFNL----GSLPWQGLKAATKRQKYERISEKKMSTPIE 238
Query: 354 QKIIQDIILVSTIALACLRSKPKSRPTMQRISQELE 389
+T C + +P + Q
Sbjct: 239 VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFR 274
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 107 bits (267), Expect = 3e-27
Identities = 54/282 (19%), Positives = 105/282 (37%), Gaps = 49/282 (17%)
Query: 142 TEYFHIRYCIGTGGYDSVYKAE-LPDGKVVALKKLHHSETEDSAFVV------------- 187
++ + + +G GG V+ A L + VA+K L D +F +
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 188 ---------------YSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAH 232
+ + + EY++ +L ++ + + R + ++
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQ 122
Query: 233 ALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQ---AGTYG 289
AL++ H I+HRD+ NI++++ V DFG R + ++ T GT
Sbjct: 123 ALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 179
Query: 290 YIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLS 349
Y++ E V + +YS G V EVL G P + S + + +
Sbjct: 180 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP------FTGDSPVSVAYQHVREDPIP 233
Query: 350 P-PINQKIIQDIILVSTIALACLRSKPKSRP-TMQRISQELE 389
P ++ + D+ + L L P++R T + +L
Sbjct: 234 PSARHEGLSADLD---AVVLKALAKNPENRYQTAAEMRADLV 272
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 106 bits (266), Expect = 5e-27
Identities = 50/280 (17%), Positives = 95/280 (33%), Gaps = 53/280 (18%)
Query: 143 EYFHIRYCIGTGGYDSVYKAE-LPDGKVVALKKLHHSETEDSA----------------- 184
E + + +G G V + P K A+K + + +
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 185 --------------FVVYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSV 230
+ F +++ M++G LF L E + L+ I++++
Sbjct: 63 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLT---EKVTLSEKETRKIMRAL 119
Query: 231 AHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTYGY 290
+ LH IVHRD+ NILL+ ++ + DFG LD GT Y
Sbjct: 120 LEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLD-PGEKLREVCGTPSY 175
Query: 291 IALELVYTMVV------TEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDIL 344
+A E++ + ++ ++S GV+ +L G+ P + +I
Sbjct: 176 LAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFW-----HRKQMLMLRMIMSG 230
Query: 345 YQRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRI 384
+ P + + L +P+ R T +
Sbjct: 231 NYQFGSPEWDDYSDTVK---DLVSRFLVVQPQKRYTAEEA 267
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 105 bits (263), Expect = 3e-26
Identities = 57/269 (21%), Positives = 89/269 (33%), Gaps = 48/269 (17%)
Query: 145 FHIRYCIGTGGYDSVYKAE-LPDGKVVALKKLHHSETEDSAF------------------ 185
F I +GTG + V+ +G+ A+K L
Sbjct: 6 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 65
Query: 186 ------VVYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHH 239
Q +F I +Y+E G LF +LR V L +
Sbjct: 66 IIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEV------CLALEY 119
Query: 240 DCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTYGYIALELVYTM 299
+ I++RD+ NILL+ N + DFG + + GT YIA E+V T
Sbjct: 120 LHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVP---DVTYTLCGTPDYIAPEVVSTK 176
Query: 300 VVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLS-PPINQKIIQ 358
+ +SFG++ E+L G P S IL L PP + ++
Sbjct: 177 PYNKSIDWWSFGILIYEMLAGYTPFY-------DSNTMKTYEKILNAELRFPPFFNEDVK 229
Query: 359 DIILVSTIALACLRSKPKSRPTMQRISQE 387
D++ + R + E
Sbjct: 230 DLL------SRLITRDLSQRLGNLQNGTE 252
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 104 bits (259), Expect = 5e-26
Identities = 34/278 (12%), Positives = 80/278 (28%), Gaps = 43/278 (15%)
Query: 145 FHIRYCIGTGGYDSVYKAE-LPDGKVVALKKLHHSETEDSA------------------- 184
+ + IG G + +++ L + + VA+K
Sbjct: 7 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNV 66
Query: 185 -FVVYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTP 243
+ + + + + + + K + + +H
Sbjct: 67 YYFGQEGLHNVLVIDLLGPSLEDLLDLCGRK---FSVKTVAMAAKQMLARVQSIHE---K 120
Query: 244 SIVHRDISSNNILLNSNLE-----AFVADFGTVRLLDVDSSNRTLQ-------AGTYGYI 291
S+V+RDI +N L+ +V DFG V+ + + + +GT Y+
Sbjct: 121 SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYM 180
Query: 292 ALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPP 351
++ + + + + G V + L G+ P ++ K I ++ S P
Sbjct: 181 SINTHLGREQSRRDDLEALGHVFMYFLRGSLP----WQGLKAATNKQKYERIGEKKQSTP 236
Query: 352 INQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELE 389
+ + + P +
Sbjct: 237 LRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFS 274
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 102 bits (255), Expect = 4e-25
Identities = 47/265 (17%), Positives = 82/265 (30%), Gaps = 45/265 (16%)
Query: 145 FHIRYCIGTGGYDSVYKAE-LPDGKVVALKKLHHSETEDSAFV----------------- 186
F +G G + V G+ A+K L V
Sbjct: 7 FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 66
Query: 187 -------VYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHH 239
+ + F+ EY G LF L + R + AL +
Sbjct: 67 LTALKYAFQTHDRLCFVMEYANGGELFFHLSRERV---FTEERARFYGAEIVSAL---EY 120
Query: 240 DCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTYGYIALELVYTM 299
+ +V+RDI N++L+ + + DFG + D + GT Y+A E++
Sbjct: 121 LHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDN 180
Query: 300 VVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPIN-QKIIQ 358
+ GVV E++ G P + + + IL + + P +
Sbjct: 181 DYGRAVDWWGLGVVMYEMMCGRLPFY-------NQDHERLFELILMEEIRFPRTLSPEAK 233
Query: 359 DIILVSTIALACLRSKPKSRPTMQR 383
++ L+ PK R
Sbjct: 234 SLL------AGLLKKDPKQRLGGGP 252
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (251), Expect = 7e-25
Identities = 50/274 (18%), Positives = 90/274 (32%), Gaps = 47/274 (17%)
Query: 143 EYFHIRYCIGTGGYDSVYKA-ELPDGKVVALKKLHHSETEDSAF---------------- 185
+Y+ +G+G + V K E G A K + T+ S
Sbjct: 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 186 -----------VVYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHAL 234
V + + I E + G LF D E + + L
Sbjct: 70 IQHPNVITLHEVYENKTDVILILELVAGGELF------DFLAEKESLTEEEATEFLKQIL 123
Query: 235 SYLHHDCTPSIVHRDISSNNILLNSN----LEAFVADFGTVRLLDVDSSNRTLQAGTYGY 290
+ +++ + I H D+ NI+L + DFG +D + GT +
Sbjct: 124 NGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID-FGNEFKNIFGTPEF 182
Query: 291 IALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSP 350
+A E+V + + ++S GV+ +L G P L + + ++ ++
Sbjct: 183 VAPEIVNYEPLGLEADMWSIGVITYILLSGASP--FLGDTKQETLANVSAVNYEFEDEYF 240
Query: 351 PINQKIIQDIILVSTIALACLRSKPKSRPTMQRI 384
+ +D I L PK R T+Q
Sbjct: 241 SNTSALAKDFI------RRLLVKDPKKRMTIQDS 268
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 99.2 bits (246), Expect = 4e-24
Identities = 50/282 (17%), Positives = 97/282 (34%), Gaps = 45/282 (15%)
Query: 143 EYFHIRYCIGTGGYDSVYKAELPDGKVVALKKLHHSETEDSA------------------ 184
E +H IG G Y VYKA+ G+ ALKK+ + ++
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 185 ----FVVYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHD 240
+ V + + L +L + +E + + L+ + +
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSF-----LLQLLNGIAYC 116
Query: 241 CTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTYGYIALE-LVYTM 299
++HRD+ N+L+N E +ADFG R + T + T Y A + L+ +
Sbjct: 117 HDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSK 176
Query: 300 VVTEKCVIYSFGVVALEVLMGTHP-------------GELLLSLSSSSGPKIMLIDILYQ 346
+ I+S G + E++ GT +L + +S + P + +
Sbjct: 177 KYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDP 236
Query: 347 RLSPPINQKIIQDIILVSTIAL----ACLRSKPKSRPTMQRI 384
+ + + + L+ P R T ++
Sbjct: 237 NFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 97.1 bits (241), Expect = 1e-23
Identities = 58/273 (21%), Positives = 94/273 (34%), Gaps = 59/273 (21%)
Query: 145 FHIRYCIGTGGYDSVYKA-ELPDGKVVALKKLHHSETEDSAF------------------ 185
+ + +G+GG+ SVY + D VA+K + D
Sbjct: 6 YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 65
Query: 186 -----------VVYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHAL 234
P I E E + A L + V A+
Sbjct: 66 SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA--LQEELARSFFWQVLEAV 123
Query: 235 SYLHHDCTPSIVHRDISSNNILLNSN-LEAFVADFGTVRLLDVDSSNRTLQAGTYGYIAL 293
+ H+ ++HRDI NIL++ N E + DFG+ LL + T GT Y
Sbjct: 124 RHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALL--KDTVYTDFDGTRVYSPP 178
Query: 294 ELV-YTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILY-QRLSPP 351
E + Y ++S G++ +++ G P E +I+ + + QR+S
Sbjct: 179 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE--------HDEEIIRGQVFFRQRVSSE 230
Query: 352 INQKIIQDIILVSTIALACLRSKPKSRPTMQRI 384
Q +I CL +P RPT + I
Sbjct: 231 -----CQHLI------RWCLALRPSDRPTFEEI 252
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 97.6 bits (242), Expect = 2e-23
Identities = 53/278 (19%), Positives = 98/278 (35%), Gaps = 50/278 (17%)
Query: 151 IGTGGYDSVYKAE-LPDGKVVALKKLHHSETEDSA--------------------FVV-- 187
+G G + +VYKA ++VA+KK+ ++ ++
Sbjct: 6 LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 65
Query: 188 ----YSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTP 243
+ ++++ME + D ++ L + + L YLH
Sbjct: 66 LDAFGHKSNISLVFDFMETDLEVII---KDNSLVLTPSHIKAYMLMTLQGLEYLHQHW-- 120
Query: 244 SIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTYGYIALELVYTM-VVT 302
I+HRD+ NN+LL+ N +ADFG + + T Q T Y A EL++ +
Sbjct: 121 -ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYG 179
Query: 303 EKCVIYSFGVVALEVLMGTHP-------------GELLLSLSSSSGPKIM-LIDILYQRL 348
+++ G + E+L+ E L + + P + L D + +
Sbjct: 180 VGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKS 239
Query: 349 SPPINQKIIQDIILVSTIAL--ACLRSKPKSRPTMQRI 384
P I I + L P +R T +
Sbjct: 240 FPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQA 277
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 97.6 bits (242), Expect = 4e-23
Identities = 49/263 (18%), Positives = 92/263 (34%), Gaps = 36/263 (13%)
Query: 151 IGTGGYDSVYKAELPD-GKVVALKKLHHSETE-----------DSAFVV----------- 187
IG G + VY+A+L D G++VA+KK+ + D +V
Sbjct: 28 IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGE 87
Query: 188 -YSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIV 246
+ + +Y+ L + + +L+Y+H I
Sbjct: 88 KKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS---FGIC 144
Query: 247 HRDISSNNILLNSNLEAF-VADFGTVRLLDVDSSNRTLQAGTYGYIALELVYTMVVTEKC 305
HRDI N+LL+ + + DFG+ + L N + Y + T
Sbjct: 145 HRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSI 204
Query: 306 VIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKIIQDIILVST 365
++S G V E+L+G L++I+ + L P ++I + +
Sbjct: 205 DVWSAGCVLAELLLGQPI-------FPGDSGVDQLVEII-KVLGTPTREQIREMNPNYTE 256
Query: 366 IALACLRSKPKSRPTMQRISQEL 388
+++ P ++ R E
Sbjct: 257 FKFPQIKAHPWTKVFRPRTPPEA 279
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 96.5 bits (239), Expect = 5e-23
Identities = 49/290 (16%), Positives = 86/290 (29%), Gaps = 50/290 (17%)
Query: 141 ATEYFHIRYCIGTGGYDSVYKAE--LPDGKVVALKKLHHSETEDS--------------- 183
A + + IG G Y V+KA G+ VALK++ E+
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64
Query: 184 -------------AFVVYSPQCMFFIYEYMERGSLFCV-LRDDDEAIELNWTRRMNIVKS 229
V + E D + +++
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124
Query: 230 VAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTYG 289
+ L +LH +VHRD+ NIL+ S+ + +ADFG R+ + + T
Sbjct: 125 LLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTS-VVVTLW 180
Query: 290 YIALELVYTMVVTEKCVIYSFGVVALEVLMGTHP---------GELLLSLSSSSGPKIML 340
Y A E++ ++S G + E+ +L + G +
Sbjct: 181 YRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 240
Query: 341 IDILYQRLSPPINQKIIQDIILVSTIALA------CLRSKPKSRPTMQRI 384
D+ R + + + L CL P R +
Sbjct: 241 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 95.3 bits (236), Expect = 1e-22
Identities = 58/275 (21%), Positives = 91/275 (33%), Gaps = 53/275 (19%)
Query: 145 FHIRYCIGTGGYDSVYKAEL----PDGKVVALKKLHHSETEDSA---------------- 184
F + +GTG Y V+ GK+ A+K L + A
Sbjct: 26 FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 85
Query: 185 ----FVV------YSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHAL 234
F+V + + I +Y+ G LF L + E + +
Sbjct: 86 RQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYV------GEIV 139
Query: 235 SYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGT-VRLLDVDSSNRTLQAGTYGYIAL 293
L H I++RDI NILL+SN + DFG + ++ GT Y+A
Sbjct: 140 LALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAP 199
Query: 294 ELVYTMV--VTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPP 351
++V + +S GV+ E+L G P I + PP
Sbjct: 200 DIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFT-----VDGEKNSQAEISRRILKSEPP 254
Query: 352 INQKI---IQDIILVSTIALACLRSKPKSRPTMQR 383
Q++ +D+I L PK R
Sbjct: 255 YPQEMSALAKDLI------QRLLMKDPKKRLGCGP 283
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 94.5 bits (234), Expect = 2e-22
Identities = 47/282 (16%), Positives = 90/282 (31%), Gaps = 47/282 (16%)
Query: 145 FHIRYCIGTGGYDSVYKAE-LPDGKVVALKKLHHSETEDSAF------------------ 185
F IG G Y VYKA G+VVALKK+ +
Sbjct: 4 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 186 -----VVYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHD 240
V+++ ++ ++E++ + + + + + + L++ H
Sbjct: 64 VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALT--GIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 241 CTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTYGYIALELVY-TM 299
++HRD+ N+L+N+ +ADFG R V T + T Y A E++
Sbjct: 122 R---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCK 178
Query: 300 VVTEKCVIYSFGVVALEVLMGTHP-------------GELLLSLSSSSGPKIMLIDILYQ 346
+ I+S G + E++ L + P + +
Sbjct: 179 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 238
Query: 347 RLSPPINQKIIQDIILVSTIAL----ACLRSKPKSRPTMQRI 384
Q + + + L P R + +
Sbjct: 239 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 94.5 bits (234), Expect = 3e-22
Identities = 53/298 (17%), Positives = 101/298 (33%), Gaps = 57/298 (19%)
Query: 137 NLIDATEYFHIRYCIGTGGYDSVYKA-ELPDGKVVALKKLHHSETEDSA----------- 184
+ D + IG G Y V A + + VA+KK+ E +
Sbjct: 2 QVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILL 61
Query: 185 -----FVV----------YSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKS 229
++ ++ ++ L+ +L+ L+ +
Sbjct: 62 RFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQ----HLSNDHICYFLYQ 117
Query: 230 VAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQ---AG 286
+ L Y+H +++HRD+ +N+LLN+ + + DFG R+ D D +
Sbjct: 118 ILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 174
Query: 287 TYGYIALELVYT-MVVTEKCVIYSFGVVALEVLMGTHP-------------GELLLSLSS 332
T Y A E++ T+ I+S G + E+L +L S S
Sbjct: 175 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQ 234
Query: 333 SSGPKIMLIDILYQRLSPPINQKIIQDIILVSTIALA------CLRSKPKSRPTMQRI 384
I+ + LS P K+ + + + + A L P R +++
Sbjct: 235 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA 292
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 92.7 bits (229), Expect = 7e-22
Identities = 41/283 (14%), Positives = 98/283 (34%), Gaps = 49/283 (17%)
Query: 145 FHIRYCIGTGGYDSVYKAE-LPDGKVVALKKLHHSETEDSA------------------- 184
+ IG G Y +V+KA+ ++VALK++ + ++
Sbjct: 4 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI 63
Query: 185 ----FVVYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHD 240
V++S + + ++E+ ++ + + + L L
Sbjct: 64 VRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCN------GDLDPEIVKSFLFQLLKGLGFC 117
Query: 241 CTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTYGYIALELVY-TM 299
+ +++HRD+ N+L+N N E +A+FG R + + + T Y ++++
Sbjct: 118 HSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAK 177
Query: 300 VVTEKCVIYSFGVVALEVLMGTHP--------------GELLLSLSSSSGPKIMLIDILY 345
+ + ++S G + E+ P LL + + P + +
Sbjct: 178 LYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYK 237
Query: 346 QRLSPPINQKIIQDIILVSTIAL----ACLRSKPKSRPTMQRI 384
P ++ + ++ L+ P R + +
Sbjct: 238 PYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 91.9 bits (227), Expect = 2e-21
Identities = 46/304 (15%), Positives = 93/304 (30%), Gaps = 63/304 (20%)
Query: 138 LIDATEYFHIRYCIGTGGYDSVYKAE-LPDGKVVALKK---------------------- 174
D + IG G + V+KA G+ VALKK
Sbjct: 5 FCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQ 64
Query: 175 ---------LHHSETEDSAFVVYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMN 225
L ++ ++ ++++ E + L
Sbjct: 65 LLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSN------VLVKFTLSE 118
Query: 226 IVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSS----NR 281
I + + L+ L++ I+HRD+ + N+L+ + +ADFG R + +
Sbjct: 119 IKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRY 178
Query: 282 TLQAGTYGYIALELVYT-MVVTEKCVIYSFGVVALEVLMGTHP-------------GELL 327
T + T Y EL+ ++ G + E+ + +L
Sbjct: 179 TNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLC 238
Query: 328 LSLSSSSGPKIMLIDILYQRLSPPINQKIIQDII---LVSTIAL----ACLRSKPKSRPT 380
S++ P + ++ + ++ ++D + + AL L P R
Sbjct: 239 GSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRID 298
Query: 381 MQRI 384
Sbjct: 299 SDDA 302
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 86.0 bits (212), Expect = 3e-19
Identities = 41/269 (15%), Positives = 83/269 (30%), Gaps = 48/269 (17%)
Query: 143 EYFHIRYCIGTGGYDSVYKAE-LPDGKVVALKKLHHSETEDSAFV--------------- 186
+ F +GTG + V + G A+K L + +
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 187 ---------VYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYL 237
++ + EY+ G +F LR + + YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR---FSEPHARFYAAQIVLTFEYL 157
Query: 238 HHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTYGYIALELVY 297
H +++RD+ N+L++ V DFG GT +A E++
Sbjct: 158 HSLD---LIYRDLKPENLLIDQQGYIQVTDFG---FAKRVKGRTWTLCGTPEALAPEIIL 211
Query: 298 TMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPIN-QKI 356
+ + ++ GV+ E+ G P + P + I+ ++ P +
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPP-------FFADQPIQIYEKIVSGKVRFPSHFSSD 264
Query: 357 IQDIILVSTIALACLRSKPKSRPTMQRIS 385
++D++ L+ R +
Sbjct: 265 LKDLL------RNLLQVDLTKRFGNLKNG 287
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 84.5 bits (208), Expect = 7e-19
Identities = 32/223 (14%), Positives = 73/223 (32%), Gaps = 37/223 (16%)
Query: 125 SVWNYDG-KILYENLIDATEYFHIRYCIGTGGYDSVYKAE-LPDGKVVALKKLHHSETED 182
W+Y+ + + N D + + +G G Y V++A + + + V +K L + +
Sbjct: 20 EYWDYESHVVEWGNQDD----YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKK 75
Query: 183 ---------------------SAFVVYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWT 221
+ ++E++ + + L
Sbjct: 76 IKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ------TLTDY 129
Query: 222 RRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNS-NLEAFVADFGTVRLLDVDSSN 280
+ + AL Y H I+HRD+ +N++++ + + + D+G
Sbjct: 130 DIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY 186
Query: 281 RTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHP 323
A Y LV + ++S G + ++ P
Sbjct: 187 NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEP 229
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 76.1 bits (186), Expect = 7e-16
Identities = 40/209 (19%), Positives = 71/209 (33%), Gaps = 40/209 (19%)
Query: 145 FHIRYCIGTGGYDSVYKA-ELPDGKVVALKKLHHSETEDSAF------------------ 185
+ IG+G V A + + VA+KKL +
Sbjct: 19 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 78
Query: 186 -----------VVYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHAL 234
+ Q ++ + E M+ + + D R ++ + +
Sbjct: 79 ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHE------RMSYLLYQMLCGI 132
Query: 235 SYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTYGYIALE 294
+LH I+HRD+ +NI++ S+ + DFG R S T T Y A E
Sbjct: 133 KHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG-TSFMMTPYVVTRYYRAPE 188
Query: 295 LVYTMVVTEKCVIYSFGVVALEVLMGTHP 323
++ M E I+S G + E++
Sbjct: 189 VILGMGYKENVDIWSVGCIMGEMVRHKIL 217
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 70.4 bits (171), Expect = 5e-14
Identities = 33/216 (15%), Positives = 64/216 (29%), Gaps = 39/216 (18%)
Query: 145 FHIRYCIGTGGYDSVYKAE-LPDGKVVALKKLHHSETEDSA------------------- 184
+ + +G G + +V+ A+ + + VA+K + + A
Sbjct: 15 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKE 74
Query: 185 --------------FVVYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSV 230
F P + + + G L E + I K +
Sbjct: 75 DSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQL 134
Query: 231 AHALSYLHHDCTPSIVHRDISSNNILLNSN-LEAFVADFGTVRLLDVDSSNRTLQ--AGT 287
L Y+H C I+H DI N+L+ + L + + T
Sbjct: 135 LLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQT 192
Query: 288 YGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHP 323
Y + E++ I+S + E++ G
Sbjct: 193 REYRSPEVLLGAPWGCGADIWSTACLIFELITGDFL 228
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 69.5 bits (169), Expect = 1e-13
Identities = 48/286 (16%), Positives = 86/286 (30%), Gaps = 49/286 (17%)
Query: 143 EYFHIRYCIGTGGYDSVYKA-ELPDGKVVALKKLHHSETEDSA----------------- 184
+ +G+G Y +V A + G VA+KKL+ +
Sbjct: 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 77
Query: 185 -------FVVYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYL 237
F Y+ + L + +L R +V + L Y+
Sbjct: 78 NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYI 137
Query: 238 HHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTYGYIALELVY 297
H HRD+ N+ +N + E + DFG R DS + ++
Sbjct: 138 HAAGII---HRDLKPGNLAVNEDCELKILDFGLARQ--ADSEMTGYVVTRWYRAPEVILN 192
Query: 298 TMVVTEKCVIYSFGVVALEVLMGTHP-------------GELLLSLSSSSGPKIMLIDIL 344
M T+ I+S G + E++ G ++ + + ++ +
Sbjct: 193 WMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAK 252
Query: 345 YQRLSPPINQKIIQDIILVSTIALA------CLRSKPKSRPTMQRI 384
P +K IL + LA L + R T
Sbjct: 253 NYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEA 298
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 68.0 bits (165), Expect = 3e-13
Identities = 47/295 (15%), Positives = 82/295 (27%), Gaps = 49/295 (16%)
Query: 134 LYENLIDATEYFHIRYCIGTGGYDSVYKAE-LPDGKVVALKKLHHSETEDSA-------- 184
L + + + E + +G+G Y SV A G VA+KKL
Sbjct: 9 LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 68
Query: 185 ----------------FVVYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVK 228
+ F Y+ + L + + +L ++
Sbjct: 69 RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY 128
Query: 229 SVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQAGTY 288
+ L Y+H HRD+ +N+ +N + E + DFG R D A +
Sbjct: 129 QILRGLKYIHSADII---HRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVATRW 183
Query: 289 GYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHP---------------GELLLSLSSS 333
++ M + I+S G + E+L G
Sbjct: 184 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 243
Query: 334 SGPKIMLIDILYQRLSPPINQKIIQDIILVSTIAL----ACLRSKPKSRPTMQRI 384
Q L+ I + +A+ L R T +
Sbjct: 244 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQA 298
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 62.9 bits (152), Expect = 3e-12
Identities = 24/159 (15%), Positives = 49/159 (30%), Gaps = 29/159 (18%)
Query: 151 IGTGGYDSVYKAELPDGKVVALKKLHHSETE-----------DSAFVVYSPQCMFFIYEY 199
+G G +V+ +K T D F V + + +
Sbjct: 8 MGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRA 67
Query: 200 M--------------ERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSI 245
+ E ++ L D E + ++ + ++ +H I
Sbjct: 68 LQKLQGLAVPKVYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFYHRG---I 124
Query: 246 VHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRTLQ 284
VH D+S N+L+ S ++ DF + + L+
Sbjct: 125 VHGDLSQYNVLV-SEEGIWIIDFPQSVEVGEEGWREILE 162
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 38.2 bits (87), Expect = 0.001
Identities = 19/50 (38%), Positives = 27/50 (54%), Gaps = 3/50 (6%)
Query: 15 SGVVEEEPSSPSFLKS-DMSFNNLDGEIPT--YLRDNPPKSFVGNKGLCG 61
G + + + FL S ++SFNNL GEIP L+ ++ NK LCG
Sbjct: 257 YGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCG 306
|
Homologous Domains Detected by HHsearch 
Original result of HHsearch against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 412 | |||
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.87 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 98.78 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 97.84 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.19 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 97.05 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 96.84 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 96.5 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 96.47 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 96.28 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 95.96 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 95.85 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 95.59 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.51 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 95.38 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 94.76 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 94.72 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 94.39 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 93.35 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 93.01 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 92.93 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 92.26 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 92.17 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 91.79 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 91.65 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 91.08 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 90.86 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 90.75 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 90.54 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 89.25 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 88.82 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 88.17 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 88.12 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 87.92 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 86.56 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 85.84 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 82.15 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 80.65 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 80.29 |
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-51 Score=379.73 Aligned_cols=235 Identities=20% Similarity=0.269 Sum_probs=184.3
Q ss_pred cCcccceeeeecCceEEEEEEeCCCcEEEEEec--------------------cCCccccceEEEecCceEEEEEEeccC
Q 042435 143 EYFHIRYCIGTGGYDSVYKAELPDGKVVALKKL--------------------HHSETEDSAFVVYSPQCMFFIYEYMER 202 (412)
Q Consensus 143 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~l--------------------~~~~~~~~~~~~~~~~~~~lv~ey~~~ 202 (412)
++|++.+.||+|+||+||+|++.+++.||||++ +|+|+....+++..++..++||||+++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~ 84 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEH 84 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTT
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCC
Confidence 578899999999999999999999999999965 688999999999999999999999999
Q ss_pred CceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCCCC-c
Q 042435 203 GSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSN-R 281 (412)
Q Consensus 203 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~-~ 281 (412)
|+|.+++.... ..++|..++.++.|+|+||+|||++ +|+||||||+|||+++++.+||+|||+++........ .
T Consensus 85 g~L~~~l~~~~--~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~ 159 (263)
T d1sm2a_ 85 GCLSDYLRTQR--GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS 159 (263)
T ss_dssp CBHHHHHHTTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC-------------
T ss_pred CcHHHHhhccc--cCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchheeccCCCceee
Confidence 99999887653 2589999999999999999999998 9999999999999999999999999999876544322 2
Q ss_pred ccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccchhhHHHHH
Q 042435 282 TLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKIIQDII 361 (412)
Q Consensus 282 ~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 361 (412)
....||+.|+|||++.+..++.++|||||||++|||+|+..|+.. ......+.+.+........+.... .
T Consensus 160 ~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~-------~~~~~~~~~~i~~~~~~~~p~~~~---~ 229 (263)
T d1sm2a_ 160 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYE-------NRSNSEVVEDISTGFRLYKPRLAS---T 229 (263)
T ss_dssp -----CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTC-------SCCHHHHHHHHHHTCCCCCCTTSC---H
T ss_pred cceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCC-------CCCHHHHHHHHHhcCCCCCccccC---H
Confidence 345789999999999999999999999999999999996544331 111122233333333332222222 2
Q ss_pred HHHHHHHhcCcCCCCCCCCHHHHHHHHhcCC
Q 042435 362 LVSTIALACLRSKPKSRPTMQRISQELEGKT 392 (412)
Q Consensus 362 ~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 392 (412)
.+.+++.+||+.||++||||+||+++|+++.
T Consensus 230 ~l~~li~~cl~~~p~~Rps~~~il~~L~~i~ 260 (263)
T d1sm2a_ 230 HVYQIMNHCWKERPEDRPAFSRLLRQLAEIA 260 (263)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHHHccCCHhHCcCHHHHHHHHHHHH
Confidence 4789999999999999999999999999864
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=6.4e-51 Score=383.90 Aligned_cols=246 Identities=27% Similarity=0.390 Sum_probs=187.3
Q ss_pred ccHHHHHHhhc---------CcccceeeeecCceEEEEEEeCC-C---cEEEEEe----------------------ccC
Q 042435 133 ILYENLIDATE---------YFHIRYCIGTGGYDSVYKAELPD-G---KVVALKK----------------------LHH 177 (412)
Q Consensus 133 ~~~~~l~~~~~---------~f~~~~~lG~G~~g~Vy~~~~~~-~---~~vAvK~----------------------l~~ 177 (412)
++|+++.+++. +|++.++||+|+||+||+|.++. + ..||||. ++|
T Consensus 7 ~t~~d~~~a~~~f~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H 86 (299)
T d1jpaa_ 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDH 86 (299)
T ss_dssp GGSSSHHHHHHHHSCBCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCC
T ss_pred CCHHHHHHHHhhhchhhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCC
Confidence 45555555544 45667899999999999998742 3 3689995 368
Q ss_pred CccccceEEEecCceEEEEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEe
Q 042435 178 SETEDSAFVVYSPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILL 257 (412)
Q Consensus 178 ~~~~~~~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl 257 (412)
+|+....+++..++..++|||||++|+|.+++..... .++|.+++.++.||++||+|||++ +|+||||||+|||+
T Consensus 87 pnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~~~~--~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl 161 (299)
T d1jpaa_ 87 PNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDG--QFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILV 161 (299)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHTTTT--CSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEE
T ss_pred CCCccEEEEEeeCCEEEEEEEecCCCcceeeeccccC--CCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEE
Confidence 9999999999999999999999999999998876432 489999999999999999999998 99999999999999
Q ss_pred cCCCcEEEeecCCccccCCCCCCc-----ccccccccccccccccCcccCcccccHHHHHHHHHHHh-CCCCcccccccc
Q 042435 258 NSNLEAFVADFGTVRLLDVDSSNR-----TLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLM-GTHPGELLLSLS 331 (412)
Q Consensus 258 ~~~~~~kl~DfGla~~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~ellt-g~~P~~~~~~~~ 331 (412)
+.++++||+|||+++......... ....||+.|+|||.+.+..++.++|||||||++|||+| |+.||...
T Consensus 162 ~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~---- 237 (299)
T d1jpaa_ 162 NSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDM---- 237 (299)
T ss_dssp CTTCCEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC----
T ss_pred CCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCC----
Confidence 999999999999998765432211 22457899999999999999999999999999999998 89998732
Q ss_pred cCCCCcchhhHHhhhccCCccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhcCCCC
Q 042435 332 SSSGPKIMLIDILYQRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELEGKTPM 394 (412)
Q Consensus 332 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~ 394 (412)
....+...+......+.+... ...+.+++.+||+.||++||||.||++.|+++...
T Consensus 238 ----~~~~~~~~i~~~~~~~~~~~~---~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~ 293 (299)
T d1jpaa_ 238 ----TNQDVINAIEQDYRLPPPMDC---PSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN 293 (299)
T ss_dssp ----CHHHHHHHHHTTCCCCCCTTC---CHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred ----CHHHHHHHHHcCCCCCCCccc---hHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcC
Confidence 111223333333333322222 23478899999999999999999999999987543
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-50 Score=376.51 Aligned_cols=235 Identities=23% Similarity=0.337 Sum_probs=190.0
Q ss_pred hcCcccceeeeecCceEEEEEEeCCCcEEEEEec--------------------cCCccccceEEEecCceEEEEEEecc
Q 042435 142 TEYFHIRYCIGTGGYDSVYKAELPDGKVVALKKL--------------------HHSETEDSAFVVYSPQCMFFIYEYME 201 (412)
Q Consensus 142 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~l--------------------~~~~~~~~~~~~~~~~~~~lv~ey~~ 201 (412)
.++|++.+.||+|+||+||+|.+++++.||||++ +|+|+.+..+++. .+..++||||++
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~-~~~~~iv~Ey~~ 90 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYME 90 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCT
T ss_pred HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcCCHHHHHHHHHHHHhCCCCCEeEEEeeec-cCCeEEEEEeCC
Confidence 4578899999999999999999988899999965 5788888877664 456799999999
Q ss_pred CCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCCC-C
Q 042435 202 RGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSS-N 280 (412)
Q Consensus 202 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~-~ 280 (412)
+|+|.+++..... ..++|..+++|+.||++||+|||++ +|+||||||+|||+++++.+||+|||+|+....... .
T Consensus 91 ~g~L~~~~~~~~~-~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~~ 166 (272)
T d1qpca_ 91 NGSLVDFLKTPSG-IKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTA 166 (272)
T ss_dssp TCBHHHHTTSHHH-HTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEEC
T ss_pred CCcHHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccceEEccCCcccc
Confidence 9999987765432 3599999999999999999999998 999999999999999999999999999997754332 2
Q ss_pred cccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccchhhHHHH
Q 042435 281 RTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKIIQDI 360 (412)
Q Consensus 281 ~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 360 (412)
.....||+.|+|||++.+..++.++|||||||++|||+||..|+... .........+.....+..+....+
T Consensus 167 ~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~-------~~~~~~~~~i~~~~~~~~p~~~~~-- 237 (272)
T d1qpca_ 167 REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG-------MTNPEVIQNLERGYRMVRPDNCPE-- 237 (272)
T ss_dssp CTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTT-------CCHHHHHHHHHTTCCCCCCTTCCH--
T ss_pred ccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCC-------CCHHHHHHHHHhcCCCCCcccChH--
Confidence 34457899999999999899999999999999999999976664411 111122233333333332232222
Q ss_pred HHHHHHHHhcCcCCCCCCCCHHHHHHHHhcC
Q 042435 361 ILVSTIALACLRSKPKSRPTMQRISQELEGK 391 (412)
Q Consensus 361 ~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 391 (412)
.+.+++.+||+.||++||||+||++.|++.
T Consensus 238 -~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ 267 (272)
T d1qpca_ 238 -ELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267 (272)
T ss_dssp -HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -HHHHHHHHHcCCCHhHCcCHHHHHHHhhhh
Confidence 378899999999999999999999999864
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-50 Score=377.45 Aligned_cols=237 Identities=23% Similarity=0.342 Sum_probs=184.0
Q ss_pred hcCcccceeeeecCceEEEEEEeCCCcEEEEEec-----------------------cCCccccceEEEecCceEEEEEE
Q 042435 142 TEYFHIRYCIGTGGYDSVYKAELPDGKVVALKKL-----------------------HHSETEDSAFVVYSPQCMFFIYE 198 (412)
Q Consensus 142 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~l-----------------------~~~~~~~~~~~~~~~~~~~lv~e 198 (412)
.++|++.+.||+|+||+||+|++++ .||||++ +|+|+.....++. .+..++|||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~~~lv~E 83 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIVTQ 83 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESSS--EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEECC--EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccEEEEEEe
Confidence 4678899999999999999998753 5999965 5788887776654 456899999
Q ss_pred eccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCC
Q 042435 199 YMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDS 278 (412)
Q Consensus 199 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~ 278 (412)
||++|+|.+++..... .++|..++.++.||++||+|||++ +|+||||||+|||++.++.+||+|||+|+......
T Consensus 84 y~~~g~L~~~l~~~~~--~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~ 158 (276)
T d1uwha_ 84 WCEGSSLYHHLHIIET--KFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS 158 (276)
T ss_dssp CCCEEEHHHHHHTSCC--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSCC-----
T ss_pred cCCCCCHHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEccccceeeccccC
Confidence 9999999999975432 589999999999999999999998 99999999999999999999999999998765432
Q ss_pred C--CcccccccccccccccccC---cccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCc-c
Q 042435 279 S--NRTLQAGTYGYIALELVYT---MVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPP-I 352 (412)
Q Consensus 279 ~--~~~~~~gt~~y~aPE~~~~---~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 352 (412)
. ......||+.|||||++.+ ..++.++|||||||++|||+||+.||... .....+...+......+ .
T Consensus 159 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~-------~~~~~~~~~~~~~~~~p~~ 231 (276)
T d1uwha_ 159 GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNI-------NNRDQIIFMVGRGYLSPDL 231 (276)
T ss_dssp -------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTC-------CCHHHHHHHHHHTSCCCCG
T ss_pred CcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCC-------ChHHHHHHHHhcCCCCCcc
Confidence 2 2345679999999999864 35899999999999999999999999732 12222333333322221 1
Q ss_pred chhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhcCCC
Q 042435 353 NQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELEGKTP 393 (412)
Q Consensus 353 ~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 393 (412)
..........+.+++.+||+.||++||||+||+++|+.+..
T Consensus 232 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~ 272 (276)
T d1uwha_ 232 SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR 272 (276)
T ss_dssp GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 11111222348899999999999999999999999987753
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-50 Score=372.81 Aligned_cols=231 Identities=23% Similarity=0.265 Sum_probs=187.7
Q ss_pred hcCcccceeeeecCceEEEEEEe-CCCcEEEEEec----------------------cCCccccceEEEecCceEEEEEE
Q 042435 142 TEYFHIRYCIGTGGYDSVYKAEL-PDGKVVALKKL----------------------HHSETEDSAFVVYSPQCMFFIYE 198 (412)
Q Consensus 142 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l----------------------~~~~~~~~~~~~~~~~~~~lv~e 198 (412)
.++|++.+.||+|+||+||+|.. .+|+.||||++ +|+|+......+.+++..|+|||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence 46799999999999999999987 46999999954 68888888888999999999999
Q ss_pred eccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCC
Q 042435 199 YMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDS 278 (412)
Q Consensus 199 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~ 278 (412)
||++|+|.+++.... .+++.++..++.|+++||+|||++ +|+||||||+|||+++++.+||+|||+|+......
T Consensus 84 y~~gg~L~~~l~~~~---~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~ 157 (271)
T d1nvra_ 84 YCSGGELFDRIEPDI---GMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 157 (271)
T ss_dssp CCTTEEGGGGSBTTT---BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred ccCCCcHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchhheeeccCC
Confidence 999999999997654 599999999999999999999999 99999999999999999999999999998764432
Q ss_pred --CCcccccccccccccccccCccc-CcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccchh
Q 042435 279 --SNRTLQAGTYGYIALELVYTMVV-TEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQK 355 (412)
Q Consensus 279 --~~~~~~~gt~~y~aPE~~~~~~~-s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 355 (412)
.......||+.|+|||++.+..+ +.++|||||||++|||+||+.||... ......................
T Consensus 158 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~------~~~~~~~~~~~~~~~~~~~~~~ 231 (271)
T d1nvra_ 158 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQP------SDSCQEYSDWKEKKTYLNPWKK 231 (271)
T ss_dssp EECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSS------STTSHHHHHHHTTCTTSTTGGG
T ss_pred ccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCC------ChHHHHHHHHhcCCCCCCcccc
Confidence 22345679999999999988776 57899999999999999999999632 1111112222222222111111
Q ss_pred hHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 356 IIQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 356 ~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
. ...+.+++.+||+.||++|||++|++++
T Consensus 232 ~---s~~~~~li~~~L~~dP~~R~t~~eil~h 260 (271)
T d1nvra_ 232 I---DSAPLALLHKILVENPSARITIPDIKKD 260 (271)
T ss_dssp S---CHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred C---CHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 1 2347789999999999999999999764
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=9.9e-51 Score=380.38 Aligned_cols=239 Identities=22% Similarity=0.279 Sum_probs=198.3
Q ss_pred hhcCcccceeeeecCceEEEEEEeC-CCcEEEEEec--------------------cCCccccceEEEecCceEEEEEEe
Q 042435 141 ATEYFHIRYCIGTGGYDSVYKAELP-DGKVVALKKL--------------------HHSETEDSAFVVYSPQCMFFIYEY 199 (412)
Q Consensus 141 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l--------------------~~~~~~~~~~~~~~~~~~~lv~ey 199 (412)
..++|++.+.||+|+||+||+|.+. +|+.||||++ +|+|+....+.+.+++..++||||
T Consensus 15 ~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~ 94 (287)
T d1opja_ 15 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 94 (287)
T ss_dssp CGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred cHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeec
Confidence 3467899999999999999999875 5889999965 688999999999999999999999
Q ss_pred ccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCCC
Q 042435 200 MERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSS 279 (412)
Q Consensus 200 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 279 (412)
|++|+|.+++..... ..++|..++.++.|+++||+|||++ +|+||||||+|||+++++.+||+|||+++.......
T Consensus 95 ~~~g~l~~~l~~~~~-~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~ 170 (287)
T d1opja_ 95 MTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 170 (287)
T ss_dssp CTTCBHHHHHHHSCT-TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSS
T ss_pred ccCcchHHHhhhccc-cchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEccccceeecCCCCc
Confidence 999999999865432 2589999999999999999999998 999999999999999999999999999997654433
Q ss_pred C-cccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccchhhHH
Q 042435 280 N-RTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKIIQ 358 (412)
Q Consensus 280 ~-~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 358 (412)
. .....||+.|+|||++.+..++.++|||||||++|||++|..|+... .....+.+.+.....++.+....+
T Consensus 171 ~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~-------~~~~~~~~~i~~~~~~~~~~~~~~ 243 (287)
T d1opja_ 171 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG-------IDLSQVYELLEKDYRMERPEGCPE 243 (287)
T ss_dssp EEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTT-------CCHHHHHHHHHTTCCCCCCTTCCH
T ss_pred eeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCc-------chHHHHHHHHhcCCCCCCCccchH
Confidence 2 23446889999999999999999999999999999999987776421 122223344444444443333333
Q ss_pred HHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhcCCC
Q 042435 359 DIILVSTIALACLRSKPKSRPTMQRISQELEGKTP 393 (412)
Q Consensus 359 ~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 393 (412)
.+.+++.+||+.||++|||++||++.|+.+..
T Consensus 244 ---~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~ 275 (287)
T d1opja_ 244 ---KVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275 (287)
T ss_dssp ---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred ---HHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 48899999999999999999999999998754
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-49 Score=367.54 Aligned_cols=233 Identities=24% Similarity=0.298 Sum_probs=194.9
Q ss_pred cCcccceeeeecCceEEEEEEeCCCcEEEEEec--------------------cCCccccceEEEecCceEEEEEEeccC
Q 042435 143 EYFHIRYCIGTGGYDSVYKAELPDGKVVALKKL--------------------HHSETEDSAFVVYSPQCMFFIYEYMER 202 (412)
Q Consensus 143 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~l--------------------~~~~~~~~~~~~~~~~~~~lv~ey~~~ 202 (412)
++|++.+.||+|+||+||+|++++++.||||.+ +|+|+.+..+++.+++..++||||+++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~ 83 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMAN 83 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTT
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCC
Confidence 689999999999999999999998999999964 688999999999999999999999999
Q ss_pred CceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCCC-Cc
Q 042435 203 GSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSS-NR 281 (412)
Q Consensus 203 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~-~~ 281 (412)
|+|.+++..... .+++..+.+++.|+++||+|||++ +|+||||||+||++++++.+||+|||+++....... ..
T Consensus 84 g~l~~~~~~~~~--~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 158 (258)
T d1k2pa_ 84 GCLLNYLREMRH--RFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSS 158 (258)
T ss_dssp EEHHHHHHSGGG--CCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCC
T ss_pred CcHHHhhhcccc--CCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhheeccCCCceee
Confidence 999988765543 589999999999999999999998 999999999999999999999999999987654432 23
Q ss_pred ccccccccccccccccCcccCcccccHHHHHHHHHHHh-CCCCcccccccccCCCCcchhhHHhhhccCCccchhhHHHH
Q 042435 282 TLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLM-GTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKIIQDI 360 (412)
Q Consensus 282 ~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 360 (412)
....||+.|+|||.+.+..++.++|||||||++|||+| |+.||... . ...+...+......+.+....
T Consensus 159 ~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~-------~-~~~~~~~i~~~~~~~~p~~~~--- 227 (258)
T d1k2pa_ 159 VGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERF-------T-NSETAEHIAQGLRLYRPHLAS--- 227 (258)
T ss_dssp CCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTS-------C-HHHHHHHHHTTCCCCCCTTCC---
T ss_pred cccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCC-------C-HHHHHHHHHhCCCCCCccccc---
Confidence 34578999999999999999999999999999999998 89998732 1 112222233333333223222
Q ss_pred HHHHHHHHhcCcCCCCCCCCHHHHHHHHhcC
Q 042435 361 ILVSTIALACLRSKPKSRPTMQRISQELEGK 391 (412)
Q Consensus 361 ~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 391 (412)
..+.+++.+||+.||++|||++|++++|.++
T Consensus 228 ~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 228 EKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp HHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred HHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence 2488999999999999999999999999764
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-49 Score=367.84 Aligned_cols=225 Identities=26% Similarity=0.363 Sum_probs=188.5
Q ss_pred cCcccceeeeecCceEEEEEEeC-CCcEEEEEec------------------------cCCccccceEEEecCceEEEEE
Q 042435 143 EYFHIRYCIGTGGYDSVYKAELP-DGKVVALKKL------------------------HHSETEDSAFVVYSPQCMFFIY 197 (412)
Q Consensus 143 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l------------------------~~~~~~~~~~~~~~~~~~~lv~ 197 (412)
++|++.+.||+|+||+||+|+.+ +|+.||+|.+ +|+++.+...++.+++..++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 57999999999999999999874 6899999953 6889999999999999999999
Q ss_pred EeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCC
Q 042435 198 EYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVD 277 (412)
Q Consensus 198 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~ 277 (412)
|||++|+|.+++.... .+++..+..++.||++||+|||++ +|+||||||+|||++.++.+||+|||+|+.....
T Consensus 86 Ey~~~g~L~~~l~~~~---~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~ 159 (263)
T d2j4za1 86 EYAPLGTVYRELQKLS---KFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 159 (263)
T ss_dssp ECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC
T ss_pred eecCCCcHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccceeeecCCC
Confidence 9999999999987543 589999999999999999999999 9999999999999999999999999999865433
Q ss_pred CCCcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccchhhH
Q 042435 278 SSNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKII 357 (412)
Q Consensus 278 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 357 (412)
......||+.|+|||++.+..++.++|||||||++|||+||+.||... ........+....... +....
T Consensus 160 --~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~-------~~~~~~~~i~~~~~~~--p~~~s 228 (263)
T d2j4za1 160 --RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN-------TYQETYKRISRVEFTF--PDFVT 228 (263)
T ss_dssp --CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCS-------SHHHHHHHHHTTCCCC--CTTSC
T ss_pred --cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCC-------CHHHHHHHHHcCCCCC--CccCC
Confidence 234567999999999999999999999999999999999999999732 1111222222222221 12222
Q ss_pred HHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 358 QDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 358 ~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
..+.+++.+||+.||++|||++|++++
T Consensus 229 ---~~~~~li~~~L~~dp~~R~t~~eil~h 255 (263)
T d2j4za1 229 ---EGARDLISRLLKHNPSQRPMLREVLEH 255 (263)
T ss_dssp ---HHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred ---HHHHHHHHHHccCCHhHCcCHHHHHcC
Confidence 237889999999999999999999864
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-49 Score=373.26 Aligned_cols=228 Identities=24% Similarity=0.334 Sum_probs=190.6
Q ss_pred cCcccceeeeecCceEEEEEEe-CCCcEEEEEec---------------------cCCccccceEEEecCceEEEEEEec
Q 042435 143 EYFHIRYCIGTGGYDSVYKAEL-PDGKVVALKKL---------------------HHSETEDSAFVVYSPQCMFFIYEYM 200 (412)
Q Consensus 143 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l---------------------~~~~~~~~~~~~~~~~~~~lv~ey~ 200 (412)
++|++.+.||+|+||+||+|.. .+|+.||||++ +|+|+......+.+++..|+|||||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 4699999999999999999976 57999999964 6888988888899999999999999
Q ss_pred cCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCCCC
Q 042435 201 ERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSN 280 (412)
Q Consensus 201 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 280 (412)
++|+|.+++... .+++.++..++.|++.||+|||++ +|+||||||+|||++.++++||+|||+++........
T Consensus 100 ~gg~L~~~~~~~----~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~ 172 (293)
T d1yhwa1 100 AGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 172 (293)
T ss_dssp TTCBHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCC
T ss_pred CCCcHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhheeecccccc
Confidence 999999887653 489999999999999999999999 9999999999999999999999999999987665555
Q ss_pred cccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhcc-CCccchhhHHH
Q 042435 281 RTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRL-SPPINQKIIQD 359 (412)
Q Consensus 281 ~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 359 (412)
.....||+.|+|||++.+..++.++|||||||++|||+||+.||... .....+..+..... ..+.+...
T Consensus 173 ~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~-------~~~~~~~~~~~~~~~~~~~~~~~--- 242 (293)
T d1yhwa1 173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNE-------NPLRALYLIATNGTPELQNPEKL--- 242 (293)
T ss_dssp BCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTS-------CHHHHHHHHHHHCSCCCSSGGGS---
T ss_pred ccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCC-------CHHHHHHHHHhCCCCCCCCcccC---
Confidence 56678999999999999999999999999999999999999999632 11111222222211 11111222
Q ss_pred HHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 360 IILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 360 ~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
...+.+++.+||+.||++|||++|++++
T Consensus 243 s~~~~~li~~~L~~dP~~R~s~~eil~H 270 (293)
T d1yhwa1 243 SAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (293)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 2347899999999999999999999874
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-49 Score=379.75 Aligned_cols=235 Identities=21% Similarity=0.319 Sum_probs=193.6
Q ss_pred hcCcccceeeeecCceEEEEEEeCC------CcEEEEEec-----------------------cCCccccceEEEecCce
Q 042435 142 TEYFHIRYCIGTGGYDSVYKAELPD------GKVVALKKL-----------------------HHSETEDSAFVVYSPQC 192 (412)
Q Consensus 142 ~~~f~~~~~lG~G~~g~Vy~~~~~~------~~~vAvK~l-----------------------~~~~~~~~~~~~~~~~~ 192 (412)
.++|++.++||+|+||+||+|++.. ...||+|.+ +|+++......+.+.+.
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~ 115 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 115 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCe
Confidence 3679999999999999999997642 236899953 58899999999999999
Q ss_pred EEEEEEeccCCceeeeeccCcc--------------------cccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCC
Q 042435 193 MFFIYEYMERGSLFCVLRDDDE--------------------AIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISS 252 (412)
Q Consensus 193 ~~lv~ey~~~gsL~~~l~~~~~--------------------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp 252 (412)
.++|||||++|+|.++++.... ...++|..++.++.|+++||+|||++ +|+||||||
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRDlKp 192 (325)
T d1rjba_ 116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAA 192 (325)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCSG
T ss_pred EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCch
Confidence 9999999999999999875431 13489999999999999999999998 999999999
Q ss_pred CCEEecCCCcEEEeecCCccccCCCCCC--cccccccccccccccccCcccCcccccHHHHHHHHHHHh-CCCCcccccc
Q 042435 253 NNILLNSNLEAFVADFGTVRLLDVDSSN--RTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLM-GTHPGELLLS 329 (412)
Q Consensus 253 ~NILl~~~~~~kl~DfGla~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~ellt-g~~P~~~~~~ 329 (412)
+|||++.++.+||+|||+|+........ .....||+.|||||++.+..++.++|||||||++|||+| |+.||...
T Consensus 193 ~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~-- 270 (325)
T d1rjba_ 193 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI-- 270 (325)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC--
T ss_pred hccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCC--
Confidence 9999999999999999999876554332 234568999999999999999999999999999999998 89998732
Q ss_pred cccCCCCcchhhHHhhhccCCccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHh
Q 042435 330 LSSSSGPKIMLIDILYQRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELE 389 (412)
Q Consensus 330 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~ 389 (412)
.....+..++.....++.+....+ .+.+|+.+||+.||++|||++||+++|.
T Consensus 271 -----~~~~~~~~~~~~~~~~~~p~~~~~---~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 271 -----PVDANFYKLIQNGFKMDQPFYATE---EIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp -----CCSHHHHHHHHTTCCCCCCTTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred -----CHHHHHHHHHhcCCCCCCCCcCCH---HHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 222334455555444433333323 3889999999999999999999999995
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-50 Score=373.82 Aligned_cols=234 Identities=25% Similarity=0.353 Sum_probs=175.1
Q ss_pred cCcccceeeeecCceEEEEEEe-CCCcEEEEEec-----------------------cCCccccceEEEec--CceEEEE
Q 042435 143 EYFHIRYCIGTGGYDSVYKAEL-PDGKVVALKKL-----------------------HHSETEDSAFVVYS--PQCMFFI 196 (412)
Q Consensus 143 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l-----------------------~~~~~~~~~~~~~~--~~~~~lv 196 (412)
++|++.+.||+|+||+||+|+. .+|+.||||.+ +|+++.+....+.+ .+..|+|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 6799999999999999999976 57999999964 57888877776654 4568999
Q ss_pred EEeccCCceeeeeccCc-ccccCCHHHHHHHHHHHHHHHHHHHhCC--CCCcEEeCCCCCCEEecCCCcEEEeecCCccc
Q 042435 197 YEYMERGSLFCVLRDDD-EAIELNWTRRMNIVKSVAHALSYLHHDC--TPSIVHRDISSNNILLNSNLEAFVADFGTVRL 273 (412)
Q Consensus 197 ~ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~~LH~~~--~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~ 273 (412)
||||++|+|.+++.... ....+++..++.++.|++.||+|||+.. ..+|+||||||+|||++.++.+||+|||+++.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 99999999999986542 2235999999999999999999999862 12599999999999999999999999999998
Q ss_pred cCCCCCCcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccc
Q 042435 274 LDVDSSNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPIN 353 (412)
Q Consensus 274 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 353 (412)
............||+.|+|||++.+..++.++|||||||++|||+||+.||... ........+...... +.+
T Consensus 164 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~-------~~~~~~~~i~~~~~~-~~~ 235 (269)
T d2java1 164 LNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAF-------SQKELAGKIREGKFR-RIP 235 (269)
T ss_dssp C-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS-------SHHHHHHHHHHTCCC-CCC
T ss_pred cccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCC-------CHHHHHHHHHcCCCC-CCC
Confidence 765544445678999999999999999999999999999999999999998732 111112222222222 222
Q ss_pred hhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 354 QKIIQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 354 ~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
.... ..+.+++.+||+.||++|||++|++++
T Consensus 236 ~~~s---~~l~~li~~~L~~dp~~Rps~~ell~h 266 (269)
T d2java1 236 YRYS---DELNEIITRMLNLKDYHRPSVEEILEN 266 (269)
T ss_dssp TTSC---HHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred cccC---HHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 2222 237889999999999999999999864
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-49 Score=372.38 Aligned_cols=238 Identities=26% Similarity=0.344 Sum_probs=187.3
Q ss_pred cCcccceeeeecCceEEEEEEeCCC-----cEEEEEec----------------------cCCccccceEEEecCceEEE
Q 042435 143 EYFHIRYCIGTGGYDSVYKAELPDG-----KVVALKKL----------------------HHSETEDSAFVVYSPQCMFF 195 (412)
Q Consensus 143 ~~f~~~~~lG~G~~g~Vy~~~~~~~-----~~vAvK~l----------------------~~~~~~~~~~~~~~~~~~~l 195 (412)
+.|+..++||+|+||+||+|.++++ ..||||++ +|+|+....+++.+.+..++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 4688899999999999999987532 47999964 68899999999999999999
Q ss_pred EEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccC
Q 042435 196 IYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLD 275 (412)
Q Consensus 196 v~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~ 275 (412)
||||+.+|++.+++.... ..++|.+++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 87 v~e~~~~~~l~~~~~~~~--~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 161 (283)
T d1mqba_ 87 ITEYMENGALDKFLREKD--GEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 161 (283)
T ss_dssp EEECCTTEEHHHHHHHTT--TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred EEEecccCcchhhhhccc--ccccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcccchhhccc
Confidence 999999999988776543 2599999999999999999999998 99999999999999999999999999998765
Q ss_pred CCCC---CcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCcc
Q 042435 276 VDSS---NRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPI 352 (412)
Q Consensus 276 ~~~~---~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 352 (412)
.... ......||+.|+|||++.+..++.++|||||||++|||+||..|+... .....+.+.+.....++.
T Consensus 162 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~-------~~~~~~~~~i~~~~~~~~ 234 (283)
T d1mqba_ 162 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWE-------LSNHEVMKAINDGFRLPT 234 (283)
T ss_dssp ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTT-------CCHHHHHHHHHTTCCCCC
T ss_pred CCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCcccc-------CCHHHHHHHHhccCCCCC
Confidence 4322 123346899999999999999999999999999999999976665421 122223344444444443
Q ss_pred chhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhcCCCCC
Q 042435 353 NQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELEGKTPMK 395 (412)
Q Consensus 353 ~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~~ 395 (412)
+.... ..+.+++.+||+.||++||||.||++.|+++.+.+
T Consensus 235 ~~~~~---~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~p 274 (283)
T d1mqba_ 235 PMDCP---SAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP 274 (283)
T ss_dssp CTTCB---HHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred chhhH---HHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhCc
Confidence 33322 34889999999999999999999999998876543
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-49 Score=367.12 Aligned_cols=232 Identities=21% Similarity=0.289 Sum_probs=187.4
Q ss_pred cCccccee-eeecCceEEEEEEeC---CCcEEEEEec----------------------cCCccccceEEEecCceEEEE
Q 042435 143 EYFHIRYC-IGTGGYDSVYKAELP---DGKVVALKKL----------------------HHSETEDSAFVVYSPQCMFFI 196 (412)
Q Consensus 143 ~~f~~~~~-lG~G~~g~Vy~~~~~---~~~~vAvK~l----------------------~~~~~~~~~~~~~~~~~~~lv 196 (412)
++|.+.+. ||+|+||+||+|.++ ++..||||.+ +|+|+....+++.+ +..++|
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv 86 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 86 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence 45667774 999999999999764 3558999964 68888888887754 568999
Q ss_pred EEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCC
Q 042435 197 YEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDV 276 (412)
Q Consensus 197 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~ 276 (412)
||||++|+|.+++..... .+++.++..++.|+++||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 87 mE~~~~g~L~~~l~~~~~--~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~ 161 (285)
T d1u59a_ 87 MEMAGGGPLHKFLVGKRE--EIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGA 161 (285)
T ss_dssp EECCTTEEHHHHHTTCTT--TSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred EEeCCCCcHHHHhhcccc--CCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccchhhhcccc
Confidence 999999999998765432 589999999999999999999998 999999999999999999999999999987754
Q ss_pred CCCC---cccccccccccccccccCcccCcccccHHHHHHHHHHHh-CCCCcccccccccCCCCcchhhHHhhhccCCcc
Q 042435 277 DSSN---RTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLM-GTHPGELLLSLSSSSGPKIMLIDILYQRLSPPI 352 (412)
Q Consensus 277 ~~~~---~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 352 (412)
.... .....||+.|+|||++.+..++.++|||||||++|||+| |+.||... . ...+...+.....++.
T Consensus 162 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~-------~-~~~~~~~i~~~~~~~~ 233 (285)
T d1u59a_ 162 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM-------K-GPEVMAFIEQGKRMEC 233 (285)
T ss_dssp CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC-------C-THHHHHHHHTTCCCCC
T ss_pred cccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCC-------C-HHHHHHHHHcCCCCCC
Confidence 3322 234568999999999999999999999999999999998 89998732 1 1122333333333333
Q ss_pred chhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhcC
Q 042435 353 NQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELEGK 391 (412)
Q Consensus 353 ~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 391 (412)
+.... ..+.+++.+||+.||++||||.+|.+.|+..
T Consensus 234 p~~~~---~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~ 269 (285)
T d1u59a_ 234 PPECP---PELYALMSDCWIYKWEDRPDFLTVEQRMRAC 269 (285)
T ss_dssp CTTCC---HHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCcCC---HHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 33322 2478999999999999999999999998764
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-49 Score=370.33 Aligned_cols=230 Identities=23% Similarity=0.310 Sum_probs=187.1
Q ss_pred cCcccceeeeecCceEEEEEEe-CCCcEEEEEec---------------------cCCccccceEEEecCceEEEEEEec
Q 042435 143 EYFHIRYCIGTGGYDSVYKAEL-PDGKVVALKKL---------------------HHSETEDSAFVVYSPQCMFFIYEYM 200 (412)
Q Consensus 143 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l---------------------~~~~~~~~~~~~~~~~~~~lv~ey~ 200 (412)
+.|++.+.||+|+||+||+|+. .+|+.||||++ +|+|+.+...++.+++..++|||||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 5689999999999999999987 46899999964 6888888888999999999999999
Q ss_pred cCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCCCC
Q 042435 201 ERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSN 280 (412)
Q Consensus 201 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 280 (412)
++|+|.+++.... ..+++.++..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+|+........
T Consensus 92 ~~g~L~~~~~~~~--~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~~ 166 (288)
T d2jfla1 92 AGGAVDAVMLELE--RPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQR 166 (288)
T ss_dssp TTEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHHH
T ss_pred CCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhhccCCCccc
Confidence 9999999876432 2589999999999999999999999 9999999999999999999999999999765433222
Q ss_pred ccccccccccccccccc-----CcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCC-ccch
Q 042435 281 RTLQAGTYGYIALELVY-----TMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSP-PINQ 354 (412)
Q Consensus 281 ~~~~~gt~~y~aPE~~~-----~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 354 (412)
.....||+.|+|||++. ...++.++|||||||++|||+||+.||... .....+..+....... ..+.
T Consensus 167 ~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~-------~~~~~~~~i~~~~~~~~~~~~ 239 (288)
T d2jfla1 167 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHEL-------NPMRVLLKIAKSEPPTLAQPS 239 (288)
T ss_dssp HTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTS-------CGGGHHHHHHHSCCCCCSSGG
T ss_pred ccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCC-------CHHHHHHHHHcCCCCCCCccc
Confidence 34567999999999984 456889999999999999999999999732 2222233333322111 1111
Q ss_pred hhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 355 KIIQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 355 ~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
.....+.+++.+||+.||++|||++|++++
T Consensus 240 ---~~s~~~~~li~~~L~~dp~~R~t~~ell~h 269 (288)
T d2jfla1 240 ---RWSSNFKDFLKKCLEKNVDARWTTSQLLQH 269 (288)
T ss_dssp ---GSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred ---cCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 222347899999999999999999999875
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-49 Score=370.50 Aligned_cols=237 Identities=21% Similarity=0.272 Sum_probs=182.8
Q ss_pred cCcccceeeeecCceEEEEEEeC------CCcEEEEEec-----------------------cCCccccceEEEec-Cce
Q 042435 143 EYFHIRYCIGTGGYDSVYKAELP------DGKVVALKKL-----------------------HHSETEDSAFVVYS-PQC 192 (412)
Q Consensus 143 ~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vAvK~l-----------------------~~~~~~~~~~~~~~-~~~ 192 (412)
++|++.+.||+|+||.||+|.+. +++.||||++ +|+++......+.. ++.
T Consensus 13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~ 92 (299)
T d1ywna1 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 92 (299)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSC
T ss_pred HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCe
Confidence 67999999999999999999763 3578999976 34555555555554 456
Q ss_pred EEEEEEeccCCceeeeeccCcc-------------cccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecC
Q 042435 193 MFFIYEYMERGSLFCVLRDDDE-------------AIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNS 259 (412)
Q Consensus 193 ~~lv~ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~ 259 (412)
.++|||||++|+|.++++.... ...++|.+++.++.||++||+|||++ +|+||||||+|||+++
T Consensus 93 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlKp~NILl~~ 169 (299)
T d1ywna1 93 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSE 169 (299)
T ss_dssp CEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECG
T ss_pred EEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcCCccceeECC
Confidence 8999999999999999875431 22489999999999999999999999 9999999999999999
Q ss_pred CCcEEEeecCCccccCCCCC--CcccccccccccccccccCcccCcccccHHHHHHHHHHHhCC-CCcccccccccCCCC
Q 042435 260 NLEAFVADFGTVRLLDVDSS--NRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGT-HPGELLLSLSSSSGP 336 (412)
Q Consensus 260 ~~~~kl~DfGla~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~-~P~~~~~~~~~~~~~ 336 (412)
++.+||+|||+|+....... ......||+.|+|||++.+..++.++|||||||++|||+||. .||... ..
T Consensus 170 ~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~-------~~ 242 (299)
T d1ywna1 170 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV-------KI 242 (299)
T ss_dssp GGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC-------CC
T ss_pred CCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCC-------CH
Confidence 99999999999987654332 234567999999999999999999999999999999999975 566521 22
Q ss_pred cchhhHHhhhccCCccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhcCC
Q 042435 337 KIMLIDILYQRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELEGKT 392 (412)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 392 (412)
...+...+.....++.+..... .+.+++.+||+.||++|||++|++++|+++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~---~l~~li~~cl~~dP~~Rpt~~eil~~L~~il 295 (299)
T d1ywna1 243 DEEFCRRLKEGTRMRAPDYTTP---EMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 295 (299)
T ss_dssp SHHHHHHHHHTCCCCCCTTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHHhcCCCCCCCccCCH---HHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 2233444444444433333222 3789999999999999999999999998763
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-49 Score=365.52 Aligned_cols=225 Identities=21% Similarity=0.267 Sum_probs=182.3
Q ss_pred eeeeecCceEEEEEEeC---CCcEEEEEec-----------------------cCCccccceEEEecCceEEEEEEeccC
Q 042435 149 YCIGTGGYDSVYKAELP---DGKVVALKKL-----------------------HHSETEDSAFVVYSPQCMFFIYEYMER 202 (412)
Q Consensus 149 ~~lG~G~~g~Vy~~~~~---~~~~vAvK~l-----------------------~~~~~~~~~~~~~~~~~~~lv~ey~~~ 202 (412)
++||+|+||+||+|.++ .++.||||++ +|+|+....+++.. +..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 57999999999999764 3568999964 68888888887754 567899999999
Q ss_pred CceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCCCCc-
Q 042435 203 GSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNR- 281 (412)
Q Consensus 203 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~- 281 (412)
|+|.++++... .++|..++.++.||++||+|||++ +|+||||||+|||++.++.+||+|||+++.........
T Consensus 92 g~L~~~l~~~~---~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~ 165 (277)
T d1xbba_ 92 GPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 165 (277)
T ss_dssp EEHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEE
T ss_pred CcHHHHHhhcc---CCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhccccccccc
Confidence 99999987654 599999999999999999999998 99999999999999999999999999998765443222
Q ss_pred --ccccccccccccccccCcccCcccccHHHHHHHHHHHh-CCCCcccccccccCCCCcchhhHHhhhccCCccchhhHH
Q 042435 282 --TLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLM-GTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKIIQ 358 (412)
Q Consensus 282 --~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 358 (412)
....||+.|+|||.+.+..++.++|||||||++|||+| |+.||... ....+...+.....++.+...+
T Consensus 166 ~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~--------~~~~~~~~i~~~~~~~~p~~~~- 236 (277)
T d1xbba_ 166 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM--------KGSEVTAMLEKGERMGCPAGCP- 236 (277)
T ss_dssp C----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTC--------CHHHHHHHHHTTCCCCCCTTCC-
T ss_pred cccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCC--------CHHHHHHHHHcCCCCCCCcccC-
Confidence 33568999999999999999999999999999999998 89998732 1122333333333333333322
Q ss_pred HHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhcC
Q 042435 359 DIILVSTIALACLRSKPKSRPTMQRISQELEGK 391 (412)
Q Consensus 359 ~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 391 (412)
..+.+++.+||+.||++|||++||.+.|+..
T Consensus 237 --~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~ 267 (277)
T d1xbba_ 237 --REMYDLMNLCWTYDVENRPGFAAVELRLRNY 267 (277)
T ss_dssp --HHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred --HHHHHHHHHHcCCCHhHCcCHHHHHHHhhCH
Confidence 3478999999999999999999999988753
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-48 Score=365.79 Aligned_cols=237 Identities=24% Similarity=0.342 Sum_probs=187.6
Q ss_pred cCcccceeeeecCceEEEEEEeCCCcEEEEEec--------------------cCCccccceEEEecCceEEEEEEeccC
Q 042435 143 EYFHIRYCIGTGGYDSVYKAELPDGKVVALKKL--------------------HHSETEDSAFVVYSPQCMFFIYEYMER 202 (412)
Q Consensus 143 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~l--------------------~~~~~~~~~~~~~~~~~~~lv~ey~~~ 202 (412)
++|++.+.||+|+||+||+|.+++++.||||++ +|+++......+. .+..++||||+++
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~Ey~~~ 95 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMSK 95 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEECCCTT
T ss_pred HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCCHHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEEEEEecCC
Confidence 579999999999999999999988889999965 5788888887774 5568999999999
Q ss_pred CceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCC-CCc
Q 042435 203 GSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDS-SNR 281 (412)
Q Consensus 203 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~-~~~ 281 (412)
|+|..++...... .++|.+++.++.||+.||+|||++ +|+||||||+|||+|.++++||+|||+++...... ...
T Consensus 96 g~l~~~~~~~~~~-~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 171 (285)
T d1fmka3 96 GSLLDFLKGETGK-YLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR 171 (285)
T ss_dssp CBHHHHHSHHHHT-TCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC----------
T ss_pred Cchhhhhhhcccc-cchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchhhhccCCCceee
Confidence 9999887754322 499999999999999999999998 99999999999999999999999999998764433 223
Q ss_pred ccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccchhhHHHHH
Q 042435 282 TLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKIIQDII 361 (412)
Q Consensus 282 ~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 361 (412)
....||+.|+|||++....++.++|||||||++|||+||..|+... .....+...+......+.+....+
T Consensus 172 ~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~-------~~~~~~~~~i~~~~~~~~~~~~~~--- 241 (285)
T d1fmka3 172 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG-------MVNREVLDQVERGYRMPCPPECPE--- 241 (285)
T ss_dssp ----CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTT-------CCHHHHHHHHHTTCCCCCCTTSCH---
T ss_pred ccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCC-------CCHHHHHHHHHhcCCCCCCcccCH---
Confidence 4457899999999999999999999999999999999977775421 112223333333333333333323
Q ss_pred HHHHHHHhcCcCCCCCCCCHHHHHHHHhcCCCC
Q 042435 362 LVSTIALACLRSKPKSRPTMQRISQELEGKTPM 394 (412)
Q Consensus 362 ~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~ 394 (412)
.+.+++.+||+.||++||||++|++.|++.-..
T Consensus 242 ~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~ 274 (285)
T d1fmka3 242 SLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 274 (285)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred HHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcC
Confidence 488999999999999999999999999986543
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.2e-48 Score=368.98 Aligned_cols=244 Identities=22% Similarity=0.283 Sum_probs=194.8
Q ss_pred HHHHHHhhcCcccceeeeecCceEEEEEEeC------CCcEEEEEec----------------------cCCccccceEE
Q 042435 135 YENLIDATEYFHIRYCIGTGGYDSVYKAELP------DGKVVALKKL----------------------HHSETEDSAFV 186 (412)
Q Consensus 135 ~~~l~~~~~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vAvK~l----------------------~~~~~~~~~~~ 186 (412)
+.+++...++|++.+.||+|+||+||+|+++ +++.||||++ +|+++......
T Consensus 5 ~~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~ 84 (301)
T d1lufa_ 5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGV 84 (301)
T ss_dssp HHHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred hhhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceee
Confidence 3445556788999999999999999999863 4678999975 47888888888
Q ss_pred EecCceEEEEEEeccCCceeeeeccCc---------------------ccccCCHHHHHHHHHHHHHHHHHHHhCCCCCc
Q 042435 187 VYSPQCMFFIYEYMERGSLFCVLRDDD---------------------EAIELNWTRRMNIVKSVAHALSYLHHDCTPSI 245 (412)
Q Consensus 187 ~~~~~~~~lv~ey~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~i 245 (412)
+...+..+++|||+++|+|.++++... ....++|..++.++.|++.||+|||++ +|
T Consensus 85 ~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~i 161 (301)
T d1lufa_ 85 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KF 161 (301)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TC
T ss_pred eccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---Ce
Confidence 999999999999999999999886422 123489999999999999999999998 99
Q ss_pred EEeCCCCCCEEecCCCcEEEeecCCccccCCCCC--CcccccccccccccccccCcccCcccccHHHHHHHHHHHhCC-C
Q 042435 246 VHRDISSNNILLNSNLEAFVADFGTVRLLDVDSS--NRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGT-H 322 (412)
Q Consensus 246 vHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~-~ 322 (412)
+||||||+|||+|.++.+||+|||+++....... ......||+.|+|||.+.+..++.++|||||||++|||++|. .
T Consensus 162 vHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~ 241 (301)
T d1lufa_ 162 VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 241 (301)
T ss_dssp CCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred EeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCC
Confidence 9999999999999999999999999986543322 223457889999999999999999999999999999999986 4
Q ss_pred CcccccccccCCCCcchhhHHhhhccCCccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhcCC
Q 042435 323 PGELLLSLSSSSGPKIMLIDILYQRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELEGKT 392 (412)
Q Consensus 323 P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 392 (412)
||... ... .+...+.....++.+..... .+.+|+.+||+.||++||||.||++.|+++.
T Consensus 242 p~~~~-------~~~-e~~~~v~~~~~~~~p~~~~~---~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 242 PYYGM-------AHE-EVIYYVRDGNILACPENCPL---ELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp TTTTS-------CHH-HHHHHHHTTCCCCCCTTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CCCCC-------CHH-HHHHHHHcCCCCCCCccchH---HHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 66521 111 22222322222322222222 4789999999999999999999999999875
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-48 Score=365.23 Aligned_cols=227 Identities=22% Similarity=0.328 Sum_probs=185.7
Q ss_pred cCcccceeeeecCceEEEEEEe-CCCcEEEEEec------------------------cCCccccceEEEecCceEEEEE
Q 042435 143 EYFHIRYCIGTGGYDSVYKAEL-PDGKVVALKKL------------------------HHSETEDSAFVVYSPQCMFFIY 197 (412)
Q Consensus 143 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l------------------------~~~~~~~~~~~~~~~~~~~lv~ 197 (412)
++|++.+.||+|+||+||+|.. .+|+.||||.+ +|+++......+.+++..|+||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 5799999999999999999987 57999999954 6888988888899999999999
Q ss_pred EeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCC
Q 042435 198 EYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVD 277 (412)
Q Consensus 198 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~ 277 (412)
|||++|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+|+.+...
T Consensus 88 Ey~~gg~L~~~~~~~~---~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~ 161 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKIG---SFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 161 (288)
T ss_dssp CCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EccCCCCHHHhhhccC---CCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccccceecccC
Confidence 9999999999877544 589999999999999999999999 9999999999999999999999999999977543
Q ss_pred CC--CcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccchh
Q 042435 278 SS--NRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQK 355 (412)
Q Consensus 278 ~~--~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 355 (412)
.. ......||+.|+|||++.+..++.++|||||||++|||+||+.||... ........+....... +..
T Consensus 162 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~-------~~~~~~~~i~~~~~~~--p~~ 232 (288)
T d1uu3a_ 162 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG-------NEYLIFQKIIKLEYDF--PEK 232 (288)
T ss_dssp --------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCS-------SHHHHHHHHHTTCCCC--CTT
T ss_pred CcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCc-------CHHHHHHHHHcCCCCC--Ccc
Confidence 22 234457999999999999999999999999999999999999999732 1111222233222221 122
Q ss_pred hHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 356 IIQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 356 ~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
. ...+.+++.+||+.||++|||++|++++
T Consensus 233 ~---s~~~~~li~~~L~~dP~~R~t~~e~~~~ 261 (288)
T d1uu3a_ 233 F---FPKARDLVEKLLVLDATKRLGCEEMEGY 261 (288)
T ss_dssp C---CHHHHHHHHTTSCSSGGGSTTSGGGTCH
T ss_pred C---CHHHHHHHHHHccCCHhHCcCHHHHcCC
Confidence 2 2237899999999999999999997543
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-48 Score=357.39 Aligned_cols=227 Identities=22% Similarity=0.301 Sum_probs=177.6
Q ss_pred cccceeeeecCceEEEEEEeC-CCcEEEEEec-----------------------cCCccccceEEEec----CceEEEE
Q 042435 145 FHIRYCIGTGGYDSVYKAELP-DGKVVALKKL-----------------------HHSETEDSAFVVYS----PQCMFFI 196 (412)
Q Consensus 145 f~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l-----------------------~~~~~~~~~~~~~~----~~~~~lv 196 (412)
|+..++||+|+||+||+|... +++.||+|++ +|+|+.+....+.+ ....++|
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv 90 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 90 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence 356678999999999999874 6889999954 67888887776543 4568999
Q ss_pred EEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEec-CCCcEEEeecCCccccC
Q 042435 197 YEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLN-SNLEAFVADFGTVRLLD 275 (412)
Q Consensus 197 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~-~~~~~kl~DfGla~~~~ 275 (412)
|||+++|+|.+++.... .+++..+..++.||++||+|||++ .++|+||||||+|||++ +++.+||+|||+++...
T Consensus 91 mE~~~~g~L~~~l~~~~---~~~~~~~~~~~~qi~~gl~yLH~~-~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~ 166 (270)
T d1t4ha_ 91 TELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 166 (270)
T ss_dssp EECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EeCCCCCcHHHHHhccc---cccHHHHHHHHHHHHHHHHHHHHC-CCCEEeCCcChhhceeeCCCCCEEEeecCcceecc
Confidence 99999999999987543 589999999999999999999998 22399999999999996 57899999999998643
Q ss_pred CCCCCcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccchh
Q 042435 276 VDSSNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQK 355 (412)
Q Consensus 276 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 355 (412)
.. ......||+.|+|||++.+ .++.++|||||||++|||+||+.||... .....+...+.....+...
T Consensus 167 ~~--~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~-------~~~~~~~~~i~~~~~~~~~-- 234 (270)
T d1t4ha_ 167 AS--FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSEC-------QNAAQIYRRVTSGVKPASF-- 234 (270)
T ss_dssp TT--SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTC-------SSHHHHHHHHTTTCCCGGG--
T ss_pred CC--ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCc-------ccHHHHHHHHHcCCCCccc--
Confidence 32 2345689999999998865 5999999999999999999999998622 1111222222222222111
Q ss_pred hHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 356 IIQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 356 ~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
.......+.+++.+||+.||++|||++|++++
T Consensus 235 ~~~~~~~~~~li~~~l~~dp~~R~s~~ell~H 266 (270)
T d1t4ha_ 235 DKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 266 (270)
T ss_dssp GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CccCCHHHHHHHHHHccCCHhHCcCHHHHhCC
Confidence 11112347899999999999999999999874
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.6e-48 Score=368.56 Aligned_cols=231 Identities=23% Similarity=0.289 Sum_probs=177.4
Q ss_pred hcCcccceeeeecCceEEEEEEeC-CCcEEEEEec----------------------cCCccccceEEEecCceEEEEEE
Q 042435 142 TEYFHIRYCIGTGGYDSVYKAELP-DGKVVALKKL----------------------HHSETEDSAFVVYSPQCMFFIYE 198 (412)
Q Consensus 142 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l----------------------~~~~~~~~~~~~~~~~~~~lv~e 198 (412)
.+.|++.+.||+|+||+||+|... +|+.||||.+ +|+++.....++.+++..|+|||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 466999999999999999999874 6899999964 67888888888999999999999
Q ss_pred eccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEec---CCCcEEEeecCCccccC
Q 042435 199 YMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLN---SNLEAFVADFGTVRLLD 275 (412)
Q Consensus 199 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~---~~~~~kl~DfGla~~~~ 275 (412)
||++|+|.+++.... .+++.....++.|++.||+|||++ +|+||||||+|||+. +++.+||+|||+++...
T Consensus 88 ~~~gg~L~~~l~~~~---~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~ 161 (307)
T d1a06a_ 88 LVSGGELFDRIVEKG---FYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED 161 (307)
T ss_dssp CCCSCBHHHHHHTCS---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC-------
T ss_pred ccCCCcHHHhhhccc---CCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEeccceeEEcc
Confidence 999999999997654 599999999999999999999999 999999999999994 57899999999998664
Q ss_pred CCCCCcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccchh
Q 042435 276 VDSSNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQK 355 (412)
Q Consensus 276 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 355 (412)
... ......||+.|+|||++.+..++.++|||||||++|||+||+.||... ........+.......+. ..
T Consensus 162 ~~~-~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~-------~~~~~~~~i~~~~~~~~~-~~ 232 (307)
T d1a06a_ 162 PGS-VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDE-------NDAKLFEQILKAEYEFDS-PY 232 (307)
T ss_dssp ------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS-------SHHHHHHHHHTTCCCCCT-TT
T ss_pred CCC-eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCC-------CHHHHHHHHhccCCCCCC-cc
Confidence 432 233457999999999999999999999999999999999999999732 111122222222222111 11
Q ss_pred hHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 356 IIQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 356 ~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
.......+.+++.+||+.||++|||++|++++
T Consensus 233 ~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 233 WDDISDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp TTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred ccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 11122347899999999999999999999986
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.1e-48 Score=366.68 Aligned_cols=225 Identities=21% Similarity=0.299 Sum_probs=183.6
Q ss_pred cCcccceeeeecCceEEEEEEe-CCCcEEEEEec------------------------cCCccccceEEEecCceEEEEE
Q 042435 143 EYFHIRYCIGTGGYDSVYKAEL-PDGKVVALKKL------------------------HHSETEDSAFVVYSPQCMFFIY 197 (412)
Q Consensus 143 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l------------------------~~~~~~~~~~~~~~~~~~~lv~ 197 (412)
+.|+..+.||+|+||+||+|.. .+|+.||||++ +|+|+.....++.+++..++||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 4589999999999999999976 57899999964 5888988888999999999999
Q ss_pred EeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCC
Q 042435 198 EYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVD 277 (412)
Q Consensus 198 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~ 277 (412)
|||++|+|..++.... .+++.++..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 95 E~~~~g~l~~~~~~~~---~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~ 168 (309)
T d1u5ra_ 95 EYCLGSASDLLEVHKK---PLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 168 (309)
T ss_dssp ECCSEEHHHHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB
T ss_pred EecCCCchHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeecccccccCCC
Confidence 9999999876655433 599999999999999999999999 9999999999999999999999999999865432
Q ss_pred CCCcccccccccccccccccC---cccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccch
Q 042435 278 SSNRTLQAGTYGYIALELVYT---MVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQ 354 (412)
Q Consensus 278 ~~~~~~~~gt~~y~aPE~~~~---~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 354 (412)
....||+.|+|||++.+ ..|+.++|||||||++|||++|+.||... .....+..+...........
T Consensus 169 ----~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~-------~~~~~~~~i~~~~~~~~~~~ 237 (309)
T d1u5ra_ 169 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM-------NAMSALYHIAQNESPALQSG 237 (309)
T ss_dssp ----CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTS-------CHHHHHHHHHHSCCCCCSCT
T ss_pred ----CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCC-------CHHHHHHHHHhCCCCCCCCC
Confidence 34579999999999864 46899999999999999999999998632 11112223333222222112
Q ss_pred hhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 355 KIIQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 355 ~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
.. ...+.+++.+||+.||++|||++|++++
T Consensus 238 ~~---s~~~~~li~~~L~~dP~~Rpt~~ell~H 267 (309)
T d1u5ra_ 238 HW---SEYFRNFVDSCLQKIPQDRPTSEVLLKH 267 (309)
T ss_dssp TS---CHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred CC---CHHHHHHHHHHCcCChhHCcCHHHHHhC
Confidence 12 2247899999999999999999999874
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-48 Score=370.66 Aligned_cols=236 Identities=23% Similarity=0.293 Sum_probs=185.1
Q ss_pred hcCcccceeeeecCceEEEEEEe-CCCcEEEEEec----------------------cCCccccceEEEecCceEEEEEE
Q 042435 142 TEYFHIRYCIGTGGYDSVYKAEL-PDGKVVALKKL----------------------HHSETEDSAFVVYSPQCMFFIYE 198 (412)
Q Consensus 142 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l----------------------~~~~~~~~~~~~~~~~~~~lv~e 198 (412)
.++|++.+.||+|+||+||+|.. .+|+.||+|++ +|+|+.+...++.+++..++|||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE 84 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 84 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 57899999999999999999986 57899999964 58888888899999999999999
Q ss_pred eccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHh-CCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCC
Q 042435 199 YMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHH-DCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVD 277 (412)
Q Consensus 199 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~-~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~ 277 (412)
||++|+|.+++.... .+++..+..++.|++.||+|||+ + +|+||||||+|||++.++.+||+|||+|+.....
T Consensus 85 y~~gg~L~~~l~~~~---~l~~~~~~~~~~qil~aL~yLH~~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~ 158 (322)
T d1s9ja_ 85 HMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 158 (322)
T ss_dssp CCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred cCCCCcHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHHhC---CEEccccCHHHeeECCCCCEEEeeCCCccccCCC
Confidence 999999999987543 58999999999999999999997 5 8999999999999999999999999999865432
Q ss_pred CCCcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccc------c---C---------------
Q 042435 278 SSNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLS------S---S--------------- 333 (412)
Q Consensus 278 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~------~---~--------------- 333 (412)
. .....||+.|+|||++.+..++.++||||+||++|||++|+.||....... . .
T Consensus 159 ~--~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (322)
T d1s9ja_ 159 M--ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 236 (322)
T ss_dssp T--C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC---------------------
T ss_pred c--cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccccc
Confidence 2 234589999999999999999999999999999999999999996321000 0 0
Q ss_pred -------CCCcchhhHH---hhhccCCccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 334 -------SGPKIMLIDI---LYQRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 334 -------~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
..+.....+. ......+..+.. .....+.+++.+||..||++|||++|+++|
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~s~~~~dli~~~L~~dP~~R~ta~e~L~H 298 (322)
T d1s9ja_ 237 LSSYGMDSRPPMAIFELLDYIVNEPPPKLPSG--VFSLEFQDFVNKCLIKNPAERADLKQLMVH 298 (322)
T ss_dssp ---------CCCCHHHHHHHHHTSCCCCCCBT--TBCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccccccchhHHHHHhhhhccCCccCccc--cCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 0000000000 001111111000 012347889999999999999999999885
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-47 Score=356.98 Aligned_cols=231 Identities=22% Similarity=0.270 Sum_probs=188.3
Q ss_pred hcCcccceeeeecCceEEEEEEe-CCCcEEEEEec---------------------------cCCccccceEEEecCceE
Q 042435 142 TEYFHIRYCIGTGGYDSVYKAEL-PDGKVVALKKL---------------------------HHSETEDSAFVVYSPQCM 193 (412)
Q Consensus 142 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l---------------------------~~~~~~~~~~~~~~~~~~ 193 (412)
.+.|++.+.||+|+||+||+|.. .+|+.||||.+ +|+|+.+...++.+.+..
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 36799999999999999999987 57999999954 578888888889999999
Q ss_pred EEEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCC----cEEEeecC
Q 042435 194 FFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNL----EAFVADFG 269 (412)
Q Consensus 194 ~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~----~~kl~DfG 269 (412)
++|||||++|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+|||++.++ .+|++|||
T Consensus 89 ~iv~E~~~gg~L~~~i~~~~---~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~DfG 162 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFG 162 (293)
T ss_dssp EEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEEcCCCccccchhcccc---ccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccceEecchh
Confidence 99999999999999987543 599999999999999999999999 999999999999998766 59999999
Q ss_pred CccccCCCCCCcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccC
Q 042435 270 TVRLLDVDSSNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLS 349 (412)
Q Consensus 270 la~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 349 (412)
+++...... ......||+.|+|||++.+..++.++|||||||++|||+||+.||... ........+......
T Consensus 163 ~a~~~~~~~-~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~-------~~~~~~~~i~~~~~~ 234 (293)
T d1jksa_ 163 LAHKIDFGN-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD-------TKQETLANVSAVNYE 234 (293)
T ss_dssp TCEECTTSC-BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS-------SHHHHHHHHHTTCCC
T ss_pred hhhhcCCCc-cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCC-------CHHHHHHHHHhcCCC
Confidence 998765432 233457899999999999999999999999999999999999998732 111112222222222
Q ss_pred CccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 350 PPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 350 ~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
.+ ..........+.+++.+||+.||++|||++|++++
T Consensus 235 ~~-~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 271 (293)
T d1jksa_ 235 FE-DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 271 (293)
T ss_dssp CC-HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CC-chhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11 11111223347899999999999999999999875
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=3.8e-47 Score=365.20 Aligned_cols=232 Identities=21% Similarity=0.255 Sum_probs=189.9
Q ss_pred hcCcccceeeeecCceEEEEEEe-CCCcEEEEEec---------------------cCCccccceEEEecCceEEEEEEe
Q 042435 142 TEYFHIRYCIGTGGYDSVYKAEL-PDGKVVALKKL---------------------HHSETEDSAFVVYSPQCMFFIYEY 199 (412)
Q Consensus 142 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l---------------------~~~~~~~~~~~~~~~~~~~lv~ey 199 (412)
.++|++.+.||+|+||.||+|.. .+|+.||||++ +|+++.....++.+.+..++||||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 35899999999999999999986 57999999964 688999999999999999999999
Q ss_pred ccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEec--CCCcEEEeecCCccccCCC
Q 042435 200 MERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLN--SNLEAFVADFGTVRLLDVD 277 (412)
Q Consensus 200 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~--~~~~~kl~DfGla~~~~~~ 277 (412)
|++|+|.+++..... .+++..+..++.||+.||+|||++ +|+||||||+|||++ .++.+||+|||+++.+...
T Consensus 105 ~~gg~L~~~l~~~~~--~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~ 179 (350)
T d1koaa2 105 MSGGELFEKVADEHN--KMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 179 (350)
T ss_dssp CCSCBHHHHHTCTTS--CBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT
T ss_pred CCCCCHHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecchheecccc
Confidence 999999998865432 489999999999999999999999 999999999999995 4678999999999876543
Q ss_pred CCCcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccchhhH
Q 042435 278 SSNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKII 357 (412)
Q Consensus 278 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 357 (412)
. ......||+.|+|||++.+..++.++|||||||++|||+||+.||... .....+..+.......+. ....
T Consensus 180 ~-~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~-------~~~~~~~~i~~~~~~~~~-~~~~ 250 (350)
T d1koaa2 180 Q-SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGE-------NDDETLRNVKSCDWNMDD-SAFS 250 (350)
T ss_dssp S-CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCS-------SHHHHHHHHHHTCCCSCC-GGGG
T ss_pred c-ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCC-------CHHHHHHHHHhCCCCCCc-cccc
Confidence 3 234568999999999999999999999999999999999999998632 111222333332222211 1111
Q ss_pred HHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 358 QDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 358 ~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
.....+.+++.+||+.||++|||++|++++
T Consensus 251 ~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 251 GISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp GCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred CCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 122347899999999999999999999986
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-47 Score=353.64 Aligned_cols=231 Identities=22% Similarity=0.324 Sum_probs=182.5
Q ss_pred cCcccceeeeecCceEEEEEEeCCCcEEEEEec-------------------cCCccccceEEEec-CceEEEEEEeccC
Q 042435 143 EYFHIRYCIGTGGYDSVYKAELPDGKVVALKKL-------------------HHSETEDSAFVVYS-PQCMFFIYEYMER 202 (412)
Q Consensus 143 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~l-------------------~~~~~~~~~~~~~~-~~~~~lv~ey~~~ 202 (412)
++|++.+.||+|+||.||+|++ .|+.||||++ +|+|+....+.+.+ .+..++||||+++
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~ 85 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAK 85 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTT
T ss_pred HHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccCC
Confidence 5688899999999999999998 5788999965 58888888887755 4568999999999
Q ss_pred CceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCCCCcc
Q 042435 203 GSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSNRT 282 (412)
Q Consensus 203 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 282 (412)
|+|.+++..... ..++|..+++++.||+.||+|||+. +|+||||||+|||++.++.+|++|||+++..... ..
T Consensus 86 g~L~~~l~~~~~-~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~---~~ 158 (262)
T d1byga_ 86 GSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST---QD 158 (262)
T ss_dssp EEHHHHHHHHHH-HHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC------------
T ss_pred CCHHHHHHhcCC-CCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccceecCCC---Cc
Confidence 999999975432 2589999999999999999999998 9999999999999999999999999999865432 23
Q ss_pred cccccccccccccccCcccCcccccHHHHHHHHHHHh-CCCCcccccccccCCCCcchhhHHhhhccCCccchhhHHHHH
Q 042435 283 LQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLM-GTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKIIQDII 361 (412)
Q Consensus 283 ~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 361 (412)
...+|..|+|||++.+..++.++|||||||++|||+| |+.||... ....+...+.....++.+.... .
T Consensus 159 ~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~--------~~~~~~~~i~~~~~~~~~~~~~---~ 227 (262)
T d1byga_ 159 TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI--------PLKDVVPRVEKGYKMDAPDGCP---P 227 (262)
T ss_dssp ---CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTS--------CGGGHHHHHTTTCCCCCCTTCC---H
T ss_pred cccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCC--------CHHHHHHHHHcCCCCCCCccCC---H
Confidence 3467899999999999999999999999999999998 67776521 1222333333333333333322 2
Q ss_pred HHHHHHHhcCcCCCCCCCCHHHHHHHHhcCC
Q 042435 362 LVSTIALACLRSKPKSRPTMQRISQELEGKT 392 (412)
Q Consensus 362 ~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 392 (412)
.+.+++.+||+.||++||||.|++++|++++
T Consensus 228 ~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~ 258 (262)
T d1byga_ 228 AVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 258 (262)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence 4789999999999999999999999998764
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.9e-47 Score=360.25 Aligned_cols=228 Identities=22% Similarity=0.305 Sum_probs=191.0
Q ss_pred hcCcccceeeeecCceEEEEEEe-CCCcEEEEEec------------------------cCCccccceEEEecCceEEEE
Q 042435 142 TEYFHIRYCIGTGGYDSVYKAEL-PDGKVVALKKL------------------------HHSETEDSAFVVYSPQCMFFI 196 (412)
Q Consensus 142 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l------------------------~~~~~~~~~~~~~~~~~~~lv 196 (412)
.++|++.+.||+|+||.||+|+. .+|+.||||++ +|+++......+.+.+..|+|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence 35799999999999999999976 57999999964 588888889999999999999
Q ss_pred EEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCC
Q 042435 197 YEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDV 276 (412)
Q Consensus 197 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~ 276 (412)
||||++|+|.+++.... .++......++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+|+....
T Consensus 84 ~ey~~gg~L~~~~~~~~---~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~ 157 (337)
T d1o6la_ 84 MEYANGGELFFHLSRER---VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp EECCTTCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred eeccCCCchhhhhhccc---CCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeeccccccccc
Confidence 99999999999887654 588899999999999999999999 999999999999999999999999999997655
Q ss_pred CCCCcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccchhh
Q 042435 277 DSSNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKI 356 (412)
Q Consensus 277 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 356 (412)
........+||+.|+|||++.+..++.++||||+||++|||++|+.||... ........+.......+ ...
T Consensus 158 ~~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~-------~~~~~~~~i~~~~~~~p--~~~ 228 (337)
T d1o6la_ 158 DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ-------DHERLFELILMEEIRFP--RTL 228 (337)
T ss_dssp TTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCS-------SHHHHHHHHHHCCCCCC--TTS
T ss_pred CCcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCc-------CHHHHHHHHhcCCCCCC--ccC
Confidence 555556678999999999999999999999999999999999999998732 11112222222222221 222
Q ss_pred HHHHHHHHHHHHhcCcCCCCCCCC-----HHHHHHH
Q 042435 357 IQDIILVSTIALACLRSKPKSRPT-----MQRISQE 387 (412)
Q Consensus 357 ~~~~~~~~~l~~~Cl~~dP~~RPs-----~~evl~~ 387 (412)
. ..+.+++.+||+.||++||+ ++|+++|
T Consensus 229 s---~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 229 S---PEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp C---HHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred C---HHHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence 2 23788999999999999994 8888875
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-47 Score=358.36 Aligned_cols=246 Identities=24% Similarity=0.336 Sum_probs=188.3
Q ss_pred cCcccceeeeecCceEEEEEEeCCCcEEEEEec--------------------cCCccccceEEEecCc----eEEEEEE
Q 042435 143 EYFHIRYCIGTGGYDSVYKAELPDGKVVALKKL--------------------HHSETEDSAFVVYSPQ----CMFFIYE 198 (412)
Q Consensus 143 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~l--------------------~~~~~~~~~~~~~~~~----~~~lv~e 198 (412)
.+|.+.+.||+|+||.||+|++ +|+.||||++ +|+|+.....++...+ .+++|||
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~E 81 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD 81 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEe
Confidence 4577889999999999999997 6899999964 5788888888776543 6899999
Q ss_pred eccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhC-----CCCCcEEeCCCCCCEEecCCCcEEEeecCCccc
Q 042435 199 YMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHD-----CTPSIVHRDISSNNILLNSNLEAFVADFGTVRL 273 (412)
Q Consensus 199 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~-----~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~ 273 (412)
||++|+|.++++.. .++|.++++++.|+|.||+|+|+. ..++|+||||||+|||++.++.+||+|||+++.
T Consensus 82 y~~~g~L~~~l~~~----~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~ 157 (303)
T d1vjya_ 82 YHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 157 (303)
T ss_dssp CCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred cccCCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcccc
Confidence 99999999999764 499999999999999999999974 135999999999999999999999999999987
Q ss_pred cCCCCC----CcccccccccccccccccCc------ccCcccccHHHHHHHHHHHhCCCCccccccccc-------CCCC
Q 042435 274 LDVDSS----NRTLQAGTYGYIALELVYTM------VVTEKCVIYSFGVVALEVLMGTHPGELLLSLSS-------SSGP 336 (412)
Q Consensus 274 ~~~~~~----~~~~~~gt~~y~aPE~~~~~------~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~-------~~~~ 336 (412)
...... ......||+.|+|||++.+. .++.++|||||||++|||+||..|+........ ....
T Consensus 158 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~ 237 (303)
T d1vjya_ 158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 237 (303)
T ss_dssp EETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred ccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccch
Confidence 654332 22346799999999998754 367899999999999999999988753221110 0000
Q ss_pred cchhh-HHhhhccCCccchh--hHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhcCCC
Q 042435 337 KIMLI-DILYQRLSPPINQK--IIQDIILVSTIALACLRSKPKSRPTMQRISQELEGKTP 393 (412)
Q Consensus 337 ~~~~~-~~~~~~~~~~~~~~--~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 393 (412)
..... ........++.+.. ..+....+.+++.+||+.||++|||+.||+++|+++..
T Consensus 238 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~ 297 (303)
T d1vjya_ 238 VEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297 (303)
T ss_dssp HHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence 01111 12222333322221 22334458899999999999999999999999987753
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-47 Score=360.33 Aligned_cols=239 Identities=26% Similarity=0.359 Sum_probs=190.8
Q ss_pred cCcccceeeeecCceEEEEEEeC-CCc--EEEEEec-----------------------cCCccccceEEEecCceEEEE
Q 042435 143 EYFHIRYCIGTGGYDSVYKAELP-DGK--VVALKKL-----------------------HHSETEDSAFVVYSPQCMFFI 196 (412)
Q Consensus 143 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~--~vAvK~l-----------------------~~~~~~~~~~~~~~~~~~~lv 196 (412)
++|++.++||+|+||+||+|.+. +|. .||||++ +|+|+....+.+.+++..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 67889999999999999999875 344 5778853 588999999999999999999
Q ss_pred EEeccCCceeeeeccCc-------------ccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcE
Q 042435 197 YEYMERGSLFCVLRDDD-------------EAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEA 263 (412)
Q Consensus 197 ~ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~ 263 (412)
|||+++|+|.++++... ....++|.+++.++.||++||.|||++ +|+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEcCCCce
Confidence 99999999999997542 224699999999999999999999999 99999999999999999999
Q ss_pred EEeecCCccccCCCCCCcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCC-CcccccccccCCCCcchhhH
Q 042435 264 FVADFGTVRLLDVDSSNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTH-PGELLLSLSSSSGPKIMLID 342 (412)
Q Consensus 264 kl~DfGla~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~-P~~~~~~~~~~~~~~~~~~~ 342 (412)
||+|||+++....... .....||..|+|||.+.+..++.++|||||||++|||++|.. ||... ....+.+
T Consensus 167 kl~DfG~a~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~--------~~~~~~~ 237 (309)
T d1fvra_ 167 KIADFGLSRGQEVYVK-KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM--------TCAELYE 237 (309)
T ss_dssp EECCTTCEESSCEECC-C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC--------CHHHHHH
T ss_pred EEcccccccccccccc-ccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCC--------CHHHHHH
Confidence 9999999986543322 234468999999999999999999999999999999999765 55421 1122233
Q ss_pred HhhhccCCccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhcCCCCCC
Q 042435 343 ILYQRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELEGKTPMKK 396 (412)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~~~ 396 (412)
.+.....++.+....+ .+.+++.+||+.||++||||+||+++|+++....+
T Consensus 238 ~i~~~~~~~~~~~~~~---~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~~ 288 (309)
T d1fvra_ 238 KLPQGYRLEKPLNCDD---EVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 288 (309)
T ss_dssp HGGGTCCCCCCTTBCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred HHHhcCCCCCCccCCH---HHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcCc
Confidence 3333333333333222 48899999999999999999999999988765443
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-47 Score=354.72 Aligned_cols=233 Identities=22% Similarity=0.316 Sum_probs=178.0
Q ss_pred cCcccceeeeecCceEEEEEEeCC----CcEEEEEec----------------------cCCccccceEEEecCceEEEE
Q 042435 143 EYFHIRYCIGTGGYDSVYKAELPD----GKVVALKKL----------------------HHSETEDSAFVVYSPQCMFFI 196 (412)
Q Consensus 143 ~~f~~~~~lG~G~~g~Vy~~~~~~----~~~vAvK~l----------------------~~~~~~~~~~~~~~~~~~~lv 196 (412)
++|++.+.||+|+||.||+|.+.. +..||||.+ +|+|+....+.+. .+..++|
T Consensus 7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv 85 (273)
T d1mp8a_ 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWII 85 (273)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEEE
Confidence 579999999999999999997743 457899954 6888888888775 5678999
Q ss_pred EEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCC
Q 042435 197 YEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDV 276 (412)
Q Consensus 197 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~ 276 (412)
|||+++|+|.+++.... ..+++..++.++.|+++||+|||++ +|+||||||+||+++.++.+||+|||+++....
T Consensus 86 ~E~~~~g~l~~~~~~~~--~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~ 160 (273)
T d1mp8a_ 86 MELCTLGELRSFLQVRK--YSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 160 (273)
T ss_dssp EECCTTEEHHHHHHHTT--TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC---------
T ss_pred EEeccCCcHHhhhhccC--CCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccchhheeccC
Confidence 99999999998876543 2589999999999999999999999 999999999999999999999999999987654
Q ss_pred CCC-CcccccccccccccccccCcccCcccccHHHHHHHHHHHh-CCCCcccccccccCCCCcchhhHHhhhccCCccch
Q 042435 277 DSS-NRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLM-GTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQ 354 (412)
Q Consensus 277 ~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 354 (412)
... ......||+.|+|||++.+..++.++|||||||++|||+| |..||... .... +...+......+.+.
T Consensus 161 ~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~-------~~~~-~~~~i~~~~~~~~~~ 232 (273)
T d1mp8a_ 161 STYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV-------KNND-VIGRIENGERLPMPP 232 (273)
T ss_dssp ----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTC-------CGGG-HHHHHHTTCCCCCCT
T ss_pred CcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCC-------CHHH-HHHHHHcCCCCCCCC
Confidence 332 2344568999999999999999999999999999999998 88898732 1112 222222222222223
Q ss_pred hhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhcCC
Q 042435 355 KIIQDIILVSTIALACLRSKPKSRPTMQRISQELEGKT 392 (412)
Q Consensus 355 ~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 392 (412)
... ..+.+++.+||+.||++|||+.||+++|+.+.
T Consensus 233 ~~~---~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~ 267 (273)
T d1mp8a_ 233 NCP---PTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 267 (273)
T ss_dssp TCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCC---HHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 322 34889999999999999999999999998764
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=9.1e-47 Score=362.80 Aligned_cols=232 Identities=21% Similarity=0.264 Sum_probs=189.3
Q ss_pred hcCcccceeeeecCceEEEEEEe-CCCcEEEEEec---------------------cCCccccceEEEecCceEEEEEEe
Q 042435 142 TEYFHIRYCIGTGGYDSVYKAEL-PDGKVVALKKL---------------------HHSETEDSAFVVYSPQCMFFIYEY 199 (412)
Q Consensus 142 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l---------------------~~~~~~~~~~~~~~~~~~~lv~ey 199 (412)
.++|++.+.||+|+||.||+|.. .+|+.||||.+ +|+++.....++.+++..|+||||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 107 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 107 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 35799999999999999999976 57999999964 688999999999999999999999
Q ss_pred ccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEec--CCCcEEEeecCCccccCCC
Q 042435 200 MERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLN--SNLEAFVADFGTVRLLDVD 277 (412)
Q Consensus 200 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~--~~~~~kl~DfGla~~~~~~ 277 (412)
|++|+|.+++.... ..+++.++..++.||+.||+|||++ +|+||||||+|||++ .++.+||+|||+|+.....
T Consensus 108 ~~gg~L~~~~~~~~--~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~ 182 (352)
T d1koba_ 108 LSGGELFDRIAAED--YKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 182 (352)
T ss_dssp CCCCBHHHHTTCTT--CCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred CCCChHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeecccceecCCC
Confidence 99999988776543 2489999999999999999999999 999999999999997 6789999999999877544
Q ss_pred CCCcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccchhhH
Q 042435 278 SSNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKII 357 (412)
Q Consensus 278 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 357 (412)
. ......||+.|+|||++.+..++.++||||+||++|||+||+.||... .....+..+.......+. ....
T Consensus 183 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~-------~~~~~~~~i~~~~~~~~~-~~~~ 253 (352)
T d1koba_ 183 E-IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGE-------DDLETLQNVKRCDWEFDE-DAFS 253 (352)
T ss_dssp S-CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCS-------SHHHHHHHHHHCCCCCCS-STTT
T ss_pred C-ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCC-------CHHHHHHHHHhCCCCCCc-cccc
Confidence 3 234457999999999999999999999999999999999999999732 111122222222222111 1111
Q ss_pred HHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 358 QDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 358 ~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
.....+.+++.+||+.||.+|||+.|++++
T Consensus 254 ~~s~~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 254 SVSPEAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp TSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred CCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 122347899999999999999999999886
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-47 Score=357.59 Aligned_cols=237 Identities=22% Similarity=0.311 Sum_probs=189.6
Q ss_pred hcCcccceeeeecCceEEEEEEeCC--------CcEEEEEec-----------------------cCCccccceEEEecC
Q 042435 142 TEYFHIRYCIGTGGYDSVYKAELPD--------GKVVALKKL-----------------------HHSETEDSAFVVYSP 190 (412)
Q Consensus 142 ~~~f~~~~~lG~G~~g~Vy~~~~~~--------~~~vAvK~l-----------------------~~~~~~~~~~~~~~~ 190 (412)
.++|++.+.||+|+||.||+|+... +..||||++ +|+++.....++.++
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~ 91 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 91 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence 3578899999999999999997532 357999965 588999999999999
Q ss_pred ceEEEEEEeccCCceeeeeccCcc-------------cccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEe
Q 042435 191 QCMFFIYEYMERGSLFCVLRDDDE-------------AIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILL 257 (412)
Q Consensus 191 ~~~~lv~ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl 257 (412)
+..++||||+++|+|.+++..... ...+++.+++.++.|++.||+|||++ +|+||||||+|||+
T Consensus 92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~NiLl 168 (299)
T d1fgka_ 92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLV 168 (299)
T ss_dssp SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEE
T ss_pred CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeecccceee
Confidence 999999999999999999975431 23589999999999999999999999 99999999999999
Q ss_pred cCCCcEEEeecCCccccCCCCC--CcccccccccccccccccCcccCcccccHHHHHHHHHHHh-CCCCcccccccccCC
Q 042435 258 NSNLEAFVADFGTVRLLDVDSS--NRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLM-GTHPGELLLSLSSSS 334 (412)
Q Consensus 258 ~~~~~~kl~DfGla~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~ellt-g~~P~~~~~~~~~~~ 334 (412)
+.++.+||+|||+++....... ......||+.|+|||.+.+..++.++|||||||++|||+| |..||...
T Consensus 169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~------- 241 (299)
T d1fgka_ 169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV------- 241 (299)
T ss_dssp CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC-------
T ss_pred cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCC-------
Confidence 9999999999999987654332 2244578999999999999999999999999999999998 68887622
Q ss_pred CCcchhhHHhhhccCCccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhcCC
Q 042435 335 GPKIMLIDILYQRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELEGKT 392 (412)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 392 (412)
....+.+.+.....++.+....+ .+.+++.+||+.||++|||+.||++.|+++.
T Consensus 242 -~~~~~~~~i~~~~~~~~p~~~~~---~l~~li~~cl~~dP~~Rps~~eil~~L~~i~ 295 (299)
T d1fgka_ 242 -PVEELFKLLKEGHRMDKPSNCTN---ELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 295 (299)
T ss_dssp -CHHHHHHHHHTTCCCCCCSSCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -CHHHHHHHHHcCCCCCCCccchH---HHHHHHHHHccCCHhHCcCHHHHHHHHHHHh
Confidence 11223344444443333333223 3889999999999999999999999998764
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-47 Score=359.62 Aligned_cols=226 Identities=23% Similarity=0.357 Sum_probs=189.5
Q ss_pred cCcccceeeeecCceEEEEEEe-CCCcEEEEEec-------------------------cCCccccceEEEecCceEEEE
Q 042435 143 EYFHIRYCIGTGGYDSVYKAEL-PDGKVVALKKL-------------------------HHSETEDSAFVVYSPQCMFFI 196 (412)
Q Consensus 143 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l-------------------------~~~~~~~~~~~~~~~~~~~lv 196 (412)
++|++.+.||+|+||+||+|.. .+|+.||||++ +|+++......+.+++..|+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 6799999999999999999977 47999999964 578888888899999999999
Q ss_pred EEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCC
Q 042435 197 YEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDV 276 (412)
Q Consensus 197 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~ 276 (412)
||||++|+|.+++.... .++...+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++....
T Consensus 82 mEy~~~g~L~~~i~~~~---~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~ 155 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCH---KFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENML 155 (320)
T ss_dssp EECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EeecCCCcHHHHhhccC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceeccccchhhhccc
Confidence 99999999999997544 588999999999999999999999 999999999999999999999999999987765
Q ss_pred CCCCcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccchhh
Q 042435 277 DSSNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKI 356 (412)
Q Consensus 277 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 356 (412)
.........||+.|+|||++.+..++.++|||||||++|||+||+.||... ........+..... ..+...
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~-------~~~~~~~~i~~~~~--~~p~~~ 226 (320)
T d1xjda_ 156 GDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQ-------DEEELFHSIRMDNP--FYPRWL 226 (320)
T ss_dssp TTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS-------SHHHHHHHHHHCCC--CCCTTS
T ss_pred ccccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCC-------CHHHHHHHHHcCCC--CCCccC
Confidence 555556678999999999999999999999999999999999999999732 11112222222222 112222
Q ss_pred HHHHHHHHHHHHhcCcCCCCCCCCHH-HHHH
Q 042435 357 IQDIILVSTIALACLRSKPKSRPTMQ-RISQ 386 (412)
Q Consensus 357 ~~~~~~~~~l~~~Cl~~dP~~RPs~~-evl~ 386 (412)
. ..+.+++.+||+.||++|||+. |+++
T Consensus 227 s---~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 227 E---KEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp C---HHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred C---HHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 2 2378999999999999999995 6754
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1e-46 Score=364.21 Aligned_cols=226 Identities=20% Similarity=0.283 Sum_probs=185.1
Q ss_pred cCcccceeeeecCceEEEEEEeC-CCcEEEEEec---------------------------cCCccccceEEEecCceEE
Q 042435 143 EYFHIRYCIGTGGYDSVYKAELP-DGKVVALKKL---------------------------HHSETEDSAFVVYSPQCMF 194 (412)
Q Consensus 143 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l---------------------------~~~~~~~~~~~~~~~~~~~ 194 (412)
++|++.++||+|+||.||+|+.. +|+.||||.+ +|+++.....++.+.+..|
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 68999999999999999999874 6999999964 4788888888899999999
Q ss_pred EEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCcccc
Q 042435 195 FIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLL 274 (412)
Q Consensus 195 lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~ 274 (412)
+|||||++|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+..
T Consensus 84 ivmE~~~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGla~~~ 157 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQHG---VFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDF 157 (364)
T ss_dssp EEECCCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTTCEEC
T ss_pred EEEEecCCCcHHHHHHhcc---cccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEeeeceeeec
Confidence 9999999999999987543 588999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCCcccccccccccccccccC-cccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccC--Cc
Q 042435 275 DVDSSNRTLQAGTYGYIALELVYT-MVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLS--PP 351 (412)
Q Consensus 275 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~--~~ 351 (412)
.... .....||+.|+|||++.. ..++.++|||||||++|||+||+.||.... . .....+...... ..
T Consensus 158 ~~~~--~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~-------~-~~~~~~~~~~~~~~~~ 227 (364)
T d1omwa3 158 SKKK--PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHK-------T-KDKHEIDRMTLTMAVE 227 (364)
T ss_dssp SSSC--CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSC-------S-SCHHHHHHHSSSCCCC
T ss_pred CCCc--ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCC-------H-HHHHHHHHhcccCCCC
Confidence 5432 334579999999999874 568999999999999999999999997321 1 111122222111 11
Q ss_pred cchhhHHHHHHHHHHHHhcCcCCCCCCCC-----HHHHHHH
Q 042435 352 INQKIIQDIILVSTIALACLRSKPKSRPT-----MQRISQE 387 (412)
Q Consensus 352 ~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs-----~~evl~~ 387 (412)
.+... ...+.+++.+||+.||++||| ++|+++|
T Consensus 228 ~~~~~---s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H 265 (364)
T d1omwa3 228 LPDSF---SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 265 (364)
T ss_dssp CCSSS---CHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred CCCCC---CHHHHHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence 11222 223789999999999999999 6888764
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.7e-47 Score=358.68 Aligned_cols=233 Identities=23% Similarity=0.375 Sum_probs=185.6
Q ss_pred cCcccceeeeecCceEEEEEEeC-CCc----EEEEEec----------------------cCCccccceEEEecCceEEE
Q 042435 143 EYFHIRYCIGTGGYDSVYKAELP-DGK----VVALKKL----------------------HHSETEDSAFVVYSPQCMFF 195 (412)
Q Consensus 143 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~----~vAvK~l----------------------~~~~~~~~~~~~~~~~~~~l 195 (412)
++|++.++||+|+||+||+|.+. +|+ .||+|++ +|+|+....+++.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 46999999999999999999774 444 6899854 688888888888764 5678
Q ss_pred EEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccC
Q 042435 196 IYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLD 275 (412)
Q Consensus 196 v~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~ 275 (412)
++||+.+|+|.+++.... ..+++..+++++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 88 v~e~~~~~~l~~~~~~~~--~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~ 162 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 162 (317)
T ss_dssp EEECCTTCBHHHHHHHTS--SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHHHTT
T ss_pred EEEeccCCcccccccccc--cCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeeccccceecc
Confidence 899999999988776543 2589999999999999999999998 99999999999999999999999999998765
Q ss_pred CCCCC--cccccccccccccccccCcccCcccccHHHHHHHHHHHh-CCCCcccccccccCCCCcchhhHHhhhccCCcc
Q 042435 276 VDSSN--RTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLM-GTHPGELLLSLSSSSGPKIMLIDILYQRLSPPI 352 (412)
Q Consensus 276 ~~~~~--~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 352 (412)
..... .....||+.|+|||++.+..++.++|||||||++|||+| |+.||+.. ....+...+.....++.
T Consensus 163 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~--------~~~~~~~~i~~~~~~~~ 234 (317)
T d1xkka_ 163 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI--------PASEISSILEKGERLPQ 234 (317)
T ss_dssp TTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTS--------CGGGHHHHHHHTCCCCC
T ss_pred cccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCC--------CHHHHHHHHHcCCCCCC
Confidence 44332 234468999999999999999999999999999999999 78888632 12223444444443333
Q ss_pred chhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhcCC
Q 042435 353 NQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELEGKT 392 (412)
Q Consensus 353 ~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 392 (412)
+.... ..+.+++.+||+.||++|||+.|++++|+.+.
T Consensus 235 p~~~~---~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~ 271 (317)
T d1xkka_ 235 PPICT---IDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 271 (317)
T ss_dssp CTTBC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CcccC---HHHHHHHHHhCCCChhhCcCHHHHHHHHHHHH
Confidence 33322 24789999999999999999999999987653
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-47 Score=353.76 Aligned_cols=233 Identities=24% Similarity=0.305 Sum_probs=181.3
Q ss_pred cCcccceeeeecCceEEEEEEeC--CC--cEEEEEec------------------------cCCccccceEEEecCceEE
Q 042435 143 EYFHIRYCIGTGGYDSVYKAELP--DG--KVVALKKL------------------------HHSETEDSAFVVYSPQCMF 194 (412)
Q Consensus 143 ~~f~~~~~lG~G~~g~Vy~~~~~--~~--~~vAvK~l------------------------~~~~~~~~~~~~~~~~~~~ 194 (412)
++|++.+.||+|+||+||+|++. ++ ..||||++ +|+|+....+++.+ +..+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 56899999999999999999763 22 37899954 68888888888865 5678
Q ss_pred EEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCcccc
Q 042435 195 FIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLL 274 (412)
Q Consensus 195 lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~ 274 (412)
+||||+++|++.+++.... ..+++..++.++.|++.||+|||++ +|+||||||+||+++.++++||+|||+++..
T Consensus 87 lv~e~~~~~~l~~~~~~~~--~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl~~~~ 161 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKHQ--GHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRAL 161 (273)
T ss_dssp EEEECCTTCBHHHHHHHHG--GGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred eeeeeecCcchhhhhhccc--CCCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeeccchhhhhc
Confidence 9999999999998776543 2599999999999999999999998 9999999999999999999999999999976
Q ss_pred CCCCCC---cccccccccccccccccCcccCcccccHHHHHHHHHHHh-CCCCcccccccccCCCCcchhhHHhhhccCC
Q 042435 275 DVDSSN---RTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLM-GTHPGELLLSLSSSSGPKIMLIDILYQRLSP 350 (412)
Q Consensus 275 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 350 (412)
...... .....|+..|+|||++.+..++.++|||||||++|||+| |+.||... ........+......+
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~-------~~~~~~~~i~~~~~~~ 234 (273)
T d1u46a_ 162 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL-------NGSQILHKIDKEGERL 234 (273)
T ss_dssp CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTC-------CHHHHHHHHHTSCCCC
T ss_pred ccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCc-------CHHHHHHHHHhCCCCC
Confidence 544332 233467889999999999999999999999999999998 89998732 1112223333333333
Q ss_pred ccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhcC
Q 042435 351 PINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELEGK 391 (412)
Q Consensus 351 ~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 391 (412)
+.+..... .+.+++.+||+.||++||||.||.+.|++.
T Consensus 235 ~~~~~~~~---~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 235 PRPEDCPQ---DIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp CCCTTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCcccccH---HHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 33332222 378999999999999999999999999864
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-46 Score=357.04 Aligned_cols=238 Identities=21% Similarity=0.285 Sum_probs=195.3
Q ss_pred hcCcccceeeeecCceEEEEEEe------CCCcEEEEEec-----------------------cCCccccceEEEecCce
Q 042435 142 TEYFHIRYCIGTGGYDSVYKAEL------PDGKVVALKKL-----------------------HHSETEDSAFVVYSPQC 192 (412)
Q Consensus 142 ~~~f~~~~~lG~G~~g~Vy~~~~------~~~~~vAvK~l-----------------------~~~~~~~~~~~~~~~~~ 192 (412)
.++|++.+.||+|+||.||+|.+ .+++.||||++ +|+++....+.+.+++.
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~ 101 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCE
Confidence 46899999999999999999975 34679999965 48889989999999999
Q ss_pred EEEEEEeccCCceeeeeccCc---------------ccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEe
Q 042435 193 MFFIYEYMERGSLFCVLRDDD---------------EAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILL 257 (412)
Q Consensus 193 ~~lv~ey~~~gsL~~~l~~~~---------------~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl 257 (412)
.++|||||++|+|.++++... ....+++..+..++.||++||+|||++ +++||||||+||++
T Consensus 102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~NIl~ 178 (311)
T d1t46a_ 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILL 178 (311)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEE
T ss_pred EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeecccccccccc
Confidence 999999999999999986542 123589999999999999999999999 99999999999999
Q ss_pred cCCCcEEEeecCCccccCCCCCC--cccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCC-cccccccccCC
Q 042435 258 NSNLEAFVADFGTVRLLDVDSSN--RTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHP-GELLLSLSSSS 334 (412)
Q Consensus 258 ~~~~~~kl~DfGla~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P-~~~~~~~~~~~ 334 (412)
+.++.+|++|||+++........ .....||+.|+|||++.+..++.++|||||||++|||+|+..| |.. .
T Consensus 179 ~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~-------~ 251 (311)
T d1t46a_ 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPG-------M 251 (311)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTT-------C
T ss_pred cccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCC-------C
Confidence 99999999999999876544322 2345789999999999999999999999999999999995544 431 1
Q ss_pred CCcchhhHHhhhccCCccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhcCC
Q 042435 335 GPKIMLIDILYQRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELEGKT 392 (412)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 392 (412)
.....+..++.....+..+..... .+.+|+.+||+.||++||||+||+++|+++.
T Consensus 252 ~~~~~~~~~i~~~~~~~~~~~~~~---~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i 306 (311)
T d1t46a_ 252 PVDSKFYKMIKEGFRMLSPEHAPA---EMYDIMKTCWDADPLKRPTFKQIVQLIEKQI 306 (311)
T ss_dssp CSSHHHHHHHHHTCCCCCCTTSCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CHHHHHHHHHhcCCCCCCcccccH---HHHHHHHHHcCCChhHCcCHHHHHHHHHHhh
Confidence 222334455555555444333323 3889999999999999999999999998653
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=2.1e-46 Score=348.84 Aligned_cols=230 Identities=23% Similarity=0.281 Sum_probs=188.4
Q ss_pred cCcccceeeeecCceEEEEEEe-CCCcEEEEEec-------------------------------cCCccccceEEEecC
Q 042435 143 EYFHIRYCIGTGGYDSVYKAEL-PDGKVVALKKL-------------------------------HHSETEDSAFVVYSP 190 (412)
Q Consensus 143 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l-------------------------------~~~~~~~~~~~~~~~ 190 (412)
++|++.+.||+|+||+||+|+. .+|+.||||++ .|+++.....++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 6899999999999999999976 57999999975 378888888889999
Q ss_pred ceEEEEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCC
Q 042435 191 QCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGT 270 (412)
Q Consensus 191 ~~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGl 270 (412)
+..|+|||||++|+|.++++... .+++.++..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~~~---~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~ 156 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTEKV---TLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGF 156 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred cceEEEEEcCCCchHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCeEEccchh
Confidence 99999999999999999997543 599999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCCcccccccccccccccccC------cccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHh
Q 042435 271 VRLLDVDSSNRTLQAGTYGYIALELVYT------MVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDIL 344 (412)
Q Consensus 271 a~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 344 (412)
++....... .....||+.|+|||.+.+ ..++.++||||+||++|||+||+.||... ........+.
T Consensus 157 a~~~~~~~~-~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~-------~~~~~~~~i~ 228 (277)
T d1phka_ 157 SCQLDPGEK-LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHR-------KQMLMLRMIM 228 (277)
T ss_dssp CEECCTTCC-BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCS-------SHHHHHHHHH
T ss_pred eeEccCCCc-eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCC-------CHHHHHHHHH
Confidence 987755432 344579999999999853 34688999999999999999999999732 1112222233
Q ss_pred hhccCCccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 345 YQRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
......+. .........+.+++.+||+.||++|||++|++++
T Consensus 229 ~~~~~~~~-~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 229 SGNYQFGS-PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp HTCCCCCT-TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred hCCCCCCC-cccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 33222211 1111223348899999999999999999999765
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=4e-46 Score=353.39 Aligned_cols=224 Identities=26% Similarity=0.317 Sum_probs=187.5
Q ss_pred cCcccceeeeecCceEEEEEEe-CCCcEEEEEec------------------------cCCccccceEEEecCceEEEEE
Q 042435 143 EYFHIRYCIGTGGYDSVYKAEL-PDGKVVALKKL------------------------HHSETEDSAFVVYSPQCMFFIY 197 (412)
Q Consensus 143 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l------------------------~~~~~~~~~~~~~~~~~~~lv~ 197 (412)
++|++.+.||+|+||+||+|+. .+|+.||||++ +|+++.....++.+++..|+||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 5799999999999999999987 56999999964 6889999999999999999999
Q ss_pred EeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCC
Q 042435 198 EYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVD 277 (412)
Q Consensus 198 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~ 277 (412)
|||++|+|..++.... .+++.....++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+.....
T Consensus 84 E~~~gg~l~~~~~~~~---~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~ 157 (316)
T d1fota_ 84 DYIEGGELFSLLRKSQ---RFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 157 (316)
T ss_dssp CCCCSCBHHHHHHHTS---SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred eecCCccccccccccc---cccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCccceEeccc
Confidence 9999999998887654 578889999999999999999998 9999999999999999999999999999876433
Q ss_pred CCCcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccchhhH
Q 042435 278 SSNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKII 357 (412)
Q Consensus 278 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 357 (412)
.....||+.|+|||++.+..++.++|||||||++|||+||+.||... ........+.......+ ....
T Consensus 158 ---~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~-------~~~~~~~~i~~~~~~~p--~~~s 225 (316)
T d1fota_ 158 ---TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDS-------NTMKTYEKILNAELRFP--PFFN 225 (316)
T ss_dssp ---BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCS-------SHHHHHHHHHHCCCCCC--TTSC
T ss_pred ---cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCc-------CHHHHHHHHHcCCCCCC--CCCC
Confidence 23468999999999999999999999999999999999999999732 11122223333322221 2222
Q ss_pred HHHHHHHHHHHhcCcCCCCCCC-----CHHHHHHH
Q 042435 358 QDIILVSTIALACLRSKPKSRP-----TMQRISQE 387 (412)
Q Consensus 358 ~~~~~~~~l~~~Cl~~dP~~RP-----s~~evl~~ 387 (412)
..+.+++.+||+.||.+|| |++|+++|
T Consensus 226 ---~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 226 ---EDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp ---HHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred ---HHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence 2378899999999999996 89999875
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-46 Score=355.88 Aligned_cols=237 Identities=23% Similarity=0.289 Sum_probs=183.9
Q ss_pred hcCcccce-eeeecCceEEEEEEe-CCCcEEEEEec-----------------cCCccccceEEEec----CceEEEEEE
Q 042435 142 TEYFHIRY-CIGTGGYDSVYKAEL-PDGKVVALKKL-----------------HHSETEDSAFVVYS----PQCMFFIYE 198 (412)
Q Consensus 142 ~~~f~~~~-~lG~G~~g~Vy~~~~-~~~~~vAvK~l-----------------~~~~~~~~~~~~~~----~~~~~lv~e 198 (412)
.++|++.. +||+|+||+||+|.. .+++.||||++ +|+++.....++.+ ....|+|||
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmE 89 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVME 89 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCcHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEEE
Confidence 46788764 699999999999976 57999999965 57888887776543 467899999
Q ss_pred eccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecC---CCcEEEeecCCccccC
Q 042435 199 YMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNS---NLEAFVADFGTVRLLD 275 (412)
Q Consensus 199 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~---~~~~kl~DfGla~~~~ 275 (412)
||++|+|.+++..... ..+++.++..++.|++.||+|||++ +|+||||||+|||++. ++.+||+|||+++...
T Consensus 90 y~~gg~L~~~i~~~~~-~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~ 165 (335)
T d2ozaa1 90 CLDGGELFSRIQDRGD-QAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT 165 (335)
T ss_dssp CCCSEEHHHHHHSCSC-CCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECCCTTCEECC
T ss_pred CCCCCcHHHHHHhcCC-CCcCHHHHHHHHHHHHHHHHHHHHc---CCccccccccccccccccccccccccccceeeecc
Confidence 9999999999976432 2589999999999999999999999 9999999999999975 5679999999998765
Q ss_pred CCCCCcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccchh
Q 042435 276 VDSSNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQK 355 (412)
Q Consensus 276 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 355 (412)
... ......||+.|+|||++.+..++.++|||||||++|||+||+.||......... ......+.......+. ..
T Consensus 166 ~~~-~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~---~~~~~~i~~~~~~~~~-~~ 240 (335)
T d2ozaa1 166 SHN-SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS---PGMKTRIRMGQYEFPN-PE 240 (335)
T ss_dssp CCC-CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-----------CCCSCSSSCCT-TH
T ss_pred CCC-ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHH---HHHHHHHhcCCCCCCC-cc
Confidence 433 234567999999999999999999999999999999999999999742111000 0000001111111111 11
Q ss_pred hHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 356 IIQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 356 ~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
.......+.+++.+||+.||++|||+.|++++
T Consensus 241 ~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 241 WSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp HHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred cccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 12233458899999999999999999999985
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-46 Score=352.38 Aligned_cols=232 Identities=22% Similarity=0.299 Sum_probs=183.6
Q ss_pred ceeeeecCceEEEEEEeCCC----cEEEEEec----------------------cCCccccceEEEec-CceEEEEEEec
Q 042435 148 RYCIGTGGYDSVYKAELPDG----KVVALKKL----------------------HHSETEDSAFVVYS-PQCMFFIYEYM 200 (412)
Q Consensus 148 ~~~lG~G~~g~Vy~~~~~~~----~~vAvK~l----------------------~~~~~~~~~~~~~~-~~~~~lv~ey~ 200 (412)
.++||+|+||+||+|.+.++ ..||||++ +|+|+....+.+.. +...++|||||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 47899999999999987442 36899964 68888888877664 56899999999
Q ss_pred cCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCCCC
Q 042435 201 ERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSN 280 (412)
Q Consensus 201 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 280 (412)
++|+|.+++..... .+++..+++++.|+++||.|||+. +|+||||||+|||+++++.+||+|||+++........
T Consensus 112 ~~g~l~~~~~~~~~--~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~ 186 (311)
T d1r0pa_ 112 KHGDLRNFIRNETH--NPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD 186 (311)
T ss_dssp TTCBHHHHHHCTTC--CCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred ecCchhhhhccccc--cchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhhccccccc
Confidence 99999998876543 478899999999999999999998 9999999999999999999999999999876543222
Q ss_pred ----cccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccchhh
Q 042435 281 ----RTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKI 356 (412)
Q Consensus 281 ----~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 356 (412)
.....||+.|+|||.+.+..++.++||||||+++|||+||..||.... ........+.....+..+...
T Consensus 187 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~-------~~~~~~~~i~~g~~~~~p~~~ 259 (311)
T d1r0pa_ 187 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV-------NTFDITVYLLQGRRLLQPEYC 259 (311)
T ss_dssp CTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-------------CHHHHHTTCCCCCCTTC
T ss_pred cceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCC-------CHHHHHHHHHcCCCCCCcccC
Confidence 233568999999999999999999999999999999999888876321 111112222222222222222
Q ss_pred HHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhcCCCC
Q 042435 357 IQDIILVSTIALACLRSKPKSRPTMQRISQELEGKTPM 394 (412)
Q Consensus 357 ~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~ 394 (412)
. ..+.+++.+||+.||++||||.||+++|+++...
T Consensus 260 ~---~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~ 294 (311)
T d1r0pa_ 260 P---DPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 294 (311)
T ss_dssp C---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred c---HHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 2 2478999999999999999999999999988643
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=2.4e-46 Score=349.03 Aligned_cols=236 Identities=22% Similarity=0.310 Sum_probs=179.7
Q ss_pred hcCcccceeeeecCceEEEEEEe-CCCcEEEEEec------------------------cCCccccceEEEecC----ce
Q 042435 142 TEYFHIRYCIGTGGYDSVYKAEL-PDGKVVALKKL------------------------HHSETEDSAFVVYSP----QC 192 (412)
Q Consensus 142 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l------------------------~~~~~~~~~~~~~~~----~~ 192 (412)
.++|++.+.||+|+||+||+|.. .+|+.||||.+ +|+++.....++... ..
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 46799999999999999999976 57999999975 466666666555433 34
Q ss_pred EEEEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCcc
Q 042435 193 MFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVR 272 (412)
Q Consensus 193 ~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~ 272 (412)
.|+||||+++|+|.+++.... .+++.++..++.|++.||+|||++ +|+||||||+|||++.++..+++|||.++
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~~---~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~~~~ 159 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIAR 159 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCTTCE
T ss_pred EEEEEECCCCCEehhhhcccC---CCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehhhhhh
Confidence 899999999999998876543 599999999999999999999998 99999999999999999999999999987
Q ss_pred ccCCCC---CCcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccC
Q 042435 273 LLDVDS---SNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLS 349 (412)
Q Consensus 273 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 349 (412)
...... .......||+.|+|||++.+..++.++|||||||++|||+||+.||... .........+.....
T Consensus 160 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~-------~~~~~~~~~~~~~~~ 232 (277)
T d1o6ya_ 160 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGD-------SPVSVAYQHVREDPI 232 (277)
T ss_dssp ECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS-------SHHHHHHHHHHCCCC
T ss_pred hhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCc-------CHHHHHHHHHhcCCC
Confidence 654332 2234557999999999999999999999999999999999999999732 111122222222222
Q ss_pred CccchhhHHHHHHHHHHHHhcCcCCCCCCC-CHHHHHHHHhcC
Q 042435 350 PPINQKIIQDIILVSTIALACLRSKPKSRP-TMQRISQELEGK 391 (412)
Q Consensus 350 ~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RP-s~~evl~~L~~~ 391 (412)
++. .........+.+++.+||+.||++|| |++++.+.|.++
T Consensus 233 ~~~-~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~ 274 (277)
T d1o6ya_ 233 PPS-ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 274 (277)
T ss_dssp CGG-GTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred CCc-hhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHH
Confidence 111 11111223478899999999999999 899999988765
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-46 Score=351.78 Aligned_cols=238 Identities=21% Similarity=0.270 Sum_probs=191.4
Q ss_pred hcCcccceeeeecCceEEEEEEeC------CCcEEEEEec----------------------cCCccccceEEEecCceE
Q 042435 142 TEYFHIRYCIGTGGYDSVYKAELP------DGKVVALKKL----------------------HHSETEDSAFVVYSPQCM 193 (412)
Q Consensus 142 ~~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vAvK~l----------------------~~~~~~~~~~~~~~~~~~ 193 (412)
.++|++.+.||+|+||+||+|.+. +++.||||++ +|+++....+++...+..
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~ 98 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT 98 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCce
Confidence 467889999999999999999763 3678999975 577888888889999999
Q ss_pred EEEEEeccCCceeeeeccCcc-------cccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEe
Q 042435 194 FFIYEYMERGSLFCVLRDDDE-------AIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVA 266 (412)
Q Consensus 194 ~lv~ey~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~ 266 (412)
++||||+++|+|.+++..... ...++|..+.+++.|+++||.|||++ +|+||||||+|||+++++++||+
T Consensus 99 ~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~~~Kl~ 175 (308)
T d1p4oa_ 99 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIG 175 (308)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCEEEC
T ss_pred eEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCCceEEEe
Confidence 999999999999998865421 13479999999999999999999998 99999999999999999999999
Q ss_pred ecCCccccCCCCCC--cccccccccccccccccCcccCcccccHHHHHHHHHHHhCC-CCcccccccccCCCCcchhhHH
Q 042435 267 DFGTVRLLDVDSSN--RTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGT-HPGELLLSLSSSSGPKIMLIDI 343 (412)
Q Consensus 267 DfGla~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~-~P~~~~~~~~~~~~~~~~~~~~ 343 (412)
|||+++........ .....||+.|+|||.+.+..++.++||||||+++|||+||. .||... ........+
T Consensus 176 DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~-------~~~~~~~~i 248 (308)
T d1p4oa_ 176 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL-------SNEQVLRFV 248 (308)
T ss_dssp CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS-------CHHHHHHHH
T ss_pred ecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCC-------CHHHHHHHH
Confidence 99999876543322 23346899999999999999999999999999999999985 665421 111122222
Q ss_pred hhhccCCccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhcCCC
Q 042435 344 LYQRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELEGKTP 393 (412)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 393 (412)
.+.. .++.+.... ..+.+++.+||+.||++||||+||+++|++..+
T Consensus 249 ~~~~-~~~~p~~~~---~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 249 MEGG-LLDKPDNCP---DMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp HTTC-CCCCCTTCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred HhCC-CCCCcccch---HHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 2222 222222222 248899999999999999999999999988754
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.8e-45 Score=353.70 Aligned_cols=224 Identities=19% Similarity=0.255 Sum_probs=187.5
Q ss_pred cCcccceeeeecCceEEEEEEe-CCCcEEEEEec------------------------cCCccccceEEEecCceEEEEE
Q 042435 143 EYFHIRYCIGTGGYDSVYKAEL-PDGKVVALKKL------------------------HHSETEDSAFVVYSPQCMFFIY 197 (412)
Q Consensus 143 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l------------------------~~~~~~~~~~~~~~~~~~~lv~ 197 (412)
++|++.+.||+|+||.||+|+. .+|+.||||.+ +|+++......+...+..++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 5799999999999999999987 57999999964 6788888888899999999999
Q ss_pred EeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCC
Q 042435 198 EYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVD 277 (412)
Q Consensus 198 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~ 277 (412)
||+.+|+|.+++.... .+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+|+.....
T Consensus 121 e~~~~g~l~~~l~~~~---~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~ 194 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRIG---RFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp ECCTTCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred ccccccchhhhHhhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeeceeeeecccc
Confidence 9999999998886543 589999999999999999999999 9999999999999999999999999999876533
Q ss_pred CCCcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccchhhH
Q 042435 278 SSNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKII 357 (412)
Q Consensus 278 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 357 (412)
.....||+.|||||++.+..++.++|||||||++|||+||+.||... ........+.......+ ....
T Consensus 195 ---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~-------~~~~~~~~i~~~~~~~p--~~~s 262 (350)
T d1rdqe_ 195 ---TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD-------QPIQIYEKIVSGKVRFP--SHFS 262 (350)
T ss_dssp ---BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS-------SHHHHHHHHHHCCCCCC--TTCC
T ss_pred ---cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCc-------CHHHHHHHHhcCCCCCC--ccCC
Confidence 23457999999999999999999999999999999999999999732 11122223333322221 2222
Q ss_pred HHHHHHHHHHHhcCcCCCCCCC-----CHHHHHHH
Q 042435 358 QDIILVSTIALACLRSKPKSRP-----TMQRISQE 387 (412)
Q Consensus 358 ~~~~~~~~l~~~Cl~~dP~~RP-----s~~evl~~ 387 (412)
..+.+++.+||+.||.+|+ |++|+++|
T Consensus 263 ---~~~~~li~~~L~~dP~kR~~~~r~t~~ell~H 294 (350)
T d1rdqe_ 263 ---SDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp ---HHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred ---HHHHHHHHHHhhhCHHhccccccccHHHHHcC
Confidence 2378899999999999994 89999864
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-45 Score=350.23 Aligned_cols=232 Identities=22% Similarity=0.236 Sum_probs=189.6
Q ss_pred hcCcccceeeeecCceEEEEEEe-CCCcEEEEEec--------------------cCCccccceEEEecCceEEEEEEec
Q 042435 142 TEYFHIRYCIGTGGYDSVYKAEL-PDGKVVALKKL--------------------HHSETEDSAFVVYSPQCMFFIYEYM 200 (412)
Q Consensus 142 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l--------------------~~~~~~~~~~~~~~~~~~~lv~ey~ 200 (412)
.++|++.+.||+|+||+||+|.. .+|+.||||.+ +|+++.....++.+.+..|+|||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~ 83 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFI 83 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecC
Confidence 46799999999999999999977 46899999954 6889999999999999999999999
Q ss_pred cCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecC--CCcEEEeecCCccccCCCC
Q 042435 201 ERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNS--NLEAFVADFGTVRLLDVDS 278 (412)
Q Consensus 201 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~--~~~~kl~DfGla~~~~~~~ 278 (412)
++|+|.+++.... ..+++.++..++.||+.||+|||++ +|+||||||+|||++. ...+||+|||+++......
T Consensus 84 ~gg~L~~~i~~~~--~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~ 158 (321)
T d1tkia_ 84 SGLDIFERINTSA--FELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD 158 (321)
T ss_dssp CCCBHHHHHTSSS--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC
T ss_pred CCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccchhhccccCC
Confidence 9999999987653 2489999999999999999999999 9999999999999974 4589999999998764332
Q ss_pred CCcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCccchhhHH
Q 042435 279 SNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPPINQKIIQ 358 (412)
Q Consensus 279 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 358 (412)
......||+.|+|||...+..++.++||||+||++|||++|+.||... ........+.......+. .....
T Consensus 159 -~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~-------~~~~~~~~i~~~~~~~~~-~~~~~ 229 (321)
T d1tkia_ 159 -NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAE-------TNQQIIENIMNAEYTFDE-EAFKE 229 (321)
T ss_dssp -EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCS-------SHHHHHHHHHHTCCCCCH-HHHTT
T ss_pred -cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCC-------CHHHHHHHHHhCCCCCCh-hhccC
Confidence 234457899999999999999999999999999999999999998732 111222333333332221 11111
Q ss_pred HHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 359 DIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 359 ~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
....+.+++.+||..||++|||++|++++
T Consensus 230 ~s~~~~~li~~~L~~dp~~R~s~~eil~h 258 (321)
T d1tkia_ 230 ISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp SCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 23347899999999999999999999985
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-45 Score=344.76 Aligned_cols=234 Identities=21% Similarity=0.250 Sum_probs=178.0
Q ss_pred ceeeeecCceEEEEEEe-CCCcEEEEEec--------------------------cCCccccceEEEecCceEEEEEEec
Q 042435 148 RYCIGTGGYDSVYKAEL-PDGKVVALKKL--------------------------HHSETEDSAFVVYSPQCMFFIYEYM 200 (412)
Q Consensus 148 ~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l--------------------------~~~~~~~~~~~~~~~~~~~lv~ey~ 200 (412)
.++||+|+||+||+|.. .+|+.||||++ +|+++.....++..++..++||||+
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence 57899999999999987 46999999965 4677888888899999999999999
Q ss_pred cCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCCCC
Q 042435 201 ERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSSN 280 (412)
Q Consensus 201 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 280 (412)
+++++..+..... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++........
T Consensus 83 ~~~~~~~~~~~~~---~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~ 156 (299)
T d1ua2a_ 83 ETDLEVIIKDNSL---VLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA 156 (299)
T ss_dssp SEEHHHHHTTCCS---SCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCC
T ss_pred cchHHhhhhhccc---CCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCccccccCCCccc
Confidence 9887776654332 588899999999999999999999 9999999999999999999999999999877655545
Q ss_pred cccccccccccccccccCc-ccCcccccHHHHHHHHHHHhCCCCcccccccc-------------cCCCCcc-hhhHHh-
Q 042435 281 RTLQAGTYGYIALELVYTM-VVTEKCVIYSFGVVALEVLMGTHPGELLLSLS-------------SSSGPKI-MLIDIL- 344 (412)
Q Consensus 281 ~~~~~gt~~y~aPE~~~~~-~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~-------------~~~~~~~-~~~~~~- 344 (412)
.....||+.|+|||++... .++.++|||||||++|||+||+.||....... ....+.. ......
T Consensus 157 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~ 236 (299)
T d1ua2a_ 157 YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVT 236 (299)
T ss_dssp CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCC
T ss_pred ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhh
Confidence 5556899999999998654 57999999999999999999999986321100 0000000 000000
Q ss_pred hhccCC-ccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 345 YQRLSP-PINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 345 ~~~~~~-~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
...... +...........+.+++.+||+.||++|||++|+++|
T Consensus 237 ~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H 280 (299)
T d1ua2a_ 237 FKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280 (299)
T ss_dssp CCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred hccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence 000000 0000000112348899999999999999999999875
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.9e-45 Score=337.52 Aligned_cols=219 Identities=24% Similarity=0.316 Sum_probs=177.7
Q ss_pred cCcccceeeeecCceEEEEEEe-CCCcEEEEEecc-----------------------------CCccccceEEEecCce
Q 042435 143 EYFHIRYCIGTGGYDSVYKAEL-PDGKVVALKKLH-----------------------------HSETEDSAFVVYSPQC 192 (412)
Q Consensus 143 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l~-----------------------------~~~~~~~~~~~~~~~~ 192 (412)
++|++.+.||+|+||+||+|.. .+|+.||||+++ |+|+......+.+++.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 5799999999999999999976 579999999642 5677777778888999
Q ss_pred EEEEEEeccC-CceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecC-CCcEEEeecCC
Q 042435 193 MFFIYEYMER-GSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNS-NLEAFVADFGT 270 (412)
Q Consensus 193 ~~lv~ey~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~-~~~~kl~DfGl 270 (412)
.++||||+.+ +++.+++.... .+++..+..++.|++.||+|||++ +|+||||||+|||++. ++.+||+|||+
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~~~---~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~DFG~ 157 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITERG---ALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGS 157 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred EEEEEEeccCcchHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCeEEECcccc
Confidence 9999999976 56666665433 589999999999999999999999 9999999999999985 47999999999
Q ss_pred ccccCCCCCCcccccccccccccccccCccc-CcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccC
Q 042435 271 VRLLDVDSSNRTLQAGTYGYIALELVYTMVV-TEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLS 349 (412)
Q Consensus 271 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 349 (412)
++..... ......||+.|+|||++.+..+ +.++||||+||++|||+||+.||.... ++......
T Consensus 158 a~~~~~~--~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-------------~i~~~~~~ 222 (273)
T d1xwsa_ 158 GALLKDT--VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-------------EIIRGQVF 222 (273)
T ss_dssp CEECCSS--CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-------------HHHHCCCC
T ss_pred ceecccc--cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch-------------HHhhcccC
Confidence 9865432 2345679999999999987665 567999999999999999999987321 11221111
Q ss_pred CccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 350 PPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 350 ~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
.+ .... ..+.+++.+||+.||++|||++|++++
T Consensus 223 ~~--~~~s---~~~~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 223 FR--QRVS---SECQHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp CS--SCCC---HHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CC--CCCC---HHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 11 1111 237889999999999999999999875
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.4e-45 Score=341.70 Aligned_cols=244 Identities=19% Similarity=0.253 Sum_probs=183.6
Q ss_pred cCcccceeeeecCceEEEEEEe-CCCcEEEEEec-----------------------cCCccccceEEEecCceEEEEEE
Q 042435 143 EYFHIRYCIGTGGYDSVYKAEL-PDGKVVALKKL-----------------------HHSETEDSAFVVYSPQCMFFIYE 198 (412)
Q Consensus 143 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l-----------------------~~~~~~~~~~~~~~~~~~~lv~e 198 (412)
++|++.+.||+|+||+||+|.. .+|+.||||++ +|+++.+....+.+++..++|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 6899999999999999999976 57999999964 57788888888999999999999
Q ss_pred eccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCC
Q 042435 199 YMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDS 278 (412)
Q Consensus 199 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~ 278 (412)
|+.++ +.+++..... ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+|+......
T Consensus 82 ~~~~~-~~~~~~~~~~-~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~ 156 (298)
T d1gz8a_ 82 FLHQD-LKKFMDASAL-TGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 156 (298)
T ss_dssp CCSEE-HHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS
T ss_pred ecCCc-hhhhhhhhcc-cCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCcceeccCCc
Confidence 99764 4444432221 2589999999999999999999999 99999999999999999999999999998776555
Q ss_pred CCcccccccccccccccccCcc-cCcccccHHHHHHHHHHHhCCCCccccccccc--------CCCCcchhhHHh-----
Q 042435 279 SNRTLQAGTYGYIALELVYTMV-VTEKCVIYSFGVVALEVLMGTHPGELLLSLSS--------SSGPKIMLIDIL----- 344 (412)
Q Consensus 279 ~~~~~~~gt~~y~aPE~~~~~~-~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~--------~~~~~~~~~~~~----- 344 (412)
.......||+.|+|||.+.... ++.++|||||||++|||++|+.||........ ....+.......
T Consensus 157 ~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 236 (298)
T d1gz8a_ 157 RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236 (298)
T ss_dssp BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccccccc
Confidence 5555668999999999877655 57899999999999999999999963210000 000000000000
Q ss_pred hhccC----CccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH--HhcC
Q 042435 345 YQRLS----PPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQE--LEGK 391 (412)
Q Consensus 345 ~~~~~----~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~--L~~~ 391 (412)
..... .............+.+++.+||+.||++|||++|++++ ++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~ 289 (298)
T d1gz8a_ 237 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 289 (298)
T ss_dssp CTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTC
T ss_pred ccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccC
Confidence 00000 00000001112347889999999999999999999987 5544
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-44 Score=339.72 Aligned_cols=246 Identities=20% Similarity=0.258 Sum_probs=179.8
Q ss_pred hhcCcccceeeeecCceEEEEEEe-CC-CcEEEEEec--------------------------cCCccccceEEEe----
Q 042435 141 ATEYFHIRYCIGTGGYDSVYKAEL-PD-GKVVALKKL--------------------------HHSETEDSAFVVY---- 188 (412)
Q Consensus 141 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~-~~~vAvK~l--------------------------~~~~~~~~~~~~~---- 188 (412)
..++|++.+.||+|+||+||+|.. .+ ++.||||++ +|+++.+...++.
T Consensus 5 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~ 84 (305)
T d1blxa_ 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 84 (305)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred CcCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccc
Confidence 357899999999999999999986 34 678999964 3667766665553
Q ss_pred -cCceEEEEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEee
Q 042435 189 -SPQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVAD 267 (412)
Q Consensus 189 -~~~~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~D 267 (412)
.....+++|||++++++........ ..+++.....++.|++.||+|||++ +|+||||||+|||++.++.+||+|
T Consensus 85 ~~~~~~~~~~e~~~~~~~~~~~~~~~--~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~d 159 (305)
T d1blxa_ 85 DRETKLTLVFEHVDQDLTTYLDKVPE--PGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLAD 159 (305)
T ss_dssp SSEEEEEEEEECCSCBHHHHHHHSCT--TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECS
T ss_pred ccCceEEEEEEeccCCchhhhhhccC--CCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeeecc
Confidence 2357899999998877654433322 2489999999999999999999999 999999999999999999999999
Q ss_pred cCCccccCCCCCCcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccc-------------cCC
Q 042435 268 FGTVRLLDVDSSNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLS-------------SSS 334 (412)
Q Consensus 268 fGla~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~-------------~~~ 334 (412)
||+++..... .......||+.|+|||++.+..++.++||||+||++|||+||+.||....... ...
T Consensus 160 fg~~~~~~~~-~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 238 (305)
T d1blxa_ 160 FGLARIYSFQ-MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 238 (305)
T ss_dssp CCSCCCCCGG-GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGG
T ss_pred hhhhhhhccc-ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhc
Confidence 9998865332 22345679999999999999999999999999999999999999996321000 000
Q ss_pred CC-cch-hhHHhhhccCCccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH--HhcCC
Q 042435 335 GP-KIM-LIDILYQRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQE--LEGKT 392 (412)
Q Consensus 335 ~~-~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~--L~~~~ 392 (412)
.+ ... ...........+...........+.+|+.+||+.||++|||++|++++ ++++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~ 300 (305)
T d1blxa_ 239 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLE 300 (305)
T ss_dssp SCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred ccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCch
Confidence 00 000 000000000000000001112237789999999999999999999886 55543
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=2.3e-44 Score=337.12 Aligned_cols=239 Identities=21% Similarity=0.237 Sum_probs=178.7
Q ss_pred cCcccceeeeecCceEEEEEEeCCCcEEEEEec-----------------------cCCccccceEEEecCceEEEEEEe
Q 042435 143 EYFHIRYCIGTGGYDSVYKAELPDGKVVALKKL-----------------------HHSETEDSAFVVYSPQCMFFIYEY 199 (412)
Q Consensus 143 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~l-----------------------~~~~~~~~~~~~~~~~~~~lv~ey 199 (412)
++|++.+.||+|+||+||+|+.++|+.||||++ +|+++......+...+..++++||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 689999999999999999999999999999965 577777778888999999999999
Q ss_pred ccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCCC
Q 042435 200 MERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDSS 279 (412)
Q Consensus 200 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 279 (412)
+.++.+..+..... .++...+..++.||+.||+|||++ +|+||||||+|||++.++.+|++|||.+........
T Consensus 82 ~~~~~~~~~~~~~~---~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~ 155 (286)
T d1ob3a_ 82 LDQDLKKLLDVCEG---GLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR 155 (286)
T ss_dssp CSEEHHHHHHTSTT---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred ehhhhHHHHHhhcC---CcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEecccccceecccCcc
Confidence 98877766655443 599999999999999999999998 999999999999999999999999999987655444
Q ss_pred CcccccccccccccccccCc-ccCcccccHHHHHHHHHHHhCCCCcccccccc----------cCC-CCcchhhHHh--h
Q 042435 280 NRTLQAGTYGYIALELVYTM-VVTEKCVIYSFGVVALEVLMGTHPGELLLSLS----------SSS-GPKIMLIDIL--Y 345 (412)
Q Consensus 280 ~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~----------~~~-~~~~~~~~~~--~ 345 (412)
......|++.|+|||.+.+. .++.++|||||||++|||++|+.||....... ... .......... .
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T d1ob3a_ 156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD 235 (286)
T ss_dssp ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcc
Confidence 44555789999999998754 56899999999999999999999996321100 000 0000000000 0
Q ss_pred hcc----CCccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 346 QRL----SPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 346 ~~~----~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
... ..+...........+.+++.+||+.||++|||++|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H 281 (286)
T d1ob3a_ 236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (286)
T ss_dssp TTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000 000000000112247899999999999999999999864
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.7e-43 Score=333.19 Aligned_cols=239 Identities=16% Similarity=0.224 Sum_probs=177.5
Q ss_pred cCcccceeeeecCceEEEEEEe-CCCcEEEEEecc-------------------CCc-cccceEEEecCceEEEEEEecc
Q 042435 143 EYFHIRYCIGTGGYDSVYKAEL-PDGKVVALKKLH-------------------HSE-TEDSAFVVYSPQCMFFIYEYME 201 (412)
Q Consensus 143 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l~-------------------~~~-~~~~~~~~~~~~~~~lv~ey~~ 201 (412)
++|++.+.||+|+||.||+|.. .+|+.||||.++ |.+ +..........+..++||||+
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~- 85 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL- 85 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECC-
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEc-
Confidence 5699999999999999999976 568999999653 333 223334456778889999999
Q ss_pred CCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEec---CCCcEEEeecCCccccCCCC
Q 042435 202 RGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLN---SNLEAFVADFGTVRLLDVDS 278 (412)
Q Consensus 202 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~---~~~~~kl~DfGla~~~~~~~ 278 (412)
+|+|.+.+.... ..+++..+..++.|++.||+|||++ +|+||||||+|||++ .+..+|++|||+|+......
T Consensus 86 ~~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~ 160 (299)
T d1ckia_ 86 GPSLEDLFNFCS--RKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 160 (299)
T ss_dssp CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTT
T ss_pred CCchhhhhhhcc--CCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccCcceeccccc
Confidence 456665554332 2589999999999999999999999 999999999999985 45679999999998765432
Q ss_pred C-------CcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccCCc
Q 042435 279 S-------NRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLSPP 351 (412)
Q Consensus 279 ~-------~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 351 (412)
. ......||+.|+|||.+.+..++.++|||||||++|||+||+.||....... ...............+
T Consensus 161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~----~~~~~~~~~~~~~~~~ 236 (299)
T d1ckia_ 161 THQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAAT----KRQKYERISEKKMSTP 236 (299)
T ss_dssp TCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-----------HHHHHHHHHHSC
T ss_pred cccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHH----HHHHHHHhhcccCCCC
Confidence 2 1234579999999999999999999999999999999999999997431110 0111111111111111
Q ss_pred cchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhcC
Q 042435 352 INQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELEGK 391 (412)
Q Consensus 352 ~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 391 (412)
...........+.+++.+||+.||++||+++++.+.|++.
T Consensus 237 ~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~ 276 (299)
T d1ckia_ 237 IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 276 (299)
T ss_dssp HHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHH
T ss_pred hhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence 1111111223478899999999999999999998888765
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1e-42 Score=326.81 Aligned_cols=240 Identities=15% Similarity=0.153 Sum_probs=182.7
Q ss_pred cCcccceeeeecCceEEEEEEe-CCCcEEEEEecc--------------------CCccccceEEEecCceEEEEEEecc
Q 042435 143 EYFHIRYCIGTGGYDSVYKAEL-PDGKVVALKKLH--------------------HSETEDSAFVVYSPQCMFFIYEYME 201 (412)
Q Consensus 143 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l~--------------------~~~~~~~~~~~~~~~~~~lv~ey~~ 201 (412)
++|++.+.||+|+||+||+|+. .+|+.||||.++ ++++.........+...++||||+
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~- 83 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL- 83 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec-
Confidence 5799999999999999999986 468999999752 234444555677788999999999
Q ss_pred CCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecC-----CCcEEEeecCCccccCC
Q 042435 202 RGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNS-----NLEAFVADFGTVRLLDV 276 (412)
Q Consensus 202 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~-----~~~~kl~DfGla~~~~~ 276 (412)
+|+|.+++..... .+++.++..++.|++.||+|||+. +|+||||||+|||++. ++.+||+|||+|+....
T Consensus 84 ~~~l~~~~~~~~~--~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~ 158 (293)
T d1csna_ 84 GPSLEDLLDLCGR--KFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRD 158 (293)
T ss_dssp CCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBC
T ss_pred CCCHHHHHHhhcc--chhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEcccceeEEccc
Confidence 6899888765432 589999999999999999999998 9999999999999964 57899999999987643
Q ss_pred CCC-------CcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhhccC
Q 042435 277 DSS-------NRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQRLS 349 (412)
Q Consensus 277 ~~~-------~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 349 (412)
... ......||+.|||||++.+..++.++|||||||++|||+||+.||...... ........+......
T Consensus 159 ~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~----~~~~~~~~i~~~~~~ 234 (293)
T d1csna_ 159 PVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAA----TNKQKYERIGEKKQS 234 (293)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSC----CHHHHHHHHHHHHHH
T ss_pred CccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccch----hHHHHHHHHHhccCC
Confidence 221 123457999999999999999999999999999999999999999732100 000111111111111
Q ss_pred CccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHHHhcCC
Q 042435 350 PPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQELEGKT 392 (412)
Q Consensus 350 ~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 392 (412)
.+........+..+.+++..|++.+|++||+++.+.+.|+++.
T Consensus 235 ~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~ 277 (293)
T d1csna_ 235 TPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVL 277 (293)
T ss_dssp SCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred CChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 1111100111234788999999999999999999988887653
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-42 Score=333.99 Aligned_cols=244 Identities=19% Similarity=0.234 Sum_probs=174.5
Q ss_pred CcccceeeeecCceEEEEEEe-CCCcEEEEEec-----------------cCCccccceEEEec------CceEEEEEEe
Q 042435 144 YFHIRYCIGTGGYDSVYKAEL-PDGKVVALKKL-----------------HHSETEDSAFVVYS------PQCMFFIYEY 199 (412)
Q Consensus 144 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l-----------------~~~~~~~~~~~~~~------~~~~~lv~ey 199 (412)
+|+..++||+|+||+||+|+. .+|+.||||++ +|+++.....++.. ....++||||
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~Ey 100 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDY 100 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEEC
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchHHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEEec
Confidence 588889999999999999987 46999999965 56777776666532 3357999999
Q ss_pred ccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCC-cEEEeecCCccccCCCC
Q 042435 200 MERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNL-EAFVADFGTVRLLDVDS 278 (412)
Q Consensus 200 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~-~~kl~DfGla~~~~~~~ 278 (412)
|+++.+..+.........+++.++..++.|++.||+|||++ +|+||||||+|||++.++ .+||+|||+++......
T Consensus 101 ~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~~ 177 (350)
T d1q5ka_ 101 VPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 177 (350)
T ss_dssp CSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTCEECCTTS
T ss_pred cCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccchhhccCCc
Confidence 98764443332222233699999999999999999999998 999999999999999764 89999999998765433
Q ss_pred CCcccccccccccccccccC-cccCcccccHHHHHHHHHHHhCCCCccccccccc--------CCCCcchhhHHhh----
Q 042435 279 SNRTLQAGTYGYIALELVYT-MVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSS--------SSGPKIMLIDILY---- 345 (412)
Q Consensus 279 ~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~--------~~~~~~~~~~~~~---- 345 (412)
. .....||+.|+|||.+.+ ..++.++||||+||++|||++|+.||........ .............
T Consensus 178 ~-~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~ 256 (350)
T d1q5ka_ 178 P-NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTE 256 (350)
T ss_dssp C-CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC---C
T ss_pred c-cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccchhh
Confidence 2 234579999999998765 5689999999999999999999999963211000 0000000000000
Q ss_pred ---hccCCcc-c-hhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH--HhcC
Q 042435 346 ---QRLSPPI-N-QKIIQDIILVSTIALACLRSKPKSRPTMQRISQE--LEGK 391 (412)
Q Consensus 346 ---~~~~~~~-~-~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~--L~~~ 391 (412)
+...... . .........+.+|+.+||+.||++|||+.|++++ ++++
T Consensus 257 ~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~ 309 (350)
T d1q5ka_ 257 FKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309 (350)
T ss_dssp CCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred ccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccc
Confidence 0000000 0 0000112237889999999999999999999975 4444
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-42 Score=327.11 Aligned_cols=240 Identities=17% Similarity=0.183 Sum_probs=172.8
Q ss_pred hcCcccceeeeecCceEEEEEEe-CCCcEEEEEec-----------------------cCCccccceEEEec--------
Q 042435 142 TEYFHIRYCIGTGGYDSVYKAEL-PDGKVVALKKL-----------------------HHSETEDSAFVVYS-------- 189 (412)
Q Consensus 142 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l-----------------------~~~~~~~~~~~~~~-------- 189 (412)
.++|++.+.||+|+||+||+|.. .+|+.||||++ +|+++.....++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 47899999999999999999986 57999999975 35555555444432
Q ss_pred CceEEEEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecC
Q 042435 190 PQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFG 269 (412)
Q Consensus 190 ~~~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG 269 (412)
.+..++||||++++.+........ .++...+..++.|++.||.|||++ +|+||||||+|||++.++.+|++|||
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~~~~---~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~dfg 162 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSNVLV---KFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFG 162 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTCTTC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCT
T ss_pred CceEEEEEeccCCCccchhhhccc---ccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEeeecc
Confidence 456899999998877664443332 578889999999999999999999 99999999999999999999999999
Q ss_pred CccccCCCC----CCcccccccccccccccccCc-ccCcccccHHHHHHHHHHHhCCCCcccccccc---------cCC-
Q 042435 270 TVRLLDVDS----SNRTLQAGTYGYIALELVYTM-VVTEKCVIYSFGVVALEVLMGTHPGELLLSLS---------SSS- 334 (412)
Q Consensus 270 la~~~~~~~----~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~---------~~~- 334 (412)
+++...... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||+...... ...
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~ 242 (318)
T d3blha1 163 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT 242 (318)
T ss_dssp TCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred eeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence 998665322 122345799999999998765 68999999999999999999999996321000 000
Q ss_pred ------CCcchhhHHhhhccC-Cccchhh---HHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 335 ------GPKIMLIDILYQRLS-PPINQKI---IQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 335 ------~~~~~~~~~~~~~~~-~~~~~~~---~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
............... ....... ......+.+|+.+||+.||++|||++|+++|
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 243 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp TTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 000000000000000 0000000 0112246789999999999999999999977
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-42 Score=324.89 Aligned_cols=229 Identities=27% Similarity=0.366 Sum_probs=180.0
Q ss_pred cCcccceeeeecCceEEEEEEe----CCCcEEEEEecc-------------------------C-CccccceEEEecCce
Q 042435 143 EYFHIRYCIGTGGYDSVYKAEL----PDGKVVALKKLH-------------------------H-SETEDSAFVVYSPQC 192 (412)
Q Consensus 143 ~~f~~~~~lG~G~~g~Vy~~~~----~~~~~vAvK~l~-------------------------~-~~~~~~~~~~~~~~~ 192 (412)
++|++.+.||+|+||+||+|+. .+|+.||||.++ | +++......+.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 6699999999999999999975 258999999652 3 567677777888999
Q ss_pred EEEEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCcc
Q 042435 193 MFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVR 272 (412)
Q Consensus 193 ~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~ 272 (412)
.+++|||+.+|+|.+++.... .+.......++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~---~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG~a~ 177 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRE---RFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSK 177 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred eeeeeecccccHHHHHHHhcc---cccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEEeeccchh
Confidence 999999999999999887654 467788889999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCC-CcccccccccccccccccCc--ccCcccccHHHHHHHHHHHhCCCCcccccccccCCCCcchhhHHhhh--c
Q 042435 273 LLDVDSS-NRTLQAGTYGYIALELVYTM--VVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSSSGPKIMLIDILYQ--R 347 (412)
Q Consensus 273 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~--~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~--~ 347 (412)
....... ......|++.|+|||.+.+. .++.++|||||||+||||+||+.||... ........+... .
T Consensus 178 ~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~-------~~~~~~~~i~~~~~~ 250 (322)
T d1vzoa_ 178 EFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVD-------GEKNSQAEISRRILK 250 (322)
T ss_dssp ECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCT-------TSCCCHHHHHHHHHH
T ss_pred hhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCC-------CHHHHHHHHHHhccc
Confidence 6643322 23456799999999998754 4678999999999999999999999732 111112222211 1
Q ss_pred cCCccchhhHHHHHHHHHHHHhcCcCCCCCCC-----CHHHHHHH
Q 042435 348 LSPPINQKIIQDIILVSTIALACLRSKPKSRP-----TMQRISQE 387 (412)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RP-----s~~evl~~ 387 (412)
..++.+.. ....+.+++.+||+.||++|| |++|+++|
T Consensus 251 ~~~~~~~~---~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~H 292 (322)
T d1vzoa_ 251 SEPPYPQE---MSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 292 (322)
T ss_dssp CCCCCCTT---SCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred CCCCCccc---CCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcC
Confidence 11121222 223488899999999999999 48898874
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-41 Score=319.65 Aligned_cols=239 Identities=17% Similarity=0.225 Sum_probs=183.1
Q ss_pred cCcccceeeeecCceEEEEEEe-CCCcEEEEEec-----------------------cCCccccceEEEecCceEEEEEE
Q 042435 143 EYFHIRYCIGTGGYDSVYKAEL-PDGKVVALKKL-----------------------HHSETEDSAFVVYSPQCMFFIYE 198 (412)
Q Consensus 143 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l-----------------------~~~~~~~~~~~~~~~~~~~lv~e 198 (412)
++|++.+.||+|+||+||+|+. .+|+.||||++ +|+++......+...+..++|+|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 5799999999999999999986 57899999965 46677777778889999999999
Q ss_pred eccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccccCCCC
Q 042435 199 YMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRLLDVDS 278 (412)
Q Consensus 199 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~ 278 (412)
|+.+++|..++.... .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||.++......
T Consensus 82 ~~~~~~l~~~~~~~~---~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~ 155 (292)
T d1unla_ 82 FCDQDLKKYFDSCNG---DLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp CCSEEHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSCC
T ss_pred ecccccccccccccc---ccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecchhhcccCCC
Confidence 999999888776554 588999999999999999999999 99999999999999999999999999999876655
Q ss_pred CCcccccccccccccccccCcc-cCcccccHHHHHHHHHHHhCCCCcccccccc----------cC-CCCc-chhhHHhh
Q 042435 279 SNRTLQAGTYGYIALELVYTMV-VTEKCVIYSFGVVALEVLMGTHPGELLLSLS----------SS-SGPK-IMLIDILY 345 (412)
Q Consensus 279 ~~~~~~~gt~~y~aPE~~~~~~-~s~ksDv~S~Gvil~elltg~~P~~~~~~~~----------~~-~~~~-~~~~~~~~ 345 (412)
.......+++.|+|||.+.... ++.++||||+||++|||++|+.||....... .. .... ........
T Consensus 156 ~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (292)
T d1unla_ 156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPD 235 (292)
T ss_dssp SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTT
T ss_pred ccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhccc
Confidence 5555567889999999987655 6899999999999999999999974211000 00 0000 00000000
Q ss_pred hc------cCCccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 346 QR------LSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 346 ~~------~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
.. ...............+.+++.+||+.||++|||++|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H 283 (292)
T d1unla_ 236 YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp CCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred ccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00 0000000011112347789999999999999999999875
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-42 Score=328.43 Aligned_cols=240 Identities=21% Similarity=0.233 Sum_probs=172.4
Q ss_pred hhcCcccceeeeecCceEEEEEEe-CCCcEEEEEec----------------------cCCccccceEEEecCc----eE
Q 042435 141 ATEYFHIRYCIGTGGYDSVYKAEL-PDGKVVALKKL----------------------HHSETEDSAFVVYSPQ----CM 193 (412)
Q Consensus 141 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l----------------------~~~~~~~~~~~~~~~~----~~ 193 (412)
.+++|++.+.||+|+||+||+|.. .+|+.||||++ +|+++.....++.... ..
T Consensus 6 i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~ 85 (345)
T d1pmea_ 6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 85 (345)
T ss_dssp CCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred cCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccce
Confidence 346799999999999999999975 68999999976 4566666666654432 23
Q ss_pred EEEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCccc
Q 042435 194 FFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVRL 273 (412)
Q Consensus 194 ~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~~ 273 (412)
+++++|+.+|+|.+++... .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 86 ~~l~~~~~~g~L~~~l~~~----~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a~~ 158 (345)
T d1pmea_ 86 VYLVTHLMGADLYKLLKTQ----HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARV 158 (345)
T ss_dssp EEEEEECCCEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEEeecCCchhhhhhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCceee
Confidence 4555667799999998654 489999999999999999999999 999999999999999999999999999986
Q ss_pred cCCCCC---CcccccccccccccccccC-cccCcccccHHHHHHHHHHHhCCCCcccccccc--------cCCCCcc---
Q 042435 274 LDVDSS---NRTLQAGTYGYIALELVYT-MVVTEKCVIYSFGVVALEVLMGTHPGELLLSLS--------SSSGPKI--- 338 (412)
Q Consensus 274 ~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~--------~~~~~~~--- 338 (412)
...... ......||+.|+|||++.. ..++.++||||+||++|||++|+.||....... .......
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (345)
T d1pmea_ 159 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLN 238 (345)
T ss_dssp CCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHH
T ss_pred ccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhh
Confidence 544322 2244579999999999854 567899999999999999999999996321000 0000000
Q ss_pred -----hhhHHhhhcc--CC-ccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 339 -----MLIDILYQRL--SP-PINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 339 -----~~~~~~~~~~--~~-~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
.......... .. +...........+.+++.+||+.||++|||++|++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 239 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp TCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0000000000 00 0000000111247899999999999999999999987
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-41 Score=326.23 Aligned_cols=240 Identities=22% Similarity=0.251 Sum_probs=172.6
Q ss_pred hcCcccceeeeecCceEEEEEEe-CCCcEEEEEec-----------------------cCCccccceEEEecCc------
Q 042435 142 TEYFHIRYCIGTGGYDSVYKAEL-PDGKVVALKKL-----------------------HHSETEDSAFVVYSPQ------ 191 (412)
Q Consensus 142 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l-----------------------~~~~~~~~~~~~~~~~------ 191 (412)
.++|++.+.||+|+||+||+|.. .+|+.||||++ +|+++.....++...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 46899999999999999999976 56999999975 4666666666665543
Q ss_pred eEEEEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCc
Q 042435 192 CMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTV 271 (412)
Q Consensus 192 ~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla 271 (412)
..++||||+ +.+|..+.+.. .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+|++|||++
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg~a 168 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKHE----KLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLA 168 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEecc-cccHHHHHHhc----cccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhcccccccccccccce
Confidence 579999999 55676665433 499999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCCcccccccccccccccccCc-ccCcccccHHHHHHHHHHHhCCCCccccccccc--------CCCCc-----
Q 042435 272 RLLDVDSSNRTLQAGTYGYIALELVYTM-VVTEKCVIYSFGVVALEVLMGTHPGELLLSLSS--------SSGPK----- 337 (412)
Q Consensus 272 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~--------~~~~~----- 337 (412)
+..... .....||+.|+|||++.+. .++.++||||+||++|||++|+.||........ ...+.
T Consensus 169 ~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (346)
T d1cm8a_ 169 RQADSE---MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQR 245 (346)
T ss_dssp EECCSS---CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHT
T ss_pred eccCCc---cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhh
Confidence 876433 3446799999999998764 578999999999999999999999863211000 00000
Q ss_pred --chhhHHhhhcc---CC-ccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH--HhcCC
Q 042435 338 --IMLIDILYQRL---SP-PINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQE--LEGKT 392 (412)
Q Consensus 338 --~~~~~~~~~~~---~~-~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~--L~~~~ 392 (412)
........... .. ............+.+|+.+||..||++|||+.|++++ ++.+.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~ 308 (346)
T d1cm8a_ 246 LQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 308 (346)
T ss_dssp CSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred hcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence 00000000000 00 0000001112247789999999999999999999987 66554
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=4.4e-41 Score=320.76 Aligned_cols=235 Identities=15% Similarity=0.160 Sum_probs=175.2
Q ss_pred cCcccceeeeecCceEEEEEEe-CCCcEEEEEec-------------------cCCccccceEEEe--cCceEEEEEEec
Q 042435 143 EYFHIRYCIGTGGYDSVYKAEL-PDGKVVALKKL-------------------HHSETEDSAFVVY--SPQCMFFIYEYM 200 (412)
Q Consensus 143 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l-------------------~~~~~~~~~~~~~--~~~~~~lv~ey~ 200 (412)
++|++.++||+|+||+||+|+. .+|+.||||++ .|+++......+. .....++|||||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~~ 114 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHV 114 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEECC
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHHHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEeec
Confidence 5799999999999999999977 57999999975 2677777666665 345799999999
Q ss_pred cCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCC-cEEEeecCCccccCCCCC
Q 042435 201 ERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNL-EAFVADFGTVRLLDVDSS 279 (412)
Q Consensus 201 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~-~~kl~DfGla~~~~~~~~ 279 (412)
++|+|..+.+ .++...+..++.||+.||+|||++ +|+||||||+|||++.++ .+||+|||+++......
T Consensus 115 ~~~~L~~~~~------~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~- 184 (328)
T d3bqca1 115 NNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ- 184 (328)
T ss_dssp CSCBGGGTTT------SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTC-
T ss_pred CCCcHHHHhc------CCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeecccccceeccCCC-
Confidence 9999976642 488999999999999999999999 999999999999998654 68999999998765433
Q ss_pred CcccccccccccccccccCc-ccCcccccHHHHHHHHHHHhCCCCccccccccc---------------------CCCCc
Q 042435 280 NRTLQAGTYGYIALELVYTM-VVTEKCVIYSFGVVALEVLMGTHPGELLLSLSS---------------------SSGPK 337 (412)
Q Consensus 280 ~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~---------------------~~~~~ 337 (412)
......+|+.|+|||.+.+. .++.++||||+||++|||++|+.||........ .....
T Consensus 185 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~ 264 (328)
T d3bqca1 185 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD 264 (328)
T ss_dssp CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCC
T ss_pred cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccC
Confidence 23445789999999998765 479999999999999999999999863210000 00000
Q ss_pred chhhHHhhhccCCcc-----chhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 338 IMLIDILYQRLSPPI-----NQKIIQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 338 ~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
....+.......... ..........+.+|+.+||..||++|||++|+++|
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~H 319 (328)
T d3bqca1 265 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 319 (328)
T ss_dssp GGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000000000000000 00001112347899999999999999999999874
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-40 Score=318.35 Aligned_cols=235 Identities=21% Similarity=0.191 Sum_probs=168.4
Q ss_pred cCcccceeeeecCceEEEEEEeC-CCcEEEEEec-----------------------cCCccccceEEEe------cCce
Q 042435 143 EYFHIRYCIGTGGYDSVYKAELP-DGKVVALKKL-----------------------HHSETEDSAFVVY------SPQC 192 (412)
Q Consensus 143 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l-----------------------~~~~~~~~~~~~~------~~~~ 192 (412)
++|++.++||+|+||+||+|... +|+.||||++ +|+++.....++. ....
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 67999999999999999999864 6999999975 4677777666664 3468
Q ss_pred EEEEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCcc
Q 042435 193 MFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVR 272 (412)
Q Consensus 193 ~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~ 272 (412)
.|+|||||.++.+. .+.. .+++..+..++.|++.||+|||+. +|+||||||+|||++.++..|++|||+++
T Consensus 97 ~~iv~Ey~~~~l~~-~~~~-----~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~~~~ 167 (355)
T d2b1pa1 97 VYLVMELMDANLCQ-VIQM-----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR 167 (355)
T ss_dssp EEEEEECCSEEHHH-HHTS-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred eEEEEeccchHHHH-hhhc-----CCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeechhhhh
Confidence 89999999765444 3322 488999999999999999999999 99999999999999999999999999988
Q ss_pred ccCCCCCCcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccc-----------------cC--
Q 042435 273 LLDVDSSNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLS-----------------SS-- 333 (412)
Q Consensus 273 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~-----------------~~-- 333 (412)
...... ......||+.|+|||++.+..++.++||||+||++|||++|+.||....... ..
T Consensus 168 ~~~~~~-~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 246 (355)
T d2b1pa1 168 TAGTSF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 246 (355)
T ss_dssp --------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSC
T ss_pred cccccc-ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhh
Confidence 654332 2344578999999999999999999999999999999999999985221000 00
Q ss_pred -----------CCCcchhhHHhhhccCCccchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 334 -----------SGPKIMLIDILYQRLSPPINQKIIQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 334 -----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
.............................+.+++.+|++.||++|||++|+++|
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 247 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp HHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 000000011111111111112222334558899999999999999999999976
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-40 Score=317.50 Aligned_cols=236 Identities=21% Similarity=0.201 Sum_probs=171.1
Q ss_pred hcCcccceeeeecCceEEEEEEe-CCCcEEEEEec-----------------------cCCccccceEEEec-----Cce
Q 042435 142 TEYFHIRYCIGTGGYDSVYKAEL-PDGKVVALKKL-----------------------HHSETEDSAFVVYS-----PQC 192 (412)
Q Consensus 142 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l-----------------------~~~~~~~~~~~~~~-----~~~ 192 (412)
+++|++.+.||+|+||+||+|+. .+|+.||||++ +|+++.....++.. ...
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 56799999999999999999976 57999999976 35555555555532 234
Q ss_pred EEEEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCCcc
Q 042435 193 MFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTVR 272 (412)
Q Consensus 193 ~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGla~ 272 (412)
.+++++|+.+|+|.+++... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+|++|||++.
T Consensus 97 ~~~i~~~~~gg~L~~~~~~~----~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~a~ 169 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR 169 (348)
T ss_dssp CCEEEEECCSEEHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC----
T ss_pred eEEEEEeecCCchhhhcccc----cccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccchhc
Confidence 46677888899999988654 499999999999999999999999 99999999999999999999999999987
Q ss_pred ccCCCCCCcccccccccccccccccCc-ccCcccccHHHHHHHHHHHhCCCCcccccccc---------c-------CCC
Q 042435 273 LLDVDSSNRTLQAGTYGYIALELVYTM-VVTEKCVIYSFGVVALEVLMGTHPGELLLSLS---------S-------SSG 335 (412)
Q Consensus 273 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~---------~-------~~~ 335 (412)
.... ......||+.|+|||...+. .++.++|||||||++|||++|+.||....... . ...
T Consensus 170 ~~~~---~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~ 246 (348)
T d2gfsa1 170 HTDD---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 246 (348)
T ss_dssp CCTG---GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTC
T ss_pred ccCc---ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhc
Confidence 5432 22345789999999987665 46889999999999999999999986321000 0 000
Q ss_pred CcchhhHHhhhccCCcc---chhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHHH
Q 042435 336 PKIMLIDILYQRLSPPI---NQKIIQDIILVSTIALACLRSKPKSRPTMQRISQE 387 (412)
Q Consensus 336 ~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~ 387 (412)
...............+. ..........+.+|+.+||+.||++|||++|++++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H 301 (348)
T d2gfsa1 247 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 301 (348)
T ss_dssp CCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcC
Confidence 00000000000000000 00000112347889999999999999999999985
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.8e-36 Score=292.32 Aligned_cols=238 Identities=18% Similarity=0.192 Sum_probs=166.2
Q ss_pred CcccceeeeecCceEEEEEEe-CCCcEEEEEeccCC-------------------------------ccccceEEE--ec
Q 042435 144 YFHIRYCIGTGGYDSVYKAEL-PDGKVVALKKLHHS-------------------------------ETEDSAFVV--YS 189 (412)
Q Consensus 144 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l~~~-------------------------------~~~~~~~~~--~~ 189 (412)
+|++.++||+|+||+||+|+. .+|+.||||+++.. ++......+ ..
T Consensus 14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~ 93 (362)
T d1q8ya_ 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKG 93 (362)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEE
T ss_pred cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeecc
Confidence 499999999999999999976 57999999987532 222222222 23
Q ss_pred CceEEEEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHh-CCCCCcEEeCCCCCCEEecCCC------c
Q 042435 190 PQCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHH-DCTPSIVHRDISSNNILLNSNL------E 262 (412)
Q Consensus 190 ~~~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~-~~~~~ivHrDlkp~NILl~~~~------~ 262 (412)
....+++++++..+..............+++..+..++.|++.||+|||+ . +|+||||||+|||++.++ .
T Consensus 94 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~---~IvHrDlKp~NIll~~~~~~~~~~~ 170 (362)
T d1q8ya_ 94 PNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC---GIIHTDIKPENVLMEIVDSPENLIQ 170 (362)
T ss_dssp TTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CEECSCCSGGGEEEEEEETTTTEEE
T ss_pred ccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhc---CcccccCChhHeeeeccCcccccce
Confidence 45667777777665543333222233458889999999999999999998 5 899999999999997654 4
Q ss_pred EEEeecCCccccCCCCCCcccccccccccccccccCcccCcccccHHHHHHHHHHHhCCCCcccccccccC---------
Q 042435 263 AFVADFGTVRLLDVDSSNRTLQAGTYGYIALELVYTMVVTEKCVIYSFGVVALEVLMGTHPGELLLSLSSS--------- 333 (412)
Q Consensus 263 ~kl~DfGla~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvil~elltg~~P~~~~~~~~~~--------- 333 (412)
++++|||.+...... .....||+.|+|||++.+..++.++||||+||+++||++|+.||.........
T Consensus 171 ~kl~dfg~s~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~ 247 (362)
T d1q8ya_ 171 IKIADLGNACWYDEH---YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQI 247 (362)
T ss_dssp EEECCCTTCEETTBC---CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHH
T ss_pred eeEeecccccccccc---cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHH
Confidence 899999999765332 23457999999999999999999999999999999999999998632110000
Q ss_pred -----CCCcchhh------HHhh-----hccCC----c-------cchhhHHHHHHHHHHHHhcCcCCCCCCCCHHHHHH
Q 042435 334 -----SGPKIMLI------DILY-----QRLSP----P-------INQKIIQDIILVSTIALACLRSKPKSRPTMQRISQ 386 (412)
Q Consensus 334 -----~~~~~~~~------~~~~-----~~~~~----~-------~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~ 386 (412)
..+..... .... ..... + ...........+.+++.+|+..||.+|||++|+++
T Consensus 248 ~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~ 327 (362)
T d1q8ya_ 248 IELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVN 327 (362)
T ss_dssp HHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHT
T ss_pred HHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 00000000 0000 00000 0 00011233456889999999999999999999998
Q ss_pred H
Q 042435 387 E 387 (412)
Q Consensus 387 ~ 387 (412)
|
T Consensus 328 H 328 (362)
T d1q8ya_ 328 H 328 (362)
T ss_dssp C
T ss_pred C
Confidence 6
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.87 E-value=3.3e-23 Score=180.75 Aligned_cols=146 Identities=15% Similarity=0.171 Sum_probs=100.3
Q ss_pred ccceeeeecCceEEEEEEeCCCcEEEEEeccCCccc-----cceE--------------------------E----EecC
Q 042435 146 HIRYCIGTGGYDSVYKAELPDGKVVALKKLHHSETE-----DSAF--------------------------V----VYSP 190 (412)
Q Consensus 146 ~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~l~~~~~~-----~~~~--------------------------~----~~~~ 190 (412)
.+.+.||+|+||+||+|...+|+.||||.++..... .... . ....
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 467899999999999999889999999976532110 0000 0 0011
Q ss_pred ceEEEEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEeCCCCCCEEecCCCcEEEeecCC
Q 042435 191 QCMFFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGT 270 (412)
Q Consensus 191 ~~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DfGl 270 (412)
...+++|||++++.+.+ ++......++.|++.+++|||++ +|+||||||+|||++++ .++|+|||.
T Consensus 83 ~~~~lvme~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~-~~~liDFG~ 148 (191)
T d1zara2 83 EGNAVLMELIDAKELYR----------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE-GIWIIDFPQ 148 (191)
T ss_dssp ETTEEEEECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT-EEEECCCTT
T ss_pred cCCEEEEEeeccccccc----------hhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCC-CEEEEECCC
Confidence 22368999998754432 33444567899999999999998 99999999999999864 599999999
Q ss_pred ccccCCCCCCccccccccccccc------ccccCcccCcccccHHHHHHH
Q 042435 271 VRLLDVDSSNRTLQAGTYGYIAL------ELVYTMVVTEKCVIYSFGVVA 314 (412)
Q Consensus 271 a~~~~~~~~~~~~~~gt~~y~aP------E~~~~~~~s~ksDv~S~Gvil 314 (412)
|+........ .|... +. ....|+.++|+||..--+
T Consensus 149 a~~~~~~~~~--------~~l~rd~~~~~~~-f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 149 SVEVGEEGWR--------EILERDVRNIITY-FSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp CEETTSTTHH--------HHHHHHHHHHHHH-HHHHHCCCCCHHHHHHHH
T ss_pred cccCCCCCcH--------HHHHHHHHHHHHH-HcCCCCCcccHHHHHHHH
Confidence 9765322110 11111 11 135678899999975433
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=98.78 E-value=8.5e-10 Score=101.80 Aligned_cols=65 Identities=28% Similarity=0.362 Sum_probs=56.4
Q ss_pred eechhhccCCC-ceeeCCC-CCCCCCCCEEeCccccccccCCC-CCcCC-CCcccccCcCCCCCCCCCCcc
Q 042435 3 VLLAFLSISAA-CSGVVEE-EPSSPSFLKSDMSFNNLDGEIPT-YLRDN-PPKSFVGNKGLCGHVQGFLSC 69 (412)
Q Consensus 3 ~~~~~l~~~~~-~~G~ip~-~~~~~~l~~~~ls~N~l~G~iP~-~~~~~-~~~~~~gn~~lcg~~~~~~~c 69 (412)
..|++|||+.| ++|.||+ +.++++|+.||||+|+|+|+||. +-+.+ ....+.||+.|||.|+ ++|
T Consensus 244 ~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~~~L~~L~~l~l~~N~~l~g~pl--p~c 312 (313)
T d1ogqa_ 244 KNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSPL--PAC 312 (313)
T ss_dssp TTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTCSSSEEESTTS--SCC
T ss_pred cccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCCcccCCCCCHHHhCCCccccCCCC--CCC
Confidence 46889999999 9999998 89999999999999999999998 33445 7788899999999875 466
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=97.84 E-value=4e-05 Score=67.47 Aligned_cols=128 Identities=13% Similarity=0.055 Sum_probs=80.4
Q ss_pred HHHHHhhcCcccceeeeecCceEEEEEEeCCCcEEEEEeccCCc----------------------cccceEEEecCceE
Q 042435 136 ENLIDATEYFHIRYCIGTGGYDSVYKAELPDGKVVALKKLHHSE----------------------TEDSAFVVYSPQCM 193 (412)
Q Consensus 136 ~~l~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~l~~~~----------------------~~~~~~~~~~~~~~ 193 (412)
.++....+.|+..+..+.++.+.||+... +++.+.+|+..... ..........++..
T Consensus 7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~ 85 (263)
T d1j7la_ 7 PELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS 85 (263)
T ss_dssp HHHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred HHHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCce
Confidence 46666667777666554455678999876 55666778653211 11112234456778
Q ss_pred EEEEEeccCCceeeeeccCcccccCCHHHHHHHHHHHHHHHHHHHhCC--------------------------------
Q 042435 194 FFIYEYMERGSLFCVLRDDDEAIELNWTRRMNIVKSVAHALSYLHHDC-------------------------------- 241 (412)
Q Consensus 194 ~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~-------------------------------- 241 (412)
++||+++++.++.+..... .....++.++++.++.||+..
T Consensus 86 ~lv~~~l~G~~~~~~~~~~--------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (263)
T d1j7la_ 86 NLLMSEADGVLCSEEYEDE--------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCEN 157 (263)
T ss_dssp EEEEECCSSEEHHHHTTTC--------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGG
T ss_pred EEEEEeccccccccccccc--------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhc
Confidence 9999999887765432211 112224455555555555421
Q ss_pred ------------------------CCCcEEeCCCCCCEEecCCCcEEEeecCCcc
Q 042435 242 ------------------------TPSIVHRDISSNNILLNSNLEAFVADFGTVR 272 (412)
Q Consensus 242 ------------------------~~~ivHrDlkp~NILl~~~~~~kl~DfGla~ 272 (412)
.+.++|+|+.|.||+++++...-|+||+.+.
T Consensus 158 ~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 158 WEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp GSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred ccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 1137899999999999987666799998775
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.19 E-value=0.00029 Score=61.33 Aligned_cols=29 Identities=21% Similarity=0.265 Sum_probs=25.1
Q ss_pred CcEEeCCCCCCEEecCCCcEEEeecCCcc
Q 042435 244 SIVHRDISSNNILLNSNLEAFVADFGTVR 272 (412)
Q Consensus 244 ~ivHrDlkp~NILl~~~~~~kl~DfGla~ 272 (412)
.++|+|+.|.||+++++..+-|+||+.+.
T Consensus 176 ~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 176 VVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp EEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred eEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 47999999999999987667899998765
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.05 E-value=0.00021 Score=57.75 Aligned_cols=58 Identities=21% Similarity=0.229 Sum_probs=39.8
Q ss_pred ceechhhccCCC-ceeeCCC-CCCCCCCCEEeCccccccccCCCCCcCC-C--CcccccCcCCC
Q 042435 2 IVLLAFLSISAA-CSGVVEE-EPSSPSFLKSDMSFNNLDGEIPTYLRDN-P--PKSFVGNKGLC 60 (412)
Q Consensus 2 ~~~~~~l~~~~~-~~G~ip~-~~~~~~l~~~~ls~N~l~G~iP~~~~~~-~--~~~~~gn~~lc 60 (412)
+..|+.|+|+.| +++..|. +.++++|+.||||+|+|+ .+|...|.. + .-...+|+--|
T Consensus 55 l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~-~l~~~~~~~~~l~~L~L~~Np~~C 117 (156)
T d2ifga3 55 LGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLHC 117 (156)
T ss_dssp CCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCS-CCCSTTTCSCCCCEEECCSSCCCC
T ss_pred ccccCcceeeccccCCcccccccccccccceeccCCCCc-ccChhhhccccccccccCCCcccC
Confidence 346788888888 7776666 677888888888888887 677655544 2 23344665544
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.84 E-value=0.00034 Score=61.61 Aligned_cols=57 Identities=21% Similarity=0.154 Sum_probs=45.1
Q ss_pred eechhhccCCC-ceeeCCC-CCCCCCCCEEeCccccccccCCCCCcCC---CCcccccCcCCC
Q 042435 3 VLLAFLSISAA-CSGVVEE-EPSSPSFLKSDMSFNNLDGEIPTYLRDN---PPKSFVGNKGLC 60 (412)
Q Consensus 3 ~~~~~l~~~~~-~~G~ip~-~~~~~~l~~~~ls~N~l~G~iP~~~~~~---~~~~~~gn~~lc 60 (412)
..|+.|+++.| +++..|. +..+++|+.||||+|+|+ .||.+++.. ..-...|||--|
T Consensus 148 ~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~C 209 (266)
T d1p9ag_ 148 PKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLC 209 (266)
T ss_dssp TTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCC
T ss_pred ccchhcccccccccccCccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCCCC
Confidence 35788999999 9987776 788999999999999999 899866544 334455777666
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=96.50 E-value=0.00098 Score=55.45 Aligned_cols=36 Identities=11% Similarity=0.154 Sum_probs=19.8
Q ss_pred echhhccCCC-ceeeCCC-CCCCCCCCEEeCccccccc
Q 042435 4 LLAFLSISAA-CSGVVEE-EPSSPSFLKSDMSFNNLDG 39 (412)
Q Consensus 4 ~~~~l~~~~~-~~G~ip~-~~~~~~l~~~~ls~N~l~G 39 (412)
.|+.|+|+.| +++.++. +..+++|+.|++|+|++++
T Consensus 55 ~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N~l~~ 92 (192)
T d1w8aa_ 55 HLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKE 92 (192)
T ss_dssp TCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCE
T ss_pred eEeeeeccccccccccccccccccccceeeeccccccc
Confidence 4555555555 5555544 4455555555555555553
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=96.47 E-value=0.0017 Score=60.43 Aligned_cols=30 Identities=20% Similarity=0.306 Sum_probs=25.6
Q ss_pred CCcEEeCCCCCCEEecCCCcEEEeecCCccc
Q 042435 243 PSIVHRDISSNNILLNSNLEAFVADFGTVRL 273 (412)
Q Consensus 243 ~~ivHrDlkp~NILl~~~~~~kl~DfGla~~ 273 (412)
..++|+|+.|.|||++++ .++|+||..+..
T Consensus 223 ~~LiHGDl~~gNIlv~~~-~~~vID~E~a~~ 252 (392)
T d2pula1 223 ETLIHGDLHTGSIFASEH-ETKVIDPEFAFY 252 (392)
T ss_dssp CEEECSCCCGGGEEECSS-CEEECCCTTCEE
T ss_pred cceeccCCcCCceeEcCC-ceEEechhhccc
Confidence 368999999999999876 489999988764
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=96.28 E-value=0.00089 Score=60.13 Aligned_cols=43 Identities=14% Similarity=0.064 Sum_probs=38.8
Q ss_pred eechhhccCCC-ceeeCCCCCCCCCCCEEeCccccccccCCCCC
Q 042435 3 VLLAFLSISAA-CSGVVEEEPSSPSFLKSDMSFNNLDGEIPTYL 45 (412)
Q Consensus 3 ~~~~~l~~~~~-~~G~ip~~~~~~~l~~~~ls~N~l~G~iP~~~ 45 (412)
..|+.|+++.| ++|.+|.+..+++|+.||+|+|+|+|.||..+
T Consensus 221 ~~l~~l~~~~~~l~~~~~~~~~~~~L~~L~Ls~N~l~g~iP~~l 264 (313)
T d1ogqa_ 221 KNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGL 264 (313)
T ss_dssp SCCSEEECCSSEECCBGGGCCCCTTCCEEECCSSCCEECCCGGG
T ss_pred ccccccccccccccccccccccccccccccCccCeecccCChHH
Confidence 45788999999 99999999899999999999999999999853
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=95.96 E-value=0.0013 Score=50.73 Aligned_cols=35 Identities=17% Similarity=0.131 Sum_probs=20.0
Q ss_pred echhhccCCC-ceeeCCC-CCCCCCCCEEeCccccccc
Q 042435 4 LLAFLSISAA-CSGVVEE-EPSSPSFLKSDMSFNNLDG 39 (412)
Q Consensus 4 ~~~~l~~~~~-~~G~ip~-~~~~~~l~~~~ls~N~l~G 39 (412)
.|++||||+| ++ .+|+ +..+++|+.||+|+|.+++
T Consensus 21 ~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~ 57 (124)
T d1dcea3 21 LVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN 57 (124)
T ss_dssp TCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC
T ss_pred CCCEEECCCCccC-cchhhhhhhhcccccccccccccc
Confidence 4556666666 54 3433 5556666666666666653
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=95.85 E-value=0.0018 Score=49.80 Aligned_cols=37 Identities=19% Similarity=0.200 Sum_probs=32.1
Q ss_pred hhhccCCC-ceeeCCCCCCCCCCCEEeCccccccccCCCC
Q 042435 6 AFLSISAA-CSGVVEEEPSSPSFLKSDMSFNNLDGEIPTY 44 (412)
Q Consensus 6 ~~l~~~~~-~~G~ip~~~~~~~l~~~~ls~N~l~G~iP~~ 44 (412)
++||||+| ++ .+|.+.+++.|+.||+|+|.++ .+|..
T Consensus 1 R~L~Ls~n~l~-~l~~l~~l~~L~~L~ls~N~l~-~lp~~ 38 (124)
T d1dcea3 1 RVLHLAHKDLT-VLCHLEQLLLVTHLDLSHNRLR-ALPPA 38 (124)
T ss_dssp SEEECTTSCCS-SCCCGGGGTTCCEEECCSSCCC-CCCGG
T ss_pred CEEEcCCCCCC-CCcccccCCCCCEEECCCCccC-cchhh
Confidence 47999999 87 6677889999999999999998 58863
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=95.59 E-value=0.0034 Score=51.97 Aligned_cols=40 Identities=18% Similarity=0.219 Sum_probs=31.4
Q ss_pred echhhccCCC-ceeeCCC--CCCCCCCCEEeCccccccccCCC
Q 042435 4 LLAFLSISAA-CSGVVEE--EPSSPSFLKSDMSFNNLDGEIPT 43 (412)
Q Consensus 4 ~~~~l~~~~~-~~G~ip~--~~~~~~l~~~~ls~N~l~G~iP~ 43 (412)
.+++|+|+.| +++.++. +.++++|+.|++++|++++..|.
T Consensus 30 ~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~ 72 (192)
T d1w8aa_ 30 HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPN 72 (192)
T ss_dssp TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTT
T ss_pred CCCEEEeCCCCCcccccccccCCCceEeeeecccccccccccc
Confidence 4778888888 8877744 56788888888888888877765
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.51 E-value=0.02 Score=50.98 Aligned_cols=31 Identities=16% Similarity=0.267 Sum_probs=27.0
Q ss_pred CCCcEEeCCCCCCEEecCCCcEEEeecCCcc
Q 042435 242 TPSIVHRDISSNNILLNSNLEAFVADFGTVR 272 (412)
Q Consensus 242 ~~~ivHrDlkp~NILl~~~~~~kl~DfGla~ 272 (412)
..+++|+|+.+.||+++++...-|.||+.+.
T Consensus 182 ~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 182 PAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp CEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred ccccccCCcchhhhhcccccceeEecccccc
Confidence 3479999999999999988777899999774
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=95.38 E-value=0.0037 Score=50.41 Aligned_cols=35 Identities=9% Similarity=-0.009 Sum_probs=22.6
Q ss_pred echhhccCCC-ceeeCCCCCCCCCCCEEeCccccccc
Q 042435 4 LLAFLSISAA-CSGVVEEEPSSPSFLKSDMSFNNLDG 39 (412)
Q Consensus 4 ~~~~l~~~~~-~~G~ip~~~~~~~l~~~~ls~N~l~G 39 (412)
.|++||||.| ++ .++.+..+++|+.|++|+|.++.
T Consensus 42 ~L~~L~Ls~N~i~-~l~~~~~l~~L~~L~ls~N~i~~ 77 (162)
T d1a9na_ 42 QFDAIDFSDNEIR-KLDGFPLLRRLKTLLVNNNRICR 77 (162)
T ss_dssp CCSEEECCSSCCC-EECCCCCCSSCCEEECCSSCCCE
T ss_pred cCCEEECCCCCCC-ccCCcccCcchhhhhcccccccC
Confidence 4666777777 54 34556666677777777777665
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=94.76 E-value=0.0064 Score=53.45 Aligned_cols=41 Identities=20% Similarity=0.059 Sum_probs=32.0
Q ss_pred echhhccCCC-ceeeCCC-CCCCCCCCEEeCccccccccCCCC
Q 042435 4 LLAFLSISAA-CSGVVEE-EPSSPSFLKSDMSFNNLDGEIPTY 44 (412)
Q Consensus 4 ~~~~l~~~~~-~~G~ip~-~~~~~~l~~~~ls~N~l~G~iP~~ 44 (412)
.|+.|+|+.| +++..|. +.++++|..+++++|++++-.|..
T Consensus 154 ~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~ 196 (284)
T d1ozna_ 154 NLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHA 196 (284)
T ss_dssp TCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTT
T ss_pred chhhcccccCcccccchhhhccccccchhhhhhccccccChhH
Confidence 4778888888 7776665 678888888888888888877753
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=94.72 E-value=0.03 Score=50.16 Aligned_cols=29 Identities=28% Similarity=0.391 Sum_probs=23.9
Q ss_pred CCCcEEeCCCCCCEEecCCCcEEEeecCCcc
Q 042435 242 TPSIVHRDISSNNILLNSNLEAFVADFGTVR 272 (412)
Q Consensus 242 ~~~ivHrDlkp~NILl~~~~~~kl~DfGla~ 272 (412)
..+++|+|+.+.|||++++ ..++||+-+.
T Consensus 191 p~~liHgDlh~~NvL~~~~--~~~IDFdd~~ 219 (325)
T d1zyla1 191 TVLRLHGDCHAGNILWRDG--PMFVDLDDAR 219 (325)
T ss_dssp CCEECCSSCSGGGEEESSS--EEECCCTTCC
T ss_pred CceeecCCCCcccEEEeCC--ceEEechhcc
Confidence 3478999999999999753 4689998775
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=94.39 E-value=0.0072 Score=52.63 Aligned_cols=39 Identities=8% Similarity=0.008 Sum_probs=32.1
Q ss_pred echhhccCCC-ceeeCCC-CCCCCCCCEEeCccccccccCCC
Q 042435 4 LLAFLSISAA-CSGVVEE-EPSSPSFLKSDMSFNNLDGEIPT 43 (412)
Q Consensus 4 ~~~~l~~~~~-~~G~ip~-~~~~~~l~~~~ls~N~l~G~iP~ 43 (412)
.|++|||+.| +++..+. +.++++|+.|+|++|+|+ .||.
T Consensus 32 ~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~-~l~~ 72 (266)
T d1p9ag_ 32 DTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQV 72 (266)
T ss_dssp TCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCC-EEEC
T ss_pred CCCEEECcCCcCCCcCHHHhhcccccccccccccccc-cccc
Confidence 4789999999 8876655 788999999999999997 4664
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=93.35 E-value=0.017 Score=49.10 Aligned_cols=45 Identities=13% Similarity=-0.034 Sum_probs=36.4
Q ss_pred echhhccCCC-ceeeCCC-CCCCCCCCEEeCccccccccCCCCCcCC
Q 042435 4 LLAFLSISAA-CSGVVEE-EPSSPSFLKSDMSFNNLDGEIPTYLRDN 48 (412)
Q Consensus 4 ~~~~l~~~~~-~~G~ip~-~~~~~~l~~~~ls~N~l~G~iP~~~~~~ 48 (412)
.+++|||+.| ++...+. +.++++|+.||+|+|.+...+|...|.+
T Consensus 30 ~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~ 76 (242)
T d1xwdc1 30 NAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSN 76 (242)
T ss_dssp CCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEES
T ss_pred CCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeecccccc
Confidence 5889999999 7754443 7899999999999999999888754443
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=93.01 E-value=0.0055 Score=51.07 Aligned_cols=39 Identities=10% Similarity=0.077 Sum_probs=28.9
Q ss_pred eechhhccCCC-ceeeCCCCCCCCCCCEEeCccccccccCCC
Q 042435 3 VLLAFLSISAA-CSGVVEEEPSSPSFLKSDMSFNNLDGEIPT 43 (412)
Q Consensus 3 ~~~~~l~~~~~-~~G~ip~~~~~~~l~~~~ls~N~l~G~iP~ 43 (412)
..|++|||+.| ++ .|+.+.++++|+.||+|+|.++ .||.
T Consensus 48 ~~L~~L~Ls~n~I~-~i~~l~~l~~L~~L~Ls~N~i~-~i~~ 87 (198)
T d1m9la_ 48 KACKHLALSTNNIE-KISSLSGMENLRILSLGRNLIK-KIEN 87 (198)
T ss_dssp TTCCEEECSEEEES-CCCCHHHHTTCCEEECCEEEEC-SCSS
T ss_pred cccceeECcccCCC-CcccccCCccccChhhcccccc-cccc
Confidence 45778888888 55 5666777888888888888876 4664
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=92.93 E-value=0.017 Score=48.21 Aligned_cols=34 Identities=15% Similarity=0.097 Sum_probs=18.1
Q ss_pred chhhccCCC-ceeeCCCCCCCCCCCEEeCccccccc
Q 042435 5 LAFLSISAA-CSGVVEEEPSSPSFLKSDMSFNNLDG 39 (412)
Q Consensus 5 ~~~l~~~~~-~~G~ip~~~~~~~l~~~~ls~N~l~G 39 (412)
|+.|+++.| ++. ++.+..+++|+.||+|+|++++
T Consensus 48 L~~L~l~~~~i~~-l~~l~~l~~L~~L~L~~n~i~~ 82 (210)
T d1h6ta2 48 IDQIIANNSDIKS-VQGIQYLPNVTKLFLNGNKLTD 82 (210)
T ss_dssp CCEEECTTSCCCC-CTTGGGCTTCCEEECCSSCCCC
T ss_pred ccEEECcCCCCCC-chhHhhCCCCCEEeCCCccccC
Confidence 455555555 332 3334555556666666666555
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=92.26 E-value=0.039 Score=48.56 Aligned_cols=33 Identities=15% Similarity=0.042 Sum_probs=15.5
Q ss_pred chhhccCCC-ceeeCCC-CCCCCCCCEEeCcccccc
Q 042435 5 LAFLSISAA-CSGVVEE-EPSSPSFLKSDMSFNNLD 38 (412)
Q Consensus 5 ~~~l~~~~~-~~G~ip~-~~~~~~l~~~~ls~N~l~ 38 (412)
|++|+|+.| ++ .||+ +.++++|+.|+||+|+++
T Consensus 221 L~~L~L~~N~L~-~lp~~l~~l~~L~~L~Ls~N~i~ 255 (305)
T d1xkua_ 221 LRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNIS 255 (305)
T ss_dssp CCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCC
T ss_pred ceeeeccccccc-ccccccccccCCCEEECCCCccC
Confidence 444555555 43 2332 444555555555555544
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=92.17 E-value=0.044 Score=47.75 Aligned_cols=40 Identities=8% Similarity=0.039 Sum_probs=30.8
Q ss_pred echhhccCCC-ceeeCCC-CCCCCCCCEEeCccccccccCCC
Q 042435 4 LLAFLSISAA-CSGVVEE-EPSSPSFLKSDMSFNNLDGEIPT 43 (412)
Q Consensus 4 ~~~~l~~~~~-~~G~ip~-~~~~~~l~~~~ls~N~l~G~iP~ 43 (412)
.|+.|+++.| +++..+. +.+++.|+.|++++|+|++-.|.
T Consensus 130 ~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~ 171 (284)
T d1ozna_ 130 ALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPER 171 (284)
T ss_dssp TCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTT
T ss_pred ccchhhhccccccccChhHhccccchhhcccccCcccccchh
Confidence 4678888888 8765555 67888899999999998875553
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=91.79 E-value=0.026 Score=51.17 Aligned_cols=36 Identities=11% Similarity=0.086 Sum_probs=21.2
Q ss_pred eechhhccCCC-ceeeCCCCCCCCCCCEEeCccccccc
Q 042435 3 VLLAFLSISAA-CSGVVEEEPSSPSFLKSDMSFNNLDG 39 (412)
Q Consensus 3 ~~~~~l~~~~~-~~G~ip~~~~~~~l~~~~ls~N~l~G 39 (412)
..|++|||+.| +++ +|++.++++|+.|++++|.+++
T Consensus 66 ~nL~~L~Ls~N~l~~-l~~l~~L~~L~~L~L~~n~i~~ 102 (384)
T d2omza2 66 NNLTQINFSNNQLTD-ITPLKNLTKLVDILMNNNQIAD 102 (384)
T ss_dssp TTCCEEECCSSCCCC-CGGGTTCTTCCEEECCSSCCCC
T ss_pred CCCCEEeCcCCcCCC-CccccCCccccccccccccccc
Confidence 34566666666 554 3345566666666666666654
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=91.65 E-value=0.069 Score=42.14 Aligned_cols=41 Identities=12% Similarity=-0.070 Sum_probs=31.8
Q ss_pred eechhhccCCC--ceeeCCC-CCCCCCCCEEeCccccccccCCC
Q 042435 3 VLLAFLSISAA--CSGVVEE-EPSSPSFLKSDMSFNNLDGEIPT 43 (412)
Q Consensus 3 ~~~~~l~~~~~--~~G~ip~-~~~~~~l~~~~ls~N~l~G~iP~ 43 (412)
..|+.|+|+.| ++..-+. +.++++|+.|++|+|+|+.--|.
T Consensus 31 ~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~ 74 (156)
T d2ifga3 31 ENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPD 74 (156)
T ss_dssp SCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTT
T ss_pred cccCeeecCCCccccccCchhhccccccCcceeeccccCCcccc
Confidence 46788999766 6654444 88999999999999999875453
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=91.08 E-value=0.29 Score=44.62 Aligned_cols=27 Identities=19% Similarity=0.193 Sum_probs=19.7
Q ss_pred eeeeecCceEEEEEEeCCC--------cEEEEEec
Q 042435 149 YCIGTGGYDSVYKAELPDG--------KVVALKKL 175 (412)
Q Consensus 149 ~~lG~G~~g~Vy~~~~~~~--------~~vAvK~l 175 (412)
+.|+.|-.-.+|++..+++ +.|.++..
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~ 82 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVY 82 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEE
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEec
Confidence 5688899999999987543 45666654
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=90.86 E-value=0.033 Score=44.46 Aligned_cols=38 Identities=16% Similarity=0.157 Sum_probs=31.9
Q ss_pred ceechhhccCCC-ceeeCCC-CCCCCCCCEEeCccccccc
Q 042435 2 IVLLAFLSISAA-CSGVVEE-EPSSPSFLKSDMSFNNLDG 39 (412)
Q Consensus 2 ~~~~~~l~~~~~-~~G~ip~-~~~~~~l~~~~ls~N~l~G 39 (412)
+..|++|+|+.| ++...|. +.++++|+.|++++|+++.
T Consensus 62 l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~L~L~~N~i~~ 101 (162)
T d1a9na_ 62 LRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVE 101 (162)
T ss_dssp CSSCCEEECCSSCCCEECSCHHHHCTTCCEEECCSCCCCC
T ss_pred CcchhhhhcccccccCCCccccccccccccceeccccccc
Confidence 457899999999 8776666 4679999999999999974
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=90.75 E-value=0.061 Score=47.68 Aligned_cols=36 Identities=25% Similarity=0.243 Sum_probs=30.1
Q ss_pred echhhccCCC-ceeeCCCCCCCCCCCEEeCccccccccCCC
Q 042435 4 LLAFLSISAA-CSGVVEEEPSSPSFLKSDMSFNNLDGEIPT 43 (412)
Q Consensus 4 ~~~~l~~~~~-~~G~ip~~~~~~~l~~~~ls~N~l~G~iP~ 43 (412)
.|+.||||.+ ++ .+|++ +++|+.||+|+|+|+ ++|.
T Consensus 39 ~l~~LdLs~~~L~-~lp~~--~~~L~~L~Ls~N~l~-~lp~ 75 (353)
T d1jl5a_ 39 QAHELELNNLGLS-SLPEL--PPHLESLVASCNSLT-ELPE 75 (353)
T ss_dssp TCSEEECTTSCCS-CCCSC--CTTCSEEECCSSCCS-SCCC
T ss_pred CCCEEEeCCCCCC-CCCCC--CCCCCEEECCCCCCc-cccc
Confidence 3789999999 76 57874 568999999999998 8886
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=90.54 E-value=0.014 Score=46.67 Aligned_cols=37 Identities=19% Similarity=0.173 Sum_probs=28.0
Q ss_pred eechhhccCCC-ceee--CCC-CCCCCCCCEEeCccccccc
Q 042435 3 VLLAFLSISAA-CSGV--VEE-EPSSPSFLKSDMSFNNLDG 39 (412)
Q Consensus 3 ~~~~~l~~~~~-~~G~--ip~-~~~~~~l~~~~ls~N~l~G 39 (412)
..|++||||.| ++.. ++. +..+++|+.||+|+|.++-
T Consensus 65 ~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~ 105 (162)
T d1koha1 65 PELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKS 105 (162)
T ss_dssp TTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCC
T ss_pred CCCCEeeCCCccccCCchhHHHHhhCCcccccccccCcccc
Confidence 36889999999 6542 223 4568899999999999875
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=89.25 E-value=0.11 Score=45.39 Aligned_cols=40 Identities=10% Similarity=0.040 Sum_probs=33.4
Q ss_pred echhhccCCC-ceeeCCC-CCCCCCCCEEeCccccccccCCC
Q 042435 4 LLAFLSISAA-CSGVVEE-EPSSPSFLKSDMSFNNLDGEIPT 43 (412)
Q Consensus 4 ~~~~l~~~~~-~~G~ip~-~~~~~~l~~~~ls~N~l~G~iP~ 43 (412)
.|++|||++| ++.-.+. +.+++.|+.+|+++|.++.-.|.
T Consensus 32 ~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~ 73 (305)
T d1xkua_ 32 DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPG 73 (305)
T ss_dssp TCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTT
T ss_pred CCCEEECcCCcCCCcChhHhhccccccccccccccccccchh
Confidence 4789999999 7766554 78999999999999999976564
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=88.82 E-value=0.074 Score=43.62 Aligned_cols=38 Identities=13% Similarity=0.121 Sum_probs=29.2
Q ss_pred echhhccCCC-ceeeCCCCCCCCCCCEEeCccccccccCC
Q 042435 4 LLAFLSISAA-CSGVVEEEPSSPSFLKSDMSFNNLDGEIP 42 (412)
Q Consensus 4 ~~~~l~~~~~-~~G~ip~~~~~~~l~~~~ls~N~l~G~iP 42 (412)
.|++|++++| ++ .++.+..+++|+.||+|+|++++.-|
T Consensus 41 ~l~~L~l~~~~i~-~l~~l~~l~nL~~L~Ls~N~l~~~~~ 79 (199)
T d2omxa2 41 QVTTLQADRLGIK-SIDGVEYLNNLTQINFSNNQLTDITP 79 (199)
T ss_dssp TCCEEECTTSCCC-CCTTGGGCTTCCEEECCSSCCCCCGG
T ss_pred CCCEEECCCCCCC-CccccccCCCcCcCccccccccCccc
Confidence 4678888888 44 46667788899999999999987433
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=88.17 E-value=0.086 Score=43.18 Aligned_cols=36 Identities=11% Similarity=0.086 Sum_probs=30.7
Q ss_pred eechhhccCCC-ceeeCCCCCCCCCCCEEeCccccccc
Q 042435 3 VLLAFLSISAA-CSGVVEEEPSSPSFLKSDMSFNNLDG 39 (412)
Q Consensus 3 ~~~~~l~~~~~-~~G~ip~~~~~~~l~~~~ls~N~l~G 39 (412)
..|++|||+.| +++. +++.++++|+.|++++|.+..
T Consensus 62 ~nL~~L~Ls~N~l~~~-~~l~~l~~L~~L~l~~n~~~~ 98 (199)
T d2omxa2 62 NNLTQINFSNNQLTDI-TPLKNLTKLVDILMNNNQIAD 98 (199)
T ss_dssp TTCCEEECCSSCCCCC-GGGTTCTTCCEEECCSSCCCC
T ss_pred CCcCcCccccccccCc-ccccCCccccccccccccccc
Confidence 46899999999 8874 448899999999999998865
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=88.12 E-value=0.13 Score=45.43 Aligned_cols=36 Identities=28% Similarity=0.342 Sum_probs=28.1
Q ss_pred echhhccCCC-ceeeCCCCCCCCCCCEEeCccccccccCCC
Q 042435 4 LLAFLSISAA-CSGVVEEEPSSPSFLKSDMSFNNLDGEIPT 43 (412)
Q Consensus 4 ~~~~l~~~~~-~~G~ip~~~~~~~l~~~~ls~N~l~G~iP~ 43 (412)
.|++|+|+.| ++ .||+ .+++|+.|++++|+|+ .||.
T Consensus 285 ~L~~L~Ls~N~l~-~lp~--~~~~L~~L~L~~N~L~-~l~~ 321 (353)
T d1jl5a_ 285 SLEELNVSNNKLI-ELPA--LPPRLERLIASFNHLA-EVPE 321 (353)
T ss_dssp TCCEEECCSSCCS-CCCC--CCTTCCEEECCSSCCS-CCCC
T ss_pred CCCEEECCCCccC-cccc--ccCCCCEEECCCCcCC-cccc
Confidence 5888999888 66 5665 3578888999999987 6885
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=87.92 E-value=0.18 Score=42.21 Aligned_cols=39 Identities=13% Similarity=0.114 Sum_probs=27.2
Q ss_pred hccCCC-ceeeCCC--CCCCCCCCEEeCccccccccCCCCCcCC
Q 042435 8 LSISAA-CSGVVEE--EPSSPSFLKSDMSFNNLDGEIPTYLRDN 48 (412)
Q Consensus 8 l~~~~~-~~G~ip~--~~~~~~l~~~~ls~N~l~G~iP~~~~~~ 48 (412)
++++.| ++ .||. +.++++|+.||+|+|+++ .+|...|.+
T Consensus 182 ~~l~~n~l~-~l~~~~f~~l~~L~~L~Ls~N~l~-~l~~~~~~~ 223 (242)
T d1xwdc1 182 NLSDNNNLE-ELPNDVFHGASGPVILDISRTRIH-SLPSYGLEN 223 (242)
T ss_dssp ECTTCTTCC-CCCTTTTTTSCCCSEEECTTSCCC-CCCSSSCTT
T ss_pred ccccccccc-cccHHHhcCCCCCCEEECCCCcCC-ccCHHHHcC
Confidence 345555 54 4644 678889999999999988 677654544
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=86.56 E-value=0.094 Score=47.18 Aligned_cols=37 Identities=14% Similarity=0.181 Sum_probs=27.2
Q ss_pred echhhccCCC-ceeeCCCCCCCCCCCEEeCccccccccCC
Q 042435 4 LLAFLSISAA-CSGVVEEEPSSPSFLKSDMSFNNLDGEIP 42 (412)
Q Consensus 4 ~~~~l~~~~~-~~G~ip~~~~~~~l~~~~ls~N~l~G~iP 42 (412)
.|++|||+.| +++. +++.++++|+.|++++|++++ +|
T Consensus 308 ~l~~L~ls~n~l~~l-~~l~~l~~L~~L~L~~n~l~~-l~ 345 (384)
T d2omza2 308 NLTYLTLYFNNISDI-SPVSSLTKLQRLFFANNKVSD-VS 345 (384)
T ss_dssp TCSEEECCSSCCSCC-GGGGGCTTCCEEECCSSCCCC-CG
T ss_pred ccCeEECCCCCCCCC-cccccCCCCCEEECCCCCCCC-Ch
Confidence 4677888888 7764 346777888888888888875 44
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=85.84 E-value=0.18 Score=41.99 Aligned_cols=38 Identities=13% Similarity=0.141 Sum_probs=32.2
Q ss_pred echhhccCCC-ceeeCCCCCCCCCCCEEeCccccccccCC
Q 042435 4 LLAFLSISAA-CSGVVEEEPSSPSFLKSDMSFNNLDGEIP 42 (412)
Q Consensus 4 ~~~~l~~~~~-~~G~ip~~~~~~~l~~~~ls~N~l~G~iP 42 (412)
.|+.|+++.| ++ .++.+..+++|+.|++|+|++++..|
T Consensus 42 ~L~~L~l~~~~i~-~l~~l~~l~~L~~L~ls~n~i~~~~~ 80 (227)
T d1h6ua2 42 GITTLSAFGTGVT-TIEGVQYLNNLIGLELKDNQITDLAP 80 (227)
T ss_dssp TCCEEECTTSCCC-CCTTGGGCTTCCEEECCSSCCCCCGG
T ss_pred CcCEEECCCCCCC-cchhHhcCCCCcEeecCCceeecccc
Confidence 5788999999 76 46778899999999999999988655
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=82.15 E-value=0.26 Score=40.86 Aligned_cols=38 Identities=21% Similarity=0.229 Sum_probs=30.0
Q ss_pred echhhccCCC-ceeeCCCCCCCCCCCEEeCccccccccCCC
Q 042435 4 LLAFLSISAA-CSGVVEEEPSSPSFLKSDMSFNNLDGEIPT 43 (412)
Q Consensus 4 ~~~~l~~~~~-~~G~ip~~~~~~~l~~~~ls~N~l~G~iP~ 43 (412)
.|+.|+++.| +++ ++++.++++|+.||+|+|.+++ +|.
T Consensus 152 ~L~~L~l~~n~~~~-~~~l~~l~~L~~L~Ls~n~l~~-l~~ 190 (227)
T d1h6ua2 152 NLQYLSIGNAQVSD-LTPLANLSKLTTLKADDNKISD-ISP 190 (227)
T ss_dssp TCCEEECCSSCCCC-CGGGTTCTTCCEEECCSSCCCC-CGG
T ss_pred cccccccccccccc-chhhcccccceecccCCCccCC-Chh
Confidence 4788999988 543 4458889999999999999986 553
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=80.65 E-value=0.049 Score=44.93 Aligned_cols=35 Identities=20% Similarity=0.032 Sum_probs=26.8
Q ss_pred echhhccCCC-ceeeCCCCCCCCCCCEEeCccccccc
Q 042435 4 LLAFLSISAA-CSGVVEEEPSSPSFLKSDMSFNNLDG 39 (412)
Q Consensus 4 ~~~~l~~~~~-~~G~ip~~~~~~~l~~~~ls~N~l~G 39 (412)
.|++|+++.| ++. ++.+.++++|+.||+|+|+++.
T Consensus 94 ~L~~L~l~~N~i~~-l~~~~~l~~L~~L~L~~N~i~~ 129 (198)
T d1m9la_ 94 TLEELWISYNQIAS-LSGIEKLVNLRVLYMSNNKITN 129 (198)
T ss_dssp HCCEEECSEEECCC-HHHHHHHHHSSEEEESEEECCC
T ss_pred cccccccccccccc-cccccccccccccccccchhcc
Confidence 4778888888 653 4556678888888888888864
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=80.29 E-value=0.41 Score=39.22 Aligned_cols=40 Identities=5% Similarity=0.013 Sum_probs=33.4
Q ss_pred ceechhhccCCC-ceeeCCCCCCCCCCCEEeCccccccccCCC
Q 042435 2 IVLLAFLSISAA-CSGVVEEEPSSPSFLKSDMSFNNLDGEIPT 43 (412)
Q Consensus 2 ~~~~~~l~~~~~-~~G~ip~~~~~~~l~~~~ls~N~l~G~iP~ 43 (412)
+..|++|+|+.| +++ +|++.++++|+.|++++|++++ +|.
T Consensus 67 l~~L~~L~L~~n~i~~-l~~~~~l~~L~~L~l~~n~i~~-l~~ 107 (210)
T d1h6ta2 67 LPNVTKLFLNGNKLTD-IKPLANLKNLGWLFLDENKVKD-LSS 107 (210)
T ss_dssp CTTCCEEECCSSCCCC-CGGGTTCTTCCEEECCSSCCCC-GGG
T ss_pred CCCCCEEeCCCccccC-ccccccCccccccccccccccc-ccc
Confidence 346899999999 887 5567889999999999999986 554
|